Citrus Sinensis ID: 036792

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450---
Protein Sequence
DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK
Secondary Structure (PSIPRED)
cccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEccccccccccccccccccccccccccHHHHHHcccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEccccccHHHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccEEEccccEEEEcccccccccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEcccccccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHccEEcccccEEEEEEEEEEEcccccccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccEEEEcHHHcccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
dilnfdfssnslegplsldignLKAVVEINLsrnnlssdmpatigGLISLKTLSLAYNKLDVASLEILNlsnneiygliPTSLEKLLYLKELSLSFNKLEgeilrggpfvnftamsfkgneplcgspnlqvppcklnkpgkhqksrknmLPLVIVLPLSTALIIVVIILALKYKLtkcgkrgldvsndgilpsqATLRRLSNligmgsfgSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEympkgslenclysstCMLDIFQRLNIMIDATSTLEYlyfghttpiihcdlkpisvlLDEDMVahlsdfeygmegqvstrsdIYGYGIVLMETftrkkptdrmFVEELSLKDWVNNLLPISLMEVVDKTLLSgekkgfvaKEQCVLSILGLAMECAMelpekrinAKDIVTRLLKIRDTLSK
Flexible Loop (DISEMBL)
dilnfdfssnslegplsldiGNLKAVVEINLSrnnlssdmpaTIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCGKRgldvsndgilpsQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMElpekrinakdivTRLLkirdtlsk
Low Complexity Region (SEG)
DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTslekllylkelslsFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTaliivviilalKYKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK
Disordered region (IsUnstruct)
***************LSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLC************************MLPLVIVLPLSTALIIVVIILALKYKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI******
Disordered Region (DISOPRED)
DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPN**********************PLVIVLPLSTALIIVVIILALK******************LPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT*S*
Disordered Region (DISEMBL)
DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK
Disordered Region (DISPRO)
DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPP***********SRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	453	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.988	0.443	0.332	8e-69
C0LGT6	1031	LRR receptor-like serine/	no	no	0.944	0.415	0.341	6e-63
Q9SD62	1025	Putative receptor-like pr	no	no	0.991	0.438	0.332	4e-62
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.960	0.443	0.293	2e-53
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.964	0.349	0.291	4e-48
Q9FL28	1173	LRR receptor-like serine/	no	no	0.918	0.354	0.279	1e-47
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.913	0.405	0.291	9e-47
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.969	0.351	0.289	4e-46
Q9FN37	1036	Phytosulfokine receptor 2	no	no	0.898	0.392	0.278	2e-43
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.953	0.362	0.281	7e-42

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  261 bits (667), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 175/527 (33%), Positives = 273/527 (51%), Gaps = 79/527 (14%)

Query: 1    DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
             +L  D S NSL G L  DIG L+ +  ++L  N LS  +P T+G  +++++L L  N  
Sbjct: 482  QLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLF 541

Query: 61   --DVASLEIL------NLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNF 112
              D+  L+ L      +LSNN++ G IP        L+ L+LSFN LEG++   G F N 
Sbjct: 542  YGDIPDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENA 601

Query: 113  TAMSFKGNEPLCGS-PNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILAL 171
            T +S  GN  LCG     Q+ PC    P   +K    +  +VI + +   L++++ + ++
Sbjct: 602  TTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASV 661

Query: 172  KYKLTKCGKRGLDVSNDGILPSQATLRRL------------------SNLIGMGSFGSVY 213
                 +  K+  + +N    P+ +TL  L                  SN++G GSFG+VY
Sbjct: 662  TLIWLRKRKKNKETNN----PTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVY 717

Query: 214  RARL-RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN-----DDFK 267
            +A L  +   VAVKV + +   A+KSF A+CE +K IRH NLVK++++CS+     ++F+
Sbjct: 718  KALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFR 777

Query: 268  ALVLEYMPKGSLENCLYSSTC--------MLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
            AL+ E+MP GSL+  L+             L + +RLNI ID  S L+YL+     PI H
Sbjct: 778  ALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAH 837

Query: 320  CDLKPISVLLDEDMVAHLSDF--------------------------------EYGMEGQ 347
            CDLKP +VLLD+D+ AH+SDF                                EYG+ GQ
Sbjct: 838  CDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQ 897

Query: 348  VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS-GEK 406
             S   D+Y +GI+L+E FT K+PT+ +F    +L  +  + LP  ++++VD+++L  G +
Sbjct: 898  PSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLR 957

Query: 407  KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK 453
             GF   E C+  +  + + C  E P  R+    +V  L+ IR+   K
Sbjct: 958  VGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  241 bits (616), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 177/518 (34%), Positives = 258/518 (49%), Gaps = 90/518 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVA-- 63
           D S+N L G    ++G L+ +V +  S N LS  MP  IGG +S++ L +  N  D A  
Sbjct: 495 DLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP 554

Query: 64  ------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSF 117
                 SL+ ++ SNN + G IP  L  L  L+ L+LS NK EG +   G F N TA+S 
Sbjct: 555 DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSV 614

Query: 118 KGNEPLCGS-PNLQVPPCKLNKPGKHQKS---RKNMLPLVIVLPLSTALIIVVIILA--L 171
            GN  +CG    +Q+ PC +    + +K    RK ++  + +   S  LII+V  L   +
Sbjct: 615 FGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFM 674

Query: 172 KYKLTKCGKRG--LDVSNDGILPSQATLRRL---------SNLIGMGSFGSVYRARLRDG 220
           K K       G   D +  G+   + +   L         +NLIG G+FG+V++  L  G
Sbjct: 675 KRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLL--G 732

Query: 221 IE---VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN-----DDFKALVLE 272
            E   VAVKV +     A KSF A+CE  K IRH NLVK+I+ CS+     +DF+ALV E
Sbjct: 733 PENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYE 792

Query: 273 YMPKGSLENCLY--------SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKP 324
           +MPKGSL+  L           +  L   ++LNI ID  S LEYL+     P+ HCD+KP
Sbjct: 793 FMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKP 852

Query: 325 ISVLLDEDMVAHLSDF--------------------------------EYGMEGQVSTRS 352
            ++LLD+D+ AH+SDF                                EYGM GQ S + 
Sbjct: 853 SNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQG 912

Query: 353 DIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG--EKKGFV 410
           D+Y +GI+L+E F+ KKPTD  F  + +L  +              K++LSG     G  
Sbjct: 913 DVYSFGILLLEMFSGKKPTDESFAGDYNLHSYT-------------KSILSGCTSSGGSN 959

Query: 411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR 448
           A ++ +  +L + ++C+ E P  R+   + V  L+ IR
Sbjct: 960 AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  239 bits (609), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 174/524 (33%), Positives = 268/524 (51%), Gaps = 75/524 (14%)

Query: 2    ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
            +LN  F  N L GPL  DIG LK ++ +++S N LS  +P T+   +SL+ L L  N   
Sbjct: 501  VLNVSF--NLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFV 558

Query: 61   -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                    +  L  L+LS N + G IP  +     L+ L+LS N  +G +   G F N +
Sbjct: 559  GPIPDIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTS 618

Query: 114  AMSFKGNEPLCGS-PNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALK 172
            AMS  GN  LCG  P+LQ+ PC +  P +H   RK +   V  +  +  L+ + ++    
Sbjct: 619  AMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCW 678

Query: 173  YKLTKCGKRGLDVSND-GILPSQATLRRLS--------------NLIGMGSFGSVYRARL 217
            YKL     R  +  ND    P ++   ++S              NLIG G+FG+V++  L
Sbjct: 679  YKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFL 738

Query: 218  -RDGIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSN-----DDFKALV 270
                  VA+KV +  C R A KSF A+CE +  IRH NLVK+++ CS+     +DF+ALV
Sbjct: 739  GSKNKAVAIKVLNL-CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALV 797

Query: 271  LEYMPKGSLENCLY--------SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             E+MP G+L+  L+        + +  L +F RLNI ID  S L YL+     PI HCD+
Sbjct: 798  YEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDI 857

Query: 323  KPISVLLDEDMVAHLSDF--------------------------------EYGMEGQVST 350
            KP ++LLD+D+ AH+SDF                                EYGM G  S 
Sbjct: 858  KPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSI 917

Query: 351  RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI-SLMEVVDKTLLSGEKKGF 409
              D+Y +GIVL+E FT K+PT+++FV+ L+L  +  + L     +++ D+T+L G     
Sbjct: 918  MGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQH 977

Query: 410  VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK 453
                +C+  +  + + C+ E P  RI+  + +++L+ IR++  +
Sbjct: 978  FNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFR 1021

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  210 bits (535), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 155/529 (29%), Positives = 254/529 (48%), Gaps = 94/529 (17%)

Query: 3   LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-- 60
           L  + SSN L GP+ L++  +  V+ ++LS N LS  +P  +G  I+L+ L+L+ N    
Sbjct: 446 LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSS 505

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                   +  L+ L++S N + G IP S ++   LK L+ SFN L G +   G F   T
Sbjct: 506 TLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLT 565

Query: 114 AMSFKGNEPLCGS-PNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALK 172
             SF G+  LCGS   +Q   CK  K  K+      +L  +I  P         ++    
Sbjct: 566 IESFLGDSLLCGSIKGMQA--CK--KKHKYPSVLLPVLLSLIATP---------VLCVFG 612

Query: 173 YKLTKCGKRGLDVS---------------NDGILPSQATLRRL---------SNLIGMGS 208
           Y L +  + G +++               ND   P + + ++L         S+LIG G 
Sbjct: 613 YPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYP-RISYQQLIAATGGFNASSLIGSGR 671

Query: 209 FGSVYRARLRDGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVKVISSCSNDDFK 267
           FG VY+  LR+  +VAVKV   + A     SF+ +C+++K  RH NL+++I++CS   F 
Sbjct: 672 FGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFN 731

Query: 268 ALVLEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKP 324
           ALVL  MP GSLE  LY    S+  LD+ Q +NI  D    + YL+      ++HCDLKP
Sbjct: 732 ALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKP 791

Query: 325 ISVLLDEDMVAHLSDF-------------------------------------EYGMEGQ 347
            ++LLD++M A ++DF                                     EYGM  +
Sbjct: 792 SNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKR 851

Query: 348 VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
            ST  D+Y +G++L+E  + ++PTD +  E  SL +++ +  P SL  ++++ L   + +
Sbjct: 852 ASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQ 911

Query: 408 GFVAK-----EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
           G   K      + +L ++ L + C    P  R +  D+   + ++++ L
Sbjct: 912 GKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  192 bits (489), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 160/549 (29%), Positives = 256/549 (46%), Gaps = 112/549 (20%)

Query: 1    DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            +IL      NSL G +  +IGNL+A+  +NL  N LS  +P+TIG L  L  L L+ N L
Sbjct: 697  NILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNAL 756

Query: 61   ------------DVAS----------------------LEILNLSNNEIYGLIPTSLEKL 86
                        D+ S                      LE L+LS+N++ G +P  +  +
Sbjct: 757  TGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDM 816

Query: 87   LYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSR 146
              L  L+LS+N LEG++ +   F  + A +F GN  LCGSP   +  C  N+ G   K++
Sbjct: 817  KSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSP---LSHC--NRAGS--KNQ 867

Query: 147  KNMLP--LVIVLPLST----ALIIVVIILALKYK------------------------LT 176
            +++ P  +VI+  +S+    AL+++VIIL  K                          L 
Sbjct: 868  RSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLF 927

Query: 177  KCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAV-KVFHQECARA 235
              G    D+  D I+ +   L     +IG G  G VY+A L++G  +AV K+  ++   +
Sbjct: 928  SNGGAKSDIKWDDIMEATHYLNE-EFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMS 986

Query: 236  LKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVLEYMPKGSLENCLYSSTC----- 288
             KSF  + + + +IRH +LVK++  CS+  D    L+ EYM  GS+ + L+++       
Sbjct: 987  NKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKE 1046

Query: 289  MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------- 340
            +L    RL I +     +EYL++    PI+H D+K  +VLLD ++ AHL DF        
Sbjct: 1047 VLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTG 1106

Query: 341  ---------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEEL 379
                                 EY    + + +SD+Y  GIVLME  T K PT+ MF EE 
Sbjct: 1107 NYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEET 1166

Query: 380  SLKDWVNNLLPISLMEVVDKTLLSGEKKGFV-AKEQCVLSILGLAMECAMELPEKRINAK 438
             +  WV  +L         + L+  E K  +  +E+    +L +A++C    P++R +++
Sbjct: 1167 DMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSR 1226

Query: 439  DIVTRLLKI 447
                 LL +
Sbjct: 1227 QASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  191 bits (484), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 144/516 (27%), Positives = 254/516 (49%), Gaps = 100/516 (19%)

Query: 1    DILNFDFSSNSLEGPLSLDI-GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK 59
            ++   DFS N+L G +  ++   +  ++ +NLSRN+ S ++P + G +  L +L      
Sbjct: 674  NVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSL------ 727

Query: 60   LDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKG 119
                     +LS+N + G IP SL  L  LK L L+ N L+G +   G F N  A    G
Sbjct: 728  ---------DLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMG 778

Query: 120  NEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCG 179
            N  LCGS    + PC + +   H   R  ++ +++      +   ++++L L   LT C 
Sbjct: 779  NTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIIL-----GSAAALLLVLLLVLILTCCK 832

Query: 180  KRGLDVSN--DGILP---SQATLRRL--------------SNLIGMGSFGSVYRARLRDG 220
            K+   + N  +  LP   S   L+R               +N+IG  S  +VY+ +L DG
Sbjct: 833  KKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDG 892

Query: 221  IEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVIS-SCSNDDFKALVLEYMPKG 277
              +AVKV +  +  A + K F  + + +  ++H NLVK++  +  +   KALVL +M  G
Sbjct: 893  TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENG 952

Query: 278  SLENCLYSSTCML-DIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH 336
            +LE+ ++ S   +  + +++++ +   S ++YL+ G+  PI+HCDLKP ++LLD D VAH
Sbjct: 953  NLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAH 1012

Query: 337  LSDF------------------------------EYGMEGQVSTRSDIYGYGIVLMETFT 366
            +SDF                              E+    +V+T++D++ +GI++ME  T
Sbjct: 1013 VSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMT 1072

Query: 367  RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV--------------AK 412
            +++PT        SL D   +   ++L ++V+K++ +G +KG V               +
Sbjct: 1073 KQRPT--------SLND--EDSQDMTLRQLVEKSIGNG-RKGMVRVLDMELGDSIVSLKQ 1121

Query: 413  EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR 448
            E+ +   L L + C    PE R +  +I+T L+K+R
Sbjct: 1122 EEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  188 bits (477), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 148/507 (29%), Positives = 233/507 (45%), Gaps = 93/507 (18%)

Query: 6    DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASL 65
            D S NSL G +  + G+L+ +  +NL  NNLS ++PA + G+                SL
Sbjct: 539  DLSYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGM---------------TSL 583

Query: 66   EILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCG 125
            E+L+LS+N + G IP SL KL +L   S+++NKL G I  G  F  F   SF+GN+ LCG
Sbjct: 584  EVLDLSHNNLSGNIPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCG 643

Query: 126  SPNLQVPPCKLNKPGKHQ---KSRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCGKRG 182
                   PC +     H    KS+KN+  +V V  + T L  V ++      + +   RG
Sbjct: 644  E---HASPCHITDQSPHGSAVKSKKNIRKIVAV-AVGTGLGTVFLLTVTLLIILRTTSRG 699

Query: 183  L-----------------------------DVSNDGILPSQATLRRLSNLIGMGSFGSVY 213
                                          ++S D IL S ++  + +N+IG G FG VY
Sbjct: 700  EVDPEKKADADEIELGSRSVVLFHNKDSNNELSLDDILKSTSSFNQ-ANIIGCGGFGLVY 758

Query: 214  RARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY 273
            +A L DG +VA+K    +  +  + F+A+ E +   +HPNLV ++  C+  + K L+  Y
Sbjct: 759  KATLPDGTKVAIKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSY 818

Query: 274  MPKGSLENCLYSST---CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD 330
            M  GSL+  L+        LD   RL I   A   L YL+      I+H D+K  ++LL 
Sbjct: 819  MDNGSLDYWLHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLS 878

Query: 331  EDMVAHLSDF--------------------------EYGMEGQVSTRSDIYGYGIVLMET 364
            +  VAHL+DF                          EYG     + + D+Y +G+VL+E 
Sbjct: 879  DTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLEL 938

Query: 365  FTRKKPTDRMFVEELSLKDWVNNLLPISL----MEVVDKTLLSGEKKGFVAKEQCVLSIL 420
             T ++P D    +    +D ++ +L +       E+ D  +   +     A+E  +L +L
Sbjct: 939  LTGRRPMD--VCKPRGSRDLISWVLQMKTEKRESEIFDPFIYDKDH----AEE--MLLVL 990

Query: 421  GLAMECAMELPEKRINAKDIVTRLLKI 447
             +A  C  E P+ R   + +V+ L  I
Sbjct: 991  EIACRCLGENPKTRPTTQQLVSWLENI 1017

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  186 bits (471), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 153/529 (28%), Positives = 248/529 (46%), Gaps = 90/529 (17%)

Query: 1    DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKT-LSLAYNK 59
            ++LN D   N   G L   +G L  + E+ LSRN+L+ ++P  IG L  L++ L L+YN 
Sbjct: 722  NVLNLD--KNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNN 779

Query: 60   L--DVAS-------LEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFV 110
               D+ S       LE L+LS+N++ G +P S+  +  L  L++SFN L G++ +   F 
Sbjct: 780  FTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFS 837

Query: 111  NFTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLS--TALIIVVII 168
             + A SF GN  LCGSP  +    + N   +   +R     +VI+  +S  TA+ +++++
Sbjct: 838  RWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARS----VVIISAISALTAIGLMILV 893

Query: 169  LALKYK-----------------------------LTKCGKRGLDVSNDGILPSQATLRR 199
            +AL +K                             L + G    D+  + I+ +   L  
Sbjct: 894  IALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSE 953

Query: 200  LSNLIGMGSFGSVYRARLRDGIEVAVK-VFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
               +IG G  G VY+A L +G  VAVK +  ++   + KSF  + + +  IRH +LVK++
Sbjct: 954  -EFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLM 1012

Query: 259  SSCSN--DDFKALVLEYMPKGSLENCLYSSTC-------MLDIFQRLNIMIDATSTLEYL 309
              CS+  +    L+ EYM  GS+ + L+           +LD   RL I +     +EYL
Sbjct: 1013 GYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYL 1072

Query: 310  YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------- 340
            +     PI+H D+K  +VLLD +M AHL DF                             
Sbjct: 1073 HHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAP 1132

Query: 341  EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT 400
            EY    + + +SD+Y  GIVLME  T K PTD +F  E+ +  WV   L ++     DK 
Sbjct: 1133 EYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVA-GSARDKL 1191

Query: 401  LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
            +    K     +E     +L +A++C    P++R +++     LL + +
Sbjct: 1192 IDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHVYN 1240

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score =  177 bits (448), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 143/514 (27%), Positives = 233/514 (45%), Gaps = 107/514 (20%)

Query: 7    FSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLE 66
             ++N L G +  +IG LK +  ++LSRNN +  +P +I GL                +LE
Sbjct: 543  LNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGL---------------DNLE 587

Query: 67   ILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGS 126
            +L+LS N +YG IP S + L +L   S+++N+L G I  GG F +F   SF+GN  LC +
Sbjct: 588  VLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRA 647

Query: 127  PNLQVPPCK------LNKPGKHQKS-------RKNMLPLVIVLPLSTALIIVVIILALKY 173
             +    PC       LN  G  +++       R +++ L I L +   L++ VI+L +  
Sbjct: 648  ID---SPCDVLMSNMLNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISR 704

Query: 174  K----------------------------LTKCGKRGLDVSNDGILPSQATLRRLSNLIG 205
            K                               CG +  D+S + +L S     + +N+IG
Sbjct: 705  KDVDDRINDVDEETISGVSKALGPSKIVLFHSCGCK--DLSVEELLKSTNNFSQ-ANIIG 761

Query: 206  MGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD 265
             G FG VY+A   DG + AVK    +C +  + F+A+ E +    H NLV +   C + +
Sbjct: 762  CGGFGLVYKANFPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGN 821

Query: 266  FKALVLEYMPKGSLENCLYSS-----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
             + L+  +M  GSL+  L+       T + D+  RL I   A   L YL+      +IH 
Sbjct: 822  DRLLIYSFMENGSLDYWLHERVDGNMTLIWDV--RLKIAQGAARGLAYLHKVCEPNVIHR 879

Query: 321  DLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTRSDI 354
            D+K  ++LLDE   AHL+DF                          EY      + R D+
Sbjct: 880  DVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDV 939

Query: 355  YGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISL----MEVVDKTLLSGEKKGFV 410
            Y +G+VL+E  T ++P +    +  S +D V+ +  +       E++D T+         
Sbjct: 940  YSFGVVLLELVTGRRPVE--VCKGKSCRDLVSRVFQMKAEKREAELIDTTIREN------ 991

Query: 411  AKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
              E+ VL +L +A +C    P +R   +++VT L
Sbjct: 992  VNERTVLEMLEIACKCIDHEPRRRPLIEEVVTWL 1025

Phytosulfokine receptor with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  171 bits (434), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 149/529 (28%), Positives = 241/529 (45%), Gaps = 97/529 (18%)

Query: 2    ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
            ++  + + N L+GP+   +GNLK +  ++LS NNLS ++ + +  +  L  L +  NK  
Sbjct: 678  LVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFT 737

Query: 61   --------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNF 112
                    ++  LE L++S N + G IPT +  L  L+ L+L+ N L GE+   G   + 
Sbjct: 738  GEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDP 797

Query: 113  TAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALK 172
            +     GN+ LCG   +    CK+   G   +S   +  L+    L   +I+ V + +L+
Sbjct: 798  SKALLSGNKELCG--RVVGSDCKIE--GTKLRSAWGIAGLM----LGFTIIVFVFVFSLR 849

Query: 173  -YKLTKCGK-------------RGLDVSNDGILPSQATLRRLS----------------- 201
             + +TK  K             +G    N   L    +   LS                 
Sbjct: 850  RWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGD 909

Query: 202  -----------NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR 250
                       N+IG G FG+VY+A L     VAVK   +   +  + F A+ E +  ++
Sbjct: 910  IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVK 969

Query: 251  HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF---QRLNIMIDATSTLE 307
            HPNLV ++  CS  + K LV EYM  GSL++ L + T ML++    +RL I + A   L 
Sbjct: 970  HPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLA 1029

Query: 308  YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------E 341
            +L+ G    IIH D+K  ++LLD D    ++DF                          E
Sbjct: 1030 FLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPE 1089

Query: 342  YGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEEL--SLKDW-VNNLLPISLMEVVD 398
            YG   + +T+ D+Y +G++L+E  T K+PT   F E    +L  W +  +     ++V+D
Sbjct: 1090 YGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVID 1149

Query: 399  KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
              L+S      VA +   L +L +AM C  E P KR N  D++  L +I
Sbjct: 1150 PLLVS------VALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
359483198	1087	PREDICTED: probable LRR receptor-like se	0.971	0.404	0.475	1e-119
224116832	1061	predicted protein [Populus trichocarpa]	0.975	0.416	0.472	1e-115
255572272	1089	serine-threonine protein kinase, plant-t	0.980	0.407	0.462	1e-115
359485453	1202	PREDICTED: probable LRR receptor-like se	0.975	0.367	0.486	1e-113
224139658	1019	predicted protein [Populus trichocarpa]	0.975	0.433	0.458	1e-110
359485449	1583	PREDICTED: LRR receptor-like serine/thre	0.969	0.277	0.475	1e-109
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.962	0.307	0.480	1e-109
255578886	1043	serine-threonine protein kinase, plant-t	0.931	0.404	0.455	1e-106
358344055	996	Receptor-like kinase [Medicago truncatul	0.964	0.438	0.450	1e-106
358344065	815	Receptor-like protein kinase [Medicago t	0.975	0.542	0.454	1e-105

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  434 bits (1117), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 242/509 (47%), Positives = 319/509 (62%), Gaps = 69/509 (13%)

Query: 2    ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
            IL+ D SSN L G L  D+GNLK +V+I+LSRN LS ++P+ IGGL  L +LSLA+N+ +
Sbjct: 591  ILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFE 650

Query: 62   ---------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNF 112
                     + SLE ++LS+N ++G IP SLE L+YLK L +SFN L GEI   GPF NF
Sbjct: 651  GPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANF 710

Query: 113  TAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALK 172
            +A SF  N+ LCGSP L++PPC+    G    +  + L L  +LP   A++  ++ LAL 
Sbjct: 711  SAESFMMNKALCGSPRLKLPPCR---TGTRWSTTISWLLLKYILP---AILSTLLFLALI 764

Query: 173  YKLTKCGKRGLDVSNDGILPSQ------ATLRRLS--------------NLIGMGSFGSV 212
            +  T+C KR      + +LP+Q      AT RR+S              NL+G GS GSV
Sbjct: 765  FVWTRCRKR------NAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSV 818

Query: 213  YRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKALV 270
            YR  L DG   A+KVF+ +   A KSF+A+CEVM  IRH NL+K++SSCSN   DFKALV
Sbjct: 819  YRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALV 878

Query: 271  LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD 330
            LEY+P GSLE  LYS    LDI QRLNIMID    +EYL+ G +TP++HCDLKP ++LLD
Sbjct: 879  LEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLD 938

Query: 331  EDMVAHLSDF--------------------------EYGMEGQVSTRSDIYGYGIVLMET 364
            ED   H+ DF                          +Y   G V+T  D+Y YGIVLMET
Sbjct: 939  EDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMET 998

Query: 365  FTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAM 424
            FTR++PTD +F EE+S+K+WV + L  S+ EVVD  LL GE + F+AK+QC+  ILGLAM
Sbjct: 999  FTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAM 1058

Query: 425  ECAMELPEKRINAKDIVTRLLKIRDTLSK 453
            +C  + PE+RI  KD+VT L KI+  +S 
Sbjct: 1059 DCVADSPEERIKMKDVVTTLKKIKTHISS 1087

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  422 bits (1086), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 235/497 (47%), Positives = 313/497 (62%), Gaps = 55/497 (11%)

Query: 1    DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            D+L  + S NSL G L L+IGNLK V  I+ S N LS D+P +I  L +L   SL+ N++
Sbjct: 556  DLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRM 615

Query: 61   ---------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                     D+ SLE L+LS N + G IP SLEKL++LK  ++SFN+L+GEIL GGPF N
Sbjct: 616  QGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFAN 675

Query: 112  FTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILAL 171
            F+  SF  NE LCG   +QVPPCK      H++S++    ++  +  + A II+V+ LA+
Sbjct: 676  FSFRSFMDNEALCGPIRMQVPPCK--SISTHRQSKRPREFVIRYIVPAIAFIILVLALAV 733

Query: 172  KYKLTKCGKRGLDVSNDGILPSQATLRRLS--------------NLIGMGSFGSVYRARL 217
                 +  KR L    D + P  AT R++S              NL+G GS GSVY+  L
Sbjct: 734  II-FRRSHKRKLSTQEDPLPP--ATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTL 790

Query: 218  RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG 277
             DG+ +AVKVFH +    L  F+++CEV++ +RH NLVK+ISSC N DFKAL+LE++P G
Sbjct: 791  SDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHG 850

Query: 278  SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHL 337
            SLE  LYS    LDI QRLNIMID  S LEYL+ G T P++HCDLKP +VL++EDMVAH+
Sbjct: 851  SLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHV 910

Query: 338  SDF--------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPT 371
            SDF                          EYG+EG VS + D+Y YGI LMETFTRKKPT
Sbjct: 911  SDFGISRLLGEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPT 970

Query: 372  DRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELP 431
            D MF  E+SLK+WV   LP ++ EV+D  LL  E++ FVAK+ C+ SIL LA+EC+ +LP
Sbjct: 971  DDMFGGEMSLKNWVKQSLPKAITEVIDANLLI-EEEHFVAKKDCITSILNLALECSADLP 1029

Query: 432  EKRINAKDIVTRLLKIR 448
             +RI  +D++  L KI+
Sbjct: 1030 GERICMRDVLPALEKIK 1046

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  421 bits (1082), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 230/497 (46%), Positives = 309/497 (62%), Gaps = 53/497 (10%)

Query: 1    DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            DIL  + +SN L G L  +I NL+AV  IN+S+N LS ++P +IGGL  L  L L+ NKL
Sbjct: 586  DILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKL 645

Query: 61   ---------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                     D+ SLE L+LS+N + G+IP SL+ LLYLK  ++SFN L+GEI  GG F N
Sbjct: 646  QGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSN 705

Query: 112  FTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILAL 171
            F+A SF GNE LCGS  LQV PCK +   +  ++  + + L  VLP   A++  V +LA 
Sbjct: 706  FSAQSFIGNEALCGSARLQVSPCK-DDNSRATETPGSKIVLRYVLP---AIVFAVFVLAF 761

Query: 172  KYKLTKCGKRGLDVSNDGILPSQATLRRLS--------------NLIGMGSFGSVYRARL 217
               L +  +R    S +    +  T+RR+S              N +GMGSFGSVY+  L
Sbjct: 762  VIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTL 821

Query: 218  RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG 277
             DG  +A KVF+ +  RA KSF+ +CEV++++RH NLVK+I+SCS  +FKALVLE+MP  
Sbjct: 822  SDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNW 881

Query: 278  SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHL 337
            SLE  LYS    L+  QRLNIM+D  S LEYL+ G+T P+ HCD+KP +VLL+EDMVA L
Sbjct: 882  SLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFL 941

Query: 338  SDF--------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPT 371
            +DF                          EYG EG VS R D+Y YG++LMETFT+KKPT
Sbjct: 942  ADFGISKLLGEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPT 1001

Query: 372  DRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELP 431
            D+MF E+LSLK WV   L   + +V+D  LL  E+    AK+ C++SIL LA++C+ +LP
Sbjct: 1002 DKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQCSADLP 1061

Query: 432  EKRINAKDIVTRLLKIR 448
              RI+ K +VT L KI+
Sbjct: 1062 HDRIDMKHVVTTLQKIK 1078

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  413 bits (1062), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 243/499 (48%), Positives = 314/499 (62%), Gaps = 57/499 (11%)

Query: 2    ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
            +L  + SSN L   L L +GN+K++V ++LS+N  S ++P+TI  L +L  L L++NKL 
Sbjct: 706  LLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQ 765

Query: 61   --------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNF 112
                    D+ SLE L+LS N + G IP SLE L YL+ L++SFNKL+GEI  GGPF NF
Sbjct: 766  GHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANF 825

Query: 113  TAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVI--VLPLSTAL---IIVVI 167
            TA SF  N  LCG+P  QV  C+       + SRKN   L++  ++PLS +L   I+VV+
Sbjct: 826  TAESFISNLALCGAPRFQVMACE-------KDSRKNTKSLLLKCIVPLSVSLSTIILVVL 878

Query: 168  ILALKYKLTKCGKR-GLDVS---NDGILPSQATLRRLS-----NLIGMGSFGSVYRARLR 218
             +  K + TK      +D+S      ++P Q  L   +     NLIG GS G VY+  L 
Sbjct: 879  FVQWKRRQTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLS 938

Query: 219  DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS 278
            DG+ VAVKVF+ E   A KSFE +CEVM++IRH NL K+ISSCSN DFKALVLEYMP GS
Sbjct: 939  DGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGS 998

Query: 279  LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS 338
            LE  LYS    LD  QRL IMID  S LEYL+  ++ P++HCDLKP +VLLD+DMVAH+S
Sbjct: 999  LEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHIS 1058

Query: 339  DF--------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTD 372
            DF                          EYG EG VST+ DIY YGI+LMETF RKKPTD
Sbjct: 1059 DFGIAKLLMGSEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTD 1118

Query: 373  RMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPE 432
             MFVEEL+LK WV +    ++MEV+D  LL+ E + F  K  C  SI+ LA++C +E PE
Sbjct: 1119 EMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALKRACFSSIMTLALDCTVEPPE 1177

Query: 433  KRINAKDIVTRLLKIRDTL 451
            KRIN KD+V RL K+ + +
Sbjct: 1178 KRINTKDVVVRLKKLLNQI 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  404 bits (1039), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 228/497 (45%), Positives = 304/497 (61%), Gaps = 55/497 (11%)

Query: 1    DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            D+L  +  SN L G L   +G ++A + I LS N LS ++P+TIG L +L   SL+ N  
Sbjct: 517  DLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSF 576

Query: 61   D---------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                      + SLE+L+LS N + G IP SLE L YL+  S+SFN L+GEI RGGPF N
Sbjct: 577  QGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFAN 636

Query: 112  FTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILAL 171
            FTA SF  N+ LCG   LQVPPC + +  K  K++  +L     LP   ++++VV   A 
Sbjct: 637  FTARSFIMNKGLCGPSRLQVPPCSI-ESRKDSKTKSRLLRFS--LPTVASILLVV---AF 690

Query: 172  KYKLTKCGKRGLDVSNDGILPSQATLRRLS--------------NLIGMGSFGSVYRARL 217
             + +  C +R         LP  A  RR+S              NL+G+GSFGSVY+ RL
Sbjct: 691  IFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRL 750

Query: 218  RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG 277
            RDG+ VAVK+F+ +  RA +SF+ +CE+M++IRH NLVK+I SCSN DFKALVLEYMPKG
Sbjct: 751  RDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKG 810

Query: 278  SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHL 337
            SLE  LYS    LDI QR+NIMID  S LEYL+ G+ +P++HCDLKP +VLLDEDMVAH+
Sbjct: 811  SLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHV 870

Query: 338  SDF--------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPT 371
             DF                          EYG++G VST+ D+Y +GI+LME  TRK+PT
Sbjct: 871  CDFGIAKLLGENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPT 930

Query: 372  DRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELP 431
            D MF  E+SLK  V   LP S++++VD  +L+      V KE CV SI+ LA++C  E P
Sbjct: 931  DEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESP 990

Query: 432  EKRINAKDIVTRLLKIR 448
             +R+   +I+ RL  I+
Sbjct: 991  GERMAMVEILARLKNIK 1007

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485449|ref|XP_002276919.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  402 bits (1034), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 236/496 (47%), Positives = 306/496 (61%), Gaps = 57/496 (11%)

Query: 2    ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
            IL  + SSN L G L L+IGN+K +++++LS+N  S  +P+++G L +L  LSL+ N L 
Sbjct: 1091 ILYLNLSSNFLNGNLPLEIGNMKTIIKLDLSKNQFSGYIPSSVGQLQNLVELSLSKNNLQ 1150

Query: 61   --------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNF 112
                    DV SLE L+LS N + G IP SLE L+YLK L++SFNK +GEI  GGPFVNF
Sbjct: 1151 GPIPLKFGDVVSLESLDLSWNNLSGTIPQSLEALIYLKHLNVSFNKRQGEIRNGGPFVNF 1210

Query: 113  TAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALK 172
            TA SF  NE LCG+P  QV  CK  K    + ++   L L  VLP   + II++ ++ L 
Sbjct: 1211 TAKSFISNEALCGAPRFQVMACK--KVTTRKSTKAKSLLLKCVLPTIASTIIILALIILL 1268

Query: 173  YKLTKCGKRGLDVSNDGILPSQATLRRLS--------------NLIGMGSFGSVYRARLR 218
             +  K  +  + +  D  LP+  T R++S              NLIG GS G+VY+  L 
Sbjct: 1269 IRRQK--RLDIPIQVDSSLPT--TYRKISHQELLHATNYFSEGNLIGKGSMGTVYKGVLF 1324

Query: 219  DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS 278
            DG+  A+KVF+ E   + K FEA+CEVM++IRH NL+K+ISSCSN  FKALVLE+MP  S
Sbjct: 1325 DGLTAAIKVFNLEFLGSFKGFEAECEVMRNIRHRNLIKIISSCSNLGFKALVLEFMPNRS 1384

Query: 279  LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS 338
            LE  LYS    LD+ QRLNIMID  S LEYL+  ++ P++HCDLKP +VLLDED VAH+ 
Sbjct: 1385 LERWLYSHNYCLDLIQRLNIMIDVASALEYLHHDYSNPVVHCDLKPNNVLLDEDRVAHVG 1444

Query: 339  DF--------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTD 372
            DF                          EYG EG VST SD+Y  GI+L+E F RKKPTD
Sbjct: 1445 DFGIAKLLPGSESRQQTKTLGPIGYMAPEYGSEGIVST-SDVYSNGIMLLEVFARKKPTD 1503

Query: 373  RMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPE 432
             MFV + +LK WV +L   ++ME VD  LL  E + F  KE CVL I+ LA+EC  E PE
Sbjct: 1504 EMFVGDPTLKSWVESLAS-TVMEFVDTNLLDKEDEHFAIKENCVLCIMALALECTAESPE 1562

Query: 433  KRINAKDIVTRLLKIR 448
             RIN +D+V RL KIR
Sbjct: 1563 DRINMRDVVARLKKIR 1578

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  401 bits (1030), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 240/499 (48%), Positives = 307/499 (61%), Gaps = 63/499 (12%)

Query: 1    DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            D+L  + SSN L   L L++GN+K+++ ++LS+N  S ++P+TI  L +L  L L++NKL
Sbjct: 706  DLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLSHNKL 765

Query: 61   D---------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                      + SLE L+LS N   G IPTSLE L YLK L++SFNKL+GEI   GPF N
Sbjct: 766  QGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRGPFAN 825

Query: 112  FTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVI--VLPLSTAL---IIVV 166
            FTA SF  N  LCG+P  QV  C+       + +R+N   L++  ++PLS +L   I+VV
Sbjct: 826  FTAESFISNLALCGAPRFQVMACE-------KDARRNTKSLLLKCIVPLSVSLSTMILVV 878

Query: 167  IILALKYKLTKCGKRGLDVSNDGILP-------SQATLRRLS-----NLIGMGSFGSVYR 214
            +    K + T+       V  D +LP        Q  L   S     NLIG GS G VY+
Sbjct: 879  LFTLWKRRQTESES---PVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVYK 935

Query: 215  ARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM 274
              L DG+ VAVKVF+ E   A KSFE +CEVM++IRH NL K+ISSCSN DFKALVLEYM
Sbjct: 936  GVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYM 995

Query: 275  PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV 334
            P  SLE  LYS    LD  QRL IMID  S LEYL+  ++ P++HCDLKP +VLLD+DMV
Sbjct: 996  PNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMV 1055

Query: 335  AHLSDF--------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRK 368
            AH+SDF                          EYG EG VST+ D Y YGI+LME F RK
Sbjct: 1056 AHISDFGIAKLLMGSEFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVRK 1115

Query: 369  KPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAM 428
            KPTD MFVEEL+LK WV +    ++MEV+D  LL+ E + F  K+ C  SI+ LA++C +
Sbjct: 1116 KPTDEMFVEELTLKSWVESSAN-NIMEVIDANLLTEEDESFALKQACFSSIMTLALDCTI 1174

Query: 429  ELPEKRINAKDIVTRLLKI 447
            E PEKRIN KD+V RL KI
Sbjct: 1175 EPPEKRINMKDVVARLKKI 1193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  392 bits (1007), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 218/479 (45%), Positives = 302/479 (63%), Gaps = 57/479 (11%)

Query: 17   SLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEI 67
            ++DIGNLKAV  I+LS N LS  +P++IGGL +L  LSLA N+L         D  SL++
Sbjct: 559  AVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQL 618

Query: 68   LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSP 127
            L+LSNN + G IP SLE+L YL   ++SFN+L+GEI  G  F+N +A SF GN+ LCG+ 
Sbjct: 619  LDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAA 678

Query: 128  NLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALKYKLTKCGKRGLDVSN 187
             LQV PC+ +    HQ S K    L +   L    + ++ + A+     +  KR + ++ 
Sbjct: 679  KLQVQPCETST---HQGS-KAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMRIT- 733

Query: 188  DGILPSQATLRRLS--------------NLIGMGSFGSVYRARLRDGIEVAVKVFHQECA 233
            +G+LP  ATL+R+S              NL+G GSFGSVY+    DG  VAVKVF+ +  
Sbjct: 734  EGLLP-LATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVE 792

Query: 234  RALKSFEAQCEVMKSIRHPNLVKVISSCS--NDDFKALVLEYMPKGSLENCLYSSTCMLD 291
             A KSF+ +CEV++ IRH NLVK+I+SCS  N DFKALVLE+MP  SLE  L S    L+
Sbjct: 793  GAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLE 852

Query: 292  IFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------- 340
            + +RLNIM+D  S +EYL+ G+  PI+HCDLKP ++LLDE+MVAH++DF           
Sbjct: 853  LLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGDEHS 912

Query: 341  ---------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWV 385
                           EYG EG VST  DIY +GI+LMETFTRKKPTD MF EE+S+K WV
Sbjct: 913  FIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQWV 972

Query: 386  NNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
               +P  + ++ D  LL  E++ F AK+ C+LS++ +A++C+ +LPE+R N +D++  L
Sbjct: 973  QESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTL 1031

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358344055|ref|XP_003636109.1| Receptor-like kinase [Medicago truncatula] gi|355502044|gb|AES83247.1| Receptor-like kinase [Medicago truncatula]

 Score =  390 bits (1002), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 226/502 (45%), Positives = 304/502 (60%), Gaps = 65/502 (12%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           DIL  D SSN+  G    DIGNL+ +V ++LSRN +SS++P TI  L +L+ LSLA+NKL
Sbjct: 497 DILILDLSSNAFIGDFPPDIGNLRELVILDLSRNQISSNIPTTISSLQNLQNLSLAHNKL 556

Query: 61  D---------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
           +         + SL  L+LS N + G+IP SLE LLYL+ ++ S+N+L+GEI  GG F N
Sbjct: 557 NGSIPASLNGMVSLISLDLSQNMLTGVIPKSLESLLYLQNINFSYNRLQGEIPNGGHFKN 616

Query: 112 FTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQK--SRKNMLPLVIVLPLS-TALIIVVII 168
           FTA SF  NE LCG P LQVP C     GK  K  S +  L L  +LP+  +A+++V  I
Sbjct: 617 FTAQSFMHNEALCGDPRLQVPTC-----GKQVKKWSMEKKLILKCILPIVVSAILVVACI 671

Query: 169 LALKYKLTKCGKRGLDVSNDGILPSQATLRRLS--------------NLIGMGSFGSVYR 214
           + LK+   K  K  L+      L +    RR+S              N +G G FGSVY+
Sbjct: 672 ILLKHNKRKKNKTSLERG----LSTLGAPRRISYYEIVQATNGFNESNFLGRGGFGSVYQ 727

Query: 215 ARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM 274
            +L DG  +AVKV   +     KSF+A+C  M+++RH N+VK+ISSCSN DFK+LV+E+M
Sbjct: 728 GKLLDGEMIAVKVIDLQSEAKSKSFDAECNAMRNLRHRNMVKIISSCSNLDFKSLVMEFM 787

Query: 275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV 334
             GS++N LYS    L+  QRLNIMID  S LEYL+ G + P++HCDLKP +VLLDE+MV
Sbjct: 788 SNGSVDNWLYSVNHCLNFLQRLNIMIDVASALEYLHHGSSVPVVHCDLKPSNVLLDENMV 847

Query: 335 AHLSDF--------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRK 368
           AH+SDF                          EYG +G VS + D+Y YGI+LME FTR+
Sbjct: 848 AHVSDFGIAKLMDEGQSKTHTQTLATIGYLAPEYGSKGIVSVKGDVYSYGIMLMEIFTRR 907

Query: 369 KPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS--GEKKGFVAKEQCVLSILGLAMEC 426
           KPTD MFV EL+LK W++   P S+MEV+D  L+   GE+   +       SI GLA+ C
Sbjct: 908 KPTDDMFVAELNLKTWISGSFPNSIMEVLDSNLVQQIGEQIDDILIYMS--SIFGLALNC 965

Query: 427 AMELPEKRINAKDIVTRLLKIR 448
             + PE RIN  D++  L+KI+
Sbjct: 966 CEDSPEARINIADVIASLIKIK 987

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358344065|ref|XP_003636114.1| Receptor-like protein kinase [Medicago truncatula] gi|355502049|gb|AES83252.1| Receptor-like protein kinase [Medicago truncatula]

 Score =  388 bits (996), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 225/495 (45%), Positives = 306/495 (61%), Gaps = 53/495 (10%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           DIL  +FSSNSL G L  +IGNL+A+V ++LSRN +SS++P TI  L++L+ LSLA NKL
Sbjct: 316 DILEINFSSNSLIGILPPEIGNLRAIVLLDLSRNQISSNIPTTINSLLTLQNLSLADNKL 375

Query: 61  D---------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
           +         + SL  L+LS N + G+IP SLE LLYL+ ++ S+N+L+GEI  GG F N
Sbjct: 376 NGSIPKSLGEMVSLISLDLSENMLTGVIPKSLESLLYLQNINFSYNRLQGEIPDGGRFKN 435

Query: 112 FTAMSFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILAL 171
           FTA SF  N+ LCG P LQVP C   +  K    +K +L  ++ + +S  LI+  IIL L
Sbjct: 436 FTAQSFMHNDALCGDPRLQVPTCG-KQVKKWSMEKKLILKCILPIVVSVVLIVACIIL-L 493

Query: 172 KYKLTKCGK----RGLD-------VSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDG 220
           K+   +  K    RGL        +S   I+ +       SN +G G FGSVY+ +L DG
Sbjct: 494 KHNKRRKNKNNVGRGLSTLGAPRRISYYEIVQATNGFNE-SNFLGRGGFGSVYQGKLLDG 552

Query: 221 IEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLE 280
             +AVKV   +     KSF+A+C  M+++RH NLVK+ISSCSN DFK+LV+E+M  GS++
Sbjct: 553 EMIAVKVIDLQSEAKSKSFDAECNAMRNLRHRNLVKIISSCSNLDFKSLVMEFMSNGSVD 612

Query: 281 NCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             LYS+   L+  QRLNIMID    LEYL+ G + P++HCDLKP +VLLDE+MVAH+SDF
Sbjct: 613 KWLYSNNYCLNFLQRLNIMIDVAYALEYLHHGSSMPVVHCDLKPSNVLLDENMVAHVSDF 672

Query: 341 --------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRM 374
                                     EYG +G VS + D+Y YGI+LME FTRKKPTD M
Sbjct: 673 GIAKLMDEGQSQTLTQTLATVGYIAPEYGSKGIVSVKGDVYSYGIMLMEIFTRKKPTDDM 732

Query: 375 FVEELSLKDWVNNLLPISLMEVVDKTL--LSGEKKGFVAKEQCVLSILGLAMECAMELPE 432
           FV ELSLK W++  LP S+MEV+D  L  ++G++  ++       SI  LA+ C  +  E
Sbjct: 733 FVAELSLKTWISRSLPNSIMEVMDSNLVQITGDQIDYILTHMS--SIFSLALSCCEDSLE 790

Query: 433 KRINAKDIVTRLLKI 447
            RIN  D++  L+KI
Sbjct: 791 ARINMADVIATLIKI 805

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.728	0.321	0.352	5.7e-61
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.309	0.138	0.474	1.1e-57
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.710	0.318	0.304	4.6e-54
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.322	0.141	0.465	3e-51
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.752	0.347	0.320	5e-49
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.512	0.462	0.367	4.4e-47
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.309	0.138	0.454	7e-45
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.306	0.135	0.458	1.1e-42
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.309	0.119	0.368	9.2e-41
TAIR|locus:2204350	980	CLV1 "AT1G75820" [Arabidopsis	0.777	0.359	0.291	4e-36

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 499 (180.7 bits), Expect = 5.7e-61, Sum P(2) = 5.7e-61
 Identities = 127/360 (35%), Positives = 188/360 (52%)

Query:     8 SSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------ 61
             S N+LEG +  +IG+LK +VE +   N LS  +P T+G    L+ L L  N L       
Sbjct:   505 SKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSA 564

Query:    62 ---VASLEILNLSNNEIYGLIPTXXXXXXXXXXXXXXFNKLEGEILRGGPFVNFTAMSFK 118
                +  LE L+LS+N + G IPT              FN   GE+   G F   + +S +
Sbjct:   565 LGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQ 624

Query:   119 GNEPLCGS-PNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTXXXXXXXXXXXKYKLTK 177
             GN  LCG  P+L +P C    P    +    +LP+ + L  +             +K TK
Sbjct:   625 GNAKLCGGIPDLHLPRCC---PLLENRKHFPVLPISVSLAAALAILSSLYLLITWHKRTK 681

Query:   178 CGKRGLDVSNDGILPSQATLRRLS------NLIGMGSFGSVYRARLRDGIEVAVKVFHQE 231
              G           L S + L + +      NL+G GSFGSVY+ +L     VAVKV   E
Sbjct:   682 KGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLE 741

Query:   232 CARALKSFEAQCEVMKSIRHPNLVKVISSCSN-----DDFKALVLEYMPKGSLENCLYSS 286
               +ALKSF A+CE ++++RH NLVK+++ CS+     +DFKA+V ++MP GSLE+ ++  
Sbjct:   742 NPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPE 801

Query:   287 TC------MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             T        L++ +R+ I++D    L+YL+     P++HCD+K  +VLLD DMVAH+ DF
Sbjct:   802 TNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDF 861

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 331 (121.6 bits), Expect = 1.1e-57, Sum P(3) = 1.1e-57
 Identities = 73/154 (47%), Positives = 101/154 (65%)

Query:   201 SNLIGMGSFGSVYRARL-RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
             SN++G GSFG+VY+A L  +   VAVKV + +   A+KSF A+CE +K IRH NLVK+++
Sbjct:   705 SNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLT 764

Query:   260 SCSNDDF-----KALVLEYMPKGSLENCLYSSTC--------MLDIFQRLNIMIDATSTL 306
             +CS+ DF     +AL+ E+MP GSL+  L+             L + +RLNI ID  S L
Sbjct:   765 ACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVL 824

Query:   307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             +YL+     PI HCDLKP +VLLD+D+ AH+SDF
Sbjct:   825 DYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDF 858

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 392 (143.0 bits), Expect = 4.6e-54, Sum P(2) = 4.6e-54
 Identities = 113/371 (30%), Positives = 184/371 (49%)

Query:     1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
             +++     +N   G L   +GN  A+ ++ L  N+    +P  I GL+ ++       ++
Sbjct:   507 NLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVR-------RV 558

Query:    61 DVASLEILNLSNNEIYGLIPTXXXXXXXXXXXXXXFNKLEGEILRGGPFVNFTAMSFKGN 120
             D        LSNN++ G IP                N   G++   G F N T +   GN
Sbjct:   559 D--------LSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGN 610

Query:   121 EPLCGS-PNLQVPPCKLNKPG---KHQKSRKNM-------LPLVIVLPLSTXXXXXXXXX 169
             + LCG   +L++ PC   +P    KH    K +       + L+++L +++         
Sbjct:   611 KNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKR 670

Query:   170 XXKYKLTKCGKRGLDVSNDGILPSQATLRRL------SNLIGMGSFGSVYRARL-RDGIE 222
                 +        L++ ++ I  S   LR        SN++G GSFG+V++A L  +   
Sbjct:   671 RKNQQTNNLVPSKLEIFHEKI--SYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKI 728

Query:   223 VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF-----KALVLEYMPKG 277
             VAVKV + +   A+KSF A+CE +K  RH NLVK++++C++ DF     +AL+ EY+P G
Sbjct:   729 VAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNG 788

Query:   278 SLENCLYSSTC--------MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL 329
             S++  L+             L + +RLNI+ID  S L+YL+     PI HCDLKP +VLL
Sbjct:   789 SVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 848

Query:   330 DEDMVAHLSDF 340
             ++D+ AH+SDF
Sbjct:   849 EDDLTAHVSDF 859

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 305 (112.4 bits), Expect = 3.0e-51, Sum P(3) = 3.0e-51
 Identities = 75/161 (46%), Positives = 100/161 (62%)

Query:   195 ATLRRLS-NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP 252
             AT R  S NLIG G+FG+V++  L  +   VAVKV +     A KSF A+CE  K IRH 
Sbjct:   708 ATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHR 767

Query:   253 NLVKVISSCSN-----DDFKALVLEYMPKGSLENCLY--------SSTCMLDIFQRLNIM 299
             NLVK+I+ CS+     +DF+ALV E+MPKGSL+  L           +  L   ++LNI 
Sbjct:   768 NLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIA 827

Query:   300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             ID  S LEYL+     P+ HCD+KP ++LLD+D+ AH+SDF
Sbjct:   828 IDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDF 868

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 414 (150.8 bits), Expect = 5.0e-49, Sum P(2) = 5.0e-49
 Identities = 121/377 (32%), Positives = 176/377 (46%)

Query:     2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
             +L+ D SSN L G +   +G+  A+  +NLSRN  SS +P+++G L  LK L +++N+L 
Sbjct:   469 VLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLT 528

Query:    62 VASLEILNLSNNEIYGLIPTXXXXXXXXXXXXXXFNKLEGEILRGGPFVNFTAMSFKGNE 121
                            G IP               FN L G +   G F   T  SF G+ 
Sbjct:   529 ---------------GAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDS 573

Query:   122 PLCGS-PNLQVPPCKLNKPGKHQKSRKNML--PLVIVLPLSTXXXXXXXXXXXKYKLTKC 178
              LCGS   +Q    K   P        +++  P++ V                 Y   + 
Sbjct:   574 LLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEV 633

Query:   179 GKRGLDVSNDGILPS---QATLR-----RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQ 230
                     ND   P    Q  +        S+LIG G FG VY+  LR+  +VAVKV   
Sbjct:   634 EDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDP 693

Query:   231 ECARALK-SFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYS---S 286
             + A     SF+ +C+++K  RH NL+++I++CS   F ALVL  MP GSLE  LY    S
Sbjct:   694 KTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYS 753

Query:   287 TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY---- 342
             +  LD+ Q +NI  D    + YL+      ++HCDLKP ++LLD++M A ++DF      
Sbjct:   754 SKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLV 813

Query:   343 -GMEGQVSTRSDIYGYG 358
              G+E  VST  D   +G
Sbjct:   814 QGVEETVST-DDSVSFG 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 332 (121.9 bits), Expect = 4.4e-47, Sum P(3) = 4.4e-47
 Identities = 96/261 (36%), Positives = 139/261 (53%)

Query:    98 KLEGEILRGGPFVNFTAMSFKGNEPLCGSP-NLQVPPCKLNKPGKHQKSRKNMLPLVIV- 155
             + EG +   G F N T +S  GNE LCG    +Q+ PC +  P   QK   ++   V V 
Sbjct:   116 EFEGSVPTKGVFQNGTTVSVFGNENLCGGVIEMQLKPC-IESP--RQKKPFSLGEKVAVG 172

Query:   156 LPLSTXXXXXXXXXXXKYKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRA 215
             + ++             +K     K+   +S + +  + +     SNLIG G+F  V++ 
Sbjct:   173 VGVALLFLFIIVASLSWFK-----KKNDKISYEELYNATSGFSS-SNLIGSGNFSDVFKG 226

Query:   216 RLRDGIE---VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN-----DDFK 267
              L  G+E   VAVKV +     A KSF A+CE  K IRH NL K+I+ CS+     +DF+
Sbjct:   227 LL--GLEEKLVAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFR 284

Query:   268 ALVLEYMPKGSLENCLY--------SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
             ALV E+MPKGSL+  L         + +  L   +++NI ID  S LEYL+     P+ H
Sbjct:   285 ALVYEFMPKGSLDMWLQPEDLESANNHSRSLTFAEKVNIAIDVASALEYLHVYCHDPVAH 344

Query:   320 CDLKPISVLLDEDMVAHLSDF 340
             CD+KP +VLLD+D+ AH+SDF
Sbjct:   345 CDIKPSNVLLDDDLTAHVSDF 365

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 328 (120.5 bits), Expect = 7.0e-45, Sum P(2) = 7.0e-45
 Identities = 70/154 (45%), Positives = 102/154 (66%)

Query:   201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
             SN++G GSFG+V++A L+ +   VAVKV + +   A+KSF A+CE +K IRH NLVK+++
Sbjct:   704 SNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLT 763

Query:   260 SCSNDDF-----KALVLEYMPKGSLENCLYSSTC--------MLDIFQRLNIMIDATSTL 306
             +C++ DF     +AL+ E+MP GSL+  L+             L + +RLNI ID  S L
Sbjct:   764 ACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVL 823

Query:   307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             +YL+     PI HCDLKP ++LLD+D+ AH+SDF
Sbjct:   824 DYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDF 857

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 304 (112.1 bits), Expect = 1.1e-42, Sum P(2) = 1.1e-42
 Identities = 71/155 (45%), Positives = 100/155 (64%)

Query:   201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVI 258
             SNLIG G+FG+V++  L    + VA+KV +  C R A KSF A+CE +  IRH NLVK++
Sbjct:   722 SNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAECEALGGIRHRNLVKLV 780

Query:   259 SSCSN-----DDFKALVLEYMPKGSLENCLY--------SSTCMLDIFQRLNIMIDATST 305
             + CS+     +DF+ALV E+MP G+L+  L+        + +  L +F RLNI ID  S 
Sbjct:   781 TICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASA 840

Query:   306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             L YL+     PI HCD+KP ++LLD+D+ AH+SDF
Sbjct:   841 LVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDF 875

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 273 (101.2 bits), Expect = 9.2e-41, Sum P(3) = 9.2e-41
 Identities = 53/144 (36%), Positives = 92/144 (63%)

Query:   201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVI 258
             +N+IG  S  +VY+ +L DG  +AVKV + +   A + K F  + + +  ++H NLVK++
Sbjct:   873 ANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL 932

Query:   259 S-SCSNDDFKALVLEYMPKGSLENCLYSSTCML-DIFQRLNIMIDATSTLEYLYFGHTTP 316
               +  +   KALVL +M  G+LE+ ++ S   +  + +++++ +   S ++YL+ G+  P
Sbjct:   933 GFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFP 992

Query:   317 IIHCDLKPISVLLDEDMVAHLSDF 340
             I+HCDLKP ++LLD D VAH+SDF
Sbjct:   993 IVHCDLKPANILLDSDRVAHVSDF 1016

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2204350 CLV1 "AT1G75820" [Arabidopsis thaliana (taxid:3702)]

 Score = 336 (123.3 bits), Expect = 4.0e-36, Sum P(2) = 4.0e-36
 Identities = 113/388 (29%), Positives = 183/388 (47%)

Query:    10 NSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------- 61
             N   G +  +I  LK +  IN S NN++  +P +I    +L ++ L+ N+++        
Sbjct:   490 NRFRGNIPREIFELKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGIN 549

Query:    62 -VASLEILNLSNNEIYGLIPTXXXXXXXXXXXXXXFNKLEGEILRGGPFVNFTAMSFKGN 120
              V +L  LN+S N++ G IPT              FN L G +  GG F+ F   SF GN
Sbjct:   550 NVKNLGTLNISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLVFNETSFAGN 609

Query:   121 EPLCGSPNLQVPPCKLNKPGKHQK----SRKNMLPLVI-----VLPLSTXXXXXXXXXXX 171
               LC  P+    P +  +   H      S   ++  VI     ++ +S            
Sbjct:   610 TYLC-LPHRVSCPTRPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQ 668

Query:   172 K---YKLTKCGKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVK-V 227
             K   +KLT   K  LD  ++ +L     L+   N+IG G  G VYR  + + ++VA+K +
Sbjct:   669 KSLAWKLTAFQK--LDFKSEDVLEC---LKE-ENIIGKGGAGIVYRGSMPNNVDVAIKRL 722

Query:   228 FHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSST 287
               +   R+   F A+ + +  IRH ++V+++   +N D   L+ EYMP GSL   L+ S 
Sbjct:   723 VGRGTGRSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSK 782

Query:   288 C-MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---EYG 343
                L    R  + ++A   L YL+   +  I+H D+K  ++LLD D  AH++DF   ++ 
Sbjct:   783 GGHLQWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFL 842

Query:   344 MEGQVST-RSDIYG-YGIVLME-TFTRK 368
             ++G  S   S I G YG +  E  +T K
Sbjct:   843 VDGAASECMSSIAGSYGYIAPEYAYTLK 870

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007172 "signal complex assembly" evidence=IDA

GO:0016021 "integral to membrane" evidence=TAS

GO:0030154 "cell differentiation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

GO:0009934 "regulation of meristem structural organization" evidence=IMP

GO:0016020 "membrane" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00025215001 SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (691 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	453
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-27
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-27
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-23
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-14
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-14
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-13
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-11
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-08
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-08
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-07
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-06
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-04
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-04
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-04
pfam03109	117	pfam03109, ABC1, ABC1 family	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.001
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	0.001
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.001
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.001
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.001
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	0.002
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.002
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.003
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	0.004
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.004
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  115 bits (291), Expect = 5e-30
 Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 32/189 (16%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           +G G FG+VY AR +  G +VA+K+  +E  +  L+    + E++K + HPN+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
            +++   LV+EY   GSL++ L  +   L   + L I++     LEYL   H+  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117

Query: 322 LKPISVLLDED-MVAHLSDF--------------------------EYGMEGQVSTRSDI 354
           LKP ++LLD D     L+DF                              +G  S +SDI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 355 YGYGIVLME 363
           +  G++L E
Sbjct: 178 WSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (289), Expect = 3e-29
 Identities = 68/281 (24%), Positives = 124/281 (44%), Gaps = 60/281 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-----GIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHP 252
            L   +G G+FG VY+ +L+       +EVAVK   ++ +   ++ F  +  +M+ + HP
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           N+VK++  C+ ++   +V+EYM  G L + L  +   L +   L+  +     +EYL   
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL--- 118

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EYG-----------------MEG 346
            +   IH DL   + L+ E++V  +SDF         +Y                   EG
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 347 QVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWV--NNLLPISLMEVVDKTLLS 403
           + +++SD++ +G++L E FT  ++P   M  EE  + +++     LP             
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--VLEYLKNGYRLPQP----------- 225

Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
                      C   +  L ++C  E PE R    ++V  L
Sbjct: 226 ---------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  109 bits (276), Expect = 2e-27
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 41/217 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG-----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHP 252
            L   +G G+FG VY+  L+       +EVAVK   ++   + ++ F  +  +M+ + HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCL-YSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           N+VK++  C+ ++   +V+EYMP G L + L  +    L +   L+  +     +EYL  
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL-- 119

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------------------- 344
             +   IH DL   + L+ E++V  +SDF  G+                           
Sbjct: 120 -ESKNFIHRDLAARNCLVGENLVVKISDF--GLSRDLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 345 -EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEEL 379
            EG+ +++SD++ +G++L E FT  ++P   M   E+
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV 213

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  109 bits (275), Expect = 3e-27
 Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 61/282 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-----GIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHP 252
            L   +G G+FG VY+  L+        +VAVK   +  +    + F  +  +MK + HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           N+V+++  C+  +   +V EYMP G L + L      L +   L + +     +EYL   
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL--- 118

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF----------EYGM-----------------E 345
            +   +H DL   + L+ E++V  +SDF           Y                   +
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 346 GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG 404
           G+ +++SD++ +G++L E FT  ++P   M                 S  EV++      
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-----------------SNEEVLELL---- 217

Query: 405 EKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
            + G+     E C   +  L ++C    PE R    ++V  L
Sbjct: 218 -EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  108 bits (273), Expect = 4e-27
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 33/196 (16%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCE--VMKSIRHPNLVKVISS 260
           +G GSFG+VY+A+ +  G  VAVK+  +   ++ K   A+ E  +++ + HPN+V++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
             + D   LV+EY   G L + L      L   +   I +     LEYL   H+  IIH 
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYL---HSNGIIHR 122

Query: 321 DLKPISVLLDEDMVAHLSDF--------------------EY------GMEGQVSTRSDI 354
           DLKP ++LLDE+ V  ++DF                     Y              + D+
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182

Query: 355 YGYGIVLMETFTRKKP 370
           +  G++L E  T K P
Sbjct: 183 WSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  101 bits (254), Expect = 2e-24
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 49/269 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVK 256
            +   +G GSFG VY AR  + G  VA+KV   ++  +  +    + +++K ++HPN+V+
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +     ++D   LV+EY   G L + L      L   +    +    S LEYL   H+  
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYL---HSKG 117

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF-------------------EYGM------EGQVSTR 351
           I+H DLKP ++LLDED    L+DF                   EY M             
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEY-MAPEVLLGKGYGKA 176

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA 411
            DI+  G++L E  T K P    F  +  L +    +          +  +S E K  + 
Sbjct: 177 VDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI- 231

Query: 412 KEQCVLSILGLAMECAMELPEKRINAKDI 440
             +       L  +     PEKR+ A++ 
Sbjct: 232 -RKL------LVKD-----PEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  106 bits (266), Expect = 2e-24
 Identities = 105/431 (24%), Positives = 191/431 (44%), Gaps = 68/431 (15%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
           N D S N   G +   +G+L  ++++ LS N LS ++P  +     L +L L++N+L   
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
                 ++  L  L+LS N++ G IP +L  +  L ++++S N L G +   G F+   A
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA 598

Query: 115 MSFKGNEPLCGSPNLQ-VPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVIILALKY 173
            +  GN  LCG      +PPCK        + RK       +     A  +V+ ++A  +
Sbjct: 599 SAVAGNIDLCGGDTTSGLPPCK--------RVRKTPSWWFYITCTLGAF-LVLALVAFGF 649

Query: 174 KLTKCGKRGLDV----SNDGILPSQATLRRLS---------------NLIGMGSFGSVYR 214
              + G+  L++    + DG    Q    ++S               N+I  G  G+ Y+
Sbjct: 650 VFIR-GRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYK 708

Query: 215 AR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY 273
            + +++G++  VK  +   +    S  A    M  ++HPN+VK+I  C ++    L+ EY
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIPS-SEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEY 764

Query: 274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM 333
           +   +L   L +    L   +R  I I     L +L+   +  ++  +L P  +++D   
Sbjct: 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820

Query: 334 VAHL---------SDFEYGMEG-----------QVSTRSDIYGYGIVLMETFTRKKPTDR 373
             HL         +D +  +              ++ +SDIYG+G++L+E  T K P D 
Sbjct: 821 EPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880

Query: 374 MFVEELSLKDW 384
            F    S+ +W
Sbjct: 881 EFGVHGSIVEW 891

Length = 968

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 99.1 bits (248), Expect = 1e-23
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 45/207 (21%)

Query: 202 NLIGMGSFGSVYRARLRDG----IEVAVKVFHQECAR--ALKSFEAQCEVMKSIRHPNLV 255
             +G G+FG VY+ +L+       EVAVK    E A     K F  +  VMK + HPN+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 256 KVISSCSNDDFKALVLEYMPKGSL-----ENCLYSSTCMLDIF---QRLNIMIDATSTLE 307
           +++  C+ ++   LVLEYM  G L     ++     +           L+  I     +E
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------- 340
           YL    +   +H DL   + L+ ED+V  +SDF                           
Sbjct: 120 YL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFTR 367
           E   +G  +++SD++ +G++L E FT 
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 29/205 (14%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           L   IG G FG V     R G +VAVK    + + A ++F A+  VM ++RHPNLV+++ 
Sbjct: 10  LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
                +   +V EYM KGSL + L S    ++ + Q+L   +D    +EYL        +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFV 124

Query: 319 HCDLKPISVLLDEDMVAHLSDF------EYGME----------------GQVSTRSDIYG 356
           H DL   +VL+ ED+VA +SDF        G +                 + ST+SD++ 
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 357 YGIVLMETFT-RKKPTDRMFVEELS 380
           +GI+L E ++  + P  R+ ++++ 
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 96.8 bits (241), Expect = 8e-23
 Identities = 61/194 (31%), Positives = 90/194 (46%), Gaps = 35/194 (18%)

Query: 203 LIGMGSFGSVYRARLRDGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVKVISSC 261
            IG G+FG VY+  L+   EVAVK         LK  F  + E++K   HPN+VK+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
                  +V+E +P GSL   L      L + + L + +DA + +EYL    +   IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRD 118

Query: 322 LKPISVLLDEDMVAHLSDFEYGME-----------------------------GQVSTRS 352
           L   + L+ E+ V  +SDF  GM                              G+ ++ S
Sbjct: 119 LAARNCLVGENNVLKISDF--GMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 353 DIYGYGIVLMETFT 366
           D++ YGI+L ETF+
Sbjct: 177 DVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 48/210 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNLV 255
               L+G GSFGSVY A  +D G  +AVK      +    L++ E +  ++ S++HPN+V
Sbjct: 3   TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62

Query: 256 KVISSCSNDDFKAL--VLEYMPKGSLENCLYSSTCMLDIFQRLNI------MIDATSTLE 307
           +   S  +++   L   LEY+  GSL     SS  +L  F +L               L 
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSL-----SS--LLKKFGKLPEPVIRKYTRQILEGLA 115

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------- 340
           YL   H+  I+H D+K  ++L+D D V  L+DF                           
Sbjct: 116 YL---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
           E     +    +DI+  G  ++E  T K P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 91.1 bits (227), Expect = 8e-21
 Identities = 58/194 (29%), Positives = 84/194 (43%), Gaps = 32/194 (16%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G FG VY+AR  R G EVA+KV   E     +    + +++K  +HPN+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+E+   GSL++ L  ST          I       L+ L + H+  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKD-LLKSTNQ--TLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124

Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVS--------------------------TRSDIYG 356
           K  ++LL  D    L DF  G+  Q+S                           ++DI+ 
Sbjct: 125 KAANILLTSDGEVKLIDF--GLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWS 182

Query: 357 YGIVLMETFTRKKP 370
            GI  +E    K P
Sbjct: 183 LGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 30/207 (14%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
            L   +G G FG V+    ++ + VA+K+   +     + F+ + + +K +RH +L+ + 
Sbjct: 9   TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           + CS  +   ++ E M KGSL   L S    +L +   +++       + YL   +    
Sbjct: 69  AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---S 125

Query: 318 IHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQVSTRS 352
           IH DL   ++L+ ED+V  ++DF                         E    G  ST+S
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKS 185

Query: 353 DIYGYGIVLMETFTRKK-PTDRMFVEE 378
           D++ +GI+L E FT  + P   M   E
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMNNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 62/205 (30%), Positives = 89/205 (43%), Gaps = 44/205 (21%)

Query: 200 LSNLIGMGSFGSVYRA-RLRDGIEVAVK--VFHQECARALKSFEAQCEVMKSIRHPNLVK 256
           L +LIG G+FG VY+   L  G  VA+K     +    ALKS   + +++K+++HPN+VK
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 257 VISSCSNDDFKALVLEYMPKGSLEN------CLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
            I S    D   ++LEY   GSL            S   + ++Q L         L YL 
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYL- 115

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------------EYGM-----EG 346
             H   +IH D+K  ++L  +D V  L+DF                    Y M     E 
Sbjct: 116 --HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 347 Q-VSTRSDIYGYGIVLMETFTRKKP 370
              ST SDI+  G  ++E  T   P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 71/291 (24%)

Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVK 256
           +G G+FG V+               VAVK   +  +  A K FE + E++ + +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS------------STCM-LDIFQRLNIMIDAT 303
               C+  D   +V EYM  G L   L S            S    L + Q L I +   
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------- 340
           S + YL   H    +H DL   + L+  D+V  + DF                       
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 341 ----EYGMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLME 395
               E  M  + +T SD++ +G+VL E FT  K+P   +  EE+               E
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI--------------E 235

Query: 396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
            + +  L    +       C   +  + + C    P++RIN KDI  RL K
Sbjct: 236 CITQGRLLQRPRT------CPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 34/193 (17%)

Query: 203 LIGMGSFGSVYRARLRDGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVKVISSC 261
           L+G G+FG V++  L+D   VAVK   ++  + LK  F ++  ++K   HPN+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
           +      +V+E +P G   + L      L   Q +   +DA + + YL    +   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRD 118

Query: 322 LKPISVLLDEDMVAHLSDFEYGME----------------------------GQVSTRSD 353
           L   + L+ E+ V  +SDF  GM                             G+ S+ SD
Sbjct: 119 LAARNCLVGENNVLKISDF--GMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 354 IYGYGIVLMETFT 366
           ++ YGI+L ETF+
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 31/205 (15%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           L  +IG G FG+V +     G +VAVK    +C    ++F  +  VM  + H NLV+++ 
Sbjct: 10  LGEIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
              ++    +V+E M KG+L N L +    ++ + Q L   +D    +EYL    +  ++
Sbjct: 67  VILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLV 122

Query: 319 HCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRSDIYG 356
           H DL   ++L+ ED VA +SDF                      E     + S++SD++ 
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182

Query: 357 YGIVLMETFTR-KKPTDRMFVEELS 380
           YG++L E F+  + P  +M ++E+ 
Sbjct: 183 YGVLLWEVFSYGRAPYPKMSLKEVK 207

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 39/209 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKS-FEAQCEVMKSIRHP 252
           +    +G G FG V   R   L D  G +VAVK  +       +S FE + E+++++ H 
Sbjct: 7   KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 253 NLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           N+VK    C     ++  L++EY+P GSL + L      +++ + L         ++YL 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL- 125

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EY 342
              +   IH DL   ++L++ + +  +SDF                            E 
Sbjct: 126 --GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 343 GMEGQVSTRSDIYGYGIVLMETFTRKKPT 371
               + S+ SD++ +G+ L E FT   P+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 31/195 (15%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   +    + ++F  + ++MK +RH  LV++ 
Sbjct: 9   KLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           + CS ++   +V EYM KGSL + L S         RL  ++D A    E + +  +   
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRNY 124

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL   ++L+ E++V  ++DF                          E    G+ + +
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 352 SDIYGYGIVLMETFT 366
           SD++ +GI+L E  T
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 31/197 (15%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V+  + R  I+VA+K+   E A +   F  + +VM  + HPNLV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                +V EYM  G L N L      L     L++  D    +EYL    +   IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLA 127

Query: 324 PISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTRSDIYGY 357
             + L+ ED V  +SDF                          E     + S++SD++ +
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSF 187

Query: 358 GIVLMETFTRKK-PTDR 373
           G+++ E F+  K P +R
Sbjct: 188 GVLMWEVFSEGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.9 bits (189), Expect = 7e-16
 Identities = 62/193 (32%), Positives = 90/193 (46%), Gaps = 32/193 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVK-VFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           +L   IG G FG V     R G +VAVK + +   A+A   F A+  VM  +RH NLV++
Sbjct: 9   KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQL 64

Query: 258 ISSCSNDDFKA-LVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           +     +     +V EYM KGSL + L S    +L     L   +D    +EYL      
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EAN 121

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRSD 353
             +H DL   +VL+ ED VA +SDF                      E   E + ST+SD
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 181

Query: 354 IYGYGIVLMETFT 366
           ++ +GI+L E ++
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 32/192 (16%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           IG G+FG V+  RLR D   VAVK   +     LK+ F  +  ++K   HPN+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
           +      +V+E +  G     L +    L + + + ++ +A + +EYL   H    IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119

Query: 322 LKPISVLLDEDMVAHLSDFEYGME---------------------------GQVSTRSDI 354
           L   + L+ E  V  +SDF    E                           G+ S+ SD+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179

Query: 355 YGYGIVLMETFT 366
           + +GI+L E F+
Sbjct: 180 WSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 69/295 (23%), Positives = 114/295 (38%), Gaps = 71/295 (24%)

Query: 199 RLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRH 251
           R    +G G+FG VY+  L           VA+K   +     ++  F  + E+M  ++H
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSST---------------CMLDIFQRL 296
           PN+V ++  C+ +    ++ EY+  G L   L  ++                 LD    L
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 297 NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------- 340
           +I I   + +EYL   H    +H DL   + L+ E +   +SDF                
Sbjct: 128 HIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 341 -----------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL 389
                      E  + G+ +T SDI+ +G+VL E F+        F  +           
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----------- 233

Query: 390 PISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
              ++E++    L          E C   +  L +EC  E+P +R   KDI TRL
Sbjct: 234 --EVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 72.5 bits (179), Expect = 2e-14
 Identities = 43/149 (28%), Positives = 63/149 (42%), Gaps = 17/149 (11%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVKVFH------QECARALKSFEAQCEVMKSIRHPNL 254
             IG GSFG VY  R   DG    +K         +E   AL   E +   +K + HPN+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN--EVKI--LKKLNHPNI 61

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF---QRLNIMIDATSTLEYLYF 311
           +K   S        +V+EY   G L   +         F   Q L+  +     L+YL  
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL-- 119

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            H+  I+H D+KP ++ L  + +  L DF
Sbjct: 120 -HSRKILHRDIKPQNIFLTSNGLVKLGDF 147

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 73.6 bits (179), Expect = 3e-14
 Identities = 63/213 (29%), Positives = 91/213 (42%), Gaps = 46/213 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVF---HQECARALKSFEAQCEVMKSIRHP-NL 254
           R+   +G GSFG VY AR  D   VA+KV     +  ++ ++ F  + +++ S+ HP N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLEN--CLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           VK+     ++    LV+EY+  GSLE+          L   + L I+    S LEYL   
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL--- 117

Query: 313 HTTPIIHCDLKPISVLLDED-MVAHLSDF------------------------------- 340
           H+  IIH D+KP ++LLD D  V  L DF                               
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                      S+ SDI+  GI L E  T   P
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 30/186 (16%)

Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G VY+A     G EVA+K          +    +  +MK  +HPN+V    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EYM  GSL + +  +   ++  Q   +  +    LEYL   H+  +IH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDI 142

Query: 323 KPISVLLDEDMVAHLSDFEYGMEG--QVSTRS-----------------------DIYGY 357
           K  ++LL +D    L+DF +  +   + S R+                       DI+  
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202

Query: 358 GIVLME 363
           GI+ +E
Sbjct: 203 GIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 9e-14
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 29/169 (17%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           D L  D  +  L G +  DI  L+ +  INLS N++  ++P ++G + SL+ L L+YN  
Sbjct: 421 DGLGLD--NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 61  DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI--LRGGPFVNFTAMSFK 118
           +               G IP SL +L  L+ L+L+ N L G +    GG  ++  + +F 
Sbjct: 479 N---------------GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523

Query: 119 GNEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVI 167
            N  LCG P L    C     G H         + I   +S A + +VI
Sbjct: 524 DNAGLCGIPGL--RAC-----GPHLSVGAK---IGIAFGVSVAFLFLVI 562

Length = 623

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 59/209 (28%), Positives = 84/209 (40%), Gaps = 47/209 (22%)

Query: 204 IGMGSFGSV----YRARLRDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVI 258
           +G G+FGSV    Y  +    +EVAVK   QE   A K  F  +  VM  + HP +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 259 SSCSNDDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
             C  +    LV+E  P G L   L       + D+     +       + YL   H   
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKH--- 115

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGME------------------------------G 346
            +H DL   +VLL     A +SDF  GM                               G
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDF--GMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 347 QVSTRSDIYGYGIVLMETFTR-KKPTDRM 374
           + S++SD++ YG+ L E F+   KP   M
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 31/206 (15%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + R   +VA+K+  +E + +   F  + +VM  + H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                +V EYM  G L N L          Q L +  D    + YL    +   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLA 127

Query: 324 PISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTRSDIYGY 357
             + L+D+     +SDF                          E  +  + S++SD++ +
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187

Query: 358 GIVLMETFTR-KKPTDRMFVEELSLK 382
           G+++ E ++  K P +R    E   K
Sbjct: 188 GVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 42/224 (18%)

Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           I PS+ TL      IG G FG V+     +  +VA+K   +E A + + F  + +VM  +
Sbjct: 1   IHPSELTL---VQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKL 56

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP LV++   C+      LV E+M  G L + L +          L + +D    + YL
Sbjct: 57  SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------------------ 345
               ++ +IH DL   + L+ E+ V  +SDF  GM                         
Sbjct: 117 ---ESSNVIHRDLAARNCLVGENQVVKVSDF--GMTRFVLDDQYTSSTGTKFPVKWSSPE 171

Query: 346 ----GQVSTRSDIYGYGIVLMETFTRKKP-----TDRMFVEELS 380
                + S++SD++ +G+++ E F+  K      ++   VE ++
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 9/160 (5%)

Query: 200 LSNLIGMGSFGSVYRA-RLRDGIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNLVK 256
             N IG G+FG VY A  L  G  +AVK         + +K    + +V++ ++HPNLVK
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                 + +   + +EY   G+LE  L        I     I +     LE L + H+  
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
           I+H D+KP ++ LD + V  L DF  G   ++   +   G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDF--GCAVKLKNNTTTMG 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 68/293 (23%), Positives = 110/293 (37%), Gaps = 79/293 (26%)

Query: 204 IGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVK 256
           IG G+FG V++AR            VAVK+  +E +  +++ F+ +  +M    HPN+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSST---------------------CMLDIFQR 295
           ++  C+      L+ EYM  G L   L   +                       L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------- 340
           L I     + + YL        +H DL   + L+ E+MV  ++DF               
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 341 ------------EYGMEGQVSTRSDIYGYGIVLMETFTRK-KPTDRMFVEELSLKDWVNN 387
                       E     + +T SD++ YG+VL E F+   +P   M  EE+        
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-------- 241

Query: 388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
                +  V D  +LS         + C L +  L   C  +LP  R +   I
Sbjct: 242 -----IYYVRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 22/157 (14%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
            +G GS+GSVY+A  ++ G  VA+KV        L+    +  ++K    P +VK   S 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID----AT---STLEYLYFGHT 314
             +    +V+EY   GS+           DI +  N  +     A     TL+ L + H+
Sbjct: 68  FKNTDLWIVMEYCGAGSV----------SDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTR 351
              IH D+K  ++LL+E+  A L+DF  G+ GQ++  
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADF--GVSGQLTDT 152

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 32/195 (16%)

Query: 200 LSNLIGMGSFGSVYRARL-RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY     +  + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 10  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             C+ +    ++ E+M  G+L + L       ++    L +    +S +EYL   +    
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125

Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYG--MEGQV------------------------STR 351
           IH DL   + L+ E+ +  ++DF     M G                          S +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 352 SDIYGYGIVLMETFT 366
           SD++ +G++L E  T
Sbjct: 186 SDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 35/197 (17%)

Query: 197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK 256
           LR+L    G G FG V+     +   VAVK          K F A+ ++MK +RHP L++
Sbjct: 11  LRKL----GAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQ 65

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTT 315
           + + C+ ++   +V E M  GSL   L       L + Q +++     S + YL   +  
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN-- 123

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   +VL+ E+ +  ++DF                          E  +  + S
Sbjct: 124 -YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS 182

Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +GI+L E  T
Sbjct: 183 IKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 50/156 (32%), Positives = 71/156 (45%), Gaps = 12/156 (7%)

Query: 203 LIGMGSFGSVYRA-RLRDGIEVAVKVF-----HQECARALKSFEAQCEVMKSIRHPNLVK 256
           L+G GSFGSVY    L DG   AVK        Q    A+K  E +  ++  ++HPN+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
            + +   +D   + LE +P GSL   L                      LEYL   H   
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYL---HDRN 122

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
            +H D+K  ++L+D + V  L+DF  GM  QV   S
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADF--GMAKQVVEFS 156

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 27/152 (17%)

Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-----------R 250
           +IG GSF +V  A+ +    E A+K+         K    + + +K +            
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLEN--CLYSSTCMLDIFQRLNIMIDATSTLEY 308
           HP ++K+  +  +++    VLEY P G L      Y S            ++ A   LEY
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA---LEY 117

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L   H+  IIH DLKP ++LLD+DM   ++DF
Sbjct: 118 L---HSKGIIHRDLKPENILLDKDMHIKITDF 146

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 49/210 (23%)

Query: 197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVK---VFHQECARALKSFEAQCEVMKSIRHP 252
           L R+  L G GS G VY+ R +  G   A+K   V   E  R  K    + + ++S   P
Sbjct: 3   LERVKVL-GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESP 59

Query: 253 NLVKVISSCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
            +VK    C    +K    ++VLEYM  GSL + L     + +      I       L+Y
Sbjct: 60  YVVK----CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDY 114

Query: 309 LYFGHTT-PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTR---------------- 351
           L   HT   IIH D+KP ++L++      ++DF  G+   +                   
Sbjct: 115 L---HTKRHIIHRDIKPSNLLINSKGEVKIADF--GISKVLENTLDQCNTFVGTVTYMSP 169

Query: 352 -----------SDIYGYGIVLMETFTRKKP 370
                      +DI+  G+ L+E    K P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 32/153 (20%)

Query: 204 IGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVIS 259
           +G GSFG V   R +   +  A+K+  +     LK  E    +  +++SIRHP LV +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---------IMIDA---TSTLE 307
           S  +D    LV+EY+P G             ++F  L              A      LE
Sbjct: 69  SFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           YL   H+  I++ DLKP ++LLD D    ++DF
Sbjct: 116 YL---HSLDIVYRDLKPENLLLDSDGYIKITDF 145

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 38/206 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH-----QECARALKSFEAQCEVMKSIRHP 252
           R   L+G G+FG VY     D G E+AVK         E  + + + E + +++K+++H 
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
            +V+      +D+  ++ +EYMP GS+++ L +   + +   R          LE + + 
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY----TRQILEGVEYL 120

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQV-- 348
           H+  I+H D+K  ++L D      L DF                       Y M  +V  
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 349 ----STRSDIYGYGIVLMETFTRKKP 370
                 ++D++  G  ++E  T K P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 44/212 (20%)

Query: 203 LIGMGSFGSVYRA-RLRDGIEVAVKVF---------HQECARAL-KSFEAQCEVMKSIRH 251
           LIG G++G VY A  +  G  +AVK           H    + + K+  ++ E +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
            N+V+ +   + +++ ++ LEY+P GS+ +CL         F+   +       LE L +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAY 123

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDFE--------YG------MEGQV--------- 348
            H+  I+H DLK  ++L+D D +  +SDF         Y       M+G V         
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183

Query: 349 ------STRSDIYGYGIVLMETFTRKKPTDRM 374
                 S + DI+  G V++E F  ++P    
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 55/265 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 9   RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 67

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L       L + Q +++     S + Y+        
Sbjct: 68  AVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNY 123

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 184 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 222

Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 223 PCPPECPESLHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 44/225 (19%)

Query: 203 LIGMGSFGSVYRA-RLRDGIEVAVKVF--HQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           ++G G+FG V+   R  D   V +K     Q       + + +C+V+K + HPN+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY-------LYFG 312
           +   D    +V+EY P G+L            I +R N ++D  + L +       L+  
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 313 HTTPIIHCDLKPISVLLDE-DMVAHLSDF----EYGMEGQVST----------------- 350
           HT  I+H DLK  ++LLD+  MV  + DF        + +  T                 
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177

Query: 351 ---RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS 392
              +SDI+  G VL E  + K+  +   +  L LK       PIS
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 51/144 (35%), Positives = 72/144 (50%), Gaps = 17/144 (11%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
              +SN L G +  ++G +K++  I L  NNLS ++P  IGGL SL  L L YN L    
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI------LRGGPF 109
                ++ +L+ L L  N++ G IP S+  L  L  L LS N L GEI      L+    
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312

Query: 110 VNFTAMSFKGNEP--LCGSPNLQV 131
           ++  + +F G  P  L   P LQV
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQV 336

Length = 968

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 55/216 (25%)

Query: 200 LSNLIGMGSFGSVYRARLR--DG--IEVAVKVF------HQECARALKSFEAQCEVMKSI 249
           L  ++G G FGSV   +L   DG  ++VAVK        + E    L   EA C  MK  
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS--EAAC--MKDF 58

Query: 250 RHPNLVKVISSC----SNDDFKA--LVLEYMPKGSLEN-CLYSSTCMLDIF---QRL-NI 298
            HPN++K+I  C    S        ++L +M  G L +  LYS    L      Q L   
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------EYGMEGQVS 349
           M+D    +EYL        IH DL   + +L EDM   ++DF         +Y  +G+++
Sbjct: 119 MVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 350 ------------------TRSDIYGYGIVLMETFTR 367
                             ++SD++ +G+ + E  TR
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 65/289 (22%), Positives = 114/289 (39%), Gaps = 70/289 (24%)

Query: 200 LSNLIGMGSFGSVYRAR------LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           L   +G G+FG V+ A        +D + VAVK        A K F+ + E++ +++H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYS---------------STCMLDIFQRLNI 298
           +VK    C + D   +V EYM  G L   L +               +   L + Q L+I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------ 340
                S + YL   H    +H DL   + L+  +++  + DF                  
Sbjct: 129 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 341 ---------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI 391
                    E  M  + +T SD++ +G++L E FT  K            + W   L   
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWF-QLSNT 232

Query: 392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
            ++E + +  +  E+     KE     +  + + C    P++R+N K+I
Sbjct: 233 EVIECITQGRVL-ERPRVCPKE-----VYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 65/290 (22%), Positives = 109/290 (37%), Gaps = 69/290 (23%)

Query: 204 IGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           +G G+FG V+ A        +D + VAVK   +    A + F+ + E++  ++H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYS--------------STCMLDIFQRLNIMIDAT 303
              C+      +V EYM  G L   L S              +   L + Q L I     
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------- 340
           S + YL   H    +H DL   + L+ + +V  + DF                       
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 341 ----EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV 396
               E  +  + +T SDI+ +G+VL E FT  K            + W      +S  E 
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQ----LSNTEA 233

Query: 397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
           ++      E +       C   +  +   C    P++R+  KDI +RL  
Sbjct: 234 IECITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 45/232 (19%)

Query: 204 IGMGSFGSV--YR---ARLRDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKV 257
           +G G FG V  Y    A    G  VAVK   +EC +   S ++ +  ++K++ H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 258 ISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
              CS    K   L++EY+P GSL + L      L       +++ A    E + + H+ 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA-----QLLLFAQQICEGMAYLHSQ 126

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF----------------------------EYGMEGQ 347
             IH DL   +VLLD D +  + DF                            E   E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 348 VSTRSDIYGYGIVLMETFTRKKPTD---RMFVEELSLKDWVNNLLP-ISLME 395
            S  SD++ +G+ L E  T         + F E +  K     ++  I L+E
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 47/209 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEV--AVKVFHQECARA-LKSFEAQCEVM-KSIRHPN 253
           +  ++IG G+FG V RA ++ DG+++  A+K+  +  +    + F  + EV+ K   HPN
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM---------------LDIFQRLNI 298
           ++ ++ +C N  +  + +EY P G+L + L  S  +               L   Q L  
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV---------- 348
             D  + ++YL        IH DL   +VL+ E++ + ++DF      +V          
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181

Query: 349 --------------STRSDIYGYGIVLME 363
                         +T+SD++ +G++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 47/212 (22%)

Query: 200 LSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPN 253
           L  ++G G FGSV  A+L+       +VAVK+   +   +  ++ F  +   MK   HPN
Sbjct: 3   LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 254 LVKVISSCSNDDFKA------LVLEYMPKGSLENCLYSSTCMLDIFQ-----RLNIMIDA 302
           ++K+I        K       ++L +M  G L   L  S    + F       +  MID 
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------EYGMEGQVS---- 349
            S +EYL    +   IH DL   + +L+E+M   ++DF         +Y  +G  S    
Sbjct: 123 ASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 350 --------------TRSDIYGYGIVLMETFTR 367
                         T SD++ +G+ + E  TR
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 37/208 (17%)

Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           I PS+ T  +    +G G FG V+  + R  I+VA+K    E A + + F  + +VM  +
Sbjct: 1   INPSELTFMKE---LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKL 56

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP LV++   C+      +V E+M  G L N L      L     L++  D    +EYL
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV--------------------- 348
                   IH DL   + L+    V  +SDF  GM   V                     
Sbjct: 117 ---ERNSFIHRDLAARNCLVSSTGVVKVSDF--GMTRYVLDDEYTSSSGAKFPVKWSPPE 171

Query: 349 -------STRSDIYGYGIVLMETFTRKK 369
                  S++SD++ +G+++ E FT  K
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 7/147 (4%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G++G VY+AR +  G   A+KV   E        + +  +MK  +H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   + +E+   GSL++ +Y  T  L       I   +  TL+ LY+ H+   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPL---SESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVS 349
           K  ++LL ++    L+DF  G+  Q++
Sbjct: 133 KGANILLTDNGHVKLADF--GVSAQIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 40/213 (18%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++ G+  A K+   E    L+ F  + +++   +HPN+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
            ++   +++E+   G+L++       ML++ + L    I       LE L F H+  +IH
Sbjct: 73  YENKLWILIEFCDGGALDS------IMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126

Query: 320 CDLKPISVLLDEDMVAHLSDF-------------------EYGMEGQV-----------S 349
            DLK  ++LL  D    L+DF                    Y M  +V            
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186

Query: 350 TRSDIYGYGIVLMETFTRKKPTDRMFVEELSLK 382
            ++DI+  GI L+E    + P   +    + LK
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 62.9 bits (154), Expect = 3e-11
 Identities = 48/145 (33%), Positives = 67/145 (46%), Gaps = 16/145 (11%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVF-------HQECARALKSFEAQCEVMKSIRHPNLV 255
           +G GSFG V   R +D G   A+KV         +E    L   E    ++  I HP +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT--ERN--ILSRINHPFIV 56

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+  +   ++   LVLEY P G L + L       +   R     +    LEYL   H+ 
Sbjct: 57  KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYL---HSL 112

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF 340
            II+ DLKP ++LLD D    L+DF
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDF 137

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 40/200 (20%)

Query: 203 LIGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK- 256
            +G G+FGSV   R   L+D  G  VAVK      A  L+ FE + E++KS++H N+VK 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 257 --VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
             V  S    + + LV+EY+P GSL + L      LD  + L         +EYL    +
Sbjct: 71  KGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF----------EYGM------------------EG 346
              +H DL   ++L++ +    + DF          EY                    E 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 347 QVSTRSDIYGYGIVLMETFT 366
           + S  SD++ +G+VL E FT
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++ G   A KV   +    L+ +  + E++ +  HP +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDI---FQRLNIMIDATSTLEYLYFGHTTPIIH 319
            D    +++E+ P G+++        ML++        I +     LE L + H+  IIH
Sbjct: 80  WDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  +VLL  D    L+DF
Sbjct: 134 RDLKAGNVLLTLDGDIKLADF 154

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 20/155 (12%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G++G VY+AR +  G  VA+KV   E     +  + +  ++K  RHPN+V    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT-------STLEYLYFGHTT 315
             D   +V+EY   GSL+          DI+Q     +           TL+ L + H T
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVST 350
             IH D+K  ++LL ED    L+DF  G+  Q++ 
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADF--GVSAQLTA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 47/206 (22%)

Query: 202 NLIGMGSFGSVYRARLR-DGIEV--AVKVFHQECARA-LKSFEAQCEVM-KSIRHPNLVK 256
           ++IG G+FG V +AR++ DG+ +  A+K   +  ++   + F  + EV+ K   HPN++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCM---------------LDIFQRLNIMID 301
           ++ +C +  +  L +EY P G+L + L  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV------------- 348
               ++YL        IH DL   ++L+ E+ VA ++DF      +V             
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 349 -----------STRSDIYGYGIVLME 363
                      +T SD++ YG++L E
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 45/209 (21%)

Query: 203 LIGMGSFGSVYRA-RLRDGIEVAVK------VFHQECARA---LKSFEAQCEVMKSIRHP 252
           LIG GSFGSVY       G  +AVK      V      R    L +   +  ++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           N+V+ + S  + D   + LEY+P GS+   L +     +   R N +      L YL   
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL--- 122

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQ 347
           H   IIH D+K  ++L+D      +SDF                          + M  +
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 348 V------STRSDIYGYGIVLMETFTRKKP 370
           V      + ++DI+  G +++E  T K P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 48/194 (24%), Positives = 79/194 (40%), Gaps = 31/194 (15%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARAL-KSFEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V +   R  G  +AVK    E   A+ K    + +++     P +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
            N+   ++ +EYM  GSL+  L      +       I +     L YL+      IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHRD 126

Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIYG 356
           +KP ++L++      L DF  G+ GQ+                         S +SDI+ 
Sbjct: 127 VKPSNILVNSRGQIKLCDF--GVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWS 184

Query: 357 YGIVLMETFTRKKP 370
            G+ L+E  T + P
Sbjct: 185 LGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 62.1 bits (152), Expect = 9e-11
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 25/149 (16%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQE---------CARALKSFEAQCEV--MKSIRH 251
           +G G++G VY+AR  + G  VA+K    +           R         E+  +K ++H
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR---------EISLLKELKH 57

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           PN+VK++     +    LV EY     L+  L      L      +IM      L Y   
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC-- 114

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            H+  I+H DLKP ++L++ D V  L+DF
Sbjct: 115 -HSHRILHRDLKPQNILINRDGVLKLADF 142

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 73/303 (24%)

Query: 191 LPSQATLRRLSNLIGMGSFGSVYRARLR-DGIE----VAVKVFHQ-ECARALKSFEAQCE 244
           LP  A   R    +G  +FG +Y+  L   G++    VA+K        +    F+ +  
Sbjct: 2   LPLSAV--RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEAS 59

Query: 245 VMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSST----------------C 288
           +M  + HPN+V ++   + +    ++ EY+ +G L   L   +                 
Sbjct: 60  LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119

Query: 289 MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------- 340
            LD    L+I I   + +EYL    +   +H DL   ++L+ E +   +SD         
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 341 -------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL 381
                              E  M G+ S+ SDI+ +G+VL E F+        F  +   
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--- 233

Query: 382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV 441
                      ++E+V K  L          E C   +  L  EC  E P +R   KDI 
Sbjct: 234 ----------EVIEMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277

Query: 442 TRL 444
           TRL
Sbjct: 278 TRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 59/178 (33%), Positives = 81/178 (45%), Gaps = 13/178 (7%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARA---LKSFEAQCEVM-KSIRHPNLVKVI 258
           IG GSFG V  A+ + DG   AVKV  ++        K   A+  V+ K+++HP LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            S    D    VL+Y+  G L   L       +   R     +  S L YL   H+  II
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYL---HSLNII 118

Query: 319 HCDLKPISVLLDEDMVAHLSDF---EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDR 373
           + DLKP ++LLD      L+DF   + G+E    T S   G    L     RK+P DR
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDR 175

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 33/154 (21%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVF---------HQECARALKSFEAQCEVMKSIRHP 252
           ++G G++G V + R +  G  VA+K F          +   R +K       V++ +RH 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK-------VLRQLRHE 60

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLE------NCLYSSTCMLDIFQRLNIMIDATSTL 306
           N+V +  +        LV EY+ +  LE        L        I+Q           L
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ----------LL 110

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           + + + H+  IIH D+KP ++L+ E  V  L DF
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 42/204 (20%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVIS 259
           IG GSFG+VY AR +R    VA+K       ++ + ++    +   ++ +RHPN ++   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81

Query: 260 SCSNDDFKA-LVLEYMPKGSLENCLYSSTCMLDI----FQRLNIMIDATSTLEYLYFGHT 314
            C   +  A LV+EY        CL S++ +L++     Q + I       L+ L + H+
Sbjct: 82  GCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF---------------EYGM---------EGQVST 350
              IH D+K  ++LL E     L+DF                Y M         EGQ   
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 351 RSDIYGYGIVLMETFTRKKPTDRM 374
           + D++  GI  +E   RK P   M
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 61/182 (33%), Positives = 86/182 (47%), Gaps = 19/182 (10%)

Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVM-------KSIRHPNL 254
           +IG GSFG V  A+ + DG   AVKV  ++    LK  E Q  +M       K+++HP L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI--LKKKE-QNHIMAERNVLLKNLKHPFL 58

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           V +  S    +    VL+Y+  G L   L    C L+   R     +  S + YL   H+
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYL---HS 114

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF---EYGMEGQVSTRSDIYGYGIVLMETFTRKKPT 371
             II+ DLKP ++LLD      L+DF   + G+E +  T S   G    L     RK+P 
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPY 173

Query: 372 DR 373
           DR
Sbjct: 174 DR 175

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 47/209 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGI--EVAVKVFHQECARA-LKSFEAQCEVMKSI-RHPN 253
           +  ++IG G+FG V +AR++ DG+  + A+K   +  ++   + F  + EV+  +  HPN
Sbjct: 10  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCL---------------YSSTCMLDIFQRLNI 298
           ++ ++ +C +  +  L +EY P G+L + L                S+   L   Q L+ 
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--EYGMEGQV-------- 348
             D    ++YL        IH DL   ++L+ E+ VA ++DF    G E  V        
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 349 --------------STRSDIYGYGIVLME 363
                         +T SD++ YG++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 49/211 (23%)

Query: 202 NLIGMGSFGSVYRARLRD-------GIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPN 253
           N +G G+FG VY     D        I VAVK   +      K  F  +  +M +  HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSS------TCMLDIFQRLNIMIDATSTLE 307
           +VK++  C  ++ + +++E M  G L + L  +        +L + + L+I +D      
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 308 YLYFGHTTPIIHCDLKPISVLLDE-----DMVAHLSDF---------------------- 340
           YL   H    IH DL   + L+ E     D V  + DF                      
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 341 -----EYGMEGQVSTRSDIYGYGIVLMETFT 366
                E  ++G+ +T+SD++ +G+++ E  T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 3/143 (2%)

Query: 200 LSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKV 257
           L  +IG+G+   VY A  L +  +VA+K    E C  ++     + + M    HPN+VK 
Sbjct: 5   LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
            +S    D   LV+ Y+  GSL + + SS           I       L+ L + H+   
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123

Query: 318 IHCDLKPISVLLDEDMVAHLSDF 340
           IH D+K  ++LL ED    ++DF
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADF 146

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 50/143 (34%), Positives = 69/143 (48%), Gaps = 17/143 (11%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-- 61
           + D   N+L GP+   +GNLK +  + L +N LS  +P +I  L  L +L L+ N L   
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 62  -------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFT 113
                  + +LEIL+L +N   G IP +L  L  L+ L L  NK  GEI +  G   N T
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359

Query: 114 AMSFKGN-------EPLCGSPNL 129
            +    N       E LC S NL
Sbjct: 360 VLDLSTNNLTGEIPEGLCSSGNL 382

Length = 968

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 42/204 (20%)

Query: 204 IGMGSFGSVYRARLRD------GIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLV 255
           +G GSFG VY    +          VA+K  + E A  R    F  +  VMK     ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYS------STCMLDIFQRLNIMIDATSTLEYL 309
           +++   S      +V+E M KG L++ L S      +   L        +  A    + +
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------------EY 342
            +      +H DL   + ++ ED+   + DF                           E 
Sbjct: 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192

Query: 343 GMEGQVSTRSDIYGYGIVLMETFT 366
             +G  +T+SD++ +G+VL E  T
Sbjct: 193 LKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 48/215 (22%)

Query: 200 LSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           L   +G G+FG V+ A        +D I VAVK        A K F  + E++ +++H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYS------------STCMLDIFQRLNIMID 301
           +VK    C   D   +V EYM  G L   L +                L   Q L+I   
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------- 340
             + + YL   H    +H DL   + L+ E+++  + DF                     
Sbjct: 129 IAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKK 369
                 E  M  + +T SD++  G+VL E FT  K
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 23/188 (12%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARA---LKSFEAQCEVMKSIRHPNLVKVI 258
           L+G G  G V+  RL+   ++ A+KV  ++       +K    + E++ ++ HP L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 259 SSCSNDDFKALVLEYMPKGSL--------ENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           +S   + +  LV++Y P G L          CL         F    +++     LEYL 
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR---FYAAEVLL----ALEYL- 119

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
             H   I++ DLKP ++LL E     LSDF+   +  V                 +    
Sbjct: 120 --HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR-KGSRRSSVNSI 176

Query: 371 TDRMFVEE 378
               F EE
Sbjct: 177 PSETFSEE 184

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 56/195 (28%), Positives = 81/195 (41%), Gaps = 49/195 (25%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG GS G V  A     G +VAVK     ++  R L   E    +M+  +HPN+V++ SS
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV--IMRDYQHPNIVEMYSS 84

Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST-----LEYLYFGHTT 315
               D   +V+E++  G+L           DI     +  +  +T     L+ L F H  
Sbjct: 85  YLVGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVS-------------------------- 349
            +IH D+K  S+LL  D    LSDF  G   QVS                          
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDF--GFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 350 -TRSDIYGYGIVLME 363
            T  DI+  GI+++E
Sbjct: 193 GTEVDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 40/141 (28%), Positives = 75/141 (53%), Gaps = 10/141 (7%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++ G+  A KV   +    L+ +  + +++ S  HPN+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTPIIH 319
            ++   +++E+   G+++        ML++ + L    I +    TLE L + H   IIH
Sbjct: 73  YENNLWILIEFCAGGAVD------AVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  ++L   D    L+DF
Sbjct: 127 RDLKAGNILFTLDGDIKLADF 147

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 31/198 (15%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+     +  +VAVK   +    ++++F  +  +MK+++H  LV++ 
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLY 67

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + ++   ++ EYM KGSL + L S      +  +L   ID ++ + E + +      
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNY 124

Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  +VL+ E ++  ++DF         EY                    G  + +
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  K
Sbjct: 185 SDVWSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 46/208 (22%), Positives = 87/208 (41%), Gaps = 43/208 (20%)

Query: 195 ATLRRLSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQECARALKS-FEAQCEVMKSI 249
            +   +  +IG G FG V R RL    +  I+VA+K      +   +  F  +  +M   
Sbjct: 3   PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HPN++++    +      ++ EYM  GSL+  L  +     + Q + ++    S ++YL
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 310 ----YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEG-------- 346
               Y        H DL   ++L++ ++V  +SDF            Y  +G        
Sbjct: 123 SEMNYV-------HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT 175

Query: 347 --------QVSTRSDIYGYGIVLMETFT 366
                   + ++ SD++ +GIV+ E  +
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 46/211 (21%)

Query: 200 LSNLIGMGSFGSVYRARLRDG---IEVAVKVFHQE-CARA-LKSFEAQCEVMKSIRHPNL 254
           L   +G G FGSV   +L      ++VAVK      C R+ ++ F ++   MK   HPN+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 255 VKVISSC----SNDDFKA--LVLEYMPKGSLEN-CLYSSTCMLDIF---QRL-NIMIDAT 303
           +++I  C     ++ + +  ++L +M  G L +  LYS       +   Q L   M D  
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------EYGMEGQVS----- 349
           S +EYL    +   IH DL   + +L+E+M   ++DF         +Y  +G+++     
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 350 -------------TRSDIYGYGIVLMETFTR 367
                        T+SD++ +G+ + E  TR
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 8/146 (5%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEV-AVKVFH-QEC--ARALKSFEAQCEVMKSIRHPNL 254
            L  +IG G+FG V   + RD  ++ A+K  + Q+C    ++++   +  +++ + HP L
Sbjct: 3   ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           V +  S  +++   LV++ +  G L   L       +   +   + +    LEYL   H+
Sbjct: 63  VNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYL---HS 118

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH D+KP ++LLDE    H++DF
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDF 144

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 71/301 (23%), Positives = 118/301 (39%), Gaps = 78/301 (25%)

Query: 200 LSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQECA-RALKSFEAQCEVMKSI-RH 251
           L   +G G+FG V +A             VAVK+   +   + L    ++ E+MK I +H
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YSSTCMLDIFQRLNIMIDA 302
            N++ ++  C+ +    +V+EY   G+L + L          S        + L    D 
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT-QKDL 134

Query: 303 TST-------LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY---- 342
            S        +E+L    +   IH DL   +VL+ ED V  ++DF         +Y    
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 343 -------------GMEGQVST-RSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNN 387
                         +  +V T +SD++ +G++L E FT    P   + VEEL        
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF------- 244

Query: 388 LLPISLMEVVDKTLLSGEKKGFVAKEQ-CVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
                      K L  G +   + K Q C   +  L  +C  E+P +R   K +V  L +
Sbjct: 245 -----------KLLKEGYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290

Query: 447 I 447
           +
Sbjct: 291 M 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 55/193 (28%), Positives = 85/193 (44%), Gaps = 31/193 (16%)

Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA+K  + +     +    +  VM+  +HPN+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM        I       L+ L F H+  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV-TETCM----DEGQIAAVCRECLQALEFLHSNQVIHRDI 141

Query: 323 KPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DIYGY 357
           K  ++LL  D    L+DF                    Y M  +V TR       DI+  
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 358 GIVLMETFTRKKP 370
           GI+ +E    + P
Sbjct: 202 GIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 40/208 (19%)

Query: 194 QATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVF---HQECARALKSFEAQCEVM 246
            A+  ++  +IG G FG V   RL+      I VA+K     + E  R  + F ++  +M
Sbjct: 2   DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIM 59

Query: 247 KSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL 306
               HPN++ +    +      +V EYM  GSL+  L        + Q + ++    S +
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR--------- 351
           +YL        +H DL   ++L++ ++V  +SDF      E   E   +TR         
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176

Query: 352 -------------SDIYGYGIVLMETFT 366
                        SD++ YGIV+ E  +
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 40/203 (19%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVIS 259
           IG GSFG+VY AR +R+   VA+K       ++ + ++    +   ++ +RHPN ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI----FQRLNIMIDATSTLEYLYFGHTT 315
               +    LV+EY        CL S++ +L++     Q + I       L+ L + H+ 
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF---------------EYGM---------EGQVSTR 351
            +IH D+K  ++LL E  +  L DF                Y M         EGQ   +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 352 SDIYGYGIVLMETFTRKKPTDRM 374
            D++  GI  +E   RK P   M
Sbjct: 195 VDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 32/195 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VA+K   ++ + + ++F A+  +MK ++HP LV++ 
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLY 67

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L +      I   +N +ID  + + E + F      
Sbjct: 68  AVVTQEPI-YIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+ E +   ++DF         EY                    G  + +
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 352 SDIYGYGIVLMETFT 366
           SD++ +GI+L E  T
Sbjct: 184 SDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 45/198 (22%), Positives = 90/198 (45%), Gaps = 32/198 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+        +VA+K   +      ++F  + ++MK +RH  LV + 
Sbjct: 9   RLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLY 67

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  S +    +V E+M KGSL + L         + +L  ++D  + + + + +      
Sbjct: 68  AVVSEEPI-YIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMNY 123

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ +++V  ++DF                          E  + G+ + +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 184 SDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 39/217 (17%)

Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLR-DG----IEVAVKVFHQECAR-ALKSFEAQC 243
            +  +  L ++  L G G+FG+VY+     +G    I VA+KV  +E +  A K    + 
Sbjct: 2   RILKETELEKIKVL-GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60

Query: 244 EVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT 303
            VM S+ HP++V+++  C +     L+ + MP G L + + +    +     LN  +   
Sbjct: 61  YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEG------ 346
             + YL       ++H DL   +VL+       ++DF           EY  EG      
Sbjct: 120 KGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 347 ----------QVSTRSDIYGYGIVLMETFT-RKKPTD 372
                       + +SD++ YG+ + E  T   KP +
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 19/165 (11%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVK---VFHQECARALKSFEAQCEV--MKSIRHPNLV 255
             +G G++  VY+AR    G  VA+K   +  ++ A+   +F A  E+  ++ ++HPN++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
            ++    +     LV E+M    LE  +   + +L      + M+     LEYL   H+ 
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSN 121

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF----EYG-----MEGQVSTR 351
            I+H DLKP ++L+  D V  L+DF     +G     M  QV TR
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 12/150 (8%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVF-----HQECARALKSFEAQCEVMKSIRHP 252
           RL  L+G G+FG VY     D G E+AVK        QE ++ + + E + +++K++RH 
Sbjct: 5   RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64

Query: 253 NLVKVISSCSNDDFKALVL--EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
            +V+      + + K L +  EYMP GS+++ L +   + +   R          L+ + 
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY----TRQILQGVS 120

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           + H+  I+H D+K  ++L D      L DF
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDF 150

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 40/140 (28%), Positives = 72/140 (51%), Gaps = 3/140 (2%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           ++G G++G VY AR L   + +A+K   +  +R ++    +  +   ++H N+V+ + S 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
           S + F  + +E +P GSL   L S    L   ++  I+      LE L + H   I+H D
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 322 LKPISVLLDE-DMVAHLSDF 340
           +K  +VL++    V  +SDF
Sbjct: 134 IKGDNVLVNTYSGVVKISDF 153

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 15/144 (10%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQ------ECARALKSFEAQCEVMKSIRHPNLVK 256
           IG G++G VY+AR    G  VA+K              AL+  +     +K + HPN++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKL----LKELNHPNIIK 62

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           ++    +     LV E+M    L   +      L      + +      L+ L F H+  
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLY---QLLQGLAFCHSHG 118

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF 340
           I+H DLKP ++L++ + V  L+DF
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADF 142

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 56/178 (31%), Positives = 80/178 (44%), Gaps = 11/178 (6%)

Query: 203 LIGMGSFGSVYRA-RLRDGIEVAVKVFHQECA---RALKSFEAQCEVM-KSIRHPNLVKV 257
           +IG GSFG V  A R  DG   AVKV  ++     +  K   A+  V+ K+++HP LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             S    +    VL+++  G L   L       +   R     +  S L YL   H+  I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYL---HSINI 117

Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG--QVSTRSDIYGYGIVLMETFTRKKPTDR 373
           ++ DLKP ++LLD      L+DF    EG  Q  T +   G    L     RK+P D 
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 64/280 (22%), Positives = 99/280 (35%), Gaps = 60/280 (21%)

Query: 203 LIGMGSFGSVYRAR----LRDGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKV 257
            +G GSFG V R          I VAVK    +  +  +  F  +  +M S+ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF--QRL-NIMIDATSTLEYLYFGHT 314
                      +V E  P GSL + L      L  F    L +  +   + + YL    +
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYL---ES 115

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGME-----------------G 346
              IH DL   ++LL  D    + DF            Y ME                  
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 347 QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK 406
             S  SD++ +G+ L E FT        + EE     W   L    +++ +DK     E 
Sbjct: 176 TFSHASDVWMFGVTLWEMFT--------YGEE----PWA-GLSGSQILKKIDK-----EG 217

Query: 407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
           +     E C   I  + ++C    P  R     +   L +
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 29/152 (19%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVM--KSIRHPNLVK---- 256
           IG G++G VY+AR  + G  VA+K    E  +      A  E+   + +RHPN+V+    
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 257 VISSCSNDDFKALVLEYMP---KGSLENCLYSST-----CMLDIFQRLNIMIDATSTLEY 308
           V S      +  +V EYM     G L++     T     C     ++L         LE 
Sbjct: 67  VTSKGKGSIY--MVFEYMDHDLTGLLDSPEVKFTESQIKC---YMKQL---------LEG 112

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L + H+  I+H D+K  ++L++ D V  L+DF
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADF 144

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFE---AQCEVMKSIRHPNL 254
                +G G+FG V+  R R      A+KV        LK  +    +  V+K + HP +
Sbjct: 4   ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYF 311
           +++  +  +  F  +++EY+P G L + L +S   +    +F    I+      LEYL  
Sbjct: 64  IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV----CALEYL-- 117

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME 345
            H+  I++ DLKP ++LLD++    L+DF +  +
Sbjct: 118 -HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK 150

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 40/203 (19%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVIS 259
           IG GSFG+VY AR +R    VA+K       ++ + ++    + + ++ I+HPN ++   
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI----FQRLNIMIDATSTLEYLYFGHTT 315
               +    LV+EY        CL S++ +L++     Q + I       L+ L + H+ 
Sbjct: 93  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF---------------EYGM---------EGQVSTR 351
            +IH D+K  ++LL E     L+DF                Y M         EGQ   +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 352 SDIYGYGIVLMETFTRKKPTDRM 374
            D++  GI  +E   RK P   M
Sbjct: 205 VDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 52/214 (24%)

Query: 199 RLSNLIGMGSFGSVYRA--RLRDG----IEVAVKVFHQECARALKS-FEAQCEVMKSIRH 251
            L   +G G+FG VY    R RDG    ++VAVK   + C+   +S F  +  +M    H
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDA 302
            N+V++I        + ++LE M  G L++ L          SS  M D+   L    D 
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDV 125

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDF------------------- 340
               +YL   H    IH D+   + LL       VA ++DF                   
Sbjct: 126 AKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 341 --------EYGMEGQVSTRSDIYGYGIVLMETFT 366
                   E  ++G  ++++D++ +G++L E F+
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 40/208 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH-----QECARALKSFEAQCEVMKSIRHP 252
           RL  L+G G+FG VY     D G E+AVK         E ++ + + E + +++K++ H 
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 253 NLVKVISSCSNDDFKAL--VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
            +V+      +   + L   +E+MP GS+++ L S   + +   R          LE + 
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY----TRQILEGVS 120

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQV 348
           + H+  I+H D+K  ++L D      L DF                       Y M  +V
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 349 ST------RSDIYGYGIVLMETFTRKKP 370
            +      ++DI+  G  ++E  T K P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 46/193 (23%), Positives = 87/193 (45%), Gaps = 32/193 (16%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V+        +VAVK   +    + +SF  + ++MK +RH  LV++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 264 DDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
           +    +V EYM KGSL + L       L +   +++     + + Y+        IH DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDL 128

Query: 323 KPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTRSDIYG 356
           +  ++L+ + +V  ++DF                          E  + G+ + +SD++ 
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 357 YGIVLMETFTRKK 369
           +GI+L E  T+ +
Sbjct: 189 FGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 45/205 (21%), Positives = 88/205 (42%), Gaps = 42/205 (20%)

Query: 199 RLSNLIGMGSFGSVYRARL----RDGIEVAVKVF---HQECARALKSFEAQCEVMKSIRH 251
           ++  +IG G FG V R RL    +  I VA+K     + E  R  + F ++  +M    H
Sbjct: 7   KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDH 64

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           PN++ +    +      ++ E+M  G+L++ L  +     + Q + ++    + ++YL  
Sbjct: 65  PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-- 122

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------EYGMEGQVSTR----- 351
                 +H DL   ++L++ ++V  +SDF                  + G++  R     
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 352 ----------SDIYGYGIVLMETFT 366
                     SD++ YGIV+ E  +
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVA---VKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           IG G F  VY+A  L DG  VA   V++F    A+A +    + +++K + HPN++K ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA----------TSTLEYL 309
           S   ++   +VLE    G L         M+  F++   +I             S LE++
Sbjct: 70  SFIENNELNIVLELADAGDLSR-------MIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG 343
              H+  I+H D+KP +V +    V  L D   G
Sbjct: 123 ---HSKRIMHRDIKPANVFITATGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 55.6 bits (135), Expect = 1e-08
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 23/152 (15%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVK----VFH--QECARALKSFEAQCEVMKSIRHPNL 254
             IG G++G V  A   R G +VA+K    VF    +  R L+    + ++++ +RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 255 VK---VISSCSNDDFKAL--VLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEY 308
           +    ++   S +DF  +  V E M    L   + S      D  Q    +      L+Y
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY--FLYQILRGLKY 118

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L   H+  +IH DLKP ++L++ +    + DF
Sbjct: 119 L---HSANVIHRDLKPSNILVNSNCDLKICDF 147

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 56/283 (19%)

Query: 200 LSNLIGMGSFGSVYRA----RLRDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNL 254
           L   IG G FG VY+        + I VAVK      + +++  F  +  +M+   HP++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+I   + ++   +V+E  P G L + L  +   LD+   +      ++ L YL    +
Sbjct: 70  VKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ES 125

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF---------EYGMEG-----------------QV 348
              +H D+   +VL+       L DF          Y                     + 
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 349 STRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
           ++ SD++ +G+ + E      KP              V N   I  +E       +GE+ 
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPF-----------QGVKNNDVIGRIE-------NGER- 226

Query: 408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT 450
                  C  ++  L  +C    P KR    ++  +L  I   
Sbjct: 227 -LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 55/178 (30%), Positives = 78/178 (43%), Gaps = 11/178 (6%)

Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS----FEAQCEVMKSIRHPNLVKV 257
           +IG GSFG V  AR + +    AVKV  ++     K        +  ++K+++HP LV +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             S    D    VL+Y+  G L   L    C L+   R     +  S L YL   H+  I
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYL---HSLNI 117

Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG--QVSTRSDIYGYGIVLMETFTRKKPTDR 373
           ++ DLKP ++LLD      L+DF    E      T S   G    L      K+P DR
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 15/153 (9%)

Query: 192 PSQATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVF---HQECARALKSFEAQCEVMK 247
            S + L R+ N IG G+ G+VY+   R  G   A+KV    H++  R  +    + E+++
Sbjct: 71  KSLSELERV-NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILR 127

Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
            + HPN+VK      ++    ++LE+M  GSLE    +    L    R        S + 
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSGIA 182

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           YL   H   I+H D+KP ++L++      ++DF
Sbjct: 183 YL---HRRHIVHRDIKPSNLLINSAKNVKIADF 212

Length = 353

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 9/169 (5%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM D  Q   +  +    LE+L   H+  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSNQVIHRDI 142

Query: 323 KPISVLLDEDMVAHLSDFEY--GMEGQVSTRSDIYGYGIVLM-ETFTRK 368
           K  ++LL  D    L+DF +   +  + S RS + G    +  E  TRK
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 18/156 (11%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVK---VFHQECARALKSFEAQCEVMKSIRHPNL 254
           R+   IG G F  VYRA  L DG+ VA+K   +F    A+A      + +++K + HPN+
Sbjct: 5   RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 64

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY------ 308
           +K  +S   D+   +VLE    G L         M+  F++   +I   +  +Y      
Sbjct: 65  IKYYASFIEDNELNIVLELADAGDLSR-------MIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 309 -LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG 343
            L   H+  ++H D+KP +V +    V  L D   G
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 39/110 (35%), Positives = 61/110 (55%), Gaps = 12/110 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVE-INLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--- 61
           + S+N L GP+  DI    + +  +NLS NN +  +P   G + +L+TL L+ N L    
Sbjct: 99  NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEI 156

Query: 62  ------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR 105
                  +SL++L+L  N + G IP SL  L  L+ L+L+ N+L G+I R
Sbjct: 157 PNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 38/103 (36%), Positives = 50/103 (48%), Gaps = 8/103 (7%)

Query: 9   SNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------- 60
            NS  G L  +   L  V  +++S NNL   + +    + SL+ LSLA NK         
Sbjct: 413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472

Query: 61  DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
               LE L+LS N+  G +P  L  L  L +L LS NKL GEI
Sbjct: 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515

Length = 968

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 39/205 (19%)

Query: 204 IGMGSFGSV----YRARLRDGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVKVI 258
           +G G+FG V    Y+ R +  I+VA+KV   E  ++++     + E+M  + +P +V++I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
             C  +    LV+E    G L   L      + +   + +M   +  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFV 117

Query: 319 HCDLKPISVLLDEDMVAHLSDFE------------------------YGME----GQVST 350
           H DL   +VLL     A +SDF                         Y  E     + S+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 351 RSDIYGYGIVLMETFTR-KKPTDRM 374
           RSD++ YGI + E F+  +KP  +M
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 38/204 (18%)

Query: 202 NLIGMGSFGSVYRARLRDG----IEVAVKVFHQ-ECARALKSFEAQCEVMKSIRHPNLVK 256
            +IG G FG VY   L D     I  AVK  ++      ++ F  +  +MK   HPN++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 257 VISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           ++  C   +   LV L YM  G L N + S T    +   +   +     +EYL    + 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG---- 346
             +H DL   + +LDE     ++DF         EY                 +E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 347 QVSTRSDIYGYGIVLMETFTRKKP 370
           + +T+SD++ +G++L E  TR  P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 31/168 (18%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFH---------QECARALKSFEAQCEVMKSIRHPN 253
           IG G+ G V++A+ R+ G  VA+K             +  R +K        +++ +HP 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK-------ALQACQHPY 60

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           +VK++    +     LV+EYMP   L   L      L   Q  + M      + Y+   H
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---H 116

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF----------EYGMEGQVSTR 351
              I+H DLKP ++L+  D V  ++DF                QV+TR
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 41/206 (19%), Positives = 73/206 (35%), Gaps = 43/206 (20%)

Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFH------QECARALKSFEAQCEVMKSIRHPNLVK 256
           IG GSFG+V +  R  DG  +  K         +E  + +    ++  +++ ++HPN+V+
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILRELKHPNIVR 63

Query: 257 VISSCSNDDFKAL--VLEYMPKGSLENCL---YSSTCMLDIFQRLNIMIDATSTLEYLYF 311
                 +   + L  V+EY   G L   +         ++      I+      L   + 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 312 GH--TTPIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYGM 344
                  ++H DLKP ++ LD +    L DF                         E   
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183

Query: 345 EGQVSTRSDIYGYGIVLMETFTRKKP 370
                 +SDI+  G ++ E      P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 31/193 (16%)

Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA+K  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM        I       L+ L F H+  +IH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV-TETCM----DEGQIAAVCRECLQALDFLHSNQVIHRDI 141

Query: 323 KPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DIYGY 357
           K  ++LL  D    L+DF                    Y M  +V TR       DI+  
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 358 GIVLMETFTRKKP 370
           GI+ +E    + P
Sbjct: 202 GIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 32/195 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+ A      +VAVK   +  + ++++F A+  VMK+++H  LVK+ 
Sbjct: 9   KLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + +    ++ E+M KGSL + L S        Q L  +ID ++ + E + F      
Sbjct: 68  AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNY 123

Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+   +V  ++DF         EY                    G  + +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 352 SDIYGYGIVLMETFT 366
           SD++ +GI+LME  T
Sbjct: 184 SDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 62/301 (20%), Positives = 109/301 (36%), Gaps = 72/301 (23%)

Query: 193 SQATLRRLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKSFEAQCEVM 246
           + +T+R +  L G   FG VY+  L           VA+K    +    L+       +M
Sbjct: 3   NLSTVRFMEEL-GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMM 61

Query: 247 KS-IRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR---------- 295
           +S ++HPN+V ++   + +   +++  Y     L   L   +   D+             
Sbjct: 62  RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121

Query: 296 -----LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------- 340
                ++I+    + +E+L   H   ++H DL   +VL+ + +   +SD           
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Query: 341 -----------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKD 383
                            E  M G+ S  SDI+ YG+VL E F+                 
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY---------------- 222

Query: 384 WVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR 443
               L P       D   +   ++     + C   +  L +EC  E P +R   KDI +R
Sbjct: 223 ---GLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279

Query: 444 L 444
           L
Sbjct: 280 L 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 40/203 (19%)

Query: 204 IGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVIS 259
           IG GSFG+VY A      E VAVK       +  + ++    + + ++ ++HPN ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI----FQRLNIMIDATSTLEYLYFGHTT 315
               +    LV+EY        CL S++ +L++     Q + I       L+ L + H+ 
Sbjct: 89  CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF---------------EYGM---------EGQVSTR 351
            +IH D+K  ++LL E     L+DF                Y M         EGQ   +
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200

Query: 352 SDIYGYGIVLMETFTRKKPTDRM 374
            D++  GI  +E   RK P   M
Sbjct: 201 VDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 40/208 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH-----QECARALKSFEAQCEVMKSIRHP 252
           R   L+G G+FG VY     D G E+A K         E ++ + + E + +++K+++H 
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64

Query: 253 NLVKVISSCSNDDFKALV--LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
            +V+      +   K L   +EYMP GS+++ L +   + +   R          LE + 
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY----TRQILEGMS 120

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQV 348
           + H+  I+H D+K  ++L D      L DF                       Y M  +V
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 349 ST------RSDIYGYGIVLMETFTRKKP 370
            +      ++D++  G  ++E  T K P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.0 bits (129), Expect = 5e-08
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 31/193 (16%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+V+ A  +  G EVA+K  + +     +    +  VMK +++PN+V  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM D  Q   +  +    LE+L   H   +IH D+
Sbjct: 87  VGDELFVVMEYLAGGSLTDVV-TETCM-DEAQIAAVCRECLQALEFL---HANQVIHRDI 141

Query: 323 KPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DIYGY 357
           K  +VLL  D    L+DF                    Y M  +V TR       DI+  
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 358 GIVLMETFTRKKP 370
           GI+ +E    + P
Sbjct: 202 GIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 35/200 (17%)

Query: 211 SVYRARLRDGIEVAVKVF---HQECARALKSFEAQCEVMKSIRHPNLVKV----ISSCSN 263
           S+Y+    +  EV ++ F   H+     +   E + + ++ I   N++K+    I    +
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
               +L+LEY  +G L   L      L    +L++ ID    L  LY     P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 324 PISVLLDED----MVAH----------------LSDFEYGMEGQV----STRSDIYGYGI 359
            +S L+ E+    ++ H                +  F Y M   +    + + DIY  G+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210

Query: 360 VLMETFTRKKPTDRMFVEEL 379
           VL E FT K P + +  +E+
Sbjct: 211 VLWEIFTGKIPFENLTTKEI 230

Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 9/107 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S+N L G +  DIG+  ++  ++L  N L   +P ++  L SL+ L+LA N+L     
Sbjct: 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                + SL+ + L  N + G IP  +  L  L  L L +N L G I
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252

Length = 968

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 36/164 (21%), Positives = 79/164 (48%), Gaps = 16/164 (9%)

Query: 202 NLIGMGSFGSVYRARLRDGIEVAVK--VFHQE----CARALKSFEAQCEVMKSIRHPNLV 255
            ++G G++G+VY      G  +AVK             +  +  + + +++KS++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI-FQRLNIMIDATSTLEYLYFGHT 314
           + + +C +D+  ++ +E++P GS+ + L     + +  F +    I     L+ + + H 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI-----LDGVAYLHN 120

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF----EYGMEGQVSTRSDI 354
             ++H D+K  +V+L  + +  L DF         G   T S++
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 45/202 (22%), Positives = 74/202 (36%), Gaps = 32/202 (15%)

Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA--QCEVMKSIRHPNLVK 256
           + N IG GSFG V++   + D    A+K          +  EA  +  V+  +    +++
Sbjct: 4   ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYFGHTT 315
              S  +     +V+EY   G L   L       L   Q     I     L +L   H+ 
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSK 120

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQVST 350
            I+H D+K +++ LD      + D                          E   +   + 
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180

Query: 351 RSDIYGYGIVLMETFTRKKPTD 372
           +SD++  G+VL E  T K P D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 40/164 (24%)

Query: 201 SNLIGMGSFGSVYRAR-LRDGIEVAVKVFH-------------QECA--RALKSFEAQCE 244
              IG G++G+VY+AR L  G  VA+K                +E A  + L+SFE    
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---- 59

Query: 245 VMKSIRHPNLVKVISSCSNDDFK-----ALVLEYMPK---GSLENCLYSSTCMLDIFQRL 296
                 HPN+V+++  C            LV E++ +     L  C       L      
Sbjct: 60  ------HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIK 110

Query: 297 NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           ++M      +++L   H+  I+H DLKP ++L+  D    ++DF
Sbjct: 111 DLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADF 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKV-----FHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           I  G++G V+ A+    G   A+KV       ++    +     + +++   + P +VK+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRK--NQVDQVLTERDILSQAQSPYVVKL 58

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             S        LV+EY+P G L + L +   + +   R   + +    LEYL   H+  I
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYL---HSNGI 114

Query: 318 IHCDLKPISVLLDEDMVAHLSDF---EYGMEGQVSTRSDI 354
           IH DLKP ++L+D +    L+DF   + G+  +    +D 
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 37/143 (25%), Positives = 67/143 (46%), Gaps = 12/143 (8%)

Query: 204 IGMGSFGSVYRARLRDGIE-VAVKVFHQECARAL---KSFEAQCEVMKSIRHPNLVKVIS 259
           +G G +G V+ A+ +D  E VA+K   +     L   +    + +++ + +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI--MIDATSTLEYLYFGHTTPI 317
           +  +D++  L +EY+P G     L +   + +   R  +  M +A   L      H    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL------HELGY 122

Query: 318 IHCDLKPISVLLDEDMVAHLSDF 340
           IH DLKP + L+D      L+DF
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDF 145

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 49/154 (31%), Positives = 69/154 (44%), Gaps = 11/154 (7%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE--VMKSIRHPNLV 255
            L   IG GSFG VY+A   R    VA+KV   E A   +  + Q E   +   R P + 
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-EIEDIQQEIQFLSQCRSPYIT 62

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K   S        +++EY   GS  + L      LD      I+ +    LEYL   H  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK--LDETYIAFILREVLLGLEYL---HEE 117

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
             IH D+K  ++LL E+    L+DF  G+ GQ++
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADF--GVSGQLT 149

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 9/153 (5%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALK---SFEAQCEVMKSIRH-PNLVKVI 258
           I  G+FGSVY A+ R  G   A+KV  +    A     + +A+  +M      P + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            S  + D+  LV+EY+  G   + + +   + + + +   + +    +E L   H   II
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDL---HQRGII 119

Query: 319 HCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTR 351
           H D+KP ++L+D+     L+DF     G  + +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 43/167 (25%), Positives = 80/167 (47%), Gaps = 14/167 (8%)

Query: 197 LRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIR 250
           L+R+ +L G G FG V   R        G +VAVK    E     +   + + E+++++ 
Sbjct: 6   LKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 251 HPNLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
           H N+VK    C+ D      L++E++P GSL+  L  +   +++ Q+L   +     ++Y
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
           L    +   +H DL   +VL++ +    + DF  G+   + T  + Y
Sbjct: 125 L---GSRQYVHRDLAARNVLVESEHQVKIGDF--GLTKAIETDKEYY 166

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 18/151 (11%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK---VFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           IG G F  VYRA  L D   VA+K   +F    A+A +    + +++K + HPN++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY-------LYFG 312
           S   D+   +VLE    G L         M+  F++   +I   +  +Y       +   
Sbjct: 70  SFIEDNELNIVLELADAGDLSQ-------MIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDFEYG 343
           H+  ++H D+KP +V +    V  L D   G
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 44/228 (19%), Positives = 85/228 (37%), Gaps = 51/228 (22%)

Query: 203 LIGMGSFGSVYRARLRDGIE-------VAVKVF-HQECARALKSFEAQCEVMKSIRHPNL 254
            +G G FG V+ A+ + GIE       V VK     +       F  + ++ + + H N+
Sbjct: 12  TLGRGEFGEVFLAKAK-GIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM--------LDIFQRLNIMIDATSTL 306
           V+++  C   +   ++LEY   G L+  L ++           L   Q++ +       +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS---------DFEYG-------------- 343
           ++L        +H DL   + L+       +S         + EY               
Sbjct: 131 DHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 344 ---MEGQVSTRSDIYGYGIVLMETFTR-----KKPTDRMFVEELSLKD 383
               E   ST+SD++ +G+++ E FT+        +D   +  L    
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 42/196 (21%), Positives = 78/196 (39%), Gaps = 51/196 (26%)

Query: 223 VAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLEN 281
           VAVKV   + +  A + F  + +++  +  PN+ +++  C+ D    +++EYM  G L  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 282 CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI------------IHCDLKPISVLL 329
            L             N    + STL Y+     T I            +H DL   + L+
Sbjct: 109 FLQKHV-AETSGLACNSKSLSFSTLLYM----ATQIASGMRYLESLNFVHRDLATRNCLV 163

Query: 330 DEDMVAHLSDFEYGME-----------------------------GQVSTRSDIYGYGIV 360
            ++    ++DF  GM                              G+ +T+SD++ +G+ 
Sbjct: 164 GKNYTIKIADF--GMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 361 LMETFT--RKKPTDRM 374
           L E  T  R++P + +
Sbjct: 222 LWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 62/296 (20%), Positives = 117/296 (39%), Gaps = 68/296 (22%)

Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARL----RDGIEVAVKVF---HQECARALKSFEAQ 242
           I PS  T +++   IG G FG V+R  L    R  + VA+K     + E  R  + F ++
Sbjct: 2   IHPSHITKQKV---IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSE 56

Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +M    H N++++    +      ++ EYM  G+L+  L         +Q + ++   
Sbjct: 57  ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR----- 351
            + ++YL        +H DL   ++L++ ++   +SDF      E   EG  +T      
Sbjct: 117 AAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173

Query: 352 -----------------SDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISL 393
                            SD++ +GIV+ E  +  ++P             W         
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY------------W--------- 212

Query: 394 MEVVDKTLLSGEKKGF--VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
            ++ +  ++     GF   A   C  ++  L ++C  +   +R    DIV  L K+
Sbjct: 213 -DMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 31/200 (15%)

Query: 197 LRRLSNLIGMGSFGSVYRA-RLRDGIEVAVKVFHQECARAL-KSFEAQCEVMKSIRHPNL 254
           L  +S+L G G+ GSV +   +  G  +A KV H     ++ K    + ++M   R P +
Sbjct: 7   LETISDL-GAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI 65

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGH 313
           V    +  N++   + +E+M  GSL+          ++I  +  I +     L YLY  H
Sbjct: 66  VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVH 123

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------------------GQVST 350
              I+H D+KP ++L++      L DF    E                       G+ + 
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTV 181

Query: 351 RSDIYGYGIVLMETFTRKKP 370
           +SD++  GI ++E    K P
Sbjct: 182 KSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 5/138 (3%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G++G VY+AR L  G   AVK+   E        + +  ++K  +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
           + +   + +EY   GSL++ +Y  T  L     L I      TL+ L + H+   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPL---SELQIAYVCRETLQGLAYLHSKGKMHRDI 132

Query: 323 KPISVLLDEDMVAHLSDF 340
           K  ++LL ++    L+DF
Sbjct: 133 KGANILLTDNGDVKLADF 150

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 23/149 (15%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVFHQ-ECARALKSFEAQCEV--MKSIRHPNLVKVI 258
           L+G GS+G V + + ++ G  VA+K F + E  + +K   A  E+  +K +RH NLV +I
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI-AMREIRMLKQLRHENLVNLI 66

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY-------F 311
                     LV E++              +LD  ++    +D +   +YL+       F
Sbjct: 67  EVFRRKKRLYLVFEFV-----------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            H+  IIH D+KP ++L+ +  V  L DF
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDF 144

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.9 bits (119), Expect = 9e-07
 Identities = 42/196 (21%), Positives = 78/196 (39%), Gaps = 34/196 (17%)

Query: 199 RLSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
           ++  ++G G FG + R  L    +  + VA+      C  +  + F A+   +    H N
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           +V++    +  +   +V EYM  G+L++ L      L   Q + ++    S ++YL    
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---S 124

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------------------GQ 347
               +H  L    VL++ D+V  +S F    E                            
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 348 VSTRSDIYGYGIVLME 363
            S+ SD++ +GIV+ E
Sbjct: 185 FSSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 18/147 (12%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVF-----HQECARALKSFEAQCEVMKSIRHPNLVK 256
           +IG G+FG V+  R +D G   A+KV       +    A     A+ +++     P +VK
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI--MIDATSTLEYLY-FGH 313
           +  S  +++   LV+EYMP G L N L       +   R  I  ++ A   L+ ++  G 
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA---LDSVHKLGF 122

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF 340
               IH D+KP ++L+D D    L+DF
Sbjct: 123 ----IHRDIKPDNILIDADGHIKLADF 145

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 38/110 (34%), Positives = 55/110 (50%), Gaps = 8/110 (7%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLI-SLKTLSLAYNKL 60
           +++ D S  ++ G +S  I  L  +  INLS N LS  +P  I     SL+ L+L+ N  
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130

Query: 61  D-------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                   + +LE L+LSNN + G IP  +     LK L L  N L G+I
Sbjct: 131 TGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180

Length = 968

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 64/241 (26%)

Query: 196 TLRRLSNLIGMGSFGSVYRARLRDGIEV-AVKV--------FHQECARALKSFEAQCEVM 246
            L RL    G G+ GSV + RL++   + A+K           ++  R L       E+ 
Sbjct: 5   ELSRL----GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILREL-------EIN 53

Query: 247 KSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMID 301
           KS + P +VK   +  ++      + +EY   GSL++ +Y    +     R+    +   
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK--VKKRGGRIGEKVLGKI 110

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV------------- 348
           A S L+ L + H+  IIH D+KP ++LL       L DF  G+ G++             
Sbjct: 111 AESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDF--GVSGELVNSLAGTFTGTSF 168

Query: 349 ------------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV 396
                       S  SD++  G+ L+E    + P    F  E         L PI L+  
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGE-----PPLGPIELLSY 219

Query: 397 V 397
           +
Sbjct: 220 I 220

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 26/206 (12%)

Query: 203 LIGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVIS 259
            +G GS+GSVY+  RL D    A+K          +  +A  E+  + S+ HPN++    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           +  + +   +V+EY P G L   +        +     I       L  L   H   I+H
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILH 126

Query: 320 CDLKPISVLLDEDMVAHLSDFEYG-----------------MEGQV------STRSDIYG 356
            DLK  ++LL  + +  + D                     M  +V      S +SDI+ 
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWS 186

Query: 357 YGIVLMETFTRKKPTDRMFVEELSLK 382
            G +L E  T   P +   +++L  K
Sbjct: 187 LGCLLYEMATFAPPFEARSMQDLRYK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 53/177 (29%), Positives = 77/177 (43%), Gaps = 50/177 (28%)

Query: 204 IGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQC----EVMKSIR----HPNL 254
           +G G+FGSVY AR ++  E VA+K   ++      S+E +C    EV KS+R    HPN+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKK----FYSWE-ECMNLREV-KSLRKLNEHPNI 60

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL-------NIMIDATSTLE 307
           VK+      +D    V EYM     E  LY    M D   +        +I+      L 
Sbjct: 61  VKLKEVFRENDELYFVFEYM-----EGNLYQL--MKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------EYGMEGQVSTR 351
           ++   H     H DLKP ++L+    V  ++DF             +Y     VSTR
Sbjct: 114 HI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY-----VSTR 162

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 39/220 (17%)

Query: 194 QATLRRLSNLIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RALKSFEAQCEVMK 247
           +  L+R+  ++G G+FG+VY+   + +G    I VA+K+ ++    +A   F  +  +M 
Sbjct: 6   ETELKRV-KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64

Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           S+ HP+LV+++  C +   + LV + MP G L + ++     +     LN  +     + 
Sbjct: 65  SMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEG---------- 346
           YL       ++H DL   +VL+       ++DF           EY  +G          
Sbjct: 124 YL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 347 ------QVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                 + + +SD++ YG+ + E  T   KP D +   E+
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 21/156 (13%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLV 255
                IG G+FG V++AR +     VA+K    E  +      A  E+  ++ ++H N+V
Sbjct: 15  EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV 74

Query: 256 KVISSCSN-----DDFKA---LVLEYMP---KGSLENCLYSSTCMLDIFQRLNIMIDATS 304
            +I  C       + +K    LV E+      G L N     T  L   +++  M+    
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT--LSEIKKVMKML---- 128

Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            L  LY+ H   I+H D+K  ++L+ +D +  L+DF
Sbjct: 129 -LNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 42/205 (20%)

Query: 197 LRRLSNLIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECARALKSFEAQCE---VMKS 248
           LR+L  L+G G FG+V++   + +G    I VA+K       R  ++F+   +    M S
Sbjct: 9   LRKL-KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGS 65

Query: 249 IRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
           + H  +V+++  C     + LV +  P GSL + +      LD  + LN  +     + Y
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------------E 341
           L       ++H +L   ++LL  D +  ++DF                           E
Sbjct: 125 L---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 342 YGMEGQVSTRSDIYGYGIVLMETFT 366
             + G+ + +SD++ YG+ + E  +
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 15/137 (10%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE-VMKSIR------HPNL 254
            +G G+F S Y+AR ++ G  +AVK             E   E + K IR      HP++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTY-VRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT-STLEYLYFGH 313
           ++++ +   D    L +E+M  GS+ + L         F+   ++I+ T   L  L + H
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKE-AVIINYTEQLLRGLSYLH 120

Query: 314 TTPIIHCDLKPISVLLD 330
              IIH D+K  ++L+D
Sbjct: 121 ENQIIHRDVKGANLLID 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 48.2 bits (114), Expect = 3e-06
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 9/148 (6%)

Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG V++    R    VA+K+   +E    ++  + +  V+     P + K   S 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
             D    +++EY+  GS  + L      LD  Q   I+ +    L+YL   H+   IH D
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYL---HSEKKIHRD 126

Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVS 349
           +K  +VLL E     L+DF  G+ GQ++
Sbjct: 127 IKAANVLLSEHGEVKLADF--GVAGQLT 152

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 28/151 (18%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISS 260
           IG G++G VY+AR    G  VA+K    +         A  E+  +K + HPN+VK++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 261 CSNDDFKALVLEYM-----------PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
              ++   LV E++           P   +   L  S     +FQ L            L
Sbjct: 68  IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSY----LFQLLQ----------GL 113

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            F H+  ++H DLKP ++L++ +    L+DF
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADF 144

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 8/141 (5%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA-QCEVMKSIRHPNLVKVISSC 261
           +G G++ +VY+ R R  G  VA+K  H +      S    +  +MK ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 262 SNDDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
             ++   LV EYM K  L+  +  +     LD     +        L+ + F H   ++H
Sbjct: 68  HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT---YQLLKGIAFCHENRVLH 123

Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLKP ++L+++     L+DF
Sbjct: 124 RDLKPQNLLINKRGELKLADF 144

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 33/123 (26%), Positives = 59/123 (47%), Gaps = 11/123 (8%)

Query: 9   SNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------- 60
           SNSLEG +   +G  +++  + L  N+ S ++P+    L  +  L ++ N L        
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448

Query: 61  -DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFK 118
            D+ SL++L+L+ N+ +G +P S      L+ L LS N+  G + R  G       +   
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLS 507

Query: 119 GNE 121
            N+
Sbjct: 508 ENK 510

Length = 968

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 37/196 (18%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  AR +  G +VAVK+      +  +    +  +M+  +H N+V++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             +   +++E++  G+L + +  +        RLN   I     S L+ L + H+  +IH
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQT--------RLNEEQIATVCESVLQALCYLHSQGVIH 140

Query: 320 CDLKPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DI 354
            D+K  S+LL  D    LSDF                    Y M  +V +R+      DI
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 355 YGYGIVLMETFTRKKP 370
           +  GI+++E    + P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 56/233 (24%)

Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V  A        +    + VAVK+   +   + L    ++ E+MK I 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YS-STCMLD----IFQR 295
           +H N++ ++ +C+ D    +++EY  KG+L   L         YS  TC L      F+ 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 296 L-NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           L +        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 13/146 (8%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVM--KSIRHPNLVK-- 256
           N IG G++G VYRAR    G  VA+K    +  R      +  E+    ++RHPN+V+  
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 257 --VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
             V+    +  F  LV+EY  +  L + L +        Q   +M+     L+YL   H 
Sbjct: 73  EVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HE 126

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLK  ++LL +     ++DF
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADF 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 44/219 (20%), Positives = 83/219 (37%), Gaps = 51/219 (23%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIE---------------VAVKVFHQECAR-ALKSFEAQ 242
           RL   +G G FG V+        E               VAVK+   +  + A   F  +
Sbjct: 8   RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67

Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL--------YSSTCMLDIFQ 294
            ++M  +++PN+++++  C +DD   ++ EYM  G L   L        ++    +    
Sbjct: 68  IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 295 RLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
             N++  A      + +  +   +H DL   + L+       ++DF              
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT 366
                        E  + G+ +T SD++ +G+ L E FT
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 39/194 (20%), Positives = 74/194 (38%), Gaps = 31/194 (15%)

Query: 198 RRLSNLIGMGSFGSVYRAR-LRDGIEVAVK-VFHQECARALKSFEA---QC--------- 243
            +    +G G++G V +A     G  VA+K V   E +  +         C         
Sbjct: 11  IQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE 70

Query: 244 -EVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            ++M  I+H N++ ++      DF  LV++ M    L+  +      L   Q   I++  
Sbjct: 71  LKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQI 128

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
            + L  L   H    +H DL P ++ ++   +  ++DF       ++ R   YGY     
Sbjct: 129 LNGLNVL---HKWYFMHRDLSPANIFINSKGICKIADF------GLARR---YGYPPYSD 176

Query: 363 ETFTRK--KPTDRM 374
                +  +  + M
Sbjct: 177 TLSKDETMQRREEM 190

Length = 335

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 37/167 (22%)

Query: 204 IGMGSFGSVYRARLRDG--IEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVI 258
           +G GSFG V  A  ++     VA+K F +      K  +   ++ +++  I HP  V + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 259 SSCSNDDFKALVLEYMPKGSL-------------ENCLYSSTCMLDIFQRLNIMIDATST 305
            S  ++ +  LVLE++  G                 C Y++  +L IF            
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF------------ 144

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
            EYL    +  I++ DLKP ++LLD+D    ++DF  G    V TR+
Sbjct: 145 -EYL---QSLNIVYRDLKPENLLLDKDGFIKMTDF--GFAKVVDTRT 185

Length = 340

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 21/147 (14%)

Query: 204 IGMGSFGSVYRARLRDGIE-VAVK-VFHQECARALKSFEAQ--CEVMKSIRHPNLVKVIS 259
           IG G++G+V++A+ R+  E VA+K V   +    + S   +  C ++K ++H N+V++  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLYD 66

Query: 260 SCSNDDFKALVLEYMP---KGSLENC---LYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
              +D    LV EY     K   ++C   +        +FQ           L+ L F H
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ----------LLKGLAFCH 116

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +  ++H DLKP ++L++++    L+DF
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADF 143

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 16/160 (10%)

Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLV 255
           +   +G GSFG V  A+ +  G   A+K   +     +K  +    +  ++  + HP +V
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFG 312
            ++ S  +++    +LE++  G L   L  +      +  F    +++      EYL   
Sbjct: 82  NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFEYL--- 134

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
           H+  II+ DLKP ++LLD      ++DF  G   +V  R+
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDF--GFAKKVPDRT 172

Length = 329

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 46.8 bits (112), Expect = 9e-06
 Identities = 35/153 (22%), Positives = 62/153 (40%), Gaps = 32/153 (20%)

Query: 204 IGMGSFGSVYRARL-RDGIEVAVK------VFHQECARALKSFEAQCEVMKSIRHPNLVK 256
           +G+G FG V   ++       A+K      +        + S   + E+++   HP +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS---------TLE 307
           +  +  +  +  +++EY   G L            I +   +  + T+           E
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFE 107

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           YL   H   II+ DLKP ++LLD +    L DF
Sbjct: 108 YL---HNRGIIYRDLKPENLLLDSNGYVKLVDF 137

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 36/147 (24%), Positives = 72/147 (48%), Gaps = 20/147 (13%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQEC------ARALKSFEAQCEVMKSIRHPNLVK 256
           IG G++G VY+AR    G  VA+K    E       + A++    +  ++K + HPN+V+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62

Query: 257 VISSCSNDDFKALVLEYMP---KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++    +++   LV E++    K  +++   +      I   L  ++        + + H
Sbjct: 63  LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG------IAYCH 116

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +  ++H DLKP ++L+D +    L+DF
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADF 143

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 58/216 (26%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVI-- 258
           +G G+FG VY+AR ++ G  VA+K       +      A  E+  +K ++HPN+V +I  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 259 ----SSCSNDDFKA--LVLEYMPK---GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
                  S     +  +V  YM     G LEN     +  L   Q    M+     + YL
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYL 131

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------EY-GM-- 344
              H   I+H D+K  ++L+D   +  ++DF                      +Y  +  
Sbjct: 132 ---HENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188

Query: 345 ------------EGQVSTRSDIYGYGIVLMETFTRK 368
                       E + +T  DI+G G V  E FTR+
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 9/111 (8%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
           +++ D S NSL G +   +  L+ +  ++L  NN +  +P  +  L  L+ L L  NK  
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345

Query: 62  VA---------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                      +L +L+LS N + G IP  L     L +L L  N LEGEI
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396

Length = 968

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 9/148 (6%)

Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG V++    R    VA+K+   +E    ++  + +  V+     P + K   S 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
                  +++EY+  GS  + L +     D FQ   ++ +    L+YL   H+   IH D
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYL---HSEKKIHRD 126

Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVS 349
           +K  +VLL E     L+DF  G+ GQ++
Sbjct: 127 IKAANVLLSEQGDVKLADF--GVAGQLT 152

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 45/145 (31%), Positives = 66/145 (45%), Gaps = 17/145 (11%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVF-HQECARALKSFEAQCEV--MKSIRHPNLVKVIS 259
           IG GS+G V++ R R+ G  VA+K F   E    +K   A  E+  +K ++HPNLV +I 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI-ALREIRMLKQLKHPNLVNLIE 67

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR----LNIMIDATSTLEYLYFGHTT 315
                    LV EY        C ++    L+   R      I      TL+ + F H  
Sbjct: 68  VFRRKRKLHLVFEY--------CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF 340
             IH D+KP ++L+ +     L DF
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDF 144

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 56/233 (24%)

Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 19  LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + D       
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  +    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 8/148 (5%)

Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVI 258
           L+G G+FG V   R +  G   A+K+  +E   A         +  V+K+ RHP L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            S    D    V+EY+  G L   L       +   R     +  S L+YL   H+  I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYL---HSGKIV 117

Query: 319 HCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           + DLK  +++LD+D    ++DF    EG
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEG 145

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 56/233 (24%)

Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V  A        +     +VAVK+   +   + L    ++ E+MK I 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTC----MLDIFQ 294
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y+ T      L    
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 295 RLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
            ++        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 200 LSNLIGMGSFGSVYRA-----RLRDGIE-VAVKVFHQECARA-LKSFEAQCEVMKSIRHP 252
           L   +G G FG V +A     + R G   VAVK+  +  + + L+   ++  ++K + HP
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSS 286
           +++K+  +CS D    L++EY   GSL + L  S
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRES 97

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)

Query: 204 IGMGSFGSVY--RARLRDGIEVAVK---VFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +G G++ +V+  R++L + + VA+K   + H+E A      E    ++K ++H N+V + 
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVS--LLKDLKHANIVTLH 70

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
                D    LV EY+ K   +   Y   C  +I    N+ I     L  L + H   ++
Sbjct: 71  DIVHTDKSLTLVFEYLDKDLKQ---YMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVL 126

Query: 319 HCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
           H DLKP ++L++E     L+DF       V T++
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 39/186 (20%), Positives = 66/186 (35%), Gaps = 43/186 (23%)

Query: 220 GIEVAVKVF---HQECARALKSFEAQCEVMKSIRHPNLVKVISS-CSNDDFKALVLEYMP 275
           G EVA+K+      E       F  +  +   + HPN+V ++ S  +       V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISV-------- 327
             +L   L ++   L   +   +M      L+ L   H   I+H DLKP ++        
Sbjct: 63  GRTLREVL-AADGALPAGETGRLM---LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 328 ----LLDEDMVAHLSDFEYGMEGQ-----------------------VSTRSDIYGYGIV 360
               +LD  +   L                                 V+  SD+Y +G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 361 LMETFT 366
            +E  T
Sbjct: 179 FLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 38/110 (34%), Positives = 51/110 (46%), Gaps = 13/110 (11%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNLS 71
           N   VV I+LS  N+S  + + I  L  ++T++L+ N+L            +SL  LNLS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI-LRGGPFVNFTAMSFKGN 120
           NN   G IP      L    L LS N L GEI    G F +   +   GN
Sbjct: 127 NNNFTGSIPRGSIPNLE--TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174

Length = 968

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 9/147 (6%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQ-ECARALKS--FEAQCEVMKSIRHPNLVKVI 258
           +IG G+FG V   R +   +V A+K+  + E  +   S  F  + ++M     P +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +  +D +  +V+EYMP G L N + +     D+ ++      A   L  L   H+  +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLA-LDAIHSMGLI 164

Query: 319 HCDLKPISVLLDEDMVAHLSDFEYGME 345
           H D+KP ++LLD+     L+DF   M+
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMK 191

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 23/162 (14%)

Query: 204 IGMGSFGSVYR-ARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSC 261
           IG G++G VY+    +DG   AVK+     +   +  EA+  +++S+  HPN+VK     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 262 SNDDFKA-----LVLEYMPKGSLENCLYSSTCMLDIFQRLN------IMIDATSTLEYLY 310
              D        LVLE    GS+   +     +L   QRL+      I+  A   L++L 
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHL- 144

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV-STR 351
             H   IIH D+K  ++LL  +    L DF  G+  Q+ STR
Sbjct: 145 --HNNRIIHRDVKGNNILLTTEGGVKLVDF--GVSAQLTSTR 182

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 19/147 (12%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISS 260
           IG G++G VY+ R  + G  VA+K    E         A  E+  +K ++HPN+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY-------FGH 313
              +    L+ E++   S++   Y  +            +DA     YLY       F H
Sbjct: 68  LMQESRLYLIFEFL---SMDLKKYLDSL------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +  ++H DLKP ++L+D   V  L+DF
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADF 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 24/166 (14%)

Query: 204 IGMGSFGSVYRA-RLRDGIEVAVK----VF--HQECARALKSFEAQCEVMKSIRHPNLVK 256
           IG G++G V  A   R G +VA+K     F       R L+    + ++++  +H N++ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR----ELKILRHFKHDNIIA 68

Query: 257 V--ISSCSNDDFKA--LVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYF 311
           +  I      DFK   +V++ M +  L + ++S      +  +    +      L+Y+  
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYF--LYQLLRGLKYI-- 123

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGY 357
            H+  +IH DLKP ++L++ED    + DF  GM   +S+    + Y
Sbjct: 124 -HSANVIHRDLKPSNLLVNEDCELRIGDF--GMARGLSSSPTEHKY 166

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 28/138 (20%), Positives = 59/138 (42%), Gaps = 19/138 (13%)

Query: 212 VYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLV-KVISSCSNDDFKAL 269
           VY    +D  +  +K+       A +  E    +++ +      V KV++S  +D +  L
Sbjct: 14  VYLLGTKDE-DYVLKINPSREKGADREREV--AILQLLARKGLPVPKVLASGESDGWSYL 70

Query: 270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI---IHCDLKPIS 326
           ++E++   +L+         +   ++ +I       L  L   H  P+    H DL P +
Sbjct: 71  LMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKL---HQLPLLVLCHGDLHPGN 119

Query: 327 VLLDEDMVAHLSDFEYGM 344
           +L+D+  +  + D+EY  
Sbjct: 120 ILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 55/205 (26%), Positives = 82/205 (40%), Gaps = 43/205 (20%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVK-----VFHQECARALKSFEAQCEVMKSIRHPNLVK 256
            IG G+FG+V +   +  G  +AVK     V  +E  R L   +    VM+S   P +VK
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV---VMRSSDCPYIVK 67

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYL-YFGHT 314
              +   +    + +E M   SL+        +L       I+   A +T++ L Y    
Sbjct: 68  FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------- 348
             IIH D+KP ++LLD +    L DF  G+ GQ+                          
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDF--GISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 349 ---STRSDIYGYGIVLMETFTRKKP 370
                RSD++  GI L E  T K P
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 45/150 (30%), Positives = 68/150 (45%), Gaps = 14/150 (9%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A  +  G +VAVK       +  +    +  +M+   H N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     S L  L + H   +IH
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIATVCLSVLRALSYLHNQGVIH 141

Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 142 RDIKSDSILLTSDGRIKLSDF--GFCAQVS 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 58/222 (26%)

Query: 203 LIGMGSFGSVYRAR-LRDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVK 256
           ++G G+FG+VY+   + +G    I VA+K   +  + +A K    +  VM S+ +P++ +
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR----------LNIMIDATSTL 306
           ++  C     + L+ + MP G          C+LD  +           LN  +     +
Sbjct: 74  LLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQIAKGM 122

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEG--------- 346
            YL       ++H DL   +VL+       ++DF           EY  EG         
Sbjct: 123 NYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 347 -------QVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
                    + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 45/225 (20%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISS 260
           IG GSFG +Y A+ + D     +K          +   ++ EV  +  ++HPN+V   +S
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 261 CSNDDFKALVLEYMPKGSL-------ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
              +    +V+EY   G L          L+S   +L  F ++++       L+++   H
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHI---H 118

Query: 314 TTPIIHCDLKPISVLLDED-MVAHLSDF-------------------EYGMEGQV----- 348
              I+H D+K  ++ L ++ MVA L DF                    Y +  ++     
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178

Query: 349 -STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS 392
            + ++DI+  G VL E  T K P +   + +L LK       PIS
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 15/152 (9%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALK----SFEAQCEVMKSIRHPNLVKVIS 259
           IG G FG V       G+  A  V  +  A A       F  + +  + + HPN+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCML------DIFQRLNIMIDATSTLEYLYFGH 313
            C       LVLE+ P G L+N L S+  M+      D+ QR+    +  S L +L   H
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWL---H 117

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGME 345
               IH DL   +  L  D+   + D+   +E
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALE 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 34/144 (23%), Positives = 64/144 (44%), Gaps = 28/144 (19%)

Query: 204 IGMGSFGSVYRARL---RDGIEVAVKVFHQECARALK-SFEAQCEVM--KSIRHPNLVKV 257
           IG G++G VY+A+    +DG E A+K F  +  +    S  A  E+   + ++H N+V +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 258 ISSCSNDDFKA--LVLEYMPKGSLENCLYSST---CMLD-------IFQRLNIMIDATST 305
           +        K+  L+ +Y      +   +        +        ++Q LN        
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN-------G 120

Query: 306 LEYLYFGHTTPIIHCDLKPISVLL 329
           + YL   H+  ++H DLKP ++L+
Sbjct: 121 VHYL---HSNWVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 69/307 (22%), Positives = 112/307 (36%), Gaps = 76/307 (24%)

Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V RA        R    + VAVK+       + L    ++ E+MK I 
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLY---------------SSTCMLDIFQ 294
           +H N++ ++  C+ +    +++EY  KG+L   L                     L    
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 295 RLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
            ++        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 136 LVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVN 386
                        E   +   + +SD++ +GI++ E FT    P   + VEEL       
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF------ 246

Query: 387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
                       K L  G +        C   +  L  EC   +P +R   K +V  L K
Sbjct: 247 ------------KLLREGHRMD--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292

Query: 447 IRDTLSK 453
           +   +S+
Sbjct: 293 VLAAVSE 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 12/154 (7%)

Query: 204 IGMGSFGSVY--RARLRDGIEVAVK---VFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +G G++ +VY  R++L D + VA+K   + H+E A      E    ++K ++H N+V + 
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVS--LLKDLKHANIVTLH 70

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
                +    LV EY+ K   +   Y   C  +     N+ +     L  L + H   ++
Sbjct: 71  DIIHTEKSLTLVFEYLDKDLKQ---YLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 319 HCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
           H DLKP ++L++E     L+DF       + T++
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 44.1 bits (105), Expect = 8e-05
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 36/155 (23%)

Query: 204 IGMGSFGSVYRARLRDGIE-VAVK-VFH--QECARALKSFEAQCEVM--KSIR-HPNLVK 256
           +G G++G V++A  R   E VA+K +F   +    A ++F    E+M  + +  HPN+VK
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR---EIMFLQELGDHPNIVK 71

Query: 257 ---VISSCSNDDFKALVLEYMP--------KGSLENCLYSSTCMLDIFQRLNIMIDATST 305
              VI + ++ D   LV EYM            LE          D+ +R  IM      
Sbjct: 72  LLNVIKAENDKDI-YLVFEYMETDLHAVIRANILE----------DVHKRY-IMYQLLKA 119

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L+Y+   H+  +IH DLKP ++LL+ D    L+DF
Sbjct: 120 LKYI---HSGNVIHRDLKPSNILLNSDCRVKLADF 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 31/175 (17%)

Query: 198 RRLSNL--IGMGSFGSV---YRARLRDGIEVAVKVFH---QECARALKSFEAQCEVMKSI 249
            R  NL  +G G++GSV   Y  RLR   +VAVK      Q    A +++  +  ++K +
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHM 71

Query: 250 RHPNLVKVIS----SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDA 302
           +H N++ ++     + S ++F  + L     G+  N +          Q+L   ++    
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK-------CQKLSDEHVQFLI 124

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------MEGQVSTR 351
              L  L + H+  IIH DLKP +V ++ED    + DF         M G V+TR
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR 179

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 38/123 (30%), Positives = 59/123 (47%), Gaps = 12/123 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S N L   L   + NL  +  ++LS N +S D+P  I  L +L+ L L+ N +     
Sbjct: 169 DLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLS 226

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSF 117
              ++ +L  L LSNN++   +P S+  L  L+ L LS N++   I   G   N   +  
Sbjct: 227 SLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDL 284

Query: 118 KGN 120
            GN
Sbjct: 285 SGN 287

Length = 394

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 34/168 (20%)

Query: 203 LIGMGSFGSVYRARLRDGIE----VAVKVFHQ-ECARALKSF---EAQCEVMKSIRHPNL 254
           ++G G +G V++ R   G +     A+KV  +    R  K     +A+  ++++++HP +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS---------T 305
           V +I +        L+LEY+  G L   L          +R  I ++ T+          
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLA 112

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----EYGMEGQVS 349
           LE+L   H   II+ DLKP ++LLD      L+DF    E   EG V+
Sbjct: 113 LEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 40/201 (19%), Positives = 82/201 (40%), Gaps = 51/201 (25%)

Query: 223 VAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL-- 279
           VAVK+  ++  + A   F  + ++M  ++ PN++++++ C   D   ++ EYM  G L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 280 -------ENCLYSSTCMLDIFQRLNIM-IDATSTLEYLYFGHTTPIIHCDLKPISVLLDE 331
                  +     +  +   +  L  M     S ++YL    +   +H DL   + L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 332 DMVAHLSDFEYGME-----------------------------GQVSTRSDIYGYGIVLM 362
           +    ++DF  GM                              G+ +T SD++ +G+ L 
Sbjct: 166 NYTIKIADF--GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223

Query: 363 ETFT--RKKP----TDRMFVE 377
           E  T  +++P    +D   +E
Sbjct: 224 EILTLCKEQPYSQLSDEQVIE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 43/156 (27%), Positives = 64/156 (41%), Gaps = 23/156 (14%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFEAQCEVMK------SIRHPNLV 255
           ++G GSFG V  A L+   EV A+KV  ++    L+  +  C + +      + +HP L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI-----FQRLNIMIDATSTLEYLY 310
            +       D    V+EY+  G L         M  I     F        A      L 
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDL---------MFQIQRSRKFDEPRSRFYAAEVTLALM 110

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           F H   +I+ DLK  ++LLD +    L+DF    EG
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 65/262 (24%), Positives = 103/262 (39%), Gaps = 51/262 (19%)

Query: 193 SQATLRRLSNLIGMGSFGSV-YRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSI 249
            QA    +S ++G G+ G+V    R+ DG   AVKV   E         AQ EV  + + 
Sbjct: 29  EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC 88

Query: 250 RHPNLVKVISSCSNDDFK------------ALVLEYMPKGSLENCLYSSTCMLDIFQRLN 297
              ++VK    C  D  K            ALVL+Y   G L   + S       F+   
Sbjct: 89  DFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144

Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------MEGQV--- 348
             +     L  ++  H+  +IH D+K  ++LL  + +  L DF +       +   V   
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 349 ------------------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-- 388
                             S ++D++  G++L E  T K+P D   +EE+  K        
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264

Query: 389 LPISL---MEVVDKTLLSGEKK 407
           LP S+   M+ +   LLS + K
Sbjct: 265 LPPSISPEMQEIVTALLSSDPK 286

Length = 496

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 32/141 (22%), Positives = 59/141 (41%), Gaps = 11/141 (7%)

Query: 207 GSFGSVYRARLRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSND 264
                + + +  + + VAVK  + +      LK  + +    + ++HPN++  ++S   D
Sbjct: 13  LMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 265 DFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTPIIHCD 321
               +V   M  GS E+ L  +    +    L    I+ D  + L+Y+   H+   IH  
Sbjct: 72  SELYVVSPLMAYGSCED-LLKTHFP-EGLPELAIAFILKDVLNALDYI---HSKGFIHRS 126

Query: 322 LKPISVLLDEDMVAHLSDFEY 342
           +K   +LL  D    LS   Y
Sbjct: 127 VKASHILLSGDGKVVLSGLRY 147

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 15/147 (10%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARA----LKSFEAQCEVMKSIRHPNLVKVIS 259
           IG G FG V    +  G   A  V  +    A       F  + +  +S++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSS------TCMLDIFQRLNIMIDATSTLEYLYFGH 313
            C+      LV+E+ P G L+  L S       T      QR+    +    L +L   H
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHL---H 117

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF 340
               IH DL   + LL  D+   + D+
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDY 144

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 33/161 (20%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNL 254
           N I  G++G VYRAR  + G  VA+K    E  +      +L+       ++  ++HPN+
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQHPNI 66

Query: 255 VKV--ISSCSNDDFKALVLEYMP---KGSLENCLYSSTCMLDIF---QRLNIMIDATSTL 306
           V V  +   SN D   +V+EY+    K  +E        M   F   +   +M+   S +
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET-------MKQPFLQSEVKCLMLQLLSGV 119

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----EYG 343
            +L   H   I+H DLK  ++LL+   +  + DF    EYG
Sbjct: 120 AHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 9/147 (6%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQ-ECARALKS--FEAQCEVMKSIRHPNLVKVI 258
           +IG G+FG V   R +   +V A+K+  + E  +   S  F  + ++M     P +V++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +  +D +  +V+EYMP G L N + +     D+ ++      A   L  L   H+   I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLA-LDAIHSMGFI 164

Query: 319 HCDLKPISVLLDEDMVAHLSDFEYGME 345
           H D+KP ++LLD+     L+DF   M+
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMK 191

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 45/206 (21%)

Query: 200 LSNLIGMGSFGSVYRA------RLRDGIEVAVKVF----HQECARALKSFEAQCEVMKSI 249
               +G G+FG V  A      +    ++VAVK+     H     AL S   + ++M  +
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELKIMSHL 95

Query: 250 -RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLE 307
             H N+V ++ +C+      ++ EY   G L N L       L +   L+        + 
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------- 340
           +L   +    IH DL   +VLL    +  + DF                           
Sbjct: 156 FLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFT 366
           E       +  SD++ YGI+L E F+
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 36/177 (20%)

Query: 196 TLRRLSNL--IGMGSFGSVYRAR-LRDGIEVAVK---------VFHQECARALKSFEAQC 243
              R  +L  +GMG+FG V  AR    G  VA+K         V  +   R LK      
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK------ 61

Query: 244 EVMKSIRHPNLV---KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMI 300
            ++K +RH N++    +  S   D +   V E +  G+  + L +S  +   F    I  
Sbjct: 62  -LLKHLRHENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSRPLEKQF----IQY 112

Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
                L  L + H+  ++H DLKP ++L++E+    + DF      +  M G VSTR
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR 169

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 38/200 (19%)

Query: 204 IGMGSFGSVYRARLRD-GIEVA---VKVFHQECARALKSFE--AQCEVMKSIRHPNLVKV 257
           IG+G++G+VY+AR    G  VA   V+V   E    L +    A  + +++  HPN+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 258 ISSC----SNDDFK-ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           +  C    ++ + K  LV E++ +             L      ++M      L++L   
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL--- 124

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------EYGMEGQV 348
           H   I+H DLKP ++L+       L+DF                        E  ++   
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY 184

Query: 349 STRSDIYGYGIVLMETFTRK 368
           +T  D++  G +  E F RK
Sbjct: 185 ATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A ++  G  VAVK       +  +    +  +M+  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     + L+ L   H   +IH
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLKALSVLHAQGVIH 139

Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 140 RDIKSDSILLTHDGRVKLSDF--GFCAQVS 167

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 16/156 (10%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVK---VFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G++ +V++ R +     VA+K   + H+E A      E    ++K+++H N+V +  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS--LLKNLKHANIVTLHD 70

Query: 260 SCSNDDFKALVLEYMP---KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
               +    LV EY+    K  L+NC        ++    N+ I     L  L + H   
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCG-------NLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
           I+H DLKP ++L++E     L+DF       V T++
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 19/153 (12%)

Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVK 256
           IG GSFG VY+     GI+      VA+K+   +E    ++  + +  V+     P + +
Sbjct: 12  IGKGSFGEVYK-----GIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
              S        +++EY+  GS  + L      L+      I+ +    L+YL   H+  
Sbjct: 67  YYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYL---HSER 121

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            IH D+K  +VLL E     L+DF  G+ GQ++
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADF--GVAGQLT 152

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 8/148 (5%)

Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVI 258
           L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +    D    V+EY   G L   L       +   R     +  S LEYL   H+  ++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDVV 117

Query: 319 HCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           + D+K  +++LD+D    ++DF    EG
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEG 145

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 39/205 (19%)

Query: 198 RRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRH--- 251
           +RL  LIG G++G+VYR + +  G  VA+K+ + +      S + Q EV  +  +R    
Sbjct: 4   QRLE-LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQP 61

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           PN+ K   S        +++EY   GS+   L  +  + + +    I +     L  L +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKY----ISVIIREVLVALKY 116

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEG 346
            H   +IH D+K  ++L+       L DF                         E   EG
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 347 QV-STRSDIYGYGIVLMETFTRKKP 370
           +   T++DI+  GI + E  T   P
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 40.3 bits (95), Expect = 3e-04
 Identities = 15/35 (42%), Positives = 20/35 (57%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKS 238
           I   S   V+RA L+DG EVAVKV      + ++S
Sbjct: 19  IAAASIAQVHRAVLKDGEEVAVKVQRPGVKKRIRS 53

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 3e-04
 Identities = 20/60 (33%), Positives = 32/60 (53%), Gaps = 9/60 (15%)

Query: 49 SLKTLSLAYNKLDV---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
          +LK+L L+ N+L V          +L++L+LS N +  + P +   L  L+ L LS N L
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 22/148 (14%)

Query: 204 IGMGSFGSVYRARLRDGIEV-AVK------VFHQECARALKSFEAQCEVMKSIRHPNLVK 256
           IG+G+FG V   R  D   + A+K      V  +  A  +K   A+ +++    +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEADNEWVVK 65

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQ----RLNIMIDATSTLEYLYFG 312
           +  S  + D    V++Y+P G + + L      L IF+    R  I  + T  +E +   
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCAIESV--- 117

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           H    IH D+KP ++L+D D    L+DF
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDF 145

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 34/206 (16%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 128

Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 129 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 356 GYGIVLMETFTRKKPTDRMFVEELSL 381
             G+ L+E    + P      +EL L
Sbjct: 187 SMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 32/173 (18%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA--QCEVMKSIRHPNLVKVISS 260
           +G GS+ +VY+   R +G  VA+KV   +    +  F A  +  ++K ++H N+V +   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71

Query: 261 CSNDDFKALVLEYM-----------PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
               +    V EYM           P G     L+     L +FQ L         L Y+
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR-------GLAYI 119

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +  H   I+H DLKP ++L+       L+DF  G+    S  S  Y   +V +
Sbjct: 120 HGQH---ILHRDLKPQNLLISYLGELKLADF--GLARAKSIPSQTYSSEVVTL 167

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 62/291 (21%), Positives = 118/291 (40%), Gaps = 60/291 (20%)

Query: 194 QATLRRLSNLIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RALKSFEAQCEVMK 247
           +  L+++  ++G G+FG+VY+   + DG    I VA+KV  +  + +A K    +  VM 
Sbjct: 6   ETELKKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64

Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
            +  P + +++  C     + LV + MP G L + +  +   +     LN  +     + 
Sbjct: 65  GVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEG---------- 346
           YL       ++H DL   +VL+       ++DF           EY  +G          
Sbjct: 124 YL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 347 ------QVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK 399
                 + + +SD++ YG+ + E  T   KP D +   E+             L+E    
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-----------DLLE---- 225

Query: 400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI-RD 449
               GE+        C + +  + ++C M   E R   +++V    ++ RD
Sbjct: 226 ---KGER--LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 47/166 (28%), Positives = 67/166 (40%), Gaps = 36/166 (21%)

Query: 194 QATLRRLSNL--IGMGSFGSVYRARLR-DGIEVAVKVFH-----QECARALKSFEAQCEV 245
            A L  L NL  IG G+ G VY+ R +  G  +AVK        +E  R L   +    V
Sbjct: 11  PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV---V 67

Query: 246 MKSIRHPNLVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLN------- 297
           +KS   P +VK        D    + +E M           STC+  + +R+        
Sbjct: 68  LKSHDCPYIVKCYG-YFITDSDVFICMELM-----------STCLDKLLKRIQGPIPEDI 115

Query: 298 ---IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
              + +     L YL   H   +IH D+KP ++LLD      L DF
Sbjct: 116 LGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDF 159

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 23/170 (13%)

Query: 199 RLSNL--IGMGSFGSVYRA-RLRDGIEVAVKVFH---QECARALKSFEAQCEVMKSIRHP 252
           R  NL  +G G++GSV  A   + G+ VAVK      Q    A +++  +  ++K ++H 
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 76

Query: 253 NLVKVIS----SCSNDDFKALVL-EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           N++ ++     + S ++F  + L  ++    L N +       D  Q L   I     L 
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 131

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------MEGQVSTR 351
            L + H+  IIH DLKP ++ ++ED    + DF         M G V+TR
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 60/288 (20%), Positives = 104/288 (36%), Gaps = 79/288 (27%)

Query: 204 IGMGSFGSVYRARLRDG-----------IEVAVKVFHQECARALKSFEAQCEVMKSIRHP 252
           +G G+F ++Y+  LR             + V +KV   +   +L  FE    +M  + H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHK 61

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           +LVK+   C  D+   +V EY+  G L+  L+     + +  +L++     S L YL   
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL--- 117

Query: 313 HTTPIIHCDLKPISVLLDED-------MVAHLSD---------------------FEYGM 344
               ++H ++   ++L+              LSD                      E   
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIR 177

Query: 345 EGQVSTRS--DIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL 402
            GQ S     D + +G  L+E  +  +                    P+S       TL 
Sbjct: 178 NGQASLTIAADKWSFGTTLLEICSNGE-------------------EPLS-------TLS 211

Query: 403 SGEKKGFVAKEQCVLSIL------GLAMECAMELPEKRINAKDIVTRL 444
           S EK+ F  ++Q  L +        L  +C    P KR + + I+  L
Sbjct: 212 SSEKERFY-QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 47/178 (26%)

Query: 202 NLIGMGSFGSVYRARLRD-GIEVAVK---------VFHQECARALKSFEAQCEVMKSIRH 251
           + +G G++G V  A     G +VA+K         +  +   R L+       ++K + H
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR-------LLKHMDH 73

Query: 252 PNLVKVIS-------SCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLN---IM 299
            N   VI        + S +DF+   LV   M    L N +          Q+L+   I 
Sbjct: 74  EN---VIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQ 121

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
                 L  L + H+  IIH DLKP ++ ++ED    + DF      +  M G V+TR
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 39/198 (19%)

Query: 203 LIGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVI- 258
            +G G++GSV  A   R G +VA+K   +     + +  A  E+  +K ++H N++ ++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 259 ---SSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
              S+ S D+F+   LV+ YM +  L         M        +       L  L + H
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYM-QTDL------QKIMGHPLSEDKVQYLVYQMLCGLKYIH 134

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------------- 351
           +  IIH DLKP ++ ++ED    + DF      +  M G V TR                
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQ 194

Query: 352 -SDIYGYGIVLMETFTRK 368
             DI+  G ++ E  T K
Sbjct: 195 TVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 42/208 (20%)

Query: 203 LIGMGSFGSVYRARLRDG---------IEVAVKVFHQECARALKSFE---AQCEVMK-SI 249
            +G G+FG VY+ R ++          I V    F ++     KS     ++  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 250 RHPNLVKVISSCSNDDFKALVLEYM---PKGSLENCLYSSTCMLDIFQRLNIMIDATSTL 306
           RHPN+V+   +   +D   +V++ +   P G   N L          +  NI +     L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------EYGMEGQVST-------- 350
            YL+      I+H DL P +++L ED    ++DF        E  +   V T        
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184

Query: 351 --------RSDIYGYGIVLMETFTRKKP 370
                   ++D++ +G +L +  T + P
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 20/153 (13%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEV-AVKVFHQE--CAR----ALKSFEAQCEVMKSIRH 251
           R   ++G G FG V  A  +   E+ A+K   +    AR    +L   +   E   S RH
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCML----DIFQRLNIMIDATSTLE 307
           P LV + +    +D    V+EY   G L         M+    D+F     +  A   + 
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDL---------MMHIHTDVFSEPRAVFYAACVVL 112

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            L + H   I++ DLK  ++LLD +    ++DF
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADF 145

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 13/99 (13%)

Query: 10  NSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS----- 64
             +   + L   NLK   E++LS N +   +P+ +  L +LK L L++N L         
Sbjct: 129 TDIPPLIGLLKSNLK---ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSN 184

Query: 65  ---LEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
              L  L+LS N+I   +P  +E L  L+EL LS N + 
Sbjct: 185 LSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII 222

Length = 394

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 34/195 (17%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V + + +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  +  +I  +++I +     L YL   H   I+H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREKHQ--IMHR 128

Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 129 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186

Query: 356 GYGIVLMETFTRKKP 370
             G+ L+E    + P
Sbjct: 187 SMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 49/166 (29%), Positives = 71/166 (42%), Gaps = 30/166 (18%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCEVMKSI-----RHPNLV 255
           ++G GSFG V  A L+   E+ AVKV  ++        E    E  K +     +HP L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE--KRVLALAGKHPFLT 59

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY------- 308
           ++ S     D    V+EY+  G L         M  I QR     +  +   Y       
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDL---------MFHI-QRSGRFDEPRARF-YAAEIVLG 108

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---EYGMEGQVSTR 351
           L F H   II+ DLK  +VLLD +    ++DF   + G+ G V+T 
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 45/156 (28%), Positives = 65/156 (41%), Gaps = 23/156 (14%)

Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMK------SIRHPNLV 255
           ++G GSFG V  ARL+  G   AVKV  ++    L+  + +C + +      +  HP L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLT 59

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI-----FQRLNIMIDATSTLEYLY 310
           ++       D    V+E++  G L         M  I     F        A      L 
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDL---------MFHIQKSRRFDEARARFYAAEITSALM 110

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           F H   II+ DLK  +VLLD +    L+DF    EG
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 23/155 (14%)

Query: 202 NLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA--QCEVMKSIRHPNLVKVI 258
             IG G++G VY+AR +D G  VA+K    +  +      A  + ++++ + H N+V + 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 259 SSCSND----DFKA------LVLEYMPK---GSLENCLYSSTCMLDIFQRLNIMIDATST 305
              ++     DFK       LV EYM     G LE+ L         F   +I       
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-------FSEDHIKSFMKQL 125

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           LE L + H    +H D+K  ++LL+      L+DF
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGI-----EVAVK-VFHQECARALKSFEAQCEVMKSIRHP 252
            LS+L+  G+FG ++   L D       EV VK V        +     +  ++  + H 
Sbjct: 9   TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68

Query: 253 NLVKVISSCSNDDFKALVLE-YMPKGS----LENCLYSSTCM---LDIFQRLNIMIDATS 304
           N++ ++  C  D     VL  YM  G+    L+ C          L   Q +++ I    
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSD 339
            + YL   H   +IH D+   + ++DE++   ++D
Sbjct: 129 GMSYL---HKRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 55/209 (26%)

Query: 203 LIGMGSFGSVYRARLRDGIEV----AVKVFHQECARALKSFEAQCE--VMKSIRHPNLVK 256
           ++G GSFG V+  R   G +     A+KV  +   +       + E  ++  + HP +VK
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN--IMI---DATSTLEYLYF 311
           +  +   +    L+L+++  G             D+F RL+  +M    D    L  L  
Sbjct: 63  LHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELAL 109

Query: 312 G----HTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------EYGMEGQ 347
                H+  II+ DLKP ++LLDE+    L+DF                    EY M  +
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY-MAPE 168

Query: 348 VSTR------SDIYGYGIVLMETFTRKKP 370
           V  R      +D + +G+++ E  T   P
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 35/141 (24%), Positives = 66/141 (46%), Gaps = 8/141 (5%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQE---CARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G+G+FG V  AR  D     A+K   ++       +   +A+ +++    +  +V++  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           S  + D    V++Y+P G + + L       +   R  I  + T  +E +   H    IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESV---HKMGFIH 124

Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            D+KP ++L+D D    L+DF
Sbjct: 125 RDIKPDNILIDRDGHIKLTDF 145

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)

Query: 191 LPSQATLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           LP    +  L  +IG G++G VY+AR  + G  VA+K+         +  + +  +++  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59

Query: 250 -RHPNLVKVI------SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN----- 297
             HPN+          +   NDD   LV+E    GS+ + L          +RL      
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGL--RKKGKRLKEEWIA 116

Query: 298 -IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            I+ +    L YL   H   +IH D+K  ++LL ++    L DF
Sbjct: 117 YILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDF 157

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 44/200 (22%)

Query: 204 IGMGSFGSV-YRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPN---LVKV 257
           +G G++G+V      R G +VA+K  ++     L +  A  E+  +K ++H N   L+ V
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 258 ISSCSN-DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY-----LYF 311
            +   + D F    L  MP        +  T +  + +   +  D    L Y     L +
Sbjct: 83  FTPDLSLDRFHDFYL-VMP--------FMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR-------------- 351
            H   IIH DLKP ++ ++ED    + DF      +  M G V TR              
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 352 ---SDIYGYGIVLMETFTRK 368
               DI+  G ++ E  T K
Sbjct: 194 TQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 45/215 (20%)

Query: 184 DVSNDGILPSQATLRRLSNLIGM--------GSFGSVYRARLRDGIE--VAVKVFHQECA 233
           D  +DG++P++   R +   +G         GS G V+ A  + G    V +K+  Q+  
Sbjct: 46  DDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKI-GQKGT 103

Query: 234 RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF 293
             +++      +++++ HP+++++  +  +     +VL +     L   L   +  L I 
Sbjct: 104 TLIEAM-----LLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPID 157

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EY 342
           Q L I       L YL   H   IIH D+K  ++ +++     + D              
Sbjct: 158 QALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214

Query: 343 GMEGQVSTRS-------------DIYGYGIVLMET 364
           G+ G V T +             DI+  GIVL E 
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 36/143 (25%), Positives = 64/143 (44%), Gaps = 7/143 (4%)

Query: 202 NLIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKS---FEAQCEVMKSIRHPNLVKV 257
           +L+G G FG V   R +   ++ A+KV  +    A ++   FE + +++     P + ++
Sbjct: 7   SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +  + D   LV+EY P G L + L       D F            +  ++  H    
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMGY 123

Query: 318 IHCDLKPISVLLDEDMVAHLSDF 340
           +H D+KP +VL+D      L+DF
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADF 146

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 35.2 bits (82), Expect = 0.004
 Identities = 18/57 (31%), Positives = 25/57 (43%), Gaps = 9/57 (15%)

Query: 28 EINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSNNEI 75
           ++LS N L+        GL +LK L L+ N L            SL  L+LS N +
Sbjct: 4  SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 46/209 (22%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVA----VKVFHQECARALKSFE--AQCEVMKSIRHPNLVK 256
           IG G++G V++AR L++G        V+V   E    L +    A    +++  HPN+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 257 VISSCS---NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY----- 308
           +   C+    D    L L +      E+     T  LD      +  +    + +     
Sbjct: 69  LFDVCTVSRTDRETKLTLVF------EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------EYGM 344
           L F H+  ++H DLKP ++L+       L+DF                        E  +
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 345 EGQVSTRSDIYGYGIVLMETFTRKKPTDR 373
           +   +T  D++  G +  E F R+KP  R
Sbjct: 183 QSSYATPVDLWSVGCIFAEMF-RRKPLFR 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 45/210 (21%), Positives = 84/210 (40%), Gaps = 46/210 (21%)

Query: 200 LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-RALKSFEAQCEVMKSIRHP 252
           +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R    F  +  VMK     
Sbjct: 10  MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYS---------STCMLDIFQRLNIMIDAT 303
           ++V+++   S      +++E M +G L++ L S               + + + +  +  
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------- 340
             + YL   +    +H DL   + ++ ED    + DF                       
Sbjct: 130 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 341 ----EYGMEGQVSTRSDIYGYGIVLMETFT 366
               E   +G  +T SD++ +G+VL E  T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 35/141 (24%), Positives = 66/141 (46%), Gaps = 8/141 (5%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G+G+FG V  A   D     A+K   ++       +   +A+ +++    +  +VK+  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           S  + D    V++Y+P G + + L       ++  R  I  + T  +E +   H    IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESV---HKMGFIH 124

Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            D+KP ++L+D D    L+DF
Sbjct: 125 RDIKPDNILIDLDGHIKLTDF 145

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	453
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.98
PHA03207	392	serine/threonine kinase US3; Provisional	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
PTZ00284	467	protein kinase; Provisional	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.91
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.9
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.9
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.89
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.87
PLN00181	793	protein SPA1-RELATED; Provisional	99.87
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.85
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.76
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.76
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.72
smart00090	237	RIO RIO-like kinase.	99.71
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.61
PLN03150	623	hypothetical protein; Provisional	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.29
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.27
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.24
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.17
KOG1243	690	consensus Protein kinase [General function predict	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.12
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.0
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.0
PLN03150	623	hypothetical protein; Provisional	98.96
KOG3087	229	consensus Serine/threonine protein kinase [General	98.93
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.85
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.83
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.79
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.77
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.76
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.75
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.71
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.7
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.7
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.7
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.67
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.64
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.63
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.63
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.52
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.51
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.45
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.44
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.43
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.42
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.42
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.41
PRK09902	216	hypothetical protein; Provisional	98.41
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.41
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.4
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.38
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.36
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.35
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.35
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.33
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.32
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.27
COG4248	637	Uncharacterized protein with protein kinase and he	98.2
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.15
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.02
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.0
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	97.99
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.99
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.99
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.95
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.91
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.91
PF01636	239	APH: Phosphotransferase enzyme family This family	97.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.87
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.84
PLN02876	822	acyl-CoA dehydrogenase	97.82
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.82
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	97.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.8

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.5e-57  Score=497.86  Aligned_cols=431  Identities=25%  Similarity=0.447  Sum_probs=324.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|+++|.+|..+.++++|+.|+|++|+++|.+|..++++++|+.|++++|.++         +++|+.|||+
T Consensus       476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  555 (968)
T PLN00113        476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS  555 (968)
T ss_pred             cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence            4788999999999999999999999999999999999999999999999999999999985         6799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCCCcceeeccccccCCCCCCCCC-CCCCCCCCCCCCCCCcccccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSP-NLQVPPCKLNKPGKHQKSRKNML  150 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn~~l~~~~-~~~~~~c~~~~~~~~~~~~~~~~  150 (453)
                      +|+++|.+|..+..+++|+.+++++|+++|.+|..+.+..+....+.||+.+|+.+ ....++|...     .+. ....
T Consensus       556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~-~~~~  629 (968)
T PLN00113        556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKT-PSWW  629 (968)
T ss_pred             CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----ccc-ceee
Confidence            99999999999999999999999999999999998888888778889999999854 3344566421     111 1111


Q ss_pred             chhhhhhHHHHHHHHHHHHHHhhhhhhccC--CCCccCCCCC--------CCcHHHHH------HHhcccCCCCccEEEE
Q 036792          151 PLVIVLPLSTALIIVVIILALKYKLTKCGK--RGLDVSNDGI--------LPSQATLR------RLSNLIGMGSFGSVYR  214 (453)
Q Consensus       151 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--------~~~~~~~~------~~~~~lg~G~~g~V~~  214 (453)
                       ++++.+++++++++++++++.+++++...  +.........        ........      ...+.||+|+||.||+
T Consensus       630 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~  708 (968)
T PLN00113        630 -FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYK  708 (968)
T ss_pred             -eehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEE
Confidence             12222222222222222222222211111  0000000000        00001111      2246799999999999


Q ss_pred             EEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHH
Q 036792          215 ARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF  293 (453)
Q Consensus       215 ~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~  293 (453)
                      |+.. ++..||||.++.....    ...|++.|++++|||||+++|+|.+++..++||||+++|+|.++++.    ++|.
T Consensus       709 ~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~  780 (968)
T PLN00113        709 GKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWE  780 (968)
T ss_pred             EEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHH
Confidence            9974 7899999998644321    23468889999999999999999999999999999999999999863    7899


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEec--c------------------ccCCCCCcCcccc
Q 036792          294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSD--F------------------EYGMEGQVSTRSD  353 (453)
Q Consensus       294 ~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~d--f------------------~~~~~~~~~~~~D  353 (453)
                      .+..++.++++|++|||..++++|+|||+||+||+++.++.+++..  .                  |+.....++.++|
T Consensus       781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD  860 (968)
T PLN00113        781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSD  860 (968)
T ss_pred             HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEEeccccccccCCCccccccccCcccccCCCCCcccc
Confidence            9999999999999999766688999999999999999988877641  1                  1222345788999


Q ss_pred             hHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC-chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcc
Q 036792          354 IYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI-SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPE  432 (453)
Q Consensus       354 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~  432 (453)
                      ||||||++|||+||+.||+..........+|.+..... ...+.+|+.+...    ...+.+.+.++.+++.+||+.+|+
T Consensus       861 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~  936 (968)
T PLN00113        861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD----VSVNQNEIVEVMNLALHCTATDPT  936 (968)
T ss_pred             hhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC----CCccHHHHHHHHHHHHhhCcCCch
Confidence            99999999999999999976555555666776654433 2334444444221    123345677899999999999999


Q ss_pred             cCCChHHHHHHHHHHHHH
Q 036792          433 KRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       433 ~RPs~~~v~~~L~~i~~~  450 (453)
                      +||||+|++++|+++...
T Consensus       937 ~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        937 ARPCANDVLKTLESASRS  954 (968)
T ss_pred             hCcCHHHHHHHHHHhhcc
Confidence            999999999999998664

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-47  Score=371.21  Aligned_cols=244  Identities=41%  Similarity=0.648  Sum_probs=208.4

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-eeEEEEeccCCCCc
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-FKALVLEYMPKGSL  279 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~E~~~~g~L  279 (453)
                      .+.||+|+||.||+|.+.+|..||||++.........+|.+|++++.+++|||+|+++|||.+.+ ..+||||||++|+|
T Consensus        80 ~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL  159 (361)
T KOG1187|consen   80 SNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSL  159 (361)
T ss_pred             hcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCH
Confidence            46899999999999999999999999887654331456999999999999999999999999988 59999999999999


Q ss_pred             hHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------------
Q 036792          280 ENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------------  345 (453)
Q Consensus       280 ~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------------  345 (453)
                      .++|+.... .++|..|++|+.++|+||+|||....++|+|||||++|||+|+++++||+|||++..             
T Consensus       160 ~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~  239 (361)
T KOG1187|consen  160 EDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVM  239 (361)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecC
Confidence            999998766 899999999999999999999988888999999999999999999999999975321             


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHhCCCCCCccc-cccccHHhHHhhhcCC-chhhhhhhhhhcCccCCch
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMF-VEELSLKDWVNNLLPI-SLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~  410 (453)
                                   +..+.|+|||||||+++|++||+.|.+... ..+..+..|....... .+.+++|+.+..+.   . 
T Consensus       240 gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~---~-  315 (361)
T KOG1187|consen  240 GTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGE---Y-  315 (361)
T ss_pred             CCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCC---C-
Confidence                         234679999999999999999999887543 3455578887655544 68899999886321   1 


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      ....+...+..++.+|++.+|.+||+|.||++.|+.+.
T Consensus       316 ~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  316 PDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            11156777999999999999999999999999997664

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=368.35  Aligned_cols=232  Identities=30%  Similarity=0.488  Sum_probs=201.9

Q ss_pred             HHHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +....+.+.||+|.||.||.|.++....||||.++.... ..++|.+|+++|++++|+|||+++|+|..++.++||||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            355677889999999999999999888999999987633 3478999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +.|+|.++|+. .+..+...+.+.++.|||+||+||   +++++|||||.++|||++++..+||+|||++.         
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999987 556788889999999999999999   99999999999999999999999999998763         


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                       .+.|+.|||||||||+|||++| |+.|+..+...+.     +         +.+      ..+
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----~---------~~l------e~G  420 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----L---------ELL------ERG  420 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----H---------HHH------hcc
Confidence                             2468899999999999999999 7888776643221     1         111      223


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .+.+.|+.||+++.++|..||..+|++||||+.+...|+++...
T Consensus       421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            35667889999999999999999999999999999999888653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=349.98  Aligned_cols=231  Identities=30%  Similarity=0.498  Sum_probs=193.8

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-eeEEEEeccCC
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-FKALVLEYMPK  276 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~E~~~~  276 (453)
                      +.+.+|+|+||+||+|.|+....||||++.....  ...++|.+|+.+|.+++|||||+++|+|.++. ..+||||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3455999999999999998655599999986542  22569999999999999999999999999988 79999999999


Q ss_pred             CCchHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCCceeeCCCC-cEEEeccccCC---------
Q 036792          277 GSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTP-IIHCDLKPISVLLDEDM-VAHLSDFEYGM---------  344 (453)
Q Consensus       277 g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~-i~Hrdlk~~NiLl~~~~-~~kl~df~~~~---------  344 (453)
                      |+|.++++. ....+++..++.++.|||+||.||   |+++ ||||||||+|||++.++ ++||+|||++.         
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~  201 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSM  201 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccc
Confidence            999999988 467899999999999999999999   7777 99999999999999997 99999997641         


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...|+.|+|||||||++|||+||+.||......+.  .               ......  .
T Consensus       202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~---------------~~v~~~--~  262 (362)
T KOG0192|consen  202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--A---------------SAVVVG--G  262 (362)
T ss_pred             cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--H---------------HHHHhc--C
Confidence                              12488999999999999999999999976533111  1               111111  1


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      .+++.+..|++.+..++.+||+.||++||++.+++..|+.+....+
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            2333455589999999999999999999999999999999877543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.6e-44  Score=362.67  Aligned_cols=227  Identities=30%  Similarity=0.533  Sum_probs=195.5

Q ss_pred             hcccCCCCccEEEEEEEC------CCCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          201 SNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      .+.||+|+||+||+|+..      +...||||.++..... ..++|++|+++|+.++|||||+++|+|..++..++|+||
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY  570 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY  570 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence            577999999999999853      3468999999977654 778999999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecc
Q 036792          274 MPKGSLENCLYSS-------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF  340 (453)
Q Consensus       274 ~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df  340 (453)
                      |..|||.++|+..             ...++..+.+.||.|||.||+||   .+..+|||||..+|+||.++..|||+||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHRDLATRNCLVge~l~VKIsDf  647 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHRDLATRNCLVGENLVVKISDF  647 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCcccccchhhhhceeccceEEEeccc
Confidence            9999999999642             12377889999999999999999   7888999999999999999999999999


Q ss_pred             ccC---------------------------CCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCc
Q 036792          341 EYG---------------------------MEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       341 ~~~---------------------------~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      |+.                           ..++|+++||||||||+|||++| |+.|+.+...++.     +       
T Consensus       648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-----I-------  715 (774)
T KOG1026|consen  648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-----I-------  715 (774)
T ss_pred             ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-----H-------
Confidence            764                           35789999999999999999999 8999877644331     1       


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                        +.+.      .+...+.++.||.++++||.+||+.+|++||+|+||-..|++....
T Consensus       716 --e~i~------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 --ECIR------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             --HHHH------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence              1111      1112457889999999999999999999999999999999887553

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=321.90  Aligned_cols=225  Identities=22%  Similarity=0.289  Sum_probs=186.1

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-eeEEEEeccCC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-FKALVLEYMPK  276 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~E~~~~  276 (453)
                      ..+.||+|..|+||+++++ +++.+|+|.+.... ....+++.+|++++++.+||+||.++|+|..+. .+.|+||||.+
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            3577999999999999987 68999999996553 345678999999999999999999999999988 49999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-------------  343 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-------------  343 (453)
                      |+|++++...+ .++....-.|+.++++||.|||  ++.+|+||||||+|||++..|++||||||.+             
T Consensus       163 GSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvG  239 (364)
T KOG0581|consen  163 GSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVG  239 (364)
T ss_pred             CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccccc
Confidence            99999887653 5777888899999999999995  3588999999999999999999999999854             


Q ss_pred             ----------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          344 ----------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       344 ----------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                .+..|+.++||||||+.++|+++|+.|+.....            .+..+.+.++..+.. +  ++..+.
T Consensus       240 T~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~------------~~~~~~~Ll~~Iv~~-p--pP~lP~  304 (364)
T KOG0581|consen  240 TSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP------------PYLDIFELLCAIVDE-P--PPRLPE  304 (364)
T ss_pred             cccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC------------CCCCHHHHHHHHhcC-C--CCCCCc
Confidence                      234678899999999999999999999864311            112333444443332 1  122333


Q ss_pred             -HHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          414 -QCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       414 -~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .+++++.+++..|+++||.+||+++|+++
T Consensus       305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             48999999999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=344.41  Aligned_cols=226  Identities=23%  Similarity=0.466  Sum_probs=198.8

Q ss_pred             HhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          200 LSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +.++||.|.||.|++|+++    ....||||.++... .+...+|+.|+.||.+++||||++|.|+........||+|||
T Consensus       633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM  712 (996)
T KOG0196|consen  633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM  712 (996)
T ss_pred             EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence            4689999999999999976    24689999999775 456679999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-----------  343 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-----------  343 (453)
                      ++|+|+.+|+.+...+.+.+...+..+||.||.||   .+.+.|||||.++|||++.+..+|++|||+.           
T Consensus       713 ENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y  789 (996)
T KOG0196|consen  713 ENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY  789 (996)
T ss_pred             hCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence            99999999999888899999999999999999999   8999999999999999999999999999865           


Q ss_pred             -----------------CCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          344 -----------------MEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       344 -----------------~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                       ..+++++.|||||||||+||.++ |..||-++...+.              ...+      .+
T Consensus       790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--------------IkaI------e~  849 (996)
T KOG0196|consen  790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------------IKAI------EQ  849 (996)
T ss_pred             cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--------------HHHH------Hh
Confidence                             13567889999999999999877 9999866543321              1111      22


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      +.+.+.|.+||..+.+||+.||++|-.+||+|.+|+..|.++-
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            3456678899999999999999999999999999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=331.19  Aligned_cols=231  Identities=26%  Similarity=0.437  Sum_probs=195.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ....+.+.||+|.||+||+|+|.+  .||||+++...  .+..+.|.+|+..+++-+|.||+-|+|||..++. +||+.+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            445678999999999999999863  59999998663  4567899999999999999999999999999888 999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      |+|.+|+.+|+..+..++..+.+.|+.|+++||.||   |.++|||||||..||++.++++|||+|||++.         
T Consensus       469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            999999999998888899999999999999999999   99999999999999999999999999998752         


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ...|+..+||||||||+|||+||..||.....+..-.+                  +..
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm------------------VGr  607 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM------------------VGR  607 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE------------------ecc
Confidence                                 13578999999999999999999999973322211100                  001


Q ss_pred             C--ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          404 G--EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       404 ~--~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      +  ..+.......|+.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            1  0112234468999999999999999999999999999999888663

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=314.01  Aligned_cols=177  Identities=32%  Similarity=0.553  Sum_probs=158.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |.+...||+|+||+||+|+++ ++..||||.+...  ..+..+....|+.+|+.++|||||++++++..++++|+|||||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC   91 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC   91 (429)
T ss_pred             ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence            455667999999999999987 6899999999876  4556677899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC------CcEEEeccccCC----
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED------MVAHLSDFEYGM----  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~------~~~kl~df~~~~----  344 (453)
                      .||||.++++.++ .++.......+.|+|.|+++|   |+++||||||||.|||++..      -.+||+|||++.    
T Consensus        92 ~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   92 NGGDLSDYIRRRG-RLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            9999999998875 678888899999999999999   99999999999999999864      468999998752    


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE  378 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~  378 (453)
                                          ..+|+.|+|+||.|+++||+++|++||+.....+
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence                                4678999999999999999999999998665444

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=353.99  Aligned_cols=228  Identities=29%  Similarity=0.491  Sum_probs=196.6

Q ss_pred             hcccCCCCccEEEEEEECC--C----CEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          201 SNLIGMGSFGSVYRARLRD--G----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      .+.||+|+||.||.|.+.+  |    ..||||.+++.. .+...+|.+|..+|++++|||||+++|+|.+....+|++||
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley  776 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY  776 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence            5789999999999998653  4    359999998764 45668999999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---
Q 036792          274 MPKGSLENCLYSS------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---  344 (453)
                      |++|||..+|++.      ...+.....+.++.|||+|+.||   +++++|||||.++|+|++....+||+|||++.   
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            9999999999887      56788889999999999999999   89999999999999999999999999998763   


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                                              .+.|++|+|||||||++||++| |..||......                 ++...
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----------------~v~~~  916 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----------------EVLLD  916 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----------------HHHHH
Confidence                                    2568999999999999999999 77888654222                 12222


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .+..+   +.+.+..||..+.++|..||+.+|++||+|..++..+.++...+
T Consensus       917 ~~~gg---RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  917 VLEGG---RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             HHhCC---ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            22222   56678899999999999999999999999999999998886543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-40  Score=325.70  Aligned_cols=222  Identities=24%  Similarity=0.344  Sum_probs=189.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEE-CCCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARL-RDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ..|...++||+|+|+.||.++. .+|+.||+|++.+..   ....+...+|+++.++|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5567789999999999999997 689999999998752   455678899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      |+|++|+|..+++ .+..++......++.||+.|+.||   |+.+|+|||||-.|+++++++++||+|||++..      
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999887 445788888999999999999999   899999999999999999999999999998742      


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                         ...+..+||||+||++|-|++|++||+.....                 +..++....   
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-----------------ety~~Ik~~---  233 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-----------------ETYNKIKLN---  233 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-----------------HHHHHHHhc---
Confidence                               23456799999999999999999999754221                 222222211   


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .+..|...+.++.+|+..+|+.+|.+|||+++|++
T Consensus       234 -~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 -EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             12334466778999999999999999999999985

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=329.05  Aligned_cols=229  Identities=26%  Similarity=0.436  Sum_probs=193.6

Q ss_pred             HhcccCCCCccEEEEEEEC--CC---CEEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          200 LSNLIGMGSFGSVYRARLR--DG---IEVAVKVFHQE---CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +.++||+|+||.||+|.++  ++   ..||||..+.+   ......+|++|+++|++++|||||+++|++.....+++||
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence            3589999999999999865  23   23899999853   3566789999999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      |+|.||+|.++|......++..+++.++.++|.||+||   |++.++||||.++|+|++.+..+||+|||++..      
T Consensus       241 El~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~  317 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM  317 (474)
T ss_pred             EecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence            99999999999998877799999999999999999999   999999999999999999999999999987532      


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         +.|+.++|||||||++||+++ |..||.+....  ...+++.               .  .
T Consensus       318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~---------------~--~  378 (474)
T KOG0194|consen  318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV---------------K--N  378 (474)
T ss_pred             ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH---------------h--c
Confidence                               357889999999999999999 78898765332  1222220               1  1


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      +.+.+.+...|.++..++.+||..+|++||+|.++.+.|+.+...
T Consensus       379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            112233446778889999999999999999999999999988654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-41  Score=312.41  Aligned_cols=226  Identities=25%  Similarity=0.388  Sum_probs=181.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh-------hHHHHHHHHHHHHcCCCCCceeEEeEEecCCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR-------ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  267 (453)
                      .+|.+.+.+|+|+||.|-+|.-+ +|+.||||++++....       ......+|+++|++++|||||++++++..++..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45667899999999999999854 7999999999765321       122357999999999999999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC---CcEEEeccccCC
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED---MVAHLSDFEYGM  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~---~~~kl~df~~~~  344 (453)
                      |+||||++||+|.+.+-.+. .+.......++.|++.|+.||   |++||+||||||+|||+..+   ..+||+|||++.
T Consensus       252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999887654 344555577889999999999   99999999999999999766   789999998762


Q ss_pred             C---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          345 E---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       345 ~---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                      -                           ..+..++|+||+||+||-+++|.+||.+..... ++.               
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~---------------  391 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLK---------------  391 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHH---------------
Confidence            1                           112348899999999999999999997543221 111               


Q ss_pred             hhhhhcC-ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLSG-EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       +.+..+ ....++...+.+++.++|+..+|..||++|||+.|+++
T Consensus       392 -eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  392 -EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             111111 11123455678889999999999999999999999985

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=324.09  Aligned_cols=228  Identities=24%  Similarity=0.411  Sum_probs=193.6

Q ss_pred             HhcccCCCCccEEEEEEECC-CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      ..++||-|.||.||.|.|+. .-.||||.++.+.. ..++|++|+.+|+.++|||+|+++|+|..+..+|||+|||..|+
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            35789999999999999874 67899999986644 46899999999999999999999999999999999999999999


Q ss_pred             chHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------------
Q 036792          279 LENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       279 L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------------  344 (453)
                      |.++|+.+. ..++..-.+.++.||+.||+||   ..+.+|||||.++|+|+.++..+|++|||++.             
T Consensus       350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA  426 (1157)
T KOG4278|consen  350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA  426 (1157)
T ss_pred             HHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc
Confidence            999998753 3456667789999999999999   89999999999999999999999999998641             


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                   ...|+.|+|||+|||+|||+.| |..||.+..     +.+..         +++.      .+.+..
T Consensus       427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSqVY---------~LLE------kgyRM~  486 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVY---------GLLE------KGYRMD  486 (1157)
T ss_pred             cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHHH---------HHHh------cccccc
Confidence                         2457889999999999999999 778886541     11111         1111      122445


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .+++||+.+++||+.||+++|++||+|.|+-+.++.+-.+.
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            67899999999999999999999999999999998876543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=314.99  Aligned_cols=232  Identities=25%  Similarity=0.450  Sum_probs=192.1

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      +.++||+|.||.|..+....+..||||+++... .....+|.+|+++|.+++|||||+++|+|..++.+++++|||++|+
T Consensus       542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD  621 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD  621 (807)
T ss_pred             hhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence            368899999999999999888999999998775 4456899999999999999999999999999999999999999999


Q ss_pred             chHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------------
Q 036792          279 LENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       279 L~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------------  344 (453)
                      |.+++..+... .+-.....|+.||+.||+||   .+.++||||+.++|+|++.++++||+|||++.             
T Consensus       622 LnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr  698 (807)
T KOG1094|consen  622 LNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR  698 (807)
T ss_pred             HHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence            99999876433 35567788999999999999   89999999999999999999999999998753             


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHh--CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFT--RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                    -+++++++|||+||+++||+++  ...||.....++     .+++.     -++++.   .+....
T Consensus       699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~-----~~~~~~---~~~~~~  765 (807)
T KOG1094|consen  699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENA-----GEFFRD---QGRQVV  765 (807)
T ss_pred             eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhh-----hhhcCC---CCccee
Confidence                          2578999999999999999866  677876543221     11111     011110   111123


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ...|.-|+.++++++++||..+.++||+++++...|.+.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            345678999999999999999999999999999888764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-38  Score=304.09  Aligned_cols=224  Identities=23%  Similarity=0.306  Sum_probs=182.4

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchh---hHHHHHHHHHHHHcCCCCCceeEEeEEec----CCeeEEEEecc
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECAR---ALKSFEAQCEVMKSIRHPNLVKVISSCSN----DDFKALVLEYM  274 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~E~~  274 (453)
                      ..+|+|++|.||+|.+ +|+.||||.++.....   ..+.|.+|+.+|++++|||||+++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4689999999999998 5889999999755322   25678899999999999999999999876    34688999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ++|+|.+++.... .+++.....++.+++.|+.||   |+ .+++||||||+||++++++.+||+|||++.         
T Consensus       105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~  180 (283)
T PHA02988        105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNL---YKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN  180 (283)
T ss_pred             CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHH---HhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccc
Confidence            9999999997654 678889999999999999999   54 478899999999999999999999998642         


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++|||||||++|||++|+.||......+                 +.+.......  +.
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----------------~~~~i~~~~~--~~  241 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----------------IYDLIINKNN--SL  241 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----------------HHHHHHhcCC--CC
Confidence                           1356779999999999999999999997542211                 1111111111  11


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ..+..++.++.+++.+||+.||++|||++|+++.|++++.
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            2233577889999999999999999999999999998763

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.8e-39  Score=288.88  Aligned_cols=238  Identities=20%  Similarity=0.261  Sum_probs=181.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |+...++|+|+||.||+++.+ +|+.||||++..+..  .-.+-.++|+++|++++|||+|.++++|......++|+|||
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            445567999999999999987 699999999976543  22345689999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +. ++.+-|......++......++.|+++|+.|+   |+++++||||||+|||++.++.+||||||++.          
T Consensus        84 dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   84 DH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             ch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            88 44445666566788888899999999999888   99999999999999999999999999998752          


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhh---hcCCchhhhhhhhh-hcC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN---LLPISLMEVVDKTL-LSG  404 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~d~~~-~~~  404 (453)
                                      ..+|...+||||.||++.||++|.+-|.+...  .+..-.+..   .+...-.+++...- ..+
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence                            13678889999999999999999999876532  221111111   11112222222111 001


Q ss_pred             -----ccCCchh---hHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          405 -----EKKGFVA---KEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       405 -----~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                           .....+.   -+..+.-+++++..|+..||.+|++.+|++
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence                 0001111   123345789999999999999999999976

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=308.70  Aligned_cols=243  Identities=20%  Similarity=0.225  Sum_probs=188.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEE-CCCCEEEEEEeeccchhhHH-HHHHHHHHHHcCC-CCCceeEEeEEecCC-eeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARL-RDGIEVAVKVFHQECARALK-SFEAQCEVMKSIR-HPNLVKVISSCSNDD-FKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lv~  271 (453)
                      ..|.+.+.||.|.||.||+|+- .+|..||||+++++.....+ --++|+..|+++. |||||++.+++.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            3467788899999999999984 47899999999876543322 2368999999999 999999999999987 999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      |||+. +|++.++.+...++......|+.||.+||+|+   |+.|++|||+||+|||+.....+||+|||++.       
T Consensus        90 E~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             Hhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence            99965 99999999888899999999999999999999   99999999999999999988899999998763       


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC--chhhh--hhhhhh
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI--SLMEV--VDKTLL  402 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~--~d~~~~  402 (453)
                                        ++.|+.+.||||+||+++|+.+-++-|.+...-+.-.+-.---..|.  .+.+.  +...+.
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence                              34678899999999999999999999987643332222111001111  11111  001110


Q ss_pred             ----cCccCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 ----SGEKKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ----~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          ...+.. ......++.++.+++.+|+++||.+||||+|+++
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                000000 0112247889999999999999999999999876

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-38  Score=309.23  Aligned_cols=233  Identities=24%  Similarity=0.402  Sum_probs=183.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC-Ce
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSND-DF  266 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~  266 (453)
                      ..+++.+.||+|+||.||+|.+.      ++..||||+++... ....+.+.+|+.++.++ +|||||+++++|... +.
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            34567889999999999999742      35789999997543 23456789999999999 899999999998764 45


Q ss_pred             eEEEEeccCCCCchHHhhcCC-----------------------------------------------------------
Q 036792          267 KALVLEYMPKGSLENCLYSST-----------------------------------------------------------  287 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~-----------------------------------------------------------  287 (453)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            789999999999999886421                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------------------
Q 036792          288 --CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------------------  344 (453)
Q Consensus       288 --~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------------------  344 (453)
                        ..+++.....++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.                     
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence              2356677788999999999999   78999999999999999999999999998652                     


Q ss_pred             ------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHH
Q 036792          345 ------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVL  417 (453)
Q Consensus       345 ------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~  417 (453)
                            ...++.++|||||||++|||++ |..||......+.    +..             .+..+.  ....+..+++
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----~~~-------------~~~~~~--~~~~~~~~~~  304 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FCQ-------------RLKDGT--RMRAPENATP  304 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----HHH-------------HHhcCC--CCCCCCCCCH
Confidence                  1235778999999999999997 9999875322111    000             000010  1112234567


Q ss_pred             HHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          418 SILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       418 ~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ++.+++.+||+.+|++|||+.|+++.|+++..+
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            799999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-38  Score=299.67  Aligned_cols=247  Identities=24%  Similarity=0.268  Sum_probs=190.5

Q ss_pred             CCCcHHHHHHHhcccCCCCccEEEEEEE-CCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--
Q 036792          190 ILPSQATLRRLSNLIGMGSFGSVYRARL-RDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND--  264 (453)
Q Consensus       190 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--  264 (453)
                      +.|.....|+..+.||+|.||.||+|+. .+|+.||+|+++.+.  .....-..+|+.+|++++||||+++.+.....  
T Consensus       111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            3444556677789999999999999984 589999999998664  33445567999999999999999999998876  


Q ss_pred             CeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          265 DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       265 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                      ..+|+|+|||+. ||.-++......++..+...++.|++.||.|+   |.++|+|||||.+|||||.+|.+||+|||++.
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEecccccee
Confidence            689999999988 99999988877899999999999999999999   99999999999999999999999999999874


Q ss_pred             ---------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc--C-C-ch
Q 036792          345 ---------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL--P-I-SL  393 (453)
Q Consensus       345 ---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~--~-~-~~  393 (453)
                                                 ...|+..+|+||.|||+.||++|++.+++...-+  ....+-...  | + .+
T Consensus       267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve--Ql~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE--QLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH--HHHHHHHHhCCCChhcc
Confidence                                       1357888999999999999999999998653221  111111111  1 0 11


Q ss_pred             h--hhhhhhhhcC-c--cC-CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 M--EVVDKTLLSG-E--KK-GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 ~--~~~d~~~~~~-~--~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .  ++-....... .  .+ ..+.-...+.++++|+..+|..||.+|.|+.++++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  1100000000 0  00 00112345678899999999999999999999874

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=306.71  Aligned_cols=220  Identities=24%  Similarity=0.378  Sum_probs=180.9

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCch
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLE  280 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~  280 (453)
                      .+-+|.|+.|.||+|+++ ++.||||+++.-       -..+++.|++++||||+.|.|+|...+-+|||||||..|-|+
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            356999999999999986 688999988632       235788899999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-----------------
Q 036792          281 NCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-----------------  343 (453)
Q Consensus       281 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-----------------  343 (453)
                      .+|+... ............+||.||.||   |...|||||||.-||||..+-.+||+|||..                 
T Consensus       201 ~VLka~~-~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa  276 (904)
T KOG4721|consen  201 EVLKAGR-PITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA  276 (904)
T ss_pred             HHHhccC-ccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence            9998865 455566677888999999999   7788999999999999999999999999643                 


Q ss_pred             -------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHH
Q 036792          344 -------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCV  416 (453)
Q Consensus       344 -------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  416 (453)
                             .....+.|+||||||||||||+||..||.+.....+     +..         +..     .....+.+..||
T Consensus       277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwG---------VGs-----NsL~LpvPstcP  337 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWG---------VGS-----NSLHLPVPSTCP  337 (904)
T ss_pred             hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEe---------ccC-----CcccccCcccCc
Confidence                   235678999999999999999999999865422111     000         000     011234677899


Q ss_pred             HHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          417 LSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       417 ~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ..+.-|+..||+-.|..||+|++|+..|+-...++
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            99999999999999999999999999987655443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.7e-38  Score=295.29  Aligned_cols=227  Identities=23%  Similarity=0.397  Sum_probs=186.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|.++    .+..||+|.++.... .....|.+|+..+++++||||++++|++..++..++|||
T Consensus         7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   86 (266)
T cd05064           7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE   86 (266)
T ss_pred             eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence            456788999999999999754    367899999986532 344678999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++......+++...+.++.+++.|+.||   |+++++||||||+||+++.++.++++|||...        
T Consensus        87 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          87 YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             eCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence            9999999999987656788999999999999999999   78899999999999999999999999997531        


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                        ...++.++|||||||++||+++ |..||......+  ....+.                .+ 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~----------------~~-  224 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVE----------------DG-  224 (266)
T ss_pred             cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHH----------------CC-
Confidence                              1235678999999999999775 999986542211  111111                00 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                       ...+.+..++..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             01123445778899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=282.94  Aligned_cols=228  Identities=25%  Similarity=0.321  Sum_probs=181.2

Q ss_pred             HHHHHhcccCCCCccEEEEEE-ECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEe-EEecCCe-eEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVIS-SCSNDDF-KALV  270 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lv  270 (453)
                      ..+++.+.||+|+||.||++. ..+|..||.|.++-..  ....+....|+.+|++++|||||++++ .+.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457889999999999999998 4589999999998542  355678899999999999999999998 4555554 8899


Q ss_pred             EeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCCceeeCCCCcEEEeccccC---
Q 036792          271 LEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTP-IIHCDLKPISVLLDEDMVAHLSDFEYG---  343 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~-i~Hrdlk~~NiLl~~~~~~kl~df~~~---  343 (453)
                      ||||..|||.+.++.   .+...+......+..|++.||..+|+.-.++ |+||||||.||+++.+|.+||+|||++   
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999988853   3456788889999999999999995432332 899999999999999999999999865   


Q ss_pred             ----------------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          344 ----------------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       344 ----------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            ....|+.||||||+||++|||..-.+||.+..  -.++.+.+                
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~KI----------------  240 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCKKI----------------  240 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHHHH----------------
Confidence                                  23578999999999999999999999998652  12222111                


Q ss_pred             hcCccCCchhh-HHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          402 LSGEKKGFVAK-EQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       402 ~~~~~~~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ..++  .++.+ +..+.++..|+..|++.||+.||+.-.++..
T Consensus       241 ~qgd--~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  241 EQGD--YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             HcCC--CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence            1121  11122 5667889999999999999999985444433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=292.75  Aligned_cols=238  Identities=26%  Similarity=0.343  Sum_probs=191.9

Q ss_pred             CCcHHHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          191 LPSQATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       191 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      +|.....|++.++||.|..++||+|+.. .++.||||++.-+ +....+.+.+|+..|+.++||||++++..|..+..+|
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            4455667889999999999999999954 7899999999866 3445688999999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---
Q 036792          269 LVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---  344 (453)
                      +||.||.+|++.+.++.. ...++......|..++++||.||   |.+|.||||+|+.|||++++|.+||+|||...   
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999998763 34577888889999999999999   89999999999999999999999999996421   


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                                                  ...|+.|+|||||||+..|+++|..||........-+... +...|......
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~~  256 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTSG  256 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccccc
Confidence                                        1357889999999999999999999998664433222111 11111111111


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .          +.........++.+++..|+++||++|||++++++
T Consensus       257 ~----------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 L----------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             C----------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1          11223344568999999999999999999999874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=303.78  Aligned_cols=226  Identities=24%  Similarity=0.421  Sum_probs=195.6

Q ss_pred             HhcccCCCCccEEEEEEECC---C--CEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          200 LSNLIGMGSFGSVYRARLRD---G--IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +.+.||+|.||.||+|.+.+   |  ..||||..+.++ .+..+.|+.|+.+|++++|||||+++|+|.+. ..|||||.
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL  471 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL  471 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence            46889999999999998642   2  469999998764 45678999999999999999999999999765 46999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ++.|.|..+|......++.......+.|+..+|.||   |+.++|||||.++|||+.+...+|++|||++.         
T Consensus       472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence            999999999998888888888889999999999999   99999999999999999999999999998652         


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                       .++|++.||||-|||.+||++. |..||.+....+..                    ..-..+
T Consensus       549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------------~~iEnG  608 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------------GHIENG  608 (974)
T ss_pred             ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------------------EEecCC
Confidence                             2467889999999999999987 89999865433221                    111223


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      .+.+.|+.||+.+..|+.+||+++|.+||++.++...|+.+..
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            4667889999999999999999999999999999999998866

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-38  Score=294.25  Aligned_cols=225  Identities=27%  Similarity=0.383  Sum_probs=181.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC--eeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD--FKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~E~~  274 (453)
                      ....+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|......  .+++.|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            345788999999999999976 59999999998764434677899999999999999999999855544  689999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC--------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME--------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~--------  345 (453)
                      ++|+|.+++...+..++.........++++||.||   |+++++||||||+|||++. ++.+||+|||.+..        
T Consensus        99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            99999999988765789999999999999999999   8999999999999999999 79999999985421        


Q ss_pred             --------------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 --------------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 --------------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          +. ...++||||+||++.||+||++||...    .....++-            ......
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~------------~ig~~~  239 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALL------------LIGRED  239 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHH------------HHhccC
Confidence                                11 123899999999999999999998642    00011100            000011


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                        ..+..+...+.++.+++.+|+..+|++||||++++..
T Consensus       240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence              1123455677889999999999999999999999864

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.5e-38  Score=295.36  Aligned_cols=221  Identities=35%  Similarity=0.578  Sum_probs=175.5

Q ss_pred             hcccCCCCccEEEEEEEC-----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          201 SNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .+.||+|.||.||+|.+.     .+..|+||.++... ....+.|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999876     25789999996543 344788999999999999999999999999888899999999


Q ss_pred             CCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          275 PKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      ++|+|.++|... ...+++..+..++.|+++||.||   |+.+++|+||+++||++++++.+||+|||+...        
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999886 56789999999999999999999   678899999999999999999999999975421        


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ..++.++||||||+++||+++ |+.|+......+     +..            .. ... 
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----~~~------------~~-~~~-  221 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----IIE------------KL-KQG-  221 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----HHH------------HH-HTT-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccc------------cc-ccc-
Confidence                               224678999999999999999 678876442111     111            00 101 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                       .....+..++..+.+++.+||+.+|++||||+++++.|
T Consensus       222 -~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 -QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             11223445777899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.2e-37  Score=295.09  Aligned_cols=233  Identities=21%  Similarity=0.408  Sum_probs=179.0

Q ss_pred             HHHHhcccCCCCccEEEEEEECC-----------------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD-----------------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVI  258 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~  258 (453)
                      .+++.+.||+|+||.||+|.+++                 +..||+|.++... .....+|.+|++++.+++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            34567889999999999997532                 3479999987653 33456799999999999999999999


Q ss_pred             eEEecCCeeEEEEeccCCCCchHHhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 036792          259 SSCSNDDFKALVLEYMPKGSLENCLYSST------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC  320 (453)
Q Consensus       259 g~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hr  320 (453)
                      +++.+.+..++||||+++|+|.+++....                  ..+++.....++.|++.|+.||   |+.+|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~ivH~  162 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR  162 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH---HHCCcccc
Confidence            99999999999999999999999885421                  2356778889999999999999   78899999


Q ss_pred             CCCCCceeeCCCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh--CCCCC
Q 036792          321 DLKPISVLLDEDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT--RKKPT  371 (453)
Q Consensus       321 dlk~~NiLl~~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t--g~~p~  371 (453)
                      ||||+|||++.++.+||+|||++.                           .+.++.++|||||||++|||++  +..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            999999999999999999998652                           1235678999999999999987  45666


Q ss_pred             CccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          372 DRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      ......+  .........        .....   ......+..++..+.+++.+||+.+|++|||++||.+.|+
T Consensus       243 ~~~~~~~--~~~~~~~~~--------~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         243 GELTDEQ--VIENAGEFF--------RDQGR---QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CcCCHHH--HHHHHHHHh--------hhccc---cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            5432111  111111000        00000   0001112356778999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.1e-37  Score=271.38  Aligned_cols=240  Identities=23%  Similarity=0.313  Sum_probs=187.4

Q ss_pred             HHHhcccCCCCccEEEEEEE-CCCCEEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARL-RDGIEVAVKVFHQECAR--ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |...+++|+|.||.||+|+. .+|+.||||+++.....  .-....+|++.|+.++|+||+.++++|.+.+...||+|||
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm   83 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM   83 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence            44567899999999999985 47999999999866432  2245689999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +. ||+..++.....+...+...++.++.+|++|+   |++.|+|||+||.|+|+++++.+||+|||++.          
T Consensus        84 ~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   84 PT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             cc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            87 99999999888899999999999999999999   99999999999999999999999999998752          


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc----CCchh---hhhhhhh
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL----PISLM---EVVDKTL  401 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~---~~~d~~~  401 (453)
                                      ...|++.+||||.||++.||+-|.+-|.+..  +.+....+-..+    ++.+.   .+-|..-
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence                            2457888999999999999999998887642  222222222211    11111   1112111


Q ss_pred             hc-CccCCc-hhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          402 LS-GEKKGF-VAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       402 ~~-~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .. -+.... ..-..++.++++|+..+|.+||.+|+|++|+++.
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11 111000 0123456678999999999999999999998753

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.9e-37  Score=303.20  Aligned_cols=230  Identities=23%  Similarity=0.359  Sum_probs=182.4

Q ss_pred             HHHHHhcccCCCCccEEEEEEE------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  267 (453)
                      ..+++.+.||+|+||.||+|.+      .++..||||+++... ....+.+.+|+++++.+ +|||||+++++|..++..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            3467789999999999999973      235689999997543 34456789999999999 899999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCC------------------------------------------------------------
Q 036792          268 ALVLEYMPKGSLENCLYSST------------------------------------------------------------  287 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~------------------------------------------------------------  287 (453)
                      ++||||+++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999885421                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          288 --------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       288 --------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                                    ..+++.....++.++++|+.||   |+++|+||||||+|||++.++.+||+|||++.         
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                          1367778889999999999999   78899999999999999999999999998642         


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                        ...++.++|||||||++|||++ |..||....... ...+++            ....    
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~------------~~~~----  334 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMI------------KEGY----  334 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHH------------HhCc----
Confidence                              1235678999999999999998 888886542221 111111            1100    


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                        ....+...+.++.+|+..||+.||++||+|.|+++.|++.
T Consensus       335 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 --RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              0011223456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=307.12  Aligned_cols=230  Identities=23%  Similarity=0.408  Sum_probs=196.6

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-C----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-D----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      +..+...+||+|+||+||+|.|- .    ..+||||++.... .+...+++.|+-.|.+++|||+++++|+|.... ..|
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            44455789999999999999753 3    3689999987653 456789999999999999999999999998776 779


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      |++||+.|+|.++++.++..+.....+.+..|||+||.||   |+++++||||.++|||+.+...+||.|||++.     
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999999999888899999999999999999999   89999999999999999999999999997542     


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            .+.|+.++|||||||++||++| |..|+++...+++              .+.+    
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------------~dll----  913 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------------PDLL----  913 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------------hHHH----
Confidence                                  2467889999999999999999 8999987644332              1111    


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ..++  +.++|+-|+.++..++.+||..|++.||+|+++...+.++..
T Consensus       914 e~ge--RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  914 EKGE--RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             hccc--cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            1122  356788999999999999999999999999999998877644

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=296.33  Aligned_cols=220  Identities=25%  Similarity=0.394  Sum_probs=179.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +..++.||+|+|++|++|+.+ ++++||||++.+.-   ....+-..+|-.+|.+| .||.||+|+.-|.++..+|+|+|
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe  154 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE  154 (604)
T ss_pred             cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence            356789999999999999855 79999999997652   22234566788889999 89999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++...+ .++.......+.+|+.|++||   |++|||||||||+|||+|+||.+||+|||.+.        
T Consensus       155 ~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  155 YAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             ecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            999999999998764 677777888999999999999   99999999999999999999999999997541        


Q ss_pred             ------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchh
Q 036792          345 ------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM  394 (453)
Q Consensus       345 ------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  394 (453)
                                                    ....+..+|+|+|||++|.|+.|++||.... +....+            
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-eyliFq------------  297 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EYLIFQ------------  297 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HHHHHH------------
Confidence                                          1234567999999999999999999997542 111111            


Q ss_pred             hhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          +.+.-    ....+++.++.+.+|+.+.|..||.+|+|.++|-+
T Consensus       298 ----kI~~l----~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 ----KIQAL----DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ----HHHHh----cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                11111    12345566778999999999999999999988754

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=304.18  Aligned_cols=223  Identities=24%  Similarity=0.402  Sum_probs=187.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC--CC--CEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR--DG--IEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      -++.++||+|.||.|++|.|+  .|  ..||||+++..... ...+|.+|+.+|-+|+|||+++++|+..+ ....+|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            456789999999999999987  34  57999999877544 67899999999999999999999999987 56789999


Q ss_pred             ccCCCCchHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC--------
Q 036792          273 YMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------  343 (453)
Q Consensus       273 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~--------  343 (453)
                      .++.|+|.+.|+. ....+.......++.|||.||.||   ..+++|||||.++|+|+.....+||+|||+.        
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999987 445566667778999999999999   9999999999999999999999999999753        


Q ss_pred             --------------------CCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          344 --------------------MEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       344 --------------------~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                          ....|+.++|||+|||++|||+| |..||.+....              .+.+.+|+   
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------qIL~~iD~---  330 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------QILKNIDA---  330 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------HHHHhccc---
Confidence                                23578999999999999999999 67888654211              23333431   


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                         +-+.+-++.|++.+++++..||+.+|++||||.++...+
T Consensus       331 ---~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  331 ---GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ---cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence               123456688999999999999999999999999997544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=284.62  Aligned_cols=216  Identities=27%  Similarity=0.340  Sum_probs=176.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      .-+++.++||+|+||+||.++.+ +++.+|+|++++..   ....+...+|..+|.+++||.||.+...|++++.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            34567899999999999999865 69999999998763   234567889999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+.||+|..+|.... .++.....-.+..++.||.||   |+++|+||||||+|||+|.+|+++|+|||+..       
T Consensus       105 d~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             eccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            9999999999998765 355555555667899999999   99999999999999999999999999997653       


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...|+..+|.||+||++|||++|.+||....                 ..++++......  
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----------------~~~~~~~I~~~k--  241 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----------------VKKMYDKILKGK--  241 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----------------HHHHHHHHhcCc--
Confidence                              2457888999999999999999999997542                 122222222211  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCC
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRI  435 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP  435 (453)
                       ....+...+.++.+++...+..||++|-
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             1112233566789999999999999995

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.9e-36  Score=283.15  Aligned_cols=230  Identities=28%  Similarity=0.466  Sum_probs=190.8

Q ss_pred             HHHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ...+.+.+.||+|+||.||+|...++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45577889999999999999998889999999998776656678999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ++|+|.+++... ...+++.....++.+++.|+.||   |+++++||||||+||++++++.+||+|||++.         
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            999999999763 34578889999999999999999   78899999999999999999999999997642         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      ...++.++||||||+++|||++ |+.||......+                 .++.... .  .
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-----------------~~~~~~~-~--~  221 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-----------------VYDQITA-G--Y  221 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-----------------HHHHHHh-C--C
Confidence                            1235668999999999999998 899986542111                 1110000 0  0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      +.+.+..++.++.+++.+||+.+|++|||++++.+.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1122345667899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-36  Score=287.39  Aligned_cols=242  Identities=27%  Similarity=0.412  Sum_probs=186.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-----CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  270 (453)
                      +++.+.||+|+||.||++.++     ++..||+|.++.......+.+.+|++++++++||||+++++++..  ....++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            456788999999999999753     578999999987666666789999999999999999999998754  3468899


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      +||+++|+|.+++......+++.....++.+++.|+.||   |+++++||||||+||++++++.+||+|||++..     
T Consensus        86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            999999999999977655688999999999999999999   889999999999999999999999999976421     


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC--Cchhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP--ISLMEVVDKT  400 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~  400 (453)
                                             ..++.++|||||||++|||++|..|+......   ..........  .....+. ..
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~  238 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLI-EL  238 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHH-HH
Confidence                                   23456799999999999999998775432111   0000000000  0000111 11


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      +...  ...+.+..++.++.+++.+||+.+|++||||+|+++.|++++
T Consensus       239 ~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         239 LKNN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HhcC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            1111  111223456778999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.2e-36  Score=282.28  Aligned_cols=222  Identities=25%  Similarity=0.419  Sum_probs=180.3

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      ++.+.||+|+||.||++.++++..+|+|.++.... ..+.+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC   85 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence            44677999999999999988888999998864432 24678899999999999999999999999999999999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------------  345 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------------  345 (453)
                      |.+++......+++.....++.+++.|+.||   |+++++||||||+||++++++.+|++|||+...             
T Consensus        86 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          86 LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             HHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            9999876555688899999999999999999   788999999999999999999999999985421             


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ..++.++||||||+++|||++ |+.||......  .....+..                ..  ....
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~----------------~~--~~~~  222 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISR----------------GF--RLYR  222 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC----------------CC--CCCC
Confidence                         234568999999999999999 89998643211  11111110                00  0011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      +...+.++.+++.+||+.+|++||+++|+++.|
T Consensus       223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            122345789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.1e-36  Score=299.90  Aligned_cols=231  Identities=22%  Similarity=0.373  Sum_probs=182.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  267 (453)
                      ..+++.+.||+|+||.||+|...      ++..||||+++... ....+.+.+|+++++.+ +|+|||+++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            34567899999999999999742      24589999997543 33456788999999999 899999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCC------------------------------------------------------------
Q 036792          268 ALVLEYMPKGSLENCLYSST------------------------------------------------------------  287 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~------------------------------------------------------------  287 (453)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885321                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------------
Q 036792          288 ---------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------  344 (453)
Q Consensus       288 ---------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------------  344 (453)
                               ..+++.....++.|++.|+.||   |+++|+||||||+|||+++++.+||+|||++.              
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     2356777889999999999999   78999999999999999999999999997642              


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                   ...++.++|||||||++|||++ |+.||........ ..            ..+....      ...
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~------------~~~~~~~------~~~  335 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY------------KMVKRGY------QMS  335 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH------------HHHHccc------Ccc
Confidence                         1235678999999999999997 9999865422111 11            1110000      001


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      .+...+.++.+++.+||+.+|++|||+.++++.|+++-
T Consensus       336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11223567899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=295.81  Aligned_cols=224  Identities=25%  Similarity=0.330  Sum_probs=186.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEE-CCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARL-RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|..-..||+|+.|.||.+.- .+++.||||++........+-..+|+.+|+..+|+|||++++.|..++.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            3344467899999999999984 478999999998877666677899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+.+...  .++..+...|+.++++||.||   |.++|+|||||.+|||++.++.+||+|||+..          
T Consensus       353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            999999988764  378889999999999999999   99999999999999999999999999997642          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...|++|+||||||++++||+-|.+||-.    +..+++...              +.....+..
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyL--------------Ia~ng~P~l  489 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYL--------------IATNGTPKL  489 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHH--------------HhhcCCCCc
Confidence                           24578999999999999999999999742    222222111              011111222


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..++..++++.+++.+||+.||++||++.|+++
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            345677889999999999999999999999985

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.7e-36  Score=285.26  Aligned_cols=240  Identities=25%  Similarity=0.399  Sum_probs=184.2

Q ss_pred             HHHhcccCCCCccEEEEEEE-----CCCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  269 (453)
                      +++.+.||+|+||+||++.+     .++..||+|.++.... ...+.+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            35667899999999988753     2578999999976532 3456788999999999999999999988763  45789


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      +|||+++|+|.+++...  .+++.....++.++++|+.||   |+++++||||||+||++++++.++|+|||++.     
T Consensus        86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            99999999999988764  488999999999999999999   78899999999999999999999999998642     


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCCchhhhhhhh
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPISLMEVVDKT  400 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~  400 (453)
                                             ...++.++||||||+++|||+||..|+................. ......+.++..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence                                   12346689999999999999999999764322111111000000 000111111111


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      .      ..+.+..++.++.+++..||+.+|++|||++++++.|+++.
T Consensus       241 ~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 M------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             C------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1      11233456788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.2e-36  Score=292.27  Aligned_cols=229  Identities=22%  Similarity=0.409  Sum_probs=184.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGI----EVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|.+. ++.    .||||.++... ....+++.+|+.+++.++||||++++|+|... ..++++
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            566788999999999999864 333    48999987543 34557889999999999999999999999765 567999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++......+++...+.++.+++.||.||   |+++|+||||||+||+++.++.+||+|||++..      
T Consensus        88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK  164 (316)
T ss_pred             ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence            99999999999987666788888999999999999999   889999999999999999999999999986521      


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ..++.++|||||||++||+++ |..||.+....+  ......            .    
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~------------~----  226 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILE------------K----  226 (316)
T ss_pred             ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHh------------C----
Confidence                                 234668999999999999998 999986532211  111111            0    


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ..  ..+.+..++.++.+++.+||+.+|++||++.+++..|.++..+
T Consensus       227 ~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         227 GE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            00  1112234566789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.1e-36  Score=279.63  Aligned_cols=221  Identities=27%  Similarity=0.466  Sum_probs=180.5

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      +.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||++++++|......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999875 78999999886543 33456789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------  345 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------------  345 (453)
                      .+++......+++.....++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||++..              
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999976655688899999999999999999   889999999999999999999999999976421              


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   +.++.++|||||||++||+++ |..||.......  ..            ..+....      ....
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~------------~~~~~~~------~~~~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TR------------EAIEQGV------RLPC  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HH------------HHHHcCC------CCCC
Confidence                         224567899999999999998 888885432111  01            1111100      1112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      +..++..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.9e-36  Score=286.03  Aligned_cols=240  Identities=21%  Similarity=0.267  Sum_probs=179.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |.+.+.||+|+||.||+|+.+ ++..||+|.++.... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            455688999999999999876 689999999875432 234567899999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      + +|.+++......+++.....++.|++.||+||   |+++|+||||||+|||++.++.+||+|||++.           
T Consensus        87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence            5 99988876655678888899999999999999   88999999999999999999999999998642           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCC-chhhhhhh-----hh
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPI-SLMEVVDK-----TL  401 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~-~~~~~~d~-----~~  401 (453)
                                     ...++.++||||+||++|||+||++||......+. +.......  .+. .+.++.+.     ..
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhhhccc
Confidence                           12356789999999999999999999975432211 11111100  000 01110000     00


Q ss_pred             hcCcc--CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEK--KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~--~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....  .........+.++.+++.+|+..||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000  000011234567899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=279.44  Aligned_cols=227  Identities=24%  Similarity=0.444  Sum_probs=185.1

Q ss_pred             HHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|.++.    ...||||.++... .....+|.+|+.++++++||||+++++++...+..+++||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            4567889999999999998752    4689999987553 3345678999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++......+++.....++.+++.|+.||   |+++|+|+||||+||++++++.++++|||+...       
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            9999999999977656788999999999999999999   789999999999999999999999999975421       


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ..++.++||||||+++||+++ |..||......+  .......                .
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~----------------~  224 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVED----------------G  224 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHc----------------C
Confidence                                234668999999999999998 999985432111  1111110                0


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      .  ..+.+..++..+.+++.+||+.+|++||+++|+++.|+++
T Consensus       225 ~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 Y--RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0  1112235567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.7e-36  Score=297.48  Aligned_cols=231  Identities=23%  Similarity=0.382  Sum_probs=183.1

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  267 (453)
                      ..+.+.+.||+|+||.||+|.+.      .+..||||+++... ....+.+.+|+++|+++. |||||+++++|...+..
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            34567899999999999999853      23579999997543 334567999999999996 99999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCC------------------------------------------------------------
Q 036792          268 ALVLEYMPKGSLENCLYSST------------------------------------------------------------  287 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~------------------------------------------------------------  287 (453)
                      ++||||+++|+|.+++....                                                            
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            99999999999998875421                                                            


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC
Q 036792          288 -----------------------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED  332 (453)
Q Consensus       288 -----------------------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~  332 (453)
                                                         ..+++.....++.++++|+.||   |+.+|+||||||+||+++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHhEEEeCC
Confidence                                               1356677788999999999999   78899999999999999999


Q ss_pred             CcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhH
Q 036792          333 MVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDW  384 (453)
Q Consensus       333 ~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~  384 (453)
                      +.+||+|||++.                           ...++.++|||||||++|||++ |..||.......... . 
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-~-  351 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-N-  351 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-H-
Confidence            999999998642                           1234678999999999999997 889986542211100 0 


Q ss_pred             HhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          385 VNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       385 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                                     .+..+.  ....+..++.++.+++.+||+.+|++||++.++.+.|+++.
T Consensus       352 ---------------~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 ---------------KIKSGY--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ---------------HHhcCC--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                           000010  11223456778999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=278.13  Aligned_cols=242  Identities=28%  Similarity=0.373  Sum_probs=182.0

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHH--cCCCCCceeEEeEEecCC----eeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMK--SIRHPNLVKVISSCSNDD----FKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~lv~E  272 (453)
                      ++.+++|+|.||.||+|.+. ++.||||++...   ..+.|..|-++.+  .++|+||++|+++-....    .++||+|
T Consensus       213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            56789999999999999986 599999999754   4467888888866  468999999999876655    7899999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCceecCCCCCceeeCCCCcEEEeccccCCCC
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF------GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEG  346 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~------~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~  346 (453)
                      |.++|+|.++|..+  ..+|....+|+..+++||+|||.      .|+++|+|||||++|||+..|+++-|+|||++..-
T Consensus       289 fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  289 FHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             eccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            99999999999875  48899999999999999999995      56788999999999999999999999999876321


Q ss_pred             -----------Cc-----------------C-----cccchHHHHHHHHHHHhCCCCCCcccccc--ccHHhHHhhhcCC
Q 036792          347 -----------QV-----------------S-----TRSDIYGYGIVLMETFTRKKPTDRMFVEE--LSLKDWVNNLLPI  391 (453)
Q Consensus       347 -----------~~-----------------~-----~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~  391 (453)
                                 ++                 .     .+.||||+|.|+|||+++..-.+.....+  ....+.+  ....
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev--G~hP  444 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV--GNHP  444 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh--cCCC
Confidence                       11                 1     25899999999999999876543111111  1111111  1112


Q ss_pred             chhhhhhhhhhcCccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          392 SLMEVVDKTLLSGEKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       392 ~~~~~~d~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      .+.++-+-.+....++..   ......+..+.+.+..||+.||+.|-|+.=|.+++.++.
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            233332222222222111   122244667889999999999999999999988887764

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8e-36  Score=280.55  Aligned_cols=223  Identities=24%  Similarity=0.398  Sum_probs=180.9

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .+.+.||+|+||.||+|.+.++..+|||.++.... ..+.+.+|+.++++++||||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC   85 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence            45678999999999999987777899999875432 34678999999999999999999999999889999999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------  344 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------------  344 (453)
                      |.+++......+++...+.++.+++.|+.||   |+.+++|+||||+||+++.++.+||+|||...              
T Consensus        86 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05113          86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK  162 (256)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence            9999876555688999999999999999999   78899999999999999999999999997542              


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                  ...++.++|||||||++|||++ |..||......+  .....               . .+.  ....
T Consensus       163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~---------------~-~~~--~~~~  222 (256)
T cd05113         163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKV---------------S-QGL--RLYR  222 (256)
T ss_pred             cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHH---------------h-cCC--CCCC
Confidence                        1234678999999999999999 999986432111  00000               0 000  0011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      +...+..+.+++.+||+.+|++||++.+++..|+
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1224567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.6e-35  Score=278.56  Aligned_cols=231  Identities=23%  Similarity=0.326  Sum_probs=184.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE---CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|+.. +++.||||.++..   .......+.+|+++++.++||||+++++++...+..++++||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            356788999999999999865 7899999988643   233446788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          274 MPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      +++|+|.+++..   ....++......++.++++|+.||   |+.+++|+||||+||+++.++.++++|||.+.      
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999988753   234577888899999999999999   88999999999999999999999999997532      


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++||||||+++|||++|..||......   ...+...         +.    ...
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~---------~~----~~~  224 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQK---------IE----QCD  224 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHH---------Hh----cCC
Confidence                               123466799999999999999999998543211   1111110         00    000


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                       .+.......+..+.+++.+||+.+|++||++.++++.|++++
T Consensus       225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence             011122345677899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-35  Score=283.39  Aligned_cols=230  Identities=28%  Similarity=0.451  Sum_probs=186.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++||
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   86 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            355678999999999999742      34679999998766556678999999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEec
Q 036792          272 EYMPKGSLENCLYSST------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSD  339 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~d  339 (453)
                      ||+++|+|.+++....            ..+++.....++.+++.++.||   |+++++||||||+||++++++.++|+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEEecc
Confidence            9999999999886432            2478889999999999999999   789999999999999999999999999


Q ss_pred             cccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCC
Q 036792          340 FEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPI  391 (453)
Q Consensus       340 f~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  391 (453)
                      ||++.                           ...++.++|||||||++|||+| |..||......+     .       
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~-------  231 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----V-------  231 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----H-------
Confidence            97642                           1234668999999999999999 899986442211     0       


Q ss_pred             chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       392 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                           ++.... +.  ....+..++.++.+++.+||+.+|.+|||++|+.+.|+++...
T Consensus       232 -----~~~i~~-~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         232 -----IECITQ-GR--VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -----HHHHHc-CC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                 000000 00  0011223456799999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.3e-36  Score=285.43  Aligned_cols=223  Identities=20%  Similarity=0.258  Sum_probs=177.0

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+.||+|+||.||++... +|+.||||.+.....   .....+.+|+.++++++|+||+++.+++.+++..++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence            4578999999999999864 789999999875432   223467889999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+.+... ...+++.....++.|++.|+.||   |+++|+||||||+|||+++++.++|+|||++.          
T Consensus        84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99998877543 33578888999999999999999   88999999999999999999999999998642          


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|+.||........ .             +.++..+...   ...
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~-------------~~~~~~~~~~---~~~  223 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-R-------------EEVDRRVKED---QEE  223 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-H-------------HHHHHHhhcc---ccc
Confidence                          12457789999999999999999999975322110 0             1111111110   011


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      .+...+.++.+|+.+||+.||++||+     ++++++
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            22345667899999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-35  Score=282.15  Aligned_cols=226  Identities=30%  Similarity=0.561  Sum_probs=183.6

Q ss_pred             HHHhcccCCCCccEEEEEEECC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|....      ...||+|.++... ......|.+|++++++++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   86 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML   86 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence            4567889999999999998642      2579999987543 33456789999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcE
Q 036792          271 LEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVA  335 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~  335 (453)
                      |||+++|+|.+++....               ..+++.....++.+++.|+.||   |+.+++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCCcE
Confidence            99999999999986531               3467788889999999999999   78899999999999999999999


Q ss_pred             EEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhh
Q 036792          336 HLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNN  387 (453)
Q Consensus       336 kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~  387 (453)
                      +|+|||++.                           ...++.++|||||||++|||++ |..||......+  ..     
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~-----  236 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VI-----  236 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH-----
Confidence            999998542                           1245678999999999999998 999986542211  11     


Q ss_pred             hcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       388 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                             +.+.    ...  ....+..++.++.+|+.+||+.+|++||+++||++.|++
T Consensus       237 -------~~i~----~~~--~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 -------EMIR----SRQ--LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -------HHHH----cCC--cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                   1111    111  112345678899999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-35  Score=281.66  Aligned_cols=218  Identities=22%  Similarity=0.354  Sum_probs=172.7

Q ss_pred             ccCCCCccEEEEEEECC-------------------------CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeE
Q 036792          203 LIGMGSFGSVYRARLRD-------------------------GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV  257 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  257 (453)
                      .||+|+||.||+|.+..                         ...||+|.+.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         14589999876655556788999999999999999999


Q ss_pred             EeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC----
Q 036792          258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM----  333 (453)
Q Consensus       258 ~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~----  333 (453)
                      +++|..++..++||||+++|+|..++......+++..++.++.|+++||+||   |+++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999876656788899999999999999999   789999999999999997543    


Q ss_pred             ---cEEEeccccCC----------------------CCCcCcccchHHHHHHHHHH-HhCCCCCCccccccccHHhHHhh
Q 036792          334 ---VAHLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMET-FTRKKPTDRMFVEELSLKDWVNN  387 (453)
Q Consensus       334 ---~~kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el-~tg~~p~~~~~~~~~~~~~~~~~  387 (453)
                         .+|++|||...                      ...++.++|||||||++||+ ++|+.||......+  ...+.  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~--  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KERFY--  234 (274)
T ss_pred             ccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HHHHH--
Confidence               37999997531                      12356789999999999998 57899986432211  11111  


Q ss_pred             hcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       388 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                                +...      .  .+.....++.+++.+||+.+|++||||.++++.|+
T Consensus       235 ----------~~~~------~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         235 ----------EKKH------R--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ----------Hhcc------C--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                      1000      0  01112346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-35  Score=288.89  Aligned_cols=232  Identities=25%  Similarity=0.410  Sum_probs=182.7

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEec-CCe
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSN-DDF  266 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~  266 (453)
                      ..+++.+.||+|+||.||+|...      +++.||+|+++... ....+.+.+|++++.++ +|+||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            45788899999999999999642      35789999987543 23446788899999999 89999999998865 456


Q ss_pred             eEEEEeccCCCCchHHhhcCC-----------------------------------------------------------
Q 036792          267 KALVLEYMPKGSLENCLYSST-----------------------------------------------------------  287 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~-----------------------------------------------------------  287 (453)
                      .++++||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999998885421                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------------------
Q 036792          288 -CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------------------  345 (453)
Q Consensus       288 -~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------------------  345 (453)
                       ..+++.....++.+++.|+.||   |+.+|+||||||+||++++++.++|+|||++..                     
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             2567888999999999999999   788999999999999999999999999985421                     


Q ss_pred             ------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHH
Q 036792          346 ------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLS  418 (453)
Q Consensus       346 ------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  418 (453)
                            ..++.++|||||||++|||++ |..||......+. +..            .+.    ...  ....+..++++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~------------~~~----~~~--~~~~~~~~~~~  304 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCR------------RLK----EGT--RMRAPEYATPE  304 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHH------------HHh----ccC--CCCCCccCCHH
Confidence                  235678999999999999998 9999864322111 100            000    000  11122345667


Q ss_pred             HHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          419 ILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       419 ~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +.+++.+||+.+|++||++.|+++.|+++.+
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-35  Score=279.00  Aligned_cols=226  Identities=24%  Similarity=0.419  Sum_probs=184.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.+.+.||+|+||.||+|..+ ++..||+|.++... ...+++.+|++++++++||||+++++++..++..+++|||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            345678999999999999865 58899999987543 3356789999999999999999999999999999999999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      |+|.+++... ...+++...+.++.|+++|+.||   |+++++||||||+||++++++.+||+|||++..          
T Consensus        87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence            9999998653 34578889999999999999999   789999999999999999999999999975421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..++.++|||||||++|||++ |..||.....++     ...         .+....      .
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~---------~~~~~~------~  223 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYE---------LLEKGY------R  223 (263)
T ss_pred             CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH---------HHHCCC------C
Confidence                            234568999999999999998 899986432211     110         010000      1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ...+..++.++.+++.+||+.+|++||++.|+.+.|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            112344677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-35  Score=277.84  Aligned_cols=225  Identities=26%  Similarity=0.471  Sum_probs=176.7

Q ss_pred             cccCCCCccEEEEEEEC----CCCEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEEEeccC
Q 036792          202 NLIGMGSFGSVYRARLR----DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALVLEYMP  275 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~E~~~  275 (453)
                      +.||+|+||.||+|.+.    ++..||||.+... .....+.+.+|+.+++.++|||++++++++.. ++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999998643 33455788899999999999999999998764 556789999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++........+...+.++.++++|+.||   |+.+++||||||+|||+++++.+||+|||++.           
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999977555567778888999999999999   78899999999999999999999999998642           


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhC-CCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                        ...++.++|||||||++|||++| .+||.....  ......+.                .+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~----------------~~~  219 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLL----------------QGR  219 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHh----------------cCC
Confidence                              12345689999999999999995 556643211  11111111                000


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                        ....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence              111223456678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=291.13  Aligned_cols=220  Identities=24%  Similarity=0.376  Sum_probs=180.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc----h-hhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC----A-RALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  269 (453)
                      .|.+.+.||+|+||.|+.|.+. +++.||||++.++.    . ...+...+|+.+|+.++ ||||++++.++.....+++
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            4567889999999999999865 78999999876642    1 23456678999999999 9999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCCC---
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGME---  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~~---  345 (453)
                      ||||+.+|+|.+++.. ...+.......++.|++.|++|+   |+++|+||||||+|+|++.+ +++||+|||++..   
T Consensus        98 vmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             EEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            9999999999999988 55677788889999999999999   99999999999999999999 9999999987531   


Q ss_pred             ----------------------CC-c-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 ----------------------GQ-V-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 ----------------------~~-~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            .. | ..++||||+||+||.|++|..||++....                 .+... +
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-----------------~l~~k-i  235 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-----------------NLYRK-I  235 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-----------------HHHHH-H
Confidence                                  12 3 36799999999999999999999863111                 11111 1


Q ss_pred             hcCccCCchhhHHH-HHHHHHHhhhccccCcccCCChHHHH
Q 036792          402 LSGEKKGFVAKEQC-VLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       402 ~~~~~~~~~~~~~~-~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                      ..+   ....+... ++++..|+.+|+..+|.+|+|+.+|+
T Consensus       236 ~~~---~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  236 RKG---EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             hcC---CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            111   12233344 77899999999999999999999998

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-35  Score=276.25  Aligned_cols=221  Identities=29%  Similarity=0.483  Sum_probs=181.2

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCch
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLE  280 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~  280 (453)
                      ++||+|+||.||+|..+++..||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999988889999999876543 33457889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------------
Q 036792          281 NCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------------  344 (453)
Q Consensus       281 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------------  344 (453)
                      +++......+++.....++.+++.++.|+   |+++++||||||+||+++.++.+|++|||++.                
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            99876655678899999999999999999   88999999999999999999999999997542                


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                ...++.++||||||+++||+++ |..||.......  ....+..                ..  +...+.
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~----------------~~--~~~~~~  217 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEK----------------GY--RMSCPQ  217 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc----------------CC--CCCCCC
Confidence                      1234567999999999999998 899986442111  1111100                00  011223


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      .++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            45678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-35  Score=279.20  Aligned_cols=226  Identities=27%  Similarity=0.483  Sum_probs=179.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-C---CCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe------
Q 036792          199 RLSNLIGMGSFGSVYRARLR-D---GIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF------  266 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------  266 (453)
                      ++.+.||+|+||.||+|.+. +   +..||||.++...  ......+.+|++.++.++||||+++++++...+.      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45678999999999999864 2   3789999987543  2345678999999999999999999998876554      


Q ss_pred             eEEEEeccCCCCchHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          267 KALVLEYMPKGSLENCLYSS-----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      .++++||+++|+|..++...     ...+++.....++.+++.|+.||   |+.+++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEEECCCCeEEECCcc
Confidence            78999999999999887442     23578888899999999999999   78899999999999999999999999998


Q ss_pred             cCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCch
Q 036792          342 YGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       342 ~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                      ++..                           ..++.++|||||||++|||++ |..||.+....+  ...++        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~--------  228 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYL--------  228 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH--------
Confidence            6421                           234668999999999999999 888886532111  11111        


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                             .. +.  ....+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       229 -------~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 -------RH-GN--RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -------Hc-CC--CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   10 00  1112345677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=278.42  Aligned_cols=223  Identities=28%  Similarity=0.465  Sum_probs=182.3

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            456788999999999999988778899999865432 2357889999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------------  344 (453)
                      +|.+++......+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||+..             
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (256)
T cd05059          85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT  161 (256)
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence            99999977655788999999999999999999   88999999999999999999999999997542             


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                   ...++.++||||||+++||+++ |+.||......+  ....+.                ...  +..
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~----------------~~~--~~~  221 (256)
T cd05059         162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVS----------------AGY--RLY  221 (256)
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHH----------------cCC--cCC
Confidence                         1234568999999999999999 788986432111  110000                000  111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      .+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2234567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.1e-35  Score=276.75  Aligned_cols=221  Identities=26%  Similarity=0.460  Sum_probs=179.0

Q ss_pred             ccCCCCccEEEEEEEC---CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          203 LIGMGSFGSVYRARLR---DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .||+|+||.||+|.++   ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999864   356799999976543 344679999999999999999999998854 56789999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------------  345 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------------  345 (453)
                      |.+++......+++.....++.+++.|+.||   |+++++||||||+||+++.++.+||+|||++..             
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999987666789999999999999999999   788999999999999999999999999985420             


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ..++.++|||||||++||+++ |..||......+  ....+.                .+.  ..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----------------~~~--~~  217 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIE----------------QGK--RL  217 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHH----------------CCC--CC
Confidence                           234568999999999999996 999986542211  111111                011  11


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ..+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            22345677899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-36  Score=285.99  Aligned_cols=219  Identities=23%  Similarity=0.303  Sum_probs=176.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            45678999999999999976 68999999997542   233467889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.+++.||.||   |+++++||||||+|||++.++.+||+|||++.          
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (291)
T cd05612          84 PGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC  159 (291)
T ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCccccc
Confidence            9999999887654 577888889999999999999   88999999999999999999999999998642          


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                  ...++.++|||||||++|||++|+.||......+     ...            ......    ...+
T Consensus       160 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----~~~------------~i~~~~----~~~~  218 (291)
T cd05612         160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----IYE------------KILAGK----LEFP  218 (291)
T ss_pred             CChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH------------HHHhCC----cCCC
Confidence                        1235678999999999999999999986532111     110            000000    0112


Q ss_pred             HHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      ...+..+.+++.+||+.||.+||+     ++|+++
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            233567899999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.3e-36  Score=290.19  Aligned_cols=216  Identities=25%  Similarity=0.333  Sum_probs=175.4

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +.||+|+||.||+++.+ +|+.||||+++...   ......+.+|++++++++||||+++.+++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999865 68999999998643   233456788999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|.+.+.... .+++.....++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++..            
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence            9998887643 578888889999999999999   889999999999999999999999999986421            


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                   ..++.++|||||||++|||++|+.||.....+.  ....               .....    ...+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~---------------~~~~~----~~~p  215 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL---------------ILMEE----IRFP  215 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHH---------------HHcCC----CCCC
Confidence                         235678999999999999999999986432111  0000               00000    0122


Q ss_pred             HHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ...+.++.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            34566789999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-35  Score=281.76  Aligned_cols=230  Identities=27%  Similarity=0.462  Sum_probs=186.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +.+.+.||+|+||.||+|...      ++..+++|.++.......+.+.+|++++++++||||+++++++..++..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF   86 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence            345678999999999999743      34679999988766666678999999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEE
Q 036792          272 EYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH  336 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~k  336 (453)
                      ||+++++|.+++....               ..+++..++.++.+++.|+.||   |+++++||||||+||+++.++.++
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEE
Confidence            9999999999986432               2478889999999999999999   899999999999999999999999


Q ss_pred             EeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhh
Q 036792          337 LSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNL  388 (453)
Q Consensus       337 l~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~  388 (453)
                      |+|||++.                           ...++.++|||||||++|||+| |+.||......+  ..+...  
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~--  239 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT--  239 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh--
Confidence            99998642                           1234668999999999999999 999986432211  111100  


Q ss_pred             cCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          389 LPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       389 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                       .             +.  ....+..++..+.+++.+||+.+|++||+++++++.|+++...
T Consensus       240 -~-------------~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         240 -Q-------------GR--VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -C-------------CC--CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             0             00  0111233567789999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.7e-35  Score=281.10  Aligned_cols=226  Identities=28%  Similarity=0.478  Sum_probs=180.9

Q ss_pred             HHHhcccCCCCccEEEEEEE-----CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|.+     .++..||+|.++... ......+.+|++++++++||||+++++++..++..+++|
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            35568899999999999984     246789999997543 334467899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcE
Q 036792          272 EYMPKGSLENCLYSS----------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVA  335 (453)
Q Consensus       272 E~~~~g~L~~~l~~~----------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~  335 (453)
                      ||+++|+|.+++...                ...+++...+.++.+++.|+.||   |+++++||||||+||++++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehhccccceEEEcCCCcE
Confidence            999999999988532                12467788889999999999999   78899999999999999999999


Q ss_pred             EEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhh
Q 036792          336 HLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNN  387 (453)
Q Consensus       336 kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~  387 (453)
                      ||+|||++..                           ..++.++|||||||++|||++ |..||.+....  .       
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~-------  234 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--E-------  234 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H-------
Confidence            9999986521                           234678999999999999999 88898643211  1       


Q ss_pred             hcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       388 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                           +.+.++...      ..+.+..++.++.+++.+||+.+|++||++.++.+.|.+
T Consensus       235 -----~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 -----VIEMVRKRQ------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -----HHHHHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                 111111100      111233466788999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-35  Score=280.12  Aligned_cols=226  Identities=31%  Similarity=0.496  Sum_probs=182.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      .+.+.+.||+|+||.||+|...      ++..||||.++..... ..+.+.+|+++++.++||||+++++++......++
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            3567789999999999999864      2478999999765443 45789999999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEE
Q 036792          270 VLEYMPKGSLENCLYSST-------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH  336 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~k  336 (453)
                      ||||+++|+|.+++....             ..+++.....++.+++.|+.||   |+++++||||||+||+++.++.+|
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCeEE
Confidence            999999999999986532             3467778889999999999999   888999999999999999999999


Q ss_pred             EeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhh
Q 036792          337 LSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNL  388 (453)
Q Consensus       337 l~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~  388 (453)
                      |+|||.+.                           ...++.++|||||||++|||++ |..||.....++  ......  
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~--  238 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT--  238 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH--
Confidence            99997542                           1234678999999999999999 999986432211  111110  


Q ss_pred             cCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          389 LPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       389 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                                    .+.  ....+..++.++.+++.+||+.+|++||+++|+++.|+
T Consensus       239 --------------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 --------------QGR--LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --------------cCC--cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                          000  01112345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=287.58  Aligned_cols=213  Identities=24%  Similarity=0.266  Sum_probs=172.3

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ||+|+||.||+|+.. +++.||+|.++...   ......+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999976 58899999997542   23446788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------  345 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------------  345 (453)
                      .+++.... .+++.....++.|++.||.||   |+++|+||||||+||+++.++.+||+|||++..              
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence            99887643 578888889999999999999   789999999999999999999999999986421              


Q ss_pred             -----------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHH
Q 036792          346 -----------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQ  414 (453)
Q Consensus       346 -----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  414 (453)
                                 ..++.++|||||||++|||++|+.||......     +....            ....    ....+..
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~------------~~~~----~~~~~~~  215 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRK------------ILQE----PLRFPDG  215 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHH------------HHcC----CCCCCCc
Confidence                       23567899999999999999999998643211     11111            1100    0112234


Q ss_pred             HHHHHHHHhhhccccCcccCCC---hHHHH
Q 036792          415 CVLSILGLAMECAMELPEKRIN---AKDIV  441 (453)
Q Consensus       415 ~~~~~~~l~~~Cl~~~P~~RPs---~~~v~  441 (453)
                      .+.++.+++.+||+.||++||+   +.|++
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            5667899999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=277.60  Aligned_cols=225  Identities=27%  Similarity=0.449  Sum_probs=183.9

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|...++..||+|.++.... ..+++.+|++++++++||||+++++++...+..+++|||++++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYG   86 (261)
T ss_pred             eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCC
Confidence            456788999999999999987788999999875432 3467899999999999999999999999999999999999999


Q ss_pred             CchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          278 SLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       278 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      +|.+++.... ..+++.....++.+++.|+.||   |+++++||||||+||+++.++.++|+|||++.            
T Consensus        87 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05068          87 SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG  163 (261)
T ss_pred             cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence            9999987643 4678999999999999999999   78899999999999999999999999997531            


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                    ...++.++||||||+++||++| |+.||.......  ...            .++.    ..  ..
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~------------~~~~----~~--~~  223 (261)
T cd05068         164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQ------------QVDQ----GY--RM  223 (261)
T ss_pred             CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH------------HHHc----CC--CC
Confidence                          1234668999999999999999 999986532111  000            0110    00  01


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      +.+..++.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1223456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.2e-35  Score=277.98  Aligned_cols=227  Identities=21%  Similarity=0.354  Sum_probs=183.9

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ...+++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++..++..++|+||
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            345678889999999999999976 5788999998766556667899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|+|..++......+++.....++.++++||.||   |+.+++||||||+||+++.++.++++|||++..        
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999999988876555788999999999999999999   788999999999999999999999999975411        


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                            ..++.++|||||||++|||++|++||......+. ......                 
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~-----------------  222 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK-----------------  222 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhh-----------------
Confidence                                  1234589999999999999999999864321110 000000                 


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........+..++.++.+++.+||+.+|.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         223 SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000011122345667899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.9e-35  Score=278.55  Aligned_cols=226  Identities=23%  Similarity=0.399  Sum_probs=183.4

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++..++..+++|||+++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK   85 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence            3456788999999999999988888999999875432 357889999999999999999999999999999999999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      |+|.+++... ...+++..+..++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||.+..          
T Consensus        86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence            9999988653 34577888889999999999999   788999999999999999999999999976421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..++.++|||||||++|||+| |..||......+  ....+....                  .
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~------------------~  222 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGY------------------R  222 (261)
T ss_pred             CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCC------------------C
Confidence                            224557999999999999998 999986432111  111111000                  1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      .+....++.++.+++.+||+.+|++||+++++.+.|++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11123456678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3e-35  Score=283.71  Aligned_cols=230  Identities=27%  Similarity=0.505  Sum_probs=182.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCC--EEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGI--EVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|.++ ++.  .+|+|.++... ......+.+|++++.++ +||||+++++++..++..++|+|
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   88 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   88 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence            456788999999999999975 454  46888776432 33456788999999999 89999999999999999999999


Q ss_pred             ccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEE
Q 036792          273 YMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHL  337 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl  337 (453)
                      |+++|+|.+++....               ..+++.....++.++++|++||   |+++++||||||+|||++.++.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCcEEe
Confidence            999999999986432               2467888999999999999999   7899999999999999999999999


Q ss_pred             eccccCCC------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCc
Q 036792          338 SDFEYGME------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       338 ~df~~~~~------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      +|||+...                        ..++.++|||||||++|||+| |..||......+  ......      
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~------  237 (303)
T cd05088         166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP------  237 (303)
T ss_pred             CccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHh------
Confidence            99986521                        224678999999999999998 999986432211  111000      


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                                ...  ....+..++.++.+++.+||+.+|++||++++++..|.++.++
T Consensus       238 ----------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         238 ----------QGY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             ----------cCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                      000  0111223456789999999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-36  Score=293.90  Aligned_cols=220  Identities=25%  Similarity=0.345  Sum_probs=184.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++++.||.|+-|.|..|++. +|+.+|||++.+...   .....+.+|+.+|+-+.|||++++++++.+..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            578899999999999999865 899999999976521   2234678999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|.|.+++..++ .+......+...||..|+.|+   |.-+|+||||||+|+|+|....+||+|||++.         
T Consensus        94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence            99999999998765 566777788999999999999   77789999999999999999999999998763         


Q ss_pred             ---------------CCCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ---------------EGQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ---------------~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                     +..| +.++||||+|||||.|+||+.||++.                 ++..++.+...+    .
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----------------Nir~LLlKV~~G----~  228 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----------------NIRVLLLKVQRG----V  228 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----------------cHHHHHHHHHcC----c
Confidence                           1222 45799999999999999999999843                 222222222221    2


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +..|...+.++.+|+.+|+..||++|.|++||.+
T Consensus       229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            3455677888999999999999999999999975

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-35  Score=287.25  Aligned_cols=216  Identities=23%  Similarity=0.337  Sum_probs=174.5

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +.||+|+||.||+++.+ +|..||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36899999999999865 68999999998653   234456788999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------------  344 (453)
                      +|..++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.             
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence            9988886543 578888899999999999999   78899999999999999999999999997532             


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                  ...++.++|||||||++|||++|+.||........     .            .......    ...+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~------------~~~~~~~----~~~p  215 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----F------------ELILMEE----IRFP  215 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-----H------------HHHhcCC----CCCC
Confidence                        12356789999999999999999999864321110     0            0000000    0112


Q ss_pred             HHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ...++++.+++.+||+.+|++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            34566789999999999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-35  Score=289.18  Aligned_cols=236  Identities=21%  Similarity=0.282  Sum_probs=174.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-----CeeEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND-----DFKALV  270 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv  270 (453)
                      ++.+.||+|+||.||+|... ++..||||.++...  ......+.+|++++++++||||+++++++...     ...++|
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            45678999999999999965 68999999987432  23345788999999999999999999988643     247999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      |||+. ++|.+++.... .+++.....++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++..     
T Consensus        83 ~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          83 FELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            99995 68988886543 578888999999999999999   788999999999999999999999999986421     


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhh-----
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME-----  395 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  395 (453)
                                               ..++.++|||||||++|||+||++||......  .....+.........+     
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHh
Confidence                                     23466899999999999999999999653211  1111111111110000     


Q ss_pred             -------hhhhhhhcCccCCc-hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 -------VVDKTLLSGEKKGF-VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 -------~~d~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             .++. +........ ......++++.+++.+||+.+|++|||++|+++
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         236 RNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                   0000 000000000 011124567889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6e-35  Score=275.62  Aligned_cols=218  Identities=19%  Similarity=0.301  Sum_probs=172.7

Q ss_pred             cccCCCCccEEEEEEECC-------------CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          202 NLIGMGSFGSVYRARLRD-------------GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      +.||+|+||.||+|.+.+             ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999887665555678899999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc-------EEEeccc
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV-------AHLSDFE  341 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~-------~kl~df~  341 (453)
                      ++|||+++|+|..++......+++.....++.|+++|++||   |+++|+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999988876656688999999999999999999   8999999999999999986653       8999998


Q ss_pred             cCC----------------------CCCcCcccchHHHHHHHHHHH-hCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          342 YGM----------------------EGQVSTRSDIYGYGIVLMETF-TRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       342 ~~~----------------------~~~~~~~~Dv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                      ++.                      ...++.++|||||||++|||+ +|..|+......+.  ....            .
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~------------~  223 (262)
T cd05077         158 IPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFY------------E  223 (262)
T ss_pred             CCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHH------------h
Confidence            542                      123566899999999999997 58888754321110  0000            0


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      ....        .....+.++.+|+.+||+.||++||++.++++.+
T Consensus       224 ~~~~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQCM--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cCcc--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0000        0011235688999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.4e-35  Score=281.74  Aligned_cols=230  Identities=25%  Similarity=0.482  Sum_probs=183.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CC--CEEEEEEeecc-chhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DG--IEVAVKVFHQE-CARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|..+ ++  ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++++|
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            345678999999999999875 33  35789888743 234456789999999999 79999999999999999999999


Q ss_pred             ccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEE
Q 036792          273 YMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHL  337 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl  337 (453)
                      |+++|+|.+++....               ..+++.....++.|++.|++||   |+.+++||||||+|||+++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCcCCcceEEECCCCeEEE
Confidence            999999999986532               2477888899999999999999   7889999999999999999999999


Q ss_pred             eccccCCC------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCc
Q 036792          338 SDFEYGME------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       338 ~df~~~~~------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      +|||++..                        ..++.++|||||||++|||++ |..||......+     ...      
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~------  229 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYE------  229 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH------
Confidence            99986421                        234678999999999999998 999986542211     111      


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                         .+....      ....+..++.++.+++.+||+.+|.+||+++++++.|+.+..+
T Consensus       230 ---~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         230 ---KLPQGY------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             ---HHhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               000000      1112234567889999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.3e-35  Score=288.76  Aligned_cols=223  Identities=22%  Similarity=0.305  Sum_probs=174.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..++..+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34456788999999999999976 689999999975432 3456789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|+|.+..     .........++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..        
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            9999986532     244566778999999999999   788999999999999999999999999986421        


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                            ...+.++|||||||++|||++|+.||......+  +....            ......
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~------------~~~~~~  291 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLM------------CAICMS  291 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHH------------HHHhcc
Confidence                                  011247999999999999999999986321111  11110            000000


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .   ....+..++.++.+|+.+||+.+|++|||+.|+++.
T Consensus       292 ~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 Q---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   111223456789999999999999999999999863

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-35  Score=279.09  Aligned_cols=243  Identities=23%  Similarity=0.391  Sum_probs=188.7

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-----CCCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  268 (453)
                      .+++.+.||+|+||.||++.+.     ++..||||.++..... ..+.|.+|+++++.++||||+++++++..  +...+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            3456688999999999999864     3689999999866443 45789999999999999999999999887  56789


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      ++|||+++++|.+++......+++.....++.+++.|+.||   |+.+++|+||||+||+++.++.++++|||.+..   
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            99999999999999987665688999999999999999999   788999999999999999999999999975421   


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                               ..++.++||||||+++|||+||..|+.........   +............+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHHH
Confidence                                     23456799999999999999999997643222111   00000000011111111


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      +...  ...+.+..++.++.+++.+||+.+|++||||.|++++|+++
T Consensus       239 ~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEG--ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcC--CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111  11222345678899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-35  Score=275.76  Aligned_cols=224  Identities=28%  Similarity=0.508  Sum_probs=178.7

Q ss_pred             cccCCCCccEEEEEEEC-CCC--EEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGI--EVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|..+ ++.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46899999999999975 343  57889887543 34456789999999999 799999999999999999999999999


Q ss_pred             CCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          277 GSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       277 g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      |+|.+++....               ..+++.....++.+++.|++||   |+.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               2467888899999999999999   78999999999999999999999999998


Q ss_pred             cCC------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          342 YGM------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       342 ~~~------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                      +..                        ...++.++|||||||++|||++ |..||......+     ....         
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~---------  223 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEK---------  223 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHH---------
Confidence            652                        1234668999999999999997 999986432111     1110         


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      +..    ..  ....+..++.++.+++.+||+.+|.+|||+.|++..|+++.
T Consensus       224 ~~~----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         224 LPQ----GY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HhC----CC--CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            000    00  01112235567899999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.6e-35  Score=277.92  Aligned_cols=228  Identities=23%  Similarity=0.411  Sum_probs=180.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCC----EEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGI----EVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|.+. ++.    .+++|.+..... ....++..|+..+++++||||+++++++.. ...++++
T Consensus         9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~   87 (279)
T cd05111           9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT   87 (279)
T ss_pred             ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence            456788999999999999864 444    478888764432 334678888889999999999999998754 4567899


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+++|+|.+++......+++.....++.|++.|+.||   |+++++||||||+||+++.++.+||+|||.+.       
T Consensus        88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            99999999999987666788999999999999999999   78899999999999999999999999997542       


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                          .+.++.++|||||||++||+++ |..||.+....+  ...++.                .
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~----------------~  226 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLE----------------K  226 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH----------------C
Confidence                                1235668999999999999998 999986542111  111111                0


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +.  ..+.+..++.++.+++.+||..+|++|||+.|+++.|..+..
T Consensus       227 ~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         227 GE--RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CC--cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            10  111122355678889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.5e-36  Score=287.77  Aligned_cols=219  Identities=26%  Similarity=0.411  Sum_probs=183.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |.+.+.||+|+||.||||+.+ +.+.||+|.+.+..  .+..+...+|+++++.++|||||.++++|++..+.|+|+||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            456788999999999999866 68999999997653  355678999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      .| +|..+|.... .++......++.+++.||.||   |+.+|+|||+||.|||++..+++|+||||++.          
T Consensus        84 ~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   84 VG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            77 9999887654 688999999999999999999   99999999999999999999999999997652          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...|+..+|.||+||++||+++|++||...                 ++.+.+.......    .
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------------si~~Lv~~I~~d~----v  217 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------------SITQLVKSILKDP----V  217 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------HHHHHHHHHhcCC----C
Confidence                           346788899999999999999999999643                 2222232222211    1


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...+..+..++...+.+||..|.|-.+++.
T Consensus       218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            123356778899999999999999999887753

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.6e-35  Score=289.85  Aligned_cols=231  Identities=22%  Similarity=0.359  Sum_probs=182.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  267 (453)
                      ....+.+.||+|+||.||+|+++      .+..||||+++... ....+.+.+|+++|.++. |||||+++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            34456789999999999999864      24689999997653 233457899999999997 99999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCC------------------------------------------------------------
Q 036792          268 ALVLEYMPKGSLENCLYSST------------------------------------------------------------  287 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~------------------------------------------------------------  287 (453)
                      ++||||+++|+|.++++...                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999885421                                                            


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          288 -------------------------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       288 -------------------------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                                                           ..+++.....++.+++.|+.||   |+++++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcceEEEe
Confidence                                                 1345667788999999999999   789999999999999999


Q ss_pred             CCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      +++.+||+|||++..                           ..++.++|||||||++|||++ |..||......+. ..
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~  352 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FY  352 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HH
Confidence            999999999986421                           124567999999999999998 8889864322111 00


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                                  +.+.    .+.  +...+..++.++.+++.+||+.+|++||+++|+++.|+++.
T Consensus       353 ------------~~~~----~~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 ------------NAIK----RGY--RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ------------HHHH----cCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                        0111    110  11122345678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-35  Score=277.84  Aligned_cols=227  Identities=23%  Similarity=0.448  Sum_probs=184.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CC---CEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DG---IEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|.++ ++   ..||||.++.. .....++|..|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            456788999999999999875 23   36999998765 33445789999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++......+++.....++.+++.|+.||   |+.+++|+||||+||+++.++.+|++|||+..        
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            9999999999987666788999999999999999999   78899999999999999999999999997531        


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            ...++.++|||||||++||+++ |..||......  ....++..              
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~--------------  226 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQ--------------  226 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHc--------------
Confidence                                  1234567999999999999887 99998643211  11111110              


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                        .  ...+.+.+++..+.+++.+||+.+|++||++++++..|+++
T Consensus       227 --~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 --D--YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --C--CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0  01122345677889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.1e-35  Score=284.61  Aligned_cols=238  Identities=20%  Similarity=0.278  Sum_probs=180.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+++.. ++..||+|.++... ....+.+.+|+++|++++||||+++++++..++..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   86 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   86 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence            455678999999999999976 68899999997653 3345679999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+++.... .++......++.+++.|+.||   |+ .+|+||||||+||+++.++.+||+|||++.          
T Consensus        87 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (331)
T cd06649          87 GGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYL---REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  162 (331)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence            999999887644 477888889999999999999   55 469999999999999999999999998642          


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC-------------------
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI-------------------  391 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-------------------  391 (453)
                                   ...++.++|||||||++|||++|+.||......+  +........ ..                   
T Consensus       163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccccccccc
Confidence                         1235778999999999999999999996432211  111110000 00                   


Q ss_pred             -----------chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          392 -----------SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       392 -----------~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                                 ...+..+... ... .........+.++.+|+.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIV-NEP-PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccchhHHHHHHHHH-hCC-CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                       0001111100 000 0000112346689999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-36  Score=262.01  Aligned_cols=221  Identities=21%  Similarity=0.322  Sum_probs=182.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      .+++..||+|.||.||.|+.+ ++..||+|++.++.   .....++.+|+++-+.++||||.+++++|.+....|+++||
T Consensus        24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy  103 (281)
T KOG0580|consen   24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY  103 (281)
T ss_pred             ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence            467899999999999999976 67899999997664   23346789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          274 MPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      .++|++++.|.... ..++......++.|+|.|+.|+   |.++++|||+||+|+|++.++..|++|||++.        
T Consensus       104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~  180 (281)
T KOG0580|consen  104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRK  180 (281)
T ss_pred             cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCce
Confidence            99999999998532 3466666777889999999999   99999999999999999999999999998652        


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++..+|+|++|++.||++.|.+||.....+ ..+++...                .    +.
T Consensus       181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k----------------~----~~  239 (281)
T KOG0580|consen  181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRK----------------V----DL  239 (281)
T ss_pred             eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHH----------------c----cc
Confidence                           234577899999999999999999999865422 11111111                0    11


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...+.++.+++++|+..+|.+|.+-.|+++
T Consensus       240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  240 KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            123445667899999999999999999999875

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=288.68  Aligned_cols=229  Identities=19%  Similarity=0.257  Sum_probs=180.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|++++..++||||+++++++..++..++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            345678999999999999976 58999999998653   23446788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .++......++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||++.         
T Consensus        83 ~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~  158 (333)
T cd05600          83 VPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV  158 (333)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence            99999999987543 577888888999999999999   78899999999999999999999999998652         


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|..||......+.. ..... .     ...+....      ....
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~i~~-~-----~~~~~~~~------~~~~  225 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-ENLKY-W-----KETLQRPV------YDDP  225 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-HHHHh-c-----cccccCCC------CCcc
Confidence                         124677899999999999999999999754222110 00000 0     00000000      0000


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ....+.++.+++.+||..+|.+||+++++++.
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            12346678999999999999999999999853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=299.21  Aligned_cols=227  Identities=24%  Similarity=0.315  Sum_probs=186.2

Q ss_pred             HHhcccCCCCccEEEEEEECCC-CEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEE-ec------CCeeEE
Q 036792          199 RLSNLIGMGSFGSVYRARLRDG-IEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSC-SN------DDFKAL  269 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~~------~~~~~l  269 (453)
                      ++.+.|.+|||+.||.|....+ ..||+|++-.......+...+|+++|+.|+ |+|||.+++.. ..      .-..+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            4567899999999999997755 999999998777777889999999999998 99999999932 21      125679


Q ss_pred             EEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          270 VLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      .||||++|.|-+++..+ ...+.....++|+.|+++|+.+||+ .+++|||||||.+|||++.++..||||||-+.    
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            99999999999999753 3458899999999999999999986 57789999999999999999999999997542    


Q ss_pred             ---------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC
Q 036792          345 ---------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI  391 (453)
Q Consensus       345 ---------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  391 (453)
                                                       ...+++|+|||++||+||-|+....||+.....              
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------------  264 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------------  264 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------------
Confidence                                             234688999999999999999999999743111              


Q ss_pred             chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       392 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                         .|+     .+. ...+..+..+..+.+|+..||+.+|.+||++-+|+..+.++..
T Consensus       265 ---aIl-----ng~-Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 ---AIL-----NGN-YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---eEE-----ecc-ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence               011     111 1112224667789999999999999999999999998887754

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.1e-35  Score=283.56  Aligned_cols=241  Identities=22%  Similarity=0.266  Sum_probs=177.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            456788999999999999976 689999999875432 223467889999999999999999999999999999999995


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                       ++|.+.+......++......++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++..          
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          87 -TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             -cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence             688888876655678888889999999999999   889999999999999999999999999986421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCC--chhhh-----hhhh-
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPI--SLMEV-----VDKT-  400 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~-----~d~~-  400 (453)
                                      ..++.++||||+||++|||++|..||.+.......+....... .+.  .+...     .++. 
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence                            1245678999999999999999999975422111111111100 000  00000     0000 


Q ss_pred             hhcCccCCch---hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFV---AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..........   .....+.++.+++.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000000   00112356889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.5e-35  Score=275.75  Aligned_cols=225  Identities=25%  Similarity=0.457  Sum_probs=176.0

Q ss_pred             HhcccCCCCccEEEEEEECC-CC--EEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeE
Q 036792          200 LSNLIGMGSFGSVYRARLRD-GI--EVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKA  268 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  268 (453)
                      +.+.||+|+||.||+|.+.+ +.  .||+|.++...  ....+.+.+|+++++.++||||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45789999999999999764 33  69999887542  34457889999999999999999999987532      2468


Q ss_pred             EEEeccCCCCchHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC
Q 036792          269 LVLEYMPKGSLENCLYS-----STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      +++||+++|+|.+++..     ....+++.....++.+++.|+.||   |+++|+||||||+||+++.++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            99999999999988742     223578888899999999999999   7889999999999999999999999999864


Q ss_pred             CC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          344 ME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       344 ~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                      ..                           ..++.++|||||||++|||++ |+.||......  .....+.         
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~---------  228 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLR---------  228 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH---------
Confidence            21                           124668999999999999999 78888643211  1111111         


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                             .+..  ...+..++..+.+++.+||+.+|++|||++++++.|+++
T Consensus       229 -------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 -------QGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -------cCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   0110  111234566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.6e-35  Score=275.19  Aligned_cols=226  Identities=23%  Similarity=0.439  Sum_probs=183.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CC---CEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DG---IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ...+.||+|+||.||+|..+ ++   ..+|+|.++... ....+.+.+|++++++++|||++++.+++...+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            44678999999999999875 33   379999987553 34457789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++++|.+++......+++.....++.+++.|+.||   |+.+++||||||+||++++++.+|++|||+..         
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  164 (268)
T cd05063          88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT  164 (268)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence            999999999977656788999999999999999999   78899999999999999999999999997542         


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                         ...++.++|||||||++||+++ |..||......+     +..         .+..    .
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~---------~i~~----~  226 (268)
T cd05063         165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMK---------AIND----G  226 (268)
T ss_pred             eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHH---------HHhc----C
Confidence                               1234567999999999999998 999985432111     111         1110    0


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                        ...+....++.++.+++.+||+.+|++||+++++++.|+++
T Consensus       227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              01112234667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=275.60  Aligned_cols=227  Identities=22%  Similarity=0.370  Sum_probs=186.1

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..+++.+.||+|+||.||++.+. ++..||+|.++.......+.+.+|++++++++|||++++++++..++..++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            44778889999999999999975 68999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++......++......++.+++.|+.||   |+.+|+|+||||+||+++.++.++|+|||...          
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99999999877655788899999999999999999   78899999999999999999999999997531          


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ...++.++||||||+++|||++|+.||....... ....+.                 ..
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-----------------~~  223 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKIL-----------------KS  223 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHh-----------------cC
Confidence                                1124557999999999999999999986432111 000000                 01


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ..+....+..++.++.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            111112233456678999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.5e-35  Score=276.03  Aligned_cols=227  Identities=25%  Similarity=0.456  Sum_probs=183.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-C---CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-D---GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|.+. +   +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            345788999999999999864 2   3479999987543 3345688999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++......+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++++|||+..        
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            9999999999987655688899999999999999999   88999999999999999999999999997542        


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                          ...++.++|||||||++||+++ |..||......+  .......                
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~----------------  224 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEE----------------  224 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhC----------------
Confidence                                1234668999999999999887 999986432211  1111110                


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      .  .+.+.+..++..+.+++.+||+.+|.+||+|.++++.|.++
T Consensus       225 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 G--YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C--CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0  01112234567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.4e-35  Score=277.27  Aligned_cols=227  Identities=24%  Similarity=0.403  Sum_probs=181.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      .+++.+.||+|+||.||+|...      ++..||||+++.... ...+.+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3567888999999999999853      257899999975543 334678899999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc
Q 036792          270 VLEYMPKGSLENCLYSS---------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV  334 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~  334 (453)
                      ++||+++++|.+++...               ...+++.....++.|++.|+.|+   |+++++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCccccccchhheEecCCCc
Confidence            99999999999988532               12467778889999999999999   7889999999999999999999


Q ss_pred             EEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHh
Q 036792          335 AHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVN  386 (453)
Q Consensus       335 ~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~  386 (453)
                      +||+|||+..                           .+.++.++|||||||++|||++ |..||......     ++..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence            9999998532                           1234668999999999999998 88887643211     1111


Q ss_pred             hhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       387 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                                  .... ..  ..+.+.+++..+.+++..||+.+|++||++++|++.|+.
T Consensus       238 ------------~i~~-~~--~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 ------------MIRN-RQ--VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ------------HHHc-CC--cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                        1000 00  112234677889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1e-34  Score=274.44  Aligned_cols=231  Identities=25%  Similarity=0.341  Sum_probs=184.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||++... ++..+|||.+....   ....+++.+|+.+++.++||||+++++++..++..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            456788999999999999964 78999999886532   23446788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          274 MPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      +++++|.+++..   ....+++.....++.++++|+.||   |+.+++|+||||+||+++.++.++++|||+..      
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999998863   234578888999999999999999   89999999999999999999999999997531      


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++||||||+++|||++|..||.....+.......+.                ...
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------~~~  224 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----------------QCD  224 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh----------------cCC
Confidence                               123456799999999999999999998543211111110000                000


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                       .........+.++.+++.+||+.+|++||||.+|++.++++.
T Consensus       225 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence             011112345678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-34  Score=276.35  Aligned_cols=228  Identities=24%  Similarity=0.433  Sum_probs=182.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGI----EVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|.+. ++.    .||+|.++... ....+.+.+|+.++..++||||+++++++... ..++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~   87 (279)
T cd05109           9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT   87 (279)
T ss_pred             eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence            345678999999999999854 444    58999987543 34456788999999999999999999999764 467999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+++|+|.+++......+++...+.++.|++.|+.||   |+++++||||||+||++++++.+||+|||++.       
T Consensus        88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            99999999999987666788999999999999999999   88999999999999999999999999998642       


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                          ...++.++|||||||++||+++ |..||+......  ...++..                
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~----------------  226 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEK----------------  226 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHC----------------
Confidence                                1224567899999999999998 888986432111  1111111                


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ..  ..+.+..++.++.+++..||+.||++||++.|+++.|+++..
T Consensus       227 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         227 GE--RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CC--cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            00  111223456788999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.2e-35  Score=287.86  Aligned_cols=220  Identities=20%  Similarity=0.260  Sum_probs=176.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+++.+.||+|+||.||+|+.+ +++.||||.++...   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            3566788999999999999976 68999999997543   2344678899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.        
T Consensus        99 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  174 (329)
T PTZ00263         99 FVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT  174 (329)
T ss_pred             CCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence            999999999887643 567777788899999999999   88999999999999999999999999998652        


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|..||......     ...+.        +     ..+.   ..
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~--------i-----~~~~---~~  233 (329)
T PTZ00263        175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEK--------I-----LAGR---LK  233 (329)
T ss_pred             ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHH--------H-----hcCC---cC
Confidence                          123577899999999999999999998643211     00000        0     0000   01


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCC-----hHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRIN-----AKDIV  441 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~  441 (453)
                      .+...+.++.+++.+||+.||++||+     ++|++
T Consensus       234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            12224456889999999999999997     56665

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.7e-35  Score=284.86  Aligned_cols=216  Identities=25%  Similarity=0.350  Sum_probs=175.3

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +.||+|+||.||+++.. +++.||||++....   ......+.+|+++++.++||||+++.+++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999865 68999999997652   234567889999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|...+.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++..            
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence            9988886543 578888899999999999999   889999999999999999999999999986421            


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                   ..++.++|||||||++|||++|+.||......+     ....            .....    ...+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~------------~~~~~----~~~p  215 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFEL------------ILMED----IKFP  215 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHH------------hccCC----ccCC
Confidence                         234678999999999999999999986432111     1110            00000    0122


Q ss_pred             HHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ...+.++.+++.+||+.+|++||     ++.|+++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            33456788999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.1e-35  Score=266.26  Aligned_cols=243  Identities=21%  Similarity=0.195  Sum_probs=181.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR--ALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALV  270 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  270 (453)
                      ..++..+.|++|+||.||+|+.+ +++.||+|+++.+...  .--.-.+|+.+|.+.+|||||.+..+...  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45667889999999999999976 7899999999865421  11235789999999999999999998766  4569999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      ||||+. ||..++..-...+...+...++.|+++|+.||   |...|+|||||++|+|++..|.+||+|||++.      
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999988 99999887666777888889999999999999   89999999999999999999999999998763      


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC-Cchhhhhhhhh--
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP-ISLMEVVDKTL--  401 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~--  401 (453)
                                          ...|++..|+||+|||+.|++++++-|.+...-+.--+-+..-..| +.+..-++..-  
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence                                2457889999999999999999999987653322111111111111 11111111000  


Q ss_pred             --hcCccCCc-----hhhH-HHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 --LSGEKKGF-----VAKE-QCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 --~~~~~~~~-----~~~~-~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ......+.     .... ..+..-.+|+...+.+||.+|-|++|.++
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence              00000000     0010 13467789999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-34  Score=282.27  Aligned_cols=239  Identities=21%  Similarity=0.283  Sum_probs=179.6

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      -|++.+.||+|+||.||++.+. ++..+|+|.++... ....+.+.+|++++++++||||++++++|..++..++||||+
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence            3567789999999999999976 68899999987653 334567899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.+++.|+.|||  +..+++||||||+||+++.++.+||+|||++.          
T Consensus        86 ~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  162 (333)
T cd06650          86 DGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  162 (333)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence            9999999987643 4777888899999999999994  23479999999999999999999999998642          


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc----------------------
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL----------------------  389 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~----------------------  389 (453)
                                   ...++.++|||||||++|||++|+.||......+.  ........                      
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (333)
T cd06650         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL--ELMFGCPVEGDPAESETSPRPRPPGRPLSS  240 (333)
T ss_pred             CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH--HHHhcCcccCCccccccCcccCCccchhhh
Confidence                         12356789999999999999999999864322111  11000000                      


Q ss_pred             --CC-----chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          390 --PI-----SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       390 --~~-----~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        +.     ......+.... ...+.. .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         241 YGPDSRPPMAIFELLDYIVN-EPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hcccccccccHHHHHHHHhc-CCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence              00     00011111110 000000 00123467899999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-34  Score=272.76  Aligned_cols=219  Identities=23%  Similarity=0.400  Sum_probs=176.4

Q ss_pred             ccCCCCccEEEEEEEC---CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          203 LIGMGSFGSVYRARLR---DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   57899999987543  2345788999999999999999999998864 4668999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|.+++.... .+++.....++.|++.|+.||   |+++++||||||+||+++.++.+||+|||.+..            
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999886543 578888999999999999999   789999999999999999999999999976421            


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..++.++|||||||++|||++ |..||......  ....            .+..    ..  .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~------------~i~~----~~--~  216 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ------------MIES----GE--R  216 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH------------HHHC----CC--C
Confidence                            123458999999999999998 99998654221  1111            1111    11  1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      .+.+..++.++.+++.+||+.+|++||++++|...|++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            12234567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.8e-35  Score=279.85  Aligned_cols=240  Identities=17%  Similarity=0.213  Sum_probs=177.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||.||+|+.+ +++.||||+++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            345678999999999999986 68899999997542  233467889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +++.+.... .....+++.....++.|++.|+.||   |+.+++||||||+||+++.++.+||+|||++.          
T Consensus        83 ~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          83 EKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             CCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            987665443 3334678888899999999999999   78899999999999999999999999998642          


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh--hhcCCchhhhh--hhhhhc-
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN--NLLPISLMEVV--DKTLLS-  403 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~--d~~~~~-  403 (453)
                                      ...++.++|||||||++|||++|++||......+. ......  ...+....+..  +..... 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchhccc
Confidence                            12356789999999999999999999975432111 111110  01111100000  000000 


Q ss_pred             ---CccCCc----hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 ---GEKKGF----VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ---~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ......    ......+.++.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               000000    011235678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-34  Score=274.25  Aligned_cols=224  Identities=21%  Similarity=0.307  Sum_probs=171.4

Q ss_pred             ccCCCCccEEEEEEEC---CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          203 LIGMGSFGSVYRARLR---DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .||+|+||.||+|.+.   ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            5899999999999864   346799999876542 334578899999999999999999999999999999999999999


Q ss_pred             chHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          279 LENCLYSST----CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       279 L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      |.+++....    ...++.....++.|++.|+.||   |+.+++||||||+||+++.++.+|++|||.+..         
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999986532    2345667778899999999999   789999999999999999999999999975421         


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                                               ..++.++||||||+++|||++ |+.||......+.  ..+......   ....  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~---~~~~--  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVREQQ---LKLP--  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhhccc---CCCC--
Confidence                                     013568999999999999996 9999865422211  111000000   0000  


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                              ........+..+.+++.+|| .+|++|||++||++.|+
T Consensus       232 --------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 --------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             --------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                    00111224456788999999 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.6e-35  Score=290.29  Aligned_cols=223  Identities=21%  Similarity=0.283  Sum_probs=174.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~   83 (381)
T cd05626           4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (381)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence            44678999999999999865 68999999997643   234567889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.          
T Consensus        84 ~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          84 PGGDMMSLLIRME-VFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            9999999887644 467777788889999999999   88999999999999999999999999998631          


Q ss_pred             --------------------------------------------------------------CCCcCcccchHHHHHHHH
Q 036792          345 --------------------------------------------------------------EGQVSTRSDIYGYGIVLM  362 (453)
Q Consensus       345 --------------------------------------------------------------~~~~~~~~Dv~S~Gvvl~  362 (453)
                                                                                    ...++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                                          123567899999999999


Q ss_pred             HHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhh--ccccCcccCCChHHH
Q 036792          363 ETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAME--CAMELPEKRINAKDI  440 (453)
Q Consensus       363 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~--Cl~~~P~~RPs~~~v  440 (453)
                      ||+||..||......+...             .+++.    ......+.....++++.+++.+  |+..+|..||+++|+
T Consensus       240 elltG~~Pf~~~~~~~~~~-------------~i~~~----~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQL-------------KVINW----ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHH-------------HHHcc----ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999997542211110             00000    0000011112345567788876  667777789999998


Q ss_pred             HH
Q 036792          441 VT  442 (453)
Q Consensus       441 ~~  442 (453)
                      +.
T Consensus       303 l~  304 (381)
T cd05626         303 KA  304 (381)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.9e-35  Score=278.54  Aligned_cols=228  Identities=26%  Similarity=0.433  Sum_probs=182.5

Q ss_pred             HHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ++.+.||+|+||.||+|...      ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.|..++..++++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            45678999999999999853      23578999887553 334567899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcee
Q 036792          272 EYMPKGSLENCLYSS-----------------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVL  328 (453)
Q Consensus       272 E~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiL  328 (453)
                      ||+++|+|.+++...                       ...+++...+.++.+++.|+.||   |+.+++||||||+||+
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---HHCCeehhhhhhheEE
Confidence            999999999987542                       12467888899999999999999   7889999999999999


Q ss_pred             eCCCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCcccccccc
Q 036792          329 LDEDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS  380 (453)
Q Consensus       329 l~~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~  380 (453)
                      +++++.+||+|||.+..                           ..++.++||||||+++|||+| |..||......  .
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~  237 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--R  237 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--H
Confidence            99999999999986421                           124667999999999999999 99998643211  1


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +.++            +....      ..+.+..++.++.+++.+||+.+|++||++.|+++.|+++-.
T Consensus       238 ~~~~------------~~~~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 LFNL------------LKTGY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHH------------HhCCC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1111            11110      111223456789999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.3e-34  Score=278.93  Aligned_cols=234  Identities=27%  Similarity=0.455  Sum_probs=186.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  265 (453)
                      ..+.+.+.||+|+||.||++...        ....||+|.++... ......+.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            34457889999999999999742        24579999987543 34456788999999999 6999999999999999


Q ss_pred             eeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          266 FKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ..+++|||+++|+|.+++....               ..+++.....++.+++.|+.||   |+++++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeeccccceeEEEc
Confidence            9999999999999999986532               3477888899999999999999   789999999999999999


Q ss_pred             CCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||.+..                           ..++.++|||||||++||+++ |..||.....++    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999986521                           234668999999999999999 888886432211    


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                       ...         .+.    ...  ....+..++.++.+++.+||+.+|++|||+.|+++.|.++...++
T Consensus       245 -~~~---------~~~----~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         245 -LFK---------LLR----EGH--RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             -HHH---------HHH----cCC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence             110         000    000  111223556688999999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-34  Score=274.71  Aligned_cols=226  Identities=24%  Similarity=0.355  Sum_probs=184.1

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|++.+.||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++|||++++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45778889999999999999976 58999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++++|..++......+++.....++.|+++++.||   |+.+++||||||+||+++.++.++|+|||....         
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99999888766555688999999999999999999   889999999999999999999999999975321         


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                           ..++.++|||||||++|||++|..||....... ....+.                 ..
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~-----------------~~  230 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIA-----------------KS  230 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHh-----------------cC
Confidence                                 123557999999999999999999986432110 000000                 00


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+....+..++.++.+++.+||..+|++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00111122345567899999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-34  Score=272.12  Aligned_cols=221  Identities=26%  Similarity=0.390  Sum_probs=179.4

Q ss_pred             cccCCCCccEEEEEEECC--C--CEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLRD--G--IEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|.+.+  +  ..||||.++.... ...+.+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998653  3  3699999987655 566789999999999999999999999988 889999999999


Q ss_pred             CCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      |+|.+++.... ..+++.....++.+++.|++||   |+++++||||||+||+++.++.+||+|||++.           
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997754 4678899999999999999999   88999999999999999999999999997542           


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                       ...++.++|||||||++|||++ |+.||......+  ....            ++.   ..  
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~------------~~~---~~--  217 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKK------------IDK---EG--  217 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HHh---cC--
Confidence                             1234667999999999999999 999986432211  1000            000   00  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      .....+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            011122345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=272.40  Aligned_cols=225  Identities=34%  Similarity=0.548  Sum_probs=184.2

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|... |+.||||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG   85 (256)
T ss_pred             ccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence            456788999999999999875 78999999976644 4578999999999999999999999999999999999999999


Q ss_pred             CchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          278 SLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       278 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      +|.+++.... ..+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||.+.            
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  162 (256)
T cd05039          86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP  162 (256)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence            9999987643 3578999999999999999999   88999999999999999999999999997532            


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                ...++.++||||||+++||+++ |..||......+  +...+            ..    ..  ....+.
T Consensus       163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~------------~~----~~--~~~~~~  222 (256)
T cd05039         163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHV------------EK----GY--RMEAPE  222 (256)
T ss_pred             ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH------------hc----CC--CCCCcc
Confidence                      1345568999999999999997 999986432111  11010            00    00  111223


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      .+++++.+++.+||+.+|++||+++|++.+|+++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            4567889999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-34  Score=276.29  Aligned_cols=230  Identities=20%  Similarity=0.363  Sum_probs=185.7

Q ss_pred             HHHhcccCCCCccEEEEEEECC-----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD-----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|.+..     +..||+|.+.... ....+.+.+|+.++++++||||+++++++.. +...+++
T Consensus         8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   87 (280)
T cd05043           8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL   87 (280)
T ss_pred             eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence            4567889999999999999765     6889999987543 3445778999999999999999999998776 5678999


Q ss_pred             EeccCCCCchHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC
Q 036792          271 LEYMPKGSLENCLYSST-------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      +||+++|+|.+++....       ..+++.....++.+++.|++||   |+.+++||||||+||++++++.+|++|||++
T Consensus        88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kl~d~g~~  164 (280)
T cd05043          88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITDNALS  164 (280)
T ss_pred             EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence            99999999999986532       3578889999999999999999   7889999999999999999999999999875


Q ss_pred             CC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          344 ME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       344 ~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                      ..                           ..++.++|||||||++||+++ |+.||.....  ..+..+.....      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~------  236 (280)
T cd05043         165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGY------  236 (280)
T ss_pred             ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCC------
Confidence            31                           224568999999999999999 9999865321  11222211110      


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                                  ....+..+++++.+++.+||..+|++|||+.++++.|+.+..+
T Consensus       237 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         237 ------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                        0111234567889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-35  Score=276.82  Aligned_cols=219  Identities=22%  Similarity=0.328  Sum_probs=173.2

Q ss_pred             cccCCCCccEEEEEEECC--------CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLRD--------GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +.||+|+||.||+|..+.        ...||+|.+........+++.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998642        235889988765555567889999999999999999999999998999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc--------EEEeccccCCC
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV--------AHLSDFEYGME  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~--------~kl~df~~~~~  345 (453)
                      +++|+|.+++......+++.....++.|++.|+.||   |+++|+||||||+||+++.++.        ++++|||....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987666788999999999999999999   8899999999999999987664        68999975421


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCC-CCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRK-KPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            ..++.++|||||||++||+++|. .|+.......  .....            ...  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~------------~~~--  221 (258)
T cd05078         158 VLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFY------------EDR--  221 (258)
T ss_pred             cCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHH------------Hcc--
Confidence                                  23566899999999999999995 5543221110  00000            000  


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                            ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       222 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  0111123356899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-34  Score=278.60  Aligned_cols=232  Identities=22%  Similarity=0.409  Sum_probs=179.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-----------------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-----------------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVIS  259 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g  259 (453)
                      +++.+.||+|+||.||++...                 ++..||+|.++... ....+.+.+|+++++.++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            466788999999999998632                 23479999997553 334568999999999999999999999


Q ss_pred             EEecCCeeEEEEeccCCCCchHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee
Q 036792          260 SCSNDDFKALVLEYMPKGSLENCLYSST----------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL  329 (453)
Q Consensus       260 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl  329 (453)
                      ++..++..+++|||+++|+|.+++....          ..+++.....++.+++.|+.||   |+.+++||||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCeecccCChheEEE
Confidence            9999999999999999999999886532          2356778899999999999999   78899999999999999


Q ss_pred             CCCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh--CCCCCCcccccccc
Q 036792          330 DEDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT--RKKPTDRMFVEELS  380 (453)
Q Consensus       330 ~~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~~  380 (453)
                      +.++.++|+|||++..                           +.++.++|||||||++|||++  |..||......+  
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~--  241 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ--  241 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--
Confidence            9999999999986421                           234668999999999999998  677875432211  


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                         .+..     ..+.......   ....+.+..++..+.+++..||+.+|++||++.|+.+.|+
T Consensus       242 ---~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ---VIEN-----TGEFFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ---HHHH-----HHHHHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               1110     0000000000   0011122346678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-35  Score=276.67  Aligned_cols=224  Identities=29%  Similarity=0.380  Sum_probs=175.7

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--------------hhHHHHHHHHHHHHcCCCCCceeEEeE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--------------RALKSFEAQCEVMKSIRHPNLVKVISS  260 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g~  260 (453)
                      ..|++...||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||+++.+
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            45678889999999999999965 789999999975421              123578899999999999999999999


Q ss_pred             Eec--CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEe
Q 036792          261 CSN--DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS  338 (453)
Q Consensus       261 ~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~  338 (453)
                      ..+  .+.+|||+|||..|.+...-... ..+...+...+..+++.||+||   |.++|+||||||+|+|+++++++||+
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCCCcEEee
Confidence            877  45789999999999886533222 2278888999999999999999   88999999999999999999999999


Q ss_pred             ccccCCC----------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhH
Q 036792          339 DFEYGME----------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDW  384 (453)
Q Consensus       339 df~~~~~----------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  384 (453)
                      |||....                                  ...+.+.||||+||+||-++.|+.||-+.+.        
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--------  324 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--------  324 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--------
Confidence            9975421                                  0123468999999999999999999864321        


Q ss_pred             HhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          385 VNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       385 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                               .+..|+.....  ...+..++..+.+.+|+.++|++||+.|.+..||..
T Consensus       325 ---------~~l~~KIvn~p--L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  325 ---------LELFDKIVNDP--LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             ---------HHHHHHHhcCc--ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence                     22222222110  011222345678899999999999999999988753

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=271.66  Aligned_cols=222  Identities=27%  Similarity=0.427  Sum_probs=179.0

Q ss_pred             cccCCCCccEEEEEEEC-C---CCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-D---GIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|.+. .   +..+|+|.++.... ...+++.+|+++++++.|||++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999754 2   27899999986543 34567899999999999999999999876 4567999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++.... .+++.....++.+++.++.||   |..+++|+||||+||+++.++.+||+|||.+.            
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997654 678899999999999999999   78899999999999999999999999997542            


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      ...++.++|||||||++||+++ |..||.....  .....++....                  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~------------------  215 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGE------------------  215 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCC------------------
Confidence                            1234568999999999999998 9999864321  11111111100                  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      ..+.+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            11223345678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=289.99  Aligned_cols=222  Identities=20%  Similarity=0.309  Sum_probs=175.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|+.. +++.||||+++...   ......+.+|+++|..++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            45678999999999999976 68999999997542   233456788999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.|++.||.||   |+.+|+||||||+|||++.++.++|+|||++.          
T Consensus        84 ~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          84 PGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            9999999887654 578888889999999999999   78899999999999999999999999998642          


Q ss_pred             -----------------------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCC
Q 036792          345 -----------------------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPT  371 (453)
Q Consensus       345 -----------------------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~  371 (453)
                                                                           ...++.++|||||||++|||++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                                                 123467899999999999999999999


Q ss_pred             CccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC---hHHHHH
Q 036792          372 DRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN---AKDIVT  442 (453)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~~v~~  442 (453)
                      ......+.     ...        +.+    .......+.....++++.+++.+|+. +|.+|++   ++|+++
T Consensus       240 ~~~~~~~~-----~~~--------i~~----~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         240 CSDNPQET-----YRK--------IIN----WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCHHHH-----HHH--------HHc----CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            65422110     000        000    00000001111345678889999996 9999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-34  Score=275.60  Aligned_cols=243  Identities=23%  Similarity=0.403  Sum_probs=185.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--Cee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  267 (453)
                      ..+++.+.||+|+||.||++.+.     ++..||+|.++... ....+.+.+|++++++++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34567788999999999999742     47899999987553 34456799999999999999999999998875  568


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---  344 (453)
                      ++||||+++++|.+++......+++..+..++.+++.++.||   |+++++||||||+||+++.++.++|+|||++.   
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            899999999999999876555688999999999999999999   78999999999999999999999999998542   


Q ss_pred             -------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC-chhhhhh
Q 036792          345 -------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI-SLMEVVD  398 (453)
Q Consensus       345 -------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d  398 (453)
                                               ...++.++|||||||++||++|+..|.........   ......... .....+ 
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-  236 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMIGPTHGQMTVTRLV-  236 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhcccccccccHHHHH-
Confidence                                     12346689999999999999998876532211000   000000000 000001 


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ..+..+  ...+.+..++.++.+|+.+||+.+|++|||++++++.|+++
T Consensus       237 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEG--KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcC--ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            011111  11122345677899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-34  Score=284.48  Aligned_cols=233  Identities=21%  Similarity=0.385  Sum_probs=180.7

Q ss_pred             HHHHHhcccCCCCccEEEEEEE------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC-Ce
Q 036792          196 TLRRLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSND-DF  266 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~  266 (453)
                      ..+++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|+.++.++ +||||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            3467889999999999999974      246899999997543 33456788999999999 689999999988654 46


Q ss_pred             eEEEEeccCCCCchHHhhcCC-----------------------------------------------------------
Q 036792          267 KALVLEYMPKGSLENCLYSST-----------------------------------------------------------  287 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~-----------------------------------------------------------  287 (453)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999886421                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------------
Q 036792          288 -------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------------  345 (453)
Q Consensus       288 -------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------------  345 (453)
                             ..+++.....++.++++|+.||   |+++|+||||||+||+++.++.+||+|||++..               
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                   1356777788999999999999   889999999999999999999999999985421               


Q ss_pred             ------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          346 ------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       346 ------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                  ..++.++||||||+++||+++ |..||........    ..         ..+    ..+.  ....+
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~---------~~~----~~~~--~~~~~  304 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FC---------RRL----KEGT--RMRAP  304 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HH---------HHH----hccC--CCCCC
Confidence                        234668999999999999997 8889864321110    00         000    0000  01111


Q ss_pred             HHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ...++++.+++..||+.+|++|||+.|+++.|+.+.+.
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            22345789999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-34  Score=275.43  Aligned_cols=226  Identities=23%  Similarity=0.393  Sum_probs=179.5

Q ss_pred             HHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      .+++.+.||+|+||.||+|.++      ++..||||.+.... .....++.+|+.+++.++||||+++++++..+...++
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   86 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV   86 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence            3566788999999999999753      25689999986432 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecc
Q 036792          270 VLEYMPKGSLENCLYSST---------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF  340 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df  340 (453)
                      ||||+++|+|.+++....         ..+++.....++.++++|+.||   |+.+++||||||+||++++++.++++||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcchheEEEcCCCCEEECCC
Confidence            999999999999886522         2356778889999999999999   7889999999999999999999999999


Q ss_pred             ccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCc
Q 036792          341 EYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       341 ~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      |++.                           ...++.++|||||||++|||++ |..||......  .....+.      
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~------  235 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVM------  235 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH------
Confidence            8642                           1235678999999999999999 68888643221  1111110      


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                           .     ..  ....+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       236 -----~-----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 -----E-----GG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----c-----CC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                 0     00  00112345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-34  Score=273.67  Aligned_cols=228  Identities=22%  Similarity=0.286  Sum_probs=179.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+++...||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||++
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~   89 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG   89 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence            3567889999999999999964 689999999976554455678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++.... .++......++.|++.|+.||   |+.+|+|||+||+||+++.++.++|+|||++.           
T Consensus        90 ~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          90 GGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence            999999886543 578888899999999999999   78899999999999999999999999997531           


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++|||||||++|||++|..||......+.. ..+            ......   ..
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~------------~~~~~~---~~  229 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLM------------SKSNFQ---PP  229 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eee------------ecCCCC---CC
Confidence                             112355799999999999999999998533211100 000            000000   00


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      ........+.++.+++.+||..+|++|||++++++.|
T Consensus       230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0011123456789999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=269.68  Aligned_cols=221  Identities=32%  Similarity=0.520  Sum_probs=181.6

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCch
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLE  280 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~  280 (453)
                      ++||+|+||.||++...+++.||+|.++..... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999777999999998765433 5578999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------------
Q 036792          281 NCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------------  344 (453)
Q Consensus       281 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------------  344 (453)
                      +++......+++.....++.+++.++.||   |+++++||||||+||+++.++.++|+|||.+.                
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99976555678888899999999999999   88999999999999999999999999997542                


Q ss_pred             -----------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          345 -----------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       345 -----------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                 .+.++.++|+|||||++|||+| |..||.......  ....            +..    ..  ....+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~------------~~~----~~--~~~~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRER------------IES----GY--RMPAP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHH------------Hhc----CC--CCCCC
Confidence                       1234668999999999999999 888886442111  1111            110    00  11123


Q ss_pred             HHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      ..++.++.+++.+||..+|.+|||++|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-35  Score=273.81  Aligned_cols=232  Identities=27%  Similarity=0.345  Sum_probs=172.1

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-----eeEEEEecc
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-----FKALVLEYM  274 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~E~~  274 (453)
                      .+++|.|+||.||+|... +++.||||++-.+..    --.+|+++|+.++|||||++..+|....     ...+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            578999999999999965 579999999865533    1247999999999999999998886522     345899999


Q ss_pred             CCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCC------
Q 036792          275 PKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGM------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~------  344 (453)
                      |. +|++.++..   ...++.....-++.|+.+|+.||   |+.+|+||||||.|+|+|.+ +.+||||||.+.      
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            87 999988742   33566666677889999999999   78999999999999999975 899999998652      


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchh----------h
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM----------E  395 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~  395 (453)
                                         ...|+.+.||||.|||+.||+-|++-|.+....+ .+...++-.-.....          +
T Consensus       181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHHHHHHhCCCCHHHHhhcCccccc
Confidence                               2467899999999999999999999998743221 122222211111111          1


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .-.+.+....... -.....+++.++|+.+++.++|.+|.++.|++.
T Consensus       260 ~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  260 FKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111111111000 123456778999999999999999999999874

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-34  Score=274.89  Aligned_cols=225  Identities=26%  Similarity=0.418  Sum_probs=179.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +.+.+.||+|+||.||+|.+.      .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..++|
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL   87 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence            456688999999999999865      35789999887543 33345789999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC---cEEEeccc
Q 036792          271 LEYMPKGSLENCLYSST------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM---VAHLSDFE  341 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~df~  341 (453)
                      |||+++|+|.+++....      ..+++...+.++.+++.|+.||   |+++++||||||+||+++.++   .+||+|||
T Consensus        88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999886542      2578889999999999999999   788999999999999998654   68999998


Q ss_pred             cCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCch
Q 036792          342 YGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       342 ~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                      ++.                           ...++.++|||||||++|||++ |..||......+  .            
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~------------  230 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--V------------  230 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H------------
Confidence            652                           1235678999999999999997 999986542211  1            


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      .+.+....      ....+..++.++.+++.+||+.+|++||++.++++.|+
T Consensus       231 ~~~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 MEFVTGGG------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHcCC------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11111100      01122345678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-35  Score=271.81  Aligned_cols=222  Identities=23%  Similarity=0.343  Sum_probs=182.6

Q ss_pred             HHHHHHhcccCCCCccEEEEEE-ECCCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +..|++.+.||+|.||.|-+|. +..|+.||||.++++..   .+.-.+.+|+++|+.++||||+.++.+|...+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4567899999999999999998 46899999999987643   4455778999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      |||..+|.|++++..++ .++......+..||+.++.|+   |+++++|||||.+|||+|+++++||+|||+...     
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999998765 678888889999999999887   999999999999999999999999999986421     


Q ss_pred             -------------------C-CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 -------------------G-QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 -------------------~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         . .-.+.+|.||+||+||-++.|..||++...     +..++             .+..+.
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvr-------------QIs~Ga  269 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVR-------------QISRGA  269 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHH-------------Hhhccc
Confidence                               1 124679999999999999999999986522     11111             112222


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.++    -|..+..|+.-++..+|++|.|..||..
T Consensus       270 YrEP~----~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  270 YREPE----TPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             ccCCC----CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            11111    2334667889999999999999999875

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=278.63  Aligned_cols=233  Identities=23%  Similarity=0.406  Sum_probs=178.4

Q ss_pred             HHHHhcccCCCCccEEEEEEECC---------------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD---------------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISS  260 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~  260 (453)
                      .+++.+.||+|+||.||+++...               ...||+|.++... ....+.|.+|++++++++|||+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            45677899999999999987532               2358999987653 3345679999999999999999999999


Q ss_pred             EecCCeeEEEEeccCCCCchHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee
Q 036792          261 CSNDDFKALVLEYMPKGSLENCLYSST-----------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL  329 (453)
Q Consensus       261 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl  329 (453)
                      +...+..++||||+++++|.+++....           ..+++...+.++.+++.|+.||   |+.+++||||||+||++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nill  162 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhEEE
Confidence            999999999999999999999885431           2367788899999999999999   78899999999999999


Q ss_pred             CCCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh--CCCCCCcccccccc
Q 036792          330 DEDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT--RKKPTDRMFVEELS  380 (453)
Q Consensus       330 ~~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~~  380 (453)
                      +.++.+||+|||++..                           ..++.++|||||||++|||++  +..||.....++ .
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-~  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-V  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-H
Confidence            9999999999976421                           234678999999999999998  556765432111 0


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      .....+         ..+...   .......+..++..+.+++.+||+.+|++||++++|++.|.
T Consensus       242 ~~~~~~---------~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IENTGE---------FFRNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHH---------hhhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            010000         000000   00000112234568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.9e-34  Score=281.17  Aligned_cols=239  Identities=22%  Similarity=0.304  Sum_probs=177.7

Q ss_pred             HhcccCCC--CccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          200 LSNLIGMG--SFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       200 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +.++||+|  +|++||++..+ +|+.||+|.++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78899999865 78999999997653  233456778999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ++|+|.+++... ...+++.....++.|++.||.||   |+.+|+||||||+||+++.++.++++||+...         
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999988653 33578888999999999999999   78899999999999999999999999984210         


Q ss_pred             -----------------------C--CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCch------
Q 036792          345 -----------------------E--GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISL------  393 (453)
Q Consensus       345 -----------------------~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------  393 (453)
                                             .  ..++.++|||||||++|||++|+.||........ .........+...      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccchh
Confidence                                   0  2366789999999999999999999975432211 1111111100000      


Q ss_pred             -hhh--------hhhhhhcC-----------ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 -MEV--------VDKTLLSG-----------EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 -~~~--------~d~~~~~~-----------~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .+.        .+......           .....+.....++++.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence             000        00000000           00000112234668899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-34  Score=276.58  Aligned_cols=224  Identities=28%  Similarity=0.449  Sum_probs=181.3

Q ss_pred             HHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..+++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            34678999999999999642      356899999887666667789999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEe
Q 036792          273 YMPKGSLENCLYSST--------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS  338 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~  338 (453)
                      |+++|+|.+++....              ..+++...+.++.+++.|+.||   |+.+++||||||+||++++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeecccccHhhEEEcCCCCEEEC
Confidence            999999999886532              2477888999999999999999   78899999999999999999999999


Q ss_pred             ccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcC
Q 036792          339 DFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLP  390 (453)
Q Consensus       339 df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  390 (453)
                      |||++.                           ...++.++|||||||++|||++ |.+||......+  .         
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~---------  233 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--A---------  233 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--H---------
Confidence            998642                           1234668999999999999998 899985432111  0         


Q ss_pred             CchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          391 ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       391 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                            ++......   ....+..++..+.+++.+||+.+|++||+++|+...|+
T Consensus       234 ------~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 ------IECITQGR---ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ------HHHHHcCc---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                  00000000   11122346677899999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5e-35  Score=284.98  Aligned_cols=216  Identities=23%  Similarity=0.326  Sum_probs=174.1

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +.||+|+||.||++... +|..||+|.++...   ......+.+|++++..++||||+++.+++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999865 68999999998643   233456788999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      +|..++.... .+++.....++.|++.||.||   |+ .+|+||||||+|||++.++.+||+|||++.            
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence            9998876543 578888899999999999999   65 799999999999999999999999998642            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||+||+.||.....+.     ...         .+.   . ..   ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~~~---------~i~---~-~~---~~~  215 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFE---------LIL---M-EE---IRF  215 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----HHH---------HHh---c-CC---CCC
Confidence                         1245678999999999999999999986432111     000         000   0 00   011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      +...++++.+++.+||+.||++|+     ++.++++
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            223456788999999999999996     8888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-35  Score=287.76  Aligned_cols=223  Identities=21%  Similarity=0.294  Sum_probs=178.1

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+++.+ +++.||+|+++....   ...+.+.+|+.+++.++||||+++.+++.+.+..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            45678999999999999876 689999999986532   34466889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++......+++.....++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++.          
T Consensus        84 ~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          84 PGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            99999999987655788888888999999999999   88999999999999999999999999998642          


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            ...++.++|||||||++|||++|+.||.......     ....        +...   
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~--------i~~~---  224 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNN--------IMNF---  224 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHH--------HHcC---
Confidence                                  1124568999999999999999999986432211     1110        0000   


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ......+.....+.++.+|+..|+. +|++||++++++.
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 -QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence             0000011112345678899999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.5e-35  Score=296.95  Aligned_cols=223  Identities=18%  Similarity=0.251  Sum_probs=179.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-C-CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-D-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .|.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+++.++|||||++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3667889999999999999854 4 6789999876555555567888999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          275 PKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ++|+|.+++...   ...++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.       
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542   33577888888999999999999   88999999999999999999999999998642       


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ...++.++|||||||++|||++|+.||......                 +++...+...
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----------------~~~~~~~~~~  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----------------EIMQQVLYGK  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHhCC
Confidence                                123566899999999999999999998643211                 1111111111


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..+.+..++.++.+++.+||+.+|++||++++++.
T Consensus       288 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 ---YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               01122345667899999999999999999999874

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.9e-34  Score=273.01  Aligned_cols=224  Identities=24%  Similarity=0.325  Sum_probs=170.7

Q ss_pred             ccCCCCccEEEEEEECC---CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          203 LIGMGSFGSVYRARLRD---GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .||+|+||.||+|...+   ...+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   4578888876543 2334678899999999999999999999999999999999999999


Q ss_pred             chHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          279 LENCLYSST----CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       279 L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      |.+++....    ...++.....++.|++.|++||   |+.+|+||||||+||++++++.+||+|||++..         
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999987643    2235667788999999999999   889999999999999999999999999986421         


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                                               ..++.++|||||||++|||++ |..||......+. +.........    .    
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~----~----  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQDI----K----  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhccCc----c----
Confidence                                     123557999999999999999 7778764322111 1111110000    0    


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                            ......+..++..+.+++..|| .||++|||++||++.|.
T Consensus       230 ------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 ------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                  0011122345667788899999 59999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.6e-35  Score=285.08  Aligned_cols=221  Identities=22%  Similarity=0.237  Sum_probs=176.8

Q ss_pred             HHHHhcccCCCCccEEEEEEECC--CCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD--GIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      -+.+.+.||+|+||.||+|.++.  +..||+|.+....   ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            35567899999999999998653  3689999987542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++.... .++......++.+++.||.||   |+++|+||||||+|||++.++.+||+|||++..      
T Consensus       111 Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~  186 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY  186 (340)
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence            9999999999987654 577888889999999999999   889999999999999999999999999987521      


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                      ..++.++|||||||++|||++|..||.......     ..            .... .+.   .
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~------------~~i~-~~~---~  245 (340)
T PTZ00426        187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-----IY------------QKIL-EGI---I  245 (340)
T ss_pred             eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----HH------------HHHh-cCC---C
Confidence                            235678999999999999999999996432110     00            0000 000   0


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ..+...+..+.+++.+|++.+|++|+     +++++++
T Consensus       246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            11223445678999999999999995     7888764

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4e-34  Score=270.17  Aligned_cols=231  Identities=23%  Similarity=0.329  Sum_probs=184.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            345678999999999999977 78999999886432   23356889999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          274 MPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      +++|+|.+++..   ....++......++.++++|+.||   |+.+++||||+|+||+++.++.++++|||+..      
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999998854   234578888999999999999999   88999999999999999999999999997531      


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++|||||||++|||++|+.||....   .....+...            ... ..
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~------------~~~-~~  224 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK------------IEK-CD  224 (267)
T ss_pred             cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh------------hhc-CC
Confidence                               1234567999999999999999999985432   111111111            000 00


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      . ........+.++.+++.+||..+|++|||+.++++.|++++
T Consensus       225 ~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 Y-PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             C-CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            0 00111245667899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-34  Score=274.61  Aligned_cols=219  Identities=21%  Similarity=0.283  Sum_probs=172.7

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ||+|+||+||++..+ +++.||+|.+.....   ...+.+..|+++++.++||||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 689999999975432   2335678899999999999999999999999999999999999999


Q ss_pred             hHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          280 ENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       280 ~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ...+..   ....+++.....++.|++.|+.||   |+.+|+||||||+||+++.++.++|+|||.+.            
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            887743   234578888999999999999999   78899999999999999999999999997642            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|+.||...... ........            ... ..   ....
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~------------~~~-~~---~~~~  220 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQ------------RIL-ND---SVTY  220 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-hhHHHHHH------------hhc-cc---CCCC
Confidence                         123466899999999999999999998643211 01111111            000 00   0112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      +...+.++.+++.+||+.+|++||     +++++++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            234567789999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-34  Score=286.12  Aligned_cols=172  Identities=21%  Similarity=0.318  Sum_probs=150.7

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+++.. +++.||||+++...   ......+.+|+.++.+++||||+++++.+.+....++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            45678999999999999865 68999999997543   233456788999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.          
T Consensus        84 ~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          84 PGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            9999999887643 578888899999999999999   88999999999999999999999999998642          


Q ss_pred             --------------------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 036792          345 --------------------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRM  374 (453)
Q Consensus       345 --------------------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  374 (453)
                                                                        ...++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                                              123567899999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=280.23  Aligned_cols=240  Identities=20%  Similarity=0.261  Sum_probs=179.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |.+.+.||+|+||.||+|+.+ ++..||+|.++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   87 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD   87 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence            455678999999999999876 688999999875432 233467889999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      + +|.+.+......+++.....++.+++.||.||   |+++|+||||||+||+++.++.+||+|||++..          
T Consensus        88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            5 88888876655678888889999999999999   789999999999999999999999999986421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCc-hhhhhhh------h
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPIS-LMEVVDK------T  400 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~~~d~------~  400 (453)
                                      ..++.++|||||||++|||+||++||......+. ........  .+.. +..+...      .
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence                            2356689999999999999999999975432211 11111100  0000 0000000      0


Q ss_pred             hhcC-ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSG-EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .... ...........+.++.+++.+|++.||.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000 00000111235667899999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.3e-35  Score=280.28  Aligned_cols=218  Identities=23%  Similarity=0.365  Sum_probs=174.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++..+||+|+||.||+|+-+ +|..+|+|++++..   ....+....|..+|...++|+||+++..|++.+++||||||+
T Consensus       144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl  223 (550)
T KOG0605|consen  144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL  223 (550)
T ss_pred             hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence            45678999999999999855 79999999998774   345677889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|||+..+|.... .|+.......+.+.+-|+.-+   |+.|++||||||+|+|||..|++||+|||+..+         
T Consensus       224 PGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  224 PGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             CCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence            9999999998765 455555555666777788888   999999999999999999999999999975410         


Q ss_pred             ---------------------------------------------------------------CCcCcccchHHHHHHHH
Q 036792          346 ---------------------------------------------------------------GQVSTRSDIYGYGIVLM  362 (453)
Q Consensus       346 ---------------------------------------------------------------~~~~~~~Dv~S~Gvvl~  362 (453)
                                                                                     ..|+..+|.||+|||+|
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy  379 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY  379 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence                                                                           12455689999999999


Q ss_pred             HHHhCCCCCCccccccc--cHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC---h
Q 036792          363 ETFTRKKPTDRMFVEEL--SLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN---A  437 (453)
Q Consensus       363 el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~  437 (453)
                      ||+.|-+||......+.  .+..|....                   ..+....++.++.+|+.+|+. ||++|--   +
T Consensus       380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l-------------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  380 EMLVGYPPFCSETPQETYRKIVNWRETL-------------------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhhhc-------------------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            99999999986544332  222232211                   112223455789999999999 9999964   4


Q ss_pred             HHH
Q 036792          438 KDI  440 (453)
Q Consensus       438 ~~v  440 (453)
                      +||
T Consensus       440 ~EI  442 (550)
T KOG0605|consen  440 EEI  442 (550)
T ss_pred             HHH
Confidence            444

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=260.10  Aligned_cols=232  Identities=21%  Similarity=0.313  Sum_probs=189.1

Q ss_pred             HHHHHhcccCCCCccEEEEEE-ECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-----CeeEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSND-----DFKAL  269 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l  269 (453)
                      ..|++.+.+|+|||+.||.++ ..++..+|+|++.....+..+..++|++..++++|||++++++++..+     ...||
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            346778899999999999998 567899999999888777888999999999999999999999887543     35899


Q ss_pred             EEeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--CceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          270 VLEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTT--PIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~--~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                      ++.|...|+|.+.+..   ++..++..+.+.++.++++||++|   |+.  +.+||||||.|||+.+++.+++.|||...
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999998865   345788899999999999999999   554  49999999999999999999999997542


Q ss_pred             -------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhh
Q 036792          345 -------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN  387 (453)
Q Consensus       345 -------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  387 (453)
                                                           ...+++++|||||||++|+|+.|..||+.....+.++.-    
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL----  253 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL----  253 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE----
Confidence                                                 124578999999999999999999999865443332221    


Q ss_pred             hcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       388 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                              .+.....     ..+.....++.+.+++..|++.||.+||++.+++..++.+
T Consensus       254 --------Av~n~q~-----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 --------AVQNAQI-----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------eeecccc-----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                    1111000     1112223677899999999999999999999999988765

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.1e-34  Score=270.26  Aligned_cols=225  Identities=26%  Similarity=0.446  Sum_probs=181.1

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+++.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK   84 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence            3567889999999999999988888899999875433 2367899999999999999999999875 4567899999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      ++|.+++... ...+++.....++.+++.|+.||   |+.+++||||||+||++++++.++|+|||.+.           
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence            9999998753 34578889999999999999999   78899999999999999999999999997542           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                     ...++.++||||||+++||+++ |..||......  .......            .    ..  .
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~------------~----~~--~  221 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVE------------R----GY--R  221 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH------------c----CC--C
Confidence                           1234568999999999999999 88898643211  1111110            0    00  1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      .+.+...+.++.+++.+||..+|++|||++++...|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11233456779999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.2e-34  Score=271.75  Aligned_cols=227  Identities=27%  Similarity=0.434  Sum_probs=181.6

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+++.+.||+|+||.||+|.+.+...||+|.++.... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            34677889999999999999987767899999975433 2367899999999999999999999875 456789999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+++... ...+++.....++.++++||.||   |+++++||||||+||++++++.++|+|||.+.          
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~  160 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  160 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence            99999999753 33578888999999999999999   88999999999999999999999999997642          


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      ...++.++|||||||++||++| |..||......+.                 .+... ...  
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-----------------~~~~~-~~~--  220 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----------------LDQVE-RGY--  220 (262)
T ss_pred             cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-----------------HHHHh-cCC--
Confidence                            1234668999999999999999 8888864421110                 00000 000  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ..+.+..++.++.+++.+||+.+|++||++.++.+.|++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1112345677899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-34  Score=277.72  Aligned_cols=231  Identities=25%  Similarity=0.451  Sum_probs=184.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  265 (453)
                      .-+.+.+.||+|+||.||+|++.        ++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            34456789999999999999742        24579999987543 34457789999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          266 FKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ..+++|||+++|+|.+++....               ..+++.....++.|+++|+.||   |+.+++||||||+||+++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nili~  171 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHCCeeecccccceEEEc
Confidence            9999999999999999986532               2467788889999999999999   788999999999999999


Q ss_pred             CCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||++.                           ...++.++||||||+++||+++ |..||......     
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----  246 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-----  246 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----
Confidence            99999999997542                           1234668999999999999998 77887543211     


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ++...         +.    ...  ....+..++.++.+++.+||..+|++|||+.|+++.|+++..
T Consensus       247 ~~~~~---------~~----~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         247 ELFKL---------LK----EGH--RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHHH---------HH----cCC--cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            11111         00    000  111223567789999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-35  Score=269.41  Aligned_cols=237  Identities=22%  Similarity=0.248  Sum_probs=180.0

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeec--cchhhHHHHHHHHHHHHcCCCCCceeEEeEEec-----CCeeEEEEe
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQ--ECARALKSFEAQCEVMKSIRHPNLVKVISSCSN-----DDFKALVLE  272 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~lv~E  272 (453)
                      .+.||+|+||.|+.+..+ +|+.||||++..  +..-..++-.+|+++|+.++|+||+.+.+.+..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            578999999999999866 799999999973  344556788999999999999999999998866     346899999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      +|+ -||.+.++... .+.......++.|+.+|+.|+   |+.+|+||||||+|+|++.+...||+|||++..       
T Consensus       107 lMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  107 LME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             HHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            995 49999888754 367777778889999999999   999999999999999999999999999987632       


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHhCCCCCCcccc-ccccHHhHHhhhcCCchhhhhh-----
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFV-EELSLKDWVNNLLPISLMEVVD-----  398 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~d-----  398 (453)
                                           ..|+...||||.||++.||++|++-|.+... +...+...+-...+......+.     
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence                                 2467789999999999999999999876422 1111111111111111111111     


Q ss_pred             hhhhcCc---cCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 KTLLSGE---KKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ~~~~~~~---~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.+.+..   +.+ ...-+...+.+++|+.+++..||.+|+|++|+++
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111111   111 1122356678999999999999999999999875

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-34  Score=277.38  Aligned_cols=228  Identities=26%  Similarity=0.473  Sum_probs=182.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  269 (453)
                      +++.+.||+|+||.||++.+.      ....+|+|.+.... .....++.+|++++.++ +|+||+++++++..++..++
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   93 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV   93 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence            456788999999999999864      23689999987543 33446788999999999 79999999999999999999


Q ss_pred             EEeccCCCCchHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc
Q 036792          270 VLEYMPKGSLENCLYSS---------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV  334 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~  334 (453)
                      +|||+++|+|.+++...               ...+++...+.++.|++.|+.||   |+.+|+||||||+||+++.++.
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~Nil~~~~~~  170 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHV  170 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCccccccceeeEEEcCCCe
Confidence            99999999999988532               23578888999999999999999   7889999999999999999999


Q ss_pred             EEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHh
Q 036792          335 AHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVN  386 (453)
Q Consensus       335 ~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~  386 (453)
                      +||+|||++.                           ...++.++|||||||++||+++ |..||......+     .. 
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~-  244 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----LF-  244 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-----HH-
Confidence            9999997542                           1234567999999999999998 888886432111     00 


Q ss_pred             hhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       387 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                              +.+.    ...  ....+..++.++.+|+.+||..+|++|||++|+++.|+++.
T Consensus       245 --------~~~~----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 --------KLLK----EGY--RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --------HHHH----cCC--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                    0000    010  11123345678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-34  Score=281.70  Aligned_cols=216  Identities=22%  Similarity=0.312  Sum_probs=172.1

Q ss_pred             cccCCCCccEEEEEEEC----CCCEEEEEEeeccc----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC----ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +.||+|+||.||+++..    +++.||||.++...    ......+.+|+++|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999852    57899999997542    22335678899999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+.+.... .+.......++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.         
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence            99999999887644 466677778899999999999   78899999999999999999999999998642         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|+.||......     ....            ......    
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~------------~~~~~~----  216 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTID------------KILKGK----  216 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHH------------HHHcCC----
Confidence                            112456899999999999999999999643211     1111            110000    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ...+...+.++.+++.+||+.+|++||     +++++++
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            112234456789999999999999999     7777754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2e-34  Score=278.45  Aligned_cols=233  Identities=26%  Similarity=0.437  Sum_probs=186.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  265 (453)
                      ..+.+.+.||+|+||.||++...        +...+|+|.++... ......+.+|++++.++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            44567889999999999999753        23579999997542 33456788899999999 7999999999999999


Q ss_pred             eeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          266 FKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ..++||||+++|+|.+++....               ..+++...+.++.+++.|++||   |+.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHHheEEc
Confidence            9999999999999999996532               2478888999999999999999   788999999999999999


Q ss_pred             CCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||.+..                           ..++.++|||||||++|||++ |..||.....+     
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-----  249 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----  249 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----
Confidence            999999999976421                           224567999999999999998 88887543211     


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ....         .+.    ...  ....+..++.++.+++.+||..+|++||++.++++.|.++....
T Consensus       250 ~~~~---------~~~----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         250 ELFK---------LLK----EGH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHH---------HHH----cCC--CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            1111         110    010  11223456678999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-34  Score=272.58  Aligned_cols=229  Identities=24%  Similarity=0.387  Sum_probs=185.1

Q ss_pred             HHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +.+.+.||+|+||.||+|.+.+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            3456889999999999998643    3579999887654 4456789999999999999999999999875 45689999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++......+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++++|||++.        
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             cCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            9999999999987655688999999999999999999   78899999999999999999999999997532        


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                        ...++.++||||||+++||+++ |..||......+  ......                ...
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~----------------~~~  225 (270)
T cd05056         164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIE----------------NGE  225 (270)
T ss_pred             ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH----------------cCC
Confidence                              1234667999999999999986 999986542211  111110                000


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                        ..+.+..++.++.+++.+||..+|++|||+.++++.|+++..+
T Consensus       226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              1112345677899999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-34  Score=269.00  Aligned_cols=220  Identities=22%  Similarity=0.280  Sum_probs=179.5

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.+.||+|+||.||+|... ++..|++|.+...  .....+++.+|++++++++|||++++++++.+++..++||||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            4577999999999999976 6899999998754  234567889999999999999999999999999999999999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      ++|.+++... ...+++.....++.+++.|+.||   |+.+++|+||||+||+++.++.++|+|||...           
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            9999998764 45678888899999999999999   78899999999999999999999999997532           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|+.||......+  ...               .... ..  ...
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~---------------~~~~-~~--~~~  220 (256)
T cd08529         161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LIL---------------KIIR-GV--FPP  220 (256)
T ss_pred             cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH---------------HHHc-CC--CCC
Confidence                          1234678999999999999999999986542111  000               0000 00  111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+...+.++.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            22345667899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-34  Score=279.12  Aligned_cols=215  Identities=23%  Similarity=0.285  Sum_probs=169.4

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHc-CCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKS-IRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.. +++.||||.++...   ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999976 58899999998643   2234455667777664 4899999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++.... .++......++.|++.||.||   |+++|+||||||+||+++.++.+||+|||++.            
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  156 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF  156 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence            99998887644 577888888999999999999   78999999999999999999999999998642            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|+.||......+     ...            .... .   ....
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~~~------------~i~~-~---~~~~  215 (316)
T cd05592         157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----LFD------------SILN-D---RPHF  215 (316)
T ss_pred             cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----HHH------------HHHc-C---CCCC
Confidence                         1235678999999999999999999997542211     110            0000 0   0112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChH-HHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAK-DIV  441 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~-~v~  441 (453)
                      +..++.++.+++.+||+.+|++||++. ++.
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            233456788999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-34  Score=271.06  Aligned_cols=225  Identities=24%  Similarity=0.431  Sum_probs=181.4

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN   84 (260)
T ss_pred             HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence            4566789999999999999988899999999875543 3467899999999999999999999874 5568999999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      |+|.+++... ...+++.....++.+++.++.||   |+.+++||||||+||++++++.++++|||+...          
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence            9999988653 34678888999999999999999   889999999999999999999999999975421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..++.++||||||+++||+++ |+.||......+  ......            .    ..  .
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~------------~----~~--~  221 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLE------------R----GY--R  221 (260)
T ss_pred             CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHH------------c----CC--C
Confidence                            223568999999999999999 999986432111  111110            0    00  1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      .+.+...+.++.+++.+||+.+|++||+++++...|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11223456679999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-34  Score=272.18  Aligned_cols=229  Identities=24%  Similarity=0.438  Sum_probs=185.3

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CC----CEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DG----IEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      .+++.+.||+|+||.||+|.++ +|    ..||+|.++.... ....++.+|+.++++++||||++++++|.. ...++|
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v   86 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI   86 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence            3456788999999999999865 33    3689998876543 345688999999999999999999999987 788999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      +||+++|+|.+++......+++.....++.|++.|+.||   |+.+++||||||+||++++++.+||+|||++.      
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            999999999999987666788999999999999999999   78999999999999999999999999997542      


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                           ...++.++|+||||+++||+++ |+.||.....++  +...+.               .
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~---------------~  226 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLE---------------K  226 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHh---------------C
Confidence                                 1234567999999999999999 999986542211  111111               0


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                       .  ...+.+..++..+.+++.+||..+|.+||++.++++.|.++..
T Consensus       227 -~--~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         227 -G--ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -C--CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             0  0112223455678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-34  Score=269.69  Aligned_cols=217  Identities=21%  Similarity=0.355  Sum_probs=171.8

Q ss_pred             cccCCCCccEEEEEEECC-C----------CEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          202 NLIGMGSFGSVYRARLRD-G----------IEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +.||+|+||.||+|.+.+ +          ..|++|.+...... ...|.+|+.+++.++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999999763 3          35788877654433 5788999999999999999999999988 778999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-------cEEEeccccC
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-------VAHLSDFEYG  343 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-------~~kl~df~~~  343 (453)
                      |||+++|+|.+++......+++..++.++.|++.|+.||   |+++|+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999987655788899999999999999999   889999999999999999887       7999999864


Q ss_pred             CC-----------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          344 ME-----------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       344 ~~-----------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                      ..                       ..++.++|||||||++||+++ |..|+......  ....+...           .
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~-----------~  222 (259)
T cd05037         156 ITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD-----------Q  222 (259)
T ss_pred             cccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc-----------C
Confidence            32                       135678999999999999999 56676543211  11111100           0


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                          ..   .+.+  ....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus       223 ----~~---~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 ----HR---LPMP--DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----CC---CCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                00   0000  1157889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.5e-34  Score=275.05  Aligned_cols=226  Identities=29%  Similarity=0.472  Sum_probs=180.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++.+.||+|+||.||++...      ++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..+++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            455678999999999999863      46789999987553 33456789999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee
Q 036792          271 LEYMPKGSLENCLYSST---------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL  329 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl  329 (453)
                      +||+++|+|.+++....                     ..+++...+.++.+++.|+.||   |+++++||||||+||++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H~~~i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCeecccccHhheEe
Confidence            99999999999986421                     2366778889999999999999   78899999999999999


Q ss_pred             CCCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 036792          330 DEDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSL  381 (453)
Q Consensus       330 ~~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~  381 (453)
                      ++++.++|+|||+..                           ...++.++|||||||++|||++ |..||.....++   
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~---  240 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---  240 (288)
T ss_pred             cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            999999999998642                           1234567999999999999998 778875432211   


Q ss_pred             HhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       382 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                        .....             ....  ..+.+..++.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       241 --~~~~~-------------~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 --VIYYV-------------RDGN--VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHHHH-------------hcCC--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              11100             0000  011223456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-34  Score=268.99  Aligned_cols=226  Identities=27%  Similarity=0.448  Sum_probs=183.9

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+.+.+.||+|+||.||+|...++..||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+++
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK   85 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence            3566788999999999999988888999999875433 346789999999999999999999999998899999999999


Q ss_pred             CCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          277 GSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       277 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      ++|.+++.... ..+++.....++.+++.|+.||   |+++++|+||||+||++++++.++++|||.+..          
T Consensus        86 ~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (261)
T cd05034          86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE  162 (261)
T ss_pred             CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence            99999997643 4678899999999999999999   788999999999999999999999999975421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..++.++||||||+++||+++ |+.||.......  .....               .. .  ..
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~---------------~~-~--~~  222 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQV---------------ER-G--YR  222 (261)
T ss_pred             ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH---------------Hc-C--CC
Confidence                            234668999999999999999 999986432111  00000               00 0  01


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      .+.+..++.++.+++.+||..+|++||+++++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11223346678999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.6e-34  Score=270.31  Aligned_cols=220  Identities=24%  Similarity=0.335  Sum_probs=176.7

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCch
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLE  280 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~  280 (453)
                      ..||+|+||.||+|..+ ++..||+|.+........+.+.+|+++++.++|+||+++++++..++..++++||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            57999999999999865 67899999988766666678999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC------------
Q 036792          281 NCLYSSTCML--DIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME------------  345 (453)
Q Consensus       281 ~~l~~~~~~l--~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~------------  345 (453)
                      +++......+  +......++.|++.|+.||   |+++|+||||||+||+++. ++.++|+|||....            
T Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  170 (268)
T cd06624          94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT  170 (268)
T ss_pred             HHHHHhcccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence            9997654444  6777888899999999999   7899999999999999986 67899999975310            


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ..++.++||||||+++||+++|..||........  ..+..             ....   ....
T Consensus       171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~-------------~~~~---~~~~  232 (268)
T cd06624         171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKV-------------GMFK---IHPE  232 (268)
T ss_pred             CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhh-------------hhhc---cCCC
Confidence                           1256789999999999999999999854211100  00000             0000   0111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+..++.++.+++.+||+.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            23345677899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=281.05  Aligned_cols=221  Identities=25%  Similarity=0.363  Sum_probs=182.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |...+.||+|+||.||+|... +++.||||++.-+. ....+..++|+.++.+++++||.+++|.+..+..+|++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            344488999999999999854 78999999998764 3556889999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC------------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------------  343 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~------------  343 (453)
                      +|++.+.|.... .++......++.++..|+.||   |..+.+|||||+.|||+..+|.+|++|||++            
T Consensus        95 gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   95 GGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             CcchhhhhccCC-CCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            999999887654 335566667888999999999   8899999999999999999999999999764            


Q ss_pred             -------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          344 -------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       344 -------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                   ....|+.|+||||+|++.+||++|.+|+......-              ..-    .+ .... ++.
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--------------vlf----lI-pk~~-PP~  230 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--------------VLF----LI-PKSA-PPR  230 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--------------EEE----ec-cCCC-CCc
Confidence                         23468999999999999999999999987543210              000    00 0111 112


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+++.+.+++..|++++|+.||+|.++++
T Consensus       231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            23377888999999999999999999999875

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=287.79  Aligned_cols=223  Identities=22%  Similarity=0.281  Sum_probs=173.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||++... +++.||||++....   ....+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            45678999999999999865 78999999987542   234467889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.          
T Consensus        84 ~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          84 PGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999887643 567777788899999999999   89999999999999999999999999998652          


Q ss_pred             --------------------------------------------------------------CCCcCcccchHHHHHHHH
Q 036792          345 --------------------------------------------------------------EGQVSTRSDIYGYGIVLM  362 (453)
Q Consensus       345 --------------------------------------------------------------~~~~~~~~Dv~S~Gvvl~  362 (453)
                                                                                    ...++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                                          113567899999999999


Q ss_pred             HHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccC---CChHH
Q 036792          363 ETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKR---INAKD  439 (453)
Q Consensus       363 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps~~~  439 (453)
                      ||++|..||......+. ......                .......+.....+.++.+++.+|+. +|.+|   +++.|
T Consensus       240 elltG~~Pf~~~~~~~~-~~~i~~----------------~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         240 ECLIGWPPFCSENSHET-YRKIIN----------------WRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhcCCCCCCCCCHHHH-HHHHHc----------------cCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999965322110 000000                00000001111345678899999997 67765   59988


Q ss_pred             HHHH
Q 036792          440 IVTR  443 (453)
Q Consensus       440 v~~~  443 (453)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.4e-34  Score=269.35  Aligned_cols=224  Identities=32%  Similarity=0.462  Sum_probs=179.8

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEe-cCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS-NDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~E~~~~  276 (453)
                      +++.+.||+|+||.||++..+ |..||+|.++...  ..+.+.+|+.++++++|+|++++++++. .++..++++||+++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            455688999999999999865 7889999986543  3467899999999999999999999764 45678999999999


Q ss_pred             CCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          277 GSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       277 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      |+|.+++.... ..+++.....++.+++.|+.||   |+.+++||||||+||++++++.+|++|||++..          
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  161 (256)
T cd05082          85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  161 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence            99999987643 3478888899999999999999   889999999999999999999999999986421          


Q ss_pred             ------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          346 ------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       346 ------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                  ..++.++|||||||++|||++ |+.||.....     ......             +....  ....+
T Consensus       162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~-------------~~~~~--~~~~~  221 (256)
T cd05082         162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR-------------VEKGY--KMDAP  221 (256)
T ss_pred             ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-------------HhcCC--CCCCC
Confidence                        245678999999999999998 9999864311     111111             00010  11122


Q ss_pred             HHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            35677899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-34  Score=286.17  Aligned_cols=224  Identities=21%  Similarity=0.262  Sum_probs=176.5

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      -+++.+.||+|+||.||+++.. ++..||+|.++...   ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            3456788999999999999976 68999999997542   2233557889999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++...  .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus       124 y~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         124 YMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999999988654  366677778889999999999   788999999999999999999999999986411       


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++|||||||++|||++|+.||......+ ...            ++.+    
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~------------~i~~----  261 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYS------------KIMD----  261 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHH------------HHHc----
Confidence                                   125668999999999999999999996532111 000            1111    


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCccc--CCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEK--RINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~~v~~  442 (453)
                      .......+.....+.++.+++.+|++.+|.+  ||+++|+++
T Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         262 HKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            0000011111234678899999999999988  999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=290.34  Aligned_cols=219  Identities=24%  Similarity=0.360  Sum_probs=183.8

Q ss_pred             ccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCchH
Q 036792          203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLEN  281 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~  281 (453)
                      ++|+|.||+||-|+.. +...+|||-+.....+..+.+..|+.+.+.++|.|||+++|.|.+++++-|.||-.|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999966 567899999988877788889999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCC--------------
Q 036792          282 CLYSSTCML--DIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGM--------------  344 (453)
Q Consensus       282 ~l~~~~~~l--~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~--------------  344 (453)
                      +|+...+++  .....--...||.+||.||   |++.|||||||-+|||++. .|.+||+|||...              
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            999876666  4555666788999999999   8999999999999999986 7899999997531              


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   .+.|...+|||||||++.||.||++||........   .            ++.-.+   .+.-++.
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---A------------MFkVGm---yKvHP~i  800 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---A------------MFKVGM---YKVHPPI  800 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---h------------hhhhcc---eecCCCC
Confidence                         24578899999999999999999999864321110   0            111011   1123457


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      |++.+.++..++++|..++|.+||++++++.
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            7888999999999999999999999999874

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.5e-34  Score=275.04  Aligned_cols=233  Identities=23%  Similarity=0.411  Sum_probs=181.2

Q ss_pred             HHHHhcccCCCCccEEEEEEECC-----------------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD-----------------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVI  258 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~  258 (453)
                      .+++.+.||+|+||.||++....                 +..||+|.+.... ....+.+.+|++++++++|||+++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            35677899999999999987542                 2468999987653 34567899999999999999999999


Q ss_pred             eEEecCCeeEEEEeccCCCCchHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcee
Q 036792          259 SSCSNDDFKALVLEYMPKGSLENCLYSST----------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVL  328 (453)
Q Consensus       259 g~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiL  328 (453)
                      +++..++..++++||+++++|.+++....          ..+++.....++.+++.|+.||   |+.+++||||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H~~~i~H~dlkp~Nil  162 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---HHcCccccccchhcee
Confidence            99999999999999999999999986543          2578888999999999999999   7889999999999999


Q ss_pred             eCCCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh--CCCCCCccccccc
Q 036792          329 LDEDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT--RKKPTDRMFVEEL  379 (453)
Q Consensus       329 l~~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~  379 (453)
                      ++.++.++|+|||++.                           ...++.++|||||||++|||++  +..||......+ 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-  241 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence            9999999999998642                           1245678999999999999998  667775432111 


Q ss_pred             cHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          380 SLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                       ........+..           .......+.+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       242 -~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 -VIENAGHFFRD-----------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -HHHHHHhcccc-----------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             11111100000           0000011122345678999999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=275.53  Aligned_cols=224  Identities=21%  Similarity=0.275  Sum_probs=176.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||++... +++.||||.+.....   .....+.+|+.+++.++||||+++++.+.+++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            45678999999999999865 689999999975432   22345778999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          275 PKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      ++|+|.+++... ...+++.....++.|++.|+.||   |+.+++||||||+||++++++.++|+|||++..        
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05605          83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR  159 (285)
T ss_pred             CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence            999999887653 34588889999999999999999   788999999999999999999999999985421        


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                      ..++.++||||+||++||+++|..||....... ....+             ...+...   ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~-------------~~~~~~~---~~  222 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEV-------------ERRVKED---QE  222 (285)
T ss_pred             cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHH-------------HHHhhhc---cc
Confidence                            234668999999999999999999997532111 00000             0011100   01


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            12234566789999999999999999     7878754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2e-34  Score=280.19  Aligned_cols=216  Identities=21%  Similarity=0.290  Sum_probs=172.4

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999976 58899999997642   23345677888888865 799999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|...+.... .+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||++.            
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF  156 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence            99998886543 577888889999999999999   78899999999999999999999999998542            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|+.||......+     ...            ......    ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~~~------------~i~~~~----~~~  215 (321)
T cd05591         157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----LFE------------SILHDD----VLY  215 (321)
T ss_pred             ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----HHH------------HHHcCC----CCC
Confidence                         1245678999999999999999999997542211     111            111000    011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCC-------ChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRI-------NAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RP-------s~~~v~~  442 (453)
                      +..++.++.+++.+||+.+|++||       +++++++
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            223456788999999999999999       6777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-34  Score=267.74  Aligned_cols=221  Identities=31%  Similarity=0.563  Sum_probs=182.0

Q ss_pred             cccCCCCccEEEEEEECC----CCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLRD----GIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|....    +..||+|.++..... ..+.+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998653    789999999866443 367889999999999999999999999999999999999999


Q ss_pred             CCchHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          277 GSLENCLYSS--------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       277 g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      |+|.+++...        ...+++.....++.++++|+.||   |+++++||||||+||+++.++.++|+|||....   
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875        46789999999999999999999   889999999999999999999999999975421   


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ..++.++||||+|+++|||++ |..||......  ...+.+.              
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~--------------  221 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLR--------------  221 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH--------------
Confidence                                    234668999999999999999 59998654211  1111110              


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                       . .  .....+..++.++.+++.+||..+|++|||+.|+++.|+
T Consensus       222 -~-~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 -K-G--YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -c-C--CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             0 0  111233455778999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.2e-34  Score=263.53  Aligned_cols=242  Identities=24%  Similarity=0.251  Sum_probs=179.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh--hHHHHHHHHHHHHcCCCCC-ceeEEeEEecCC------ee
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR--ALKSFEAQCEVMKSIRHPN-LVKVISSCSNDD------FK  267 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~  267 (453)
                      +...+.||+|+||+||+|+.+ +|+.||+|+++-+..+  .-....+|+.++++++|+| ||++++++.+..      ..
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            344566999999999999965 7899999999865432  2234578999999999999 999999998877      78


Q ss_pred             EEEEeccCCCCchHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          268 ALVLEYMPKGSLENCLYSST---CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                      ++|+||+.. +|.+++....   ..++......++.|+++|++||   |+.+|+||||||.|||+++++.+||+|||++.
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence            999999965 9999987654   3566677889999999999999   99999999999999999999999999998652


Q ss_pred             --------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC--Cchhhh
Q 036792          345 --------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP--ISLMEV  396 (453)
Q Consensus       345 --------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~  396 (453)
                                                ...|++..||||+||++.||+++++-|++....+.-..-+..-..|  ..+..+
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence                                      1257889999999999999999999998764422211111111111  112111


Q ss_pred             h---hhhh--hcCccCC--chhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          397 V---DKTL--LSGEKKG--FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       397 ~---d~~~--~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .   +...  ..-..+.  ............+++..|++++|.+|.|++.++..
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1   1110  0000000  00111122478899999999999999999999875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-34  Score=280.40  Aligned_cols=212  Identities=23%  Similarity=0.317  Sum_probs=168.4

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHH---HcCCCCCceeEEeEEecCCeeEEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVM---KSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ++.+.||+|+||.||+|... +++.||||+++...   ....+.+.+|++++   +.++||||+++++++..++..++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            34678999999999999876 68999999997543   22345566666654   5678999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|...+..  ..+++.....++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||++..      
T Consensus        82 E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          82 EYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             cCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            99999999887764  3588889999999999999999   889999999999999999999999999986421      


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                         ..++.++|||||||++|||++|+.||......+     .            .+......  
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~------------~~~i~~~~--  217 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----V------------FDSIVNDE--  217 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----H------------HHHHHhCC--
Confidence                               235668999999999999999999986532211     1            11111100  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCC
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRIN  436 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  436 (453)
                        ...+...+.++.+++.+||+.||++||+
T Consensus       218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~  245 (324)
T cd05589         218 --VRYPRFLSREAISIMRRLLRRNPERRLG  245 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCC
Confidence              0122345667889999999999999994

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2e-33  Score=267.37  Aligned_cols=224  Identities=23%  Similarity=0.330  Sum_probs=183.0

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ...++..+.||+|+||.||+|... ++..||||.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            345667788999999999999975 58899999987543 3455788999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++...  .++......++.+++.|+.||   |+.+++|+||+|+||+++.++.++++|||.+.        
T Consensus        83 ~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          83 YLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             cCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            99999999988653  477888889999999999999   78999999999999999999999999997541        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++|+|||||++|||+||+.||........     .         ..+.    .  ..
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~---------~~~~----~--~~  217 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L---------FLIP----K--NN  217 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h---------hhhh----c--CC
Confidence                             12346789999999999999999999864321110     0         0000    0  00


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .......++.++.+++.+||+.+|++||+++|++..
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            122344567889999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.9e-34  Score=271.65  Aligned_cols=222  Identities=20%  Similarity=0.284  Sum_probs=172.8

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ||+|+||.||+++.+ +|+.||+|.+.....   .....+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 689999999975322   1234556799999999999999999999999999999999999999


Q ss_pred             hHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------------
Q 036792          280 ENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------  344 (453)
Q Consensus       280 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------------  344 (453)
                      .+.+... ...+++.....++.|++.|++||   |+.+++||||||+||+++.++.++|+|||++.              
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT  157 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence            8887543 33578888889999999999999   78999999999999999999999999997542              


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQ  414 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  414 (453)
                                ...++.++||||+||++|||++|+.||...... ..........            . ....  ......
T Consensus       158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~------------~-~~~~--~~~~~~  221 (277)
T cd05607         158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRT------------L-EDEV--KFEHQN  221 (277)
T ss_pred             CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHh------------h-cccc--cccccc
Confidence                      123577899999999999999999998643211 1111111110            0 0000  001123


Q ss_pred             HHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          415 CVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       415 ~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      .+.++.+++..||+.+|++||+++|+++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            456789999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.7e-34  Score=275.12  Aligned_cols=223  Identities=25%  Similarity=0.310  Sum_probs=180.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++.+..+...++||||+++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            455678999999999999865 6899999999876555567889999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      ++|.+++...  .+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||++..           
T Consensus       102 ~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         102 GSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             CCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence            9999988653  478888999999999999999   788999999999999999999999999985421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                    ..++.++|||||||++|||++|+.||......+.. ..+...                . .+....
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-~~~~~~----------------~-~~~~~~  238 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATN----------------G-TPELQN  238 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-HHHhcC----------------C-CCCCCC
Confidence                          23457899999999999999999998643221110 000000                0 000111


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      +...+..+.+++.+||..+|++||++.|+++.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            23345678899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-34  Score=272.63  Aligned_cols=226  Identities=19%  Similarity=0.294  Sum_probs=180.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||++... ++..||+|.++... ......+.+|++++++++||||+++++.+..++..++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            467788999999999999976 78999999987542 3345678999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          276 KGSLENCLYSS--TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       276 ~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|..++...  ...+++.....++.++++|+.|||  ++.+++||||||+||+++.++.++|+|||.+..        
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (286)
T cd06622          83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT  160 (286)
T ss_pred             CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcccc
Confidence            99999888764  236788899999999999999994  246899999999999999999999999985421        


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                           ..++.++|||||||++|||++|+.||.......     ..         ..+..... .
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~---------~~~~~~~~-~  225 (286)
T cd06622         161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IF---------AQLSAIVD-G  225 (286)
T ss_pred             CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HH---------HHHHHHhh-c
Confidence                                 013568999999999999999999986431110     00         00000000 0


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .....+..++.++.+++.+||+.+|++||+++++++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         226 --DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence              011233446778899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.5e-34  Score=278.93  Aligned_cols=215  Identities=20%  Similarity=0.297  Sum_probs=170.5

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHc-CCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKS-IRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.+ +|..||+|.++...   ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36899999999999976 68999999998653   2334566778888765 4899999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|...+.... .++......++.|+++||+||   |+.+|+||||||+||+++.++.++|+|||++..           
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF  156 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence            99998886643 577888889999999999999   788999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                    ..++.++|||||||++|||++|..||......+     ..+.         +   ....    ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-----~~~~---------~---~~~~----~~~  215 (316)
T cd05620         157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-----LFES---------I---RVDT----PHY  215 (316)
T ss_pred             CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHH---------H---HhCC----CCC
Confidence                          245678999999999999999999996432111     1110         0   0000    011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChH-HHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAK-DIV  441 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~-~v~  441 (453)
                      +...+.++.+++.+||+.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            223456788999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.2e-34  Score=269.37  Aligned_cols=224  Identities=26%  Similarity=0.424  Sum_probs=179.5

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|....+..+|+|.+..... ..+.+.+|++++++++|||++++++++. .+..+++|||+++|
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG   85 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence            566788999999999999987777899998865432 3467889999999999999999999875 45678999999999


Q ss_pred             CchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          278 SLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       278 ~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      +|.+++... ...+++.....++.+++.|+.||   |+.+++||||||+||++++++.++|+|||.+..           
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05069          86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG  162 (260)
T ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence            999998754 33478888999999999999999   788999999999999999999999999986521           


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ..++.++|||||||++|||+| |..||......+  ...+...                ..  ..
T Consensus       163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~----------------~~--~~  222 (260)
T cd05069         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVER----------------GY--RM  222 (260)
T ss_pred             CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc----------------CC--CC
Confidence                           223557999999999999999 899986532211  1111110                00  01


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      +.+...+..+.+++.+||+.+|++||+++++.+.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.3e-34  Score=272.40  Aligned_cols=229  Identities=24%  Similarity=0.377  Sum_probs=180.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      ..+++.+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+.+++.++||||+++++++...+..+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            34566789999999999999754      24589999887543 233456889999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEec
Q 036792          269 LVLEYMPKGSLENCLYSST---------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSD  339 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~d  339 (453)
                      +||||+++|+|.+++....         ....+.....++.+++.|+.||   |+++++||||||+||++++++.++++|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999999986421         2345567788999999999999   889999999999999999999999999


Q ss_pred             cccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCC
Q 036792          340 FEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPI  391 (453)
Q Consensus       340 f~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  391 (453)
                      ||++.                           ...++.++|||||||++|||++ |..||.....++  ....+      
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~------  234 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFV------  234 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH------
Confidence            98642                           1234678999999999999998 788886432211  11110      


Q ss_pred             chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       392 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                               ....   ....+..+++++.+++.+||+.+|++|||+.++++.|.+.
T Consensus       235 ---------~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 ---------MDGG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ---------HcCC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                     0000   0111234567899999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.2e-34  Score=275.54  Aligned_cols=230  Identities=23%  Similarity=0.367  Sum_probs=182.7

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  267 (453)
                      ..+.+.+.||+|+||.||++...      ++..||||.++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            34566789999999999999741      35689999987553 34456789999999999 799999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-
Q 036792          268 ALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-  345 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-  345 (453)
                      +++|||+++|+|.+++.... ..+++.+...++.+++.|+.||   |+++++|+||||+||+++.++.++++|||.+.. 
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999987543 3478999999999999999999   788999999999999999999999999976421 


Q ss_pred             --------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          346 --------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       346 --------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                                                ..++.++|||||||++|||++ |..||......+. ....            ++
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~------------~~  258 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKL------------IK  258 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHH------------HH
Confidence                                      123567899999999999998 9999865422111 1111            11


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ...      ....+...+.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       259 ~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 EGY------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCC------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            000      0011123356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.6e-34  Score=278.05  Aligned_cols=216  Identities=24%  Similarity=0.295  Sum_probs=174.3

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+++.+ +++.||||.++...   ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999976 58899999998653   23345677888888877 699999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|...+.... .+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++.            
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF  156 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence            99998886643 578889999999999999999   88999999999999999999999999998642            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|+.||.......     .....        .     ..   ....
T Consensus       157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-----~~~~i--------~-----~~---~~~~  215 (318)
T cd05570         157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-----LFQSI--------L-----ED---EVRY  215 (318)
T ss_pred             ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-----HHHHH--------H-----cC---CCCC
Confidence                         1245678999999999999999999996432111     11100        0     00   0111


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCCh-----HHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINA-----KDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~~v~~  442 (453)
                      +...+.++.+++.+||+.||++||++     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            23456678999999999999999999     77654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.5e-34  Score=269.26  Aligned_cols=225  Identities=21%  Similarity=0.287  Sum_probs=177.0

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC------Ce
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSND------DF  266 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~~  266 (453)
                      ...+++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|||++++++++...      +.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            345677889999999999999865 68899999987543 2345788899999998 699999999998753      46


Q ss_pred             eEEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-
Q 036792          267 KALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-  344 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-  344 (453)
                      .+++|||+++|+|.+++... ...+++.....++.|++.|+.||   |+++|+|||+||+||++++++.++|+|||++. 
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            89999999999999988763 34678888899999999999999   78899999999999999999999999997642 


Q ss_pred             -----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          345 -----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       345 -----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                                                   ...++.++|||||||++|||++|+.||.......    .....        
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~~--------  228 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLI--------  228 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHH--------
Confidence                                         1124567999999999999999999986432110    00000        


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ..      ...+......++.++.+++.+||..+|.+|||+.|+++
T Consensus       229 -~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 -PR------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -hc------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             00      00011112245567899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-34  Score=270.99  Aligned_cols=225  Identities=26%  Similarity=0.417  Sum_probs=180.4

Q ss_pred             HHHhcccCCCCccEEEEEEECC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +.+.+.||+|+||.||+|..++      +..||+|.+.... ......+.+|+.+++.++||||+++++++......++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   87 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV   87 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence            4556889999999999998642      3789999987553 34456788999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          271 LEYMPKGSLENCLYSST---------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      |||+++|+|.+++....         ..+++.....++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~dfg  164 (277)
T cd05032          88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEECCcc
Confidence            99999999999886422         2467788899999999999999   78999999999999999999999999998


Q ss_pred             cCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCch
Q 036792          342 YGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       342 ~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                      ++.                           ...++.++|||||||++||++| |..||......+  ...+..       
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~-------  235 (277)
T cd05032         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVI-------  235 (277)
T ss_pred             cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHh-------
Confidence            541                           1235678999999999999998 888986432111  111110       


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                               ...  ....+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ---------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 ---------DGG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---------cCC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                     000  11123345778999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.3e-34  Score=280.70  Aligned_cols=217  Identities=22%  Similarity=0.296  Sum_probs=170.2

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+++.+ +++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36899999999999976 68899999998652   23345677888888776 799999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|..++.... .++......++.+++.|+.||   |+++|+||||||+||+++.++.+||+|||++..           
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF  156 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence            99988876543 578888899999999999999   788999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCcccccc---ccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE---LSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                    ..++.++|||||||++|||++|+.||.......   .....++            ...+...   .
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~------------~~~i~~~---~  221 (329)
T cd05618         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL------------FQVILEK---Q  221 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH------------HHHHhcC---C
Confidence                          234668999999999999999999996321111   0011111            0111111   0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ...+...+.++.+++.+||+.||++||++
T Consensus       222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            11233456678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-34  Score=280.29  Aligned_cols=217  Identities=21%  Similarity=0.284  Sum_probs=171.3

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+++.. +++.||||+++...   ......+.+|..++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999976 68999999998643   23345678899999888 699999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|.+++... ..+++.....++.|++.||.||   |+++++||||||+||+++.++.+||+|||++..           
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF  156 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence            9998887654 3688899999999999999999   899999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCcccccc---ccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE---LSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                    ..++.++|||||||++|||++|+.||+.....+   .....+.            ...+...   .
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~------------~~~~~~~---~  221 (329)
T cd05588         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL------------FQVILEK---Q  221 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH------------HHHHHcC---C
Confidence                          235678999999999999999999996321111   0011111            1111111   0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ...+...+.++.+++.+||+.||++||++
T Consensus       222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         222 IRIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11223456678999999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.9e-34  Score=276.82  Aligned_cols=215  Identities=23%  Similarity=0.337  Sum_probs=170.9

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHc-CCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKS-IRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.. +++.||||.++...   ....+.+..|..++.. .+||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999976 57899999998653   2234556778888775 5899999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++.... .+++.....++.|++.|+.||   |+++|+||||||+|||++.++.+||+|||++.            
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF  156 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence            99999887643 577888889999999999999   88999999999999999999999999998642            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|+.||......+  ....+.               ...    ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~---------------~~~----~~~  215 (316)
T cd05619         157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIR---------------MDN----PCY  215 (316)
T ss_pred             cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---------------hCC----CCC
Confidence                         1245778999999999999999999996532111  111110               000    011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChH-HHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAK-DIV  441 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~-~v~  441 (453)
                      +...+.++.+++.+||+.+|++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            223456788999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.2e-34  Score=278.62  Aligned_cols=211  Identities=25%  Similarity=0.329  Sum_probs=169.7

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.+ +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999976 68999999997542   23445677888888776 699999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++..           
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF  156 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence            99998886643 578888889999999999999   789999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                    ..++.++|||||||++|||++|+.||......+     ..+...             ...   ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~-------------~~~---~~~  215 (320)
T cd05590         157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAIL-------------NDE---VVY  215 (320)
T ss_pred             ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHh-------------cCC---CCC
Confidence                          234668999999999999999999996542211     111100             000   011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCCh
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      +...+.++.+++.+||+.||++||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            22345678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-34  Score=286.32  Aligned_cols=222  Identities=20%  Similarity=0.277  Sum_probs=171.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~   83 (382)
T cd05625           4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI   83 (382)
T ss_pred             EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence            34678999999999999865 68899999997543   234567889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.          
T Consensus        84 ~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          84 PGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            9999999887643 467777778899999999999   88899999999999999999999999998631          


Q ss_pred             --------------------------------------------------------------CCCcCcccchHHHHHHHH
Q 036792          345 --------------------------------------------------------------EGQVSTRSDIYGYGIVLM  362 (453)
Q Consensus       345 --------------------------------------------------------------~~~~~~~~Dv~S~Gvvl~  362 (453)
                                                                                    ...++.++||||+||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~  239 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  239 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence                                                                          123566899999999999


Q ss_pred             HHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC---hHH
Q 036792          363 ETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN---AKD  439 (453)
Q Consensus       363 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~~  439 (453)
                      ||++|++||......+.. .....                .......+.....++++.+++.+++ .+|++|++   ++|
T Consensus       240 elltG~~Pf~~~~~~~~~-~~i~~----------------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQ-MKVIN----------------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHhCCCCCCCCCHHHHH-HHHHc----------------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            999999999754221110 00000                0000001111223456777777765 59999997   777


Q ss_pred             HHH
Q 036792          440 IVT  442 (453)
Q Consensus       440 v~~  442 (453)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.7e-34  Score=275.03  Aligned_cols=239  Identities=21%  Similarity=0.273  Sum_probs=179.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |.+.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~   87 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   87 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence            455678999999999999876 68899999987543 2233567889999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                       ++|.+.+......+++.....++.++++||.||   |+.+++|+||||+||+++.++.++|+|||++..          
T Consensus        88 -~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          88 -KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence             589888876655678888899999999999999   889999999999999999999999999986421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC----chhhhhhhhhhcC-
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI----SLMEVVDKTLLSG-  404 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~~~~~-  404 (453)
                                      ..++.++|||||||++|||+||++||......+.  ..........    .+..+.+...... 
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCChhhchhhhcccccccc
Confidence                            1245679999999999999999999975432211  1111111111    1111111000000 


Q ss_pred             --ccCC----chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 --EKKG----FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 --~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ....    .......+..+.+|+.+|++.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              0000    0011234667899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=257.44  Aligned_cols=212  Identities=24%  Similarity=0.309  Sum_probs=176.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ++....+|.|+||.|.+.+.+ +|..+|+|++++...   +..+...+|..+|+.+.||.++++.+.|.+..+.++||||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey  125 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY  125 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence            456788999999999999977 689999999987643   4556778899999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      .+||.|..+|+..+ .++.....-++.+|+.|++||   |+..|++|||||+|||+|.+|..||.|||++.         
T Consensus       126 v~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~Tl  201 (355)
T KOG0616|consen  126 VPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTL  201 (355)
T ss_pred             cCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEEe
Confidence            99999999998866 466666777899999999999   89999999999999999999999999998752         


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++..+|.|||||++|||+.|.+||.....                 +++.++.+...    ...
T Consensus       202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----------------~~iY~KI~~~~----v~f  260 (355)
T KOG0616|consen  202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----------------IQIYEKILEGK----VKF  260 (355)
T ss_pred             cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----------------HHHHHHHHhCc----ccC
Confidence                         34567789999999999999999999975422                 23333333222    123


Q ss_pred             hHHHHHHHHHHhhhccccCcccC
Q 036792          412 KEQCVLSILGLAMECAMELPEKR  434 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~R  434 (453)
                      |...+.++.+|+...++.|-.+|
T Consensus       261 P~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  261 PSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CcccCHHHHHHHHHHHhhhhHhh
Confidence            44556678888888888888888

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.2e-35  Score=282.62  Aligned_cols=213  Identities=23%  Similarity=0.321  Sum_probs=171.5

Q ss_pred             cccCCCCccEEEEEEE----CCCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          202 NLIGMGSFGSVYRARL----RDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +.||+|+||.||+++.    .+|+.||+|+++....  .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5699999999999974    2589999999986532  234567789999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      +|+|.+.+.... .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++..          
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence            999999886543 578888999999999999999   788999999999999999999999999986421          


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ..++.++|||||||++|||++|+.||......+     ...            ......    ..
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~------------~i~~~~----~~  216 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----TMT------------MILKAK----LG  216 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----HHH------------HHHcCC----CC
Confidence                           234678999999999999999999986432111     110            000000    01


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKD  439 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  439 (453)
                      .+...+.++.+++.+||+.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12334567889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6e-34  Score=267.49  Aligned_cols=222  Identities=26%  Similarity=0.441  Sum_probs=179.7

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      ++.+.||+|+||.||++.+.++..+|+|.++.... ...+|.+|++++++++|||++++++++......++++||+++|+
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC   85 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence            44678999999999999987788999999875433 23578999999999999999999999999999999999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------  344 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------------  344 (453)
                      |.+++......+++.....++.+++.++.||   |+.+++||||||+||+++.++.++|+|||...              
T Consensus        86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05112          86 LSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK  162 (256)
T ss_pred             HHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence            9999887655678888899999999999999   78899999999999999999999999997532              


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                  ...++.++||||||+++||+++ |..||......     ......         .    .+.  ....
T Consensus       163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~---------~----~~~--~~~~  222 (256)
T cd05112         163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI---------N----AGF--RLYK  222 (256)
T ss_pred             cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH---------h----CCC--CCCC
Confidence                        1234567999999999999998 89998643211     111110         0    000  0001


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      +...+.++.+|+.+||+.+|++|||++|+++.|
T Consensus       223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            122356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.6e-34  Score=269.70  Aligned_cols=221  Identities=28%  Similarity=0.486  Sum_probs=176.7

Q ss_pred             cccCCCCccEEEEEEECC-------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLRD-------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +.||+|+||.||+|...+       +..+|||.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2679999886543 23456789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-----cEEEecccc
Q 036792          274 MPKGSLENCLYSS------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-----VAHLSDFEY  342 (453)
Q Consensus       274 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-----~~kl~df~~  342 (453)
                      +++|+|.+++...      ...+++...+.++.+++.|+.||   |+.+++|+||||+||+++.+.     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      23467888999999999999999   788999999999999999877     899999986


Q ss_pred             CC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchh
Q 036792          343 GM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLM  394 (453)
Q Consensus       343 ~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  394 (453)
                      ..                           .+.++.++|||||||++|||+| |..||......  .....+..       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~-------  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTA-------  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhc-------
Confidence            42                           1245678999999999999998 99998643211  11111100       


Q ss_pred             hhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       395 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                               .  .....+...+..+.+++.+||+.+|++||+++++.+.|+
T Consensus       229 ---------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ---------G--GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---------C--CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                     0  011122345678899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-34  Score=287.35  Aligned_cols=223  Identities=21%  Similarity=0.264  Sum_probs=173.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+++.. +++.||||.+....   ....+.+.+|+++|++++||||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            345678999999999999965 68999999997542   22346688999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .++......++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.         
T Consensus        83 ~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          83 IPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            99999999987644 467777778899999999999   78999999999999999999999999999741         


Q ss_pred             -----------------------------------------------------------CCCcCcccchHHHHHHHHHHH
Q 036792          345 -----------------------------------------------------------EGQVSTRSDIYGYGIVLMETF  365 (453)
Q Consensus       345 -----------------------------------------------------------~~~~~~~~Dv~S~Gvvl~el~  365 (453)
                                                                                 ...++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                                       012456899999999999999


Q ss_pred             hCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCC---ChHHHHH
Q 036792          366 TRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRI---NAKDIVT  442 (453)
Q Consensus       366 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---s~~~v~~  442 (453)
                      +|+.||......+...  .+...               ......+.....+.++.+++.+|+ .+|++|+   ++.|+++
T Consensus       239 ~G~~Pf~~~~~~~~~~--~i~~~---------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         239 VGQPPFLADTPAETQL--KVINW---------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hCCCCCCCCCHHHHHH--HHhcc---------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999997543211100  00000               000000111234556777888876 4999999   8888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=284.95  Aligned_cols=223  Identities=24%  Similarity=0.363  Sum_probs=178.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|+.. +++.||||+++...   ......+.+|++++..++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            45678999999999999976 68999999997543   234567889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++|+|.+++... ..++......++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++..         
T Consensus        84 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          84 PGGDLMNLLIRK-DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999998765 4678888889999999999999   789999999999999999999999999986421         


Q ss_pred             ---------------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCcccccccc
Q 036792          346 ---------------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELS  380 (453)
Q Consensus       346 ---------------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  380 (453)
                                                                   ..++.++|||||||++|||++|+.||......+. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-  238 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH-
Confidence                                                         1346689999999999999999999865421110 


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC-hHHHHHH
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN-AKDIVTR  443 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~~v~~~  443 (453)
                         + .        .+..    .......+.....++++.+++.+|+. +|++||+ ++|+++.
T Consensus       239 ---~-~--------~i~~----~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 ---Y-N--------KIIN----WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ---H-H--------HHhc----cCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence               0 0        0000    00000011111246778999999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-33  Score=265.05  Aligned_cols=222  Identities=26%  Similarity=0.353  Sum_probs=181.8

Q ss_pred             HHHhcccCCCCccEEEEEEECC-CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +++.+.||+|+||.||+|..+. +..+|+|.++....  .+.+.+|++++++++||||+++++++..+...++++||+++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            5667889999999999999774 89999999875533  57899999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ++|.+++......+++.....++.+++.|+.||   |+.+++|+||+|+||+++.++.++|+|||.+.            
T Consensus        83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence            999999977666789999999999999999999   78899999999999999999999999997532            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|+.||........    ...          +..    ........
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~~----------~~~----~~~~~~~~  221 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IFM----------IPN----KPPPTLSD  221 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hhh----------hcc----CCCCCCCc
Confidence                         12345689999999999999999999864322110    000          000    00011112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +...+.++.+++.+||+.+|++|||++|++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            3345567899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-33  Score=266.90  Aligned_cols=226  Identities=23%  Similarity=0.283  Sum_probs=179.1

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      -+.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            4677789999999999999865 689999999986655555678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++.... .++......++.+++.|+.||   |+.+++|+||||+||+++.++.++|+|||.+.           
T Consensus        90 ~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06645          90 GGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS  165 (267)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence            999999886544 578889999999999999999   78899999999999999999999999997531           


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++|||||||++|||++|..||........ ..........        +       .
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~--------~-------~  229 (267)
T cd06645         166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQ--------P-------P  229 (267)
T ss_pred             ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCC--------C-------C
Confidence                             12255689999999999999999999854321110 0000000000        0       0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......++..+.+++.+||+.+|++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00011124456889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.5e-34  Score=278.49  Aligned_cols=223  Identities=22%  Similarity=0.289  Sum_probs=174.3

Q ss_pred             HHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc----hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC----ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  269 (453)
                      ++.+.||+|+||.||+++..    +++.||+|+++...    ....+.+.+|++++..+ +||||+++++++..++..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            45678999999999999753    57899999997542    23345678899999999 58999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ||||+++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..    
T Consensus        83 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          83 ILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            999999999999887643 577888889999999999999   789999999999999999999999999986421    


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++|||||||++|||+||+.||....... ......             ..+.
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~-------------~~~~  224 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVS-------------RRIL  224 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHH-------------HHHh
Confidence                                   124568999999999999999999986431111 011111             1111


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ..   ....+...+.++.+++.+||+.||++||     +++++++
T Consensus       225 ~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         225 KC---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             cC---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            10   0112233456788999999999999999     6667754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.2e-34  Score=279.02  Aligned_cols=212  Identities=29%  Similarity=0.325  Sum_probs=167.7

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHH-HHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCE-VMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.. +|+.||||++.....   .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36899999999999976 689999999975432   22344555554 56789999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|..++.... .++......++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++..           
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence            99998887643 577888888999999999999   788999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                    ..++.++|||||||++|||++|..||......     +..            +......    ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~------------~~i~~~~----~~~  215 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMY------------DNILNKP----LRL  215 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHH------------HHHHcCC----CCC
Confidence                          23567899999999999999999998653211     111            1111100    011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAK  438 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~  438 (453)
                      +...+.++.+++.+|++.+|++||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            123456789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-33  Score=268.82  Aligned_cols=222  Identities=23%  Similarity=0.303  Sum_probs=180.1

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..+...+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++||||+++++++..++..++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45667788999999999999865 68899999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++++|.+++..  ..+++.....++.++++|+.||   |+++++|+||+|+||++++++.++++|||++.         
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            999999988864  3577888889999999999999   88999999999999999999999999997542         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|..|+.......  ...+.            ..    .  ..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~------------~~----~--~~  218 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLI------------PK----N--SP  218 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhh------------hc----C--CC
Confidence                            1234668999999999999999999986432111  00000            00    0  01


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......++.++.+++.+||+.+|++||++.|++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            1122345667899999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=264.65  Aligned_cols=231  Identities=27%  Similarity=0.406  Sum_probs=177.8

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHH--cCCCCCceeEEeEEecCC----eeEEEEec
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMK--SIRHPNLVKVISSCSNDD----FKALVLEY  273 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~lv~E~  273 (453)
                      +.+.||+|.||.||+|+|+ |+.||||++...   +...+.+|.++..  .++|+||..|+++-..+.    .+|||++|
T Consensus       215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY  290 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY  290 (513)
T ss_pred             EEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence            3678999999999999997 889999999643   2356778888765  469999999998755433    57999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCceeeCCCCcEEEeccccCCCC--
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-----GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEG--  346 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~-----~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~--  346 (453)
                      .+.|||+++|..  ..++....++++..+|.||++||.     .-++.|.|||||+.|||+..++.+-|+|+|++...  
T Consensus       291 He~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~  368 (513)
T KOG2052|consen  291 HEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  368 (513)
T ss_pred             ccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence            999999999987  368889999999999999999985     23567999999999999999999999999986321  


Q ss_pred             -----------CcC----------------------cccchHHHHHHHHHHHhCC----------CCCCccccccccHHh
Q 036792          347 -----------QVS----------------------TRSDIYGYGIVLMETFTRK----------KPTDRMFVEELSLKD  383 (453)
Q Consensus       347 -----------~~~----------------------~~~Dv~S~Gvvl~el~tg~----------~p~~~~~~~~~~~~~  383 (453)
                                 ++.                      ..+||||||.|+||++.+.          .||.+....+-+   
T Consensus       369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs---  445 (513)
T KOG2052|consen  369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS---  445 (513)
T ss_pred             cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC---
Confidence                       111                      1489999999999997753          455544333322   


Q ss_pred             HHhhhcCCchhhhhhhhhhcC---ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          384 WVNNLLPISLMEVVDKTLLSG---EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       384 ~~~~~~~~~~~~~~d~~~~~~---~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                               ..++.+-.....   ..+.......+...+.++|..||..+|..|-|+=-+-+.|.++.
T Consensus       446 ---------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  446 ---------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             ---------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence                     222222222111   11122344567788999999999999999999988888888776

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.1e-34  Score=266.17  Aligned_cols=222  Identities=20%  Similarity=0.285  Sum_probs=178.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.+++.++|||++++.+++.+++..+++|||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            45678999999999999876 6899999998643 334556788999999999999999999999999999999999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      |+|.+++... ...++......++.+++.|+.||   |+.+++|+||||+||++++++.++++|||...           
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            9999888653 34577888889999999999999   88999999999999999999999999997542           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|+||||+++|||++|..||......     .....            .. .+.  ..+
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~------------~~-~~~--~~~  219 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILK------------VC-QGS--YKP  219 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHH------------Hh-cCC--CCC
Confidence                          123466899999999999999999998643211     11100            00 000  011


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .+...+..+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            223455678999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-33  Score=268.05  Aligned_cols=237  Identities=20%  Similarity=0.316  Sum_probs=184.1

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..+++.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            34677889999999999999865 68999999887543 34457889999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .+++.....++.+++.++.|||  +..+++||||||+||++++++.++|+|||+..         
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT  161 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence            99999998876543 5788888999999999999995  23579999999999999999999999998542         


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++||++||..||+.....+..      ...+..+.+.++...... ... .
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~-~~~-~  233 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGILDLLQQIVQEP-PPR-L  233 (284)
T ss_pred             cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhHHHHHHHHHhhcc-CCC-C
Confidence                          124467899999999999999999999754322110      000111112222211111 011 1


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ....++.++.+++.+||+.+|++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            112366789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-33  Score=274.93  Aligned_cols=231  Identities=26%  Similarity=0.454  Sum_probs=183.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  265 (453)
                      ..+.+.+.||+|+||.||++...        ++..||+|.++... ....+++.+|+++++++ +||||++++++|..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            34567889999999999999742        12479999887543 33457889999999999 7999999999999999


Q ss_pred             eeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          266 FKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ..++++||+++|+|.+++....               ..+++...+.++.|+++|+.||   |+++++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEc
Confidence            9999999999999999986421               2467888899999999999999   789999999999999999


Q ss_pred             CCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||++.                           ...++.++|||||||++|||++ |..||.....+     
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence            99999999997642                           1234568999999999999998 88888643211     


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      .+...         +.    ...  ....+..++.++.+++.+||+.+|++||++.|++..|+++..
T Consensus       244 ~~~~~---------~~----~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 ELFKL---------LK----EGH--RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHH---------HH----cCC--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            11111         00    000  111223456688999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-33  Score=270.95  Aligned_cols=240  Identities=22%  Similarity=0.271  Sum_probs=172.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC--CCCEEEEEEeeccch--hhHHHHHHHHHHHHcC---CCCCceeEEeEEec-----CC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR--DGIEVAVKVFHQECA--RALKSFEAQCEVMKSI---RHPNLVKVISSCSN-----DD  265 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~  265 (453)
                      |++.+.||+|+||.||+|+..  ++..||||.++....  .....+.+|+.+++.+   +||||++++++|..     ..
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            456678999999999999863  468899999875432  2234566777776655   69999999999853     45


Q ss_pred             eeEEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          266 FKALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                      ..++||||++ ++|.+++... ...+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||.+.
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            6899999996 5898888653 34578888999999999999999   88999999999999999999999999997542


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---cCCchhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---LPISLMEVV  397 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  397 (453)
                                              ...++.++|||||||++|||++|++||......+ .+.......   .+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhchhhh
Confidence                                    1245678999999999999999999997543221 111111111   000110000


Q ss_pred             ---hhhhhcCcc-CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 ---DKTLLSGEK-KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 ---d~~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ......... +........+..+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence               000000000 000111235567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-34  Score=278.16  Aligned_cols=224  Identities=22%  Similarity=0.290  Sum_probs=186.6

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe-eEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF-KALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~E  272 (453)
                      .|...+++|+|+||.++..+++ ++..+++|.+....  ........+|+.++++++|||||.+.+.|..++. .+||||
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            3567889999999999999877 57899999997553  3344567889999999999999999999998887 999999


Q ss_pred             ccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          273 YMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+||++.+.+...+ ..++......++.|+..|+.||   |+++|+|||||+.||++..+..+||.|||++.       
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999887654 5677788889999999999999   79999999999999999999999999997652       


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...|+.|+||||+||++|||++-+++|......+                 .+.+.....  
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----------------Li~ki~~~~--  222 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----------------LILKINRGL--  222 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----------------HHHHHhhcc--
Confidence                              3467899999999999999999999997542221                 111111111  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                       ..+.+...+.++..++..|+..+|+.||++.+++..
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             123455677889999999999999999999999876

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=263.95  Aligned_cols=226  Identities=27%  Similarity=0.348  Sum_probs=182.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +++.+.+|+|+||.||+|... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+++
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~   84 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG   84 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence            345678999999999999875 5789999999876555668899999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ++|.+++......++......++.+++.|+.||   |+.+++|+||+|+||++++++.++|+|||++.            
T Consensus        85 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  161 (262)
T cd06613          85 GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF  161 (262)
T ss_pred             CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence            999998877645688888999999999999999   78899999999999999999999999997431            


Q ss_pred             -------------CC---CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 -------------EG---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 -------------~~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                   ..   .++.++||||||+++|||+||+.||.......... .......               ....
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~---------------~~~~  225 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNF---------------PPPK  225 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccC---------------CCcc
Confidence                         11   45667999999999999999999986432111100 0000000               0001


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......+.++.+++.+||..+|.+|||+++++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1122345677999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6e-34  Score=291.48  Aligned_cols=225  Identities=23%  Similarity=0.311  Sum_probs=178.7

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-------
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-------  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------  265 (453)
                      ..|++.+.||+|+||.||+|+.. +|+.||||.+....  ......+.+|+.++..++|+|++++.+.+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            34567889999999999999865 78999999997543  344567889999999999999999988765432       


Q ss_pred             -eeEEEEeccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          266 -FKALVLEYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       266 -~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                       ..++||||+++|+|.+++...   ...++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence             368999999999999988653   24577888889999999999999   88999999999999999999999999998


Q ss_pred             cCC---------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchh
Q 036792          342 YGM---------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM  394 (453)
Q Consensus       342 ~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  394 (453)
                      ++.                           ...++.++|||||||++|||++|+.||.....     ..           
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~-----------  252 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EE-----------  252 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HH-----------
Confidence            642                           12357789999999999999999999964321     11           


Q ss_pred             hhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       395 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                       +++..+...   ..+.+..+++++.+++.+||+.+|++||++.++++.
T Consensus       253 -~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        253 -VMHKTLAGR---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -HHHHHhcCC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             111111110   111234566789999999999999999999998753

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-33  Score=266.61  Aligned_cols=224  Identities=20%  Similarity=0.336  Sum_probs=167.2

Q ss_pred             ccCCCCccEEEEEEECCC---CEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          203 LIGMGSFGSVYRARLRDG---IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .||+|+||.||+|...++   ..+++|.++... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   356677766443 3445789999999999999999999999999999999999999999


Q ss_pred             chHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          279 LENCLYSST---CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       279 L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      |.+++....   ...+......++.++++||.||   |+.+++||||||+|||++.++.++|+|||++..          
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999987532   2345566778899999999999   788999999999999999999999999986421          


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ..++.++|||||||++|||++ +..||......+     ..............++ 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~-  232 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-----VLNHVIKDQQVKLFKP-  232 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhhcccccCCC-
Confidence                                    012457999999999999997 466775432111     1111000000011111 


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                               ......++.+.+++..|| .+|++||+++|+++.|.
T Consensus       233 ---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 ---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                     111123456788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.8e-34  Score=276.60  Aligned_cols=215  Identities=28%  Similarity=0.319  Sum_probs=167.4

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHH-HHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCE-VMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.. +++.||+|++.....   .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36899999999999976 578999999975431   22234444444 56789999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|.+.+.... .+.......++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++..           
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999887644 456667778899999999999   889999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                    ..++.++||||+||++|||++|..||......+     ....        +....        ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~--------i~~~~--------~~~  215 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDN--------ILNKP--------LQL  215 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHH--------HHhCC--------cCC
Confidence                          235678999999999999999999996432111     1110        00000        011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                      ....+.++.+++.+|++.+|.+||++.+.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            223456788999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=265.21  Aligned_cols=222  Identities=22%  Similarity=0.326  Sum_probs=177.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-----ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +.+.+.||+|+||.||++... +++.||+|.+....     ....+.+.+|++++++++||||+++++++..++..++|+
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            356788999999999999865 68999999986432     123457889999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++++|.+.+.... .++......++.+++.|+.||   |+.+++||||+|+||+++.++.++|+|||.+..      
T Consensus        84 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          84 EYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            9999999999887543 467788889999999999999   889999999999999999999999999986421      


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                            ..++.++||||||+++||+++|+.||......+    ....             ....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~-------------~~~~  222 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----AIFK-------------IATQ  222 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----HHHH-------------Hhcc
Confidence                                  124567999999999999999999986431110    0000             0000


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .  .....+..++.++.+++.+||..+|.+|||+.|+++
T Consensus       223 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         223 P--TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             C--CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            0  011223345667899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.8e-33  Score=271.32  Aligned_cols=228  Identities=24%  Similarity=0.447  Sum_probs=180.4

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCC----EEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGI----EVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +..+.||+|+||.||+|.+. +|.    .||+|.+..... ....++.+|+.+++.++||||++++|+|..+ ..++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e   88 (303)
T cd05110          10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ   88 (303)
T ss_pred             eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence            45678999999999999864 443    578998875432 3345788999999999999999999998764 4679999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++......+++.....++.+++.|+.||   |+++|+||||||+||+++.++.+||+|||++..       
T Consensus        89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            9999999999887665688888999999999999999   889999999999999999999999999976521       


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ..++.++|||||||++||+++ |..||.+....+  ...+...                .
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~----------------~  227 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEK----------------G  227 (303)
T ss_pred             cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHC----------------C
Confidence                                223567999999999999998 888986532111  1111110                0


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .  ..+.+..++..+.+++..||..+|++||+++++++.|+++.++
T Consensus       228 ~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         228 E--RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0  0111233556789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.9e-34  Score=275.73  Aligned_cols=214  Identities=21%  Similarity=0.275  Sum_probs=170.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCC-CceeEEeEEecCCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHP-NLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|.+++..++|+ +|+++.+++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            45678999999999999876 57899999997642   23456788899999999765 688899999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|+|.+.+.... .+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++..        
T Consensus        83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          83 VNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            99999998886543 577888889999999999999   788999999999999999999999999986421        


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                       ..++.++||||+||++|||+||+.||......+.     ...        +    .. .   .
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-----~~~--------i----~~-~---~  217 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----FQS--------I----ME-H---N  217 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHH--------H----Hc-C---C
Confidence                             2356789999999999999999999975422110     000        0    00 0   0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ...+...+.++.+++.+||+.+|++|++.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            01122345678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-33  Score=279.94  Aligned_cols=234  Identities=18%  Similarity=0.211  Sum_probs=174.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      |.+.+.||+|+||.||++... +++.||+|....      ..+.+|++++++++|||||++++++..+...++|+|++. 
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            566788999999999999865 689999997532      356789999999999999999999999999999999995 


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ++|..++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.            
T Consensus       167 ~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        167 TDLYCYLAAKR-NIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence            68888876543 578888999999999999999   78899999999999999999999999998652            


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccc------ccccHHhHHhhh--cC----Cc----hh
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFV------EELSLKDWVNNL--LP----IS----LM  394 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~------~~~~~~~~~~~~--~~----~~----~~  394 (453)
                                    ...++.++|||||||++|||+||..|+.....      ....+...+...  .+    ..    ..
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence                          12356789999999999999999988643211      011111111111  01    00    01


Q ss_pred             hhhhhhhh---cCc--cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 EVVDKTLL---SGE--KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 ~~~d~~~~---~~~--~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.......   ...  ..........+.++.+|+.+||+.||++|||++|+++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            11100000   000  0011112245678999999999999999999999974

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.5e-34  Score=280.45  Aligned_cols=225  Identities=21%  Similarity=0.283  Sum_probs=174.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+++.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            3566788999999999999976 58899999997532   2234567889999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++...  .++......++.+++.||.||   |+++|+||||||+|||++.++.+||+|||++..       
T Consensus       124 y~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         124 YMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            99999999988654  367778888999999999999   789999999999999999999999999986421       


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++||||+||++|||++|+.||......+. ..            .+.+.   
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-~~------------~i~~~---  262 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-YS------------KIMDH---  262 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-HH------------HHHhC---
Confidence                                   1156789999999999999999999965321110 00            11110   


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCccc--CCChHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEK--RINAKDIVTR  443 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~~v~~~  443 (453)
                       ......+.....+..+.+++..|+..+|.+  ||++.|+++.
T Consensus       263 -~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         263 -KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             000011111234566788889999865543  8899998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.5e-33  Score=267.67  Aligned_cols=226  Identities=22%  Similarity=0.382  Sum_probs=180.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++...||+|+||.||+|+.+      +...||+|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (275)
T cd05046           7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI   86 (275)
T ss_pred             ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence            345677999999999999864      2467999988765443 457899999999999999999999999998999999


Q ss_pred             EeccCCCCchHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc
Q 036792          271 LEYMPKGSLENCLYSST--------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                      |||+++|+|.+++....        ..+++..+..++.+++.++.||   |+.+++||||||+||+++.++.++++||++
T Consensus        87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccccc
Confidence            99999999999986543        1578999999999999999999   888999999999999999999999999976


Q ss_pred             CCC--------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          343 GME--------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       343 ~~~--------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                      ...                          ...+.++||||||+++||+++ |..||......     ..+.....     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~~~~~~~-----  233 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQA-----  233 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HHHHHHHc-----
Confidence            421                          234567999999999999999 77888543211     11110000     


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                              +. ...+.+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       234 --------~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 --------GK-LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --------CC-cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                    00 001112345668999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-33  Score=265.59  Aligned_cols=224  Identities=25%  Similarity=0.419  Sum_probs=180.0

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||++...++..+|+|.++... ...+.+.+|++++++++|+||+++.+++.. ...+++|||+++|
T Consensus         8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~   85 (260)
T cd05073           8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKG   85 (260)
T ss_pred             eeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence            45678899999999999998777889999887543 234678999999999999999999999887 6789999999999


Q ss_pred             CchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          278 SLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       278 ~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      +|.+++... ....++..+..++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||.+..           
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (260)
T cd05073          86 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  162 (260)
T ss_pred             cHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence            999998763 34577888899999999999999   788999999999999999999999999975321           


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ..++.++|+|||||++||++| |..||......  ....+.....                  ..
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~------------------~~  222 (260)
T cd05073         163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY------------------RM  222 (260)
T ss_pred             CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCC------------------CC
Confidence                           224568999999999999999 89998643211  1111111100                  01


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      +.+...+.++.+++.+||+.+|++||++.++...|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1123445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-33  Score=297.75  Aligned_cols=231  Identities=23%  Similarity=0.313  Sum_probs=180.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....++|.+|++++++++||||+++++++.+++..+++|||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            355688999999999999976 68999999997542   23356799999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC
Q 036792          274 MPKGSLENCLYSS----------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       274 ~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      +++|+|.+++...          ....++...+.++.++++||+||   |+.+|+||||||+||+++.++.++|+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999988531          12345567788999999999999   7889999999999999999999999999864


Q ss_pred             CC-------------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCcccccccc
Q 036792          344 ME-------------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELS  380 (453)
Q Consensus       344 ~~-------------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  380 (453)
                      ..                                           ..++.++|||||||++|||+||..||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            21                                           12456789999999999999999998653211110


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCC-ChHHHHHHHHHHHH
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRI-NAKDIVTRLLKIRD  449 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~  449 (453)
                      ..   . .       ..++.       ........++.+.+++.+|++.+|++|| +++++.+.|++...
T Consensus       241 ~~---~-~-------i~~P~-------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        241 YR---D-V-------ILSPI-------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh---h-h-------ccChh-------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00   0 0       00000       0001124566788999999999999995 67778888877644

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.3e-34  Score=277.77  Aligned_cols=215  Identities=28%  Similarity=0.341  Sum_probs=168.9

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHH-HHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCE-VMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36899999999999865 68999999997542   223345556655 46789999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|...+.... .++......++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++..           
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99988876543 578888889999999999999   789999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                    ..++.++|||||||++|||++|..||......+                 +.+..+...    ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----------------~~~~~~~~~----~~~  215 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----------------MYDNILHKP----LVL  215 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----------------HHHHHHcCC----ccC
Confidence                          235678999999999999999999986432111                 111111100    001


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                      ....+.++.+++.+|++.+|.+||++++.+
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            123455678999999999999999886443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-33  Score=271.00  Aligned_cols=224  Identities=23%  Similarity=0.285  Sum_probs=180.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            34566788999999999999964 78999999997665555577889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++++|.+++...  .+++.....++.+++.++.||   |+.+++||||||+||+++.++.++|+|||++.          
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            999999988653  467888899999999999999   78899999999999999999999999997542          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++|||||||++||+++|+.||........... .                .. ...+..
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~----------------~~-~~~~~~  235 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I----------------AT-NGTPEL  235 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-e----------------cc-CCCCCC
Confidence                           12345679999999999999999999864321110000 0                00 000011


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...+..+.+++.+||..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            122344566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-33  Score=265.76  Aligned_cols=219  Identities=24%  Similarity=0.340  Sum_probs=175.3

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      +...||+|+||.||+|... +++.||+|.+.....         ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            4578999999999999865 688999998864321         123568899999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      ++||+++++|.+++.... .++......++.+++.|++||   |+.+++||||+|+||++++++.++|+|||++.     
T Consensus        84 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          84 FLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             EEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            999999999999987643 577788889999999999999   78899999999999999999999999997531     


Q ss_pred             --------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          345 --------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       345 --------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                                                ...++.++|||||||++|||++|+.||......    ....         ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~---------~~~~  226 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIF---------KIGE  226 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHH---------HHhc
Confidence                                      112456799999999999999999998643111    0000         0000


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             ......+...+..+.+++.+||+.+|.+||++.|+++
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 -------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                   0011122345677899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.3e-33  Score=269.15  Aligned_cols=223  Identities=25%  Similarity=0.329  Sum_probs=178.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .++..+.||+|+||.||+|... +++.||+|.+....   ....+++.+|+++++.++|||++++.++|..++..++|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            3667789999999999999875 68999999986432   2344678899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |++ |++.+.+......+++.....++.|++.|+.||   |+.+++||||+|+||++++++.++|+|||...        
T Consensus        96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~  171 (307)
T cd06607          96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF  171 (307)
T ss_pred             hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence            997 577777765555688999999999999999999   78899999999999999999999999997541        


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++||||||+++|||+||+.||.......  ......                ... ..
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~----------------~~~-~~  232 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA----------------QND-SP  232 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHh----------------cCC-CC
Confidence                            1235678999999999999999999986432111  000000                000 01


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......++.++.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            1112346678999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-33  Score=280.64  Aligned_cols=237  Identities=23%  Similarity=0.295  Sum_probs=176.4

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-----eeEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-----FKALV  270 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv  270 (453)
                      ++.+.||+|+||.||++... +++.||||.+....  ....+++.+|+++++.++||||+++++++..++     ..++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            45678999999999999965 78999999986532  234567889999999999999999999998876     78999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      +||+. ++|.+.+.... .+++.....++.|++.||.||   |+.+++||||||+|||++.++.+||+|||++..     
T Consensus        83 ~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          83 TELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            99996 58887775543 578888999999999999999   889999999999999999999999999986421     


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC-chhhh------
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI-SLMEV------  396 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~------  396 (453)
                                            ..++.++|||||||++|||++|+.||......+  ....+...... ...+.      
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHhhHH
Confidence                                  125678999999999999999999997543211  11111111110 00000      


Q ss_pred             hhhhhhcCccCCc------hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGF------VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+........      ......++++.+|+.+||+.||++|||++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            0000100000000      011233567899999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=295.04  Aligned_cols=227  Identities=28%  Similarity=0.470  Sum_probs=190.6

Q ss_pred             HHhcccCCCCccEEEEEEEC----C----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeE
Q 036792          199 RLSNLIGMGSFGSVYRARLR----D----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  268 (453)
                      .+.+.+|+|.||.|++|...    .    ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|...+..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            45679999999999999743    1    3579999998653 35667899999999998 5999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          269 LVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                      +|+||++.|+|.++|+..+               ..+.....+.++.|||.||+||   ++.+++||||.++|||+..+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEEecCCC
Confidence            9999999999999998766               3478888999999999999999   899999999999999999999


Q ss_pred             cEEEeccccCCC----------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhH
Q 036792          334 VAHLSDFEYGME----------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDW  384 (453)
Q Consensus       334 ~~kl~df~~~~~----------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~  384 (453)
                      .+||+|||++..                            ..|+.|+|||||||+|||++| |..|+.+.....      
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~------  529 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE------  529 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH------
Confidence            999999987631                            256889999999999999999 778886532111      


Q ss_pred             HhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          385 VNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       385 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                                +++. .+  ..+.+...|..|+.++.++|+.||+.+|++||++.++.+.++..
T Consensus       530 ----------~l~~-~l--~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  530 ----------ELLE-FL--KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ----------HHHH-HH--hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                      1111 11  22334556788999999999999999999999999999999885

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.8e-33  Score=268.85  Aligned_cols=222  Identities=20%  Similarity=0.282  Sum_probs=175.0

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+.||+|+||.||+|... +++.||+|.+.....   .....+.+|+++|++++|+|++++.+++..++..+++|||+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            467999999999999865 689999999875432   2334578899999999999999999999999999999999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      |+|.+++... ...+++.....++.|++.|+.||   |+++|+||||||+||++++++.++|+|||++.           
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            9999888653 33688999999999999999999   88999999999999999999999999998652           


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|+|||||++||+++|..||....... ....             ++.......   ...
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-------------~~~~~~~~~---~~~  224 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-------------VDRRVLETE---EVY  224 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-------------HHHhhhccc---ccc
Confidence                         1235678999999999999999999996432111 0111             111111100   011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      +...+.++.+|+.+||+.+|++||+     +++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            2334567889999999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-33  Score=268.45  Aligned_cols=239  Identities=24%  Similarity=0.282  Sum_probs=176.4

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||+|..+ ++..||||.++...  ....+.+.+|+.+++.++|||++++++++..++..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            34578999999999999976 68999999986542  2234678889999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          276 KGSLENCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                       ++|.+++....  ..++......++.|+++||.||   |+.+++||||||+||+++.++.++|+|||++.         
T Consensus        83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence             68888875432  4678888999999999999999   78999999999999999999999999997531         


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-C-Cc----hhhhhh--h
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-P-IS----LMEVVD--K  399 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~----~~~~~d--~  399 (453)
                                       ...++.++|||||||++|||+||++||......+. ......... + ..    ....-+  .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhHHHHh
Confidence                             01246679999999999999999999875322111 111111000 0 00    000000  0


Q ss_pred             hhhc-CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 TLLS-GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .... ............++++.+++.+||+.||++|||+++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000 000000111235677889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.3e-33  Score=266.18  Aligned_cols=225  Identities=21%  Similarity=0.326  Sum_probs=174.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++.++||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++..++..++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            55678999999999999864 68999999987553 33456789999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|..+.     .+++.....++.+++.|+.||   |+.+|+|+||||+||+++.++.++|+|||++.            
T Consensus        84 ~~l~~~~-----~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (279)
T cd06619          84 GSLDVYR-----KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG  155 (279)
T ss_pred             CChHHhh-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCC
Confidence            9986542     356777788999999999999   78999999999999999999999999998642            


Q ss_pred             -----------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          345 -----------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       345 -----------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                 ...++.++||||||+++|||++|+.||...........       +....+.+...   . . ......
T Consensus       156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~~~~~~~~~~~---~-~-~~~~~~  223 (279)
T cd06619         156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------PLQLLQCIVDE---D-P-PVLPVG  223 (279)
T ss_pred             ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------hHHHHHHHhcc---C-C-CCCCCC
Confidence                       12356789999999999999999999865322111100       00000000000   0 0 000112


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ..++++.+++.+||+.+|++||+++|+++.
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            234578999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.2e-33  Score=270.20  Aligned_cols=238  Identities=20%  Similarity=0.279  Sum_probs=180.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||++.+. ++..+|+|.++... .....++.+|++++.+++||||+++++++..++..++||||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            345678999999999999866 68899999987553 3344678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+++... ..++......++.++++||.||   |+ .+++||||||+||+++.++.+||+|||+..          
T Consensus        83 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (308)
T cd06615          83 GGSLDQVLKKA-GRIPENILGKISIAVLRGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  158 (308)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence            99999998765 3577888889999999999999   54 589999999999999999999999997542          


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC---------------------
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP---------------------  390 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------------  390 (453)
                                   ...++.++|||||||++|||++|+.||......  ....+......                     
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP  236 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCCccch
Confidence                         123566899999999999999999998643211  11111110000                     


Q ss_pred             CchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          391 ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       391 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ....+..+..... ..+.. .....+.++.+++.+||..+|++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         237 MAIFELLDYIVNE-PPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hhHHHHHHHHhcC-CCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011111111111 00000 111245678999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-33  Score=263.51  Aligned_cols=222  Identities=30%  Similarity=0.509  Sum_probs=178.3

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.++++++|||++++++++..+ ..+++|||+++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            45678899999999999975 57889999986543  346789999999999999999999998765 468999999999


Q ss_pred             CchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          278 SLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       278 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      +|.+++.... ..+++.....++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||.+.            
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP  160 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence            9999987643 3578888899999999999999   78999999999999999999999999997542            


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                ...++.++|||||||++|||++ |+.||......+     ..         +.+....      ....+.
T Consensus       161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~---------~~~~~~~------~~~~~~  220 (254)
T cd05083         161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VK---------ECVEKGY------RMEPPE  220 (254)
T ss_pred             ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HH---------HHHhCCC------CCCCCC
Confidence                      1345668999999999999998 899986442211     11         1111100      111223


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      .++.++.+++.+||+.+|++||++++++..|++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            456788999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1e-33  Score=275.27  Aligned_cols=212  Identities=26%  Similarity=0.309  Sum_probs=166.6

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHH-HHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCE-VMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|+.. +++.||+|++.....   .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999976 689999999975432   22344555554 57889999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|...+.... .+.......++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++..           
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence            99988876543 466777788999999999999   788999999999999999999999999986421           


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                    ..++.++|||||||++|||++|..||......     ....            .... .   ....
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~------------~i~~-~---~~~~  215 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYD------------NILH-K---PLQL  215 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHH------------HHhc-C---CCCC
Confidence                          23567899999999999999999998643211     1111            1110 0   0111


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAK  438 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~  438 (453)
                      +...+.++.+++.+|++.+|.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            223455788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-33  Score=264.21  Aligned_cols=222  Identities=20%  Similarity=0.317  Sum_probs=176.8

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccc------hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC------ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+.+.||+|+||.||+|...+++.+|||.++...      ......+.+|++++++++|+||+++++++.+.+..++++|
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence            3467899999999999998889999999987432      1233568899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++++|.+++.... .+++.....++.+++.|++||   |+.+++|+||+|+||++++++.++|+|||....       
T Consensus        83 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          83 FVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            999999999987643 567888888999999999999   788999999999999999999999999975321       


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                              ..++.++|||||||++||+++|..||......+. ......               
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~---------------  222 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGA---------------  222 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhh---------------
Confidence                                    1246789999999999999999999864311110 000000               


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ........+...+.++.+++.+||+.+|++||++.|++.
T Consensus       223 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 --HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              000011122345667899999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.9e-33  Score=270.26  Aligned_cols=222  Identities=25%  Similarity=0.312  Sum_probs=179.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +++.+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            345678999999999999864 7899999999766555567889999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ++|.+++...  .+++..+..++.+++.++.||   |+.+++||||||+||+++.++.++|+|||+..            
T Consensus       101 ~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655         101 GSLTDVVTET--CMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence            9999988653  478899999999999999999   88899999999999999999999999997532            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++||+++|+.||......+. ......                 ........
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~-----------------~~~~~~~~  237 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT-----------------NGTPELQN  237 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-----------------cCCcccCC
Confidence                         12356789999999999999999999865322110 000000                 00001112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +..++..+.+++.+||..+|++||++.+++.
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            2345667889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-33  Score=274.22  Aligned_cols=214  Identities=20%  Similarity=0.267  Sum_probs=170.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ++.+.||+|+||.||+|+.+ +++.||||.++....   ...+.+..|..++..+ +|++|+++.+++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            34678999999999999876 578999999986532   2334567788888776 589999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|+|.+.+.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++..        
T Consensus        83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          83 VNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            99999998886543 578888899999999999999   788999999999999999999999999986421        


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                       ..++.++|||||||++|||+||+.||......+  +.               .......    
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~---------------~~i~~~~----  217 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LF---------------QSIMEHN----  217 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HH---------------HHHHhCC----
Confidence                             235678999999999999999999997542211  10               0000000    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ...+...+.++.+++.+|++.+|++|++.
T Consensus       218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            01123355678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-33  Score=265.12  Aligned_cols=226  Identities=26%  Similarity=0.453  Sum_probs=176.5

Q ss_pred             HHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------e
Q 036792          199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------F  266 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~  266 (453)
                      .+.+.||+|+||.||+|.++    +++.||||.+..+.  ....+++.+|++++++++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            35678999999999999854    36899999987543  334567899999999999999999999886532      2


Q ss_pred             eEEEEeccCCCCchHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          267 KALVLEYMPKGSLENCLYSS-----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      .++++||+++|+|.+++...     ...+++.....++.+++.|++||   |+.+|+||||||+||+++.++.+|++|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEEEcCCCCEEECccc
Confidence            47889999999998877432     22467888899999999999999   78899999999999999999999999998


Q ss_pred             cCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCch
Q 036792          342 YGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       342 ~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                      ++..                           ..++.++|||||||++|||++ |++||......  ....+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~-----  231 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIKG-----  231 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHcC-----
Confidence            6421                           123567999999999999999 88888643221  111111100     


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                                 .  ....+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       232 -----------~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 -----------N--RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----------C--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       0  0011123456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.5e-33  Score=273.18  Aligned_cols=218  Identities=22%  Similarity=0.281  Sum_probs=171.4

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+++.. +++.||+|+++....   ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999976 678999999986532   3345678899999888 699999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|...+.... .+++.....++.+++.|+.||   |+++|+||||||+|||++.++.+||+|||++.            
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF  156 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence            99988776543 588889999999999999999   78999999999999999999999999998542            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccc-ccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE-LSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                   ...++.++|||||||++|||++|..||....... .....+.            ...+...   ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~------------~~~~~~~---~~~  221 (327)
T cd05617         157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL------------FQVILEK---PIR  221 (327)
T ss_pred             cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH------------HHHHHhC---CCC
Confidence                         1235678999999999999999999996432111 1111111            1111111   011


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAK  438 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  438 (453)
                      .+...+..+.+++.+||+.||++||+++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            2233456788999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-33  Score=261.39  Aligned_cols=221  Identities=21%  Similarity=0.303  Sum_probs=179.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||++... +|+.||+|.+....  ....+++.+|+.++++++||||+++.+++...+..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            45678999999999999865 68999999987542  3344678999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +++|.+.+... ...+++.....++.+++.|+.||   |+.+++|+||+|+||+++.++.++++|||+..          
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            99999988654 33578888899999999999999   78899999999999999999999999997542          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++|||||||+++|+++|+.||.....                 .+.++..+...   ..
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------------~~~~~~~~~~~---~~  219 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----------------KNLVLKIIRGS---YP  219 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----------------HHHHHHHhcCC---CC
Confidence                           12346689999999999999999999853211                 11111111111   11


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.+...+.++.+++.+||+.+|++||++.|++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            123455677999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.1e-33  Score=269.05  Aligned_cols=225  Identities=20%  Similarity=0.249  Sum_probs=177.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            44578999999999999976 57899999987653   233467889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .+++.....++.++++|+.||   |+.+++||||||+||+++.++.++++|||+..          
T Consensus        84 ~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          84 EGGDCATLLKNIG-ALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999999997654 577888888899999999999   78899999999999999999999999998642          


Q ss_pred             ------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchh
Q 036792          345 ------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM  394 (453)
Q Consensus       345 ------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  394 (453)
                                                    ...++.++|+|||||++||+++|..||.+....     ++..        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~--------  226 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFG--------  226 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--------
Confidence                                          123466899999999999999999998643221     1111        


Q ss_pred             hhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       395 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                          .... ...........++.++.+++.+||+.+|++||++.++.+.|+
T Consensus       227 ----~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         227 ----QVIS-DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ----HHHh-cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                0000 000001111245667899999999999999999766655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-33  Score=278.02  Aligned_cols=225  Identities=21%  Similarity=0.262  Sum_probs=174.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      -+++.+.||+|+||.||+++.+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  123 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            4566788999999999999976 68899999987532   2234567889999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++...  .++......++.+++.||.||   |+++|+||||||+|||++.++.+||+|||++..       
T Consensus       124 y~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         124 YMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            99999999988654  367777788899999999999   889999999999999999999999999986410       


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++|||||||++|||++|+.||.......                 .....+.
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----------------~~~~i~~  261 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----------------TYSKIMN  261 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHc
Confidence                                   115678999999999999999999997532110                 0011110


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCccc--CCChHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEK--RINAKDIVTR  443 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~~v~~~  443 (453)
                      .......+.....+.++.+++..|+..++.+  ||+++|+++.
T Consensus       262 ~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            0000011122345667889999999844433  7788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.7e-33  Score=260.36  Aligned_cols=222  Identities=21%  Similarity=0.296  Sum_probs=179.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +..+.||+|+||.||.++.. ++..+++|.+....  ....+.+.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            44678999999999999854 68999999987542  3445678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|+|.+++... ...+++.....++.++++++.||   |+.+++|+||+|+||+++.++.+||+|||....         
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999998764 44678888999999999999999   788999999999999999999999999975321         


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                      ..++.++||||||+++|||++|..||......     +..            ..... +.  ..
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~------------~~~~~-~~--~~  219 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLV------------VKIVQ-GN--YT  219 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHH------------HHHHc-CC--CC
Confidence                            13466799999999999999999998643111     111            11110 00  11


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      +.+...+.++.+++.+||..+|++||+++|+++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1223456678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-33  Score=262.65  Aligned_cols=220  Identities=24%  Similarity=0.316  Sum_probs=178.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++...||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            456678999999999999976 68999999987553 3445678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++...  .+++.....++.+++.++.||   |+.+++|+||+|+||++++++.++++|||.+.           
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            99999988764  678899999999999999999   78899999999999999999999999997531           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||+||+.||......+  ......               . ..  ...
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~---------------~-~~--~~~  217 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIP---------------K-NN--PPS  217 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhh---------------h-cC--CCC
Confidence                          1235678999999999999999999986432111  000000               0 00  000


Q ss_pred             hhHH-HHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQ-CVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.. .+.++.+++.+||..+|++|||++++++
T Consensus       218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111 5667899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=262.60  Aligned_cols=228  Identities=23%  Similarity=0.327  Sum_probs=192.2

Q ss_pred             cHHHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          193 SQATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       193 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      .....+.+.++||+|+||.||++.++ .|+.+|||.+..+  .+.++..+|+.+|.+.+.|++|+++|.+.....+||||
T Consensus        30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            45667788999999999999999987 6999999998765  34688999999999999999999999988888999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      |||..|++.+.++.+...+.......+..+.++||+||   |...-+|||||+.|||++.+|.+|++|||.+.       
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999999999998888898888888999999999999   56667999999999999999999999998652       


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        .-.|+.++||||+|++..||..|++||.+......                ++  .+-..+.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IF--MIPT~PP  246 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IF--MIPTKPP  246 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eE--eccCCCC
Confidence                              12478899999999999999999999875422110                00  0011223


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      +.+..++.++.++-+++..|+...|++|-|+.++++.
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            3345678899999999999999999999999887653

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.5e-33  Score=260.30  Aligned_cols=222  Identities=30%  Similarity=0.587  Sum_probs=179.5

Q ss_pred             HhcccCCCCccEEEEEEECC-----CCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          200 LSNLIGMGSFGSVYRARLRD-----GIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +.+.||+|+||.||++...+     +..||+|.++..... ..+.+.+|++.+..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45789999999999998753     388999999765433 567899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          274 MPKGSLENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      +++++|.+++...... +++.....++.+++.++.||   |+.+++|+||||+||++++++.++++|||+..        
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999998765433 88999999999999999999   88999999999999999999999999997652        


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                        ...++.++||||+|++++||++ |.+||......  ...+.+..                ..
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~----------------~~  221 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKK----------------GY  221 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhc----------------CC
Confidence                              1234668999999999999998 78887642111  11111100                00


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                        ....+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 --RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              1112233667899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-33  Score=284.07  Aligned_cols=236  Identities=22%  Similarity=0.299  Sum_probs=169.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--------CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSND--------DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~  268 (453)
                      |++.+.||+|+||.||+|... +++.||||++....    ....+|+.+|+.++|||||++.+++...        ...+
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            556788999999999999975 68999999886432    2345799999999999999999876432        2467


Q ss_pred             EEEeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC
Q 036792          269 LVLEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~  344 (453)
                      +||||+++ +|.+++..   ....+++.....++.|++.||.||   |+.+|+||||||+|||++.++ .+||+|||++.
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            99999975 67666642   334678888889999999999999   788999999999999998654 79999998652


Q ss_pred             -------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC-chhhhh
Q 036792          345 -------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI-SLMEVV  397 (453)
Q Consensus       345 -------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~~~  397 (453)
                                               ...++.++|||||||++|||++|.+||.+....+. +........ +. ......
T Consensus       220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~p~~~~~~~~  298 (440)
T PTZ00036        220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVLGTPTEDQLKEM  298 (440)
T ss_pred             hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHh
Confidence                                     12367789999999999999999999975432211 111111110 00 000000


Q ss_pred             hhhhhc-------CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLS-------GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~-------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+....       ........+...+.++.+|+.+||.++|.+|||+.|+++
T Consensus       299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000000       000000122335678999999999999999999999883

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5e-33  Score=265.48  Aligned_cols=238  Identities=21%  Similarity=0.263  Sum_probs=177.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++...||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|++++++++|||++++++++..+...++||||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            44577999999999999976 689999999865432  233567899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      ++.|..+.... ..+++.....++.+++.+|.||   |+.+++||||||+||+++.++.++|+|||+...          
T Consensus        84 ~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          84 HTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            98887766543 3578999999999999999999   789999999999999999999999999975421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---chhhhhhhh-----h
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SLMEVVDKT-----L  401 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~-----~  401 (453)
                                      ..++.++|||||||++|||++|+.||.+....+. ..... .....   ...+..+..     .
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIR-KTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH-HHhCCCChHHhhhcccccccccc
Confidence                            2245689999999999999999999975432211 11110 00000   000000000     0


Q ss_pred             -hcCccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 -LSGEKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 -~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ........   ......+..+.+++.+||+.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             00000000   011233567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.6e-33  Score=267.59  Aligned_cols=239  Identities=22%  Similarity=0.285  Sum_probs=178.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh-----hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR-----ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ++.+.||+|+||.||+|... +++.||||.++.....     ....+..|++++++++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            34567999999999999976 6899999999755322     23567789999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+ +|+|.+++......+++.....++.|+++||.||   |+.+++|+||||+||+++.++.++|+|||+..        
T Consensus        83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            99 8999999876554688999999999999999999   88899999999999999999999999997542        


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC--chh---hhhhhh
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI--SLM---EVVDKT  400 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~---~~~d~~  400 (453)
                                        ...++.++|||||||++|||++|.+||......+ .+........ +.  ...   ...+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccccccc
Confidence                              1134567999999999999999988876432211 1111111100 00  000   000000


Q ss_pred             hhcC--ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSG--EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....  ...........+.++.+++.+||+.+|++|||++|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0000  00000111234678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=272.67  Aligned_cols=226  Identities=18%  Similarity=0.202  Sum_probs=173.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+++.. +++.||+|+++...   ....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            345678999999999999976 68999999997532   22345688999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|+|.+++......++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++..        
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999976555678888888999999999999   899999999999999999999999999986310        


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++|||||||++|||++|+.||......+     ....        +    ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~--------i----~~  222 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGK--------I----MN  222 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHH--------H----Hc
Confidence                                   124567999999999999999999986432111     1100        0    00


Q ss_pred             cCc-cCCchhhHHHHHHHHHHhhhcccc--CcccCCChHHHHHH
Q 036792          403 SGE-KKGFVAKEQCVLSILGLAMECAME--LPEKRINAKDIVTR  443 (453)
Q Consensus       403 ~~~-~~~~~~~~~~~~~~~~l~~~Cl~~--~P~~RPs~~~v~~~  443 (453)
                      ... ..........+.++.+++.+|+..  ++..||+++++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         223 HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000 000111123456778888886654  34447899888754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-33  Score=278.98  Aligned_cols=221  Identities=20%  Similarity=0.276  Sum_probs=170.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||++..+ +++.||||+++...   ......+.+|+.++..++||||+++++.+.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~   83 (360)
T cd05627           4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL   83 (360)
T ss_pred             eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            34578999999999999876 68999999997542   233467888999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.... .++......++.+++.||.||   |+++|+||||||+|||++.++.++|+|||++.          
T Consensus        84 ~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          84 PGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             CCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            9999999887644 577888888999999999999   88999999999999999999999999998642          


Q ss_pred             --------------------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 036792          345 --------------------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRM  374 (453)
Q Consensus       345 --------------------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  374 (453)
                                                                        ...++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                                              123566899999999999999999999654


Q ss_pred             ccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC---hHHHH
Q 036792          375 FVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN---AKDIV  441 (453)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~~v~  441 (453)
                      ...+.     ..            ...........+.....+.++.+++.+|+ .+|.+|++   ++|++
T Consensus       240 ~~~~~-----~~------------~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         240 TPQET-----YR------------KVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             CHHHH-----HH------------HHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence            22111     00            00000000000011123456778888866 49999985   55554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.4e-34  Score=252.81  Aligned_cols=221  Identities=24%  Similarity=0.378  Sum_probs=180.6

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--------hhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEE
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--------RALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  270 (453)
                      .+.+|.|..+.|.++.++ +|.++|+|++.....        ...++-.+|+.+|+++ .||+|+++.+++.++.+.++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            577999999999999866 789999999964321        2245667899999998 599999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      +|.|+.|.|.++|.+.- .++......|+.++..|+.||   |.+.|+||||||+|||+|+++++||+|||++.      
T Consensus       102 Fdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge  177 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE  177 (411)
T ss_pred             hhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEeccceeeccCCch
Confidence            99999999999998754 678888899999999999999   89999999999999999999999999997652      


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ...|+..+|+||+||++|-++.|.+||...       ++.+       +..++   
T Consensus       178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQml-------MLR~I---  240 (411)
T KOG0599|consen  178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQML-------MLRMI---  240 (411)
T ss_pred             hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHH-------HHHHH---
Confidence                                    245788899999999999999999998532       0000       00111   


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.+....+.+...+.+.++.+|+.+|++.||.+|.|++|+++
T Consensus       241 meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  241 MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            111111233445677888999999999999999999999875

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.2e-33  Score=267.12  Aligned_cols=223  Identities=20%  Similarity=0.276  Sum_probs=175.8

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+.||+|+||.||++... +++.||||.+.....   .....+.+|+.++++++|+|++.+.+.+.+.+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            4567999999999999866 689999999875422   223457789999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+.+... ...++......++.|++.|+.||   |+.+|+||||||+||++++++.++|+|||++.          
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999888543 23578888899999999999999   78999999999999999999999999998642          


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|+.||....... .... ..        ...+...       ..
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~-~~--------~~~~~~~-------~~  223 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE-VE--------RLVKEVQ-------EE  223 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH-HH--------hhhhhhh-------hh
Confidence                          1235678999999999999999999997532110 0000 00        0000000       01


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      .+...+.++.+|+..||+.||++|||     ++|+++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            12334567899999999999999999     778775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-32  Score=259.92  Aligned_cols=227  Identities=22%  Similarity=0.289  Sum_probs=181.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +..+.||+|+||.||++..+ +++.||+|.+.... ....+++.+|++++++++||||+++++.+..++..++++||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            45678999999999999976 68999999987654 34456789999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      ++|.+++......++......++.+++.++.||   |+ .+++|+||||+||+++.++.++|+|||...           
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (265)
T cd06605          84 GSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV  160 (265)
T ss_pred             CcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhccc
Confidence            999999876545678888889999999999999   78 899999999999999999999999997532           


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                  ...++.++||||||+++||+++|+.||...........            +.++..... .... ...
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~~-~~~~-~~~  226 (265)
T cd06605         161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF------------ELLQYIVNE-PPPR-LPS  226 (265)
T ss_pred             CChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH------------HHHHHHhcC-CCCC-CCh
Confidence                        13456789999999999999999999865421111111            111111110 0000 011


Q ss_pred             HHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+.++.+++.+||..+|++|||+.+++.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            126677999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=261.40  Aligned_cols=221  Identities=21%  Similarity=0.346  Sum_probs=177.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCC---CCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIR---HPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      |++.+.||+|+||.||+|.+. ++..||+|.++... ....+++.+|++++++++   |||++++++++..++..++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            566788999999999999964 68999999987542 344567889999999987   9999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++++|.+++...  .+++.....++.+++.|+.||   |+.+++|+||+|+||+++.++.++++|||++.        
T Consensus        83 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          83 YAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             cCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            99999999988654  578888999999999999999   78999999999999999999999999997431        


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...++.++|||||||++|||++|..||......     ......         ..    .. 
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~---------~~----~~-  218 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLI---------PK----SK-  218 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhcc---------cc----CC-
Confidence                              112467899999999999999999998643211     111000         00    00 


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .........+.++.+++.+||+.+|++||++.|++.
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            000001124567899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3e-33  Score=266.92  Aligned_cols=240  Identities=21%  Similarity=0.226  Sum_probs=176.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||+|... +|..||+|.++....  .....+.+|++++++++||||+++++++.+.+..++++||++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            34578999999999999976 689999999875422  223567889999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                       ++|.+++......+++.....++.|+++|+.||   |+++++||||||+||+++.++.++|+|||.+..          
T Consensus        83 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          83 -QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence             588888766555688999999999999999999   788999999999999999999999999974321          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc------hhhhhhhhhhc
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS------LMEVVDKTLLS  403 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~~~~~  403 (453)
                                      ..++.++|||||||++|||+||..|+.........+...........      +.+..+.....
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence                            12467899999999999999999886432111111111111000000      00000100000


Q ss_pred             CccCC---chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKG---FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....   .......+.++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000   0111235678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.7e-33  Score=265.91  Aligned_cols=225  Identities=22%  Similarity=0.292  Sum_probs=179.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..+.....||+|+||.||++... ++..||||.+........+.+.+|+..++.++||||+++++.+..++..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34444677999999999999865 68999999987665555677899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++++|.+++...  .+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||+..          
T Consensus       102 ~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         102 EGGALTDIVTHT--RMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence            999999887543  478888999999999999999   78899999999999999999999999998542          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++||||||+++||+++|+.||....... .... ....        ...        ..
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-~~~~--------~~~--------~~  238 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR-IRDN--------LPP--------RV  238 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhc--------CCC--------cc
Confidence                           1235678999999999999999999986431110 0000 0000        000        00


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ......+..+.+++.+||..+|++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1112334568889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-32  Score=260.42  Aligned_cols=226  Identities=19%  Similarity=0.356  Sum_probs=176.1

Q ss_pred             HHHhcccCCCCccEEEEEEECC--CCEEEEEEeeccc----------hhhHHHHHHHHHHHHc-CCCCCceeEEeEEecC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD--GIEVAVKVFHQEC----------ARALKSFEAQCEVMKS-IRHPNLVKVISSCSND  264 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~  264 (453)
                      |.+.+.||+|+||.||+|....  +..+|+|.+....          .....++.+|+.++.+ ++||||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            3456789999999999999764  6889999886321          2234567788888865 7999999999999999


Q ss_pred             CeeEEEEeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEecc
Q 036792          265 DFKALVLEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDF  340 (453)
Q Consensus       265 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df  340 (453)
                      +..+++|||+++++|.+++..   ....++......++.+++.++.||   |+ .+++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL---HKEKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHh---ccCCceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999988743   344678888999999999999999   64 78999999999999999999999999


Q ss_pred             ccCC------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          341 EYGM------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       341 ~~~~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                      |.+.                        ...++.++||||||+++||+++|+.||.....     ......        +
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~--------~  225 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATK--------I  225 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHH--------H
Confidence            7542                        12356789999999999999999999853211     111100        0


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      .+...      ........+.++.+++.+||+.+|++||++.|+..+++
T Consensus       226 ~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAVY------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhccC------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            00000      00011234567899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-32  Score=259.98  Aligned_cols=223  Identities=28%  Similarity=0.406  Sum_probs=178.4

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+.+.||+|+||.||+|... +++.||+|.++....  ...+.+.+|+++++.++|+||+++++++...+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            45678999999999999865 689999999976544  356789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      +++|.+++.... .+++.....++.++++|+.||   |+.+++|+||+|+||++++++.+||+|||+...          
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          83 GGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            999999887653 467888889999999999999   788999999999999999999999999974321          


Q ss_pred             -------------------C---CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 -------------------G---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 -------------------~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                         .   ..+.++||||||+++||+++|..||...... ........                .
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~----------------~  221 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVG----------------A  221 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHh----------------c
Confidence                               1   1466799999999999999999998643111 00000000                0


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......+....++..+.+++.+||+.+|++|||+.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111112234667889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.8e-33  Score=273.72  Aligned_cols=236  Identities=20%  Similarity=0.210  Sum_probs=172.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~  268 (453)
                      |++.+.||+|+||.||++... +|..||||.+....  ......+.+|+.+++.++||||+++++++...+      ..+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  102 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY  102 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence            456788999999999999875 68999999997542  234567889999999999999999999986543      478


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+++ +|.+.+..   .++......++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++.    
T Consensus       103 lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         103 LVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             EEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            99999975 56665543   367777888999999999999   88999999999999999999999999998652    


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh-------h
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV-------V  397 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~  397 (453)
                                          ...++.++|||||||++|||++|+.||......+ .+...... ......+.       +
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~  253 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQ-LGTPSAEFMNRLQPTV  253 (359)
T ss_pred             CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCCcHHHHHHHHHHH
Confidence                                1245678999999999999999999997542211 11111111 00000000       0


Q ss_pred             hhhhhcCcc-C---------------CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLSGEK-K---------------GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~~~~-~---------------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......... .               ........+.++.+|+.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000000 0               00011123467899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-32  Score=261.20  Aligned_cols=225  Identities=24%  Similarity=0.374  Sum_probs=175.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch----------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCee
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA----------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  267 (453)
                      .+.+.||+|+||.||+|... +|+.||+|.++....          ...+.+.+|+.+++.++|||++++++++..++..
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   83 (272)
T cd06629           4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL   83 (272)
T ss_pred             eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence            34678999999999999865 689999998863211          1235678899999999999999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--  345 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--  345 (453)
                      ++||||+++|+|.+.+... ..+++.....++.+++.++.||   |+.+++||||+|+||+++.++.++++|||....  
T Consensus        84 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          84 SIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             EEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            9999999999999988765 3678888888999999999999   788999999999999999999999999975421  


Q ss_pred             ---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          346 ---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       346 ---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                                                 ..++.++||||||+++||+++|..||......    ..+..         ...
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~---------~~~  226 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFK---------LGN  226 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHH---------hhc
Confidence                                       12466799999999999999999998532111    11110         000


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...  ...........++.++.+++.+||..+|++||+++++++
T Consensus       227 ~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         227 KRS--APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ccc--CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000  000001112245678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=275.73  Aligned_cols=224  Identities=25%  Similarity=0.337  Sum_probs=183.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ..+.-...||.|+||.||.|+.. +.+.||||++.-..   .+..+++.+|+..|.+++|||+|.+.|+|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            33444567999999999999954 78999999997543   345678899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC--------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------  343 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~--------  343 (453)
                      |||- |+-.+.+.-...++.......|..++++||.||   |+.+.||||||+.|||+++.+.||++|||.+        
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns  181 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS  181 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence            9995 588888877767788888889999999999999   8888999999999999999999999999753        


Q ss_pred             ----------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          344 ----------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       344 ----------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      ..+.|+.|+||||+||+..|+..+++|.-.+.....    .            .  .+...+. 
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA----L------------Y--HIAQNes-  242 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----L------------Y--HIAQNES-  242 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH----H------------H--HHHhcCC-
Confidence                            136789999999999999999999999644321110    0            0  0111111 


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.....+++..+..++..|++.-|.+|||.+++++
T Consensus       243 PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            12234678889999999999999999999998765

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.6e-32  Score=263.95  Aligned_cols=225  Identities=26%  Similarity=0.343  Sum_probs=179.3

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+...+.||+|+||.||++... ++..||+|.+....   .+..+.+.+|++++++++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3566788999999999999965 68999999987432   2344678899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |++ |++.+.+......+++.....++.+++.|+.||   |+.+++||||+|+||+++.++.++|+|||+..        
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF  181 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence            996 588887766556688999999999999999999   78899999999999999999999999997431        


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      .+.++.++|||||||++|||++|+.||....... ....+..                 ... .
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~-----------------~~~-~  242 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ-----------------NES-P  242 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHh-----------------ccC-C
Confidence                            1345678999999999999999999985431110 0001110                 000 0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      .......+..+.+++.+||+.+|.+||++.++++.+
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            111234556789999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-32  Score=259.67  Aligned_cols=224  Identities=23%  Similarity=0.319  Sum_probs=181.1

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ...++..+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            355677888999999999999865 68999999886443 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++...  .+++.....++.+++.++.||   |+.+++|+||+|+||+++.++.++++|||++.        
T Consensus        83 ~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          83 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            99999999988653  478888999999999999999   88999999999999999999999999997541        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++|||||||++||+++|..||......     .....         +.    ...  
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~---------~~----~~~--  217 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL---------IP----KNN--  217 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH---------Hh----cCC--
Confidence                             123456799999999999999999998643211     11100         00    000  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ........+.++.+++.+||..+|.+||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111223456678999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-32  Score=258.04  Aligned_cols=222  Identities=23%  Similarity=0.338  Sum_probs=176.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||++..+ +++.||+|.+....  ....+.+.+|++++++++|+|++++.+.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            345678999999999999865 57899999997543  2345678899999999999999999998764 4467899999


Q ss_pred             cCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          274 MPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      +++++|.+++... ...+++.+...++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||+..        
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            9999999988763 34578899999999999999999   88999999999999999999999999997541        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++||||||++++|+++|+.||......     ......            .. +.  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~------------~~-~~--  218 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRI------------IE-GK--  218 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHH------------Hh-cC--
Confidence                             123466899999999999999999998643211     111000            00 00  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+...++++.+++.+||+.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            01122345567899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-32  Score=265.02  Aligned_cols=223  Identities=23%  Similarity=0.289  Sum_probs=178.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .++....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++++||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3445567999999999999865 689999999976554555678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++...  .+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||+..           
T Consensus       102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99999877553  478888999999999999999   88899999999999999999999999997531           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|+.||......+  ..........                ....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~----------------~~~~  238 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDSPP----------------PKLK  238 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhccCC----------------CCcc
Confidence                          1235678999999999999999999986432111  1111100000                0001


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+..+.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            11233456889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-32  Score=261.59  Aligned_cols=236  Identities=21%  Similarity=0.252  Sum_probs=175.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCC-CCCceeEEeEEecC--CeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIR-HPNLVKVISSCSND--DFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~E~  273 (453)
                      ++.+.||+|+||.||+|... ++..||+|.++.... .......+|+..+.++. |+|++++++++.++  +..++|+||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            34678999999999999865 689999999875422 22234557888898885 99999999999987  889999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ++ |++.+.+......+++.....++.++++||.||   |+.+++||||+|+||+++. +.+||+|||++.         
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            97 588888876555789999999999999999999   7889999999999999999 999999997542         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc--
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK--  406 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~--  406 (453)
                                      ...++.++|||||||++|||++|.+||......+  ...+..........+. .........  
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEV-LKKFRKSRHMN  233 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHH-HHhhccccccc
Confidence                            1224668999999999999999999997542211  1111111111111100 000000000  


Q ss_pred             ---------CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 ---------KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ---------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                               .........+.++.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                     000112345788999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=253.58  Aligned_cols=226  Identities=21%  Similarity=0.332  Sum_probs=178.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ..+++.+.||+|.|+.||++.+. +|+.+|+|++...  .....+++.+|+++-+.++|||||++...+.+....++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            45788899999999999999865 7999999988644  33466889999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC-----
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM-----  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~-----  344 (453)
                      +|.||+|..-+-.+ -..+....-..+.|++.++.|.   |.++|+|||+||+|+|+.+   ...+|++|||++.     
T Consensus        91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            99999996544322 1233445566788999999998   9999999999999999954   4578999997642     


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...|+..+|||+.||+||-++.|.+||.+...+                 ++....+....
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----------------rlye~I~~g~y  229 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----------------RLYEQIKAGAY  229 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----------------HHHHHHhcccc
Confidence                               235778899999999999999999999753211                 11222222222


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+.+.....++++.+|+.+|+..||++|.|+.|.++
T Consensus       230 d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2223344566788999999999999999999999764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-32  Score=267.21  Aligned_cols=244  Identities=23%  Similarity=0.314  Sum_probs=179.4

Q ss_pred             cccCCC--CccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMG--SFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ..||+|  +||+||++++. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999975 79999999987542  33457788999999999999999999999999999999999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC------------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------------  343 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~------------  343 (453)
                      |+|.+++... ...+++.....++.|++.||.||   |+++++||||||+||+++.++.++++||+..            
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999988753 23477888889999999999999   7899999999999999999999999998411            


Q ss_pred             ----------------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---------cCCc
Q 036792          344 ----------------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---------LPIS  392 (453)
Q Consensus       344 ----------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~  392 (453)
                                            ....++.++|||||||++|||++|+.||.......... ......         .+..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL-QKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH-HHhcCCCCCCccccccchh
Confidence                                  00124678999999999999999999997543221111 110000         0000


Q ss_pred             hhhhh-----------hhhh-------hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH--HHHHHHH
Q 036792          393 LMEVV-----------DKTL-------LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT--RLLKIRD  449 (453)
Q Consensus       393 ~~~~~-----------d~~~-------~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~  449 (453)
                      .....           +...       ........+....++.++.+|+.+||+.||++|||+.|+++  .+..+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            00000           0000       00001112234457788999999999999999999999974  3444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-32  Score=258.21  Aligned_cols=221  Identities=25%  Similarity=0.361  Sum_probs=177.0

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||++... +++.+|||.+....  ....+.+.+|++++++++|||++++++.+..++..++|+||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            44578999999999999865 68999999987542  3345688999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCC---------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGM---------  344 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~---------  344 (453)
                      +++|.+++... ...+++.....++.++++++.||   |+++++|+||+|+||+++.+ ..+|++|||...         
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999764 33578888999999999999999   88999999999999999864 568999997542         


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++||||||+++|||++|+.||.......     ...            ......   ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~------------~~~~~~---~~  219 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVL------------KIMSGT---FA  219 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHH------------HHHhcC---CC
Confidence                           1234668999999999999999999986432111     110            000000   11


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.+..++.++.+++.+||+.+|++|||++|+++
T Consensus       220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            122345677899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-33  Score=264.44  Aligned_cols=241  Identities=22%  Similarity=0.252  Sum_probs=176.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            345678999999999999976 689999999875432 223456789999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      + +|.+++......+++.....++.++++||.||   |+.+++||||||+||+++.++.+||+|||++..          
T Consensus        87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            5 99998876655678888899999999999999   788999999999999999999999999985421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc---CCchhhhhhh---hhhc
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL---PISLMEVVDK---TLLS  403 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~---~~~~  403 (453)
                                      ..++.++||||+||++|||++|+.||.........+........   +.......+.   ....
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence                            12466799999999999999999999654311111111111000   0000000000   0000


Q ss_pred             C-ccCCchh---hHHH--HHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 G-EKKGFVA---KEQC--VLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~-~~~~~~~---~~~~--~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      . .......   ....  ..++.+++.+|++.+|++|||+.|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0 0000000   0011  256789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.6e-33  Score=270.43  Aligned_cols=225  Identities=17%  Similarity=0.207  Sum_probs=174.1

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+++.+ +++.||+|.+.+..   ......+.+|+.++..++|+||+++++++.+++..++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            45678999999999999976 57899999997532   223345788999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++......++......++.|++.|+.||   |+.+|+||||||+|||++.++.+||+|||++.          
T Consensus        84 ~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999977555678888888999999999999   78999999999999999999999999998531          


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ...++.++|||||||++|||++|+.||......+     ...            .....
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~------------~i~~~  223 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYG------------KIMNH  223 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHH------------HHhCC
Confidence                                 0135668999999999999999999996432111     111            00000


Q ss_pred             Ccc-CCchhhHHHHHHHHHHhhhccccCcc--cCCChHHHHHH
Q 036792          404 GEK-KGFVAKEQCVLSILGLAMECAMELPE--KRINAKDIVTR  443 (453)
Q Consensus       404 ~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~--~RPs~~~v~~~  443 (453)
                      ... ........++.++.+++.+|+..+|.  .|++++|+++.
T Consensus       224 ~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         224 KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000 01111234567788899998765444  46889888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.9e-32  Score=259.64  Aligned_cols=223  Identities=26%  Similarity=0.347  Sum_probs=182.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++..+.+|+|+||.||+|.++ ++..||+|.+..... ..+.+.+|++.++.++|+|++++++++..++..++++||+++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            456688999999999999977 689999999976544 456788999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ++|.+++......+++.....++.+++.|+.||   |+.+++|+||+|+||+++.++.++|+|||+..            
T Consensus       100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614         100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence            999999987655688999999999999999999   78999999999999999999999999997431            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|+.||....... ......                 .........
T Consensus       177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~-----------------~~~~~~~~~  238 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLIT-----------------TKGIPPLKN  238 (286)
T ss_pred             cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-----------------hcCCCCCcc
Confidence                         1235678999999999999999999986431111 000000                 000011112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...++.++.+++.+||+.+|.+||++.+++.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2336678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-32  Score=257.12  Aligned_cols=224  Identities=28%  Similarity=0.392  Sum_probs=178.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEECC-CCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ...++...||.|.-|+||+++.++ +..+|+|++.+...   +...+.+.|.+||+.++||.++++++.+..++..|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            445778889999999999999874 68999999987753   33456778999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          272 EYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      |||+||+|...++.. ...++.....-.+..++-||+||   |-.|||.|||||+|||+-++|++.|+||.+..      
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999887653 34566677777788999999999   89999999999999999999999999994320      


Q ss_pred             ---------------------------------------------------------------------------CCCcC
Q 036792          345 ---------------------------------------------------------------------------EGQVS  349 (453)
Q Consensus       345 ---------------------------------------------------------------------------~~~~~  349 (453)
                                                                                                 +...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                                                                       01123


Q ss_pred             cccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhcccc
Q 036792          350 TRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAME  429 (453)
Q Consensus       350 ~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  429 (453)
                      ..+|.|+|||++|||+.|+.||.+...++.             +..++...+      .++.....+..+.+|+.+.|.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------------l~NIv~~~l------~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------------LRNIVGQPL------KFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhh-------------HHHHhcCCC------cCCCCCcchhHHHHHHHHHhcc
Confidence            468999999999999999999987644331             122222221      1122235667899999999999


Q ss_pred             CcccCCC----hHHHH
Q 036792          430 LPEKRIN----AKDIV  441 (453)
Q Consensus       430 ~P~~RPs----~~~v~  441 (453)
                      ||.+|-.    +.||-
T Consensus       375 dP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIK  390 (459)
T ss_pred             ChhhhhccccchHHhh
Confidence            9999987    66653

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.5e-33  Score=269.83  Aligned_cols=213  Identities=21%  Similarity=0.270  Sum_probs=169.9

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEecc
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..+.||+|+||.||+|+.+ +|+.||+|+++...   ....+.+..|..++..+. |++|+++.+++.+.+..++||||+
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~   83 (323)
T cd05615           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYV   83 (323)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCC
Confidence            4578999999999999876 68999999997643   233456778888888875 577888999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++|+|.+++.... .+++.....++.+++.|+.||   |+++|+||||||+|||++.++.+||+|||++..         
T Consensus        84 ~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          84 NGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            9999998886543 578889999999999999999   788999999999999999999999999986421         


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                      ..++.++|||||||++|||++|+.||.......     ...            ......    .
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~------------~i~~~~----~  218 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-----LFQ------------SIMEHN----V  218 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHH------------HHHhCC----C
Confidence                            235678999999999999999999997542211     111            000000    0


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ..+...+.++.+++.+||+.+|++|++.
T Consensus       219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            1123345678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-33  Score=271.63  Aligned_cols=238  Identities=21%  Similarity=0.216  Sum_probs=173.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecC------Cee
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFK  267 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~  267 (453)
                      .|++.+.||+|+||.||+|... ++..||||.+.....  ...+.+.+|++++++++||||+++++++...      ...
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            3567789999999999999865 688999999875432  2345678899999999999999999887543      346


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--  345 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--  345 (453)
                      ++++|++ +++|.+++...  .++......++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++..  
T Consensus        96 ~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          96 YLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            8999988 77998877543  478888999999999999999   788999999999999999999999999986421  


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh-----
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK-----  399 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-----  399 (453)
                                           ..++.++|||||||++|||++|+.||......+ .+..+.... .....+....     
T Consensus       170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~  247 (343)
T cd07878         170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVV-GTPSPEVLKKISSEH  247 (343)
T ss_pred             CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHh-CCCCHHHHHhcchhh
Confidence                                 235678999999999999999999986532111 111111111 0000010000     


Q ss_pred             ---hhhcCccCCc----hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 ---TLLSGEKKGF----VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ---~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..........    .......+.+.+|+.+|+..||++|||++|++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000000000    001123456789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-32  Score=258.32  Aligned_cols=220  Identities=21%  Similarity=0.319  Sum_probs=170.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-----ARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALV  270 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv  270 (453)
                      +..+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+  ++..+++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            45678999999999999865 68999999886432     2334578899999999999999999998875  4678899


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      +||+++++|.+.+.... .+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||++..     
T Consensus        85 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          85 MEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            99999999999887644 477888889999999999999   788999999999999999999999999986421     


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++|||||||++||+++|+.||......+    ..             .....
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~-------------~~~~~  223 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AI-------------FKIAT  223 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HH-------------HHHhc
Confidence                                   124568999999999999999999986431110    00             00000


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..  .....+...++.+.+++ +||..+|++||+|+|+++
T Consensus       224 ~~--~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 QP--TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC--CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            00  01112233445566666 788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-32  Score=261.22  Aligned_cols=224  Identities=21%  Similarity=0.297  Sum_probs=175.7

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEec------CCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSN------DDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~  267 (453)
                      ..+++.+.+|+|+||.||+|... +++.||+|.+..... ...++..|+.++.++ +|||++++++++..      .+..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            55677889999999999999975 689999999865432 335688899999988 69999999999853      4578


Q ss_pred             EEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--
Q 036792          268 ALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--  344 (453)
                      +++|||+++|+|.+++... ...++......++.|++.|+.||   |+.+++|+|+||+||++++++.++|+|||++.  
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            9999999999999988653 33577777888999999999999   78899999999999999999999999997541  


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                                                  ...++.++|||||||++|||++|..||........    ..         . 
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----~~---------~-  237 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----LF---------L-  237 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----hh---------h-
Confidence                                        12345679999999999999999999864321100    00         0 


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +...     .........++.++.+++.+||..+|.+||++.|+++
T Consensus       238 ~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 IPRN-----PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HhhC-----CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0000     0011112345678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.7e-32  Score=260.81  Aligned_cols=219  Identities=23%  Similarity=0.287  Sum_probs=177.0

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      .+.||+|++|.||++... +++.+|+|.++.......+.+.+|+.+++.++|||++++++++..++..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            468999999999999865 6899999998765555556788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------------  344 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------------  344 (453)
                      .+++..  ..+++.....++.+++.++.||   |+.+++||||+|+||+++.++.++++|||...               
T Consensus       104 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  178 (285)
T cd06648         104 TDIVTH--TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT  178 (285)
T ss_pred             HHHHHh--CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCC
Confidence            998876  3578888899999999999999   78899999999999999999999999997431               


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQ  414 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  414 (453)
                                ...++.++|||||||++|||++|+.||......     ......             .............
T Consensus       179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~-------------~~~~~~~~~~~~~  240 (285)
T cd06648         179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRI-------------RDNLPPKLKNLHK  240 (285)
T ss_pred             ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHH-------------HhcCCCCCccccc
Confidence                      123567899999999999999999998542110     011000             0000000111122


Q ss_pred             HHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          415 CVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       415 ~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+..+.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            4567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.7e-33  Score=276.78  Aligned_cols=173  Identities=24%  Similarity=0.353  Sum_probs=148.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-C-----CCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-H-----PNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l  269 (453)
                      .|.+.++||+|+||+|.+|... +++.||||+++.... ...+-..|+.+|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            3466899999999999999854 799999999986643 3455677999999887 4     399999999999999999


Q ss_pred             EEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC--CCcEEEeccccC---
Q 036792          270 VLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE--DMVAHLSDFEYG---  343 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~--~~~~kl~df~~~---  343 (453)
                      |+|.++. +|+++++.. ...++......++.||+.||.+|   |+.+|||+||||+|||+.+  ...+||+|||.+   
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999855 999999764 35678888899999999999999   8999999999999999975  347999999754   


Q ss_pred             -------------------CCCCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 036792          344 -------------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRM  374 (453)
Q Consensus       344 -------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  374 (453)
                                         .+..|+.+.||||||||+.||++|.+-|.+.
T Consensus       342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence                               3457899999999999999999998888765

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-32  Score=262.17  Aligned_cols=222  Identities=22%  Similarity=0.301  Sum_probs=170.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHH-HHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEV-MKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||++... +|+.||||.++.... ....++..|... ++..+||||+++++++..++..+++|||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            34578999999999999976 699999999876532 233455566664 667789999999999999999999999996


Q ss_pred             CCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          276 KGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTT-PIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       276 ~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~-~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                       |+|.+++..   ....+++.....++.|++.|+.||   |++ +++||||||+||+++.++.+||+|||.+..      
T Consensus        84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence             688877754   234678889999999999999999   676 899999999999999999999999975421      


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                            ..++.++|+|||||++|||++|+.||.........+....            .     
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------~-----  222 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV------------E-----  222 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH------------h-----
Confidence                                  1235689999999999999999999864211111111111            0     


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...... .....+.++.+++.+||+.+|++||++++++.
T Consensus       223 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EPSPQL-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000 11235677899999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-32  Score=258.54  Aligned_cols=220  Identities=25%  Similarity=0.315  Sum_probs=176.9

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-----ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..+.||+|+||.||+|... ++..|++|.+....     .+..+.+.+|+++++.++|+||+++++++..++..++++||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            4578999999999999976 78999999986543     23456789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++++|.+++.... .+++.....++.++++|+.||   |+.+++|+||+|+||+++.++.+||+|||+...        
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          84 VPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            99999999887643 577888889999999999999   788999999999999999999999999975420        


Q ss_pred             ----------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      .. ++.++|+|||||++||+++|+.||.....    .......             ..  ....
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~-------------~~--~~~~  220 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKI-------------GR--SKEL  220 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHH-------------Hh--cccC
Confidence                            12 56789999999999999999999864321    0000000             00  0001


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+...+.++.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1122345667889999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.7e-33  Score=273.36  Aligned_cols=238  Identities=19%  Similarity=0.187  Sum_probs=172.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  268 (453)
                      |++.+.||+|+||.||++... +++.||||.+....  ....+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   98 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY   98 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence            456788999999999999865 68999999997542  33456788999999999999999999988653      3468


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +||||+++ ++.+.+..   .+++.....++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++..   
T Consensus        99 lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          99 LVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             EEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            99999965 67666643   367788888999999999999   889999999999999999999999999986521   


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC----------Cchh
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP----------ISLM  394 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~  394 (453)
                                           ..++.++|||||||++|||++|+.||......+. ....+.....          ....
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhcHHHH
Confidence                                 2356789999999999999999999975422111 1111110000          0000


Q ss_pred             hhhhhhhh----------cCcc--CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          395 EVVDKTLL----------SGEK--KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       395 ~~~d~~~~----------~~~~--~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ..++....          ....  ...........++.+++.+|++.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            01100000          0000  0000111234578899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-32  Score=258.57  Aligned_cols=226  Identities=23%  Similarity=0.333  Sum_probs=178.2

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC------e
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD------F  266 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------~  266 (453)
                      ...+++.+.||+|+||.||+|..+ +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....      .
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            345677899999999999999976 578999999875543 346789999999998 6999999999997644      4


Q ss_pred             eEEEEeccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC
Q 036792          267 KALVLEYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      .++||||+++++|.+++...   ...+++.....++.|++.|+.||   |+.+++|+||+|+||+++.++.++|+|||..
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            89999999999999887642   35678888999999999999999   8999999999999999999999999999753


Q ss_pred             C------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCch
Q 036792          344 M------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       344 ~------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                      .                              ...++.++|||||||++||+++|+.||....... ...+.         
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---------  230 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKI---------  230 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHh---------
Confidence            1                              0124567999999999999999999986431111 00000         


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..     ........+...+.++.+++.+||..||++|||++|+++
T Consensus       231 ---~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 ---PR-----NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---hc-----cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               00     000011122345678899999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-32  Score=262.02  Aligned_cols=224  Identities=23%  Similarity=0.320  Sum_probs=172.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEe-----cCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCS-----NDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~~lv  270 (453)
                      +++.+.||+|+||.||++... +++.+|+|.++... .....+.+|+.+++++ +||||+++++++.     .++..++|
T Consensus        20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            456788999999999999875 68899999876432 2235678899999999 6999999999874     34578999


Q ss_pred             EeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--
Q 036792          271 LEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--  345 (453)
                      |||+++|+|.+++..   ....+++.....++.++++|+.||   |+.+++||||||+||+++.++.++++|||.+..  
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999999988753   234567778888999999999999   788999999999999999999999999975421  


Q ss_pred             ----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          346 ----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       346 ----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                                  ..++.++|||||||++|||++|+.||......    .....         . 
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~~~---------~-  241 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RALFK---------I-  241 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHHhh---------c-
Confidence                                        12466899999999999999999998643211    10000         0 


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ..    ........+..++.++.+++.+||+.+|++|||++|+++.
T Consensus       242 ~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 PR----NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cc----cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00    0000011122345578999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-33  Score=266.73  Aligned_cols=239  Identities=23%  Similarity=0.284  Sum_probs=177.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||+|.++ +++.||+|.+.....  ...+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            34678999999999999976 589999998865432  234678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      +++|..+.... ..+++.....++.++++++.||   |+.+++|+|++|+||++++++.++|+|||++..          
T Consensus        84 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          84 HTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99888766543 3478999999999999999999   788999999999999999999999999975321          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccc--cHHhHHhhhcCCchhhhhh------hhh
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEEL--SLKDWVNNLLPISLMEVVD------KTL  401 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d------~~~  401 (453)
                                      ..++.++|||||||++|||++|++||......+.  ....+... ......+..+      ...
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN-LIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCC-CchhhHHHhccchHhhccc
Confidence                            1245679999999999999999999864321110  00000000 0000001100      000


Q ss_pred             hcCccCC---chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKG---FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......   .......+..+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000000   0011245678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-32  Score=263.82  Aligned_cols=241  Identities=22%  Similarity=0.271  Sum_probs=174.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++|+||+++.+++..++..++|+||+.
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            455678999999999999865 689999999875432 223467789999999999999999999999999999999995


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                       +++.+.+......+.+.....++.+++.||.||   |+.+++|+||||+||+++.++.++|+|||++..          
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence             678777765444577778888999999999999   788999999999999999999999999985421          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh-hhcCCc-hh-------hhhhhh
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN-NLLPIS-LM-------EVVDKT  400 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~-~~-------~~~d~~  400 (453)
                                      ..++.++|||||||++|||++|..||+........+..... ...+.. ..       +.....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence                            12456789999999999999999999754321111111100 000100 00       000000


Q ss_pred             hhcCccCCch---hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFV---AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..........   .....+.++.+++.+|++.||++|||++|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000000   00012457889999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-33  Score=270.54  Aligned_cols=210  Identities=22%  Similarity=0.258  Sum_probs=163.4

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcC---CCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSI---RHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ||+|+||.||+|+.. +++.||||++.....   .....+..|..++...   +||||+++++++.+++..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999976 689999999975422   2234455666776655   699999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      |+|.+.+.... .++......++.|+++|+.||   |+++|+||||||+|||++.++.++|+|||++..           
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~  156 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF  156 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence            99998887543 578888889999999999999   788999999999999999999999999986421           


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ..++.++|||||||++|||++|+.||......+     .....            .....  .. 
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~i------------~~~~~--~~-  216 (330)
T cd05586         157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRNI------------AFGKV--RF-  216 (330)
T ss_pred             cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHHH------------HcCCC--CC-
Confidence                           125678999999999999999999986532111     11100            00000  00 


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      .....+.++.+++.+||+.+|.+||++
T Consensus       217 ~~~~~~~~~~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         217 PKNVLSDEGRQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             CCccCCHHHHHHHHHHcCCCHHHCCCC
Confidence            011235567899999999999999953

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-32  Score=263.60  Aligned_cols=224  Identities=25%  Similarity=0.296  Sum_probs=179.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+.+.+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++|||++++++++..++..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            3456788999999999999864 688999999876554555778999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++...  .+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||+..           
T Consensus       100 ~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647         100 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            99999988754  467888899999999999999   89999999999999999999999999997531           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++||+++|+.||......+.... .                .. ...+...
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~----------------~~-~~~~~~~  236 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I----------------AT-NGTPELQ  236 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-h----------------hc-CCCCCCC
Confidence                          12356789999999999999999999964321110000 0                00 0001111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .+...+..+.+++.+||+.+|++||++++++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            223345678899999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.3e-32  Score=256.93  Aligned_cols=227  Identities=27%  Similarity=0.333  Sum_probs=179.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++++||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            355778999999999999865 68899999987543 3355788999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          276 KGSLENCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|.+.+....  ..+++.....++.+++.|+.||   |+.+++||||+|+||++++++.++|+|||+..         
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            999999987642  3578888889999999999999   78999999999999999999999999996421         


Q ss_pred             --------------------CC-CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 --------------------EG-QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 --------------------~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                          .. .++.++|+|||||++|||++|+.||......+ ..........+         ... 
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------~~~-  228 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP---------SLE-  228 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC---------CcC-
Confidence                                01 35667999999999999999999986442211 11111110000         000 


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          ........+.++.+++.+||+.+|++||+++++++
T Consensus       229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 ----TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ----CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                00011245677899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.3e-32  Score=270.49  Aligned_cols=237  Identities=19%  Similarity=0.183  Sum_probs=172.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  268 (453)
                      |++.+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~  105 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  105 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence            556788999999999999865 68899999997542  23446788999999999999999999987643      3579


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +||||+++ +|.+.+..   .+++.....++.|+++||.||   |+++|+||||||+||+++.++.+||+|||++..   
T Consensus       106 lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         106 IVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             EEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            99999965 67776643   367778888999999999999   889999999999999999999999999986521   


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC--Cchhhhhhhhh-
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP--ISLMEVVDKTL-  401 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~~-  401 (453)
                                           ..++.++|||||||++|||++|+.||......+ .+...+.....  ......+.... 
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhhHHHH
Confidence                                 235678999999999999999999997542211 11111111000  00000000000 


Q ss_pred             ---hcCcc----------------CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 ---LSGEK----------------KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ---~~~~~----------------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         .....                ...........++.+++.+|++.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               00000                000001112357889999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-32  Score=263.52  Aligned_cols=239  Identities=24%  Similarity=0.299  Sum_probs=170.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcC---CCCCceeEEeEEec-----CCee
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSI---RHPNLVKVISSCSN-----DDFK  267 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~~~  267 (453)
                      ++.+.||+|+||.||+|+.+ +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ....
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            45678999999999999876 689999999875422  1223456677766655   79999999998864     3457


Q ss_pred             EEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--
Q 036792          268 ALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--  344 (453)
                      ++++||+++ +|.+++... ...+++.....++.|++.|+.||   |+.+++||||||+||+++.++.+||+|||++.  
T Consensus        83 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          83 TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             EEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            899999974 888887653 23578888999999999999999   88999999999999999999999999997642  


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCC--chhhhh--
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPI--SLMEVV--  397 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~--  397 (453)
                                            ...++.++||||+||++|||++|++||......+ .+....... .+.  .+....  
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCcccccc
Confidence                                  1245778999999999999999999986542211 111111100 000  000000  


Q ss_pred             -hhhhhcCcc-CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 -DKTLLSGEK-KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 -d~~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ......... .........+.++.+++.+|++.||++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             000000000 000111234567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-32  Score=262.78  Aligned_cols=239  Identities=22%  Similarity=0.280  Sum_probs=176.0

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||+|+.. ++..||||.++...  ....+.+.+|++++++++||||+++++++.+++..++||||+.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   82 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence            34577999999999999876 68999999987543  2233578899999999999999999999999999999999996


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                       ++|.+++... ...+++.....++.++++|+.||   |+.+++||||+|+||+++.++.+|++|||++..         
T Consensus        83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence             5888887653 34678889999999999999999   788999999999999999999999999975310         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CCc-h----hhhhhhhhh
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PIS-L----MEVVDKTLL  402 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-~----~~~~d~~~~  402 (453)
                                       ..++.++|||||||++|||+||+.||......+ ...+..+... +.. .    .+..+....
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence                             113567999999999999999999986532211 1111111111 100 0    000000000


Q ss_pred             --c-CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 --S-GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 --~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        . ............+.++.+++.+||+.||++|||++|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              0 000000011224567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-32  Score=261.55  Aligned_cols=240  Identities=21%  Similarity=0.242  Sum_probs=179.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            345678999999999999975 68999999997654  233567899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                       +++|.+++......+++.....++.++++++.||   |+.+++|+||||+||+++.++.++++|||....         
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence             9999999876656788999999999999999999   788999999999999999999999999974321         


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---chhhhh-----hh
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SLMEVV-----DK  399 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----d~  399 (453)
                                        ..++.++||||+|+++|||+||.+||......+ .+..........   .+.+..     +.
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcchhhc
Confidence                              124668999999999999999988876432211 111111100000   000000     00


Q ss_pred             hhhc-CccCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 TLLS-GEKKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ~~~~-~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .... ..... .....+.+.++.+++.+|+..+|++|||+++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000 00000 0011234578899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.9e-32  Score=262.89  Aligned_cols=168  Identities=20%  Similarity=0.325  Sum_probs=138.0

Q ss_pred             hcccCCCCccEEEEEEEC---CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEEeccC
Q 036792          201 SNLIGMGSFGSVYRARLR---DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVLEYMP  275 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~E~~~  275 (453)
                      +..||+|+||.||+|+.+   +++.||+|.++....  ...+.+|+++|++++||||+++++++..  +...++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            457999999999999865   468899999875432  3457789999999999999999998854  456889999986


Q ss_pred             CCCchHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee----CCCCcEEEeccccC
Q 036792          276 KGSLENCLYSS--------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDFEYG  343 (453)
Q Consensus       276 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl----~~~~~~kl~df~~~  343 (453)
                       ++|.+++...        ...++......++.|++.||.||   |+.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4887776432        12467778889999999999999   88999999999999999    45678999999864


Q ss_pred             CC-----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 036792          344 ME-----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRM  374 (453)
Q Consensus       344 ~~-----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  374 (453)
                      ..                             ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            10                             12466799999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-32  Score=270.91  Aligned_cols=164  Identities=21%  Similarity=0.311  Sum_probs=142.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      |++.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++||||+++++++..++..++|+||+. 
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  140 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-  140 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence            456788999999999999976 5789999975432      23468999999999999999999999999999999995 


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++......+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||.+.            
T Consensus       141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence            689988877666789999999999999999999   78899999999999999999999999998642            


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhCCCCC
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPT  371 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~  371 (453)
                                  ...++.++|||||||++|||+++..|+
T Consensus       218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence                        124577899999999999999865553

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-33  Score=264.29  Aligned_cols=226  Identities=28%  Similarity=0.488  Sum_probs=176.4

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhH--HHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARAL--KSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||++... +++.||+|.+........  ....+|+.++++++||||+++++++......++||||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            34678999999999999977 567999999987654322  234569999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++.. ...+++.....++.++++||.+|   |+.+++|+||||+||+++.++.++|+|||...           
T Consensus        82 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   82 GGSLQDYLQK-NKPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             TEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999973 23578899999999999999999   77899999999999999999999999998652           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ....+.++||||+|+++|||++|..||......  ........        .........    .
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~--------~~~~~~~~~----~  223 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEK--------ILKRPLPSS----S  223 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHH--------HHHTHHHHH----T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhh--------ccccccccc----c
Confidence                           124567899999999999999999998754110  00000000        000000000    0


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........++.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001112368999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.4e-33  Score=292.46  Aligned_cols=226  Identities=18%  Similarity=0.266  Sum_probs=174.3

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVL  271 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~  271 (453)
                      .|++.+.||+|+||.||++... ++..||+|.+....  ......|..|+.++++++|||||+++++|..  ...++|||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM   93 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM   93 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence            3567789999999999999976 57899999987542  3345678999999999999999999998855  45689999


Q ss_pred             eccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCceecCCCCCceeeCC-------------
Q 036792          272 EYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGH----TTPIIHCDLKPISVLLDE-------------  331 (453)
Q Consensus       272 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h----~~~i~Hrdlk~~NiLl~~-------------  331 (453)
                      ||+++|+|.++|...   ...+++...+.++.|++.||.|||...    .++|+||||||+|||++.             
T Consensus        94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~  173 (1021)
T PTZ00266         94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN  173 (1021)
T ss_pred             eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence            999999999988652   246888999999999999999996422    256999999999999964             


Q ss_pred             ----CCcEEEeccccCCC--------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccH
Q 036792          332 ----DMVAHLSDFEYGME--------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL  381 (453)
Q Consensus       332 ----~~~~kl~df~~~~~--------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  381 (453)
                          ...+||+|||++..                          ..++.++|||||||++|||+||+.||.....    .
T Consensus       174 n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~----~  249 (1021)
T PTZ00266        174 NLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN----F  249 (1021)
T ss_pred             ccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc----H
Confidence                23589999985421                          2356789999999999999999999964311    1


Q ss_pred             HhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       382 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..++...             ....  .. .....+.++.+|+..||+.+|.+||++.|++.
T Consensus       250 ~qli~~l-------------k~~p--~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        250 SQLISEL-------------KRGP--DL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHHH-------------hcCC--CC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1111100             0000  00 11234567899999999999999999999984

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-32  Score=256.85  Aligned_cols=224  Identities=22%  Similarity=0.338  Sum_probs=176.7

Q ss_pred             HHhcccCCCCccEEEEEEE-CCCCEEEEEEeeccc------hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          199 RLSNLIGMGSFGSVYRARL-RDGIEVAVKVFHQEC------ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +..+.||+|+||.||++.. .+++.||+|.++...      ....+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~   82 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV   82 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence            3457899999999999986 478999999987432      123467899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCCC-----
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGME-----  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~~-----  345 (453)
                      ||+++++|.+++.... .+++.....++.+++.|+.||   |+.+++|+||+|+||+++.++ .++|+|||....     
T Consensus        83 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          83 EWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             eccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            9999999999887543 577888889999999999999   888999999999999998765 699999975421     


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                              ..++.++||||+|+++||+++|..||........  ....            ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~------------~~~~  224 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALI------------FKIA  224 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHH------------HHHh
Confidence                                    2346679999999999999999999853311110  0000            0000


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..  ......+...++++.+++.+||..+|++||++.|++.
T Consensus       225 ~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             cc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00  0011233455678899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-32  Score=266.64  Aligned_cols=226  Identities=22%  Similarity=0.280  Sum_probs=185.4

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  269 (453)
                      ...|.+.+.||+|.||.||+++.+ +|+.+|+|.+.+...   ...+...+|+++|+++. |||||.+.+++.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            345677899999999999999977 599999999987643   23468899999999998 9999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC----CcEEEeccccCC-
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED----MVAHLSDFEYGM-  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~----~~~kl~df~~~~-  344 (453)
                      |||++.||.|.+.+...  .++......++.+++.++.|+   |+.+|+|||+||+|+|+...    +.+|++|||++. 
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999988765  278888999999999999999   88999999999999999643    479999997652 


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ...|+..+||||.||++|.|++|.+||......+... .            +.    
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~------------i~----  251 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A------------IL----  251 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H------------HH----
Confidence                                   2467889999999999999999999997653322111 0            10    


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........+.....+..+.+++..|+..||.+|+|+.++++
T Consensus       252 ~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  252 RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            00001111223455778999999999999999999999986

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=251.47  Aligned_cols=241  Identities=20%  Similarity=0.261  Sum_probs=188.3

Q ss_pred             HHHHHH-hcccCCCCccEEEEEE-ECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEE
Q 036792          195 ATLRRL-SNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       195 ~~~~~~-~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ..+|++ .+.||+|+|+.|-.+. ..+|.++|||++.+.....+.+..+|++++.+.+ |+||+.++++|.++..+||||
T Consensus        76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            455555 6899999999999997 6789999999999887777789999999999885 999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC---cEEEeccccCCC---
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM---VAHLSDFEYGME---  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~df~~~~~---  345 (453)
                      |-|.||+|..++..+. .+.......+..+|+.||.||   |.++|.|||+||+|||.....   -+||+||.++..   
T Consensus       156 EKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             ecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            9999999999988765 466777788999999999999   999999999999999987543   579999965421   


Q ss_pred             ----------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC
Q 036792          346 ----------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI  391 (453)
Q Consensus       346 ----------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  391 (453)
                                                        ..|+.++|.||+|||+|-|++|-+||.+...++..+   -+...-.
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW---drGe~Cr  308 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW---DRGEVCR  308 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc---cCCCccH
Confidence                                              246778999999999999999999998776544321   1110000


Q ss_pred             -chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          392 -SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       392 -~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .-.+++.....+....+.......+.+..+++...+..++.+|-++.++++
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             000111111111111122233466788999999999999999999988875

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-32  Score=255.80  Aligned_cols=222  Identities=24%  Similarity=0.275  Sum_probs=169.5

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHH-HHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEV-MKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|... +++.||||.++....   .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999875 689999999875432   222334455544 4456899999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      ++|.+++.... .++......++.|+++||.||   |+.+++|+||+|+||+++.++.++|+|||....           
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTP  157 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCc
Confidence            99999887643 577888889999999999999   788999999999999999999999999975421           


Q ss_pred             ----------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHH
Q 036792          346 ----------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQC  415 (453)
Q Consensus       346 ----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~  415 (453)
                                ..++.++||||||+++||+++|..||.......     ...            ................+
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~------------~~~~~~~~~~~~~~~~~  220 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----VFD------------NILSRRINWPEEVKEFC  220 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHH------------HHHhcccCCCCcccccC
Confidence                      234678999999999999999999986432111     110            00000000011122346


Q ss_pred             HHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          416 VLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       416 ~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      +.++.+++.+||+.+|++||++.++.+.|
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            77899999999999999999876554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=261.54  Aligned_cols=239  Identities=24%  Similarity=0.282  Sum_probs=177.0

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|++|.||+|... +|..||+|++....  ....+.+.+|+++++.++|||++++++++.+++..+++|||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            34678999999999999865 79999999987543  2233568889999999999999999999999999999999995


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                       ++|.+++.... ..+++.....++.++++||.||   |+++++||||+|+||+++.++.++|+|||....         
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence             68998886543 3578999999999999999999   778999999999999999999999999975310         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCCch-----h---hhhhh
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPISL-----M---EVVDK  399 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~-----~---~~~d~  399 (453)
                                       ..++.++||||||+++|||++|++||....... ......+.. .+...     .   +....
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence                             123567999999999999999999986532211 111111111 01100     0   00000


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ................+.++.+++.+||+.+|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000111233467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-32  Score=257.50  Aligned_cols=227  Identities=23%  Similarity=0.287  Sum_probs=175.7

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEEeccCC
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVLEYMPK  276 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~E~~~~  276 (453)
                      .+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|..  .+..++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   85 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG   85 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence            467999999999999975 689999999875432 345678999999999999999999998865  3468999999999


Q ss_pred             CCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          277 GSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       277 g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ++|.+++..   ....++......++.++++++.||   |+.+++|+||+|+||+++.++.++|+|||++.         
T Consensus        86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  162 (287)
T cd06621          86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT  162 (287)
T ss_pred             CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeecccccccccccccc
Confidence            999887643   334577888889999999999999   88999999999999999999999999997642         


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccc---cccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVE---ELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                    ...++.++||||+||++|||++|+.||+.....   ......+........        +..    
T Consensus       163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~----  230 (287)
T cd06621         163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE--------LKD----  230 (287)
T ss_pred             ccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh--------hcc----
Confidence                          124566899999999999999999998754221   111122211110000        000    


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........++++.+++.+||..+|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00011224567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.9e-32  Score=255.23  Aligned_cols=224  Identities=20%  Similarity=0.285  Sum_probs=177.1

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~E~  273 (453)
                      ++.+.||+|+||.||++... ++..||+|.++...  ....+.+..|++++++++||||+++++++..  +...+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            44578999999999999865 68899999987542  3345678899999999999999999998764  4567899999


Q ss_pred             cCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          274 MPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGH--TTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h--~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +++++|.+++...   ...+++.....++.++++|+.|||..+  +.+++|+||||+||++++++.+|++|||+...   
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            9999999988653   456888899999999999999994332  89999999999999999999999999975421   


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                            ..++.++||||||+++|||++|+.||.....  ..+.+.+.                .
T Consensus       163 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~----------------~  224 (265)
T cd08217         163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIK----------------E  224 (265)
T ss_pred             CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHh----------------c
Confidence                                  2345678999999999999999999865321  11111111                0


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..  ....+...+.++.+++.+||+.+|++||++++|++
T Consensus       225 ~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 GK--FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CC--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00  11123355678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=273.69  Aligned_cols=227  Identities=23%  Similarity=0.357  Sum_probs=193.8

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ....++...||.|+||.||+|..+ ++...|.|++........+.|+-|++||+...||+||++++.|..++.+||..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            455677888999999999999876 4667789999888888889999999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      |.||-....+..-...+...+...++.+++.+|.||   |++.|||||||+.|||+.-+|.++|+|||...         
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence            999999988877777888899999999999999999   99999999999999999999999999997542         


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ...|+.++|||||||+|.||..+.+|....     .            .+.++-+. ..
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----n------------pMRVllKi-aK  249 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----N------------PMRVLLKI-AK  249 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----c------------hHHHHHHH-hh
Confidence                                 246888999999999999999999996432     1            11222111 12


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.+....|..++..+.+++.+|+..||..||++.++++
T Consensus       250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            333444567788999999999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=272.10  Aligned_cols=213  Identities=25%  Similarity=0.338  Sum_probs=178.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      .+..+||+|+||+|+++.++ +++.+|||.+++..   .++.+..+.|.+++.-. +||.++.++..|++.++++.||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            45688999999999999987 68899999999774   45677888898887766 599999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +.|||+..+.+  ...++.....-++..++.||+||   |+++||+||||.+|||+|.+|.+||+|||+..         
T Consensus       451 ~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T  525 (694)
T KOG0694|consen  451 VAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT  525 (694)
T ss_pred             cCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence            99999654433  23577777788899999999999   99999999999999999999999999997642         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...|+..+|.|||||++|||+.|..||.+...+                 +++|..+..+    
T Consensus       526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~FdsI~~d~----  584 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDSIVNDE----  584 (694)
T ss_pred             ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHhcCC----
Confidence                            346788999999999999999999999765332                 3444444332    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ...|..++.+..+++.+.+..+|++|--+
T Consensus       585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            23456678899999999999999999865

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.6e-32  Score=259.49  Aligned_cols=240  Identities=23%  Similarity=0.230  Sum_probs=177.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|..+ +++.+|+|.++....  .....+.+|+.++++++||||+++++++..+  +..++|||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            566788999999999999976 689999999975432  2234567899999999999999999998877  88999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |++ ++|.+.+......+++.....++.|+++||.||   |+.+++|+||||+||+++.++.++|+|||+...       
T Consensus        87 ~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          87 YVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             hcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            997 499988876555688999999999999999999   788999999999999999999999999975321       


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---cCCchhhhhh-----
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---LPISLMEVVD-----  398 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~d-----  398 (453)
                                         ..++.++|+||||+++|||++|.+||......+. ........   .+..+....+     
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccchhc
Confidence                               1236689999999999999999999875432111 11110000   0000000000     


Q ss_pred             -hhhhcCc--cCCchhhHH-HHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 -KTLLSGE--KKGFVAKEQ-CVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 -~~~~~~~--~~~~~~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .......  ......+.. .++.+.+++.+||+.+|++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             0000000  000001111 3567889999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-32  Score=276.84  Aligned_cols=235  Identities=17%  Similarity=0.168  Sum_probs=172.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.+.+.||+|+||.||+|.+. +++.||||....      ..+.+|+++|++++|+|||++++++..++..++|||++. 
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            455678999999999999976 578999996432      345789999999999999999999999999999999995 


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ++|.+++......+++.....++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.            
T Consensus       244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            689888876555789999999999999999999   78899999999999999999999999998642            


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccc------cccHHhHHhhh------cCCc-hhhh
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVE------ELSLKDWVNNL------LPIS-LMEV  396 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~------~~~~~~~~~~~------~~~~-~~~~  396 (453)
                                     ...++.++|||||||++|||++|..|+......      ...+...+...      ++.. ..+.
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence                           123567899999999999999988764321111      01111111110      0100 0000


Q ss_pred             hhhhh---hc--Cc-cCCchh--hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTL---LS--GE-KKGFVA--KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~---~~--~~-~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....   ..  .. ......  .......+.+|+.+||+.||.+|||+.|+++
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            00000   00  00 000000  0122346889999999999999999999986

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7e-32  Score=257.08  Aligned_cols=218  Identities=19%  Similarity=0.247  Sum_probs=167.7

Q ss_pred             ccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHH---HHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEV---MKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..+   +...+|||++.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 689999999875432   112233444433   344579999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++.... .+++.....++.|++.|+.||   |+.+++||||||+||+++.++.++++|||++.           
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV  156 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcC
Confidence            999998887543 588899999999999999999   78899999999999999999999999998642           


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|..||........  . .....            ...   .....
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~-~~~~~------------~~~---~~~~~  218 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--H-EIDRM------------TLT---VNVEL  218 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--H-HHHHH------------hhc---CCcCC
Confidence                         12356789999999999999999999964322111  1 01000            000   01112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      +...+.++.+++.+||..+|++||     +++|+++
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            334567889999999999999999     5888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.9e-32  Score=255.44  Aligned_cols=221  Identities=22%  Similarity=0.293  Sum_probs=172.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-----ARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  269 (453)
                      +++.+.||+|+||.||+|... ++..||||.+....     ....+.+.+|++++++++||||+++++++.++  ...++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            345688999999999999865 68999999886331     23346788999999999999999999988763  46789


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      +|||+++|+|.+++.... .+++.....++.+++.+|.||   |+.+++|+||||+||+++.++.++|+|||+..     
T Consensus        84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          84 FMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            999999999999887643 467788889999999999999   78899999999999999999999999998542     


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ...++.++|||||||++||+++|+.||.......    ....             ..
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~-------------~~  222 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----AIFK-------------IA  222 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----HHHH-------------Hh
Confidence                                   1134567999999999999999999986431110    0000             00


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..  ......+...+..+.+++.+||. +|++||+++|+++
T Consensus       223 ~~--~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 TQ--PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             cC--CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            00  00111233455678889999995 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.3e-32  Score=260.31  Aligned_cols=225  Identities=25%  Similarity=0.339  Sum_probs=177.6

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE---CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ..+...+.||+|+||.||+|+.. ++..+|+|.+...   .....+++.+|+++++.++|+|++++.+++..++..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            33556778999999999999975 6789999998643   2234467889999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+. |++.+.+......+++.....++.+++.|+.||   |+.+++||||+|+||+++.++.++++|||+..       
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  170 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX  170 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence            9996 688887765555678888899999999999999   78899999999999999999999999997542       


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++|||||||++|||++|..||......+ ....+..                 ... 
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~-----------------~~~-  231 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ-----------------NES-  231 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhh-----------------cCC-
Confidence                             1235678999999999999999999985431110 0000110                 000 


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ........+..+.+++.+||+.+|++||++++++..
T Consensus       232 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            011123456678999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-32  Score=267.93  Aligned_cols=224  Identities=17%  Similarity=0.210  Sum_probs=172.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+++.+ +++.||+|.+....   ......+.+|..++..++|+||+++++++.+++..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            45678999999999999976 68899999997532   223456788999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++|+|.+++......++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++..         
T Consensus        84 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          84 VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999977555678888888999999999999   889999999999999999999999999975310         


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                            +.++.++|||||||++|||++|+.||......+     ...            .....
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~------------~i~~~  223 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYG------------KIMNH  223 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-----HHH------------HHHcC
Confidence                                  235668999999999999999999986432111     000            00000


Q ss_pred             Ccc-CCchhhHHHHHHHHHHhhhccccCccc--CCChHHHHH
Q 036792          404 GEK-KGFVAKEQCVLSILGLAMECAMELPEK--RINAKDIVT  442 (453)
Q Consensus       404 ~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~~v~~  442 (453)
                      ... .........+.++.+++.+|+..++.+  |++++++.+
T Consensus       224 ~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         224 EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            000 001111234567888999988865544  467877764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.2e-32  Score=253.82  Aligned_cols=224  Identities=25%  Similarity=0.308  Sum_probs=181.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++.+.||+|++|.||+|... +++.||||++..... ...+.+.+|++.+.+++|+|++++++++..++..++|+||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            45678999999999999976 599999999876643 4457899999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      ++|.+++... ..++......++.++++++.||   |+ .+++|+||+|+||+++.++.++|+|||....          
T Consensus        84 ~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          84 GSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence            9999998765 4678889999999999999999   88 9999999999999999999999999975421          


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ..++.++||||||+++|||+||..||.....  ....+...            .... ..  ...
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~------------~~~~-~~--~~~  222 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQ------------AICD-GP--PPS  222 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHH------------HHhc-CC--CCC
Confidence                           2345689999999999999999999865421  01111111            1010 00  011


Q ss_pred             hhHH-HHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          411 AKEQ-CVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       411 ~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .+.. .+..+.+++.+||..+|++||++.|+++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1223 56789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.2e-32  Score=259.48  Aligned_cols=223  Identities=25%  Similarity=0.318  Sum_probs=173.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC-----CeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSND-----DFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-----~~~~lv  270 (453)
                      +++.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +|||++++++++...     +..++|
T Consensus        24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            455678999999999999875 689999999865422 235677899999998 799999999998753     358999


Q ss_pred             EeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--
Q 036792          271 LEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--  345 (453)
                      +||+++|+|.+++..   ....+++.....++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||....  
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999999988753   234678888999999999999999   788999999999999999999999999975320  


Q ss_pred             ----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          346 ----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       346 ----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                                  ..++.++|||||||++|||++|+.||......+ ....+.+.          
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~~----------  248 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKIPRN----------  248 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHHhcC----------
Confidence                                        014678999999999999999999986432111 01111000          


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             .......+...+.++.+++.+||+.+|++||++.|+++
T Consensus       249 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         249 -------PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -------CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                   00000112234457899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9e-32  Score=260.66  Aligned_cols=238  Identities=21%  Similarity=0.240  Sum_probs=175.0

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +.+++.+|.|+++.|+++.. +++.||||+++..  .....+.+.+|+++++.++||||+++++++..++..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            34555566666666666554 6899999999755  34456789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+++... ...++......++.++++||.||   |+.+|+||||||+||+++.++.+|++||+...          
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999998753 33577888888999999999999   78899999999999999999999999996431          


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCch----h--
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISL----M--  394 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~--  394 (453)
                                              ...++.++|||||||++|||++|+.||.......... +......+..+    .  
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhh
Confidence                                    0125678999999999999999999997532211111 11111000000    0  


Q ss_pred             ---h-------hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 ---E-------VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 ---~-------~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         .       ..+....  ...........+.++.+++.+||..+|++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNR--DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hcCCcCcccccccccchh--hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence               0       0000000  00011122344567899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-31  Score=260.22  Aligned_cols=167  Identities=21%  Similarity=0.337  Sum_probs=137.4

Q ss_pred             hcccCCCCccEEEEEEEC---CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEEeccC
Q 036792          201 SNLIGMGSFGSVYRARLR---DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVLEYMP  275 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~E~~~  275 (453)
                      +..||+|+||.||+|+.+   ++..||+|.++....  ...+.+|++++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999865   457899999875432  3467889999999999999999998854  567899999986


Q ss_pred             CCCchHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee----CCCCcEEEeccccC
Q 036792          276 KGSLENCLYSS--------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDFEYG  343 (453)
Q Consensus       276 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl----~~~~~~kl~df~~~  343 (453)
                      + +|.+++...        ...+++.....++.|++.||.||   |+.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777766421        22467788889999999999999   88999999999999999    45678999999864


Q ss_pred             CC-----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCc
Q 036792          344 ME-----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDR  373 (453)
Q Consensus       344 ~~-----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  373 (453)
                      ..                             ..++.++|||||||++|||+||++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            20                             1246679999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=262.58  Aligned_cols=225  Identities=23%  Similarity=0.314  Sum_probs=187.9

Q ss_pred             HHHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          194 QATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR--ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       194 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      .+.+|.+.+.||+|.|+.|-+|++- +|..||||++.+...+  ....+.+|++.|+-++|||||+++.+..++-.+|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            3578899999999999999999854 8999999999876543  345788999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC-CCCcEEEeccccCCC----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD-EDMVAHLSDFEYGME----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~-~~~~~kl~df~~~~~----  345 (453)
                      +|.=.+|+|++++..+...+......++..||+.++.|.   |+..+|||||||+||.+- .-|.+|+.|||+...    
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC---HqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC---HQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH---hhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999999988877788888888999999999999   666699999999999875 468899999987532    


Q ss_pred             --------------------CCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 --------------------GQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 --------------------~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ..| .+.+||||+||+||-++.|++||+.....+             .+..+.|..    
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCK----  235 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCK----  235 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhccc----
Confidence                                122 356899999999999999999998653322             122233322    


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          +..|...+.++.+|+.+|+..||.+|.+.+||+.
T Consensus       236 ----YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 ----YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ----ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                2355677889999999999999999999999874

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-31  Score=250.12  Aligned_cols=223  Identities=29%  Similarity=0.408  Sum_probs=180.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      .+.+.||+|++|.||++... ++..+++|++........+.+.+|++.+++++|+|++++.+++..+...++++||++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   82 (253)
T cd05122           3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG   82 (253)
T ss_pred             eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence            34578999999999999976 68999999998765556678999999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|.+++......+++.....++.+++.++.||   |..+++|+||+|+||+++.++.++|+|||....            
T Consensus        83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  159 (253)
T cd05122          83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG  159 (253)
T ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence            99999877645688999999999999999999   789999999999999999999999999975421            


Q ss_pred             ------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          346 ------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       346 ------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                  ...+.++||||||+++|||++|..||........  .....            .    ..........
T Consensus       160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~------------~----~~~~~~~~~~  221 (253)
T cd05122         160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIA------------T----NGPPGLRNPE  221 (253)
T ss_pred             CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHH------------h----cCCCCcCccc
Confidence                        1236689999999999999999999864311100  00000            0    0000011112


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+.++.+++.+||+.+|++|||+.|+++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            23567899999999999999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-32  Score=258.41  Aligned_cols=239  Identities=22%  Similarity=0.270  Sum_probs=177.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++.+.||+|++|.||+|+.. +|..||||.++.... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            34678999999999999976 689999999976532 2345677899999999999999999999999999999999985


Q ss_pred             CCchHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          277 GSLENCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       277 g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                       +|.+++....  ..+++.....++.+++.|+.||   |+.+++||||||+||++++++.++++|||+...         
T Consensus        83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence             8888876543  4578899999999999999999   788999999999999999999999999965420         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCC--chhhhhhhhhhcCc
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPI--SLMEVVDKTLLSGE  405 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~d~~~~~~~  405 (453)
                                       ..++.++|||||||++||+++|+.||......+. .....+.. .+.  .+..+.+.......
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchhccc
Confidence                             1246689999999999999999999875432221 11111110 010  00000000000000


Q ss_pred             cC------CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KK------GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+      .....+..+..+.+++.+|++.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00      00111234677899999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-33  Score=245.78  Aligned_cols=223  Identities=21%  Similarity=0.254  Sum_probs=174.5

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccCC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ....||+|+.|.|++++++ +|..+|||.+++.. .+..++++..+.++.+-+ .|.||+.+|+|..+...++.||.|..
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            3466999999999999977 68999999998764 455677788888776654 79999999999999999999999854


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                       .+++++..-....+..-.-++...+++||.||.  .+.+|+|||+||+|||+|+.|++|+||||++.            
T Consensus       176 -C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK--eKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA  252 (391)
T KOG0983|consen  176 -CAEKLLKRIKGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA  252 (391)
T ss_pred             -HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH--HhcceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence             566666655555666666677888899999996  44579999999999999999999999998641            


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...|+.++|||||||.++|++||..||.....+...+...++                 .+.+..
T Consensus       253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-----------------~ePP~L  315 (391)
T KOG0983|consen  253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-----------------EEPPLL  315 (391)
T ss_pred             CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-----------------cCCCCC
Confidence                           235777899999999999999999999764333222222221                 111222


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.....++.+.+++..|+..|+.+||...++++
T Consensus       316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            233346778999999999999999999988764

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-31  Score=262.99  Aligned_cols=240  Identities=23%  Similarity=0.317  Sum_probs=177.1

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC--CeeEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSI-RHPNLVKVISSCSND--DFKAL  269 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~l  269 (453)
                      ..+.+.+.||+|+||.||+|... ++..+|+|++...  .......+.+|+.+++++ +||||++++++|...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            44677889999999999999976 6889999988643  223345677899999999 999999999998653  46899


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ||||++ ++|.+++...  .+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++..    
T Consensus        87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            999997 5998888664  578888889999999999999   788999999999999999999999999975420    


Q ss_pred             ---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCc----
Q 036792          346 ---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPIS----  392 (453)
Q Consensus       346 ---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~----  392 (453)
                                                 ..++.++||||||+++|||+||+.||......+. ........  .+..    
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence                                       1245679999999999999999999865322111 11111100  0000    


Q ss_pred             -----hhhhhhhhhhcCccC-CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          393 -----LMEVVDKTLLSGEKK-GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       393 -----~~~~~d~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                           ..++++ ........ .......++.++.+++.+||+.+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         240 IKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 001111 00000000 011112256789999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.3e-32  Score=257.12  Aligned_cols=221  Identities=23%  Similarity=0.313  Sum_probs=178.7

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|... ++..||+|.+....   ....+.+.+|++++++++||||+++++.+.+++..++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            45678999999999999976 68999999997543   234578899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++++|.+.+... ..++......++.++++|+.||   |+.+++|+||+|+||++++++.++|+|||....         
T Consensus        83 ~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          83 LGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            999999988765 4678888999999999999999   788999999999999999999999999975421         


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ..++.++|+||||+++||+++|..||......  .......             ....   ....
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~-------------~~~~---~~~~  220 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRA-------------KQET---ADVL  220 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHH-------------Hhcc---cccc
Confidence                           22467899999999999999999998754221  0111110             0000   0112


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCCh--HHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINA--KDIV  441 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~--~~v~  441 (453)
                      .+...+..+.+++.+||..+|.+||++  +|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            233456788999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.6e-32  Score=255.35  Aligned_cols=221  Identities=22%  Similarity=0.335  Sum_probs=175.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+.+.||+|+||.||+|..+ +|..||+|.+....  ....+.+.+|+++++.++|+|++++++.+..++..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            34578999999999999976 58899999987542  2344678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC---------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM---------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~---------  344 (453)
                      +++|.+++.... ..+++.....++.++++|+.||   |+.+++|+||||+||++++++ .+|++||+.+.         
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999886533 3578889999999999999999   788999999999999998875 56999997531         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++||||||+++||+++|..||.....     .+++.....        ...       
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~--------~~~-------  219 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQ--------GYF-------  219 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc--------ccC-------
Confidence                            12356789999999999999999999864321     111111110        000       


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.....+.++.+++.+||+.+|++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0111234557899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=1.2e-31  Score=255.20  Aligned_cols=216  Identities=19%  Similarity=0.256  Sum_probs=169.6

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ||+|+||.||++... +|+.||+|.+.....   ...+.+.+|+++++.++|||++++.+++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 689999999875432   2345667899999999999999999999999999999999999999


Q ss_pred             hHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------------
Q 036792          280 ENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------  344 (453)
Q Consensus       280 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------------  344 (453)
                      .+++.... ..+++.....++.++++|+.||   |+.+++||||+|+||+++.++.++|+|||...              
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT  157 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence            99887643 3578888899999999999999   78899999999999999999999999997542              


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQ  414 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  414 (453)
                                ...++.++|||||||++|||++|+.||...... ........             .....   ....+..
T Consensus       158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-------------~~~~~---~~~~~~~  220 (277)
T cd05577         158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKR-------------RTLEM---AVEYPDK  220 (277)
T ss_pred             CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHh-------------ccccc---cccCCcc
Confidence                      123466899999999999999999998643211 01111000             00000   1112233


Q ss_pred             HHHHHHHHhhhccccCcccCCChHH
Q 036792          415 CVLSILGLAMECAMELPEKRINAKD  439 (453)
Q Consensus       415 ~~~~~~~l~~~Cl~~~P~~RPs~~~  439 (453)
                      .++++.+++.+||+.+|++||++++
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCc
Confidence            4667899999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=1.4e-31  Score=252.43  Aligned_cols=218  Identities=22%  Similarity=0.332  Sum_probs=174.2

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ||.|+||.||++... +++.||+|.+.....   ...+.+.+|+++++.++||||+++++++.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 589999999975432   3446789999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------  345 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------------  345 (453)
                      .+++.... .++......++.++++|+.||   |+++++|+||+|+||+++.++.++|+|||....              
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence            99987653 477888889999999999999   889999999999999999999999999976421              


Q ss_pred             ----------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHH
Q 036792          346 ----------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQC  415 (453)
Q Consensus       346 ----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~  415 (453)
                                ..++.++|+||||+++||+++|..||.....+.   ...            .........  ....+...
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~------------~~~~~~~~~--~~~~~~~~  219 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEI------------YNDILKGNG--KLEFPNYI  219 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHH------------HHHHhccCC--CCCCCccc
Confidence                      234667999999999999999999986542111   111            111110000  11123334


Q ss_pred             HHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          416 VLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       416 ~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      +.++.+++.+||+.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            678999999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.98  E-value=7.3e-32  Score=257.38  Aligned_cols=239  Identities=25%  Similarity=0.279  Sum_probs=177.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~E~  273 (453)
                      ++.+.||+|+||.||+|... +++.+|+|.+....  ....+.+.+|+++++.++|||++++++++...  +..++|+||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            34577999999999999976 58999999998663  33446788999999999999999999999988  889999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++ +|.+++......+++.....++.++++|+.||   |+.+++|+||+|+||++++++.++|+|||+..         
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            975 89888876645788899999999999999999   77899999999999999999999999997431         


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc---CCchhhhhh----h
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL---PISLMEVVD----K  399 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d----~  399 (453)
                                        ...++.++||||||+++|||+||+.||....... ..........   +..+....+    .
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchhhh
Confidence                              0124668999999999999999999986543211 1111111100   000000000    0


Q ss_pred             hhhcCccCCc---hhhHH-HHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 TLLSGEKKGF---VAKEQ-CVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ~~~~~~~~~~---~~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..........   ..... ++.++.+++.+||..+|++||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000000000   00111 3678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=2e-32  Score=273.33  Aligned_cols=235  Identities=21%  Similarity=0.245  Sum_probs=173.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC---CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR---DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||.||++...   .+..||+|.+...     ....+|++++++++|||||++++++......+++|||+
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            566788999999999999754   3578999988643     23468999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      . ++|.+++.. ...+++.....++.|++.||.||   |+++|+||||||+|||++.++.++|+|||++.          
T Consensus       169 ~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        169 K-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             C-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence            5 688888843 34688999999999999999999   78899999999999999999999999998642          


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccc--ccHHhHHhhh------cCCc----hhh
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE--LSLKDWVNNL------LPIS----LME  395 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~------~~~~----~~~  395 (453)
                                       ...++.++|||||||++|||++|+.||.+.....  ..+...++..      ++..    +.+
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence                             1235678999999999999999999986543221  1111111110      0000    000


Q ss_pred             hhhhhhhcCccCCchh-----hHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          396 VVDKTLLSGEKKGFVA-----KEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ....... ........     ....+.++.+++.+||..+|++|||+.|++..
T Consensus       324 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        324 HFKQYAI-VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHhhcc-cccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000 00000000     11234577889999999999999999998753

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=7.5e-32  Score=261.52  Aligned_cols=222  Identities=26%  Similarity=0.375  Sum_probs=176.7

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|... +++.||+|.+.....   ...+.+..|+++++.++||||+++++.+..+...++||||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            34578999999999999876 589999999976532   24567889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          275 PKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      ++++|.+++... ...+++.....++.++++|+.||   |+.+++|+||||+||+++.++.++|+|||+...        
T Consensus        84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999988653 34678888889999999999999   788999999999999999999999999975321        


Q ss_pred             ----------------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccc
Q 036792          346 ----------------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEEL  379 (453)
Q Consensus       346 ----------------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~  379 (453)
                                                                    ..++.++||||||+++|||++|+.||....... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE-  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence                                                          123557999999999999999999986442211 


Q ss_pred             cHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC----hHHHHH
Q 036792          380 SLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN----AKDIVT  442 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs----~~~v~~  442 (453)
                         .+         .++.+...      ..+.....+.++.+++.+||+.+|++||+    ++|+++
T Consensus       240 ---~~---------~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         240 ---TF---------SNILKKEV------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             ---HH---------HHHhcCCc------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence               01         11111110      01111124678999999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=7.6e-32  Score=259.02  Aligned_cols=225  Identities=22%  Similarity=0.277  Sum_probs=173.5

Q ss_pred             HHHhcccCCCCccEEEEEEECC-CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +++.+.||+|+||.||+|.+.+ ++.||||.++... .....++.+|+.++.+.. ||||++++++|.++...+++|||+
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   96 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM   96 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence            4667899999999999999874 8999999997543 233456777887776665 999999999999999999999998


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      + +++.+++......+++..+..++.++++|+.||   |+ .+|+||||+|+||++++++.+||+|||++..        
T Consensus        97 ~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~  172 (296)
T cd06618          97 S-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL---KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT  172 (296)
T ss_pred             C-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence            5 477776665445788888999999999999999   64 5899999999999999999999999975421        


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                          ..++.++||||||+++|||++|+.||.........+....            +.     .
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------~~-----~  235 (296)
T cd06618         173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL------------QE-----E  235 (296)
T ss_pred             CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh------------cC-----C
Confidence                                1246689999999999999999999864211111111111            00     0


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ....+....++.++.+++.+||+.+|++||+++++++.
T Consensus       236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00011111346678999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=9e-32  Score=257.34  Aligned_cols=227  Identities=24%  Similarity=0.303  Sum_probs=172.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+.
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~   86 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD   86 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence            34578999999999999865 68999999987543 234567889999999996 9999999999999999999999986


Q ss_pred             CCCchHHh---hc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          276 KGSLENCL---YS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       276 ~g~L~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      . ++.++.   .. ....+++.....++.++++|++|||  ++.+++||||||+||+++.++.++|+|||++.       
T Consensus        87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence            4 555433   22 2346788889999999999999995  34589999999999999999999999997531       


Q ss_pred             -----------------C---CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 -----------------E---GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 -----------------~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                       .   ..++.++|||||||++|||++|+.||....    .............     .+.+   
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~-----~~~~---  231 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD-----PPIL---  231 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC-----CCcC---
Confidence                             0   136778999999999999999999986432    1111111000000     0000   


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                         .......++.++.+|+.+||+.+|++|||+++++..
T Consensus       232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 ---SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ---CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               011113466789999999999999999999998863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=9.9e-32  Score=259.85  Aligned_cols=239  Identities=26%  Similarity=0.267  Sum_probs=175.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|..+ +|+.||+|.++....  .....+.+|+.++++++|+|++++++++.+.  +..++|||
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME   88 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence            456778999999999999975 689999999875432  2223567899999999999999999998764  56899999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++ +|.+++......+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||++..       
T Consensus        89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            9964 88888876556788999999999999999999   788999999999999999999999999974311       


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh---hhh-h--
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV---VDK-T--  400 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~-~--  400 (453)
                                         ..++.++||||+||++|||++|.+||......+  ....+...........   ++. .  
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChhhchhhhccccc
Confidence                               124678999999999999999999997542211  1111111111000000   000 0  


Q ss_pred             --h-hcCccCC--chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 --L-LSGEKKG--FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 --~-~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        . .......  .......++++.+++.+|++.||++|||++|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              0 0000000  0001123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=1.7e-31  Score=256.13  Aligned_cols=223  Identities=23%  Similarity=0.277  Sum_probs=177.1

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+.-...||+|+||.||++... ++..||||.+..........+.+|+.+++.++|+|++++++++..++..+++|||++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3333567999999999999875 689999999875555555678999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++...  .+++.....++.+++.++.||   |+.+++|+||+|+||+++.++.++|+|||+..           
T Consensus       101 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         101 GGALTDIVTHT--RMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            99999877543  467888889999999999999   78899999999999999999999999997531           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|+||||+++|||++|..||......  ..........+.                ...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~----------------~~~  237 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPP----------------KLK  237 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCc----------------ccC
Confidence                          123467899999999999999999998643111  111111110110                001


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+..+.+++.+||+.+|.+||++.+++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            11234556788999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=7.2e-32  Score=254.08  Aligned_cols=218  Identities=27%  Similarity=0.351  Sum_probs=173.6

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ||+|+||.||+++.. +|+.+|+|.+.....   ...+.+.+|++++.+++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999977 589999999975533   3456788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------  345 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------------  345 (453)
                      .+++.... .+++..+..++.|+++||.||   |+.+++|+||+|+||++++++.++|+|||+...              
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99887644 678889999999999999999   788999999999999999999999999975321              


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                         ...+.++||||||+++||+++|..||.....++     ..            +.... .. 
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~------------~~~~~-~~-  217 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IF------------QNILN-GK-  217 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HH------------HHHhc-CC-
Confidence                               123457999999999999999999986432111     11            00000 00 


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      ...+.....+.++.+++.+||+.+|++|||+.++.+.|
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            00111111267889999999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=1.2e-31  Score=256.77  Aligned_cols=218  Identities=25%  Similarity=0.329  Sum_probs=175.1

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .+.+.||+|+||.||++... +++.||+|.++...   ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            45678999999999999876 68999999987543   234567889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++|+|.+++.... .++......++.+++.|+.||   |+.+++|+||+|+||+++.++.+||+|||++..         
T Consensus        84 ~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~  159 (290)
T cd05580          84 PGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC  159 (290)
T ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCC
Confidence            9999999887653 678888889999999999999   789999999999999999999999999976531         


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                   ...+.++||||||+++|||++|+.||......  ...   .        .+.     .+.   ...+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~---~--------~~~-----~~~---~~~~  218 (290)
T cd05580         160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QIY---E--------KIL-----EGK---VRFP  218 (290)
T ss_pred             CCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHH---H--------HHh-----cCC---ccCC
Confidence                         23456799999999999999999998643211  000   0        000     000   0112


Q ss_pred             HHHHHHHHHHhhhccccCcccCC-----ChHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRI-----NAKDIV  441 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~  441 (453)
                      ...+..+.+++.+||+.+|.+||     +++|++
T Consensus       219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            23356788999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1.7e-31  Score=257.13  Aligned_cols=241  Identities=21%  Similarity=0.236  Sum_probs=177.3

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC--------
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD--------  265 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------  265 (453)
                      .+++.+.||+|+||.||+|..+ +|+.||||.++...  ......+.+|+++++.++|||++++++++.+..        
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            4567789999999999999976 58999999997543  223356788999999999999999999987655        


Q ss_pred             --eeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC
Q 036792          266 --FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       266 --~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                        ..++|+||+++ ++.+.+......+++.....++.+++.||+||   |+.+|+|+||||+||++++++.+||+|||++
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence              78999999976 77777776555688999999999999999999   7889999999999999999999999999754


Q ss_pred             CC---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---cCCch
Q 036792          344 ME---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---LPISL  393 (453)
Q Consensus       344 ~~---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~  393 (453)
                      ..                           ..++.++|||||||++|||++|++||...... ..+.......   .+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPCPAVW  242 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhc
Confidence            21                           12356799999999999999999998643211 1111111110   01001


Q ss_pred             hhhhhhhhhc----Cc---cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 MEVVDKTLLS----GE---KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 ~~~~d~~~~~----~~---~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .++.......    ..   ..........+..+.+++.+||..+|++||++.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1110000000    00   0000111234678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PTZ00284 protein kinase; Provisional

Probab=99.98  E-value=1e-31  Score=274.31  Aligned_cols=238  Identities=19%  Similarity=0.205  Sum_probs=166.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC------CCceeEEeEEecC-CeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRH------PNLVKVISSCSND-DFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~-~~~~  268 (453)
                      .|++.+.||+|+||.||+|... +++.||||+++... .....+..|+++++.++|      .+++++.+++..+ .+.+
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            3566788999999999999865 68899999996432 223445667777766654      4588899888764 5788


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCC--------------
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDM--------------  333 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~--------------  333 (453)
                      +|||++ +++|.+++.... .+++.....++.|++.||.||   |+ .+|+||||||+|||++.++              
T Consensus       209 iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYF---HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             EEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            999988 778988886543 578888899999999999999   65 6999999999999998765              


Q ss_pred             --cEEEeccccCC----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-
Q 036792          334 --VAHLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-  388 (453)
Q Consensus       334 --~~kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-  388 (453)
                        .+||+|||...                      ...++.++|||||||++|||++|+.||+.....+  ....+... 
T Consensus       284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~  361 (467)
T PTZ00284        284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE--HLHLMEKTL  361 (467)
T ss_pred             CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHc
Confidence              49999998532                      1346778999999999999999999997543211  11111111 


Q ss_pred             --cCCch---------hhhhhhhhhcCcc-----------CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          389 --LPISL---------MEVVDKTLLSGEK-----------KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       389 --~~~~~---------~~~~d~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .+..+         .++++........           ..........+.+.+|+.+||.+||++|||++|+++
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence              11111         0111100000000           000000112356789999999999999999999985

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=3.6e-31  Score=256.47  Aligned_cols=223  Identities=25%  Similarity=0.331  Sum_probs=175.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +...+.||+|+||.||+|... ++..||+|.+....   ....+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            444567999999999999865 68999999987432   23446788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +. |++.+.+......+++.....++.+++.++.||   |+.+++|+||+|+||+++.++.+||+|||+..         
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~  178 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV  178 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcc
Confidence            96 588887766555688999999999999999999   78899999999999999999999999997532         


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++|||||||++|||++|..||.......  .......                ... ..
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~----------------~~~-~~  239 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ----------------NDS-PT  239 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHh----------------cCC-CC
Confidence                           1235667899999999999999999986432111  0000000                000 00


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ......+..+.+++.+||+.+|++||++.+++..
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112334568899999999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=6.9e-32  Score=263.91  Aligned_cols=238  Identities=20%  Similarity=0.256  Sum_probs=176.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec----CCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN----DDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|... +|..||+|++....  ....+.+.+|+.+|++++||||+++++++..    ....++|
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv   86 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV   86 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence            455678999999999999865 68999999987542  2345677889999999999999999988753    3568999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      +||+. |+|.+++.... .+++.....++.+++.||.||   |+++++||||||+||+++.++.+||+|||++..     
T Consensus        87 ~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          87 MDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             Eehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            99995 68988886544 488889999999999999999   788999999999999999999999999975410     


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh--
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD--  398 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  398 (453)
                                               ..++.++|||||||++|||++|+.||.......  ..............+..+  
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChhHhhhhh
Confidence                                     235678999999999999999999996542211  111111111111111110  


Q ss_pred             --hhh----hc-CccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 --KTL----LS-GEKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 --~~~----~~-~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ...    .. ......   ......+.++.+++.+||+.+|++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              000    00 000000   111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=1.2e-31  Score=257.38  Aligned_cols=239  Identities=22%  Similarity=0.213  Sum_probs=173.4

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCe-----eEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDF-----KAL  269 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----~~l  269 (453)
                      ++.+.||+|+||.||+|... +++.||||.++....  .....+.+|+.++++++ ||||+++++++...+.     .++
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            45678999999999999976 689999998865432  23467888999999995 6999999999887665     899


Q ss_pred             EEeccCCCCchHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCC
Q 036792          270 VLEYMPKGSLENCLYSS----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGM  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~  344 (453)
                      ||||+++ +|.+++...    ...+++.....++.|+++||.||   |+++++||||||+||+++. ++.+||+|||++.
T Consensus        84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            9999985 888877543    23578889999999999999999   7889999999999999998 8899999998542


Q ss_pred             C--------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCCc--hhh
Q 036792          345 E--------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPIS--LME  395 (453)
Q Consensus       345 ~--------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~  395 (453)
                      .                          ..++.++||||||+++|||++|..||......+. ........ .+..  +..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCChhhCcc
Confidence            1                          2246789999999999999999999865321111 11111100 0000  000


Q ss_pred             hhhhhh--hcCccCC---chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTL--LSGEKKG---FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~--~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...  .......   ....+..+.++.+++.+||..+|++||+++|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000  0000000   0011235677899999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=9.7e-32  Score=256.86  Aligned_cols=240  Identities=21%  Similarity=0.272  Sum_probs=176.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +++.+.||+|+||.||+|..+ +++.||||.++...  ....+.+.+|++++++++|+||+++++++..++..++++||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            345678999999999999976 58899999987542  233467899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +++.+..+... ...++......++.+++.|+.||   |+.+++|+||+|+||++++++.+||+|||.+.          
T Consensus        83 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          83 ERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            98766655443 34578888999999999999999   78899999999999999999999999997531          


Q ss_pred             ----------------CC-CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh--hhcCCchhhhhh--hhhhc
Q 036792          345 ----------------EG-QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN--NLLPISLMEVVD--KTLLS  403 (453)
Q Consensus       345 ----------------~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~d--~~~~~  403 (453)
                                      .. .++.++||||||+++|||++|++||......+. +.....  ...+........  .....
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCccccc
Confidence                            11 456789999999999999999999865322110 000000  000000000000  00000


Q ss_pred             Ccc----CCc----hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEK----KGF----VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~----~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...    ...    ..+..++.++.+++.+||+.+|++||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000    000    012234678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=4.1e-31  Score=251.65  Aligned_cols=218  Identities=19%  Similarity=0.259  Sum_probs=168.1

Q ss_pred             ccCCCCccEEEEEEEC-CCCEEEEEEeeccchh---hHHHHHHHH---HHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR---ALKSFEAQC---EVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .||+|+||.||++... +++.||+|.+......   ....+..|.   +.++...||||+++.+++..++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 6899999998754321   112233343   34555689999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++... ..+++..+..++.++++|+.||   |+.+++|||+||+||+++.++.++|+|||++.           
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV  156 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcC
Confidence            99999888654 3688999999999999999999   78899999999999999999999999998642           


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++||||+||++|||++|+.||.........  .             ++......   ....
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~-------------~~~~~~~~---~~~~  218 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E-------------IDRMTLTM---AVEL  218 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--H-------------HHHHhhcc---CCCC
Confidence                         113567899999999999999999998653211100  0             00000000   1112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      +...+.++.+++.+|+..+|++||     +++|+++
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            233467889999999999999999     9989874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=2.3e-31  Score=260.32  Aligned_cols=240  Identities=19%  Similarity=0.204  Sum_probs=176.3

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhh--------------HHHHHHHHHHHHcCCCCCceeEEeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARA--------------LKSFEAQCEVMKSIRHPNLVKVISSC  261 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~  261 (453)
                      +..+.+.||+|+||.||+|... +++.||||.++......              ...+.+|+++++.++||||+++++++
T Consensus        10 y~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (335)
T PTZ00024         10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY   89 (335)
T ss_pred             hhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence            3455678999999999999965 68999999986542211              12477899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       262 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      ..++..++||||++ |+|.+++.... .++......++.+++.|+.||   |+.+++|+||+|+||+++.++.++++|||
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         90 VEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             ecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEECCcc
Confidence            99999999999996 68998886543 578888899999999999999   78999999999999999999999999997


Q ss_pred             cCCC----------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccH
Q 036792          342 YGME----------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL  381 (453)
Q Consensus       342 ~~~~----------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  381 (453)
                      ....                                        ..++.++|||||||++|||++|++||......+. +
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~  243 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-L  243 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence            5321                                        1246679999999999999999999875432211 1


Q ss_pred             HhHHh---hhcCCchhhhhhhhh-----hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          382 KDWVN---NLLPISLMEVVDKTL-----LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       382 ~~~~~---~~~~~~~~~~~d~~~-----~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....   ...+..+.+..+-..     .............++.++.+++.+||+.+|++||+++|++.
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11111   000000100000000     00000000111234567899999999999999999999875

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.98  E-value=1.6e-31  Score=258.90  Aligned_cols=239  Identities=18%  Similarity=0.236  Sum_probs=173.8

Q ss_pred             HHhcccCCCCccEEEEEEEC---CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR---DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKALV  270 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv  270 (453)
                      ++.+.||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.++++++||||+++++++...  +..++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            45677999999999999965   47899999998643   33446778899999999999999999999988  889999


Q ss_pred             EeccCCCCchHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC----CCcEEEecccc
Q 036792          271 LEYMPKGSLENCLYSS----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE----DMVAHLSDFEY  342 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~----~~~~kl~df~~  342 (453)
                      |||+++ ++.+.+...    ...++......++.|++.|+.||   |+.+++||||||+||+++.    ++.+||+|||+
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999975 676666432    22567788889999999999999   7899999999999999999    89999999985


Q ss_pred             CCC-----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCcccccc--------ccHHhHH
Q 036792          343 GME-----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE--------LSLKDWV  385 (453)
Q Consensus       343 ~~~-----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~--------~~~~~~~  385 (453)
                      +..                             ..++.++|||||||+++||++|.+||.......        ..+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            321                             124667999999999999999999997543322        0111111


Q ss_pred             hhhcCC------------chhhhhhhhhhcCccCCch----hhH--HHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          386 NNLLPI------------SLMEVVDKTLLSGEKKGFV----AKE--QCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       386 ~~~~~~------------~~~~~~d~~~~~~~~~~~~----~~~--~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......            ......+.... .......    ...  ..+.++.+++.+||+.+|++|||+.|++.
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccC-CCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111000            00000000000 0000000    001  33457899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=4.9e-31  Score=249.64  Aligned_cols=213  Identities=21%  Similarity=0.233  Sum_probs=166.3

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCCCCchH
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPKGSLEN  281 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~  281 (453)
                      +|+|+||.||++..+ ++..+|+|.+........     |......+ +|||++++++++..++..++||||+++|+|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            599999999999865 688999999875432211     22222212 69999999999999999999999999999999


Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC----------------
Q 036792          282 CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM----------------  344 (453)
Q Consensus       282 ~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~----------------  344 (453)
                      ++.... .+++.....++.|+++|+.||   |+.+++||||||+||+++.++ .++|+|||+..                
T Consensus        99 ~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~a  174 (267)
T PHA03390         99 LLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFS  174 (267)
T ss_pred             HHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccC
Confidence            987654 688999999999999999999   788999999999999999988 99999997542                


Q ss_pred             -----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHH
Q 036792          345 -----EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSI  419 (453)
Q Consensus       345 -----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~  419 (453)
                           ...++.++|||||||++|||++|+.||.....++.....+.....                 ...+.....++.+
T Consensus       175 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~  237 (267)
T PHA03390        175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-----------------KKLPFIKNVSKNA  237 (267)
T ss_pred             hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-----------------ccCCcccccCHHH
Confidence                 134567899999999999999999999754333322222221110                 0111223466778


Q ss_pred             HHHhhhccccCcccCCC-hHHHHH
Q 036792          420 LGLAMECAMELPEKRIN-AKDIVT  442 (453)
Q Consensus       420 ~~l~~~Cl~~~P~~RPs-~~~v~~  442 (453)
                      .+++.+||+.+|.+||+ ++|+++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhc
Confidence            99999999999999996 688864

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=4e-31  Score=247.85  Aligned_cols=221  Identities=25%  Similarity=0.352  Sum_probs=180.0

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||++... ++..||+|.+.....  ...+.+.+|+++++.++|||++++.+.+..++..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            34577999999999999976 689999999976533  455778899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          276 KGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       276 ~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      +++|.+.+...   ...+++.....++.++++|+.||   |+.+++|+||+|+||+++.++.++|+|||.+.        
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999988764   35788899999999999999999   78899999999999999999999999997542        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++||||+|++++||++|+.||.....     .....            ......   
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~------------~~~~~~---  219 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELAL------------KILKGQ---  219 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHH------------HHhcCC---
Confidence                             12356789999999999999999999864321     11111            111000   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+..++.++.+++.+||..+|++|||+.|++.
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            01122245667899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=2.7e-31  Score=254.84  Aligned_cols=240  Identities=22%  Similarity=0.225  Sum_probs=172.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence            45678999999999999976 689999999865432  233568899999999999999999999999999999999996


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC--------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME--------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~--------  345 (453)
                       ++|.+.+.... ...+......++.+++.||.||   |+++++||||+|+||+++. ++.+||+|||++..        
T Consensus        85 -~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         85 -LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             -ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence             57877775433 2356677778899999999999   7889999999999999985 56789999975421        


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC-Cch-h---hhhhhhhh
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP-ISL-M---EVVDKTLL  402 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~-~---~~~d~~~~  402 (453)
                                        ..++.++|||||||++|||+||.+||......+.....+.....+ ... .   ...+....
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence                              124568999999999999999999986542221111100000000 000 0   00000000


Q ss_pred             cC---ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SG---EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~---~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..   ...........++++.+++.+|++.+|++||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00   00000011234567899999999999999999999875

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-31  Score=247.37  Aligned_cols=220  Identities=29%  Similarity=0.396  Sum_probs=179.0

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|++|.||++... +++.||+|.+.....  ...+.+.+|++++++++|||++++++++.+++..++++||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            45678999999999999866 688999999976643  455789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      +++|.+++... ..+++.....++.+++.++.||   |+.+++||||+|+||+++.++.++|+|||++..          
T Consensus        83 ~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          83 NGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence            99999988765 4688899999999999999999   889999999999999999999999999975421          


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ...+.++||||+|+++|||++|..||.....    .......         .    . .  ....
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~---------~----~-~--~~~~  218 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRI---------V----Q-D--DHPP  218 (254)
T ss_pred             cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHH---------h----c-c--CCCC
Confidence                           1245679999999999999999999864321    1111000         0    0 0  0111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+...+.++.+++.+||..+|++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            22344667899999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=4.3e-31  Score=247.58  Aligned_cols=222  Identities=26%  Similarity=0.348  Sum_probs=180.1

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~E~  273 (453)
                      .+.+.||+|++|.||+|..+ ++..|++|.+.....  ...+.+.+|++++++++||||+++++.+...  ...++++||
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   82 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY   82 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence            34578999999999999977 689999999876542  4567889999999999999999999999988  889999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++++|.+++.... .+++.....++.++++++.||   |+.+++|+|++|+||+++.++.++|+||+....        
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          83 VSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            99999999987655 788899999999999999999   789999999999999999999999999964311        


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                         ...+.++||||||++++|+++|..||.....    .......        ..    .  ..
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~--------~~----~--~~  220 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYK--------IG----S--SG  220 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHh--------cc----c--cC
Confidence                               1246689999999999999999999865420    0000000        00    0  00


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+...+.++.+++.+|++.+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111233445678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=253.20  Aligned_cols=238  Identities=23%  Similarity=0.272  Sum_probs=179.5

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.+.||+|++|.||+|... +++.+|+|.++....  .....+.+|++++++++|+||+++++++..++..++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            4567999999999999875 689999999875532  2446788999999999999999999999999999999999975


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                       ++.+.+......+++.....++.+++.|+.||   |+.+++|+||||+||+++.++.++|+|||.+.            
T Consensus        83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence             88888877556788899999999999999999   78899999999999999999999999996431            


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---cCCc---hhhhhhhhhh--
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---LPIS---LMEVVDKTLL--  402 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~---~~~~~d~~~~--  402 (453)
                                    ....+.++||||+|+++||++||+.||......+. ........   .+..   ..+.......  
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence                          01456789999999999999999999865432111 11111100   0000   0000000000  


Q ss_pred             -cC-ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 -SG-EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 -~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .. ...........+.++.+++.+||+.+|.+||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             00 00011123456788999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=250.95  Aligned_cols=230  Identities=21%  Similarity=0.346  Sum_probs=186.0

Q ss_pred             hcccCCCCccEEEEEEECC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEEEe
Q 036792          201 SNLIGMGSFGSVYRARLRD------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALVLE  272 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~E  272 (453)
                      ..++-+|.||.||+|.|++      .+.|-+|.++... .-....++.|...+..+.|||+..+.+++.+ ....+.++.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            5678899999999997763      3557788777553 3345678899999999999999999998876 456788899


Q ss_pred             ccCCCCchHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC--
Q 036792          273 YMPKGSLENCLYSS-------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--  343 (453)
Q Consensus       273 ~~~~g~L~~~l~~~-------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~--  343 (453)
                      ++.-|+|..+|..+       ...+...+...++.|++.|++||   |+.+++|.||.++|++||+...+||+|=.++  
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhheeEEeccchhccc
Confidence            99999999999732       23456678889999999999999   8999999999999999999999999996322  


Q ss_pred             -------------------------CCCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          344 -------------------------MEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       344 -------------------------~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                               ....|+..+|||||||++|||+| |+.|+.....  ..+..++            
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--fEm~~yl------------  511 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--FEMEHYL------------  511 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--HHHHHHH------------
Confidence                                     22468899999999999999998 8889864422  1122222            


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhcC
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK  453 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~  453 (453)
                            ..+.+..+|-+||.++..+|..||+..|++||++++++..|.+....++|
T Consensus       512 ------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~  561 (563)
T KOG1024|consen  512 ------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR  561 (563)
T ss_pred             ------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence                  12334557789999999999999999999999999999999998877654

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.6e-32  Score=266.58  Aligned_cols=225  Identities=22%  Similarity=0.359  Sum_probs=179.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc----chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe--eEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE----CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF--KAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~l  269 (453)
                      +.+..++||+|+|-+||+|... +|.+||--.++..    .....++|..|+.+|+.|+|||||+++.++.+...  +-+
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            3466789999999999999865 6888885544322    24556899999999999999999999999988665  778


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGM----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~----  344 (453)
                      |+|.|..|+|..++...+ ..+.......+.||.+||.|||. |.++|+|||||-+||+|+. .|.|||+|.|+++    
T Consensus       121 iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999988765 56788888999999999999986 7899999999999999987 5899999998762    


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...|+..+||||||+.++||+|+..||..-......+++......|..+..+          
T Consensus       199 s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV----------  268 (632)
T KOG0584|consen  199 SHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV----------  268 (632)
T ss_pred             cccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc----------
Confidence                              2457889999999999999999999986433322223322222222222111          


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                              -.+++.+++.+|+.. .++|||+.|++.
T Consensus       269 --------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 --------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             --------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                    134688999999999 999999999875

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.1e-31  Score=260.85  Aligned_cols=243  Identities=19%  Similarity=0.235  Sum_probs=178.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-----CeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSND-----DFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l  269 (453)
                      |.+...||+|+||.||+|... ++..||||.++..  .......+.+|+.+++.++|+||+++++++...     ...++
T Consensus         7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l   86 (337)
T cd07858           7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI   86 (337)
T ss_pred             eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence            455678999999999999865 6899999998753  223345678899999999999999999988654     34799


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ++||+. ++|.+++.... .++......++.+++.|+.||   |+++++||||||+||+++.++.+||+|||++..    
T Consensus        87 v~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          87 VYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            999996 68988876543 588889999999999999999   788999999999999999999999999985421    


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc----CCchhhhhhh
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL----PISLMEVVDK  399 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~d~  399 (453)
                                            ..++.++|||||||++|||++|++||.......  .........    +.....+.+.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhcCch
Confidence                                  235678999999999999999999996532111  011111000    0000000000


Q ss_pred             h-------hhcCccCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHHH--HHHH
Q 036792          400 T-------LLSGEKKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR--LLKI  447 (453)
Q Consensus       400 ~-------~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i  447 (453)
                      .       ........ ......++.++.+++.+||+.+|++|||++|+++.  +..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0       00000000 01123467788999999999999999999999865  5444

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=5.6e-32  Score=264.91  Aligned_cols=223  Identities=27%  Similarity=0.354  Sum_probs=183.3

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ...|.+...||+|.|+.|..|++. ++..||||.+++...  ...+.+.+|+++|+.++|||||+++.+...+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            355677889999999999999976 799999999987643  34456899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+.+|.+++++......-+ .....+..|+..+++|+   |++.|+|||||++|+|++.++++||+|||++..      
T Consensus       135 eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999999999988765555 66667888999999999   999999999999999999999999999986531      


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                         ....+++|+||+|+++|-|+.|..||++....+.                 -++.+...- 
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------------r~rvl~gk~-  272 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------------RPRVLRGKY-  272 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------------cchheeeee-
Confidence                               1235689999999999999999999986532221                 111222111 


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..+...+.++.+++.+.+..+|.+|++++++.+
T Consensus       273 ---rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  273 ---RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ---cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence               122334456788999999999999999999875

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=3e-31  Score=256.20  Aligned_cols=238  Identities=22%  Similarity=0.291  Sum_probs=173.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC--------e
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD--------F  266 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~  266 (453)
                      |++.+.||+|+||.||+|... +++.||||.+....  ......+.+|++++++++||||++++++|...+        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            556788999999999999976 68999999986542  222345678999999999999999999987654        3


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-  345 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-  345 (453)
                      .++||||+. ++|.+.+......+++.....++.|++.|+.||   |+.+++|+||||+||+++.++.+||+|||.+.. 
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            599999996 488888876655688899999999999999999   788999999999999999999999999975410 


Q ss_pred             -----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---cCCch
Q 036792          346 -----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---LPISL  393 (453)
Q Consensus       346 -----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~  393 (453)
                                                   ..++.++||||||+++|||++|.+||.......  ....+...   .+..+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  247 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCGSITPEV  247 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhh
Confidence                                         124568999999999999999999986542211  11111111   11110


Q ss_pred             h------hhhhhhhhcCccCCchh-----hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 M------EVVDKTLLSGEKKGFVA-----KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 ~------~~~d~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .      +..+....... .....     .......+.+++.+||..+|++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         248 WPGVDKLELFKKMELPQG-QKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccccchhhhhhccCCCc-cchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0      00000000000 00000     0012346789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=261.40  Aligned_cols=238  Identities=18%  Similarity=0.222  Sum_probs=174.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-----eeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-----FKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv  270 (453)
                      |++.+.||+|+||.||+|... +|+.||||.+.... ......+.+|+.++++++||||+++++++....     ..+++
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   86 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV   86 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence            456788999999999999865 68999999986432 234567889999999999999999999876543     57999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      +||+++ +|.+.+...  .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++..     
T Consensus        87 ~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          87 QELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             ehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            999964 888777543  478888889999999999999   788999999999999999999999999975410     


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC----Cchhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP----ISLMEVV  397 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  397 (453)
                                              ..++.++|||||||++|||++|+.||......  ...........    .....+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHHhh
Confidence                                    13456799999999999999999998643211  11111111111    1111111


Q ss_pred             hhhh----hcCc-cCCch---hhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          398 DKTL----LSGE-KKGFV---AKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       398 d~~~----~~~~-~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      +...    .... ....+   .....+.++.+++.+||+.+|++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1100    0000 00000   112345678999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.4e-31  Score=251.76  Aligned_cols=239  Identities=21%  Similarity=0.240  Sum_probs=174.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+.+.||+|+||.||+|... +++.||||.+..... .......+|+..+++++ |||++++++++..++..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            34678999999999999976 578999999875532 22234567899999999 999999999999999999999999 


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+.+.... ..+++.....++.+++.++.||   |+++++|+||+|+||+++.++.++|+|||...          
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            789998887643 4678999999999999999999   78899999999999999999999999996431          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhh---hcCCchhh------hhhhh
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN---LLPISLME------VVDKT  400 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~------~~d~~  400 (453)
                                     ...++.++|+||||++++||++|++||......+. .......   .....+.+      .++..
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence                           11246689999999999999999999865422111 1100000   00000000      00000


Q ss_pred             hhcCccCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........ .......+..+.+++.+||+.+|++|||++|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000 0001112467899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=4.6e-31  Score=252.78  Aligned_cols=223  Identities=24%  Similarity=0.293  Sum_probs=172.8

Q ss_pred             HHhcccCCCCccEEEEEEE----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEE
Q 036792          199 RLSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQEC----ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  269 (453)
                      ++.+.||+|+||.||+++.    .+|..||+|+++...    ....+.+.+|++++.++ +|+||+++.+.+..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            4567899999999999985    368999999997542    22346788899999999 58999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      |+||+++++|.+++.... .++......++.++++||.||   |+.+++||||+|+||+++.++.+||+|||++..    
T Consensus        83 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          83 ILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            999999999999887643 567777788888999999999   889999999999999999999999999975421    


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                              ..++.++||||||+++|||++|..||..... ......+            .+...
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~------------~~~~~  225 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEI------------SRRIL  225 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHH------------HHHhh
Confidence                                    1234679999999999999999999853211 1111111            11111


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ...    .+.+..++..+.+++.+||+.+|++||     ++++++.
T Consensus       226 ~~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         226 KSE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ccC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            111    112234566788999999999999997     5666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=7.8e-31  Score=250.36  Aligned_cols=239  Identities=23%  Similarity=0.285  Sum_probs=173.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcC---CCCCceeEEeEEecCCe-----e
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSI---RHPNLVKVISSCSNDDF-----K  267 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~  267 (453)
                      ++.+.||+|+||.||+|+++ ++..||+|.++....  .....+.+|+.+++++   +|||++++++++...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            34578999999999999987 489999999974422  2234566787776655   69999999999988776     8


Q ss_pred             EEEEeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-
Q 036792          268 ALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-  345 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-  345 (453)
                      +++|||+.+ +|.+++.... ..+++.....++.++++||.||   |+.+++|+|++|+||+++.++.++|+|||.+.. 
T Consensus        82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            999999974 8988876533 3588999999999999999999   788999999999999999999999999975421 


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CCc--hhhhh--
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PIS--LMEVV--  397 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~--  397 (453)
                                             ..++.++|||||||++|||++|.+||......+ ....+..... +..  +....  
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCccc
Confidence                                   234668999999999999999999987543211 1122211110 000  00000  


Q ss_pred             hhhhhcCc--cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLSGE--KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~~~--~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........  ..........+..+.+++.+||+.||++||+++|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000000  0001112244577889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.7e-31  Score=260.65  Aligned_cols=244  Identities=21%  Similarity=0.268  Sum_probs=182.0

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-----eeEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-----FKALV  270 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv  270 (453)
                      ++.+.||+|+||.||+|... ++..||||.+....  ....+.+.+|+.+++.++||||+++.+++...+     ..+++
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            45678999999999999976 58999999987653  344567899999999999999999999988775     78999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      |||++ ++|.+++.... .+++.....++.++++|+.||   |+.+++||||||+||+++.++.++|+|||++..     
T Consensus        83 ~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          83 TELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             ecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            99997 48988887654 688899999999999999999   888999999999999999999999999975321     


Q ss_pred             -----------------------C-CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC----------
Q 036792          346 -----------------------G-QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI----------  391 (453)
Q Consensus       346 -----------------------~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  391 (453)
                                             . .++.++|+||||+++|||++|.+||......+. . ..+......          
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~-~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-L-NLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-H-HHHHHhcCCCChhHhhhcc
Confidence                                   1 456689999999999999999999975532211 1 111111000          


Q ss_pred             --chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH--HHHHHH
Q 036792          392 --SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR--LLKIRD  449 (453)
Q Consensus       392 --~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~  449 (453)
                        ...+.+..................+.++.+++.+||+.+|++||+++++++.  +++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence              0011111000000000001112346788999999999999999999999874  555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=4.1e-31  Score=247.91  Aligned_cols=221  Identities=23%  Similarity=0.324  Sum_probs=178.7

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||++... +++.+|+|.+....  .....++.+|++++++++|+||+++.+++.+....++|+||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            45678999999999999865 68899999987542  3345678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          276 KGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       276 ~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      +++|.+++...   ...+++.....++.++++|+.||   |+.+++|+||+|+||+++.++.+|++|||++.        
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  159 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK  159 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence            99999988652   24578888899999999999999   89999999999999999999999999997542        


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++|+||+|+++||+++|+.||......+  ....+            .    ..  ...
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~~------------~----~~--~~~  219 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYKV------------Q----RG--KYP  219 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH------------h----cC--CCC
Confidence                           1234668999999999999999999986542211  01000            0    00  011


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...+.++.+++.+||..+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            223356678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=6.9e-31  Score=256.10  Aligned_cols=240  Identities=21%  Similarity=0.233  Sum_probs=174.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||++... ++..||||.+....  ....+.+.+|++++++++||||+++.+++.. ....++++||
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            455688999999999999865 78999999886432  2334678899999999999999999998866 5678999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      + +++|.+.+...  .++......++.++++|+.||   |+.+++||||+|+||++++++.++|+|||.+..        
T Consensus        92 ~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  165 (328)
T cd07856          92 L-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY  165 (328)
T ss_pred             h-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence            8 56898877643  366777778999999999999   889999999999999999999999999975421        


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccc--cHH--------hHHhhhcCCchhhhhhhh
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEEL--SLK--------DWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~--~~~--------~~~~~~~~~~~~~~~d~~  400 (453)
                                     ..++.++|||||||++||++||++||........  .+.        ++..........+.+...
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (328)
T cd07856         166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL  245 (328)
T ss_pred             cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence                           2356789999999999999999999865422110  000        011100000011111110


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ......+.......++.++.+++.+||+.+|++|||+++++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000001112345789999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=6.2e-31  Score=259.16  Aligned_cols=237  Identities=20%  Similarity=0.213  Sum_probs=172.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  268 (453)
                      |++.+.||+|+||.||+|... +++.||||.+...  .....+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            445678999999999999865 7899999998643  233446778899999999999999999988643      3569


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+. ++|.+.+...   ++......++.|++.||.||   |+.+++||||||+||+++.++.+||+|||.+.    
T Consensus        98 lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          98 LVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             EEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            9999996 4888777543   67788888999999999999   78899999999999999999999999997642    


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhhhhhhhh-
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLMEVVDKTL-  401 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~-  401 (453)
                                          ...++.++|||||||++|||++|+.||......+ .+.......  .+....+.++... 
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhhhh
Confidence                                1235678999999999999999999986432111 011111100  0001111111000 


Q ss_pred             ---hcCc---cC--------------CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 ---LSGE---KK--------------GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ---~~~~---~~--------------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ....   ..              ........+.++.+++.+||+.||++|||++|++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               0000   00              00001234567899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=264.21  Aligned_cols=246  Identities=26%  Similarity=0.327  Sum_probs=175.9

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeEEEE
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKALVL  271 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~  271 (453)
                      ..+.||+|+||.||+|+.+ +|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+..      ...+||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            3577999999999999966 7999999999865 3466788999999999999999999998765543      467999


Q ss_pred             eccCCCCchHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC--CCC--cEEEeccccCCC
Q 036792          272 EYMPKGSLENCLYSS--TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD--EDM--VAHLSDFEYGME  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~--~~~--~~kl~df~~~~~  345 (453)
                      |||.+|||+..|...  ...++....+.+..+++.||.||   |+++|+||||||.||++-  .++  .-||+|||++..
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999764  45788999999999999999999   899999999999999984  333  469999987632


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccc-cHHhHHhhh-cCCchhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEEL-SLKDWVNNL-LPISLMEVVD  398 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~~d  398 (453)
                                               ..|+..+|.|||||++||.+||..||.......- .-..|..-. .|..+.-..+
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~  253 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ  253 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence                                     4577789999999999999999999964322110 001222111 1211111111


Q ss_pred             hhhh-----cCccCC-chhhHHHHHHHHHHhhhccccCcccCC--ChHHHHHHHHHHH
Q 036792          399 KTLL-----SGEKKG-FVAKEQCVLSILGLAMECAMELPEKRI--NAKDIVTRLLKIR  448 (453)
Q Consensus       399 ~~~~-----~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RP--s~~~v~~~L~~i~  448 (453)
                      +...     +...+. .......-..+-..+...+..+|++|.  .+.+....+..|-
T Consensus       254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            1111     000010 001112223344566677888899998  7666666665553

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=246.27  Aligned_cols=221  Identities=21%  Similarity=0.305  Sum_probs=173.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc-----chhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE-----CARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  269 (453)
                      +++.+.||+|+||.||+|... ++..||+|.+...     .......+.+|++++++++|+||+++++++.+.  +..++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            356788999999999999865 6899999987532     123456788999999999999999999998764  46789


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ++||+++++|.+++.... .+++.....++.+++.|+.||   |+.+++|+||||+||+++.++.++|+|||+...    
T Consensus        84 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          84 FVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            999999999999887643 477888889999999999999   788999999999999999999999999975521    


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                              ..++.++|+|||||++||+++|+.||......+    .             +....
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~-------------~~~~~  222 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----A-------------IFKIA  222 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----H-------------HHHHH
Confidence                                    124567999999999999999999986431111    0             00000


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...  .....+...++++.+++.+||. +|..||++.+++.
T Consensus       223 ~~~--~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQP--TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCC--CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            000  0112334456778999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.3e-31  Score=256.52  Aligned_cols=226  Identities=18%  Similarity=0.227  Sum_probs=176.1

Q ss_pred             HHHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ...|++.+.||.||.+.||++...+.+.||+|++....  ......|..|+.+|.+++ |.+||++++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            46788899999999999999998888899999876443  355678999999999996 899999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||= .-||.++|.......+-.....+..|+++++.+.   |..+|||.||||.|+|+-. |.+||+|||++..      
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence            975 4599999988765555346778889999999998   8999999999999999864 6899999987521      


Q ss_pred             --------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCch
Q 036792          346 --------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       346 --------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                                                      -+++.++||||+||+||+|+.|++||......-..            +
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aK------------l  582 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAK------------L  582 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHH------------H
Confidence                                            13567899999999999999999998643211111            1


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+.|+.-. -+  ....+.  ..++.++|..||+.||.+||+..++++
T Consensus       583 ~aI~~P~~~-Ie--fp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHE-IE--FPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCcc-cc--ccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            112221110 00  001111  223899999999999999999999885

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=5.2e-31  Score=252.13  Aligned_cols=227  Identities=22%  Similarity=0.271  Sum_probs=175.8

Q ss_pred             HHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc----hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC----ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  269 (453)
                      ++.+.||+|+||.||+++..    ++..||||.++...    ....+.+.+|++++.++ +||||+++.+.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            34578999999999999743    57899999987542    22345688999999999 59999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ||||+++|+|.+++.... .+++.....++.|+++++.||   |+.+++||||+|+||+++.++.++++|||++..    
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          83 ILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            999999999999886543 577888888999999999999   788999999999999999999999999975421    


Q ss_pred             ----------------------C--CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 ----------------------G--QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 ----------------------~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            .  ..+.++||||||+++|||++|..||..... ......+..            ...
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~------------~~~  225 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISR------------RIL  225 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHH------------HHH
Confidence                                  0  145689999999999999999999853211 001111111            001


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      . .   ..+.+...+.++.+++.+||+.+|++|||++++...|+.
T Consensus       226 ~-~---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         226 K-S---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             c-c---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0 1   011223355678999999999999999999888766643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.1e-31  Score=256.89  Aligned_cols=237  Identities=19%  Similarity=0.224  Sum_probs=173.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~  268 (453)
                      |.+.+.||+|+||.||++... ++..||||.+....  ....+.+.+|+++|++++||||+++++++..+.      ..+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY   96 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence            445678999999999999855 78999999986432  223456889999999999999999999887653      358


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +||||+ +++|.+++...  .+++.....++.++++|+.||   |+.+|+||||||+||+++.++.++++|||++..   
T Consensus        97 lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          97 LVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             EEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            999999 77898877643  578888999999999999999   889999999999999999999999999986421   


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhhhhhhh---
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLMEVVDKT---  400 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~---  400 (453)
                                          ..++.++|+||+||++||+++|..||....... .........  .+....+.+...   
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07880         171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEFVQKLQSEDAK  249 (343)
T ss_pred             CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhcchhHH
Confidence                                135568999999999999999999987542211 111111100  000010100000   


Q ss_pred             --hhcCcc-C---CchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          401 --LLSGEK-K---GFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       401 --~~~~~~-~---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                        ...... .   .......++.++.+++.+|++.+|++|||+.+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence              000000 0   0011124556789999999999999999999988

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=8.5e-31  Score=251.56  Aligned_cols=230  Identities=19%  Similarity=0.220  Sum_probs=160.8

Q ss_pred             HHHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccchhh-----------HHHHHHHHHHHHcCCCCCceeEEeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQECARA-----------LKSFEAQCEVMKSIRHPNLVKVISSC  261 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~~  261 (453)
                      .+++.+.||+|+||.||+|.+.+    +..+|+|.........           ......+...+..++|+|++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            35677899999999999998763    4566777543222110           01122333456677899999999876


Q ss_pred             ecCC----eeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEE
Q 036792          262 SNDD----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHL  337 (453)
Q Consensus       262 ~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl  337 (453)
                      ....    ..++++|++.. ++.+.+... ...++.....++.|+++|+.||   |+++|+||||||+|||++.++.++|
T Consensus        93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcEEE
Confidence            5543    34678887743 565555432 2346677788999999999999   7889999999999999999999999


Q ss_pred             eccccCCC--------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHH
Q 036792          338 SDFEYGME--------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWV  385 (453)
Q Consensus       338 ~df~~~~~--------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~  385 (453)
                      +|||++..                                ..++.++|||||||++|||++|+.||..............
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99987521                                1246689999999999999999999975522211111000


Q ss_pred             hhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          386 NNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       386 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                              .+.+.. +...    ......++.++.+++..||..+|++||+++++.+.|
T Consensus       248 --------~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        248 --------CDFIKR-LHEG----KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             --------HHHHHH-hhhh----hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                    001111 1000    001234567899999999999999999999998876

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=7.1e-31  Score=257.59  Aligned_cols=237  Identities=22%  Similarity=0.276  Sum_probs=173.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------------
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSND------------  264 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------------  264 (453)
                      +++.+.||+|+||.||+|... +|..||+|.+........+.+.+|++++++++||||+++++++...            
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT   86 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence            445678999999999999865 6899999999766555667788999999999999999999776543            


Q ss_pred             --CeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccc
Q 036792          265 --DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFE  341 (453)
Q Consensus       265 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~  341 (453)
                        ...++|+||++ ++|.+.+...  .+++.....++.|++.|+.||   |+.+++||||||+||+++. +..++++|||
T Consensus        87 ~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          87 ELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence              35789999997 5898877543  477888889999999999999   7889999999999999974 5678999997


Q ss_pred             cCCC-----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc
Q 036792          342 YGME-----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       342 ~~~~-----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      ++..                             ..++.++|||||||++|||++|+.||......+ ........ .+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~  238 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES-VPVV  238 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCC
Confidence            6420                             124567999999999999999999996542211 11111111 0100


Q ss_pred             -------hhhhhhhhhh-cCccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          393 -------LMEVVDKTLL-SGEKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       393 -------~~~~~d~~~~-~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             .......... .......   ......+.++.+++.+||+.+|++|||++|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                   0000001110 0000000   111234567889999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=8.7e-31  Score=253.10  Aligned_cols=240  Identities=23%  Similarity=0.267  Sum_probs=172.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCceeEEeEEecCC--------e
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR--ALKSFEAQCEVMKSIRHPNLVKVISSCSNDD--------F  266 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------~  266 (453)
                      +++.+.||+|+||.||+|... +++.||||.+......  ....+.+|+++++.++||||+++++++....        .
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   89 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS   89 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence            456788999999999999976 6899999998654322  2346778999999999999999999875433        4


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-  345 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-  345 (453)
                      .++|+||+.+ ++...+......+++.....++.++++||.||   |+.+++|+||||+||++++++.++|+|||+... 
T Consensus        90 ~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          90 VYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            6999999965 78777766555788999999999999999999   788999999999999999999999999975420 


Q ss_pred             ------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc
Q 036792          346 ------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL  389 (453)
Q Consensus       346 ------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~  389 (453)
                                                          ..++.++|||||||++|||++|++||........ .........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~  244 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFKLCG  244 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhC
Confidence                                                1245679999999999999999999865432111 111111000


Q ss_pred             ---CCch------hhhhhhhhhcCccCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          390 ---PISL------MEVVDKTLLSGEKKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       390 ---~~~~------~~~~d~~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         +...      ....+.......... ........+.+.+++.+|++.+|++|||+.|++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence               0000      000000000000000 0011123357889999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.4e-31  Score=258.51  Aligned_cols=238  Identities=21%  Similarity=0.229  Sum_probs=174.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe------eE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF------KA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~  268 (453)
                      |++...||+|+||.||+|+.. ++..||||.+....  ....+.+.+|+.++++++|||++++++++...+.      .+
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY   96 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence            355788999999999999976 68899999986532  2334667889999999999999999988766554      89


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +|+||+ +++|.+++...  .+++.....++.++++|+.||   |+.+++||||||+||+++.++.++|+|||++..   
T Consensus        97 lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          97 LVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             EEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            999998 66998888653  478888999999999999999   788999999999999999999999999976421   


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCch---------h
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISL---------M  394 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~---------~  394 (453)
                                          ..++.++|||||||++||+++|+.||......+ .+.......  .++.+         .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07851         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKISSESAR  249 (343)
T ss_pred             cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhccchhHH
Confidence                                134568999999999999999999986432211 111111100  01000         0


Q ss_pred             hhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+..................+.++.+++.+||+.+|++|||+.|++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000000000000000111234678999999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-30  Score=254.56  Aligned_cols=241  Identities=20%  Similarity=0.244  Sum_probs=172.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKAL  269 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l  269 (453)
                      .+.+.||+|+||.||+|... +|+.||||.+....  ......+.+|++++++++||||+++++++....      ..++
T Consensus        18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   97 (342)
T cd07879          18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL   97 (342)
T ss_pred             EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence            44678999999999999865 68999999987542  223456889999999999999999999887543      4689


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      |+||+.. +|.+...   ..+++.....++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||+...    
T Consensus        98 v~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          98 VMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             Eeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            9999964 7766542   2477888889999999999999   788999999999999999999999999985421    


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---chhhhhhhhh--
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SLMEVVDKTL--  401 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~~--  401 (453)
                                         ..++.++|||||||++|||++|+.||....... .+.... ...+.   ...+..+...  
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~  248 (342)
T cd07879         171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQIL-KVTGVPGPEFVQKLEDKAAK  248 (342)
T ss_pred             CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCCHHHHHHhcccchH
Confidence                               134668999999999999999999997532111 111111 11111   1111111000  


Q ss_pred             ---hcCcc-CCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHHH--HHHHH
Q 036792          402 ---LSGEK-KGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVTR--LLKIR  448 (453)
Q Consensus       402 ---~~~~~-~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~  448 (453)
                         ..... ...   ......+.++.+++.+||+.||++||+++|++..  ++..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence               00000 000   0011245678899999999999999999999843  54443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-30  Score=246.43  Aligned_cols=237  Identities=26%  Similarity=0.285  Sum_probs=177.4

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.+.||+|+||.||+|... +++.||+|.+....  ....+.+..|+++++.++|+|++++++++...+..++|+||++ 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            3467999999999999976 58999999998653  3334678889999999999999999999999999999999997 


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                      ++|.+++......+++.....++.++++|+.||   |+.+++||||+|+||++++++.++|+|||....           
T Consensus        82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            599999987645688999999999999999999   788999999999999999999999999975321           


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc----CCchhhhhhh-----hh
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL----PISLMEVVDK-----TL  401 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~d~-----~~  401 (453)
                                     ..++.++|||||||++||+++|.+||......+.  ........    +..+.+..+.     ..
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ--LFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHHHhCCCcHHHHHhhcccccccccc
Confidence                           1456689999999999999999999865422111  01111100    0000000000     00


Q ss_pred             hcCccCCc-hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGF-VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........ ...+..+.++.+++.+||+.+|++||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000 001122567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.8e-30  Score=244.49  Aligned_cols=221  Identities=21%  Similarity=0.273  Sum_probs=170.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-----ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      |.+.+.||+|+||.||++... .+..+++|.++...     .....++.+|+.+++.++||||+++++++.+....++|+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            345678999999999999865 34556666655321     223346778999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          272 EYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      ||+++++|.+++..   ....+++.....++.++++|+.||   |+.+++|+||||+||++++ ..++++|||++.    
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999988854   234678889999999999999999   7899999999999999986 469999997531    


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ...++.++|+||||+++|||++|..||.....     ......            .. .
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~------------~~-~  219 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLR------------IV-E  219 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH------------HH-c
Confidence                                 12345689999999999999999999853211     111100            00 0


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..  ....+..++.++.+++.+||..+|++||++.|+++
T Consensus       220 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 GP--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CC--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            10  11123456678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=241.21  Aligned_cols=221  Identities=25%  Similarity=0.295  Sum_probs=166.0

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHH-HHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEV-MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      ..||.|+||+|++-.++ .|+.+|||+++.... ...++++.|.+. |+.-+.||||+++|++..++..||.||.|.- +
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence            46899999999999887 699999999986643 556788888875 5556789999999999999999999999954 6


Q ss_pred             chHHhh---c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-----------
Q 036792          279 LENCLY---S-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-----------  343 (453)
Q Consensus       279 L~~~l~---~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-----------  343 (453)
                      |..+-.   . ....++..-.-.|..-.+.||.||.  ....|+|||+||+|||++..|.+||||||+.           
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK--~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~  226 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK--EELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV  226 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH--HHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence            654332   1 1223444444456666789999996  4557999999999999999999999999753           


Q ss_pred             ---------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          344 ---------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       344 ---------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                     ....|+.+|||||+|++|||++||+.|++.+..-...+.+.+...+|                 .
T Consensus       227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp-----------------~  289 (361)
T KOG1006|consen  227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP-----------------I  289 (361)
T ss_pred             ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC-----------------e
Confidence                           11247889999999999999999999997653322122222211111                 1


Q ss_pred             chhhH---HHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKE---QCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~---~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+.   +.+..+..++..|+.+|-++||+..++..
T Consensus       290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11122   24567899999999999999999988754

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.4e-30  Score=250.95  Aligned_cols=237  Identities=20%  Similarity=0.191  Sum_probs=170.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-C--CCEEEEEEeeccc--hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC----CeeE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-D--GIEVAVKVFHQEC--ARALKSFEAQCEVMKSI-RHPNLVKVISSCSND----DFKA  268 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~~  268 (453)
                      ++.+.||+|+||.||++... +  +..||||.+....  ....+.+.+|+++++++ +||||+++++++...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            34578999999999999965 4  7899999987532  22346788899999999 599999999875432    4578


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +++||+. ++|.+.+.... .+++.....++.|++.||.||   |+.+++||||||+||+++.++.+||+|||++..   
T Consensus        83 ~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          83 LYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            8899986 68988886543 578888999999999999999   788999999999999999999999999985421   


Q ss_pred             ---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc---CCch-h
Q 036792          346 ---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL---PISL-M  394 (453)
Q Consensus       346 ---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~-~  394 (453)
                                                 ..++.++||||+||++||+++|++||......  ..........   +... .
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence                                       12456789999999999999999998653211  1111111110   0000 0


Q ss_pred             hhhhh-------hhhcCccCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 EVVDK-------TLLSGEKKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 ~~~d~-------~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ++.+.       ......... .......+.++.+++.+|++.+|++|||++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000       000000000 0111223567899999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.5e-30  Score=247.30  Aligned_cols=219  Identities=24%  Similarity=0.377  Sum_probs=176.2

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      .+.+.||+|+||.||++..+ ++..||+|++....   ....+.+.+|++++.+++ ||||+++++++..++..++||||
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            45678999999999999976 78999999987532   233467888999999998 99999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++++|.+.+.... .+++.....++.+++.|+.||   |+.+++|+|++|+||+++.++.++++|||+...        
T Consensus        84 ~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          84 APNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            99999999987654 688999999999999999999   788999999999999999999999999975321        


Q ss_pred             -------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh
Q 036792          346 -------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL  388 (453)
Q Consensus       346 -------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~  388 (453)
                                                           ...+.++||||||++++|+++|..||......    . ...  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~--  232 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----L-TFQ--  232 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----H-HHH--
Confidence                                                 12355799999999999999999998644210    0 000  


Q ss_pred             cCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCCh----HHHHH
Q 036792          389 LPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINA----KDIVT  442 (453)
Q Consensus       389 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~~v~~  442 (453)
                            ...+    .    ....+...++.+.+++.+||+.+|++||++    +++++
T Consensus       233 ------~~~~----~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 ------KILK----L----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ------HHHh----c----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                  0000    0    011223346678999999999999999999    77653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.3e-30  Score=252.30  Aligned_cols=237  Identities=22%  Similarity=0.247  Sum_probs=171.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKAL  269 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l  269 (453)
                      .+.+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++||||+++++++...      ...++
T Consensus        20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   99 (345)
T cd07877          20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL   99 (345)
T ss_pred             EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence            45678999999999999854 78999999987542  22346688899999999999999999988643      34678


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ++|++ +++|.+++...  .+++.....++.|+++|+.||   |+.+++||||||+||+++.++.+||+|||++..    
T Consensus       100 v~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~  173 (345)
T cd07877         100 VTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  173 (345)
T ss_pred             Eehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence            88877 78998877653  478888899999999999999   788999999999999999999999999976421    


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhh--hcCCchhhhhh-h----
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN--LLPISLMEVVD-K----  399 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~d-~----  399 (453)
                                         ..++.++|||||||++|||++|+.||....... ........  ..+..+...+. .    
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence                               234668999999999999999999986432211 11111110  01111100000 0    


Q ss_pred             ---hhhcCccCCc-hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 ---TLLSGEKKGF-VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ---~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         .+........ ......+.++.+++.+|++.+|.+||++.+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence               0000000000 001123567899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.6e-30  Score=238.49  Aligned_cols=211  Identities=28%  Similarity=0.338  Sum_probs=170.8

Q ss_pred             cCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ||+|+||.||++... +++.+|+|.++....   .....+..|++++++++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 589999999876532   2456788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------  345 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------------  345 (453)
                      .+++.... .+++.....++.++++|+.|+   |+.+++|+||+|+||+++.++.++++|||....              
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            99987654 578888999999999999999   789999999999999999999999999975421              


Q ss_pred             -----------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHH
Q 036792          346 -----------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQ  414 (453)
Q Consensus       346 -----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  414 (453)
                                 ...+.++|+||||+++||+++|..||.....     .....            .... .   ....+..
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~------------~~~~-~---~~~~~~~  215 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYE------------KILK-D---PLRFPEF  215 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHH------------HHhc-C---CCCCCCC
Confidence                       1235679999999999999999999864321     11110            0000 0   1112233


Q ss_pred             HHHHHHHHhhhccccCcccCCChHH
Q 036792          415 CVLSILGLAMECAMELPEKRINAKD  439 (453)
Q Consensus       415 ~~~~~~~l~~~Cl~~~P~~RPs~~~  439 (453)
                      .+.++.+++.+||..+|++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            3567899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.8e-30  Score=265.05  Aligned_cols=242  Identities=17%  Similarity=0.199  Sum_probs=162.9

Q ss_pred             HHHHhcccCCCCccEEEEEEECC--CCEEEEEEe--------------ec---cchhhHHHHHHHHHHHHcCCCCCceeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD--GIEVAVKVF--------------HQ---ECARALKSFEAQCEVMKSIRHPNLVKV  257 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~H~niv~l  257 (453)
                      .|++.+.||+|+||.||++.++.  +..+++|.+              .+   ........+.+|+++|++++|||||++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            35677899999999999987642  222222211              00   111234568899999999999999999


Q ss_pred             EeEEecCCeeEEEEeccCCCCchHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          258 ISSCSNDDFKALVLEYMPKGSLENCLYSST----CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       258 ~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                      ++++..++..++|+|++. ++|.+++....    ..........++.|++.||.||   |+++|+||||||+|||++.++
T Consensus       229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             eEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCC
Confidence            999999999999999985 57777765421    1122345667899999999999   788999999999999999999


Q ss_pred             cEEEeccccCC--------------------------CCCcCcccchHHHHHHHHHHHhCCCC-CCccccc-cccHHhHH
Q 036792          334 VAHLSDFEYGM--------------------------EGQVSTRSDIYGYGIVLMETFTRKKP-TDRMFVE-ELSLKDWV  385 (453)
Q Consensus       334 ~~kl~df~~~~--------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p-~~~~~~~-~~~~~~~~  385 (453)
                      .+||+|||++.                          ...++.++|||||||++|||++|..+ +...... ...+.+..
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            99999998652                          12356789999999999999998754 3321111 11111111


Q ss_pred             hh------hcCCc---hhhhhhhhhhcCccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          386 NN------LLPIS---LMEVVDKTLLSGEKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       386 ~~------~~~~~---~~~~~d~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..      .++..   ..+.++...........   ......+..+.+++.+|++.||.+|||+.|++.
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11      01111   11111111100000000   001123456788899999999999999999975

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-32  Score=281.24  Aligned_cols=219  Identities=26%  Similarity=0.361  Sum_probs=175.6

Q ss_pred             hcccCCCCccEEEEEE-ECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          201 SNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +..||.|.||.||.|. ..+|...|+|-++...  ....+...+|..++..+.|||+|+++|+-.+.+..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            5689999999999998 5579999999886442  344567789999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|.+.+...+ ..+..-...+..|++.|+.||   |+.+|||||+||+||+++.+|..|.+|||.+..            
T Consensus      1320 sLa~ll~~gr-i~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1320 SLASLLEHGR-IEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             cHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence            9999886543 345555566778999999999   899999999999999999999999999976421            


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                          .....++||||+|||+.||+||+.||.....+- .                +...+..+.
T Consensus      1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-a----------------IMy~V~~gh 1458 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-A----------------IMYHVAAGH 1458 (1509)
T ss_pred             HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-H----------------HHhHHhccC
Confidence                                112346899999999999999999986543221 1                111112222


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .+..|+..+.+-.+++.+|++.||+.|.++.|+++
T Consensus      1459 --~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 --KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             --CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence              23455668889999999999999999999887654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1e-29  Score=236.18  Aligned_cols=199  Identities=18%  Similarity=0.132  Sum_probs=158.0

Q ss_pred             CCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCchHHhhc
Q 036792          207 GSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYS  285 (453)
Q Consensus       207 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~  285 (453)
                      |.||.||+++.. +++.||+|.++...     .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+.+..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999965 68999999997543     233455555566799999999999999999999999999999998865


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------------------
Q 036792          286 STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------------------  344 (453)
Q Consensus       286 ~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------------------  344 (453)
                      .. .+++.....++.+++.|+.||   |+++++||||||+||+++.++.++++|||...                     
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~  154 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG  154 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCccc
Confidence            43 478888999999999999999   78999999999999999999999999997421                     


Q ss_pred             -CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHh
Q 036792          345 -EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLA  423 (453)
Q Consensus       345 -~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~  423 (453)
                       ...++.++||||+|+++|||++|..|+......               +..    .      .....+...+..+.+++
T Consensus       155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~----~------~~~~~~~~~~~~~~~li  209 (237)
T cd05576         155 GISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INT----H------TTLNIPEWVSEEARSLL  209 (237)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------ccc----c------cccCCcccCCHHHHHHH
Confidence             123567899999999999999999886432110               000    0      00011223456788999


Q ss_pred             hhccccCcccCCChHH
Q 036792          424 MECAMELPEKRINAKD  439 (453)
Q Consensus       424 ~~Cl~~~P~~RPs~~~  439 (453)
                      .+|++.||++||++.+
T Consensus       210 ~~~l~~dp~~R~~~~~  225 (237)
T cd05576         210 QQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHccCCHHHhcCCCc
Confidence            9999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=4.3e-30  Score=267.35  Aligned_cols=222  Identities=23%  Similarity=0.324  Sum_probs=162.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------------
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSND------------  264 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------------  264 (453)
                      +..++||+||||.||+++.+ +|+.||||++.... ........+|+..+++++|||||+++..+.+.            
T Consensus       482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~  561 (1351)
T KOG1035|consen  482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS  561 (1351)
T ss_pred             HHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence            44678999999999999987 89999999997653 33446788999999999999999998765310            


Q ss_pred             --------------------------------------------------------------------------------
Q 036792          265 --------------------------------------------------------------------------------  264 (453)
Q Consensus       265 --------------------------------------------------------------------------------  264 (453)
                                                                                                      
T Consensus       562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~  641 (1351)
T KOG1035|consen  562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI  641 (1351)
T ss_pred             chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence                                                                                            


Q ss_pred             ---------------------------CeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 036792          265 ---------------------------DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI  317 (453)
Q Consensus       265 ---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i  317 (453)
                                                 ..+||-||||+.-.+.+.+......-.......+..+|+.|+.|+   |+++|
T Consensus       642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI---H~~gi  718 (1351)
T KOG1035|consen  642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI---HDQGI  718 (1351)
T ss_pred             cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH---HhCce
Confidence                                       125788999988777777765442223455667899999999999   99999


Q ss_pred             eecCCCCCceeeCCCCcEEEeccccCCC----------------------------------------------CCcCcc
Q 036792          318 IHCDLKPISVLLDEDMVAHLSDFEYGME----------------------------------------------GQVSTR  351 (453)
Q Consensus       318 ~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------------------------------------------~~~~~~  351 (453)
                      |||||||.||++|++..+||+|||++..                                              ..|+.|
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            9999999999999999999999976421                                              257889


Q ss_pred             cchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCc
Q 036792          352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELP  431 (453)
Q Consensus       352 ~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P  431 (453)
                      +|+||+|||++||+.-   |......-..+........|..                ........+.-.+++..+++.||
T Consensus       799 iDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP~~----------------~~f~~~~~~~e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIPEP----------------ADFFDPEHPEEASLIRWLLSHDP  859 (1351)
T ss_pred             hhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCCCC----------------cccccccchHHHHHHHHHhcCCC
Confidence            9999999999999763   4321110000110000001100                00111223345678999999999


Q ss_pred             ccCCChHHHHH
Q 036792          432 EKRINAKDIVT  442 (453)
Q Consensus       432 ~~RPs~~~v~~  442 (453)
                      ++||||.|+++
T Consensus       860 ~kRPtA~eLL~  870 (1351)
T KOG1035|consen  860 SKRPTATELLN  870 (1351)
T ss_pred             ccCCCHHHHhh
Confidence            99999999885

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=6.6e-30  Score=230.77  Aligned_cols=174  Identities=22%  Similarity=0.315  Sum_probs=147.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC---C--CCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR---D--GIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  267 (453)
                      ..|++...||+|.||.||+|.-+   +  ...+|||+++.+.  .......-+|+.+++.++|||+|.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            44677888999999999999643   2  2379999998663  2334667899999999999999999998877 7889


Q ss_pred             EEEEeccCCCCchHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC----CcEEEec
Q 036792          268 ALVLEYMPKGSLENCLYSS----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED----MVAHLSD  339 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~----~~~kl~d  339 (453)
                      ++++||.+. ||.+.++-+    ...++......|+.|+..|+.||   |++-|+||||||+|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999988 898888543    24577778889999999999999   99999999999999999887    8999999


Q ss_pred             cccCC-----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCc
Q 036792          340 FEYGM-----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDR  373 (453)
Q Consensus       340 f~~~~-----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  373 (453)
                      +|++.                             ...|+...||||.||++.||+|-++-|.+
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            98652                             24578899999999999999999988764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-29  Score=208.54  Aligned_cols=239  Identities=20%  Similarity=0.204  Sum_probs=174.2

Q ss_pred             HhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      -.++||+|.||+||+|+.+ +++.||+|.++-+..  .--....+|+-+++.++|.|||+++++...+...-+|+|||..
T Consensus         6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq   85 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_pred             HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence            3578999999999999955 689999999975532  2224678999999999999999999999999999999999965


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----------  345 (453)
                       +|..+..+....++.......+.|+.+|+.|.   |+..+.|||+||.|.|++.+|+.|++|||++..           
T Consensus        86 -dlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   86 -DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             -HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence             88888877777788888889999999999998   888899999999999999999999999986531           


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH-hHHhhhcC-Cc---hhhhhhhhhhcC
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK-DWVNNLLP-IS---LMEVVDKTLLSG  404 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~-~~~~~~~~-~~---~~~~~d~~~~~~  404 (453)
                                     .-|++..|+||-||++.|+.. |.+-|.+...++.-.+ -|+-.... +.   +...-|......
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence                           236778999999999999987 4544665544332221 12211111 11   122222111110


Q ss_pred             ccCCch---hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFV---AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......   .-+.....-.+++...+.-+|..|.++++.++
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            000000   01111223357778888889999999998765

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=262.61  Aligned_cols=224  Identities=22%  Similarity=0.259  Sum_probs=173.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      .-+++..+||+|+||.|...+++ +++.||.|++.+..   .....-|..|..+|..-..+-||.++.+|.++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            33578899999999999999987 68999999998642   334567889999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC--------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------  343 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~--------  343 (453)
                      |||+||||-.++.... .++.....-++..++-||.-+   |+.|.||||+||+|||+|..|++||+|||..        
T Consensus       155 dY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             ecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            9999999999988766 566665555566777777777   9999999999999999999999999999631        


Q ss_pred             ----------------------CC-CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          344 ----------------------ME-GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       344 ----------------------~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                            .+ +.|+..+|.||+||++|||+.|..||+...                 +.+.+.+.
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----------------lveTY~KI  293 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----------------LVETYGKI  293 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----------------HHHHHHHH
Confidence                                  12 568889999999999999999999997432                 11222222


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC---hHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN---AKDIV  441 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~~v~  441 (453)
                      +...+...+|.....++++.+|+.+.+. +|+.|..   ++|+-
T Consensus       294 m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  294 MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            2221111222223466778888777554 4677766   66653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=247.68  Aligned_cols=215  Identities=20%  Similarity=0.239  Sum_probs=169.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHH-cCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMK-SIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .|.+...+|.|+|+.|-++.+. +++..+||++.+...    .-.+|+.++. .-+||||+++.+.+.++.+.|+|||++
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            3455667999999999999865 689999999976622    2345665544 447999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee-CCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL-DEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl-~~~~~~kl~df~~~~---------  344 (453)
                      .||-+.+.+......  ...+..++.+++.++.||   |+++++||||||+|||+ ++.++++|+|||.+.         
T Consensus       399 ~g~ell~ri~~~~~~--~~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp  473 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEF--CSEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTP  473 (612)
T ss_pred             cccHHHHHHHhcchh--HHHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhccc
Confidence            999887777654322  255667999999999999   88999999999999999 588999999997542         


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++..+|+||||++||||++|+.||...... ..+.                ..+..+     ..
T Consensus       474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~----------------~~i~~~-----~~  531 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIH----------------TRIQMP-----KF  531 (612)
T ss_pred             chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHH----------------HhhcCC-----cc
Confidence                         245788999999999999999999999765333 1111                111111     12


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+.++.+|+..||+.||.+||+|+++..
T Consensus       532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2456778999999999999999999999863

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=2.1e-28  Score=259.00  Aligned_cols=141  Identities=26%  Similarity=0.385  Sum_probs=124.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |.+.+.||+|+||.||+|... +++.||||+++...   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy   85 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY   85 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence            345678999999999999976 68999999997543   23346788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                      +++++|.+++.... .++......++.+++.||.||   |..+|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          86 LIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence            99999999886543 467788899999999999999   778999999999999999999999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=225.43  Aligned_cols=220  Identities=19%  Similarity=0.261  Sum_probs=173.3

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEec----CCeeEEEEecc
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSN----DDFKALVLEYM  274 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lv~E~~  274 (453)
                      .++||-|-.|.|..+.++ +++.+|+|++...     ....+|+++.-.. .|||||.++++|.+    ...+.+|||+|
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            478999999999999876 7999999998643     4456788875544 69999999998765    44567999999


Q ss_pred             CCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCCC-----
Q 036792          275 PKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGME-----  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~~-----  345 (453)
                      +||.|...+..++ ..+...+.-.|+.+|..|++||   |+..|.||||||+|+|...   +..+||+|||++..     
T Consensus       142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~  218 (400)
T KOG0604|consen  142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG  218 (400)
T ss_pred             cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence            9999999887754 4577888899999999999999   8999999999999999964   56899999998742     


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                         .+|+..+|+||+||++|-|+.|-+||.+......+              .-...++..+..
T Consensus       219 ~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--------------pgMk~rI~~gqy  284 (400)
T KOG0604|consen  219 DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------------PGMKRRIRTGQY  284 (400)
T ss_pred             cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--------------hhHHhHhhccCc
Confidence                               34667799999999999999999999865332111              111122222221


Q ss_pred             -CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 -KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 -~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .+.+.....++++.+++...+..+|++|.|++++++
T Consensus       285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence             223344567788999999999999999999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-29  Score=212.60  Aligned_cols=187  Identities=22%  Similarity=0.300  Sum_probs=153.0

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHH-HHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEV-MKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      .+.||+|+||.|-+-++. +|...|+|.++..- .+..++.++|+.+ ++....|.+|+++|....+...||.||.|.. 
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence            456999999999999865 79999999998653 3445677888886 4556799999999999999999999999954 


Q ss_pred             CchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          278 SLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       278 ~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|..+-..   .....+..-.-+|+..+.+||.|||  .+..++|||+||+|||++.+|.+|+||||...          
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~  207 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM  207 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence            77665432   3445667777789999999999996  55689999999999999999999999997531          


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcC
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP  390 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  390 (453)
                                        ...|+.|+||||+|+++.||.+++.||+.+......+++.++...|
T Consensus       208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP  271 (282)
T ss_pred             hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence                              1367889999999999999999999999877666667776665443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.1e-28  Score=225.57  Aligned_cols=214  Identities=29%  Similarity=0.370  Sum_probs=171.0

Q ss_pred             CccEEEEEEEC-CCCEEEEEEeeccchhh-HHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCchHHhhc
Q 036792          208 SFGSVYRARLR-DGIEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYS  285 (453)
Q Consensus       208 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~  285 (453)
                      +||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 58999999997665433 67899999999999999999999999999999999999999999998876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------------------
Q 036792          286 STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------------------  344 (453)
Q Consensus       286 ~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------------------  344 (453)
                      ... +++.....++.++++++.||   |+.+++|+|++|+||++++++.++++|||...                     
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            443 78888999999999999999   77899999999999999999999999996532                     


Q ss_pred             ---CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHH
Q 036792          345 ---EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILG  421 (453)
Q Consensus       345 ---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~  421 (453)
                         ...++.++||||||++++|+++|..||...... .....+..                .............+.++.+
T Consensus       157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~  219 (244)
T smart00220      157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIG----------------KPKPPFPPPEWKISPEAKD  219 (244)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHh----------------ccCCCCccccccCCHHHHH
Confidence               134567899999999999999999998642111 11111111                0000000011115667899


Q ss_pred             HhhhccccCcccCCChHHHHH
Q 036792          422 LAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       422 l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ++.+||..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999975

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-28  Score=246.51  Aligned_cols=230  Identities=23%  Similarity=0.336  Sum_probs=184.0

Q ss_pred             CCcHHHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEec-----
Q 036792          191 LPSQATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSN-----  263 (453)
Q Consensus       191 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-----  263 (453)
                      +|......++.++||.|.+|.||+++.+ +++.+|||++...... .++...|.++++.. .|||++.++|++..     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            3444455677899999999999999854 7899999998765433 36677888888877 69999999998864     


Q ss_pred             CCeeEEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc
Q 036792          264 DDFKALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       264 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                      ++.+|||||||.+|+..+++.+. ...+.|.....|+..++.|+.+|   |...++|||+|-.|||++.++.+|+.|||.
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEEeeeee
Confidence            67899999999999999988763 45678888889999999999999   889999999999999999999999999975


Q ss_pred             CC------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc
Q 036792          343 GM------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       343 ~~------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      ..                              ...|+.++|+||+|++..||.-|.+|+.++...-.        .++  
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--------LF~--  239 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--------LFL--  239 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------hcc--
Confidence            41                              23467899999999999999999999876532110        000  


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                              +-..+.+....+.....++.+++..|+..|-++||++.++++
T Consensus       240 --------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 --------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                    001111122346778899999999999999999999998764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=8.9e-29  Score=237.04  Aligned_cols=223  Identities=20%  Similarity=0.330  Sum_probs=173.5

Q ss_pred             HHHHH--hcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          196 TLRRL--SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       196 ~~~~~--~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +.|++  .++||+|.||+||-|.++ +|+.||||++.+..  .+....+.+|+++|.+++||.||.+.-.|++++..+.|
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV  641 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV  641 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence            55555  589999999999999976 79999999998653  34447788999999999999999999999999999999


Q ss_pred             EeccCCCCchHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC---CcEEEeccccCC--
Q 036792          271 LEYMPKGSLENC-LYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED---MVAHLSDFEYGM--  344 (453)
Q Consensus       271 ~E~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~---~~~kl~df~~~~--  344 (453)
                      ||-+.| |+.+. |......++.....-++.||+-||.||   |.++|+|+||||+|||+.+.   -.+||||||++.  
T Consensus       642 MEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  642 MEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             ehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            999955 65554 455566788877778889999999999   88899999999999999753   279999998763  


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            ...|+..-|+||.||++|--++|..||...    .++.            +.+...-.
T Consensus       718 gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIn------------dQIQNAaF  781 (888)
T KOG4236|consen  718 GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDIN------------DQIQNAAF  781 (888)
T ss_pred             chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchh------------HHhhcccc
Confidence                                  234677789999999999999999998632    1111            11111110


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                         -.+.....+.++++++|+...++..=.+|-|.+..+
T Consensus       782 ---MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  782 ---MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ---ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence               011122345667788888888888888888877644

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=232.44  Aligned_cols=219  Identities=23%  Similarity=0.306  Sum_probs=177.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh---hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR---ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +.-.+||+|+||.||-++.+ +|+.+|.|++.+....   ...-.+.|-.+|.+++.+.||.+-.+|.+.+.+++|+..|
T Consensus       188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM  267 (591)
T KOG0986|consen  188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM  267 (591)
T ss_pred             eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence            44578999999999999866 7999999998765322   2234578999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      .||||.-+|.+.. ..++.....-.+.+|+-||++|   |+.+||.|||||+|||+|+.|+++|+|.|++.         
T Consensus       268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            9999998887754 4577777888899999999999   99999999999999999999999999997652         


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     .+.|+...|.||+||++|||+.|+.||... .+..             ..+-+|......+   .
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~-KeKv-------------k~eEvdrr~~~~~---~  407 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR-KEKV-------------KREEVDRRTLEDP---E  407 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh-hhhh-------------hHHHHHHHHhcch---h
Confidence                           245788899999999999999999999643 1111             1122344443321   2


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ..++..++++.+|....+..||++|--.
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhccC
Confidence            3446677889999999999999999644

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=230.54  Aligned_cols=229  Identities=25%  Similarity=0.362  Sum_probs=174.6

Q ss_pred             HHHHHhcccCCCCccEEEEEE-ECCCCEEEEEEeecc--ch-----hhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCe
Q 036792          196 TLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQE--CA-----RALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDF  266 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  266 (453)
                      ..|-+.++||+|+|+.||+|. +...+.||||+-...  ..     ...+...+|.++.+.+.||-||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            445567899999999999998 445788999976432  21     234556789999999999999999999865 567


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccC
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYG  343 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~  343 (453)
                      +|-|+|||+|.+|.-+|..+. .++......|+.||+.+|.||.. -+++|+|-||||.|||+-+   .|.+||.|||+.
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            899999999999998887765 56778888999999999999953 4678999999999999854   578999999754


Q ss_pred             C------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhh
Q 036792          344 M------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN  387 (453)
Q Consensus       344 ~------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  387 (453)
                      .                                    ..+++.|+||||.||++|..+.|+.||...    ...+..++.
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn----qsQQdILqe  696 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN----QSQQDILQE  696 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc----hhHHHHHhh
Confidence            1                                    135678999999999999999999998643    222222211


Q ss_pred             hcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       388 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                      .           .+.......++..+..+.++.+++.+|+++.-++|....++.
T Consensus       697 N-----------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 N-----------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             h-----------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            1           011111111223344567889999999999999999887765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=5e-28  Score=250.15  Aligned_cols=232  Identities=20%  Similarity=0.220  Sum_probs=145.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-C----CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeE------EecCCe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-D----GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISS------CSNDDF  266 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~~~~~  266 (453)
                      +.+.+.||+|+||.||+|++. +    +..||||++......  +.+..|  .+....+.+++.+...      +..+..
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence            456789999999999999975 4    789999988643221  112221  1122222222222211      245677


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCC-------------------HHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLD-------------------IFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISV  327 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~-------------------~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~Ni  327 (453)
                      .++|+||+++++|.+++........                   ......++.|++.||.||   |+++|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL---H~~gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL---HSTGIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH---HHCCEEeCcCCHHHE
Confidence            8999999999999998865321111                   122346888999999999   788999999999999


Q ss_pred             eeCC-CCcEEEeccccCCCC------------------------------------------------CcCcccchHHHH
Q 036792          328 LLDE-DMVAHLSDFEYGMEG------------------------------------------------QVSTRSDIYGYG  358 (453)
Q Consensus       328 Ll~~-~~~~kl~df~~~~~~------------------------------------------------~~~~~~Dv~S~G  358 (453)
                      |++. ++.+||+|||++..-                                                .++.++||||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9986 579999999876310                                                122346999999


Q ss_pred             HHHHHHHhCCCCCCccccccccHHhHHhhhc--CC---chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCccc
Q 036792          359 IVLMETFTRKKPTDRMFVEELSLKDWVNNLL--PI---SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEK  433 (453)
Q Consensus       359 vvl~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~  433 (453)
                      |++|||+++..|++..      ...+.....  ..   .+...+.......................+|+.+|++.||++
T Consensus       367 viL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        367 LIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             HHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            9999999977665421      111111000  00   011111110000000000011112234568999999999999


Q ss_pred             CCChHHHHH
Q 036792          434 RINAKDIVT  442 (453)
Q Consensus       434 RPs~~~v~~  442 (453)
                      |||++|+++
T Consensus       441 R~ta~e~L~  449 (566)
T PLN03225        441 RISAKAALA  449 (566)
T ss_pred             CCCHHHHhC
Confidence            999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.2e-29  Score=221.20  Aligned_cols=237  Identities=23%  Similarity=0.326  Sum_probs=175.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--------Ce
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSND--------DF  266 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~~  266 (453)
                      ++-..++|+|.||.||+|+.+ +|+.||+|++-.+  ....-....+|+.+|..++|+|++.+++.|...        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            444578999999999999976 5788898866332  222234567899999999999999999888652        34


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--  344 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--  344 (453)
                      +++|+++|+. +|.-.|.+....++......++.++..||.|+   |+..|+|||+|++|+||+.++..||+|||++.  
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence            8999999987 89988888767788888889999999999999   89999999999999999999999999998762  


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh----cCCc
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL----LPIS  392 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~  392 (453)
                                                  ...++++.|||.-||++.||+||.+-+++....  .....+...    .++-
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSITKEV  252 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHHHHHHHHhccCCccc
Confidence                                        135678899999999999999999988754321  111112111    1111


Q ss_pred             hhh--------hhhhh-hhcCccCCchhhHHH------HHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          393 LME--------VVDKT-LLSGEKKGFVAKEQC------VLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       393 ~~~--------~~d~~-~~~~~~~~~~~~~~~------~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      +.+        .+.-. +..+..   ..-++.      .++.++|+..++..||.+|++++++++.
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~---rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQK---RKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchh---hhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            111        11100 111100   001111      2367899999999999999999998754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.7e-27  Score=240.50  Aligned_cols=235  Identities=18%  Similarity=0.233  Sum_probs=159.6

Q ss_pred             HHHHhcccCCCCccEEEEEEE-----------------CCCCEEEEEEeeccchhhHHH--------------HHHHHHH
Q 036792          197 LRRLSNLIGMGSFGSVYRARL-----------------RDGIEVAVKVFHQECARALKS--------------FEAQCEV  245 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~  245 (453)
                      .+++.++||+|+||.||+|.+                 ..++.||||++........++              +..|+..
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            356678999999999999964                 235689999987543322233              3446667


Q ss_pred             HHcCCCCCc-----eeEEeEEec--------CCeeEEEEeccCCCCchHHhhcCC-----------------------CC
Q 036792          246 MKSIRHPNL-----VKVISSCSN--------DDFKALVLEYMPKGSLENCLYSST-----------------------CM  289 (453)
Q Consensus       246 l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~  289 (453)
                      +.+++|.++     ++++++|..        .+..++||||+++|+|.++++...                       ..
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777776654     677787753        356899999999999999886421                       12


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCCC---------------Cc------
Q 036792          290 LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEG---------------QV------  348 (453)
Q Consensus       290 l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~---------------~~------  348 (453)
                      +++.....++.+++.++.|+   |+.+|+||||||+||+++.++.+||+|||++...               .|      
T Consensus       306 ~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            34566778899999999999   7889999999999999999999999999865210               00      


Q ss_pred             ---------------------------CcccchHHHHHHHHHHHhCCC-CCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          349 ---------------------------STRSDIYGYGIVLMETFTRKK-PTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       349 ---------------------------~~~~Dv~S~Gvvl~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                                 ..+.||||+||+++||+++.. |+.....-......+..     .. ....  
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~-----~~-~~~r--  454 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN-----DL-NRWR--  454 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc-----hH-HHHH--
Confidence                                       123699999999999999875 65432111111110000     00 0000  


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCc---ccCCChHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELP---EKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P---~~RPs~~~v~~  442 (453)
                      .........+.....+....+|+.+++..+|   .+|+|++|+++
T Consensus       455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0000111122233456778999999999766   68999999875

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=216.98  Aligned_cols=213  Identities=24%  Similarity=0.316  Sum_probs=169.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ++..++||+|.||.|.+++-+ +++.+|+|+++++-   .+....-+.|-++|...+||.+..+...|+..+.+|.||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            355788999999999999866 79999999998763   23445567789999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ..||.|.-+|...+ .++.....-.-..|+.||.||   |+++||.||+|.+|.|+|.||++||+|||+..         
T Consensus       250 anGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~  325 (516)
T KOG0690|consen  250 ANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT  325 (516)
T ss_pred             ccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence            99999998887655 344444445566789999999   88999999999999999999999999997642         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...|...+|.|.+|||+|||+.|+.||.....+.+              .+++-   . .+   
T Consensus       326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------------FeLIl---~-ed---  384 (516)
T KOG0690|consen  326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------------FELIL---M-ED---  384 (516)
T ss_pred             ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------------HHHHH---h-hh---
Confidence                            13467789999999999999999999975432211              11110   0 00   


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCC
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRI  435 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP  435 (453)
                      ...|...++++..|+.-.+..||.+|.
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            112344566788899999999999995

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-27  Score=219.26  Aligned_cols=242  Identities=19%  Similarity=0.259  Sum_probs=176.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC--C----CceeEEeEEecCCeeE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRH--P----NLVKVISSCSNDDFKA  268 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~~~~  268 (453)
                      ..|.+...+|+|.||.|-.+..+ .+..||||+++.- ....++.+-|++++.++.+  |    -+|.+.++|...++.|
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            44677889999999999999865 5899999999743 2344667789999999842  2    3677888899999999


Q ss_pred             EEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC----------------
Q 036792          269 LVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE----------------  331 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~----------------  331 (453)
                      ||+|.+ |-++.++|... -...+......|+.|+++++.||   |+.+++|-||||+|||+.+                
T Consensus       168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999988 66999999773 45678889999999999999999   9999999999999999831                


Q ss_pred             ----CCcEEEeccccCC----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccc-ccccHHhH
Q 036792          332 ----DMVAHLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFV-EELSLKDW  384 (453)
Q Consensus       332 ----~~~~kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~  384 (453)
                          +..+++.|||-+.                      +-.++.++||||+||||.|+.||..-|+.... +.+.+.+-
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer  323 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER  323 (415)
T ss_pred             ccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence                3457899997553                      23578899999999999999999999875432 22223333


Q ss_pred             HhhhcCCchhhhh------hh-hhh------cC--------ccCC---chhhHHHHHHHHHHhhhccccCcccCCChHHH
Q 036792          385 VNNLLPISLMEVV------DK-TLL------SG--------EKKG---FVAKEQCVLSILGLAMECAMELPEKRINAKDI  440 (453)
Q Consensus       385 ~~~~~~~~~~~~~------d~-~~~------~~--------~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v  440 (453)
                      +-...|..+..-.      .. .+.      .+        ..+-   .........++.+|+.+++.+||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            3222222211111      00 000      00        0000   00112334578999999999999999999998


Q ss_pred             HH
Q 036792          441 VT  442 (453)
Q Consensus       441 ~~  442 (453)
                      ++
T Consensus       404 L~  405 (415)
T KOG0671|consen  404 LS  405 (415)
T ss_pred             hc
Confidence            75

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=7.1e-27  Score=202.82  Aligned_cols=237  Identities=16%  Similarity=0.249  Sum_probs=169.4

Q ss_pred             HHHHHhcccCCCCccEEEEEE-ECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCC--eeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDD--FKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv~  271 (453)
                      .-|++.+.+|+|.|+.||.|. ..+.+.++||+++.-.   .+...+|+.+|..++ ||||+++++...++.  ...+|+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            346888999999999999998 4578899999997543   356789999999998 999999999988754  567999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC-----
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME-----  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~-----  345 (453)
                      ||+.+.+....-.    .+........+.++++||.|+   |++||.|||+||.|+++|. ....+|.|+|++..     
T Consensus       115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            9998877655332    344455667788899999998   9999999999999999996 56899999986521     


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---------------cC
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---------------LP  390 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------------~~  390 (453)
                                          ..|+..-|+|||||++.+|+..+.||-........+.....-.               .+
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence                                2356678999999999999999999743222222222111111               11


Q ss_pred             CchhhhhhhhhhcC--ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          391 ISLMEVVDKTLLSG--EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       391 ~~~~~~~d~~~~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+++....+..  .........-..+++++++...+.+|-.+|||++|++.
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            11111111111000  00000011123478999999999999999999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=2e-25  Score=201.60  Aligned_cols=185  Identities=35%  Similarity=0.549  Sum_probs=161.6

Q ss_pred             cCCCCccEEEEEEECC-CCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCchH
Q 036792          204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLEN  281 (453)
Q Consensus       204 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~  281 (453)
                      ||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 899999999866432 34678999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC---------------
Q 036792          282 CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME---------------  345 (453)
Q Consensus       282 ~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~---------------  345 (453)
                      ++......+++..+..++.++++++.+|   |+.+++|+|++|.||+++. +..++++||+....               
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  157 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP  157 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence            9876534578889999999999999999   7889999999999999999 89999999975421               


Q ss_pred             ----------C-CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHH
Q 036792          346 ----------G-QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQ  414 (453)
Q Consensus       346 ----------~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  414 (453)
                                . ..+.++|+|++|++++|+                                                  
T Consensus       158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------------  187 (215)
T cd00180         158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------------  187 (215)
T ss_pred             CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------------
Confidence                      1 345679999999999999                                                  


Q ss_pred             HHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          415 CVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       415 ~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                        .++.+++..|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              246778899999999999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4e-27  Score=219.91  Aligned_cols=213  Identities=21%  Similarity=0.268  Sum_probs=164.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +....+||+|+||.|.+|..+ +.+.+|||+++++-   .++.+--+.|-++|+-. +-|.++.++..|++-+.+|.|||
T Consensus       351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME  430 (683)
T KOG0696|consen  351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME  430 (683)
T ss_pred             cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence            345678999999999999876 57899999998763   23344445666676654 57899999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+.||+|--+++..+ .+......-.+..||-||-+|   |+++|+.||||.+||++|.+|.+||+|||+..        
T Consensus       431 yvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  431 YVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence            999999987776643 233344556677888899888   99999999999999999999999999997642        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...|+..+|.|||||+||||+.|++||++...+++- +.            +.+.        
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-~a------------I~eh--------  565 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-QA------------IMEH--------  565 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HH------------HHHc--------
Confidence                             345677899999999999999999999876333211 10            1110        


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCC
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRI  435 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP  435 (453)
                      ....+...+.++.+++..-+...|.+|.
T Consensus       566 nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            1123455667788888888888888884

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.1e-26  Score=225.07  Aligned_cols=174  Identities=23%  Similarity=0.362  Sum_probs=143.5

Q ss_pred             cccCCCCccEEEEEE-ECCCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      ..||-|+||.|.+++ .++...+|.|.+++...   ........|..||..-+.+-||+|+..|.+++.+|+||||++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            569999999999997 55678899999987643   33456778999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      |+-.+|..-+..-+...|+.| ..++.++++.   |+.|+|||||||+|||||.+|.+||.|||+.++            
T Consensus       715 DmMSLLIrmgIFeE~LARFYI-AEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~  790 (1034)
T KOG0608|consen  715 DMMSLLIRMGIFEEDLARFYI-AELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE  790 (1034)
T ss_pred             cHHHHHHHhccCHHHHHHHHH-HHHHHHHHHH---HhccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence            999888665433223344444 5788899999   999999999999999999999999999965321            


Q ss_pred             -------------------------------------------------------CCcCcccchHHHHHHHHHHHhCCCC
Q 036792          346 -------------------------------------------------------GQVSTRSDIYGYGIVLMETFTRKKP  370 (453)
Q Consensus       346 -------------------------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p  370 (453)
                                                                             ..++.-+|.||.|||||||+.|++|
T Consensus       791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p  870 (1034)
T KOG0608|consen  791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP  870 (1034)
T ss_pred             CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence                                                                   1245568999999999999999999


Q ss_pred             CCccccccc
Q 036792          371 TDRMFVEEL  379 (453)
Q Consensus       371 ~~~~~~~~~  379 (453)
                      |-.....+.
T Consensus       871 f~~~tp~~t  879 (1034)
T KOG0608|consen  871 FLADTPGET  879 (1034)
T ss_pred             ccCCCCCcc
Confidence            976544443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7.6e-26  Score=201.04  Aligned_cols=227  Identities=17%  Similarity=0.258  Sum_probs=171.6

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEe-EEecCCeeEEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVIS-SCSNDDFKALVL  271 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g-~~~~~~~~~lv~  271 (453)
                      ...|.+...+|+|.||.+.+++++ ..+.+++|.+..... ...+|.+|...--.+ .|.||+.-++ .|++.+.++.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            356788899999999999999988 478899999876643 347899998765555 4889987655 577788889999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC--CCCcEEEeccccCCC----
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD--EDMVAHLSDFEYGME----  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~--~~~~~kl~df~~~~~----  345 (453)
                      ||+|.|||..-+...  .+.......++.|++.|+.|+   |++.+||||||.+|||+-  +...+|+||||....    
T Consensus       102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            999999998866553  366677788999999999999   999999999999999983  345899999986432    


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ....+.+|||.|||+++.++||+.||+.....+..+.+|.........      .  
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~------~--  248 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP------A--  248 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc------c--
Confidence                                   123456899999999999999999999877777766666544322111      0  


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI  440 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v  440 (453)
                       .+    ..-...++.++++..+-+..+|++|=...++
T Consensus       249 -~P----~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  249 -LP----KKFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             -Cc----hhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence             00    0011233456777788888888888444433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-26  Score=204.85  Aligned_cols=235  Identities=20%  Similarity=0.284  Sum_probs=171.4

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-----eeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-----FKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~E~  273 (453)
                      +.||-|+||.||..... +|+.||.|++..-.  ....+++.+|+++|..++|.|+...++......     .+|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            56999999999999864 79999999986443  234578999999999999999999988776543     46788999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      |.. +|.+.+-+.. .++.........||.+||.||   |+.+|.||||||.|.|++++...||||||++.         
T Consensus       139 mQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h  213 (449)
T KOG0664|consen  139 MQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN  213 (449)
T ss_pred             HHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence            854 8888776544 466666777889999999999   99999999999999999999999999998763         


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh-------h
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD-------K  399 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d-------~  399 (453)
                                        .+.|+...||||.||++.|++.++.-|+....  ....+.+.........|...       .
T Consensus       214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence                              24578899999999999999999988864321  11112222222221111111       1


Q ss_pred             hhhcCccCCc--------hhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          400 TLLSGEKKGF--------VAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       400 ~~~~~~~~~~--------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .+.....+.+        ..+..--.+.+.+...++..||.+|.+..+.+..
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            1111111000        1122334467788888999999999998887654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-26  Score=225.22  Aligned_cols=226  Identities=24%  Similarity=0.340  Sum_probs=180.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .|++...+|.|.||.|||++.. .++..|||.++-+.....+-.++|+-+++..+|||||.++|.+...+..|+.||||.
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg   95 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG   95 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence            3677889999999999999965 789999999998877777788899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC------------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------------  343 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~------------  343 (453)
                      +|+|++.-+.. ..+...+...+.....+|+.||   |+++-+|||+|-.|||+++.+.+|++|||.+            
T Consensus        96 ggslQdiy~~T-gplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   96 GGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             CCcccceeeec-ccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            99998865543 3677777778888999999999   9999999999999999999999999999753            


Q ss_pred             ----------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          344 ----------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       344 ----------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      ..+.|..++|||+.|+...|+..-.+|--+...    ++...  .+..   ..+++.       
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~l~--LmTk---S~~qpp-------  235 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRALF--LMTK---SGFQPP-------  235 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHHHH--Hhhc---cCCCCC-------
Confidence                            135678899999999999999998888322111    01000  0000   001111       


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+....+.+-++++.|+-.+|++||+++-+++
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11123456677889999999999999999987654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.92  E-value=8e-26  Score=227.95  Aligned_cols=214  Identities=25%  Similarity=0.389  Sum_probs=158.7

Q ss_pred             hcccCCCCccE-EEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          201 SNLIGMGSFGS-VYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       201 ~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .+++|.|+-|+ ||+|.+. |+.||||++-.+..   .-..+|+..|..- +|||||++++.-.++.+.||..|.|.. +
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            35788998875 7999985 78999998864432   3457899998877 599999999998899999999999955 9


Q ss_pred             chHHhhcCC--CC-CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---C--CcEEEeccccCCC-----
Q 036792          279 LENCLYSST--CM-LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---D--MVAHLSDFEYGME-----  345 (453)
Q Consensus       279 L~~~l~~~~--~~-l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~--~~~kl~df~~~~~-----  345 (453)
                      |.+++....  .. ........+..|+++|+++|   |+.+||||||||.||||+.   +  ..++|+|||+...     
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            999998741  11 11134467788999999999   8899999999999999976   2  5789999986421     


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhC-CCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ..-+..+||+|+||++|..++| +.||.+....+..+..   ...          .+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---~~~----------~L  732 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---GNY----------TL  732 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---Ccc----------ce
Confidence                                   1123467999999999999986 8999654332221110   000          00


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .     ......+|  ++.+|+.++++++|..||++.+|+.
T Consensus       733 ~-----~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 V-----HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             e-----eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0     00111233  7899999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=5.8e-24  Score=194.94  Aligned_cols=171  Identities=32%  Similarity=0.468  Sum_probs=149.7

Q ss_pred             HhcccCCCCccEEEEEEECC-CCEEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            45789999999999999774 899999999876554 5678999999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------------  344 (453)
                      +|.+++......+++.....++.+++.++.||   |+.+++|+|++|.||+++.++.++|+|||...             
T Consensus        83 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       83 DLFDYLRKKGGKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            99998876543378888899999999999999   77899999999999999999999999997431             


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCc
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDR  373 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  373 (453)
                                    ...++.++|||+||++++|+++|+.||+.
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                          12234579999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-25  Score=197.71  Aligned_cols=229  Identities=24%  Similarity=0.325  Sum_probs=179.0

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+..+|.+...|..|+|+|.. .-+++|++...  ..+...+|..|.-.|+-+.||||..++|.|..+++..++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            445678899999999999974 44556766543  345567899999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecc--ccC--C-CCCc--
Q 036792          277 GSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--EYG--M-EGQV--  348 (453)
Q Consensus       277 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df--~~~--~-~~~~--  348 (453)
                      |+|+.+|+... ...+..+..+++.++|+|+.|||.. ++-|..--|.+..+++|++.+++|+--  .++  . +..|  
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~p  350 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSP  350 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeeccccccCc
Confidence            99999998753 3456678899999999999999642 223444478899999999999887532  111  0 0111  


Q ss_pred             ----------------CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          349 ----------------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       349 ----------------~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                      -..+|+|||++++||+.|+..||.+....+..++--+                   ++.+...+
T Consensus       351 awmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------------------eglrv~ip  411 (448)
T KOG0195|consen  351 AWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------------------EGLRVHIP  411 (448)
T ss_pred             ccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------------------ccccccCC
Confidence                            1358999999999999999999987766554443222                   22234456


Q ss_pred             HHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      ++.+..+.+|+.-|.++||.+||.++.|+-.|++++
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            677788999999999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.7e-25  Score=211.61  Aligned_cols=213  Identities=20%  Similarity=0.315  Sum_probs=166.6

Q ss_pred             hcccCCCCccEEEEEEECCC-CEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          201 SNLIGMGSFGSVYRARLRDG-IEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ...||-|+||.|-+...... ..+|+|++++..   .+..+....|-.+|...+.|.||+++--|.+....|+.||-|-|
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG  504 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG  504 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence            45699999999999987643 358999887652   34456788899999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |.|-..|+.++ .++.....-++..+.+|++||   |+++||.|||||+|.+++.+|-+||.|||++.            
T Consensus       505 GElWTiLrdRg-~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFc  580 (732)
T KOG0614|consen  505 GELWTILRDRG-SFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFC  580 (732)
T ss_pred             chhhhhhhhcC-CcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeec
Confidence            99999888765 344444555666789999999   99999999999999999999999999998752            


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                  ....+..+|.||+|+++||+++|.+||.+...    ++.|..      +..-+|.         ...|
T Consensus       581 GTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktYn~------ILkGid~---------i~~P  641 (732)
T KOG0614|consen  581 GTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTYNL------ILKGIDK---------IEFP  641 (732)
T ss_pred             CCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHHHH------HHhhhhh---------hhcc
Confidence                        12345678999999999999999999975421    111111      1111111         1234


Q ss_pred             HHHHHHHHHHhhhccccCcccCCC
Q 036792          413 EQCVLSILGLAMECAMELPEKRIN  436 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs  436 (453)
                      ...+....+|+.+.+..+|.+|--
T Consensus       642 r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  642 RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             cccchhHHHHHHHHHhcCcHhhhc
Confidence            456667888999989999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.8e-24  Score=193.64  Aligned_cols=219  Identities=21%  Similarity=0.278  Sum_probs=163.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++..+||+|+|+.|..++++ +.+.+|+|+++++-.   ++..-.+.|-.+..+. +||.+|.+..+|.++..++.|.|
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            356789999999999999976 689999999987643   2333445566666554 69999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |.+||+|--+++..+ .++.....-....|.-+|.||   |+++|+.||||..|+|+|..+.+|+.|+|+..        
T Consensus       332 yv~ggdlmfhmqrqr-klpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  332 YVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            999999976665433 567766666677788888888   99999999999999999999999999996532        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCcc--ccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRM--FVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                       +..|...+|.|++||+++||+.|+.||+-.  ...+.....|+-       .-++.+.++   
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf-------qvilekqir---  477 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF-------QVILEKQIR---  477 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH-------HHHhhhccc---
Confidence                             235667899999999999999999999742  122222222221       111122221   


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCC
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRI  435 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP  435 (453)
                           .+...+..+..++..-+++||.+|.
T Consensus       478 -----iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 -----IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----ccceeehhhHHHHHHhhcCCcHHhc
Confidence                 2233344556677888999999985

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.90  E-value=9.1e-24  Score=192.10  Aligned_cols=229  Identities=21%  Similarity=0.238  Sum_probs=163.2

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeEEEEe
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKALVLE  272 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~E  272 (453)
                      ..+|.|.- .|..+... .+++||+|++....  ....++..+|..+|..+.|+|+++++.++....      ..|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            34666666 45555433 58999999886542  234567789999999999999999999987643      5789999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      ||. .+|.+++..   .++......+..|+..|++||   |+.+|+||||||+||++..+..+||.|||++..       
T Consensus       102 ~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~m  174 (369)
T KOG0665|consen  102 LMD-ANLCQVILM---ELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMM  174 (369)
T ss_pred             hhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhcccCccccc
Confidence            995 488887763   356677888999999999999   999999999999999999999999999987632       


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh----cCC-chhhhhhh----
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL----LPI-SLMEVVDK----  399 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~-~~~~~~d~----  399 (453)
                                       ..+.+.+||||.||++.||++|+.-|.+.    ..+.+|.+..    .|+ +..+-..+    
T Consensus       175 tpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             CchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence                             23677899999999999999999887632    2233333211    111 11000000    


Q ss_pred             -------hhh-------cC-ccC-CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 -------TLL-------SG-EKK-GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 -------~~~-------~~-~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             ...       .+ ..+ ....+.-....+.+++.++|..+|++|.+++++++
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                   000       00 000 00111122345788999999999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=8.6e-23  Score=194.94  Aligned_cols=130  Identities=23%  Similarity=0.285  Sum_probs=107.7

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-----C---CCceeEEeEEec----
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-----H---PNLVKVISSCSN----  263 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~----  263 (453)
                      .|.+..+||.|.|++||+++.. +.+.||+|+.+... ...+..+.|+++|++++     |   .+||+|+++|..    
T Consensus        79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            3556788999999999999965 57899999987543 33466788999999884     3   379999999876    


Q ss_pred             CCeeEEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          264 DDFKALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       264 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      +.+.|+|+|++ |-+|..++... -..++......|+.|++.||.|||  .+.+|||-||||+|||+.
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCCcceeeee
Confidence            45899999999 66888888653 346888899999999999999997  567999999999999984

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.89  E-value=9.7e-24  Score=202.48  Aligned_cols=239  Identities=21%  Similarity=0.250  Sum_probs=174.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC------CCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRH------PNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~~~~~lv  270 (453)
                      |.+....|+|-|+.|.+|... .|..||||+|+..... .+.=++|+++|++|..      -|.++++-.|...+++|||
T Consensus       434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV  512 (752)
T KOG0670|consen  434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV  512 (752)
T ss_pred             eEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence            344566899999999999865 5889999999865432 2445789999999952      4889999999999999999


Q ss_pred             EeccCCCCchHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCC---
Q 036792          271 LEYMPKGSLENCLYSS--TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGM---  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~---  344 (453)
                      +|-+. -+|.++|...  ...|.......++.|+.-||..|   -..+|+|.||||.|||+++. ..+||||||.+.   
T Consensus       513 FE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  513 FEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             ehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence            99874 4899999764  34567788889999999999999   78899999999999999874 578999997542   


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccc-ccHHhHHhhhcCCchh-------hh
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE-LSLKDWVNNLLPISLM-------EV  396 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~-------~~  396 (453)
                                          +-.|+...|+||.||.|||++||+.-|.+..... +.+..-+...+|..+.       +.
T Consensus       589 eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqH  668 (752)
T KOG0670|consen  589 ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQH  668 (752)
T ss_pred             cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhh
Confidence                                3457888999999999999999999887654331 1111111111221100       00


Q ss_pred             h--------------------------hh------hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 V--------------------------DK------TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~--------------------------d~------~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +                          .+      .+.... ..+.........+.+|+..|+..||++|.|..+++.
T Consensus       669 FD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q-~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  669 FDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQ-RLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             cccccceEEEeccccccceeEEEecccCcchhHHHHHhccC-CCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            0                          00      000000 011122345678899999999999999999998874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=202.84  Aligned_cols=168  Identities=23%  Similarity=0.373  Sum_probs=140.6

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccch------h--hHHHHHHHHHHHHcCC---CCCceeEEeEEecCCeeE
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA------R--ALKSFEAQCEVMKSIR---HPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~--~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~  268 (453)
                      ...+|+|+||.|+.|.++ +..+|+||.+.++..      +  .....-.|+++|..++   |+||++++++|++++++|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            467999999999999987 467899999976532      1  1123456999999997   999999999999999999


Q ss_pred             EEEecc-CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---
Q 036792          269 LVLEYM-PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---  344 (453)
Q Consensus       269 lv~E~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---  344 (453)
                      |+||-- ++-+|.+++..+. .++......|..|++.|+++|   |+.+|+|||||-+||.++.+|-+||.|||.+.   
T Consensus       646 l~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfgsaa~~k  721 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK  721 (772)
T ss_pred             EEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence            999964 4558888887654 577788888999999999999   99999999999999999999999999997542   


Q ss_pred             CCC---------------------cCcccchHHHHHHHHHHHhCCCCCC
Q 036792          345 EGQ---------------------VSTRSDIYGYGIVLMETFTRKKPTD  372 (453)
Q Consensus       345 ~~~---------------------~~~~~Dv~S~Gvvl~el~tg~~p~~  372 (453)
                      .+.                     ....-|||++||+||-++....||.
T Consensus       722 sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  722 SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            111                     1334699999999999999999985

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.87  E-value=2.2e-22  Score=189.62  Aligned_cols=242  Identities=24%  Similarity=0.342  Sum_probs=174.4

Q ss_pred             CcHHHHHHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCe
Q 036792          192 PSQATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDF  266 (453)
Q Consensus       192 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  266 (453)
                      |.....+...++||+|.|++||++.+.    ..+.||+|.+.....  -.+...|+++|..+. +.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            334455677899999999999999743    468899999875432  245789999999885 8999999999999999


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME  345 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~  345 (453)
                      .++|+||++.-+..++...    ++............+||.++   |.+||||||+||.|+|.+. .+.-.|.|||++..
T Consensus       110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999888887764    45667777888899999999   9999999999999999986 45678999965420


Q ss_pred             ----------------------------------------------------------------------CCcCcccchH
Q 036792          346 ----------------------------------------------------------------------GQVSTRSDIY  355 (453)
Q Consensus       346 ----------------------------------------------------------------------~~~~~~~Dv~  355 (453)
                                                                                            ..-++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence                                                                                  0114568999


Q ss_pred             HHHHHHHHHHhCCCCCCccccccccHHhHHhhh----------cCCc-----------hhhh------hh-hhhhcCcc-
Q 036792          356 GYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL----------LPIS-----------LMEV------VD-KTLLSGEK-  406 (453)
Q Consensus       356 S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~----------~~~~-----------~~~~------~d-~~~~~~~~-  406 (453)
                      |.||++.-++++..||-....+-..+.+.+.-.          .++.           +.+.      ++ ..+..... 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            999999999999999854433322222221100          0111           0010      11 11111111 


Q ss_pred             --CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 --KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 --~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ......+..+..+++++.+|++.||.+|.|++|+++
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence              011111223447899999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.87  E-value=9.5e-23  Score=220.88  Aligned_cols=168  Identities=15%  Similarity=0.224  Sum_probs=121.2

Q ss_pred             CCC-CCceeEEeEE-------ecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 036792          249 IRH-PNLVKVISSC-------SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC  320 (453)
Q Consensus       249 l~H-~niv~l~g~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hr  320 (453)
                      ++| +||++++++|       ...+.++.++||+ +++|.++|......++......++.|+++||.||   |+++|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeeec
Confidence            445 5777788877       2234567889988 5699999976556688999999999999999999   89999999


Q ss_pred             CCCCCceeeCC-------------------CCcEEEeccccCC-------------------------------------
Q 036792          321 DLKPISVLLDE-------------------DMVAHLSDFEYGM-------------------------------------  344 (453)
Q Consensus       321 dlk~~NiLl~~-------------------~~~~kl~df~~~~-------------------------------------  344 (453)
                      ||||+|||++.                   ++.+|++|||.+.                                     
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999953                   4567777876431                                     


Q ss_pred             ----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHH
Q 036792          345 ----EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSIL  420 (453)
Q Consensus       345 ----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~  420 (453)
                          ...++.++|||||||++|||+++.+|+....   .....+.....+                   +.......+..
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~-------------------~~~~~~~~~~~  242 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLP-------------------PQILLNWPKEA  242 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcC-------------------hhhhhcCHHHH
Confidence                1235778999999999999999988864210   000111000000                   00011123456


Q ss_pred             HHhhhccccCcccCCChHHHHH
Q 036792          421 GLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       421 ~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +++..||+.+|.+||+|.|+++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhh
Confidence            7888999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.85  E-value=1.1e-20  Score=167.14  Aligned_cols=150  Identities=20%  Similarity=0.182  Sum_probs=109.4

Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-------------  343 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-------------  343 (453)
                      |+|.+++......+++.....++.|+++||.||   |+.+      ||+|||++.++.+|+  ||..             
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~   69 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALREL---HRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPY   69 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HhcC------CcccEeEcCccceee--ccceEeeccccCCCccc
Confidence            689999987666799999999999999999999   4444      999999999999998  7643             


Q ss_pred             -------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHH
Q 036792          344 -------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCV  416 (453)
Q Consensus       344 -------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~  416 (453)
                             ....++.++|||||||++|||+||+.||.........+..+.....+..             ...........
T Consensus        70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~  136 (176)
T smart00750       70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------PRDRSNLESVS  136 (176)
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------ccccccHHHHH
Confidence                   1245678999999999999999999998643221112222221111100             00001122233


Q ss_pred             H--HHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          417 L--SILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       417 ~--~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .  ++.+++.+||+.+|++||++.|+++.+..+..+
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            3  689999999999999999999999998777543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=8e-21  Score=184.42  Aligned_cols=134  Identities=22%  Similarity=0.187  Sum_probs=106.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC--CCCEEEEEEeecc-----chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR--DGIEVAVKVFHQE-----CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      -|.+.+.||+|+||+||+|.++  +++.||||++...     .....+.|.+|+++|++++|+|++..+..   .+..++
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~L   95 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGL   95 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEE
Confidence            3667889999999999999865  5778899987533     12234678999999999999999853322   245799


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCceeeCCCCcEEEeccccCC
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL-KPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdl-k~~NiLl~~~~~~kl~df~~~~  344 (453)
                      ||||+++++|... ..    ..   ...++.++++++.||   |+++|+|||| ||+|||++.++.+||+|||++.
T Consensus        96 VmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         96 VRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            9999999999632 11    11   135677899999999   8899999999 9999999999999999999864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=5.8e-21  Score=170.48  Aligned_cols=138  Identities=17%  Similarity=0.209  Sum_probs=105.9

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchh--h-------HH-----------------HHHHHHHHHHcCCCCCc
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECAR--A-------LK-----------------SFEAQCEVMKSIRHPNL  254 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~H~ni  254 (453)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ..                 ....|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999999754221  0       01                 22349999999988776


Q ss_pred             eeEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc
Q 036792          255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV  334 (453)
Q Consensus       255 v~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~  334 (453)
                      .....+..  ...++||||++++++...... ...++......++.+++.++.|+|  |+.+|+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCc
Confidence            43332222  223899999998877654322 235778888999999999999996  678999999999999998 478


Q ss_pred             EEEeccccCC
Q 036792          335 AHLSDFEYGM  344 (453)
Q Consensus       335 ~kl~df~~~~  344 (453)
                      ++++|||.+.
T Consensus       156 v~LiDFG~a~  165 (190)
T cd05147         156 LYIIDVSQSV  165 (190)
T ss_pred             EEEEEccccc
Confidence            9999999875

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.9e-20  Score=183.84  Aligned_cols=188  Identities=29%  Similarity=0.430  Sum_probs=147.7

Q ss_pred             HHcCCCCCceeEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-eecCCCC
Q 036792          246 MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI-IHCDLKP  324 (453)
Q Consensus       246 l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i-~Hrdlk~  324 (453)
                      |+.+.|.|+.++.|.+.+++..++|.+||+.|+|.+.+......+++.....++.++++||.|+   |..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~yl---h~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYL---HNSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHH---hcCcceeeeeecc
Confidence            4678999999999999999999999999999999999998888899999999999999999999   55554 9999999


Q ss_pred             CceeeCCCCcEEEeccccCCCC----------------------------------CcCcccchHHHHHHHHHHHhCCCC
Q 036792          325 ISVLLDEDMVAHLSDFEYGMEG----------------------------------QVSTRSDIYGYGIVLMETFTRKKP  370 (453)
Q Consensus       325 ~NiLl~~~~~~kl~df~~~~~~----------------------------------~~~~~~Dv~S~Gvvl~el~tg~~p  370 (453)
                      .|+++|..+.+|++|||+..-.                                  ..+.++||||||++++|+++++.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999753211                                  135679999999999999999999


Q ss_pred             CCccccccccHHhHHhhhcCCchhhhhhhhhhcCc-cCCch-h-hHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          371 TDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE-KKGFV-A-KEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~-~-~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      |+.....+..             .+++......+. ..++. . ..+.++++..++..||.++|++||++++|-..++.+
T Consensus       158 ~~~~~~~~~~-------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  158 FDLRNLVEDP-------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cccccccCCh-------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9764332221             111111111011 01111 1 114555789999999999999999999999888776


Q ss_pred             HH
Q 036792          448 RD  449 (453)
Q Consensus       448 ~~  449 (453)
                      ..
T Consensus       225 ~~  226 (484)
T KOG1023|consen  225 NK  226 (484)
T ss_pred             cc
Confidence            54

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.8e-20  Score=169.44  Aligned_cols=153  Identities=15%  Similarity=0.145  Sum_probs=119.5

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhh---HHH------HHHHHHHHHcCCCCCceeEEeEEecC----
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARA---LKS------FEAQCEVMKSIRHPNLVKVISSCSND----  264 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~H~niv~l~g~~~~~----  264 (453)
                      +++.+++|+|+||.||.... ++..+|||.++......   .+.      +.+|++.+.+++|++|.....++...    
T Consensus        33 y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~  111 (232)
T PRK10359         33 IKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT  111 (232)
T ss_pred             eEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence            35578899999999999765 57789999997553222   122      68999999999999999998875532    


Q ss_pred             ----CeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecc
Q 036792          265 ----DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF  340 (453)
Q Consensus       265 ----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df  340 (453)
                          ...+++|||++|.+|.++..     .+.    ....+++.++..+   |+.+++|||++|+|++++.++ ++++||
T Consensus       112 ~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        112 LRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             ccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                35789999999999987632     111    2345788888888   899999999999999999888 999999


Q ss_pred             ccCCC-------------CCcCcccchHHHHHHHHHH
Q 036792          341 EYGME-------------GQVSTRSDIYGYGIVLMET  364 (453)
Q Consensus       341 ~~~~~-------------~~~~~~~Dv~S~Gvvl~el  364 (453)
                      |....             ..+..++|+||||+++.-.
T Consensus       179 g~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        179 SGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CCcccccchhhHHHHHHHhHhcccccccceeEeehHH
Confidence            75432             3456789999999976654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.3e-19  Score=160.67  Aligned_cols=137  Identities=20%  Similarity=0.252  Sum_probs=106.8

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchh--------------------------hHHHHHHHHHHHHcCCCCCc
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECAR--------------------------ALKSFEAQCEVMKSIRHPNL  254 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni  254 (453)
                      ...||+|+||.||+|...+|+.||||+++.....                          ....+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999999778999999999754210                          01234578999999999987


Q ss_pred             eeEEeEEecCCeeEEEEeccCCCCchHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCC
Q 036792          255 VKVISSCSNDDFKALVLEYMPKGSLENC-LYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDED  332 (453)
Q Consensus       255 v~l~g~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~  332 (453)
                      .....+....  .++||||++++++... +..  ..++......++.+++.++.++   |. .+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~l---H~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRL---YQEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCChhhEEEE-C
Confidence            5544433332  4899999998865433 332  3466677889999999999999   55 8999999999999999 7


Q ss_pred             CcEEEeccccCCC
Q 036792          333 MVAHLSDFEYGME  345 (453)
Q Consensus       333 ~~~kl~df~~~~~  345 (453)
                      +.++|+|||.+..
T Consensus       154 ~~~~liDFG~a~~  166 (190)
T cd05145         154 GKPYIIDVSQAVE  166 (190)
T ss_pred             CCEEEEEccccee
Confidence            8999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=1.9e-18  Score=155.83  Aligned_cols=132  Identities=13%  Similarity=0.243  Sum_probs=102.2

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcC-----CCCCceeEEeEEecCC---e-eEEEE
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI-----RHPNLVKVISSCSNDD---F-KALVL  271 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lv~  271 (453)
                      .+.||+|+||.||.  +++....+||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+|+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            35799999999996  443333379988765444557799999999999     5799999999998863   3 34789


Q ss_pred             ec--cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCceecCCCCCceeeCC----CCcEEEeccc
Q 036792          272 EY--MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPIIHCDLKPISVLLDE----DMVAHLSDFE  341 (453)
Q Consensus       272 E~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l-~~L~~~h~~~i~Hrdlk~~NiLl~~----~~~~kl~df~  341 (453)
                      ||  +++|+|.+++....  ++..  ..++.++..++ +||   |+.+|+||||||+|||++.    +..++|+||.
T Consensus        85 e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         85 DFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99  66899999996632  4333  34566777666 899   8999999999999999974    3479999953

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=1.9e-17  Score=160.78  Aligned_cols=234  Identities=20%  Similarity=0.249  Sum_probs=170.1

Q ss_pred             HHHHhcccCCCCccEEEEEEECC--CCEEEEEEeeccchhhHHHHHHHHHHHHcCCC----CCceeEEeEE-ecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD--GIEVAVKVFHQECARALKSFEAQCEVMKSIRH----PNLVKVISSC-SNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l  269 (453)
                      .+.+...||+|+||.||.+....  ...+|+|.-..........+..|..++..+..    +++.++++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            35677899999999999999664  35788888765533222267788888888863    5888888888 47778899


Q ss_pred             EEeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-----CcEEEeccccC
Q 036792          270 VLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-----MVAHLSDFEYG  343 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-----~~~kl~df~~~  343 (453)
                      ||+.+ |.+|.++..... ..++....+.|+.|+..+|+++   |+.+++||||||.|+++...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99977 779999775443 5788899999999999999999   89999999999999999754     46899999887


Q ss_pred             C--C----C-----------------------------CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh
Q 036792          344 M--E----G-----------------------------QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL  388 (453)
Q Consensus       344 ~--~----~-----------------------------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~  388 (453)
                      .  .    .                             ..+.+.|+||++-++.|+..|..||........ ........
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence            5  1    0                             113457999999999999999999865422111 11111000


Q ss_pred             cCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          389 LPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       389 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ..         ....      .....++.++.++...+-..+..++|....+...|.+....
T Consensus       254 ~~---------~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  254 RK---------LLTD------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hh---------hccc------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            00         0000      01122345666777777778999999999999888776543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=1.8e-18  Score=151.87  Aligned_cols=234  Identities=20%  Similarity=0.209  Sum_probs=171.9

Q ss_pred             HHHHhcccCCCCccEEEEEE-ECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC-CCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRH-PNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      -+++...||.|+||.+|.|. ..+|..||||.=....  ....+..|..+.+.++| ..|..+..+..+...-.+|||..
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            35667889999999999998 5579999999754332  22456788889888886 57777777888888889999988


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC---CcEEEeccccCCCC-----
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED---MVAHLSDFEYGMEG-----  346 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~---~~~kl~df~~~~~~-----  346 (453)
                       |.+|+++..-+...++....+-++-|++.-++|+   |.++++||||||+|.|..-+   ..+.+.|||++...     
T Consensus        94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence             8899998877666788889999999999999999   88899999999999998643   46789999876310     


Q ss_pred             ---------------------------CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          347 ---------------------------QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       347 ---------------------------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                                                 .-+.+-|+=|+|-++....-|..||++......  ++..+.        +...
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~QKyEk--------I~Ek  239 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQKYEK--------ISEK  239 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HHHHHH--------HHHh
Confidence                                       124467999999999999999999987643211  111111        1111


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      .+..   +....-.+.|.++.-.+.-|-...-++-|...-+.+.+.-+..
T Consensus       240 K~s~---~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  240 KMST---PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             hcCC---CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            1100   0001123456778888888988888888987776666555443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.76  E-value=3.7e-17  Score=157.56  Aligned_cols=230  Identities=31%  Similarity=0.393  Sum_probs=170.5

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchh---hHHHHHHHHHHHHcCCCC-CceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECAR---ALKSFEAQCEVMKSIRHP-NLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .+...+|.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            34567899999999999976  88999999765432   467899999999999988 7999999998777789999999


Q ss_pred             CCCCchHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC-------
Q 036792          275 PKGSLENCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM-------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~-------  344 (453)
                      .++++.+++....  ..+.......++.+++.++.|+   |+.+++|||+||+||+++... .++++|||.+.       
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            9999997666543  2577788889999999999999   888899999999999999988 79999997531       


Q ss_pred             ------------------------C---CCcCcccchHHHHHHHHHHHhCCCCCCccccc--cccHHhHHhhhcCCchhh
Q 036792          345 ------------------------E---GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVE--ELSLKDWVNNLLPISLME  395 (453)
Q Consensus       345 ------------------------~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  395 (453)
                                              .   ..++...|+||+|+++++++++..|+......  .......+......    
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----  233 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----  233 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc----
Confidence                                    0   24556789999999999999999997544221  00111111100000    


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                          ......  ...........+.+++..|+..+|..|.++.+....
T Consensus       234 ----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ----SLASPL--SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ----cccccc--CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                000000  000001223567889999999999999988876653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.5e-17  Score=151.59  Aligned_cols=134  Identities=19%  Similarity=0.241  Sum_probs=111.5

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +.||+|++|.||+|.+ +|..|++|.......        .....+.+|++++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 677899997653321        1124678899999999999988777777777788999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~  345 (453)
                      ++|++|.+++....    . ....++.+++.++.++   |+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886532    2 6778889999999999   889999999999999999 78899999997643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.7e-18  Score=179.08  Aligned_cols=227  Identities=19%  Similarity=0.207  Sum_probs=159.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEee-----ccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFH-----QECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      .-.+++|.|++|.|+..... .....+.|..+     .... .....+..|.-+-..++|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988877643 33334444332     1111 11122556777778899999988777776655555559


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      |||++ ||...+... ..+....+..+..|+..|+.|+   |+.+|.|||+|++|+++..++.+||+|||.+.       
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 999888764 2466777888999999999999   99999999999999999999999999996431       


Q ss_pred             ----------------------CCCcCc-ccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 ----------------------EGQVST-RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 ----------------------~~~~~~-~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            ...|.+ -.||||.||++..|.+|+.||.....++.....            ......
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------------~~~~~~  543 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------------NNYSDQ  543 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------------hccccc
Confidence                                  112222 379999999999999999998755443332100            000000


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..............+.+...++.++++.+|.+|.|+++|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00000111233455677889999999999999999999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.72  E-value=1.8e-18  Score=179.60  Aligned_cols=218  Identities=22%  Similarity=0.284  Sum_probs=156.7

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccc-hhhHHHHH---HHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC-ARALKSFE---AQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ...+.+|.+.|=+|.+|+++.|. |+||++-+.. .-....|.   .|++ ..-++|||.+.+-.+...+.-.|+|-+|.
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            34577999999999999998887 8999886553 22333343   4444 55678999999887777777778888888


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-----------  343 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-----------  343 (453)
                      .+ +|++.|..+. .+......-|+.|+..|+.-.   |+.+|+|+|||.+|||++...-+.|+||.-.           
T Consensus       104 kh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  104 KH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             hh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            55 8988776543 555666778999999999888   9999999999999999999888999999210           


Q ss_pred             -------------------------------C-CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcC
Q 036792          344 -------------------------------M-EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLP  390 (453)
Q Consensus       344 -------------------------------~-~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  390 (453)
                                                     . ....+++.||||.||++.|+++ |.+||.-.     .+-.|.... .
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~-~  252 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN-A  252 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC-c
Confidence                                           0 0124678899999999999988 57777421     111121110 0


Q ss_pred             CchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          391 ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       391 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                       ...+.+-+.+             ....+..++..|++.||++|-++++.++.
T Consensus       253 -~~~e~~Le~I-------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  253 -DDPEQLLEKI-------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -cCHHHHHHhC-------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             0001110011             01246789999999999999999999876

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=1.1e-16  Score=141.98  Aligned_cols=128  Identities=18%  Similarity=0.206  Sum_probs=101.4

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccch--h--hHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccC
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--R--ALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ...|++|+||+||.+.. .+.+++.+.+.....  .  ....+.+|+++|++++ |+++++++++    +..+++|||++
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            46799999999997665 678888887765432  1  1235789999999995 4889999886    34689999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCceeeCCCCcEEEeccccCC
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL-KPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdl-k~~NiLl~~~~~~kl~df~~~~  344 (453)
                      |.+|.+.+..        ....+..++.+++.++   |+.+|+|||| ||+|||++.++.++|+|||.+.
T Consensus        82 G~~L~~~~~~--------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         82 GAAMYQRPPR--------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             CccHHhhhhh--------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            9998754321        1234667888899998   8999999999 7999999999999999998764

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=5.7e-17  Score=149.69  Aligned_cols=139  Identities=19%  Similarity=0.219  Sum_probs=106.2

Q ss_pred             HHHHhcccCCCCccEEEEEE--ECCCCEEEEEEeeccchh------------------------hHHHHHHHHHHHHcCC
Q 036792          197 LRRLSNLIGMGSFGSVYRAR--LRDGIEVAVKVFHQECAR------------------------ALKSFEAQCEVMKSIR  250 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  250 (453)
                      .+.+.+.||+|+||.||+|.  ..+|+.||||+++.....                        ....+.+|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35778899999999999998  458999999998753210                        1123568999999997


Q ss_pred             CCC--ceeEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCCce
Q 036792          251 HPN--LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP-IIHCDLKPISV  327 (453)
Q Consensus       251 H~n--iv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~-i~Hrdlk~~Ni  327 (453)
                      +.+  +.+++++    ...++||||+++++|........ .........++.+++.++.+|   |+.+ ++|||+||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKL---YKEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCCChhhE
Confidence            633  3444442    23489999999988866543222 344455678899999999999   8888 99999999999


Q ss_pred             eeCCCCcEEEeccccCC
Q 036792          328 LLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       328 Ll~~~~~~kl~df~~~~  344 (453)
                      +++ ++.++++|||.+.
T Consensus       181 li~-~~~i~LiDFg~a~  196 (237)
T smart00090      181 LVH-DGKVVIIDVSQSV  196 (237)
T ss_pred             EEE-CCCEEEEEChhhh
Confidence            999 7899999998764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.71  E-value=2.6e-16  Score=144.44  Aligned_cols=234  Identities=18%  Similarity=0.188  Sum_probs=166.9

Q ss_pred             HHHHhcccCCCCccEEEEEE-ECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .++++.+||+|+||.++.|. +-++++||||.=...+  ...++..|.+..+.+. .++|..++.+-..+.+-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            45778899999999999998 5589999999754332  2234566777666664 588888887777777778999988


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-----CcEEEeccccCCC----
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-----MVAHLSDFEYGME----  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-----~~~kl~df~~~~~----  345 (453)
                       |.+|+++..-+...++......+|.|+..-++|+   |++.+|.|||||+|+||...     ..+.+.|||++..    
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence             8899998887888899999999999999999999   88899999999999999643     3578999987632    


Q ss_pred             ----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          346 ----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       346 ----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                                  ..-+.+-|.=|+|-+++..+-|..||++...... -+.+-.         +-
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeK---------IG  252 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEK---------IG  252 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHHH---------hc
Confidence                                        1224567999999999999999999987633221 111110         00


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +.....   +.....++.|.++..-+.---..+-.+-|..+-+...+..+-+
T Consensus       253 e~Kr~T---~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  253 ETKRST---PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             cccccC---CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            000000   0011223456666666666556666777776665555555444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=8.1e-17  Score=145.35  Aligned_cols=130  Identities=18%  Similarity=0.279  Sum_probs=105.1

Q ss_pred             ccCCCCccEEEEEEECCCCEEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          203 LIGMGSFGSVYRARLRDGIEVAVKVFHQECA--------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .||+|+||.||+|.+ +|..|++|.......        ....++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999995 578899998653211        12356788999999999887665555556667779999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~  345 (453)
                      +|++|.+.+.....        .++.++++++.++   |+.+++|+|++|.||+++ ++.+++.|||.+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999887654221        7788999999999   899999999999999999 78999999997644

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.1e-16  Score=144.36  Aligned_cols=134  Identities=22%  Similarity=0.247  Sum_probs=104.1

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchh----------------------hHHHHHHHHHHHHcCCCCC--
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECAR----------------------ALKSFEAQCEVMKSIRHPN--  253 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n--  253 (453)
                      +.+.+.||+|+||.||++..++|+.||||+++.....                      ....+..|..++.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            5567889999999999999888999999987643210                      1123567888899888874  


Q ss_pred             ceeEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       254 iv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                      +.+.++.    ...++||||+++++|.+....       .....++.+++.++.++   |..+++||||||+||++++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~Nill~~~~  162 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCcccEEEcCCC
Confidence            4444432    345899999999998764321       23346778889999999   778999999999999999999


Q ss_pred             cEEEeccccCCC
Q 036792          334 VAHLSDFEYGME  345 (453)
Q Consensus       334 ~~kl~df~~~~~  345 (453)
                      .++|+|||.+..
T Consensus       163 ~~~liDfg~~~~  174 (198)
T cd05144         163 KIYIIDWPQMVS  174 (198)
T ss_pred             cEEEEECCcccc
Confidence            999999998744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=8.4e-17  Score=150.79  Aligned_cols=170  Identities=21%  Similarity=0.307  Sum_probs=126.3

Q ss_pred             CCCCceeEEeEEecC---------------------------CeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHH
Q 036792          250 RHPNLVKVISSCSND---------------------------DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA  302 (453)
Q Consensus       250 ~H~niv~l~g~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i  302 (453)
                      +|||||++.++|.+.                           ...|+||.-++. +|.+++....  .+......++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            599999999887541                           246788887755 8888886643  4455666788899


Q ss_pred             HHHHHHHHhcCCCCceecCCCCCceee--CCCC--cEEEeccccCCC---------------------------------
Q 036792          303 TSTLEYLYFGHTTPIIHCDLKPISVLL--DEDM--VAHLSDFEYGME---------------------------------  345 (453)
Q Consensus       303 ~~~l~~L~~~h~~~i~Hrdlk~~NiLl--~~~~--~~kl~df~~~~~---------------------------------  345 (453)
                      .+|+.||   |+.+|.|||+|++|||+  |+|.  ...++|||....                                 
T Consensus       351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999   89999999999999998  4444  467899964311                                 


Q ss_pred             CC----cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHH
Q 036792          346 GQ----VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILG  421 (453)
Q Consensus       346 ~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~  421 (453)
                      +.    --.|+|.|+.|.+.||+++...||++.-..-++...|.+...|                   ..+..|++.+.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-------------------alp~~vpp~~rq  488 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-------------------ALPSRVPPVARQ  488 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-------------------CCcccCChHHHH
Confidence            00    0137999999999999999999998643333333333332222                   245678888999


Q ss_pred             HhhhccccCcccCCChHHHHHHH
Q 036792          422 LAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       422 l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                      ++...++.||++|++..-..+.|
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHH
Confidence            99999999999999987766655

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=2.4e-16  Score=163.32  Aligned_cols=133  Identities=18%  Similarity=0.237  Sum_probs=107.3

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEE-eecc-ch------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKV-FHQE-CA------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      ...+.||+|+||.||+|.+.... +++|+ +.+. ..      ...+++.+|+++++.++|++++....++..+...++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            34678999999999999876443 33343 2211 11      1235688999999999999999888888777788999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~  345 (453)
                      |||+++++|.+++.         ....++.++++++.||   |+.+++|||+||+|||+ +++.++|+|||++..
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999988764         3467888999999999   88999999999999999 577899999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.67  E-value=2.1e-16  Score=147.41  Aligned_cols=205  Identities=20%  Similarity=0.252  Sum_probs=130.2

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCC----------CCceeEEeEE-----
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRH----------PNLVKVISSC-----  261 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~-----  261 (453)
                      .+.||.|+++.||.+.+. +++.+|+|+.....   ....+++.+|.-....+.+          -.++--++..     
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            567999999999999976 69999999886432   2345667776644443322          1111111111     


Q ss_pred             ----ecCC--------eeEEEEeccCCCCchHHhhc---CCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 036792          262 ----SNDD--------FKALVLEYMPKGSLENCLYS---STC---MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK  323 (453)
Q Consensus       262 ----~~~~--------~~~lv~E~~~~g~L~~~l~~---~~~---~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk  323 (453)
                          ....        +.+++|+-+ .+||.+++..   ...   .+....++.+..|+++.+++|   |..+++|+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L---h~~GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL---HSYGLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH---hhcceEecccc
Confidence                1111        235677777 5588877542   111   233456778889999999999   88899999999


Q ss_pred             CCceeeCCCCcEEEeccccCC------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCc
Q 036792          324 PISVLLDEDMVAHLSDFEYGM------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDR  373 (453)
Q Consensus       324 ~~NiLl~~~~~~kl~df~~~~------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  373 (453)
                      |+|++++.+|.+.|+||+...                              .-.++.+.|.|++|+++|.|+++..||..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            999999999999999994321                              01256678999999999999999999975


Q ss_pred             cccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccC
Q 036792          374 MFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKR  434 (453)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R  434 (453)
                      ...+.....                  ..      .... +.|+.+..|+...++++|++|
T Consensus       253 ~~~~~~~~~------------------~f------~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPEW------------------DF------SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSGG------------------GG------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCccccccc------------------cc------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            432211100                  00      1122 667789999999999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=2.3e-15  Score=128.83  Aligned_cols=147  Identities=19%  Similarity=0.260  Sum_probs=119.0

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC--CCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRH--PNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .+.+|+|.++.||++...+ ..+++|.......  ...+.+|+..++.++|  .++++++++...++..++++||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            3568999999999999754 7899999865533  4678899999999976  589999998888888999999999887


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHH
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYG  358 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~G  358 (453)
                      +...        +......++.++++++.++|..+..+++|+|++|+||++++++.+++.|||.+...     ...|.++
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~-----~~~~d~~  146 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG-----PPAFDLA  146 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC-----ChHHHHH
Confidence            7543        45666778889999999997666678999999999999999889999999976432     2345565


Q ss_pred             HHHHH
Q 036792          359 IVLME  363 (453)
Q Consensus       359 vvl~e  363 (453)
                      .+++-
T Consensus       147 ~~~~~  151 (155)
T cd05120         147 AALLF  151 (155)
T ss_pred             HHHHH
Confidence            55543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.61  E-value=2.7e-16  Score=155.90  Aligned_cols=167  Identities=25%  Similarity=0.336  Sum_probs=132.4

Q ss_pred             ccCCCCccEEEEEE----ECCCCEEEEEEeeccch--hhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccC
Q 036792          203 LIGMGSFGSVYRAR----LRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       203 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++|+|.||.|+..+    ...|..+|.|..++...  ........|..++...+ ||.+|++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999875    33578899998876532  22225566888888887 9999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      +|+|...+.... ..+...........+-+++++   |+.+|+|||+|++||+++.+|.+++.|||....          
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGT  156 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccc
Confidence            999988776644 233333334444556677777   999999999999999999999999999975321          


Q ss_pred             ---------CCcCcccchHHHHHHHHHHHhCCCCCCc
Q 036792          346 ---------GQVSTRSDIYGYGIVLMETFTRKKPTDR  373 (453)
Q Consensus       346 ---------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~  373 (453)
                               ......+|.||||++++||+||..||..
T Consensus       157 ~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  157 YEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence                     1246679999999999999999999864

>PLN03150 hypothetical protein; Provisional

Probab=99.60  E-value=2.4e-15  Score=157.69  Aligned_cols=117  Identities=33%  Similarity=0.577  Sum_probs=95.3

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCCCCCCcEEEcccccccccCch
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPT   81 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~~~~l~~l~l~~n~~~g~~P~   81 (453)
                      ++.|+|++|.+.|.+|+.|++|++|+.|+|++|+|+|.+|..+++++               +|+.|||++|+++|.+|.
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~---------------~L~~LdLs~N~lsg~iP~  484 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT---------------SLEVLDLSYNSFNGSIPE  484 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCC---------------CCCEEECCCCCCCCCCch
Confidence            46788999999999999999999999999999999998998888876               567888999999999999


Q ss_pred             hhhcCCCCCEEECccCcccccccCCCc--ceeeccccccCCCCCCCCCCCCCCCCC
Q 036792           82 SLEKLLYLKELSLSFNKLEGEILRGGP--FVNFTAMSFKGNEPLCGSPNLQVPPCK  135 (453)
Q Consensus        82 ~~~~~~~l~~l~ls~n~l~g~~p~~~~--~~~~~~~~~~gn~~l~~~~~~~~~~c~  135 (453)
                      +++.+++|+.|++++|.++|.+|..-.  ..+.....+.+|..+|+.+.  .++|.
T Consensus       485 ~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             HHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            999999999999999999999987421  12333456778888888654  34453

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=7.6e-15  Score=131.02  Aligned_cols=133  Identities=23%  Similarity=0.259  Sum_probs=93.3

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchh--hHHH----------------------HHHHHHHHHcCCCCC--c
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECAR--ALKS----------------------FEAQCEVMKSIRHPN--L  254 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i  254 (453)
                      .+.||+|+||.||+|...+++.||||+++.....  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4579999999999999888999999998754211  1111                      134555566554432  3


Q ss_pred             eeEEeEEecCCeeEEEEeccCCCCchH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCC
Q 036792          255 VKVISSCSNDDFKALVLEYMPKGSLEN-CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDED  332 (453)
Q Consensus       255 v~l~g~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~  332 (453)
                      .+.++.    ...++||||++++++.. .+....  .. .....++.+++.++.++   |. .+|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhEEEE-C
Confidence            344432    23589999999965432 111111  00 44567788899999999   66 8999999999999999 8


Q ss_pred             CcEEEeccccCC
Q 036792          333 MVAHLSDFEYGM  344 (453)
Q Consensus       333 ~~~kl~df~~~~  344 (453)
                      +.++++|||.+.
T Consensus       151 ~~~~liDfg~a~  162 (187)
T cd05119         151 GKVYIIDVPQAV  162 (187)
T ss_pred             CcEEEEECcccc
Confidence            899999998763

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=4.4e-15  Score=157.17  Aligned_cols=166  Identities=27%  Similarity=0.343  Sum_probs=127.8

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR---HPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +.+...+|+|+||+||+|...+|+.||+|+=+....-   +|.--.+++.+|+   -+.|..+..++...+-.++|+||.
T Consensus       700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~  776 (974)
T KOG1166|consen  700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS  776 (974)
T ss_pred             EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence            3456789999999999999888999999987654321   1222223444444   134444555555567778999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC-------CCCcEEEeccccC----
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD-------EDMVAHLSDFEYG----  343 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~-------~~~~~kl~df~~~----  343 (453)
                      +.|+|.+++... ...++.-.+.++.++++.++.|   |..+|||+||||+|.|+.       +...++|+|||.+    
T Consensus       777 ~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  777 PYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             ccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            999999988744 4678888999999999999999   899999999999999983       2456899999764    


Q ss_pred             -----------------------CCCCcCcccchHHHHHHHHHHHhCCCC
Q 036792          344 -----------------------MEGQVSTRSDIYGYGIVLMETFTRKKP  370 (453)
Q Consensus       344 -----------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p  370 (453)
                                             .+..++..+|-|.++.+++-|+.|+.-
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence                                   234567789999999999999998754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=5.3e-14  Score=130.19  Aligned_cols=136  Identities=16%  Similarity=0.211  Sum_probs=103.9

Q ss_pred             hcccC-CCCccEEEEEEECCCCEEEEEEeeccc-------------hhhHHHHHHHHHHHHcCCCCCc--eeEEeEEecC
Q 036792          201 SNLIG-MGSFGSVYRARLRDGIEVAVKVFHQEC-------------ARALKSFEAQCEVMKSIRHPNL--VKVISSCSND  264 (453)
Q Consensus       201 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~  264 (453)
                      ...+| .|+.|+||..... +..++||.+....             ......+.+|++++..++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8999999999875 6789999885421             1123467889999999998875  6777764432


Q ss_pred             C----eeEEEEeccCC-CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEec
Q 036792          265 D----FKALVLEYMPK-GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSD  339 (453)
Q Consensus       265 ~----~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~d  339 (453)
                      .    ..++||||+++ .+|.+++...  .++..    .+.++++++.++   |+.+|+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 6888887653  23332    356788899999   899999999999999999888999999


Q ss_pred             cccCCCC
Q 036792          340 FEYGMEG  346 (453)
Q Consensus       340 f~~~~~~  346 (453)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9976544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=5.6e-13  Score=133.97  Aligned_cols=137  Identities=22%  Similarity=0.247  Sum_probs=95.0

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhH----------------------------------------HHHHH
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARAL----------------------------------------KSFEA  241 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~  241 (453)
                      +.||.|++|+||+|++++|+.||||+.+.......                                        -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            56999999999999999999999999865321000                                        02455


Q ss_pred             HHHHHHcC----CCCCceeEEeEEec-CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 036792          242 QCEVMKSI----RHPNLVKVISSCSN-DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST-LEYLYFGHTT  315 (453)
Q Consensus       242 E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~-l~~L~~~h~~  315 (453)
                      |++.+.++    +|.+-+.+-.++.+ ....++||||++|++|.+.........+   +..++..+++. +..+   |..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql---~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV---LRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH---HhC
Confidence            66655554    34333444443322 3456899999999999887643221222   23455555442 3444   788


Q ss_pred             CceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          316 PIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       316 ~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                      +++|+|++|.||+++.++.+++.|||+..
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~  305 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVG  305 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCee
Confidence            99999999999999999999999999863

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.41  E-value=9.6e-13  Score=146.64  Aligned_cols=104  Identities=35%  Similarity=0.519  Sum_probs=80.4

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      |+.|+|++|.+.|.+|..+ .+++|+.|+|++|+++|.+|..++++++|+.|++++|.+.         +++|+.|+|++
T Consensus       454 L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  532 (968)
T PLN00113        454 LQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH  532 (968)
T ss_pred             CcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCC
Confidence            4455555555555555443 3356677777777777777878888888888888888873         57889999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccccccCC
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG  106 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~  106 (453)
                      |.++|.+|.++..+++|+.|++++|.++|.+|..
T Consensus       533 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  566 (968)
T PLN00113        533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN  566 (968)
T ss_pred             CcccccCChhHhCcccCCEEECCCCcccccCChh
Confidence            9999999999999999999999999999988864

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.31  E-value=9.7e-11  Score=119.35  Aligned_cols=137  Identities=18%  Similarity=0.161  Sum_probs=88.5

Q ss_pred             cccCCCCccEEEEEEECC-CCEEEEEEeeccchh----------------------------------hHH------HHH
Q 036792          202 NLIGMGSFGSVYRARLRD-GIEVAVKVFHQECAR----------------------------------ALK------SFE  240 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~------~~~  240 (453)
                      +.+|+|++|+||+|++++ |+.||||+.+.....                                  ..+      +|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999987 999999999744110                                  011      234


Q ss_pred             HHHHHHHcC----CCCCceeEEeEEec-CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036792          241 AQCEVMKSI----RHPNLVKVISSCSN-DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT  315 (453)
Q Consensus       241 ~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~  315 (453)
                      +|+..+.++    .+.+.+.+-.++.+ ....+|||||++|+++.+.-.-.....+..   .++...++  .|+......
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~--~~~~Qif~~  279 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVE--VFFTQVFRD  279 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHH--HHHHHHHhC
Confidence            455444444    24444554444433 445689999999999976422111112211   12222222  122222567


Q ss_pred             CceecCCCCCceeeCCCC----cEEEeccccC
Q 036792          316 PIIHCDLKPISVLLDEDM----VAHLSDFEYG  343 (453)
Q Consensus       316 ~i~Hrdlk~~NiLl~~~~----~~kl~df~~~  343 (453)
                      +++|+|++|.||+++.++    .+++.|||+.
T Consensus       280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGiv  311 (537)
T PRK04750        280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIV  311 (537)
T ss_pred             CeeeCCCChHHeEEecCCCCCCeEEEEecceE
Confidence            899999999999999887    8999999976

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=1.8e-11  Score=107.21  Aligned_cols=141  Identities=21%  Similarity=0.246  Sum_probs=99.6

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCce-eEEeEEecCCeeEEEEeccCCCCch
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLV-KVISSCSNDDFKALVLEYMPKGSLE  280 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~E~~~~g~L~  280 (453)
                      +.++.|.++.||+++.. +..|++|....... ....+.+|+.+++.+.+.+++ +++++.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46889999999999875 77899998765432 123467888888888665544 444443  23357999999998875


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----ceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchH
Q 036792          281 NCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP-----IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY  355 (453)
Q Consensus       281 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~-----i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~  355 (453)
                      +.  .       .....++.++++++..|   |..+     ++|+|++|.||+++ ++.+++.|||++..+     .-.|
T Consensus        80 ~~--~-------~~~~~~~~~l~~~l~~L---H~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~-----~~~~  141 (170)
T cd05151          80 TE--D-------FSDPENLEKIAKLLKKL---HSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN-----DPLF  141 (170)
T ss_pred             cc--c-------ccCHHHHHHHHHHHHHH---hCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC-----ChHH
Confidence            42  0       11123456788899999   5544     59999999999999 567999999986432     1245


Q ss_pred             HHHHHHHHH
Q 036792          356 GYGIVLMET  364 (453)
Q Consensus       356 S~Gvvl~el  364 (453)
                      -+|.++.+.
T Consensus       142 Dla~~~~~~  150 (170)
T cd05151         142 DLANFFSEA  150 (170)
T ss_pred             HHHHHHHhc
Confidence            667666543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.29  E-value=3.5e-12  Score=133.29  Aligned_cols=178  Identities=25%  Similarity=0.283  Sum_probs=117.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +..+.+..|+||.||..+++ +.+++|.|+-++.-      +.+-  ++.....|.+|                     |
T Consensus        86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------g  136 (1205)
T KOG0606|consen   86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------G  136 (1205)
T ss_pred             ceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------c
Confidence            33578999999999999987 46788885433221      0110  22222233322                     4


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------------  344 (453)
                      |-...+..-+ .++.        +.+.+++||   |+.+|+|||+||+|.+|..-|..|+.|||+..             
T Consensus       137 Dc~tllk~~g-~lPv--------dmvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  137 DCATLLKNIG-PLPV--------DMVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             hhhhhcccCC-CCcc--------hhhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence            4444444322 1211        226789999   99999999999999999999999999996431             


Q ss_pred             ---------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          345 ---------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       345 ---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                                 ...|...+|.|++|+++||.+.|+.||.+...+++--             .++
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg-------------~vi  271 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-------------QVI  271 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh-------------hhh
Confidence                                       1346778999999999999999999998765443211             111


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCC
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRI  435 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP  435 (453)
                      ...+.     ..+..+..++++.+++.+.++.+|..|-
T Consensus       272 sd~i~-----wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  272 SDDIE-----WPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhcc-----ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            11111     1112234456788999999999999994

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.27  E-value=1.4e-12  Score=127.36  Aligned_cols=145  Identities=23%  Similarity=0.302  Sum_probs=104.1

Q ss_pred             eeEEEEeccCCCCchHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC
Q 036792          266 FKALVLEYMPKGSLENCLYSS--TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      ..+|.|++|...+|.+|+..+  ....++.....++.+++.++.|      ++.+|||+||.||....+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999643  3456677788899999999987      78899999999999999999999999754


Q ss_pred             C-------------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCC
Q 036792          344 M-------------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPI  391 (453)
Q Consensus       344 ~-------------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  391 (453)
                      .                               +..|+.|+||||+|++++|+++ -..+++....               
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---------------  468 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---------------  468 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---------------
Confidence            2                               2357889999999999999988 3334322100               


Q ss_pred             chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHH
Q 036792          392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKD  439 (453)
Q Consensus       392 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~  439 (453)
                       ..++-|..+      ++.. ...-++-..|+..++.+.|++||++.+
T Consensus       469 -~~d~r~g~i------p~~~-~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  469 -LTDIRDGII------PPEF-LQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             -hhhhhcCCC------ChHH-hhcCcHHHHHHHHhcCCCcccCchHHH
Confidence             001101000      0001 111223467889999999999995444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=6e-13  Score=138.00  Aligned_cols=227  Identities=23%  Similarity=0.251  Sum_probs=163.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv  270 (453)
                      ..+++...||+|+|+.|-.....  ....+|+|.+....  ....+....|..+-..+. |+|++++++....++..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            34566677999999999888753  34567777665443  233344455777766776 99999999999999999999


Q ss_pred             EeccCCCCchHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCceeeCCCC-cEEEeccccCCCC-
Q 036792          271 LEYMPKGSLENCL-YSSTCMLDIFQRLNIMIDATSTLEYLYFGH-TTPIIHCDLKPISVLLDEDM-VAHLSDFEYGMEG-  346 (453)
Q Consensus       271 ~E~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h-~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~~~-  346 (453)
                      +||..+|++...+ .......+....-....++..++.|+   | ..++.|||+||+|.+++..+ ..+++|||++... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999998877 44322333444456677888999999   8 89999999999999999998 9999999765321 


Q ss_pred             -----------------------------CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          347 -----------------------------QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       347 -----------------------------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                                   ......|+||.|+++.-+++|..|++...........|......       
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------  249 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR-------  249 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc-------
Confidence                                         11345799999999999999999987654444333333322100       


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                               ..............++...++..+|+.|.+.+++.
T Consensus       250 ---------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 ---------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ---------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence                     00011123344567788889999999999887753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=4.2e-11  Score=110.42  Aligned_cols=172  Identities=23%  Similarity=0.281  Sum_probs=119.3

Q ss_pred             HHcCCCCCceeEEeEEecC-----CeeEEEEeccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 036792          246 MKSIRHPNLVKVISSCSND-----DFKALVLEYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPI  317 (453)
Q Consensus       246 l~~l~H~niv~l~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i  317 (453)
                      +-++.|.|||+++.|+.+.     ....+++|||+.|++.++|+..   ...+....-.+.+.||..||.|||. .+++|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            4566799999999998663     3567899999999999999752   3345555566788999999999975 57899


Q ss_pred             eecCCCCCceeeCCCCcEEEecc-----------------------------ccCCCCCcCcccchHHHHHHHHHHHhCC
Q 036792          318 IHCDLKPISVLLDEDMVAHLSDF-----------------------------EYGMEGQVSTRSDIYGYGIVLMETFTRK  368 (453)
Q Consensus       318 ~Hrdlk~~NiLl~~~~~~kl~df-----------------------------~~~~~~~~~~~~Dv~S~Gvvl~el~tg~  368 (453)
                      +|+++.-+-|.+..++-+|+.--                             +++.....+..+|||+||.-..||..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999998888887542                             1112223456799999999999998886


Q ss_pred             CC-CCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          369 KP-TDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       369 ~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .- ..+...-+              ..+.+...+...+...          =.+++..|++..|..||+|++.+.
T Consensus       280 iq~tnseS~~~--------------~ee~ia~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  280 IQSTNSESKVE--------------VEENIANVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eccCCCcceee--------------hhhhhhhheeeccCcc----------ccCcCcccccCCCCCCcchhhhhc
Confidence            54 32221100              0011111111111000          123567899999999999998764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.15  E-value=7e-10  Score=111.79  Aligned_cols=145  Identities=20%  Similarity=0.261  Sum_probs=113.9

Q ss_pred             CCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHH
Q 036792          218 RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN  297 (453)
Q Consensus       218 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~  297 (453)
                      .++.+|.|...+.......+...+-++.|+.+|||||++++..+...+..|||+|-+.  .|..++...    ......-
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~~  108 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVCL  108 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHHH
Confidence            3688999998876655444556677888999999999999999999999999999874  455555542    2334445


Q ss_pred             HHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCCCC---------------cC----cc----cch
Q 036792          298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQ---------------VS----TR----SDI  354 (453)
Q Consensus       298 i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~---------------~~----~~----~Dv  354 (453)
                      .+.||++||.|||  ++..++|+++.-..|.++..|..||.+||+.....               .+    ..    .|.
T Consensus       109 Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s~D~  186 (690)
T KOG1243|consen  109 GLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWSIDS  186 (690)
T ss_pred             HHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccchhh
Confidence            6789999999996  68889999999999999999999999998752110               11    12    499


Q ss_pred             HHHHHHHHHHHhCCCC
Q 036792          355 YGYGIVLMETFTRKKP  370 (453)
Q Consensus       355 ~S~Gvvl~el~tg~~p  370 (453)
                      |-|||+++|++.|..+
T Consensus       187 ~~Lg~li~el~ng~~~  202 (690)
T KOG1243|consen  187 WGLGCLIEELFNGSLL  202 (690)
T ss_pred             hhHHHHHHHHhCcccC
Confidence            9999999999999433

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.12  E-value=7.2e-10  Score=101.43  Aligned_cols=142  Identities=16%  Similarity=0.168  Sum_probs=103.7

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCC--CceeEEeEEecC---CeeEEEEeccC
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHP--NLVKVISSCSND---DFKALVLEYMP  275 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lv~E~~~  275 (453)
                      +.++.|.++.||++...+|..+++|....... .....+.+|+++++.+++.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999987778999999765432 2345788999999998763  456677776653   25689999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG-------------------------------------------  312 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~-------------------------------------------  312 (453)
                      |.++.+.+..  ..++......++.++++.+.+||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888664421  1345555566666677777666521                                           


Q ss_pred             ----------CCCCceecCCCCCceeeCC--CCcEEEeccccCCC
Q 036792          313 ----------HTTPIIHCDLKPISVLLDE--DMVAHLSDFEYGME  345 (453)
Q Consensus       313 ----------h~~~i~Hrdlk~~NiLl~~--~~~~kl~df~~~~~  345 (453)
                                ....++|+|+.+.||+++.  ++.+.+.|||.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1245799999999999998  56788999987643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.11  E-value=5.2e-12  Score=105.97  Aligned_cols=96  Identities=29%  Similarity=0.489  Sum_probs=53.0

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~n   73 (453)
                      ++.|-||+|.++ .+|+.|..|.+|+.|++++|+++. +|.++++|+.|+.|+++-|++.        ++.|+.|||+.|
T Consensus        35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltyn  112 (264)
T KOG0617|consen   35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYN  112 (264)
T ss_pred             hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcccc
Confidence            345556666666 456666666666666666666653 5666666666666666666552        455555555555


Q ss_pred             ccc-ccCchhhhcCCCCCEEECccCcc
Q 036792           74 EIY-GLIPTSLEKLLYLKELSLSFNKL   99 (453)
Q Consensus        74 ~~~-g~~P~~~~~~~~l~~l~ls~n~l   99 (453)
                      +++ -.+|..|..+..|..|.++.|.|
T Consensus       113 nl~e~~lpgnff~m~tlralyl~dndf  139 (264)
T KOG0617|consen  113 NLNENSLPGNFFYMTTLRALYLGDNDF  139 (264)
T ss_pred             ccccccCCcchhHHHHHHHHHhcCCCc
Confidence            553 23444444444444444444444

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.05  E-value=3.7e-09  Score=93.87  Aligned_cols=135  Identities=20%  Similarity=0.240  Sum_probs=93.2

Q ss_pred             cccCCCCccEEEEEEECC-------CCEEEEEEeeccc----------------------hhhHHHH----HHHHHHHHc
Q 036792          202 NLIGMGSFGSVYRARLRD-------GIEVAVKVFHQEC----------------------ARALKSF----EAQCEVMKS  248 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~  248 (453)
                      ..||.|.-+.||.|...+       +..+|||+.+...                      ....+.+    .+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       4799999885321                      0011222    379999988


Q ss_pred             CCC--CCceeEEeEEecCCeeEEEEeccCCCCchH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 036792          249 IRH--PNLVKVISSCSNDDFKALVLEYMPKGSLEN-CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPI  325 (453)
Q Consensus       249 l~H--~niv~l~g~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~  325 (453)
                      +..  -++.+.+++    ..-++||||+.++.+.. .+...  .++......+..++..++..++  |+.+++|+||++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCHH
Confidence            853  355556654    34579999997654422 22221  2333344566778888888874  7889999999999


Q ss_pred             ceeeCCCCcEEEeccccCCC
Q 036792          326 SVLLDEDMVAHLSDFEYGME  345 (453)
Q Consensus       326 NiLl~~~~~~kl~df~~~~~  345 (453)
                      ||++++ +.+.++||+.+..
T Consensus       155 NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         155 NMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             HEEEEC-CcEEEEECCCcee
Confidence            999974 6799999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=4.2e-09  Score=90.54  Aligned_cols=142  Identities=19%  Similarity=0.264  Sum_probs=99.1

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccc---hh-----hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQEC---AR-----ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..+++|+-+.+|.+.+. |.++.+|.-..+.   +.     ..++-.+|+.++.+++--.|....=+..+++...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 4446666432221   11     134567899999888755554444455677778899999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCCCC--cCcc
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQ--VSTR  351 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~--~~~~  351 (453)
                      ++|-.|.+.+...        +..++..+-..+.-|   |..+|+|+||.++||++..+. +.+.|||++....  -+..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~Ed~a  148 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEVEDKA  148 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCcccccccHHhhh
Confidence            9998888887654        233444555555667   999999999999999998765 8899999875322  2335


Q ss_pred             cchHH
Q 036792          352 SDIYG  356 (453)
Q Consensus       352 ~Dv~S  356 (453)
                      +|+|-
T Consensus       149 VDl~V  153 (204)
T COG3642         149 VDLHV  153 (204)
T ss_pred             chHHH
Confidence            67663

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.00  E-value=1.3e-11  Score=103.55  Aligned_cols=97  Identities=31%  Similarity=0.506  Sum_probs=87.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      +|+.|++++|++. .+|..|++|+.|++|+++-|++.- +|..||++|.|+.|||.+|+++          ++.|+.|+|
T Consensus        57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~-lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl  134 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNI-LPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL  134 (264)
T ss_pred             hhhhhhcccchhh-hcChhhhhchhhhheecchhhhhc-CccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence            5778999999998 699999999999999999999984 9999999999999999999985          457889999


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCccc
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      +.|-|. .+|..++.+++|+.|.+..|.+-
T Consensus       135 ~dndfe-~lp~dvg~lt~lqil~lrdndll  163 (264)
T KOG0617|consen  135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLL  163 (264)
T ss_pred             cCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence            999998 67999999999999999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.00  E-value=4.4e-10  Score=112.03  Aligned_cols=219  Identities=23%  Similarity=0.207  Sum_probs=150.3

Q ss_pred             HHhcccCC--CCccEEEEEEE--C-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEE
Q 036792          199 RLSNLIGM--GSFGSVYRARL--R-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       199 ~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  270 (453)
                      .....+|+  |.+|.||.+..  + ++..+|+|.-+..  .......-.+|.....++ .|+|.|+....+.+.+..++-
T Consensus       117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq  196 (524)
T KOG0601|consen  117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ  196 (524)
T ss_pred             ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence            34567888  99999999986  3 6889999974432  223333445666666666 499999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCC-
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS----TLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGM-  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~----~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~-  344 (453)
                      +|++. .+|..+.......++.........+..+    |+..+   |...++|-|+||.||....+ ...++.||+... 
T Consensus       197 tE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  197 TELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             ecccc-chhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCcceeEE
Confidence            99884 6888777665544565666666666666    77766   99999999999999999998 788999995421 


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                                                  .+-++...|+||+|.+..|..++..+.......     .|.+..   .+ .+
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-----~W~~~r---~~-~i  343 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-----SWSQLR---QG-YI  343 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-----Cccccc---cc-cC
Confidence                                        122455789999999999999887664321111     111100   00 00


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                      -++           .-.....++......+++.+|-.|++++++.
T Consensus       344 p~e-----------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  344 PLE-----------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             chh-----------hhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            000           1111122333477789999999999977654

>PLN03150 hypothetical protein; Provisional

Probab=98.96  E-value=9.9e-10  Score=115.59  Aligned_cols=86  Identities=27%  Similarity=0.470  Sum_probs=76.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCCCCCCcEEEcccccccccCc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIP   80 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~~~~l~~l~l~~n~~~g~~P   80 (453)
                      +|+.|+|++|+|.|.+|+.+++|++|+.|+|++|+|+|.+|..+++|+               +|+.|+|++|+++|.+|
T Consensus       443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~---------------~L~~L~Ls~N~l~g~iP  507 (623)
T PLN03150        443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT---------------SLRILNLNGNSLSGRVP  507 (623)
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCC---------------CCCEEECcCCcccccCC
Confidence            478999999999999999999999999999999999999999999886               56788888899999999


Q ss_pred             hhhhcC-CCCCEEECccCcccc
Q 036792           81 TSLEKL-LYLKELSLSFNKLEG  101 (453)
Q Consensus        81 ~~~~~~-~~l~~l~ls~n~l~g  101 (453)
                      .++..+ .++..+++++|....
T Consensus       508 ~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        508 AALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             hHHhhccccCceEEecCCcccc
Confidence            998874 467889999987543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.93  E-value=1.1e-08  Score=87.63  Aligned_cols=151  Identities=17%  Similarity=0.188  Sum_probs=101.7

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEe-eccc-------hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVF-HQEC-------ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ..++-+|+-+.|+++.+. |+...||.- .+..       .-..++..+|++++.+++--.|.-..=++.+...-.|.||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            456889999999999885 666666643 2221       1123567889999988865444433334445555579999


Q ss_pred             ccCC-CCchHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC---cEEEeccccCCCCC
Q 036792          273 YMPK-GSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM---VAHLSDFEYGMEGQ  347 (453)
Q Consensus       273 ~~~~-g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~df~~~~~~~  347 (453)
                      |+++ .++.+++..... ..........+..+-+.+.-|   |..+|+|+||..+||++..++   .+.+.|||++....
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~  167 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR  167 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence            9976 367777755321 122222256677777778888   899999999999999986543   56899999875433


Q ss_pred             c--CcccchH
Q 036792          348 V--STRSDIY  355 (453)
Q Consensus       348 ~--~~~~Dv~  355 (453)
                      .  +..+|+|
T Consensus       168 ~~EDKgVDLY  177 (229)
T KOG3087|consen  168 LPEDKGVDLY  177 (229)
T ss_pred             Ccccccceee
Confidence            2  3456777

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.85  E-value=6.4e-10  Score=105.18  Aligned_cols=56  Identities=30%  Similarity=0.627  Sum_probs=47.7

Q ss_pred             EEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC
Q 036792            4 NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD   61 (453)
Q Consensus         4 ~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~   61 (453)
                      .+.+++|.++ .+|..++.+++|+.|+|++|-+. .+|-+++.+..|+.++++.|+|.
T Consensus       416 ~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr  471 (565)
T KOG0472|consen  416 DLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR  471 (565)
T ss_pred             HHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc
Confidence            3455666555 79999999999999999888777 49999999999999999999984

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.83  E-value=5.5e-10  Score=110.19  Aligned_cols=105  Identities=26%  Similarity=0.244  Sum_probs=82.6

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      ++.|+|+.|++...--..+-+|+.|++|+||+|.+...-++.|.-+++|++|+|++|+++         +..|+.|+|+.
T Consensus       271 me~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~  350 (873)
T KOG4194|consen  271 MEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSH  350 (873)
T ss_pred             cceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccc
Confidence            578888999888655566778889999999999999888888888999999999999884         55777777777


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccccccCC
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG  106 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~  106 (453)
                      |+++-..-..|..+++|..||++.|.+++.|-++
T Consensus       351 Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa  384 (873)
T KOG4194|consen  351 NSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA  384 (873)
T ss_pred             cchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence            7777544456666777777888888777776553

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.79  E-value=3.5e-09  Score=105.73  Aligned_cols=221  Identities=21%  Similarity=0.185  Sum_probs=149.2

Q ss_pred             HHhcccCCCCccEEEEEEEC--CCCEEEEEEeeccchhhHHH--HHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR--DGIEVAVKVFHQECARALKS--FEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      .+...||.|.|+.|+....+  ++..|++|.+.+.......+  -..|+-+...+ .|.++++....+...+..++--||
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            34667999999999998744  67899999887654322221  13344444444 588888888777777777899999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCCC-------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGME-------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~~-------  345 (453)
                      ++++++...... ...++...++.+..+++.++.++   |++.++|+|+||+||++..+ +..++.||+.+..       
T Consensus       348 ~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~  423 (524)
T KOG0601|consen  348 CEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV  423 (524)
T ss_pred             hcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhccccccccccceeccc
Confidence            999988655421 12455566677777887777776   89999999999999999886 7788888866531       


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                       ..+..+.|++|||..+.|.+++..-....       .+|....              .+   .
T Consensus       424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------~~~~~i~--------------~~---~  479 (524)
T KOG0601|consen  424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------VQSLTIR--------------SG---D  479 (524)
T ss_pred             ccccccccccchhhccccccccccccccccccccccccCcccCccc-------ccceeee--------------cc---c
Confidence                             12345789999999999998887542211       0111000              00   0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      .+........+..+.......++..||.+.+.....+-.
T Consensus       480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            000111124566677788899999999988876554433

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.77  E-value=7.6e-10  Score=104.68  Aligned_cols=115  Identities=28%  Similarity=0.423  Sum_probs=74.8

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC----------------------
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----------------------   60 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~----------------------   60 (453)
                      +.+++.+|.+.. +|++.-+|+.|++||.-+|-++ .+|+++|+|.+|..|+|..|++                      
T Consensus       163 ~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i  240 (565)
T KOG0472|consen  163 SKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGENQI  240 (565)
T ss_pred             HHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcccHH
Confidence            345555555553 3333233555555555444444 3555555555555555555554                      


Q ss_pred             ---------CCCCCcEEEcccccccccCchhhhcCCCCCEEECccCcccccccCCCcceeeccccccCCC
Q 036792           61 ---------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNE  121 (453)
Q Consensus        61 ---------~~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn~  121 (453)
                               ++.+|..|||..|++. +.|+++--+.+|..||+|+|.+++-.+.-+.+ .+.+..+.||+
T Consensus       241 ~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  241 EMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             HhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence                     2678899999999999 68999999999999999999998866554444 44455556664

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.76  E-value=1.4e-09  Score=108.13  Aligned_cols=96  Identities=33%  Similarity=0.477  Sum_probs=67.3

Q ss_pred             ccEEEcCCCcCcCCCCcC-CCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------------------
Q 036792            2 ILNFDFSSNSLEGPLSLD-IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------------------   61 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~-~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------------------   61 (453)
                      +..|+||+|++. +||.. +-+|+.|-.||||+|+|.. +|+.+..+..|++|.|++|.+.                   
T Consensus       128 ~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms  205 (1255)
T KOG0444|consen  128 SIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEM-LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS  205 (1255)
T ss_pred             cEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhh-cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence            345666666666 45655 4477777777777777774 7888888888888888888762                   


Q ss_pred             ---------------CCCCcEEEcccccccccCchhhhcCCCCCEEECccCccc
Q 036792           62 ---------------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        62 ---------------~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                                     +.+|..+|+|.|++. .+|+-+.++.+|..|++|+|.++
T Consensus       206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it  258 (1255)
T KOG0444|consen  206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT  258 (1255)
T ss_pred             cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence                           345666777777776 56777777777777777777664

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.75  E-value=1.1e-08  Score=108.25  Aligned_cols=40  Identities=28%  Similarity=0.284  Sum_probs=23.9

Q ss_pred             CcEEEcccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           65 LEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        65 l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |+.|++++|+++ .+|.++.++++|+.+++++|+|+|.+|.
T Consensus       424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            444455555554 4566666666666777777776665543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.71  E-value=1.8e-07  Score=87.67  Aligned_cols=156  Identities=13%  Similarity=0.047  Sum_probs=100.8

Q ss_pred             cCCCCccEEEEEEECCCCEEEEEEeeccchh-hH----------HHHHHHHHHHHcCCCCCc--eeEEeEEec-----CC
Q 036792          204 IGMGSFGSVYRARLRDGIEVAVKVFHQECAR-AL----------KSFEAQCEVMKSIRHPNL--VKVISSCSN-----DD  265 (453)
Q Consensus       204 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----~~  265 (453)
                      +-+.....|++..+ +|+.|.||........ ..          ..+.+|...+.++...+|  .+.+++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333344667665 5778999976433211 11          247788888877753333  344455432     23


Q ss_pred             eeEEEEeccCCC-CchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-------CCcEE
Q 036792          266 FKALVLEYMPKG-SLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-------DMVAH  336 (453)
Q Consensus       266 ~~~lv~E~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-------~~~~k  336 (453)
                      ..++|||++++- +|.+++... ....+......++.++++.+.-|   |..+|+|+|+++.|||++.       +..+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence            468999999876 788887532 12334455667888899999999   8999999999999999975       46889


Q ss_pred             EeccccCCCC-CcCcccchHHHHHHHHH
Q 036792          337 LSDFEYGMEG-QVSTRSDIYGYGIVLME  363 (453)
Q Consensus       337 l~df~~~~~~-~~~~~~Dv~S~Gvvl~e  363 (453)
                      ++||+-.... ....+.-+.-++.+.+-
T Consensus       186 LIDl~r~~~~~~~~~~~r~~dL~~L~~s  213 (268)
T PRK15123        186 VIDLHRAQIRARVPRRWRDKDLAGLYFS  213 (268)
T ss_pred             EEECCcccccCCCChHHHHHHHHHHHHH
Confidence            9999876322 22333334445544433

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=1.5e-07  Score=83.34  Aligned_cols=125  Identities=22%  Similarity=0.288  Sum_probs=77.2

Q ss_pred             EEEEEEECCCCEEEEEEeeccch--------------------------hhHHHHHHHHHHHHcCCCC--CceeEEeEEe
Q 036792          211 SVYRARLRDGIEVAVKVFHQECA--------------------------RALKSFEAQCEVMKSIRHP--NLVKVISSCS  262 (453)
Q Consensus       211 ~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~  262 (453)
                      .||.|...+|..+|||..+....                          .......+|.+.|.++..-  ++.+.+++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999988899999998853210                          0123457899999999765  455555442 


Q ss_pred             cCCeeEEEEeccC--CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecc
Q 036792          263 NDDFKALVLEYMP--KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF  340 (453)
Q Consensus       263 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df  340 (453)
                         .-+|||||++  |..+.. +....  ++......+..++...+..++  |..+|+|+||.+.||+++++ .+.+.||
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eEEEEec
Confidence               2369999998  544443 32211  001223344555666555542  78999999999999999987 8999999


Q ss_pred             ccCCC
Q 036792          341 EYGME  345 (453)
Q Consensus       341 ~~~~~  345 (453)
                      +.+..
T Consensus       151 ~qav~  155 (188)
T PF01163_consen  151 GQAVD  155 (188)
T ss_dssp             TTEEE
T ss_pred             Cccee
Confidence            87644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.70  E-value=1.3e-07  Score=86.34  Aligned_cols=134  Identities=23%  Similarity=0.250  Sum_probs=94.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccch----------------------hhHHHHHHHHHHHHcCCCC-
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA----------------------RALKSFEAQCEVMKSIRHP-  252 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~-  252 (453)
                      ..+.+++.||.|.-+.||.|..+.|.++|||.-+....                      -.....++|.++|.++... 
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            45677899999999999999999999999996642211                      0123457889999988754 


Q ss_pred             -CceeEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC
Q 036792          253 -NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE  331 (453)
Q Consensus       253 -niv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~  331 (453)
                       .+.+.+++    +.-++||||++|-.|...-      ++....-.+...|..-+.-.   -..+++|+|+.+-||++++
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEEec
Confidence             55555543    4457999999987775421      11222223333444444433   4678999999999999999


Q ss_pred             CCcEEEecccc
Q 036792          332 DMVAHLSDFEY  342 (453)
Q Consensus       332 ~~~~kl~df~~  342 (453)
                      |+.+.+.||--
T Consensus       238 dg~~~vIDwPQ  248 (304)
T COG0478         238 DGDIVVIDWPQ  248 (304)
T ss_pred             CCCEEEEeCcc
Confidence            99999999954

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.70  E-value=1.3e-08  Score=72.75  Aligned_cols=60  Identities=32%  Similarity=0.424  Sum_probs=49.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL   60 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~   60 (453)
                      +|+.|++++|++....+..|.++++|+.|++++|+++..-|..|.++++|+.|++++|++
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            478899999999965556788999999999999999876666888998888888888864

...

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.67  E-value=3.5e-08  Score=85.91  Aligned_cols=95  Identities=31%  Similarity=0.447  Sum_probs=26.3

Q ss_pred             ccEEEcCCCcCcCCCCcCCC-CCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            2 ILNFDFSSNSLEGPLSLDIG-NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      ++.|+|++|.++- | +.++ .+.+|+.|+||+|.++. ++ .+..++.|+.|++++|.++         +++|+.|+++
T Consensus        21 ~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~   96 (175)
T PF14580_consen   21 LRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLS   96 (175)
T ss_dssp             -----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-T
T ss_pred             ccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECc
Confidence            3456666776662 3 3455 45666677777777664 33 3555666666666666653         4566666666


Q ss_pred             cccccccC-chhhhcCCCCCEEECccCccc
Q 036792           72 NNEIYGLI-PTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        72 ~n~~~g~~-P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      +|++...- =..+..+++|+.|++.+|++.
T Consensus        97 ~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   97 NNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             TS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            66664211 134445566666666666554

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.64  E-value=4.5e-09  Score=103.86  Aligned_cols=99  Identities=26%  Similarity=0.316  Sum_probs=79.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      .|++|+||+|.+.-.=++...-..+|++|+||+|+++..-|.+|.-|.+|+.|+|++|.++         +.+|+.|||+
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr  373 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR  373 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence            3678899999888777777778888999999999998877778888888888888888885         6788888888


Q ss_pred             cccccccCch---hhhcCCCCCEEECccCcc
Q 036792           72 NNEIYGLIPT---SLEKLLYLKELSLSFNKL   99 (453)
Q Consensus        72 ~n~~~g~~P~---~~~~~~~l~~l~ls~n~l   99 (453)
                      +|.+++.|-+   .+..|++|+.|++.+|++
T Consensus       374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNql  404 (873)
T KOG4194|consen  374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQL  404 (873)
T ss_pred             CCeEEEEEecchhhhccchhhhheeecCcee
Confidence            8888776653   344577778888888876

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.63  E-value=6.2e-09  Score=103.63  Aligned_cols=93  Identities=31%  Similarity=0.495  Sum_probs=75.1

Q ss_pred             EEcCCCcCcCC-CCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccccc
Q 036792            5 FDFSSNSLEGP-LSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNNE   74 (453)
Q Consensus         5 l~ls~n~l~g~-~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n~   74 (453)
                      +++..|+|.-+ ||++|..|..|+.||||+|+|. +.|..+..-+++-.|+|++|++.         ++.|-.||||+|+
T Consensus        83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr  161 (1255)
T KOG0444|consen   83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR  161 (1255)
T ss_pred             HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence            34444555332 8888888888888888888887 58888888888888888888874         6678889999999


Q ss_pred             ccccCchhhhcCCCCCEEECccCcc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKL   99 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l   99 (453)
                      +. .+|.++.++..|++|++|+|++
T Consensus       162 Le-~LPPQ~RRL~~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  162 LE-MLPPQIRRLSMLQTLKLSNNPL  185 (1255)
T ss_pred             hh-hcCHHHHHHhhhhhhhcCCChh
Confidence            98 5788889999999999999986

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.63  E-value=1.2e-06  Score=86.32  Aligned_cols=160  Identities=18%  Similarity=0.203  Sum_probs=117.7

Q ss_pred             CccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec----CCeeEEEEeccCC-CCchH
Q 036792          208 SFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN----DDFKALVLEYMPK-GSLEN  281 (453)
Q Consensus       208 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~E~~~~-g~L~~  281 (453)
                      .-.+.|++... +|..|+.|+++.........-..-++..+++.|+|+|++..++..    +..+++||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34568899754 899999999954432222223345678899999999999998874    4568899999986 57766


Q ss_pred             HhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC---C
Q 036792          282 CLYSS--------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG---M  344 (453)
Q Consensus       282 ~l~~~--------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~---~  344 (453)
                      .-...              ....+......++.|++.||.++   |+.|+.-+-|.+.+||++.+..++|+..+.-   .
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            44321              12344566778899999999999   8889988999999999999988888765432   1


Q ss_pred             CCC-----cCcccchHHHHHHHHHHHhCCCC
Q 036792          345 EGQ-----VSTRSDIYGYGIVLMETFTRKKP  370 (453)
Q Consensus       345 ~~~-----~~~~~Dv~S~Gvvl~el~tg~~p  370 (453)
                      ...     --.+-|.-.||.++.-+.||..-
T Consensus       445 ~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPTEPLESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCCcchhHHhhhhHHHHHHHHHHHhhcccc
Confidence            111     12357999999999999999643

>PLN03210 Resistant to P

Probab=98.52  E-value=3.1e-07  Score=103.78  Aligned_cols=102  Identities=23%  Similarity=0.201  Sum_probs=88.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC-C-----CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-D-----VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~-~-----~~~l~~l~l~~n~   74 (453)
                      +|+.|+|++|...+.+|..+++|++|+.|+|++|+..+.+|..+ ++++|+.|++++|.. .     .++|+.|+|++|.
T Consensus       779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~  857 (1153)
T PLN03210        779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTG  857 (1153)
T ss_pred             cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCCCC
Confidence            47889999999999999999999999999999987777899877 799999999998754 1     4689999999999


Q ss_pred             ccccCchhhhcCCCCCEEECccC-cccccccC
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFN-KLEGEILR  105 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n-~l~g~~p~  105 (453)
                      ++ .+|.++..+++|++|+++++ ++.+ +|.
T Consensus       858 i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~~  887 (1153)
T PLN03210        858 IE-EVPWWIEKFSNLSFLDMNGCNNLQR-VSL  887 (1153)
T ss_pred             Cc-cChHHHhcCCCCCEEECCCCCCcCc-cCc
Confidence            98 68999999999999999984 5543 443

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.51  E-value=1.5e-07  Score=99.88  Aligned_cols=34  Identities=35%  Similarity=0.376  Sum_probs=19.1

Q ss_pred             CCcEEEcccccccccCchhhhcCCCCCEEECccCcccc
Q 036792           64 SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        64 ~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|+.|++++|++++ +|..   .++|+.|++++|.|++
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss  416 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS  416 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC
Confidence            45566666666653 4432   2456666666666654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.45  E-value=2.5e-08  Score=103.63  Aligned_cols=96  Identities=32%  Similarity=0.421  Sum_probs=55.8

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCccc-ccCCCCCCEEeCcCCcCC--------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPAT-IGGLISLKTLSLAYNKLD--------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~-~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~   72 (453)
                      |+.|+|-+|.|+...-+-+-+..+|+.|+||+|+|.. +|+. +.++..|+.|+|++|++.        +..|++|...+
T Consensus       361 Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~-fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahs  439 (1081)
T KOG0618|consen  361 LQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS-FPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHS  439 (1081)
T ss_pred             HHHHHHhcCcccccchhhhccccceeeeeeccccccc-CCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcC
Confidence            3455566666666666666666666666666666653 5553 455666666666666663        44555555555


Q ss_pred             ccccccCchhhhcCCCCCEEECccCccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      |++. ..| ++..+++|+++|+|.|+|+
T Consensus       440 N~l~-~fP-e~~~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  440 NQLL-SFP-ELAQLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             Ccee-ech-hhhhcCcceEEecccchhh
Confidence            5555 335 5555556666666655554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.44  E-value=2.2e-07  Score=98.89  Aligned_cols=53  Identities=25%  Similarity=0.391  Sum_probs=32.1

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL   60 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~   60 (453)
                      |+.|+|++|++. .+|..+.  .+|+.|+|++|+|+. +|..+.  ++|+.|++++|+|
T Consensus       243 L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~L  295 (754)
T PRK15370        243 IQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSI  295 (754)
T ss_pred             ccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcc
Confidence            566677777666 4565543  356666666666663 565443  3566666666665

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.43  E-value=7e-08  Score=95.42  Aligned_cols=96  Identities=31%  Similarity=0.428  Sum_probs=79.2

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------------------
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------------------   61 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------------------   61 (453)
                      |+.|||+.|+++ .+|..++.|+ |+.|-+++|+++- +|.+++.+..|..|+.++|.+.                    
T Consensus       123 lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn  199 (722)
T KOG0532|consen  123 LTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRN  199 (722)
T ss_pred             HHHhhhccchhh-cCChhhhcCc-ceeEEEecCcccc-CCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhh
Confidence            567888888888 6788888777 7888888888774 7888887778888888888762                    


Q ss_pred             ----------CCCCcEEEcccccccccCchhhhcCCCCCEEECccCcccc
Q 036792           62 ----------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ----------~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                                .-.|..||+|.|.++ .||..|..|+.|+++.|.+|.|..
T Consensus       200 ~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  200 HLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             hhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence                      125789999999999 799999999999999999999865

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.42  E-value=2.6e-07  Score=80.46  Aligned_cols=91  Identities=27%  Similarity=0.385  Sum_probs=45.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccc-cCCCCCCEEeCcCCcCC----------CCCCcEEE
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKLD----------VASLEILN   69 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~-~~l~~l~~l~l~~n~~~----------~~~l~~l~   69 (453)
                      .|+.||||+|+++. +. .+..|+.|+.|+|++|+++. ++..+ ..+++|+.|++++|++.          +++|+.|+
T Consensus        43 ~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~  119 (175)
T PF14580_consen   43 KLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLS  119 (175)
T ss_dssp             T--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE
T ss_pred             CCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceee
Confidence            37899999999995 43 58889999999999999996 65555 46999999999999983          78999999


Q ss_pred             cccccccccCch----hhhcCCCCCEEECc
Q 036792           70 LSNNEIYGLIPT----SLEKLLYLKELSLS   95 (453)
Q Consensus        70 l~~n~~~g~~P~----~~~~~~~l~~l~ls   95 (453)
                      |.+|.++.. +.    -+..+++|+.||-.
T Consensus       120 L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen  120 LEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             -TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred             ccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence            999999844 32    34457788877643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.42  E-value=6.3e-08  Score=102.12  Aligned_cols=216  Identities=23%  Similarity=0.263  Sum_probs=138.6

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+-+-+|+++.++.+.-. .|...++|......   ....+....+-.++-..+||-+++...-+.-....+++++|..+
T Consensus       809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~  888 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG  888 (1205)
T ss_pred             cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence            446778888888877633 34444444433221   11122233333333334567777665555556778999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      ++|...|+...+.-....+ .....+.+.++||   |...+.|||++|.|.+...++.-+++||+...            
T Consensus       889 ~~~~Skl~~~~~~saepaR-s~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s  964 (1205)
T KOG0606|consen  889 GDLPSKLHNSGCLSAEPAR-SPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS  964 (1205)
T ss_pred             CCchhhhhcCCCccccccc-chhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence            9999998876533222333 3344567788999   88889999999999999999999999984210            


Q ss_pred             --------------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccccc
Q 036792          345 --------------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELS  380 (453)
Q Consensus       345 --------------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  380 (453)
                                                                  .......+|.|+.|++++|.++|.+||.....+.  
T Consensus       965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~-- 1042 (1205)
T KOG0606|consen  965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ-- 1042 (1205)
T ss_pred             cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh--
Confidence                                                        0112345899999999999999999987543221  


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChH
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAK  438 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  438 (453)
                                     +++..+. ........+...+.++.++...-+..+|.+|-.|.
T Consensus      1043 ---------------~f~ni~~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ---------------IFENILN-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             ---------------hhhcccc-CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                           1111111 11112223345556677888888888888887654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.41  E-value=1.8e-07  Score=66.82  Aligned_cols=61  Identities=34%  Similarity=0.489  Sum_probs=49.0

Q ss_pred             cCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCCCCCCcEEEcccccccccCchhhhcCCCCCEEECccCcc
Q 036792           24 KAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL   99 (453)
Q Consensus        24 ~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l   99 (453)
                      ++|+.|+|++|+++..-+..|.+++               +|+.|++++|.++...|..|..+++|+.+++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~---------------~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLP---------------NLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGT---------------TESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCC---------------CCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4789999999999974445677776               556777888888766678889999999999999875

...

>PRK09902 hypothetical protein; Provisional

Probab=98.41  E-value=3.3e-06  Score=75.37  Aligned_cols=137  Identities=13%  Similarity=0.073  Sum_probs=98.6

Q ss_pred             cCCCCccEEEEEEECCCCEEEEEEeeccc------hhhHHHHHHHHHHHHcCCCCC--ceeEEeEEe-c----CCeeEEE
Q 036792          204 IGMGSFGSVYRARLRDGIEVAVKVFHQEC------ARALKSFEAQCEVMKSIRHPN--LVKVISSCS-N----DDFKALV  270 (453)
Q Consensus       204 lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~----~~~~~lv  270 (453)
                      -|+||.+.|++-.+. |..+=+|.-....      +.....|.+|...+.++..-+  +.+.. ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            366888899987765 4468888765221      223467999999998885422  33433 222 1    1235799


Q ss_pred             EeccCC-CCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc--EEEeccccCCC
Q 036792          271 LEYMPK-GSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV--AHLSDFEYGME  345 (453)
Q Consensus       271 ~E~~~~-g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~--~kl~df~~~~~  345 (453)
                      +|-+++ -+|.+++.... ...+...+..+..++++.+.-|   |+.++.|+|+.+.||+++.++.  +++.|||-...
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997763 48888876532 2456667778999999999999   8999999999999999986666  99999997543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.41  E-value=5.9e-07  Score=95.68  Aligned_cols=91  Identities=25%  Similarity=0.393  Sum_probs=62.2

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEcccccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNEI   75 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~~   75 (453)
                      |+.|+|++|+++ .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.|+|++|.+.      ..+|+.|++++|++
T Consensus       201 L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~~LP~~l~s~L~~L~Ls~N~L  274 (754)
T PRK15370        201 ITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRITELPERLPSALQSLDLFHNKI  274 (754)
T ss_pred             CcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccCcCChhHhCCCCEEECcCCcc
Confidence            567777777777 4666554  467777777777774 666553  35777777777764      23677778887777


Q ss_pred             cccCchhhhcCCCCCEEECccCcccc
Q 036792           76 YGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        76 ~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      + .+|..+.  .+|+.|++++|+|++
T Consensus       275 ~-~LP~~l~--~sL~~L~Ls~N~Lt~  297 (754)
T PRK15370        275 S-CLPENLP--EELRYLSVYDNSIRT  297 (754)
T ss_pred             C-ccccccC--CCCcEEECCCCcccc
Confidence            7 4666553  467777777777764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.40  E-value=2e-06  Score=87.46  Aligned_cols=136  Identities=21%  Similarity=0.203  Sum_probs=90.1

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccch------------------------------hhHH----------HHHH
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECA------------------------------RALK----------SFEA  241 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------------------~~~~----------~~~~  241 (453)
                      +.++.++-|+||+|++++|+.||||+.+..-.                              ...+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67889999999999999999999999864210                              0011          2345


Q ss_pred             HHHHHHcC----CCCCceeEEeEEec-CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 036792          242 QCEVMKSI----RHPNLVKVISSCSN-DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST-LEYLYFGHTT  315 (453)
Q Consensus       242 E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~-l~~L~~~h~~  315 (453)
                      |+..+.++    +...-+++-.+|.+ .....|+|||++|-.+.+...-.....+.   ..++..++++ +..+   -.-
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~---~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQL---LRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHH---Hhc
Confidence            55555544    23333444444433 45668999999998888764332233442   2233333322 2222   346


Q ss_pred             CceecCCCCCceeeCCCCcEEEeccccC
Q 036792          316 PIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       316 ~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      +++|.|..|.||+++.++...+.|||+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~  312 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIV  312 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcce
Confidence            7999999999999999999999999864

>PLN03210 Resistant to P

Probab=98.38  E-value=1.3e-06  Score=98.77  Aligned_cols=117  Identities=22%  Similarity=0.224  Sum_probs=69.1

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC---------------------
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------------------   60 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~---------------------   60 (453)
                      |+.|+|++|.....+|..+++|++|+.|++++|+..+.+|..+ ++++|+.|++++|..                     
T Consensus       659 Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i  737 (1153)
T PLN03210        659 LETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI  737 (1153)
T ss_pred             ccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence            5566666655555666666666666666666655445566544 455555555554421                     


Q ss_pred             C--------------------------------------CCCCcEEEcccccccccCchhhhcCCCCCEEECccCccccc
Q 036792           61 D--------------------------------------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        61 ~--------------------------------------~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      .                                      .++|+.|+|++|...+.+|.+++++++|+.|++++|...+.
T Consensus       738 ~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~  817 (1153)
T PLN03210        738 EEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLET  817 (1153)
T ss_pred             ccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCe
Confidence            0                                      02455666666666667788888888888888887765566


Q ss_pred             ccCCCcceeeccccccC
Q 036792          103 ILRGGPFVNFTAMSFKG  119 (453)
Q Consensus       103 ~p~~~~~~~~~~~~~~g  119 (453)
                      +|....+..+....+.+
T Consensus       818 LP~~~~L~sL~~L~Ls~  834 (1153)
T PLN03210        818 LPTGINLESLESLDLSG  834 (1153)
T ss_pred             eCCCCCccccCEEECCC
Confidence            66543333333333333

syringae 6; Provisional

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.36  E-value=6.8e-08  Score=100.46  Aligned_cols=94  Identities=33%  Similarity=0.441  Sum_probs=81.3

Q ss_pred             ccEEEcCCCcCcCCCCcC-CCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLD-IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~-~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      |..|+|++|+|. .+|.. +.+|..|++|+||+|.|.. +|..+.+|..|++|...+|.+.       +++|+.+|+|.|
T Consensus       385 LKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N  462 (1081)
T KOG0618|consen  385 LKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCN  462 (1081)
T ss_pred             eeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccc
Confidence            788999999998 56654 7899999999999999995 9999999999999999999984       789999999999


Q ss_pred             ccc-ccCchhhhcCCCCCEEECccCc
Q 036792           74 EIY-GLIPTSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        74 ~~~-g~~P~~~~~~~~l~~l~ls~n~   98 (453)
                      +++ +.+|..... ++|++||+++|.
T Consensus       463 ~L~~~~l~~~~p~-p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  463 NLSEVTLPEALPS-PNLKYLDLSGNT  487 (1081)
T ss_pred             hhhhhhhhhhCCC-cccceeeccCCc
Confidence            986 445543333 799999999997

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.35  E-value=2.4e-07  Score=89.72  Aligned_cols=101  Identities=28%  Similarity=0.323  Sum_probs=75.3

Q ss_pred             CccEEEcCCCcCcC------CCCcCCCCCcCCCEEECcCCcccccCcccccCCCC---CCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSNSLEG------PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLIS---LKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g------~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~---l~~l~l~~n~~~----------   61 (453)
                      +|+.|+++.|.+.+      .++..+..+++|+.|+|++|.+.+..+..+..+.+   |+.|++++|+++          
T Consensus        52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~  131 (319)
T cd00116          52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG  131 (319)
T ss_pred             CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence            36788888888763      24456677888888888888888777776666665   888888888874          


Q ss_pred             ---C-CCCcEEEccccccccc----CchhhhcCCCCCEEECccCcccc
Q 036792           62 ---V-ASLEILNLSNNEIYGL----IPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ---~-~~l~~l~l~~n~~~g~----~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                         + ++|+.|++++|.+++.    ++..+..+.+|+.|++++|.+.+
T Consensus       132 l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~  179 (319)
T cd00116         132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD  179 (319)
T ss_pred             HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence               3 6788888888888853    33455566788888888888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.35  E-value=1.9e-06  Score=78.03  Aligned_cols=104  Identities=21%  Similarity=0.235  Sum_probs=77.7

Q ss_pred             HHHHHHHHHHHcCCCC--CceeEEeEEecC----CeeEEEEeccCCC-CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 036792          237 KSFEAQCEVMKSIRHP--NLVKVISSCSND----DFKALVLEYMPKG-SLENCLYSSTCMLDIFQRLNIMIDATSTLEYL  309 (453)
Q Consensus       237 ~~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L  309 (453)
                      ....+|...+..+..-  .+.+.+++....    ...++|+|++++. +|.+++..... .+......++.++++.+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4567788877776533  334555655442    2357999999874 78888876332 44556778888999999999


Q ss_pred             HhcCCCCceecCCCCCceeeCCCC---cEEEeccccCC
Q 036792          310 YFGHTTPIIHCDLKPISVLLDEDM---VAHLSDFEYGM  344 (453)
Q Consensus       310 ~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~df~~~~  344 (453)
                         |..+|+|+|+++.|||++.+.   .+.+.||+-..
T Consensus       135 ---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  135 ---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             ---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence               899999999999999999876   78899998643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.33  E-value=7.8e-08  Score=88.04  Aligned_cols=94  Identities=27%  Similarity=0.382  Sum_probs=73.4

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~n   73 (453)
                      |+.+|||+|.++ .+-.+..-++.++.|+||+|.+.- +- .+..+++|+.|||++|.++        +-++++|+|++|
T Consensus       286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N  362 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQN  362 (490)
T ss_pred             hhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhh
Confidence            678899999888 677777777889999999999884 33 3788889999999999885        557788888888


Q ss_pred             cccccCchhhhcCCCCCEEECccCccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      .+..  -..+..+-+|..||++.|++.
T Consensus       363 ~iE~--LSGL~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  363 KIET--LSGLRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             hHhh--hhhhHhhhhheeccccccchh
Confidence            8752  123456667888888888873

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.32  E-value=3.4e-07  Score=88.69  Aligned_cols=102  Identities=28%  Similarity=0.331  Sum_probs=80.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcC---CCEEECcCCcccc----cCcccccCC-CCCCEEeCcCCcCC-----------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKA---VVEINLSRNNLSS----DMPATIGGL-ISLKTLSLAYNKLD-----------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~---l~~l~ls~N~l~g----~~p~~~~~l-~~l~~l~l~~n~~~-----------   61 (453)
                      +|+.|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.++           
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            4788999999998877777777766   9999999999983    344456677 88999999999885           


Q ss_pred             --CCCCcEEEccccccccc----CchhhhcCCCCCEEECccCccccc
Q 036792           62 --VASLEILNLSNNEIYGL----IPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        62 --~~~l~~l~l~~n~~~g~----~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                        +..|+.|++++|.+++.    ++..+..+++|+.|++++|.+++.
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~  208 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE  208 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence              35799999999998853    444556667899999999988643

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.27  E-value=1.3e-05  Score=73.48  Aligned_cols=138  Identities=10%  Similarity=0.064  Sum_probs=83.1

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--ceeEEeEEecCCeeEEEEeccCCCC-
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN--LVKVISSCSNDDFKALVLEYMPKGS-  278 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~E~~~~g~-  278 (453)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   24567788876533  2244678999998876433  4567777777777889999998863 


Q ss_pred             chHHh---------------------hcCC-CCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCceecCCC
Q 036792          279 LENCL---------------------YSST-CMLDIFQRLN-IMI----------DATS-TLEYLYFG-HTTPIIHCDLK  323 (453)
Q Consensus       279 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~i~~-~l~~L~~~-h~~~i~Hrdlk  323 (453)
                      +...+                     +... .......... +..          .+.+ ...+|... -...++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            11111                     1100 0111110000 000          0111 11222111 12346899999


Q ss_pred             CCceeeCCCCcEEEeccccCCC
Q 036792          324 PISVLLDEDMVAHLSDFEYGME  345 (453)
Q Consensus       324 ~~NiLl~~~~~~kl~df~~~~~  345 (453)
                      |.||++++++ +.+.|||++..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999887 99999997643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.20  E-value=1.6e-05  Score=76.65  Aligned_cols=239  Identities=15%  Similarity=0.114  Sum_probs=137.4

Q ss_pred             hcccCCCCccEEEEEE-ECCCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEE----e---cCCeeEEEE
Q 036792          201 SNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSC----S---NDDFKALVL  271 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~----~---~~~~~~lv~  271 (453)
                      +..||+|+-+.+|--- .++  . +.|+..........+..   +.|.+. .||-+-.=+.+-    .   .+....+.|
T Consensus        16 gr~LgqGgea~ly~l~e~~d--~-VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD--Q-VAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CccccCCccceeeecchhhc--h-hheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            5669999999998643 222  2 33555444332222222   223333 455332201110    0   112245666


Q ss_pred             eccCCCC-chHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc---
Q 036792          272 EYMPKGS-LENCLYS-----STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY---  342 (453)
Q Consensus       272 E~~~~g~-L~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~---  342 (453)
                      ..+++.. +..++..     +-...+|...+.++..++.+.+.|   |..|-+-+|+.++|+|++++..+.+.|-..   
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccccCccceeeecCceEEEEcccceee
Confidence            6665532 2222211     112457888899999999999999   777778899999999999999999887411   


Q ss_pred             --------------------------CCCCCcCcccchHHHHHHHHHHHhC-CCCCCccccccc---cHHhHHhhhcCCc
Q 036792          343 --------------------------GMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEEL---SLKDWVNNLLPIS  392 (453)
Q Consensus       343 --------------------------~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~---~~~~~~~~~~~~~  392 (453)
                                                ..+..-+...|-|-+||++++++.| +.||.+......   ....-+   ....
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I---a~g~  243 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI---AHGR  243 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh---hcce
Confidence                                      0112234568999999999999886 999976532110   000000   0000


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccC--cccCCChHHHHHHHHHHHHHh
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMEL--PEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~--P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ....-|........+....-.-.++.+..+..+|....  +.-|||++.-+..|.++++++
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            00111111100111111222345677888999999874  678999999999998888776

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.15  E-value=2e-07  Score=75.80  Aligned_cols=78  Identities=21%  Similarity=0.405  Sum_probs=45.9

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCC-cCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNL-KAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l-~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~   72 (453)
                      |+..+||+|.|. .+|+.|... +.++.|||++|.++. +|.++..|+.|+.++++.|.|+        +.++..||..+
T Consensus        55 l~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~~  132 (177)
T KOG4579|consen   55 LTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSPE  132 (177)
T ss_pred             EEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCCC
Confidence            445677777777 466555544 356777777777774 7777777766666666665553        33444444444


Q ss_pred             ccccccCchh
Q 036792           73 NEIYGLIPTS   82 (453)
Q Consensus        73 n~~~g~~P~~   82 (453)
                      |... +||..
T Consensus       133 na~~-eid~d  141 (177)
T KOG4579|consen  133 NARA-EIDVD  141 (177)
T ss_pred             Cccc-cCcHH
Confidence            4444 34433

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.02  E-value=3.5e-05  Score=66.21  Aligned_cols=127  Identities=20%  Similarity=0.265  Sum_probs=83.6

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcee-EEeEEecCCeeEEEEeccCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK-VISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +....|++|.+|.||+|.++ |..+|+|+-+.+.  ....+..|++++..+.-.++.+ ++.|  +  ...+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y--g--~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY--G--EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe--c--hhhhhhhhhcCc
Confidence            45678999999999999997 4588999876543  3467889999999888766644 3332  1  223559999988


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC--CceeeCCCCcEEEeccccCC
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKP--ISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~--~NiLl~~~~~~kl~df~~~~  344 (453)
                      .|.+.-...    +....    ..++...--|   -..+|-|..+.-  .||++. +..+-|.||+-++
T Consensus        98 ~L~~~~~~~----~rk~l----~~vlE~a~~L---D~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIGG----DRKHL----LRVLEKAYKL---DRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSAT  154 (201)
T ss_pred             chhhhhhcc----cHHHH----HHHHHHHHHH---HHhccchhhhcCCceeEEec-CCcEEEEEccchh
Confidence            886543211    12222    2333332223   556788887754  455554 4589999999775

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.00  E-value=5.9e-05  Score=76.68  Aligned_cols=137  Identities=21%  Similarity=0.211  Sum_probs=86.8

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhh-------------------------------H------HHHHHHHH
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARA-------------------------------L------KSFEAQCE  244 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~------~~~~~E~~  244 (453)
                      +.||.-+.|+||+|++++|+.||||+-+..-...                               .      -+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999876421100                               0      12445554


Q ss_pred             HHH----cCCCCC---ceeEEeEEec-CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 036792          245 VMK----SIRHPN---LVKVISSCSN-DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP  316 (453)
Q Consensus       245 ~l~----~l~H~n---iv~l~g~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~  316 (453)
                      -..    .+.|-+   =|.+-.++.+ .....|+||||+|..+.+.-.-.....+..   .++..+.++...+  .-..|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~~~~q--If~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEAYLEQ--IFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHHHHHH--HHhcC
Confidence            333    334555   1223233322 345789999999988876543222234433   3333333332222  24456


Q ss_pred             ceecCCCCCceeeCC----CCcEEEeccccC
Q 036792          317 IIHCDLKPISVLLDE----DMVAHLSDFEYG  343 (453)
Q Consensus       317 i~Hrdlk~~NiLl~~----~~~~kl~df~~~  343 (453)
                      ++|+|-.|.||++..    +..+.+-|||+.
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~  352 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLY  352 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence            999999999999983    678899999864

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=97.99  E-value=2e-07  Score=94.72  Aligned_cols=95  Identities=35%  Similarity=0.435  Sum_probs=69.5

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCCC--------CCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--------ASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~~--------~~l~~l~l~~n   73 (453)
                      |...+.+.|+|. .+-..+.-++.|++||||+|+|...-  .+..|+.|++|||++|.++.        -.|+.|+++||
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN  242 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNN  242 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeeccc
Confidence            345667777777 56666777778888888888888643  67788888888888888751        13778888888


Q ss_pred             cccccCchhhhcCCCCCEEECccCcccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      .++..  ..+.++++|..||+|+|.+++
T Consensus       243 ~l~tL--~gie~LksL~~LDlsyNll~~  268 (1096)
T KOG1859|consen  243 ALTTL--RGIENLKSLYGLDLSYNLLSE  268 (1096)
T ss_pred             HHHhh--hhHHhhhhhhccchhHhhhhc
Confidence            87742  356678888888888887765

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.99  E-value=9.9e-05  Score=68.62  Aligned_cols=152  Identities=15%  Similarity=0.106  Sum_probs=89.0

Q ss_pred             cCCCCc-cEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccCCCCchH
Q 036792          204 IGMGSF-GSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMPKGSLEN  281 (453)
Q Consensus       204 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~  281 (453)
                      |..|.. ..||+.... +..+.||......   .....+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 788998764 4678888875442   234667888887774 3345577777776667789999999877653


Q ss_pred             Hh-------------------hcCC---CCCC-H-HHHHHHHHH--------------------HHHHHHHHHh----cC
Q 036792          282 CL-------------------YSST---CMLD-I-FQRLNIMID--------------------ATSTLEYLYF----GH  313 (453)
Q Consensus       282 ~l-------------------~~~~---~~l~-~-~~~~~i~~~--------------------i~~~l~~L~~----~h  313 (453)
                      ..                   +...   .... . .........                    +......|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            31                   1100   0000 0 000000000                    1111122211    12


Q ss_pred             CCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHH
Q 036792          314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMET  364 (453)
Q Consensus       314 ~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el  364 (453)
                      ...++|+|+.|.|||++++..+.|.|||.+..+  .   =.|-|+.++..+
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g--d---p~~Dla~~~~~~  207 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA--D---RYQDLALAVRSL  207 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccccc--c---HHHHHHHHHHHh
Confidence            345799999999999999877889999876332  1   145566665554

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.99  E-value=2.3e-06  Score=81.37  Aligned_cols=82  Identities=28%  Similarity=0.400  Sum_probs=77.1

Q ss_pred             cCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcccccccccCchhhhcCCC
Q 036792           18 LDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNNEIYGLIPTSLEKLLY   88 (453)
Q Consensus        18 ~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n~~~g~~P~~~~~~~~   88 (453)
                      ..|..|++|+.|+|++|.+++.-+.+|.++.+++.|.|..|++.         +.+|++|+|.+|+++-.-|.+|..+.+
T Consensus       268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~  347 (498)
T KOG4237|consen  268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS  347 (498)
T ss_pred             HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence            34889999999999999999999999999999999999999983         789999999999999999999999999


Q ss_pred             CCEEECccCcc
Q 036792           89 LKELSLSFNKL   99 (453)
Q Consensus        89 l~~l~ls~n~l   99 (453)
                      |+++++-.|.|
T Consensus       348 l~~l~l~~Np~  358 (498)
T KOG4237|consen  348 LSTLNLLSNPF  358 (498)
T ss_pred             eeeeehccCcc
Confidence            99999999987

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.95  E-value=6e-06  Score=54.33  Aligned_cols=36  Identities=31%  Similarity=0.525  Sum_probs=21.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLS   37 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~   37 (453)
                      +|+.|++++|+++ .+|++|++|++|+.|+|++|.++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            3566666666666 45656666666666666666666

...

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.91  E-value=4.9e-05  Score=67.48  Aligned_cols=98  Identities=23%  Similarity=0.295  Sum_probs=77.6

Q ss_pred             HHHHHHHHcCCC-CCceeEEeEEecCCeeEEEEeccCCCCchHH---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036792          240 EAQCEVMKSIRH-PNLVKVISSCSNDDFKALVLEYMPKGSLENC---LYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT  315 (453)
Q Consensus       240 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~E~~~~g~L~~~---l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~  315 (453)
                      ..|.-+|..+++ +++.+++|+|-    ..+|+||...+++...   +.. -...+|..|.+|+.++++.+.++++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357788888877 69999999993    2679999987765321   111 12357999999999999999999766556


Q ss_pred             CceecCCCCCceeeCCCCcEEEecccc
Q 036792          316 PIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       316 ~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                      .+.-.|++++|+-+++++.+|+.|.+.
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~  108 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDD  108 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechh
Confidence            677789999999999999999999854

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00044  Score=68.45  Aligned_cols=74  Identities=22%  Similarity=0.240  Sum_probs=53.0

Q ss_pred             cccCCCCccEEEEEEECCC-CEEEEEEeecc-------chhhHHHHHHHHHHHHcCC---CCCceeEEeEEecCCeeEEE
Q 036792          202 NLIGMGSFGSVYRARLRDG-IEVAVKVFHQE-------CARALKSFEAQCEVMKSIR---HPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv  270 (453)
                      +.+|.|.+..||+....+| +.|.||.-...       ..-..+++..|.+.|..+.   ..++.+++.+  +++..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999998876 58999985421       1223456777888877753   3456667666  44557899


Q ss_pred             EeccCCC
Q 036792          271 LEYMPKG  277 (453)
Q Consensus       271 ~E~~~~g  277 (453)
                      |||+++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.91  E-value=3.4e-06  Score=77.53  Aligned_cols=88  Identities=25%  Similarity=0.322  Sum_probs=76.2

Q ss_pred             cCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccccccccCchhh
Q 036792           11 SLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNNEIYGLIPTSL   83 (453)
Q Consensus        11 ~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n~~~g~~P~~~   83 (453)
                      ...|..-.++..+..|+.||||+|.++ .|-.+..=+|.++.|++++|.+.       +++|+.||||+|.++ .+-.|-
T Consensus       271 t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh  348 (490)
T KOG1259|consen  271 TSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWH  348 (490)
T ss_pred             ccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhH
Confidence            456777778888899999999999998 47777888999999999999984       789999999999998 566777


Q ss_pred             hcCCCCCEEECccCccc
Q 036792           84 EKLLYLKELSLSFNKLE  100 (453)
Q Consensus        84 ~~~~~l~~l~ls~n~l~  100 (453)
                      ..+.+.++|+++.|.+.
T Consensus       349 ~KLGNIKtL~La~N~iE  365 (490)
T KOG1259|consen  349 LKLGNIKTLKLAQNKIE  365 (490)
T ss_pred             hhhcCEeeeehhhhhHh
Confidence            78889999999999763

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.89  E-value=0.00012  Score=67.18  Aligned_cols=77  Identities=19%  Similarity=0.385  Sum_probs=55.0

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCC--CceeEEeEEec---CCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP--NLVKVISSCSN---DDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lv~E~~~~  276 (453)
                      +.++.|..+.||+....+ ..+++|.....  .......+|..+++.+...  .+.+++.+...   ....+++||++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            468899999999999877 69999997654  3446677888888777533  34566664433   3457899999998


Q ss_pred             CCchH
Q 036792          277 GSLEN  281 (453)
Q Consensus       277 g~L~~  281 (453)
                      ..+..
T Consensus        80 ~~~~~   84 (239)
T PF01636_consen   80 RPLDD   84 (239)
T ss_dssp             EEHHH
T ss_pred             ccccc
Confidence            87766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.87  E-value=3.2e-06  Score=86.17  Aligned_cols=123  Identities=11%  Similarity=0.177  Sum_probs=80.5

Q ss_pred             HHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC----------------------------------CCC
Q 036792          301 DATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG----------------------------------MEG  346 (453)
Q Consensus       301 ~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~----------------------------------~~~  346 (453)
                      +++.|+.|+|  .+..+||+++.|++|.++..+..|++.|++.                                  ...
T Consensus       107 ~v~dgl~flh--~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLH--RSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhc--cCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4558999996  5678999999999999999999999999432                                  112


Q ss_pred             CcCcccchHHHHHHHHHHH-hCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhh
Q 036792          347 QVSTRSDIYGYGIVLMETF-TRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAME  425 (453)
Q Consensus       347 ~~~~~~Dv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~  425 (453)
                      ..+.++|+||+||++|-+. .|+.-+..... ..... ..         ...+      ...........|.++.+=+.+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~-~~---------~~~~------~~~~~~~s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYS-FS---------RNLL------NAGAFGYSNNLPSELRESLKK  247 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCC-cchhh-hh---------hccc------ccccccccccCcHHHHHHHHH
Confidence            2356899999999999998 45544432110 00000 00         0000      000111224556677888888


Q ss_pred             ccccCcccCCChHHHHH
Q 036792          426 CAMELPEKRINAKDIVT  442 (453)
Q Consensus       426 Cl~~~P~~RPs~~~v~~  442 (453)
                      .+..++..||++.++..
T Consensus       248 ~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HhcCCcccCcchhhhhc
Confidence            89999999997776543

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.84  E-value=1.7e-05  Score=52.19  Aligned_cols=35  Identities=31%  Similarity=0.599  Sum_probs=19.3

Q ss_pred             CCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC
Q 036792           25 AVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL   60 (453)
Q Consensus        25 ~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~   60 (453)
                      +|++|+|++|+++. +|+.+++|++|+.|++++|++
T Consensus         2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i   36 (44)
T PF12799_consen    2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPI   36 (44)
T ss_dssp             T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCC
T ss_pred             cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCC
Confidence            46666666666663 565666666555555555544

...

>PLN02876 acyl-CoA dehydrogenase

Probab=97.82  E-value=0.00029  Score=77.09  Aligned_cols=78  Identities=14%  Similarity=0.304  Sum_probs=56.8

Q ss_pred             hcccCCCCccEEEEEEECCC---CEEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCc--eeEEeEEecC---CeeEEE
Q 036792          201 SNLIGMGSFGSVYRARLRDG---IEVAVKVFHQEC-ARALKSFEAQCEVMKSIR-HPNL--VKVISSCSND---DFKALV  270 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv  270 (453)
                      ...++.|.++.+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            35688999999999877653   467777765432 123356889999999995 6665  7788888764   457899


Q ss_pred             EeccCCCC
Q 036792          271 LEYMPKGS  278 (453)
Q Consensus       271 ~E~~~~g~  278 (453)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.82  E-value=0.00027  Score=63.11  Aligned_cols=127  Identities=19%  Similarity=0.257  Sum_probs=85.8

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccc----------------hhhHHHHHHHHHHHHcCC------CCCceeEEe
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQEC----------------ARALKSFEAQCEVMKSIR------HPNLVKVIS  259 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~g  259 (453)
                      ..||+|+.-.||.  +++.....||+++...                .....+..+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            5689999988885  4445567788887554                122355666766555554      889999999


Q ss_pred             EEecCCeeEEEEeccCC--C----CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-
Q 036792          260 SCSNDDFKALVLEYMPK--G----SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-  332 (453)
Q Consensus       260 ~~~~~~~~~lv~E~~~~--g----~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-  332 (453)
                      +..+..-..+|+|.+..  |    +|.+++....  ++. .   +...+-+-..||   .+..|+.+|++|.||++... 
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~---~~~~L~~f~~~l---~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-E---LRQALDEFKRYL---LDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-H---HHHHHHHHHHHH---HHcCCeecCCCcccEEEEecC
Confidence            99999888999998643  2    5666665432  333 2   222223334555   67779999999999999642 


Q ss_pred             -C--cEEEec
Q 036792          333 -M--VAHLSD  339 (453)
Q Consensus       333 -~--~~kl~d  339 (453)
                       +  .+.|.|
T Consensus       156 ~~~~~lvlID  165 (199)
T PF10707_consen  156 SGEFRLVLID  165 (199)
T ss_pred             CCceEEEEEe
Confidence             2  466777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=97.81  E-value=1.3e-05  Score=80.24  Aligned_cols=94  Identities=36%  Similarity=0.565  Sum_probs=79.7

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCc-CCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLK-AVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~-~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~   72 (453)
                      +..|++.+|+++ .+|+.++.+. +|+.|++++|.+.- +|..++.++.|+.|+++.|+++        .+.|+.|++++
T Consensus       118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~  195 (394)
T COG4886         118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSG  195 (394)
T ss_pred             eeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccC
Confidence            578889999998 6888888885 89999999999884 7778899999999999999884        56788999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~   98 (453)
                      |+++ .+|..+..+..|+.+.+++|.
T Consensus       196 N~i~-~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         196 NKIS-DLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             Cccc-cCchhhhhhhhhhhhhhcCCc
Confidence            9998 678877777778889999885

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.80  E-value=0.00028  Score=65.11  Aligned_cols=154  Identities=16%  Similarity=0.200  Sum_probs=87.8

Q ss_pred             cccCCCCccEEEEEEECC--CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-eeEEeEEecCCeeEEEEeccCCCC
Q 036792          202 NLIGMGSFGSVYRARLRD--GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL-VKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      +.+..|-...+|+....+  +..|++|........ .....+|+.+++.+...++ .++++.+.    -.++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            346778888999998664  678889976543221 1223468888887754333 44444332    248999999876


Q ss_pred             chHH--------------h---hcCCC----------CCCHHHHH-HHH----------------------HHHHHHHHH
Q 036792          279 LENC--------------L---YSSTC----------MLDIFQRL-NIM----------------------IDATSTLEY  308 (453)
Q Consensus       279 L~~~--------------l---~~~~~----------~l~~~~~~-~i~----------------------~~i~~~l~~  308 (453)
                      +...              +   +....          ........ ...                      ..+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6311              1   11110          11111110 000                      011111111


Q ss_pred             H----Hh-cCCCCceecCCCCCceeeCC-CCcEEEeccccCCCCCcCcccchHHHHHHHHHHH
Q 036792          309 L----YF-GHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETF  365 (453)
Q Consensus       309 L----~~-~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~  365 (453)
                      +    .. .....++|+|+.+.|||+++ +..+.+.|||++..+.     =.|-+|+++.|+.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~-----~~~Dla~~~~e~~  216 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY-----RAFDIANHFNEWA  216 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc-----hheeHHHHHHHHc
Confidence            1    10 12345899999999999998 5789999999875432     1456777788854

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.80  E-value=0.00025  Score=64.45  Aligned_cols=136  Identities=21%  Similarity=0.257  Sum_probs=85.2

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchhhH---------H---------------HHHHHHHHHHcCCC--CCc
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARAL---------K---------------SFEAQCEVMKSIRH--PNL  254 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------~---------------~~~~E~~~l~~l~H--~ni  254 (453)
                      ...|++|.-+.||+|...++..+|||+.+.......         .               -..+|..-|.++.-  =.+
T Consensus        53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            346888999999999988899999999874421110         0               11346666666532  222


Q ss_pred             eeEEeEEecCCeeEEEEeccCCCCc-hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          255 VKVISSCSNDDFKALVLEYMPKGSL-ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       255 v~l~g~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                      .+.+++.    .-.|||||+..... .-.|...  .+.......+..++++.+.-|.  +..++||+||..=|||+. ++
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~--~~a~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLY--KEAGLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHH--HhcCcccccchhhheEEE-CC
Confidence            2323221    22599999865311 1122221  1222234445556667776662  558999999999999999 78


Q ss_pred             cEEEeccccCCC
Q 036792          334 VAHLSDFEYGME  345 (453)
Q Consensus       334 ~~kl~df~~~~~  345 (453)
                      .+.++|++-+..
T Consensus       204 ~p~iID~~QaV~  215 (268)
T COG1718         204 EPYIIDVSQAVT  215 (268)
T ss_pred             eEEEEECccccc
Confidence            999999986543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	453
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-23
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-23
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-23
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-14
3iok_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-07
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-07
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-05
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-05
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-05
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-05
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-04
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-04
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-04
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-04
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-04
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-04
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 109/214 (50%), Gaps = 34/214 (15%)
Query: 203 LIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           LIG G FG VY+  LRDG +VA+K    E ++ ++ FE + E +   RHP+LV +I  C 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 263 NDDFKALVLEYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
             +   L+ +YM  G+L+  LY S   T  +   QRL I I A   L YL   HT  IIH
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIH 162
Query: 320 CDLKPISVLLDEDMVAHLSDF---------------------------EYGMEGQVSTRS 352
            D+K I++LLDE+ V  ++DF                           EY ++G+++ +S
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKS 222
Query: 353 DIYGYGIVLMETF-TRKKPTDRMFVEELSLKDWV 385
           D+Y +G+VL E    R      +  E ++L +W 
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/214 (34%), Positives = 109/214 (50%), Gaps = 34/214 (15%)
Query: 203 LIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           LIG G FG VY+  LRDG +VA+K    E ++ ++ FE + E +   RHP+LV +I  C 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 263 NDDFKALVLEYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
             +   L+ +YM  G+L+  LY S   T  +   QRL I I A   L YL   HT  IIH
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIH 162
Query: 320 CDLKPISVLLDEDMVAHLSDF---------------------------EYGMEGQVSTRS 352
            D+K I++LLDE+ V  ++DF                           EY ++G+++ +S
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKS 222
Query: 353 DIYGYGIVLMETF-TRKKPTDRMFVEELSLKDWV 385
           D+Y +G+VL E    R      +  E ++L +W 
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 40/277 (14%)
Query: 202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVKVISS 260
           N++G G FG VY+ RL DG  VAVK   +E  +  +  F+ + E++    H NL+++   
Sbjct: 36  NILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 261 CSNDDFKALVLEYMPKGSLENCLY---SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP- 316
           C     + LV  YM  GS+ +CL     S   LD  +R  I + +   L YL+  H  P 
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDPK 154
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVST 350
           IIH D+K  ++LLDE+  A + DF                          EY   G+ S 
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSE 214
Query: 351 RSDIYGYGIVLMETFTRKKPTDRMFV---EELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
           ++D++GYG++L+E  T ++  D   +   +++ L DWV  LL    +E +    L G   
Sbjct: 215 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN-- 272
Query: 408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
               K++ V  ++ +A+ C    P +R    ++V  L
Sbjct: 273 ---YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 40/277 (14%)
Query: 202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVKVISS 260
           N++G G FG VY+ RL DG  VAVK   +E  +  +  F+ + E++    H NL+++   
Sbjct: 44  NILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGF 103
Query: 261 CSNDDFKALVLEYMPKGSLENCLY---SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP- 316
           C     + LV  YM  GS+ +CL     S   LD  +R  I + +   L YL+  H  P 
Sbjct: 104 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDPK 162
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVST 350
           IIH D+K  ++LLDE+  A + DF                          EY   G+ S 
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSE 222
Query: 351 RSDIYGYGIVLMETFTRKKPTDRMFV---EELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
           ++D++GYG++L+E  T ++  D   +   +++ L DWV  LL    +E +    L G   
Sbjct: 223 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN-- 280
Query: 408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
               K++ V  ++ +A+ C    P +R    ++V  L
Sbjct: 281 ---YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 31/196 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG+V+RA    G +VAVK+  ++   A  +  F  +  +MK +RHPN+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           +     ++V EY+ +GSL   L+ S     LD  +RL++  D    + YL+     PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 320 CDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQVSTRSDI 354
            DLK  ++L+D+     + DF                         E   +   + +SD+
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 355 YGYGIVLMETFTRKKP 370
           Y +G++L E  T ++P
Sbjct: 223 YSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 31/196 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG+V+RA    G +VAVK+  ++   A  +  F  +  +MK +RHPN+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           +     ++V EY+ +GSL   L+ S     LD  +RL++  D    + YL+     PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 320 CDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQVSTRSDI 354
            +LK  ++L+D+     + DF                         E   +   + +SD+
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 355 YGYGIVLMETFTRKKP 370
           Y +G++L E  T ++P
Sbjct: 223 YSFGVILWELATLQQP 238

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 7   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L +    +D  + L      
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI 126
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 244 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 127/303 (41%), Gaps = 48/303 (15%)
Query: 189 GILPSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEA 241
           G  P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE 
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 242 QCEVMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIM 299
           + E++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------- 340
                 +EYL    T   IH DL   ++L++ +    + DF                   
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 341 ---------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLL 389
                    E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 390 PISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
              L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD
Sbjct: 238 VFHLIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
Query: 450 TLS 452
            ++
Sbjct: 292 NMA 294

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 127/303 (41%), Gaps = 48/303 (15%)
Query: 189 GILPSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEA 241
           G  P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE 
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 242 QCEVMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIM 299
           + E++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------- 340
                 +EYL    T   IH DL   ++L++ +    + DF                   
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 341 ---------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLL 389
                    E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 390 PISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
              L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD
Sbjct: 238 VFHLIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
Query: 450 TLS 452
            ++
Sbjct: 292 NMA 294

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 7   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 126
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 244 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 35  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 272 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 9   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 68
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 128
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 129 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 245
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 246 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 299

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 11  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 70
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 71  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 130
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 131 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 247
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 248 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 301

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 241 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 3   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 62
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 122
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 123 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 239
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 240 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 293

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 10  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 69
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 129
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 130 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 246
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 247 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 300

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 8   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 67
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 127
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 128 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 244
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 245 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 298

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 2   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 61
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 121
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 122 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 238
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 239 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 292

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 5   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 64
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++EY+P GSL + L      +D  + L      
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 124
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------EYG--------- 343
              +EYL    T   IH +L   ++L++ +    + DF          EY          
Sbjct: 125 CKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 344 ---------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                     E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 241
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 242 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 295

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 48/300 (16%)
Query: 192 PSQATLRRLSNL--IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCE 244
           P+Q   R L  L  +G G+FGSV   R   L+D  G  VAVK         L+ FE + E
Sbjct: 7   PTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 245 VMKSIRHPNLVKVISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           ++KS++H N+VK    C +   +   L++E++P GSL   L      +D  + L      
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI 126
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              +EYL    T   IH DL   ++L++ +    + DF                      
Sbjct: 127 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPIS 392
                 E   E + S  SD++ +G+VL E FT  + +     E + +   D    ++   
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L+E++          G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 244 LIELLKNNGRLPRPDG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 297

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKV 257
           L   IG G+FG V+  RLR D   VAVK   +     LK+ F  +  ++K   HPN+V++
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           I  C+      +V+E +  G     L +    L +   L ++ DA + +EYL    +   
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCC 234
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGME---------------------------GQVST 350
           IH DL   + L+ E  V  +SDF    E                           G+ S+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 351 RSDIYGYGIVLMETFT 366
            SD++ +GI+L ETF+
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 46/286 (16%)
Query: 204 IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +G G+FGSV   R   L+D  G  VAVK         L+ FE + E++KS++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 259 SSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
             C +   +   L++EY+P GSL + L      +D  + L         +EYL    T  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 152
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------------EYGMEGQV 348
            IH DL   ++L++ +    + DF                            E   E + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 349 STRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPISLMEVVDKTLLSGEK 406
           S  SD++ +G+VL E FT  + +     E + +   D    ++   L+E++         
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 272
Query: 407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
            G      C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 273 DG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 312

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKV 257
           L   IG G+FG V+  RLR D   VAVK   +     LK+ F  +  ++K   HPN+V++
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           I  C+      +V+E +  G     L +    L +   L ++ DA + +EYL    +   
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCC 234
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGME---------------------------GQVST 350
           IH DL   + L+ E  V  +SDF    E                           G+ S+
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 351 RSDIYGYGIVLMETFT 366
            SD++ +GI+L ETF+
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 46/285 (16%)
Query: 204 IGMGSFGSVYRAR---LRD--GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +G G+FGSV   R   L+D  G  VAVK         L+ FE + E++KS++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 259 SSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
             C +   +   L++EY+P GSL + L      +D  + L         +EYL    T  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKR 152
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------------EYGMEGQV 348
            IH DL   ++L++ +    + DF                            E   E + 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 349 STRSDIYGYGIVLMETFTRKKPTDRMFVEELSL--KDWVNNLLPISLMEVVDKTLLSGEK 406
           S  SD++ +G+VL E FT  + +     E + +   D    ++   L+E++         
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 272
Query: 407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            G      C   I  +  EC      +R + +D+  R+ +IRD +
Sbjct: 273 DG------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 30/200 (15%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +  ++G G+FG V +A+ R   +VA+K    E  R  K+F  +   +  + HPN+VK+  
Sbjct: 13  VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 69
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCM--LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +C N     LV+EY   GSL N L+ +  +        ++  +  +  + YL+      +
Sbjct: 70  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 318 IHCDLKPISVLL-DEDMVAHLSDFEYGMEGQV----------------------STRSDI 354
           IH DLKP ++LL     V  + DF    + Q                       S + D+
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 187
Query: 355 YGYGIVLMETFTRKKPTDRM 374
           + +GI+L E  TR+KP D +
Sbjct: 188 FSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 30/200 (15%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +  ++G G+FG V +A+ R   +VA+K    E  R  K+F  +   +  + HPN+VK+  
Sbjct: 12  VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCM--LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +C N     LV+EY   GSL N L+ +  +        ++  +  +  + YL+      +
Sbjct: 69  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 318 IHCDLKPISVLL-DEDMVAHLSDFEYGMEGQV----------------------STRSDI 354
           IH DLKP ++LL     V  + DF    + Q                       S + D+
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 355 YGYGIVLMETFTRKKPTDRM 374
           + +GI+L E  TR+KP D +
Sbjct: 187 FSWGIILWEVITRRKPFDEI 206

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQ----ECARALKSFEAQCEVMKSIRHPNLVKV 257
           N +G G FG VY+  + +   VAVK              + F+ + +VM   +H NLV++
Sbjct: 37  NKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 258 ISSCSNDDFKALVLEYMPKGSLEN---CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +   S+ D   LV  YMP GSL +   CL   T  L    R  I   A + + +L+  H 
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQV 348
              IH D+K  ++LLDE   A +SDF                             + G++
Sbjct: 155 ---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEI 211
Query: 349 STRSDIYGYGIVLMETFT 366
           + +SDIY +G+VL+E  T
Sbjct: 212 TPKSDIYSFGVVLLEIIT 229

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQ----ECARALKSFEAQCEVMKSIRHPNLVKV 257
           N +G G FG VY+  + +   VAVK              + F+ + +VM   +H NLV++
Sbjct: 37  NKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 258 ISSCSNDDFKALVLEYMPKGSLEN---CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +   S+ D   LV  YMP GSL +   CL   T  L    R  I   A + + +L+  H 
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQV 348
              IH D+K  ++LLDE   A +SDF                             + G++
Sbjct: 155 ---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEI 211
Query: 349 STRSDIYGYGIVLMETFT 366
           + +SDIY +G+VL+E  T
Sbjct: 212 TPKSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQ----ECARALKSFEAQCEVMKSIRHPNLVKV 257
           N +G G FG VY+  + +   VAVK              + F+ + +VM   +H NLV++
Sbjct: 31  NKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 258 ISSCSNDDFKALVLEYMPKGSLEN---CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +   S+ D   LV  YMP GSL +   CL   T  L    R  I   A + + +L+  H 
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENHH 148
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQV 348
              IH D+K  ++LLDE   A +SDF                             + G++
Sbjct: 149 ---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEI 205
Query: 349 STRSDIYGYGIVLMETFT 366
           + +SDIY +G+VL+E  T
Sbjct: 206 TPKSDIYSFGVVLLEIIT 223

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 34/201 (16%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           LS  IG GSFG+VY+ +    + V +           ++F  +  V++  RH N++  + 
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
             + D+  A+V ++    SL   L+       +FQ ++I       ++YL   H   IIH
Sbjct: 100 YMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIH 155
Query: 320 CDLKPISVLLDEDMVAHLSDF-------EYGMEGQV-----------------------S 349
            D+K  ++ L E +   + DF        +    QV                       S
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 350 TRSDIYGYGIVLMETFTRKKP 370
            +SD+Y YGIVL E  T + P
Sbjct: 216 FQSDVYSYGIVLYELMTGELP 236

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 51/273 (18%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + +   +VAVK+  +E + +   F  + + M  + HP LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
           +    +V EY+  G L N L S    L+  Q L +  D    + +L    +   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLA 131
Query: 324 PISVLLDEDMVAHLSDF---EYGMEGQ-----------------------VSTRSDIYGY 357
             + L+D D+   +SDF    Y ++ Q                        S++SD++ +
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191
Query: 358 GIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCV 416
           GI++ E F+  K P D     E+ LK        +S    + +  L+ +           
Sbjct: 192 GILMWEVFSLGKMPYDLYTNSEVVLK--------VSQGHRLYRPHLASD----------- 232
Query: 417 LSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
            +I  +   C  ELPEKR   + +++ +  +R+
Sbjct: 233 -TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   IG G FG V     R G +VAVK    +     ++F A+  VM  +RH NLV+++
Sbjct: 15  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 71
Query: 259 SSCSNDDFK-ALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                +     +V EYM KGSL + L S    +L     L   +D    +EYL       
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNN 128
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRSDI 354
            +H DL   +VL+ ED VA +SDF                      E   E   ST+SD+
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 355 YGYGIVLMETFT 366
           + +GI+L E ++
Sbjct: 189 WSFGILLWEIYS 200

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 88/192 (45%), Gaps = 30/192 (15%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   IG G FG V     R G +VAVK    +     ++F A+  VM  +RH NLV+++
Sbjct: 9   KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 65
Query: 259 SSCSNDDFK-ALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                +     +V EYM KGSL + L S    +L     L   +D    +EYL       
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNN 122
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRSDI 354
            +H DL   +VL+ ED VA +SDF                      E   E + ST+SD+
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 355 YGYGIVLMETFT 366
           + +GI+L E ++
Sbjct: 183 WSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 88/192 (45%), Gaps = 30/192 (15%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   IG G FG V     R G +VAVK    +     ++F A+  VM  +RH NLV+++
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 80
Query: 259 SSCSNDDFK-ALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                +     +V EYM KGSL + L S    +L     L   +D    +EYL       
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNN 137
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRSDI 354
            +H DL   +VL+ ED VA +SDF                      E   E + ST+SD+
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 355 YGYGIVLMETFT 366
           + +GI+L E ++
Sbjct: 198 WSFGILLWEIYS 209

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 38/206 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFH----QECARALKSFEAQCEVMKSIRHPNLV 255
           L  +IG+G FG VYRA    G EVAVK       ++ ++ +++   + ++   ++HPN++
Sbjct: 11  LEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
            +   C  +    LV+E+   G L   L       DI   +N  +     + YL+     
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIV 127
Query: 316 PIIHCDLKPISVLLDEDM--------VAHLSDFEYGMEGQVSTR---------------- 351
           PIIH DLK  ++L+ + +        +  ++DF    E   +T+                
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187
Query: 352 -------SDIYGYGIVLMETFTRKKP 370
                  SD++ YG++L E  T + P
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 184 DVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQ 242
           D S+D  +P  Q T+      IG GSFG+VY+ +    + V +        + L++F+ +
Sbjct: 14  DSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNE 70
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             V++  RH N++  +   +     A+V ++    SL + L++S    ++ + ++I    
Sbjct: 71  VGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------GQV 348
              ++YL   H   IIH DLK  ++ L ED    + DF    E              G +
Sbjct: 130 ARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 349 ----------------STRSDIYGYGIVLMETFTRKKP 370
                           S +SD+Y +GIVL E  T + P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 174 KLTKCGKRGLDVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC 232
           ++   G+R  D S+D  +P  Q T+      IG GSFG+VY+ +    + V +       
Sbjct: 10  RMKTLGRR--DSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT 64
Query: 233 ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI 292
            + L++F+ +  V++  RH N++  +   +     A+V ++    SL + L+      ++
Sbjct: 65  PQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEM 123
Query: 293 FQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------- 345
            + ++I       ++YL   H   IIH DLK  ++ L ED+   + DF    E       
Sbjct: 124 IKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS 180
Query: 346 -------GQV----------------STRSDIYGYGIVLMETFTRKKP 370
                  G +                S +SD+Y +GIVL E  T + P
Sbjct: 181 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 88/192 (45%), Gaps = 30/192 (15%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   IG G FG V     R G +VAVK    +     ++F A+  VM  +RH NLV+++
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 252
Query: 259 SSCSNDDFK-ALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                +     +V EYM KGSL + L S    +L     L   +D    +EYL       
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNN 309
Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRSDI 354
            +H DL   +VL+ ED VA +SDF                      E   E + ST+SD+
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 355 YGYGIVLMETFT 366
           + +GI+L E ++
Sbjct: 370 WSFGILLWEIYS 381

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 174 KLTKCGKRGLDVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC 232
           ++   G+R  D S+D  +P  Q T+      IG GSFG+VY+ +    + V +       
Sbjct: 18  RMKTLGRR--DSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT 72
Query: 233 ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI 292
            + L++F+ +  V++  RH N++  +   +     A+V ++    SL + L+      ++
Sbjct: 73  PQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEM 131
Query: 293 FQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------- 345
            + ++I       ++YL   H   IIH DLK  ++ L ED+   + DF    E       
Sbjct: 132 IKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGS 188
Query: 346 -------GQV----------------STRSDIYGYGIVLMETFTRKKP 370
                  G +                S +SD+Y +GIVL E  T + P
Sbjct: 189 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 184 DVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQ 242
           D ++D  +P  Q T+      IG GSFG+VY+ +    + V +        + L++F+ +
Sbjct: 14  DAADDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNE 70
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             V++  RH N++  +   +     A+V ++    SL + L++S    ++ + ++I    
Sbjct: 71  VGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------------GQV 348
              ++YL   H   IIH DLK  ++ L ED    + DF    E              G +
Sbjct: 130 ARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 349 ----------------STRSDIYGYGIVLMETFTRKKP 370
                           S +SD+Y +GIVL E  T + P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 86/198 (43%), Gaps = 38/198 (19%)
Query: 202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQ----ECARALKSFEAQCEVMKSIRHPNLVKV 257
           N  G G FG VY+  + +   VAVK              + F+ + +V    +H NLV++
Sbjct: 28  NKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 258 ISSCSNDDFKALVLEYMPKGSLEN---CLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +   S+ D   LV  Y P GSL +   CL   T  L    R  I   A + + +L+  H 
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLSWHXRCKIAQGAANGINFLHENHH 145
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQV 348
              IH D+K  ++LLDE   A +SDF                             + G++
Sbjct: 146 ---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI 202
Query: 349 STRSDIYGYGIVLMETFT 366
           + +SDIY +G+VL+E  T
Sbjct: 203 TPKSDIYSFGVVLLEIIT 220

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 182 GLDVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFE 240
           G D S+D  +P  Q T+      IG GSFG+VY+ +    + V +        + L++F+
Sbjct: 1   GSDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFK 57
Query: 241 AQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMI 300
            +  V++  RH N++  +   +     A+V ++    SL + L+      ++ + ++I  
Sbjct: 58  NEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 116
Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------------MEG 346
                ++YL   H   IIH DLK  ++ L ED+   + DF                 + G
Sbjct: 117 QTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 347 QV----------------STRSDIYGYGIVLMETFTRKKP 370
            +                S +SD+Y +GIVL E  T + P
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 182 GLDVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFE 240
           G D S+D  +P  Q T+      IG GSFG+VY+ +    + V +        + L++F+
Sbjct: 1   GSDSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFK 57
Query: 241 AQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMI 300
            +  V++  RH N++  +   +     A+V ++    SL + L+      ++ + ++I  
Sbjct: 58  NEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR 116
Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------------MEG 346
                ++YL   H   IIH DLK  ++ L ED+   + DF                 + G
Sbjct: 117 QTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 347 QV----------------STRSDIYGYGIVLMETFTRKKP 370
            +                S +SD+Y +GIVL E  T + P
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 174 KLTKCGKRGLDVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC 232
           ++   G+R  D S+D  +P  Q T+      IG GSFG+VY+ +    + V +       
Sbjct: 17  RMKTLGRR--DSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT 71
Query: 233 ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI 292
            + L++F+ +  V++  RH N++  +   +     A+V ++    SL + L+      ++
Sbjct: 72  PQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEM 130
Query: 293 FQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------- 343
            + ++I       ++YL   H   IIH DLK  ++ L ED+   + DF            
Sbjct: 131 IKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 187
Query: 344 -----MEGQV----------------STRSDIYGYGIVLMETFTRKKP 370
                + G +                S +SD+Y +GIVL E  T + P
Sbjct: 188 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 174 KLTKCGKRGLDVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC 232
           ++   G+R  D S+D  +P  Q T+      IG GSFG+VY+ +    + V +       
Sbjct: 18  RMKTLGRR--DSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT 72
Query: 233 ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI 292
            + L++F+ +  V++  RH N++  +   +     A+V ++    SL + L+      ++
Sbjct: 73  PQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEM 131
Query: 293 FQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------- 343
            + ++I       ++YL   H   IIH DLK  ++ L ED+   + DF            
Sbjct: 132 IKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 188
Query: 344 -----MEGQV----------------STRSDIYGYGIVLMETFTRKKP 370
                + G +                S +SD+Y +GIVL E  T + P
Sbjct: 189 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 184 DVSNDGILP-SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQ 242
           D S+D  +P  Q T+      IG GSFG+VY+ +    + V +        + L++F+ +
Sbjct: 2   DSSDDWEIPDGQITV---GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNE 58
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             V++  RH N++  +   +     A+V ++    SL + L++S    ++ + ++I    
Sbjct: 59  VGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 117
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG--------------MEGQV 348
              ++YL   H   IIH DLK  ++ L ED    + DF                 + G +
Sbjct: 118 ARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 349 ----------------STRSDIYGYGIVLMETFTRKKP 370
                           S +SD+Y +GIVL E  T + P
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+ A      +VAVK   +  + ++++F A+  VMK+++H  LVK+ 
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLH 243
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + +    ++ E+M KGSL + L S        Q L  +ID ++ + E + F      
Sbjct: 244 AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNY 299
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---EYGME-------------GQVSTRSDIYGYGIVL 361
           IH DL+  ++L+   +V  ++DF     G +             G  + +SD++ +GI+L
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 359
Query: 362 METFT 366
           ME  T
Sbjct: 360 MEIVT 364

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           IG GSFG+VY+ +    + V +        + L++F+ +  V++  RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
               A+V ++    SL + L+      ++ + ++I       ++YL   H   IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 131
Query: 324 PISVLLDEDMVAHLSDFEYGME--------------GQV----------------STRSD 353
             ++ L ED+   + DF    E              G +                S +SD
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 354 IYGYGIVLMETFTRKKP 370
           +Y +GIVL E  T + P
Sbjct: 192 VYAFGIVLYELMTGQLP 208

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 329 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 384
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 445 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 483
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEER 508

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 11  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 69
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 70  AVVSEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 125
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 186 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 224
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 225 PCPPECPESLHDLMCQCWRKEPEER 249

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 32/195 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+ A      +VAVK   +  + ++++F A+  VMK+++H  LVK+ 
Sbjct: 18  KLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLH 76
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + +    ++ E+M KGSL + L S        Q L  +ID ++ + E + F      
Sbjct: 77  AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNY 132
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+   +V  ++DF         EY                    G  + +
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 352 SDIYGYGIVLMETFT 366
           SD++ +GI+LME  T
Sbjct: 193 SDVWSFGILLMEIVT 207

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAVK+    Q    +L+    +  +MK + HPN+V
Sbjct: 18  RLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV+EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQK 133
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E  V  + D +
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTF 173

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 47/209 (22%)
Query: 199 RLSNLIGMGSFGSVYRARLR-DGI--EVAVKVFHQECARA-LKSFEAQCEVM-KSIRHPN 253
           +  ++IG G+FG V +AR++ DG+  + A+K   +  ++   + F  + EV+ K   HPN
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLY---------------SSTCMLDIFQRLNI 298
           ++ ++ +C +  +  L +EY P G+L + L                S+   L   Q L+ 
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--EYGMEGQV-------- 348
             D    ++YL        IH DL   ++L+ E+ VA ++DF    G E  V        
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 349 --------------STRSDIYGYGIVLME 363
                         +T SD++ YG++L E
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 246 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV- 410
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 362 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 400
Query: 411 -AKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEER 425

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 246 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV- 410
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 362 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 400
Query: 411 -AKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEER 425

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAVK+    Q  + +L+    +  +MK + HPN+V
Sbjct: 10  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 69
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV+EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYC---HQK 125
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E     + D +
Sbjct: 126 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF 165

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 47/209 (22%)
Query: 199 RLSNLIGMGSFGSVYRARLR-DGI--EVAVKVFHQECARA-LKSFEAQCEVM-KSIRHPN 253
           +  ++IG G+FG V +AR++ DG+  + A+K   +  ++   + F  + EV+ K   HPN
Sbjct: 18  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 77
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLY---------------SSTCMLDIFQRLNI 298
           ++ ++ +C +  +  L +EY P G+L + L                S+   L   Q L+ 
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--EYGMEGQV-------- 348
             D    ++YL        IH DL   ++L+ E+ VA ++DF    G E  V        
Sbjct: 138 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 349 --------------STRSDIYGYGIVLME 363
                         +T SD++ YG++L E
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 223

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 14  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 72
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 73  AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 128
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 189 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 227
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 228 PCPPECPESLHDLMCQCWRKEPEER 252

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 116/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY-LYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T     + RL  ++D ++ +   + +      
Sbjct: 77  AVVSEEPI-YIVTEYMNKGSLLDFLKGET---GKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 193 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 231
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 232 PCPPECPESLHDLMCQCWRKEPEER 256

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 116/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 76
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY-LYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T     + RL  ++D ++ +   + +      
Sbjct: 77  AVVSEEPI-YIVTEYMNKGSLLDFLKGET---GKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 193 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 231
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 232 PCPPECPESLHDLMCQCWRKEPEER 256

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           IG GSFG+VY+ +    + V +        + L++F+ +  V++  RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
               A+V ++    SL + L+      ++ + ++I       ++YL   H   IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 131
Query: 324 PISVLLDEDMVAHLSDFEYG--------------MEGQV----------------STRSD 353
             ++ L ED+   + DF                 + G +                S +SD
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 354 IYGYGIVLMETFTRKKP 370
           +Y +GIVL E  T + P
Sbjct: 192 VYAFGIVLYELMTGQLP 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           IG GSFG+VY+ +    + V +        + L++F+ +  V++  RH N++  +   + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
               A+V ++    SL + L+      ++ + ++I       ++YL   H   IIH DLK
Sbjct: 78  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 133
Query: 324 PISVLLDEDMVAHLSDFEYG--------------MEGQV----------------STRSD 353
             ++ L ED+   + DF                 + G +                S +SD
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 193
Query: 354 IYGYGIVLMETFTRKKP 370
           +Y +GIVL E  T + P
Sbjct: 194 VYAFGIVLYELMTGQLP 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V+EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVIEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK IRH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 32/195 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+ A      +VAVK   +  + ++++F A+  VMK+++H  LVK+ 
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + +    ++ E+M KGSL + L S        Q L  +ID ++ + E + F      
Sbjct: 250 AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+   +V  ++DF         EY                    G  + +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 352 SDIYGYGIVLMETFT 366
           SD++ +GI+LME  T
Sbjct: 366 SDVWSFGILLMEIVT 380

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V+EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVIEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           IG GSFG+VY+ +    + V +        + L++F+ +  V++  RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
               A+V ++    SL + L+      ++ + ++I       ++YL   H   IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 131
Query: 324 PISVLLDEDMVAHLSDFEYG--------------MEGQV----------------STRSD 353
             ++ L ED+   + DF                 + G +                S +SD
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 354 IYGYGIVLMETFTRKKP 370
           +Y +GIVL E  T + P
Sbjct: 192 VYAFGIVLYELMTGQLP 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 246 AVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV- 410
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 362 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 400
Query: 411 -AKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 401 PCPPECPESLHDLMCQCWRKEPEER 425

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAVK+    Q  + +L+    +  +MK + HPN+V
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV+EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E     + D +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF 172

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAVK+    Q  + +L+    +  +MK + HPN+V
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV+EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E     + D +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF 172

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAVK+    Q  + +L+    +  +MK + HPN+V
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV+EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E     + D +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAF 172

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 179 GKRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKS 238
           G  GL   +  I P   T  +    +G G FG V   + R   +VA+K+  +E + +   
Sbjct: 1   GTAGLGYGSWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDE 56
Query: 239 FEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI 298
           F  + +VM ++ H  LV++   C+      ++ EYM  G L N L          Q L +
Sbjct: 57  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 116
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------EYG------ 343
             D    +EYL    +   +H DL   + L+++  V  +SDF         EY       
Sbjct: 117 CKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 173
Query: 344 -----------MEGQVSTRSDIYGYGIVLMETFT-RKKPTDRM 374
                      M  + S++SDI+ +G+++ E ++  K P +R 
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 216

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 12  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 70
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 71  AVVSEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 187 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 225
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 226 PCPPECPESLHDLMCQCWRKDPEER 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------EGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF  G       E   +TR          
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 10  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 68
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 69  AVVSEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 185 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 223
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 224 PCPPECPESLHDLMCQCWRKDPEER 248

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 47/209 (22%)
Query: 199 RLSNLIGMGSFGSVYRARLR-DGI--EVAVKVFHQECARA-LKSFEAQCEVM-KSIRHPN 253
           +  ++IG G+FG V +AR++ DG+  + A+K   +  ++   + F  + EV+ K   HPN
Sbjct: 25  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 84
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLY---------------SSTCMLDIFQRLNI 298
           ++ ++ +C +  +  L +EY P G+L + L                S+   L   Q L+ 
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--EYGMEGQV-------- 348
             D    ++YL        IH +L   ++L+ E+ VA ++DF    G E  V        
Sbjct: 145 AADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 349 --------------STRSDIYGYGIVLME 363
                         +T SD++ YG++L E
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 230

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVA+K+    Q    +L+    +  +MK + HPN+V
Sbjct: 15  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 74
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    L++EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYC---HQK 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E  V  + D +
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF 170

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAV++    Q  + +L+    +  +MK + HPN+V
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV+EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E     + D +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF 172

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVCEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 40/199 (20%)
Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVIS 259
           IG GSFG+VY AR +R+   VA+K       ++ + ++    +   ++ +RHPN ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI----FQRLNIMIDATSTLEYLYFGHTT 315
               +    LV+EY        CL S++ +L++     Q + I       L+ L + H+ 
Sbjct: 122 CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF---------------EYGM---------EGQVSTR 351
            +IH D+K  ++LL E  +  L DF                Y M         EGQ   +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 352 SDIYGYGIVLMETFTRKKP 370
            D++  GI  +E   RK P
Sbjct: 234 VDVWSLGITCIELAERKPP 252

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + R   +VA+K+  +E + +   F  + +VM ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                ++ EYM  G L N L          Q L +  D    +EYL    +   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 147
Query: 324 PISVLLDEDMVAHLSDF---------EYG-----------------MEGQVSTRSDIYGY 357
             + L+++  V  +SDF         EY                  M  + S++SDI+ +
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207
Query: 358 GIVLMETFT-RKKPTDRM 374
           G+++ E ++  K P +R 
Sbjct: 208 GVLMWEIYSLGKMPYERF 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVA+K+    Q    +L+    +  +MK + HPN+V
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    L++EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYC---HQK 133
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD DM   ++DF +  E  V  + D +
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 34/194 (17%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           IG G FG V+     +  +VA+K   +E A + + F  + EVM  + HP LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                LV E+M  G L + L +   +      L + +D    + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEASVIHRDLA 130
Query: 324 PISVLLDEDMVAHLSDFEYGME----------------------------GQVSTRSDIY 355
             + L+ E+ V  +SDF  GM                              + S++SD++
Sbjct: 131 ARNCLVGENQVIKVSDF--GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 356 GYGIVLMETFTRKK 369
            +G+++ E F+  K
Sbjct: 189 SFGVLMWEVFSEGK 202

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 114/265 (43%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 188 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLY 246
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 247 AVVSEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 302
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV- 410
           SD++ +GI+L E  T+ +                   +P   M  V++ +L   ++G+  
Sbjct: 363 SDVWSFGILLTELTTKGR-------------------VPYPGM--VNREVLDQVERGYRM 401
Query: 411 -AKEQCVLSILGLAMECAMELPEKR 434
               +C  S+  L  +C  + PE+R
Sbjct: 402 PCPPECPESLHDLMCQCWRKDPEER 426

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + R   +VA+K+  +E + +   F  + +VM ++ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                ++ EYM  G L N L          Q L +  D    +EYL    +   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 132
Query: 324 PISVLLDEDMVAHLSDF---------EYG-----------------MEGQVSTRSDIYGY 357
             + L+++  V  +SDF         EY                  M  + S++SDI+ +
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 192
Query: 358 GIVLMETFT-RKKPTDRM 374
           G+++ E ++  K P +R 
Sbjct: 193 GVLMWEIYSLGKMPYERF 210

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + R   +VA+K+  +E + +   F  + +VM ++ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                ++ EYM  G L N L          Q L +  D    +EYL    +   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 132
Query: 324 PISVLLDEDMVAHLSDF---------EYG-----------------MEGQVSTRSDIYGY 357
             + L+++  V  +SDF         EY                  M  + S++SDI+ +
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAF 192
Query: 358 GIVLMETFT-RKKPTDRM 374
           G+++ E ++  K P +R 
Sbjct: 193 GVLMWEIYSLGKMPYERF 210

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + R   +VA+K+  +E + +   F  + +VM ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                ++ EYM  G L N L          Q L +  D    +EYL    +   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 147
Query: 324 PISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTRSDIYGY 357
             + L+++  V  +SDF                          E  M  + S++SDI+ +
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207
Query: 358 GIVLMETFT-RKKPTDRM 374
           G+++ E ++  K P +R 
Sbjct: 208 GVLMWEIYSLGKMPYERF 225

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + R   +VA+K+  +E + +   F  + +VM ++ H  LV++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                ++ EYM  G L N L          Q L +  D    +EYL    +   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 131
Query: 324 PISVLLDEDMVAHLSDF---------EYG-----------------MEGQVSTRSDIYGY 357
             + L+++  V  +SDF         EY                  M  + S++SDI+ +
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 191
Query: 358 GIVLMETFT-RKKPTDRM 374
           G+++ E ++  K P +R 
Sbjct: 192 GVLMWEIYSLGKMPYERF 209

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 40/199 (20%)
Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVIS 259
           IG GSFG+VY AR +R+   VA+K       ++ + ++    +   ++ +RHPN ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI----FQRLNIMIDATSTLEYLYFGHTT 315
               +    LV+EY        CL S++ +L++     Q + I       L+ L + H+ 
Sbjct: 83  CYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF---------------EYGM---------EGQVSTR 351
            +IH D+K  ++LL E  +  L DF                Y M         EGQ   +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 352 SDIYGYGIVLMETFTRKKP 370
            D++  GI  +E   RK P
Sbjct: 195 VDVWSLGITCIELAERKPP 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V+EYM KG L + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVMEYMSKGCLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 32  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 89
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 90  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 149
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 150 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 206
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 207 PEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN 263
           +G G FG V   + R   +VA+K+  +E + +   F  + +VM ++ H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 264 DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLK 323
                ++ EYM  G L N L          Q L +  D    +EYL    +   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLA 127
Query: 324 PISVLLDEDMVAHLSDF---------EYG-----------------MEGQVSTRSDIYGY 357
             + L+++  V  +SDF         EY                  M  + S++SDI+ +
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 358 GIVLMETFT-RKKPTDRM 374
           G+++ E ++  K P +R 
Sbjct: 188 GVLMWEIYSLGKMPYERF 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           I PS+ T       IG G FG V+     +  +VA+K   +E A + + F  + EVM  +
Sbjct: 7   IDPSELTF---VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 62
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP LV++   C       LV E+M  G L + L +   +      L + +D    + YL
Sbjct: 63  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 122
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------------------ 345
                  +IH DL   + L+ E+ V  +SDF  GM                         
Sbjct: 123 ---EEACVIHRDLAARNCLVGENQVIKVSDF--GMTRFVLDDQYTSSTGTKFPVKWASPE 177
Query: 346 ----GQVSTRSDIYGYGIVLMETFTRKK 369
                + S++SD++ +G+++ E F+  K
Sbjct: 178 VFSFSRYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 7/158 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAV++    Q  + +L+    +  +MK + HPN+V
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIV 76
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV+EY   G + + L +   M +   R        S ++Y    H  
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSD 353
            I+H DLK  ++LLD DM   ++DF +  E     + D
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD 170

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 72
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           I PS+ T       IG G FG V+     +  +VA+K   +E A + + F  + EVM  +
Sbjct: 4   IDPSELTF---VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 59
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP LV++   C       LV E+M  G L + L +   +      L + +D    + YL
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------------------ 345
                  +IH DL   + L+ E+ V  +SDF  GM                         
Sbjct: 120 ---EEACVIHRDLAARNCLVGENQVIKVSDF--GMTRFVLDDQYTSSTGTKFPVKWASPE 174
Query: 346 ----GQVSTRSDIYGYGIVLMETFTRKK 369
                + S++SD++ +G+++ E F+  K
Sbjct: 175 VFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL   ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 70/289 (24%)
Query: 200 LSNLIGMGSFGSVYRAR------LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           L   +G G+FG V+ A        +D + VAVK        A K F+ + E++ +++H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYS---------------STCMLDIFQRLNI 298
           +VK    C + D   +V EYM  G L   L +               +   L + Q L+I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------ 340
                S + YL   H    +H DL   + L+  +++  + DF                  
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 341 ---------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI 391
                    E  M  + +T SD++ +G++L E FT  K            + W      +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ----L 239
Query: 392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
           S  EV++      + +       C   +  + + C    P++R+N K+I
Sbjct: 240 SNTEVIECIT---QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           I PS+ T       IG G FG V+     +  +VA+K   +E A + + F  + EVM  +
Sbjct: 2   IDPSELTF---VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 57
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP LV++   C       LV E+M  G L + L +   +      L + +D    + YL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------------------ 345
                  +IH DL   + L+ E+ V  +SDF  GM                         
Sbjct: 118 ---EEACVIHRDLAARNCLVGENQVIKVSDF--GMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 346 ----GQVSTRSDIYGYGIVLMETFTRKK 369
                + S++SD++ +G+++ E F+  K
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+D+ G
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 169

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 42  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 99
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V EYM  GSL++ L        + Q + ++    S ++
Sbjct: 100 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 159
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 160 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+D+ G
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 168

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+D+ G
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 168

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 81  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+D+ G
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 173

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 102 YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R D+ G
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCG 194

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 113/257 (43%), Gaps = 27/257 (10%)
Query: 210 GSVYRARLRDGIEVAVKVF--HQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-- 265
           G +++ R + G ++ VKV        R  + F  +C  ++   HPN++ V+ +C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 266 FKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHT-TPII--HCD 321
              L+  +MP GSL N L+  T  ++D  Q +   +D    + +L   HT  P+I  H  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHA- 138
Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDR------MF 375
           L   SV++DEDM A +S  +     Q   R  +Y    V  E   +KKP D       M+
Sbjct: 139 LNSRSVMIDEDMTARISMADVKFSFQSPGR--MYAPAWVAPEAL-QKKPEDTNRRSADMW 195
Query: 376 VEELSLKDWVNNLLP---ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPE 432
              + L + V   +P   +S ME+  K  L G +          +S   L   C  E P 
Sbjct: 196 SFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS--KLMKICMNEDPA 253
Query: 433 KRINAKDIVTRLLKIRD 449
           KR     IV  L K++D
Sbjct: 254 KRPKFDMIVPILEKMQD 270

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           I PS+ T       IG G FG V+     +  +VA+K   +E A + + F  + EVM  +
Sbjct: 5   IDPSELTF---VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 60
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP LV++   C       LV E+M  G L + L +   +      L + +D    + YL
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------------------ 345
                  +IH DL   + L+ E+ V  +SDF  GM                         
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDF--GMTRFVLDDQYTSSTGTKFPVKWASPE 175
Query: 346 ----GQVSTRSDIYGYGIVLMETFTRKK 369
                + S++SD++ +G+++ E F+  K
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K   +    + ++F  + +VMK +RH  LV++ 
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KG L + L      +  + RL  ++D A      + +      
Sbjct: 80  AVVSEEPI-YIVTEYMSKGCLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T+ +
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR R     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL  +    ++DF + +    S R+ + G
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCG 172

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R D+ G
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCG 171

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 75/141 (53%), Gaps = 10/141 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++ G   A KV   +    L+ +  + E++ +  HP +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTPIIH 319
           +D    +++E+ P G+++        ML++ + L    I +     LE L F H+  IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 132
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  +VL+  +    L+DF
Sbjct: 133 RDLKAGNVLMTLEGDIRLADF 153

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P+G     +Y     L  F         T     L + H+  +IH
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R  + G
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXG 173

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 75/141 (53%), Gaps = 10/141 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++ G   A KV   +    L+ +  + E++ +  HP +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTPIIH 319
           +D    +++E+ P G+++        ML++ + L    I +     LE L F H+  IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  +VL+  +    L+DF
Sbjct: 141 RDLKAGNVLMTLEGDIRLADF 161

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P+G +    Y     L  F         T     L + H+  +IH
Sbjct: 81  YFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 173

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 168
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 169 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 268
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 269 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 316

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 169
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 170 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 269
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 270 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 317

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 37/208 (17%)
Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI 249
           I PS+ T       IG G FG V+     +  +VA+K   +E + +   F  + EVM  +
Sbjct: 24  IDPSELTF---VQEIGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKL 79
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP LV++   C       LV E+M  G L + L +   +      L + +D    + YL
Sbjct: 80  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 139
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------------------ 345
                  +IH DL   + L+ E+ V  +SDF  GM                         
Sbjct: 140 ---EEACVIHRDLAARNCLVGENQVIKVSDF--GMTRFVLDDQYTSSTGTKFPVKWASPE 194
Query: 346 ----GQVSTRSDIYGYGIVLMETFTRKK 369
                + S++SD++ +G+++ E F+  K
Sbjct: 195 VFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR R     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL  +    ++DF + +    S R  + G
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCG 172

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 142
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 143 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 242
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 243 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 290

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 148
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 149 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 248
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 249 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 150
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 151 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 250
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 251 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 36  MKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 94
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    +V EYMP G+L +  Y   C  +    + ++  AT   S +EYL      
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLD--YLRECNREEVTAVVLLYMATQISSAMEYL---EKK 149
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYG--MEGQVST----------------------- 350
             IH DL   + L+ E+ V  ++DF     M G   T                       
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 351 -RSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 210 IKSDVWAFGVLLWEIAT 226

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+     +  +VAVK   +    ++++F  +  +MK+++H  LV++ 
Sbjct: 16  KLVKRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + ++   ++ EYM KGSL + L S      +  +L   ID ++ + E + +      
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNY 131
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  +VL+ E ++  ++DF         EY                    G  + +
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  K
Sbjct: 192 SDVWSFGILLYEIVTYGK 209

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 147
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 148 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 247
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 145
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 245
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 246 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 10/171 (5%)
Query: 192 PSQATLR--RLSNLIGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEV 245
           P Q  L    +   +G G FG+VY AR +     +A+KV  +   E A        + E+
Sbjct: 2   PRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 246 MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
              +RHPN++++     +     L+LEY P G++    Y     L  F         T  
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITEL 117
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
              L + H+  +IH D+KP ++LL       ++DF + +    S R+++ G
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCG 168

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 149
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 150 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 249
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 250 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR ++    +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 76  YFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKKVIH 131
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG 168

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 254 LVKVISSCSNDDFKALV-LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   LV L YM  G L N + + T    +   +   +     ++YL   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 150
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY----------------GMEG- 346
            +   +H DL   + +LDE     ++DF         EY                 +E  
Sbjct: 151 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 347 ---QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 250
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 251 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     ++YL   
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 149
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 150 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 249
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 250 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 48/215 (22%)
Query: 200 LSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           L   +G G+FG V+ A        +D I VAVK        A K F  + E++ +++H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSS------------TCMLDIFQRLNIMID 301
           +VK    C   D   +V EYM  G L   L +                L   Q L+I   
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------- 340
             + + YL   H    +H DL   + L+ E+++  + DF                     
Sbjct: 137 IAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKK 369
                 E  M  + +T SD++  G+VL E FT  K
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 102 YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 194

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 93  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 148
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 185

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 41/216 (18%)
Query: 192 PSQATLR-RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALK---SFEAQCEVM 246
           PS  + R  L  ++G G    V+ AR LRD  +VAVKV   + AR       F  + +  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 247 KSIRHPNLVKVISSCSNDD----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            ++ HP +V V  +   +        +V+EY+   +L + +++   M    + + ++ DA
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADA 125
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              L    F H   IIH D+KP ++L+       + DF                      
Sbjct: 126 CQALN---FSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                 E      V  RSD+Y  G VL E  T + P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 168

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 194 QATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQ-ECARALKSFEAQCEVMKS 248
           +A+   +  +IG G  G V   RLR      + VA+K        R  + F ++  +M  
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 249 IRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
             HPN++++    +      +V EYM  GSL+  L +      I Q + ++    + + Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 309 LY-FGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L   G+    +H DL   +VL+D ++V  +SDF
Sbjct: 167 LSDLGY----VHRDLAARNVLVDSNLVCKVSDF 195

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 72
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V E M  GSL++ L        + Q + ++    S ++
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 132
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 133 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 204 IGMGSFGSVYRARL-RDGIEVAVKVF-------HQECARALKSFEAQCEVMKSIRHPNLV 255
           IG G FG V++ RL +D   VA+K           E     + F+ +  +M ++ HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+     N     +V+E++P G L + L      +    +L +M+D    +EY+      
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 316 PIIHCDLKPISVL---LDED--MVAHLSDFEYGM------------------------EG 346
           PI+H DL+  ++    LDE+  + A ++DF                            E 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 347 QVSTRSDIYGYGIVLMETFTRKKPTD 372
             + ++D Y + ++L    T + P D
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 171

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 135
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 136 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 172

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 81  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 173

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 75  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 130
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 167

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V E M  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM D  Q   +  +    LE+L   H+  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSNQVIHRDI 142
Query: 323 KPISVLLDEDMVAHLSDFEY--GMEGQVSTRSDIYGYGIVLM-ETFTRK 368
           K  ++LL  D    L+DF +   +  + S RS++ G    +  E  TRK
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRK 191

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 194 QATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQ-ECARALKSFEAQCEVMKS 248
           +A+   +  +IG G  G V   RLR      + VA+K        R  + F ++  +M  
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 249 IRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
             HPN++++    +      +V EYM  GSL+  L +      I Q + ++    + + Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 309 LY-FGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L   G+    +H DL   +VL+D ++V  +SDF
Sbjct: 167 LSDLGY----VHRDLAARNVLVDSNLVCKVSDF 195

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 171

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 81  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 173

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 11/178 (6%)
Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVM-KSIRHPNLVKV 257
           +IG GSFG V  AR + + +  AVKV  ++     +  K   ++  V+ K+++HP LV +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             S    D    VL+Y+  G L   L    C L+   R     +  S L YL   H+  I
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYL---HSLNI 160
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG--QVSTRSDIYGYGIVLMETFTRKKPTDR 373
           ++ DLKP ++LLD      L+DF    E     ST S   G    L      K+P DR
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 40/207 (19%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVMK 247
           AT   +  ++G G FG V   RL+      I VA+K   V + E  R  + F  +  +M 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMG 101
Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
              HPN++++    +      +V E M  GSL++ L        + Q + ++    S ++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR---------- 351
           YL        +H DL   ++L++ ++V  +SDF      E   E   +TR          
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 352 ------------SDIYGYGIVLMETFT 366
                       SD++ YGIVL E  +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM D  Q   +  +    LE+L   H+  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSNQVIHRDI 142
Query: 323 KPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DIYGY 357
           K  ++LL  D    L+DF                    Y M  +V TR       DI+  
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 358 GIVLMETFTRKKP 370
           GI+ +E    + P
Sbjct: 203 GIMAIEMIEGEPP 215

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCG 168

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG 171

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF +      S R+ + G
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSG 169

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCG 168

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM D  Q   +  +    LE+L   H+  +IH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSNQVIHRDI 143
Query: 323 KPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DIYGY 357
           K  ++LL  D    L+DF                    Y M  +V TR       DI+  
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSL 203
Query: 358 GIVLMETFTRKKP 370
           GI+ +E    + P
Sbjct: 204 GIMAIEMIEGEPP 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM D  Q   +  +    LE+L   H+  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSNQVIHRDI 142
Query: 323 KPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DIYGY 357
           K  ++LL  D    L+DF                    Y M  +V TR       DI+  
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 358 GIVLMETFTRKKP 370
           GI+ +E    + P
Sbjct: 203 GIMAIEMIEGEPP 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 151
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 152 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 251
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 252 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 150
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 151 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 250
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 251 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 209
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 309
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 310 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R  + G
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCG 169

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 40/206 (19%)
Query: 204 IGMGSFGSVYRARL-RDGIEVAVKVF-------HQECARALKSFEAQCEVMKSIRHPNLV 255
           IG G FG V++ RL +D   VA+K           E     + F+ +  +M ++ HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+     N     +V+E++P G L + L      +    +L +M+D    +EY+      
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 316 PIIHCDLKPISVL---LDED--MVAHLSDF-----------------------EYGMEGQ 347
           PI+H DL+  ++    LDE+  + A ++DF                         G E +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 348 VST-RSDIYGYGIVLMETFTRKKPTD 372
             T ++D Y + ++L    T + P D
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 148
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 149 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 248
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 249 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 155
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 156 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 255
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 256 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 303

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 73  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 128
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R+ + G
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG 165

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 151
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 152 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 251
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 252 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 299

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 40/206 (19%)
Query: 204 IGMGSFGSVYRARL-RDGIEVAVKVF-------HQECARALKSFEAQCEVMKSIRHPNLV 255
           IG G FG V++ RL +D   VA+K           E     + F+ +  +M ++ HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+     N     +V+E++P G L + L      +    +L +M+D    +EY+      
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 316 PIIHCDLKPISVL---LDED--MVAHLSDF-----------------------EYGMEGQ 347
           PI+H DL+  ++    LDE+  + A ++DF                         G E +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 348 VST-RSDIYGYGIVLMETFTRKKPTD 372
             T ++D Y + ++L    T + P D
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 57/288 (19%)
Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 150
Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------------EYG 343
            +   +H DL   + +LDE     ++DF                             E  
Sbjct: 151 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + +T+SD++ +G++L E  TR  P                   P   +   D T+  
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYL 250
Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
            + +  +  E C   +  + ++C     E R +  ++V+R+  I  T 
Sbjct: 251 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 41/216 (18%)
Query: 192 PSQATLR-RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALK---SFEAQCEVM 246
           PS  + R  L  ++G G    V+ AR LRD  +VAVKV   + AR       F  + +  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 247 KSIRHPNLVKVISSCSNDD----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            ++ HP +V V  +   +        +V+EY+   +L + +++   M    + + ++ DA
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADA 125
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              L    F H   IIH D+KP ++++       + DF                      
Sbjct: 126 CQALN---FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                 E      V  RSD+Y  G VL E  T + P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 78  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R  + G
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCG 170

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 41/216 (18%)
Query: 192 PSQATLR-RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALK---SFEAQCEVM 246
           PS  + R  L  ++G G    V+ AR LRD  +VAVKV   + AR       F  + +  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 247 KSIRHPNLVKVISSCSNDD----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            ++ HP +V V  +   +        +V+EY+   +L + +++   M    + + ++ DA
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADA 125
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              L    F H   IIH D+KP ++++       + DF                      
Sbjct: 126 CQALN---FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                 E      V  RSD+Y  G VL E  T + P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 69/288 (23%)
Query: 204 IGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           +G G+FG V+ A        +D + VAVK   +    A + F+ + E++  ++H ++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYS--------------STCMLDIFQRLNIMIDAT 303
              C+      +V EYM  G L   L S              +   L + Q L +     
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------EYGMEGQV----- 348
           + + YL   H    +H DL   + L+ + +V  + DF           Y + G+      
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 349 ------------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV 396
                       +T SD++ +G+VL E FT  K            + W      +S  E 
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSNTEA 269
Query: 397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
           +D      E +       C   +  +   C    P++R + KD+  RL
Sbjct: 270 IDCITQGRELE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 112/289 (38%), Gaps = 81/289 (28%)
Query: 204 IGMGSFGSVYRAR------LRDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVK 256
           IG G+FG V++AR            VAVK+  +E +  +++ F+ +  +M    +PN+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS----STCM-------------------LDIF 293
           ++  C+      L+ EYM  G L   L S    + C                    L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------EYG 343
           ++L I     + + YL        +H DL   + L+ E+MV  ++DF           Y 
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 344 MEG-----------------QVSTRSDIYGYGIVLMETFTRK-KPTDRMFVEELSLKDWV 385
            +G                 + +T SD++ YG+VL E F+   +P   M  EE+      
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV------ 285
Query: 386 NNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKR 434
                  +  V D  +L+         E C L +  L   C  +LP  R
Sbjct: 286 -------IYYVRDGNILA-------CPENCPLELYNLMRLCWSKLPADR 320

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R  + G
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCG 168

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 202 NLIGMGSFGSVYRARLRDGIEVA----VKVFHQECARALKSFEA--QCEVMKSIRHPNLV 255
           + +G G F +VY+AR ++  ++     +K+ H+  A+   +  A  + ++++ + HPN++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
            ++ +  +    +LV ++M +  LE  +  ++ +L        M+     LEYL   H  
Sbjct: 76  GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQH 131
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIV 360
            I+H DLKP ++LLDE+ V  L+DF  G+     + +  Y + +V
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADF--GLAKSFGSPNRAYXHQVV 174

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G++    Y     L  F         T     L + H+  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +    S R  + G
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCG 171

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 40/208 (19%)
Query: 194 QATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVK---VFHQECARALKSFEAQCEVM 246
           +A+   +  +IG G FG V   RL+      + VA+K   V + E  R  + F  +  +M
Sbjct: 20  EASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR--RDFLGEASIM 77
Query: 247 KSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL 306
               HPN++ +    +      +V EYM  GSL+  L  +     + Q + ++   ++ +
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR--------- 351
           +YL        +H DL   ++L++ ++V  +SDF      E   E   +TR         
Sbjct: 138 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 352 -------------SDIYGYGIVLMETFT 366
                        SD++ YGIV+ E  +
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQC---EVMKSIRHPNLVKV-- 257
           +G G FG V R   +D G +VA+K   QE +   K+ E  C   ++MK + HPN+V    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 258 ----ISSCSNDDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTLEYLYF 311
               +   + +D   L +EY   G L   L  + + C L       ++ D +S L YL  
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL-- 137
Query: 312 GHTTPIIHCDLKPISVLLD---EDMVAHLSDFEYGME 345
            H   IIH DLKP +++L    + ++  + D  Y  E
Sbjct: 138 -HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 18/156 (11%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVA---VKVFHQECARALKSFEAQCEVMKSIRHPNL 254
           R+   IG G F  VYRA  L DG+ VA   V++F    A+A      + +++K + HPN+
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY------ 308
           +K  +S   D+   +VLE    G L         M+  F++   +I   +  +Y      
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSR-------MIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 309 -LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG 343
            L   H+  ++H D+KP +V +    V  L D   G
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 69/288 (23%)
Query: 204 IGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           +G G+FG V+ A        +D + VAVK   +    A + F+ + E++  ++H ++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYS--------------STCMLDIFQRLNIMIDAT 303
              C+      +V EYM  G L   L S              +   L + Q L +     
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------EYGMEGQV----- 348
           + + YL   H    +H DL   + L+ + +V  + DF           Y + G+      
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 349 ------------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV 396
                       +T SD++ +G+VL E FT  K            + W      +S  E 
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSNTEA 240
Query: 397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
           +D      E +       C   +  +   C    P++R + KD+  RL
Sbjct: 241 IDCITQGRELE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQC---EVMKSIRHPNLVKV-- 257
           +G G FG V R   +D G +VA+K   QE +   K+ E  C   ++MK + HPN+V    
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 258 ----ISSCSNDDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTLEYLYF 311
               +   + +D   L +EY   G L   L  + + C L       ++ D +S L YL  
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL-- 138
Query: 312 GHTTPIIHCDLKPISVLLD---EDMVAHLSDFEYGME 345
            H   IIH DLKP +++L    + ++  + D  Y  E
Sbjct: 139 -HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 174

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 3/140 (2%)
Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           ++G G++G VY  R L + + +A+K   +  +R  +    +  + K ++H N+V+ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
           S + F  + +E +P GSL   L S    L   ++  I       LE L + H   I+H D
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 322 LKPISVLLDE-DMVAHLSDF 340
           +K  +VL++    V  +SDF
Sbjct: 134 IKGDNVLINTYSGVLKISDF 153

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 3/140 (2%)
Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           ++G G++G VY  R L + + +A+K   +  +R  +    +  + K ++H N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
           S + F  + +E +P GSL   L S    L   ++  I       LE L + H   I+H D
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 322 LKPISVLLDE-DMVAHLSDF 340
           +K  +VL++    V  +SDF
Sbjct: 148 IKGDNVLINTYSGVLKISDF 167

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR---------- 250
           ++IG G    V R   R  G E AVK+      R   S E   EV ++ R          
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL--SPEQLEEVREATRRETHILRQVA 157
Query: 251 -HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HP+++ +I S  +  F  LV + M KG L + L     + +   R +IM    S LE +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-SIM---RSLLEAV 213
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY 342
            F H   I+H DLKP ++LLD++M   LSDF +
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 49/227 (21%)
Query: 187 NDGILPSQATLRRLSNLIGMGSFGSVYRARLR--DG--IEVAVKVFHQE--CARALKSFE 240
            D ++P Q     L  ++G G FGSV  A+L+  DG  ++VAVK+   +   +  ++ F 
Sbjct: 16  EDVLIPEQQF--TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 241 AQCEVMKSIRHPNLVKVISSCSNDDFKA------LVLEYMPKGSLENCLYSSTCMLDIFQ 294
            +   MK   HP++ K++        K       ++L +M  G L   L +S    + F 
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 295 -----RLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------- 340
                 +  M+D    +EYL    +   IH DL   + +L EDM   ++DF         
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 341 EYGMEGQVS------------------TRSDIYGYGIVLMETFTRKK 369
           +Y  +G  S                    SD++ +G+ + E  TR +
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G+    +Y     L  F         T     L + H+  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       +++F + +    S R+ + G
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCG 171

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 69/288 (23%)
Query: 204 IGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           +G G+FG V+ A        +D + VAVK   +    A + F+ + E++  ++H ++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYS--------------STCMLDIFQRLNIMIDAT 303
              C+      +V EYM  G L   L S              +   L + Q L +     
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------EYGMEGQV----- 348
           + + YL   H    +H DL   + L+ + +V  + DF           Y + G+      
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 349 ------------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV 396
                       +T SD++ +G+VL E FT  K            + W      +S  E 
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQ----LSNTEA 246
Query: 397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
           +D      E +       C   +  +   C    P++R + KD+  RL
Sbjct: 247 IDCITQGRELE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G FG VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 15  MKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 128
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYG--MEGQVST----------------------- 350
             IH DL   + L+ E+ +  ++DF     M G   T                       
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 351 -RSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)
Query: 185 VSNDGILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQEC 232
           ++  G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K+ ++  
Sbjct: 20  LTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 79
Query: 233 A-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD 291
             +A   F  +  +M S+ HP+LV+++  C +   + LV + MP G L   ++     + 
Sbjct: 80  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 138
Query: 292 IFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------- 340
               LN  +     + YL       ++H DL   +VL+       ++DF           
Sbjct: 139 SQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195
Query: 341 EYGMEG----------------QVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
           EY  +G                + + +SD++ YG+ + E  T   KP D +   E+
Sbjct: 196 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++  +  A KV   +    L+ +  + +++ S  HPN+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTPIIH 319
            ++   +++E+   G+++        ML++ + L    I +    TL+ L + H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  ++L   D    L+DF
Sbjct: 159 RDLKAGNILFTLDGDIKLADF 179

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P G+    +Y     L  F         T     L + H+  +IH
Sbjct: 78  YFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       +++F + +    S R+ + G
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCG 170

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++  +  A KV   +    L+ +  + +++ S  HPN+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTPIIH 319
            ++   +++E+   G+++        ML++ + L    I +    TL+ L + H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  ++L   D    L+DF
Sbjct: 159 RDLKAGNILFTLDGDIKLADF 179

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 18  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 76
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    +++E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 131
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 74/141 (52%), Gaps = 10/141 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+ ++  +  A KV   +    L+ +  + +++ S  HPN+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTPIIH 319
            ++   +++E+   G+++        ML++ + L    I +    TL+ L + H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  ++L   D    L+DF
Sbjct: 159 RDLKAGNILFTLDGDIKLADF 179

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 46/211 (21%)
Query: 200 LSNLIGMGSFGSVYRARLR--DG--IEVAVKV--FHQECARALKSFEAQCEVMKSIRHPN 253
           L  ++G G FGSV    L+  DG  ++VAVK         R ++ F ++   MK   HPN
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 254 LVKVISSCSNDDFKAL-----VLEYMPKGSLENCLYSSTC-----MLDIFQRLNIMIDAT 303
           +++++  C     + +     +L +M  G L   L  S        + +   L  M+D  
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------EYGMEGQV------ 348
             +EYL        +H DL   + +L +DM   ++DF         +Y  +G++      
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 349 ------------STRSDIYGYGIVLMETFTR 367
                       +++SD++ +G+ + E  TR
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    +++E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 135
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 93/198 (46%), Gaps = 31/198 (15%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+     +  +VAVK   +    ++++F  +  +MK+++H  LV++ 
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL-EYLYFGHTTPI 317
           +  + ++   ++ E+M KGSL + L S      +  +L   ID ++ + E + +      
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNY 130
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  +VL+ E ++  ++DF         EY                    G  + +
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 352 SDIYGYGIVLMETFTRKK 369
           S+++ +GI+L E  T  K
Sbjct: 191 SNVWSFGILLYEIVTYGK 208

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 15  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    +++E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 128
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    +++E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    +++E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM D  Q   +  +    LE+L   H+  +IH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSNQVIHRNI 143
Query: 323 KPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DIYGY 357
           K  ++LL  D    L+DF                    Y M  +V TR       DI+  
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 203
Query: 358 GIVLMETFTRKKP 370
           GI+ +E    + P
Sbjct: 204 GIMAIEMIEGEPP 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 203 LIGMGSFGSVYRARLRDGIEVAVK----VFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           ++G G FG   +   R+  EV V      F +E  R   +F  + +VM+ + HPN++K I
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVKVMRCLEHPNVLKFI 73
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
                D     + EY+  G+L   + S        QR++   D  S + YL   H+  II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNII 130
Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           H DL   + L+ E+    ++DF
Sbjct: 131 HRDLNSHNCLVRENKNVVVADF 152

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 42/208 (20%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECA-RALKSFEAQCEVMKSI 249
           A+  ++  +IG+G FG V   RL+      I VA+K        +  + F ++  +M   
Sbjct: 28  ASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF 87
Query: 250 RHPNLVK---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL 306
            HPN++    V++ C       ++ EYM  GSL+  L  +     + Q + ++    S +
Sbjct: 88  DHPNIIHLEGVVTKCKP---VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 144
Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR--------- 351
           +YL        +H DL   ++L++ ++V  +SDF      E   E   +TR         
Sbjct: 145 KYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 201
Query: 352 -------------SDIYGYGIVLMETFT 366
                        SD++ YGIV+ E  +
Sbjct: 202 APEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 36/205 (17%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECA-RALKSFEAQCEVMKSI 249
           A+  ++  +IG+G FG V   RL+      I VA+K        +  + F ++  +M   
Sbjct: 7   ASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF 66
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HPN++ +    +      ++ EYM  GSL+  L  +     + Q + ++    S ++YL
Sbjct: 67  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR------------ 351
                   +H DL   ++L++ ++V  +SDF      E   E   +TR            
Sbjct: 127 ---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 183
Query: 352 ----------SDIYGYGIVLMETFT 366
                     SD++ YGIV+ E  +
Sbjct: 184 AIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIE----VAVKVFHQ-ECARALKSFEAQCEVMKSIRHPN 253
           ++  +IG G FG V R RL+   +    VA+K        R  + F ++  +M    HPN
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++++    +N     ++ E+M  G+L++ L  +     + Q + ++    S + YL    
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---A 135
Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF---------------EYGMEGQVSTR------- 351
               +H DL   ++L++ ++V  +SDF                  + G++  R       
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 352 --------SDIYGYGIVLMETFT 366
                   SD + YGIV+ E  +
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALK---SFEAQCEVMKSIRHPNLV 255
           L + +G+G+FG V   +    G +VAVK+ +++  R+L        + + +K  RHP+++
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+    S      +V+EY+  G L + +      LD  +   +     S ++Y    H  
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYC---HRH 135
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF 340
            ++H DLKP +VLLD  M A ++DF
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADF 160

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 45/232 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K+ ++    +A
Sbjct: 1   GTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA 60
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
              F  +  +M S+ HP+LV+++  C +   + LV + MP G L   ++     +     
Sbjct: 61  NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLL 119
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 120 LNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176
Query: 345 EG----------------QVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
           +G                + + +SD++ YG+ + E  T   KP D +   E+
Sbjct: 177 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 18/150 (12%)
Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALK---SFEAQCEVMKSIRHPNLV 255
           L + +G+G+FG V     +  G +VAVK+ +++  R+L      + + + +K  RHP+++
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 256 KVISSCSNDDFKALVLEYMPKGSLEN--CLYSSTCMLD---IFQRLNIMIDATSTLEYLY 310
           K+    S      +V+EY+  G L +  C +     ++   +FQ++   +D         
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD--------- 125
Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           + H   ++H DLKP +VLLD  M A ++DF
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNAKIADF 155

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALK---SFEAQCEVMKSIRHPNLV 255
           L + +G+G+FG V     +  G +VAVK+ +++  R+L      + + + +K  RHP+++
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+    S      +V+EY+  G L    +   C     + +         L  + + H  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF 340
            ++H DLKP +VLLD  M A ++DF
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADF 155

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 36/205 (17%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECA-RALKSFEAQCEVMKSI 249
           A+  ++  +IG+G FG V   RL+      I VA+K        +  + F ++  +M   
Sbjct: 13  ASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF 72
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HPN++ +    +      ++ EYM  GSL+  L  +     + Q + ++    S ++YL
Sbjct: 73  DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR------------ 351
                   +H DL   ++L++ ++V  +SDF      E   E   +TR            
Sbjct: 133 ---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 189
Query: 352 ----------SDIYGYGIVLMETFT 366
                     SD++ YGIV+ E  +
Sbjct: 190 AIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/265 (20%), Positives = 112/265 (42%), Gaps = 55/265 (20%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VA+K   +    + +SF  + ++MK ++H  LV++ 
Sbjct: 12  QLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLY 70
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L       L +   +++     + + Y+        
Sbjct: 71  AVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNY 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+   ++  ++DF                          E  + G+ + +
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF-- 409
           SD++ +GI+L E  T+ +                   +P   M   ++ +L   ++G+  
Sbjct: 187 SDVWSFGILLTELVTKGR-------------------VPYPGMN--NREVLEQVERGYRM 225
Query: 410 VAKEQCVLSILGLAMECAMELPEKR 434
              + C +S+  L + C  + PE+R
Sbjct: 226 PCPQDCPISLHELMIHCWKKDPEER 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 38/203 (18%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIE----VAVKVFHQ-ECARALKSFEAQCEVMKSIRHPN 253
           ++  +IG G FG V R RL+   +    VA+K        R  + F ++  +M    HPN
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++++    +N     ++ E+M  G+L++ L  +     + Q + ++    S + YL    
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---A 133
Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF---------------EYGMEGQVSTR------- 351
               +H DL   ++L++ ++V  +SDF                  + G++  R       
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 352 --------SDIYGYGIVLMETFT 366
                   SD + YGIV+ E  +
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 18  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 76
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 131
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 197 LRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECA-RALKSFEAQCEVMKSIR 250
           L+R+ +L G G FG V   R        G +VAVK    E     +   + + E+++++ 
Sbjct: 11  LKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 251 HPNLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
           H N+VK    C+ D      L++E++P GSL+  L  +   +++ Q+L   +     ++Y
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------------- 340
           L    +   +H DL   +VL++ +    + DF                            
Sbjct: 130 L---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFT 366
           E  M+ +    SD++ +G+ L E  T
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 135
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 197 LRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECA-RALKSFEAQCEVMKSIR 250
           L+R+ +L G G FG V   R        G +VAVK    E     +   + + E+++++ 
Sbjct: 23  LKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 251 HPNLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
           H N+VK    C+ D      L++E++P GSL+  L  +   +++ Q+L   +     ++Y
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------------- 340
           L    +   +H DL   +VL++ +    + DF                            
Sbjct: 142 L---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFT 366
           E  M+ +    SD++ +G+ L E  T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 11/134 (8%)
Query: 203 LIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS-SC 261
           +IG GSFG V++A+L +  EVA+K   Q+  +  K+ E Q  +M+ ++HPN+V + +   
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQ--IMRIVKHPNVVDLKAFFY 102
Query: 262 SNDD-----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           SN D     F  LVLEY+P+       + +  +      L I +     L  L + H+  
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 317 IIHCDLKPISVLLD 330
           I H D+KP ++LLD
Sbjct: 162 ICHRDIKPQNLLLD 175

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 22  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 81  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+ + +   ++DF         EY                    G  + +
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 197 SDVWSFGILLTEIVTHGR 214

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 15  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 73
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 128
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 11  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 69
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 70  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 125
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+ + +   ++DF         EY                    G  + +
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 186 SDVWSFGILLTEIVTHGR 203

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 77
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 21  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 80  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 135
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+ + +   ++DF         EY                    G  + +
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 196 SDVWSFGILLTEIVTHGR 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 30  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 88
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 143
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 75  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+ + +   ++DF         EY                    G  + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   +E    ++ F  +  VMK I+HPNLV+++
Sbjct: 19  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 135
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 135
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 21  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 134
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 195 IKSDVWAFGVLLWEIAT 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 26  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 84
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 85  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 140
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH DL+  ++L+ + +   ++DF         EY                    G  + +
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 201 SDVWSFGILLTEIVTHGR 218

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV+++
Sbjct: 22  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 80
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 135
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH DL   + L+ E+ +  ++DF                          E     + S
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 7/160 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVAVK+    Q  + +L+    +  + K + HPN+V
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIV 76
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K+      +    LV EY   G + + L +     +   R        S ++Y    H  
Sbjct: 77  KLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYC---HQK 132
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            I+H DLK  ++LLD D    ++DF +  E     + D +
Sbjct: 133 FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAF 172

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 150
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 64/141 (45%), Gaps = 4/141 (2%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +  LIG G FG VY  R    + + +    ++    LK+F+ +    +  RH N+V  + 
Sbjct: 37  IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           +C +    A++       +L + +  +  +LD+ +   I  +    + YL   H   I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLK  +V  D   V  ++DF
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDF 173

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 125
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 126 KGIIHRDLKPENILLNEDMHIQITDF 151

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 126
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDF 152

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 128
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 129 KGIIHRDLKPENILLNEDMHIQITDF 154

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 76/146 (52%), Gaps = 7/146 (4%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           ++ NL+G GSF  VYRA  +  G+EVA+K+  ++    A  ++  + + ++   ++HP++
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +++ +   + ++  LVLE    G +   L +        +  + M    + + YL   H+
Sbjct: 74  LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---HS 130
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             I+H DL   ++LL  +M   ++DF
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADF 156

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 153
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 154 KGIIHRDLKPENILLNEDMHIQITDF 179

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 150
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 151
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDF 177

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 150
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 150
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 127
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 128 KGIIHRDLKPENILLNEDMHIQITDF 153

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 151
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDF 177

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 150
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 147
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDF 173

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 148
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 148
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 148
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 147
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDF 173

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 60/129 (46%), Gaps = 19/129 (14%)
Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASL 65
           D S N LEG  S+  G+ K   +I+L++N+L+ D+     G + L             +L
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-----GKVGLS-----------KNL 246
Query: 66  EILNLSNNEIYGLIPTXXXXXXXXXXXXXXFNKLEGEILRGGPFVNFTAMSFKGNEPLCG 125
             L+L NN IYG +P               FN L GEI +GG    F   ++  N+ LCG
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
Query: 126 SPNLQVPPC 134
           SP   +P C
Sbjct: 307 SP---LPAC 312

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 132
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 133 KGIIHRDLKPENILLNEDMHIQITDF 158

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 41/216 (18%)
Query: 192 PSQATLR-RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALK---SFEAQCEVM 246
           PS  + R  L  ++G G    V+ AR LR   +VAVKV   + AR       F  + +  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 247 KSIRHPNLVKVISSCSNDD----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            ++ HP +V V ++   +        +V+EY+   +L + +++   M    + + ++ DA
Sbjct: 67  AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADA 125
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              L    F H   IIH D+KP ++++       + DF                      
Sbjct: 126 CQALN---FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                 E      V  RSD+Y  G VL E  T + P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 17  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 75
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 76  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 131
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 192 SDVWSFGILLTEIVTHGR 209

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVKVIS 259
           IG GSFG V   + +  G   A+K+  ++    LK  E    +  +++++  P LVK+  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS---TLEYLYFGHTTP 316
           S  ++    +V+EYMP G     ++S    +  F   +    A     T EYL   H+  
Sbjct: 109 SFKDNSNLYMVMEYMPGGD----MFSHLRRIGRFSEPHARFYAAQIVLTFEYL---HSLD 161
Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
           +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADF--GFAKRVKGRT 195

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 150
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 18  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 76
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 77  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 132
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 193 SDVWSFGILLTEIVTHGR 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 75  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR +     VA+KV  +   E          + E+   + HPN++++ +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LEY P+G L   L  S C  D  +   IM +    L Y    H   +IH
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYC---HGKKVIH 146
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++LL       ++DF + +      R  + G
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCG 183

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 24  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 82
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 83  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 138
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 199 SDVWSFGILLTEIVTHGR 216

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVKVIS 259
           IG GSFG V   + +  G   A+K+  ++    LK  E    +  +++++  P LVK+  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS---TLEYLYFGHTTP 316
           S  ++    +V+EYMP G     ++S    +  F   +    A     T EYL   H+  
Sbjct: 109 SFKDNSNLYMVMEYMPGGD----MFSHLRRIGRFSEPHARFYAAQIVLTFEYL---HSLD 161
Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
           +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADF--GFAKRVKGRT 195

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/295 (20%), Positives = 104/295 (35%), Gaps = 71/295 (24%)
Query: 199 RLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRH 251
           R    +G   FG VY+  L           VA+K    +    L+  F  +  +   ++H
Sbjct: 29  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 88
Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR---------------L 296
           PN+V ++   + D   +++  Y   G L   L   +   D+                  +
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 297 NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------- 340
           +++    + +EYL   H   ++H DL   +VL+ + +   +SD                 
Sbjct: 149 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 341 -----------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL 389
                      E  M G+ S  SDI+ YG+VL E F+                     L 
Sbjct: 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------------------YGLQ 246
Query: 390 PISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
           P       D   +   ++     + C   +  L +EC  E P +R   KDI +RL
Sbjct: 247 PYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 25  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 83
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 84  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 139
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 200 SDVWSFGILLTEIVTHGR 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 12  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 70
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 71  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------EYGME-----------------GQVSTR 351
           IH +L+  ++L+ + +   ++DF         EY                    G  + +
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 187 SDVWSFGILLTEIVTHGR 204

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/295 (20%), Positives = 104/295 (35%), Gaps = 71/295 (24%)
Query: 199 RLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRH 251
           R    +G   FG VY+  L           VA+K    +    L+  F  +  +   ++H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR---------------L 296
           PN+V ++   + D   +++  Y   G L   L   +   D+                  +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 297 NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------- 340
           +++    + +EYL   H   ++H DL   +VL+ + +   +SD                 
Sbjct: 132 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 341 -----------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL 389
                      E  M G+ S  SDI+ YG+VL E F+                     L 
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------------------YGLQ 229
Query: 390 PISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
           P       D   +   ++     + C   +  L +EC  E P +R   KDI +RL
Sbjct: 230 PYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/302 (20%), Positives = 117/302 (38%), Gaps = 68/302 (22%)
Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDG-----IEVAVKVFHQECARALK-SFEAQC 243
           I PS  T +++   IG G FG VY+  L+       + VA+K          +  F  + 
Sbjct: 41  IHPSCVTRQKV---IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97
Query: 244 EVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT 303
            +M    H N++++    S      ++ EYM  G+L+  L        + Q + ++    
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------EYGMEG----- 346
           + ++YL        +H DL   ++L++ ++V  +SDF             Y   G     
Sbjct: 158 AGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 347 -----------QVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLM 394
                      + ++ SD++ +GIV+ E  T  ++P                        
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----------------------YW 252
Query: 395 EVVDKTLLSGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVT---RLLKIRD 449
           E+ +  ++     GF       C  +I  L M+C  +   +R    DIV+   +L++  D
Sbjct: 253 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312
Query: 450 TL 451
           +L
Sbjct: 313 SL 314

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 22  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 81  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 136
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 197 SDVWSFGILLTEIVTHGR 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 75  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   +E    ++ F  +  VMK I+HPNLV+++
Sbjct: 263 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL---EKK 376
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH +L   + L+ E+ +  ++DF                          E     + S
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 437 IKSDVWAFGVLLWEIAT 453

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVF-HQECARALKSFE-AQCEVMKSIRHPNLVKVISS 260
           IG GS+G V++ R RD G  VA+K F   E    +K     +  ++K ++HPNLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR---LNIMIDAT-STLEYLYFGHTTP 316
                   LV EY        C ++    LD +QR    +++   T  TL+ + F H   
Sbjct: 71  FRRKRRLHLVFEY--------CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIY 355
            IH D+KP ++L+ +  V  L DF  G    ++  SD Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDF--GFARLLTGPSDYY 159

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 41/216 (18%)
Query: 192 PSQATLR-RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALK---SFEAQCEVM 246
           PS  + R  L  ++G G    V+ AR LR   +VAVKV   + AR       F  + +  
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 247 KSIRHPNLVKVISSCSNDD----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            ++ HP +V V  +   +        +V+EY+   +L + +++   M    + + ++ DA
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADA 125
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              L    F H   IIH D+KP ++++       + DF                      
Sbjct: 126 CQALN---FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                 E      V  RSD+Y  G VL E  T + P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           + + +G G +G VY    +   + VAVK   +E    ++ F  +  VMK I+HPNLV+++
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTT 315
             C+ +    ++ E+M  G+L +  Y   C       + ++  AT   S +EYL      
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKK 337
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
             IH +L   + L+ E+ +  ++DF                          E     + S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 350 TRSDIYGYGIVLMETFT 366
            +SD++ +G++L E  T
Sbjct: 398 IKSDVWAFGVLLWEIAT 414

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 41/216 (18%)
Query: 192 PSQATLR-RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALK---SFEAQCEVM 246
           PS  + R  L  ++G G    V+ AR LR   +VAVKV   + AR       F  + +  
Sbjct: 24  PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 83
Query: 247 KSIRHPNLVKVISSCSNDD----FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            ++ HP +V V  +   +        +V+EY+   +L + +++   M    + + ++ DA
Sbjct: 84  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADA 142
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              L    F H   IIH D+KP ++++       + DF                      
Sbjct: 143 CQALN---FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                 E      V  RSD+Y  G VL E  T + P
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 42/208 (20%)
Query: 195 ATLRRLSNLIGMGSFGSVYRARL-----RDGIEVAVK---VFHQECARALKSFEAQCEVM 246
           A+  ++  +IG G FG V   RL     RD + VA+K   V + E  R  + F  +  +M
Sbjct: 42  ASCIKIERVIGAGEFGEVCSGRLKLPGKRD-VAVAIKTLKVGYTEKQR--RDFLCEASIM 98
Query: 247 KSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL 306
               HPN+V +    +      +V+E+M  G+L+  L        + Q + ++    + +
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGM 158
Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE------------YGMEG-------- 346
            YL        +H DL   ++L++ ++V  +SDF             Y   G        
Sbjct: 159 RYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWT 215
Query: 347 --------QVSTRSDIYGYGIVLMETFT 366
                   + ++ SD++ YGIV+ E  +
Sbjct: 216 APEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 65/146 (44%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+     +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 100 VKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 155
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 156 KGIIHRDLKPENILLNEDMHIQITDF 181

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 8/146 (5%)
Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +   AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       +   R     +  S LEYL   H 
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL---HG 148
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             IIH DLKP ++LL+EDM   ++DF
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 56/146 (38%), Gaps = 15/146 (10%)
Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS 64
            D S N L G +  +IG++  +  +NL  N++S  +P  +G L  L  L L+ NKLD   
Sbjct: 634 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD--- 690
Query: 65  LEILNLSNNEIYGLIPTXXXXXXXXXXXXXXFNKLEGEILRGGPFVNFTAMSFKGNEPLC 124
                       G IP                N L G I   G F  F    F  N  LC
Sbjct: 691 ------------GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 738
Query: 125 GSPNLQVPPCKLNKPGKHQKSRKNML 150
           G P  +  P   +    HQ+S    L
Sbjct: 739 GYPLPRCDPSNADGYAHHQRSHGRRL 764

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 187 NDGILPSQATLRRLSNLIGMGSFGSVY---RARLRDGIE--VAVKVFHQECARALKS-FE 240
           +D  +  +  L+++ +L G G FG V         DG    VAVK   + C   L+S ++
Sbjct: 1   SDPTVFHKRYLKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ 59
Query: 241 AQCEVMKSIRHPNLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNI 298
            + E+++++ H ++VK    C +   K+  LV+EY+P GSL + L      L       +
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-----AQL 114
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           ++ A    E + + H    IH  L   +VLLD D +  + DF
Sbjct: 115 LLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDF 156

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 196

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 196

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 196

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 54  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 168
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 169 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 14/152 (9%)
Query: 197 LRRLSNLIGMGSFGSVY---RARLRDGIE--VAVKVFHQECARALKS-FEAQCEVMKSIR 250
           L+++ +L G G FG V         DG    VAVK   + C   L+S ++ + E+++++ 
Sbjct: 10  LKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 251 HPNLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
           H ++VK    C +   K+  LV+EY+P GSL + L      L       +++ A    E 
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-----AQLLLFAQQICEG 123
Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           + + H    IH  L   +VLLD D +  + DF
Sbjct: 124 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDF 155

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISS 260
           +G G+F  V R   +  G+E A K+ + +   AR  +  E +  + + ++HPN+V++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              + F  LV + +  G     L+      + +   +        LE + + H+  I+H 
Sbjct: 97  IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHR 152
Query: 321 DLKPISVLL---DEDMVAHLSDFEYGMEGQVSTRSDIYGYG 358
           +LKP ++LL    +     L+DF  G+  +V+     +G+ 
Sbjct: 153 NLKPENLLLASKAKGAAVKLADF--GLAIEVNDSEAWHGFA 191

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 16/170 (9%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 26  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G + + L       +   R       
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQI 143
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
             T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 144 VLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 188

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 26  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 140
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 141 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 188

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 196

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 16/170 (9%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G + + L       +   R       
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQI 150
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
             T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 151 VLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVKVIS 259
           IG GSFG V   + +  G   A+K+  ++    LK  E    +  +++++  P LVK+  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS---TLEYLYFGHTTP 316
           S  ++    +V+EY+P G +    +S    +  F   +    A     T EYL   H+  
Sbjct: 109 SFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYL---HSLD 161
Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
           +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADF--GFAKRVKGRT 195

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 196

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 19  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 77
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 133
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 134 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 181

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVIS 259
           L+G GS+G V + R +D G  VA+K F +     +    A  E+  +K +RH NLV ++ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 260 SCSNDDFKALVLEYMPKGSLENC-LYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            C       LV E++    L++  L+ +     + Q+    I     +  + F H+  II
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----INGIGFCHSHNII 146
Query: 319 HCDLKPISVLLDEDMVAHLSDFEYG 343
           H D+KP ++L+ +  V  L DF + 
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFA 171

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 196

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 8/147 (5%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G GS+GSVY+A  ++ G  VA+K    E    L+    +  +M+    P++VK   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
            +    +V+EY   GS+ + +      L   +   I+      LEYL+F      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVS 349
           K  ++LL+ +  A L+DF  G+ GQ++
Sbjct: 152 KAGNILLNTEGHAKLADF--GVAGQLT 176

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 187 NDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVM 246
           + G++P  +   +L  +   G FG V++A+L +   VAVK+F  +  ++ +S E +    
Sbjct: 8   SSGLVPRGSL--QLLEIKARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFST 63
Query: 247 KSIRHPNLVKVISS---CSNDDFK-ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             ++H NL++ I++    SN + +  L+  +  KGSL + L  +    +  +  ++    
Sbjct: 64  PGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWN--ELCHVAETM 121
Query: 303 TSTLEYLYF--------GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------- 344
           +  L YL+         GH   I H D K  +VLL  D+ A L+DF   +          
Sbjct: 122 SRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD 181
Query: 345 -EGQVSTRS---------------------DIYGYGIVLMETFTRKKPTD 372
             GQV TR                      D+Y  G+VL E  +R K  D
Sbjct: 182 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 189 GILPSQATLR-------RLSNLIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR       R   ++G G+FG+VY+   + DG    I VA+KV  +  + +A
Sbjct: 3   GAAPNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA 62
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM  +  P + +++  C     + LV + MP G L + +  +   L     
Sbjct: 63  NKEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDL 121
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 122 LNWCMQIAKGMSYL---EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 345 EG----------------QVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
           +G                + + +SD++ YG+ + E  T   KP D +   E+
Sbjct: 179 DGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 186 SNDGILPSQATLRRLSNLIGMGSFGSVY---RARLRDGIE--VAVKVFHQECARALKS-F 239
           ++D  +  +  L+++ +L G G FG V         DG    VAVK    +C    +S +
Sbjct: 5   ASDPTVFHKRYLKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGW 63
Query: 240 EAQCEVMKSIRHPNLVKVISSCSNDDFKAL--VLEYMPKGSLENCLYSSTCMLDIFQRLN 297
           + + ++++++ H +++K    C +   K+L  V+EY+P GSL + L   +  L       
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL-----AQ 118
Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +++ A    E + + H+   IH +L   +VLLD D +  + DF
Sbjct: 119 LLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDF 161

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 8/144 (5%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCE---VMKSIRHPNLVKVIS 259
           +G GSFG V+  R R +G   A+KV  +E    LK  E   +   ++  + HP ++++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           +  +     ++++Y+  G L + L  S    +   +     +    LEYL   H+  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYL---HSKDIIY 129
Query: 320 CDLKPISVLLDEDMVAHLSDFEYG 343
            DLKP ++LLD++    ++DF + 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFA 153

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISS 260
           +G G+F  V R   +  G+E A K+ + +   AR  +  E +  + + ++HPN+V++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              + F  LV + +  G     L+      + +   +        LE + + H+  I+H 
Sbjct: 74  IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 321 DLKPISVLL---DEDMVAHLSDFEYGMEGQVSTRSDIYGYG 358
           +LKP ++LL    +     L+DF  G+  +V+     +G+ 
Sbjct: 130 NLKPENLLLASKAKGAAVKLADF--GLAIEVNDSEAWHGFA 168

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISSC 261
           +G G++G VY+A+   G  VA+K    +         A  E+  +K + HPN+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
            ++    LV E+M K  L+  L  +   L   Q   I I     L  +   H   I+H D
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           LKP ++L++ D    L+DF       +  RS  Y + +V +
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTL 183

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISS 260
           +G G+F  V R   +  G+E A K+ + +   AR  +  E +  + + ++HPN+V++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              + F  LV + +  G     L+      + +   +        LE + + H+  I+H 
Sbjct: 74  IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 321 DLKPISVLL---DEDMVAHLSDFEYGMEGQVSTRSDIYGYG 358
           +LKP ++LL    +     L+DF  G+  +V+     +G+ 
Sbjct: 130 NLKPENLLLASKAKGAAVKLADF--GLAIEVNDSEAWHGFA 168

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 84/203 (41%), Gaps = 38/203 (18%)
Query: 199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQ-ECARALKSFEAQCEVMKSIRHPN 253
           ++  +IG G FG V    L+      I VA+K        +  + F ++  +M    HPN
Sbjct: 36  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 95
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++ +    +      ++ E+M  GSL++ L  +     + Q + ++    + ++YL    
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---A 152
Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF---------------EYGMEGQVSTR------- 351
               +H DL   ++L++ ++V  +SDF                  + G++  R       
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 352 --------SDIYGYGIVLMETFT 366
                   SD++ YGIV+ E  +
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISS 260
           +G G+F  V R   +  G+E A K+ + +   AR  +  E +  + + ++HPN+V++  S
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              + F  LV + +  G     L+      + +   +        LE + + H+  I+H 
Sbjct: 73  IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHR 128
Query: 321 DLKPISVLL---DEDMVAHLSDFEYGMEGQVSTRSDIYGYG 358
           +LKP ++LL    +     L+DF  G+  +V+     +G+ 
Sbjct: 129 NLKPENLLLASKAKGAAVKLADF--GLAIEVNDSEAWHGFA 167

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 8/161 (4%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISSC 261
           +G G++G VY+A+   G  VA+K    +         A  E+  +K + HPN+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
            ++    LV E+M K  L+  L  +   L   Q   I I     L  +   H   I+H D
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           LKP ++L++ D    L+DF       +  RS  Y + +V +
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTL 183

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 64/130 (49%), Gaps = 2/130 (1%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPNLVKVISSC 261
           +G G+FG V+    R  G+E  +K  +++ ++  ++  EA+ EV+KS+ HPN++K+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
            +     +V+E    G L   + S+           +       +  L + H+  ++H D
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKD 149
Query: 322 LKPISVLLDE 331
           LKP ++L  +
Sbjct: 150 LKPENILFQD 159

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 20  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 78
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 134
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+DE     ++DF  G   +V  R+
Sbjct: 135 AQIVLTFEYL---HSLDLIYRDLKPENLLIDEQGYIQVTDF--GFAKRVKGRT 182

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q   +A K+ E Q  +M+ + H N+V++  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKNRELQ--IMRKLDHCNIVRLRY 80
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYF 311
              SS    D  +  LVL+Y+P+       + S     L +      M     +L Y+  
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI-- 138
Query: 312 GHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
            H+  I H D+KP ++LLD D  V  L DF
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIRTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             + +++  P LVK+  S  ++    +VLEY P G +    +S    +  F   +    A
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIKVADF--GFAKRVKGRT 196

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G+  +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIQVTDF--GLAKRVKGRT 195

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q   +A K+ E Q  +M+ + H N+V++  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKNRELQ--IMRKLDHCNIVRLRY 80
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYF 311
              SS    D  +  LVL+Y+P+       + S     L +      M     +L Y+  
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI-- 138
Query: 312 GHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
            H+  I H D+KP ++LLD D  V  L DF
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 186 SNDGILPSQATLRRLSNLIGMGSFGSVY---RARLRDGIE--VAVKVFHQECARALKS-F 239
           ++D  +  +  L+++ +L G G FG V         DG    VAVK    +C    +S +
Sbjct: 5   ASDPTVFHKRYLKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGW 63
Query: 240 EAQCEVMKSIRHPNLVKVISSCSNDDFKAL--VLEYMPKGSLENCLYSSTCMLDIFQRLN 297
           + + ++++++ H +++K    C +   K+L  V+EY+P GSL + L   +  L       
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL-----AQ 118
Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +++ A    E + + H    IH +L   +VLLD D +  + DF
Sbjct: 119 LLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDF 161

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 45/236 (19%)
Query: 186 SNDGILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA 233
           S  G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  +
Sbjct: 2   SPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 61
Query: 234 -RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI 292
            +A K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +  
Sbjct: 62  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGS 120
Query: 293 FQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------E 341
              LN  +     + YL       ++H DL   +VL+       ++DF           E
Sbjct: 121 QYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177
Query: 342 YGMEGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           Y  EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 178 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G+  +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIKVTDF--GLAKRVKGRT 195

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIKVTDF--GFAKRVKGRT 196

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q   +A K+ E Q  +M+ + H N+V++  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKNRELQ--IMRKLDHCNIVRLRY 80
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P        + S     +  I+ +L  M     +L Y+ 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 138
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 139 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 32/198 (16%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G  G V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 16  KLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID-ATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +    I   +N ++D A    E + F      
Sbjct: 75  AVVTQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 352 SDIYGYGIVLMETFTRKK 369
           SD++ +GI+L E  T  +
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISS 260
           +G G+F  V R  ++  G E A K+ + +   AR  +  E +  + + ++HPN+V++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            S + F  LV + +  G     L+      + +   +        LE +   H   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 321 DLKPISVLL---DEDMVAHLSDFEYGMEGQ 347
           DLKP ++LL    +     L+DF   +E Q
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQ 157

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIKVTDF--GFAKRVKGRT 195

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIKVTDF--GFAKRVKGRT 195

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR + +   +A+KV  +   E          + E+   +RHPN++++ +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LE+ P+G L   L       D  +    M +    L Y    H   +IH
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYC---HERKVIH 138
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++L+       ++DF + +      R  + G
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCG 175

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 194 QATLRR---LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI- 249
           Q T+ R   L   IG G FG V+R + R G EVAVK+F    +R  +S+  + E+ +++ 
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVM 92
Query: 250 -RHPNLVKVISSCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS 304
            RH N++  I++ + D+       LV +Y   GSL + L   T  ++    + + +   S
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS 150
Query: 305 TLEYLYF----GHTTP-IIHCDLKPISVLLDEDMVAHLSDF 340
            L +L+         P I H DLK  ++L+ ++    ++D 
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G FG+VY AR + +   +A+KV  +   E          + E+   +RHPN++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              +     L+LE+ P+G L   L       D  +    M +    L Y    H   +IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYC---HERKVIH 137
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYG 356
            D+KP ++L+       ++DF + +      R  + G
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCG 174

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 194 QATLRR---LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI- 249
           Q T+ R   L   IG G FG V+R + R G EVAVK+F    +R  +S+  + E+ +++ 
Sbjct: 24  QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVM 79
Query: 250 -RHPNLVKVISSCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS 304
            RH N++  I++ + D+       LV +Y   GSL + L   T  ++    + + +   S
Sbjct: 80  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS 137
Query: 305 TLEYLYF----GHTTP-IIHCDLKPISVLLDEDMVAHLSDF 340
            L +L+         P I H DLK  ++L+ ++    ++D 
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 178

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 16/170 (9%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 28  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 86
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G + + L       +   R       
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQI 145
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
             T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 146 VLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 190

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 19/141 (13%)
Query: 200 LSNLIGMGSFGSVYRA-----RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL 254
           L N IG GS+G V  A     R+R   +   K F ++  R    F+ + E+MKS+ HPN+
Sbjct: 30  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHPNI 85
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYF 311
           +++  +  ++    LV+E    G     L+       +F+  +   IM D  S + Y   
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYC-- 139
Query: 312 GHTTPIIHCDLKPISVLLDED 332
            H   + H DLKP + L   D
Sbjct: 140 -HKLNVAHRDLKPENFLFLTD 159

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 2   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYL 120
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 121 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 178 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 38/222 (17%)
Query: 187 NDGILPSQATLRRLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQECA-RALKSFEA 241
            D ++P +  +     +IG G FG VY     D     I+ A+K   +    + +++F  
Sbjct: 12  KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR 71
Query: 242 QCEVMKSIRHPNLVKVIS-SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMI 300
           +  +M+ + HPN++ +I      +    ++L YM  G L   + S      +   ++  +
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------EY--------- 342
                +EYL        +H DL   + +LDE     ++DF         EY         
Sbjct: 132 QVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 343 -------GMEG----QVSTRSDIYGYGIVLMETFTRKKPTDR 373
                   +E     + +T+SD++ +G++L E  TR  P  R
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISS 260
           +G G+F  V R  ++  G E A K+ + +   AR  +  E +  + + ++HPN+V++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            S + F  LV + +  G     L+      + +   +        LE +   H   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 321 DLKPISVLL---DEDMVAHLSDFEYGMEGQ 347
           DLKP ++LL    +     L+DF   +E Q
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQ 157

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 19/141 (13%)
Query: 200 LSNLIGMGSFGSVYRA-----RLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL 254
           L N IG GS+G V  A     R+R   +   K F ++  R    F+ + E+MKS+ HPN+
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHPNI 68
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYF 311
           +++  +  ++    LV+E    G     L+       +F+  +   IM D  S + Y   
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYC-- 122
Query: 312 GHTTPIIHCDLKPISVLLDED 332
            H   + H DLKP + L   D
Sbjct: 123 -HKLNVAHRDLKPENFLFLTD 142

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 3   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 122 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 4   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 123 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI--RHPNLVKV 257
           L   IG G FG V+R + R G EVAVK+F    +R  +S+  + E+ +++  RH N++  
Sbjct: 13  LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 68
Query: 258 ISSCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-- 311
           I++ + D+       LV +Y   GSL + L   T  ++    + + +   S L +L+   
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEI 126
Query: 312 --GHTTP-IIHCDLKPISVLLDEDMVAHLSDF 340
                 P I H DLK  ++L+ ++    ++D 
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 158

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 34  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 196

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 3   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 122 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI--RHPNLVKV 257
           L   IG G FG V+R + R G EVAVK+F    +R  +S+  + E+ +++  RH N++  
Sbjct: 10  LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 65
Query: 258 ISSCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-- 311
           I++ + D+       LV +Y   GSL + L   T  ++    + + +   S L +L+   
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEI 123
Query: 312 --GHTTP-IIHCDLKPISVLLDEDMVAHLSDF 340
                 P I H DLK  ++L+ ++    ++D 
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 155

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 16/170 (9%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 54  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G + + L       +   R       
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQI 171
Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
             T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 172 VLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 3   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 122 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 2   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 120
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 121 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 178 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI--RHPNLVKV 257
           L   IG G FG V+R + R G EVAVK+F    +R  +S+  + E+ +++  RH N++  
Sbjct: 8   LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 63
Query: 258 ISSCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-- 311
           I++ + D+       LV +Y   GSL + L   T  ++    + + +   S L +L+   
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEI 121
Query: 312 --GHTTP-IIHCDLKPISVLLDEDMVAHLSDF 340
                 P I H DLK  ++L+ ++    ++D 
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 153

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI--RHPNLVKV 257
           L   IG G FG V+R + R G EVAVK+F    +R  +S+  + E+ +++  RH N++  
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 62
Query: 258 ISSCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-- 311
           I++ + D+       LV +Y   GSL + L   T  ++    + + +   S L +L+   
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEI 120
Query: 312 --GHTTP-IIHCDLKPISVLLDEDMVAHLSDF 340
                 P I H DLK  ++L+ ++    ++D 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 88
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 146
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 147 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 175

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 92
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 150
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 151 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 179

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 99
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 157
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 158 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 186

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 92
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 150
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 151 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 179

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 80
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYF 311
              SS    D  +  LVL+Y+P+       + S     L +      M     +L Y+  
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI-- 138
Query: 312 GHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
            H+  I H D+KP ++LLD D  V  L DF
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 114
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 172
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 173 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 201

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 80
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 138
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 139 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 159
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 217
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 218 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 246

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 93
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 151
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 152 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 180

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 118
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 176
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 177 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 205

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 81
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 139
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 140 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 168

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 80
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 138
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 139 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 84
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 142
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 143 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 171

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 38/204 (18%)
Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH---QECARALKSFEAQCEVMKSIRHPNL 254
           ++ + +G G   +VY A      I+VA+K      +E    LK FE +      + H N+
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           V +I     DD   LV+EY+   +L   +  S   L +   +N        L+ +   H 
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINF---TNQILDGIKHAHD 129
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS---------------------- 352
             I+H D+KP ++L+D +    L  F++G+   +S  S                      
Sbjct: 130 MRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 353 ------DIYGYGIVLMETFTRKKP 370
                 DIY  GIVL E    + P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 85
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 143
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 144 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 172

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 80
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYF 311
              SS    D  +  LVL+Y+P+       + S     L +      M     +L Y+  
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI-- 138
Query: 312 GHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
            H+  I H D+KP ++LLD D  V  L DF
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 54  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 168
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG 343
                T EYL   H+  +I+ DLKP ++L+D+     ++DF + 
Sbjct: 169 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 108
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 166
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 167 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 195

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 116
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 174
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 175 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 203

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 85/172 (49%), Gaps = 25/172 (14%)
Query: 198 RRLSNL--IGMGSFGSV---YRARLRDGIEVAVKVFH---QECARALKSFEAQCEVMKSI 249
           +RL  L  +G G++GSV   Y ARLR   +VAVK      Q    A +++  +  ++K +
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHL 84
Query: 250 RHPNLVKVIS----SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           +H N++ ++     + S +DF  + L     G+  N +  S  + D  + +  ++     
Sbjct: 85  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD--EHVQFLV--YQL 140
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
           L  L + H+  IIH DLKP +V ++ED    + DF      +  M G V+TR
Sbjct: 141 LRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR 192

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 19/151 (12%)
Query: 201 SNLIGMGSFGSVYRARLRDGIE-VAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV-- 257
           + +IG GSFG VY+A+L D  E VA+K   Q+  +  K+ E Q  +M+ + H N+V++  
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQ--IMRKLDHCNIVRLRY 114
Query: 258 --ISSCSNDD--FKALVLEYMPKGSLENCLYSSTC---MLDIFQRLNIMIDATSTLEYLY 310
              SS    D  +  LVL+Y+P+       + S     +  I+ +L  M     +L Y+ 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 172
Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             H+  I H D+KP ++LLD D  V  L DF
Sbjct: 173 --HSFGICHRDIKPQNLLLDPDTAVLKLCDF 201

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 192 PSQATLR-----RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA---Q 242
           PSQ T +     R+  L G GSFG V   + ++ G   A+K+  ++    LK  E    +
Sbjct: 33  PSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLIIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 45/230 (19%)
Query: 192 PSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RALKS 238
           P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A K 
Sbjct: 8   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 67
Query: 239 FEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI 298
              +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     LN 
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 126
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEGQ 347
            +     + YL       ++H DL   +VL+       ++DF           EY  EG 
Sbjct: 127 CVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 348 ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
                            + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYL 119
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 3   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 122 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 45/239 (18%)
Query: 183 LDVSNDGILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQ 230
           L     G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +
Sbjct: 20  LYFQGSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 79
Query: 231 ECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM 289
             + +A K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      
Sbjct: 80  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN 138
Query: 290 LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------- 340
           +     LN  +     + YL       ++H DL   +VL+       ++DF         
Sbjct: 139 IGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 195
Query: 341 --EYGMEGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
             EY  EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 196 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 33  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P LVK+  S  ++    +V+EY+  G +    +S    +  F   +    A
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYA 147
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++L+D+     ++DF  G   +V  R+
Sbjct: 148 AQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDF--GFAKRVKGRT 195

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P L K+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIKVTDF--GFAKRVKGRT 196

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 31/160 (19%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQ---------ECARALKSFEAQCEVMKSI 249
           +S  +G G+ G V  A  R   + VA+K+  +         E   AL + E + E++K +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEILKKL 72
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRLNIMIDAT 303
            HP ++K+ +    +D+  +VLE M  G L         L  +TC L  +Q L       
Sbjct: 73  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 124
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 125 LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P L K+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIKVTDF--GFAKRVKGRT 196

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 31/160 (19%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQ---------ECARALKSFEAQCEVMKSI 249
           +S  +G G+ G V  A  R   + VA+K+  +         E   AL + E + E++K +
Sbjct: 13  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEILKKL 71
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRLNIMIDAT 303
            HP ++K+ +    +D+  +VLE M  G L         L  +TC L  +Q L       
Sbjct: 72  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 123
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 124 LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 160

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 8   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 127 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 22/173 (12%)
Query: 192 PSQAT-----LRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---Q 242
           P+Q T       R+  L G GSFG V   + +  G   A+K+  ++    LK  E    +
Sbjct: 34  PAQNTAHLDQFERIKTL-GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 243 CEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
             +++++  P L K+  S  ++    +V+EY P G +    +S    +  F   +    A
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYA 148
Query: 303 TS---TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
                T EYL   H+  +I+ DLKP ++++D+     ++DF  G   +V  R+
Sbjct: 149 AQIVLTFEYL---HSLDLIYRDLKPENLMIDQQGYIKVTDF--GFAKRVKGRT 196

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 31/160 (19%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQ---------ECARALKSFEAQCEVMKSI 249
           +S  +G G+ G V  A  R   + VA+K+  +         E   AL + E + E++K +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEILKKL 72
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRLNIMIDAT 303
            HP ++K+ +    +D+  +VLE M  G L         L  +TC L  +Q L       
Sbjct: 73  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 124
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 125 LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 4   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 123 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 4   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 123 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 3   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 122 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 31/160 (19%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQ---------ECARALKSFEAQCEVMKSI 249
           +S  +G G+ G V  A  R   + VA+K+  +         E   AL + E + E++K +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEILKKL 72
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRLNIMIDAT 303
            HP ++K+ +    +D+  +VLE M  G L         L  +TC L  +Q L       
Sbjct: 73  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 124
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 125 LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 8   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 127 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 183
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 31/160 (19%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQ---------ECARALKSFEAQCEVMKSI 249
           +S  +G G+ G V  A  R   + VA+K+  +         E   AL + E + E++K +
Sbjct: 20  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEILKKL 78
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRLNIMIDAT 303
            HP ++K+ +    +D+  +VLE M  G L         L  +TC L  +Q L       
Sbjct: 79  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 130
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 131 LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 167

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 7   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 66
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 67  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 125
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 126 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 183 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/203 (20%), Positives = 83/203 (40%), Gaps = 38/203 (18%)
Query: 199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQ-ECARALKSFEAQCEVMKSIRHPN 253
           ++  +IG G FG V    L+      I VA+K        +  + F ++  +M    HPN
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++ +    +      ++ E+M  GSL++ L  +     + Q + ++    + ++YL    
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---A 126
Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF---------------EYGMEGQVSTR------- 351
               +H  L   ++L++ ++V  +SDF                  + G++  R       
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 352 --------SDIYGYGIVLMETFT 366
                   SD++ YGIV+ E  +
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 4   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 123 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 26/169 (15%)
Query: 203 LIGMGSFGSVYRAR--LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP-------- 252
           ++G G+FG V +AR  L        K+ H E    L +  ++  ++ S+ H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 253 -----NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATST 305
                N VK +++        + +EY   G+L + ++S       D + RL   I     
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI----- 125
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
           LE L + H+  IIH DLKP+++ +DE     + DF  G+   V    DI
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF--GLAKNVHRSLDI 172

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 176
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 187 NDGILPSQATLRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECARALKSFEA 241
            D  +  +  L+ +S L G G+FGSV   R        G  VAVK          + F+ 
Sbjct: 2   QDPTIFEERHLKYISQL-GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 242 QCEVMKSIRHPNLVKV--ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIM 299
           + +++K++    +VK   +S         LV+EY+P G          C+ D  QR    
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG----------CLRDFLQRHRAR 110
Query: 300 IDATSTLEYL--------YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------E 341
           +DA+  L Y         Y G +   +H DL   ++L++ +    ++DF          +
Sbjct: 111 LDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 169
Query: 342 YGM---EGQ---------------VSTRSDIYGYGIVLMETFT 366
           Y +    GQ                S +SD++ +G+VL E FT
Sbjct: 170 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 14/174 (8%)
Query: 204 IGMGSFGSVYRARLRDGIEV-AVKVFH-QECAR--ALKSFEAQCEVMKSIRHPNLVKVIS 259
           IG GSFG V   +  D  ++ A+K  + Q+C     +++   + ++M+ + HP LV +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           S  +++   +V++ +  G L   L  +    +   +L  + +    L+YL       IIH
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALDYL---QNQRIIH 138
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGM----EGQVSTRSDIYGYGIVLMETFTRKK 369
            D+KP ++LLDE    H++DF        E Q++T +    Y  +  E F+ +K
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY--MAPEMFSSRK 190

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 55/227 (24%)
Query: 183 LDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECARALK 237
           L    D  +  +  L+ +S L G G+FGSV   R        G  VAVK          +
Sbjct: 11  LYACQDPTIFEERHLKYISQL-GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR 69
Query: 238 SFEAQCEVMKSIRHPNLVKV--ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            F+ + +++K++    +VK   +S         LV+EY+P G          C+ D  QR
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG----------CLRDFLQR 119
Query: 296 LNIMIDATSTLEYL--------YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------- 340
               +DA+  L Y         Y G +   +H DL   ++L++ +    ++DF       
Sbjct: 120 HRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178
Query: 341 ---EYGM---EGQ---------------VSTRSDIYGYGIVLMETFT 366
              +Y +    GQ                S +SD++ +G+VL E FT
Sbjct: 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA--QCEVMKSIRHPNLVKVISS 260
           IG G+FG V++AR R  G +VA+K    E  +      A  + ++++ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 261 CSN-----DDFKALVL------EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
           C       +  KA +       E+   G L N L   T  L   +R+  M+     L  L
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFT--LSEIKRVMQML-----LNGL 138
Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           Y+ H   I+H D+K  +VL+  D V  L+DF
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADF 169

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 55/223 (24%)
Query: 187 NDGILPSQATLRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECARALKSFEA 241
            D  +  +  L+ +S L G G+FGSV   R        G  VAVK          + F+ 
Sbjct: 3   QDPTIFEERHLKYISQL-GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 61
Query: 242 QCEVMKSIRHPNLVKV--ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIM 299
           + +++K++    +VK   +S         LV+EY+P G          C+ D  QR    
Sbjct: 62  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG----------CLRDFLQRHRAR 111
Query: 300 IDATSTLEYL--------YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------E 341
           +DA+  L Y         Y G +   +H DL   ++L++ +    ++DF          +
Sbjct: 112 LDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 170
Query: 342 YGM---EGQ---------------VSTRSDIYGYGIVLMETFT 366
           Y +    GQ                S +SD++ +G+VL E FT
Sbjct: 171 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 9/141 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G GSFG V  A     G +VA+K+ +++    +      E +   ++ +RHP+++K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              + D   +V+EY       N L+      D              +  + + H   I+H
Sbjct: 82  VIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVH 136
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLKP ++LLDE +   ++DF
Sbjct: 137 RDLKPENLLLDEHLNVKIADF 157

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 9/142 (6%)
Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQ-ECARALKS--FEAQCEVMKSIRHPNLVKVI 258
           +IG G+FG V   R +   +V A+K+  + E  +   S  F  + ++M     P +V++ 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +  +D +  +V+EYMP G L N + +     D+ ++      A   L  L   H+  +I
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLA-LDAIHSMGLI 196
Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           H D+KP ++LLD+     L+DF
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADF 218

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 9/141 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G GSFG V  A     G +VA+K+ +++    +      E +   ++ +RHP+++K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              + D   +V+EY       N L+      D              +  + + H   I+H
Sbjct: 81  VIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVH 135
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLKP ++LLDE +   ++DF
Sbjct: 136 RDLKPENLLLDEHLNVKIADF 156

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 120/311 (38%), Gaps = 91/311 (29%)
Query: 200 LSNLIGMGSFGSVYRA-----RLRDG-IEVAVKVFHQECARA-LKSFEAQCEVMKSIRHP 252
           L   +G G FG V +A     + R G   VAVK+  +  + + L+   ++  V+K + HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM----------------------- 289
           +++K+  +CS D    L++EY   GSL   L  S  +                       
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 290 LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----- 344
           L +   ++     +  ++YL       ++H DL   ++L+ E     +SDF         
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 345 -------EGQV---------------STRSDIYGYGIVLMETFTRKK------PTDRMFV 376
                  +G++               +T+SD++ +G++L E  T         P +R+F 
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF- 262
Query: 377 EELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN 436
                     NLL         KT    E+      + C   +  L ++C  + P+KR  
Sbjct: 263 ----------NLL---------KTGHRMER-----PDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 437 AKDIVTRLLKI 447
             DI   L K+
Sbjct: 299 FADISKDLEKM 309

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 9/142 (6%)
Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQ-ECARALKS--FEAQCEVMKSIRHPNLVKVI 258
           +IG G+FG V   R +   +V A+K+  + E  +   S  F  + ++M     P +V++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +  +D +  +V+EYMP G L N + +     D+ ++      A   L  L   H+   I
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLA-LDAIHSMGFI 190
Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           H D+KP ++LLD+     L+DF
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADF 212

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 120/311 (38%), Gaps = 91/311 (29%)
Query: 200 LSNLIGMGSFGSVYRA-----RLRDG-IEVAVKVFHQECARA-LKSFEAQCEVMKSIRHP 252
           L   +G G FG V +A     + R G   VAVK+  +  + + L+   ++  V+K + HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM----------------------- 289
           +++K+  +CS D    L++EY   GSL   L  S  +                       
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 290 LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----- 344
           L +   ++     +  ++YL       ++H DL   ++L+ E     +SDF         
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 345 -------EGQV---------------STRSDIYGYGIVLMETFTRKK------PTDRMFV 376
                  +G++               +T+SD++ +G++L E  T         P +R+F 
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF- 262
Query: 377 EELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN 436
                     NLL         KT    E+      + C   +  L ++C  + P+KR  
Sbjct: 263 ----------NLL---------KTGHRMER-----PDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 437 AKDIVTRLLKI 447
             DI   L K+
Sbjct: 299 FADISKDLEKM 309

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 9/141 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G GSFG V  A     G +VA+K+ +++    +      E +   ++ +RHP+++K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              + D   +V+EY       N L+      D              +  + + H   I+H
Sbjct: 72  VIKSKDEIIMVIEYA-----GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVH 126
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLKP ++LLDE +   ++DF
Sbjct: 127 RDLKPENLLLDEHLNVKIADF 147

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 9/141 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G GSFG V  A     G +VA+K+ +++    +      E +   ++ +RHP+++K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
              + D   +V+EY       N L+      D              +  + + H   I+H
Sbjct: 76  VIKSKDEIIMVIEYA-----GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVH 130
Query: 320 CDLKPISVLLDEDMVAHLSDF 340
            DLKP ++LLDE +   ++DF
Sbjct: 131 RDLKPENLLLDEHLNVKIADF 151

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 9/142 (6%)
Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQ-ECARALKS--FEAQCEVMKSIRHPNLVKVI 258
           +IG G+FG V   R +   +V A+K+  + E  +   S  F  + ++M     P +V++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +  +D +  +V+EYMP G L N + +     D+ ++      A   L  L   H+   I
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLA-LDAIHSMGFI 195
Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           H D+KP ++LLD+     L+DF
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADF 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 45/230 (19%)
Query: 192 PSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RALKS 238
           P+QA LR L         ++G G+FG+VY+   + +G    I VA+K   +  + +A K 
Sbjct: 14  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 73
Query: 239 FEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI 298
              +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     LN 
Sbjct: 74  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 132
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEGQ 347
            +     + YL       ++H DL   +VL+       ++DF           EY  EG 
Sbjct: 133 CVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 348 ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
                            + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 191 LPSQAT---LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQ-ECARALKSFEAQCEV 245
           + SQ+T   L  LS+++G G+  +V+R R +  G   A+KVF+     R +     + EV
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 246 MKSIRHPNLVKV--ISSCSNDDFKALVLEYMPKGSLENCLY--SSTCMLDIFQRLNIMID 301
           +K + H N+VK+  I   +    K L++E+ P GSL   L   S+   L   + L ++ D
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDF 340
               + +L       I+H ++KP +++     D   V  L+DF
Sbjct: 121 VVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 9/142 (6%)
Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQ-ECARALKS--FEAQCEVMKSIRHPNLVKVI 258
           +IG G+FG V   R +   +V A+K+  + E  +   S  F  + ++M     P +V++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +  +D +  +V+EYMP G L N + +     D+ ++      A   L  L   H+   I
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLA-LDAIHSMGFI 195
Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           H D+KP ++LLD+     L+DF
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADF 217

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 54/206 (26%)
Query: 204 IGMGSFGSVYRARL-----RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV- 257
           +G G+FGSV   R        G  VAVK          + F+ + +++K++    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 258 -ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL------- 309
            +S         LV+EY+P G          C+ D  QR    +DA+  L Y        
Sbjct: 75  GVSYGPGRPELRLVMEYLPSG----------CLRDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 310 -YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------EGQ-------- 347
            Y G +   +H DL   ++L++ +    ++DF                  GQ        
Sbjct: 125 EYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 348 -------VSTRSDIYGYGIVLMETFT 366
                   S +SD++ +G+VL E FT
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 51/130 (39%), Gaps = 18/130 (13%)
Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS 64
            D S N L G +  +IG++  +  +NL  N++S  +P  +G L  L  L L+ NKLD   
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD--- 693
Query: 65  LEILNLSNNEIYGLIPTXXXXXXXXXXXXXXFNKLEGEILRGGPFVNFTAMSFKGNEPLC 124
                       G IP                N L G I   G F  F    F  N  LC
Sbjct: 694 ------------GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741
Query: 125 GSPNLQVPPC 134
           G P   +P C
Sbjct: 742 GYP---LPRC 748

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 120/311 (38%), Gaps = 91/311 (29%)
Query: 200 LSNLIGMGSFGSVYRA-----RLRDG-IEVAVKVFHQECARA-LKSFEAQCEVMKSIRHP 252
           L   +G G FG V +A     + R G   VAVK+  +  + + L+   ++  V+K + HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM----------------------- 289
           +++K+  +CS D    L++EY   GSL   L  S  +                       
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 290 LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----- 344
           L +   ++     +  ++YL       ++H DL   ++L+ E     +SDF         
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 345 -------EGQV---------------STRSDIYGYGIVLMETFTRKK------PTDRMFV 376
                  +G++               +T+SD++ +G++L E  T         P +R+F 
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF- 262
Query: 377 EELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN 436
                     NLL         KT    E+      + C   +  L ++C  + P+KR  
Sbjct: 263 ----------NLL---------KTGHRMER-----PDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 437 AKDIVTRLLKI 447
             DI   L K+
Sbjct: 299 FADISKDLEKM 309

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 31/160 (19%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQ---------ECARALKSFEAQCEVMKSI 249
           +S  +G G+ G V  A  R   + VA+++  +         E   AL + E + E++K +
Sbjct: 153 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL-NVETEIEILKKL 211
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRLNIMIDAT 303
            HP ++K+ +    +D+  +VLE M  G L         L  +TC L  +Q L       
Sbjct: 212 NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 263
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 264 LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 300

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 31/160 (19%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFHQ---------ECARALKSFEAQCEVMKSI 249
           +S  +G G+ G V  A  R   + VA+++  +         E   AL + E + E++K +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL-NVETEIEILKKL 197
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRLNIMIDAT 303
            HP ++K+ +    +D+  +VLE M  G L         L  +TC L  +Q L       
Sbjct: 198 NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 249
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 250 LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 286

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 29/155 (18%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA--QCEVMKSIRHPNLVKVISS 260
           IG G+FG V++AR R  G +VA+K    E  +      A  + ++++ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 261 CSND---------------DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           C                  DF     E+   G L N L   T  L   +R+  M+     
Sbjct: 86  CRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFT--LSEIKRVMQML----- 134
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L  LY+ H   I+H D+K  +VL+  D V  L+DF
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 169

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 29/155 (18%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA--QCEVMKSIRHPNLVKVISS 260
           IG G+FG V++AR R  G +VA+K    E  +      A  + ++++ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 261 CSND---------------DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           C                  DF     E+   G L N L   T  L   +R+  M+     
Sbjct: 86  CRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFT--LSEIKRVMQML----- 134
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L  LY+ H   I+H D+K  +VL+  D V  L+DF
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 169

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 197 LRRLSNLIGMGSFGSVY---RARLRDGIE--VAVKVFHQECARALKS-FEAQCEVMKSIR 250
           L+++ +L G G FG V         DG    VAVK    +     +S ++ + ++++++ 
Sbjct: 33  LKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 251 HPNLVKVISSCSNDDFKAL--VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
           H +++K    C +    +L  V+EY+P GSL + L   +  L       +++ A    E 
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL-----AQLLLFAQQICEG 146
Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           + + H    IH DL   +VLLD D +  + DF
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G+E A K   +  +RA +        E +  +++ + HPN++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG---- 312
           +     N     L+LE +  G L + L     + +         +ATS ++ +  G    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 313 HTTPIIHCDLKPISV-LLDEDM-VAHLSDFEYGMEGQV 348
           HT  I H DLKP ++ LLD+++ + H+   ++G+  ++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++  G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 8   GEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+++ MP G L + +      +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 127 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 183 LDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRD-GIEVAVKV-----FHQECARAL 236
           LD+++D +L     +  L  +IG G+F  V R   R+ G + AVK+     F      + 
Sbjct: 13  LDMADDDVLFED--VYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 237 KSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL 296
           +  + +  +   ++HP++V+++ + S+D    +V E+M    L  C        +I +R 
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--C-------FEIVKRA 121
Query: 297 N---IMIDATST------LEYLYFGHTTPIIHCDLKPISVLL 329
           +   +  +A ++      LE L + H   IIH D+KP +VLL
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLL 163

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 29/155 (18%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEA--QCEVMKSIRHPNLVKVISS 260
           IG G+FG V++AR R  G +VA+K    E  +      A  + ++++ ++H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 261 CSND---------------DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           C                  DF     E+   G L N L   T  L   +R+  M+     
Sbjct: 85  CRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFT--LSEIKRVMQML----- 133
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L  LY+ H   I+H D+K  +VL+  D V  L+DF
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 199 RLSNLIGMGSFGSVYR-ARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLV 255
           +L   IG G+F  V R  +L  G E A K+ + +   AR  +  E +  + + ++H N+V
Sbjct: 7   QLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIV 66
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           ++  S S + F  LV + +  G     L+      + +   +        LE +   H  
Sbjct: 67  RLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 316 PIIHCDLKPISVLLD---EDMVAHLSDFEYGMEGQ 347
            ++H DLKP ++LL    +     L+DF   +E Q
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 157

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI---RHPNLVKVIS 259
           IG G FGSV++   R DG   A+K   +  A ++    A  EV       +H ++V+  S
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTP 316
           + + DD   +  EY   GSL + +  +  ++  F+     ++++     L Y+   H+  
Sbjct: 79  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMS 135
Query: 317 IIHCDLKPISVLL 329
           ++H D+KP ++ +
Sbjct: 136 LVHMDIKPSNIFI 148

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 98/237 (41%), Gaps = 45/237 (18%)
Query: 185 VSNDGILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDGIEVAVKVFHQE----- 231
           ++  G  P+QA LR L         ++G G+FG+VY+   + +G +V + V   E     
Sbjct: 31  LTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT 90
Query: 232 CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD 291
             +A K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      + 
Sbjct: 91  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 149
Query: 292 IFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------- 340
               LN  +     + YL       ++H DL   +VL+       ++DF           
Sbjct: 150 SQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 206
Query: 341 EYGMEGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EY  EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 207 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 16/161 (9%)
Query: 193 SQAT---LRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQ-ECARALKSFEAQCEVMK 247
           SQ+T   L  LS+++G G+  +V+R R +  G   A+KVF+     R +     + EV+K
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 248 SIRHPNLVKV--ISSCSNDDFKALVLEYMPKGSLENCLY--SSTCMLDIFQRLNIMIDAT 303
            + H N+VK+  I   +    K L++E+ P GSL   L   S+   L   + L ++ D  
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDF 340
             + +L       I+H ++KP +++     D   V  L+DF
Sbjct: 123 GGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI---RHPNLVKVIS 259
           IG G FGSV++   R DG   A+K   +  A ++    A  EV       +H ++V+  S
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 74
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTP 316
           + + DD   +  EY   GSL + +  +  ++  F+     ++++     L Y+   H+  
Sbjct: 75  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMS 131
Query: 317 IIHCDLKPISVLL 329
           ++H D+KP ++ +
Sbjct: 132 LVHMDIKPSNIFI 144

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 25/172 (14%)
Query: 198 RRLSNL--IGMGSFGSV---YRARLRDGIEVAVKVFH---QECARALKSFEAQCEVMKSI 249
           +RL  L  +G G++GSV   Y ARLR   +VAVK      Q    A +++  +  ++K +
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHL 84
Query: 250 RHPNLVKVIS----SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           +H N++ ++     + S +DF  + L     G+  N +     + D  + +  ++     
Sbjct: 85  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLV--YQL 140
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
           L  L + H+  IIH DLKP +V ++ED    + DF      +  M G V+TR
Sbjct: 141 LRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR 192

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI---RHPNLVKVIS 259
           IG G FGSV++   R DG   A+K   +  A ++    A  EV       +H ++V+  S
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTP 316
           + + DD   +  EY   GSL + +  +  ++  F+     ++++     L Y+   H+  
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMS 133
Query: 317 IIHCDLKPISVLL 329
           ++H D+KP ++ +
Sbjct: 134 LVHMDIKPSNIFI 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI---RHPNLVKVIS 259
           IG G FGSV++   R DG   A+K   +  A ++    A  EV       +H ++V+  S
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL---NIMIDATSTLEYLYFGHTTP 316
           + + DD   +  EY   GSL + +  +  ++  F+     ++++     L Y+   H+  
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMS 133
Query: 317 IIHCDLKPISVLL 329
           ++H D+KP ++ +
Sbjct: 134 LVHMDIKPSNIFI 146

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 76/301 (25%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVN 386
                        E   +   + +SD++ +G+++ E FT    P   + VEEL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------ 269
Query: 387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
                       K L  G +    A   C   +  +  +C   +P +R   K +V  L +
Sbjct: 270 ------------KLLKEGHRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 447 I 447
           I
Sbjct: 316 I 316

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++  + H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 76/301 (25%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVN 386
                        E   +   + +SD++ +G+++ E FT    P   + VEEL       
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------ 269
Query: 387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
                       K L  G +    A   C   +  +  +C   +P +R   K +V  L +
Sbjct: 270 ------------KLLKEGHRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 447 I 447
           I
Sbjct: 316 I 316

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           HPN++++  +   + F  LV + M KG L + L     + +   R  IM    + LE + 
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIM---RALLEVIC 125
Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY 342
             H   I+H DLKP ++LLD+DM   L+DF +
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 157

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++  + H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 25/172 (14%)
Query: 198 RRLSNL--IGMGSFGSV---YRARLRDGIEVAVKVFH---QECARALKSFEAQCEVMKSI 249
           +RL  L  +G G++GSV   Y ARLR   +VAVK      Q    A +++  +  ++K +
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHL 76
Query: 250 RHPNLVKVIS----SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           +H N++ ++     + S +DF  + L     G+  N +     + D  + +  ++     
Sbjct: 77  KHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLV--YQL 132
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
           L  L + H+  IIH DLKP +V ++ED    + DF      +  M G V+TR
Sbjct: 133 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR 184

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           HPN++++  +   + F  LV + M KG L + L     + +   R  IM    + LE + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIM---RALLEVIC 138
Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY 342
             H   I+H DLKP ++LLD+DM   L+DF +
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++  G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 8   GEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 127 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           HPN++++  +   + F  LV + M KG L + L     + +   R  IM    + LE + 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KIM---RALLEVIC 138
Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY 342
             H   I+H DLKP ++LLD+DM   L+DF +
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 53/268 (19%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 77  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 132
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 133 DVKPSNILVNSRGEIKLCDF--GVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIW 190
Query: 356 GYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQC 415
             G+ L+E    + P   M + EL   D++ N  P  L   V     S E + FV K   
Sbjct: 191 SMGLSLVEMAVGRYPRPPMAIFELL--DYIVNEPPPKLPSAV----FSLEFQDFVNK--- 241
Query: 416 VLSILGLAMECAMELPEKRINAKDIVTR 443
                     C ++ P +R + K ++  
Sbjct: 242 ----------CLIKNPAERADLKQLMVH 259

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 48/234 (20%)
Query: 182 GLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEA 241
           G+D+  +  L  Q+   +L  +   G FG V++A+L +   VAVK+F  +  ++ ++ E 
Sbjct: 11  GVDLGTEN-LYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EY 67
Query: 242 QCEVMKSIRHPNLVKVISS----CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN 297
           +   +  ++H N+++ I +     S D    L+  +  KGSL + L ++    +  +  +
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWN--ELCH 125
Query: 298 IMIDATSTLEYLYF-------GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----- 345
           I       L YL+        GH   I H D+K  +VLL  ++ A ++DF   ++     
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 346 ------GQVSTRS---------------------DIYGYGIVLMETFTRKKPTD 372
                 GQV TR                      D+Y  G+VL E  +R    D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 45/236 (19%)
Query: 204 IGMGSFG-SVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISS 260
           IG GSFG ++      DG +  +K  +     + +  E++ EV  + +++HPN+V+   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 261 CSNDDFKALVLEYMPKGSL-------ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
              +    +V++Y   G L       +  L+    +LD F ++ + +            H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---------H 142
Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF-------------------EYGMEGQV------ 348
              I+H D+K  ++ L +D    L DF                    Y +  ++      
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 349 STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD-KTLLS 403
           + +SDI+  G VL E  T K   +   ++ L LK    +  P+SL    D ++L+S
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 71/156 (45%), Gaps = 10/156 (6%)
Query: 196 TLRRLSNLIGMGSFGSVYR-ARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHP 252
           ++ +L   +G G+F  V R  ++  G E A K+ + +   AR  +  E +  + + ++HP
Sbjct: 22  SMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 81
Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           N+V++  S S +    L+ + +  G     L+      + +   +        LE +   
Sbjct: 82  NIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 313 HTTPIIHCDLKPISVLLDEDM---VAHLSDFEYGME 345
           H   ++H DLKP ++LL   +      L+DF   +E
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE 173

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 172 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 195
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 162 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 308 YLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 182 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 45/233 (19%)
Query: 189 GILPSQATLRRLSN-------LIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RA 235
           G  P+QA LR L         ++  G+FG+VY+   + +G    I VA+K   +  + +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 236 LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR 295
            K    +  VM S+ +P++ +++  C     + L+ + MP G L + +      +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM 344
           LN  +     + YL       ++H DL   +VL+       ++DF           EY  
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 345 EGQ----------------VSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           EG                  + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 147 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + ++LE M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 172
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 173 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECARA-LKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +     L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 26/162 (16%)
Query: 183 LDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRD-GIEVAVKV-----FHQECARAL 236
           LD+++D +L     +  L  +IG G F  V R   R+ G + AVK+     F      + 
Sbjct: 13  LDMADDDVLFED--VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 237 KSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL 296
           +  + +  +   ++HP++V+++ + S+D    +V E+M    L           +I +R 
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRA 121
Query: 297 N---IMIDATST------LEYLYFGHTTPIIHCDLKPISVLL 329
           +   +  +A ++      LE L + H   IIH D+KP  VLL
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLL 163

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/129 (23%), Positives = 62/129 (48%), Gaps = 4/129 (3%)
Query: 201 SNLIGMGSFGSVYR-ARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           + ++G G FG V++      G+++A K+      +  +  + +  VM  + H NL+++  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           +  + +   LV+EY+  G L + +   +  L     L+ ++      E +   H   I+H
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNL---TELDTILFMKQICEGIRHMHQMYILH 210
Query: 320 CDLKPISVL 328
            DLKP ++L
Sbjct: 211 LDLKPENIL 219

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 192 PSQATLRRLSNLIGMGSFGSVYRARLRDGIEV----AVKVFHQECARALKSFEAQCE--V 245
           PSQ  L ++   +G GSFG V+  +   G +     A+KV  +   +       + E  +
Sbjct: 23  PSQFELLKV---LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 246 MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           +  + HP +VK+  +   +    L+L+++  G L   L S   M         + +    
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALA 138
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L++L   H+  II+ DLKP ++LLDE+    L+DF
Sbjct: 139 LDHL---HSLGIIYRDLKPENILLDEEGHIKLTDF 170

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG V++    R    VA+K+   +E    ++  + +  V+     P + K   S 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
             D    +++EY+  GS  + L      LD  Q   I+ +    L+YL   H+   IH D
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYL---HSEKKIHRD 149
Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVS 349
           +K  +VLL E     L+DF  G+ GQ++
Sbjct: 150 IKAANVLLSEHGEVKLADF--GVAGQLT 175

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 192 PSQATLRRLSNLIGMGSFGSVYRARLRDGIEV----AVKVFHQECARALKSFEAQCE--V 245
           PSQ  L ++   +G GSFG V+  +   G +     A+KV  +   +       + E  +
Sbjct: 24  PSQFELLKV---LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 246 MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           +  + HP +VK+  +   +    L+L+++  G L   L S   M         + +    
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALA 139
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L++L   H+  II+ DLKP ++LLDE+    L+DF
Sbjct: 140 LDHL---HSLGIIYRDLKPENILLDEEGHIKLTDF 171

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 26/169 (15%)
Query: 203 LIGMGSFGSVYRAR--LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP-------- 252
           ++G G+FG V +AR  L        K+ H E    L +  ++  ++ S+ H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 253 -----NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATST 305
                N VK +++        + +EY    +L + ++S       D + RL   I     
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI----- 125
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
           LE L + H+  IIH DLKP+++ +DE     + DF  G+   V    DI
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF--GLAKNVHRSLDI 172

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG V++    R    VA+K+   +E    ++  + +  V+     P + K   S 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
             D    +++EY+  GS  + L      LD  Q   I+ +    L+YL   H+   IH D
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYL---HSEKKIHRD 129
Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVS 349
           +K  +VLL E     L+DF  G+ GQ++
Sbjct: 130 IKAANVLLSEHGEVKLADF--GVAGQLT 155

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG V++    R    VA+K+   +E    ++  + +  V+     P + K   S 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
             D    +++EY+  GS  + L      LD  Q   I+ +    L+YL   H+   IH D
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYL---HSEKKIHRD 129
Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVS 349
           +K  +VLL E     L+DF  G+ GQ++
Sbjct: 130 IKAANVLLSEHGEVKLADF--GVAGQLT 155

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 37/196 (18%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  AR +  G +VAVK+      +  +    +  +M+  +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTTPIIH 319
             +   +++E++  G+L + +           RLN    AT   + L+ L + H   +IH
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQV--------RLNEEQIATVCEAVLQALAYLHAQGVIH 164
Query: 320 CDLKPISVLLDEDMVAHLSDF-------------------EYGMEGQVSTRS------DI 354
            D+K  S+LL  D    LSDF                    Y M  +V +RS      DI
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDI 224
Query: 355 YGYGIVLMETFTRKKP 370
           +  GI+++E    + P
Sbjct: 225 WSLGIMVIEMVDGEPP 240

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 90/219 (41%), Gaps = 55/219 (25%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT 366
                        E   +   + +SD++ +G+++ E FT
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/301 (21%), Positives = 116/301 (38%), Gaps = 76/301 (25%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 85
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 146 LVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVN 386
                        E   +   + +SD++ +G+++ E FT    P   + VEEL       
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF------ 256
Query: 387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
                       K L  G +    A   C   +  +  +C   +P +R   K +V  L +
Sbjct: 257 ------------KLLKEGHRMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 302
Query: 447 I 447
           I
Sbjct: 303 I 303

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           IG GSFG V++    R    VA+K+   +E    ++  + +  V+     P + K   S 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
             D    +++EY+  GS  + L      LD  Q   I+ +    L+YL   H+   IH D
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYL---HSEKKIHRD 144
Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQVS 349
           +K  +VLL E     L+DF  G+ GQ++
Sbjct: 145 IKAANVLLSEHGEVKLADF--GVAGQLT 170

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 51/216 (23%)
Query: 199 RLSNLIGMGSFGSVYRARL-----RDGI-EVAVKVF----HQECARALKSFEAQCEVMKS 248
           +    +G G+FG V  A        D + +VAVK+     H +   AL S   + ++M  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSH 105
Query: 249 I-RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           + +H N+V ++ +C++     ++ EY   G L N L   + +L+      I     ST +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 308 YLYFGHTTP----------IIHCDLKPISVLLDEDMVAHLSDF----------EYGMEGQ 347
            L+F                IH D+   +VLL    VA + DF           Y ++G 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 348 V-----------------STRSDIYGYGIVLMETFT 366
                             + +SD++ YGI+L E F+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 87
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 148 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 257

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              ++   LV E++   S++   +     L       I       L+ L F H+  ++H 
Sbjct: 74  IHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 131 DLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 170

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + +++E M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 90
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++EY  KG+L   L           Y    + +       
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 151 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 260

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 192 PSQATLRRLSNLIGMGSFGSVYRARLRDGIEV----AVKVFHQECARALKSFEAQCE--V 245
           PSQ  L ++   +G GSFG V+  +   G +     A+KV  +   +       + E  +
Sbjct: 23  PSQFELLKV---LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 246 MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           +  + HP +VK+  +   +    L+L+++  G L   L S   M         + +    
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALA 138
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L++L   H+  II+ DLKP ++LLDE+    L+DF
Sbjct: 139 LDHL---HSLGIIYRDLKPENILLDEEGHIKLTDF 170

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 53/211 (25%)
Query: 200 LSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQECARALKSFEAQCE--VMKSIRHPN 253
           L  ++G GSFG V+  R       G   A+KV  +   +       + E  ++  + HP 
Sbjct: 32  LLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMI-----DATSTLEY 308
           +VK+  +   +    L+L+++  G             D+F RL+  +     D    L  
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 138
Query: 309 LYFG----HTTPIIHCDLKPISVLLDEDMVAHLSDF------------EYGMEGQV---- 348
           L  G    H+  II+ DLKP ++LLDE+    L+DF             Y   G V    
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198
Query: 349 ---------STRSDIYGYGIVLMETFTRKKP 370
                    S  +D + YG+++ E  T   P
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 52/209 (24%)
Query: 204 IGMGSFGSVYRARLR------DGIEVAVKVFHQECARALK-SFEAQCEVMKSIRHPNLVK 256
           +G G+FG VY  ++         ++VAVK   + C+   +  F  +  ++    H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDATSTLE 307
            I        + +++E M  G L++ L          SS  MLD+   L++  D     +
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 308 YLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF------------------------ 340
           YL   H    IH D+   + LL       VA + DF                        
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFT 366
              E  MEG  ++++D + +G++L E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              ++   LV E++   S++   +     L       I       L+ L F H+  ++H 
Sbjct: 72  IHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 129 DLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 168

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 77/177 (43%), Gaps = 38/177 (21%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST--------------- 305
              ++   LV E++                   Q L   +DA++                
Sbjct: 74  IHTENKLYLVFEFL------------------HQDLKTFMDASALTGIPLPLIKSYLFQL 115
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           L+ L F H+  ++H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 170

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 50/230 (21%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGS------------LENCLYSSTCMLDIFQRLN 297
           +H N++ ++ +C+ D    +++EY  KG+            LE C   S    +     +
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------- 340
           ++  A      + +  +   IH DL   +VL+ ED V  ++DF                 
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 341 ----------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                     E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 50/230 (21%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGS------------LENCLYSSTCMLDIFQRLN 297
           +H N++ ++ +C+ D    +++EY  KG+            LE C   S    +     +
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------- 340
           ++  A      + +  +   IH DL   +VL+ ED V  ++DF                 
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 341 ----------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                     E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKV 257
           L  +IG G+   V  A      E VA+K  + ++C  ++     + + M    HPN+V  
Sbjct: 14  LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 73
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYS-------STCMLDIFQRLNIMIDATSTLEYLY 310
            +S    D   LV++ +  GS+ + +          + +LD      I+ +    LEYL 
Sbjct: 74  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL- 132
Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
             H    IH D+K  ++LL ED    ++DF  G+   ++T  DI
Sbjct: 133 --HKNGQIHRDVKAGNILLGEDGSVQIADF--GVSAFLATGGDI 172

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YSSTCMLDIFQRL---- 296
           +H N++ ++ +C+ D    +++EY  KG+L   L         YS     +  ++L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 297 --NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
             +        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIE-VAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVKV 257
           L  +IG G+   V  A      E VA+K  + ++C  ++     + + M    HPN+V  
Sbjct: 19  LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYS-------STCMLDIFQRLNIMIDATSTLEYLY 310
            +S    D   LV++ +  GS+ + +          + +LD      I+ +    LEYL 
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL- 137
Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
             H    IH D+K  ++LL ED    ++DF  G+   ++T  DI
Sbjct: 138 --HKNGQIHRDVKAGNILLGEDGSVQIADF--GVSAFLATGGDI 177

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              ++   LV E++   S++   +     L       I       L+ L F H+  ++H 
Sbjct: 74  IHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 170

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
              ++   LV E++   S++   +     L       I       L+ L F H+  ++H 
Sbjct: 73  IHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 169

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 78  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 131
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 174

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L++ + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 167

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 167

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YSSTCMLDIFQRL---- 296
           +H N++ ++ +C+ D    +++EY  KG+L   L         YS     +  ++L    
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 297 --NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
             +        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 253

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 77/177 (43%), Gaps = 38/177 (21%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST--------------- 305
              ++   LV E+                  + Q L   +DA++                
Sbjct: 70  IHTENKLYLVFEH------------------VHQDLKTFMDASALTGIPLPLIKSYLFQL 111
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           L+ L F H+  ++H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 166

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YSSTCMLDIFQRL---- 296
           +H N++ ++ +C+ D    +++EY  KG+L   L         YS     +  ++L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 297 --NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
             +        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 51/216 (23%)
Query: 199 RLSNLIGMGSFGSVYRARL-----RDGI-EVAVKVF----HQECARALKSFEAQCEVMKS 248
           +    +G G+FG V  A        D + +VAVK+     H +   AL S   + ++M  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSH 105
Query: 249 I-RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           + +H N+V ++ +C++     ++ EY   G L N L   + +L+      I     ST +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 308 YLYFGHTTP----------IIHCDLKPISVLLDEDMVAHLSDF----------EYGMEGQ 347
            L+F                IH D+   +VLL    VA + DF           Y ++G 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 348 V-----------------STRSDIYGYGIVLMETFT 366
                             + +SD++ YGI+L E F+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YSSTCMLDIFQRL---- 296
           +H N++ ++ +C+ D    +++EY  KG+L   L         YS     +  ++L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 297 --NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
             +        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YSSTCMLDIFQRL---- 296
           +H N++ ++ +C+ D    +++EY  KG+L   L         YS     +  ++L    
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 297 --NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
             +        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 250

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------YSSTCMLDIFQRL---- 296
           +H N++ ++ +C+ D    +++EY  KG+L   L         YS     +  ++L    
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 297 --NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
             +        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 254

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 204 IGMGSFGSVYR-ARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISS 260
           +G G+F  V R  +     E A K+ + +   AR  +  E +  + + ++HPN+V++  S
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            S + F  LV + +  G     L+      + +   +        LE +   H   I+H 
Sbjct: 99  ISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHR 154
Query: 321 DLKPISVLLD---EDMVAHLSDFEYGMEGQ 347
           DLKP ++LL    +     L+DF   +E Q
Sbjct: 155 DLKPENLLLASKCKGAAVKLADFGLAIEVQ 184

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKV 257
            L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    D    V+EY   G L   L       +   R     +  S LEYL   H+  +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           ++ D+K  +++LD+D    ++DF    EG
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEG 155

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRARL----RDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A      +D      +VAVK+   +   + L    ++ E+MK I 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL---------------YSSTCMLDIFQ 294
           +H N++ ++ +C+ D    +++EY  KG+L   L               ++    L    
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 295 RLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
            ++        +EYL    +   IH DL   +VL+ ED V  ++DF              
Sbjct: 152 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G++L E FT    P   + VEEL
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 78  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 131
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 132 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 174

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 75  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 128
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 171

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 167

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 127
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 170

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 166

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 127
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 170

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 169

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 167

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 168

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 127 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 169

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 167

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 75  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 128
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 129 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 171

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 202 NLIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLV 255
            ++G G+FG+VY+   + +G    I VA+K   +  + +A K    +  VM S+ +P++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           +++  C     + L+ + MP G L + +      +     LN  +     + YL      
Sbjct: 78  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL---EDR 133
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEGQ----------------V 348
            ++H DL   +VL+       ++DF           EY  EG                  
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 193
Query: 349 STRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 194 THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 166

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 166

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 168

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLSFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 167

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKV 257
            L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    D    V+EY   G L   L       +   R     +  S LEYL   H+  +
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDV 129
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           ++ D+K  +++LD+D    ++DF    EG
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCKEG 158

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKV 257
            L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    D    V+EY   G L   L       +   R     +  S LEYL   H+  +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           ++ D+K  +++LD+D    ++DF    EG
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEG 155

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 167

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 191 LPSQATLRRLSNLIGMGSFGSVYRARLR-DG-IEVAVKVFHQECARALKS-FEAQCEVMK 247
           +PS+A    +   IG GS+G   + R + DG I V  ++ +     A K    ++  +++
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 248 SIRHPNLVKVISSCSNDDFKAL--VLEYMPKGSLENCLYSST---CMLDIFQRLNIMIDA 302
            ++HPN+V+      +     L  V+EY   G L + +   T     LD    L +M   
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 303 TSTLEYLYF----GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           T  L+  +     GHT  ++H DLKP +V LD      L DF
Sbjct: 121 TLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDF 160

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 191 LPSQATLRRLSNLIGMGSFGSVYRARLR-DG-IEVAVKVFHQECARALKS-FEAQCEVMK 247
           +PS+A    +   IG GS+G   + R + DG I V  ++ +     A K    ++  +++
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 248 SIRHPNLVKVISSCSNDDFKAL--VLEYMPKGSLENCLYSST---CMLDIFQRLNIMIDA 302
            ++HPN+V+      +     L  V+EY   G L + +   T     LD    L +M   
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 303 TSTLEYLYF----GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           T  L+  +     GHT  ++H DLKP +V LD      L DF
Sbjct: 121 TLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDF 160

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKV 257
            L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    D    V+EY   G L   L       +   R     +  S LEYL   H+  +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           ++ D+K  +++LD+D    ++DF    EG
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEG 155

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKV 257
            L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    D    V+EY   G L   L       +   R     +  S LEYL   H+  +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           ++ D+K  +++LD+D    ++DF    EG
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEG 155

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 167

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 202 NLIGMGSFGSVYRA-RLRDG----IEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLV 255
            ++G G+FG+VY+   + +G    I VA+K   +  + +A K    +  VM S+ +P++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           +++  C     + L+ + MP G L + +      +     LN  +     + YL      
Sbjct: 75  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDR 130
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF-----------EYGMEGQ----------------V 348
            ++H DL   +VL+       ++DF           EY  EG                  
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 349 STRSDIYGYGIVLMETFT-RKKPTDRMFVEELS 380
           + +SD++ YG+ + E  T   KP D +   E+S
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKV 257
            L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    D    V+EY   G L   L       +   R     +  S LEYL   H+  +
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDV 131
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           ++ D+K  +++LD+D    ++DF    EG
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCKEG 160

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 166

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 127 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 169

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 191 LPSQATLRRLSNLIGMGSFGSVYRARLR-DG-IEVAVKVFHQECARALKS-FEAQCEVMK 247
           +PS+A    +   IG GS+G   + R + DG I V  ++ +     A K    ++  +++
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 248 SIRHPNLVKVISSCSNDDFKAL--VLEYMPKGSLENCLYSST---CMLDIFQRLNIMIDA 302
            ++HPN+V+      +     L  V+EY   G L + +   T     LD    L +M   
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 303 TSTLEYLYF----GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           T  L+  +     GHT  ++H DLKP +V LD      L DF
Sbjct: 121 TLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDF 160

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A +R  G  VAVK       +  +    +  +M+  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     + L+ L   H   +IH
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQGVIH 139
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 140 RDIKSDSILLTHDGRVKLSDF--GFCAQVS 167

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 126 LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 168

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 136 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 191
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 192 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 249
Query: 356 GYGIVLMETFTRKKPTDRMFVEELSL 381
             G+ L+E    + P      +EL L
Sbjct: 250 SMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKV 257
            L+G G+FG V   R +  G   A+K+  +E   A         +  V+++ RHP L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    D    V+EY   G L   L       +   R     +  S LEYL   H+  +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDV 126
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
           ++ D+K  +++LD+D    ++DF    EG
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEG 155

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 167

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 125
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 126 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 168

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G GSFG V+R + +  G + AVK    E  R  +     C  + S   P +V +  +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV--ACAGLSS---PRIVPLYGAVR 120
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
              +  + +E +  GSL   +    C+ +  + L  +  A   LEYL   HT  I+H D+
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYL---HTRRILHGDV 176
Query: 323 KPISVLLDEDMV-AHLSDFEYGM 344
           K  +VLL  D   A L DF + +
Sbjct: 177 KADNVLLSSDGSRAALCDFGHAL 199

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVKVI 258
           ++G GSFG V   + +  G E AVKV  +   +     E+   + +++K + HPN++K+ 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
               +  +  LV E    G L + + S     ++     I+    S + Y+   H   I+
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM---HKNKIV 172
Query: 319 HCDLKPISVLLD 330
           H DLKP ++LL+
Sbjct: 173 HRDLKPENLLLE 184

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++ Y  KG+L   L           Y    + +       
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVKVI 258
           ++G GSFG V   + +  G E AVKV  +   +     E+   + +++K + HPN++K+ 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
               +  +  LV E    G L + + S     ++     I+    S + Y+   H   I+
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM---HKNKIV 171
Query: 319 HCDLKPISVLLD 330
           H DLKP ++LL+
Sbjct: 172 HRDLKPENLLLE 183

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A  +  G +VAVK       +  +    +  +M+   H N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---STLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N    AT   S L  L + H   +IH
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIATVCLSVLRALSYLHNQGVIH 164
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 165 RDIKSDSILLTSDGRIKLSDF--GFCAQVS 192

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G GSFG V+R + +  G + AVK    E  R  +     C  + S   P +V +  +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV--ACAGLSS---PRIVPLYGAVR 136
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
              +  + +E +  GSL   +    C+ +  + L  +  A   LEYL   HT  I+H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYL---HTRRILHGDV 192
Query: 323 KPISVLLDED-MVAHLSDFEYGM 344
           K  +VLL  D   A L DF + +
Sbjct: 193 KADNVLLSSDGSRAALCDFGHAL 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A +R  G  VAVK       +  +    +  +M+  +H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     + L+ L   H   +IH
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQGVIH 143
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 144 RDIKSDSILLTHDGRVKLSDF--GFCAQVS 171

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 8/134 (5%)
Query: 201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVK 256
             ++G GSFG V   + +  G E AVKV  +   +     E+   + +++K + HPN++K
Sbjct: 37  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +     +  +  LV E    G L + + S     ++     I+    S + Y+   H   
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM---HKNK 152
Query: 317 IIHCDLKPISVLLD 330
           I+H DLKP ++LL+
Sbjct: 153 IVHRDLKPENLLLE 166

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +  G  VA+K      E      +   +  ++K + HPN+VK++  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 74  IHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 127
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTL 170

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A +R  G  VAVK       +  +    +  +M+  +H N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     + L+ L   H   +IH
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQGVIH 150
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 151 RDIKSDSILLTHDGRVKLSDF--GFCAQVS 178

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVKVI 258
           ++G GSFG V   + +  G E AVKV  +   +     E+   + +++K + HPN++K+ 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
               +  +  LV E    G L + + S     ++     I+    S + Y+   H   I+
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM---HKNKIV 148
Query: 319 HCDLKPISVLLD 330
           H DLKP ++LL+
Sbjct: 149 HRDLKPENLLLE 160

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A +R  G  VAVK       +  +    +  +M+  +H N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     + L+ L   H   +IH
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQGVIH 148
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 149 RDIKSDSILLTHDGRVKLSDF--GFCAQVS 176

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G GSFG V+R + +  G + AVK    E  R  +     C  + S   P +V +  +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV--ACAGLSS---PRIVPLYGAVR 134
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
              +  + +E +  GSL   +    C+ +  + L  +  A   LEYL   HT  I+H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYL---HTRRILHGDV 190
Query: 323 KPISVLLDEDMV-AHLSDFEYGM 344
           K  +VLL  D   A L DF + +
Sbjct: 191 KADNVLLSSDGSRAALCDFGHAL 213

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/152 (20%), Positives = 62/152 (40%), Gaps = 4/152 (2%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG V+R   R  G   A K          ++   + + M  +RHP LV +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
           +D+   ++ E+M  G L   +      +   + +  M      L ++   H    +H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDL 281
Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
           KP +++        L   ++G+   +  +  +
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 13/151 (8%)
Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMK------SIRHPNLV 255
           ++G GSFG V  AR+++ G   AVKV  ++    L+  + +C + +      +  HP L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLT 87
Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           ++       D    V+E++  G L   +  S      F        A   +  L F H  
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK 143
Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEG 346
            II+ DLK  +VLLD +    L+DF    EG
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 56/233 (24%)
Query: 200 LSNLIGMGSFGSVYRA--------RLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSI- 249
           L   +G G+FG V  A        + ++ + VAVK+   +   + L    ++ E+MK I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------YSSTCMLDIFQRLNI 298
           +H N++ ++ +C+ D    +++ Y  KG+L   L           Y    + +       
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 299 MIDATSTL----EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
           ++  T  L    EYL    +   IH DL   +VL+ E+ V  ++DF              
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL 379
                        E   +   + +SD++ +G+++ E FT    P   + VEEL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 69/146 (47%), Gaps = 19/146 (13%)
Query: 204 IGMGSFGSVYRA-RLRDGIEVAVKVFHQECARALK---SFEAQCEVMKSIRHPNLVKVIS 259
           +G GSFG V  A   +   +VA+K   ++  +        E +   +K +RHP+++K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-----IFQRLNIMIDATSTLEYLYFGHT 314
             +      +V+EY   G L + +     M +      FQ++   I+         + H 
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE---------YCHR 126
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             I+H DLKP ++LLD+++   ++DF
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADF 152

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/152 (20%), Positives = 62/152 (40%), Gaps = 4/152 (2%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG V+R   R  G   A K          ++   + + M  +RHP LV +  +  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
           +D+   ++ E+M  G L   +      +   + +  M      L ++   H    +H DL
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDL 175
Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
           KP +++        L   ++G+   +  +  +
Sbjct: 176 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 207

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 156
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 157 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 214
Query: 356 GYGIVLMETFTRKKPTDRMFVEELSL 381
             G+ L+E    + P      +EL L
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G+E A K   +  +RA +        E +  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG---- 312
           +     N     L+LE +  G L + L     + +         +ATS ++ +  G    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--------EATSFIKQILDGVNYL 131
Query: 313 HTTPIIHCDLKPISV-LLDEDM-VAHLSDFEYGMEGQVS 349
           HT  I H DLKP ++ LLD+++ + H+   ++G+  ++ 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 204 IGMGSFGSVYR--ARLRDGIEV--AVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G++ +VY+  ++L D +     +++ H+E A      E    ++K ++H N+V +  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS--LLKDLKHANIVTLHD 67
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
               +    LV EY+ K   +   Y   C  +I    N+ +     L  L + H   ++H
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQ---YLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLH 123
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRS 352
            DLKP ++L++E     L+DF       + T++
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKT 156

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G+E A K   +  +RA +        E +  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG---- 312
           +     N     L+LE +  G L + L     + +         +ATS ++ +  G    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--------EATSFIKQILDGVNYL 131
Query: 313 HTTPIIHCDLKPISV-LLDEDM-VAHLSDFEYGMEGQVS 349
           HT  I H DLKP ++ LLD+++ + H+   ++G+  ++ 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A +R  G  VAVK       +  +    +  +M+  +H N+V++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     + L+ L   H   +IH
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQGVIH 193
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 194 RDIKSDSILLTHDGRVKLSDF--GFCAQVS 221

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 35/202 (17%)
Query: 197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNL 254
             R+S L G G+ G V + + R  G+ +A K+ H E   A+++    + +V+     P +
Sbjct: 18  FERISEL-GAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGH 313
           V    +  +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREKH 134
Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV------------------------- 348
              I+H D+KP ++L++      L DF  G+ GQ+                         
Sbjct: 135 Q--IMHRDVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMAPERLQGTHY 190
Query: 349 STRSDIYGYGIVLMETFTRKKP 370
           S +SDI+  G+ L+E    + P
Sbjct: 191 SVQSDIWSMGLSLVELAVGRYP 212

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 40/202 (19%)
Query: 199 RLSNL--IGMGSFGSVYRA-RLRDGIEVAVKVF---HQECARALKSFEAQCEVMKSIRHP 252
           R  NL  +G G++GSV  A   + G+ VAVK      Q    A +++  +  ++K ++H 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 253 NLVKVIS----SCSNDDFKALVL-EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           N++ ++     + S ++F  + L  ++    L N + S     D  Q L   I     L 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQI-----LR 136
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTRS--------- 352
            L + H+  IIH DLKP ++ ++ED    + DF      +  M G V+TR          
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLN 196
Query: 353 --------DIYGYGIVLMETFT 366
                   DI+  G ++ E  T
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLT 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G+E A K   +  +RA +        E +  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG---- 312
           +     N     L+LE +  G L + L     + +         +ATS ++ +  G    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--------EATSFIKQILDGVNYL 131
Query: 313 HTTPIIHCDLKPISV-LLDEDM-VAHLSDFEYGMEGQVS 349
           HT  I H DLKP ++ LLD+++ + H+   ++G+  ++ 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 129
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 130 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 356 GYGIVLMETFTRKKPTDRMFVEELSL 381
             G+ L+E    + P      +EL L
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G+E A K   +  +RA +        E +  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG---- 312
           +     N     L+LE +  G L + L     + +         +ATS ++ +  G    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--------EATSFIKQILDGVNYL 131
Query: 313 HTTPIIHCDLKPISV-LLDEDM-VAHLSDFEYGMEGQVS 349
           HT  I H DLKP ++ LLD+++ + H+   ++G+  ++ 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G+E A K   +  +RA +        E +  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG---- 312
           +     N     L+LE +  G L + L     + +         +ATS ++ +  G    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE--------EATSFIKQILDGVNYL 131
Query: 313 HTTPIIHCDLKPISV-LLDEDM-VAHLSDFEYGMEGQVS 349
           HT  I H DLKP ++ LLD+++ + H+   ++G+  ++ 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 67/159 (42%), Gaps = 19/159 (11%)
Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L  LIG G +G+VY+  L D   VAVKVF     +   + E     +  + H N+ + I
Sbjct: 16  KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFI 73
Query: 259 SSCSNDDFKA-------LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
               ++   A       LV+EY P GSL   L   T   D      +    T  L YL+ 
Sbjct: 74  --VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHT 129
Query: 312 -----GHTTPII-HCDLKPISVLLDEDMVAHLSDFEYGM 344
                 H  P I H DL   +VL+  D    +SDF   M
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 129
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 130 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 356 GYGIVLMETFTRKKPTDRMFVEELSL 381
             G+ L+E    + P      +EL L
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 129
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 130 HSLQIAHFDLKPENIML 146

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 129
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 130 HSLQIAHFDLKPENIML 146

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 129
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 130 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 356 GYGIVLMETFTRKKPTDRMFVEELSL 381
             G+ L+E    + P      +EL L
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 129
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 130 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 356 GYGIVLMETFTRKKPTDRMFVEELSL 381
             G+ L+E    + P      +EL L
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G GSFG V+R   +  G + AVK    E  RA +     C  + S   P +V +  +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELM--ACAGLTS---PRIVPLYGAVR 155
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
              +  + +E +  GSL   +    C+ +  + L  +  A   LEYL   H+  I+H D+
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYL---HSRRILHGDV 211
Query: 323 KPISVLLDEDMV-AHLSDFEYGM 344
           K  +VLL  D   A L DF + +
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAV 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G GSFG V+R   +  G + AVK    E  RA +     C  + S   P +V +  +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELM--ACAGLTS---PRIVPLYGAVR 136
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
              +  + +E +  GSL   +    C+ +  + L  +  A   LEYL   H+  I+H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYL---HSRRILHGDV 192
Query: 323 KPISVLLDEDMV-AHLSDFEYGM 344
           K  +VLL  D   A L DF + +
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAV 215

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 48/224 (21%)
Query: 189 GILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-RALK 237
           G +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R   
Sbjct: 1   GSVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 238 SFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-----I 292
            F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++      
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 293 FQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------- 344
              L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM       
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDIYET 178
Query: 345 ----------------------EGQVSTRSDIYGYGIVLMETFT 366
                                 +G  +T SD++ +G+VL E  T
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 24/145 (16%)
Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKV-----FHQECARALKSFEAQCEVMKSIRHPN 253
           L  +IG G F  V R   R+ G + AVK+     F      + +  + +  +   ++HP+
Sbjct: 30  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 89
Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATST----- 305
           +V+++ + S+D    +V E+M    L           +I +R +   +  +A ++     
Sbjct: 90  IVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQ 140
Query: 306 -LEYLYFGHTTPIIHCDLKPISVLL 329
            LE L + H   IIH D+KP  VLL
Sbjct: 141 ILEALRYCHDNNIIHRDVKPHCVLL 165

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLRDGIEVAV--KV-FHQECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +   EV    K+    E      +   +  ++K + HPN+VK++  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 124
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 167

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 204 IGMGSFGSVYRARLRDGIEVAV--KV-FHQECARALKSFEAQCEVMKSIRHPNLVKVISS 260
           IG G++G VY+AR +   EV    K+    E      +   +  ++K + HPN+VK++  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCM---LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
              ++   LV E++ +  L+  + +S      L + +     +     L+ L F H+  +
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL-----LQGLAFCHSHRV 123
Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLM 362
           +H DLKP ++L++ +    L+DF       V  R+  Y + +V +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 166

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNLVKVI 258
           ++G GSFG V   + +  G E AVKV  +   +     E+   + +++K + HPN+ K+ 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
               +  +  LV E    G L + + S       F  ++        L  + + H   I+
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYXHKNKIV 148
Query: 319 HCDLKPISVLLD 330
           H DLKP ++LL+
Sbjct: 149 HRDLKPENLLLE 160

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  A +R  G  VAVK       +  +    +  +M+  +H N+V++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEYLYFGHTTPIIH 319
             D   +V+E++  G+L + +  +        R+N   I     + L+ L   H   +IH
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIAAVCLAVLQALSVLHAQGVIH 270
Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            D+K  S+LL  D    LSDF  G   QVS
Sbjct: 271 RDIKSDSILLTHDGRVKLSDF--GFCAQVS 298

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 2   AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 61
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--- 291
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++   
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 292 --IFQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
                 L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM    
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDI 179
Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +G  +T SD++ +G+VL E  T
Sbjct: 180 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 200 LSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNL 254
           L+ ++G G FG VY         + I VAVK   ++C    K  F ++  +MK++ HP++
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+I     +    +++E  P G L + L  +   L +   +   +     + YL    +
Sbjct: 88  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ES 143
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
              +H D+   ++L+       L DF
Sbjct: 144 INCVHRDIAVRNILVASPECVKLGDF 169

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 18/141 (12%)
Query: 204 IGMGSFGSVYRARLRDG-IEVAVKVF---------HQECARALKSFEAQC----EVMKSI 249
           +G G++G V   + ++G  E A+KV          + +  + ++ F  +      ++KS+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            HPN++K+     +  +  LV E+   G L   + +     D     NIM    S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL 162
Query: 310 YFGHTTPIIHCDLKPISVLLD 330
              H   I+H D+KP ++LL+
Sbjct: 163 ---HKHNIVHRDIKPENILLE 180

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 5   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 64
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--- 291
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++   
Sbjct: 65  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 292 --IFQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
                 L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM    
Sbjct: 125 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDI 182
Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +G  +T SD++ +G+VL E  T
Sbjct: 183 XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 40/207 (19%)
Query: 200 LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-RALKSFEAQCEVMKSIRHP 252
           +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R    F  +  VMK     
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-----IFQRLNIMID-ATSTL 306
           ++V+++   S      +++E M +G L++ L S    ++         L+ MI  A    
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------------------- 340
           + + + +    +H DL   + ++ ED    + DF                          
Sbjct: 134 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 341 -EYGMEGQVSTRSDIYGYGIVLMETFT 366
            E   +G  +T SD++ +G+VL E  T
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 200 LSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNL 254
           L+ ++G G FG VY         + I VAVK   ++C    K  F ++  +MK++ HP++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+I     +    +++E  P G L + L  +   L +   +   +     + YL    +
Sbjct: 76  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ES 131
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
              +H D+   ++L+       L DF
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDF 157

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 52/206 (25%)
Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVK 256
           +G GSFG VY    RD I+      VAVK  ++  + R    F  +  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS------------STCMLDIFQRLNIMIDATS 304
           ++   S      +V+E M  G L++ L S               + ++ Q    + D  +
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------ 340
            L    F      +H DL   + ++  D    + DF                        
Sbjct: 145 YLNAKKF------VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLME 363
              E   +G  +T SD++ +G+VL E
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 62/137 (45%), Gaps = 19/137 (13%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALK------SFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G++ A K   +   ++ +        E +  ++K I+HPN++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL----YFG 312
           +     N     L+LE +  G L + L     + +         +AT  L+ +    Y+ 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 313 HTTPIIHCDLKPISVLL 329
           H+  I H DLKP +++L
Sbjct: 131 HSLQIAHFDLKPENIML 147

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 129
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 130 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 356 GYGIVLMETFTRKKP 370
             G+ L+E    + P
Sbjct: 188 SMGLSLVEMAVGRYP 202

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 52/206 (25%)
Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVK 256
           +G GSFG VY    RD I+      VAVK  ++  + R    F  +  VMK     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS------------STCMLDIFQRLNIMIDATS 304
           ++   S      +V+E M  G L++ L S               + ++ Q    + D  +
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------ 340
            L    F      +H DL   + ++  D    + DF                        
Sbjct: 142 YLNAKKF------VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLME 363
              E   +G  +T SD++ +G+VL E
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWE 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 200 LSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNL 254
           L+ ++G G FG VY         + I VAVK   ++C    K  F ++  +MK++ HP++
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+I     +    +++E  P G L + L  +   L +   +   +     + YL    +
Sbjct: 72  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ES 127
Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
              +H D+   ++L+       L DF
Sbjct: 128 INCVHRDIAVRNILVASPECVKLGDF 153

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 52/206 (25%)
Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVK 256
           +G GSFG VY    RD I+      VAVK  ++  + R    F  +  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS------------STCMLDIFQRLNIMIDATS 304
           ++   S      +V+E M  G L++ L S               + ++ Q    + D  +
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------ 340
            L    F      +H DL   + ++  D    + DF                        
Sbjct: 145 YLNAKKF------VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLME 363
              E   +G  +T SD++ +G+VL E
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--- 291
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++   
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 130
Query: 292 --IFQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
                 L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM    
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDI 188
Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +G  +T SD++ +G+VL E  T
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--- 291
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++   
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 292 --IFQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
                 L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM    
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDI 181
Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +G  +T SD++ +G+VL E  T
Sbjct: 182 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQE---CAR---ALKSFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G E A K   +     +R   + +  E +  +++ IRHPN++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCML--DIFQRLNIMIDATSTLEYLYFGHT 314
           +     N     L+LE +  G L + L     +   +  Q L  ++D       +++ H+
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG------VHYLHS 126
Query: 315 TPIIHCDLKPISVLL 329
             I H DLKP +++L
Sbjct: 127 KRIAHFDLKPENIML 141

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 191 LPSQATLRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFE-AQCEVMKS 248
           + S +  ++L  L G G++ +VY+   +  G+ VA+K    +      S    +  +MK 
Sbjct: 1   MSSSSQFKQLEKL-GNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE 59
Query: 249 IRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTC----------MLDIFQRLNI 298
           ++H N+V++      ++   LV E+M    L+  + S T           ++  FQ    
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ---- 114
Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
                  L+ L F H   I+H DLKP ++L+++     L DF
Sbjct: 115 ----WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF 152

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 52/206 (25%)
Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVK 256
           +G GSFG VY    RD I+      VAVK  ++  + R    F  +  VMK     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS------------STCMLDIFQRLNIMIDATS 304
           ++   S      +V+E M  G L++ L S               + ++ Q    + D  +
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------ 340
            L    F      +H DL   + ++  D    + DF                        
Sbjct: 144 YLNAKKF------VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLME 363
              E   +G  +T SD++ +G+VL E
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWE 223

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQE---CAR---ALKSFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G E A K   +     +R   + +  E +  +++ IRHPN++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCML--DIFQRLNIMIDATSTLEYLYFGHT 314
           +     N     L+LE +  G L + L     +   +  Q L  ++D       +++ H+
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG------VHYLHS 147
Query: 315 TPIIHCDLKPISVLL 329
             I H DLKP +++L
Sbjct: 148 KRIAHFDLKPENIML 162

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 5   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 64
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--- 291
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++   
Sbjct: 65  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 292 --IFQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
                 L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM    
Sbjct: 125 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDI 182
Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +G  +T SD++ +G+VL E  T
Sbjct: 183 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQE---CAR---ALKSFEAQCEVMKSIRHPNLVK 256
           +G G F  V + R +  G E A K   +     +R   + +  E +  +++ IRHPN++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCML--DIFQRLNIMIDATSTLEYLYFGHT 314
           +     N     L+LE +  G L + L     +   +  Q L  ++D       +++ H+
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG------VHYLHS 133
Query: 315 TPIIHCDLKPISVLL 329
             I H DLKP +++L
Sbjct: 134 KRIAHFDLKPENIML 148

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--- 291
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++   
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 292 --IFQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
                 L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM    
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDI 181
Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +G  +T SD++ +G+VL E  T
Sbjct: 182 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 19/137 (13%)
Query: 203 LIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR--ALKSFEAQCEVMKSIRHPNLVKVIS 259
           ++G GSFG V + + R    E AVKV ++  A+     +   + E++K + HPN++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIM-IDATSTLEYLYFG----H 313
                     +LE      +   LY+   + D I +R      DA   ++ ++ G    H
Sbjct: 89  ----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 314 TTPIIHCDLKPISVLLD 330
              I+H DLKP ++LL+
Sbjct: 139 KHNIVHRDLKPENILLE 155

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 199 RLSNL--IGMGSFGSVYRA-RLRDGIEVAVKVF---HQECARALKSFEAQCEVMKSIRHP 252
           R  NL  IG G++GSV  A   + G+ VAVK      Q    A +++  +  ++K ++H 
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 253 NLVKVIS----SCSNDDFKALVL-EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           N++ ++     + S ++F  + L  ++    L N +       D  Q L   I     L 
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 141
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
            L + H+  IIH DLKP ++ ++ED    + DF      +  M G V+TR
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 33  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 92
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--- 291
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    ++   
Sbjct: 93  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 152
Query: 292 --IFQRLNIMID-ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
                 L+ MI  A    + + + +    +H DL   + ++ ED    + DF  GM    
Sbjct: 153 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF--GMTRDI 210
Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +G  +T SD++ +G+VL E  T
Sbjct: 211 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 199 RLSNL--IGMGSFGSVYRA-RLRDGIEVAVKVF---HQECARALKSFEAQCEVMKSIRHP 252
           R  NL  +G G++GSV  A   + G+ VAVK      Q    A +++  +  ++K ++H 
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 253 NLVKVIS----SCSNDDFKALVL-EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           N++ ++     + S ++F  + L  ++    L N +       D  Q L   I     L 
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI-----LR 136
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
            L + H+  IIH DLKP ++ ++ED    + DF      +  M G V+TR
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 186

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 34/195 (17%)
Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V    + 
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
            +D   ++ +E+M  GSL+  L  +  + + I  +++I +     L YL   H   I+H 
Sbjct: 93  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHR 148
Query: 321 DLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIY 355
           D+KP ++L++      L DF  G+ GQ+                         S +SDI+
Sbjct: 149 DVKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 206
Query: 356 GYGIVLMETFTRKKP 370
             G+ L+E    + P
Sbjct: 207 SMGLSLVEMAVGRYP 221

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 52/206 (25%)
Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVK 256
           +G GSFG VY    RD I+      VAVK  ++  + R    F  +  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS------------STCMLDIFQRLNIMIDATS 304
           ++   S      +V+E M  G L++ L S               + ++ Q    + D  +
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------ 340
            L    F      +H DL   + ++  D    + DF                        
Sbjct: 145 YLNAKKF------VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLME 363
              E   +G  +T SD++ +G+VL E
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 78/206 (37%), Gaps = 52/206 (25%)
Query: 204 IGMGSFGSVYRARLRDGIE------VAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVK 256
           +G GSFG VY    RD I+      VAVK  ++  + R    F  +  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS------------STCMLDIFQRLNIMIDATS 304
           ++   S      +V+E M  G L++ L S               + ++ Q    + D  +
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------ 340
            L    F      +H DL   + ++  D    + DF                        
Sbjct: 145 YLNAKKF------VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 341 ---EYGMEGQVSTRSDIYGYGIVLME 363
              E   +G  +T SD++ +G+VL E
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWE 224

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/143 (21%), Positives = 66/143 (46%), Gaps = 6/143 (4%)
Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISSC 261
           +G G+FG V+R   +    V V  F       L  +  + E+  M  + HP L+ +  + 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
            +     L+LE++  G L + + +    +   + +N M  A   L+++   H   I+H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLD 174
Query: 322 LKPISVLLDEDMVAHLSDFEYGM 344
           +KP +++ +    + +   ++G+
Sbjct: 175 IKPENIMCETKKASSVKIIDFGL 197

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 26/169 (15%)
Query: 203 LIGMGSFGSVYRAR--LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP-------- 252
           ++G G+FG V +AR  L        K+ H E    L +  ++  ++ S+ H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 253 -----NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATST 305
                N VK  ++        +  EY    +L + ++S       D + RL   I     
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI----- 125
Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
           LE L + H+  IIH +LKP ++ +DE     + DF  G+   V    DI
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF--GLAKNVHRSLDI 172

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 54/230 (23%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 1   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 60
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCML---- 290
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    +    
Sbjct: 61  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 120
Query: 291 -----DIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM- 344
                 + + + +  +    + YL   +    +H DL   + ++ ED    + DF  GM 
Sbjct: 121 VLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF--GMT 175
Query: 345 ----------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                       +G  +T SD++ +G+VL E  T
Sbjct: 176 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 199 RLSNL--IGMGSFGSVYRA-RLRDGIEVAVKVF---HQECARALKSFEAQCEVMKSIRHP 252
           R  NL  +G G++GSV  A   + G+ VAVK      Q    A +++  +  ++K ++H 
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 92
Query: 253 NLVKVIS----SCSNDDFKALVL-EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           N++ ++     + S ++F  + L  ++    L N +       D  Q L   I     L 
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-----LR 147
Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------MEGQVSTR 351
            L + H+  IIH DLKP ++ ++ED    + DF         M G V+TR
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 197

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 54/230 (23%)
Query: 186 SNDGILPSQATLRR----LSNLIGMGSFGSVY----RARLRDGIE--VAVKVFHQECA-R 234
           + D  +P +  + R    +S  +G GSFG VY    +  ++D  E  VA+K  ++  + R
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 235 ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCML---- 290
               F  +  VMK     ++V+++   S      +++E M +G L++ L S    +    
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 291 -----DIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM- 344
                 + + + +  +    + YL   +    +H DL   + ++ ED    + DF  GM 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF--GMT 185
Query: 345 ----------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                       +G  +T SD++ +G+VL E  T
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEV----AVKVFHQEC----ARALKSFEAQCEVMKSIRH 251
           L  ++G G +G V++ R   G       A+KV  +      A+     +A+  +++ ++H
Sbjct: 21  LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           P +V +I +        L+LEY+  G L   L      ++       + + +  L +L  
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHL-- 137
Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            H   II+ DLKP +++L+      L+DF
Sbjct: 138 -HQKGIIYRDLKPENIMLNHQGHVKLTDF 165

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 200 LSNLIGMGSFGSVYRARLRDGIEV----AVKVFHQEC----ARALKSFEAQCEVMKSIRH 251
           L  ++G G +G V++ R   G       A+KV  +      A+     +A+  +++ ++H
Sbjct: 21  LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH 80
Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           P +V +I +        L+LEY+  G L   L      ++       + + +  L +L  
Sbjct: 81  PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHL-- 137
Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            H   II+ DLKP +++L+      L+DF
Sbjct: 138 -HQKGIIYRDLKPENIMLNHQGHVKLTDF 165

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	453
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-56
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-54
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-50
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-40
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-38
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-38
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-37
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-36
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-36
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-17
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-16
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-05
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-22
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-21
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-18
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-18
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-17
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-09
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-17
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-17
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-16
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-16
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-16
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-16
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-16
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-16
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-16
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-15
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-04
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-15
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-04
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-05
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-15
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-15
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-15
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-13
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-13
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-08
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-07
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-13
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-06
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-13
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-05
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-08
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-09
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-09
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-08
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-05
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-11
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-11
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-11
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-10
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-10
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-10
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-06
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-10
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-05
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-04
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-04
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-05
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-09
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-09
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-09
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-05
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-04
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-06
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-04
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-07
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-06
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-04
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	8e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  188 bits (479), Expect = 3e-56
 Identities = 82/276 (29%), Positives = 129/276 (46%), Gaps = 41/276 (14%)

Query: 201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISS 260
             LIG G FG VY+  LRDG +VA+K    E ++ ++ FE + E +   RHP+LV +I  
Sbjct: 44  KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103

Query: 261 CSNDDFKALVLEYMPKGSLENCLY---SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           C   +   L+ +YM  G+L+  LY     T  +   QRL I I A   L YL   HT  I
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAI 160

Query: 318 IHCDLKPISVLLDEDMVAHLSDF---------------------------EYGMEGQVST 350
           IH D+K I++LLDE+ V  ++DF                           EY ++G+++ 
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE 220

Query: 351 RSDIYGYGIVLMETFTRKKPTDRMF-VEELSLKDWVNNLLPIS-LMEVVDKTLLSGEKKG 408
           +SD+Y +G+VL E    +    +    E ++L +W         L ++VD  L       
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-----AD 275

Query: 409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
            +  E  +      A++C     E R +  D++ +L
Sbjct: 276 KIRPE-SLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  182 bits (464), Expect = 6e-54
 Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 40/278 (14%)

Query: 201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVKVIS 259
            N++G G FG VY+ RL DG  VAVK   +E  +  +  F+ + E++    H NL+++  
Sbjct: 35  KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 260 SCSNDDFKALVLEYMPKGSLENCLY---SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
            C     + LV  YM  GS+ +CL     S   LD  +R  I + +   L YL+      
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVST 350
           IIH D+K  ++LLDE+  A + DF                          EY   G+ S 
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 214

Query: 351 RSDIYGYGIVLMETFTRKKPTDRMFV---EELSLKDWVNNLLPI-SLMEVVDKTLLSGEK 406
           ++D++GYG++L+E  T ++  D   +   +++ L DWV  LL    L  +VD  L    +
Sbjct: 215 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL----Q 270

Query: 407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
             +  +E  V  ++ +A+ C    P +R    ++V  L
Sbjct: 271 GNYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  173 bits (440), Expect = 1e-50
 Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 48/287 (16%)

Query: 193 SQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARA----LKSFEAQCEVMKS 248
            +  +    N +G G FG VY+  + +   VAVK              + F+ + +VM  
Sbjct: 28  DERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86

Query: 249 IRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLY--SSTCMLDIFQRLNIMIDATSTL 306
            +H NLV+++   S+ D   LV  YMP GSL + L     T  L    R  I   A + +
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------------------- 340
            +L   H    IH D+K  ++LLDE   A +SDF                          
Sbjct: 147 NFL---HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203

Query: 341 -EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL--PISLMEVV 397
            E  + G+++ +SDIY +G+VL+E  T     D    E   L D    +     ++ + +
Sbjct: 204 PEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEEIEDEEKTIEDYI 261

Query: 398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
           DK +         +    V ++  +A +C  E   KR + K +   L
Sbjct: 262 DKKM-----NDADSTS--VEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  157 bits (400), Expect = 8e-45
 Identities = 63/296 (21%), Positives = 113/296 (38%), Gaps = 53/296 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVK 256
           +L  +   G FG V++A+L     VAVK+F     +  +S++ + EV  +  ++H N+++
Sbjct: 27  QLLEVKARGRFGCVWKAQLL-NEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQ 82

Query: 257 VISSCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL--- 309
            I +            L+  +  KGSL + L ++   +   +  +I       L YL   
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHED 140

Query: 310 ----YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------- 340
                 GH   I H D+K  +VLL  ++ A ++DF                         
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200

Query: 341 --EY-----GMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVE-ELSLKDWVNNLLPIS 392
             E        +     R D+Y  G+VL E  +R    D    E  L  ++ +     + 
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260

Query: 393 LM-EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
            M EVV         + +  K   +  +     EC     E R++A  +  R+ ++
Sbjct: 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (372), Expect = 8e-41
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 31/200 (15%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKV 257
           +   IG GSFG+V+RA    G +VAVK+  ++   A  +  F  +  +MK +RHPN+V  
Sbjct: 41  IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYFGHTT 315
           + + +     ++V EY+ +GSL   L+ S     LD  +RL++  D    + YL+     
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF---------EYGMEGQV----------------ST 350
           PI+H +LK  ++L+D+     + DF             +                   + 
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 351 RSDIYGYGIVLMETFTRKKP 370
           +SD+Y +G++L E  T ++P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  145 bits (367), Expect = 2e-40
 Identities = 59/279 (21%), Positives = 104/279 (37%), Gaps = 51/279 (18%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKV 257
               +     G +++ R + G ++ VKV        R  + F  +C  ++   HPN++ V
Sbjct: 14  FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 258 ISSCSN--DDFKALVLEYMPKGSLENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYFGHT 314
           + +C +       L+  +MP GSL N L+  T   +D  Q +   +D    + +L+    
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF----EYGMEGQVST-------------------R 351
             I    L   SV++DEDM A +S       +   G++                      
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRS 191

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPISLMEVVDKTLLSGEKKGFV 410
           +D++ + ++L E  TR+ P   +   E+ +K  +  L   I                   
Sbjct: 192 ADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP------------------ 233

Query: 411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
                   +  L   C  E P KR     IV  L K++D
Sbjct: 234 --PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  145 bits (368), Expect = 3e-40
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 52/280 (18%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +  ++G G+FG V +A+ R   +VA+K    E     K+F  +   +  + HPN+VK+  
Sbjct: 12  VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSS--TCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +C N     LV+EY   GSL N L+ +           ++  +  +  + YL+      +
Sbjct: 69  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 318 IHCDLKPISVLLDEDM-VAHLSDF------EYGMEGQV----------------STRSDI 354
           IH DLKP ++LL     V  + DF      +  M                    S + D+
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 186

Query: 355 YGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN--LLPISLMEVVDKTLLSGEKKGFVAK 412
           + +GI+L E  TR+KP D +      +   V+N    P+                     
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI-------------------- 226

Query: 413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           +     I  L   C  + P +R + ++IV  +  +     
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  146 bits (369), Expect = 3e-40
 Identities = 64/312 (20%), Positives = 106/312 (33%), Gaps = 64/312 (20%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMK--SIRHPNLVKV 257
           L  LIG G +G+VY+  L     VAVKVF        ++F  +  + +   + H N+ + 
Sbjct: 17  LLELIGRGRYGAVYKGSLD-ERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 258 ISSCSNDDFKA-----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL--- 309
           I               LV+EY P GSL   L   T   D      +    T  L YL   
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTE 130

Query: 310 ---YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------EYGMEGQVS 349
                 +   I H DL   +VL+  D    +SDF                 +     +V 
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 350 T-----------------------RSDIYGYGIVLMETFTRKK---PTDRMFVEELSLKD 383
           T                       + D+Y  G++  E F R     P + +   +++ + 
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250

Query: 384 WVNNLLPISLME--VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV 441
            V N      M+  V  +       + +      V S+     +C  +  E R+ A+   
Sbjct: 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310

Query: 442 TRLLKIRDTLSK 453
            R+ ++     +
Sbjct: 311 ERMAELMMIWER 322

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  144 bits (365), Expect = 4e-40
 Identities = 58/288 (20%), Positives = 107/288 (37%), Gaps = 63/288 (21%)

Query: 200 LSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-------ARALKSFEAQCEVMKSIRH 251
               IG G FG V++ RL  D   VA+K                 + F+ +  +M ++ H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           PN+VK+     N     +V+E++P G L + L      +    +L +M+D    +EY+  
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ- 139

Query: 312 GHTTPIIHCDLKPISVLLDE-----DMVAHLSDF------EYGMEGQV------------ 348
               PI+H DL+  ++ L        + A ++DF       + + G +            
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIG 199

Query: 349 ------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWV--NNL-LPISLMEVVDK 399
                 + ++D Y + ++L    T + P D     ++   + +    L   I        
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP------- 252

Query: 400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
                        E C   +  +   C    P+KR +   IV  L ++
Sbjct: 253 -------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  140 bits (355), Expect = 2e-38
 Identities = 73/310 (23%), Positives = 114/310 (36%), Gaps = 68/310 (21%)

Query: 194 QATLRR---LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKS 248
           Q T+ R   L   +G G +G V+R   + G  VAVK+F     R  KS+  + E+     
Sbjct: 3   QRTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVM 58

Query: 249 IRHPNLVKVISSCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATS 304
           +RH N++  I+S       +    L+  Y   GSL + L  +T  LD    L I++   S
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIAS 116

Query: 305 TLEYL-----YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------EYGMEG 346
            L +L            I H DLK  ++L+ ++    ++D              + G   
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 347 QVST----------------------RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDW 384
           +V T                      R DI+ +G+VL E   R      +   +    D 
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236

Query: 385 VNNLLPISLM-EVVDKTLLSGEKK------GFVAKEQCVLSILGLAMECAMELPEKRINA 437
           V N      M +VV         +           +  + S+  L  EC  + P  R+ A
Sbjct: 237 VPNDPSFEDMRKVV------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

Query: 438 KDIVTRLLKI 447
             I   L KI
Sbjct: 291 LRIKKTLTKI 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  140 bits (354), Expect = 2e-38
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 41/213 (19%)

Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMK 247
           I   Q T+ +    IG GSFG+VY+ +     +VAVK+ +      + L++F+ +  V++
Sbjct: 21  IPDGQITVGQR---IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLR 75

Query: 248 SIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
             RH N++  +   +     A+V ++    SL + L++S    ++ + ++I       ++
Sbjct: 76  KTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------- 340
           YL   H   IIH DLK  ++ L ED    + DF                           
Sbjct: 135 YL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                      S +SD+Y +GIVL E  T + P
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  140 bits (354), Expect = 4e-38
 Identities = 65/300 (21%), Positives = 111/300 (37%), Gaps = 53/300 (17%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           +   IG G +G V+  + R G +VAVKVF      A    E +      +RH N++  I+
Sbjct: 41  MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIA 98

Query: 260 SCSNDDFK----ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL-----Y 310
           +            L+ +Y   GSL + L S+T  LD    L +   + S L +L      
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------EYGMEGQVST------- 350
                 I H DLK  ++L+ ++    ++D              +     +V T       
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 351 ---------------RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME 395
                           +D+Y +G++L E   R      +   +L   D V +      M 
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 396 --VVDKTL-LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
             V  K L  S   +   + ++C+  +  L  EC    P  R+ A  +   L K+ ++  
Sbjct: 277 EIVCIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  138 bits (350), Expect = 5e-38
 Identities = 61/285 (21%), Positives = 107/285 (37%), Gaps = 59/285 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFH----QECARALKSFEAQCEVMKSIRHPNL 254
            L  +IG+G FG VYRA    G EVAVK       ++ ++ +++   + ++   ++HPN+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           + +   C  +    LV+E+   G L   L      +     +N  +     + YL+    
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAI 126

Query: 315 TPIIHCDLKPISVLLDEDMVAH--------LSDF-------EYGMEGQV----------- 348
            PIIH DLK  ++L+ + +           ++DF                          
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVI 186

Query: 349 -----STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPISLMEVVDKTLL 402
                S  SD++ YG++L E  T + P   +    ++    +N L LPI           
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP---------- 236

Query: 403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
                       C      L  +C    P  R +  +I+ +L  I
Sbjct: 237 ----------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  137 bits (348), Expect = 2e-37
 Identities = 56/289 (19%), Positives = 98/289 (33%), Gaps = 66/289 (22%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKV 257
           +  LIG G FG VY  R     EVA+++   E      LK+F+ +    +  RH N+V  
Sbjct: 37  IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           + +C +    A++       +L + +  +  +LD+ +   I  +    + YL   H   I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGI 151

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------EYGMEGQV--------------- 348
           +H DLK  +V  D   V  ++DF              E  +  Q                
Sbjct: 152 LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 349 ----------STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD 398
                     S  SD++  G +  E   R+ P      E +  +        +S      
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS------ 264

Query: 399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
                        +      I  + + C     E+R     ++  L K+
Sbjct: 265 -------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  136 bits (343), Expect = 2e-36
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 64/320 (20%)

Query: 182 GLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEA 241
           GL +     +     L      IG G FG V+R + R G EVAVK+F     R  +S+  
Sbjct: 31  GLPLLVQRTIARTIVL---QESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFR 83

Query: 242 QCEV--MKSIRHPNLVKVISSCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIFQR 295
           + E+     +RH N++  I++ + D+       LV +Y   GSL + L   T  + +   
Sbjct: 84  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGM 141

Query: 296 LNIMIDATSTLEYL-----YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------- 340
           + + +   S L +L            I H DLK  ++L+ ++    ++D           
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201

Query: 341 ---EYGMEGQVST----------------------RSDIYGYGIVLMETFTRKKPTDRMF 375
              +     +V T                      R+DIY  G+V  E   R        
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 376 VEELSLKDWVNNLLPISLME--VVDKTL---LSGEKKGFVAKEQCVLSILGLAMECAMEL 430
             +L   D V +   +  M   V ++ L   +    +      + +  +  +  EC    
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ----SCEALRVMAKIMRECWYAN 317

Query: 431 PEKRINAKDIVTRLLKIRDT 450
              R+ A  I   L ++   
Sbjct: 318 GAARLTALRIKKTLSQLSQQ 337

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  134 bits (340), Expect = 3e-36
 Identities = 48/137 (35%), Positives = 67/137 (48%), Gaps = 12/137 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             S N L G +     NL  +  ++LSRN L  D     G   + + + LA N L     
Sbjct: 180 TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSF 117
                 +L  L+L NN IYG +P  L +L +L  L++SFN L GEI +GG    F   ++
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298

Query: 118 KGNEPLCGSPNLQVPPC 134
             N+ LCGSP   +P C
Sbjct: 299 ANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 25/109 (22%), Positives = 47/109 (43%), Gaps = 11/109 (10%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--- 61
              +  ++ G +   +  +K +V ++ S N LS  +P +I  L +L  ++   N++    
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 62  -------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                        + +S N + G IP +    L L  + LS N LEG+ 
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDA 213

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 28/107 (26%), Positives = 48/107 (44%), Gaps = 10/107 (9%)

Query: 7   FSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL------ 60
              N+L GP+   I  L  +  + ++  N+S  +P  +  + +L TL  +YN L      
Sbjct: 84  GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKE-LSLSFNKLEGEI 103
               + +L  +    N I G IP S      L   +++S N+L G+I
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 26/110 (23%), Positives = 46/110 (41%), Gaps = 12/110 (10%)

Query: 6   DFSSNSLEG--PLSLDIGNLKAVVEINLS-RNNLSSDMPATIGGLISLKTLSLAYNKLD- 61
           D S  +L    P+   + NL  +  + +   NNL   +P  I  L  L  L + +  +  
Sbjct: 56  DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115

Query: 62  --------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                   + +L  L+ S N + G +P S+  L  L  ++   N++ G I
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 76.8 bits (190), Expect = 8e-16
 Identities = 26/112 (23%), Positives = 43/112 (38%), Gaps = 12/112 (10%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDM--PATIGGLISLKTLSLA-YNKL 60
             D  + +  G L         V  ++LS  NL      P+++  L  L  L +   N L
Sbjct: 30  TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

Query: 61  ---------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                     +  L  L +++  + G IP  L ++  L  L  S+N L G +
Sbjct: 90  VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 44.4 bits (106), Expect = 4e-05
 Identities = 17/55 (30%), Positives = 26/55 (47%), Gaps = 1/55 (1%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK 59
            D  +N + G L   +  LK +  +N+S NNL  ++P   G L      + A NK
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  133 bits (337), Expect = 7e-36
 Identities = 57/295 (19%), Positives = 97/295 (32%), Gaps = 65/295 (22%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
              ++G G FG   +   R+ G  + +K   +      ++F  + +VM+ + HPN++K I
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
                D     + EY+  G+L   + S        QR++   D  S + YL   H+  II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNII 130

Query: 319 HCDLKPISVLLDEDMVAHLSDF---------EYGMEGQV--------------------- 348
           H DL   + L+ E+    ++DF         +   EG                       
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 349 ---------STRSDIYGYGIVLMETFTRKKPTD--RMFVEELSLKDWVNNLLPISLMEVV 397
                      + D++ +GIVL E   R            +  L                
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP----- 245

Query: 398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
                            C  S   + + C    PEKR +   +   L  +R  L+
Sbjct: 246 ---------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  136 bits (344), Expect = 1e-34
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 9/153 (5%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
            + +S    G  S    N  +++ +++S N LS  +P  IG +  L  L+L +N +    
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAM 115
                D+  L IL+LS+N++ G IP ++  L  L E+ LS N L G I   G F  F   
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA 732

Query: 116 SFKGNEPLCGSPNLQVPPCKLNKPGKHQKSRKN 148
            F  N  LCG P  +  P   +    HQ+S  +
Sbjct: 733 KFLNNPGLCGYPLPRCDPSNADGYAHHQRSHHH 765

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 93.4 bits (233), Expect = 2e-20
 Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 9/108 (8%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
               +N   G +   + N   +V ++LS N LS  +P+++G L  L+ L L  N L    
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                 V +LE L L  N++ G IP+ L     L  +SLS N+L GEI
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.8 bits (221), Expect = 6e-19
 Identities = 35/110 (31%), Positives = 47/110 (42%), Gaps = 12/110 (10%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
           + D S N L G  S  I     +  +N+S N     +P     L SL+ LSLA NK    
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGE 284

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                     +L  L+LS N  YG +P        L+ L+LS N   GE+
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 85.0 bits (211), Expect = 1e-17
 Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 13/112 (11%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLSLAYNKLD-- 61
            D S N   G +    G+   +  + LS NN S ++P  T+  +  LK L L++N+    
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358

Query: 62  --------VASLEILNLSNNEIYGLIPTSLEK--LLYLKELSLSFNKLEGEI 103
                    ASL  L+LS+N   G I  +L +     L+EL L  N   G+I
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 25/110 (22%), Positives = 51/110 (46%), Gaps = 13/110 (11%)

Query: 5   FDFSSNSLEGPLSLDI---GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
            D S+NS+ G   +          +  + +S N +S D+   +   ++L+ L ++ N   
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                  D ++L+ L++S N++ G    ++     LK L++S N+  G I
Sbjct: 214 TGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.0 bits (206), Expect = 4e-17
 Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 13/112 (11%)

Query: 5   FDFSSNSLEGPLSLD-IGNLKAVVEINLSRNNLSSDMPATIGGL-ISLKTLSLAYNKL-- 60
              SSN+  G L +D +  ++ +  ++LS N  S ++P ++  L  SL TL L+ N    
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382

Query: 61  ---------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                       +L+ L L NN   G IP +L     L  L LSFN L G I
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 81.1 bits (201), Expect = 2e-16
 Identities = 32/125 (25%), Positives = 55/125 (44%), Gaps = 20/125 (16%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA--TIGGLISLKTLSLAYNKLD 61
           +   S++ + G +S       ++  ++LSRN+LS  +    ++G    LK L+++ N LD
Sbjct: 81  SLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 139

Query: 62  VA----------SLEILNLSNNEIYGLIPTSLE---KLLYLKELSLSFNKLEGEILRGGP 108
                       SLE+L+LS N I G              LK L++S NK+ G++     
Sbjct: 140 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV----D 195

Query: 109 FVNFT 113
                
Sbjct: 196 VSRCV 200

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 13/109 (11%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
                 N L G +   + N   +  I+LS N L+ ++P  IG L +L  L L+ N     
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                 D  SL  L+L+ N   G IP ++ K        ++ N + G+ 
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKR 574

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 32/150 (21%), Positives = 56/150 (37%), Gaps = 25/150 (16%)

Query: 6   DFSSNSLE---GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-- 60
           D SS  L      +S  + +L  +  + LS ++++  +        SL +L L+ N L  
Sbjct: 56  DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSG 114

Query: 61  ---------DVASLEILNLSNNEIYGLIPTSLE-KLLYLKELSLSFNKLEGEILRG-GPF 109
                      + L+ LN+S+N +      S   KL  L+ L LS N + G  + G    
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174

Query: 110 VNFTAM--------SFKGNEPLCGSPNLQV 131
                +           G+  +    NL+ 
Sbjct: 175 DGCGELKHLAISGNKISGDVDVSRCVNLEF 204

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 13/91 (14%)

Query: 26  VVEINLSRNNLSSDM---PATIGGLISLKTLSLAYNKL--------DVASLEILNLSNNE 74
           V  I+LS   L+       +++  L  L++L L+ + +          ASL  L+LS N 
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNS 111

Query: 75  IYGLIPT--SLEKLLYLKELSLSFNKLEGEI 103
           + G + T  SL     LK L++S N L+   
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  111 bits (280), Expect = 2e-27
 Identities = 72/286 (25%), Positives = 111/286 (38%), Gaps = 65/286 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSF--EAQCEVMKSIRHPNL 254
            L   IG G+FG V+  RLR D   VAVK   +         F  EA+  ++K   HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR--ILKQYSHPNI 174

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           V++I  C+      +V+E +  G     L +    L +   L ++ DA + +EYL    +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ES 231

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------------------------E 345
              IH DL   + L+ E  V  +SDF  GM                              
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDF--GMSREEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 346 GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG 404
           G+ S+ SD++ +GI+L ETF+    P   +                 S  +  +      
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNL-----------------SNQQTREFV---- 328

Query: 405 EKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR 448
            +KG      E C  ++  L  +C    P +R +   I   L  IR
Sbjct: 329 -EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (271), Expect = 6e-27
 Identities = 63/281 (22%), Positives = 106/281 (37%), Gaps = 55/281 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
                IG G FG V+     +  +VA+K    E A + + F  + EVM  + HP LV++ 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
             C       LV E+M  G L + L +   +      L + +D    + YL       +I
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126

Query: 319 HCDLKPISVLLDEDMVAHLSDF---------EYG-----------------MEGQVSTRS 352
           H DL   + L+ E+ V  +SDF         +Y                     + S++S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 353 DIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV- 410
           D++ +G+++ E F+  K P +                   S  EVV+         GF  
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENR-----------------SNSEVVEDI-----STGFRL 224

Query: 411 -AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT 450
                    +  +   C  E PE R     ++ +L +I ++
Sbjct: 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  106 bits (267), Expect = 4e-26
 Identities = 68/294 (23%), Positives = 116/294 (39%), Gaps = 52/294 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           +    +G G+FGSV   R        G  VAVK         L+ FE + E++KS++H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 254 LVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           +VK    C +   +   L++EY+P GSL + L      +D  + L         +EYL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 130

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EYG 343
             T   IH DL   ++L++ +    + DF                            E  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 344 MEGQVSTRSDIYGYGIVLMETFT---RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT 400
            E + S  SD++ +G+VL E FT   + K     F+  +           + +  +++  
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG----QMIVFHLIELL 245

Query: 401 LLSGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
                K        + C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 246 -----KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (266), Expect = 4e-26
 Identities = 59/283 (20%), Positives = 106/283 (37%), Gaps = 55/283 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
                +G G FG V   + R   +VA+K+   E + +   F  + +VM ++ H  LV++ 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
             C+      ++ EYM  G L N L          Q L +  D    +EYL        +
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FL 142

Query: 319 HCDLKPISVLLDEDMVAHLSDF---------EYG-----------------MEGQVSTRS 352
           H DL   + L+++  V  +SDF         EY                  M  + S++S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 353 DIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV- 410
           DI+ +G+++ E ++  K P +R                  +  E  +        +G   
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERF-----------------TNSETAEHI-----AQGLRL 240

Query: 411 -AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
                    +  +   C  E  ++R   K +++ +L + D  S
Sbjct: 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 5e-26
 Identities = 68/294 (23%), Positives = 116/294 (39%), Gaps = 52/294 (17%)

Query: 199 RLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           +    +G G+FGSV   R        G  VAVK         L+ FE + E++KS++H N
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 254 LVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           +VK    C +   +   L++EY+P GSL + L      +D  + L         +EYL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-- 161

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EYG 343
             T   IH DL   ++L++ +    + DF                            E  
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 344 MEGQVSTRSDIYGYGIVLMETFT---RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT 400
            E + S  SD++ +G+VL E FT   + K     F+  +           + +  +++  
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG----QMIVFHLIELL 276

Query: 401 LLSGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
                K        + C   I  +  EC      +R + +D+  R+ +IRD ++
Sbjct: 277 -----KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (263), Expect = 8e-26
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 63/284 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSF--EAQCEVMKSIRHPNLVK 256
            L   +G G FG V   + +   +VAVK+   E + +   F  EAQ   M  + HP LVK
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQ--TMMKLSHPKLVK 67

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
               CS +    +V EY+  G L N L S    L+  Q L +  D    + +L       
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--- 124

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGM----------------------------EGQV 348
            IH DL   + L+D D+   +SDF  GM                              + 
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDF--GMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182

Query: 349 STRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
           S++SD++ +GI++ E F+  K P D                   +  EVV K       +
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLY-----------------TNSEVVLKV-----SQ 220

Query: 408 GFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
           G           +I  +   C  ELPEKR   + +++ +  +R+
Sbjct: 221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  107 bits (270), Expect = 1e-25
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 33/208 (15%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+ A      +VAVK      + ++++F A+  VMK+++H  LVK+ 
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  + +    ++ E+M KGSL + L S       + + ++        + ++        
Sbjct: 250 AVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNY 305

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+   +V  ++DF                          E    G  + +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 352 SDIYGYGIVLMETFTR-KKPTDRMFVEE 378
           SD++ +GI+LME  T  + P   M   E
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPE 393

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  108 bits (271), Expect = 1e-25
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K        + ++F  + +VMK +RH  LV++ 
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 329 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 384

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 352 SDIYGYGIVLMETFTR-KKPTDRMFVEE 378
           SD++ +GI+L E  T+ + P   M   E
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNRE 472

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  107 bits (269), Expect = 1e-25
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K        + ++F  + +VMK +RH  LV++ 
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T   L + Q +++     S + Y+        
Sbjct: 246 AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 301

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 352 SDIYGYGIVLMETFTR-KKPTDRMFVEE 378
           SD++ +GI+L E  T+ + P   M   E
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNRE 389

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  107 bits (269), Expect = 2e-25
 Identities = 58/285 (20%), Positives = 106/285 (37%), Gaps = 57/285 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            + + +G G +G VY    +   + VAVK   +E    ++ F  +  VMK I+HPNLV++
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +  C+ +    ++ E+M  G+L + L       +     L +    +S +EYL       
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKN 338

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVST 350
            IH +L   + L+ E+ +  ++DF                          E     + S 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 351 RSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF 409
           +SD++ +G++L E  T    P   +                  L +V +       +K +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGI-----------------DLSQVYELL-----EKDY 436

Query: 410 V--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
                E C   +  L   C    P  R +  +I      +    S
Sbjct: 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (268), Expect = 2e-25
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 35/208 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSF--EAQCEVMKSIRHPNLVK 256
           +L   IG G FG V     R G +VAVK    +     ++F  EA   VM  +RH NLV+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEAS--VMTQLRHSNLVQ 250

Query: 257 VISSCSNDDFKA-LVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHT 314
           ++     +     +V EYM KGSL + L S    +L     L   +D    +EYL     
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EG 307

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRS 352
              +H DL   +VL+ ED VA +SDF                      E   E + ST+S
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 367

Query: 353 DIYGYGIVLMETFTR-KKPTDRMFVEEL 379
           D++ +GI+L E ++  + P  R+ ++++
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDV 395

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  103 bits (259), Expect = 4e-25
 Identities = 63/292 (21%), Positives = 100/292 (34%), Gaps = 67/292 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC---ARALKSF--EAQCEVMKSI 249
           RL   +G GSFG V R          + VAVK    +      A+  F  E     M S+
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN--AMHSL 78

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            H NL+++         K +V E  P GSL + L        +       +     + YL
Sbjct: 79  DHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGME------------- 345
               +   IH DL   ++LL    +  + DF            Y M+             
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 346 ----GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT 400
                  S  SD + +G+ L E FT  ++P   +                 +  +++ K 
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----------------NGSQILHKI 237

Query: 401 LLSGEKKGF--VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT 450
               +K+G      E C   I  + ++C    PE R     +   LL+ + T
Sbjct: 238 ----DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  103 bits (258), Expect = 1e-24
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 38/203 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           +  + +G G+FGSV   R        G  VAVK          + F+ + +++K++    
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 254 LVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           +VK          ++  LV+EY+P G L + L      LD  + L         +EYL  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-- 143

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGM---------------- 344
             +   +H DL   ++L++ +    ++DF            Y +                
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 345 -EGQVSTRSDIYGYGIVLMETFT 366
            +   S +SD++ +G+VL E FT
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (257), Expect = 1e-24
 Identities = 54/288 (18%), Positives = 108/288 (37%), Gaps = 50/288 (17%)

Query: 199 RLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHP 252
           +    +G G FG V   R        G +VAVK    E     +   + + E+++++ H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 253 NLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           N+VK    C+ D      L++E++P GSL+  L  +   +++ Q+L   +     ++YL 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL- 142

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EY 342
              +   +H DL   +VL++ +    + DF                            E 
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 343 GMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL 401
            M+ +    SD++ +G+ L E  T     +  M +    +      +    L+  +    
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL---- 256

Query: 402 LSGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
               K+G        C   +  L  +C    P  R + ++++     +
Sbjct: 257 ----KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  102 bits (256), Expect = 2e-24
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 49/225 (21%)

Query: 189 GILPSQATLR-------RLSNLIGMGSFGSVYRARLRDG-----IEVAVKVFHQEC-ARA 235
           G  P+QA LR       +   ++G G+FG+VY+           I VA+K   +    +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 236 LKSF--EAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF 293
            K    EA   VM S+ +P++ +++  C     + L+ + MP G L + +      +   
Sbjct: 61  NKEILDEAY--VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EY 342
             LN  +     + YL       ++H DL   +VL+       ++DF           EY
Sbjct: 118 YLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 343 GMEG----------------QVSTRSDIYGYGIVLMETFTR-KKP 370
             EG                  + +SD++ YG+ + E  T   KP
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  100 bits (252), Expect = 3e-24
 Identities = 46/210 (21%), Positives = 91/210 (43%), Gaps = 37/210 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK    + + +  +F A+  +MK ++H  LV++ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + +   L I + L++       + ++   +    
Sbjct: 75  AVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130

Query: 318 IHCDLKPISVLLDEDMVAHLSDFEYGM----------------------------EGQVS 349
           IH DL+  ++L+ + +   ++DF  G+                             G  +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADF--GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 350 TRSDIYGYGIVLMETFTR-KKPTDRMFVEE 378
            +SD++ +GI+L E  T  + P   M   E
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (251), Expect = 6e-24
 Identities = 45/217 (20%), Positives = 87/217 (40%), Gaps = 42/217 (19%)

Query: 188 DGILPSQATLRRLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQ 242
           D ++P +  +     +IG G FG VY     D     I+ A+K   +    + +++F  +
Sbjct: 13  DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72

Query: 243 CEVMKSIRHPNLVKVISSCSNDD-FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID 301
             +M+ + HPN++ +I      +    ++L YM  G L   + S      +   ++  + 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------------- 344
               +EYL        +H DL   + +LDE     ++DF  G+                 
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADF--GLARDILDREYYSVQQHRH 187

Query: 345 --------------EGQVSTRSDIYGYGIVLMETFTR 367
                           + +T+SD++ +G++L E  TR
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  100 bits (250), Expect = 6e-24
 Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 59/296 (19%)

Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDG---IEVAVKVFHQECARALKS-FEAQCEV 245
           +      +  +   +G G+FGSV +   R     I+VA+KV  Q   +A       + ++
Sbjct: 6   LKRDNLLIADIE--LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63

Query: 246 MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATST 305
           M  + +P +V++I  C  +    LV+E    G L   L      + +     ++   +  
Sbjct: 64  MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGME--------- 345
           ++YL   +    +H DL   +VLL     A +SDF            Y            
Sbjct: 123 MKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 346 --------GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEV 396
                    + S+RSD++ YG+ + E  +  +KP  +M                    EV
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----------------KGPEV 222

Query: 397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           +   +  G++       +C   +  L  +C +   E R +   +  R+     +L+
Sbjct: 223 MAF-IEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  100 bits (250), Expect = 1e-23
 Identities = 57/294 (19%), Positives = 106/294 (36%), Gaps = 54/294 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHP 252
           +    +G G FG V            G  VAVK    +   +    ++ + ++++++ H 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 253 NLVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           +++K    C +    +  LV+EY+P GSL + L   +  + + Q L         + YL 
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYL- 150

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------------------- 344
             H    IH DL   +VLLD D +  + DF  G+                          
Sbjct: 151 --HAQHYIHRDLAARNVLLDNDRLVKIGDF--GLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 345 ----EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT 400
               E +    SD++ +G+ L E  T    +     + L L       +    M V+   
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-----IAQGQMTVLR-- 259

Query: 401 LLSGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
           L    ++G      ++C   +  L   C       R   ++++  L  + +   
Sbjct: 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 57/285 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG-IEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            + + +G G +G VY    +   + VAVK    E    ++ F  +  VMK I+HPNLV++
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQL 74

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +  C+ +    ++ E+M  G+L + L       +     L +    +S +EYL   +   
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 131

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF---------EYG-----------------MEGQVST 350
            IH DL   + L+ E+ +  ++DF          Y                     + S 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 351 RSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF 409
           +SD++ +G++L E  T    P   +                  L +V +       +K +
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGI-----------------DLSQVYELL-----EKDY 229

Query: 410 V--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS 452
                E C   +  L   C    P  R +  +I      +    S
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 42/206 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     ++YL   
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------------------------- 344
                +H DL   + +LDE     ++DF  G+                            
Sbjct: 148 K---FVHRDLAARNCMLDEKFTVKVADF--GLARDMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 345 ---EGQVSTRSDIYGYGIVLMETFTR 367
                + +T+SD++ +G++L E  TR
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTR 228

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  102 bits (256), Expect = 1e-23
 Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 45/215 (20%)

Query: 197 LRRLSNLIGMGSFGSVYRARLRDG---IEVAVKVFHQECARALKS-FEAQCEVMKSIRHP 252
           L      +G G+FGSV +   R     I+VA+KV  Q   +A       + ++M  + +P
Sbjct: 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL--- 309
            +V++I  C  +    LV+E    G L   L      + +     ++   +  ++YL   
Sbjct: 397 YIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 310 -YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGME------------ 345
            +       +H +L   +VLL     A +SDF            Y               
Sbjct: 456 NF-------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508

Query: 346 -----GQVSTRSDIYGYGIVLMETFTR-KKPTDRM 374
                 + S+RSD++ YG+ + E  +  +KP  +M
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 60/303 (19%), Positives = 115/303 (37%), Gaps = 77/303 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQECA--RALKSFEAQCEVMKSIRHP 252
            L  ++G G FGSV    L+      ++VAVK    + +  R ++ F ++   MK   HP
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 253 NLVKVISSCSNDDFKA-----LVLEYMPKGSL-----ENCLYSSTCMLDIFQRLNIMIDA 302
           N+++++  C     +      ++L +M  G L      + L +    + +   L  M+D 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------------ 344
              +EYL   +    +H DL   + +L +DM   ++DF  G+                  
Sbjct: 157 ALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADF--GLSKKIYSGDYYRQGRIAKM 211

Query: 345 -----------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP--- 390
                      +   +++SD++ +G+ + E  TR                      P   
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT-------------------PYPG 252

Query: 391 ISLMEVVDKTLLSGEKKGFVAK-EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
           +   E+ D  LL G     + + E C+  +  +   C    P  R     +  +L K+ +
Sbjct: 253 VQNHEMYDY-LLHG---HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

Query: 450 TLS 452
           +L 
Sbjct: 309 SLP 311

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 58/287 (20%), Positives = 108/287 (37%), Gaps = 65/287 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
            +  +IG G  G V   RLR      + VA+K        R  + F ++  +M    HPN
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++++    +      +V EYM  GSL+  L +      I Q + ++    + + YL    
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------------------------- 344
               +H DL   +VL+D ++V  +SDF  G+                             
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDF--GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 345 -EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL 402
                S+ SD++ +G+V+ E     ++P   M                 +  +V+     
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-----------------TNRDVISSV-- 267

Query: 403 SGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
              ++G+   A   C  ++  L ++C  +   +R     IV+ L  +
Sbjct: 268 ---EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 38/204 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
             + +IG G FG VY   L D     I  AVK  ++      +  F  +  +MK   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 254 LVKVISSCSNDDFKAL-VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ ++  C   +   L VL YM  G L N + + T    +   +   +     +++L   
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------EYG-------------------- 343
                +H DL   + +LDE     ++DF         E+                     
Sbjct: 212 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 344 MEGQVSTRSDIYGYGIVLMETFTR 367
              + +T+SD++ +G++L E  TR
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTR 292

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 97.3 bits (243), Expect = 5e-23
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 35/208 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   IG G FG V     R G +VAVK    +     ++F A+  VM  +RH NLV+++
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 80

Query: 259 SSCSNDDFKA-LVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                +     +V EYM KGSL + L S    +L     L   +D    +EYL   +   
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 137

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGM------------------------EGQVSTRS 352
            +H DL   +VL+ ED VA +SDF  G+                        E + ST+S
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDF--GLTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 353 DIYGYGIVLMETFTR-KKPTDRMFVEEL 379
           D++ +GI+L E ++  + P  R+ ++++
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDV 223

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 98.2 bits (245), Expect = 6e-23
 Identities = 64/323 (19%), Positives = 116/323 (35%), Gaps = 84/323 (26%)

Query: 178 CGKRGLDVSNDGILPSQATLR----------RLSNLIGMGSFGSVYRARLRDG-----IE 222
             +        G  P+QA L+              +IG G FG VY+  L+       + 
Sbjct: 16  TTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP 75

Query: 223 VAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLEN 281
           VA+K        +    F  +  +M    H N++++    S      ++ EYM  G+L+ 
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135

Query: 282 CLYSSTCMLDIFQRLNIMIDATSTLEYL----YFGHTTPIIHCDLKPISVLLDEDMVAHL 337
            L        + Q + ++    + ++YL    Y       +H DL   ++L++ ++V  +
Sbjct: 136 FLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY-------VHRDLAARNILVNSNLVCKV 188

Query: 338 SDFEYGM------------------------------EGQVSTRSDIYGYGIVLMETFTR 367
           SDF  G+                                + ++ SD++ +GIV+ E  T 
Sbjct: 189 SDF--GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 246

Query: 368 -KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV--AKEQCVLSILGLAM 424
            ++P   +                 S  EV+          GF       C  +I  L M
Sbjct: 247 GERPYWEL-----------------SNHEVMKAI-----NDGFRLPTPMDCPSAIYQLMM 284

Query: 425 ECAMELPEKRINAKDIVTRLLKI 447
           +C  +   +R    DIV+ L K+
Sbjct: 285 QCWQQERARRPKFADIVSILDKL 307

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 63/304 (20%), Positives = 113/304 (37%), Gaps = 78/304 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQECA--RALKSFEAQCEVMKSIRHP 252
            L  ++G G FGSV  A+L+      ++VAVK+   +      ++ F  +   MK   HP
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 253 NLVKVISSCSNDDFKA------LVLEYMPKGSLENCLYSSTCM-----LDIFQRLNIMID 301
           ++ K++        K       ++L +M  G L   L +S        L +   +  M+D
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------------- 344
               +EYL   +    IH DL   + +L EDM   ++DF  G+                 
Sbjct: 146 IACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADF--GLSRKIYSGDYYRQGCASK 200

Query: 345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLP-- 390
                       +   +  SD++ +G+ + E  TR +                    P  
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT-------------------PYA 241

Query: 391 -ISLMEVVDKTLLSGEKKGFVAK-EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR 448
            I   E+ +  L+ G     + +  +C+  +  L  +C    P++R +   +   L  I 
Sbjct: 242 GIENAEIYNY-LIGG---NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297

Query: 449 DTLS 452
             LS
Sbjct: 298 GHLS 301

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 58/285 (20%), Positives = 109/285 (38%), Gaps = 61/285 (21%)

Query: 199 RLSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
            +  ++G G FG V   RL    +  I VA+K        +  + F  +  +M    HPN
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++++    +      +V EYM  GSL++ L        + Q + ++    S ++YL    
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EYGME 345
               +H DL   ++L++ ++V  +SDF                            E    
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 346 GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG 404
            + ++ SD++ YGIVL E  +  ++P   M                 S  +V+       
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKAV---- 263

Query: 405 EKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
             +G+       C  ++  L ++C  +    R   + IV+ L K+
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 37/211 (17%), Positives = 72/211 (34%), Gaps = 42/211 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRD--------GIEVAVKVFHQECARALKSFEAQCEVMKSIR 250
             +  +G G+F  +++   R+          EV +KV  +      +SF     +M  + 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           H +LV     C   D   LV E++  GSL+  L  +   ++I  +L +     + + +L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 311 FGHTTPIIHCDL--------KPISVLLDEDMVAHLSDF---------EYG---------- 343
                 +IH ++        +             LSD          +            
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPE 187

Query: 344 --MEGQV-STRSDIYGYGIVLMETFTR-KKP 370
                +  +  +D + +G  L E  +   KP
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 58/303 (19%), Positives = 105/303 (34%), Gaps = 59/303 (19%)

Query: 185 VSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRDG---IEVAVKVFHQEC--ARALKSF 239
           +    +   +  L      +G G+FG+V +   +       VAVK+   E          
Sbjct: 6   IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65

Query: 240 EAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIM 299
            A+  VM+ + +P +V++I  C  + +  LV+E    G L   L  +   +     + ++
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELV 123

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EYGME--- 345
              +  ++YL   +    +H DL   +VLL     A +SDF            Y  +   
Sbjct: 124 HQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180

Query: 346 --------------GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLP 390
                          + S++SD++ +G+++ E F+  +KP   M                
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---------------- 224

Query: 391 ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT 450
               EV    L  GE+        C   +  L   C     E R     +  RL      
Sbjct: 225 -KGSEVTAM-LEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280

Query: 451 LSK 453
           +  
Sbjct: 281 VVN 283

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 49/225 (21%)

Query: 189 GILPSQATLR-------RLSNLIGMGSFGSVYRARLRDG-----IEVAVKVFHQEC-ARA 235
           G  P+QA LR       +   ++G G+FG+VY+           I VA+K   +    +A
Sbjct: 1   GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 236 LKSF--EAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF 293
            K    EA   VM S+ +P++ +++  C     + L+ + MP G L + +      +   
Sbjct: 61  NKEILDEAY--VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------EY 342
             LN  +     + YL       ++H DL   +VL+       ++DF           EY
Sbjct: 118 YLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 343 GMEG----------------QVSTRSDIYGYGIVLMETFTR-KKP 370
             EG                  + +SD++ YG+ + E  T   KP
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 45/211 (21%), Positives = 83/211 (39%), Gaps = 50/211 (23%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSF--EAQCEVMKSIRH 251
            L+ ++G G FG VY     +     I VAVK   ++C     + F  EA   +MK++ H
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV--IMKNLDH 72

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL-- 309
           P++VK+I     +    +++E  P G L + L  +   L +   +   +     + YL  
Sbjct: 73  PHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 310 -YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------------------ 344
                    +H D+   ++L+       L DF  G+                        
Sbjct: 132 INC------VHRDIAVRNILVASPECVKLGDF--GLSRYIEDEDYYKASVTRLPIKWMSP 183

Query: 345 E----GQVSTRSDIYGYGIVLMETFTR-KKP 370
           E     + +T SD++ + + + E  +  K+P
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 38/201 (18%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           ++G G++G VY  R L + + +A+K   +  +R  +    +  + K ++H N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL--NIMIDATSTLEYLYFGHTTPIIH 319
           S + F  + +E +P GSL   L S    L   ++            L+YL   H   I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVH 145

Query: 320 CDLKPISVLLDEDM-VAHLSDFEYGMEGQV-----------------------------S 349
            D+K  +VL++    V  +SDF  G   ++                              
Sbjct: 146 RDIKGDNVLINTYSGVLKISDF--GTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203

Query: 350 TRSDIYGYGIVLMETFTRKKP 370
             +DI+  G  ++E  T K P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 42/217 (19%), Positives = 86/217 (39%), Gaps = 42/217 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG-----IEVAVKVFHQEC-ARALKSF--EAQCEVMKSIR 250
           R   ++G G FG+V++           I V +KV   +   ++ ++         + S+ 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML--AIGSLD 73

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           H ++V+++  C     + LV +Y+P GSL + +      L     LN  +     + YL 
Sbjct: 74  HAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL- 131

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------EYGME--------------- 345
                 ++H +L   +VLL       ++DF          +  +                
Sbjct: 132 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189

Query: 346 --GQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEEL 379
             G+ + +SD++ YG+ + E  T   +P   + + E+
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 40/210 (19%), Positives = 75/210 (35%), Gaps = 48/210 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPN 253
            L   IG G FG V++          + VA+K           + F  +   M+   HP+
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL---- 309
           +VK+I   + +    +++E    G L + L      LD+   +      ++ L YL    
Sbjct: 78  IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------------------- 344
           +       +H D+   +VL+  +    L DF  G+                         
Sbjct: 137 F-------VHRDIAARNVLVSSNDCVKLGDF--GLSRYMEDSTYYKASKGKLPIKWMAPE 187

Query: 345 ---EGQVSTRSDIYGYGIVLMETFTR-KKP 370
                + ++ SD++ +G+ + E      KP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 96.5 bits (240), Expect = 2e-21
 Identities = 42/218 (19%), Positives = 77/218 (35%), Gaps = 48/218 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG----IEVAVKVFHQEC-ARALKSF--EAQCEVMKSIRH 251
            L   IG G FG V++          + VA+K           + F  EA    M+   H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL--TMRQFDH 450

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL-- 309
           P++VK+I   + +    +++E    G L + L      LD+   +      ++ L YL  
Sbjct: 451 PHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 310 --YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------E 341
             +       +H D+   +VL+  +    L DF                          E
Sbjct: 510 KRF-------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562

Query: 342 YGMEGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEE 378
                + ++ SD++ +G+ + E      KP   +   +
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 44/203 (21%), Positives = 77/203 (37%), Gaps = 34/203 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVF--HQECARALKSFEAQCEVMKSIRHPNLV 255
           +    IG GSF +VY+       +EVA       +      + F+ + E++K ++HPN+V
Sbjct: 29  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 256 KVISSCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           +   S  +         LV E M  G+L+        ++ I    +        L++L+ 
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLH- 146

Query: 312 GHTTPIIHCDLKPISVLLD-EDMVAHLSDF-----------------------EYGMEGQ 347
             T PIIH DLK  ++ +        + D                        E   E  
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK- 205

Query: 348 VSTRSDIYGYGIVLMETFTRKKP 370
                D+Y +G+ ++E  T + P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYP 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 28/179 (15%), Positives = 54/179 (30%), Gaps = 12/179 (6%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARA---LKSFEAQCEVMKSIRHPNL 254
           RL    G       ++A       +VA+     +       L+   ++   +  I  P +
Sbjct: 34  RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
            +V+          +V E++  GSL+    +S         +  M    +  +     H 
Sbjct: 94  ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HR 147

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDR 373
             +      P  V +  D    L+          + + DI G G  L      + P   
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATM--PDANPQDDIRGIGASLYALLVNRWPLPE 204

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 80/305 (26%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG------IEVAVKVFHQECARALKSFEAQCEVMKSIRHP 252
            L   +G G+FG V+ A   +       + VAVK        A K F+ + E++ +++H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCL---------------YSSTCMLDIFQRLN 297
           ++VK    C + D   +V EYM  G L   L                 +   L + Q L+
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------- 344
           I     S + YL   H    +H DL   + L+  +++  + DF  GM             
Sbjct: 138 IASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDF--GMSRDVYSTDYYRVG 192

Query: 345 ----------------EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNN 387
                             + +T SD++ +G++L E FT  K+P  ++             
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL------------- 239

Query: 388 LLPISLMEVVDKTLLSGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL 445
               S  EV++        +G V      C   +  + + C    P++R+N K+I   L 
Sbjct: 240 ----SNTEVIECI-----TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290

Query: 446 KIRDT 450
            +   
Sbjct: 291 ALGKA 295

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 63/304 (20%), Positives = 109/304 (35%), Gaps = 79/304 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIE------VAVKVFHQECARALKSFEAQCEVMKSIRHP 252
            L   +G G+FG V+ A   + +       VAVK   +    A + F+ + E++  ++H 
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSS--------------TCMLDIFQRLNI 298
           ++V+    C+      +V EYM  G L   L S                  L + Q L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------- 344
                + + YL   H    +H DL   + L+ + +V  + DF  GM              
Sbjct: 164 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDF--GMSRDIYSTDYYRVGG 218

Query: 345 ---------------EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNL 388
                            + +T SD++ +G+VL E FT  K+P  ++              
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-------------- 264

Query: 389 LPISLMEVVDKTLLSGEKKGFV--AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
              S  E +D        +G        C   +  +   C    P++R + KD+  RL  
Sbjct: 265 ---SNTEAIDCI-----TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316

Query: 447 IRDT 450
           +   
Sbjct: 317 LAQA 320

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.5 bits (235), Expect = 7e-21
 Identities = 39/200 (19%), Positives = 75/200 (37%), Gaps = 35/200 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR-LR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLV 255
            +   I  G  G +Y A     +G  V +K       A A     A+ + +  + HP++V
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 256 KVISSCSNDDFKA-----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           ++ +   + D        +V+EY+   SL+         L + + +  +++    L YL 
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYL- 198

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------EYGM-------------EGQVST 350
             H+  +++ DLKP +++L E+ +  L D         +G                  + 
Sbjct: 199 --HSIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRINSFGYLYGTPGFQAPEIVRTGPTV 255

Query: 351 RSDIYGYGIVLMETFTRKKP 370
            +DIY  G  L         
Sbjct: 256 ATDIYTVGRTLAALTLDLPT 275

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 42/214 (19%), Positives = 77/214 (35%), Gaps = 50/214 (23%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIE------VAVKVFHQEC-ARALKSFEAQCEVMKSIRH 251
            +S  +G GSFG VY    +  ++      VA+K  ++    R    F  +  VMK    
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSL---------ENCLYSSTCMLDIFQRLNIMIDA 302
            ++V+++   S      +++E M +G L                     + + + +  + 
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------------ 344
              + YL        +H DL   + ++ ED    + DF  GM                  
Sbjct: 148 ADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDF--GMTRDIYETDYYRKGGKGLL 202

Query: 345 -----------EGQVSTRSDIYGYGIVLMETFTR 367
                      +G  +T SD++ +G+VL E  T 
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 32/150 (21%), Positives = 62/150 (41%), Gaps = 11/150 (7%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
                +G G F  V     L DG   A+K       +  +  + + ++ +   HPN++++
Sbjct: 32  LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91

Query: 258 ISSCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIF---QRLNIMIDATSTLEYLY 310
           ++ C  +        L+L +  +G+L N +       +     Q L +++     LE + 
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI- 150

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             H     H DLKP ++LL ++    L D 
Sbjct: 151 --HAKGYAHRDLKPTNILLGDEGQPVLMDL 178

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 44/207 (21%), Positives = 71/207 (34%), Gaps = 45/207 (21%)

Query: 198 RRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK 256
                 +G GSFG V+R +  + G + AVK    E  R       +      +  P +V 
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +  +     +  + +E +  GSL   +    C+    + L  +  A   LEYL   HT  
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL-PEDRALYYLGQALEGLEYL---HTRR 170

Query: 317 IIHCDLKPISVLLDED-MVAHLSDFEYGMEGQV--------------------------- 348
           I+H D+K  +VLL  D   A L DF  G    +                           
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDF--GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 349 -----STRSDIYGYGIVLMETFTRKKP 370
                  + DI+    +++       P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 59/297 (19%), Positives = 104/297 (35%), Gaps = 75/297 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG------IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRH 251
            L   +G G+FG VY  ++         ++VAVK   + C  +    F  +  ++    H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSS------TCMLDIFQRLNIMIDATST 305
            N+V+ I        + +++E M  G L++ L  +         L +   L++  D    
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDFEYGM------------------ 344
            +YL   H    IH D+   + LL       VA + DF  GM                  
Sbjct: 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDF--GMARDIYRASYYRKGGCAML 207

Query: 345 -----------EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPIS 392
                      EG  ++++D + +G++L E F+    P      +E              
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 253

Query: 393 LMEVVDKTLLSGEKKGFVAK--EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
           ++E V          G      + C   +  +  +C    PE R N   I+ R+   
Sbjct: 254 VLEFV--------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 88.8 bits (221), Expect = 6e-20
 Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 38/204 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR---ALKSF--EAQCEVMKSIRHP 252
           ++ + +G G   +VY A      I+VA+K            LK F  E        + H 
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH--NSSQLSHQ 71

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           N+V +I     DD   LV+EY+   +L   +  S   L +   +N        +++    
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKH---A 127

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEG 346
           H   I+H D+KP ++L+D +    + DF                          E     
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 347 QVSTRSDIYGYGIVLMETFTRKKP 370
                +DIY  GIVL E    + P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 43/219 (19%), Positives = 80/219 (36%), Gaps = 56/219 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG------IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRH 251
           R    +G   FG VY+  L           VA+K    +      + F  +  +   ++H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSL---------------ENCLYSSTCMLDIFQRL 296
           PN+V ++   + D   +++  Y   G L                +   +    L+    +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 297 NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------ 344
           +++    + +EYL   H   ++H DL   +VL+ + +   +SD   G+            
Sbjct: 132 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDL--GLFREVYAADYYKL 186

Query: 345 -----------------EGQVSTRSDIYGYGIVLMETFT 366
                             G+ S  SDI+ YG+VL E F+
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 60/299 (20%), Positives = 104/299 (34%), Gaps = 75/299 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG------IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRH 251
            L   +G G+FG VY  ++         ++VAVK   + C  +    F  +  ++    H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSS------TCMLDIFQRLNIMIDATST 305
            N+V+ I        + ++LE M  G L++ L  +         L +   L++  D    
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDFEYGM------------------ 344
            +YL   H    IH D+   + LL       VA + DF  GM                  
Sbjct: 194 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDF--GMARDIYRAGYYRKGGCAML 248

Query: 345 -----------EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPIS 392
                      EG  ++++D + +G++L E F+    P      +E              
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 294

Query: 393 LMEVVDKTLLSGEKKGFVAK--EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
           ++E V          G      + C   +  +  +C    PE R N   I+ R+     
Sbjct: 295 VLEFV--------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 51/214 (23%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG---IEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPN 253
           +  ++IG G+FG V +AR++     ++ A+K   +       + F  + EV+  +  HPN
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSL---------------ENCLYSSTCMLDIFQRLNI 298
           ++ ++ +C +  +  L +EY P G+L                    S+   L   Q L+ 
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------- 344
             D    ++YL        IH DL   ++L+ E+ VA ++DF  G+              
Sbjct: 148 AADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF--GLSRGQEVYVKKTMGR 202

Query: 345 ------------EGQVSTRSDIYGYGIVLMETFT 366
                           +T SD++ YG++L E  +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 43/222 (19%), Positives = 75/222 (33%), Gaps = 59/222 (26%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIE------VAVKVFHQEC-ARALKSFEAQCEVMKSI-R 250
                +G G+FG V  A     I+      VAVK+          ++  ++ +V+  +  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-----------------YSSTCMLDIF 293
           H N+V ++ +C+      ++ EY   G L N L                       LD+ 
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------- 344
             L+        + +L   +    IH DL   ++LL    +  + DF  G+         
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDF--GLARDIKNDSN 200

Query: 345 --------------------EGQVSTRSDIYGYGIVLMETFT 366
                                   +  SD++ YGI L E F+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 37/214 (17%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVK---VFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
            IG G F  VYRA  L DG+ VA+K   +F    A+A      + +++K + HPN++K  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF---QRLNIMIDATSTLEYLYFGHTT 315
           +S   D+   +VLE    G L   +        +          +   S LE++   H+ 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSR 155

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQVST 350
            ++H D+KP +V +    V  L D                          E   E   + 
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 215

Query: 351 RSDIYGYGIVLMETFTRKKP--TDRMFVEELSLK 382
           +SDI+  G +L E    + P   D+M +  L  K
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 53/227 (23%), Positives = 85/227 (37%), Gaps = 64/227 (28%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIE------VAVKVFHQEC-ARALKSFEAQCEVMKSIRH 251
                IG G+FG V++AR    +       VAVK+  +E  A     F+ +  +M    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSS-----------------------TC 288
           PN+VK++  C+      L+ EYM  G L   L S                          
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 289 MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
            L   ++L I     + + YL        +H DL   + L+ E+MV  ++DF  G+    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF--GLSRNI 224

Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                      + +T SD++ YG+VL E F+
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 59/222 (26%)

Query: 199 RLSNLIGMGSFGSVYRARLRD--------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSI 249
            L   +G G+FG V  A              +VAVK+   +   + L    ++ E+MK I
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 250 -RHPNLVKVISSCSNDDFKALVLEYMPKGSL---------------ENCLYSSTCMLDIF 293
            +H N++ ++ +C+ D    +++EY  KG+L                N  ++    L   
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------- 344
             ++        +EYL        IH DL   +VL+ ED V  ++DF  G+         
Sbjct: 192 DLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADF--GLARDIHHIDY 246

Query: 345 --------------------EGQVSTRSDIYGYGIVLMETFT 366
                               +   + +SD++ +G++L E FT
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 8/147 (5%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG GS G V  AR    G +VAVK+      +  +    +  +M+  +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             +   +++E++  G+L + + S   +        I     + L+ L + H   +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRL----NEEQIATVCEAVLQALAYLHAQGVIHRDI 167

Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVS 349
           K  S+LL  D    LSDF  G   Q+S
Sbjct: 168 KSDSILLTLDGRVKLSDF--GFCAQIS 192

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 35/149 (23%), Positives = 67/149 (44%), Gaps = 17/149 (11%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV---MKSIRHPNLVK 256
             +++G G+ G++    + D  +VAVK    EC           EV    +S  HPN+++
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR-----EVQLLRESDEHPNVIR 82

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
              +  +  F+ + +E     +L+  +          + + ++   TS L +L   H+  
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLN 138

Query: 317 IIHCDLKPISVLLDE-----DMVAHLSDF 340
           I+H DLKP ++L+        + A +SDF
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDF 167

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 64/227 (28%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG------IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRH 251
            L   +G G FG V +A             VAVK+  +      L+   ++  V+K + H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSL-----------------------ENCLYSSTC 288
           P+++K+  +CS D    L++EY   GSL                        +  +    
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 289 MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
            L +   ++     +  ++YL       ++H DL   ++L+ E     +SDF  G+    
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDF--GLSRDV 200

Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    +   +T+SD++ +G++L E  T
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 8/147 (5%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
             D   +V+EY+  GSL + + + TCM        I       L+ L F H+  +IH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTD-VVTETCM----DEGQIAAVCRECLQALEFLHSNQVIHRDI 142

Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVS 349
           K  ++LL  D    L+DF  G   Q++
Sbjct: 143 KSDNILLGMDGSVKLTDF--GFCAQIT 167

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 45/222 (20%), Positives = 85/222 (38%), Gaps = 59/222 (26%)

Query: 199 RLSNLIGMGSFGSVYRARLRD--------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSI 249
            L   +G G+FG V  A             + VAVK+   +   + L    ++ E+MK I
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 250 -RHPNLVKVISSCSNDDFKALVLEYMPKGSL---------------ENCLYSSTCMLDIF 293
            +H N++ ++ +C+ D    +++EY  KG+L                +        +   
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------- 344
             ++        +EYL        IH DL   +VL+ E+ V  ++DF  G+         
Sbjct: 158 DLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADF--GLARDINNIDY 212

Query: 345 --------------------EGQVSTRSDIYGYGIVLMETFT 366
                               +   + +SD++ +G+++ E FT
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 60/306 (19%), Positives = 111/306 (36%), Gaps = 84/306 (27%)

Query: 199 RLSNLIGMGSFGSVYRARLRD--------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSI 249
            L   +G G FG V  A             + VAVK+   +   + L    ++ E+MK I
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 250 -RHPNLVKVISSCSNDDFKALVLEYMPKGSL---------------ENCLYSSTCMLDIF 293
            +H N++ ++ +C+ D    +++EY  KG+L                +        +   
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------- 344
             ++        +EYL        IH DL   +VL+ E+ V  ++DF  G+         
Sbjct: 204 DLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADF--GLARDINNIDY 258

Query: 345 --------------------EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKD 383
                               +   + +SD++ +G+++ E FT    P   + VEE     
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313

Query: 384 WVNNLLPISLMEVVDKTLLSGEKKGFVAK--EQCVLSILGLAMECAMELPEKRINAKDIV 441
                    L +++        K+G        C   +  +  +C   +P +R   K +V
Sbjct: 314 ---------LFKLL--------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

Query: 442 TRLLKI 447
             L +I
Sbjct: 357 EDLDRI 362

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 15/153 (9%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVK 256
            LS+++G G+  +V+R R +  G   A+KVF+     R +     + EV+K + H N+VK
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 257 ---VISSCSNDDFKALVLEYMPKGSLENCLYS--STCMLDIFQRLNIMIDATSTLEYLYF 311
              +    +    K L++E+ P GSL   L    +   L   + L ++ D    + +L  
Sbjct: 72  LFAIEEE-TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-- 128

Query: 312 GHTTPIIHCDLKP----ISVLLDEDMVAHLSDF 340
                I+H ++KP      +  D   V  L+DF
Sbjct: 129 -RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 39/221 (17%), Positives = 78/221 (35%), Gaps = 58/221 (26%)

Query: 199 RLSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-R 250
           +L   +G G+FG V  A             VAVK+  +       ++  ++ +++  I  
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 251 HPNLVKVISSCSNDDFKA-LVLEYMPKGSL---------------ENCLYSSTCMLDIFQ 294
           H N+V ++ +C+       +++E+   G+L                         L +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 295 RLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------- 344
            +         +E+L        IH DL   ++LL E  V  + DF  G+          
Sbjct: 150 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDF--GLARDIYKDPDY 204

Query: 345 -------------------EGQVSTRSDIYGYGIVLMETFT 366
                              +   + +SD++ +G++L E F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 64/227 (28%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG------IEVAVKVFHQEC-ARALKSFEAQCEVMKSI-R 250
               ++G G+FG V  A           I+VAVK+  ++  +   ++  ++ ++M  +  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCL----------------------YSSTC 288
           H N+V ++ +C+      L+ EY   G L N L                           
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 289 MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---- 344
           +L     L         +E+L F      +H DL   +VL+    V  + DF  G+    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDF--GLARDI 222

Query: 345 -------------------------EGQVSTRSDIYGYGIVLMETFT 366
                                    EG  + +SD++ YGI+L E F+
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 43/202 (21%), Positives = 69/202 (34%), Gaps = 34/202 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR---ALKSFEAQCEVMKSIRHPNL 254
           RL  L+G G  G VY A        VA+K+  +  +         + +      ++ P++
Sbjct: 37  RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           V +      D    + +  +    L   L      L   + + I+    S L+     H 
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDA---AHA 152

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQV 348
               H D+KP ++L+  D  A+L DF                          E   E   
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 349 STRSDIYGYGIVLMETFTRKKP 370
           + R+DIY    VL E  T   P
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 15/153 (9%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVK 256
            LS+++G G+  +V+R R +  G   A+KVF+     R +     + EV+K + H N+VK
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 257 ---VISSCSNDDFKALVLEYMPKGSLENCLYS--STCMLDIFQRLNIMIDATSTLEYLYF 311
              +    +    K L++E+ P GSL   L    +   L   + L ++ D    + +L  
Sbjct: 72  LFAIEEE-TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-- 128

Query: 312 GHTTPIIHCDLKP----ISVLLDEDMVAHLSDF 340
                I+H ++KP      +  D   V  L+DF
Sbjct: 129 -RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 6/147 (4%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G+FG VY+A+    G   A KV   +    L+ +  + E++ +  HP +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDL 322
           +D    +++E+ P G+++  +      L   Q   +       L +L   H+  IIH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDL 143

Query: 323 KPISVLLDEDMVAHLSDFEYGMEGQVS 349
           K  +VL+  +    L+DF  G+  +  
Sbjct: 144 KAGNVLMTLEGDIRLADF--GVSAKNL 168

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 41/218 (18%), Positives = 79/218 (36%), Gaps = 55/218 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIE------VAVKVFHQEC-ARALKSFEAQCEVMKSI-R 250
           +    +G G+FG V  A      +      VAVK+      A   ++  ++ ++M  + +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSL-------------ENCLYSSTCMLDIFQRLN 297
           H N+V ++ +C++     ++ EY   G L             +     +         L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------- 344
                   + +L   +    IH D+   +VLL    VA + DF  G+             
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDF--GLARDIMNDSNYIVK 223

Query: 345 ----------------EGQVSTRSDIYGYGIVLMETFT 366
                           +   + +SD++ YGI+L E F+
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 42/196 (21%), Positives = 68/196 (34%), Gaps = 33/196 (16%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV---MKSIRHPNLVKVI 258
            +G GS+G V++ R   DG   AVK                 EV    K  +HP  V++ 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            +        L  E     SL+    +    L   Q    + D    L +L   H+  ++
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL---HSQGLV 179

Query: 319 HCDLKPISVLLDEDMVAHLSDF-------------------EYGM-----EGQVSTRSDI 354
           H D+KP ++ L       L DF                    Y M     +G   T +D+
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRY-MAPELLQGSYGTAADV 238

Query: 355 YGYGIVLMETFTRKKP 370
           +  G+ ++E     + 
Sbjct: 239 FSLGLTILEVACNMEL 254

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 44/210 (20%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR---ALKSF--EAQCEVMKSIRHP 252
            L  ++G G    V+ AR LRD  +VAVKV   + AR       F  EAQ     ++ HP
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHP 72

Query: 253 NLVKVISSCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
            +V V  +   +        +V+EY+   +L + +++    +   + + ++ DA   L +
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNF 131

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------------- 340
               H   IIH D+KP ++++       + DF                            
Sbjct: 132 ---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
           E      V  RSD+Y  G VL E  T + P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 29/112 (25%), Positives = 48/112 (42%), Gaps = 11/112 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
              SNS++   +      K ++ ++LS N LSS    T   L +L+ L L+ NK+     
Sbjct: 103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162

Query: 63  --------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                   +SL+ L LS+N+I    P     +  L  L L+  +L   +   
Sbjct: 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 9/114 (7%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           +I   + + N L    + +      +  +++  N +S   P     L  LK L+L +N+L
Sbjct: 26  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85

Query: 61  DV---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR 105
                       +L  L+L +N I  +      K   L  L LS N L    L 
Sbjct: 86  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 34/126 (26%), Positives = 47/126 (37%), Gaps = 15/126 (11%)

Query: 6   DFSSNSLEGPLSLD-IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
           D   N +   L+      L+ + EI LS N        +   + SL+ L L    L    
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE---GEILRGGPFV 110
                   + +L IL+LSNN I  +    LE L  L+ L L  N L         GGP  
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIY 530

Query: 111 NFTAMS 116
               +S
Sbjct: 531 FLKGLS 536

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 20/112 (17%), Positives = 43/112 (38%), Gaps = 14/112 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIG---GLISLKTLSLAYNK--- 59
           + SSN ++         +  +  + L+   L   +   +       S++ LSL+ ++   
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 60  --------LDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                   L   +L +L+LS N +  +   S   L  L+   L +N ++   
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.2 bits (188), Expect = 6e-15
 Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 17/115 (14%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS--------DMPATIGGLISLKTLSLAY 57
           D S+N++       +  L+ +  ++L  NNL+              + GL  L  L+L  
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545

Query: 58  NKL---------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
           N           D+  L+I++L  N +  L  +     + LK L+L  N +    
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 75.8 bits (187), Expect = 8e-15
 Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 14/125 (11%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK-- 59
                 S  SL          LK +  +N+  N++         GLI+LK LSL+ +   
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

Query: 60  -----------LDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGP 108
                      L  + L ILNL+ N+I  +   +   L +L+ L L  N++  E+  G  
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL-TGQE 425

Query: 109 FVNFT 113
           +    
Sbjct: 426 WRGLE 430

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 18/129 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVA-- 63
           D S N+L    +     L  +    L  NN+      ++ GL +++ L+L  +    +  
Sbjct: 254 DLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313

Query: 64  ----------------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGG 107
                            LE LN+ +N+I G+       L+ LK LSLS +      L   
Sbjct: 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE 373

Query: 108 PFVNFTAMS 116
            FV+     
Sbjct: 374 TFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 69.6 bits (171), Expect = 8e-13
 Identities = 24/125 (19%), Positives = 41/125 (32%), Gaps = 20/125 (16%)

Query: 6   DFSSNSLEGP-------LSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYN 58
             S++            +SL    L     +NL++N +S         L  L+ L L  N
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLH---ILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415

Query: 59  KLDVA----------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGP 108
           ++             ++  + LS N+   L   S   +  L+ L L    L+       P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475

Query: 109 FVNFT 113
           F    
Sbjct: 476 FQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 18/124 (14%)

Query: 6   DFSSNSLEG--PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVA 63
             S+N ++      LDI    ++ ++ LS N +    P     +  L  L L   +L  +
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPS 210

Query: 64  ------------SLEILNLSNNEIYGLIPTSLEKLLY--LKELSLSFNKLEGEILRGGPF 109
                       S+  L+LSN+++     T+   L +  L  L LS+N L    +    F
Sbjct: 211 LTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV--VGNDSF 268

Query: 110 VNFT 113
               
Sbjct: 269 AWLP 272

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 26/117 (22%), Positives = 44/117 (37%), Gaps = 14/117 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S   L     +       +  +NL+ N L     A       L +L + +N +     
Sbjct: 10  DCSHLKLT---QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                +  L++LNL +NE+  L   +      L EL L  N ++   ++  PFV   
Sbjct: 67  ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK--IKNNPFVKQK 121

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 21/113 (18%), Positives = 42/113 (37%), Gaps = 10/113 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           +  SN  +        +L  +  I+L  NNL++   +     +SLK+L+L  N +     
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601

Query: 63  -------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGP 108
                   +L  L++  N       +    + ++ E   +  +L    L   P
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 82.4 bits (203), Expect = 6e-17
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 20/157 (12%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQC---EVMKSIRHPNL 254
            +   +G G FG V R   +D G +VA+K   QE   + K+ E  C   ++MK + HPN+
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNV 74

Query: 255 VKVI------SSCSNDDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTL 306
           V            + +D   L +EY   G L   L  + + C L       ++ D +S L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 307 EYLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDF 340
            YL   H   IIH DLKP +++L    + ++  + D 
Sbjct: 135 RYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 79.7 bits (197), Expect = 9e-17
 Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 18/152 (11%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC 261
           ++G G+FG V +AR   D    A+K         L +  ++  ++ S+ H  +V+  ++ 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 262 SNDDFKA-------------LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY 308
                               + +EY   G+L + ++S        +   +       L Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +   H+  IIH DLKP+++ +DE     + DF
Sbjct: 132 I---HSQGIIHRDLKPMNIFIDESRNVKIGDF 160

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 78.7 bits (195), Expect = 1e-16
 Identities = 37/152 (24%), Positives = 75/152 (49%), Gaps = 19/152 (12%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQE---CARALKSFEAQCEVMKSIRHPNL 254
           ++ NL+G GSF  VYRA  +  G+EVA+K+  ++    A  ++  + + ++   ++HP++
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD------IFQRLNIMIDATSTLEY 308
           +++ +   + ++  LVLE    G +   L +               ++   I     + Y
Sbjct: 74  LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI---ITG---MLY 127

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           L   H+  I+H DL   ++LL  +M   ++DF
Sbjct: 128 L---HSHGILHRDLTLSNLLLTRNMNIKIADF 156

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 9/110 (8%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
              N D S N L    S    +   +  ++LSR  + +        L  L TL L  N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 61  DV---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                      +SL+ L      +  L    +  L  LKEL+++ N ++ 
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 24/109 (22%), Positives = 48/109 (44%), Gaps = 11/109 (10%)

Query: 6   DFSSNSLEGPLSLDI-GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
           DF  ++L+      +  +L+ ++ +++S  +          GL SL+ L +A N      
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                 ++ +L  L+LS  ++  L PT+   L  L+ L++S N      
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 11/115 (9%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
            L+   +  S +G  S       ++  ++LS N + + M +   GL  L+ L   ++ L 
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409

Query: 62  VA----------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                       +L  L++S+             L  L+ L ++ N  +   L  
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 28/110 (25%), Positives = 47/110 (42%), Gaps = 14/110 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVA-- 63
             + N ++         L ++ ++     NL+S     IG L +LK L++A+N +     
Sbjct: 82  ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 64  --------SLEILNLSNNEIYGLIPTSLEKL----LYLKELSLSFNKLEG 101
                   +LE L+LS+N+I  +  T L  L    L    L LS N +  
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 26/115 (22%), Positives = 52/115 (45%), Gaps = 15/115 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKL---- 60
                +L    +  IG+LK + E+N++ N + S  +P     L +L+ L L+ NK+    
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 61  -----DVASLEI----LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                 +  + +    L+LS N +  + P +  K + L +L+L  N     +++ 
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKT 219

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 22/99 (22%), Positives = 33/99 (33%), Gaps = 16/99 (16%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASL 65
           D S   LE        +L ++  +N+S NN  S        L                SL
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL---------------NSL 520

Query: 66  EILNLSNNEIYGLIPTSLEKLLY-LKELSLSFNKLEGEI 103
           ++L+ S N I       L+     L  L+L+ N      
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 559

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 18/116 (15%), Positives = 34/116 (29%), Gaps = 14/116 (12%)

Query: 2   ILNFDFSSNSLEGPLS-LDIGNLKAVVEINLSRNNLSS------DMPATIGGLISLKTLS 54
           +          EG L   D   L+ +  + +    L+       D+      L ++ + S
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288

Query: 55  LAYNKLDV-------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
           L    ++           + L L N +        L+ L  L   S        E+
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 19/115 (16%), Positives = 34/115 (29%), Gaps = 20/115 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPAT-IGGLISLKTLSLAYNKLD--- 61
           D S N +          ++ + ++ L  N  S ++  T I GL  L+   L   +     
Sbjct: 183 DLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241

Query: 62  ---------VASLEILNLSNNEI------YGLIPTSLEKLLYLKELSLSFNKLEG 101
                    +  L  L +    +         I      L  +   SL    +E 
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 40/164 (24%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE----VMKSIRHPN 253
            + +L+G GS+G V            AVK+  ++  R + + EA  +    +++ +RH N
Sbjct: 8   LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67

Query: 254 LVK---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD--------------IFQRL 296
           +++   V+ +        +V+EY   G  E        MLD               F +L
Sbjct: 68  VIQLVDVLYNEEKQKM-YMVMEYCVCGMQE--------MLDSVPEKRFPVCQAHGYFCQL 118

Query: 297 NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
              ID    LEYL   H+  I+H D+KP ++LL       +S  
Sbjct: 119 ---IDG---LEYL---HSQGIVHKDIKPGNLLLTTGGTLKISAL 153

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 32/142 (22%), Positives = 63/142 (44%), Gaps = 7/142 (4%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
            IG GSFG     +   DG +  +K     +  ++  +    +  V+ +++HPN+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
           S   +    +V++Y   G L   + +    +    Q L+  +     L+++   H   I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---HDRKIL 147

Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           H D+K  ++ L +D    L DF
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDF 169

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 10/152 (6%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKV---FHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           IG GSFG+VY AR +R+   VA+K      ++     +    +   ++ +RHPN ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
               +    LV+EY   GS  + L      L   +   +   A   L YL   H+  +IH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIH 177

Query: 320 CDLKPISVLLDEDMVAHLSDFEYGMEGQVSTR 351
            D+K  ++LL E  +  L DF  G    ++  
Sbjct: 178 RDVKAGNILLSEPGLVKLGDF--GSASIMAPA 207

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 31/166 (18%)

Query: 197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV---MKSIRHPN 253
           L     ++G GS G+V       G  VAVK    +            E+    +S  HPN
Sbjct: 16  LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM-----EIKLLTESDDHPN 70

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLE------NCLYSSTCMLDIFQRLNIMIDATSTLE 307
           +++   S + D F  + LE     +L+      N    +  +   +  ++++    S + 
Sbjct: 71  VIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 308 YLYFGHTTPIIHCDLKPISVLLD-------------EDMVAHLSDF 340
           +L   H+  IIH DLKP ++L+              E++   +SDF
Sbjct: 130 HL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 40/153 (26%), Positives = 63/153 (41%), Gaps = 12/153 (7%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVK 256
           R+  ++  G F  VY A+ +  G E A+K          ++   +   MK +  HPN+V+
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 257 VISSCS-------NDDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTLE 307
             S+ S           + L+L  + KG L   L    S   L     L I       ++
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +++     PIIH DLK  ++LL       L DF
Sbjct: 151 HMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 36/157 (22%), Positives = 63/157 (40%), Gaps = 25/157 (15%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISS 260
            LIG G FG V++A+   DG    +K       +A +  E   + +  + H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER--EV--KALAKLDHVNIVHYNGC 72

Query: 261 CSNDDFKA----------------LVLEYMPKGSLENCL-YSSTCMLDIFQRLNIMIDAT 303
               D+                  + +E+  KG+LE  +       LD    L +    T
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             ++Y+   H+  +I+ DLKP ++ L +     + DF
Sbjct: 133 KGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIGDF 166

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 14/165 (8%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPNLVK 256
            L  +IG G+   V  A       +VA+K  + E  +  +     + + M    HPN+V 
Sbjct: 18  ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCL-YSSTCMLDIFQRLN------IMIDATSTLEYL 309
             +S    D   LV++ +  GS+ + + +           L+      I+ +    LEYL
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
              H    IH D+K  ++LL ED    ++DF  G+   ++T  DI
Sbjct: 138 ---HKNGQIHRDVKAGNILLGEDGSVQIADF--GVSAFLATGGDI 177

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 14/148 (9%)

Query: 200 LSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQC----EVMKSIRHPNL 254
           +   +G G FG+VY AR  +    +A+KV  +         E Q     E+   +RHPN+
Sbjct: 13  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNI 71

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI--MIDATSTLEYLYFG 312
           +++     +     L+LEY P G++   L   +   +      I  + +A   L Y    
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA---LSYC--- 125

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           H+  +IH D+KP ++LL       ++DF
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADF 153

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 28/151 (18%), Positives = 56/151 (37%), Gaps = 18/151 (11%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
                +G G F   +           A K+  +         +    +  + +S+ H ++
Sbjct: 44  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-----IFQRLNIMIDATSTLEYL 309
           V       ++DF  +VLE   + SL         + +       +++   +      +YL
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI---VLG---CQYL 157

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
              H   +IH DLK  ++ L+ED+   + DF
Sbjct: 158 ---HRNRVIHRDLKLGNLFLNEDLEVKIGDF 185

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 8/155 (5%)

Query: 196 TLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL 254
            +  +   +G GS+GSVY+A     G  VA+K    E    L+    +  +M+    P++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHV 86

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK   S   +    +V+EY   GS+ + +      L   +   I+      LEYL   H 
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---HF 143

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
              IH D+K  ++LL+ +  A L+DF  G+ GQ++
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADF--GVAGQLT 176

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 28/151 (18%), Positives = 56/151 (37%), Gaps = 18/151 (11%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNL 254
                +G G F   +           A K+  +         +    +  + +S+ H ++
Sbjct: 18  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-----IFQRLNIMIDATSTLEYL 309
           V       ++DF  +VLE   + SL         + +       +++   +      +YL
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI---VLG---CQYL 131

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
              H   +IH DLK  ++ L+ED+   + DF
Sbjct: 132 ---HRNRVIHRDLKLGNLFLNEDLEVKIGDF 159

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 27/146 (18%), Positives = 58/146 (39%), Gaps = 10/146 (6%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNL-- 254
            +   IG G    V++         A+K     +   + L S+  +   +  ++  +   
Sbjct: 59  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +++      D +  +V+E      L + L      +D ++R +   +    +  +   H 
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI---HQ 173

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             I+H DLKP + L+ + M+  L DF
Sbjct: 174 HGIVHSDLKPANFLIVDGML-KLIDF 198

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 14/148 (9%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQC----EVMKSIRHPNL 254
           +   +G G FG+VY AR +     +A+KV  +         E Q     E+   +RHPN+
Sbjct: 18  IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNI 76

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI--MIDATSTLEYLYFG 312
           +++ +   +     L+LE+ P+G L   L       +      +  + DA   L Y    
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA---LHYC--- 130

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           H   +IH D+KP ++L+       ++DF
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADF 158

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 21/120 (17%), Positives = 47/120 (39%), Gaps = 18/120 (15%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
             N +           L   NLK + ++ +      + +P  +  L  ++ +++A N+  
Sbjct: 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286

Query: 62  VA-----------------SLEILNLSNNEIYGL-IPTSLEKLLYLKELSLSFNKLEGEI 103
                               ++I+ +  N +    + TSL+K+  L  L   +N+LEG++
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 12/107 (11%), Positives = 34/107 (31%), Gaps = 5/107 (4%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           D++    +S+  +  +           +I    NN++  +   +  L  L+   +  +  
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                  + E  N    + Y       + L  L ++ +       ++
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 24/122 (19%), Positives = 45/122 (36%), Gaps = 24/122 (19%)

Query: 4   NFDFSSNSLEG-PLSLDIGNLKAVVEINLSRNNLSS-------DMPATIGGLISLKTLSL 55
           N  F+ N L+  P   D  ++  +  I+ S N + S        +  T    I++ +++L
Sbjct: 381 NLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440

Query: 56  AYNKL---------DVASLEILNLSNN-------EIYGLIPTSLEKLLYLKELSLSFNKL 99
           + N++           + L  +NL  N               + +    L  + L FNKL
Sbjct: 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL 500

Query: 100 EG 101
             
Sbjct: 501 TK 502

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 18/118 (15%), Positives = 39/118 (33%), Gaps = 15/118 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEI------NLSRNNLSSDMPATIGGLISLKTLSLAYNK 59
           D S NS          N   +         +   N    + P  I    SL  L +  N 
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 60  LDV------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
           +         ++ +L++ +N    +  + +   +      L ++K +   +RG   ++
Sbjct: 578 IRKVNEKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD--IRGCDALD 633

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 25/116 (21%), Positives = 48/116 (41%), Gaps = 18/116 (15%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
            +   N LEG L    G+   +  +NL+ N ++       G    ++ LS A+NKL    
Sbjct: 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIP 393

Query: 61  ------DVASLEILNLSNNEIYGL-------IPTSLEKLLYLKELSLSFNKLEGEI 103
                  V+ +  ++ S NEI  +       +  +  K + +  ++LS N++    
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFP 449

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 18/97 (18%), Positives = 28/97 (28%), Gaps = 11/97 (11%)

Query: 6   DFSSNSLEG-PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS 64
           D   N L           L  +V I+LS N+ S   P       +LK   +         
Sbjct: 494 DLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ------ 546

Query: 65  LEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
               +   N      P  +     L +L +  N +  
Sbjct: 547 ---RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 17/114 (14%)

Query: 5   FDFSSNSLEGPLSL--------DIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSL 55
            + + N       L        D    + +  I +  NNL +  +  ++  +  L  L  
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337

Query: 56  AYNKL--------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
            YN+L            L  LNL+ N+I  +          ++ LS + NKL+ 
Sbjct: 338 LYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 27/121 (22%), Positives = 39/121 (32%), Gaps = 24/121 (19%)

Query: 5   FDFSSNSLEG-------PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAY 57
            DFS N +         PL         V  INLS N +S            L +++L  
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466

Query: 58  NKL----------------DVASLEILNLSNNEIYGLIPT-SLEKLLYLKELSLSFNKLE 100
           N L                +   L  ++L  N++  L        L YL  + LS+N   
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS 526

Query: 101 G 101
            
Sbjct: 527 K 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 14/111 (12%), Positives = 30/111 (27%), Gaps = 15/111 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDM----PATIGGLISLKTLSLAYN--- 58
                   G +   IG L  +  + L  +    +     P  I   +S +          
Sbjct: 87  SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQ 146

Query: 59  --------KLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                   + D + L    ++++     I  S    L   ++    N +  
Sbjct: 147 KTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 18/115 (15%), Positives = 34/115 (29%), Gaps = 15/115 (13%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV- 62
           NF+   +       + + +   V  ++L     S  +P  IG L  L+ L+L  +   V 
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 63  ------------ASLEILNLSNNEIYGLIPTSL--EKLLYLKELSLSFNKLEGEI 103
                        S E                   E    L +  ++ +  +  I
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 4/113 (3%), Positives = 23/113 (20%), Gaps = 16/113 (14%)

Query: 3   LNFDFSSNSLEG--PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
                     +          +   +++  ++ +     +  +    +    +    N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 61  DV--------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSL------SFNKL 99
                       L    + N+           +    +           ++ L
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 10/45 (22%), Positives = 20/45 (44%)

Query: 64  SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGP 108
            +  L+L      G +P ++ +L  L+ L+L  +  +      GP
Sbjct: 82  RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 35/156 (22%), Positives = 71/156 (45%), Gaps = 10/156 (6%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV---MKSIRHPNLVKVI 258
            IG G FGSV++     DG   A+K   +  A ++    A  EV       +H ++V+  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF---QRLNIMIDATSTLEYLYFGHTT 315
           S+ + DD   +  EY   GSL + +  +  ++  F   +  ++++     L Y+   H+ 
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSM 134

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTR 351
            ++H D+KP ++ +    + + +  E   +   S +
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 10/148 (6%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
            IG GS+G   + R   DG  +  K   +        +   ++  +++ ++HPN+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 260 SCSNDDFKAL--VLEYMPKGSLENCLYSSTCMLDIF---QRLNIMIDATSTLEYLYFGHT 314
              +     L  V+EY   G L + +   T           L +M   T  L+  +    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 315 TP--IIHCDLKPISVLLDEDMVAHLSDF 340
               ++H DLKP +V LD      L DF
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDF 160

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 10/117 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           D S N L+   S    N   +  ++LSR  + +       GL  L  L L  N +     
Sbjct: 38  DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP 97

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                  SLE L     ++  L    + +L+ LK+L+++ N +         F N T
Sbjct: 98  GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 21/106 (19%), Positives = 44/106 (41%), Gaps = 10/106 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLSLAYNKLDV-- 62
           D S  + +         L ++  + ++ N+   +  +       +L  L L+  +L+   
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 63  -------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                    L++LN+S+N +  L  +   +L  L  L  SFN++E 
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 24/113 (21%), Positives = 37/113 (32%), Gaps = 13/113 (11%)

Query: 6   DFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV- 62
           D S N+L   G  S       ++  ++LS N     M A   GL  L+ L   ++ L   
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRV 414

Query: 63  ---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                      L  L++S              L  L  L ++ N  +   L  
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 15/115 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKLDV-- 62
                 L    S  IG L  + ++N++ N + S  +PA    L +L  + L+YN +    
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169

Query: 63  -----------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                           L++S N I  +   +  + + L EL+L  N     I++ 
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF-QGIKLHELTLRGNFNSSNIMKT 223

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 22/97 (22%), Positives = 31/97 (31%), Gaps = 11/97 (11%)

Query: 26  VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIY 76
              I+LS N L      +      L+ L L+  ++          +  L  L L+ N I 
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 77  GLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
              P S   L  L+ L     KL    L   P     
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLAS--LESFPIGQLI 128

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 24/122 (19%), Positives = 48/122 (39%), Gaps = 16/122 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             + N ++         L ++  +      L+S     IG LI+LK L++A+N +     
Sbjct: 86  ILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKL 145

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKL----LYLKELSLSFNKLEGEILRGGPFVN 111
                ++ +L  ++LS N I  +    L+ L         L +S N ++   ++   F  
Sbjct: 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF--IQDQAFQG 203

Query: 112 FT 113
             
Sbjct: 204 IK 205

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 25/127 (19%), Positives = 40/127 (31%), Gaps = 28/127 (22%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPAT------------------ 43
           I  F  +  +      +    L  V  ++L+  ++                         
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF 322

Query: 44  -IGGLISLKTLSLAYNKLDVA-------SLEILNLSNNEIYGLIPTSLE--KLLYLKELS 93
               L  LK+L+L  NK  ++       SL  L+LS N +      S        L+ L 
Sbjct: 323 PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 94  LSFNKLE 100
           LSFN   
Sbjct: 383 LSFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 21/94 (22%), Positives = 29/94 (30%), Gaps = 15/94 (15%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASL 65
           D S   LE         L  +  +N+S NNL     +    L SL T             
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST------------- 525

Query: 66  EILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
             L+ S N I             L   +L+ N +
Sbjct: 526 --LDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 18/116 (15%), Positives = 38/116 (32%), Gaps = 19/116 (16%)

Query: 3   LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPAT-IGGLISLKTLSLAYNK-- 59
           L+ D S N ++  +         + E+ L  N  SS++  T +  L  L    L   +  
Sbjct: 184 LSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242

Query: 60  ---------------LDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                          L   +++   L+    +         L  +  +SL+   ++
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 14/57 (24%), Positives = 22/57 (38%), Gaps = 6/57 (10%)

Query: 51  KTLSLAYNKLDV------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
            T      KL        +S + ++LS N +  L   S      L+ L LS  ++E 
Sbjct: 14  ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 27/146 (18%), Positives = 58/146 (39%), Gaps = 10/146 (6%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNL-- 254
            +   IG G    V++         A+K     +   + L S+  +   +  ++  +   
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +++      D +  +V+E      L + L      +D ++R +   +    +  +   H 
Sbjct: 91  IRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI---HQ 145

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             I+H DLKP + L+ + M+  L DF
Sbjct: 146 HGIVHSDLKPANFLIVDGML-KLIDF 170

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 9/153 (5%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPNLVK 256
                IG GSFG V++    R    VA+K+   E A   ++  + +  V+     P + K
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
              S   D    +++EY+  GS  + L      LD  Q   I+ +    L+YL   H+  
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYL---HSEK 139

Query: 317 IIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
            IH D+K  +VLL E     L+DF  G+ GQ++
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADF--GVAGQLT 170

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 29/148 (19%), Positives = 56/148 (37%), Gaps = 23/148 (15%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSD-MPATIGGLISLKTLSLAYNKLDV-- 62
             S+N  E    +   N  ++  +++  N    +     +  L +L+ L L+++ ++   
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 63  ---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                    + L+ LNLS NE   L   + ++   L+ L L+F +L+       PF N  
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425

Query: 114 A----------MSFKGNEPLCGSPNLQV 131
                      +     +   G P LQ 
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQH 453

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 22/105 (20%), Positives = 34/105 (32%), Gaps = 9/105 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           +FS N L    +     L  +  ++L+R  +      T      L TL L  N L     
Sbjct: 39  EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAE 98

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                  +L+ L      I  +    L     L+ L L  N +  
Sbjct: 99  TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 25/111 (22%), Positives = 36/111 (32%), Gaps = 10/111 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKA--VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
            F     E         L    V  INL ++   +    T      L+ L L    L   
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                 +++L+ L LS N+   L   S      L  LS+  N    E+  G
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 29/122 (23%), Positives = 51/122 (41%), Gaps = 11/122 (9%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
           + + +   +      S        + E++L+  +LS  +P+ + GL +LK L L+ NK +
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFE 314

Query: 62  V---------ASLEILNLSNNEIYGLIPT-SLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                      SL  L++  N     + T  LE L  L+EL LS + +E          N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 112 FT 113
            +
Sbjct: 375 LS 376

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 13/109 (11%)

Query: 6   DFSSNSLEGPLSLDI-GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
           D +   L+   +     NL  +  +NLS + L         GL +L+ L+L  N      
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465

Query: 61  --------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                    +  LEIL LS  ++  +   +   L  +  + LS N+L  
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 27/111 (24%), Positives = 45/111 (40%), Gaps = 12/111 (10%)

Query: 6   DFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV- 62
           D S + +E     +L + NL  +  +NLS N   S           L+ L LA+ +L V 
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 63  ---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL 104
                      L++LNLS++ +        + L  L+ L+L  N      +
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 24/119 (20%), Positives = 41/119 (34%), Gaps = 12/119 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
            F    +     + + N K +  + L  N++SS           LK L    N +     
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170

Query: 61  -DVASLE-----ILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
            D++SL+      LNL+ N+I G I          + L+    +    I +G       
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 20/97 (20%), Positives = 32/97 (32%), Gaps = 11/97 (11%)

Query: 26  VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIY 76
              +  S N L +    T   LI+L  L L   ++             L+ L L+ N + 
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 77  GLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
            +  T+L     LK L      +    +   P  N  
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISS--IDFIPLHNQK 129

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 11/107 (10%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV 62
           +   N               L  +  + LS  +LSS        L  +  + L++N+L  
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514

Query: 63  --------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                        LNL++N I  ++P+ L  L   + ++L  N L+ 
Sbjct: 515 SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 29/122 (23%), Positives = 50/122 (40%), Gaps = 14/122 (11%)

Query: 3   LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGL--ISLKTLSLAYNKL 60
           LNF  + N L     L    ++++        +     PA   GL  +S+++++L  +  
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF 266

Query: 61  DV---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                      + L+ L+L+   +   +P+ L  L  LK+L LS NK E   L      N
Sbjct: 267 FNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFEN--LCQISASN 323

Query: 112 FT 113
           F 
Sbjct: 324 FP 325

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 15/111 (13%), Positives = 43/111 (38%), Gaps = 16/111 (14%)

Query: 6   DFSSNSLEGPLSLDIGNLKA--VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK---- 59
           DF +N++      D+ +L+    + +NL+ N+++  +          ++L+    +    
Sbjct: 159 DFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLV 217

Query: 60  -------LDVASLEILNLSNNEIYGLIPTSLEKL--LYLKELSLSFNKLEG 101
                    + SL +    + +   + P   E L  + ++ ++L  +    
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 13/57 (22%), Positives = 23/57 (40%), Gaps = 6/57 (10%)

Query: 51  KTLSLAYNKLDV------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
           KT +     L+        S E L  S N +  +  T+  +L+ L  L L+  ++  
Sbjct: 15  KTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 26/162 (16%), Positives = 55/162 (33%), Gaps = 29/162 (17%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQC-----------------EVM 246
           +  G F  +     +D    A+K + +      + F                     +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 247 KSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA---- 302
             I++   +      +N D   ++ EYM   S+         +   +     +       
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 303 ---TSTLEYLYFGHTT-PIIHCDLKPISVLLDEDMVAHLSDF 340
               ++  Y+   H    I H D+KP ++L+D++    LSDF
Sbjct: 158 KSVLNSFSYI---HNEKNICHRDVKPSNILMDKNGRVKLSDF 196

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 29/152 (19%), Positives = 55/152 (36%), Gaps = 13/152 (8%)

Query: 200 LSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN 253
           + +L+G G+F  VY A   D        +  +KV                E +K      
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCL----YSSTCMLDIFQRLNIMIDATSTLEYL 309
            +K  S+    +   LV E    G+L N +     +   ++     ++  +     +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE 341
              H   IIH D+KP + +L    +    + +
Sbjct: 189 ---HDCEIIHGDIKPDNFILGNGFLEQDDEDD 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 29/154 (18%), Positives = 63/154 (40%), Gaps = 19/154 (12%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVK-VFHQECARALKSFEAQCEVMKSIRHPNLVKVISS 260
            +G G FG V+ A+   D    A+K +       A +    + + +  + HP +V+  ++
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 261 CSNDDFKA------------LVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTL 306
               +               + ++   K +L++ +    +    +    L+I +     +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           E+L   H+  ++H DLKP ++    D V  + DF
Sbjct: 132 EFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDF 162

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 74.4 bits (183), Expect = 8e-15
 Identities = 27/146 (18%), Positives = 58/146 (39%), Gaps = 10/146 (6%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKV--FHQECARALKSFEAQCEVMKSIRHPNL-- 254
            +   IG G    V++         A+K     +   + L S+  +   +  ++  +   
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +++      D +  +V+E      L + L      +D ++R +   +    +  +   H 
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI---HQ 126

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF 340
             I+H DLKP + L+ + M+  L DF
Sbjct: 127 HGIVHSDLKPANFLIVDGML-KLIDF 151

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 34/156 (21%), Positives = 58/156 (37%), Gaps = 9/156 (5%)

Query: 191 LPSQATLRRLSNLIGMG--SFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE--V 245
              +     L  +IG G     +V  AR    G  V V+  + E          Q E  V
Sbjct: 20  FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79

Query: 246 MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCL-YSSTCMLDIFQRLNIMIDATS 304
            K   HPN+V   ++   D+   +V  +M  GS ++ +       ++      I+     
Sbjct: 80  SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139

Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            L+Y+   H    +H  +K   +L+  D   +LS  
Sbjct: 140 ALDYI---HHMGYVHRSVKASHILISVDGKVYLSGL 172

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 30/235 (12%), Positives = 65/235 (27%), Gaps = 70/235 (29%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVF----------------------------HQECA 233
           ++G     +   A     G    V V                             +Q+ A
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 234 RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM-PKGSLENCL------YSS 286
           +    F    +++K  +   +++V     +    +    Y   + +L+          S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 287 TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------ 340
              L    RL + +     L  L   H   ++H  L+P+ ++LD+     L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 341 ---------------EY----------GMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                          E                ++   D +  G+ +   +    P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 33/162 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVF---------HQECARALKSFEAQCEVMKS 248
               ++G G    V R   +    E AVK+           +E     ++   + ++++ 
Sbjct: 20  EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79

Query: 249 I-RHPNLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNI 298
           +  HPN++++  +   + F  LV + M KG L     E    S       M  +      
Sbjct: 80  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL----- 134

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
                  +  L   H   I+H DLKP ++LLD+DM   L+DF
Sbjct: 135 -----EVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDF 168

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 26/151 (17%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK----VIS 259
           IG GSFG V++A+L +  EVA+K   Q+     +  E Q  +M+ ++HPN+V       S
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR--ELQ--IMRIVKHPNVVDLKAFFYS 103

Query: 260 SCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY------- 310
           +    D     LVLEY+P+      +Y        + +L   +       Y+Y       
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-----TVYR---ASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 311 FGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
           + H+  I H D+KP ++LLD    V  L DF
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 25/232 (10%), Positives = 53/232 (22%), Gaps = 64/232 (27%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNL 254
           +L   + +G    V+  R  +   + A+KVF          L+           +   + 
Sbjct: 65  KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124

Query: 255 VKVISSC----------------------SNDDFKA----LVLEYMPKGSLENC------ 282
            +                             DD+      L++       LE        
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDF 183

Query: 283 LYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-- 340
           +Y       I     +          L    +  ++H    P ++ +  D    L D   
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANL---QSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 341 ---------------EY-------GMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                           Y             +   + +  G+ +   +    P
Sbjct: 241 LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 24/154 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNL 254
            L + +G+G+FG V        G +VAVK+ +++  R+L        + + +K  RHP++
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 255 VK---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-----LDIFQRLNIMIDATSTL 306
           +K   VIS+   D F  +V+EY+  G L + +     +       +FQ++   + A   +
Sbjct: 74  IKLYQVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI---LSA---V 124

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +Y    H   ++H DLKP +VLLD  M A ++DF
Sbjct: 125 DYC---HRHMVVHRDLKPENVLLDAHMNAKIADF 155

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 41/163 (25%), Positives = 64/163 (39%), Gaps = 35/163 (21%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKV-----FHQECARALKSFEAQCEVMKSIRHPN 253
           L  +IG G F  V R   R+ G + AVK+     F      + +  + +  +   ++HP+
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSL---------ENCLYS----STCMLDIFQRLNIMI 300
           +V+++ + S+D    +V E+M    L            +YS    S  M  I        
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL------- 140

Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
                L Y    H   IIH D+KP  VLL   +      L  F
Sbjct: 141 ---EALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 71.0 bits (175), Expect = 5e-14
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 28/157 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
            +   +G G+F  V R   +  G+E A K+ +  +  AR  +  E +  + + ++HPN+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 256 KVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDATSTL 306
           ++  S   + F  LV + +  G L         YS    S C+  I            ++
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESI 118

Query: 307 EYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
            Y    H+  I+H +LKP ++LL    +     L+DF
Sbjct: 119 AYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADF 152

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 71.4 bits (176), Expect = 6e-14
 Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 26/155 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
               ++G G+F  V+  + R  G   A+K   +  A    S E +  V+K I+H N+V +
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 258 ISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDATSTLEY 308
                +     LV++ +  G L     E  +Y+    S  +  +           S ++Y
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----------SAVKY 121

Query: 309 LYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           L   H   I+H DLKP ++L    +E+    ++DF
Sbjct: 122 L---HENGIVHRDLKPENLLYLTPEENSKIMITDF 153

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.4 bits (180), Expect = 6e-14
 Identities = 22/118 (18%), Positives = 47/118 (39%), Gaps = 13/118 (11%)

Query: 5   FDFSSNSLEG-PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
           F    N+LE  P S  +  +  +  ++   N +   + A  G  + L  L L YN++   
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEA-FGTNVKLTDLKLDYNQIEEI 610

Query: 61  ------DVASLEILNLSNNEIYGLIPT-SLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                     +E L  S+N++  +    + + +  +  +  S+NK+  E       ++
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 71.1 bits (174), Expect = 3e-13
 Identities = 21/117 (17%), Positives = 42/117 (35%), Gaps = 19/117 (16%)

Query: 3   LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV 62
            + +           L   NLK + ++ L      + +P  +  L  L++L++A N+   
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529

Query: 63  A------------------SLEILNLSNNEIYGL-IPTSLEKLLYLKELSLSFNKLE 100
           A                   ++I  +  N +       SL+K++ L  L    NK+ 
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 18/97 (18%), Positives = 29/97 (29%), Gaps = 11/97 (11%)

Query: 6   DFSSNSLEG-PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS 64
           D   N L           L  +  +++S N  SS  P        LK   + +       
Sbjct: 734 DLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ------ 786

Query: 65  LEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
               +   N I    PT +     L +L +  N +  
Sbjct: 787 ---RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 21/113 (18%), Positives = 36/113 (31%), Gaps = 17/113 (15%)

Query: 6   DFSSNSLEGPLSL---------DIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSL 55
           + + N       L         D      +    +  NNL      A++  ++ L  L  
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580

Query: 56  AYNKL-------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
            +NK+           L  L L  N+I  +          ++ L  S NKL+ 
Sbjct: 581 VHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 21/119 (17%), Positives = 36/119 (30%), Gaps = 22/119 (18%)

Query: 5   FDFSSNSLEG-----PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK 59
            DFS N +         S+D         + LS N +             + T+ L+ N 
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708

Query: 60  LDV----------------ASLEILNLSNNEIYGLIPT-SLEKLLYLKELSLSFNKLEG 101
           +                    L  ++L  N++  L        L YL  + +S+N    
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS 767

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 21/118 (17%), Positives = 38/118 (32%), Gaps = 15/118 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSR------NNLSSDMPATIGGLISLKTLSLAYNK 59
           D S N           N   +    +        N +    P  I    SL  L +  N 
Sbjct: 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817

Query: 60  LDV------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
           +          L IL++++N    +  TS+   +      L ++K   + +RG   + 
Sbjct: 818 IRKVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT--QDIRGCDALG 873

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 17/113 (15%), Positives = 39/113 (34%), Gaps = 19/113 (16%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIG-GLISLKTLSLAYNKLDV- 62
            D   N +    +   G    + ++ L  N +   +P         ++ L  ++NKL   
Sbjct: 578 LDCVHNKVRHLEA--FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYI 634

Query: 63  ---------ASLEILNLSNNEIYGLIPT-----SLEKLLYLKELSLSFNKLEG 101
                      +  ++ S N+I              K +    ++LS+N+++ 
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 5/107 (4%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           D+L    + N    P+  D        +I    N ++  +   I  L  L+ +  A +  
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPF 460

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
                    E  N    + Y     S   L  L ++ L       ++
Sbjct: 461 TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 21/140 (15%), Positives = 43/140 (30%), Gaps = 11/140 (7%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
           NF+   +       +D+ N   V  ++L+       +P  IG L  LK LS   +     
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 61  ------DVASLEILNLSNNEIYGLI-PTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                 +  + ++     + I        L+    L    L  + +        P    +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDS 421

Query: 114 AMSFKGNEPLCGSPNLQVPP 133
            +S K  +    +  +    
Sbjct: 422 RISLKDTQIGNLTNRITFIS 441

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 12/137 (8%), Positives = 39/137 (28%), Gaps = 38/137 (27%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA----------------------- 42
             +    +G +   IG L  +  ++   ++ +                            
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388

Query: 43  --TIGGLISLKTLSLAYNKL-------DVASLEILNLSNNEIYGL------IPTSLEKLL 87
              +     L    L  + +        +     ++L + +I  L      I  ++++L 
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLT 448

Query: 88  YLKELSLSFNKLEGEIL 104
            L+ +  + +    + +
Sbjct: 449 KLQIIYFANSPFTYDNI 465

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 26/174 (14%), Positives = 55/174 (31%), Gaps = 39/174 (22%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVF----------------------------HQECA 233
           ++G     +   A     G    V V                             +Q+ A
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 234 RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM-PKGSLENCL------YSS 286
           +    F    +++K  +   +++V     +    +    Y   + +L+          S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 287 TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
              L    RL + +     L  L   H   ++H  L+P+ ++LD+     L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGF 250

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 44/177 (24%), Positives = 67/177 (37%), Gaps = 46/177 (25%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE------------- 244
            L + IG GS+G V  A    D    A+KV  ++       F  +               
Sbjct: 16  TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75

Query: 245 -------------VMKSIRHPNLVK---VISSCSNDDFKALVLEYMPKGSL-----ENCL 283
                        ++K + HPN+VK   V+   + D    +V E + +G +        L
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPL 134

Query: 284 YSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
                    FQ L   I     +EYL   H   IIH D+KP ++L+ ED    ++DF
Sbjct: 135 SEDQARF-YFQDL---IKG---IEYL---HYQKIIHRDIKPSNLLVGEDGHIKIADF 181

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 23/153 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLV 255
           RL   IG G+F  V  AR +  G EVA+K+  +         +   EV  MK + HPN+V
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77

Query: 256 K---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-----IFQRLNIMIDATSTLE 307
           K   VI +     +  L++EY   G + + L +   M +      F+++   + A   ++
Sbjct: 78  KLFEVIET-EKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI---VSA---VQ 128

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           Y    H   I+H DLK  ++LLD DM   ++DF
Sbjct: 129 YC---HQKRIVHRDLKAENLLLDADMNIKIADF 158

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 45/154 (29%), Positives = 82/154 (53%), Gaps = 24/154 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNL 254
            L + +G+G+FG V   +    G +VAVK+ +++  R+L        + + +K  RHP++
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 255 VK---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-----LDIFQRLNIMIDATSTL 306
           +K   VIS+  +D F  +V+EY+  G L + +  +  +       +FQ++   +     +
Sbjct: 79  IKLYQVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI---LSG---V 129

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           +Y    H   ++H DLKP +VLLD  M A ++DF
Sbjct: 130 DYC---HRHMVVHRDLKPENVLLDAHMNAKIADF 160

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 28/157 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
            +   +G G+F  V R   +  G+E A K+ +  +  AR  +  E +  + + ++HPN+V
Sbjct: 32  DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91

Query: 256 KVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDATSTL 306
           ++  S   + F  LV + +  G L         YS    S C+  I            ++
Sbjct: 92  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESI 141

Query: 307 EYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
            Y    H+  I+H +LKP ++LL    +     L+DF
Sbjct: 142 AYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADF 175

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 44/194 (22%), Positives = 79/194 (40%), Gaps = 32/194 (16%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPNLVKVISSC 261
           +G G+ G V++   +  G+ +A K+ H E   A       + +V+     P +V    + 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
            +D   ++ +E+M  GSL+  +      +       + I     L YL   H   I+H D
Sbjct: 101 YSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRD 157

Query: 322 LKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------STRSDIYG 356
           +KP ++L++      L DF  G+ GQ+                         S +SDI+ 
Sbjct: 158 VKPSNILVNSRGEIKLCDF--GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 215

Query: 357 YGIVLMETFTRKKP 370
            G+ L+E    + P
Sbjct: 216 MGLSLVEMAVGRYP 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 28/155 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE----VMKSIRHPN 253
            L   +G G++G V  A        VAVK+   +            +    + K + H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPENIKKEICINKMLNHEN 66

Query: 254 LVK---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-----LDIFQRLNIMIDATST 305
           +VK         N  +  L LEY   G L + +     M        F +L   +     
Sbjct: 67  VVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MAG--- 117

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           + YL   H   I H D+KP ++LLDE     +SDF
Sbjct: 118 VVYL---HGIGITHRDIKPENLLLDERDNLKISDF 149

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 35/163 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH--------QECARALKSFEAQCEVMKSI 249
            +S  +G G+ G V  A  R    +VA+++             A    + E + E++K +
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMI 300
            HP ++K+ +    +D+  +VLE M  G L      N              +        
Sbjct: 198 NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 249

Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
                ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 250 ---LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 286

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 28/157 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH--QECARALKSFEAQCEVMKSIRHPNLV 255
            +  ++G GSFG V + + R    E AVKV +      +   +   + E++K + HPN++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 256 KVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDATSTL 306
           K+     +     +V E    G L     +   +S    +  +  +F          S +
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----------SGI 134

Query: 307 EYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
            Y+   H   I+H DLKP ++LL   ++D    + DF
Sbjct: 135 TYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDF 168

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 28/157 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVF--HQECARALKSFEAQCEVMKSIRHPNLV 255
           +L   +G G+F  V R      G E A  +    +  AR  +  E +  + + ++HPN+V
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 256 KVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDATSTL 306
           ++  S S +    L+ + +  G L         YS    S C+  I             +
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAV 123

Query: 307 EYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
            +    H   ++H +LKP ++LL    +     L+DF
Sbjct: 124 LHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADF 157

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 24/157 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQC--------EVMKSI 249
              + +G G+FG V+ A       EV VK   +E        E            ++  +
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGS-LENCLYSSTCMLD-----IFQRLNIMIDAT 303
            H N++KV+    N  F  LV+E    G  L   +     + +     IF++L   + A 
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL---VSA- 142

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             + YL       IIH D+K  ++++ ED    L DF
Sbjct: 143 --VGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDF 174

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 27/117 (23%), Positives = 43/117 (36%), Gaps = 10/117 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           D S N L    S    +   +  ++LSR  + +        L  L TL L  N +     
Sbjct: 34  DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL 93

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                 +SL+ L      +  L    +  L  LKEL+++ N ++        F N T
Sbjct: 94  GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 24/105 (22%), Positives = 50/105 (47%), Gaps = 11/105 (10%)

Query: 6   DFSSNSLEGPLSLDI-GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
           DF  ++L+      +  +L+ ++ +++S  +          GL SL+ L +A N      
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                 ++ +L  L+LS  ++  L PT+   L  L+ L+++ N+L
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 13/113 (11%)

Query: 6   DFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV- 62
           D S N L   G  S       ++  ++LS N + + M +   GL  L+ L   ++ L   
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 63  ---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                     +L  L++S+             L  L+ L ++ N  +   L  
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 26/115 (22%), Positives = 49/115 (42%), Gaps = 15/115 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKLDV-- 62
                +L    +  IG+LK + E+N++ N + S  +P     L +L+ L L+ NK+    
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165

Query: 63  -----------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                           L+LS N +  + P +  K + L +L+L  N     +++ 
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKT 219

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 11/97 (11%)

Query: 26  VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIY 76
              ++LS N L      +      L+ L L+  ++          ++ L  L L+ N I 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 77  GLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
            L   +   L  L++L      L    L   P  +  
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLAS--LENFPIGHLK 124

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 19/104 (18%), Positives = 45/104 (43%), Gaps = 10/104 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKLDV-- 62
           D S        +     L ++  + ++ N+   +    I   L +L  L L+  +L+   
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 63  -------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                  +SL++LN+++N++  +     ++L  L+++ L  N  
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 28/105 (26%), Positives = 38/105 (36%), Gaps = 16/105 (15%)

Query: 5   FDFSSNSLEGPLSLDI-GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVA 63
           F   S ++E           + +  +N       +        L SLK L+   NK   A
Sbjct: 287 FSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNA 340

Query: 64  -------SLEILNLSNNEIY--GLIPTSLEKLLYLKELSLSFNKL 99
                  SLE L+LS N +   G    S      LK L LSFN +
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 28/155 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE----VMKSIRHPN 253
            L   +G G++G V  A        VAVK+   +            +    + K + H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPENIKKEICINKMLNHEN 66

Query: 254 LVK---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-----LDIFQRLNIMIDATST 305
           +VK         N  +  L LEY   G L + +     M        F +L   +     
Sbjct: 67  VVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL---MAG--- 117

Query: 306 LEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           + YL   H   I H D+KP ++LLDE     +SDF
Sbjct: 118 VVYL---HGIGITHRDIKPENLLLDERDNLKISDF 149

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 32/161 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVF--------HQECARALKSFEAQCEVMKSI 249
              ++IG G    V R   R  G E AVK+          ++     ++   +  +++ +
Sbjct: 97  DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 250 R-HPNLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIM 299
             HP+++ +I S  +  F  LV + M KG L     E    S     + M  +       
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL------ 210

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
                 + +L   H   I+H DLKP ++LLD++M   LSDF
Sbjct: 211 ----EAVSFL---HANNIVHRDLKPENILLDDNMQIRLSDF 244

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 42/144 (29%), Positives = 64/144 (44%), Gaps = 12/144 (8%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVI 258
           ++G GSF +V  AR      E A+K+  +              + +VM  + HP  VK+ 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNI--MIDATSTLEYLYFGHTTP 316
            +  +D+     L Y   G L   +       +   R     ++ A   LEYL   H   
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA---LEYL---HGKG 150

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF 340
           IIH DLKP ++LL+EDM   ++DF
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDF 174

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 35/163 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH--------QECARALKSFEAQCEVMKSI 249
            +S  +G G+ G V  A  R    +VA+K+             A    + E + E++K +
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 250 RHPNLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMI 300
            HP ++K+ +    +D+  +VLE M  G L      N              +        
Sbjct: 73  NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML------- 124

Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
                ++YL   H   IIH DLKP +VLL   +ED +  ++DF
Sbjct: 125 ---LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 40/155 (25%), Positives = 63/155 (40%), Gaps = 26/155 (16%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            L N IG GS+G V  A  +   I  A K   +     +  F+ + E+MKS+ HPN++++
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 258 ISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDATSTLEY 308
             +  ++    LV+E    G L        ++     +  M D+           S + Y
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL----------SAVAY 121

Query: 309 LYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
               H   + H DLKP + L      D    L DF
Sbjct: 122 C---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 25/108 (23%), Positives = 44/108 (40%), Gaps = 9/108 (8%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
           + + D S   +    S     LK +  +NL+ N ++        GL +L+ L+L+YN L 
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 62  V---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                       +  ++L  N I  +   + + L  L+ L L  N L 
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 27/102 (26%), Positives = 45/102 (44%), Gaps = 10/102 (9%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----------DVASLEILNLS 71
            L     + LS N + +   ++   L  L+ L L               ++ +L IL+L 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
           +++IY L P + + L +L EL L F  L   +L+ G F N  
Sbjct: 82  SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 29/110 (26%), Positives = 46/110 (41%), Gaps = 16/110 (14%)

Query: 6   DFSSNSLEG-PLSLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKLDVA 63
             S N LE   +   +  +  +  + L++N  SS     T     SL+ L L  N L +A
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466

Query: 64  --------------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                          L++L L++N +  L P     L  L+ LSL+ N+L
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 14/108 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDM--PATIGGLISLKTLSLAYNKLDV- 62
           D  S+ +          L  + E+ L    LS  +        L +L  L L+ N++   
Sbjct: 79  DLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138

Query: 63  ---------ASLEILNLSNNEIYGLIPTSLEKL--LYLKELSLSFNKL 99
                     SL+ ++ S+N+I+ +    LE L    L   SL+ N L
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 29/153 (18%), Positives = 55/153 (35%), Gaps = 24/153 (15%)

Query: 6   DFSSNSLEGPL--SLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNK--- 59
                 L   +       NLKA+  ++LS+N + S  +  + G L SLK++  + N+   
Sbjct: 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162

Query: 60  --------LDVASLEILNLSNNEIYGLIPTSLEKL------LYLKELSLSFNKLEGEILR 105
                   L   +L   +L+ N +Y  +     K       + L+ L +S N    +I  
Sbjct: 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI-- 220

Query: 106 GGPFVNFTAMSFKGNEPLCGSPNLQVPPCKLNK 138
                   A+S      L  + ++       + 
Sbjct: 221 --TGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 35/183 (19%), Positives = 68/183 (37%), Gaps = 21/183 (11%)

Query: 6   DFSSNSLEGPLSLDI-----GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
               N L+     ++       L  +  + L+ N L+S  P     L +L+ LSL  N+L
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 61  DV-------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
            V       A+LEIL++S N++    P        L  L ++ NK   E      F+N+ 
Sbjct: 517 TVLSHNDLPANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICEC-ELSTFINWL 572

Query: 114 AMSFKG-----NEPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLSTALIIVVII 168
             +         +  C  P+        +   +     + +  L   L +   + + + +
Sbjct: 573 NHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFL 632

Query: 169 LAL 171
           + +
Sbjct: 633 MTI 635

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 21/103 (20%), Positives = 41/103 (39%), Gaps = 14/103 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           + + N +          L  +  +NLS N L     +   GL  +  + L  N +     
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                +  L+ L+L +N +     T++  +  + ++ LS NKL
Sbjct: 356 QTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL 393

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 25/129 (19%), Positives = 49/129 (37%), Gaps = 29/129 (22%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVV------EINLSRNNLSSDMPATIGGLIS----- 49
            +  F  ++NSL   +S+D G             +++S N  + D+       IS     
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234

Query: 50  -------LKTLSLAYNKLDV-----------ASLEILNLSNNEIYGLIPTSLEKLLYLKE 91
                  +      ++ +             +S+  L+LS+  ++ L     E L  LK 
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294

Query: 92  LSLSFNKLE 100
           L+L++NK+ 
Sbjct: 295 LNLAYNKIN 303

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 20/103 (19%), Positives = 42/103 (40%), Gaps = 11/103 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKA--VVEINLSRNNLSSDMPATIGGL------ISLKTLSLAY 57
           DFSSN +      ++  L+   +   +L+ N+L S +    G        + L+ L ++ 
Sbjct: 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213

Query: 58  NKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           N     +++I    +N I      SL    ++      F+ ++
Sbjct: 214 NGW---TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 25/122 (20%), Positives = 43/122 (35%), Gaps = 20/122 (16%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D   N+L       I  + ++ +I LS N L +     +    +   + L+ N+L     
Sbjct: 368 DLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDI 418

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKLLY-LKELSLSFNKLEGEILRGGPFVNFTA 114
                 V  L+IL L+ N                L++L L  N L+        +  F  
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478

Query: 115 MS 116
           +S
Sbjct: 479 LS 480

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 34/162 (20%), Positives = 62/162 (38%), Gaps = 36/162 (22%)

Query: 196 TLRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPN 253
            L      +G GSF    +   +      AVK+  +   R   + + +   +K    HPN
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPN 67

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL------------NIMID 301
           +VK+     +     LV+E +  G L             F+R+             IM  
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRK 114

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
             S + ++   H   ++H DLKP ++L    ++++   + DF
Sbjct: 115 LVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 6/117 (5%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           D    D  +N +      D  NLK +  + L  N +S   P     L+ L+ L L+ N+L
Sbjct: 53  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

Query: 61  DV------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                    +L+ L +  NEI  +  +    L  +  + L  N L+   +  G F  
Sbjct: 113 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 22/135 (16%), Positives = 51/135 (37%), Gaps = 23/135 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             +  ++    ++  G   ++ E++L  N ++    A++ GL +L  L L++N +     
Sbjct: 177 RIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 233

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMS 116
               +   L  L+L+NN++   +P  L    Y++ + L  N +              +  
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS----------AIGSND 282

Query: 117 FKGNEPLCGSPNLQV 131
           F          +   
Sbjct: 283 FCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 23/87 (26%), Positives = 36/87 (41%), Gaps = 8/87 (9%)

Query: 22  NLKAVVEINLSRNNLSSDM--PATIGGLISLKTLSLAYNKLDV------ASLEILNLSNN 73
            L  ++ + L  N L S         G+  L  + +A   +         SL  L+L  N
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGN 202

Query: 74  EIYGLIPTSLEKLLYLKELSLSFNKLE 100
           +I  +   SL+ L  L +L LSFN + 
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSIS 229

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 23/123 (18%), Positives = 45/123 (36%), Gaps = 14/123 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N +    +  +  L  + ++ LS N++S+    ++     L+ L L  NKL     
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 257

Query: 61  ---DVASLEILNLSNNEIYGL------IPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
              D   ++++ L NN I  +       P    K      +SL  N ++   ++   F  
Sbjct: 258 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317

Query: 112 FTA 114
              
Sbjct: 318 VYV 320

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 12/88 (13%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSN 72
            +K +  I ++  N+++ +P   G   SL  L L  NK+            +L  L LS 
Sbjct: 169 GMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           N I  +   SL    +L+EL L+ NKL 
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV 253

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 29/132 (21%), Positives = 55/132 (41%), Gaps = 24/132 (18%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS 262
           +G G FG V++      G+++A K+      +  +  + +  VM  + H NL+++  +  
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156

Query: 263 NDDFKALVLEYMPKGSL------ENCLYS----STCMLDIFQRLNIMIDATSTLEYLYFG 312
           + +   LV+EY+  G L      E+   +       M  I             + ++   
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC----------EGIRHM--- 203

Query: 313 HTTPIIHCDLKP 324
           H   I+H DLKP
Sbjct: 204 HQMYILHLDLKP 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 25/154 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEA---QCEVMKSIRHPNL 254
            +   +G GSFG V  A   +   +VA+K   ++  +          +   +K +RHP++
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71

Query: 255 VK---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-----LDIFQRLNIMIDATSTL 306
           +K   VI++   D    +V+EY   G L + +     M        FQ++   I A   +
Sbjct: 72  IKLYDVITT-PTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI---ICA---I 121

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
           EY    H   I+H DLKP ++LLD+++   ++DF
Sbjct: 122 EYC---HRHKIVHRDLKPENLLLDDNLNVKIADF 152

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 24/117 (20%), Positives = 40/117 (34%), Gaps = 6/117 (5%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           D    D  +N +      D   L+ +  + L  N +S         L  L+ L ++ N L
Sbjct: 55  DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

Query: 61  DV------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVN 111
                   +SL  L + +N I  +       L  +  + +  N LE      G F  
Sbjct: 115 VEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 21/134 (15%), Positives = 41/134 (30%), Gaps = 23/134 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             S   L     +     + + E++L  N + +     +     L  L L +N++     
Sbjct: 178 RISEAKLT---GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN 234

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMS 116
                + +L  L+L NN++   +P  L  L  L+ + L  N +                 
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----------KVGVND 283

Query: 117 FKGNEPLCGSPNLQ 130
           F             
Sbjct: 284 FCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 23/125 (18%), Positives = 42/125 (33%), Gaps = 14/125 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N ++     D+     +  + L  N +      ++  L +L+ L L  NKL     
Sbjct: 199 HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPA 258

Query: 61  ---DVASLEILNLSNNEIYGLIPTS------LEKLLYLKELSLSFNKLEGEILRGGPFVN 111
              D+  L+++ L  N I  +            K  Y   +SL  N +    ++   F  
Sbjct: 259 GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

Query: 112 FTAMS 116
            T   
Sbjct: 319 VTDRL 323

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 12/82 (14%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSNNEIYGL 78
            + +S   L+  +P       +L  L L +NK+           + L  L L +N+I  +
Sbjct: 176 YLRISEAKLTG-IPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232

Query: 79  IPTSLEKLLYLKELSLSFNKLE 100
              SL  L  L+EL L  NKL 
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLS 254

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 9/103 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKLDV-- 62
             ++N +     LD G    V  ++L  N + + +         +L+ L+L YN +    
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK 185

Query: 63  -----ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                A L+ L+LS+N++   +    +    +  +SL  NKL 
Sbjct: 186 GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 13/101 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           + SSN L   L  D+ +L  +  ++L+ N +       +    S++TL  A N +     
Sbjct: 64  NLSSNVLYETL--DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRVSC 116

Query: 63  ---ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                 + + L+NN+I  L          ++ L L  N+++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 24/102 (23%), Positives = 45/102 (44%), Gaps = 12/102 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             + +SL+  L+    +   V E++LS N LS    A +     L+ L+L+ N L     
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
              +++L  L+L+NN +       L     ++ L  + N + 
Sbjct: 76  LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 22/90 (24%), Positives = 39/90 (43%), Gaps = 11/90 (12%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNL 70
             N        ++ ++L   + +      ++K L L+ N L             LE+LNL
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 71  SNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           S+N +Y  +   LE L  L+ L L+ N ++
Sbjct: 66  SSNVLYETLD--LESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 27/141 (19%), Positives = 48/141 (34%), Gaps = 13/141 (9%)

Query: 6   DFSSNSLEG-PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
           D   N ++    +    +   +  +NL  N +   +   +     LKTL L+ NKL    
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLAFMG 207

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMS 116
                 A +  ++L NN++  LI  +L     L+   L  N      LR   F     + 
Sbjct: 208 PEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQ 265

Query: 117 FKGNEPLCGSPNLQVPPCKLN 137
               + +          C + 
Sbjct: 266 TVAKQTVKKLTGQNEEECTVP 286

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 2/94 (2%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASL 65
           D SSN L   +  +  +   V  I+L  N L   +   +    +L+   L  N     +L
Sbjct: 197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 66  EILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                 N  +  +   +++KL    E   +   L
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 29/154 (18%), Positives = 59/154 (38%), Gaps = 26/154 (16%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +   +G G+FG V+R   +  G     K  +        + + +  +M  + HP L+ + 
Sbjct: 55  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114

Query: 259 SSCSNDDFKALVLEYMPKGSL------ENCLYS----STCMLDIFQRLNIMIDATSTLEY 308
            +  +     L+LE++  G L      E+   S       M                L++
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC----------EGLKH 164

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHL--SDF 340
           +   H   I+H D+KP +++ +    + +   DF
Sbjct: 165 M---HEHSIVHLDIKPENIMCETKKASSVKIIDF 195

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 26/144 (18%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK----VI 258
           IG GSFG VY+A+L D G  VA+K   Q+     +  E Q  +M+ + H N+V+      
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--ELQ--IMRKLDHCNIVRLRYFFY 117

Query: 259 SSCSNDDFKAL--VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY------ 310
           SS    D   L  VL+Y+P    E  +Y    +   + R    +       Y+Y      
Sbjct: 118 SSGEKKDEVYLNLVLDYVP----ET-VYR---VARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 311 -FGHTTPIIHCDLKPISVLLDEDM 333
            + H+  I H D+KP ++LLD D 
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDT 193

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 39/161 (24%), Positives = 65/161 (40%), Gaps = 35/161 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVF---HQECARALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSFG V   + +  G E AVKV      +     +S   + +++K + HPN+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL------------NIMIDA 302
           +K+     +  +  LV E    G L             F  +             I+   
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARIIRQV 135

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
            S + Y+   H   I+H DLKP ++LL    +D    + DF
Sbjct: 136 LSGITYM---HKNKIVHRDLKPENLLLESKSKDANIRIIDF 173

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 36/160 (22%), Positives = 63/160 (39%), Gaps = 34/160 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVF--HQECARALKSFEAQCEVMKSIRHPNLV 255
           +    +G G++G V   R +   +E A+K+         +      +  V+K + HPN++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL------------NIMIDAT 303
           K+     +     LV+E    G L             F  +             I+    
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFNEVDAAVIIKQVL 146

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           S + YL   H   I+H DLKP ++LL   ++D +  + DF
Sbjct: 147 SGVTYL---HKHNIVHRDLKPENLLLESKEKDALIKIVDF 183

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 9/103 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           D   N ++     +  +   + E+ L+ N +S+  P     L +L+TL L  N+L +   
Sbjct: 38  DLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPL 97

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                 ++L  L++S N+I  L+    + L  LK L +  N L
Sbjct: 98  GVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 24/103 (23%), Positives = 39/103 (37%), Gaps = 9/103 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S N +   L     +L  +  + +  N+L         GL SL+ L+L    L     
Sbjct: 110 DISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                +  L +L L +  I  +   S ++L  LK L +S    
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 19/104 (18%), Positives = 48/104 (46%), Gaps = 9/104 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           + S       ++ +      +  ++++  NL++     +  L+ L+ L+L+YN +     
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG 265

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               ++  L+ + L   ++  + P +   L YL+ L++S N+L 
Sbjct: 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 9/88 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
            L  + ++++S N +   +      L +LK+L +  N L          + SLE L L  
Sbjct: 102 GLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK 161

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
             +  +   +L  L  L  L L    + 
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 22/118 (18%), Positives = 41/118 (34%), Gaps = 11/118 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
                ++          L  +  + +S       M       ++L +LS+ +  L     
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
                +  L  LNLS N I  +  + L +LL L+E+ L   +L   ++    F     
Sbjct: 242 LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL--AVVEPYAFRGLNY 297

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 23/103 (22%), Positives = 45/103 (43%), Gaps = 9/103 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             +  +L     L + +L  +  +NLS N +S+   + +  L+ L+ + L   +L     
Sbjct: 230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                +  L +LN+S N++  L  +    +  L+ L L  N L
Sbjct: 290 YAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 19/98 (19%), Positives = 36/98 (36%), Gaps = 11/98 (11%)

Query: 26  VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIY 76
              ++L +N + +           L+ L L  N +         ++ +L  L L +N + 
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93

Query: 77  GLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
            +       L  L +L +S NK+   IL    F +   
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKI--VILLDYMFQDLYN 129

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 15/160 (9%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVK 256
            L  L+G G++G VY+ R ++ G   A+KV         +  + +  ++K    H N+  
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 257 VISS------CSNDDFKALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYL 309
              +         DD   LV+E+   GS+ + + ++    L       I  +    L +L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVS 349
              H   +IH D+K  +VLL E+    L DF  G+  Q+ 
Sbjct: 146 ---HQHKVIHRDIKGQNVLLTENAEVKLVDF--GVSAQLD 180

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 13/101 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           + SSN L   L  D+ +L  +  ++L+ N +       +    S++TL  A N +     
Sbjct: 64  NLSSNVLYETL--DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRVSC 116

Query: 63  ---ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                 + + L+NN+I  L          ++ L L  N+++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 9/103 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKLDV-- 62
             ++N +     LD G    V  ++L  N + + +         +L+ L+L YN +    
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK 185

Query: 63  -----ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                A L+ L+LS+N++   +    +    +  +SL  NKL 
Sbjct: 186 GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 24/102 (23%), Positives = 45/102 (44%), Gaps = 12/102 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             + +SL+  L+    +   V E++LS N LS    A +     L+ L+L+ N L     
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD 75

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
              +++L  L+L+NN +       L     ++ L  + N + 
Sbjct: 76  LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 2/94 (2%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASL 65
           D SSN L   +  +  +   V  I+L  N L   +   +    +L+   L  N     +L
Sbjct: 197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 66  EILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                 N  +  +   +++KL    E   +   L
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 14/82 (17%), Positives = 27/82 (32%), Gaps = 15/82 (18%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLI 79
             N        ++ ++L   + +      ++K L               +LS N +  + 
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKEL---------------DLSGNPLSQIS 50

Query: 80  PTSLEKLLYLKELSLSFNKLEG 101
              L     L+ L+LS N L  
Sbjct: 51  AADLAPFTKLELLNLSSNVLYE 72

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 34/160 (21%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVF--HQECARALKSFEAQCEVMKSIRHPNLV 255
            +  ++G GSFG V + + R    E AVKV        +   +   + E++K + HPN++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL------------NIMIDAT 303
           K+     +     +V E    G L             F  +             I+    
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVF 131

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           S + Y+   H   I+H DLKP ++LL   ++D    + DF
Sbjct: 132 SGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDF 168

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 21/103 (20%), Positives = 44/103 (42%), Gaps = 12/103 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             + +++     L   NL  +  +NL  N+  SD  + +  +  L  L++  +K+     
Sbjct: 116 YLNEDNISDISPL--ANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP 172

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
             ++  L  L+L+ N+I  + P  L  L  L   +   N++  
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 63.7 bits (156), Expect = 3e-11
 Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 11/103 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
              +N +     L   NL  +  + +  N +S      +  L  LK L++  N++     
Sbjct: 227 KIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV 282

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
             +++ L  L L+NN++       +  L  L  L LS N +  
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 58.7 bits (143), Expect = 1e-09
 Identities = 23/124 (18%), Positives = 47/124 (37%), Gaps = 16/124 (12%)

Query: 19  DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLS 71
            I  L  +  +NL+ N ++   P  +  L+ L  L +  NK+       ++ +L  L L+
Sbjct: 61  GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQNLTNLRELYLN 118

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGN-----EPLCGS 126
            + I  + P  L  L  +  L+L  N    ++           ++   +      P+   
Sbjct: 119 EDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANL 176

Query: 127 PNLQ 130
            +L 
Sbjct: 177 TDLY 180

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.9 bits (141), Expect = 2e-09
 Identities = 20/104 (19%), Positives = 40/104 (38%), Gaps = 15/104 (14%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           +  +N +    ++   +L  +  +N+  N +S    + +  L  L +L L  N+L     
Sbjct: 249 EIGTNQISDINAV--KDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDM 304

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                  +L  L LS N I  + P  L  L  +     +   ++
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 19/103 (18%), Positives = 47/103 (45%), Gaps = 13/103 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
                S+   ++     L+++ ++ ++   ++S     I  L +L+ L+L  N++     
Sbjct: 28  VLQKASVTDVVTQ--EELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP 83

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
             ++  L  L +  N+I     ++L+ L  L+EL L+ + +  
Sbjct: 84  LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD 124

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 19/138 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N +     +   N+  +  + +  N ++   P  +  L  L  L +  N++     
Sbjct: 205 TAYVNQITDITPV--ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA 260

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSF 117
             D+  L++LN+ +N+I  +    L  L  L  L L+ N+L  E +   G   N T +  
Sbjct: 261 VKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318

Query: 118 KGN-----EPLCGSPNLQ 130
             N      PL     + 
Sbjct: 319 SQNHITDIRPLASLSKMD 336

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 56.0 bits (136), Expect = 8e-09
 Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 11/88 (12%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSN 72
             +L   +   L + +++     T   L S+  L +A  K+        + +LE LNL+ 
Sbjct: 18  DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNG 75

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           N+I  + P  L  L+ L  L +  NK+ 
Sbjct: 76  NQITDISP--LSNLVKLTNLYIGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 40.2 bits (95), Expect = 9e-04
 Identities = 11/81 (13%), Positives = 29/81 (35%), Gaps = 11/81 (13%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSNNEIYGLIP 80
            +      ++   P     L       L    +       ++ S+  L ++  ++  +  
Sbjct: 4   TLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASI-- 59

Query: 81  TSLEKLLYLKELSLSFNKLEG 101
             +E L  L+ L+L+ N++  
Sbjct: 60  QGIEYLTNLEYLNLNGNQITD 80

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 37/154 (24%), Positives = 57/154 (37%), Gaps = 26/154 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE----VMKSIRHPN 253
                IG G+FG     R       VAVK   +       + +   +      +S+RHPN
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-----AAIDENVQREIINHRSLRHPN 77

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-----LDIFQRLNIMIDATSTLEY 308
           +V+           A+++EY   G L   + ++           FQ+L   +     + Y
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL---LSG---VSY 131

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHL--SDF 340
               H+  I H DLK  + LLD      L   DF
Sbjct: 132 C---HSMQICHRDLKLENTLLDGSPAPRLKICDF 162

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 35/154 (22%), Positives = 58/154 (37%), Gaps = 26/154 (16%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +   +G G+FG V+R   R  G   A K          ++   + + M  +RHP LV + 
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 259 SSCSNDDFKALVLEYMPKGSL------ENCLYS----STCMLDIFQRLNIMIDATSTLEY 308
            +  +D+   ++ E+M  G L      E+   S       M  + + L  M         
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM--------- 271

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHL--SDF 340
               H    +H DLKP +++        L   DF
Sbjct: 272 ----HENNYVHLDLKPENIMFTTKRSNELKLIDF 301

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 47/223 (21%), Positives = 74/223 (33%), Gaps = 46/223 (20%)

Query: 180 KRGLDVSNDGILPSQATLRRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARA-LK 237
              L +S +      A   +    IG G++GSV +      G  +AVK           K
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65

Query: 238 SFEAQCEV-MKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL 296
                 +V M+S   P +V+   +   +    + +E M   S +           +   +
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVI 122

Query: 297 N------IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV-- 348
                  I +     L +L       IIH D+KP ++LLD      L DF  G+ GQ+  
Sbjct: 123 PEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF--GISGQLVD 178

Query: 349 ----------------------------STRSDIYGYGIVLME 363
                                         RSD++  GI L E
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 36/171 (21%), Positives = 67/171 (39%), Gaps = 45/171 (26%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKV-------------FHQECARALKSFEAQCE 244
                +G G++G V   + +    E A+KV              ++   +  +    +  
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 245 VMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL-------- 296
           ++KS+ HPN++K+     +  +  LV E+   G L             F+++        
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDE 145

Query: 297 ----NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
               NIM    S + YL   H   I+H D+KP ++LL   +  +   + DF
Sbjct: 146 CDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIKIVDF 193

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 30/140 (21%), Positives = 55/140 (39%), Gaps = 34/140 (24%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVM-KSIRHPNLVK 256
            +   IG+GS+    R   +   +E AVK+  +         E + E++ +  +HPN++ 
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTE-EIEILLRYGQHPNIIT 80

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL------------NIMIDATS 304
           +     +  +  +V E M  G L               ++             ++   T 
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITK 127

Query: 305 TLEYLYFGHTTPIIHCDLKP 324
           T+EYL   H   ++H DLKP
Sbjct: 128 TVEYL---HAQGVVHRDLKP 144

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 62.2 bits (152), Expect = 7e-11
 Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 16/160 (10%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISS 260
           IG GS+G V++ R RD G  VA+K F +     +    A  E+  +K ++HPNLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC 320
                   LV EY    ++ + L      +      +I      TL+ + F H    IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW---QTLQAVNFCHKHNCIHR 126

Query: 321 DLKPISVLLDEDMVAHLSDF----EYGMEG-----QVSTR 351
           D+KP ++L+ +  V  L DF               +V+TR
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR 166

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 61.9 bits (151), Expect = 7e-11
 Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 11/150 (7%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH-QECARALKSFEAQCEVMKSIRHPNLVK 256
                +G G+FG V+    R  G+E  +K  +       ++  EA+ EV+KS+ HPN++K
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF---QRLNIMIDATSTLEYLYFGH 313
           +     +     +V+E    G L   + S+              +M    + L Y    H
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---H 141

Query: 314 TTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           +  ++H DLKP ++L           + DF
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDF 171

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 14/143 (9%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNLVKV 257
           +G G++G VY+A+   G  VA+K    +         A++  E    ++K + HPN+V +
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR--EIS--LLKELHHPNIVSL 84

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           I    ++    LV E+M K  L+  L  +   L   Q    +      + +    H   I
Sbjct: 85  IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC---HQHRI 140

Query: 318 IHCDLKPISVLLDEDMVAHLSDF 340
           +H DLKP ++L++ D    L+DF
Sbjct: 141 LHRDLKPQNLLINSDGALKLADF 163

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 39/188 (20%), Positives = 64/188 (34%), Gaps = 50/188 (26%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVF-----HQECARALKSFEAQCEVMKSIRHPN 253
           L   IG GS+G V  A         A+K+       Q   + ++  + +  +MK + HPN
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSL------ENCLYSSTCMLDIFQRL----------- 296
           + ++     ++ +  LV+E    G L           +  C +D+ +             
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 297 ----------------------NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV 334
                                 NIM    S L YL   H   I H D+KP + L   +  
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYL---HNQGICHRDIKPENFLFSTNKS 206

Query: 335 AHL--SDF 340
             +   DF
Sbjct: 207 FEIKLVDF 214

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 41/213 (19%), Positives = 69/213 (32%), Gaps = 59/213 (27%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVK--VFHQECARALKSFEAQC-------EV--MKSIRHP 252
           I  GS+G+V      +GI VA+K         R +              E+  +    HP
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 253 NLVK---VISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLD-------IFQRLNIMI 300
           N++    +             LV E M    L   ++    ++        ++  L    
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILL--- 145

Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------EYGMEGQVSTR- 351
                L  L   H   ++H DL P ++LL ++    + DF        +      V+ R 
Sbjct: 146 ----GLHVL---HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198

Query: 352 ----------------SDIYGYGIVLMETFTRK 368
                            D++  G V+ E F RK
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 32/155 (20%), Positives = 58/155 (37%), Gaps = 33/155 (21%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISS 260
           ++G G+   V          E AVK+  ++          + E++   + H N++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRL------------NIMIDATSTLEY 308
              +D   LV E M  GS+                +             ++ D  S L++
Sbjct: 80  FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126

Query: 309 LYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           L   H   I H DLKP ++L    ++     + DF
Sbjct: 127 L---HNKGIAHRDLKPENILCEHPNQVSPVKICDF 158

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 20/154 (12%), Positives = 53/154 (34%), Gaps = 27/154 (17%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           ++  +G G FG V+R            K    +        + +  ++   RH N++ + 
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLH 67

Query: 259 SSCSNDDFKALVLEYMPKGSL------ENCLYS----STCMLDIFQRLNIMIDATSTLEY 308
            S  + +   ++ E++    +           +     + +  +             L++
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC----------EALQF 117

Query: 309 LYFGHTTPIIHCDLKPISVLL--DEDMVAHLSDF 340
           L   H+  I H D++P +++          + +F
Sbjct: 118 L---HSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 36/157 (22%), Positives = 65/157 (41%), Gaps = 37/157 (23%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK----VFHQE--CARALKSFEAQCEV--MKSIRHPNL 254
           IG GS+G V  A    +   VA+K    VF     C R L+      E+  +  + H ++
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR------EIAILNRLNHDHV 114

Query: 255 VK---VISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLD------IFQRLNIMIDAT 303
           VK   ++     + F    +VLE       +    +   + +      ++  L       
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLV------ 167

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             ++Y+   H+  I+H DLKP + L+++D    + DF
Sbjct: 168 -GVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDF 200

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 14/108 (12%), Positives = 33/108 (30%), Gaps = 9/108 (8%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
             +      + +     +   L     +    + +     A +     ++ L+L   ++ 
Sbjct: 23  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82

Query: 61  --------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                      +++ L +  N I  L P   + +  L  L L  N L 
Sbjct: 83  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 13/130 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S N LE  +      ++ +  + +S N L + +      + +LK L L++N L     
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVER 312

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSF 117
                  LE L L +N I  L  ++   L   K L+LS N  +   LR   F N    + 
Sbjct: 313 NQPQFDRLENLYLDHNSIVTLKLSTHHTL---KNLTLSHNDWDCNSLR-ALFRNVARPAV 368

Query: 118 KGNEPLCGSP 127
              +  C   
Sbjct: 369 DDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 19/104 (18%), Positives = 41/104 (39%), Gaps = 9/104 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
            F ++++    +  + + + V  +NL+   +            +++ L + +N +     
Sbjct: 51  TFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP 110

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               +V  L +L L  N++  L          L  LS+S N LE
Sbjct: 111 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 9/104 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           + +   +E   +        + ++ +  N +    P     +  L  L L  N L     
Sbjct: 75  NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 134

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               +   L  L++SNN +  +   + +    L+ L LS N+L 
Sbjct: 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 16/101 (15%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
             SSN L     +D+  + ++   N+S N LS+     +   I+++ L  ++N ++V   
Sbjct: 171 QLSSNRLT---HVDLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRG 222

Query: 63  ---ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                L IL L +N +       L     L E+ LS+N+LE
Sbjct: 223 PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE 261

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 11/103 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N+L     L   N   +VE++LS N L   M      +  L+ L ++ N+L     
Sbjct: 232 KLQHNNLTDTAWL--LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNL 289

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               + +L++L+LS+N +   +  +  +   L+ L L  N + 
Sbjct: 290 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV 331

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 13/96 (13%), Positives = 34/96 (35%), Gaps = 11/96 (11%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYGL 78
           ++++               L + K ++   + +             +E+LNL++ +I  +
Sbjct: 25  DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 84

Query: 79  IPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
              +      +++L + FN +    L    F N   
Sbjct: 85  DTYAFAYAHTIQKLYMGFNAI--RYLPPHVFQNVPL 118

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 30/156 (19%), Positives = 63/156 (40%), Gaps = 27/156 (17%)

Query: 204 IGMGSFGSVYRARLRD---GIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVK-- 256
           +G G++G VY+A+ +D     + A+K           S  A  E+  ++ ++HPN++   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQ 84

Query: 257 -VISSCSNDDFKALVLEYMP---KGSLENC----LYSSTCMLDIFQRLNIMIDATSTLEY 308
            V  S ++     L+ +Y        ++             L      +++      + Y
Sbjct: 85  KVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAH----LSDF 340
           L   H   ++H DLKP ++L+  +        ++D 
Sbjct: 144 L---HANWVLHRDLKPANILVMGEGPERGRVKIADM 176

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 29/166 (17%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKS---FEAQCEVMKSIRHPNLVKVI 258
           +IG G+FG V   R +   +V A+K+  +           F  + ++M     P +V++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA--------TSTLEYLY 310
            +  +D +  +V+EYMP G L          +++    ++               L+ + 
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDAI- 184

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF----EYGMEGQVSTRS 352
             H+   IH D+KP ++LLD+     L+DF    +   EG V   +
Sbjct: 185 --HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 29/117 (24%), Positives = 49/117 (41%), Gaps = 13/117 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           D  S S     S+  G   A+  ++LS N ++      +    +L+ L L  ++++    
Sbjct: 11  DGRSRSFT---SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                  SLE L+LS+N +  L  +    L  LK L+L  N  +  +     F N T
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLT 123

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 21/106 (19%), Positives = 39/106 (36%), Gaps = 11/106 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDM-PATIGGLISLKTLSLAYNKL---- 60
           D S N L    S   G L ++  +NL  N   +    +    L +L+TL +   +     
Sbjct: 80  DLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEI 139

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                  + SL  L +    +      SL+ +  +  L+L  ++  
Sbjct: 140 RRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 13/104 (12%)

Query: 5   FDFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV 62
              S N L         +  LK +  +++SRN     MP +      ++ L+L+   + V
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRV 424

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                  +LE+L++SNN +       L +   L+EL +S NKL+
Sbjct: 425 VKTCIPQTLEVLDVSNNNL-DSFSLFLPR---LQELYISRNKLK 464

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 12/120 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           DF+ +  +    L       +  +++ +  L  D+      L  +K +++  +K+ +   
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327

Query: 63  ------ASLEILNLSNNEIYGLI---PTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                  SLE L+LS N +                L+ L LS N L      G   +   
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 25/114 (21%), Positives = 37/114 (32%), Gaps = 14/114 (12%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            I         L   LS     L+ V  I +  + +     +    L SL+ L L+ N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346

Query: 61  ------------DVASLEILNLSNNEIYGL--IPTSLEKLLYLKELSLSFNKLE 100
                          SL+ L LS N +  +      L  L  L  L +S N   
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 28/111 (25%), Positives = 44/111 (39%), Gaps = 10/111 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S N +      D+     +  + L  + +++        L SL+ L L+ N L     
Sbjct: 32  DLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS 91

Query: 61  ----DVASLEILNLSNNEIYGLIPTSL-EKLLYLKELSLSFNKLEGEILRG 106
                ++SL+ LNL  N    L  TSL   L  L+ L +   +   EI R 
Sbjct: 92  SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 23/100 (23%), Positives = 42/100 (42%), Gaps = 11/100 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           D S N+   P+       + +  +NLS   +   +        +L+ L ++ N LD    
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKT--CIPQTLEVLDVSNNNLDSFSL 448

Query: 63  --ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               L+ L +S N++  L   SL     L  + +S N+L+
Sbjct: 449 FLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLK 486

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 20/101 (19%), Positives = 42/101 (41%), Gaps = 14/101 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           + SS  +     +     + +  +++S NNL S        L  L+ L ++ NKL     
Sbjct: 416 NLSSTGIR---VVKTCIPQTLEVLDVSNNNLDS-FSL---FLPRLQELYISRNKLKTLPD 468

Query: 63  ----ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                 L ++ +S N++  +     ++L  L+++ L  N  
Sbjct: 469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 19/160 (11%), Positives = 51/160 (31%), Gaps = 15/160 (9%)

Query: 10  NSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV------- 62
            +      +D   L ++ E+ +   +L +    ++  +  +  L+L  ++          
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193

Query: 63  --ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGN 120
             +S+  L L +  +     + L        +     +  G +L    F     +     
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR--GSVLTDESFNELLKL----L 247

Query: 121 EPLCGSPNLQVPPCKLNKPGKHQKSRKNMLPLVIVLPLST 160
             +     ++   C LN  G    S  +++  +  +   T
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 16/99 (16%), Positives = 42/99 (42%), Gaps = 11/99 (11%)

Query: 15  PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASL 65
            +  D   L  + + N S +++ S++       ++++ L +    L             +
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312

Query: 66  EILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL 104
           + + + N++++ +  +  + L  L+ L LS N +  E L
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 41/199 (20%), Positives = 75/199 (37%), Gaps = 47/199 (23%)

Query: 204 IGMGSFGSVYRARLR-DGIEVAVKVFHQECARA-LKSFEAQCEV-MKSIRHPNLVKVISS 260
           +G G++G V + R    G  +AVK           K      ++ M+++  P  V    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 261 CSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN------IMIDATSTLEYLYFGHT 314
              +    + +E M   SL+        ++D  Q +       I +     LE+L+   +
Sbjct: 75  LFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQV-------------------------- 348
             +IH D+KP +VL++      + DF  G+ G +                          
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDF--GISGYLVDDVAKDIDAGCKPYMAPERINPELN 186

Query: 349 ----STRSDIYGYGIVLME 363
               S +SDI+  GI ++E
Sbjct: 187 QKGYSVKSDIWSLGITMIE 205

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 7/142 (4%)

Query: 202 NLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVI 258
            L+G GS+G V + R +D G  VA+K F +     +    A  E+  +K +RH NLV ++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
             C       LV E++   ++ + L      LD       +      +  + F H+  II
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLF---QIINGIGFCHSHNII 146

Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           H D+KP ++L+ +  V  L DF
Sbjct: 147 HRDIKPENILVSQSGVVKLCDF 168

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 59.8 bits (146), Expect = 3e-10
 Identities = 33/143 (23%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNLVKV 257
           IG G++G VY+A+   G   A+K    E          ++  E    ++K ++H N+VK+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR--EIS--ILKELKHSNIVKL 65

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
                      LV E++ +  L+  L      L+     + ++   + + Y    H   +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRV 121

Query: 318 IHCDLKPISVLLDEDMVAHLSDF 340
           +H DLKP ++L++ +    ++DF
Sbjct: 122 LHRDLKPQNLLINREGELKIADF 144

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 23/99 (23%), Positives = 38/99 (38%), Gaps = 9/99 (9%)

Query: 10  NSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKLDV------ 62
            +  G  S        +  ++LS N+L     A        L +L+L++  L        
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP 273

Query: 63  ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
           A L +L+LS N +      S ++L  +  LSL  N    
Sbjct: 274 AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 18/123 (14%), Positives = 41/123 (33%), Gaps = 20/123 (16%)

Query: 1   DILNFDFSSNSLEGPLSL--DIGNL--KAVVEINLSRNNLSSDMPATIGGLISLKTLSLA 56
           D+   +  + S     +   ++       +  +++++ +  +     +    +L TL L+
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 57  YNKL-------------DVASLEILNLSNNE---IYGLIPTSLEKLLYLKELSLSFNKLE 100
            N                  +L++L L N       G+        + L+ L LS N L 
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241

Query: 101 GEI 103
              
Sbjct: 242 DAA 244

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.3 bits (102), Expect = 9e-05
 Identities = 16/121 (13%), Positives = 35/121 (28%), Gaps = 18/121 (14%)

Query: 1   DILNFDFSSNSLEGPL---SLDIGNLKAVVEINLSRNNLSSDMPATIGGLI--SLKTLSL 55
            +      +  +   +   +L +  +  + E+ L    ++   P  +       L  L+L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 56  AYNKLDV-------------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGE 102
                                 L++L+++           +     L  L LS N   GE
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 103 I 103
            
Sbjct: 189 R 189

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 59.5 bits (145), Expect = 4e-10
 Identities = 36/161 (22%), Positives = 60/161 (37%), Gaps = 33/161 (20%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFH------QECARALKSFEAQCEVMKSIRHP 252
           +   +G G F  V + R +  G E A K              + +  E +  +++ IRHP
Sbjct: 9   MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDAT 303
           N++ +     N     L+LE +  G L     E    +    +  +  I           
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL---------- 118

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDF 340
             + YL   H+  I H DLKP +++L      +    L DF
Sbjct: 119 DGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 14/108 (12%), Positives = 34/108 (31%), Gaps = 9/108 (8%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD 61
             +      + +     +   L     +    + +     A +     ++ L+L   +++
Sbjct: 29  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 88

Query: 62  V---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                      +++ L +  N I  L P   + +  L  L L  N L 
Sbjct: 89  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 19/104 (18%), Positives = 41/104 (39%), Gaps = 9/104 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
            F ++++    +  + + + V  +NL+   +            +++ L + +N +     
Sbjct: 57  TFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP 116

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               +V  L +L L  N++  L          L  LS+S N LE
Sbjct: 117 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 160

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 9/104 (8%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           + +   +E   +        + ++ +  N +    P     +  L  L L  N L     
Sbjct: 81  NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 140

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               +   L  L++SNN +  +   + +    L+ L LS N+L 
Sbjct: 141 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 11/103 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N+L     L   N   +VE++LS N L   M      +  L+ L ++ N+L     
Sbjct: 238 KLQHNNLTDTAWL--LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNL 295

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               + +L++L+LS+N +   +  +  +   L+ L L  N + 
Sbjct: 296 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV 337

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 16/101 (15%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
             SSN L     +D+  + ++   N+S N LS+     +   I+++ L  ++N ++V   
Sbjct: 177 QLSSNRLT---HVDLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRG 228

Query: 63  ---ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                L IL L +N +       L     L E+ LS+N+LE
Sbjct: 229 PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE 267

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 32/140 (22%), Positives = 52/140 (37%), Gaps = 32/140 (22%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
           N+  +  + L RN+LSS           L TLS++ N L            SL+ L LS+
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 180

Query: 73  NEIYGLIP----------------TSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMS 116
           N +  +                  ++L   + ++EL  S N +   ++RG   V  T + 
Sbjct: 181 NRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI--NVVRGPVNVELTILK 238

Query: 117 FKGNE-----PLCGSPNLQV 131
            + N       L   P L  
Sbjct: 239 LQHNNLTDTAWLLNYPGLVE 258

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 15/97 (15%), Positives = 36/97 (37%), Gaps = 13/97 (13%)

Query: 27  VEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYG 77
           V I++   ++          L + K ++   + +             +E+LNL++ +I  
Sbjct: 32  VHIDMQTQDVYFGFEDI--TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE 89

Query: 78  LIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
           +   +      +++L + FN +    L    F N   
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAI--RYLPPHVFQNVPL 124

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 12/144 (8%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVI 258
            IG GSFG V   +  D  ++ A+K  +++             + ++M+ + HP LV + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA--TSTLEYLYFGHTTP 316
            S  +++   +V++ +  G L   L  +    +   +L I         L+YL       
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI---CELVMALDYL---QNQR 135

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF 340
           IIH D+KP ++LLDE    H++DF
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDF 159

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 19/112 (16%), Positives = 36/112 (32%), Gaps = 19/112 (16%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           +  S  L          L  +  + +    L   +P T+     L+TL+LA N L     
Sbjct: 87  ELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRALPA 144

Query: 61  ---DVASLEILNLSNN--------EIYGL-IPTSLEKLLYLKELSLSFNKLE 100
               +  L  L++            +         + L+ L+ L L +  + 
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 20/104 (19%), Positives = 37/104 (35%), Gaps = 10/104 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLA-YNKL---- 60
              ++ L   L   I +L  + E++L       + P   GG   LK L L   + L    
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                +  LE L+L        +P+ + +L     + +  +   
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 22/114 (19%), Positives = 46/114 (40%), Gaps = 20/114 (17%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIG---------GLISLKTLSL 55
              + N L   L   I +L  + E+++      +++P  +          GL++L++L L
Sbjct: 132 LTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190

Query: 56  AYNKLDV--------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLS-FNKLE 100
            +  +           +L+ L + N+ +  L   ++  L  L+EL L     L 
Sbjct: 191 EWTGIRSLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALR 243

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 22/94 (23%), Positives = 34/94 (36%), Gaps = 10/94 (10%)

Query: 16  LSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--------ASLEI 67
            S +   L  +  + L    + S +PA+I  L +LK+L +  + L            LE 
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEE 233

Query: 68  LNLSNNEIYGLIPTSLEKLLYLKELSLS-FNKLE 100
           L+L         P        LK L L   + L 
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 12/91 (13%), Positives = 24/91 (26%), Gaps = 12/91 (13%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
            D    +         G    +  + L   +    +P  I  L  L+ L L         
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293

Query: 61  -----DVASLEILNLSNNEIYGLI---PTSL 83
                 + +  I+ +  +    L    P + 
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 31/141 (21%), Positives = 52/141 (36%), Gaps = 29/141 (20%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFH------QECARALKSFEAQCEVMKSIRHP 252
           +   +G G F  V + R +  G+E A K                +  E +  +++ + HP
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDAT 303
           N++ +     N     L+LE +  G L     +    S    ++ +  I           
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL---------- 125

Query: 304 STLEYLYFGHTTPIIHCDLKP 324
             + YL   HT  I H DLKP
Sbjct: 126 DGVNYL---HTKKIAHFDLKP 143

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 28/155 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            + + +G G+   VYR + +      A+KV  +      K    +  V+  + HPN++K+
Sbjct: 56  EVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKL 113

Query: 258 ISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDATSTLEY 308
                     +LVLE +  G L     E   YS    +  +  I             + Y
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----------EAVAY 163

Query: 309 LYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           L   H   I+H DLKP ++L      D    ++DF
Sbjct: 164 L---HENGIVHRDLKPENLLYATPAPDAPLKIADF 195

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 24/98 (24%), Positives = 40/98 (40%), Gaps = 10/98 (10%)

Query: 26  VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVA----------SLEILNLSNNEI 75
           V  ++LS N+++     +   L  L+ L +      +           SL IL L  N+ 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 76  YGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
             L   +   L  L+ L+L+   L+G +L G  F   T
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 25/107 (23%), Positives = 47/107 (43%), Gaps = 13/107 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKA--VVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL-- 60
            F   + + P +     L+A  V   +LS++ + + +  ++      L+ L+LA N++  
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINK 313

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                   +  L  LNLS N +  +     E L  L+ L LS+N + 
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 15/107 (14%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-- 60
           D S + +    +L      +   + ++ L++N ++        GL  L  L+L+ N L  
Sbjct: 281 DLSKSKIF---ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS 337

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                  ++  LE+L+LS N I  L   S   L  LKEL+L  N+L+
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 9/85 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
            L  ++++NLS+N L S        L  L+ L L+YN +          + +L+ L L  
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFN 97
           N++  +     ++L  L+++ L  N
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 18/99 (18%), Positives = 33/99 (33%), Gaps = 20/99 (20%)

Query: 22  NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKLDV-----------ASLEILN 69
            L ++  + L  NN+    PA+    +     L L +NK+                 +L 
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186

Query: 70  LSNNEIYGL--------IPTSLEKLLYLKELSLSFNKLE 100
           LS+  +  +           +  K   +  L LS N  +
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 30/158 (18%), Positives = 64/158 (40%), Gaps = 25/158 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVF--HQECARALKSFEAQCE----VMKSIRH 251
           ++  L+G G FGSVY    + D + VA+K     +           +      ++K +  
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 252 --PNLVKVISSCSNDDFKALVLEY-MPKGSLENCLYSSTCMLD-----IFQRLNIMIDAT 303
               +++++      D   L+LE   P   L + +     + +      F ++   ++A 
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV---LEA- 161

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDF 340
             + +    H   ++H D+K  ++L+D +     L DF
Sbjct: 162 --VRHC---HNCGVLHRDIKDENILIDLNRGELKLIDF 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 10/105 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           +   N+++   +    +L  +  + L RN++         GL SL TL L  N L     
Sbjct: 81  NLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPS 140

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLS-FNKLE 100
                ++ L  L L NN I  +   +  ++  L  L L    KLE
Sbjct: 141 GAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 9/85 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
            L  + E+ +S N+     P +  GL SLK L +  +++          +ASL  LNL++
Sbjct: 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFN 97
           N +  L       L YL EL L  N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 19/101 (18%), Positives = 40/101 (39%), Gaps = 10/101 (9%)

Query: 22  NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL-------DVASLEILNLSNN 73
            + +++ ++L        +      GL +LK L+L    +        +  LE L +S N
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGN 228

Query: 74  EIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
               + P S   L  LK+L +  +++   ++    F    +
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQV--SLIERNAFDGLAS 267

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 19/88 (21%), Positives = 38/88 (43%), Gaps = 11/88 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSN 72
            L  +  +NL   N+       +  L+ L+ L ++ N             +SL+ L + N
Sbjct: 194 GLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           +++  +   + + L  L EL+L+ N L 
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 11/98 (11%)

Query: 27  VEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYG 77
             +NL  NN+      T   L  L+ L L  N +          +ASL  L L +N +  
Sbjct: 78  RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV 137

Query: 78  LIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAM 115
           +   + E L  L+EL L  N +  E +    F    ++
Sbjct: 138 IPSGAFEYLSKLRELWLRNNPI--ESIPSYAFNRVPSL 173

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 30/141 (21%), Positives = 52/141 (36%), Gaps = 29/141 (20%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFH------QECARALKSFEAQCEVMKSIRHP 252
           +   +G G F  V + R +  G+E A K              + +  E +  +++ + H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDAT 303
           N++ +     N     L+LE +  G L     +    S    ++ +  I           
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL---------- 125

Query: 304 STLEYLYFGHTTPIIHCDLKP 324
             + YL   HT  I H DLKP
Sbjct: 126 DGVNYL---HTKKIAHFDLKP 143

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 13/103 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
             ++N +     L  G L  + E++L+ N L      T+  L +L  L LA N++     
Sbjct: 205 IATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

Query: 63  ----ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                 L  L L  N+I  + P  L  L  L  L L+ N+LE 
Sbjct: 261 LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 26/104 (25%), Positives = 44/104 (42%), Gaps = 13/104 (12%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
            D ++N +       +  L  + E+ L  N +S+  P  + GL +L  L L  N+L    
Sbjct: 248 LDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
              ++ +L  L L  N I  + P  +  L  L+ L    NK+  
Sbjct: 304 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 13/107 (12%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
           +         ++      +  L  + +IN S N L+   P  +  L  L  + +  N++ 
Sbjct: 48  VTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                 ++ +L  L L NN+I  + P  L+ L  L  L LS N +  
Sbjct: 104 DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 28/105 (26%), Positives = 52/105 (49%), Gaps = 14/105 (13%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV- 62
             + SSN++    +L    L ++ +++   N ++   P  +  L +L+ L ++ NK+   
Sbjct: 138 RLELSSNTISDISAL--SGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI 192

Query: 63  ------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
                  +LE L  +NN+I  + P  L  L  L ELSL+ N+L+ 
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.5 bits (137), Expect = 8e-09
 Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 13/103 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
              +N +       +  L A+  + L+ N L    P  I  L +L  L+L +N +     
Sbjct: 271 KLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
              +  L+ L   NN++  +    L  L  +  LS   N++  
Sbjct: 327 VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISD 367

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 16/89 (17%), Positives = 36/89 (40%), Gaps = 11/89 (12%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV-------ASLEILNLSN 72
              L   ++  L + N++     +   L  + TL      +          +L  +N SN
Sbjct: 20  DTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSN 77

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
           N++  + P  L+ L  L ++ ++ N++  
Sbjct: 78  NQLTDITP--LKNLTKLVDILMNNNQIAD 104

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 32/138 (23%), Positives = 56/138 (40%), Gaps = 20/138 (14%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           +FS+N L     L   NL  +V+I ++ N ++   P  +  L +L  L+L  N++     
Sbjct: 74  NFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFK 118
             ++ +L  L LS+N I  +    L  L  L++LS      + + L          +   
Sbjct: 130 LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTDLKPL--ANLTTLERLDIS 185

Query: 119 GN-----EPLCGSPNLQV 131
            N       L    NL+ 
Sbjct: 186 SNKVSDISVLAKLTNLES 203

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 11/101 (10%), Positives = 33/101 (32%), Gaps = 11/101 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N++     +   +L  +  +    N +S    +++  L ++  LS  +N++     
Sbjct: 315 TLYFNNISDISPV--SSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
             ++  +  L L++             +     +      L
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 44.2 bits (105), Expect = 7e-05
 Identities = 11/79 (13%), Positives = 26/79 (32%), Gaps = 10/79 (12%)

Query: 30  NLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSNNEIYGLIPTS 82
            ++++   + +      L       L    +       D+  +  L      I  +    
Sbjct: 7   TITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DG 63

Query: 83  LEKLLYLKELSLSFNKLEG 101
           +E L  L +++ S N+L  
Sbjct: 64  VEYLNNLTQINFSNNQLTD 82

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 39/193 (20%), Positives = 67/193 (34%), Gaps = 37/193 (19%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCE---VMKSIRHPNLVKVIS 259
           +G G+ G V++ R  + G  +AVK   +   +         +   V+KS   P +V+   
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-RILMDLDVVLKSHDCPYIVQCFG 91

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
           +   +    + +E M     E         +       + +     L YL   H   +IH
Sbjct: 92  TFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIH 148

Query: 320 CDLKPISVLLDEDMVAHLSDF-----------------------------EYGMEGQVST 350
            D+KP ++LLDE     L DF                                 +     
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208

Query: 351 RSDIYGYGIVLME 363
           R+D++  GI L+E
Sbjct: 209 RADVWSLGISLVE 221

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 31/128 (24%), Positives = 53/128 (41%), Gaps = 8/128 (6%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRH-PNLVK 256
           R+   IG G+FG +   + L     VA+K+   +        E +    K +     + +
Sbjct: 12  RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR--FYKQLGSGDGIPQ 69

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           V        + A+VLE +   SLE+          +   L I I   S +EY+   H+  
Sbjct: 70  VYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV---HSKN 125

Query: 317 IIHCDLKP 324
           +I+ D+KP
Sbjct: 126 LIYRDVKP 133

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 59.1 bits (144), Expect = 9e-10
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKS---FEAQCEV--MKSIRHPNLVKV 257
           +G G F +VY+AR       VA+K          K      A  E+  ++ + HPN++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           + +  +    +LV ++M    LE  +  ++ +L        M+     LEYL   H   I
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWI 133

Query: 318 IHCDLKPISVLLDEDMVAHLSDF 340
           +H DLKP ++LLDE+ V  L+DF
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADF 156

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.3 bits (139), Expect = 9e-10
 Identities = 14/105 (13%), Positives = 38/105 (36%), Gaps = 10/105 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
                 +      ++  L ++  +++S +     +   I  L  + ++ L+YN       
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGE 102
               +  L+ LN+  + ++      +E    L +L      + G+
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.4 bits (134), Expect = 4e-09
 Identities = 20/89 (22%), Positives = 40/89 (44%), Gaps = 10/89 (11%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS---------LEILNL 70
           I  L  +  + +   +++SD    + GL SL  L ++++  D +          +  ++L
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 71  SNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
           S N     I   L+ L  LK L++ F+ +
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 52.3 bits (126), Expect = 4e-08
 Identities = 16/94 (17%), Positives = 37/94 (39%), Gaps = 9/94 (9%)

Query: 18  LDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNL 70
           +    + ++  I L+  N++      I    ++K L++             +++LE L +
Sbjct: 38  ITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPISGLSNLERLRI 95

Query: 71  SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL 104
              ++      +L  L  L  L +S +  +  IL
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 45.3 bits (108), Expect = 9e-06
 Identities = 14/90 (15%), Positives = 34/90 (37%), Gaps = 12/90 (13%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS-------LEILNLSNNE 74
             KA +   L +++ +     T   + SL  ++LA   +   +       ++ L ++N  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIH 77

Query: 75  IYGLIPTSLEKLLYLKELSLSFNKLEGEIL 104
                P  +  L  L+ L +    +  + +
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKI 105

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 1e-09
 Identities = 71/458 (15%), Positives = 151/458 (32%), Gaps = 117/458 (25%)

Query: 61  DVASLEILNLSNNEIYGLI--PTSLEKLLYLKELSLSFNK-----LEGEILRGG-PFVNF 112
           DV  +    LS  EI  +I    ++   L L    LS  +        E+LR    F+  
Sbjct: 37  DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL-M 95

Query: 113 TAMSFKGNEP-------------LCGSPNLQVPPCKLNKPGKHQKSRKNMLPL-----VI 154
           + +  +  +P             L     +      +++   + K R+ +L L     V+
Sbjct: 96  SPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-FAKYNVSRLQPYLKLRQALLELRPAKNVL 154

Query: 155 VLPLS----TALIIVVIILALKYKLTKCGKRG---LDVSN----DGILPSQATLRRL--S 201
           +  +     T + + V    L YK+          L++ N    + +L     L      
Sbjct: 155 IDGVLGSGKTWVALDV---CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211

Query: 202 NLIGMGSFGSVYRARLRDGIEVAVKVF----HQEC---------ARALKSFEAQCEVMKS 248
           N        S  + R+        ++     ++ C         A+A  +F   C+++ +
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT 271

Query: 249 IRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR-LNIMIDATSTLE 307
            R      V    S      + L++           +   +  +  + L+        L 
Sbjct: 272 TRFKQ---VTDFLSAATTTHISLDHHSMT------LTPDEVKSLLLKYLDCRPQ---DL- 318

Query: 308 YLYFGHTTPIIHCDLKP--ISVL--LDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLME 363
                   P       P  +S++     D +A   ++++    +++T          ++E
Sbjct: 319 --------PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT----------IIE 360

Query: 364 TFTRK-KPTD--RMFVEELSL--KD-----------WVNNLLPISLMEVVDKTLLSGEKK 407
           +     +P +  +MF + LS+               W  +++   +M VV+K      K 
Sbjct: 361 SSLNVLEPAEYRKMF-DRLSVFPPSAHIPTILLSLIW-FDVIKSDVMVVVNKL----HKY 414

Query: 408 GFVAKEQC--VLSILGLAMECAMELPEKRINAKDIVTR 443
             V K+     +SI  + +E  ++L  +    + IV  
Sbjct: 415 SLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 38/166 (22%), Positives = 64/166 (38%), Gaps = 25/166 (15%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVF---------HQECARALKSFEAQCEVMKSIRHP 252
           ++G G FG V+  +++   ++ A K             + A   K       ++  +   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK------ILAKVHSR 245

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA---TSTLEYL 309
            +V +  +        LV+  M  G +   +Y+       FQ    +       S LE+L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---EYGMEGQVSTRS 352
              H   II+ DLKP +VLLD+D    +SD         GQ  T+ 
Sbjct: 306 ---HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 34/160 (21%), Positives = 68/160 (42%), Gaps = 42/160 (26%)

Query: 203 LIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEV---MKSIRHPNLVKVI 258
           ++G+G  G V     R  G + A+K+ +        S +A+ EV    ++   P++V ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 259 ----SSCSNDDFKALVLEYMPKGSL-------ENCLYS----STCMLDIFQRLNIMIDAT 303
               +         +++E M  G L        +  ++    +  M DI           
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG---------- 138

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           + +++L   H+  I H D+KP ++L    ++D V  L+DF
Sbjct: 139 TAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 35/172 (20%), Positives = 69/172 (40%), Gaps = 39/172 (22%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFEAQC-----EVMKSIRHPNLVK 256
           +IG G+F  V   +++   +V A+K+ ++     LK  E  C     +V+ +     + +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID----------ATSTL 306
           +  +  ++++  LV+EY   G L   L           +    I               +
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAI 175

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAH--LSDF----EYGMEGQVSTRS 352
           + +   H    +H D+KP ++LLD     H  L+DF    +   +G V +  
Sbjct: 176 DSV---HRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV 222

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 31/141 (21%), Positives = 53/141 (37%), Gaps = 29/141 (20%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFH------QECARALKSFEAQCEVMKSIRHP 252
               +G G F  V + R +  G++ A K              + +  E +  ++K I+HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSL-----ENCLYS----STCMLDIFQRLNIMIDAT 303
           N++ +     N     L+LE +  G L     E    +    +  +  I           
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL---------- 124

Query: 304 STLEYLYFGHTTPIIHCDLKP 324
           + + YL   H+  I H DLKP
Sbjct: 125 NGVYYL---HSLQIAHFDLKP 142

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 8/142 (5%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE---AQCEVMKSIRHPNLVKVI 258
            +G GSFG V   + ++     A+K+  ++    LK  E    +  +++++  P LVK+ 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            S  ++    +V+EY+  G + + L       +   R         T EYL   H+  +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYL---HSLDLI 163

Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           + DLKP ++L+D+     ++DF
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDF 185

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 32/128 (25%), Positives = 57/128 (44%), Gaps = 8/128 (6%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRH-PNLVK 256
           RL   IG GSFG +Y    +  G EVA+K+   +        E++  + K ++    +  
Sbjct: 12  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK--IYKMMQGGVGIPT 69

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +    +  D+  +V+E +   SLE+     +    +   L +     S +EY+   H+  
Sbjct: 70  IRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKN 125

Query: 317 IIHCDLKP 324
            IH D+KP
Sbjct: 126 FIHRDVKP 133

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 57.5 bits (140), Expect = 2e-09
 Identities = 34/144 (23%), Positives = 67/144 (46%), Gaps = 15/144 (10%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNLVK 256
           IG G++G+V++A+       VA+K    +         AL+  E    ++K ++H N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR--EIC--LLKELKHKNIVR 65

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +     +D    LV E+  +  L+    S    LD     + +      L +    H+  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---HSRN 121

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF 340
           ++H DLKP ++L++ +    L++F
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANF 145

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 33/160 (20%), Positives = 66/160 (41%), Gaps = 27/160 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV------MKSIR- 250
           RL  L+G G FG+V+    L D ++VA+KV  +                     +  +  
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 251 ---HPNLVKVISSCSNDDFKALVLEY-MPKGSLENCLYSSTCMLD-----IFQRLNIMID 301
              HP +++++      +   LVLE  +P   L + +     + +      F ++     
Sbjct: 94  GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV----- 148

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDF 340
             + +++    H+  ++H D+K  ++L+D     A L DF
Sbjct: 149 -VAAIQHC---HSRGVVHRDIKDENILIDLRRGCAKLIDF 184

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 36/151 (23%), Positives = 63/151 (41%), Gaps = 25/151 (16%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK----VFHQE--CARALKSFEAQCEV--MKSIRHPNL 254
           IG GS+G VY A        VA+K    +F     C R L+      E+  +  ++   +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR------EITILNRLKSDYI 87

Query: 255 VK---VISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
           ++   +I       F    +VLE      L+    +   + +   +  I+ +      ++
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFI 145

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
              H + IIH DLKP + LL++D    + DF
Sbjct: 146 ---HESGIIHRDLKPANCLLNQDCSVKVCDF 173

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 28/121 (23%), Positives = 49/121 (40%), Gaps = 12/121 (9%)

Query: 6   DFSSNSLEG-PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
           D S N+L           L  +  + LS N+L+         + +L+ L L+ N L    
Sbjct: 45  DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLD 104

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAM 115
                D+ +LE+L L NN I  +   + E +  L++L LS N++           +   +
Sbjct: 105 EFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI--SRFPVELIKDGNKL 162

Query: 116 S 116
            
Sbjct: 163 P 163

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 29/110 (26%), Positives = 42/110 (38%), Gaps = 14/110 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
            +  +  ++LS N+L +        L +L+ L L  N +         D+A L+ L LS 
Sbjct: 86  PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145

Query: 73  NEIYGLIP---TSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKG 119
           N+I            KL  L  L LS NKL+   L         A    G
Sbjct: 146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLKK--LPLTDLQKLPAWVKNG 193

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 26/107 (24%), Positives = 47/107 (43%), Gaps = 18/107 (16%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-- 60
           D SSN L    +LD     +L+A+  + L  N++          +  L+ L L+ N++  
Sbjct: 94  DLSSNHLH---TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150

Query: 61  ----------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFN 97
                      +  L +L+LS+N++  L  T L+KL    +  L  +
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 18/84 (21%), Positives = 33/84 (39%), Gaps = 19/84 (22%)

Query: 30  NLSRNNLSS---DMPATIGGLISLKTLSLAYNKL----------DVASLEILNLSNNEIY 76
           + S+  L +    +P+          L L++N L           + +L  L LS+N + 
Sbjct: 24  SCSKQQLPNVPQSLPSYT------ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 77  GLIPTSLEKLLYLKELSLSFNKLE 100
            +   +   +  L+ L LS N L 
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLH 101

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 9/87 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
            L  +  ++L R  L    P    GL +L+ L L  N L         D+ +L  L L  
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKL 99
           N I  +   +   L  L  L L  N++
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRV 189

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 23/88 (26%), Positives = 33/88 (37%), Gaps = 9/88 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSN 72
            L A+  + L  N L +    T   L +L  L L  N++            SL+ L L  
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           N +  + P +   L  L  L L  N L 
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 10/104 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N +    +      + +  + L  N L+    A   GL  L+ L L+ N       
Sbjct: 38  FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97

Query: 61  -----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                 +  L  L+L    +  L P     L  L+ L L  N L
Sbjct: 98  PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 23/83 (27%), Positives = 33/83 (39%), Gaps = 10/83 (12%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNE-IYG 77
            I L  N +S    A+     +L  L L  N L          +A LE L+LS+N  +  
Sbjct: 36  RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95

Query: 78  LIPTSLEKLLYLKELSLSFNKLE 100
           + P +   L  L  L L    L+
Sbjct: 96  VDPATFHGLGRLHTLHLDRCGLQ 118

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 24/85 (28%), Positives = 35/85 (41%), Gaps = 9/85 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
           +L  +  + L  N +SS       GL SL  L L  N++         D+  L  L L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFN 97
           N +  L   +L  L  L+ L L+ N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 13/113 (11%)

Query: 6   DFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV- 62
             SSN L   G  S       ++  ++LS N + + M +   GL  L+ L   ++ L   
Sbjct: 58  SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 116

Query: 63  ---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG 106
                     +L  L++S+             L  L+ L ++ N  +   L  
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 16/108 (14%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKLD 61
           D S            G    L ++  + ++ N+   +    I   L +L  L L+  +L+
Sbjct: 132 DISHTHTR---VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188

Query: 62  V---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                     +SL++LN+S+N  + L     + L  L+ L  S N + 
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 13/96 (13%)

Query: 29  INLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV-----------ASLEILNLSNNEIYG 77
           + L  N L S        L  L  LSL+ N L              SL+ L+LS N +  
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 92

Query: 78  LIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
            + ++   L  L+ L    + L+ ++     F++  
Sbjct: 93  -MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLR 126

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 24/106 (22%), Positives = 42/106 (39%), Gaps = 11/106 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLS--SDMPATIGGLISLKTLSLAYNKL--- 60
           +  SN L+         L  + +++LS N LS       +  G  SLK L L++N +   
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM 93

Query: 61  -----DVASLEILNLSNNEIYGLIPTSL-EKLLYLKELSLSFNKLE 100
                 +  LE L+  ++ +  +   S+   L  L  L +S     
Sbjct: 94  SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 139

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 10/88 (11%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
            L+ +  ++LS+  L    P     L SL+ L++++N            + SL++L+ S 
Sbjct: 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232

Query: 73  NEIYGLIPTSLEKLLY-LKELSLSFNKL 99
           N I       L+     L  L+L+ N  
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 17/72 (23%), Positives = 26/72 (36%), Gaps = 6/72 (8%)

Query: 49  SLKTLSLAYNKLDV------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGE 102
           S   +      L        +S   L L +N++  L     +KL  L +LSLS N L  +
Sbjct: 8   SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 103 ILRGGPFVNFTA 114
                     T+
Sbjct: 68  GCCSQSDFGTTS 79

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 26/97 (26%), Positives = 40/97 (41%), Gaps = 11/97 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--A 63
               N+L   L      L+    + +S N L+S +P    GL+ L   S     L    +
Sbjct: 67  VIPDNNLTS-LPALPPELR---TLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPS 121

Query: 64  SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
            L  L +  N++  L P        L+ELS+S N+L 
Sbjct: 122 GLCKLWIFGNQLTSL-PVLPPG---LQELSVSDNQLA 154

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 18/81 (22%), Positives = 30/81 (37%), Gaps = 9/81 (11%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----VASLEILNLSNNEIYGLIPTS 82
            +N+  + L++ +P  +     + TL +  N L         L  L +S N++  L P  
Sbjct: 44  VLNVGESGLTT-LPDCLPA--HITTLVIPDNNLTSLPALPPELRTLEVSGNQLTSL-PVL 99

Query: 83  LEKLLYLKELSLSFNKLEGEI 103
              LL L   S     L    
Sbjct: 100 PPGLLELSIFSNPLTHLPALP 120

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 25/103 (24%), Positives = 42/103 (40%), Gaps = 14/103 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
               N L   L +    L+   E+++S N L+S +PA       L  L    N+L     
Sbjct: 127 WIFGNQLTS-LPVLPPGLQ---ELSVSDNQLAS-LPALPS---ELCKLWAYNNQLTSLPM 178

Query: 61  DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
             + L+ L++S+N++  L PT   +L  L   +     L    
Sbjct: 179 LPSGLQELSVSDNQLASL-PTLPSELYKLWAYNNRLTSLPALP 220

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 27/100 (27%), Positives = 39/100 (39%), Gaps = 17/100 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             S N L   L      L    ++    N L+S +P        L+ LS++ N+L     
Sbjct: 147 SVSDNQLAS-LPALPSELC---KLWAYNNQLTS-LPMLPS---GLQELSVSDNQLASLPT 198

Query: 61  DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
             + L  L   NN +  L P     L   KEL +S N+L 
Sbjct: 199 LPSELYKLWAYNNRLTSL-PALPSGL---KELIVSGNRLT 234

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 27/117 (23%), Positives = 44/117 (37%), Gaps = 31/117 (26%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLI----------------- 48
              +N L   L +    L+   E+++S N L+S +P     L                  
Sbjct: 167 WAYNNQLTS-LPMLPSGLQ---ELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPS 221

Query: 49  SLKTLSLAYNKL-----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
            LK L ++ N+L       + L+ L +S N +  L P        L  LS+  N+L 
Sbjct: 222 GLKELIVSGNRLTSLPVLPSELKELMVSGNRLTSL-PMLPSG---LLSLSVYRNQLT 274

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 24/105 (22%), Positives = 45/105 (42%), Gaps = 10/105 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           +   N ++        +L+ +  + LSRN++ +       GL +L TL L  N+L     
Sbjct: 70  NLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPN 129

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLS-FNKLE 100
                ++ L+ L L NN I  +   +  ++  L+ L L    +L 
Sbjct: 130 GAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 21/101 (20%), Positives = 48/101 (47%), Gaps = 10/101 (9%)

Query: 22  NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL-------DVASLEILNLSNN 73
            + ++  ++L      S +      GL +L+ L+LA   L        +  L+ L+LS N
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGN 217

Query: 74  EIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
            +  + P S + L++L++L +  +++  +++    F N  +
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQI--QVIERNAFDNLQS 256

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 11/88 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSN 72
            L  +  +NL+  NL       +  LI L  L L+ N L             L+ L +  
Sbjct: 183 GLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           ++I  +   + + L  L E++L+ N L 
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 9/83 (10%)

Query: 27  VEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYG 77
             +NL  N +      +   L  L+ L L+ N +          +A+L  L L +N +  
Sbjct: 67  RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT 126

Query: 78  LIPTSLEKLLYLKELSLSFNKLE 100
           +   +   L  LKEL L  N +E
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPIE 149

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 56.8 bits (138), Expect = 4e-09
 Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 20/149 (13%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNL 254
             IG G++G VY+AR    G  VA+K    +         A++  E    ++K + HPN+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR--EIS--LLKELNHPNI 64

Query: 255 VKVISSCSNDDFKALVLEYMP---KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           VK++     ++   LV E++    K  ++     +   + +    + +      L +   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFC-- 119

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            H+  ++H DLKP ++L++ +    L+DF
Sbjct: 120 -HSHRVLHRDLKPQNLLINTEGAIKLADF 147

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 24/103 (23%), Positives = 37/103 (35%), Gaps = 15/103 (14%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
             D S N +     LD+   K +  +N   NN++      +   I L  L  + NKL   
Sbjct: 174 TLDCSFNKIT---ELDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEI 227

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               +  L   + S N +  L  ++L K   L  L      L 
Sbjct: 228 DVTPLTQLTYFDCSVNPLTELDVSTLSK---LTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 18/99 (18%), Positives = 38/99 (38%), Gaps = 11/99 (11%)

Query: 8   SSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV----- 62
           ++  ++   ++    L  +  ++   ++++ DM   I  L  L  L    N +       
Sbjct: 26  AAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTLDLSQ 83

Query: 63  -ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
             +L  L   +N++  L    +  L  L  L+   NKL 
Sbjct: 84  NTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT 119

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 16/105 (15%), Positives = 35/105 (33%), Gaps = 13/105 (12%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            ++ F            LD+ +   +  ++     ++      +     L  L L   +L
Sbjct: 276 QLIYFQAEGCRKIK--ELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTEL 330

Query: 61  ---DVA---SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
              DV+    L+ L+  N  I     +S+ K+  L     +  + 
Sbjct: 331 TELDVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 19/101 (18%), Positives = 29/101 (28%), Gaps = 10/101 (9%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
             D SSN L     +D+  L  +   + S N L+      +  L  L TL      L   
Sbjct: 216 FLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLTE---LDVSTLSKLTTLHCIQTDLLEI 269

Query: 61  DVASLEIL-NLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           D+     L          +    +     L  L      + 
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 21/104 (20%), Positives = 35/104 (33%), Gaps = 16/104 (15%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
             +  +N L     LD+     +  +N +RN L+      +     L  L    NK    
Sbjct: 110 YLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITK 163

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                   L  L+ S N+I  L    + +   L  L+   N + 
Sbjct: 164 LDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 16/104 (15%)

Query: 4   NFDFSSNSLEGPLSLD-IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-- 60
           + D  ++S+     +  I  L  + ++  + NN+++     +    +L  L+   NKL  
Sbjct: 46  SLDCHNSSIT---DMTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLTN 99

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                +  L  LN   N++  L  +       L  L+ + N L 
Sbjct: 100 LDVTPLTKLTYLNCDTNKLTKLDVSQNPL---LTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 15/108 (13%), Positives = 33/108 (30%), Gaps = 18/108 (16%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
            D  +  +     LD+     +V + L+   L+  +   +     LK+LS     +    
Sbjct: 302 LDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQDFS 355

Query: 61  ---DVASLEILNLSNNEIYGLIP-----TSLEKLLYLKELSLSFNKLE 100
               + +L     +  +   +        SL   +    L    N + 
Sbjct: 356 SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 13/86 (15%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSNNE 74
           N  + V          +    +   L +L +L    + +        +  L  L  ++N 
Sbjct: 19  NFASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNN 75

Query: 75  IYGLIPTSLEKLLYLKELSLSFNKLE 100
           I  L    L +   L  L+   NKL 
Sbjct: 76  ITTL---DLSQNTNLTYLACDSNKLT 98

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 42/266 (15%), Positives = 83/266 (31%), Gaps = 98/266 (36%)

Query: 199 RLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQE-CARALKSFEAQCEVMKSI-R 250
           +L   +G G+FG V  A             VAVK+  +       ++  ++ +++  I  
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 251 HPNLVKVISSCSNDDFKALV-LEYMPKGSLENCL----------------------YSST 287
           H N+V ++ +C+      +V +E+   G+L   L                      Y   
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 288 CMLDIFQRLNIMIDATST----------------LEYLYFGHTTPIIHCDLKPIS----- 326
             +D+ +RL+ +  + S+                 E     +   +    L   S     
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204

Query: 327 -------------------VLLDEDMVAHLSDF--------------------------- 340
                              +LL E  V  + DF                           
Sbjct: 205 GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264

Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFT 366
           E   +   + +SD++ +G++L E F+
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.4 bits (137), Expect = 5e-09
 Identities = 36/163 (22%), Positives = 64/163 (39%), Gaps = 50/163 (30%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVF---------HQECARALKSFEAQCEVMKSIRHP 252
            +G GSFG V+  R R      A+KV            E     +       ++  + HP
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL------MLSIVTHP 66

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSL-----------EN--CLYSSTCMLDIFQRLNIM 299
            ++++  +  +     ++++Y+  G L                 Y++   L         
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL--------- 117

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH--LSDF 340
                 LEYL   H+  II+ DLKP ++LLD++   H  ++DF
Sbjct: 118 -----ALEYL---HSKDIIYRDLKPENILLDKN--GHIKITDF 150

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 23/128 (17%), Positives = 47/128 (36%), Gaps = 8/128 (6%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRH-PNLVK 256
           ++   IG GSFG ++    L +  +VA+K   +         E +    K +     +  
Sbjct: 13  KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR--TYKLLAGCTGIPN 70

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           V           LV++ +   SLE+ L        +           + ++ +   H   
Sbjct: 71  VYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKS 126

Query: 317 IIHCDLKP 324
           +++ D+KP
Sbjct: 127 LVYRDIKP 134

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 35/172 (20%), Positives = 70/172 (40%), Gaps = 39/172 (22%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFEAQC-----EVMKSIRHPNLVK 256
           +IG G+FG V   +L++  +V A+K+ ++     LK  E  C     +V+ +     +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNK--WEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID----------ATSTL 306
           +  +  +D+   LV++Y   G L   L           +    +               +
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAI 188

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAH--LSDF----EYGMEGQVSTRS 352
           + +   H    +H D+KP ++L+D +   H  L+DF    +   +G V +  
Sbjct: 189 DSV---HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV 235

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 29/128 (22%), Positives = 59/128 (46%), Gaps = 8/128 (6%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVK 256
           RL   IG GSFG +Y    ++   EVA+K+ + +       +E++  + + ++    +  
Sbjct: 10  RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK--IYRILQGGTGIPN 67

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           V       D+  LV++ +   SLE+     +  L +   L +     + +E++   H+  
Sbjct: 68  VRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV---HSKS 123

Query: 317 IIHCDLKP 324
            +H D+KP
Sbjct: 124 FLHRDIKP 131

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.1 bits (137), Expect = 7e-09
 Identities = 25/113 (22%), Positives = 48/113 (42%), Gaps = 15/113 (13%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--------ASLEILNLSNNEIYGLI 79
            ++L+  +L+      +  L+ +  L L++N+L            LE+L  S+N +  + 
Sbjct: 445 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV- 501

Query: 80  PTSLEKLLYLKELSLSFNKLEG--EILRGGPFVNFTAMSFKGNEPLCGSPNLQ 130
              +  L  L+EL L  N+L+    I           ++ +GN  LC    +Q
Sbjct: 502 -DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN-SLCQEEGIQ 552

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.9 bits (108), Expect = 2e-05
 Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 13/93 (13%)

Query: 20  IGNLKAVVEINLS-----RNNLSSDMPATIGGLISLKTLSLAYNKLDV-------ASLEI 67
              LKAV  +  +     R+    +          ++ L LA+  L V         +  
Sbjct: 408 FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTH 467

Query: 68  LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           L+LS+N +   +P +L  L  L+ L  S N LE
Sbjct: 468 LDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.5 bits (107), Expect = 3e-05
 Identities = 22/94 (23%), Positives = 34/94 (36%), Gaps = 14/94 (14%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---- 61
           D S N L   L   +  L+ +  +  S N L +     +  L  L+ L L  N+L     
Sbjct: 469 DLSHNRLRA-LPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRLQQSAA 525

Query: 62  ------VASLEILNLSNNEIYGLIPTSLEKLLYL 89
                    L +LNL  N +        E+L  +
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 558

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 16/141 (11%)

Query: 3   LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD- 61
           +        +E  +   +  LKA   + LS NN+     +++ G+ +L+ LSL  N +  
Sbjct: 28  VELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK--ISSLSGMENLRILSLGRNLIKK 84

Query: 62  -------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE--GEILRGGPFVNF 112
                    +LE L +S N+I  L  + +EKL+ L+ L +S NK+   GEI +       
Sbjct: 85  IENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142

Query: 113 TAMSFKGNEPLCGSPNLQVPP 133
             +   GN PL          
Sbjct: 143 EDLLLAGN-PLYNDYKENNAT 162

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 34/174 (19%), Positives = 66/174 (37%), Gaps = 44/174 (25%)

Query: 185 VSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQE---CARALKSFE 240
            + D     +    ++  + G G+FG+V   + +  G+ VA+K   Q+     R L    
Sbjct: 12  AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---- 67

Query: 241 AQCEVMK---SIRHPNLVK---VISSCSNDDFK----ALVLEYMP---KGSLENCLYSST 287
              ++M+    + HPN+V+      +    D +     +V+EY+P        N      
Sbjct: 68  ---QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV 124

Query: 288 CMLDIFQRLNIMIDATSTLEYLY-------FGHTTP--IIHCDLKPISVLLDED 332
               I  ++           +L+         H     + H D+KP +VL++E 
Sbjct: 125 APPPILIKV-----------FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 34/149 (22%), Positives = 67/149 (44%), Gaps = 21/149 (14%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQEC-----ARALKSFEAQCEV--MKSIRHPNLV 255
           +G G++ +VY+      G+ VA+K    +      + A++      E+  MK ++H N+V
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENIV 66

Query: 256 KVISSCSNDDFKALVLEYMP---KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYF 311
           ++      ++   LV E+M    K  +++    +T   L++             L +   
Sbjct: 67  RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC-- 124

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
            H   I+H DLKP ++L+++     L DF
Sbjct: 125 -HENKILHRDLKPQNLLINKRGQLKLGDF 152

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 34/158 (21%), Positives = 54/158 (34%), Gaps = 37/158 (23%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKV-----FHQECARALKSFEAQCEVMKSIRH-PNLVK 256
           +G G F  V +   +  G E A K        Q+C   +   E    V++  +  P ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH-EIA--VLELAKSCPRVIN 93

Query: 257 VISSCSNDDFKALVLEYMPKGSL-------ENCLYS----STCMLDIFQRLNIMIDATST 305
           +     N     L+LEY   G +          + S       +  I             
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL----------EG 143

Query: 306 LEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           + YL   H   I+H DLKP ++LL          + DF
Sbjct: 144 VYYL---HQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 31/163 (19%), Positives = 66/163 (40%), Gaps = 42/163 (25%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEV---MKSIRHPNLV 255
            S ++G+G  G V +   +    + A+K+            +A+ EV    ++ + P++V
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIV 74

Query: 256 KVI----SSCSNDDFKALVLEYMPKGSL-------ENCLYS----STCMLDIFQRLNIMI 300
           +++    +  +      +V+E +  G L        +  ++    S  M  I        
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG------- 127

Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
                ++YL   H+  I H D+KP ++L      + +  L+DF
Sbjct: 128 ---EAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDF 164

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 11/88 (12%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSN 72
           + NLK +  + L  N +  D+ + +  L  LK+LSL +N +        +  LE L L N
Sbjct: 83  LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGN 140

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           N+I  +  T L +L  L  LSL  N++ 
Sbjct: 141 NKITDI--TVLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 13/102 (12%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           +    S+   ++ +   L ++ +I  + +++ S     I  L ++  L L  NKL     
Sbjct: 27  NLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP 82

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
             ++ +L  L L  N+I  L    L+ L  LK LSL  N + 
Sbjct: 83  LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS 122

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 15/86 (17%), Positives = 35/86 (40%), Gaps = 11/86 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSNNE 74
                ++ NL + +++  +      L S+  +    + +        + ++  L L+ N+
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNK 76

Query: 75  IYGLIPTSLEKLLYLKELSLSFNKLE 100
           +  + P  L  L  L  L L  NK++
Sbjct: 77  LTDIKP--LTNLKNLGWLFLDENKIK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 48.2 bits (114), Expect = 4e-06
 Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 11/101 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
              +N +     L    L  +  ++L  N +S  +P  + GL  L+ L L+ N +     
Sbjct: 137 YLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA 192

Query: 61  --DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
              + +L++L L + E           L+    +  +   L
Sbjct: 193 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 17/116 (14%), Positives = 37/116 (31%), Gaps = 17/116 (14%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSNNEIYGLIP 80
           E       +    P            +L    +       ++ S++ +  +N++I  +  
Sbjct: 3   ETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV-- 58

Query: 81  TSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGN-----EPLCGSPNLQV 131
             ++ L  + +L L+ NKL  +I       N   +    N       L     L+ 
Sbjct: 59  QGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKS 113

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 9/97 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--A 63
           + ++  L   L     +L+    +  S N+L+  +P     L SL   +     L     
Sbjct: 77  ELNNLGLS-SLPELPPHLE---SLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPP 131

Query: 64  SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
            LE L +SNN++  L    L+   +LK + +  N L+
Sbjct: 132 LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK 166

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 23/100 (23%), Positives = 35/100 (35%), Gaps = 13/100 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV--- 62
           D  +NSL+  L     +L+    I    N L       +  L  L  +    N L     
Sbjct: 159 DVDNNSLKK-LPDLPPSLE---FIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPD 212

Query: 63  --ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
              SLE +   NN +       L+ L +L  +    N L+
Sbjct: 213 LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK 250

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 19/112 (16%), Positives = 34/112 (30%), Gaps = 20/112 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLI-------------SLKT 52
              S++L   + ++  N+K+  E   + +    + P   G                    
Sbjct: 17  LRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHE 75

Query: 53  LSLAYNKL-----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
           L L    L         LE L  S N +   +P   + L  L   + +   L
Sbjct: 76  LELNNLGLSSLPELPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKAL 126

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 25/104 (24%), Positives = 37/104 (35%), Gaps = 12/104 (11%)

Query: 5   FDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
               +NSL+  L     +L+    I    N L       +  L  L T+    N L    
Sbjct: 200 IYADNNSLKK-LPDLPLSLE---SIVAGNNILEE--LPELQNLPFLTTIYADNNLLKTLP 253

Query: 61  -DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI 103
               SLE LN+ +N +  L P   + L +L      F+ L    
Sbjct: 254 DLPPSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELP 296

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 21/104 (20%)

Query: 6   DFSSNSLEGPLSL-DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV-- 62
             S+N LE    L ++ N   +  I++  N+L   +P       SL+ ++   N+L+   
Sbjct: 137 GVSNNQLE---KLPELQNSSFLKIIDVDNNSLKK-LPDLPP---SLEFIAAGNNQLEELP 189

Query: 63  -----ASLEILNLSNNEIYGLIPTSLEKLLY-LKELSLSFNKLE 100
                  L  +   NN +       L  L   L+ +    N LE
Sbjct: 190 ELQNLPFLTAIYADNNSL-----KKLPDLPLSLESIVAGNNILE 228

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 29/100 (29%), Positives = 41/100 (41%), Gaps = 17/100 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S N   G LS    NL     +N S N + S          SL+ L+++ NKL     
Sbjct: 283 DVSENIFSG-LSELPPNLY---YLNASSNEIRS----LCDLPPSLEELNVSNNKLIELPA 334

Query: 61  DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
               LE L  S N +  + P   +    LK+L + +N L 
Sbjct: 335 LPPRLERLIASFNHLAEV-PELPQN---LKQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 19/117 (16%), Positives = 36/117 (30%), Gaps = 26/117 (22%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLI--------------- 48
               S N L   +     NLK   ++++  N L    P     +                
Sbjct: 341 RLIASFNHLAE-VPELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELP 395

Query: 49  -SLKTLSLAYNKLDV-----ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
            +LK L +  N L        S+E L +++  +      + E    L++     +  
Sbjct: 396 QNLKQLHVETNPLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 28/115 (24%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           + SSN +   L     +L+   E+N+S N L   +PA       L+ L  ++N L     
Sbjct: 303 NASSNEIRS-LCDLPPSLE---ELNVSNNKLIE-LPALPP---RLERLIASFNHLAEVPE 354

Query: 61  DVASLEILNLSNNEIYGL--IPTSLEKLLY-------------LKELSLSFNKLE 100
              +L+ L++  N +     IP S+E L               LK+L +  N L 
Sbjct: 355 LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 32/163 (19%), Positives = 65/163 (39%), Gaps = 42/163 (25%)

Query: 200 LSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEV---MKSIRHPNLV 255
            S ++G+G  G V +   +    + A+K+            +A+ EV    ++ + P++V
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIV 118

Query: 256 KVI----SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLD-IFQRLN----------IMI 300
           +++    +  +      +V+E +  G L             I  R +          IM 
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMK 168

Query: 301 DATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
                ++YL   H+  I H D+KP ++L      + +  L+DF
Sbjct: 169 SIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDF 208

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 46/208 (22%), Positives = 75/208 (36%), Gaps = 60/208 (28%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK----VF--HQECARALKSFEAQCEV--MKSIRHPNL 254
           IG G+ G V  A        VA+K     F       RA +      E+  MK + H N+
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR------ELVLMKCVNHKNI 86

Query: 255 VKV----ISSCSNDDFKA--LVLEYMPKGSLENC----LYSSTCMLDIFQRLNIMIDATS 304
           + +        S ++F+   +V+E M   +L       L        ++Q L        
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC------- 138

Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------EYGMEGQVSTRS---- 352
            +++L   H+  IIH DLKP ++++  D    + DF         + M   V TR     
Sbjct: 139 GIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

Query: 353 ------------DIYGYGIVLMETFTRK 368
                       DI+  G ++ E     
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 60/208 (28%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK----VFHQE--CARALKSFEAQCEV--MKSIRHPNL 254
           +G G++GSV  A   + G+ VAVK     F       R  +      E+  +K ++H N+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR------ELRLLKHMKHENV 90

Query: 255 VKV----ISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLD-----IFQRLNIMIDAT 303
           + +      + S ++F    LV   M    L N +       D     I+Q L       
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR------ 143

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR------ 351
             L+Y+   H+  IIH DLKP ++ ++ED    + DF         M G V+TR      
Sbjct: 144 -GLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPE 199

Query: 352 -----------SDIYGYGIVLMETFTRK 368
                       DI+  G ++ E  T +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 34/162 (20%), Positives = 56/162 (34%), Gaps = 40/162 (24%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVF---------HQECARALKSFEAQCEVMKSIRHP 252
           ++G G FG V   ++R   ++ A K            +  A   K       +++ +   
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ------ILEKVNSR 244

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID----------A 302
            +V +  +    D   LVL  M  G L            I+                   
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDL---------KFHIYHMGQAGFPEARAVFYAAEI 295

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM 344
              LE L   H   I++ DLKP ++LLD+     +SD   G+
Sbjct: 296 CCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDL--GL 332

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 32/154 (20%), Positives = 63/154 (40%), Gaps = 31/154 (20%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNLVK 256
           +G G++G VY+A        VA+K    E         A++  E    ++K ++H N+++
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR--EVS--LLKELQHRNIIE 97

Query: 257 VISSCSNDDFKALVLEYMP---KGSLENC--LYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           + S   ++    L+ EY     K  ++    +        ++Q           +  + F
Sbjct: 98  LKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ----------LINGVNF 147

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAH-----LSDF 340
            H+   +H DLKP ++LL     +      + DF
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 17/100 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           + + N+L   L     +L+    ++   N LS+ +P       SLK L +  N+L     
Sbjct: 86  EITQNALI-SLPELPASLE---YLDACDNRLST-LPELPA---SLKHLDVDNNQLTMLPE 137

Query: 61  DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
             A LE +N  NN++  L P        L+ LS+  N+L 
Sbjct: 138 LPALLEYINADNNQLTML-PELPTS---LEVLSVRNNQLT 173

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 17/100 (17%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D   N L   L     +LK    +++  N L+  +P        L+ ++   N+L     
Sbjct: 106 DACDNRLST-LPELPASLK---HLDVDNNQLTM-LPELPA---LLEYINADNNQLTMLPE 157

Query: 61  DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
              SLE+L++ NN++   +P   E    L+ L +S N LE
Sbjct: 158 LPTSLEVLSVRNNQL-TFLPELPES---LEALDVSTNLLE 193

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 27/99 (27%), Positives = 41/99 (41%), Gaps = 14/99 (14%)

Query: 8   SSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----V 62
             N  E    L    +    E+ L+R NLSS +P  +     +  L +  N L       
Sbjct: 43  GENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLPP--QITVLEITQNALISLPELP 99

Query: 63  ASLEILNLSNNEIYGLIPTSL-EKLLYLKELSLSFNKLE 100
           ASLE L+  +N +     ++L E    LK L +  N+L 
Sbjct: 100 ASLEYLDACDNRL-----STLPELPASLKHLDVDNNQLT 133

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 16/112 (14%), Positives = 33/112 (29%), Gaps = 17/112 (15%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKT----LSLAYNKL- 60
              +N L   L     +L+    +++S N L S +PA        +          N++ 
Sbjct: 166 SVRNNQLTF-LPELPESLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT 220

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR 105
                   +     + L +N +   I  SL +     +             +
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 53.4 bits (129), Expect = 5e-08
 Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 21/151 (13%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVK---V 257
           IG G+FG V++AR  + G +VA+K    E  +      A  E+  ++ ++H N+V    +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 258 ISSCSNDDFKA-----LVLEYMP---KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
             + ++   +      LV ++      G L N          + +   +M    + L Y+
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYI 140

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
              H   I+H D+K  +VL+  D V  L+DF
Sbjct: 141 ---HRNKILHRDMKAANVLITRDGVLKLADF 168

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 20/162 (12%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE-----VMKSIRHPNLV 255
           +IG G FG VY  R  D  ++ A+K   ++  +  +    A  E     ++ +   P +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA---TSTLEYLYFG 312
            +  +    D  + +L+ M  G L   L        +F   ++   A      LE++   
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHM--- 308

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---EYGMEGQVSTR 351
           H   +++ DLKP ++LLDE     +SD        + +    
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 14/104 (13%)

Query: 4   NFDFSSNSLEGPLSLD-IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK--- 59
           NF+  +++++   SL  +     + E++LS N +S D+   +  L  L+ LS+  N+   
Sbjct: 45  NFNGDNSNIQ---SLAGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN 99

Query: 60  ---LDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
              +  A L  L L NNE+      SL  L  L+ LS+  NKL+
Sbjct: 100 LNGIPSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK 141

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 28/124 (22%), Positives = 55/124 (44%), Gaps = 18/124 (14%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSN 72
              L   V+ NL + +++     +   L  ++  +   + +          +L+ L+LS+
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSH 72

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGN-----EPLCGSP 127
           N+I  L P  L+ L  L+ELS++ N+L  + L G P    + +    N     + L    
Sbjct: 73  NQISDLSP--LKDLTKLEELSVNRNRL--KNLNGIPSACLSRLFLDNNELRDTDSLIHLK 128

Query: 128 NLQV 131
           NL++
Sbjct: 129 NLEI 132

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 11/88 (12%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSN 72
           I  L+++  ++L+   ++   P  + GL +L+ L L  N++        + +L+ L++ N
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
            ++  L P  L  L  L  L    NK+ 
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 23/86 (26%), Positives = 38/86 (44%), Gaps = 11/86 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSNNE 74
            L   ++I   ++N++     T   L  + TLS     +        + +L  L L +N+
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQ 74

Query: 75  IYGLIPTSLEKLLYLKELSLSFNKLE 100
           I  L P  L+ L  + EL LS N L+
Sbjct: 75  ITDLAP--LKNLTKITELELSGNPLK 98

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 11/88 (12%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSN 72
           + NL  + E+ LS N L +     I GL S+KTL L   ++        +++L++L L  
Sbjct: 81  LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           N+I  + P  L  L  L+ LS+   ++ 
Sbjct: 139 NQITNISP--LAGLTNLQYLSIGNAQVS 164

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 14/106 (13%), Positives = 42/106 (39%), Gaps = 13/106 (12%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           + +      +++   ++    +L  +  ++     +++     +  L +L  L L  N++
Sbjct: 20  NAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQI 75

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                  ++  +  L LS N +  +    +  L  +K L L+  ++
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQI 119

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 9/87 (10%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS-------LEILNLSN 72
           + NL  +  +    N +S D+   +  L +L  + L  N++   S       L I+ L+N
Sbjct: 169 LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKL 99
             I          L+    +       
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAP 253

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 47/211 (22%), Positives = 79/211 (37%), Gaps = 66/211 (31%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK----VF--HQECARALKSFEAQCEV--MKSIRHPNL 254
           IG G+ G V  A        VA+K     F       RA +      E+  MK + H N+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR------ELVLMKCVNHKNI 123

Query: 255 VKVI----SSCSNDDFKA--LVLEYMP-------KGSLENCLYSSTCMLDIFQRLNIMID 301
           + ++       + ++F+   LV+E M        +  L++   S      ++Q L     
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQMLC---- 175

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------EYGMEGQVSTRS- 352
               +++L   H+  IIH DLKP ++++  D    + DF         + M   V TR  
Sbjct: 176 ---GIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229

Query: 353 ---------------DIYGYGIVLMETFTRK 368
                          DI+  G ++ E    K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 50/212 (23%), Positives = 83/212 (39%), Gaps = 59/212 (27%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVK----VFHQE--CARALKSFEAQCEV--MKSI 249
                +G G++GSV  A   R G +VA+K     F  E    RA +      E+  +K +
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR------ELLLLKHM 80

Query: 250 RHPNLVK----VISSCSNDDFKA--LVLEYMPKGSLENC----LYSSTCMLDIFQRLNIM 299
           +H N++        + S  +F    LV+ +M    L+               ++Q L   
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK-- 137

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR-- 351
                 L+Y+   H+  ++H DLKP ++ ++ED    + DF      +  M G V TR  
Sbjct: 138 -----GLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWY 189

Query: 352 ---------------SDIYGYGIVLMETFTRK 368
                           DI+  G ++ E  T K
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 10/88 (11%)

Query: 21  GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLS 71
           G L  +  ++LS N L S +P     L +L  L +++N+L          +  L+ L L 
Sbjct: 74  GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKL 99
            NE+  L P  L     L++LSL+ N L
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNL 160

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 33/104 (31%), Positives = 45/104 (43%), Gaps = 10/104 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S N L+  L L    L A+  +++S N L+S     + GL  L+ L L  N+L     
Sbjct: 83  DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                   LE L+L+NN +  L    L  L  L  L L  N L 
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 10/102 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
             S N L       +     + ++NL R  L+  +    G L  L TL L++N+L     
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQV-DGTLPVLGTLDLSHNQLQSLPL 94

Query: 61  ---DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
               + +L +L++S N +  L   +L  L  L+EL L  N+L
Sbjct: 95  LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 35/145 (24%), Positives = 65/145 (44%), Gaps = 18/145 (12%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQEC-----ARALKSFEAQCEV--MKSIRHPNLV 255
           +G G++ +VY+ + +     VA+K    E        A++      EV  +K ++H N+V
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLKDLKHANIV 63

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
            +      +    LV EY+ K  L+  L     ++++      +      L Y    H  
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC---HRQ 119

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF 340
            ++H DLKP ++L++E     L+DF
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADF 144

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 27/119 (22%), Positives = 59/119 (49%), Gaps = 13/119 (10%)

Query: 5   FDFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSD-MPATIGGLISLKTLSLAYNKLD 61
                N L+    ++     +K++ ++++S+N++S D          SL +L+++ N L 
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

Query: 62  VA-------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                     +++L+L +N+I  + P  + KL  L+EL+++ N+L  + +  G F   T
Sbjct: 413 DTIFRCLPPRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQL--KSVPDGIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 26/140 (18%), Positives = 47/140 (33%), Gaps = 12/140 (8%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
                + S N +    + DI +L  +  + +S N +     +       L+ L L++NKL
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 61  DV------ASLEILNLSNNEIYGLIPTSL-EKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                    +L+ L+LS N    L        +  LK L LS        L     +   
Sbjct: 82  VKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH-----LEKSSVLPIA 136

Query: 114 AMSFKGNEPLCGSPNLQVPP 133
            ++      + G    +   
Sbjct: 137 HLNISKVLLVLGETYGEKED 156

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 24/106 (22%), Positives = 42/106 (39%), Gaps = 12/106 (11%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           +F+ +       L    +   + ++ S N L+  +    G L  L+TL L  N+L     
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK 365

Query: 61  ------DVASLEILNLSNNEI-YGLIPTSLEKLLYLKELSLSFNKL 99
                  + SL+ L++S N + Y            L  L++S N L
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 15/109 (13%), Positives = 32/109 (29%), Gaps = 9/109 (8%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
            I N                 +LKA+    +  +              ++   +   +  
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312

Query: 61  DV---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
            +         +    L+ SNN +   +  +   L  L+ L L  N+L+
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 20/80 (25%), Positives = 36/80 (45%), Gaps = 12/80 (15%)

Query: 29 INLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYGLI 79
          ++ S+N L   +P  +        L+++ N +          ++ L IL +S+N I  L 
Sbjct: 5  VDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 80 PTSLEKLLYLKELSLSFNKL 99
           +  +    L+ L LS NKL
Sbjct: 62 ISVFKFNQELEYLDLSHNKL 81

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 22/101 (21%), Positives = 47/101 (46%), Gaps = 11/101 (10%)

Query: 6   DFSSNSLEGPLSLDI-GNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---- 60
           D S NS+            K+++ +N+S N L+  +   +     +K L L  NK+    
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIP 437

Query: 61  ----DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFN 97
                + +L+ LN+++N++  +     ++L  L+++ L  N
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 52.6 bits (127), Expect = 9e-08
 Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 33/161 (20%)

Query: 202 NLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEV-------------MK 247
             IG+G++G+VY+AR    G  VA+K                  +             ++
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG-----GGGGGLPISTVREVALLRRLE 69

Query: 248 SIRHPNLVK---VISSCSNDDFKA--LVLEYMP---KGSLENCLYSSTCMLDIFQRLNIM 299
           +  HPN+V+   V ++   D      LV E++    +  L+         L      ++M
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETIKDLM 126

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
                 L++L   H   I+H DLKP ++L+       L+DF
Sbjct: 127 RQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLADF 164

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 10/93 (10%)

Query: 30  NLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSNNEIYGLIP 80
           +LS N ++    + +   ++L+ L L  N ++           SLE L+LS N +  L  
Sbjct: 58  DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSS 117

Query: 81  TSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
           +  + L  L  L+L  N  +  +     F + T
Sbjct: 118 SWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLT 149

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 10/111 (9%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----- 60
           D S+N +    + D+     +  + L+ N +++    +   L SL+ L L+YN L     
Sbjct: 58  DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSS 117

Query: 61  ----DVASLEILNLSNNEIYGLIPTSL-EKLLYLKELSLSFNKLEGEILRG 106
                ++SL  LNL  N    L  TSL   L  L+ L +       +I R 
Sbjct: 118 SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 14/97 (14%), Positives = 34/97 (35%), Gaps = 18/97 (18%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV-----------------AS 64
           +++ V  + L        +   +    S++ L L    LD                   +
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255

Query: 65  LEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG 101
              + +++  ++  +   L ++  L EL  S N+L+ 
Sbjct: 256 FRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 11/89 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL----------DVASLEILNL 70
            L ++  +NL  N   +    ++   L  L+ L +                +  LE L +
Sbjct: 122 PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI 181

Query: 71  SNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
             +++    P SL+ +  +  L L   + 
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQH 210

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 11/89 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----------DVASLEILNLS 71
           +L ++  ++LS N LS+   +    L SL  L+L  N             +  L+IL + 
Sbjct: 98  SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVG 157

Query: 72  NNEIYGLIPT-SLEKLLYLKELSLSFNKL 99
           N + +  I       L +L+EL +  + L
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDL 186

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 14/107 (13%), Positives = 35/107 (32%), Gaps = 13/107 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLSLAYNKL---------DVASLEILNLS 71
           +L  +  + +   +  + +      GL  L+ L +  + L          + ++  L L 
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKLEG---EILRGGPFVNFTAM 115
             +   L+   ++    ++ L L    L+      L  G   +    
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 9/87 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
            L  + +IN S N ++        G   +  + L  N+L          + SL+ L L +
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKL 99
           N I  +   S   L  ++ LSL  N++
Sbjct: 115 NRITCVGNDSFIGLSSVRLLSLYDNQI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 15/83 (18%), Positives = 33/83 (39%), Gaps = 10/83 (12%)

Query: 28  EINLSRNNLSSDMP-ATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYG 77
           E+ L+ N  +          L  L+ ++ + NK+           + +  + L++N +  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95

Query: 78  LIPTSLEKLLYLKELSLSFNKLE 100
           +     + L  LK L L  N++ 
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT 118

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 9/84 (10%)

Query: 23  LKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNN 73
              V EI L+ N L +       GL SLKTL L  N++          ++S+ +L+L +N
Sbjct: 80  ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139

Query: 74  EIYGLIPTSLEKLLYLKELSLSFN 97
           +I  + P + + L  L  L+L  N
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLAN 163

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 7/142 (4%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE--VMKSIRHPNLVKVI 258
           L+G G+FG V   + +      A+K+  +E   A         E  V+++ RHP L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
            S    D    V+EY   G L   L       +   R     +  S L+YL+      ++
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN--VV 271

Query: 319 HCDLKPISVLLDEDMVAHLSDF 340
           + DLK  +++LD+D    ++DF
Sbjct: 272 YRDLKLENLMLDKDGHIKITDF 293

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 35/187 (18%), Positives = 66/187 (35%), Gaps = 65/187 (34%)

Query: 204 IGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK---VIS 259
           +G GSFG V      + G   A+K   Q+     +      ++MK + H N++K      
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNREL----DIMKVLDHVNIIKLVDYFY 70

Query: 260 SCSNDDFKA-----------------------------------LVLEYMP---KGSLEN 281
           +  +++ K                                    +++EY+P      L++
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 282 CLYSSTCMLDIFQRLNIMIDATSTLEYLY-------FGHTTPIIHCDLKPISVLLD-EDM 333
            + S   +      +           Y+Y       F H+  I H D+KP ++L++ +D 
Sbjct: 131 FIRSGRSIPMNLISI-----------YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 334 VAHLSDF 340
              L DF
Sbjct: 180 TLKLCDF 186

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 26/154 (16%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE--VMKSIRHPNLVKVI 258
           L+G G+FG V   R +      A+K+  +E   A         E  V+++ RHP L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT--------STLEYLY 310
            +    D    V+EY   G L            + +      +          S LEYL 
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL---------FFHLSRERVFTEERARFYGAEIVSALEYL- 121

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM 344
             H+  +++ D+K  +++LD+D    ++DF  G+
Sbjct: 122 --HSRDVVYRDIKLENLMLDKDGHIKITDF--GL 151

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 54/207 (26%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK---VFHQE--CARALKSFEAQCEV--MKSIRHPNLV 255
           IG G++G V  A    + + VA+K    F  +  C R L+      E+  +   RH N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR------EIKILLRFRHENII 88

Query: 256 K---VISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
               +I + + +  K   +V + M    L   L +     D       +      L+Y+ 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC--YFLYQILRGLKYI- 144

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------EYGMEGQVSTR------- 351
             H+  ++H DLKP ++LL+      + DF               +   V+TR       
Sbjct: 145 --HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

Query: 352 ----------SDIYGYGIVLMETFTRK 368
                      DI+  G +L E  + +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 39/157 (24%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK---VFHQE--CARALKSFEAQCEV--MKSIRHPNLV 255
           +G G++G V  A     G  VA+K    F +     R L+      E+  +K  +H N++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR------EIKILKHFKHENII 72

Query: 256 K---VISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLD-------IFQRLNIMIDAT 303
               +    S ++F    ++ E M    L   +  ST ML        I+Q L       
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQMLSDDHIQYFIYQTLR------ 123

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
             ++ L   H + +IH DLKP ++L++ +    + DF
Sbjct: 124 -AVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDF 156

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 60/214 (28%)

Query: 198 RRLSNLIGMGSFGSVYRAR-LRDGIEVAVK----VFHQE--CARALKSFEAQCEV--MKS 248
            R    +G G++G+V  A   R G +VA+K     F  E    RA +      E+  +K 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR------ELRLLKH 80

Query: 249 IRHPNLVKVI----SSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLD-----IFQRLN 297
           +RH N++ ++       + DDF    LV+ +M    L   +       D     ++Q L 
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK 139

Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------EYGMEGQVSTR 351
                   L Y+   H   IIH DLKP ++ ++ED    + DF      +  M G V TR
Sbjct: 140 -------GLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 189

Query: 352 -----------------SDIYGYGIVLMETFTRK 368
                             DI+  G ++ E  T K
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 9/87 (10%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSN 72
             K +  I+LS N +S   P    GL SL +L L  NK+          + SL++L L+ 
Sbjct: 54  PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKL 99
           N+I  L   + + L  L  LSL  NKL
Sbjct: 114 NKINCLRVDAFQDLHNLNLLSLYDNKL 140

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 9/84 (10%)

Query: 26  VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIY 76
           + EI L +N +    P        L+ + L+ N++          + SL  L L  N+I 
Sbjct: 34  ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 77  GLIPTSLEKLLYLKELSLSFNKLE 100
            L  +  E L  L+ L L+ NK+ 
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN 117

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.7 bits (101), Expect = 8e-05
 Identities = 23/104 (22%), Positives = 47/104 (45%), Gaps = 15/104 (14%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-- 60
           D S+N +     L       L+++  + L  N ++    +   GL SL+ L L  NK+  
Sbjct: 62  DLSNNQIS---ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC 118

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFN 97
                  D+ +L +L+L +N++  +   +   L  ++ + L+ N
Sbjct: 119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 35/161 (21%)

Query: 202 NLIGMGSFGSVYRAR--LRDGIEVAVKVFHQECAR------------ALKSFEAQCEVMK 247
             IG G++G V++AR     G  VA+K    +                L+        ++
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-------LE 69

Query: 248 SIRHPNLVK---VISSCSNDDFKA--LVLEYMP---KGSLENCLYSSTCMLDIFQRLNIM 299
           +  HPN+V+   V +    D      LV E++       L+         +      ++M
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMM 126

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
                 L++L   H+  ++H DLKP ++L+       L+DF
Sbjct: 127 FQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADF 164

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 29/119 (24%), Positives = 56/119 (47%), Gaps = 13/119 (10%)

Query: 5   FDFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSDM-PATIGGLISLKTLSLAYNKLD 61
                N L+    ++L   N+ ++  +++S N+L+S     T     S+  L+L+ N L 
Sbjct: 382 LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441

Query: 62  -------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
                     +++L+L NN I  + P  +  L  L+EL+++ N+L  + +  G F   T
Sbjct: 442 GSVFRCLPPKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQL--KSVPDGVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 13/93 (13%)

Query: 30  NLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSNNEIYGLIP 80
           +LS+N++S      I  L  L+ L L++N++             LE L++S+N +  +  
Sbjct: 58  SLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI-- 115

Query: 81  TSLEKLLYLKELSLSFNKLEGEILRGGPFVNFT 113
            S   +  L+ L LSFN  +  +     F N T
Sbjct: 116 -SCCPMASLRHLDLSFNDFD-VLPVCKEFGNLT 146

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 16/109 (14%), Positives = 32/109 (29%), Gaps = 9/109 (8%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           +I N   +        +     LK+++  ++          A       +    L+ +  
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

Query: 61  DV---------ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                      +S   LN + N     +      L  L+ L L  N L+
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 32/146 (21%), Positives = 65/146 (44%), Gaps = 34/146 (23%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK----VFHQE--CARALKSFEAQCEV--MKSIR-HPN 253
           +G G++G V+++   R G  VAVK     F       R  +      E+  +  +  H N
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR------EIMILTELSGHEN 70

Query: 254 LVKVISSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLD-----IFQRLNIMIDATSTL 306
           +V +++    D+ +   LV +YM    L   + ++          ++Q +         +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIK-------VI 122

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDED 332
           +YL   H+  ++H D+KP ++LL+ +
Sbjct: 123 KYL---HSGGLLHRDMKPSNILLNAE 145

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 11/89 (12%)

Query: 19  DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLS 71
            + NLK +  + L  N +       +  L  LK+LSL +N +        +  LE L L 
Sbjct: 85  PLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLG 142

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           NN+I  +  T L +L  L  LSL  N++ 
Sbjct: 143 NNKITDI--TVLSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 11/88 (12%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSN 72
           + +LK +  ++L  N +S D+   +  L  L++L L  NK+        +  L+ L+L +
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKLE 100
           N+I  ++P  L  L  L+ L LS N + 
Sbjct: 166 NQISDIVP--LAGLTKLQNLYLSKNHIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 25/106 (23%), Positives = 48/106 (45%), Gaps = 13/106 (12%)

Query: 2   ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL- 60
            +  +    S+   ++ +   L ++ +I  + +++ S     I  L ++  L L  NKL 
Sbjct: 26  TIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT 81

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
                 ++ +L  L L  N++  L  +SL+ L  LK LSL  N + 
Sbjct: 82  DIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS 125

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 17/87 (19%), Positives = 35/87 (40%), Gaps = 9/87 (10%)

Query: 20  IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSN 72
           +  L  +  ++L  N +S  +P  + GL  L+ L L+ N +        + +L++L L +
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 209

Query: 73  NEIYGLIPTSLEKLLYLKELSLSFNKL 99
            E           L+    +  +   L
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSL 236

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 16/107 (14%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-- 60
           D S   ++   +++ G   +L  +  + L+ N + S       GL SL+ L      L  
Sbjct: 58  DLSRCEIQ---TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 61  -------DVASLEILNLSNNEIYGLI-PTSLEKLLYLKELSLSFNKL 99
                   + +L+ LN+++N I     P     L  L+ L LS NK+
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 19/96 (19%), Positives = 33/96 (34%), Gaps = 11/96 (11%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYGL 78
            ++LS N L      +      L+ L L+  ++          ++ L  L L+ N I  L
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 79  IPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
              +   L  L++L      L    L   P  +   
Sbjct: 92  ALGAFSGLSSLQKLVAVETNL--ASLENFPIGHLKT 125

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 15/94 (15%)

Query: 21  GNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKL---------DVASLEI--- 67
           G+LK + E+N++ N + S  +P     L +L+ L L+ NK+          +  + +   
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 68  -LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE 100
            L+LS N +   I     K + LKEL+L  N+L+
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK 213

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 51/167 (30%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVF---------HQECARALKSFEAQCEVMKSIRHP 252
           +IG GSFG V  AR +      AVKV           ++   + ++      ++K+++HP
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-----LLKNVKHP 99

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSL-----------EN--CLYSSTCMLDIFQRLNIM 299
            LV +  S    D    VL+Y+  G L           E     Y++             
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS--------- 150

Query: 300 IDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH--LSDFEYGM 344
                 L YL   H+  I++ DLKP ++LLD     H  L+DF  G+
Sbjct: 151 -----ALGYL---HSLNIVYRDLKPENILLDSQ--GHIVLTDF--GL 185

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 11/88 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL---------DVASLEILNLS 71
            L  +  + L+ N L + +PA I   L +L+TL +  NKL          + +L  L L 
Sbjct: 59  RLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKL 99
            N++  L P   + L  L  LSL +N+L
Sbjct: 118 RNQLKSLPPRVFDSLTKLTYLSLGYNEL 145

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 30/107 (28%), Positives = 48/107 (44%), Gaps = 17/107 (15%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL- 60
             + N L+   +L  G    LK +  + ++ N L + +P  +   L++L  L L  N+L 
Sbjct: 67  YLNDNKLQ---TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK 122

Query: 61  --------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                    +  L  L+L  NE+  L     +KL  LKEL L  N+L
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 37/125 (29%), Positives = 57/125 (45%), Gaps = 19/125 (15%)

Query: 6   DFSSNSLEGPLSLDIG---NLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL- 60
             + N L+   +L IG    L  + E+ L RN L S +P  +   L  L  LSL YN+L 
Sbjct: 91  WVTDNKLQ---ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ 146

Query: 61  --------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNF 112
                    + SL+ L L NN++  +   + +KL  LK L L  N+L+   +  G F + 
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR--VPEGAFDSL 204

Query: 113 TAMSF 117
             +  
Sbjct: 205 EKLKM 209

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 9/80 (11%)

Query: 30  NLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYGLIP 80
           +L  N LSS        L  L+ L L  NKL         ++ +LE L +++N++  L  
Sbjct: 43  DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPI 102

Query: 81  TSLEKLLYLKELSLSFNKLE 100
              ++L+ L EL L  N+L+
Sbjct: 103 GVFDQLVNLAELRLDRNQLK 122

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 22/116 (18%), Positives = 41/116 (35%), Gaps = 11/116 (9%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV-------ASLEILNLSNNE 74
           N     E++L R      +      L     +  + N++           L+ L ++NN 
Sbjct: 17  NAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNR 75

Query: 75  IYGLIPTSLEKLLYLKELSLSFNKLE--GEILRGGPFVNFTAMSFKGNEPLCGSPN 128
           I  +     + L  L EL L+ N L   G++       + T +    N P+    +
Sbjct: 76  ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN-PVTNKKH 130

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 32/158 (20%)

Query: 203 LIGMGSFGSVYRARLRDGIEV----AVKVFHQECARALKSFEAQCE--VMKSIRHPNLVK 256
           ++G GSFG V+  +   G +     A+KV  +   +       + E  ++  + HP +VK
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT--------STLEY 308
           +  +   +    L+L+++  G L            + + +    +            L++
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDL---------FTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAH--LSDFEYGM 344
           L   H+  II+ DLKP ++LLDE+   H  L+DF  G+
Sbjct: 142 L---HSLGIIYRDLKPENILLDEE--GHIKLTDF--GL 172

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 37/160 (23%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE---VMKSIRHPNLVKV 257
           ++G GSFG V  AR+++  ++ AVKV  ++        E    E   +  +  HP L ++
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 258 ISSCSNDDFKALVLEYMPKGSL-----------EN--CLYSSTCMLDIFQRLNIMIDATS 304
                  D    V+E++  G L           E     Y++  +               
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS-------------- 135

Query: 305 TLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM 344
            L +L   H   II+ DLK  +VLLD +    L+DF  GM
Sbjct: 136 ALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADF--GM 170

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 38/156 (24%), Positives = 63/156 (40%), Gaps = 29/156 (18%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE---VMKSIRHPNLVKV 257
           ++G GSFG V  +  +   E+ AVK+  ++        E    E   +    + P L ++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA---------TSTLEY 308
            S     D    V+EY+  G L         M  I Q++    +             L +
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDL---------MYHI-QQVGRFKEPHAVFYAAEIAIGLFF 457

Query: 309 LYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM 344
           L    +  II+ DLK  +V+LD +    ++DF  GM
Sbjct: 458 L---QSKGIIYRDLKLDNVMLDSEGHIKIADF--GM 488

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 48.0 bits (115), Expect = 3e-06
 Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 27/155 (17%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE---VMKSIRHPNLVKV 257
           +IG GS+  V   RL+    + A+KV  +E     +  +  Q E     ++  HP LV +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT--------STLEYL 309
            S    +     V+EY+  G L         M  + ++  +  +            L YL
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDL---------MFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM 344
              H   II+ DLK  +VLLD +    L+D+  GM
Sbjct: 127 ---HERGIIYRDLKLDNVLLDSEGHIKLTDY--GM 156

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 29/123 (23%), Positives = 45/123 (36%), Gaps = 11/123 (8%)

Query: 16  LSLDIGNLKAVVEINLS-RNNLSSDMPATIGGLISLKTLSLAYNKLDVAS-------LEI 67
           L L      AV E+ L    +    +       ++L+ LSL    L   S       L+ 
Sbjct: 16  LELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKK 75

Query: 68  LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE--GEILRGGPFVNFTAMSFKGNEPLCG 125
           L LS N I+G +    EKL  L  L+LS NKL+    +          ++       +  
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC-EVTN 134

Query: 126 SPN 128
             +
Sbjct: 135 LND 137

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 40/155 (25%), Positives = 65/155 (41%), Gaps = 27/155 (17%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE---VMKSIRHPNLVKV 257
           +IG GS+  V   RL+    + A++V  +E     +  +  Q E     ++  HP LV +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT--------STLEYL 309
            S    +     V+EY+  G L         M  + ++  +  +            L YL
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDL---------MFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM 344
              H   II+ DLK  +VLLD +    L+D+  GM
Sbjct: 170 ---HERGIIYRDLKLDNVLLDSEGHIKLTDY--GM 199

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 15/149 (10%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE---VMKSIRHPNLVKV 257
           ++G GSFG V+ A  +   +  A+K   ++        E    E   +  +  HP L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +    +    V+EY+  G L   + S               +    L++L   H+  I
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFL---HSKGI 139

Query: 318 IHCDLKPISVLLDEDMVAH--LSDFEYGM 344
           ++ DLK  ++LLD+D   H  ++DF  GM
Sbjct: 140 VYRDLKLDNILLDKD--GHIKIADF--GM 164

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 60/207 (28%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK----VFHQECARALKSFEAQCEVMKSIR-HPNLVK- 256
           +G G +  V+ A  + +  +V VK    V  ++  R +K       +++++R  PN++  
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-------ILENLRGGPNIITL 96

Query: 257 ---VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDI----FQRLNIMIDATSTLEYL 309
              V    S     ALV E++     +  LY +    DI    ++           L+ L
Sbjct: 97  ADIVKDPVSRTP--ALVFEHVNNTDFKQ-LYQTLTDYDIRFYMYE----------ILKAL 143

Query: 310 YFGHTTPIIHCDLKPISVLLD-EDMVAHLSDF---EYGMEGQ-----VSTR--------- 351
            + H+  I+H D+KP +V++D E     L D+   E+   GQ     V++R         
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203

Query: 352 --------SDIYGYGIVLMETFTRKKP 370
                    D++  G +L     RK+P
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 34/159 (21%)

Query: 204 IGMGSFGSVYRAR-LRDGIEVAVK--VF--HQECARALKSFEAQCEV--MKSIRHPNLVK 256
           +G G  G V+ A        VA+K  V    Q    AL+      E+  ++ + H N+VK
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR------EIKIIRRLDHDNIVK 72

Query: 257 VI------------SSCSNDDFKA--LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
           V                S  +  +  +V EYM    L N L     + +  +    M   
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHAR--LFMYQL 129

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLD-EDMVAHLSDF 340
              L+Y+   H+  ++H DLKP ++ ++ ED+V  + DF
Sbjct: 130 LRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIGDF 165

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 33/199 (16%), Positives = 59/199 (29%), Gaps = 64/199 (32%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAV-----------------------KVFHQECARALKS 238
            +G G FG V+ A+   D    A+                       K+ H    R   +
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 239 FEAQC-----------------------------------EVMKSIRHPNLVKVISSCSN 263
           +                                         M      N V  +   S 
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 264 DDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD 321
             +  + ++   K +L++ +    S    +    L+I I     +E+L   H+  ++H D
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL---HSKGLMHRD 189

Query: 322 LKPISVLLDEDMVAHLSDF 340
           LKP ++    D V  + DF
Sbjct: 190 LKPSNIFFTMDDVVKVGDF 208

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 30/106 (28%), Positives = 44/106 (41%), Gaps = 11/106 (10%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL-- 60
             D  S  L          L  +  +NL  N L + + A +   L  L TL LA N+L  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLAS 97

Query: 61  -------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKL 99
                   +  L+ L L  N++  L     ++L  LKEL L+ N+L
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 38/155 (24%), Positives = 60/155 (38%), Gaps = 27/155 (17%)

Query: 203 LIGMGSFGSVYRARLRDGIEV-AVKVFHQECARALKSFE-AQCE---VMKSIRHPNLVKV 257
           ++G GSFG V  +  +   E+ AVK+  ++        E    E   +    + P L ++
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT--------STLEYL 309
            S     D    V+EY+  G L         M  I Q                   L +L
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDL---------MYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM 344
               +  II+ DLK  +V+LD +    ++DF  GM
Sbjct: 138 ---QSKGIIYRDLKLDNVMLDSEGHIKIADF--GM 167

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 28/166 (16%), Positives = 59/166 (35%), Gaps = 29/166 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR---------LRDGIEVAVKV------FHQECA---RALKSFE 240
           +L +     + G +Y A               + ++K+         E     RA K  +
Sbjct: 45  KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ 104

Query: 241 AQCEV-MKSIRHPNLVKVISSCSN-DDFKALVLEYMPKGSLENCL-YSSTCMLDIFQRLN 297
                 + S     +   +    + D ++ LVL  + + SL++ L  S   +L     L 
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQ 163

Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           +       LE+L   H    +H ++   ++ +   D+  V  L+ +
Sbjct: 164 VACRLLDALEFL---HENEYVHGNVTAENIFVDPEDQSQV-TLAGY 205

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 38/171 (22%), Positives = 68/171 (39%), Gaps = 56/171 (32%)

Query: 203 LIGMGSFGSVYRARLRDGIEV----AVKVF----------HQECARALKSFEAQCEVMKS 248
           ++G G +G V++ R   G       A+KV                +A ++      +++ 
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN------ILEE 77

Query: 249 IRHPNLVKVISSCSNDDFKALVLEYMPKGSL-----------EN--CLYSSTCMLDIFQR 295
           ++HP +V +I +        L+LEY+  G L           E+  C Y +   +     
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM----- 132

Query: 296 LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH--LSDFEYGM 344
                     L +L   H   II+ DLKP +++L+     H  L+DF  G+
Sbjct: 133 ---------ALGHL---HQKGIIYRDLKPENIMLNHQ--GHVKLTDF--GL 167

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 29/166 (17%), Positives = 60/166 (36%), Gaps = 29/166 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR------LRDGIEVAVKVFHQEC------ARALKSFEAQCEVM 246
           ++   IG G FG +Y A       +       VKV   +        +  +      ++ 
Sbjct: 38  KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97

Query: 247 KSIRHPNLVKV---------ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLN 297
           K IR   L  +         +   +   ++ ++++      L+    ++         L 
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQ 156

Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
           + +     LEY+   H    +H D+K  ++LL   + D V +L D+
Sbjct: 157 LSLRILDILEYI---HEHEYVHGDIKASNLLLNYKNPDQV-YLVDY 198

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 26/119 (21%), Positives = 41/119 (34%), Gaps = 15/119 (12%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGG---LISLKTLSLAYNKLDV-------ASLEILNLS 71
               V E+ L  +N  S+     G       L+ LS     L           L+ L LS
Sbjct: 15  TPSDVKELVL--DNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELS 72

Query: 72  NNEIYGLIPTSLEKLLYLKELSLSFNKLE--GEILRGGPFVNFTAMSFKGNEPLCGSPN 128
           +N + G +    EK   L  L+LS NK++    I       N  ++       +    +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC-EVTNLND 130

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.5 bits (107), Expect = 2e-05
 Identities = 19/110 (17%), Positives = 34/110 (30%), Gaps = 15/110 (13%)

Query: 27  VEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----------DVASLEILNLSNNEIY 76
             +  +R+         + G  +L  L +   +            +  L  L +  + + 
Sbjct: 11  SGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 77  GLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNF--TAMSFKGNEPLC 124
            + P +      L  L+LSFN L  E L            +   GN   C
Sbjct: 70  FVAPDAFHFTPRLSRLNLSFNAL--ESLSWKTVQGLSLQELVLSGNPLHC 117

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.6 bits (107), Expect = 2e-05
 Identities = 35/216 (16%), Positives = 64/216 (29%), Gaps = 59/216 (27%)

Query: 204 IGMGSFGSVYRARLRDGIEVAVKV--------FHQECARALKSFEAQCEVMKSI------ 249
           IG G FG V++    D   VA+K+         +    +  +    +  + K +      
Sbjct: 28  IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 250 ---RHPNLVKVISSC------------------------------SNDDFKALVLEYMPK 276
              R    + + S                                  DD   +VLE+   
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 277 G-SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVA 335
           G  LE        +  +    +I+   T++L       +    H DL   +VLL +  + 
Sbjct: 147 GIDLEQMRTK---LSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLLKKTSLK 201

Query: 336 HLSDFEYGMEGQVSTRSDIYGYGIVLMETFTRKKPT 371
            L     G    + +     G   V +  +T  +  
Sbjct: 202 KLHYTLNGKSSTIPS----CGL-QVSIIDYTLSRLE 232

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 46/173 (26%)

Query: 199 RLSNLIGMGSFGSVYRA-RLRDGIEVAVKVFHQEC---------ARALKSFEAQCEVMKS 248
            L   IG G FG +Y A       + A  V   E           +  +    +  + K 
Sbjct: 40  VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99

Query: 249 IRHPNLVKV---------ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQR---- 295
           I    L  +         ++      ++ +V+E +    L+           I  +    
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ----------KISGQNGTF 148

Query: 296 -----LNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDF 340
                L + I     LEY+   H    +H D+K  ++LL   + D V +L+D+
Sbjct: 149 KKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLLGYKNPDQV-YLADY 197

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 19/103 (18%), Positives = 34/103 (33%), Gaps = 11/103 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLSLA-YNKL--- 60
            F    L             + +I +S+N++   + A     L  L  + +   N L   
Sbjct: 36  RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 95

Query: 61  ------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFN 97
                 ++ +L+ L +SN  I  L        L    L +  N
Sbjct: 96  NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 17/81 (20%), Positives = 29/81 (35%), Gaps = 9/81 (11%)

Query: 27  VEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSNNEIYG 77
           V + L++N +     +   G    +      N L+          +   IL++S   I+ 
Sbjct: 157 VILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216

Query: 78  LIPTSLEKLLYLKELSLSFNK 98
           L    LE L  L+  S    K
Sbjct: 217 LPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 12/86 (13%), Positives = 31/86 (36%), Gaps = 11/86 (12%)

Query: 26  VVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL----------DVASLEILNLSN-NE 74
            +E+      L         G   L+ + ++ N +          ++  L  + +   N 
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 75  IYGLIPTSLEKLLYLKELSLSFNKLE 100
           +  + P + + L  L+ L +S   ++
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIK 117

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 32/173 (18%), Positives = 53/173 (30%), Gaps = 38/173 (21%)

Query: 203 LIGMGSFGSVYRA--RLRDGIEVAVKVFHQECARALKSFEAQ----CEVMKSIRH---PN 253
            +G G+FG V       R   +VA+K+      R +  +         V+K I+     N
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 254 LVKVISSCSNDDFKA---LVLEYMPKGSLENCLYSSTCMLDIFQRLN---------IMID 301
               +      +F     +  E      L    +        F + N         +   
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFE-------FLKENNFQPYPLPHVRHM 128

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
           A      L F H   + H DLKP ++L        L +     E +    + I
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 11/82 (13%)

Query: 28  EINLSRNNLSSDMPATI-GGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYG 77
            + L+ N L S +P  +   L +LK L L  N+L          + +L  LNL++N++  
Sbjct: 89  YLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS 147

Query: 78  LIPTSLEKLLYLKELSLSFNKL 99
           L     +KL  L EL LS+N+L
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQL 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 9/79 (11%)

Query: 30  NLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYGLIP 80
            L  N ++   P     LI+LK L L  N+L          +  L +L+L  N++  L  
Sbjct: 46  YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPS 105

Query: 81  TSLEKLLYLKELSLSFNKL 99
              ++L++LKEL +  NKL
Sbjct: 106 AVFDRLVHLKELFMCCNKL 124

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 29/79 (36%), Positives = 38/79 (48%), Gaps = 9/79 (11%)

Query: 30  NLSRNNLSSDMPATIGGLISLKTLSLAYNKL---------DVASLEILNLSNNEIYGLIP 80
           +L  N+L S        L SL  L L  NKL          + SL  LNLS N++  L  
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN 93

Query: 81  TSLEKLLYLKELSLSFNKL 99
              +KL  LKEL+L+ N+L
Sbjct: 94  GVFDKLTQLKELALNTNQL 112

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 15/107 (14%), Positives = 32/107 (29%), Gaps = 14/107 (13%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNN-LSSDMPATIGGLISLKTLSLAYNKL---- 60
                 L    S    NL  +  I +S +  L      +   L  +  + +   +     
Sbjct: 37  KLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96

Query: 61  ------DVASLEILNLSNNEIYGLIP--TSLEKLLYLKELSLSFNKL 99
                 ++  L+ L + N  +  + P  T +        L ++ N  
Sbjct: 97  DPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPY 142

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 11/84 (13%), Positives = 33/84 (39%), Gaps = 11/84 (13%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNK----------LDVASLEILNLSNN-EIY 76
            + L   +L +        L ++  + ++ +            +++ +  + + N   + 
Sbjct: 35  TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94

Query: 77  GLIPTSLEKLLYLKELSLSFNKLE 100
            + P +L++L  LK L +    L+
Sbjct: 95  YIDPDALKELPLLKFLGIFNTGLK 118

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 42/141 (29%), Positives = 59/141 (41%), Gaps = 25/141 (17%)

Query: 203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSF--EAQCEV-----MKSIRHPNL 254
           +IG GSFG V +A   +    VA+K+      R  K F  +A  E+     ++     N 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM-----VRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 255 VKVISSCSNDDFKA---LVLEYMPKGSLENCLYSSTCMLDIFQRLN---IMIDATSTLEY 308
           + VI    N  F+    +  E      L   LY        FQ  +   +   A S L+ 
Sbjct: 159 MNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNK-FQGFSLPLVRKFAHSILQC 212

Query: 309 LYFGHTTPIIHCDLKPISVLL 329
           L   H   IIHCDLKP ++LL
Sbjct: 213 LDALHKNRIIHCDLKPENILL 233

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 29/173 (16%), Positives = 56/173 (32%), Gaps = 38/173 (21%)

Query: 203 LIGMGSFGSVYRA--RLRDGIEVAVKVFHQECARALKSFEAQ----CEVMKSIRH---PN 253
            +G G+FG V         G  VAVK+      + +  +        +V++ +      +
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 254 LVKVISSCSNDDFKA---LVLEYMPKGSLENCLYSSTCMLDIFQRLN---------IMID 301
             + +      +      +V E      L    Y        F + N         I   
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFE-----LLGLSTYD-------FIKENGFLPFRLDHIRKM 123

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDI 354
           A    + + F H+  + H DLKP ++L  +       + +   + +     DI
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 19/81 (23%), Positives = 33/81 (40%), Gaps = 10/81 (12%)

Query: 28  EINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV---------ASLEILNLSNNEIYGL 78
           E+ L  N  +  +P  +     L  + L+ N++             L  L LS N +  +
Sbjct: 35  ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93

Query: 79  IPTSLEKLLYLKELSLSFNKL 99
            P + + L  L+ LSL  N +
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDI 114

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 40/167 (23%), Positives = 65/167 (38%), Gaps = 47/167 (28%)

Query: 203 LIGMGSFGSVYRARLRDGIEV----AVKVF----------HQECARALKSFEAQCEVMKS 248
           ++G G++G V+  R   G +     A+KV             E  R  +       V++ 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ------VLEH 114

Query: 249 IRH-PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT---- 303
           IR  P LV +  +   +    L+L+Y+  G L            + QR            
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL---------FTHLSQRERFTEHEVQIYV 165

Query: 304 ----STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH--LSDFEYGM 344
                 LE+L   H   II+ D+K  ++LLD +   H  L+DF  G+
Sbjct: 166 GEIVLALEHL---HKLGIIYRDIKLENILLDSN--GHVVLTDF--GL 205

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	453
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.75
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.65
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.56
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.54
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.53
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.52
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.51
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.51
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.49
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.48
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.48
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.46
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.46
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.45
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.45
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.43
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.42
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.42
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.42
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.42
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.42
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.41
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.41
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.4
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.4
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.4
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.39
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.39
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.37
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.37
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.36
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.36
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.35
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.35
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.34
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.34
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.34
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.33
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.32
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.32
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.32
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.32
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.31
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.31
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.29
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.29
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.28
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.27
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.27
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.25
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.24
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.24
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.24
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.24
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.22
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.21
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.2
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.2
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.19
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.19
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.17
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.15
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.1
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.1
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.1
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.03
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.02
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.01
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.01
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.99
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.98
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.97
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.97
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.96
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.95
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.93
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.84
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.83
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.72
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.71
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.69
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.64
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.63
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.58
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.54
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.47
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.42
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.37
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.37
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.31
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.23
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.22
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.12
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.08
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.06
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.99
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.83
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.81
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.79
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.79
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.74
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.74
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.43
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.39
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.3
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.13
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.02
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.97
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.92
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.91
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.89
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.84
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.8
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.68
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.6
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.47
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.41
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.26
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	95.84
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.36
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	95.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.99
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.43
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.29
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	91.29
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	90.53
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	90.11
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.73
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	88.44
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	84.81
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	84.31

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.1e-52  Score=396.74  Aligned_cols=229  Identities=29%  Similarity=0.458  Sum_probs=192.0

Q ss_pred             HHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+.+.||+|+||.||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            45678999999999999864      478899999987766677899999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecc
Q 036792          273 YMPKGSLENCLYSS------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF  340 (453)
Q Consensus       273 ~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df  340 (453)
                      ||++|+|.++|+..            ...+++..++.++.|+++||.||   |+++|+||||||+|||+++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccCHhhEEECCCCcEEECCc
Confidence            99999999999753            24689999999999999999999   7889999999999999999999999999


Q ss_pred             ccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCc
Q 036792          341 EYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       341 ~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      |++.                           ...++.++|||||||++|||+| |+.||.+....+              
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------------  238 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------------  238 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------------
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------------
Confidence            8651                           2457889999999999999999 899997643221              


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                         ++..... +  .+.+.+..|++++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus       239 ---~~~~i~~-~--~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          239 ---VIECITQ-G--RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             ---HHHHHHH-T--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHc-C--CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence               1111111 1  11223456788999999999999999999999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=398.85  Aligned_cols=228  Identities=26%  Similarity=0.450  Sum_probs=191.6

Q ss_pred             HHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+.+.||+|+||.||+|+++      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            34578999999999999875      478999999987766677899999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEe
Q 036792          273 YMPKGSLENCLYSST--------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS  338 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~  338 (453)
                      ||++|+|.++++...              ..++|..++.++.|+++||.||   |+++|+||||||+|||+++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHhhEEECCCCcEEEc
Confidence            999999999997532              3589999999999999999999   77899999999999999999999999


Q ss_pred             ccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcC
Q 036792          339 DFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLP  390 (453)
Q Consensus       339 df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  390 (453)
                      |||++.                           ...++.++|||||||++|||+| |+.||......+            
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------------  268 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------------  268 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------------
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------------
Confidence            998752                           2356789999999999999999 899997543211            


Q ss_pred             CchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          391 ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       391 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                           +++.... +  .+.+.+..|++++.+|+.+||+.||++||||+||++.|+.+.+
T Consensus       269 -----~~~~i~~-g--~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          269 -----AIDCITQ-G--RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             -----HHHHHHH-T--CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHc-C--CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                 1111111 1  1223445688899999999999999999999999999999865

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=391.85  Aligned_cols=232  Identities=26%  Similarity=0.434  Sum_probs=190.2

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+.+.||+|+||+||+|++++  .||||+++..  .....++|.+|+++|++++|||||+++|+|.+ +..+||||||++
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g  115 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG  115 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred             EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence            457889999999999999753  5999999744  33456789999999999999999999999865 568999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.++|......+++..++.++.|+++||.||   |+++|+||||||+|||+++++.+||+|||++.            
T Consensus       116 GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~  192 (307)
T 3omv_A          116 SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE  192 (307)
T ss_dssp             CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence            999999987777899999999999999999999   77899999999999999999999999998752            


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        .+.|+.++|||||||++|||+||+.||.+...... +...+...            ..  ..
T Consensus       193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~------------~~--~p  257 (307)
T 3omv_A          193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRG------------YA--SP  257 (307)
T ss_dssp             -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTT------------CC--CC
T ss_pred             ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcC------------CC--CC
Confidence                              12367799999999999999999999975432211 11111100            00  00


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .....+..|++++.+|+.+||+.||++||||.||++.|+.+++.+
T Consensus       258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            011234567889999999999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-51  Score=393.33  Aligned_cols=226  Identities=24%  Similarity=0.430  Sum_probs=188.0

Q ss_pred             HHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ++.+.||+|+||+||+|++.      +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+++..+|||
T Consensus        29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~  108 (308)
T 4gt4_A           29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIF  108 (308)
T ss_dssp             EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEE
Confidence            45678999999999999873      46789999997553 344578999999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEE
Q 036792          272 EYMPKGSLENCLYSS---------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH  336 (453)
Q Consensus       272 E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~k  336 (453)
                      |||++|+|.++|...               ...+++..++.++.|+|+||.||   |+++|+||||||+|||+++++.+|
T Consensus       109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLK~~NILl~~~~~~K  185 (308)
T 4gt4_A          109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVK  185 (308)
T ss_dssp             ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCccccceEECCCCCEE
Confidence            999999999999643               23588999999999999999999   788999999999999999999999


Q ss_pred             EeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhh
Q 036792          337 LSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNL  388 (453)
Q Consensus       337 l~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~  388 (453)
                      |+|||++.                           .+.++.++|||||||++|||+| |..||.+....+  +...    
T Consensus       186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~~----  259 (308)
T 4gt4_A          186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVEM----  259 (308)
T ss_dssp             ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHHH----
T ss_pred             ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHHH----
Confidence            99998752                           1356889999999999999999 899997643211  1111    


Q ss_pred             cCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          389 LPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       389 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                              +    ..+  .+.+.+..|+.++.+|+.+||+.||++||||+||++.|++.
T Consensus       260 --------i----~~~--~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 --------I----RNR--QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --------H----HTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --------H----HcC--CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                    1    111  12234567888999999999999999999999999999764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.8e-49  Score=378.25  Aligned_cols=245  Identities=24%  Similarity=0.287  Sum_probs=182.5

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----eeEEEEeccC
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----FKALVLEYMP  275 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~E~~~  275 (453)
                      +.+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+++    ..+||||||+
T Consensus         7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            467899999999999998 5899999999754322 123345666667899999999999998754    5799999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG-----HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~-----h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      +|+|.++|+..  .++|..+..++.|+++||.|||..     |+++|+||||||+|||++.++.+||+|||++..     
T Consensus        85 ~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  162 (303)
T 3hmm_A           85 HGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT  162 (303)
T ss_dssp             TCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             CCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence            99999999865  488999999999999999999743     466999999999999999999999999987410     


Q ss_pred             -----------------------C-------CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          346 -----------------------G-------QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       346 -----------------------~-------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                                             +       .++.++|||||||++|||+||.+|+............+...  .....+
T Consensus       163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~--~~~~~~  240 (303)
T 3hmm_A          163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS--DPSVEE  240 (303)
T ss_dssp             TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS--SCCHHH
T ss_pred             CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc--cchHHH
Confidence                                   0       24568999999999999999998875432222111111000  001111


Q ss_pred             hhhhhhhcCcc---CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          396 VVDKTLLSGEK---KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       396 ~~d~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      +..........   +......+++..+.+|+.+||+.||++||||.||++.|+++.++
T Consensus       241 ~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            11111111111   11112345778899999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.2e-48  Score=375.39  Aligned_cols=222  Identities=21%  Similarity=0.293  Sum_probs=179.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||+||+|+++ +|+.||||+++...  ....+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            567789999999999999976 69999999997653  345678999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      ++|+|.+++... ...+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.         
T Consensus       106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            999999999754 34568888899999999999999   78999999999999999999999999998652         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...|+.++||||+||++|||+||+.||......+                 ++...... .  .
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----------------~~~~i~~~-~--~  242 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----------------LVLKIISG-S--F  242 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----------------HHHHHHHT-C--C
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----------------HHHHHHcC-C--C
Confidence                            2457889999999999999999999997542211                 11111111 1  1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.+..+++++.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1123356678999999999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-48  Score=377.91  Aligned_cols=232  Identities=22%  Similarity=0.372  Sum_probs=189.5

Q ss_pred             HHHhcccCCCCccEEEEEEECC------CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCC-CCceeEEeEEecC-CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRH-PNLVKVISSCSND-DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~-~~~~  268 (453)
                      +++.+.||+|+||.||+|.+..      ++.||||.++... ....++|.+|+++|.+++| ||||+++|+|.++ +..+
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~  145 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  145 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence            4567899999999999998642      3689999997654 3445789999999999965 8999999999764 5689


Q ss_pred             EEEeccCCCCchHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          269 LVLEYMPKGSLENCLYSS---------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                      ||||||++|+|.++|+..               ...+++..++.++.|+|+||.||   |+++|+||||||+|||+++++
T Consensus       146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL---H~~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH---hhCCeecCccCccceeeCCCC
Confidence            999999999999999653               23478999999999999999999   788999999999999999999


Q ss_pred             cEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHH
Q 036792          334 VAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWV  385 (453)
Q Consensus       334 ~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~  385 (453)
                      .+||+|||++..                           ..|+.++|||||||++|||+| |+.||.+....+. +..  
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-~~~--  299 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCR--  299 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHH--
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-HHH--
Confidence            999999987631                           346789999999999999998 8999976432211 111  


Q ss_pred             hhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          386 NNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       386 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                                    .+..+  .+.+.+..+++++.+++.+||+.||++||||+||++.|+++.+.-
T Consensus       300 --------------~i~~g--~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          300 --------------RLKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             --------------HHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --------------HHHcC--CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence                          11111  122344567888999999999999999999999999999986653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-48  Score=374.54  Aligned_cols=224  Identities=22%  Similarity=0.269  Sum_probs=186.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|++.+.||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            34566788999999999999986 69999999998665555567899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++...  .+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.          
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999988764  488999999999999999999   78899999999999999999999999998752          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...|+.++||||+||++|||++|++||.+....+  ....+..                ......
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~----------------~~~~~~  290 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRD----------------NLPPRL  290 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH----------------SSCCCC
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHc----------------CCCCCC
Confidence                           2357889999999999999999999997542211  1111111                111112


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+++++.+|+.+||+.||++|||++|+++
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            233456778999999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-47  Score=369.43  Aligned_cols=227  Identities=22%  Similarity=0.266  Sum_probs=187.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +++.+.||+|+||.||+|+++ +|+.||||+++.+..     ..+|+.+|++++|||||++++++.+++..|||||||++
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            345678999999999999976 699999999986532     24699999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC-----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~-----------  344 (453)
                      |+|.+++.... .+++.....++.|++.||.||   |+++|+||||||+|||++.++ .+||+|||++.           
T Consensus       135 g~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          135 GSLGQLIKQMG-CLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             CBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            99999997654 689999999999999999999   889999999999999999987 69999998652           


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...|+.++|||||||++|||+||++||......+.. .....                 ..
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~-----------------~~  272 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-LKIAS-----------------EP  272 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-HHHHH-----------------SC
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHc-----------------CC
Confidence                               134678999999999999999999999765332221 11111                 11


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .+....+..+++++.+++.+||+.||++|||+.|+++.|.++..+.
T Consensus       273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            1111234567788999999999999999999999999998876553

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-47  Score=361.63  Aligned_cols=222  Identities=23%  Similarity=0.354  Sum_probs=178.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec----CCeeEEEE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN----DDFKALVL  271 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~  271 (453)
                      ++.+.||+|+||.||+|.++ ++..||||.+....  ....+.|.+|+++|++++|||||+++++|.+    ++..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999976 68999999997553  3445789999999999999999999999865    35689999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceeeCC-CCcEEEeccccCC----
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP--IIHCDLKPISVLLDE-DMVAHLSDFEYGM----  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~--i~Hrdlk~~NiLl~~-~~~~kl~df~~~~----  344 (453)
                      |||++|+|.+++.... .+++.....++.|++.||.||   |+++  |+||||||+|||++. ++.+||+|||++.    
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997643 688899999999999999999   5555  999999999999985 7899999998752    


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        .+.|+.++|||||||++|||+||+.||.+.....    ....             .+..+ .
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~----~~~~-------------~i~~~-~  246 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYR-------------RVTSG-V  246 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHH-------------HHTTT-C
T ss_pred             CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH----HHHH-------------HHHcC-C
Confidence                              1357889999999999999999999996432111    1111             01111 1


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+...+..+++++.+|+.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112233445667899999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=375.95  Aligned_cols=224  Identities=22%  Similarity=0.269  Sum_probs=186.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|++.+.||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            44667788999999999999976 69999999998665555567899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++...  .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.          
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999998764  488899999999999999999   78899999999999999999999999998752          


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...|+.++|||||||++|||++|++||.+....+  ....+..                ......
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~----------------~~~~~~  367 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRD----------------NLPPRL  367 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH----------------SCCCCC
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHc----------------CCCCCC
Confidence                           2357889999999999999999999997542211  1111111                000111


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+++++.+|+.+||+.||++|||++|+++
T Consensus       368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222345678999999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.7e-46  Score=351.27  Aligned_cols=219  Identities=23%  Similarity=0.371  Sum_probs=177.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||++++..   ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            566789999999999999975 69999999997653   23356799999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      + +|+|.+.+.... .++......++.|++.||+||   |+++|+||||||+|||++.++.+||+|||++.         
T Consensus        95 ~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           95 A-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             C-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             C-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            9 689999887654 689999999999999999999   78999999999999999999999999998762         


Q ss_pred             ---------------CCCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ---------------EGQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ---------------~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                     ...+ +.++||||+||++|||+||+.||.+....     ...+            .... +.   
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-----~~~~------------~i~~-~~---  228 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-----VLFK------------NISN-GV---  228 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH------------HHHH-TC---
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHH------------HHHc-CC---
Confidence                           1223 56899999999999999999999753211     1111            1111 10   


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1122345678899999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.1e-47  Score=361.11  Aligned_cols=219  Identities=23%  Similarity=0.315  Sum_probs=183.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||++++..   ....+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            577889999999999999976 79999999997653   23457899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      |++|+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++..        
T Consensus       114 ~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          114 AKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            99999999997644 588889999999999999999   789999999999999999999999999987621        


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                         ..|+.++||||+||++|||+||++||......+                 ++.......  
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----------------~~~~i~~~~--  250 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-----------------IFAKIIKLE--  250 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHTC--
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHcCC--
Confidence                               246778999999999999999999997542211                 111111111  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                        ...+...++++.+|+.+||+.||++|||++|+.
T Consensus       251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence              112234566789999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.1e-46  Score=356.81  Aligned_cols=216  Identities=22%  Similarity=0.294  Sum_probs=173.6

Q ss_pred             HHHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      .|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|+++|++++|||||++++++.+++..|+|
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4678899999999999999863    47899999997543  22334688999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      ||||+||+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.      
T Consensus       105 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             ECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999997644 588899999999999999999   78999999999999999999999999998652      


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++||||+||++|||+||+.||.+....+                 ++....... 
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----------------~~~~i~~~~-  242 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-----------------TMTMILKAK-  242 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC-
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-----------------HHHHHHcCC-
Confidence                               2356789999999999999999999997542211                 111111111 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                         ...+..+++++.+|+.+||+.||++|||+
T Consensus       243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence               11234467789999999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-44  Score=343.59  Aligned_cols=220  Identities=19%  Similarity=0.298  Sum_probs=171.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----------
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----------  265 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----------  265 (453)
                      |++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            456788999999999999976 79999999997554 334578999999999999999999999987644          


Q ss_pred             --eeEEEEeccCCCCchHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          266 --FKALVLEYMPKGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       266 --~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                        ..|+|||||++|+|.+++.....  ..++.....++.|+++||.||   |+++|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcHHHeEECCCCcEEEccCc
Confidence              36899999999999999976532  345566788999999999999   78899999999999999999999999998


Q ss_pred             cCC-------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhH
Q 036792          342 YGM-------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDW  384 (453)
Q Consensus       342 ~~~-------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  384 (453)
                      ++.                                     ...|+.++|||||||++|||++   ||......   .. .
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~~-~  236 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---VR-T  236 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HH-H
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---HH-H
Confidence            752                                     1346789999999999999996   76532110   00 0


Q ss_pred             HhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          385 VNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       385 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .            ... ...  ..++.....++++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~------------~~~-~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 L------------TDV-RNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H------------HHH-HTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H------------HHH-hcC--CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0            000 001  111233445566788999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=344.65  Aligned_cols=239  Identities=21%  Similarity=0.261  Sum_probs=180.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec------CCeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN------DDFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~  268 (453)
                      |++.+.||+|+||.||+|+++ +|+.||||+++...  ....+.+.+|+++|+.++|||||++++++..      .+..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            567889999999999999976 79999999997543  3445678999999999999999999998764      35789


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      ||||||+ |+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++..   
T Consensus       136 ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence            9999996 68999887654 688999999999999999999   789999999999999999999999999987521   


Q ss_pred             ---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhhh
Q 036792          346 ---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLMEV  396 (453)
Q Consensus       346 ---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~  396 (453)
                                                 ..++.++||||+||++|||++|++||.+....+. +.......  .+......
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGGTC-
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhh
Confidence                                       1357789999999999999999999976432211 11111111  11110000


Q ss_pred             h-----hhhhhcCcc-CCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 V-----DKTLLSGEK-KGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~-----d~~~~~~~~-~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +     ......... ...   ......++++.+|+.+||..||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0     000000000 000   111234568899999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.7e-42  Score=355.95  Aligned_cols=226  Identities=18%  Similarity=0.232  Sum_probs=187.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..++|||||+
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~  237 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  237 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            3567889999999999999976 699999999987766666789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC--CcEEEeccccCC---------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED--MVAHLSDFEYGM---------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~--~~~kl~df~~~~---------  344 (453)
                      +|+|.+++......++......++.|++.||.||   |+++|+||||||+|||++.+  +.+||+|||++.         
T Consensus       238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            9999999977666788999999999999999999   78899999999999999854  799999998752         


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...|+.++||||+||++|||++|.+||.+....+.                 +............
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-----------------~~~i~~~~~~~~~  377 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----------------LRNVKSCDWNMDD  377 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----------------HHHHHTTCCCCCS
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----------------HHHHHhCCCCCCc
Confidence                           23567889999999999999999999975422211                 1000110101111


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......++++.+|+.+||+.||++|||++|+++
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            223455678899999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=325.18  Aligned_cols=233  Identities=24%  Similarity=0.382  Sum_probs=194.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.+.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   91 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG   91 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence            455788999999999999976 6899999998776666778899999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++......+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||.+.            
T Consensus        92 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           92 GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             CBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            999999988666789999999999999999999   78899999999999999999999999998652            


Q ss_pred             ---------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          345 ---------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       345 ---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                                 ...++.++|||||||++|||++|..|+............        ......
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------~~~~~~  240 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------NVRGFL  240 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------CHHHHH
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------hhhccc
Confidence                                       123577899999999999999999998654222111000        001111


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      +..          .+..+++++.+++.+||+.||++|||++|+++.|++++..+
T Consensus       241 ~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          241 DRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            110          12345567899999999999999999999999999998765

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-41  Score=331.32  Aligned_cols=238  Identities=18%  Similarity=0.251  Sum_probs=177.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  270 (453)
                      ..|++.+.||+|+||+||+|+.+    +++.||||.+....  ...++.+|+++|+.+ +|||||++++++.+++..++|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            44677889999999999999853    46889999986543  235678999999988 699999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGM-----  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~-----  344 (453)
                      |||+++|+|.+++.    .++......++.|++.||.||   |+++|+||||||+|||++.+ +.+||+|||++.     
T Consensus        99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            99999999999884    378888999999999999999   78999999999999999876 799999999762     


Q ss_pred             ------------------------------------------------C-CCcCcccchHHHHHHHHHHHhCCCCCCccc
Q 036792          345 ------------------------------------------------E-GQVSTRSDIYGYGIVLMETFTRKKPTDRMF  375 (453)
Q Consensus       345 ------------------------------------------------~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~  375 (453)
                                                                      . ..++.++||||+||++|||+||+.||....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                                            0 135678999999999999999999985432


Q ss_pred             cccccHHhHHhhh---------------------cC-CchhhhhhhhhhcCc------------cCCchhhHHHHHHHHH
Q 036792          376 VEELSLKDWVNNL---------------------LP-ISLMEVVDKTLLSGE------------KKGFVAKEQCVLSILG  421 (453)
Q Consensus       376 ~~~~~~~~~~~~~---------------------~~-~~~~~~~d~~~~~~~------------~~~~~~~~~~~~~~~~  421 (453)
                      .+...+.......                     .+ ...............            ..........++++.+
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            2211111111100                     00 000011000000000            0000111234567899


Q ss_pred             HhhhccccCcccCCChHHHHH
Q 036792          422 LAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       422 l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      |+.+||+.||++|||++|+++
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHCcCChhHCcCHHHHhc
Confidence            999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.1e-40  Score=320.83  Aligned_cols=244  Identities=32%  Similarity=0.535  Sum_probs=199.1

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|.+++++.||||++........+.+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus        41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  120 (321)
T 2qkw_B           41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG  120 (321)
T ss_dssp             CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred             cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence            35567899999999999998889999999998766666788999999999999999999999999999999999999999


Q ss_pred             CchHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          278 SLENCLYSST---CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       278 ~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|.+++....   ..+++.....++.++++||.||   |+++|+||||||+||+++.++.+||+|||.+.          
T Consensus       121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999986543   3588999999999999999999   77899999999999999999999999998652          


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccc-ccHHhHHhhhc-CCchhhhhhhhhhcCc
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE-LSLKDWVNNLL-PISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~d~~~~~~~  405 (453)
                                       ...++.++|||||||++|||+||+.||......+ .....|..... .....+.+++..    
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  273 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL----  273 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC----
T ss_pred             ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh----
Confidence                             1235678999999999999999999987543322 23333332211 111222222222    


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                        .......++.++.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus       274 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          274 --ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             --TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence              1223467888999999999999999999999999999988653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4e-41  Score=333.26  Aligned_cols=232  Identities=30%  Similarity=0.477  Sum_probs=193.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..+.+.+.||+|+||.||+|.++ +++.||||.++... ....++|.+|+++|++++|||||++++++..++..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            34456789999999999999987 78999999997553 33446789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|+|.+++......+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++..        
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            999999999987655688999999999999999999   788999999999999999999999999986521        


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ..++.++|||||||++|||+| |..||......+  ....+.            .    + 
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~------------~----~-  331 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVE------------K----G-  331 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHH------------T----T-
T ss_pred             cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH------------c----C-
Confidence                               234668999999999999999 999987542211  111111            0    1 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                       .+.+.+..++.++.+++.+||+.||++|||++++++.|++++++
T Consensus       332 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          332 -GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence             11223445778899999999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.9e-40  Score=321.31  Aligned_cols=245  Identities=23%  Similarity=0.312  Sum_probs=187.4

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----eeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----FKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|++. ++.||||+++.... ....+.+|+.++++++|||||++++++..+.    ..++||||
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~  103 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF  103 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             chhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence            456789999999999999876 78999999975533 3345667899999999999999999998744    46999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CceecCCCCCceeeCCCCcEEEeccccC
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT----------PIIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~----------~i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      +++|+|.+++...  .+++.....++.++++||.||   |+.          +|+||||||+|||++.++.+||+|||.+
T Consensus       104 ~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          104 HEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            9999999999764  388999999999999999999   666          9999999999999999999999999875


Q ss_pred             CC--------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-C
Q 036792          344 ME--------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-P  390 (453)
Q Consensus       344 ~~--------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~  390 (453)
                      ..                                ..++.++|||||||++|||+||+.||.........  .+..... .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~  256 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML--PFEEEIGQH  256 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC--TTHHHHCSS
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc--chhhhhccC
Confidence            10                                12234679999999999999999999764332211  1111111 1


Q ss_pred             CchhhhhhhhhhcCcc---CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          391 ISLMEVVDKTLLSGEK---KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       391 ~~~~~~~d~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ....++.+........   ........++.++.+|+.+||+.||++|||++|+++.|+++++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1111111111111111   111123456788999999999999999999999999999998753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.9e-40  Score=325.23  Aligned_cols=234  Identities=25%  Similarity=0.448  Sum_probs=191.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  265 (453)
                      ..+++.+.||+|+||.||+|++.        ++..||||+++... ....+.+.+|+++|+++ +||||++++++|..++
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            34566789999999999999852        35679999997653 34567899999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          266 FKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ..++||||+++|+|.+++....               ..+++.....++.|+++||.||   |+++|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchhhEEEC
Confidence            9999999999999999997643               3478889999999999999999   788999999999999999


Q ss_pred             CCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||++.                           ...++.++|||||||++|||+| |..||......+  +.
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~~  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LF  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH
Confidence            99999999998652                           1235678999999999999999 999987543221  11


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      ..+.                .+  .....+..++.++.+++.+||+.+|++|||+.|+++.|+++....+
T Consensus       316 ~~~~----------------~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          316 KLLK----------------EG--HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HHHH----------------TT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHh----------------cC--CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            1111                00  0112334567789999999999999999999999999999876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=320.77  Aligned_cols=231  Identities=25%  Similarity=0.431  Sum_probs=191.6

Q ss_pred             HHHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      .+++.+.||+|+||.||+|.+.    .+..||||.++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  129 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT  129 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence            3566789999999999999975    34569999998653 345578999999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..      
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            99999999999987766789999999999999999999   788999999999999999999999999986521      


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            ..++.++|||||||++|||++ |..||......+  ....+            ..   
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~------------~~---  269 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSV------------EE---  269 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHH------------HT---
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH------------Hc---
Confidence                                  234668999999999999999 999986542211  11000            00   


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                       .  ...+.+..++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       270 -~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          270 -G--YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             -T--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -C--CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence             0  01123345677899999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-40  Score=318.66  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=195.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-----CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l  269 (453)
                      .+++.+.||+|+||.||+|++.     +++.||||+++.......+.+.+|++++++++||||+++++++..  ....++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   90 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL   90 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence            3466789999999999999852     588999999987766667889999999999999999999999865  356899


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ||||+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++..    
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            9999999999999987766689999999999999999999   788999999999999999999999999986531    


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc-hhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS-LMEVVDKT  400 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~  400 (453)
                                              ..++.++||||||+++|||+||..|+.....+.   ........... ....+...
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH---HHHHCTTCCTHHHHHHHHHH
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH---HhhhcCccccchhHHHHHHH
Confidence                                    235678999999999999999999986432211   11111000000 00011111


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      +...  ...+.+..+++++.+++.+||+.||++|||++|+++.|+++++.+.
T Consensus       245 ~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          245 LKNN--GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHTT--CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             Hhcc--CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            1111  1223345678889999999999999999999999999999988653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-40  Score=342.08  Aligned_cols=222  Identities=19%  Similarity=0.243  Sum_probs=177.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHH---HHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALK---SFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      |++.++||+|+||.||+|+.+ +|+.||||++++...   ....   ....++.+++.++|||||++++++.+++.+|+|
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            456788999999999999976 699999999975431   1122   233446677888999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      ||||+||+|.++|.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.      
T Consensus       271 mEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             ECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            99999999999997644 588888999999999999999   89999999999999999999999999998752      


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...|+.++||||+||++|||++|.+||.+....+.  .            ++........  
T Consensus       347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~------------~i~~~i~~~~--  410 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--H------------EIDRMTLTMA--  410 (689)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--H------------HHHHHHHHCC--
T ss_pred             CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H------------HHHHhhcCCC--
Confidence                              12478899999999999999999999975422211  1            1111111110  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCC-----hHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRIN-----AKDIV  441 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~  441 (453)
                        ...+...++++.+|+.+||+.||++|++     ++||.
T Consensus       411 --~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          411 --VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence              1123345678999999999999999998     56664

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.2e-40  Score=318.03  Aligned_cols=242  Identities=32%  Similarity=0.503  Sum_probs=194.4

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      ++.+.||+|+||.||+|+.++++.||||++..... .....+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  112 (326)
T 3uim_A           33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG  112 (326)
T ss_dssp             CSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTC
T ss_pred             ccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCC
Confidence            45678999999999999988899999999976532 22236899999999999999999999999999999999999999


Q ss_pred             CchHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          278 SLENCLYSST---CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       278 ~L~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|.+++....   ..+++..+..++.+++.||.|||..+..+|+||||||+|||++.++.+||+|||.+..         
T Consensus       113 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  192 (326)
T 3uim_A          113 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT  192 (326)
T ss_dssp             BHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEE
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccccc
Confidence            9999997643   3488999999999999999999655555999999999999999999999999987521         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCcc---ccccccHHhHHhhhcCCc-hhhhhhhhhhcC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRM---FVEELSLKDWVNNLLPIS-LMEVVDKTLLSG  404 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~  404 (453)
                                       ..++.++|||||||++|||+||+.||+..   ...+.....|+....... .....+....  
T Consensus       193 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  270 (326)
T 3uim_A          193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ--  270 (326)
T ss_dssp             CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT--
T ss_pred             ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc--
Confidence                             23466899999999999999999999632   123344555555443322 2222222221  


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                          ......++.++.+++.+||+.||++|||++|+++.|+.
T Consensus       271 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          271 ----GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             ----TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             ----cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                12346678899999999999999999999999999964

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.3e-40  Score=309.19  Aligned_cols=229  Identities=24%  Similarity=0.399  Sum_probs=190.7

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|.+.++..||||++...... .+++.+|++++++++||||+++++++.+++..++||||+++|
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   90 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             ceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence            4567889999999999999988899999999865432 367899999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------------  344 (453)
                      +|.+++......+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||.+.             
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  167 (269)
T 4hcu_A           91 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  167 (269)
T ss_dssp             BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred             cHHHHHHhcCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence            99999987766789999999999999999999   78899999999999999999999999998652             


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                   ...++.++||||+|+++|||++ |+.||......+  ....+.               . ..  ...
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~---------------~-~~--~~~  227 (269)
T 4hcu_A          168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIS---------------T-GF--RLY  227 (269)
T ss_dssp             TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---------------T-TC--CCC
T ss_pred             ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHh---------------c-Cc--cCC
Confidence                         1345678999999999999999 999986542211  110000               0 00  011


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .+...+.++.+++.+||+.+|++|||++|+++.|+++.+.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            1233456789999999999999999999999999998763

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-39  Score=313.71  Aligned_cols=229  Identities=28%  Similarity=0.439  Sum_probs=187.0

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+|++ +|..||||++....  ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus        39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS  117 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred             ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence            45678999999999999987 58899999997553  3445789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          276 KGSLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYFGHTTP--IIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~L~~~h~~~--i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      +|+|.+++.....  .+++.....++.++++||.||   |+.+  |+||||||+||+++.++.+||+|||++.       
T Consensus       118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence            9999999976432  378889999999999999999   6777  9999999999999999999999998642       


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...++.++|||||||++|||++|+.||......+.  ...+.               ..  .
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~---------------~~--~  255 (309)
T 3p86_A          195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVG---------------FK--C  255 (309)
T ss_dssp             -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHH---------------HS--C
T ss_pred             ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH---------------hc--C
Confidence                              12357789999999999999999999975422111  00000               00  0


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      .....+..+++++.+++.+||+.+|++|||++|+++.|+.+.+
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0112234566789999999999999999999999999998864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-39  Score=312.26  Aligned_cols=222  Identities=24%  Similarity=0.297  Sum_probs=183.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      |++.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  101 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence            556788999999999999964 7899999999876655667889999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++...  .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.            
T Consensus       102 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          102 GSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             CBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence            9999998764  478889999999999999999   78899999999999999999999999998642            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|..||.......... ....                 ........
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~-----------------~~~~~~~~  238 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIAT-----------------NGTPELQN  238 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHH-----------------HCSCCCSC
T ss_pred             cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh-----------------CCCCCCCC
Confidence                         1346778999999999999999999996542211100 0000                 00011122


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +..++..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            3456678899999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.3e-40  Score=324.58  Aligned_cols=230  Identities=25%  Similarity=0.467  Sum_probs=186.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|+++    ++..||||.++... ....+.|.+|+.+|++++||||+++++++..++..++|||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            455788999999999999865    57789999997653 3455789999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++......+++.....++.++++||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus       127 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          127 YMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            9999999999987766789999999999999999999   788999999999999999999999999986421       


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ..++.++|||||||++||+++ |+.||......+     .         .+.++...  
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~---------~~~i~~~~--  267 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----V---------IKAVDEGY--  267 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----H---------HHHHHTTE--
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---------HHHHHcCC--
Confidence                                 235678999999999999998 999986542211     1         11111111  


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                          ..+.+..++.++.+++.+||+.+|++||+++|+++.|+++...
T Consensus       268 ----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 ----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                1112335677899999999999999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.3e-39  Score=327.88  Aligned_cols=226  Identities=31%  Similarity=0.467  Sum_probs=188.2

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC-eeEEEEeccCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD-FKALVLEYMPKG  277 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~E~~~~g  277 (453)
                      ++.+.||+|+||.||+|.++ |+.||||+++...  ..+.|.+|+++|++++|||||++++++...+ ..++||||+++|
T Consensus       196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g  272 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG  272 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred             EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence            45688999999999999986 7799999997653  3478999999999999999999999987755 789999999999


Q ss_pred             CchHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          278 SLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       278 ~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      +|.+++..... .++......++.++++||.||   |+++|+||||||+|||++.++.+||+|||++.            
T Consensus       273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  349 (450)
T 1k9a_A          273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  349 (450)
T ss_dssp             BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------CCC
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCC
Confidence            99999976433 468889999999999999999   78899999999999999999999999998652            


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                ...++.++|||||||++|||+| |+.||......+  ....+.                .+  .+.+.+.
T Consensus       350 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~----------------~~--~~~~~p~  409 (450)
T 1k9a_A          350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE----------------KG--YKMDAPD  409 (450)
T ss_dssp             TTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHH----------------TT--CCCCCCT
T ss_pred             cceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----------------cC--CCCCCCC
Confidence                      2346778999999999999999 999997543221  111111                01  1122345


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .+++++.+++.+||+.||++|||+.++++.|+++...
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            6788899999999999999999999999999998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-39  Score=312.06  Aligned_cols=224  Identities=14%  Similarity=0.216  Sum_probs=183.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      |++.+.||+|+||.||+|... +++.||+|.++... ...+.+.+|+++|+.++||||+++++++.+.+..++||||+++
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            456788999999999999976 68999999987543 3346788999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC--CCcEEEeccccCCC---------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE--DMVAHLSDFEYGME---------  345 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~--~~~~kl~df~~~~~---------  345 (453)
                      |+|.+++......+++.....++.|++.|+.||   |+.+|+||||||+|||++.  ++.+||+|||++..         
T Consensus        86 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  162 (321)
T 1tki_A           86 LDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence            999999987666789999999999999999999   7889999999999999987  78999999987521         


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ..++.++|||||||++|||++|..||......+     .            ++............
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~------------~~~i~~~~~~~~~~  225 (321)
T 1tki_A          163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----I------------IENIMNAEYTFDEE  225 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H------------HHHHHHTCCCCCHH
T ss_pred             ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-----H------------HHHHHcCCCCCChh
Confidence                           235778999999999999999999997542211     1            11111111001111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+.++.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22345678999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.7e-39  Score=308.41  Aligned_cols=232  Identities=24%  Similarity=0.406  Sum_probs=188.6

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+++.+.||+|+||.||+|.++++..||||+++..... .+++.+|++++++++||||+++++++.+++..++||||+++
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  103 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN  103 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence            34567889999999999999998889999999865432 36789999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++......+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||.+.            
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             CBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred             CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence            999999987555689999999999999999999   78899999999999999999999999998652            


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                    ...++.++||||||+++|||+| |+.||......+  ....+            ....      ..
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~------------~~~~------~~  240 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHI------------AQGL------RL  240 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH------------HTTC------CC
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHH------------hccc------CC
Confidence                          1245678999999999999998 999987542211  01000            0000      01


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      ..+..+++++.+++.+||+.+|++|||++|+++.|+++.++-|
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~es  283 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES  283 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhccC
Confidence            1123345678999999999999999999999999999987643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6e-40  Score=309.05  Aligned_cols=229  Identities=28%  Similarity=0.422  Sum_probs=188.7

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|.++++..||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||+++|
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG   88 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence            456788999999999999999888999999976543 2367899999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|.+++......+++.....++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||.+..            
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  165 (268)
T 3sxs_A           89 CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT  165 (268)
T ss_dssp             BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred             cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence            99999977655688999999999999999999   788999999999999999999999999986421            


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ..++.++||||||+++|||+| |+.||......+..  ..+.               . ..  ...
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~~---------------~-~~--~~~  225 (268)
T 3sxs_A          166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--LKVS---------------Q-GH--RLY  225 (268)
T ss_dssp             CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHHH---------------T-TC--CCC
T ss_pred             CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH--HHHH---------------c-CC--CCC
Confidence                          134678999999999999999 99998654222110  0000               0 00  011


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .+..+++++.+++.+||+.+|++|||+.|+++.|++++++
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            1223456789999999999999999999999999988654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-39  Score=313.33  Aligned_cols=220  Identities=25%  Similarity=0.369  Sum_probs=181.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+++|+.++||||+++++++.+++..++||||+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~   96 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA   96 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence            566789999999999999974 79999999997653  345577899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++|+|.+++.... .++......++.|++.|+.||   |+.+|+||||||+|||++.++.+||+|||++..         
T Consensus        97 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A           97 SGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             TTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            9999999986643 578889999999999999999   788999999999999999999999999987521         


Q ss_pred             ---------------CCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ---------------GQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ---------------~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ..+ +.++||||+||++|||++|+.||+.....+     .            ........    .
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~------------~~~i~~~~----~  231 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-----L------------RERVLRGK----Y  231 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H------------HHHHHHCC----C
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-----H------------HHHHHhCC----C
Confidence                           122 368999999999999999999997542211     1            11111111    1


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...++++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            122335667899999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-39  Score=329.91  Aligned_cols=229  Identities=25%  Similarity=0.431  Sum_probs=188.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++|||||++++++. .+..++||||++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            3446678999999999999999888999999998654 34578999999999999999999999986 567899999999


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|+|.+++.... ..+++.....++.+++.||.||   |+++|+||||||+|||++.++.+||+|||++..         
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~  342 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  342 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence            999999997532 2577888899999999999999   788999999999999999999999999986521         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ..++.++|||||||++|||+| |+.||......+  ....            +..    +  .
T Consensus       343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~------------i~~----~--~  402 (454)
T 1qcf_A          343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRA------------LER----G--Y  402 (454)
T ss_dssp             CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH------------HHH----T--C
T ss_pred             CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HHc----C--C
Confidence                             345778999999999999999 999997542211  1111            110    0  0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +.+.+..+++++.+|+.+||+.||++||||+++++.|+++..
T Consensus       403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            112334677889999999999999999999999999987643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=314.52  Aligned_cols=222  Identities=18%  Similarity=0.275  Sum_probs=177.7

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      .+.||+|+||.||+|... +|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            467999999999999975 6899999999877666678899999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee--CCCCcEEEeccccCC-------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL--DEDMVAHLSDFEYGM-------------  344 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl--~~~~~~kl~df~~~~-------------  344 (453)
                      .+++......+++.....++.|+++||.||   |+.+|+||||||+|||+  +.++.+||+|||++.             
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  250 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG  250 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence            998877666788999999999999999999   78899999999999999  567899999998652             


Q ss_pred             -----------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          345 -----------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       345 -----------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                 ...++.++|||||||++|||++|..||......+ .+........                ........
T Consensus       251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~----------------~~~~~~~~  313 (373)
T 2x4f_A          251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRW----------------DLEDEEFQ  313 (373)
T ss_dssp             SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC----------------CSCSGGGT
T ss_pred             CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccC----------------CCChhhhc
Confidence                       1235668999999999999999999997542211 1111111100                00111223


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..++++.+|+.+||+.||++|||++|+++
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            45678999999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.8e-39  Score=305.95  Aligned_cols=228  Identities=25%  Similarity=0.405  Sum_probs=183.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh-------hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR-------ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      +++.+.||+|+||.||+|++. +++.||||++......       ..+.+.+|++++++++||||+++++++.+..  ++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l   98 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM   98 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence            566788999999999999975 7899999998654321       1267899999999999999999999987665  69


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceeeCCCCc-----EEEecccc
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP--IIHCDLKPISVLLDEDMV-----AHLSDFEY  342 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~--i~Hrdlk~~NiLl~~~~~-----~kl~df~~  342 (453)
                      ||||+++|+|.+.+......+++.....++.+++.|+.||   |+.+  |+||||||+||+++.++.     +||+|||+
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence            9999999999999987777899999999999999999999   6777  999999999999987776     99999976


Q ss_pred             CC------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          343 GM------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       343 ~~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                      +.                        ...++.++|||||||++|||++|+.||................           
T Consensus       176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------  244 (287)
T 4f0f_A          176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-----------  244 (287)
T ss_dssp             CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-----------
T ss_pred             cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-----------
Confidence            42                        1224668999999999999999999997543322211111110           


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                            .......+..+++++.+++.+||+.||++|||++|+++.|+++
T Consensus       245 ------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 ------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                  0011123345677899999999999999999999999999753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.4e-39  Score=304.96  Aligned_cols=229  Identities=26%  Similarity=0.410  Sum_probs=186.6

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--CeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|+++ +..||||+++...  ....+.+.+|+.++++++||||+++++++.++  +..++||||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW   90 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred             hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence            456788999999999999985 8899999997653  34457899999999999999999999999887  788999999


Q ss_pred             cCCCCchHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceeeCCCCcEEEeccccCCCC----
Q 036792          274 MPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTP--IIHCDLKPISVLLDEDMVAHLSDFEYGMEG----  346 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~L~~~h~~~--i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~----  346 (453)
                      +++|+|.+++..... .+++.....++.++++||.||   |+.+  ++||||||+||+++.++.++++||+++...    
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~  167 (271)
T 3kmu_A           91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG  167 (271)
T ss_dssp             CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTT
T ss_pred             cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcCCcceeEEeccceeeecccC
Confidence            999999999987543 589999999999999999999   7777  999999999999999999999988765221    


Q ss_pred             ----------------CcC---cccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          347 ----------------QVS---TRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       347 ----------------~~~---~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      .++   .++|||||||++|||++|+.||......+...                 ......  .
T Consensus       168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----------------~~~~~~--~  228 (271)
T 3kmu_A          168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-----------------KVALEG--L  228 (271)
T ss_dssp             CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-----------------HHHHSC--C
T ss_pred             ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-----------------HHHhcC--C
Confidence                            122   26999999999999999999997542221100                 001001  0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ....+..++.++.+++.+||+.||++|||++|+++.|+++.+
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            112234566789999999999999999999999999998864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-38  Score=305.36  Aligned_cols=235  Identities=27%  Similarity=0.353  Sum_probs=179.8

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHc--CCCCCceeEEeEEec----CCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKS--IRHPNLVKVISSCSN----DDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|++ +++.||||++....   ...+.+|.+++..  ++||||+++++++..    ....++||
T Consensus        10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            45678899999999999998 68999999987542   3455667776665  899999999998654    34589999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCceeeCCCCcEEEeccccCCC-
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-----GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~-----~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-  345 (453)
                      ||+++|+|.+++...  .+++.....++.+++.|+.|||.     .++++|+||||||+|||++.++.+||+|||++.. 
T Consensus        86 e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  163 (301)
T 3q4u_A           86 HYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH  163 (301)
T ss_dssp             CCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             hhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence            999999999999653  58899999999999999999952     1288999999999999999999999999986510 


Q ss_pred             ----------------------------C------CcCcccchHHHHHHHHHHHhC----------CCCCCccccccccH
Q 036792          346 ----------------------------G------QVSTRSDIYGYGIVLMETFTR----------KKPTDRMFVEELSL  381 (453)
Q Consensus       346 ----------------------------~------~~~~~~Dv~S~Gvvl~el~tg----------~~p~~~~~~~~~~~  381 (453)
                                                  .      .++.++|||||||++|||+||          ..||..........
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~  243 (301)
T 3q4u_A          164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF  243 (301)
T ss_dssp             ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence                                        0      223579999999999999999          77776543333222


Q ss_pred             HhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       382 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ..........         ......+.......++.++.+++.+||+.||++|||++|+++.|++|
T Consensus       244 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          244 EDMRKVVCVD---------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             HHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhhHHHhcc---------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2221111000         00000011123456788999999999999999999999999999886

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=318.44  Aligned_cols=230  Identities=24%  Similarity=0.413  Sum_probs=186.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|.+.      +++.||||+++... ......+.+|+.++++++|||||++++++..+...++|
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  152 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  152 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence            456788999999999999853      46789999997543 34456789999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC---cEEEeccc
Q 036792          271 LEYMPKGSLENCLYSST------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM---VAHLSDFE  341 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~df~  341 (453)
                      |||+++|+|.+++....      ..+++.....++.++++||.||   |+++|+||||||+|||++.++   .+||+|||
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            99999999999997532      3588899999999999999999   788999999999999999544   59999997


Q ss_pred             cCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCch
Q 036792          342 YGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       342 ~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                      ++.                           ...++.++|||||||++|||+| |..||......+  ....+.       
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i~-------  300 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVT-------  300 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH-------
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH-------
Confidence            541                           1346778999999999999998 999986542211  111111       


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                              . +.  ....+..++.++.+|+.+||+.+|++|||+.|+++.|+.+...
T Consensus       301 --------~-~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          301 --------S-GG--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             --------T-TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------c-CC--CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                    0 00  1112345667899999999999999999999999999988653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-38  Score=308.50  Aligned_cols=223  Identities=22%  Similarity=0.279  Sum_probs=183.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .++..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            3444568999999999999987 799999999987665666789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++...  .+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||++.           
T Consensus       126 ~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          126 GGALTDIVSQV--RLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             SCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             CCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            99999988753  588999999999999999999   77899999999999999999999999998642           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|+.||......+  ....+...                ......
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~----------------~~~~~~  262 (321)
T 2c30_A          201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDS----------------PPPKLK  262 (321)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHS----------------SCCCCT
T ss_pred             ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhcC----------------CCCCcC
Confidence                          1245778999999999999999999986532111  11111110                001111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....++++.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          263 NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22345667899999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=317.69  Aligned_cols=234  Identities=26%  Similarity=0.423  Sum_probs=190.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  265 (453)
                      ..+.+.+.||+|+||.||+|++.        .+..||||+++... ....+.+.+|+++++++ +|||||++++++..++
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            34566789999999999999852        23579999997653 34457899999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          266 FKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ..++||||+++|+|.+++....               ..+++.....++.+++.||.||   |+.+|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCcceEEEc
Confidence            9999999999999999997643               3588999999999999999999   788999999999999999


Q ss_pred             CCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||.+..                           ..++.++|||||||++|||++ |..||......+  +.
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--~~  303 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LF  303 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence            999999999986531                           234668999999999999999 999986542211  11


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      ..+.            ...      ....+..++.++.+++.+||+.+|++|||++|+++.|+++....+
T Consensus       304 ~~~~------------~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          304 KLLK------------EGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHHH------------TTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHH------------cCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            1111            000      111223466789999999999999999999999999999976543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=307.10  Aligned_cols=227  Identities=19%  Similarity=0.266  Sum_probs=184.1

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh------hHHHHHHHHHHHHcCCCCCceeEEeEEecCCee
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  267 (453)
                      ...|++.+.||+|+||.||+|..+ +|+.||||.++.....      ..+.+.+|+.+|++++||||+++++++.+++..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            355677889999999999999976 6899999999765321      357899999999999999999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC----cEEEeccccC
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM----VAHLSDFEYG  343 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~----~~kl~df~~~  343 (453)
                      ++||||+++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999987643 688999999999999999999   788999999999999999877    7999999865


Q ss_pred             C------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          344 M------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       344 ~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                      .                        ...++.++|||||||++|||++|..||......+. +....              
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~--------------  230 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVS--------------  230 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH--------------
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHH--------------
Confidence            2                        13457789999999999999999999965422110 00000              


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .............++.++.+++.+||+.||++|||++|+++
T Consensus       231 --~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          231 --AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              00000111122345677899999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.8e-39  Score=303.06  Aligned_cols=231  Identities=21%  Similarity=0.362  Sum_probs=184.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      ..+++.+.||+|+||.||+|.+..    +..||||.++... ....+.+.+|+.++++++||||+++++++. ++..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            445678899999999999998752    4579999987543 344578999999999999999999999984 5568899


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      |||+++|+|.+++......+++.....++.+++.||.||   |+.+++||||||+||+++.++.+||+|||++..     
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            999999999999987666789999999999999999999   788999999999999999999999999986521     


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ..++.++|||||||++|||++ |..||......+  ....+..                
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~----------------  232 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIEN----------------  232 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT----------------
T ss_pred             ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHc----------------
Confidence                                 235668999999999999997 999987543221  1111110                


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ..  ..+.+..+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       233 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          233 GE--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00  1112345677899999999999999999999999999998765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-38  Score=312.30  Aligned_cols=226  Identities=19%  Similarity=0.271  Sum_probs=183.4

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh------hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      ..|++.+.||+|+||.||+|..+ +|+.||||.++.....      ..+.+.+|+.+|++++||||+++++++.+++..+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            34567889999999999999976 6899999999765321      3578999999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC----cEEEeccccCC
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM----VAHLSDFEYGM  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~----~~kl~df~~~~  344 (453)
                      +||||+++|+|.+++.... .+++.....++.+++.|+.||   |+.+|+||||||+|||++.++    .+||+|||++.
T Consensus        92 lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            9999999999999987643 688999999999999999999   788999999999999998776    79999998652


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ...++.++|||||||++|||++|..||.+....+     ..            ...
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-----~~------------~~i  230 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TL------------ANI  230 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HH------------HHH
T ss_pred             EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----HH------------HHH
Confidence                                    1246778999999999999999999997542211     11            000


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...............+.++.+|+.+||..||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000111222345678899999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.7e-39  Score=300.73  Aligned_cols=229  Identities=24%  Similarity=0.398  Sum_probs=189.8

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|.+.++..||+|.++.... ..+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG   88 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred             eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence            455788999999999999998889999999986543 2367899999999999999999999999999999999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|.+++......+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||.+..            
T Consensus        89 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  165 (267)
T 3t9t_A           89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  165 (267)
T ss_dssp             BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred             cHHHHHhhCcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence            99999987766788999999999999999999   788999999999999999999999999976421            


Q ss_pred             --------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 --------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 --------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ..++.++||||||+++|||++ |+.||......+  ....+..                ..  ...
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~----------------~~--~~~  225 (267)
T 3t9t_A          166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST----------------GF--RLY  225 (267)
T ss_dssp             TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT----------------TC--CCC
T ss_pred             cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhc----------------CC--cCC
Confidence                          235668999999999999999 899986532211  1101100                00  011


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .+..++.++.+++.+||+.+|++|||++|+++.|+++.++
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1223456789999999999999999999999999999763

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=314.98  Aligned_cols=227  Identities=18%  Similarity=0.244  Sum_probs=185.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|++.+.||+|+||.||+|..+ +|+.||+|.+..........+.+|+++|+.++||||+++++++.++...++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            34667889999999999999976 68999999998766555678899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC--CCcEEEeccccCC--------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE--DMVAHLSDFEYGM--------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~--~~~~kl~df~~~~--------  344 (453)
                      ++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.  ++.+||+|||++.        
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  207 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  207 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence            99999999987666789999999999999999999   7889999999999999974  5789999998652        


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|..||......+  ....+.               .......
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i~---------------~~~~~~~  270 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVK---------------RCDWEFD  270 (387)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHH---------------HCCCCCC
T ss_pred             eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHHH---------------hCCCCCC
Confidence                            1346778999999999999999999997542111  111010               0000001


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......++++.+++.+||+.||++|||+.|+++
T Consensus       271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            1122345677899999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.4e-39  Score=315.55  Aligned_cols=232  Identities=21%  Similarity=0.375  Sum_probs=187.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC-eeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD-FKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~  268 (453)
                      +++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|++++.++ +|||||++++++..++ ..+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            456789999999999999842      46899999998653 34457899999999999 7899999999998755 489


Q ss_pred             EEEeccCCCCchHHhhcCCC------------------------------------------------------------
Q 036792          269 LVLEYMPKGSLENCLYSSTC------------------------------------------------------------  288 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~------------------------------------------------------------  288 (453)
                      +||||+++|+|.+++.....                                                            
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            99999999999999976432                                                            


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------------
Q 036792          289 -----MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------------  345 (453)
Q Consensus       289 -----~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------------  345 (453)
                           .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||.+..                  
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence                 178888999999999999999   788999999999999999999999999986531                  


Q ss_pred             ---------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHH
Q 036792          346 ---------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQC  415 (453)
Q Consensus       346 ---------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~  415 (453)
                               ..++.++|||||||++|||+| |..||......+.... .+..                ..  ....+..+
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~----------------~~--~~~~~~~~  321 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-RLKE----------------GT--RMRAPDYT  321 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-HHHH----------------TC--CCCCCTTC
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-HHHc----------------CC--CCCCCCCC
Confidence                     235678999999999999999 9999975432221111 1110                00  11122345


Q ss_pred             HHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          416 VLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       416 ~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ++++.+++.+||+.||++|||+.|+++.|+++....
T Consensus       322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            667899999999999999999999999999997754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=305.34  Aligned_cols=231  Identities=26%  Similarity=0.410  Sum_probs=184.3

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +++.+.||+|+||.||+|.+. ++.||||.+...  ...+.|.+|++++++++||||+++++++.+  ..++||||+++|
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            456788999999999999985 788999998644  345789999999999999999999998874  478999999999


Q ss_pred             CchHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc-EEEeccccCC----------
Q 036792          278 SLENCLYSSTC--MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV-AHLSDFEYGM----------  344 (453)
Q Consensus       278 ~L~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~-~kl~df~~~~----------  344 (453)
                      +|.+++.....  .++....+.++.++++||.|||..|.++|+||||||+||+++.++. +||+|||.+.          
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (307)
T 2eva_A           85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK  164 (307)
T ss_dssp             BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence            99999976542  4678888999999999999997666589999999999999988876 7999998652          


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK  412 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  412 (453)
                                  ...++.++|||||||++|||++|+.||...............                ..  ...+..
T Consensus       165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------------~~--~~~~~~  226 (307)
T 2eva_A          165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH----------------NG--TRPPLI  226 (307)
T ss_dssp             CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH----------------TT--CCCCCB
T ss_pred             CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh----------------cC--CCCCcc
Confidence                        134678999999999999999999999753222111110000                00  011122


Q ss_pred             HHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       413 ~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ..++.++.+++.+||+.||++|||++|+++.|+++...+
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            345677899999999999999999999999999987643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=332.94  Aligned_cols=226  Identities=24%  Similarity=0.427  Sum_probs=188.7

Q ss_pred             ccCCCCccEEEEEEEC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          203 LIGMGSFGSVYRARLR---DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .||+|+||.||+|.++   ++..||||+++... ....++|.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999864   46789999998653 3456789999999999999999999999976 56899999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------------  345 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------------  345 (453)
                      |.+++......+++.....++.+++.||.||   |+++|+||||||+|||++.++.+||+|||++..             
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            9999987766789999999999999999999   788999999999999999999999999987531             


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ..++.++|||||||++|||+| |+.||......+  ....+.                .+  .+.
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~----------------~~--~~~  558 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE----------------QG--KRM  558 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHH----------------TT--CCC
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH----------------cC--CCC
Confidence                           245678999999999999998 999997643221  111111                01  112


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      ..+..++.++.+|+..||+.+|++||++.++++.|+++...+.
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            2345678889999999999999999999999999999876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.2e-39  Score=329.03  Aligned_cols=228  Identities=24%  Similarity=0.413  Sum_probs=189.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..+++.+.||+|+||.||+|.++ ++..||||.++.... ..++|.+|+++|++++|||||+++++|..++..++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            34566789999999999999987 488999999976533 3578999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          275 PKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      ++|+|.+++... ...+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++..        
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  375 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  375 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence            999999999763 34688899999999999999999   788999999999999999999999999986521        


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ..++.++|||||||++|||+| |..||......+  ..+.            +....     
T Consensus       376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~------------~~~~~-----  436 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL------------LEKDY-----  436 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH------------HHTTC-----
T ss_pred             cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HHcCC-----
Confidence                              234668999999999999999 999987543221  1111            11111     


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                       +...+..++.++.+|+.+||+.+|++||||.++++.|+++
T Consensus       437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence             1123346778899999999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.8e-38  Score=302.04  Aligned_cols=238  Identities=31%  Similarity=0.459  Sum_probs=190.8

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccc----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC----ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+.||+|+||.||+|.. +++.||||++....    ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  113 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP  113 (307)
T ss_dssp             TCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             cCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence            357899999999999987 58899999987532    2345789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          276 KGSLENCLYSS--TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       276 ~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +|+|.+++...  ...+++.....++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+..        
T Consensus       114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            99999988642  34588999999999999999999   788999999999999999999999999986421        


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhhhhhhhhhcCc
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~~~~~  405 (453)
                                        +.++.++||||||+++|||++|..||........ ...+....  ....+.+.+++.+    
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----  265 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKM----  265 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSC----
T ss_pred             cccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHHHHHhhhhhhhhhhhccccc----
Confidence                              1246789999999999999999999976433221 11222111  1112233333222    


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                         ...+..++..+.+++.+||+.+|++|||++++++.|+++..
T Consensus       266 ---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          266 ---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             ---SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             ---cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence               12345678889999999999999999999999999998854

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-39  Score=308.08  Aligned_cols=226  Identities=19%  Similarity=0.308  Sum_probs=183.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CC-------CEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DG-------IEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      +.+.+.||+|+||.||+|..+ ++       ..||+|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL   89 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence            456788999999999999865 33       5799999987766677889999999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc--------EEEeccc
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV--------AHLSDFE  341 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~--------~kl~df~  341 (453)
                      ||||+++|+|.+++......+++.....++.+++.||.||   |+++|+||||||+|||++.++.        +||+|||
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           90 VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             EEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             EEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            9999999999999987765688999999999999999999   7889999999999999998876        9999998


Q ss_pred             cCCC----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          342 YGME----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       342 ~~~~----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                      .+..                      ..++.++|||||||++|||++|..|+........ .......            
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~------------  233 (289)
T 4fvq_A          167 ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED------------  233 (289)
T ss_dssp             SCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT------------
T ss_pred             ccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc------------
Confidence            7521                      3467789999999999999996554332211110 0111100            


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                          .    ...+...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus       234 ----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l  273 (289)
T 4fvq_A          234 ----R----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL  273 (289)
T ss_dssp             ----T----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----c----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                0    001112244578899999999999999999999999876

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5e-39  Score=325.67  Aligned_cols=228  Identities=27%  Similarity=0.427  Sum_probs=187.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+++.+.||+|+||.||+|.++++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            34566789999999999999998888899999986543 34689999999999999999999999876 67899999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|+|.+++... ...+++.....++.+++.||.||   |+++|+||||||+|||++.++.+||+|||++..         
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence            99999999753 23578899999999999999999   788999999999999999999999999987531         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ..++.++|||||||++|||+| |+.||......+  ....+            .    .+  .
T Consensus       339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i------------~----~~--~  398 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV------------E----RG--Y  398 (452)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH------------H----TT--C
T ss_pred             cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHH------------H----cC--C
Confidence                             245678999999999999999 999987542211  11111            0    01  1


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      +.+.+..+++++.+++.+||+.+|++|||++++++.|+++.
T Consensus       399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            12233467788999999999999999999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-39  Score=317.78  Aligned_cols=231  Identities=24%  Similarity=0.452  Sum_probs=184.9

Q ss_pred             HHhcccCCCCccEEEEEEEC--C--CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLR--D--GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~E  272 (453)
                      ++.+.||+|+||.||+|.+.  +  +..||||.++... ....+.|.+|+.++++++||||++++++|.. ++..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            44678999999999999864  2  2468999987543 3456789999999999999999999998754 567899999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++......+++.....++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++.        
T Consensus       172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            9999999999988776788999999999999999999   78899999999999999999999999998652        


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                           ...++.++|||||||++|||+| |.+||......+  ....+..               
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~---------------  311 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ---------------  311 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHT---------------
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHc---------------
Confidence                                 1235678999999999999999 677776442211  1111110               


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                       +  .....+..++.++.+++.+||+.+|++|||++|+++.|+++...+.
T Consensus       312 -~--~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          312 -G--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -T--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -C--CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence             0  0111234567789999999999999999999999999999987653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-39  Score=313.52  Aligned_cols=231  Identities=29%  Similarity=0.462  Sum_probs=188.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|++.      +++.||||.++... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  128 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL  128 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence            456788999999999999874      34889999998653 34457899999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 036792          271 LEYMPKGSLENCLYSST-----------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISV  327 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~Ni  327 (453)
                      |||+++|+|.+++....                       ..+++.....++.++++||.||   |+.+|+||||||+||
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NI  205 (343)
T 1luf_A          129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNC  205 (343)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred             EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceE
Confidence            99999999999997632                       4688899999999999999999   788999999999999


Q ss_pred             eeCCCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccc
Q 036792          328 LLDEDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL  379 (453)
Q Consensus       328 Ll~~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~  379 (453)
                      +++.++.+||+|||++.                           ...++.++|||||||++|||+| |..||......+ 
T Consensus       206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  284 (343)
T 1luf_A          206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-  284 (343)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred             EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-
Confidence            99999999999997541                           1245778999999999999999 999987542211 


Q ss_pred             cHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          380 SLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                       ....+.                .+.  ....+..++.++.+++.+||+.+|++|||+.|+++.|+++.+..
T Consensus       285 -~~~~~~----------------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          285 -VIYYVR----------------DGN--ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             -HHHHHH----------------TTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             -HHHHHh----------------CCC--cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence             111110                000  11123456678999999999999999999999999999886543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-38  Score=304.99  Aligned_cols=240  Identities=24%  Similarity=0.292  Sum_probs=183.9

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||.||+|+..+|+.||||+++....  ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  102 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME  102 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred             hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence            466789999999999999998899999999975432  234678899999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      + +|.+.+......++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.           
T Consensus       103 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          103 K-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             E-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             C-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            5 88888877766789999999999999999999   78899999999999999999999999998642           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---cCCchhhhhhhh------
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---LPISLMEVVDKT------  400 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~------  400 (453)
                                     ...++.++||||+||++|||++|+.||......+. +.......   .+..+....+..      
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  257 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELPLWKQRT  257 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence                           12467789999999999999999999976533322 22221111   111111111000      


Q ss_pred             hhc-CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLS-GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ... ............++++.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000 000001122345568899999999999999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-38  Score=303.51  Aligned_cols=229  Identities=14%  Similarity=0.083  Sum_probs=185.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|+..+++++||||+++++++.+++..++||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            567789999999999999976 58999999997653   23457899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccc
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSD  353 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~D  353 (453)
                      +++++|.+++...   ........++.|++.||.||   |+.+|+||||||+|||++.++.+||+++++.  ..++.++|
T Consensus       113 ~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~kl~~~~~~--~~~~~~~D  184 (286)
T 3uqc_A          113 IRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDVVLAYPATM--PDANPQDD  184 (286)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCEEECSCCCC--TTCCHHHH
T ss_pred             cCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCEEEEecccc--CCCCchhH
Confidence            9999999998643   34556788999999999999   7889999999999999999999999988765  45899999


Q ss_pred             hHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCccc
Q 036792          354 IYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEK  433 (453)
Q Consensus       354 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~  433 (453)
                      ||||||++|||+||+.||......+...              ...................+++++.+++.+||+.||++
T Consensus       185 i~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  250 (286)
T 3uqc_A          185 IRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGI  250 (286)
T ss_dssp             HHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSC
T ss_pred             HHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCcc
Confidence            9999999999999999997643221000              00000000000001122356778999999999999999


Q ss_pred             CCChHHHHHHHHHHHH
Q 036792          434 RINAKDIVTRLLKIRD  449 (453)
Q Consensus       434 RPs~~~v~~~L~~i~~  449 (453)
                      | |+.|+++.|+++..
T Consensus       251 R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          251 R-SASTLLNLMQQATA  265 (286)
T ss_dssp             C-CHHHHHHHHHHHHC
T ss_pred             C-CHHHHHHHHHHHhc
Confidence            9 99999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-38  Score=305.03  Aligned_cols=231  Identities=22%  Similarity=0.336  Sum_probs=187.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            566789999999999999976 68999999986432   34457899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++|+|.+++.... .+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||++..        
T Consensus        93 ~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           93 IEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            99999999987643 588999999999999999999   788999999999999999999999999986521        


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++|||||||++|||+||+.||........... ......+.               .
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~---------------~  232 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK-HIQDSVPN---------------V  232 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-HHSSCCCC---------------H
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HhhccCCC---------------c
Confidence                              2356789999999999999999999975432211111 00000000               0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCC-ChHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRI-NAKDIVTRLLKIR  448 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~  448 (453)
                      .......+++.+.+++.+||+.||++|| +++++.+.|+++.
T Consensus       233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            0112234567899999999999999998 9999999887653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-38  Score=306.47  Aligned_cols=232  Identities=25%  Similarity=0.409  Sum_probs=189.4

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      ..+.+.+.||+|+||.||+|...      ++..||||+++... ....+.+.+|++++++++||||+++++++..++..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            34567789999999999999862      35889999997653 345578999999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 036792          269 LVLEYMPKGSLENCLYSST-----------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPI  325 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~  325 (453)
                      +||||+++|+|.+++....                       ..+++.....++.++++||.||   |+.+|+||||||+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dikp~  179 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAAR  179 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGG
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH---HHCCCcccccchh
Confidence            9999999999999997643                       2377888999999999999999   7889999999999


Q ss_pred             ceeeCCCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccc
Q 036792          326 SVLLDEDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVE  377 (453)
Q Consensus       326 NiLl~~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~  377 (453)
                      ||+++.++.+||+|||++..                           ..++.++|||||||++|||+| |..||......
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999986521                           124668999999999999999 99998754322


Q ss_pred             cccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          378 ELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .  ....+...                .  ....+..+++++.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       260 ~--~~~~~~~~----------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          260 R--LFNLLKTG----------------H--RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             G--HHHHHHTT----------------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             H--HHHHhhcC----------------C--cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            1  11111100                0  1112234567899999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.4e-39  Score=305.21  Aligned_cols=232  Identities=25%  Similarity=0.398  Sum_probs=181.9

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .+++.+.||+|+||.||+|++.  ..||||+++...  ....+.+.+|++++++++||||+++++++ ..+..++||||+
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~  101 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC  101 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred             ceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence            3566789999999999999864  359999997543  34557899999999999999999999965 455679999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++++|.+++......+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.+.          
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred             CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence            99999999987767789999999999999999999   78899999999999999999999999998642          


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ...++.++||||||+++|||++|+.||......+..............            
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  246 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD------------  246 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC------------
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc------------
Confidence                                123456899999999999999999999754322111111111000000            


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                         .......+++++.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus       247 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          247 ---LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence               011223567789999999999999999999999999988743

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-38  Score=309.78  Aligned_cols=226  Identities=21%  Similarity=0.324  Sum_probs=182.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ..|++.+.||+|+||.||+|..+ +|+.||||+++...  ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            44567889999999999999976 68999999997653  3445778999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC---CcEEEeccccCCC----
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED---MVAHLSDFEYGME----  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~---~~~kl~df~~~~~----  345 (453)
                      |+++|+|.+.+.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.+   +.+||+|||++..    
T Consensus       109 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          109 LVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999999887643 578899999999999999999   78899999999999999864   4599999986521    


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                          ..++.++|||||||++|||++|.+||......+  +...+               .....
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i---------------~~~~~  247 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQI---------------KAGAY  247 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---------------HHTCC
T ss_pred             cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH---------------HhCCC
Confidence                                246778999999999999999999986532111  11111               00000


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+....+++++.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0011122345678899999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-38  Score=313.72  Aligned_cols=241  Identities=15%  Similarity=0.176  Sum_probs=186.5

Q ss_pred             HHHHhcccCCCCccEEEEEEECC------CCEEEEEEeeccchhh-----------HHHHHHHHHHHHcCCCCCceeEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQECARA-----------LKSFEAQCEVMKSIRHPNLVKVIS  259 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g  259 (453)
                      .|++.+.||+|+||.||+|.++.      ++.||||++.......           ...+..|+..++.++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            35677899999999999998764      4789999987654211           123445666788889999999999


Q ss_pred             EEecC----CeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC--CCC
Q 036792          260 SCSND----DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD--EDM  333 (453)
Q Consensus       260 ~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~--~~~  333 (453)
                      ++...    ...++||||+ +|+|.+++......+++..+..++.|++.||.||   |+.+|+||||||+|||++  .++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEESSCTT
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHHEEEecCCCC
Confidence            98774    4589999999 9999999987766799999999999999999999   788999999999999999  889


Q ss_pred             cEEEeccccCC--------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccH
Q 036792          334 VAHLSDFEYGM--------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL  381 (453)
Q Consensus       334 ~~kl~df~~~~--------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~  381 (453)
                      .+||+|||++.                                ...++.++|||||||++|||+||+.||....... ..
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-KY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-HH
Confidence            99999998751                                1135678999999999999999999997543221 11


Q ss_pred             HhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       382 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ...........+.+.++..+.         ...++.++.+++..||+.+|++||+++++++.|+++..+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            112222222223333332221         1234678999999999999999999999999999987754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.2e-38  Score=305.06  Aligned_cols=246  Identities=22%  Similarity=0.371  Sum_probs=191.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-----CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-----DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  268 (453)
                      ++++.+.||+|+||.||++.++     +++.||||+++... ....+.+.+|++++++++||||+++++++.+  ....+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3467889999999999998753     57899999998653 3456789999999999999999999999987  46789


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +||||+++|+|.+++....  +++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||.+..   
T Consensus       112 lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999997654  88899999999999999999   788999999999999999999999999986521   


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                               ..++.++||||||+++|||+||..||............+.....  ...+ +...
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~-~~~~  263 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM--TVLR-LTEL  263 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH--HHHH-HHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch--hHHH-HHHH
Confidence                                     12355789999999999999999998643221111100000000  0000 1111


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      +...  ...+.+..++.++.+|+.+||+.||++|||++|+++.|+++.+++.
T Consensus       264 ~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          264 LERG--ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             Hhcc--cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            1111  1122345667889999999999999999999999999999988764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-38  Score=309.90  Aligned_cols=227  Identities=21%  Similarity=0.287  Sum_probs=180.9

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-----hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-----RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      ...|++.+.||+|+||.||+|..+ +|+.||||+++....     ...+.+.+|+++++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            345677899999999999999976 689999999975421     13578999999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc---EEEecccc
Q 036792          269 LVLEYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV---AHLSDFEY  342 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~---~kl~df~~  342 (453)
                      +||||+++|+|.+.+...   ...++......++.|++.||.||   |+++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877542   33578888999999999999999   7889999999999999986554   99999986


Q ss_pred             CC-------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          343 GM-------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       343 ~~-------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                      +.                         ...++.++|||||||++|||++|..||.....  ........           
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~-----------  246 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIK-----------  246 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHH-----------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHc-----------
Confidence            42                         12467789999999999999999999975311  00111110           


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                           .............+.++.+|+.+||+.||++|||+.|+++
T Consensus       247 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          247 -----GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -----TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0000011122345678899999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.6e-38  Score=304.54  Aligned_cols=234  Identities=23%  Similarity=0.356  Sum_probs=190.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEE------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  267 (453)
                      ..+++.+.||+|+||.||+|.+      .+++.||||.++... ....+.+.+|+++++++ +||||+++++++..++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            3456678999999999999985      246899999997654 34457899999999999 999999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          268 ALVLEYMPKGSLENCLYSSTC-----------------MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ++||||+++|+|.+++.....                 .+++.....++.++++||.||   |+.+|+||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEc
Confidence            999999999999999976432                 478899999999999999999   788999999999999999


Q ss_pred             CCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||.+..                           ..++.++||||||+++|||+| |..||........ ..
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~  258 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY  258 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-HH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-HH
Confidence            999999999986521                           234667999999999999999 9999875432211 11


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ..            +....      ....+..++.++.+++.+||+.||++|||+.|+++.|+++..+.
T Consensus       259 ~~------------~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          259 KM------------IKEGF------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HH------------HHHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HH------------hccCC------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            11            11111      01122345677899999999999999999999999999987654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=309.54  Aligned_cols=247  Identities=27%  Similarity=0.405  Sum_probs=193.0

Q ss_pred             HHHhcccCCCCccEEEEEEE-----CCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC--eeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD--FKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv  270 (453)
                      +++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            46678999999999999985     268899999998766666788999999999999999999999987644  78999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      |||+++|+|.+++......+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||.+..     
T Consensus       123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            999999999999987766789999999999999999999   788999999999999999999999999986521     


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc-hhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS-LMEVVDKTL  401 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~  401 (453)
                                             ..++.++||||||+++|||+||..|+.....+   ............ ....+...+
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHHHHH
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHHHHh
Confidence                                   12356799999999999999999987532111   000000000000 000011111


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      ....  ..+.+..++.++.+++.+||+.+|++|||+.|+++.|+++++++.
T Consensus       277 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          277 KNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hcCC--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            1111  122344677889999999999999999999999999999998864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.1e-38  Score=306.44  Aligned_cols=234  Identities=25%  Similarity=0.434  Sum_probs=189.1

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC--------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSND  264 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  264 (453)
                      ...+++.+.||+|+||.||+|.+.        ++..||||+++... ....+.+.+|+++++++ +||||+++++++..+
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            345567889999999999999863        46789999997653 34567899999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee
Q 036792          265 DFKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL  329 (453)
Q Consensus       265 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl  329 (453)
                      +..++||||+++|+|.+++....               ..+++.....++.++++||.||   |+.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCccceEEE
Confidence            99999999999999999997643               2378889999999999999999   78899999999999999


Q ss_pred             CCCCcEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccH
Q 036792          330 DEDMVAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSL  381 (453)
Q Consensus       330 ~~~~~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~  381 (453)
                      +.++.+||+|||.+..                           ..++.++|||||||++|||++ |..||......+  +
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--H
Confidence            9999999999986521                           124568999999999999999 999986542211  1


Q ss_pred             HhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       382 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ...+.            ...      ....+..++.++.+++.+||+.+|++|||++|+++.|+++....
T Consensus       269 ~~~~~------------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          269 FKLLK------------EGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHH------------HTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHh------------cCC------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            11110            000      11122346678999999999999999999999999999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-38  Score=307.16  Aligned_cols=223  Identities=25%  Similarity=0.305  Sum_probs=179.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   88 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence            456788999999999999976 789999999975532 334678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      +|+|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++..          
T Consensus        89 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           89 GGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             TEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            999999887543 588999999999999999999   788999999999999999999999999986521          


Q ss_pred             -----------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       .. .+.++|||||||++|||++|+.||............+.....                  
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------  226 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------  226 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT------------------
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc------------------
Confidence                             11 255799999999999999999999754333222222221110                  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........+.++.+|+.+||+.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            01112345667889999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-38  Score=302.78  Aligned_cols=247  Identities=20%  Similarity=0.260  Sum_probs=188.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC--eeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD--FKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++....  ..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence            456789999999999999976 58999999997653 344577889999999999999999999988755  77999999


Q ss_pred             cCCCCchHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee----CCCCcEEEeccccCC---
Q 036792          274 MPKGSLENCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDFEYGM---  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl----~~~~~~kl~df~~~~---  344 (453)
                      +++|+|.+++....  ..+++.....++.++++||.||   |+.+|+||||||+||++    +.++.+||+|||.+.   
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            99999999997643  2388999999999999999999   78899999999999999    778889999997651   


Q ss_pred             -----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccccc---HHhHHhhhcCCc
Q 036792          345 -----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELS---LKDWVNNLLPIS  392 (453)
Q Consensus       345 -----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~  392 (453)
                                                   ...++.++|||||||++|||+||+.||.........   +........+..
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (319)
T 4euu_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (319)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred             CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence                                         235677899999999999999999998643222211   111111111111


Q ss_pred             hhhh---hhhhhh--cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          393 LMEV---VDKTLL--SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       393 ~~~~---~d~~~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      +...   ......  .............+..+.+++.+||+.||++|||++|+++...+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1100   000000  000111234467788899999999999999999999999887654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=310.34  Aligned_cols=233  Identities=23%  Similarity=0.334  Sum_probs=185.1

Q ss_pred             HHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  268 (453)
                      .+++.+.||+|+||.||+|.+.      ++..||||.++... ....+.+.+|+.+++++ +||||+++++++..++..+
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  125 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  125 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence            3456789999999999999862      45689999997543 33456889999999999 8999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCc
Q 036792          269 LVLEYMPKGSLENCLYSSTC----------------------MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPIS  326 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~N  326 (453)
                      +||||+++|+|.+++.....                      .+++.....++.+++.||.||   |+.+|+||||||+|
T Consensus       126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~N  202 (344)
T 1rjb_A          126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARN  202 (344)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCSGGG
T ss_pred             EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhh
Confidence            99999999999999976532                      378888999999999999999   78899999999999


Q ss_pred             eeeCCCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCcccccc
Q 036792          327 VLLDEDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEE  378 (453)
Q Consensus       327 iLl~~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~  378 (453)
                      |+++.++.+||+|||++.                           ...++.++|||||||++|||+| |..||.......
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  282 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  282 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence            999999999999998652                           1235678999999999999998 999997543221


Q ss_pred             ccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          379 LSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      . ....+.            ...      ....+..+++++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       283 ~-~~~~~~------------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          283 N-FYKLIQ------------NGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             H-HHHHHH------------TTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             H-HHHHHh------------cCC------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            1 111111            100      11122345678999999999999999999999999999886543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-38  Score=309.65  Aligned_cols=228  Identities=21%  Similarity=0.401  Sum_probs=182.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCC----EEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGI----EVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|++. +++    .||+|.++... ....+.+.+|+.++++++||||++++++|.++. .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~   95 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence            456789999999999999965 444    46888876443 345578999999999999999999999998765 67999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.       
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            99999999999988777799999999999999999999   78899999999999999999999999997541       


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                          ...++.++|||||||++|||+| |+.||......+  +...+            ....  
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~------------~~~~--  236 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL------------EKGE--  236 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH------------HTTC--
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHH------------HcCC--
Confidence                                1235778999999999999999 999997543221  11111            1110  


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                          ..+.+..++.++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       237 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                111234466789999999999999999999999999998864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-38  Score=304.87  Aligned_cols=245  Identities=21%  Similarity=0.374  Sum_probs=187.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEE-----CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC--Cee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSND--DFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  267 (453)
                      ..+++.+.||+|+||.||+|++     .+++.||||+++... ....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3456778999999999999984     268999999997543 33457889999999999999999999999876  668


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--  345 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--  345 (453)
                      ++||||+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.+..  
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            999999999999999976666789999999999999999999   788999999999999999999999999986521  


Q ss_pred             --------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          346 --------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       346 --------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                                                ..++.++||||+|+++|||+||..|+......   ................+..
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHHH
Confidence                                      12345799999999999999999986432111   0000000000011111111


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      .+...  ...+.+..+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus       255 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEG--KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTT--CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcc--CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111  122234456788999999999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-38  Score=297.63  Aligned_cols=226  Identities=24%  Similarity=0.424  Sum_probs=186.4

Q ss_pred             cccCCCCccEEEEEEEC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRARLR---DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      ..||+|+||.||+|.++   ++..||||.++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            48999999999999864   57889999998653 34567899999999999999999999999 455689999999999


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------------  345 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------------  345 (453)
                      +|.+++......+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||.+..            
T Consensus        95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  171 (287)
T 1u59_A           95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  171 (287)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence            99999987666789999999999999999999   788999999999999999999999999986521            


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..++.++||||||+++|||+| |+.||......+  ....+..                ..  .
T Consensus       172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~----------------~~--~  231 (287)
T 1u59_A          172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQ----------------GK--R  231 (287)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHT----------------TC--C
T ss_pred             cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhc----------------CC--c
Confidence                            234568999999999999999 999986542211  1111110                00  1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ...+..+++++.+++..||+.+|++||++.|+++.|+++..+.
T Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            1223456778999999999999999999999999999987653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-38  Score=307.22  Aligned_cols=232  Identities=25%  Similarity=0.448  Sum_probs=180.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEECC-C---CEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCee--
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRD-G---IEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK--  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--  267 (453)
                      ..+++.+.||+|+||.||+|.+.. +   ..||||+++..  .....+.+.+|++++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            345678899999999999998663 3   38999999765  234567899999999999999999999999887655  


Q ss_pred             ----EEEEeccCCCCchHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEe
Q 036792          268 ----ALVLEYMPKGSLENCLYSS-----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS  338 (453)
Q Consensus       268 ----~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~  338 (453)
                          ++||||+++|+|.+++...     ...+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCCcceEEEcCCCCEEEe
Confidence                8999999999999988542     22588899999999999999999   78899999999999999999999999


Q ss_pred             ccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcC
Q 036792          339 DFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLP  390 (453)
Q Consensus       339 df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  390 (453)
                      |||.+..                           ..++.++|||||||++|||++ |..||......+  ....+.    
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~----  253 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYNYLI----  253 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHH----
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHHHHh----
Confidence            9986521                           235678999999999999999 899987542221  111110    


Q ss_pred             CchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          391 ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       391 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                                 . ..  ....+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus       254 -----------~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          254 -----------G-GN--RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             -----------T-TC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----------c-CC--CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                       0 00  1112334567899999999999999999999999999998764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.9e-38  Score=315.70  Aligned_cols=226  Identities=19%  Similarity=0.253  Sum_probs=181.4

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ..|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+++|+.++|||||++++++.+++..++|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            44567889999999999999875 78999999997653  3345678999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC---CCCcEEEeccccCC-----
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDFEYGM-----  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~---~~~~~kl~df~~~~-----  344 (453)
                      |+++|+|.+.+.... .++......++.+++.|+.||   |+++|+||||||+|||++   .++.+||+|||++.     
T Consensus        91 ~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           91 LVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999887654 588899999999999999999   788999999999999998   46789999998752     


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ...++.++||||+||++|||++|.+||......+  .               ........
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~---------------~~~i~~~~  229 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--L---------------YQQIKAGA  229 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H---------------HHHHHHTC
T ss_pred             CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--H---------------HHHHHhCC
Confidence                                1246788999999999999999999996532111  1               11101100


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+....+++++.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00111122345678999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-38  Score=299.44  Aligned_cols=232  Identities=23%  Similarity=0.382  Sum_probs=185.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CC---CEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCee-EEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DG---IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK-ALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv~E  272 (453)
                      ++.+.||+|+||.||+|.+. ++   ..||+|.++... ....+.+.+|+.++++++||||+++++++.+++.. ++|||
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  103 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP  103 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence            34578999999999999854 22   379999997543 34567899999999999999999999999876554 99999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+.+|+|.+++......+++.....++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+.        
T Consensus       104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            9999999999988666788999999999999999999   78899999999999999999999999998763        


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ...++.++||||||+++|||++|..|+..... .......+....              
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~--------------  245 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGR--------------  245 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTC--------------
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCC--------------
Confidence                                 12346789999999999999996555432211 111111111100              


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                          ....+..++.++.+++.+||+.+|++|||++++++.|+++...+.
T Consensus       246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                111233456779999999999999999999999999999987654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=305.07  Aligned_cols=230  Identities=20%  Similarity=0.265  Sum_probs=185.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEe----cCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS----NDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lv~E  272 (453)
                      |++.+.||+|+||.||++... +++.||||++........+.+.+|+++++.++||||+++++++.    .....++|||
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            456788999999999999974 78999999997766666788999999999999999999999987    3457899999


Q ss_pred             ccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          273 YMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      |+++|+|.+++..   ....+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||.+..    
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            9999999998865   345688999999999999999999   788999999999999999999999999984310    


Q ss_pred             ---------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc
Q 036792          346 ---------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       346 ---------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                                                       ..++.++|||||||++|||++|+.||...............      
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------  261 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ------  261 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH------
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh------
Confidence                                             01467899999999999999999998643222211111111      


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                            ...      ..+....++.++.+++.+||+.||++|||++|+++.|++++
T Consensus       262 ------~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          262 ------NQL------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ------CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ------ccC------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                  000      01112345667999999999999999999999999998874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-38  Score=304.07  Aligned_cols=229  Identities=24%  Similarity=0.427  Sum_probs=187.4

Q ss_pred             HHhcccCCCCccEEEEEEECC-----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLRD-----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+.+.||+|+||.||+|.+..     +..||||.++... ......+.+|++++++++||||+++++++...+..++|||
T Consensus        47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  126 (333)
T 1mqb_A           47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE  126 (333)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence            456889999999999998652     2469999997653 3445679999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.+.        
T Consensus       127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            9999999999987666789999999999999999999   78899999999999999999999999998642        


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                          ...++.++|||||||++|||++ |+.||......+  ....            +.    .
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~------------~~----~  265 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKA------------IN----D  265 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH------------HH----T
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHH------------HH----C
Confidence                                1235668999999999999999 999986542211  1100            10    0


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      +.  ..+.+..++.++.+++.+||+.+|++||++.|+++.|+++...
T Consensus       266 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          266 GF--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             TC--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CC--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            00  1112335667899999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.8e-38  Score=302.32  Aligned_cols=231  Identities=24%  Similarity=0.461  Sum_probs=185.0

Q ss_pred             HHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEe-cCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCS-NDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|.+.+    ...||+|.++... ....+.+.+|+.++++++||||+++++++. .++..++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            4557889999999999998642    2368999987543 345578999999999999999999999865 456789999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++......+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||.+..      
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            99999999999987766788999999999999999999   788999999999999999999999999986531      


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ..++.++||||||+++|||++ +.+||......+  .......              
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~--------------  247 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ--------------  247 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHT--------------
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhc--------------
Confidence                                   234678999999999999999 555665432211  1111110              


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                        .  .....+..++.++.+++.+||+.+|++|||++|+++.|+++...+
T Consensus       248 --~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          248 --G--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             --T--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             --C--CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence              0  011122345667999999999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-38  Score=309.63  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=190.6

Q ss_pred             HHHHhcccCCCCccEEEEEEE-----CCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEe--cCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARL-----RDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS--NDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l  269 (453)
                      .+++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            356678999999999999985     257899999998776666788999999999999999999999887  4567899


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ||||+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.+..    
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            9999999999999977555689999999999999999999   788999999999999999999999999986521    


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                              ..++.++|||||||++|||++|..||.....+......+  ........+..+. +
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~  257 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC--ERDVPALSRLLEL-L  257 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH-H
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc--ccccccHHHHHHH-h
Confidence                                    123568999999999999999999986432211100000  0000011111111 1


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ...  ...+.+..+++++.+++.+||+.||++|||++|+++.|+++...
T Consensus       258 ~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          258 EEG--QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             hcc--cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            111  12223456778899999999999999999999999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-38  Score=297.93  Aligned_cols=228  Identities=25%  Similarity=0.422  Sum_probs=176.5

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccch----hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA----RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|.+. +..||||+++....    ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF   87 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred             eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence            345688999999999999975 88999999875432    2356789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC--------CCcEEEeccccCCC
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE--------DMVAHLSDFEYGME  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~--------~~~~kl~df~~~~~  345 (453)
                      +++|+|.+++...  .+++.....++.++++|+.|||.....+++||||||+||+++.        ++.+||+|||.+..
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           88 ARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             CTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             CCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            9999999988643  5888999999999999999994322223999999999999986        67899999987531


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++||||||+++|||++|+.||...........                 ...
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------------~~~  228 (271)
T 3dtc_A          166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG-----------------VAM  228 (271)
T ss_dssp             ----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH-----------------HHT
T ss_pred             cccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh-----------------hhc
Confidence                                   2357789999999999999999999975422111000                 000


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      .  ....+.+..+++++.+++.+||+.+|++|||++|+++.|+++
T Consensus       229 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          229 N--KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             S--CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             C--CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            0  001122345667899999999999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.7e-38  Score=301.47  Aligned_cols=238  Identities=18%  Similarity=0.240  Sum_probs=181.8

Q ss_pred             HHH-hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRL-SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++ .+.||+|+||.||+|... +++.||||+++.......+.+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus        14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   93 (316)
T 2ac3_A           14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM   93 (316)
T ss_dssp             CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence            344 467999999999999965 7899999999876555567899999999885 7999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc---EEEeccccCCC------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV---AHLSDFEYGME------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~---~kl~df~~~~~------  345 (453)
                      ++|+|.+++.... .++......++.|++.||.||   |+.+|+||||||+||+++.++.   +||+|||++..      
T Consensus        94 ~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           94 RGGSILSHIHKRR-HFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             CCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            9999999987643 578889999999999999999   7889999999999999998765   99999986531      


Q ss_pred             -------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CCch
Q 036792          346 -------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PISL  393 (453)
Q Consensus       346 -------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~  393 (453)
                                                     ..++.++|||||||++|||++|+.||......+....   .... +...
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~  246 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD---RGEACPACQ  246 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc---ccccchhHH
Confidence                                           1246689999999999999999999976533221110   0000 0000


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...................+.++.+|+.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0111111111110111112245678999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-37  Score=299.42  Aligned_cols=241  Identities=24%  Similarity=0.368  Sum_probs=180.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcC--CCCCceeEEeEEecC----CeeEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI--RHPNLVKVISSCSND----DFKAL  269 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~~~l  269 (453)
                      ..+++.+.||+|+||.||+|+++ ++.||||++....   ...+.+|.+++...  +||||+++++++...    ...++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            34566789999999999999986 8999999986543   23455566666554  899999999999887    78999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG-----HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~-----h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                      ||||+++|+|.+++...  .+++.....++.+++.||.|||..     |.++|+||||||+|||++.++.+||+|||.+.
T Consensus       113 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            99999999999999764  488899999999999999999522     23399999999999999999999999998652


Q ss_pred             C-----------------------------CCcCc------ccchHHHHHHHHHHHhC----------CCCCCccccccc
Q 036792          345 E-----------------------------GQVST------RSDIYGYGIVLMETFTR----------KKPTDRMFVEEL  379 (453)
Q Consensus       345 ~-----------------------------~~~~~------~~Dv~S~Gvvl~el~tg----------~~p~~~~~~~~~  379 (453)
                      .                             .....      ++|||||||++|||+||          ..||........
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            0                             01112      38999999999999999          445443322222


Q ss_pred             cHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          380 SLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .......         .+.........+.......++.++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       271 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          271 SYEDMRE---------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CHHHHHH---------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             chhhhHH---------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            1111111         11000000111111223478899999999999999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5e-38  Score=312.30  Aligned_cols=244  Identities=20%  Similarity=0.292  Sum_probs=184.4

Q ss_pred             HHHHHHhcccCCC--CccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          195 ATLRRLSNLIGMG--SFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       195 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      ...|++.+.||+|  +||.||+|+.+ +|+.||||+++...  ....+.+.+|+.+++.++|||||++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3456788999999  99999999987 69999999998653  3445678899999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          270 VLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      ||||+++|+|.+++... ...+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||.+.    
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999998764 34688999999999999999999   78899999999999999999999999996431    


Q ss_pred             ----------------------------C--CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc--
Q 036792          345 ----------------------------E--GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS--  392 (453)
Q Consensus       345 ----------------------------~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  392 (453)
                                                  .  ..++.++|||||||++|||++|+.||......+.....+ ....+..  
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~  259 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLD  259 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCcccc
Confidence                                        1  346788999999999999999999997643322211111 0000000  


Q ss_pred             ---------------------hhhhhh---hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          393 ---------------------LMEVVD---KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       393 ---------------------~~~~~d---~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                                           ..+.+.   ...........+.+...++++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                 000000   00000000111233456678999999999999999999999974

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-37  Score=299.27  Aligned_cols=234  Identities=24%  Similarity=0.335  Sum_probs=185.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE---CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|... +|+.||||+++..   .....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            466788999999999999975 7899999999753   234557889999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          274 MPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      +++|+|.+++..   ....++......++.+++.||.||   |+.+++||||||+||+++.++.+||+|||++.      
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            999999998864   345688899999999999999999   78899999999999999999999999998642      


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++||||||+++|||++|..||.............+..                ..
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------~~  254 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ----------------CD  254 (310)
T ss_dssp             --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT----------------TC
T ss_pred             ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc----------------cc
Confidence                               1245678999999999999999999986432211111111110                00


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      . .......++.++.+++.+||+.||++|||++++++.|+++....
T Consensus       255 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          255 Y-PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             S-CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C-CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            0 00111345667899999999999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.1e-38  Score=307.45  Aligned_cols=224  Identities=25%  Similarity=0.331  Sum_probs=181.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ..+++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            34556788999999999999964 78999999997542   234467899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||++ |+|.+.+......+++.....++.++++||.||   |+.+|+||||||+|||++.++.+||+|||++.       
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~  209 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS  209 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence            9997 688888865556789999999999999999999   78899999999999999999999999998652       


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++|||||||++|||++|+.||......+. +......                .  .
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~----------------~--~  270 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN----------------E--S  270 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS----------------C--C
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc----------------C--C
Confidence                             24567889999999999999999999865421110 0001100                0  0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......++..+.+++.+||+.+|++|||++++++
T Consensus       271 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          271 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            01112345667899999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=328.67  Aligned_cols=228  Identities=27%  Similarity=0.424  Sum_probs=187.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+++.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++|||||++++++.+ +..++||||++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            34566789999999999999998888899999986543 34689999999999999999999999876 67899999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|+|.+++... ...+++.....++.+++.||.||   |+++|+||||||+|||++.++.+||+|||++..         
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            99999999753 23578899999999999999999   788999999999999999999999999987531         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ..++.++|||||||++|||+| |+.||......+  ....+.                .+  .
T Consensus       422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~----------------~~--~  481 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVE----------------RG--Y  481 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHH----------------TT--C
T ss_pred             cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----------------cC--C
Confidence                             235678999999999999999 899987542211  111110                00  0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      +.+.+..++.++.+|+.+||+.||++|||++++++.|+++.
T Consensus       482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            11233467788999999999999999999999999998763

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1e-37  Score=300.71  Aligned_cols=234  Identities=24%  Similarity=0.451  Sum_probs=183.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  265 (453)
                      ..+.+.+.||+|+||.||+|.+.    ++..||||.++...  ....+.+.+|+.++++++||||+++++++...+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            34566788999999999999864    34589999997553  344578999999999999999999999998755    


Q ss_pred             -eeEEEEeccCCCCchHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEec
Q 036792          266 -FKALVLEYMPKGSLENCLYS-----STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSD  339 (453)
Q Consensus       266 -~~~lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~d  339 (453)
                       ..++||||+++|+|.+++..     ....+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEEee
Confidence             34999999999999998843     234688999999999999999999   788999999999999999999999999


Q ss_pred             cccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCC
Q 036792          340 FEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPI  391 (453)
Q Consensus       340 f~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  391 (453)
                      ||++..                           ..++.++||||||+++|||++ |..||......+  ......     
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~-----  263 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDYLL-----  263 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHH-----
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHHH-----
Confidence            986521                           234668999999999999999 888986542211  111110     


Q ss_pred             chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       392 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                                . ..  ....+..++.++.+++.+||+.+|++|||+.++++.|+++.+.+.
T Consensus       264 ----------~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          264 ----------H-GH--RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ----------T-TC--CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ----------c-CC--CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                      0 00  111234566789999999999999999999999999999987754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.2e-38  Score=305.15  Aligned_cols=234  Identities=20%  Similarity=0.204  Sum_probs=185.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+|... +++.||||++.....  .+.+.+|+++++++ +||||+++++++..++..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            456788999999999999964 789999999875432  24588999999999 9999999999999999999999999 


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc-----EEEeccccCCC-----
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV-----AHLSDFEYGME-----  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~-----~kl~df~~~~~-----  345 (453)
                      +|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.++.     +||+|||++..     
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            9999999987666789999999999999999999   7889999999999999998887     99999986521     


Q ss_pred             ---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          346 ---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       346 ---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                                                 ..++.++|||||||++|||++|+.||........  .+....        +.+
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~--------i~~  234 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQK--------IGD  234 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHH--------HHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHH--------HHh
Confidence                                       1246689999999999999999999976432211  111110        000


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .....   ........++ ++.+++..||+.+|.+||+++++.+.|+++.+..
T Consensus       235 ~~~~~---~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          235 TKRAT---PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHS---CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhccC---CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            00000   0000112245 8999999999999999999999999999887654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-37  Score=295.06  Aligned_cols=226  Identities=23%  Similarity=0.278  Sum_probs=184.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|++.+.||+|+||.||+|..+ ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            44667889999999999999976 57899999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee---CCCCcEEEeccccCC-------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl---~~~~~~kl~df~~~~-------  344 (453)
                      ++++|.+.+.... .+++.....++.+++.|+.||   |+.+|+||||||+||++   +.++.+||+|||.+.       
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           89 TGGELFERVVHKR-VFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             CSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            9999998886643 578899999999999999999   78899999999999999   778999999998652       


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      .+.++.++||||||+++|||++|+.||......+. ......                ......
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~----------------~~~~~~  227 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIRE----------------GTFTFP  227 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH----------------CCCCCC
T ss_pred             hhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHh----------------CCCCCC
Confidence                            12357789999999999999999999975422111 001100                000001


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......+++++.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111245678999999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.4e-38  Score=299.74  Aligned_cols=239  Identities=21%  Similarity=0.235  Sum_probs=182.9

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++.+.||+|+||.||+|+..+|+.||||+++....  ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence            45678999999999999998899999999975432  2346788999999999999999999999999999999999975


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                       +|.+++......++......++.|+++||.||   |+++|+||||||+||+++.++.+||+|||.+.            
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           85 -DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             -EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             -CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence             99998887666788999999999999999999   78899999999999999999999999997431            


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc---CCchhhh-----hhhhhh
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL---PISLMEV-----VDKTLL  402 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~d~~~~  402 (453)
                                    ...++.++||||+||++|||++|+.||......+. +........   ...+...     .++...
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhcccccccccc
Confidence                          12467889999999999999999999976432221 111111110   0001000     000000


Q ss_pred             cCc-cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGE-KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~-~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ... ..........++++.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000 0001112345677899999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.7e-38  Score=298.13  Aligned_cols=231  Identities=23%  Similarity=0.400  Sum_probs=190.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+++.+.||+|+||.||+|.+. ++..||||.++... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            3456788999999999999987 58899999997543 345789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|+|.+++... ...+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||.+..         
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  169 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  169 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence            99999999763 34588899999999999999999   788999999999999999999999999986521         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ..++.++||||||+++|||++ |..||.......  ....            +....      
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~------------~~~~~------  229 (288)
T 3kfa_A          170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL------------LEKDY------  229 (288)
T ss_dssp             TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH------------HHTTC------
T ss_pred             cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HhccC------
Confidence                             235668999999999999999 999986542211  1111            11110      


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ....+..+++++.+++.+||+.||++|||+.|+++.|+++..+.
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            11123455678999999999999999999999999999887654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.5e-38  Score=303.92  Aligned_cols=220  Identities=22%  Similarity=0.319  Sum_probs=180.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|+.+ +|+.||||+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~   86 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence            345678999999999999976 68999999997652   23456788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.         
T Consensus        87 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           87 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            99999999887543 578888899999999999999   78899999999999999999999999998653         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|+.||.......                 +........    
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----------------~~~~i~~~~----  221 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----------------LFELILMEE----  221 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC----
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-----------------HHHHHHcCC----
Confidence                            1246778999999999999999999996532111                 111111110    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ...+...++++.+++.+||+.||++||     +++|+++
T Consensus       222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            012234567789999999999999999     8888864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-37  Score=295.82  Aligned_cols=240  Identities=20%  Similarity=0.214  Sum_probs=180.3

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||+|+.+ +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence            45678999999999999976 68999999997543  2345778899999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      + ++.+.+......++......++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||.+.           
T Consensus        85 ~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           85 Q-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             E-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            5 67666666556789999999999999999999   78899999999999999999999999998652           


Q ss_pred             --------------C-CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---chhhhh---hhhh--
Q 036792          345 --------------E-GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SLMEVV---DKTL--  401 (453)
Q Consensus       345 --------------~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~---d~~~--  401 (453)
                                    . ..++.++|||||||++|||++|..|+.........+..........   .+....   +...  
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence                          1 1267889999999999999998888533222222222222211110   000000   0000  


Q ss_pred             -hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 -LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 -~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ..............+.++.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence             00000001122345678899999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-37  Score=297.93  Aligned_cols=235  Identities=15%  Similarity=0.125  Sum_probs=187.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||.||+|... +++.||||++....  ..+.+.+|+.+++.+ +|+|++++++++..+...++||||+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            456788999999999999964 78999999986543  224578899999999 7999999999999999999999999 


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc-----EEEeccccCC------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV-----AHLSDFEYGM------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~-----~kl~df~~~~------  344 (453)
                      +|+|.+++......+++.....++.|++.||.||   |+.+|+||||||+||+++.++.     +||+|||.+.      
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            9999999987666789999999999999999999   7889999999999999987765     9999998642      


Q ss_pred             --------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          345 --------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       345 --------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                                                ...++.++|||||||++|||++|+.||........  .....        .+..
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~--------~~~~  235 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYE--------RIGE  235 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHH--------HHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHH--------HHHh
Confidence                                      12346789999999999999999999976422111  11100        0000


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .....   ........+++++.+++.+||+.+|++|||++++++.|+++.+++
T Consensus       236 ~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          236 KKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hccCc---cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            00000   001112245778999999999999999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.2e-38  Score=296.61  Aligned_cols=230  Identities=21%  Similarity=0.381  Sum_probs=186.1

Q ss_pred             HHHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      .+++.+.||+|+||.||+|.+.+    +..||||.++... ....+.+.+|+.++++++||||+++++++.++ ..++||
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~   91 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM   91 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence            35667899999999999998642    3469999998653 34567899999999999999999999998654 568999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++......+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||.+..      
T Consensus        92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            99999999999977666788999999999999999999   788999999999999999999999999986421      


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ..++.++||||||+++|||+| |+.||......+  ....+..                .
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~----------------~  230 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEK----------------G  230 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHH----------------T
T ss_pred             cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhc----------------C
Confidence                                235668999999999999998 999986432221  1111110                0


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .  ..+.+..+++.+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus       231 ~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          231 D--RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            0  0112234567789999999999999999999999999988653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-37  Score=298.96  Aligned_cols=227  Identities=19%  Similarity=0.257  Sum_probs=183.9

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh------hHHHHHHHHHHHHcCCCCCceeEEeEEecCCee
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  267 (453)
                      ...|++.+.||+|+||.||+|... +|+.||||.++.....      ..+.+.+|+.++++++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            355677899999999999999976 6899999999765321      357899999999999999999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC----cEEEeccccC
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM----VAHLSDFEYG  343 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~----~~kl~df~~~  343 (453)
                      ++||||+++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+||+++.++    .+||+|||.+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997643 578889999999999999999   788999999999999999887    7999999865


Q ss_pred             C------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          344 M------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       344 ~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                      .                        ...++.++|||||||++|||++|..||......+     ....            
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~------------  229 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLAN------------  229 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHH------------
T ss_pred             eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH------------
Confidence            2                        1345778999999999999999999996542211     1100            


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ................+..+.+++.+||+.||++|||++|+++
T Consensus       230 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          230 ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000000111122345667899999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=304.99  Aligned_cols=224  Identities=19%  Similarity=0.248  Sum_probs=173.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            3566789999999999999987 58899999997543  33568899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC--------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM--------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~--------  344 (453)
                      +|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.   ++.+||+|||++.        
T Consensus       132 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  207 (349)
T 2w4o_A          132 GGELFDRIVEKG-YYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM  207 (349)
T ss_dssp             SCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence            999999887654 588899999999999999999   7889999999999999975   8899999998642        


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|..||................                .....
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~----------------~~~~~  271 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC----------------EYYFI  271 (349)
T ss_dssp             -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT----------------CCCCC
T ss_pred             ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC----------------CCccC
Confidence                            1246789999999999999999999986542221111111110                00001


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1122345667899999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-38  Score=307.52  Aligned_cols=228  Identities=22%  Similarity=0.407  Sum_probs=181.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCE----EEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIE----VAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +++.+.||+|+||.||+|.+. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++||
T Consensus        15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~   93 (325)
T 3kex_A           15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT   93 (325)
T ss_dssp             EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred             ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence            456788999999999999975 4544    7888775442 223356788999999999999999999986 45678999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..      
T Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            99999999999987656788888999999999999999   788999999999999999999999999986521      


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ..++.++|||||||++|||+| |..||......+  ....+..                
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~----------------  232 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEK----------------  232 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHT----------------
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHc----------------
Confidence                                 235678999999999999999 999997542211  1111110                


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ..  ....+..++.++.+++.+||+.+|++|||++|+++.|+++..
T Consensus       233 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          233 GE--RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TC--BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CC--CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00  111223355568889999999999999999999999988753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-37  Score=303.88  Aligned_cols=227  Identities=20%  Similarity=0.246  Sum_probs=178.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-----ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      ..|++.+.||+|+||.||+|... ++..||||++....     ....+.+.+|++++++++||||+++++++.+++..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            44566889999999999999975 68899999997542     3445789999999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 036792          270 VLEYMPKGSLENCLYSS---------------------------------------TCMLDIFQRLNIMIDATSTLEYLY  310 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~l~~L~  310 (453)
                      ||||+++|+|.+++...                                       ...++......++.++++||.|| 
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-  184 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL-  184 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH-
Confidence            99999999999988521                                       11123455678999999999999 


Q ss_pred             hcCCCCceecCCCCCceeeCCCC--cEEEeccccCC-------------------------------CCCcCcccchHHH
Q 036792          311 FGHTTPIIHCDLKPISVLLDEDM--VAHLSDFEYGM-------------------------------EGQVSTRSDIYGY  357 (453)
Q Consensus       311 ~~h~~~i~Hrdlk~~NiLl~~~~--~~kl~df~~~~-------------------------------~~~~~~~~Dv~S~  357 (453)
                        |+.+|+||||||+||+++.++  .+||+|||.+.                               ...++.++|||||
T Consensus       185 --H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          185 --HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             --HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             --HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence              788999999999999998766  89999998642                               1345678999999


Q ss_pred             HHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          358 GIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       358 Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ||++|||++|+.||......+. .....            .    .......+.....++++.+++.+||+.+|++|||+
T Consensus       263 G~il~el~~g~~pf~~~~~~~~-~~~~~------------~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADT-ISQVL------------N----KKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHH-HHHHH------------H----CCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHCCCCCCCCChHHH-HHHHH------------h----cccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            9999999999999975432211 11111            1    11111112223456789999999999999999999


Q ss_pred             HHHHH
Q 036792          438 KDIVT  442 (453)
Q Consensus       438 ~~v~~  442 (453)
                      .|+++
T Consensus       326 ~~~l~  330 (345)
T 3hko_A          326 MRALQ  330 (345)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            99976

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-37  Score=298.78  Aligned_cols=220  Identities=21%  Similarity=0.306  Sum_probs=180.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+++.+ +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~   87 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   87 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence            455688999999999999976 68999999998653   23456788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.         
T Consensus        88 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~  163 (318)
T 1fot_A           88 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  163 (318)
T ss_dssp             CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence            99999999997654 578888899999999999999   78899999999999999999999999998652         


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++|||||||++|||++|..||......+                 .....+...    ...
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------------~~~~i~~~~----~~~  222 (318)
T 1fot_A          164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----------------TYEKILNAE----LRF  222 (318)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HHHHHHHCC----CCC
T ss_pred             cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhCC----CCC
Confidence                         2346788999999999999999999996532111                 111111110    011


Q ss_pred             hHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      +...+.++.+++.+||+.||++||     +++|+++
T Consensus       223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            233456789999999999999999     8888764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9e-38  Score=295.94  Aligned_cols=231  Identities=24%  Similarity=0.407  Sum_probs=186.7

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ..+++.+.||+|+||.||+|...++..||||.++.... ..+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            34567789999999999999998888999999975532 34789999999999999999999999864 45789999999


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|+|.+++.... ..+++.....++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+..         
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence            999999986532 2578889999999999999999   788999999999999999999999999986521         


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ..++.++||||||+++|||++ |+.||......+  ....+..                ..  
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~----------------~~--  227 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLER----------------GY--  227 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT----------------TC--
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhc----------------cc--
Confidence                             224567999999999999999 899986542211  1111100                00  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ....+..++.++.+++.+||+.+|++|||++++++.|+++....
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            01122345678999999999999999999999999999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=304.95  Aligned_cols=220  Identities=23%  Similarity=0.303  Sum_probs=179.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|+.+ +++.||||+++...   ....+.+.+|..++..+ +||||+++++++.+++..++|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E  104 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME  104 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence            455788999999999999976 68999999998652   23456788999999988 69999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus       105 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          105 FVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence            999999999887643 588889999999999999999   788999999999999999999999999987542       


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++||||+||++|||++|..||......+                 +........   
T Consensus       181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------~~~~i~~~~---  240 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----------------LFEAILNDE---  240 (353)
T ss_dssp             -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC---
T ss_pred             ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHcCC---
Confidence                              125678999999999999999999997542211                 111111111   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCCh------HHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINA------KDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~------~~v~~  442 (453)
                       ...+...+.++.+++.+||+.||++||++      +|+++
T Consensus       241 -~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 -VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence             01122355678999999999999999998      66653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.2e-38  Score=304.30  Aligned_cols=245  Identities=26%  Similarity=0.361  Sum_probs=176.2

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHH--HHcCCCCCceeEEeEEec-----CCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLVKVISSCSN-----DDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|++ +++.||||+++....   ..+..|.++  +..++||||+++++.+..     ....++|
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            45678999999999999987 589999999975432   344444444  455899999999985543     3357899


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CceecCCCCCceeeCCCCcEEEeccc
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT---------PIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~---------~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      |||+++|+|.+++....  .++.....++.++++||.||   |+.         +|+||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYL---HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             ECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHH---HhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            99999999999997654  47888899999999999999   555         99999999999999999999999998


Q ss_pred             cCCC----------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCcc-cccccc
Q 036792          342 YGME----------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRM-FVEELS  380 (453)
Q Consensus       342 ~~~~----------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~-~~~~~~  380 (453)
                      ++..                                        ..++.++|||||||++|||++|..|+... ...+..
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            7621                                        01234689999999999999997765322 111111


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhc-Ccc----CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLS-GEK----KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~-~~~----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      . .+..........+........ ...    ........+++++.+|+.+||+.||++|||++|+++.|+++.+...
T Consensus       246 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          246 M-AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             C-TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             H-hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            1 111111111111111111100 000    0111223577789999999999999999999999999999987544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-37  Score=299.33  Aligned_cols=241  Identities=23%  Similarity=0.283  Sum_probs=170.2

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .|++.+.||+|+||.||+|..+ +|+.||||.++.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            3567889999999999999976 689999999975532 33467889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          275 PKGSLENCLYSS-----TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       275 ~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      + |+|.+++...     ...+++.....++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||.+.     
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            8 5999888542     23578888899999999999999   78899999999999999999999999998642     


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhhhhhh--
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLMEVVDK--  399 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~--  399 (453)
                                           ...++.++|||||||++|||++|+.||......+. +.......  .+......+..  
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhhhhhhh
Confidence                                 12367789999999999999999999976432221 11111110  00000000000  


Q ss_pred             ----hhhcCccC------CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 ----TLLSGEKK------GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ----~~~~~~~~------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          ........      ........+.++.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                00000000      00011134567999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-37  Score=301.75  Aligned_cols=233  Identities=27%  Similarity=0.488  Sum_probs=187.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCE--EEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIE--VAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  270 (453)
                      ..+++.+.||+|+||.||+|+.. ++..  ||||.++... ....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            44567889999999999999865 5654  4999987542 33456789999999999 899999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcE
Q 036792          271 LEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVA  335 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~  335 (453)
                      |||+++|+|.+++....               ..+++.....++.++++||.||   |+.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCccceEEEcCCCeE
Confidence            99999999999987643               4688999999999999999999   78899999999999999999999


Q ss_pred             EEeccccCCC------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcC
Q 036792          336 HLSDFEYGME------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLP  390 (453)
Q Consensus       336 kl~df~~~~~------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  390 (453)
                      ||+|||++..                        ..++.++|||||||++|||+| |..||......+     ....   
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~---  253 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEK---  253 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHH---
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----HHHH---
Confidence            9999986521                        124678999999999999998 999996542211     1110   


Q ss_pred             CchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          391 ISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       391 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                            +..    .  .....+..++.++.+++.+||+.+|++|||++|+++.|+++.++.
T Consensus       254 ------~~~----~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          254 ------LPQ----G--YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             ------GGG----T--CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ------hhc----C--CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence                  000    0  011122345677999999999999999999999999999987653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.6e-38  Score=304.65  Aligned_cols=232  Identities=22%  Similarity=0.368  Sum_probs=187.0

Q ss_pred             HHHhcccCCCCccEEEEEEECC-C-----CEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD-G-----IEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  269 (453)
                      +++.+.||+|+||.||+|.... +     ..||||.++... ....+.+.+|+++++++ +||||+++++++..++..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            4567889999999999999652 3     479999997653 34557899999999999 89999999999999999999


Q ss_pred             EEeccCCCCchHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEE
Q 036792          270 VLEYMPKGSLENCLYSS-------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAH  336 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~k  336 (453)
                      ||||+++|+|.+++...             ...+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCcccceEEECCCCeEE
Confidence            99999999999988642             23578889999999999999999   788999999999999999999999


Q ss_pred             EeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhh
Q 036792          337 LSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNL  388 (453)
Q Consensus       337 l~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~  388 (453)
                      |+|||++..                           ..++.++|||||||++|||+| |..||........ ....+.  
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~--  281 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVK--  281 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHHH--
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHHh--
Confidence            999986531                           235678999999999999999 9999875422211 111111  


Q ss_pred             cCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          389 LPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       389 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                                ...      ....+..++.++.+++.+||+.+|++|||++|+++.|+++..+.
T Consensus       282 ----------~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          282 ----------DGY------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             ----------HTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------cCC------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence                      110      01112334667899999999999999999999999999987654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1e-37  Score=298.98  Aligned_cols=226  Identities=22%  Similarity=0.354  Sum_probs=183.4

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            44677889999999999999986 58999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-----------  343 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-----------  343 (453)
                      ++|+|.+++......+++.....++.+++.||.||   |+.+++||||||+||+++.++.+||+|||++           
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence            99999998876555689999999999999999999   7889999999999999999999999999742           


Q ss_pred             -------------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          344 -------------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       344 -------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                         ....++.++||||||+++|||++|..||........ ......                 .
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----------------~  237 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK-----------------S  237 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH-----------------S
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhc-----------------c
Confidence                               123467789999999999999999999875422110 000000                 0


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......+..++.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11111223455678999999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-37  Score=304.83  Aligned_cols=226  Identities=21%  Similarity=0.250  Sum_probs=177.6

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .|++.+.||+|+||.||+++.+ +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            3567889999999999999977 789999999976533 23668899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc--EEEeccccCCC--------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV--AHLSDFEYGME--------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~--~kl~df~~~~~--------  345 (453)
                      +|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.  +||+|||++..        
T Consensus       100 ~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~  175 (361)
T 3uc3_A          100 GGELYERICNAG-RFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  175 (361)
T ss_dssp             SCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence            999999886543 588899999999999999999   7889999999999999987765  99999986531        


Q ss_pred             ----------------CCcCcc-cchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQVSTR-SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~~~~-~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..++.+ +||||+||++|||++|+.||........ ......            ......  ..
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~------------~~~~~~--~~  240 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQ------------RILSVK--YS  240 (361)
T ss_dssp             -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHH------------HHHTTC--CC
T ss_pred             CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHH------------HHhcCC--CC
Confidence                            123334 8999999999999999999975422211 111111            111000  01


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.....++++.+|+.+||+.+|++|||+.|+++
T Consensus       241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          241 IPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1111234567899999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.5e-37  Score=297.44  Aligned_cols=220  Identities=20%  Similarity=0.275  Sum_probs=174.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----------
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----------  265 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----------  265 (453)
                      |++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+.+          
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            456788999999999999987 79999999997543 335578999999999999999999999986543          


Q ss_pred             -----------------------------------------------eeEEEEeccCCCCchHHhhcCC--CCCCHHHHH
Q 036792          266 -----------------------------------------------FKALVLEYMPKGSLENCLYSST--CMLDIFQRL  296 (453)
Q Consensus       266 -----------------------------------------------~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~  296 (453)
                                                                     ..++||||+++|+|.+++....  ...++....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  167 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL  167 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence                                                           3799999999999999997643  234556678


Q ss_pred             HHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------------------------------
Q 036792          297 NIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------------------------  344 (453)
Q Consensus       297 ~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------------------------------  344 (453)
                      .++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++.                                
T Consensus       168 ~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          168 HIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            9999999999999   78899999999999999999999999998642                                


Q ss_pred             -----CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHH
Q 036792          345 -----EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSI  419 (453)
Q Consensus       345 -----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~  419 (453)
                           ...++.++|||||||++|||++|..|+...    .......               . ..  .........++++
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~~~~---------------~-~~--~~~~~~~~~~~~~  302 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRIITDV---------------R-NL--KFPLLFTQKYPQE  302 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHHHHH---------------H-TT--CCCHHHHHHCHHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHHHHh---------------h-cc--CCCcccccCChhH
Confidence                 124577899999999999999987774211    0000000               0 00  1122334556778


Q ss_pred             HHHhhhccccCcccCCChHHHHH
Q 036792          420 LGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       420 ~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+++.+||+.||++|||++|+++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            99999999999999999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=303.85  Aligned_cols=228  Identities=21%  Similarity=0.395  Sum_probs=184.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCE----EEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIE----VAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      |++.+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++..+. .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~   95 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence            456789999999999999965 4544    577777543 2345678999999999999999999999998765 78999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..      
T Consensus        96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            99999999999988766789999999999999999999   788999999999999999999999999986521      


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ..++.++|||||||++|||++ |..||......+  ....+            ....  
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~------------~~~~--  236 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL------------EKGE--  236 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH------------HTTC--
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH------------HcCC--
Confidence                                 235678999999999999999 999997543221  11111            1110  


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                          ..+.+..++.++.+++.+||+.||++|||++|+++.|+++..
T Consensus       237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                111233466779999999999999999999999999998864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.1e-38  Score=296.57  Aligned_cols=228  Identities=30%  Similarity=0.455  Sum_probs=183.3

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-CeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSND-DFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~E~~~  275 (453)
                      .+++.+.||+|+||.||+|.++ |+.||||.++...  ..+.+.+|++++++++||||+++++++... +..++||||++
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            3566789999999999999875 8899999997543  456789999999999999999999987654 47899999999


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      +|+|.+++.... ..+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||++..         
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  175 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK  175 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCCcEEEeeccccccccccccCCC
Confidence            999999986542 2367888899999999999999   788999999999999999999999999986521         


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ..++.++||||||+++|||+| |..||......+  ....+            .    ..  .....
T Consensus       176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~------------~----~~--~~~~~  235 (278)
T 1byg_A          176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV------------E----KG--YKMDA  235 (278)
T ss_dssp             CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH------------T----TT--CCCCC
T ss_pred             ccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH------------h----cC--CCCCC
Confidence                         235778999999999999998 999987542211  11100            0    00  01122


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      +..+++++.+++.+||+.||++|||+.|+++.|++++..
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            345677899999999999999999999999999999764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-37  Score=326.79  Aligned_cols=225  Identities=24%  Similarity=0.382  Sum_probs=185.4

Q ss_pred             cccCCCCccEEEEEEEC---CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLR---DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|.+.   +++.||||+++....  ...+++.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   468899999986532  346789999999999999999999999975 457899999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.            
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997643 588999999999999999999   78899999999999999999999999997541            


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      ...++.++|||||||++|||++ |+.||......+  ...            .+..    +.  
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~------------~i~~----~~--  589 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTA------------MLEK----GE--  589 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH------------HHHT----TC--
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------------HHHc----CC--
Confidence                            1246778999999999999999 999997543221  111            1111    10  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ....+..++.++.+|+..||+.||++||+++++++.|+++..++
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            11233467788999999999999999999999999999987665

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.1e-38  Score=303.37  Aligned_cols=230  Identities=21%  Similarity=0.341  Sum_probs=180.6

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe----eE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF----KA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~  268 (453)
                      .|++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|++++++++||||+++++++.....    .+
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            3567789999999999999974 78999999997653   2345678999999999999999999999876543    49


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++.    
T Consensus        93 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            9999999999999987643 588899999999999999999   78899999999999999999999999998652    


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ...++.++|||||||++|||++|+.||......+.... .                
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-~----------------  231 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-H----------------  231 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-H----------------
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-H----------------
Confidence                                    12456789999999999999999999975432211111 0                


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHH-HHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV-TRLLKI  447 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~-~~L~~i  447 (453)
                      ..............++.++.+++.+||+.||++||++.+++ ..+.++
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          232 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             hcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            11111011111234567899999999999999999665544 555544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-37  Score=300.63  Aligned_cols=232  Identities=21%  Similarity=0.368  Sum_probs=186.0

Q ss_pred             HHHhcccCCCCccEEEEEEE------CCCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC-eeE
Q 036792          198 RRLSNLIGMGSFGSVYRARL------RDGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD-FKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~  268 (453)
                      +++.+.||+|+||.||+|.+      .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+ ..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            45678999999999999984      246899999997653 34456889999999999 7999999999987754 589


Q ss_pred             EEEeccCCCCchHHhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          269 LVLEYMPKGSLENCLYSSTCM---------------LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~---------------l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                      +||||+++|+|.+++......               +++.....++.++++||.||   |+.+|+||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCC
Confidence            999999999999999765422               77888999999999999999   788999999999999999999


Q ss_pred             cEEEeccccCCC---------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHH
Q 036792          334 VAHLSDFEYGME---------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWV  385 (453)
Q Consensus       334 ~~kl~df~~~~~---------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~  385 (453)
                      .+||+|||.+..                           ..++.++|||||||++|||+| |..||......+.......
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~  265 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  265 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence            999999986531                           235668999999999999998 9999875432221111111


Q ss_pred             hhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          386 NNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       386 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .                 ..  ....+..+++++.+++.+||+.+|++|||+.|+++.|+++.+.-
T Consensus       266 ~-----------------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          266 E-----------------GT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             H-----------------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             c-----------------Cc--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            0                 00  01122335667899999999999999999999999999987653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.4e-37  Score=298.60  Aligned_cols=238  Identities=24%  Similarity=0.346  Sum_probs=185.0

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHc--CCCCCceeEEeEEecCC----eeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKS--IRHPNLVKVISSCSNDD----FKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~  271 (453)
                      +++.+.||+|+||.||+|.+ +++.||||++...   ....+.+|.+++..  ++||||+++++++...+    ..++||
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           44 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             EEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            45678899999999999998 4899999999654   23567788888877  78999999999998876    789999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCceeeCCCCcEEEeccccCCC-
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-----GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~-----~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-  345 (453)
                      ||+++|+|.+++...  .+++.....++.+++.|+.|||.     .++.+|+||||||+||+++.++.+||+|||++.. 
T Consensus       120 e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  197 (342)
T 1b6c_B          120 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  197 (342)
T ss_dssp             CCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred             eecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence            999999999999764  47889999999999999999952     1278999999999999999999999999986510 


Q ss_pred             ----------------------------C------CcCcccchHHHHHHHHHHHhC----------CCCCCccccccccH
Q 036792          346 ----------------------------G------QVSTRSDIYGYGIVLMETFTR----------KKPTDRMFVEELSL  381 (453)
Q Consensus       346 ----------------------------~------~~~~~~Dv~S~Gvvl~el~tg----------~~p~~~~~~~~~~~  381 (453)
                                                  .      .++.++|||||||++|||+||          ..||......+...
T Consensus       198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  277 (342)
T 1b6c_B          198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  277 (342)
T ss_dssp             ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence                                        0      112579999999999999999          66775443333222


Q ss_pred             HhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       382 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ..+.......        ... ...+.......++..+.+|+.+||+.||++|||++|+++.|+++.++
T Consensus       278 ~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          278 EEMRKVVCEQ--------KLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHTTS--------CCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHH--------HhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            2222211110        000 00001112346788899999999999999999999999999999765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-37  Score=299.75  Aligned_cols=224  Identities=19%  Similarity=0.245  Sum_probs=175.4

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      .+.||+|+||.||+|.++ +++.||||++...   ....+.+|+.+++.++ ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            367999999999999976 6899999999754   3356788999999997 9999999999999999999999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC---cEEEeccccCC-----------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM---VAHLSDFEYGM-----------  344 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~df~~~~-----------  344 (453)
                      |.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++   .+||+|||++.           
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  168 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT  168 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccc
Confidence            999997754 688999999999999999999   788999999999999997655   89999998652           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|..||........          .....++..............
T Consensus       169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHHHHHHHHHcCCCCCCcc
Confidence                          12457789999999999999999999975422110          001111121111111111122


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                      ....+++++.+|+.+||+.||++|||++|++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            2345678899999999999999999999876

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-37  Score=294.12  Aligned_cols=228  Identities=24%  Similarity=0.332  Sum_probs=182.2

Q ss_pred             HHHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          194 QATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       194 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ....+.+.+.||+|+||.||++..+ ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3455677899999999999999976 68999999997654 334578999999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee---CCCCcEEEeccccCCC
Q 036792          272 EYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDFEYGME  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl---~~~~~~kl~df~~~~~  345 (453)
                      ||+++|+|.+.+...   ...+++.....++.+++.||.||   |+.+|+||||||+||++   +.++.+||+|||.+..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999988542   34688899999999999999999   78899999999999999   4567899999987631


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                             ..++.++||||||+++|||++|+.||......+..  .......+            
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~------------  242 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKATYKEP------------  242 (285)
T ss_dssp             ----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCC------------
T ss_pred             cCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhhccCCc------------
Confidence                                   23567899999999999999999999754322111  11100000            


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          .........++++.+++.+||+.||++|||+.|+++
T Consensus       243 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 ----NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                000011123567889999999999999999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.1e-38  Score=302.13  Aligned_cols=229  Identities=23%  Similarity=0.387  Sum_probs=185.6

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      ..+++.+.||+|+||.||+|.+.      +++.||||.+.... ......+.+|++++++++||||+++++++.+++..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            34567789999999999999864      36889999997553 344567899999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEec
Q 036792          269 LVLEYMPKGSLENCLYSST---------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSD  339 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~d  339 (453)
                      +||||+++|+|.+++....         ..+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCCccceEEEcCCCeEEECc
Confidence            9999999999999886421         3567889999999999999999   788999999999999999999999999


Q ss_pred             cccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCC
Q 036792          340 FEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPI  391 (453)
Q Consensus       340 f~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  391 (453)
                      ||.+.                           ...++.++|||||||++|||++ |..||......+  ....+.     
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~-----  254 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVM-----  254 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHH-----
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHHHHH-----
Confidence            98652                           1235678999999999999999 889986542211  111110     


Q ss_pred             chhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          392 SLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       392 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                            .     ..  ....+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       255 ------~-----~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          255 ------E-----GG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             ------T-----TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ------c-----CC--cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence                  0     00  0112235567789999999999999999999999999765

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.7e-37  Score=290.02  Aligned_cols=232  Identities=19%  Similarity=0.267  Sum_probs=185.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      .|++.+.||+|+||.||+|+.. +++.||||.++....      ...+.+.+|++++++++||||+++++++..++..++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            3556788999999999999987 689999999975532      135789999999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC----cEEEeccccCC-
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM----VAHLSDFEYGM-  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~----~~kl~df~~~~-  344 (453)
                      ||||+++++|.+++.... .+++.....++.+++.||.||   |+.+++||||||+||+++.++    .+||+|||.+. 
T Consensus        86 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            999999999999986543 578999999999999999999   788999999999999998876    89999998652 


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ...++.++||||||+++|||++|..||......+. .....                
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----------------  224 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNIS----------------  224 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH----------------
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhH----------------
Confidence                                   13457789999999999999999999975422110 00000                


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH--HHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT--RLLKIRD  449 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~  449 (453)
                      ..............+..+.+++.+||+.||++|||+.|+++  .+++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          225 AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            00000111122345667899999999999999999999986  4555544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4e-37  Score=292.15  Aligned_cols=224  Identities=21%  Similarity=0.329  Sum_probs=180.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||.||+|..+ +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   87 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   87 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence            456788999999999999976 68999999997653  344577889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc---EEEeccccCC-------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV---AHLSDFEYGM-------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~---~kl~df~~~~-------  344 (453)
                      ++|+|.+.+.... .++......++.+++.|+.||   |+.+|+||||||+||+++.++.   +||+|||.+.       
T Consensus        88 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           88 TGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            9999988886543 578899999999999999999   7889999999999999986654   9999998651       


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++||||||+++|||++|..||.......  ....+.               ......
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~---------------~~~~~~  226 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIK---------------AGAYDY  226 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---------------HTCCCC
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHHH---------------hccccC
Confidence                             1235778999999999999999999986542211  110000               000000


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+....+++++.+++.+||+.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11122345677899999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=298.69  Aligned_cols=220  Identities=19%  Similarity=0.210  Sum_probs=175.6

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+++.+.||+|+||+||+|+.. +|+.||||++....  ......+..|+..+.++ +||||++++++|.+++..++|||
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e  137 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE  137 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence            3456788999999999999987 79999999986542  23334555666665554 89999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+ +|+|.+++......+++..+..++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.        
T Consensus       138 ~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             CC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence            99 6799998877666799999999999999999999   77899999999999999999999999998642        


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     .+.++.++|||||||++|||++|..|+....    ........                  ....
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~------------------~~~~  271 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQG------------------YLPP  271 (311)
T ss_dssp             -CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTT------------------CCCH
T ss_pred             cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhcc------------------CCCc
Confidence                           1246778999999999999999977654220    11111000                  0011


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+..+++++.+++.+||+.||++|||++|+++
T Consensus       272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            223445678999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=304.82  Aligned_cols=223  Identities=21%  Similarity=0.290  Sum_probs=180.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .|++.+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+++|+.++|||||++++++.+.+..++|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            3566789999999999999976 68999999997543   2345678899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.        
T Consensus        96 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           96 LLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             CCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence            999999999987643 588889999999999999999   78899999999999999999999999998642        


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++|||||||++|||++|+.||.......  ......            .....  
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~------------~~~~~--  235 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVH------------TFETT--  235 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHH------------HHHHC--
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHH------------HHhhc--
Confidence                               1236778999999999999999999996432211  111111            00000  


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCC-hHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRIN-AKDIV  441 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~~v~  441 (453)
                        ....+..++.++.+|+.+||+.||++||+ ++++.
T Consensus       236 --~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          236 --VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             --ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence              01122345678999999999999999998 66654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=310.08  Aligned_cols=249  Identities=20%  Similarity=0.259  Sum_probs=189.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC--eeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD--FKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++||||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            456789999999999999976 58999999997653 344577889999999999999999999998755  77999999


Q ss_pred             cCCCCchHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee----CCCCcEEEeccccCCC--
Q 036792          274 MPKGSLENCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDFEYGME--  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl----~~~~~~kl~df~~~~~--  345 (453)
                      +++|+|.+++....  ..+++.....++.+++.||.||   |+.+|+||||||+|||+    +.++.+||+|||++..  
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            99999999987642  2388999999999999999999   78899999999999999    7778899999986521  


Q ss_pred             ------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHH---hHHhhhcCCc
Q 036792          346 ------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLK---DWVNNLLPIS  392 (453)
Q Consensus       346 ------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~  392 (453)
                                                    ..++.++|||||||++|||++|+.||...........   .......+..
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~  247 (396)
T 4eut_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA  247 (396)
T ss_dssp             CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred             CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence                                          1234578999999999999999999864322221111   1111111111


Q ss_pred             hhhh---hhhhh--hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          393 LMEV---VDKTL--LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       393 ~~~~---~d~~~--~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +...   .+...  ..............+..+.+++.+||+.||++||+++|+++.++++.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            1000   00000  000011122346778889999999999999999999999999988754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-37  Score=296.20  Aligned_cols=230  Identities=20%  Similarity=0.248  Sum_probs=185.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|... +++.||||++.....   ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL  115 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence            466789999999999999976 689999999975532   3347789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++++|.+++.... .+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||++.         
T Consensus       116 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          116 INGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             CCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            99999999987643 588899999999999999999   78899999999999999999999999998542         


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++||||||+++|||++|+.||......  .+...+..                ....
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~----------------~~~~  253 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQ----------------AIPR  253 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHS----------------CCCC
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhcc----------------CCCC
Confidence                             123567899999999999999999999754221  11111110                0000


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCC-ChHHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRI-NAKDIVTRLLKIRD  449 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~  449 (453)
                      ....+..++.++.+++.+||+.||++|| +++++++.|+++.+
T Consensus       254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            1112345566789999999999999999 99999999987643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.4e-38  Score=303.74  Aligned_cols=219  Identities=24%  Similarity=0.353  Sum_probs=178.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|.+. +++.||||++.....   ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            566789999999999999975 789999999975432   2245789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      + +|+|.+++.... .+++.....++.|++.|+.||   |+.+|+||||||+|||++.++.+||+|||++..        
T Consensus        91 ~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           91 A-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             C-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             C-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            9 789988886543 588899999999999999999   788999999999999999999999999986521        


Q ss_pred             ----------------CCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ..+ +.++|||||||++|||++|+.||+.......                 ... +...   .
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~-i~~~---~  224 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKK-VNSC---V  224 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCC-CCSS---C
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHH-HHcC---C
Confidence                            112 5689999999999999999999965422111                 000 0000   1


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1123345667899999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3e-37  Score=302.05  Aligned_cols=221  Identities=19%  Similarity=0.252  Sum_probs=181.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+++.+.||+|+||.||+++.+ +|+.||||+++...   ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            3566789999999999999976 68999999997653   2345678899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.        
T Consensus       122 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~  197 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT  197 (350)
T ss_dssp             CCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCEEEcccccceeccCCccc
Confidence            999999999987643 578889999999999999999   78899999999999999999999999998652        


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||++|..||......+                 +........    ..
T Consensus       198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----------------~~~~i~~~~----~~  256 (350)
T 1rdq_E          198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----------------IYEKIVSGK----VR  256 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC----CC
T ss_pred             ccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-----------------HHHHHHcCC----CC
Confidence                          2346788999999999999999999996532111                 111111110    01


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      .+...+.++.+++.+||+.||++||+     ++|+.+
T Consensus       257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            22345677899999999999999998     787764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=292.36  Aligned_cols=221  Identities=21%  Similarity=0.394  Sum_probs=179.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|+.. +|+.||||.+.....   ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM   92 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence            456788999999999999975 789999999975432   2346789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++++|.+++......+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||.+..        
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            999999999987666789999999999999999999   788999999999999999999999999986421        


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                       ..++.++||||||+++|||++|+.||......+.                 ........    
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~----  228 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------LNKVVLAD----  228 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCSSC----
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------HHHHhhcc----
Confidence                             2346689999999999999999999875422111                 00000000    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1112234567899999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-37  Score=304.23  Aligned_cols=219  Identities=22%  Similarity=0.331  Sum_probs=178.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|+.+ +|+.||||+++...   ....+.+..|..++..+ +||||+++++++.+++..++|||
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E   98 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   98 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            456788999999999999986 68999999998653   23456778899998876 89999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus        99 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A           99 YLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            999999999987643 578889999999999999999   788999999999999999999999999986531       


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++||||+||++|||++|..||......+                 +........   
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----------------~~~~i~~~~---  234 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----------------LFHSIRMDN---  234 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC---
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHHhCC---
Confidence                              235778999999999999999999997542211                 111111110   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChH-HHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAK-DIV  441 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-~v~  441 (453)
                       ...+...+.++.+++.+||+.||++||++. |+.
T Consensus       235 -~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 -PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence             011233566789999999999999999987 554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-37  Score=312.51  Aligned_cols=221  Identities=26%  Similarity=0.397  Sum_probs=181.7

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .|.+.+.||+|+||.||+|++. +|+.||||+++....   ...+.+.+|+++|+.++||||+++++++.+++..++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3567789999999999999976 799999999976532   335678999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++.... .++......++.|++.|+.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus        97 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           97 YVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             CCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            999999999987643 588999999999999999999   788999999999999999999999999986521       


Q ss_pred             -----------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       .. .+.++||||+||++|||++|..||+......     ...        .+.+     +.  
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----~~~--------~i~~-----~~--  232 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-----LFK--------KICD-----GI--  232 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-----HHH--------HHHT-----TC--
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-----HHH--------HHhc-----CC--
Confidence                             11 2568999999999999999999997542211     110        0000     00  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       233 -~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 -FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence             0112334567899999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-37  Score=293.17  Aligned_cols=228  Identities=24%  Similarity=0.375  Sum_probs=183.0

Q ss_pred             HHHhc-ccCCCCccEEEEEEEC---CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSN-LIGMGSFGSVYRARLR---DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +++.+ .||+|+||.||+|.+.   +++.||||+++...  ....+++.+|+++++.++||||+++++++ ..+..++||
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            34455 8999999999999643   46899999997653  23357899999999999999999999999 566788999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME------  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~------  345 (453)
                      ||+++|+|.+++.... .+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||++..      
T Consensus        97 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           97 EMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             ECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            9999999999997653 588899999999999999999   788999999999999999999999999986521      


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            ..++.++||||||+++|||++ |+.||......+  ....+..               
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~---------------  235 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK---------------  235 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT---------------
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHc---------------
Confidence                                  123557999999999999999 999987542211  1111110               


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                       ..  ....+..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus       236 -~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          236 -GE--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             -TC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -CC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             00  1112345677899999999999999999999999999998654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.2e-37  Score=299.27  Aligned_cols=221  Identities=21%  Similarity=0.292  Sum_probs=173.1

Q ss_pred             HHHHhcccCCCCccEEEEEEE----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQEC----ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      .+++.+.||+|+||.||+++.    .+++.||+|+++...    ......+.+|+++|+.++||||+++++++..++..+
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            356778999999999999987    368999999997652    233456789999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.    
T Consensus        98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           98 LILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            9999999999999887543 577888889999999999999   78899999999999999999999999998642    


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ...++.++|||||||++|||++|+.||......+                 .++.....
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~~~~i~~~  236 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----------------TIDKILKC  236 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----------------HHHHHHHT
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----------------HHHHHHhC
Confidence                                 1235678999999999999999999997542211                 01111110


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      .    ...+...+.++.+++.+||+.||++||     +++|+++
T Consensus       237 ~----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 K----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             C----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             C----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            0    011234566789999999999999999     6667654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.4e-37  Score=312.39  Aligned_cols=225  Identities=16%  Similarity=0.203  Sum_probs=179.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.++||+|+||.||+|+++ +++.||||++++...   ...+.+.+|..++..++||||++++++|.+++..++|||||
T Consensus        77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~  156 (437)
T 4aw2_A           77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY  156 (437)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence            34678999999999999987 588999999975422   22234889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.          
T Consensus       157 ~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~  233 (437)
T 4aw2_A          157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  233 (437)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence            99999999987656789999999999999999999   78899999999999999999999999998651          


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                           ...++.++|||||||++|||++|+.||......+. ..            .++..... 
T Consensus       234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~------------~i~~~~~~-  299 (437)
T 4aw2_A          234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YG------------KIMNHKER-  299 (437)
T ss_dssp             CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH------------HHHTHHHH-
T ss_pred             ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HH------------hhhhcccc-
Confidence                                 12356789999999999999999999975422111 00            01110000 


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCccc--CCChHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEK--RINAKDIVT  442 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~~v~~  442 (453)
                      .  ..+......++++.+|+.+|+..+|++  ||+++|+++
T Consensus       300 ~--~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          300 F--QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             C--CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             c--cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0  000111235667899999999988888  999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=299.89  Aligned_cols=226  Identities=23%  Similarity=0.292  Sum_probs=179.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEe--------cCCee
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCS--------NDDFK  267 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--------~~~~~  267 (453)
                      +++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.++.++. ||||+++++++.        .....
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            466789999999999999976 68999999997766666778999999999996 999999999984        34457


Q ss_pred             EEEEeccCCCCchHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceeeCCCCcEEEeccccC
Q 036792          268 ALVLEYMPKGSLENCLYS--STCMLDIFQRLNIMIDATSTLEYLYFGHTTP--IIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~--i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      ++||||+. |+|.+++..  ....+++.....++.+++.||.||   |+.+  |+||||||+|||++.++.+||+|||.+
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence            99999995 799988864  344689999999999999999999   6777  999999999999999999999999865


Q ss_pred             C----------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHh
Q 036792          344 M----------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKD  383 (453)
Q Consensus       344 ~----------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~  383 (453)
                      .                                        ...++.++|||||||++|||++|+.||.......     
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----  260 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----  260 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence            2                                        1224568999999999999999999986432111     


Q ss_pred             HHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          384 WVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       384 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ..            .....      .+....++..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus       261 ~~------------~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          261 IV------------NGKYS------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             -----------------CC------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hh------------cCccc------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            00            00000      001122234578899999999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.3e-37  Score=307.04  Aligned_cols=224  Identities=21%  Similarity=0.265  Sum_probs=175.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|+.+ +++.||||++++...   ...+.+.+|..++.++ +|||||++++++.+++..++|||
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E  133 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE  133 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence            456789999999999999977 588999999986532   2234578899999876 89999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|..++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus       134 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          134 YVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence            999999999887643 588899999999999999999   788999999999999999999999999987531       


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++|||||||++|||++|+.||......+....         ...+.+...+...   
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---------~~~~~~~~~i~~~---  277 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------NTEDYLFQVILEK---  277 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHHHHHHHHHHC---
T ss_pred             cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---------hhHHHHHHHHhcc---
Confidence                              2457789999999999999999999964321111000         0001011111111   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ....+...+.++.+|+.+||+.||++||++
T Consensus       278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            111233456788999999999999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=296.05  Aligned_cols=221  Identities=24%  Similarity=0.298  Sum_probs=171.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--------------------------hhHHHHHHHHHHHHcCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--------------------------RALKSFEAQCEVMKSIR  250 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~  250 (453)
                      |++.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|++++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            456788999999999999976 689999999975431                          11356889999999999


Q ss_pred             CCCceeEEeEEec--CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCcee
Q 036792          251 HPNLVKVISSCSN--DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVL  328 (453)
Q Consensus       251 H~niv~l~g~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiL  328 (453)
                      ||||+++++++.+  .+..++||||+++|+|.+++..  ..+++.....++.|+++||.||   |+.+|+||||||+||+
T Consensus        95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYL---HYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred             CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEE
Confidence            9999999999987  5688999999999999876543  3588999999999999999999   7889999999999999


Q ss_pred             eCCCCcEEEeccccCCC-------------------------CC---cCcccchHHHHHHHHHHHhCCCCCCcccccccc
Q 036792          329 LDEDMVAHLSDFEYGME-------------------------GQ---VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELS  380 (453)
Q Consensus       329 l~~~~~~kl~df~~~~~-------------------------~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~  380 (453)
                      ++.++.+||+|||++..                         ..   ++.++|||||||++|||++|+.||......   
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---  246 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM---  246 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH---
Confidence            99999999999986521                         01   245689999999999999999999653211   


Q ss_pred             HHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          381 LKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       381 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .+...         +..    .. ...+....+++++.+++.+||+.||++|||++|+++
T Consensus       247 --~~~~~---------~~~----~~-~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          247 --CLHSK---------IKS----QA-LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             --HHHHH---------HHH----CC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --HHHHH---------Hhc----cc-CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence              11100         000    00 001111234567899999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.6e-37  Score=294.61  Aligned_cols=238  Identities=22%  Similarity=0.283  Sum_probs=181.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD   85 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence            45678999999999999976 589999999865532  335678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++... ..+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||.+.           
T Consensus        86 ~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           86 HTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             EEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             CchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            99998877654 3588899999999999999999   78899999999999999999999999998652           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---chhhhhhh-hhhcCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SLMEVVDK-TLLSGE  405 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~-~~~~~~  405 (453)
                                     ...++.++|||||||++|||++|+.||......+..  ..+......   ........ ......
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL--YLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhcccccccccccccccccccC
Confidence                           134578899999999999999999999764332211  111111000   00000000 000000


Q ss_pred             c--------CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 K--------KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~--------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .        .........+.++.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0        000011245677899999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.5e-37  Score=291.34  Aligned_cols=223  Identities=22%  Similarity=0.344  Sum_probs=178.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec----CCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN----DDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|... ++..||+|.+....  ....+.+.+|+.++++++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            456778999999999999976 68899999997553  3456789999999999999999999998865    4568999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceeeC-CCCcEEEeccccCC---
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP--IIHCDLKPISVLLD-EDMVAHLSDFEYGM---  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~--i~Hrdlk~~NiLl~-~~~~~kl~df~~~~---  344 (453)
                      |||+++|+|.+++.... .+++.....++.+++.||.||   |+.+  ++||||||+||+++ .++.+||+|||++.   
T Consensus       108 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            99999999999997643 578889999999999999999   6766  99999999999998 78899999998652   


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         .+.++.++||||+||++|||++|+.||........    .......             . 
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~-------------~-  245 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTS-------------G-  245 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTT-------------T-
T ss_pred             ccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----HHHHHhc-------------c-
Confidence                               12457789999999999999999999965322111    1110000             0 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......+...++++.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0011223334567899999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.4e-37  Score=292.87  Aligned_cols=221  Identities=17%  Similarity=0.279  Sum_probs=174.9

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHH-HcCCCCCceeEEeEEec----CCeeEEEEecc
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVM-KSIRHPNLVKVISSCSN----DDFKALVLEYM  274 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lv~E~~  274 (453)
                      .+.||+|+||.||+|... +++.||||+++..     ..+.+|++++ +..+||||+++++++..    ....++||||+
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~   97 (299)
T 3m2w_A           23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   97 (299)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             CcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence            377999999999999975 6899999999643     4567788887 66799999999999876    67789999999


Q ss_pred             CCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccC---CCCC
Q 036792          275 PKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYG---MEGQ  347 (453)
Q Consensus       275 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~---~~~~  347 (453)
                      ++|+|.+++.... ..+++.....++.+++.||.||   |+.+|+||||||+||+++.   ++.+||+|||++   ....
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (299)
T 3m2w_A           98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK  174 (299)
T ss_dssp             CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCG
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccccc
Confidence            9999999997653 3688999999999999999999   7889999999999999998   789999999986   3467


Q ss_pred             cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhcc
Q 036792          348 VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECA  427 (453)
Q Consensus       348 ~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  427 (453)
                      ++.++|||||||++|||++|..||.........         . ..   .............+....++.++.+++.+||
T Consensus       175 ~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (299)
T 3m2w_A          175 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------P-GM---KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL  241 (299)
T ss_dssp             GGGHHHHHHHHHHHHHHHHSSCSCCC----------------C-CS---CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHT
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------H-HH---HHHHhhccccCCchhcccCCHHHHHHHHHHc
Confidence            889999999999999999999999654221100         0 00   0000000000111122346778999999999


Q ss_pred             ccCcccCCChHHHHH
Q 036792          428 MELPEKRINAKDIVT  442 (453)
Q Consensus       428 ~~~P~~RPs~~~v~~  442 (453)
                      +.||++|||+.|+++
T Consensus       242 ~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          242 KTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSTTTSCCHHHHHT
T ss_pred             ccChhhCCCHHHHhc
Confidence            999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-37  Score=300.92  Aligned_cols=221  Identities=19%  Similarity=0.309  Sum_probs=176.9

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCC--CCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRH--PNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||++...+++.||||++....  ....+.+.+|+++|.+++|  |||+++++++..++..++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            45678899999999999998889999999997543  3445788999999999986  999999999999999999999 


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +.+|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++ ++.+||+|||++..        
T Consensus        90 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           90 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence            45889999998754 678889999999999999999   788999999999999997 57899999986521        


Q ss_pred             ------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          346 ------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       346 ------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                                                    ..++.++|||||||++|||++|+.||.........+.            .
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------------~  232 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------------A  232 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH------------H
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH------------H
Confidence                                          2346679999999999999999999965322111111            1


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .++...      ....+..++.++.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          233 IIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhcCCc------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            111111      01112233457889999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.6e-37  Score=300.96  Aligned_cols=224  Identities=21%  Similarity=0.250  Sum_probs=176.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|+.+ +++.||||+++...   ....+.+.+|..++.++ +||||+++++++.+++..++|||
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e   90 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   90 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence            456788999999999999986 68999999998653   23456788999999987 89999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus        91 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           91 YVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            999999999887643 578889999999999999999   788999999999999999999999999986531       


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++|||||||++|||++|+.||......+....        .....+...... ..  
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~~~i~~-~~--  235 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVILE-KQ--  235 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHHH-CC--
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------ccHHHHHHHHHc-CC--
Confidence                              2456789999999999999999999964321110000        000001111111 10  


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                       ...+...+.++.+++.+||+.||++||++
T Consensus       236 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence             11223456778999999999999999996

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.7e-37  Score=312.21  Aligned_cols=227  Identities=21%  Similarity=0.304  Sum_probs=183.9

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ...|++.+.||+|+||.||+|..+ +++.||||++....  ......+.+|+++|++++|||||++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            355677899999999999999976 78999999997542  234578899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC---CCCcEEEeccccCCC---
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDFEYGME---  345 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~---~~~~~kl~df~~~~~---  345 (453)
                      ||+++|+|.+.+.... .++......++.+++.||.||   |+.+|+||||||+|||++   .++.+||+|||++..   
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999998886543 588899999999999999999   788999999999999995   456899999986531   


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                          +.++.++||||+||++|||++|.+||......+                 ++........
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------------~~~~i~~~~~  239 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----------------ILKRVETGKY  239 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHTCC
T ss_pred             CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhCCC
Confidence                                235678999999999999999999997542211                 1111111111


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+....+++++.+++.+||+.+|++|||+.|+++
T Consensus       240 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1112223456678999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.6e-37  Score=291.04  Aligned_cols=220  Identities=23%  Similarity=0.324  Sum_probs=176.3

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCCch
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLE  280 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~L~  280 (453)
                      ..||+|+||.||+|... +++.||||.++.......+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            47999999999999975 68999999998766666678999999999999999999999999999999999999999999


Q ss_pred             HHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC------------
Q 036792          281 NCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME------------  345 (453)
Q Consensus       281 ~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~------------  345 (453)
                      +++....  ..+++.....++.++++||.||   |+.+++||||||+||+++. ++.+||+|||.+..            
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  184 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT  184 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccC
Confidence            9997653  2456778888999999999999   7889999999999999987 89999999986521            


Q ss_pred             ---------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          346 ---------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       346 ---------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                     ..++.++||||||+++|||++|+.||.............               .....   ...
T Consensus       185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------------~~~~~---~~~  246 (295)
T 2clq_A          185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---------------GMFKV---HPE  246 (295)
T ss_dssp             CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---------------HHHCC---CCC
T ss_pred             CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---------------ccccc---ccc
Confidence                           115678999999999999999999986432111100000               00000   111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+..++.++.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22345678899999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-37  Score=310.40  Aligned_cols=222  Identities=20%  Similarity=0.263  Sum_probs=177.6

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|+.+ +++.||+|++++...   ...+.+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  151 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  151 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            44678999999999999987 589999999975421   22345789999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++|+|.+++...  .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..         
T Consensus       152 ~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~  226 (410)
T 3v8s_A          152 PGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC  226 (410)
T ss_dssp             TTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence            999999998764  478888889999999999999   788999999999999999999999999987521         


Q ss_pred             -----------------C----CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 -----------------G----QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 -----------------~----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                       .    .++.++|||||||++|||++|+.||......+. ..            .+......  
T Consensus       227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~------------~i~~~~~~--  291 (410)
T 3v8s_A          227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YS------------KIMNHKNS--  291 (410)
T ss_dssp             CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH------------HHHTHHHH--
T ss_pred             cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HH------------HHHhcccc--
Confidence                             0    156789999999999999999999975422111 01            11110000  


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCccc--CCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEK--RINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~~v~~  442 (453)
                        ...+.....+.++.+|+.+||..+|.+  ||+++||++
T Consensus       292 --~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          292 --LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             --CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             --ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence              011111235667899999999999998  999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.5e-37  Score=313.05  Aligned_cols=227  Identities=23%  Similarity=0.326  Sum_probs=184.9

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      ...|++.+.||+|+||.||+|+.+ +|+.||||++....   ....+.+.+|++++++++|||||++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            345677889999999999999976 78999999997542   33467899999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee---CCCCcEEEeccccCC---
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDFEYGM---  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl---~~~~~~kl~df~~~~---  344 (453)
                      |||+++|+|.+.+.... .+++.....++.+++.||.||   |+.+|+||||||+|||+   +.++.+||+|||++.   
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999887654 588899999999999999999   78899999999999999   467899999998541   


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          .+.++.++||||+||++|||++|.+||......+  ....+               ....
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i---------------~~~~  243 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKKV---------------EKGK  243 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---------------HHCC
T ss_pred             cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH---------------HcCC
Confidence                                1356789999999999999999999997542211  11111               1111


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+.....++++.+|+.+||+.+|++|||+.|+++
T Consensus       244 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          244 YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            11111223456778999999999999999999999885

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-36  Score=287.21  Aligned_cols=224  Identities=24%  Similarity=0.294  Sum_probs=182.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .+++.+.||+|+||.||+|..+ +++.||||.++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence            3456788999999999999976 68999999997553 344578899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---------  345 (453)
                      ++|+|.+++... ..++......++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+..         
T Consensus        88 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           88 SGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             TTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            999999988654 3588899999999999999999   788999999999999999999999999986521         


Q ss_pred             ------------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          346 ------------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       346 ------------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        .. .+.++||||||+++|||++|+.||............+.....                 
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  226 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-----------------  226 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-----------------
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-----------------
Confidence                              11 245799999999999999999999764333222222221100                 


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ........+.++.+++.+||+.||++|||++|+++
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             01112345567889999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.3e-37  Score=289.38  Aligned_cols=221  Identities=21%  Similarity=0.346  Sum_probs=180.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|... ++..||||++.....   .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            456788999999999999976 578999999975432   2346788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .++......++.+++.|+.||   |+.+|+||||||+||+++.++.++|+|||++.         
T Consensus        91 ~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  166 (279)
T 3fdn_A           91 APLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD  166 (279)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence            99999999887643 578889999999999999999   78999999999999999999999999998542         


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++||||||+++|||++|..||......+     ...            .... .   ...
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~------------~~~~-~---~~~  225 (279)
T 3fdn_A          167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYK------------RISR-V---EFT  225 (279)
T ss_dssp             -CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHH------------HHHH-T---CCC
T ss_pred             cCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----HHH------------HHHh-C---CCC
Confidence                          1345678999999999999999999997532211     000            0000 0   011


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      .+...+.++.+++.+||+.+|++|||++|+++.
T Consensus       226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            123355678899999999999999999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.9e-37  Score=297.33  Aligned_cols=230  Identities=24%  Similarity=0.415  Sum_probs=183.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      .+++.+.||+|+||.||+|++.      ++..||||.+.... ......+.+|+.++++++||||+++++++..++..++
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  110 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence            3566789999999999999842      47899999997543 3455688999999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEecc
Q 036792          270 VLEYMPKGSLENCLYSST------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDF  340 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df  340 (453)
                      ||||+++|+|.+++....      ..+++.....++.+++.||.||   |+.+|+||||||+||+++.   +..+||+||
T Consensus       111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence            999999999999997643      3588889999999999999999   7889999999999999984   456999999


Q ss_pred             ccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCc
Q 036792          341 EYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       341 ~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      |.+.                           ...++.++||||||+++|||+| |..||......+  ....+..     
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~-----  260 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTS-----  260 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHT-----
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHhc-----
Confidence            7431                           1345778999999999999998 999986532211  1111110     


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                                 ..  ....+..++.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       261 -----------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          261 -----------GG--RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -----------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CC--CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                       00  111223456788999999999999999999999999998865

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8e-37  Score=293.24  Aligned_cols=226  Identities=19%  Similarity=0.247  Sum_probs=179.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..+++.+.||+|+||.||+++.. +|+.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            44566789999999999999976 78999999998665445567899999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee---CCCCcEEEeccccCC-------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl---~~~~~~kl~df~~~~-------  344 (453)
                      ++|+|.+++.... .++......++.+++.|+.||   |+.+|+||||||+||++   +.++.+||+|||.+.       
T Consensus        89 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  164 (304)
T 2jam_A           89 SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM  164 (304)
T ss_dssp             CSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred             CCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence            9999999886543 578889999999999999999   78899999999999999   778899999998642       


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++||||+||++|||++|..||......+  ....+..               ......
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~---------------~~~~~~  227 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEKIKE---------------GYYEFE  227 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH---------------CCCCCC
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHc---------------CCCCCC
Confidence                            1245678999999999999999999986542211  1110100               000001


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+.....+.++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1122345678899999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.7e-37  Score=312.80  Aligned_cols=227  Identities=20%  Similarity=0.294  Sum_probs=178.6

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ...|++.+.||+|+||.||+|+.+ ++..||||+++...  ......+.+|+.+++.++|||||+++++|.++...++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            345677889999999999999976 68999999997653  233567899999999999999999999999999999999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC----
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM----  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~----  344 (453)
                      ||+++|+|.+.+.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.   ++.+||+|||++.    
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999998886543 578889999999999999999   7889999999999999976   4569999998652    


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++||||+||++|||++|.+||......+     .            +........
T Consensus       192 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~------------~~~i~~~~~  254 (494)
T 3lij_A          192 QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-----I------------LRKVEKGKY  254 (494)
T ss_dssp             TBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H------------HHHHHHTCC
T ss_pred             CccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----H------------HHHHHhCCC
Confidence                               1346788999999999999999999997542211     1            111111110


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+.....++++.+++.+||+.+|++|||+.|+++
T Consensus       255 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          255 TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            0111122345678899999999999999999999984

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.8e-38  Score=311.16  Aligned_cols=226  Identities=16%  Similarity=0.172  Sum_probs=173.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc---chhhHHHHHHHH---HHHHcCCCCCceeEE-------eEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE---CARALKSFEAQC---EVMKSIRHPNLVKVI-------SSCSN  263 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~~~  263 (453)
                      +++.+.||+|+||.||+|++. +|+.||||+++..   .....+.+.+|+   +++++++|||||+++       +++..
T Consensus        75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~  154 (377)
T 3byv_A           75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  154 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred             EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence            456789999999999999964 6999999999743   334567899999   555666899999998       55554


Q ss_pred             CC-----------------eeEEEEeccCCCCchHHhhcCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 036792          264 DD-----------------FKALVLEYMPKGSLENCLYSSTC------MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHC  320 (453)
Q Consensus       264 ~~-----------------~~~lv~E~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hr  320 (453)
                      ++                 ..++||||+ +|+|.+++.....      .+++..+..++.|++.||.||   |+.+|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHr  230 (377)
T 3byv_A          155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGLVHT  230 (377)
T ss_dssp             TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH---HHTTEECS
T ss_pred             cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecC
Confidence            43                 278999999 6899999875321      223577788999999999999   78899999


Q ss_pred             CCCCCceeeCCCCcEEEeccccCCC---------------------C-----------CcCcccchHHHHHHHHHHHhCC
Q 036792          321 DLKPISVLLDEDMVAHLSDFEYGME---------------------G-----------QVSTRSDIYGYGIVLMETFTRK  368 (453)
Q Consensus       321 dlk~~NiLl~~~~~~kl~df~~~~~---------------------~-----------~~~~~~Dv~S~Gvvl~el~tg~  368 (453)
                      ||||+|||++.++.+||+|||++..                     .           .++.++|||||||++|||++|+
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~  310 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD  310 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence            9999999999999999999987531                     1           5778999999999999999999


Q ss_pred             CCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH--HHHH
Q 036792          369 KPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT--RLLK  446 (453)
Q Consensus       369 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~--~L~~  446 (453)
                      .||......+.                 ......        ....+++++.+|+.+||+.||++|||+.|+++  .+.+
T Consensus       311 ~Pf~~~~~~~~-----------------~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          311 LPITKDAALGG-----------------SEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             CCC------CC-----------------SGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             CCCcccccccc-----------------hhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99865422111                 000000        01234567899999999999999999999985  5666


Q ss_pred             HHHHhc
Q 036792          447 IRDTLS  452 (453)
Q Consensus       447 i~~~~~  452 (453)
                      +++.++
T Consensus       366 ~~~~~~  371 (377)
T 3byv_A          366 LRTELS  371 (377)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            665543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-37  Score=294.60  Aligned_cols=231  Identities=26%  Similarity=0.355  Sum_probs=177.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC--CCC--EEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR--DGI--EVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      .+++.+.||+|+||.||+|.+.  ++.  .||||+++...   ....+.+.+|++++++++||||+++++++..++ .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            3566788999999999999864  333  68999987542   345678999999999999999999999998765 789


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      |+||+++|+|.+++......+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||++..    
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            9999999999999976555688899999999999999999   788999999999999999999999999986421    


Q ss_pred             ------------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          346 ------------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       346 ------------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ..++.++||||||+++|||++ |..||......+     ...            ..
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~------------~~  237 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILH------------KI  237 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHH------------HH
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-----HHH------------HH
Confidence                                    124568999999999999999 999986542211     111            00


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ....  ...+.+..++.++.+++.+||+.+|++|||+.++++.|+++...
T Consensus       238 ~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          238 DKEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HTSC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HccC--CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            0000  01122345677899999999999999999999999999988654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.3e-37  Score=303.47  Aligned_cols=221  Identities=19%  Similarity=0.304  Sum_probs=176.9

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCC--CCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIR--HPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+++|++++  ||||+++++++..++..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            56678999999999999998889999999997543  345578999999999996  5999999999999999999999 


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +.+|+|.+++.... .+++..+..++.+++.||.||   |+.+|+||||||+|||++ ++.+||+|||++..        
T Consensus       137 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          137 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            56889999997754 678888999999999999999   788999999999999996 57899999986521        


Q ss_pred             ------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          346 ------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       346 ------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                                                    ..++.++|||||||++|||++|+.||.........+.            .
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------------~  279 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------------A  279 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------------H
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH------------H
Confidence                                          1356689999999999999999999965321111111            1


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +++....      ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       280 ~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          280 IIDPNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHCTTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCcccc------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1111110      1111223457889999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.4e-37  Score=303.41  Aligned_cols=238  Identities=21%  Similarity=0.355  Sum_probs=170.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCC--eeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDD--FKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lv~  271 (453)
                      |++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.++.++. ||||+++++++..++  ..++||
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~   90 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF   90 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence            456788999999999999975 6899999998644  2345567889999999997 999999999997644  689999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      |||+ |+|.+++...  .++......++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.       
T Consensus        91 e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           91 DYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             ECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             cccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9997 5899888763  578888899999999999999   78899999999999999999999999998652       


Q ss_pred             ----------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhH
Q 036792          345 ----------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDW  384 (453)
Q Consensus       345 ----------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  384 (453)
                                                              ...++.++||||+||++|||++|++||.+....+. +...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i  243 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-LERI  243 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence                                                    13467789999999999999999999976432211 1111


Q ss_pred             Hhhh-cCCc----------hhhhhhhhhhc----CccCC--ch----------hhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          385 VNNL-LPIS----------LMEVVDKTLLS----GEKKG--FV----------AKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       385 ~~~~-~~~~----------~~~~~d~~~~~----~~~~~--~~----------~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      .... .|..          ....++.....    .....  .+          ....+++++.+|+.+||+.||++|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            1111 0100          00000000000    00000  00          011446789999999999999999999


Q ss_pred             HHHHH
Q 036792          438 KDIVT  442 (453)
Q Consensus       438 ~~v~~  442 (453)
                      +|+++
T Consensus       324 ~e~l~  328 (388)
T 3oz6_A          324 NDALK  328 (388)
T ss_dssp             HHHTT
T ss_pred             HHHhC
Confidence            99875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=303.97  Aligned_cols=235  Identities=21%  Similarity=0.198  Sum_probs=175.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccchh-----------hHHHHHHHHHHHHcCCCCCceeEEeEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECAR-----------ALKSFEAQCEVMKSIRHPNLVKVISSCS  262 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g~~~  262 (453)
                      |++.+.||+|+||.||+|...    ++..||||++......           ....+.+|+..++.++||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~  118 (345)
T 2v62_A           39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL  118 (345)
T ss_dssp             EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred             EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence            456789999999999999976    5789999998755321           1134678889999999999999999998


Q ss_pred             c----CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC--cEE
Q 036792          263 N----DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM--VAH  336 (453)
Q Consensus       263 ~----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~--~~k  336 (453)
                      .    ....++||||+ +++|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++  .+|
T Consensus       119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          119 TEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            8    77899999999 999999987654 688999999999999999999   788999999999999998877  999


Q ss_pred             EeccccCC--------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhH
Q 036792          337 LSDFEYGM--------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDW  384 (453)
Q Consensus       337 l~df~~~~--------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  384 (453)
                      |+|||++.                                ...++.++|||||||++|||++|+.||.............
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            99998762                                1135678999999999999999999996432222211111


Q ss_pred             HhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          385 VNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       385 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      .....+ .+...+....         ....++.++.+++.+||+.+|++|||++++++.|+++
T Consensus       274 ~~~~~~-~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          274 KTNLLD-ELPQSVLKWA---------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHH-TTTHHHHHHS---------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHhhcc-cccHHHHhhc---------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            111100 0000000000         0114566899999999999999999999999999765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.7e-37  Score=300.92  Aligned_cols=239  Identities=21%  Similarity=0.306  Sum_probs=185.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+|.+. ++..||+|+++... ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  114 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD  114 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence            456788999999999999976 68999999998653 3445789999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT-PIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~-~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      +|+|.+++.... .+++.....++.+++.|+.||   |+. +|+||||||+||+++.++.+||+|||++.          
T Consensus       115 ~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  190 (360)
T 3eqc_A          115 GGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  190 (360)
T ss_dssp             TCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred             CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence            999999987643 578888999999999999999   554 89999999999999999999999998641          


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHH-------------------------h
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWV-------------------------N  386 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-------------------------~  386 (453)
                                   ...++.++|||||||++|||++|+.||......+.....-.                         .
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (360)
T 3eqc_A          191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD  270 (360)
T ss_dssp             CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred             CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence                         23467889999999999999999999975432221110000                         0


Q ss_pred             hhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       387 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+....+.++.......  .......++.++.+|+.+||+.||++|||++|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          271 SRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            0000111222222221111  11112235668999999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-36  Score=309.12  Aligned_cols=165  Identities=22%  Similarity=0.360  Sum_probs=134.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec-----CCeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN-----DDFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~l  269 (453)
                      |++.+.||+|+||.||+|+.+ +++.||||++....  ....+.+.+|+++|+.++|||||++++++..     ....++
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            567889999999999999976 68999999997542  3445789999999999999999999999854     356899


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      ||||+ +|+|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.     
T Consensus       135 v~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            99998 569998887643 688899999999999999999   78899999999999999999999999998652     


Q ss_pred             ------------------------------------------------CCCcCcccchHHHHHHHHHHHhC
Q 036792          345 ------------------------------------------------EGQVSTRSDIYGYGIVLMETFTR  367 (453)
Q Consensus       345 ------------------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg  367 (453)
                                                                      ...++.++|||||||++|||++|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence                                                            12356789999999999999993

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=299.93  Aligned_cols=239  Identities=20%  Similarity=0.259  Sum_probs=180.1

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhh-HHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++.+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++||||+++++++..++..++||||++ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence            45678999999999999976 78999999997543221 1245679999999999999999999999999999999997 


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++......+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++.            
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  160 (324)
T 3mtl_A           84 KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE  160 (324)
T ss_dssp             EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence            599999887766788999999999999999999   78899999999999999999999999997541            


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh---cCCchhhhhhhhhh---cC
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL---LPISLMEVVDKTLL---SG  404 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~~~---~~  404 (453)
                                    ...++.++||||+||++|||++|+.||......+. +.......   .+..+.........   ..
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhccccc
Confidence                          13467789999999999999999999976533221 11111111   11111111111000   00


Q ss_pred             ----ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 ----EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ----~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          ...........++++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                00001122345677899999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=307.52  Aligned_cols=224  Identities=19%  Similarity=0.233  Sum_probs=177.8

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+++.+ +|+.||||++++...   ...+.+.+|..++..++||||+++++++.+++..++||||+
T Consensus        64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~  143 (412)
T 2vd5_A           64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY  143 (412)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence            45678999999999999986 699999999975422   23345889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.          
T Consensus       144 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~  220 (412)
T 2vd5_A          144 VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS  220 (412)
T ss_dssp             CSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence            99999999976555688889999999999999999   78899999999999999999999999998641          


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ...++.++|||||||++|||++|+.||......+. ...            ++....
T Consensus       221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~------------i~~~~~  287 (412)
T 2vd5_A          221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGK------------IVHYKE  287 (412)
T ss_dssp             SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH------------HHTHHH
T ss_pred             ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHH------------HHhccc
Confidence                                   12357789999999999999999999975422111 001            110000


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccC---CChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKR---INAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps~~~v~~  442 (453)
                      .   ..........++++.+|+.+||. +|++|   |+++|+++
T Consensus       288 ~---~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 H---LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             H---CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             C---cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0   00011123456789999999999 99998   58888753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-36  Score=298.58  Aligned_cols=223  Identities=23%  Similarity=0.342  Sum_probs=178.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--------hhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeE
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--------RALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  268 (453)
                      ++.+.||+|+||.||+|.++ +|+.||||+++....        ...+.+.+|+.+++++ +||||+++++++......+
T Consensus        97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  176 (365)
T 2y7j_A           97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF  176 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEE
T ss_pred             ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEE
Confidence            34578999999999999986 799999999875431        2245688999999999 7999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++.    
T Consensus       177 lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          177 LVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            9999999999999887543 588899999999999999999   77899999999999999999999999998542    


Q ss_pred             --------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          345 --------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       345 --------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                                                ...++.++|||||||++|||++|..||......  .....+.            
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i~------------  318 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMIM------------  318 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH------------
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHH------------
Confidence                                      113567899999999999999999998643211  1111110            


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ........+.....+.++.+++.+||+.||++|||+.|+++
T Consensus       319 ---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          319 ---EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               00000011122245667899999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=299.49  Aligned_cols=216  Identities=23%  Similarity=0.322  Sum_probs=177.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCee
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  267 (453)
                      .|++.+.||+|+||.||+|+.. +++.||||+++....        ...+.+.+|++++++++||||+++++++.+.+..
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            3456788999999999999965 689999999976531        1234677899999999999999999999999999


Q ss_pred             EEEEeccCCC-CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-
Q 036792          268 ALVLEYMPKG-SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-  345 (453)
Q Consensus       268 ~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-  345 (453)
                      ++||||+.+| +|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||.+.. 
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            9999999777 9998887654 588999999999999999999   788999999999999999999999999986521 


Q ss_pred             -----------------------CCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 -----------------------GQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 -----------------------~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ..+ +.++|||||||++|||++|..||.....                   ......
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------~~~~~~  241 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------TVEAAI  241 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------------GTTTCC
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------------HHhhcc
Confidence                                   122 6678999999999999999999864211                   000000


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                              ..+..++.++.+|+.+||+.||++|||++|+++.
T Consensus       242 --------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          242 --------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0112245678999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-36  Score=289.63  Aligned_cols=224  Identities=21%  Similarity=0.305  Sum_probs=180.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---------hhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---------ARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDF  266 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  266 (453)
                      |++.+.||+|+||.||+|..+ +|+.||||+++...         ....+.+.+|++++++++ ||||+++++++..++.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   98 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence            456788999999999999986 68999999997542         123467889999999996 9999999999999999


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--  344 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--  344 (453)
                      .++||||+++|+|.+++... ..+++.....++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+.  
T Consensus        99 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           99 FFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999998764 3578899999999999999999   78899999999999999999999999998642  


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                                                  ...++.++||||||+++|||++|..||......+  ....+.          
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~----------  242 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIM----------  242 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----------
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHHHHh----------
Confidence                                        1235678999999999999999999986532111  110000          


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                           ........+....++.++.+++.+||+.||++|||+.|+++
T Consensus       243 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 -----SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -----HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----cCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                 00000011122345678999999999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-36  Score=290.84  Aligned_cols=237  Identities=20%  Similarity=0.234  Sum_probs=183.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEE-ecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC-SNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~E~~  274 (453)
                      .|++.+.||+|+||.||+|+.. +++.||||++.....  .+.+.+|+++++.++|++++..++.+ ..++..++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            3566789999999999999974 789999998765432  23578899999999988877766655 6677889999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee---CCCCcEEEeccccCCC------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDFEYGME------  345 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl---~~~~~~kl~df~~~~~------  345 (453)
                       +|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+|||+   +.++.+||+|||.+..      
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence             9999999986666789999999999999999999   78899999999999999   7889999999986521      


Q ss_pred             --------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          346 --------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       346 --------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                                                ..++.++|||||||++|||++|+.||..........          ....+...
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~  233 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----------KYERISEK  233 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS----------HHHHHHHH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh----------hhhhhhcc
Confidence                                      134568899999999999999999997643221100          00011111


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      ....   +.......++.++.+++.+||+.+|++|||++++++.|+++..+..
T Consensus       234 ~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          234 KMST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHS---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cccc---hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            1100   0001113346789999999999999999999999999999987653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-36  Score=312.02  Aligned_cols=225  Identities=20%  Similarity=0.281  Sum_probs=179.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-------------hhHHHHHHHHHHHHcCCCCCceeEEeEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-------------RALKSFEAQCEVMKSIRHPNLVKVISSCS  262 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~  262 (453)
                      .|++.+.||+|+||.||+|..+ +++.||||+++....             ...+.+.+|+.+|++++|||||++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3566789999999999999976 689999999975431             23467899999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC---cEEEec
Q 036792          263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM---VAHLSD  339 (453)
Q Consensus       263 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~d  339 (453)
                      ++...++||||+++|+|.+.+.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++   .+||+|
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            9999999999999999999886643 588999999999999999999   788999999999999998765   699999


Q ss_pred             cccCC-----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          340 FEYGM-----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       340 f~~~~-----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                      ||++.                       .+.++.++||||+||++|||++|..||......+                 +
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------------~  255 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-----------------I  255 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------H
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----------------H
Confidence            98652                       1246788999999999999999999997542211                 1


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +............+.....++++.+|+.+||+.||++|||++|+++
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111111110111222345678999999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.1e-37  Score=300.01  Aligned_cols=215  Identities=19%  Similarity=0.254  Sum_probs=176.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|+.+ +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++|||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E  101 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  101 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence            455788999999999999987 48899999998653   23456788999999988 79999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus       102 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          102 YVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            999999999987643 578889999999999999999   788999999999999999999999999986531       


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++|||||||++|||++|+.||......+                 +........   
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------~~~~i~~~~---  237 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----------------LFQSIMEHN---  237 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC---
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----------------HHHHHHhCC---
Confidence                              245678999999999999999999997542211                 111111110   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                       ...+...+.++.+|+.+||+.||++||++
T Consensus       238 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          238 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             11223456788999999999999999964

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-37  Score=312.25  Aligned_cols=220  Identities=23%  Similarity=0.313  Sum_probs=172.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|... +|+.||||+++...   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            456789999999999999976 68999999998642   23346778899999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      +++|+|.+++.... .+++.....++.+++.||.||   |+ .+|+||||||+|||++.++.+||+|||++..       
T Consensus       230 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          230 ANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             CSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence            99999999886643 578899999999999999999   65 8899999999999999999999999987531       


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++|||||||++|||++|+.||.......                 ..+......   
T Consensus       306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----------------~~~~i~~~~---  365 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELILMEE---  365 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC---
T ss_pred             cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----------------HHHHHHhCC---
Confidence                              346778999999999999999999996542211                 111111110   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                       ...+...++++.+|+.+||+.||++||     +++|+++
T Consensus       366 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 -IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             011233566789999999999999999     9999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-36  Score=300.78  Aligned_cols=219  Identities=17%  Similarity=0.279  Sum_probs=172.6

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHH-HcCCCCCceeEEeEEec----CCeeEEEEecc
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVM-KSIRHPNLVKVISSCSN----DDFKALVLEYM  274 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lv~E~~  274 (453)
                      .+.||+|+||.||+|..+ +++.||||+++..     ..+.+|++++ +..+||||+++++++..    ....++||||+
T Consensus        67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             cceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            368999999999999976 6899999999643     3566788876 45689999999998875    56789999999


Q ss_pred             CCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC------
Q 036792          275 PKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~------  344 (453)
                      ++|+|.+++.... ..+++.....++.+++.||.||   |+.+|+||||||+|||++.   ++.+||+|||++.      
T Consensus       142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            9999999998653 3588999999999999999999   7789999999999999997   7899999998642      


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccccc--HHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELS--LKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                        ...++.++|||||||++|||++|..||.........  ....+.               ...
T Consensus       219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---------------~~~  283 (400)
T 1nxk_A          219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---------------MGQ  283 (400)
T ss_dssp             --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---------------HTC
T ss_pred             ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---------------cCc
Confidence                              235678899999999999999999999754322110  111110               000


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+....++.++.+|+.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00011112345678999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-36  Score=296.09  Aligned_cols=238  Identities=20%  Similarity=0.185  Sum_probs=179.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-----CCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-----HPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lv~  271 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.+++.++     ||||+++++++...+..++||
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~  115 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF  115 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence            566789999999999999975 6899999999743 234466788999999986     999999999999999999999


Q ss_pred             eccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-------------------
Q 036792          272 EYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-------------------  331 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-------------------  331 (453)
                      ||+ +++|.+++.... ..+++.....++.|++.||.||   |+.+|+||||||+|||++.                   
T Consensus       116 e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          116 EPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             CCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             cCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            999 899999987643 3588899999999999999999   7889999999999999975                   


Q ss_pred             ------CCcEEEeccccCC----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHh
Q 036792          332 ------DMVAHLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKD  383 (453)
Q Consensus       332 ------~~~~kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~  383 (453)
                            ++.+||+|||.+.                      ...++.++|||||||++|||++|+.||......+  ...
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~  269 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME--HLA  269 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH
T ss_pred             cccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH--HHH
Confidence                  7899999998652                      2356789999999999999999999997543221  111


Q ss_pred             HHhhhcCCchhhhhhhhhh------------cCc---c------------CCchhhHHHHHHHHHHhhhccccCcccCCC
Q 036792          384 WVNNLLPISLMEVVDKTLL------------SGE---K------------KGFVAKEQCVLSILGLAMECAMELPEKRIN  436 (453)
Q Consensus       384 ~~~~~~~~~~~~~~d~~~~------------~~~---~------------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  436 (453)
                      .+.................            ...   .            ..........+.+.+|+.+||+.||++|||
T Consensus       270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  349 (360)
T 3llt_A          270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS  349 (360)
T ss_dssp             HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence            1111111100000000000            000   0            000011112367889999999999999999


Q ss_pred             hHHHHH
Q 036792          437 AKDIVT  442 (453)
Q Consensus       437 ~~~v~~  442 (453)
                      ++|+++
T Consensus       350 a~elL~  355 (360)
T 3llt_A          350 PAELLK  355 (360)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-36  Score=319.83  Aligned_cols=229  Identities=21%  Similarity=0.358  Sum_probs=187.1

Q ss_pred             HHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|.+..    +..||||.++... ....+.+.+|+.+|++++||||+++++++. ++..++|||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E  470 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME  470 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence            4557789999999999998752    4679999987543 344578999999999999999999999985 456899999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++......+++.....++.++++||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus       471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            9999999999987666789999999999999999999   778999999999999999999999999987531       


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ..++.++|||||||++|||++ |..||......+  ....+.               . +.
T Consensus       548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~---------------~-~~  609 (656)
T 2j0j_A          548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE---------------N-GE  609 (656)
T ss_dssp             ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---------------H-TC
T ss_pred             eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH---------------c-CC
Confidence                               235668999999999999997 999987542211  111110               0 00


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                        ..+.+..+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       610 --~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence              1122345677899999999999999999999999999998654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-36  Score=289.34  Aligned_cols=233  Identities=20%  Similarity=0.240  Sum_probs=183.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEE-ecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSC-SNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||.||+|+.. +++.||||++.....  .+.+.+|+.+++.++|++++..++++ ..++..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            456788999999999999974 789999999875432  24688999999999998877666655 5677889999999 


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee---CCCCcEEEeccccCCC-------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl---~~~~~~kl~df~~~~~-------  345 (453)
                      +|+|.+++......+++.....++.+++.||.||   |+.+|+||||||+||++   +.++.+||+|||.+..       
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            8999999986666789999999999999999999   78899999999999999   4788999999986421       


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccc--cHHhHHhhhcCCchhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEEL--SLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d  398 (453)
                                               ..++.++|||||||++|||++|+.||........  ......            .
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------~  232 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------------E  232 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH------------H
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc------------c
Confidence                                     1346689999999999999999999975432111  111111            1


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .....   +.......+++++.+++.+||+.||++|||++++++.|+++..+.
T Consensus       233 ~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          233 KKMST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHS---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccCC---chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            11100   001112345678999999999999999999999999999997764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-36  Score=289.18  Aligned_cols=220  Identities=17%  Similarity=0.241  Sum_probs=180.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |.+.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (294)
T 2rku_A           17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL   96 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence            456789999999999999977 58899999997653   34457789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++++|.+++.... .+++.....++.++++|+.||   |+.+++||||||+||+++.++.+||+|||.+..        
T Consensus        97 ~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           97 CRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             CTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            99999999876543 578899999999999999999   788999999999999999999999999986521        


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                       ..++.++||||||+++|||++|+.||......+.     ...        +..     .   .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~--------~~~-----~---~  231 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLR--------IKK-----N---E  231 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHH--------HHT-----T---C
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHH--------Hhh-----c---c
Confidence                             2356689999999999999999999975422110     000        000     0   0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0112234567889999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.3e-36  Score=304.95  Aligned_cols=225  Identities=22%  Similarity=0.264  Sum_probs=175.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCee
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  267 (453)
                      .|.+.+.||+|+||.||+|..+ +++.||||++.....        .....+.+|+++|++++|||||++++++.. +..
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence            3566789999999999999976 689999999975421        122357899999999999999999999854 457


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC---CcEEEeccccCC
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED---MVAHLSDFEYGM  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~---~~~kl~df~~~~  344 (453)
                      ++||||+++|+|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.+   +.+||+|||++.
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             EEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            89999999999999887644 588999999999999999999   78899999999999999754   459999998652


Q ss_pred             C---------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          345 E---------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       345 ~---------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                      .                           ..++.++|||||||++|||++|..||....... .+...+....        
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~--------  361 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGK--------  361 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTC--------
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCC--------
Confidence            1                           234568999999999999999999997542221 1111111100        


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             ...........+.++.+++.+||+.||++|||++|+++
T Consensus       362 -------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          362 -------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                   00011122345678999999999999999999999886

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-36  Score=292.60  Aligned_cols=236  Identities=19%  Similarity=0.226  Sum_probs=179.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEec--CCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSN--DDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~E  272 (453)
                      .|++.+.||+|+||.||+|+.. +++.||||+++...   .+.+.+|++++++++ ||||+++++++..  ....++|||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            3566789999999999999865 78999999997543   367889999999997 9999999999988  667899999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM-------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~-------  344 (453)
                      |+++++|.+++..    ++......++.+++.||.||   |+.+|+||||||+|||++.++ .+||+|||.+.       
T Consensus       114 ~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~  186 (330)
T 3nsz_A          114 HVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  186 (330)
T ss_dssp             CCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred             ccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence            9999999988753    77888899999999999999   788999999999999999766 89999998652       


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh-----
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL-----  401 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-----  401 (453)
                                        ...++.++|||||||++|||++|+.||.........+.............+.++...     
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  266 (330)
T 3nsz_A          187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP  266 (330)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred             cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence                              134677899999999999999999998543222222222111111111111111000     


Q ss_pred             ------hcCc------cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 ------LSGE------KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ------~~~~------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                            ....      ..........++++.+|+.+||+.||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  0000      0001112235778999999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.2e-36  Score=291.41  Aligned_cols=221  Identities=19%  Similarity=0.234  Sum_probs=178.7

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      +.||+|+||.||+|... +++.||||+++....  .....+.+|+.++..++ ||||+++++++..++..++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            78999999999999976 689999999976532  34578899999999995 699999999999999999999999999


Q ss_pred             CchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC---------
Q 036792          278 SLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM---------  344 (453)
Q Consensus       278 ~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~---------  344 (453)
                      +|.+++... ...+++.....++.+++.||.||   |+.+|+||||||+||+++.   ++.+||+|||++.         
T Consensus       115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~  191 (327)
T 3lm5_A          115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR  191 (327)
T ss_dssp             EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------
T ss_pred             cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccc
Confidence            999988653 35688999999999999999999   7889999999999999998   7899999998652         


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++|||||||++|||++|+.||......+.. .....                .......
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~----------------~~~~~~~  254 (327)
T 3lm5_A          192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-LNISQ----------------VNVDYSE  254 (327)
T ss_dssp             --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHH----------------TCCCCCT
T ss_pred             cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHh----------------cccccCc
Confidence                           234677899999999999999999999754221110 00000                0000111


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....++..+.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            222345677899999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.6e-37  Score=301.89  Aligned_cols=219  Identities=28%  Similarity=0.305  Sum_probs=168.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHH-HHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEV-MKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|+.+ +++.||||+++....   .....+.+|..+ ++.++|||||++++++.+.+..++|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            456789999999999999986 588999999986532   233556677776 577899999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++..       
T Consensus       120 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          120 YINGGELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence            999999999887643 577888888999999999999   788999999999999999999999999986531       


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        ..++.++|||||||++|||++|..||......+                 +.+..+...   
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----------------~~~~i~~~~---  255 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----------------MYDNILNKP---  255 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----------------HHHHHHHSC---
T ss_pred             cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----------------HHHHHHhcc---
Confidence                              235778999999999999999999997542211                 111111110   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                       ...+...+.++.+|+.+||+.||++||++.+.+
T Consensus       256 -~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence             011223456789999999999999999986433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-36  Score=286.60  Aligned_cols=220  Identities=21%  Similarity=0.333  Sum_probs=180.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|... +++.||||++.....   ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   95 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF   95 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence            456788999999999999976 578999999975432   2346789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .++......++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||++.         
T Consensus        96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (284)
T 2vgo_A           96 APRGELYKELQKHG-RFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT  171 (284)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence            99999999887643 578889999999999999999   78899999999999999999999999998642         


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++||||||+++|||++|..||......+.     ..        .+..     ..   ..
T Consensus       172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~--------~~~~-----~~---~~  230 (284)
T 2vgo_A          172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-----HR--------RIVN-----VD---LK  230 (284)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HH--------HHHT-----TC---CC
T ss_pred             ccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-----HH--------HHhc-----cc---cC
Confidence                          13467789999999999999999999975422110     00        0000     00   01


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+...+.++.+++.+||+.+|++|||++|+++
T Consensus       231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            12334567899999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-36  Score=296.12  Aligned_cols=220  Identities=17%  Similarity=0.237  Sum_probs=180.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  122 (335)
T 2owb_A           43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL  122 (335)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence            456788999999999999976 58899999997652   34557789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++++|.+++.... .+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||++..        
T Consensus       123 ~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          123 CRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            99999999886543 578899999999999999999   788999999999999999999999999986521        


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                       ..++.++||||||+++|||++|+.||......+. ......                ..    
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~----------------~~----  257 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKK----------------NE----  257 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH----------------TC----
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhc----------------CC----
Confidence                             2356689999999999999999999975422111 000000                00    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+..++.++.+++.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0112234567889999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=290.95  Aligned_cols=223  Identities=25%  Similarity=0.326  Sum_probs=178.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+++.+.||+|+||.||+|... +|+.||||.+....  ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            3456788999999999999976 58999999997543  34678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++......+++.....++.+++.|+.||   |+.+++|+||||+||+++.++.+||+|||.+.           
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  184 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT  184 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence            9999999875555788999999999999999999   78899999999999999999999999998651           


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++||||||+++|||++|..||.......  .......                .......
T Consensus       185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~----------------~~~~~~~  246 (314)
T 3com_A          185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPT----------------NPPPTFR  246 (314)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH----------------SCCCCCS
T ss_pred             cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhc----------------CCCcccC
Confidence                          1235778999999999999999999986532111  0000000                0001111


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+..++.++.+++.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            23345678899999999999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.1e-36  Score=305.76  Aligned_cols=237  Identities=20%  Similarity=0.205  Sum_probs=177.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  268 (453)
                      |++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+|+.++|||||++++++...      ...+
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            566789999999999999876 6899999999765  234457889999999999999999999999664      3579


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+++ +|.+.+..   .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.    
T Consensus       144 lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             EEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            99999976 56666643   378888899999999999999   78899999999999999999999999998652    


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC-chh----hhhh
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI-SLM----EVVD  398 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~----~~~d  398 (453)
                                          ...++.++||||+||++|||++|+.||.+....+. +...++... +. ...    ....
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHcchhhh
Confidence                                13467899999999999999999999976432211 111111110 00 000    0000


Q ss_pred             hhhhcCc----------------cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 KTLLSGE----------------KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ~~~~~~~----------------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......                ..........++++.+|+.+||+.||++|||++|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000                0001112234678999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-36  Score=298.73  Aligned_cols=238  Identities=22%  Similarity=0.250  Sum_probs=174.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~  268 (453)
                      |++.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++|+.++||||+++++++..++      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            456788999999999999975 69999999996542  334567899999999999999999999997753      459


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+ +++|.+++...  .++......++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++.    
T Consensus       107 lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             EEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            999999 78999988763  578888999999999999999   78899999999999999999999999998652    


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhhhhh-----
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLMEVVD-----  398 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~d-----  398 (453)
                                         ...++.++||||+||++|||++|+.||.+....+ .+.......  .+....+.+.     
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~~~~~~~  259 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQSDEAK  259 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence                               1356788999999999999999999997543221 111111111  1111100000     


Q ss_pred             ---hhhhcCcc-CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 ---KTLLSGEK-KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ---~~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..+..... .........++++.+|+.+||..||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence               00000000 011122345678999999999999999999999876

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-36  Score=290.04  Aligned_cols=223  Identities=20%  Similarity=0.229  Sum_probs=170.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +++.+.||+|+||.||+|+.. +|+.||||+++....  ...+.+.++...++.++||||+++++++.+++..++||||+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~   88 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM   88 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred             hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence            456788999999999999975 789999999976532  22234445555688899999999999999999999999999


Q ss_pred             CCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          275 PKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTT-PIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       275 ~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~-~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      + |+|.+++..   ....+++.....++.+++.|+.||   |++ +|+||||||+||+++.++.+||+|||.+.      
T Consensus        89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence            7 588777653   445789999999999999999999   666 99999999999999999999999997541      


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            ...++.++|||||||++|||++|+.||..................             
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------  231 (290)
T 3fme_A          165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-------------  231 (290)
T ss_dssp             -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-------------
T ss_pred             cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-------------
Confidence                                  123567899999999999999999999753222211111111110             


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                           .......++.++.+++.+||+.||++|||++|+++
T Consensus       232 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 -----PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 00112345667899999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2e-36  Score=290.30  Aligned_cols=223  Identities=23%  Similarity=0.313  Sum_probs=182.8

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..+++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            34566788999999999999875 68999999997553 34567899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++++|.+++...  .+++.....++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+.         
T Consensus       102 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          102 LGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             CTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            9999999988653  588999999999999999999   78899999999999999999999999998651         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++||||||+++|||++|..||.......  ....+....                  .
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~------------------~  236 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNN------------------P  236 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC------------------C
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCC------------------C
Confidence                            1245678999999999999999999986532211  111110000                  0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR  443 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~  443 (453)
                      ...+..++.++.+++.+||+.+|++|||+.|+++.
T Consensus       237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11123445678999999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=303.08  Aligned_cols=236  Identities=14%  Similarity=0.154  Sum_probs=182.6

Q ss_pred             HHHHhcccCCCCccEEEEEEECC---------CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcee-----------
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD---------GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK-----------  256 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-----------  256 (453)
                      .|++.+.||+|+||.||+|+...         ++.||||.+...     +.+.+|++++++++||||++           
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            35677899999999999999763         789999998754     45789999999999999987           


Q ss_pred             ----EEeEEec-CCeeEEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          257 ----VISSCSN-DDFKALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       257 ----l~g~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                          +++++.. +...++||||+ +|+|.+++... ...+++.....++.|++.||.||   |+.+|+||||||+|||++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL---HENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCGGGEEEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEEc
Confidence                5677765 77889999999 99999999765 34689999999999999999999   788999999999999999


Q ss_pred             CCC--cEEEeccccCCC--------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCcccc
Q 036792          331 EDM--VAHLSDFEYGME--------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFV  376 (453)
Q Consensus       331 ~~~--~~kl~df~~~~~--------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  376 (453)
                      .++  .+||+|||++..                                ..++.++|||||||++|||++|+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            988  899999987621                                1356689999999999999999999975432


Q ss_pred             ccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          377 EELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .............. ......+         ........+.++.+++.+||+.||++|||++++++.|+++..+.
T Consensus       274 ~~~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          274 NTEDIMKQKQKFVD-KPGPFVG---------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             CHHHHHHHHHHHHH-SCCCEEC---------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHhccC-Chhhhhh---------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            22212111111000 0000000         00001134567999999999999999999999999999997764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.1e-37  Score=291.85  Aligned_cols=223  Identities=22%  Similarity=0.330  Sum_probs=179.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec------------
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN------------  263 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------------  263 (453)
                      .+++.+.||+|+||.||+|.+. +++.||||.++...    +.+.+|++++++++||||+++++++..            
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            3456789999999999999986 79999999997653    346789999999999999999998864            


Q ss_pred             ----CCeeEEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEe
Q 036792          264 ----DDFKALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLS  338 (453)
Q Consensus       264 ----~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~  338 (453)
                          ....++||||+++|+|.+++... ...+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHEEEcCCCCEEEC
Confidence                34579999999999999999653 34688899999999999999999   78899999999999999999999999


Q ss_pred             ccccCC------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchh
Q 036792          339 DFEYGM------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM  394 (453)
Q Consensus       339 df~~~~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  394 (453)
                      |||.+.                        ...++.++||||||+++|||++|..|+....       .+...       
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~~~-------  230 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFFTD-------  230 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHHHH-------
T ss_pred             cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHHHH-------
Confidence            998642                        1235778999999999999999998863210       01100       


Q ss_pred             hhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       395 ~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                       ..+..          .+...+.++.+++.+||+.||++|||+.|+++.|..++...
T Consensus       231 -~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          231 -LRDGI----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -HHTTC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -hhccc----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence             00000          11223456789999999999999999999999999886543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2e-36  Score=294.13  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=183.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ..|++.+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            33566789999999999999976 589999999865432  334668899999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------  345 (453)
                      |+++++|.+++.... .+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.+||+|||.+..       
T Consensus       105 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          105 FVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             CCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            999988887765433 588999999999999999999   788999999999999999999999999986521       


Q ss_pred             -------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhhhhhhhh---
Q 036792          346 -------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLMEVVDKTL---  401 (453)
Q Consensus       346 -------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~~---  401 (453)
                                         ..++.++|||||||++|||++|+.||......+. ........  ......+......   
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhccccc
Confidence                               1457789999999999999999999976432221 11111110  0000111111000   


Q ss_pred             ---hc---CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 ---LS---GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ---~~---~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..   ...........+++++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               00   000001112245678999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-36  Score=287.80  Aligned_cols=221  Identities=18%  Similarity=0.238  Sum_probs=177.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      ..|++.+.||+|+||.||+|... +++.||||.++...  ......+.+|+..+..+ +||||+++++++.+++..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            44567789999999999999986 79999999998643  33456788999999999 9999999999999999999999


Q ss_pred             eccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-----------------
Q 036792          272 EYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-----------------  331 (453)
Q Consensus       272 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-----------------  331 (453)
                      ||+++|+|.+++...   ...+++.....++.|++.||.||   |+.+|+||||||+||+++.                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999998653   24588899999999999999999   7889999999999999984                 


Q ss_pred             --CCcEEEeccccCCC----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhh
Q 036792          332 --DMVAHLSDFEYGME----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN  387 (453)
Q Consensus       332 --~~~~kl~df~~~~~----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  387 (453)
                        ...+||+|||.+..                      ..++.++|||||||++|||++|.+|+...    .........
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~  243 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQG  243 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHTT
T ss_pred             CCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHcC
Confidence              44799999986421                      13446899999999999999999876422    111111110


Q ss_pred             hcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       388 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .                   ....+..++.++.+++.+||+.||++|||+.|+++
T Consensus       244 ~-------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          244 R-------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             C-------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            0                   01122345667899999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=290.73  Aligned_cols=240  Identities=23%  Similarity=0.277  Sum_probs=176.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-----hhHHHHHHHHHHHHcC---CCCCceeEEeEEecCC---
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-----RALKSFEAQCEVMKSI---RHPNLVKVISSCSNDD---  265 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~---  265 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++....     .....+.+|+++++.+   +||||+++++++....   
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~   90 (308)
T 3g33_A           11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR   90 (308)
T ss_dssp             CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence            456788999999999999965 789999999974421     1124566777776665   4999999999998755   


Q ss_pred             --eeEEEEeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc
Q 036792          266 --FKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       266 --~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                        ..++||||+. |+|.+++.... ..+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.
T Consensus        91 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           91 EIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             EEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             ceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence              5799999997 59999887654 3488999999999999999999   788999999999999999999999999986


Q ss_pred             CC------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc--C-Cchhh
Q 036792          343 GM------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL--P-ISLME  395 (453)
Q Consensus       343 ~~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~  395 (453)
                      +.                        ...++.++|||||||++|||++|++||......+. +........  + ..+..
T Consensus       167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  245 (308)
T 3g33_A          167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPR  245 (308)
T ss_dssp             TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSCS
T ss_pred             ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccc
Confidence            52                        23467789999999999999999999976433221 111111110  0 00000


Q ss_pred             hh---hhhhhcC-ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VV---DKTLLSG-EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~---d~~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..   ....... ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00   0000000 00001112345678899999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.3e-36  Score=291.43  Aligned_cols=226  Identities=23%  Similarity=0.279  Sum_probs=176.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF  266 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  266 (453)
                      ..|++.+.||+|+||.||+|... +++.||||.+.....        .....+.+|++++++++||||+++++++..++ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            44567889999999999999976 689999999865421        22345889999999999999999999987665 


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC---cEEEeccccC
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM---VAHLSDFEYG  343 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~---~~kl~df~~~  343 (453)
                      .++||||+++|+|.+++.... .++......++.+++.||.||   |+.+|+||||||+||+++.++   .+||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            799999999999999887543 678889999999999999999   788999999999999998755   4999999864


Q ss_pred             C---------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          344 M---------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       344 ~---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                      .                           ...++.++|||||||++|||++|..||....... .+...+.....      
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~------  237 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKY------  237 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCC------
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCcc------
Confidence            2                           2345778999999999999999999997542221 11111111000      


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                               .........++.++.+++.+||+.||++|||+.|+++
T Consensus       238 ---------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 ---------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                     0011122345678899999999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.7e-37  Score=289.85  Aligned_cols=225  Identities=21%  Similarity=0.286  Sum_probs=179.3

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVL  271 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~  271 (453)
                      .|++.+.||+|+||.||++... +++.||+|.+....  ....+.+.+|++++++++||||+++++++..  ....++||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            3566788999999999999976 68999999997543  3445789999999999999999999998753  67889999


Q ss_pred             eccCCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----ceecCCCCCceeeCCCCcEEEeccccC
Q 036792          272 EYMPKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTP-----IIHCDLKPISVLLDEDMVAHLSDFEYG  343 (453)
Q Consensus       272 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~-----i~Hrdlk~~NiLl~~~~~~kl~df~~~  343 (453)
                      ||+++|+|.+++...   ...+++.....++.+++.||.||   |+.+     |+||||||+||+++.++.+||+|||.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC---HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH---hcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999998652   34588999999999999999999   5555     999999999999999999999999753


Q ss_pred             C-------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          344 M-------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       344 ~-------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                      .                         ...++.++||||||+++|||++|+.||......+  ....+..           
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~~-----------  230 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIRE-----------  230 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-----------
T ss_pred             eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHHHhh-----------
Confidence            1                         1245778999999999999999999987542111  1111100           


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL  444 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L  444 (453)
                           +.  ....+..++.++.+++.+||+.+|++|||++|+++.+
T Consensus       231 -----~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          231 -----GK--FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             -----TC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             -----cc--cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                 00  0112234567899999999999999999999998754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.8e-36  Score=303.74  Aligned_cols=170  Identities=22%  Similarity=0.327  Sum_probs=146.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-----CeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND-----DFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l  269 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++...  ....+.+.+|+++|++++||||+++++++...     ...++
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  107 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI  107 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence            567889999999999999976 68899999997542  34457889999999999999999999999776     57899


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      ||||++ |+|.+++... ..+++.....++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++.     
T Consensus       108 v~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          108 VLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            999996 5999988764 3588999999999999999999   78899999999999999999999999998652     


Q ss_pred             -------------------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCC
Q 036792          345 -------------------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTD  372 (453)
Q Consensus       345 -------------------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~  372 (453)
                                                                 ...++.++||||+||++|||++|..||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence                                                       1235678999999999999998655543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-36  Score=295.48  Aligned_cols=225  Identities=19%  Similarity=0.279  Sum_probs=174.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ..|++.+.||+|+||.||+|..+ +++.||||+++.....    ..+|++++.++ +||||+++++++.+++..++||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            44567789999999999999976 6899999999765432    34678888777 799999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC----CcEEEeccccCCC----
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED----MVAHLSDFEYGME----  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~----~~~kl~df~~~~~----  345 (453)
                      +++|+|.+.+.... .+++.....++.+++.|+.||   |+.+|+||||||+|||+.++    +.+||+|||++..    
T Consensus        98 ~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           98 MKGGELLDKILRQK-FFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999887654 588899999999999999999   78899999999999998543    3599999987531    


Q ss_pred             ---------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          346 ---------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       346 ---------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                           ..++.++|||||||++|||++|..||......  ...+..            .......
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~------------~~i~~~~  239 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEIL------------ARIGSGK  239 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHH------------HHHHHCC
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHH------------HHHccCC
Confidence                                 01456799999999999999999999743211  111111            1111100


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...........+.++.+|+.+||..||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00011122345678899999999999999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=290.53  Aligned_cols=237  Identities=20%  Similarity=0.259  Sum_probs=175.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEe--------------
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCS--------------  262 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--------------  262 (453)
                      |++.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.              
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            456788999999999999987 58999999998776666788999999999999999999999874              


Q ss_pred             cCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC-CCCcEEEeccc
Q 036792          263 NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD-EDMVAHLSDFE  341 (453)
Q Consensus       263 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~-~~~~~kl~df~  341 (453)
                      .....++||||++ |+|.+++...  .++......++.++++||.||   |+.+|+||||||+||+++ +++.+||+|||
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence            3467899999997 6999988653  578888999999999999999   788999999999999997 56799999998


Q ss_pred             cCCC-----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCc
Q 036792          342 YGME-----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       342 ~~~~-----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      .+..                             ..++.++|||||||++|||++|+.||......+ ........ .+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~  244 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILES-IPVV  244 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH-SCCC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCC
Confidence            6521                             245668999999999999999999997643211 11111111 1110


Q ss_pred             ----hhhh-------hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          393 ----LMEV-------VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       393 ----~~~~-------~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          ..+.       +.................++.++.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                0000       0000100000001112345778999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.9e-37  Score=302.65  Aligned_cols=236  Identities=11%  Similarity=0.091  Sum_probs=165.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHH---HHHHcCCCCCceeEE-------eEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQC---EVMKSIRHPNLVKVI-------SSCSN  263 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~-------g~~~~  263 (453)
                      +++.+.||+|+||.||+|.+. +|+.||||+++....   ...+.+.+|+   +.|+. +||||++++       +++..
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence            456789999999999999976 789999999987542   3445677785   45555 799988855       34433


Q ss_pred             C-----------------CeeEEEEeccCCCCchHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCceec
Q 036792          264 D-----------------DFKALVLEYMPKGSLENCLYSSTCMLDIFQR------LNIMIDATSTLEYLYFGHTTPIIHC  320 (453)
Q Consensus       264 ~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~L~~~h~~~i~Hr  320 (453)
                      +                 ...++||||++ |+|.+++......+++..+      ..++.|+++||.||   |+.+|+||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L---H~~~ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL---QSKGLVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH---HHTTEEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH---HHCCCccC
Confidence            2                 34799999998 8999999764333444555      77889999999999   78899999


Q ss_pred             CCCCCceeeCCCCcEEEeccccCC----------------------C--CCcCcccchHHHHHHHHHHHhCCCCCCcccc
Q 036792          321 DLKPISVLLDEDMVAHLSDFEYGM----------------------E--GQVSTRSDIYGYGIVLMETFTRKKPTDRMFV  376 (453)
Q Consensus       321 dlk~~NiLl~~~~~~kl~df~~~~----------------------~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~  376 (453)
                      ||||+|||++.++.+||+|||++.                      .  ..++.++|||||||++|||+||+.||.....
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            999999999999999999998641                      1  3467889999999999999999999976532


Q ss_pred             ccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH--HHHHHHHH
Q 036792          377 EELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT--RLLKIRDT  450 (453)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i~~~  450 (453)
                      ....  .+..          .............+....+++++.+|+.+||+.||++|||+.|+++  .++++...
T Consensus       299 ~~~~--~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          299 GIKG--SWKR----------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             TCTT--CCCB----------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             cccc--chhh----------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            2110  0000          0000000001111222355678999999999999999999999974  45555443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2e-36  Score=293.90  Aligned_cols=239  Identities=21%  Similarity=0.256  Sum_probs=175.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++....  ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA  115 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence            456788999999999999866 789999999975532  23456789999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee-----CCCCcEEEeccccCC-----
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL-----DEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl-----~~~~~~kl~df~~~~-----  344 (453)
                      + |+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||+     +.++.+||+|||.+.     
T Consensus       116 ~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          116 E-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             S-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             C-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            7 59999887654 588899999999999999999   78899999999999999     445569999997531     


Q ss_pred             ---------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCC-c-hhhhhh--
Q 036792          345 ---------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPI-S-LMEVVD--  398 (453)
Q Consensus       345 ---------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~-~-~~~~~d--  398 (453)
                                           ...++.++|||||||++|||++|+.||......+. +....... .+. . +.....  
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGST
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchhhhhhhhhhh
Confidence                                 12368899999999999999999999975432221 11111111 111 0 000000  


Q ss_pred             ---hhhhc--CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 ---KTLLS--GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ---~~~~~--~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         .....  ............+.++.+|+.+||+.||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence               00000  000000112235678899999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3e-36  Score=310.45  Aligned_cols=225  Identities=19%  Similarity=0.247  Sum_probs=181.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      +++.+.||+|+||.||+|+.+ +|+.||||++....   ......+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            455688999999999999976 79999999997643   23346788999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          274 MPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      +++|+|.+++.... ..+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.        
T Consensus       266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~  342 (576)
T 2acx_A          266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  342 (576)
T ss_dssp             CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence            99999999887643 3488999999999999999999   78899999999999999999999999998652        


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|..||....... ......         +    .+...   .
T Consensus       343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~---------~----~i~~~---~  405 (576)
T 2acx_A          343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVE---------R----LVKEV---P  405 (576)
T ss_dssp             ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHH---------H----HHHHC---C
T ss_pred             cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHH---------H----Hhhcc---c
Confidence                            1245778999999999999999999997542211 111110         0    01000   0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      ...+...++++.+|+.+||+.||++||     +++|+++
T Consensus       406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            112234567889999999999999999     6788764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-37  Score=294.39  Aligned_cols=231  Identities=25%  Similarity=0.303  Sum_probs=165.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+|... +++.||||.+.... ....+++.+|++++++++||||+++++++..++..++||||++
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   96 (303)
T 2vwi_A           17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS   96 (303)
T ss_dssp             CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred             hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence            456789999999999999865 68999999987543 3345678899999999999999999999999999999999999


Q ss_pred             CCCchHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          276 KGSLENCLYS-------STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       276 ~g~L~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +|+|.+++..       ....+++.....++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||.+.    
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  173 (303)
T 2vwi_A           97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT  173 (303)
T ss_dssp             TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred             CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence            9999998863       234588999999999999999999   78899999999999999999999999997431    


Q ss_pred             ---------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhh
Q 036792          345 ---------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV  397 (453)
Q Consensus       345 ---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (453)
                                                 ...++.++||||||+++|||++|+.||.......... .......+ ......
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~-~~~~~~  251 (303)
T 2vwi_A          174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LTLQNDPP-SLETGV  251 (303)
T ss_dssp             --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HHHTSSCC-CTTC--
T ss_pred             CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HHhccCCC-cccccc
Confidence                                       0135778999999999999999999997543221111 01110000 000000


Q ss_pred             hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                               ........++.++.+++.+||+.||++|||+.|+++
T Consensus       252 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          252 ---------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             ------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                     000111234567899999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.4e-36  Score=283.38  Aligned_cols=225  Identities=21%  Similarity=0.293  Sum_probs=181.1

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      .|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++++++||||+++++++...+..++|+||
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  102 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL  102 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence            3456789999999999999976 68999999997543  23467899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC---CcEEEeccccCCC-----
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED---MVAHLSDFEYGME-----  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~---~~~kl~df~~~~~-----  345 (453)
                      +++++|.+.+.... .+++.....++.+++.|+.||   |+.+++||||||+||+++.+   +.+||+|||.+..     
T Consensus       103 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          103 YTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            99999998886543 578899999999999999999   78899999999999999754   4799999986421     


Q ss_pred             ------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 ------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 ------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                        +.++.++||||||+++|||++|..||......+  ....+.               ......
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~---------------~~~~~~  241 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVE---------------TGKYAF  241 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---------------HCCCCC
T ss_pred             ccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---------------cCCCCC
Confidence                              235778999999999999999999987542211  111110               000001


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+.....+.++.+++.+||+.+|++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11222345678899999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.9e-36  Score=293.72  Aligned_cols=242  Identities=23%  Similarity=0.303  Sum_probs=180.3

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEec--------C
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSN--------D  264 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~  264 (453)
                      ..|++.+.||+|+||.||+|+.. +|+.||||++.....  .....+.+|+++++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            34567789999999999999975 789999999865432  234578899999999999999999999987        3


Q ss_pred             CeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          265 DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       265 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                      +..++||||+++ +|.+.+......+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999975 88888877666789999999999999999999   78899999999999999999999999998641


Q ss_pred             ------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh--hhcCCc
Q 036792          345 ------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN--NLLPIS  392 (453)
Q Consensus       345 ------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~  392 (453)
                                                    ...++.++|||||||++|||+||++||......+. ......  ...+..
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPE  251 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChh
Confidence                                          12357789999999999999999999976432211 111111  111111


Q ss_pred             hhhhhhh-hhh----cCccCCchhhH-----HHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          393 LMEVVDK-TLL----SGEKKGFVAKE-----QCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       393 ~~~~~d~-~~~----~~~~~~~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+. ...    ...........     ..++++.+|+.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1100100 000    00000000111     12457899999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=300.82  Aligned_cols=229  Identities=24%  Similarity=0.339  Sum_probs=180.1

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+|.+++  .||+|.++...  ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            4567899999999999999754  59999987542  2233567889999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +++|.+++......+++.....++.+++.|+.||   |+.+++||||||+||+++ ++.+||+|||++.           
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            9999999987666788899999999999999999   788999999999999998 6799999998631           


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                                                  ...++.++|||||||++|||++|+.||.....+..  ...+..         
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~---------  257 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IWQMGT---------  257 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HHHHHT---------
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcc---------
Confidence                                        01256789999999999999999999975432211  000000         


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                             ... .......++.++.+++.+||+.+|++|||++++++.|+++....
T Consensus       258 -------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          258 -------GMK-PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -------TCC-CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -------CCC-CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                   000 00011134556889999999999999999999999999887654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-36  Score=296.37  Aligned_cols=242  Identities=22%  Similarity=0.286  Sum_probs=178.6

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh-----hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR-----ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  269 (453)
                      ..|++.+.||+|+||.||+|... +|+.||||+++.....     ..+.+.+|++++++++||||+++++++...+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            34566789999999999999976 6899999999754221     12467899999999999999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      ||||+++ +|.+.+......+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||++..    
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999976 89888877666788888999999999999999   788999999999999999999999999986421    


Q ss_pred             ----------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-C--Cchhhhhh--
Q 036792          346 ----------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-P--ISLMEVVD--  398 (453)
Q Consensus       346 ----------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~d--  398 (453)
                                            ..++.++|||||||++|||++|.+||......+ .+........ +  ..+.+...  
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhhhccCc
Confidence                                  125678999999999999999999987543221 1112221111 1  00100000  


Q ss_pred             hhhhcCccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 KTLLSGEKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........+..   ......+.++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00000000000   111345678999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-36  Score=296.19  Aligned_cols=239  Identities=19%  Similarity=0.230  Sum_probs=180.7

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccch-----------hhHHHHHHHHHHHHcCCCCCceeEEeEEec----
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA-----------RALKSFEAQCEVMKSIRHPNLVKVISSCSN----  263 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----  263 (453)
                      ++.+.||+|+||.||+|...+|..||||++.....           ...+.+.+|++++++++||||+++++++..    
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (362)
T 3pg1_A           25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP  104 (362)
T ss_dssp             EEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred             EEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence            45688999999999999988899999999864321           224789999999999999999999999854    


Q ss_pred             -CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc
Q 036792          264 -DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       264 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                       ....++||||++ |+|.+.+......+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.
T Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  180 (362)
T 3pg1_A          105 AMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNILLADNNDITICDFNL  180 (362)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred             CcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence             346899999997 689888887766789999999999999999999   788999999999999999999999999986


Q ss_pred             CC-------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchh---
Q 036792          343 GM-------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM---  394 (453)
Q Consensus       343 ~~-------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  394 (453)
                      +.                         ...++.++|||||||++|||++|+.||......+ .+.............   
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  259 (362)
T 3pg1_A          181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNKIVEVVGTPKIEDVV  259 (362)
T ss_dssp             ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChHHhh
Confidence            52                         1346778999999999999999999997643221 111111111111111   


Q ss_pred             --------hhhhhhhhcCcc-CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 --------EVVDKTLLSGEK-KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 --------~~~d~~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                              +.+......... .........++.+.+|+.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                    111111100000 011122344677899999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.5e-36  Score=283.07  Aligned_cols=220  Identities=26%  Similarity=0.386  Sum_probs=179.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|... +|+.||||.+....   ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            456788999999999999986 78999999997543   23356789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +++++|.+++.... .++......++.+++.|+.||   |+.+++||||||+||+++.++.+||+|||.+..        
T Consensus        93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  168 (276)
T 2h6d_A           93 VSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  168 (276)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             cCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence            99999999987643 578889999999999999999   778999999999999999999999999986421        


Q ss_pred             ----------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 ----------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 ----------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      .. .+.++||||||+++|||++|..||.......     ...         .+.   . ..   
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~---------~~~---~-~~---  227 (276)
T 2h6d_A          169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-----LFK---------KIR---G-GV---  227 (276)
T ss_dssp             --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHH---------HHH---H-CC---
T ss_pred             cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHH---------Hhh---c-Cc---
Confidence                            11 2468999999999999999999986532111     110         000   0 00   


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ...+..++.++.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0112234567899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.9e-36  Score=285.39  Aligned_cols=223  Identities=20%  Similarity=0.296  Sum_probs=175.5

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec------------
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN------------  263 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------------  263 (453)
                      .+++.+.||+|+||.||+|+.. +++.||||.++.. ....+.+.+|+.++++++||||+++++++.+            
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            3456788999999999999975 7899999999654 3445788999999999999999999998865            


Q ss_pred             -CCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc
Q 036792          264 -DDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       264 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                       .+..++||||+++|+|.+++......++......++.++++|+.||   |+.+++||||||+||+++.++.+||+|||.
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHH---HhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence             3567899999999999999987665677888899999999999999   788999999999999999999999999986


Q ss_pred             CCC----------------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHH
Q 036792          343 GME----------------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLK  382 (453)
Q Consensus       343 ~~~----------------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~  382 (453)
                      +..                                        ..++.++|||||||++|||++   ||..... .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~~~~~  238 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-RVNIL  238 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-HHHHH
Confidence            521                                        246778999999999999998   5432111 00011


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+..               .....+.......+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          239 KKLRS---------------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHS---------------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhccc---------------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            01000               0000011122345567899999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.3e-35  Score=291.26  Aligned_cols=237  Identities=18%  Similarity=0.165  Sum_probs=177.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~  268 (453)
                      |++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            566788999999999999876 68999999997542  344567889999999999999999999997755      789


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+++ +|.+.+..   .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||++.    
T Consensus       107 lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          107 IVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            99999975 78887763   478888899999999999999   78899999999999999999999999998652    


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC--chhhhhhh---
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI--SLMEVVDK---  399 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~---  399 (453)
                                          ...++.++|||||||++|||++|+.||.+....+ .+..........  .....+.+   
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHhhhHHH
Confidence                                1246789999999999999999999997543211 111111100000  00000000   


Q ss_pred             -hhhcC----------------ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 -TLLSG----------------EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 -~~~~~----------------~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       .....                ...........+.++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence             00000                00011123345778999999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.4e-36  Score=296.59  Aligned_cols=237  Identities=22%  Similarity=0.224  Sum_probs=168.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  268 (453)
                      |++.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      ...+
T Consensus        31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~  110 (367)
T 2fst_X           31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY  110 (367)
T ss_dssp             EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence            456788999999999999865 68999999997542  34457788999999999999999999998754      5679


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +|+||+ +++|.+++..  ..+++.....++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++.    
T Consensus       111 lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          111 LVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             EEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             EEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            999999 7899988865  3588899999999999999999   78899999999999999999999999998652    


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC-ch---------h
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI-SL---------M  394 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-~~---------~  394 (453)
                                         ...++.++||||+||++|||++|+.||.+....+ .+........ +. ..         .
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~~~~~~~  263 (367)
T 2fst_X          185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESAR  263 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred             cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence                               1356788999999999999999999997643211 1111111110 10 00         0


Q ss_pred             hhhhhhhhcCccCC-chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 EVVDKTLLSGEKKG-FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 ~~~d~~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +.+. .+....... .......++++.+|+.+||+.||++|||+.|+++
T Consensus       264 ~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          264 NYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            0000 000000000 0111234677899999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-36  Score=298.06  Aligned_cols=226  Identities=23%  Similarity=0.281  Sum_probs=178.9

Q ss_pred             HHHHhcccCCCCccEEEEEEE----CCCCEEEEEEeeccc----hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCee
Q 036792          197 LRRLSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQEC----ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFK  267 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  267 (453)
                      .|++.+.||+|+||.||+++.    .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++..++..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            356778999999999999987    368999999987542    22345677899999999 699999999999999999


Q ss_pred             EEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---
Q 036792          268 ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---  344 (453)
                      ++||||+++|+|.+++.... .++......++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++.   
T Consensus       135 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999987643 578889999999999999999   78899999999999999999999999998542   


Q ss_pred             -------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhh
Q 036792          345 -------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDK  399 (453)
Q Consensus       345 -------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  399 (453)
                                               ...++.++|||||||++|||++|+.||....... ....+.            ..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~------------~~  277 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEIS------------RR  277 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHH------------HH
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHH------------HH
Confidence                                     0124678999999999999999999996432211 111111            11


Q ss_pred             hhhcCccCCchhhHHHHHHHHHHhhhccccCcccCC-----ChHHHHHH
Q 036792          400 TLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRI-----NAKDIVTR  443 (453)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~~  443 (453)
                      .....    ...+..++..+.+|+.+||+.||++||     +++|+++.
T Consensus       278 ~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          278 ILKSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HhccC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            11110    112234566789999999999999999     89998753

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.1e-36  Score=303.21  Aligned_cols=234  Identities=18%  Similarity=0.205  Sum_probs=183.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC-CCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRH-PNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||.||+|++. +++.||||++.....  .+.+.+|+++++.++| +++..+..++...+..++||||+ 
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            456789999999999999975 689999998875432  2357889999999987 56666667777888999999999 


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee---CCCCcEEEeccccCC--------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL---DEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl---~~~~~~kl~df~~~~--------  344 (453)
                      +++|.+++......+++.....++.|++.||.||   |+.+|+||||||+|||+   +.++.+||+|||++.        
T Consensus        86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            9999999986666799999999999999999999   78899999999999999   578999999998652        


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ...++.++|||||||++|||++|+.||........  .+...        .+....
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~--------~i~~~~  232 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYE--------KISEKK  232 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHH--------HHHHHH
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHH--------HHhhcc
Confidence                                    11345688999999999999999999976432211  11111        011111


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      ...   ........++.++.+++..||+.+|++||+++++++.|+++...
T Consensus       233 ~~~---~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          233 VAT---SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHS---CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccc---cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            100   00112234567899999999999999999999999999998654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.7e-36  Score=305.70  Aligned_cols=219  Identities=20%  Similarity=0.269  Sum_probs=176.9

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ++.+.||+|+||.||+|+.+ +|+.||||++.....   ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus       188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            34567999999999999986 699999999976532   33567889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          275 PKGSLENCLYSS---TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ++|+|.+++...   ...+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.       
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            999999988753   34688889999999999999999   78899999999999999999999999998652       


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...++.++|||||||++|||++|..||...... ........            ......  
T Consensus       345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~------------~i~~~~--  409 (543)
T 3c4z_A          345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQ------------RVLEQA--  409 (543)
T ss_dssp             CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHH------------HHHHCC--
T ss_pred             ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHH------------HHhhcc--
Confidence                              124677899999999999999999999754211 11111111            111110  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                        ...+...+.++.+|+.+||+.||++||++
T Consensus       410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 --VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             --cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence              11223456788999999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=285.17  Aligned_cols=220  Identities=20%  Similarity=0.297  Sum_probs=173.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc----hhhHHHHHHHHHHHHcCCCCCceeEEeEEe--cCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC----ARALKSFEAQCEVMKSIRHPNLVKVISSCS--NDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lv  270 (453)
                      |++.+.||+|+||.||++... +++.||||+++...    ....+.+.+|++++++++||||+++++++.  +.+..++|
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV   86 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred             eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence            455788999999999999975 68999999997653    234578999999999999999999999984  45678999


Q ss_pred             EeccCCCCchHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----
Q 036792          271 LEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----  345 (453)
                      |||+++| |.+.+.. ....+++.....++.++++||.||   |+.+|+||||||+||+++.++.+||+|||.+..    
T Consensus        87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999876 7666654 344688899999999999999999   788999999999999999999999999986521    


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                               ..++.++||||||+++|||++|+.||......     ....         .+   
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~---------~i---  225 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-----KLFE---------NI---  225 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHH---------HH---
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----HHHH---------HH---
Confidence                                     11255799999999999999999999753211     1111         00   


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .. .   ....+..++.++.+++.+||+.||++|||++|+++
T Consensus       226 ~~-~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          226 GK-G---SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HH-C---CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hc-C---CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00 0   01122345667899999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=293.13  Aligned_cols=222  Identities=16%  Similarity=0.137  Sum_probs=178.1

Q ss_pred             HHHhcccCCCCccEEEEEE------ECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCceeEEeEEecCCeeE
Q 036792          198 RRLSNLIGMGSFGSVYRAR------LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR---HPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~  268 (453)
                      +++.+.||+|+||.||+|.      ..+++.||||+++...   ..++.+|+++++.++   |+||+++++++..++..+
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            4567889999999999994      3468999999997553   356778888888887   999999999999999999


Q ss_pred             EEEeccCCCCchHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-----------CC
Q 036792          269 LVLEYMPKGSLENCLYS----STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-----------DM  333 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-----------~~  333 (453)
                      +||||+++|+|.+++..    ....+++.....++.|+++||.||   |+.+|+||||||+|||++.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEecccccCccccccccC
Confidence            99999999999999964    345689999999999999999999   7889999999999999998           89


Q ss_pred             cEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh
Q 036792          334 VAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN  386 (453)
Q Consensus       334 ~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  386 (453)
                      .+||+|||++.                           ...++.++|||||||++|||+||+.||.........      
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------  294 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------  294 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE------
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee------
Confidence            99999998761                           124678999999999999999999998543211100      


Q ss_pred             hhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccC-CChHHHHHHHHHHHHH
Q 036792          387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKR-INAKDIVTRLLKIRDT  450 (453)
Q Consensus       387 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R-Ps~~~v~~~L~~i~~~  450 (453)
                                ++...     ...+    .++.+.+++..|++.+|.+| |+++++.+.|+++.+.
T Consensus       295 ----------~~~~~-----~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          295 ----------PEGLF-----RRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ----------ECSCC-----TTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----------echhc-----cccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                      00000     0111    13456788999999999999 6888888888877554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-35  Score=294.15  Aligned_cols=236  Identities=19%  Similarity=0.261  Sum_probs=173.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec-------------
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN-------------  263 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------------  263 (453)
                      |++.+.||+|+||.||+|... +|+.||||++.....    ...+|+++|+.++|||||++++++..             
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~   84 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD   84 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence            456788999999999999975 799999999875532    22479999999999999999999844             


Q ss_pred             -------------------------CCeeEEEEeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036792          264 -------------------------DDFKALVLEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTT  315 (453)
Q Consensus       264 -------------------------~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~  315 (453)
                                               ....++||||++ |+|.+.+..   ....+++.....++.|+++||.||   |+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~  160 (383)
T 3eb0_A           85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI---HSL  160 (383)
T ss_dssp             -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHC
Confidence                                     334889999998 588777653   345688999999999999999999   789


Q ss_pred             CceecCCCCCceeeC-CCCcEEEeccccCC-------------------------CCCcCcccchHHHHHHHHHHHhCCC
Q 036792          316 PIIHCDLKPISVLLD-EDMVAHLSDFEYGM-------------------------EGQVSTRSDIYGYGIVLMETFTRKK  369 (453)
Q Consensus       316 ~i~Hrdlk~~NiLl~-~~~~~kl~df~~~~-------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~  369 (453)
                      +|+||||||+|||++ .++.+||+|||.+.                         ...++.++||||+||++|||++|+.
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            999999999999997 68899999998652                         1236788999999999999999999


Q ss_pred             CCCccccccccHHhHHhhhcCCchhhhh--hhhhhc-------CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHH
Q 036792          370 PTDRMFVEELSLKDWVNNLLPISLMEVV--DKTLLS-------GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI  440 (453)
Q Consensus       370 p~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~~~~-------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v  440 (453)
                      ||......+ .+...+..........+.  ++....       ........+...+.++.+|+.+||+.||++|||+.|+
T Consensus       241 pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (383)
T 3eb0_A          241 LFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA  319 (383)
T ss_dssp             SSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            997643222 112222111111111100  000000       0000011223456789999999999999999999999


Q ss_pred             HH
Q 036792          441 VT  442 (453)
Q Consensus       441 ~~  442 (453)
                      ++
T Consensus       320 l~  321 (383)
T 3eb0_A          320 MA  321 (383)
T ss_dssp             HT
T ss_pred             hc
Confidence            84

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.7e-36  Score=294.03  Aligned_cols=238  Identities=20%  Similarity=0.277  Sum_probs=181.3

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhh-----------------HHHHHHHHHHHHcCCCCCceeEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARA-----------------LKSFEAQCEVMKSIRHPNLVKVIS  259 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l~g  259 (453)
                      .|++.+.||+|+||.||+|.. +++.||||.+.......                 .+.+.+|++++++++||||+++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            356678999999999999999 89999999997543211                 278999999999999999999999


Q ss_pred             EEecCCeeEEEEeccCCCCchHH------hhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCceeeCC
Q 036792          260 SCSNDDFKALVLEYMPKGSLENC------LYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHT-TPIIHCDLKPISVLLDE  331 (453)
Q Consensus       260 ~~~~~~~~~lv~E~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~-~~i~Hrdlk~~NiLl~~  331 (453)
                      ++.+++..++||||+++|+|.++      +... ...+++.....++.+++.|+.||   |+ .+++||||||+||+++.
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGGGEEECT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChHhEEEcC
Confidence            99999999999999999999998      5442 45788999999999999999999   66 89999999999999999


Q ss_pred             CCcEEEeccccCCC-----------------------C-CcCc-ccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh
Q 036792          332 DMVAHLSDFEYGME-----------------------G-QVST-RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN  386 (453)
Q Consensus       332 ~~~~kl~df~~~~~-----------------------~-~~~~-~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  386 (453)
                      ++.+||+|||.+..                       . .++. ++|||||||++|||++|..||....... .....+.
T Consensus       188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~i~  266 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-ELFNNIR  266 (348)
T ss_dssp             TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-HHHHHHT
T ss_pred             CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHh
Confidence            99999999986521                       1 3344 8999999999999999999997543211 1111111


Q ss_pred             hh-c--CCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          387 NL-L--PISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       387 ~~-~--~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .. .  +........... .  .........++.++.+++.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          267 TKNIEYPLDRNHFLYPLT-N--KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCCCCCCCSSSSSTTTTC-C----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCcCCccchhhhhcccc-c--cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11 0  000000000000 0  0000111345678999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-35  Score=290.79  Aligned_cols=238  Identities=20%  Similarity=0.233  Sum_probs=178.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-----CeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSND-----DFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lv  270 (453)
                      +++.+.||+|+||.||+|.+. +|+.||||+++... ......+.+|++++++++||||+++++++..+     ...++|
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   92 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII   92 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred             eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence            456788999999999999976 68999999997543 34456788999999999999999999988764     678999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      |||++ |+|.+++...  .+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.+.      
T Consensus        93 ~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           93 QELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             ECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            99997 5899988763  588899999999999999999   78899999999999999999999999998642      


Q ss_pred             ------------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cCC--
Q 036792          345 ------------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LPI--  391 (453)
Q Consensus       345 ------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~--  391 (453)
                                                    ...++.++|||||||++|||++|+.||......+. +....... .+.  
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTPHSD  245 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCST
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCchh
Confidence                                          12356689999999999999999999976432211 11111000 000  


Q ss_pred             ch---------hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          392 SL---------MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       392 ~~---------~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..         .+.+.................+++++.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00         0000000000000001112345678999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=287.06  Aligned_cols=224  Identities=21%  Similarity=0.294  Sum_probs=178.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEec------CCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSN------DDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~~~~  267 (453)
                      ..|++.+.||+|+||.||+|++. +++.||||++..... ..+.+.+|+.+++++ +||||+++++++..      .+..
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~  102 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL  102 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence            34567889999999999999975 789999999975433 346788999999998 79999999999977      4678


Q ss_pred             EEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--
Q 036792          268 ALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--  344 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--  344 (453)
                      ++||||+++|+|.+++... ...++......++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++.  
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            9999999999999998764 24678888999999999999999   78899999999999999999999999998642  


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                                                  ...++.++|||||||++|||++|..||........  ...+..         
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---------  248 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPR---------  248 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH---------
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhc---------
Confidence                                        12356789999999999999999999865421110  000000         


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             ... .......++.++.+++.+||+.||++|||++|+++
T Consensus       249 -------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          249 -------NPA-PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -------SCC-CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -------Ccc-ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                   000 00111234567899999999999999999999886

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1e-35  Score=299.20  Aligned_cols=172  Identities=21%  Similarity=0.302  Sum_probs=148.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcC------CCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSI------RHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~~lv  270 (453)
                      |++.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+++++.+      .|+||+++++++...+..++|
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  177 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT  177 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence            567889999999999999876 58999999997543 3345677888887776      577999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc--EEEeccccCC---
Q 036792          271 LEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV--AHLSDFEYGM---  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~--~kl~df~~~~---  344 (453)
                      |||+. |+|.+++.... ..+++.....++.++++||.||   |+.+|+||||||+|||++.++.  +||+|||++.   
T Consensus       178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            99996 68998887643 4588999999999999999999   7789999999999999999887  9999998652   


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRM  374 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  374 (453)
                                         ...++.++|||||||++|||+||.+||...
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence                               134678999999999999999999999765

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-35  Score=293.04  Aligned_cols=237  Identities=19%  Similarity=0.226  Sum_probs=178.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCee------E
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFK------A  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~------~  268 (453)
                      |.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..      +
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  123 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  123 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred             EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence            456788999999999999976 68999999997643  33457889999999999999999999999887654      9


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+. |+|.+.+..   .+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.+.    
T Consensus       124 lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          124 LVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             EEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             EEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            9999997 588877643   478899999999999999999   78899999999999999999999999998652    


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-cC-Cchhhhh------
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-LP-ISLMEVV------  397 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~------  397 (453)
                                         ...++.++|||||||++|||++|+.||......+. +....... .+ ......+      
T Consensus       197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~  275 (371)
T 4exu_A          197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLNDKAAK  275 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred             CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCcHHHHHHhhhhhhh
Confidence                               13567889999999999999999999976432211 11111111 01 0000000      


Q ss_pred             --hhhhhcCccC-CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          398 --DKTLLSGEKK-GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       398 --d~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ...+...... .......+++++.+|+.+||+.||++|||+.|+++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence              0000000000 01112345678999999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-35  Score=313.45  Aligned_cols=214  Identities=19%  Similarity=0.250  Sum_probs=176.5

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEec
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      ++.+.||+|+||.||+|+.+ +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus       344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~  423 (674)
T 3pfq_A          344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY  423 (674)
T ss_dssp             EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred             EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence            45678999999999999976 68899999998642   23456788899999987 799999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||++.         
T Consensus       424 ~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~  499 (674)
T 3pfq_A          424 VNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT  499 (674)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence            99999999997643 588889999999999999999   78899999999999999999999999998652         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|..||......+                 ++...+...    
T Consensus       500 ~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-----------------~~~~i~~~~----  558 (674)
T 3pfq_A          500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----------------LFQSIMEHN----  558 (674)
T ss_dssp             CCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHSSC----
T ss_pred             ccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-----------------HHHHHHhCC----
Confidence                            1346778999999999999999999997542211                 111111111    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCCh
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINA  437 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  437 (453)
                      ...+...+.++.+|+.+||+.||++||++
T Consensus       559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            11223456789999999999999999997

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.9e-35  Score=291.05  Aligned_cols=238  Identities=19%  Similarity=0.192  Sum_probs=180.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-----CeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSND-----DFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l  269 (453)
                      .|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            3567889999999999999976 68899999997543 34457889999999999999999999998764     36899


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      ||||++ |+|.+++...  .+++.....++.+++.||.||   |+.+|+||||||+|||++.++.+||+|||.+.     
T Consensus       108 v~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            999997 5999988764  488899999999999999999   78899999999999999999999999998642     


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh--
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD--  398 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  398 (453)
                                              ...++.++||||+||++|||++|+.||......+. +.......... ..+.+.  
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~-~~~~~~~~  259 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSP-SQEDLNCI  259 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSC-CHHHHHTC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCC-CHHHHHHh
Confidence                                    12357789999999999999999999976533221 11111111110 000000  


Q ss_pred             ------hhhhcC---c-cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 ------KTLLSG---E-KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ------~~~~~~---~-~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                            ......   . ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  000000   0 0001111234678899999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-35  Score=294.71  Aligned_cols=240  Identities=21%  Similarity=0.265  Sum_probs=177.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC--------CCCceeEEeEEe----cC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR--------HPNLVKVISSCS----ND  264 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~----~~  264 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+++++.++        |+||+++++++.    ..
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~  117 (397)
T 1wak_A           39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG  117 (397)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred             EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence            566788999999999999865 6899999999754 334567889999999886        788999999987    56


Q ss_pred             CeeEEEEeccCCCCchHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceeeCCCC---------
Q 036792          265 DFKALVLEYMPKGSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTT-PIIHCDLKPISVLLDEDM---------  333 (453)
Q Consensus       265 ~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~-~i~Hrdlk~~NiLl~~~~---------  333 (453)
                      ...++||||+ +|+|.+.+.. ....+++.....++.|+++||.||   |++ +|+||||||+|||++.++         
T Consensus       118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence            6889999999 5566666544 335688999999999999999999   676 999999999999998765         


Q ss_pred             ----------------------------------------cEEEeccccCC----------------------CCCcCcc
Q 036792          334 ----------------------------------------VAHLSDFEYGM----------------------EGQVSTR  351 (453)
Q Consensus       334 ----------------------------------------~~kl~df~~~~----------------------~~~~~~~  351 (453)
                                                              .+||+|||.+.                      ...++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  273 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP  273 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcH
Confidence                                                    79999998652                      2346789


Q ss_pred             cchHHHHHHHHHHHhCCCCCCcccccccc-----HHhHHhhh--cCCchh-------hhhhhh--hhcCcc---------
Q 036792          352 SDIYGYGIVLMETFTRKKPTDRMFVEELS-----LKDWVNNL--LPISLM-------EVVDKT--LLSGEK---------  406 (453)
Q Consensus       352 ~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~-----~~~~~~~~--~~~~~~-------~~~d~~--~~~~~~---------  406 (453)
                      +|||||||++|||+||+.||......+..     +.......  .+....       +.....  ......         
T Consensus       274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (397)
T 1wak_A          274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV  353 (397)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHH
T ss_pred             HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHh
Confidence            99999999999999999999754333221     11111100  010000       000000  000000         


Q ss_pred             --CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 --KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 --~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .....+...+.++.+|+.+||+.||++|||++|+++
T Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence              001123567788999999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.2e-35  Score=284.41  Aligned_cols=221  Identities=18%  Similarity=0.304  Sum_probs=177.2

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCC--CCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIR--HPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||++...+++.||||++....  ....+.+.+|++++++++  ||||+++++++..++..++||| 
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-  108 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  108 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence            45678999999999999998889999999997543  345578999999999997  5999999999999999999999 


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME--------  345 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~--------  345 (453)
                      +.+++|.+++.... .+++.....++.++++||.||   |+.+|+||||||+||++++ +.+||+|||++..        
T Consensus       109 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          109 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence            56889999997654 678889999999999999999   7889999999999999974 8899999986521        


Q ss_pred             ------------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          346 ------------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       346 ------------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                                                    ..++.++|||||||++|||++|+.||...........            .
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~------------~  251 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH------------A  251 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH------------H
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH------------H
Confidence                                          1456689999999999999999999965422111111            1


Q ss_pred             hhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .++...      ....+..++.++.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          252 IIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhccc------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            111111      01112233567899999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.1e-35  Score=295.04  Aligned_cols=236  Identities=22%  Similarity=0.289  Sum_probs=171.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv  270 (453)
                      |++.+.||+|+||.||+|++. +|+.||||++.....    .+.+|+++|+.++|||||+++++|...      ...++|
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            566788999999999999986 689999999875432    234799999999999999999988542      236799


Q ss_pred             EeccCCCCchHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-CcEEEeccccCC--
Q 036792          271 LEYMPKGSLENCLY---SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-MVAHLSDFEYGM--  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-~~~kl~df~~~~--  344 (453)
                      |||+++ ++.+.+.   .....+++.....++.|+++||.||   |+.+|+||||||+|||++.+ +.+||+|||++.  
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999976 6666554   2345688999999999999999999   78999999999999999965 578999998652  


Q ss_pred             ----------------------C-CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh--hhh
Q 036792          345 ----------------------E-GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV--VDK  399 (453)
Q Consensus       345 ----------------------~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~d~  399 (453)
                                            . ..++.++|||||||++|||++|++||.+....+ .+.+.+..........+  .++
T Consensus       208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHHHHCS
T ss_pred             ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhCh
Confidence                                  1 246778999999999999999999997643221 12222221111110000  000


Q ss_pred             hhhcCccC---Cc----hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          400 TLLSGEKK---GF----VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       400 ~~~~~~~~---~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .......+   ..    ......++++.+|+.+||+.||++|||+.|+++
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00000000   00    011234678999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-35  Score=288.42  Aligned_cols=237  Identities=18%  Similarity=0.223  Sum_probs=178.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe------eE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF------KA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~  268 (453)
                      |.+.+.||+|+||.||+|..+ +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+.      .+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            456788999999999999976 68999999997543  2345678999999999999999999999987654      49


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +||||++ |+|.+.+..   .+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.+..   
T Consensus       106 lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             EEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             EEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            9999997 588877643   478899999999999999999   788999999999999999999999999986521   


Q ss_pred             --------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh-c-CCchhhhhh-----
Q 036792          346 --------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL-L-PISLMEVVD-----  398 (453)
Q Consensus       346 --------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~d-----  398 (453)
                                          ..++.++|||||||++|||++|..||......+. +....... . +....+.+.     
T Consensus       179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~  257 (353)
T 3coi_A          179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLNDKAAK  257 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred             CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHHhhHHHH
Confidence                                3467789999999999999999999975432211 11111110 0 000000000     


Q ss_pred             ---hhhhcCcc-CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 ---KTLLSGEK-KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ---~~~~~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..+..... ........++.++.+++.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               00000000 001122345778999999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.6e-35  Score=284.14  Aligned_cols=224  Identities=21%  Similarity=0.242  Sum_probs=164.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hh-HHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RA-LKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +++.+.||+|+||.||+|.++ +|+.||||++..... .. .+.+.++..+++.++||||+++++++..++..++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM  106 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence            455688999999999999986 689999999976532 22 234445556788899999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT-PIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~-~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                       ++.+..........+++.....++.++++||.||   |++ +++||||||+||+++.++.+||+|||.+.         
T Consensus       107 -~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (318)
T 2dyl_A          107 -GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL---KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD  182 (318)
T ss_dssp             -SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             -CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence             4455554444345688899999999999999999   554 89999999999999999999999998652         


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ...++.++|||||||++|||++|+.||.........+......                 
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----------------  245 (318)
T 2dyl_A          183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-----------------  245 (318)
T ss_dssp             ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-----------------
T ss_pred             ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-----------------
Confidence                                1235668999999999999999999986532211111111110                 


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .....+....++.++.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            00011111235567899999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-35  Score=286.87  Aligned_cols=226  Identities=23%  Similarity=0.261  Sum_probs=171.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHH-HHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCE-VMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      +++.+.||+|+||.||+|... +|+.||||+++... .....++..|+. +++.++||||+++++++..++..++||||+
T Consensus        24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~  103 (327)
T 3aln_A           24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM  103 (327)
T ss_dssp             EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence            345688999999999999986 68999999997653 233455666666 677889999999999999999999999999


Q ss_pred             CCCCchHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          275 PKGSLENCLYS----STCMLDIFQRLNIMIDATSTLEYLYFGHTT-PIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       275 ~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~-~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      ++ +|.+++..    ....+++.....++.+++.|+.||   |+. +|+||||||+||+++.++.+||+|||.+.     
T Consensus       104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            75 78777652    245688889999999999999999   666 99999999999999999999999998652     


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ...++.++|||||||++|||++|+.||.........+    .        .+.....
T Consensus       180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~--------~~~~~~~  247 (327)
T 3aln_A          180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----T--------QVVKGDP  247 (327)
T ss_dssp             --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------C--------CCCCSCC
T ss_pred             cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----H--------HHhcCCC
Confidence                                   1235678999999999999999999986532111000    0        0000000


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                         ..........++.++.+++.+||+.||++|||+.|+++
T Consensus       248 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 ---PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ---CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               00000111235667999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.4e-35  Score=291.03  Aligned_cols=168  Identities=20%  Similarity=0.326  Sum_probs=136.5

Q ss_pred             hcccCCCCccEEEEEEEC---CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEEeccC
Q 036792          201 SNLIGMGSFGSVYRARLR---DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVLEYMP  275 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~E~~~  275 (453)
                      +++||+|+||.||+|+++   +++.||||++.....  ...+.+|+++|++++|||||++++++..  +...++||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            468999999999999976   578999999975432  2467899999999999999999999954  778999999996


Q ss_pred             CCCchHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee----CCCCcEEEeccccC
Q 036792          276 KGSLENCLYSS--------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL----DEDMVAHLSDFEYG  343 (453)
Q Consensus       276 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl----~~~~~~kl~df~~~  343 (453)
                       |+|.+++...        ...+++.....++.+++.||.||   |+.+|+||||||+|||+    +.++.+||+|||++
T Consensus       104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence             4887777521        22478888999999999999999   78899999999999999    67789999999865


Q ss_pred             CC-----------------------------CCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 036792          344 ME-----------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRM  374 (453)
Q Consensus       344 ~~-----------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  374 (453)
                      ..                             ..++.++|||||||++|||++|++||...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            21                             23677899999999999999999999654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-34  Score=284.12  Aligned_cols=241  Identities=19%  Similarity=0.240  Sum_probs=164.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe-------eEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF-------KAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-------~~l  269 (453)
                      |++.+.||+|+||.||+|+.. +|+.||||++..... ....+.+|++.++.++||||+++++++...+.       .++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l  103 (360)
T 3e3p_A           25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV  103 (360)
T ss_dssp             EEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence            345788999999999999976 689999999865432 23456778888899999999999999866333       789


Q ss_pred             EEeccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC
Q 036792          270 VLEYMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME  345 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~  345 (453)
                      ||||+++ +|.+.+..   ....++......++.+++.|+.|||. |+.+|+||||||+|||++. ++.+||+|||++..
T Consensus       104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            9999986 55554432   34567888889999999999999942 3999999999999999997 89999999986521


Q ss_pred             -------------------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC--chhhhhh
Q 036792          346 -------------------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI--SLMEVVD  398 (453)
Q Consensus       346 -------------------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~d  398 (453)
                                               ..++.++|||||||++|||++|+.||......+ .+....+.....  .....++
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCCCCHHHHHhcc
Confidence                                     236788999999999999999999997643221 122222211111  1111111


Q ss_pred             hhhhc-----CccCC-----chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          399 KTLLS-----GEKKG-----FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       399 ~~~~~-----~~~~~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +....     .....     ......++.++.+|+.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            10000     00000     0011125678999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.7e-35  Score=291.31  Aligned_cols=236  Identities=24%  Similarity=0.313  Sum_probs=171.8

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~lv~  271 (453)
                      |++.+.||+|+||.||+|++..+..||+|++......    ..+|+++|+.++||||+++++++...+      ..++||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            5667899999999999999887777999988654321    236999999999999999999986533      378999


Q ss_pred             eccCCCCchHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC-CCCcEEEeccccCC---
Q 036792          272 EYMPKGSLENCLY---SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD-EDMVAHLSDFEYGM---  344 (453)
Q Consensus       272 E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~-~~~~~kl~df~~~~---  344 (453)
                      ||++++ +.+.+.   .....+++.....++.|+++||.||   |+.+|+||||||+|||++ .++.+||+|||.+.   
T Consensus       118 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          118 EYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             ECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            999875 433332   2244688888999999999999999   788999999999999999 78999999998652   


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCch--hhhhhhh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISL--MEVVDKT  400 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~d~~  400 (453)
                                            ...++.++||||+||++|||++|+.||.+....+ .+............  ....++.
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhChh
Confidence                                  1246788999999999999999999997653221 11112211111110  0001111


Q ss_pred             hhcCcc---CC----chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEK---KG----FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~---~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......   ..    ...+...++++.+|+.+||+.||++|||+.|+++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            100000   00    0112235678999999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-35  Score=283.52  Aligned_cols=242  Identities=22%  Similarity=0.283  Sum_probs=177.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC--CCCEEEEEEeeccchh--hHHHHHHHHHHHHcC---CCCCceeEEeEEe-----c
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR--DGIEVAVKVFHQECAR--ALKSFEAQCEVMKSI---RHPNLVKVISSCS-----N  263 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~  263 (453)
                      ..|++.+.||+|+||.||+|+..  +|+.||||+++.....  ....+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            34567889999999999999973  6889999999754321  223566777776655   8999999999987     5


Q ss_pred             CCeeEEEEeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc
Q 036792          264 DDFKALVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY  342 (453)
Q Consensus       264 ~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~  342 (453)
                      ....++||||++ |+|.+++.... ..+++.....++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||.
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence            567899999997 69999887643 3588899999999999999999   788999999999999999999999999986


Q ss_pred             CC------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC--chhh
Q 036792          343 GM------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI--SLME  395 (453)
Q Consensus       343 ~~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~  395 (453)
                      +.                        ...++.++|||||||++|||++|+.||......+ .+........ +.  .+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGSCT
T ss_pred             cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCcccCcc
Confidence            52                        1345778999999999999999999997543221 1111111110 00  0000


Q ss_pred             hh---hhhhhcC-ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VV---DKTLLSG-EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~---d~~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..   ....... ..........++.++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00   0000000 00011122345678899999999999999999999974

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.9e-35  Score=282.26  Aligned_cols=238  Identities=17%  Similarity=0.250  Sum_probs=179.5

Q ss_pred             HHHHhcccCCCCccEEEEEEE-C-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCC------CceeEEeEEecCCeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARL-R-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP------NLVKVISSCSNDDFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~~~~~~~~  268 (453)
                      .|++.+.||+|+||.||+|.. . +++.||||+++... ...+.+.+|+++++.++|+      +++++++++...+..+
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            356778999999999999987 3 68899999997542 3456788999999888765      4999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC----------------
Q 036792          269 LVLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE----------------  331 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~----------------  331 (453)
                      +||||+ +++|.+++.... ..+++.....++.|+++||.||   |+.+|+||||||+||+++.                
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            999999 889999887653 3578889999999999999999   7889999999999999987                


Q ss_pred             ---CCcEEEeccccCC----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh
Q 036792          332 ---DMVAHLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN  386 (453)
Q Consensus       332 ---~~~~kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  386 (453)
                         ++.+||+|||.+.                      ...++.++|||||||++|||++|..||......+  ....+.
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~  247 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE--HLAMME  247 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH--HHHHHH
T ss_pred             cccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH
Confidence               6689999998642                      2346788999999999999999999997543221  111111


Q ss_pred             hh---cCCchhhh-----------------------hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHH
Q 036792          387 NL---LPISLMEV-----------------------VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI  440 (453)
Q Consensus       387 ~~---~~~~~~~~-----------------------~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v  440 (453)
                      ..   .+..+...                       +..... ...........+++++.+|+.+||+.||++|||++|+
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  326 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA  326 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence            11   11110000                       000000 0000011223567889999999999999999999999


Q ss_pred             HH
Q 036792          441 VT  442 (453)
Q Consensus       441 ~~  442 (453)
                      ++
T Consensus       327 l~  328 (339)
T 1z57_A          327 LK  328 (339)
T ss_dssp             TT
T ss_pred             hc
Confidence            74

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.3e-34  Score=285.22  Aligned_cols=175  Identities=23%  Similarity=0.310  Sum_probs=147.7

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CC-----CceeEEeEEecCCeeEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HP-----NLVKVISSCSNDDFKAL  269 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~l  269 (453)
                      .|++.+.||+|+||.||+|... +++.||||+++... ....++.+|+.+++.++ |+     +|+++.+++...+..++
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  133 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL  133 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence            3566789999999999999976 68899999997542 33466778888888875 44     49999999999999999


Q ss_pred             EEeccCCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC--CCCcEEEeccccCC--
Q 036792          270 VLEYMPKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD--EDMVAHLSDFEYGM--  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~--~~~~~kl~df~~~~--  344 (453)
                      ||||++ |+|.+++.... ..+++.....++.+++.||.|||. |+.+|+||||||+|||++  .++.+||+|||++.  
T Consensus       134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            999996 59999987653 458899999999999999999952 468999999999999995  47789999998652  


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRM  374 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~  374 (453)
                                          ...++.++|||||||++|||+||+.||...
T Consensus       212 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          212 GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                                234678999999999999999999999754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-34  Score=288.85  Aligned_cols=220  Identities=21%  Similarity=0.316  Sum_probs=168.1

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      +.+.||+|+||+||.+...+|+.||||++....   .+.+.+|++++.++ +|||||++++++.+++..++||||+. |+
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            457899999999987766689999999987543   35678899999876 89999999999999999999999995 69


Q ss_pred             chHHhhcCCCCC------CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCC-------------CcEEEec
Q 036792          279 LENCLYSSTCML------DIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDED-------------MVAHLSD  339 (453)
Q Consensus       279 L~~~l~~~~~~l------~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~-------------~~~kl~d  339 (453)
                      |.+++.......      .+.....++.|++.||.||   |+.+|+||||||+|||++.+             +.+||+|
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence            999997643211      1223467999999999999   78899999999999999653             5899999


Q ss_pred             cccCC------------------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          340 FEYGM------------------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       340 f~~~~------------------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      ||++.                                    ...++.++|||||||++|||+| |..||......+   .
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~  248 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---S  248 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---H
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---H
Confidence            97542                                    1345678999999999999999 999986542221   1


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .........             ..........++.++.+++.+||+.||++|||+.|+++
T Consensus       249 ~i~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 NIIRGIFSL-------------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHTCCCC-------------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCCc-------------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            111111100             00011123456788999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-34  Score=279.98  Aligned_cols=222  Identities=18%  Similarity=0.239  Sum_probs=163.8

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec----CCeeEEEEeccC
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN----DDFKALVLEYMP  275 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~E~~~  275 (453)
                      .++||+|+||.||+|..+ +++.||||++..... .   ..+....++.++||||+++++++..    +...++||||++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-A---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-H---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-H---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            457999999999999987 689999999975421 1   1222234567799999999999876    445899999999


Q ss_pred             CCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC-------
Q 036792          276 KGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM-------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~-------  344 (453)
                      +|+|.+++.... ..+++.....++.+++.||.||   |+.+|+||||||+||+++.   ++.+||+|||.+.       
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~  186 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL  186 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccccc
Confidence            999999997653 3688999999999999999999   7889999999999999976   4569999998652       


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++|||||||++|||++|..||........... .         ...+.   .......
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~---------~~~~~---~~~~~~~  253 (336)
T 3fhr_A          187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-M---------KRRIR---LGQYGFP  253 (336)
T ss_dssp             -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------------CCC
T ss_pred             ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-H---------HHhhh---ccccccC
Confidence                            12345679999999999999999999965432211000 0         00000   0000001


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+....++.++.+|+.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1112345678899999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=288.29  Aligned_cols=219  Identities=20%  Similarity=0.314  Sum_probs=165.9

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEeccCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLEYMPKG  277 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E~~~~g  277 (453)
                      ++.+.||+|+||+|+.....+++.||||++.....   ..+.+|+++|+++ +|||||++++++.+....++||||++ |
T Consensus        27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g  102 (432)
T 3p23_A           27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A  102 (432)
T ss_dssp             EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence            34678999999997665566799999999975432   2356799999999 79999999999999999999999996 5


Q ss_pred             CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-----CCcEEEeccccCC--------
Q 036792          278 SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-----DMVAHLSDFEYGM--------  344 (453)
Q Consensus       278 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-----~~~~kl~df~~~~--------  344 (453)
                      +|.+++..............++.|+++||.||   |+.+|+||||||+|||++.     ...+||+|||++.        
T Consensus       103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             CHHHHHHhcCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            99999987654455455678899999999999   7889999999999999943     3468899998641        


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                             ...++.++|||||||++|||+| |..||........   .....             
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---~~~~~-------------  243 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---NILLG-------------  243 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---HHHTT-------------
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---HHHhc-------------
Confidence                                   1223457999999999999999 8999854321110   00000             


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .............+..+.+|+.+||+.||++|||++|+++
T Consensus       244 --~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 --ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             --CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence              0000001112344566889999999999999999999983

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-34  Score=279.86  Aligned_cols=238  Identities=16%  Similarity=0.216  Sum_probs=177.0

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CC-CEEEEEEeeccchhhHHHHHHHHHHHHcCCCCC------ceeEEeEEecCCeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DG-IEVAVKVFHQECARALKSFEAQCEVMKSIRHPN------LVKVISSCSNDDFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~  268 (453)
                      .|++.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|++++++++|++      ++.+.+++...+..+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            3567789999999999999975 44 78999999754 234567888999999887765      999999999999999


Q ss_pred             EEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceee------------------
Q 036792          269 LVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLL------------------  329 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl------------------  329 (453)
                      +||||+ +|++.+.+... ...+++.....++.|++.||.||   |+.+|+||||||+|||+                  
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999 56777766554 34688999999999999999999   78899999999999999                  


Q ss_pred             -CCCCcEEEeccccCC----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh
Q 036792          330 -DEDMVAHLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN  386 (453)
Q Consensus       330 -~~~~~~kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  386 (453)
                       +.++.+||+|||.+.                      ...++.++|||||||++|||++|..||......+.  ...+.
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~  252 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH--LVMME  252 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH
T ss_pred             ccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence             567899999998652                      23567889999999999999999999975432211  11111


Q ss_pred             hh---cCCchhhhh-----------------------hhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHH
Q 036792          387 NL---LPISLMEVV-----------------------DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI  440 (453)
Q Consensus       387 ~~---~~~~~~~~~-----------------------d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v  440 (453)
                      ..   .|.......                       ...... ...........+.++.+|+.+||+.||++|||+.|+
T Consensus       253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP-LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCc-ccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence            11   111100000                       000000 000001123446689999999999999999999999


Q ss_pred             HH
Q 036792          441 VT  442 (453)
Q Consensus       441 ~~  442 (453)
                      ++
T Consensus       332 l~  333 (355)
T 2eu9_A          332 LL  333 (355)
T ss_dssp             TT
T ss_pred             hc
Confidence            74

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.9e-35  Score=283.73  Aligned_cols=214  Identities=18%  Similarity=0.258  Sum_probs=174.1

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchh------hHHHHHHHHHHHHcCC--CCCceeEEeEEecCCeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR------ALKSFEAQCEVMKSIR--HPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~  268 (453)
                      |++.+.||+|+||.||+|... +++.||||.++.....      ..+.+.+|+.++++++  ||||+++++++..++..+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            567789999999999999865 6899999999765321      2245678999999996  599999999999999999


Q ss_pred             EEEeccCC-CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC-CCCcEEEeccccCCC-
Q 036792          269 LVLEYMPK-GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD-EDMVAHLSDFEYGME-  345 (453)
Q Consensus       269 lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~-~~~~~kl~df~~~~~-  345 (453)
                      +|+||+.+ ++|.+++.... .+++.....++.++++||.||   |+.+|+||||||+||+++ +++.+||+|||.+.. 
T Consensus       125 lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~  200 (320)
T 3a99_A          125 LILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  200 (320)
T ss_dssp             EEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence            99999976 89999887643 578889999999999999999   788999999999999999 788999999986421 


Q ss_pred             ----------------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 ----------------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 ----------------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            .. .+.++|||||||++|||++|+.||....       ....            ... 
T Consensus       201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~------------~~~-  260 (320)
T 3a99_A          201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR------------GQV-  260 (320)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH------------CCC-
T ss_pred             ccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhc------------ccc-
Confidence                                  11 2457899999999999999999986421       0000            000 


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             ..+..++.++.+++.+||+.||++|||++|+++
T Consensus       261 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 -------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   011234567899999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=283.46  Aligned_cols=214  Identities=21%  Similarity=0.332  Sum_probs=168.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHcC----CCCCceeEEeEEecCCe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA------RALKSFEAQCEVMKSI----RHPNLVKVISSCSNDDF  266 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g~~~~~~~  266 (453)
                      |++.+.||+|+||.||+|+.. +++.||||+++....      .....+.+|+.++.++    +||||+++++++...+.
T Consensus        33 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~  112 (312)
T 2iwi_A           33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG  112 (312)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----
T ss_pred             eEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCe
Confidence            456789999999999999865 689999999975532      1223456789988888    89999999999999999


Q ss_pred             eEEEEec-cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC-CCCcEEEeccccCC
Q 036792          267 KALVLEY-MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD-EDMVAHLSDFEYGM  344 (453)
Q Consensus       267 ~~lv~E~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~-~~~~~kl~df~~~~  344 (453)
                      .++|+|| +++++|.+++.... .+++.....++.++++||.||   |+.+|+||||||+||+++ .++.+||+|||.+.
T Consensus       113 ~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          113 FMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            9999999 78999999987643 588999999999999999999   778999999999999999 78999999998642


Q ss_pred             C-----------------------CCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 E-----------------------GQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ~-----------------------~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                      .                       ..+ +.++|||||||++|||++|+.||....       ..            .+..
T Consensus       189 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~------------~~~~  249 (312)
T 2iwi_A          189 LLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EI------------LEAE  249 (312)
T ss_dssp             ECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH------------HHTC
T ss_pred             hcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HH------------hhhc
Confidence            1                       112 347999999999999999999986421       00            0000


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .        ..+..++.++.+++.+||+.+|++|||++|+++
T Consensus       250 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 L--------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             C--------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             c--------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0        112234567889999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-34  Score=285.63  Aligned_cols=242  Identities=17%  Similarity=0.232  Sum_probs=176.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-----------CCCceeEEeEEec
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-----------HPNLVKVISSCSN  263 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~  263 (453)
                      ..|++.+.||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            34567889999999999999975 78999999997543 33467888999988876           8999999999876


Q ss_pred             CC----eeEEEEeccCCCCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCceeeC------C
Q 036792          264 DD----FKALVLEYMPKGSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTT-PIIHCDLKPISVLLD------E  331 (453)
Q Consensus       264 ~~----~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~-~i~Hrdlk~~NiLl~------~  331 (453)
                      .+    ..++||||+ +++|.+++... ...+++.....++.+++.||.||   |++ +|+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM---HRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEecCCChHHeEEeccCCCcC
Confidence            44    789999999 88999998763 34588899999999999999999   676 999999999999994      4


Q ss_pred             CCcEEEeccccCC----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccc-----ccHHhH
Q 036792          332 DMVAHLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE-----LSLKDW  384 (453)
Q Consensus       332 ~~~~kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-----~~~~~~  384 (453)
                      .+.+||+|||++.                      ...++.++|||||||++|||+||..||.......     ..+...
T Consensus       174 ~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             cceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            4589999998652                      1346788999999999999999999997543211     111111


Q ss_pred             Hhhh--cCCchh-------hhhhhh-----hhcCc--------cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          385 VNNL--LPISLM-------EVVDKT-----LLSGE--------KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       385 ~~~~--~~~~~~-------~~~d~~-----~~~~~--------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....  .|....       ..++..     +....        ......+..++.++.+|+.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            1110  010000       000000     00000        0011233567889999999999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-33  Score=300.61  Aligned_cols=219  Identities=22%  Similarity=0.286  Sum_probs=174.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC--CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCe-----eE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR--DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDF-----KA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~  268 (453)
                      .|++.+.||+|+||.||+|.+.  +|+.||||++.... ....+.+.+|++++++++|||||++++++...+.     .+
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            3567789999999999999975  58999999986543 3455678999999999999999999999987655     69


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC---
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME---  345 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~---  345 (453)
                      +||||+++++|.+++..   .+++.....++.+++.||.||   |+.+|+||||||+|||++.+ .+||+|||.+..   
T Consensus       161 lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             EEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            99999999999887654   588999999999999999999   78899999999999999986 899999986521   


Q ss_pred             -----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          346 -----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       346 -----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                       ...+.++|||||||++|||++|.+|+........          +                 .
T Consensus       234 ~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~-----------------~  286 (681)
T 2pzi_A          234 FGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P-----------------E  286 (681)
T ss_dssp             CSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C-----------------T
T ss_pred             CCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc----------c-----------------c
Confidence                             1235689999999999999999988764321110          0                 0


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCC-ChHHHHHHHHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRI-NAKDIVTRLLKIRD  449 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~  449 (453)
                      .......++.+.+++.+||+.||++|| +++++...|..+..
T Consensus       287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            011123456788999999999999999 56777777776643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-33  Score=294.48  Aligned_cols=239  Identities=22%  Similarity=0.274  Sum_probs=176.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEec------CCee
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSN------DDFK  267 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~  267 (453)
                      ..|++.+.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            34677889999999999999975 6899999998765 34456789999999999999999999998765      6678


Q ss_pred             EEEEeccCCCCchHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCc---EEEecccc
Q 036792          268 ALVLEYMPKGSLENCLYSST--CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMV---AHLSDFEY  342 (453)
Q Consensus       268 ~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~---~kl~df~~  342 (453)
                      ++||||+++|+|.+++....  ..+++.....++.+++.|+.||   |+.+|+||||||+||+++.++.   +||+|||.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999997643  2577788899999999999999   7789999999999999997654   99999976


Q ss_pred             CC------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchh----
Q 036792          343 GM------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM----  394 (453)
Q Consensus       343 ~~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  394 (453)
                      +.                        ...++.++|||||||++|||++|..||.....    ...|..........    
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------CCS
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchhhhh
Confidence            52                        13457789999999999999999999864311    11121111100000    


Q ss_pred             -hhhhhhhhc--CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHH
Q 036792          395 -EVVDKTLLS--GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV  441 (453)
Q Consensus       395 -~~~d~~~~~--~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~  441 (453)
                       +........  ............+..+.+++.+||+.||++|||+.|++
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence             000000000  00011123345678899999999999999999998843

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-33  Score=282.16  Aligned_cols=223  Identities=15%  Similarity=0.131  Sum_probs=161.7

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHHHHHHHHHcCCC-CCcee-----------------
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRH-PNLVK-----------------  256 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~-----------------  256 (453)
                      .+.+.||+|+||.||+|.+. +|+.||||+++....   ...+.+.+|+.+++.++| +|...                 
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  160 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  160 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence            34678999999999999965 799999999874322   235778999999999987 32211                 


Q ss_pred             ----EEeEEec-----CCeeEEEEeccCCCCchHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 036792          257 ----VISSCSN-----DDFKALVLEYMPKGSLENCLY------SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCD  321 (453)
Q Consensus       257 ----l~g~~~~-----~~~~~lv~E~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrd  321 (453)
                          +..++..     ....+++|+++ +++|.+++.      .....+++..++.++.|+++||.||   |+++|+|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~iiHrD  236 (413)
T 3dzo_A          161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGLVHTY  236 (413)
T ss_dssp             C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEECSC
T ss_pred             CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCC
Confidence                1111111     22356777765 679998884      2233466778889999999999999   788999999


Q ss_pred             CCCCceeeCCCCcEEEeccccCC-------------------------------CCCcCcccchHHHHHHHHHHHhCCCC
Q 036792          322 LKPISVLLDEDMVAHLSDFEYGM-------------------------------EGQVSTRSDIYGYGIVLMETFTRKKP  370 (453)
Q Consensus       322 lk~~NiLl~~~~~~kl~df~~~~-------------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p  370 (453)
                      |||+|||++.++.+||+|||++.                               ...++.++|||||||++|||+||+.|
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P  316 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP  316 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred             cccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence            99999999999999999998742                               11245689999999999999999999


Q ss_pred             CCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHH--HHHHH
Q 036792          371 TDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTR--LLKIR  448 (453)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~  448 (453)
                      |......+.                 .+.... .       ...+++++.+|+.+||+.||++||++.|+++.  +++++
T Consensus       317 f~~~~~~~~-----------------~~~~~~-~-------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          317 NTDDAALGG-----------------SEWIFR-S-------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             CCTTGGGSC-----------------SGGGGS-S-------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCCcchhhh-----------------HHHHHh-h-------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence            975422111                 111111 0       01234678999999999999999999888653  44444


Q ss_pred             HH
Q 036792          449 DT  450 (453)
Q Consensus       449 ~~  450 (453)
                      +.
T Consensus       372 ~~  373 (413)
T 3dzo_A          372 TE  373 (413)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=5.3e-32  Score=263.45  Aligned_cols=222  Identities=19%  Similarity=0.197  Sum_probs=167.5

Q ss_pred             HHHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccc--------hhhHHHHHHHHHHHHcCC---------CCCceeEE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--------ARALKSFEAQCEVMKSIR---------HPNLVKVI  258 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~  258 (453)
                      ..|++.+.||+|+||.||+|++ +|+.||||+++...        ....+.+.+|+.+|+.++         |||||++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4577889999999999999998 68999999998653        223477889999988885         88888777


Q ss_pred             eEEe------------------------------cCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 036792          259 SSCS------------------------------NDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEY  308 (453)
Q Consensus       259 g~~~------------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~  308 (453)
                      +++.                              .++..++||||+++|++.+.+..  ..++......++.|++.||.|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            7643                              26789999999999987766644  357889999999999999999


Q ss_pred             HHhcC-CCCceecCCCCCceeeCCCC--------------------cEEEeccccCCC-------------------CCc
Q 036792          309 LYFGH-TTPIIHCDLKPISVLLDEDM--------------------VAHLSDFEYGME-------------------GQV  348 (453)
Q Consensus       309 L~~~h-~~~i~Hrdlk~~NiLl~~~~--------------------~~kl~df~~~~~-------------------~~~  348 (453)
                      |   | +.+|+||||||+|||++.++                    .+||+|||++..                   +..
T Consensus       177 l---H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~  253 (336)
T 2vuw_A          177 A---EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG  253 (336)
T ss_dssp             H---HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS
T ss_pred             H---HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC
Confidence            9   6 78999999999999999886                    899999987521                   223


Q ss_pred             CcccchHHHHHH-HHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhcc
Q 036792          349 STRSDIYGYGIV-LMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECA  427 (453)
Q Consensus       349 ~~~~Dv~S~Gvv-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  427 (453)
                      +.++||||++++ .+++++|..||...        .|....    ...+.. ................++++.+|+.+||
T Consensus       254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          254 DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYL----TDKMLK-QMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHH----HHHHHH-TCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             ccceehhhhhCCCCcccccccCCCcch--------hhhhHH----HHhhhh-hhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            678999998776 78899999997431        111100    000010 0011111223345678899999999999


Q ss_pred             ccCcccCCChHHHH
Q 036792          428 MELPEKRINAKDIV  441 (453)
Q Consensus       428 ~~~P~~RPs~~~v~  441 (453)
                      +.|     |++|++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=2e-26  Score=238.71  Aligned_cols=162  Identities=19%  Similarity=0.164  Sum_probs=123.2

Q ss_pred             ccCCCCccEEEEEE-ECCCCEEEEEEeeccc----------hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEE
Q 036792          203 LIGMGSFGSVYRAR-LRDGIEVAVKVFHQEC----------ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       203 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv  270 (453)
                      ..+.|++|.+..++ +..|+.+|+|.+....          ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777666655 3368999999997542          23356799999999999 699999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCCC---C
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEG---Q  347 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~---~  347 (453)
                      |||++||+|.+.|.... .++..   .|+.|++.||.|+   |+++|+||||||+|||++.++.+||+|||++...   .
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999998754 45543   5789999999999   8999999999999999999999999999987432   2


Q ss_pred             cCcccchHHHHHHHHHHHhCCCCC
Q 036792          348 VSTRSDIYGYGIVLMETFTRKKPT  371 (453)
Q Consensus       348 ~~~~~Dv~S~Gvvl~el~tg~~p~  371 (453)
                      ....+++|+.|.+..|+++|+.++
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~~~~  417 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAENKSW  417 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC------
T ss_pred             ccccCceechhhccHHHhCCCCCC
Confidence            334567888888888888887654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.86  E-value=4.2e-22  Score=205.22  Aligned_cols=130  Identities=17%  Similarity=0.214  Sum_probs=104.3

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .+.||+|+||.||+|.+ .+..+|+|.......        ...+.+.+|+++|++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            56899999999999954 578899998643321        123568999999999999999966666667778899999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME  345 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~  345 (453)
                      |+++|+|.+++..         ...++.|++++|.||   |+++|+||||||+|||++.  .+||+|||++..
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            9999999998875         457889999999999   7889999999999999998  999999998743

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=4.1e-21  Score=181.63  Aligned_cols=129  Identities=16%  Similarity=0.192  Sum_probs=105.2

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccch------------------hhHHHHHHHHHHHHcCCCCCceeEEeEE
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA------------------RALKSFEAQCEVMKSIRHPNLVKVISSC  261 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~  261 (453)
                      +.+.||+|+||.||+|.+.+|+.||||.++....                  .....+.+|+++|++++|   +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence            3588999999999999997799999999964321                  134678999999999994   5555544


Q ss_pred             ecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       262 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      .. +..++||||+++|+|.+ +..       .....++.++++|+.||   |+.+|+||||||+|||++ ++.+||+|||
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             ec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            33 45699999999999988 422       12346899999999999   788999999999999999 9999999999


Q ss_pred             cCC
Q 036792          342 YGM  344 (453)
Q Consensus       342 ~~~  344 (453)
                      .+.
T Consensus       238 ~a~  240 (282)
T 1zar_A          238 QSV  240 (282)
T ss_dssp             TCE
T ss_pred             CCe
Confidence            874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=2.3e-19  Score=167.54  Aligned_cols=133  Identities=17%  Similarity=0.245  Sum_probs=100.6

Q ss_pred             HhcccCCCCccEEEEEEE-CCCCE--EEEEEeeccchh------------------------hHHHHHHHHHHHHcCCCC
Q 036792          200 LSNLIGMGSFGSVYRARL-RDGIE--VAVKVFHQECAR------------------------ALKSFEAQCEVMKSIRHP  252 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~  252 (453)
                      +.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.+|.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            457899999999999997 67888  999987543111                        113678999999999887


Q ss_pred             Cc--eeEEeEEecCCeeEEEEeccCC-C----CchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCC
Q 036792          253 NL--VKVISSCSNDDFKALVLEYMPK-G----SLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH-TTPIIHCDLKP  324 (453)
Q Consensus       253 ni--v~l~g~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h-~~~i~Hrdlk~  324 (453)
                      ++  ...++.    +..++||||+.+ |    +|.+....    .+......++.+++.++.||   | +.+|+||||||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l---H~~~givHrDlkp  199 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL---YQEAELVHADLSE  199 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH---HHTSCEECSSCST
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH---HHHCCEEeCCCCH
Confidence            64  334432    346899999942 4    56554432    11234567889999999999   7 88999999999


Q ss_pred             CceeeCCCCcEEEeccccCCC
Q 036792          325 ISVLLDEDMVAHLSDFEYGME  345 (453)
Q Consensus       325 ~NiLl~~~~~~kl~df~~~~~  345 (453)
                      +|||++.  .++|+|||.+..
T Consensus       200 ~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEE
T ss_pred             HHEEEcC--cEEEEECccccc
Confidence            9999998  999999998743

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.75  E-value=2.7e-18  Score=184.76  Aligned_cols=115  Identities=36%  Similarity=0.563  Sum_probs=105.7

Q ss_pred             CCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcccccccccCchhhhcCCCC
Q 036792           19 DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNNEIYGLIPTSLEKLLYL   89 (453)
Q Consensus        19 ~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n~~~g~~P~~~~~~~~l   89 (453)
                      .++++++|+.|+||+|+|+|.+|.++++++.|+.|+|++|.++         +++|+.|||++|+++|.+|.++..+++|
T Consensus       627 ~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L  706 (768)
T 3rgz_A          627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML  706 (768)
T ss_dssp             SCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC
T ss_pred             hhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence            3445678999999999999999999999999999999999995         6899999999999999999999999999


Q ss_pred             CEEECccCcccccccCCCcceeeccccccCCCCCCCCCCCCCCCCCC
Q 036792           90 KELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPCKL  136 (453)
Q Consensus        90 ~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn~~l~~~~~~~~~~c~~  136 (453)
                      +.||+++|+++|.||..+.+..+...+|.||+.+||.|-   ++|..
T Consensus       707 ~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~  750 (768)
T 3rgz_A          707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDP  750 (768)
T ss_dssp             SEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCS
T ss_pred             CEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCC
Confidence            999999999999999999999998889999999999763   36764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.65  E-value=2.4e-16  Score=151.26  Aligned_cols=125  Identities=37%  Similarity=0.607  Sum_probs=95.0

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~n   73 (453)
                      |+.|+|++|+++|.+|..++++. |+.|+|++|.+++.+|..++++++|+.|++++|.++        +++|+.|++++|
T Consensus       176 L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N  254 (313)
T 1ogq_A          176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN  254 (313)
T ss_dssp             CCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSS
T ss_pred             CcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCC
Confidence            44555555555555555555554 555555555555556666666777777777777663        578999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCcccccccCCCcceeeccccccCCCCCCCCC
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSP  127 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn~~l~~~~  127 (453)
                      +++|.+|.++..+++|+.|++++|.++|.+|..+.+.++....+.+|+.+|+.|
T Consensus       255 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             CCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             cccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence            999999999999999999999999999999998778888888888998888865

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.62  E-value=8e-16  Score=136.77  Aligned_cols=127  Identities=28%  Similarity=0.362  Sum_probs=103.4

Q ss_pred             CccEEEcCCCcCcCCCCc-CCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSL-DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~-~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|+|++|++++..+. .++++++|+.|+|++|.|++..|..|+++++|+.|+|++|+++         +++|+.|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            478999999999976665 3899999999999999999988999999999999999999984         688999999


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCcccccccCCCcceeeccccccCCCCCCCCC
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSP  127 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn~~l~~~~  127 (453)
                      ++|++++.+|..+..+++|+.|++++|.+.+..+..+....+....+.++.+.|+.|
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            999999999999999999999999999999876532211111222334445555544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=5.5e-17  Score=157.86  Aligned_cols=133  Identities=14%  Similarity=0.199  Sum_probs=94.5

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeeccch--------------hhHH--------HHHHHHHHHHcCCCCCce
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--------------RALK--------SFEAQCEVMKSIRHPNLV  255 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~H~niv  255 (453)
                      |++...||+|+||.||+|...+|+.||||+++....              ....        ...+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            456788999999999999998999999998753210              0011        123466667766554432


Q ss_pred             --eEEeEEecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          256 --KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       256 --~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                        ..++.  .  ..+|||||+++++|.++....       ....++.|++.++.||   |+.+||||||||.|||+++++
T Consensus       177 vp~p~~~--~--~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~l---H~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          177 VPEPIAQ--S--RHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRL---AKHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CCCEEEE--E--TTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEEEEE
T ss_pred             CCeeeec--c--CceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeCCC
Confidence              22221  1  237999999998887643221       2245678999999999   778999999999999998766


Q ss_pred             ----------cEEEeccccCC
Q 036792          334 ----------VAHLSDFEYGM  344 (453)
Q Consensus       334 ----------~~kl~df~~~~  344 (453)
                                .+.|+||+-+.
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCE
T ss_pred             CcccccccccceEEEEeCCcc
Confidence                      38899997543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.56  E-value=1.5e-14  Score=131.33  Aligned_cols=121  Identities=29%  Similarity=0.316  Sum_probs=102.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..+..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.++         +++|+.|+|+
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~  112 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN  112 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence            4789999999999877778999999999999999999988999999999999999999984         6799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCC-CcceeeccccccCCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFKGNE  121 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~gn~  121 (453)
                      +|.+++..|..+..+++|+.|++++|.+++-.+.. ..+.++....+.+|+
T Consensus       113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  163 (220)
T 2v9t_B          113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNP  163 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCC
Confidence            99999999999999999999999999998755432 122333334445554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.54  E-value=9.1e-15  Score=132.82  Aligned_cols=104  Identities=21%  Similarity=0.211  Sum_probs=80.9

Q ss_pred             ccEEEcCCCcCcCCCCc-CCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            2 ILNFDFSSNSLEGPLSL-DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~-~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      ++.|+|++|++++..|. .|.++++|+.|+|++|.+++..|..|+++++|+.|+|++|.++         +++|+.|+|+
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  113 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR  113 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence            56788888888876554 3678888888888888888766667888888888888888773         5678888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++..|..+..+++|+.|++++|.+++..|.
T Consensus       114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  147 (220)
T 2v70_A          114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG  147 (220)
T ss_dssp             TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred             CCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence            8888887788888888888888888888776554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.53  E-value=5.5e-14  Score=128.47  Aligned_cols=102  Identities=23%  Similarity=0.261  Sum_probs=91.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..|..+.++++|+.|+|++|+|++..+..|+++++|+.|+|++|.++         +++|+.|+|+
T Consensus        41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls  120 (229)
T 3e6j_A           41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC  120 (229)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEecc
Confidence            5789999999999988999999999999999999998744456799999999999999984         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      +|+++ .+|..+..+++|+.|++++|.+.+-.
T Consensus       121 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~  151 (229)
T 3e6j_A          121 CNKLT-ELPRGIERLTHLTHLALDQNQLKSIP  151 (229)
T ss_dssp             SSCCC-SCCTTGGGCTTCSEEECCSSCCCCCC
T ss_pred             CCccc-ccCcccccCCCCCEEECCCCcCCccC
Confidence            99999 78999999999999999999998543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.52  E-value=3.8e-14  Score=128.69  Aligned_cols=100  Identities=19%  Similarity=0.229  Sum_probs=64.8

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcc-cccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      +.+++++|.++. +|..+..  .++.|+|++|+|++..|. .|+++++|+.|+|++|.++         +++|+.|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            356777777663 6655542  346677777777765443 3567777777777777663         45677777777


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |.+++..|..+..+++|++|++++|.+++..|.
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  123 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGND  123 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTT
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHh
Confidence            777766666667777777777777777665443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.51  E-value=2.4e-14  Score=154.03  Aligned_cols=59  Identities=32%  Similarity=0.439  Sum_probs=34.8

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL   60 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~   60 (453)
                      |+.|+|++|+++|.+|..++++++|+.|+|++|.++|.+|..++++++|+.|++++|.+
T Consensus       492 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  550 (768)
T 3rgz_A          492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF  550 (768)
T ss_dssp             CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred             CCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCcc
Confidence            45556666666655665556666666666666666655665565565555555555543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.51  E-value=1.1e-13  Score=128.12  Aligned_cols=104  Identities=29%  Similarity=0.348  Sum_probs=88.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..|..++++++|+.|+|++|.+++..|..+.++++|+.|++++|.+.         +++|+.|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            4778999999999888888999999999999999999877777899999999999999874         5788999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +|.+++..|..+..+++|+.|++++|.+.+-.+
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  148 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA  148 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence            999987766677888899999999998876444

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.49  E-value=5e-14  Score=135.04  Aligned_cols=104  Identities=24%  Similarity=0.405  Sum_probs=82.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CC-CCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VA-SLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~-~l~~l~l   70 (453)
                      +|+.|+|++|+++|.+|..|+++++|++|+|++|.++|.+|..++++++|+.|++++|.++         ++ .|+.|++
T Consensus       102 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L  181 (313)
T 1ogq_A          102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI  181 (313)
T ss_dssp             TCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred             CCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEEC
Confidence            4678888888888888888888888888888888888888888888888888888888873         33 7788888


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      ++|.++|.+|..+..+. |+.|++++|.+++.+|.
T Consensus       182 ~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~  215 (313)
T 1ogq_A          182 SRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV  215 (313)
T ss_dssp             CSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGG
T ss_pred             cCCeeeccCChHHhCCc-ccEEECcCCcccCcCCH
Confidence            88888888888887776 88888888887776554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.48  E-value=1.8e-13  Score=119.66  Aligned_cols=104  Identities=22%  Similarity=0.266  Sum_probs=82.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|++.+..+..++++++|+.|+|++|++++..|..++++++|+.|++++|.++         +++|+.|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  108 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD  108 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence            4678888888888766666788888888888888888755555788888888888888874         5678888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +|.+++..|..+..+++|+.|++++|.+.+..|
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            888886655556778888888888888887655

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.48  E-value=2.9e-13  Score=126.94  Aligned_cols=101  Identities=29%  Similarity=0.380  Sum_probs=66.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|.+.+.  +.++++++|+.|+|++|.+++..|..++++++|+.|++++|.++         +++|+.|+++
T Consensus        64 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  141 (272)
T 3rfs_A           64 NVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA  141 (272)
T ss_dssp             TCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECC
Confidence            356677777777652  35667777777777777777655555667777777777777663         4566777777


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      +|.+++..|..+..+++|+.|++++|.+++-.
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  173 (272)
T 3rfs_A          142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP  173 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence            77776655555666677777777777666543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.47  E-value=4.7e-13  Score=120.17  Aligned_cols=121  Identities=25%  Similarity=0.282  Sum_probs=95.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|++++..+..+.++++|+.|+|++|++++..+..++++++|+.|++++|.++         +++|+.|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            4789999999999766667889999999999999999755556789999999999999884         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCC-CcceeeccccccCCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFKGNE  121 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~gn~  121 (453)
                      +|.+++..|..+..+++|+.|++++|.+++-.+.. ..+.++....+.+|.
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  159 (208)
T 2o6s_A          109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  159 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred             CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCC
Confidence            99999877777889999999999999988644321 123334334445553

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.46  E-value=1.2e-13  Score=133.29  Aligned_cols=105  Identities=19%  Similarity=0.193  Sum_probs=86.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCC---------CcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CC
Q 036792            1 DILNFDFSSNSLEGPLSLDIGN---------LKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VA   63 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~---------l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~   63 (453)
                      +|+.|+|++|++.|.+|..+++         +++|+.|+|++|.++ .+|..++++++|+.|++++|.++        ++
T Consensus       151 ~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~  229 (328)
T 4fcg_A          151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLP  229 (328)
T ss_dssp             TCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCT
T ss_pred             CCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCC
Confidence            4778888888888888887765         888888888888888 68888888888888888888874        57


Q ss_pred             CCcEEEcccccccccCchhhhcCCCCCEEECccCcccccccCC
Q 036792           64 SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG  106 (453)
Q Consensus        64 ~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~  106 (453)
                      +|+.|++++|.+.+.+|.++..+++|+.|++++|.+.+.+|..
T Consensus       230 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~  272 (328)
T 4fcg_A          230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD  272 (328)
T ss_dssp             TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTT
T ss_pred             CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchh
Confidence            8888888888888888888888888888888888888887754

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.46  E-value=2.5e-13  Score=120.61  Aligned_cols=93  Identities=26%  Similarity=0.353  Sum_probs=45.5

Q ss_pred             EEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccccc
Q 036792            4 NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNNE   74 (453)
Q Consensus         4 ~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n~   74 (453)
                      .+++++|++. .+|..+.  .+|+.|+|++|+|+ .+|..|+++++|+.|+|++|.++         +++|+.|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            3445555544 3444332  34555555555554 34445555555555555555442         3445555555555


Q ss_pred             ccccCchhhhcCCCCCEEECccCccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      +++..|..+..+++|+.|++++|.++
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~  115 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDIS  115 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCC
Confidence            55444444555555555555555544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.45  E-value=4e-13  Score=124.45  Aligned_cols=104  Identities=25%  Similarity=0.295  Sum_probs=81.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..|..+.++++|+.|+|++|++++..|..++++++|+.|+|++|.++         +++|+.|+|+
T Consensus        60 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  139 (251)
T 3m19_A           60 KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN  139 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             cCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECc
Confidence            4678888888888777777888888888888888888766666788888888888888773         5678888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +|.+++..|..+..+++|+.|++++|.+.+-.+
T Consensus       140 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A          140 TNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            888887666678888888888888888875443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.45  E-value=3.2e-13  Score=114.51  Aligned_cols=101  Identities=27%  Similarity=0.264  Sum_probs=92.3

Q ss_pred             CccEEEcCCCcCc-CCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLE-GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~-g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|++++|.++ |.+|..+.++++|+.|+|++|.+++.  ..++++++|+.|++++|.+.         +++|+.|++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            4789999999999 89999999999999999999999985  78999999999999999985         789999999


Q ss_pred             cccccccc-CchhhhcCCCCCEEECccCcccccc
Q 036792           71 SNNEIYGL-IPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        71 ~~n~~~g~-~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      ++|.+++. .|..+..+++|+.|++++|.+++..
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  129 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN  129 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGST
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchH
Confidence            99999974 4588999999999999999998753

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.44  E-value=2.9e-13  Score=122.82  Aligned_cols=101  Identities=21%  Similarity=0.308  Sum_probs=92.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|.+.         +++|+.|+|+
T Consensus        57 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  136 (220)
T 2v9t_B           57 KLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY  136 (220)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECC
Confidence            4889999999999988999999999999999999999744445799999999999999984         6799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|++++..|..+..+++|+.+++++|.+..
T Consensus       137 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          137 DNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            999999888889999999999999999864

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.43  E-value=2.5e-13  Score=131.02  Aligned_cols=118  Identities=18%  Similarity=0.300  Sum_probs=100.5

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccC---------CCCCCEEeCcCCcCC--------CC
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGG---------LISLKTLSLAYNKLD--------VA   63 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~---------l~~l~~l~l~~n~~~--------~~   63 (453)
                      +|+.|+|++|+++ .+|..++++++|+.|+|++|++.|.+|..++.         +++|+.|++++|.++        ++
T Consensus       128 ~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~  206 (328)
T 4fcg_A          128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQ  206 (328)
T ss_dssp             TCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCT
T ss_pred             CCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCC
Confidence            4889999999999 89999999999999999999999999998765         999999999999984        67


Q ss_pred             CCcEEEcccccccccCchhhhcCCCCCEEECccCcccccccCC-CcceeeccccccCC
Q 036792           64 SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFKGN  120 (453)
Q Consensus        64 ~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~gn  120 (453)
                      +|+.|++++|.+++ +|..+..+++|+.|++++|.+.+.+|.. +.+.++....+.+|
T Consensus       207 ~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n  263 (328)
T 4fcg_A          207 NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC  263 (328)
T ss_dssp             TCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTC
T ss_pred             CCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCC
Confidence            89999999999996 6778999999999999999999998864 22333333333443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.42  E-value=1e-12  Score=124.52  Aligned_cols=96  Identities=29%  Similarity=0.427  Sum_probs=46.8

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      |+.|+|++|.+++. |.. +.+++|+.|+|++|.++ .+|..+.++++|+.|++++|+++         +++|+.|+|++
T Consensus        57 L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~  133 (290)
T 1p9a_G           57 LTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG  133 (290)
T ss_dssp             CCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred             CCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence            44555555555532 221 44555555555555554 24444555555555555555442         33455555555


Q ss_pred             ccccccCchhhhcCCCCCEEECccCccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      |++++..|..+..+++|+.|++++|.++
T Consensus       134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~  161 (290)
T 1p9a_G          134 NELKTLPPGLLTPTPKLEKLSLANNNLT  161 (290)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCCccChhhcccccCCCEEECCCCcCC
Confidence            5555444444444555555555555544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.42  E-value=7.8e-13  Score=118.75  Aligned_cols=105  Identities=23%  Similarity=0.247  Sum_probs=93.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..+..+.++++|+.|+|++|.+++..+..++++++|+.|++++|.+.         +++|+.|+++
T Consensus        53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  132 (208)
T 2o6s_A           53 SLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLY  132 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             cCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECC
Confidence            4889999999999766666899999999999999999865566899999999999999984         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++..+..+..+++|+.|++++|.+.+..|.
T Consensus       133 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  166 (208)
T 2o6s_A          133 QNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  166 (208)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred             CCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence            9999987777789999999999999999887653

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.42  E-value=6.7e-13  Score=124.46  Aligned_cols=122  Identities=25%  Similarity=0.249  Sum_probs=100.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|.+++..+..++++++|+.|+|++|++++..|..++++++|+.|++++|.++         +++|+.|+++
T Consensus        86 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  165 (272)
T 3rfs_A           86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS  165 (272)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECC
Confidence            4789999999999877777899999999999999999876667899999999999999874         5789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCC-CcceeeccccccCCCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFKGNEP  122 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~gn~~  122 (453)
                      +|.+++..|..+..+++|+.|++++|.+++..+.. ..+.++....+.+|+-
T Consensus       166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  217 (272)
T 3rfs_A          166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  217 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             CCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence            99999887777889999999999999998865532 2334444445555543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.42  E-value=2.8e-13  Score=142.56  Aligned_cols=119  Identities=19%  Similarity=0.361  Sum_probs=104.0

Q ss_pred             CccEEEcCCCcCcCC-----------------CCcCCC--CCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCc-C
Q 036792            1 DILNFDFSSNSLEGP-----------------LSLDIG--NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK-L   60 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~-----------------~p~~~~--~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~-~   60 (453)
                      +|+.|+|++|+|+|.                 +|+.++  ++++|++|+|++|+++|.+|..++++++|+.|++++|. +
T Consensus       207 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l  286 (636)
T 4eco_A          207 KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI  286 (636)
T ss_dssp             TCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTS
T ss_pred             CCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCC
Confidence            488999999999997                 999999  99999999999999999999999999999999999998 6


Q ss_pred             CC----------------CCCcEEEcccccccccCch--hhhcCCCCCEEECccCcccccccCCCcceeeccccccCC
Q 036792           61 DV----------------ASLEILNLSNNEIYGLIPT--SLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGN  120 (453)
Q Consensus        61 ~~----------------~~l~~l~l~~n~~~g~~P~--~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn  120 (453)
                      +-                ++|+.|++++|+++ .+|.  ++..+++|+.|++++|.+.|.+|.-+.+.++....+.+|
T Consensus       287 ~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N  363 (636)
T 4eco_A          287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN  363 (636)
T ss_dssp             CHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred             ccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence            52                89999999999999 8998  999999999999999999999993223334433333333

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=7.7e-13  Score=114.93  Aligned_cols=100  Identities=22%  Similarity=0.262  Sum_probs=90.1

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      .+.+++++|+|.. +|..+.  ++|+.|+|++|+|++..|..|+++++|+.|+|++|+++         +++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            4689999999995 887774  88999999999999988889999999999999999984         67899999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCccccccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      |++++..|..+..+++|+.|++++|.+....+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            99998777789999999999999999986543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.42  E-value=4.8e-13  Score=138.36  Aligned_cols=101  Identities=26%  Similarity=0.263  Sum_probs=94.5

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEccccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNNE   74 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n~   74 (453)
                      |+.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..++++++|+.|+|++|.++       +++|+.|+|++|+
T Consensus       443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~l~~l~~L~~L~Ls~N~  519 (567)
T 1dce_A          443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNR  519 (567)
T ss_dssp             CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSC
T ss_pred             ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCcccCCCCCCcEEECCCCC
Confidence            6789999999997 776 999999999999999999 79999999999999999999985       7899999999999


Q ss_pred             ccccC-chhhhcCCCCCEEECccCcccccccC
Q 036792           75 IYGLI-PTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        75 ~~g~~-P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +++.+ |..+..+++|+.|++++|.+++.+|.
T Consensus       520 l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          520 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            99987 99999999999999999999987653

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.42  E-value=2.5e-13  Score=138.17  Aligned_cols=103  Identities=25%  Similarity=0.232  Sum_probs=89.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCccccc-CCCCCCEEeCcCCcCC-------CCCCcEEEccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIG-GLISLKTLSLAYNKLD-------VASLEILNLSN   72 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~-~l~~l~~l~l~~n~~~-------~~~l~~l~l~~   72 (453)
                      +|+.|+|++|.+++..|..++++++|+.|+|++|.+++.+|..+. ++++|+.|+|++|.++       +++|+.|+|++
T Consensus       121 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~  200 (487)
T 3oja_A          121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSS  200 (487)
T ss_dssp             SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCS
T ss_pred             CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCC
Confidence            367888999999988888899999999999999999998888886 7999999999999984       78899999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |.+++. |..+..+++|+.|++++|.+++ +|.
T Consensus       201 N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~  231 (487)
T 3oja_A          201 NKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEK  231 (487)
T ss_dssp             SCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECT
T ss_pred             CCCCCC-CHhHcCCCCccEEEecCCcCcc-cch
Confidence            999975 4458889999999999999986 554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.41  E-value=1e-12  Score=120.02  Aligned_cols=104  Identities=23%  Similarity=0.254  Sum_probs=92.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSN   72 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~   72 (453)
                      +|+.|+|++|++.+..+..+.++++|+.|+|++|+|++..+..++++++|+.|+|++|.++        +++|+.|+|++
T Consensus        65 ~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~  144 (229)
T 3e6j_A           65 NLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQ  144 (229)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCS
T ss_pred             CCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCC
Confidence            4889999999998655566799999999999999999866667899999999999999985        67999999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCccccccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      |++++..+..+..+++|+.|++++|.+.+..+
T Consensus       145 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          145 NQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            99998777889999999999999999987643

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.41  E-value=5.6e-13  Score=115.44  Aligned_cols=102  Identities=23%  Similarity=0.202  Sum_probs=92.0

Q ss_pred             CccEEEcCCCcCc-CCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLE-GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~-g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|++++|++. |.+|..+..+++|+.|+|++|.+++.  ..++++++|+.|++++|.+.         +++|+.|++
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            4789999999998 88999999999999999999999985  78999999999999999984         789999999


Q ss_pred             ccccccccC-chhhhcCCCCCEEECccCccccccc
Q 036792           71 SNNEIYGLI-PTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        71 ~~n~~~g~~-P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      ++|.+++.. +..+..+++|+.|++++|.+++..+
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  137 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND  137 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence            999999742 2789999999999999999986543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.40  E-value=1.3e-12  Score=115.91  Aligned_cols=116  Identities=23%  Similarity=0.259  Sum_probs=95.9

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcc-cccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      +.+++++|++. .+|..+..  +|+.|+|++|++++..|. .++++++|+.|+|++|.++         +++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            57999999995 78987765  899999999999985554 3899999999999999984         67899999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccccccCCC-cceeeccccccCCC
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGG-PFVNFTAMSFKGNE  121 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~gn~  121 (453)
                      |++++..|..+..+++|+.|++++|.+++.+|... .+.++....+.+|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  137 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP  137 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCC
Confidence            99999999899999999999999999999776532 22333334444543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.40  E-value=9.4e-13  Score=132.61  Aligned_cols=121  Identities=25%  Similarity=0.272  Sum_probs=100.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|.+.+.+|..++++++|+.|+|++|.+++..|..|+++++|+.|++++|.+.         +++|+.|+|+
T Consensus       276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  355 (455)
T 3v47_A          276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS  355 (455)
T ss_dssp             CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred             CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence            3788999999999989999999999999999999999988889999999999999999884         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCC-CcceeeccccccCCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFKGNE  121 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~gn~  121 (453)
                      +|.+++..|.++..+++|+.|++++|.+.+-.+.. ..+.++....+.+|+
T Consensus       356 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  406 (455)
T 3v47_A          356 YNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  406 (455)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCC
Confidence            99999988999999999999999999998643322 223344444455554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.40  E-value=8.4e-13  Score=124.55  Aligned_cols=105  Identities=25%  Similarity=0.260  Sum_probs=85.4

Q ss_pred             CccEEEcCCCc-CcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNS-LEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~-l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|+|++|. +.+..|..+.++++|+.|+|++|.+++..|..++++++|+.|++++|.+.         +++|+.|++
T Consensus        81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  160 (285)
T 1ozn_A           81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL  160 (285)
T ss_dssp             TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEEC
Confidence            47888888887 66655777888888888888888888877778888888888888888873         567888888


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      ++|.+++..+..+..+++|+.|++++|.+.+..|.
T Consensus       161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  195 (285)
T 1ozn_A          161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH  195 (285)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             CCCcccccCHHHhcCccccCEEECCCCcccccCHh
Confidence            88888876666788888888888888888776554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.39  E-value=1.5e-12  Score=113.47  Aligned_cols=97  Identities=21%  Similarity=0.280  Sum_probs=87.9

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcccc
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNN   73 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n   73 (453)
                      +.+++++|++. .+|..+.  ++|+.|+|++|+|++..|..|+++++|+.|+|++|+++         +++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            57899999996 7898776  88999999999999988889999999999999999984         679999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      ++++..|..+..+++|+.|++++|.+...
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            99977666799999999999999998754

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.39  E-value=2.2e-12  Score=120.75  Aligned_cols=104  Identities=26%  Similarity=0.263  Sum_probs=81.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..+..+.++++|+.|+|++|.+++..+..+.++++|+.|++++|.++         +++|+.|+|+
T Consensus        62 ~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls  141 (270)
T 2o6q_A           62 KLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG  141 (270)
T ss_dssp             TCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECC
Confidence            4778888888888544445678888888888888888755556788888888888888773         5788888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +|.+++..+..+..+++|+.|++++|.+.+-.+
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A          142 YNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            888887666667888888888888888876433

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.37  E-value=1.5e-12  Score=124.71  Aligned_cols=101  Identities=17%  Similarity=0.153  Sum_probs=49.0

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCC-----cCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC-------------CCC
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNL-----KAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------------DVA   63 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l-----~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~-------------~~~   63 (453)
                      |+.|+|++|++++. |..++++     ++|++|+|++|++++..|..++++++|+.|++++|++             .++
T Consensus       123 L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~  201 (312)
T 1wwl_A          123 LNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP  201 (312)
T ss_dssp             CSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCT
T ss_pred             ccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCC
Confidence            45555555555554 4444444     4555555555555554444555555555555555542             134


Q ss_pred             CCcEEEcccccccc--cCc-hhhhcCCCCCEEECccCcccccc
Q 036792           64 SLEILNLSNNEIYG--LIP-TSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        64 ~l~~l~l~~n~~~g--~~P-~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      +|+.|++++|.+++  .+| ..+..+++|+.|++++|.+.+.+
T Consensus       202 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  244 (312)
T 1wwl_A          202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA  244 (312)
T ss_dssp             TCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred             CCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence            45555555555542  122 12233445555555555554433

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.37  E-value=2.1e-12  Score=123.13  Aligned_cols=103  Identities=23%  Similarity=0.337  Sum_probs=81.8

Q ss_pred             CccEEEcCCCcCcCCCC-cCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEE
Q 036792            1 DILNFDFSSNSLEGPLS-LDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILN   69 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p-~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~   69 (453)
                      +|+.|++++|++.+..+ ..+.++++|+.|+|++|.+++..|..++++++|+.|++++|.+.          +++|+.|+
T Consensus       102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  181 (306)
T 2z66_A          102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD  181 (306)
T ss_dssp             TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred             CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEE
Confidence            47788888888887555 56788888888888888888877777888888888888888763          56788888


Q ss_pred             cccccccccCchhhhcCCCCCEEECccCcccccc
Q 036792           70 LSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        70 l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      +++|.+++..|..+..+++|+.|++++|.+.+..
T Consensus       182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  215 (306)
T 2z66_A          182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD  215 (306)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred             CCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence            8888888877888888888888888888876643

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.36  E-value=1.8e-12  Score=126.75  Aligned_cols=101  Identities=27%  Similarity=0.256  Sum_probs=89.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCC-CCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIG-NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|.++++|+.|+|++|++.         +++|+.|+|
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            367899999999987777777 8999999999999999877778999999999999999984         678999999


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCcccc
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ++|++++..|..+..+++|+.|++++|.+++
T Consensus       120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  150 (361)
T 2xot_A          120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISR  150 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred             CCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence            9999998888999999999999999999876

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.36  E-value=1.3e-12  Score=136.74  Aligned_cols=101  Identities=25%  Similarity=0.260  Sum_probs=89.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +++.||||+|+|++..|..|.++++|+.|+|++|+|++..|..|++|++|+.|+|++|+++         +++|+.|+|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls  132 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  132 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence            4789999999999877778999999999999999999866668999999999999999884         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|++++..|..++.+++|+.|++++|.+.+
T Consensus       133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~  162 (635)
T 4g8a_A          133 ETNLASLENFPIGHLKTLKELNVAHNLIQS  162 (635)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred             CCcCCCCChhhhhcCcccCeeccccCcccc
Confidence            999998777788999999999999998865

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.35  E-value=2e-12  Score=115.06  Aligned_cols=98  Identities=21%  Similarity=0.306  Sum_probs=84.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|.+.  .++.+.++++|+.|+|++|.+++..|..++++++|+.|++++|.++         +++|+.|+++
T Consensus        67 ~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~  144 (197)
T 4ezg_A           67 NIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS  144 (197)
T ss_dssp             TCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred             CCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence            4789999999665  4567889999999999999999888889999999999999999984         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|.+.+.+| .+..+++|+.|++++|.+++
T Consensus       145 ~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~  173 (197)
T 4ezg_A          145 YNGAITDIM-PLKTLPELKSLNIQFDGVHD  173 (197)
T ss_dssp             SCTBCCCCG-GGGGCSSCCEEECTTBCCCC
T ss_pred             CCCCccccH-hhcCCCCCCEEECCCCCCcC
Confidence            998555677 68889999999999999876

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.35  E-value=2.3e-12  Score=129.83  Aligned_cols=106  Identities=23%  Similarity=0.286  Sum_probs=98.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..|..|+++++|+.|+|++|.+++..|..++++++|+.|++++|.++         +++|+.|+++
T Consensus       300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  379 (455)
T 3v47_A          300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD  379 (455)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence            4889999999999988999999999999999999999988899999999999999999984         6899999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG  106 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~  106 (453)
                      +|++++..|..+..+++|+.|++++|++++..|.-
T Consensus       380 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          380 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            99999876677889999999999999999988743

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.35  E-value=9.4e-13  Score=140.25  Aligned_cols=102  Identities=25%  Similarity=0.345  Sum_probs=95.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSN   72 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~   72 (453)
                      .|+.|+|++|.+. .+|..+.++++|+.|+|++|.|+ .+|..|++|++|+.|+|++|.|+        +++|+.|+|++
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~  302 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFD  302 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCS
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCC
Confidence            4789999999999 79999999999999999999999 79999999999999999999985        67999999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |.++ .+|.+++.+++|+.|+|++|.|+|.+|.
T Consensus       303 N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~  334 (727)
T 4b8c_D          303 NMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK  334 (727)
T ss_dssp             SCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred             CCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence            9997 7899999999999999999999998875

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.34  E-value=5.7e-12  Score=111.79  Aligned_cols=100  Identities=27%  Similarity=0.390  Sum_probs=92.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|+++ .+|..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.++         +++|+.|+|+
T Consensus        32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            4789999999998 78899999999999999999999977788999999999999999984         6799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|.+++..+..+..+++|+.|++++|.+..
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            999997766778999999999999999865

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.34  E-value=2.3e-12  Score=109.14  Aligned_cols=94  Identities=21%  Similarity=0.207  Sum_probs=86.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      +|+.|++++|.+++.  ..++++++|+.|+|++|.+++.+|..++++++|+.|++++|.++          +++|+.|++
T Consensus        43 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l  120 (149)
T 2je0_A           43 ELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL  120 (149)
T ss_dssp             TCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEEC
T ss_pred             CCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeC
Confidence            488999999999986  88999999999999999999999998999999999999999985          679999999


Q ss_pred             ccccccccCc---hhhhcCCCCCEEECcc
Q 036792           71 SNNEIYGLIP---TSLEKLLYLKELSLSF   96 (453)
Q Consensus        71 ~~n~~~g~~P---~~~~~~~~l~~l~ls~   96 (453)
                      ++|.+++..+   ..+..+++|+.|++++
T Consensus       121 ~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          121 FNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             TTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             cCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            9999998766   5899999999999874

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.34  E-value=1.9e-12  Score=123.75  Aligned_cols=103  Identities=18%  Similarity=0.231  Sum_probs=55.9

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCccccc--Ccc--cccCCCCCCEEeCcCCcCC------------CCCC
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSD--MPA--TIGGLISLKTLSLAYNKLD------------VASL   65 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~--~p~--~~~~l~~l~~l~l~~n~~~------------~~~l   65 (453)
                      |+.|+|++|++.+..|..++++++|++|+|++|++.+.  +|.  .++++++|+.|++++|.++            +++|
T Consensus       147 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L  226 (310)
T 4glp_A          147 LKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQP  226 (310)
T ss_dssp             CCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCC
T ss_pred             CCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCC
Confidence            45555555555555555555555555555555555542  221  1245555555555555553            2555


Q ss_pred             cEEEcccccccccCchhhhcC---CCCCEEECccCcccccccC
Q 036792           66 EILNLSNNEIYGLIPTSLEKL---LYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        66 ~~l~l~~n~~~g~~P~~~~~~---~~l~~l~ls~n~l~g~~p~  105 (453)
                      +.|||++|++++.+|..+..+   ++|+.|++++|.++ .+|.
T Consensus       227 ~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~  268 (310)
T 4glp_A          227 HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPK  268 (310)
T ss_dssp             SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCS
T ss_pred             CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhh
Confidence            666666666665555555554   35666666666655 4443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.33  E-value=2.1e-12  Score=111.73  Aligned_cols=99  Identities=21%  Similarity=0.199  Sum_probs=90.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      +|+.|+|++|.+++.  ..++++++|+.|+|++|.+++.+|..++++++|+.|++++|.++          +++|+.|++
T Consensus        50 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l  127 (168)
T 2ell_A           50 NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDL  127 (168)
T ss_dssp             GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEEC
T ss_pred             CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEe
Confidence            478999999999986  88999999999999999999988988889999999999999984          578999999


Q ss_pred             ccccccccCc---hhhhcCCCCCEEECccCcccc
Q 036792           71 SNNEIYGLIP---TSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        71 ~~n~~~g~~P---~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ++|.+++..+   ..+..+++|+.|+++.|.+..
T Consensus       128 ~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          128 FNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             CSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             eCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence            9999997765   588899999999999998753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.32  E-value=1.1e-12  Score=141.62  Aligned_cols=104  Identities=17%  Similarity=0.285  Sum_probs=89.2

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEEC-cCCccccc-----------------------------------------
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINL-SRNNLSSD-----------------------------------------   39 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~l-s~N~l~g~-----------------------------------------   39 (453)
                      ++.|+|++|+|.|.+|++|++|++|+.|+| ++|.++|.                                         
T Consensus       325 V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~  404 (876)
T 4ecn_A          325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL  404 (876)
T ss_dssp             EEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHH
T ss_pred             EEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHH
Confidence            568899999999999999999999999999 77776665                                         


Q ss_pred             -----------------------------------CcccccCCCCCCEEeCcCCcCC-----------------------
Q 036792           40 -----------------------------------MPATIGGLISLKTLSLAYNKLD-----------------------   61 (453)
Q Consensus        40 -----------------------------------~p~~~~~l~~l~~l~l~~n~~~-----------------------   61 (453)
                                                         ||..|++|++|+.|+|++|.++                       
T Consensus       405 ~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~  484 (876)
T 4ecn_A          405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE  484 (876)
T ss_dssp             HHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC
T ss_pred             HHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh
Confidence                                               8888889999999999988764                       


Q ss_pred             -----CCCCcEEEcccccccccCchhhhcCCCCCEEECccCc-ccc-cccC
Q 036792           62 -----VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNK-LEG-EILR  105 (453)
Q Consensus        62 -----~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~-l~g-~~p~  105 (453)
                           +++|+.|+|++|.+.|.+|.++..+++|+.|++++|. ++| .+|.
T Consensus       485 l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~  535 (876)
T 4ecn_A          485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA  535 (876)
T ss_dssp             CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHH
T ss_pred             hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchH
Confidence                 4678899999999999999999999999999999997 888 7764

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.32  E-value=1.1e-12  Score=137.99  Aligned_cols=103  Identities=16%  Similarity=0.279  Sum_probs=85.1

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCC-----------------------------------------------
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRN-----------------------------------------------   34 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N-----------------------------------------------   34 (453)
                      ++.|+|++|++.|.+|++|++|++|+.|+|++|                                               
T Consensus        83 V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~  162 (636)
T 4eco_A           83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI  162 (636)
T ss_dssp             EEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHH
T ss_pred             EEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHH
Confidence            567888888888888888888888888888887                                               


Q ss_pred             -------------------------------cccccCcccccCCCCCCEEeCcCCcCC----------------------
Q 036792           35 -------------------------------NLSSDMPATIGGLISLKTLSLAYNKLD----------------------   61 (453)
Q Consensus        35 -------------------------------~l~g~~p~~~~~l~~l~~l~l~~n~~~----------------------   61 (453)
                                                     +|+| ||.+++++++|+.|+|++|.++                      
T Consensus       163 ~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~  241 (636)
T 4eco_A          163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE  241 (636)
T ss_dssp             HHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred             HHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch
Confidence                                           4456 8888888888888888888763                      


Q ss_pred             ------CCCCcEEEcccccccccCchhhhcCCCCCEEECccCc-ccc-cccC
Q 036792           62 ------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNK-LEG-EILR  105 (453)
Q Consensus        62 ------~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~-l~g-~~p~  105 (453)
                            +++|+.|+|++|.++|.+|.+++.+++|+.|++++|. ++| .+|.
T Consensus       242 ~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~  293 (636)
T 4eco_A          242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD  293 (636)
T ss_dssp             CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHH
T ss_pred             hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchH
Confidence                  3578888888888888888888888888888888887 888 7765

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.32  E-value=5.4e-12  Score=118.39  Aligned_cols=100  Identities=25%  Similarity=0.261  Sum_probs=61.1

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      |+.|+|++|++++..+..+.++++|+.|+|++|.+++..|..++++++|+.|++++|.+.         +++|+.|++++
T Consensus        30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~  109 (276)
T 2z62_A           30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE  109 (276)
T ss_dssp             CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence            566666666666655556666666666666666666655556666666666666666652         34555666666


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      |.+++..+..+..+++|+.|++++|.+.+
T Consensus       110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  138 (276)
T 2z62_A          110 TNLASLENFPIGHLKTLKELNVAHNLIQS  138 (276)
T ss_dssp             SCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred             CCccccCchhcccCCCCCEEECcCCccce
Confidence            65555444455555555555555555544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.32  E-value=7.4e-12  Score=118.05  Aligned_cols=104  Identities=29%  Similarity=0.280  Sum_probs=93.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCc-ccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNN-LSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~-l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|+|++|.+.+..|..+.++++|+.|+|++|. +++..|..+.++++|+.|++++|.+.         +++|+.|++
T Consensus        57 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  136 (285)
T 1ozn_A           57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL  136 (285)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEEC
Confidence            47899999999999889999999999999999998 77766888999999999999999874         679999999


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCccccccc
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      ++|.+++..+..+..+++|+.|++++|.+++-.+
T Consensus       137 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  170 (285)
T 1ozn_A          137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (285)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             CCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence            9999998777789999999999999999986433

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.32  E-value=5.9e-12  Score=112.03  Aligned_cols=116  Identities=16%  Similarity=0.263  Sum_probs=94.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|.+. .+| .+..+++|+.|+|++|.++  .++.+.++++|+.|++++|.++         +++|+.|+++
T Consensus        45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            4789999999999 677 7999999999999999765  4458999999999999999984         6799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCCCcceeeccccccCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGN  120 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn  120 (453)
                      +|.+++..|..+..+++|+.|++++|.+.+.+|.-..+.++....+.+|
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n  169 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFD  169 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTB
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCC
Confidence            9999999999999999999999999985555653223333333333333

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.32  E-value=3.3e-12  Score=137.82  Aligned_cols=118  Identities=21%  Similarity=0.315  Sum_probs=102.5

Q ss_pred             CccEEEcCCCcCcC-----------------CCCcCCC--CCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCc-C
Q 036792            1 DILNFDFSSNSLEG-----------------PLSLDIG--NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK-L   60 (453)
Q Consensus         1 ~l~~l~ls~n~l~g-----------------~~p~~~~--~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~-~   60 (453)
                      +|+.|+|++|+|+|                 .+|++++  +|++|+.|+|++|+++|.+|..|+++++|+.|+|++|+ +
T Consensus       449 ~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~l  528 (876)
T 4ecn_A          449 KLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI  528 (876)
T ss_dssp             TCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTS
T ss_pred             CCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCc
Confidence            58899999999999                 4999998  99999999999999999999999999999999999998 5


Q ss_pred             C-----------------CCCCcEEEcccccccccCch--hhhcCCCCCEEECccCcccccccCCCcceeeccccccCC
Q 036792           61 D-----------------VASLEILNLSNNEIYGLIPT--SLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGN  120 (453)
Q Consensus        61 ~-----------------~~~l~~l~l~~n~~~g~~P~--~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn  120 (453)
                      +                 +++|+.|+|++|+++ .+|.  ++..+++|+.|++++|.++ .+|.-+.+.++....+.+|
T Consensus       529 sg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N  605 (876)
T 4ecn_A          529 SAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN  605 (876)
T ss_dssp             CHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSS
T ss_pred             ccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcCC
Confidence            4                 238999999999999 8998  9999999999999999998 8884333444444444444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.31  E-value=4.1e-12  Score=132.74  Aligned_cols=102  Identities=25%  Similarity=0.287  Sum_probs=49.1

Q ss_pred             ccEEEcCCCcCcCCCC-cCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            2 ILNFDFSSNSLEGPLS-LDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p-~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      |+.|++++|.+.+..| ..+.++++|+.|+|++|.+++.+|..++++++|+.|++++|.+.          +++|+.|++
T Consensus       401 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L  480 (606)
T 3vq2_A          401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL  480 (606)
T ss_dssp             CCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred             CCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEEC
Confidence            4445555555554444 34445555555555555555444444445555555555444431          234444444


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCcccccc
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      ++|++++.+|.++..+++|+.|++++|.+++.+
T Consensus       481 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  513 (606)
T 3vq2_A          481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD  513 (606)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCEE
T ss_pred             CCCcCCccChhhhcccccCCEEECCCCcCCCcC
Confidence            444444444444444444444444444444433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.31  E-value=1.6e-12  Score=132.24  Aligned_cols=103  Identities=23%  Similarity=0.264  Sum_probs=88.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------------------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------------------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------------------   61 (453)
                      +|+.|+|++|.+++..|..|+++++|+.|+|++|.+++.+|  ++++++|+.|+|++|.++                   
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~  112 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS  112 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCC
Confidence            47899999999999888899999999999999999998665  899999999999988762                   


Q ss_pred             ------CCCCcEEEcccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           62 ------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        62 ------~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                            +++|+.|+|++|.+++..|..++.+++|+.|++++|.+++.+|.
T Consensus       113 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  162 (487)
T 3oja_A          113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA  162 (487)
T ss_dssp             CEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGG
T ss_pred             CCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChH
Confidence                  45678888888888887788888888888888888888876654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.31  E-value=3.4e-12  Score=121.59  Aligned_cols=121  Identities=20%  Similarity=0.304  Sum_probs=102.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccc-cCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS-DMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g-~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|++++|.+.+..|..+.++++|+.|+|++|.+++ .+|..++++++|+.|++++|.++         +++|+.|++
T Consensus       127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  206 (306)
T 2z66_A          127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  206 (306)
T ss_dssp             TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence            48899999999999999999999999999999999998 68889999999999999999984         678999999


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCcccccccCCC-cc-eeeccccccCCC
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGG-PF-VNFTAMSFKGNE  121 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~-~~-~~~~~~~~~gn~  121 (453)
                      ++|.+++..+..+..+++|+.|++++|.+.+..|... .+ .++....+.+|.
T Consensus       207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~  259 (306)
T 2z66_A          207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND  259 (306)
T ss_dssp             TTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCC
T ss_pred             CCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCC
Confidence            9999998878889999999999999999998776531 12 133334445554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.31  E-value=1.1e-11  Score=115.91  Aligned_cols=102  Identities=29%  Similarity=0.356  Sum_probs=82.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..+..|.++++|+.|+|++|.++...+..+.++++|+.|++++|.+.         +++|+.|+++
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            4678888888888766667888888888988888888644444688888888888888873         5688888998


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +|.+++..|..+..+++|+.|++++|.+.+-
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  148 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSL  148 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence            8888887777788888899999988888753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.31  E-value=5.9e-12  Score=123.06  Aligned_cols=101  Identities=29%  Similarity=0.232  Sum_probs=89.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|.+.         +++|+.|+|+
T Consensus        65 ~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  144 (361)
T 2xot_A           65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS  144 (361)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             ccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECC
Confidence            5889999999999877788999999999999999999877778999999999999999984         6899999999


Q ss_pred             cccccccCchhh---hcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSL---EKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~---~~~~~l~~l~ls~n~l~g  101 (453)
                      +|++++..+..+   ..+++|+.|++++|.|.+
T Consensus       145 ~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A          145 QNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            999997444444   579999999999999985

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.29  E-value=7.7e-12  Score=130.66  Aligned_cols=103  Identities=25%  Similarity=0.326  Sum_probs=65.2

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      |+.|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|+.|++++|.+.         +++|+.|++++
T Consensus        58 L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  137 (606)
T 3vq2_A           58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAH  137 (606)
T ss_dssp             CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCS
T ss_pred             CcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCC
Confidence            556666666666555555666666666666666666655666666666666666666552         45666777777


Q ss_pred             ccccc-cCchhhhcCCCCCEEECccCccccccc
Q 036792           73 NEIYG-LIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        73 n~~~g-~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      |.+++ .+|..++.+++|+.|++++|.+.+..|
T Consensus       138 n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~  170 (606)
T 3vq2_A          138 NFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV  170 (606)
T ss_dssp             SCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred             CcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence            76664 556677777777777777776665443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.29  E-value=2e-11  Score=106.55  Aligned_cols=98  Identities=29%  Similarity=0.360  Sum_probs=85.9

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      .+.+++++|++. .+|..+.  ++|+.|+|++|++++..|..++++++|+.|++++|.++         +++|+.|++++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            467999999998 4776554  68999999999999866667899999999999999984         67899999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCccccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      |.+++..|..+..+++|+.|++++|.+++-
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  115 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSV  115 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEe
Confidence            999988777889999999999999999853

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.29  E-value=4.5e-12  Score=129.96  Aligned_cols=102  Identities=25%  Similarity=0.186  Sum_probs=95.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~   74 (453)
                      +|+.|+|++|.+.+..|..|.++++|+.|+|++|++++..|..|+++++|+.|+|++|.+.      +++|+.|++++|.
T Consensus        22 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L~L~~N~  101 (520)
T 2z7x_B           22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNA  101 (520)
T ss_dssp             TCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECCCCCCCSEEECCSSC
T ss_pred             cccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCccccCCccEEeccCCc
Confidence            4789999999999888889999999999999999999988999999999999999999984      6899999999999


Q ss_pred             ccc-cCchhhhcCCCCCEEECccCccccc
Q 036792           75 IYG-LIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        75 ~~g-~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +++ .+|..++.+++|+.|++++|.+.+.
T Consensus       102 l~~~~~p~~~~~l~~L~~L~L~~n~l~~~  130 (520)
T 2z7x_B          102 FDALPICKEFGNMSQLKFLGLSTTHLEKS  130 (520)
T ss_dssp             CSSCCCCGGGGGCTTCCEEEEEESSCCGG
T ss_pred             cccccchhhhccCCcceEEEecCcccchh
Confidence            998 6899999999999999999999763

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.28  E-value=9.4e-12  Score=130.29  Aligned_cols=105  Identities=24%  Similarity=0.283  Sum_probs=94.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|||++|++++..|..|.+|++|++|+|++|+|++..|..|++|++|+.|+|++|+++         +++|+.|+|+
T Consensus        77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls  156 (635)
T 4g8a_A           77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA  156 (635)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence            4899999999999877778999999999999999999866667999999999999999984         6799999999


Q ss_pred             cccccc-cCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYG-LIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g-~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++ .+|..+..+++|+.|++++|.+.+-.|.
T Consensus       157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  191 (635)
T 4g8a_A          157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  191 (635)
T ss_dssp             SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             cCccccCCCchhhccchhhhhhcccCccccccccc
Confidence            999976 5789999999999999999999876554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.28  E-value=9.2e-12  Score=130.10  Aligned_cols=101  Identities=22%  Similarity=0.154  Sum_probs=85.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +++.|+|++|.+++..|..|+++++|+.|+|++|.+++..|..|+++++|+.|+|++|.+.         +++|+.|+++
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            4678899999998877888889999999999999998888888889999999999988873         6788888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|.+++..|..+..+++|++|++++|.+.+
T Consensus       114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~  143 (606)
T 3t6q_A          114 QTGISSIDFIPLHNQKTLESLYLGSNHISS  143 (606)
T ss_dssp             TSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred             ccCcccCCcchhccCCcccEEECCCCcccc
Confidence            888887667778888888888888888876

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.28  E-value=1.6e-11  Score=116.24  Aligned_cols=121  Identities=31%  Similarity=0.275  Sum_probs=99.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++. .+|..+.++++|+.|+|++|+|++..|..|+++++|+.|+|++|.+.         +++|+.|+|+
T Consensus        78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  156 (290)
T 1p9a_G           78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA  156 (290)
T ss_dssp             TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence            4889999999999 68999999999999999999999876778999999999999999984         5789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCCC-cceeeccccccCCCCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGG-PFVNFTAMSFKGNEPL  123 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~gn~~l  123 (453)
                      +|++++..+..+..+++|+.|++++|.+. .+|.+. ....+....+.+|+..
T Consensus       157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            99999765666788999999999999998 455532 1223333445566533

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.27  E-value=1.1e-11  Score=128.58  Aligned_cols=101  Identities=27%  Similarity=0.194  Sum_probs=93.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~   74 (453)
                      +|+.|+|++|.+.+..|..|.++++|+.|+|++|++++..|..|+++++|+.|+|++|.++      +++|+.|++++|.
T Consensus        53 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L~Ls~N~  132 (562)
T 3a79_B           53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFND  132 (562)
T ss_dssp             TCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSCCCTTCSEEECCSSC
T ss_pred             CcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCccccccCCEEECCCCC
Confidence            4789999999999888889999999999999999999988899999999999999999985      6899999999999


Q ss_pred             ccc-cCchhhhcCCCCCEEECccCcccc
Q 036792           75 IYG-LIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        75 ~~g-~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +++ .+|..+..+++|+.|++++|.+.+
T Consensus       133 l~~l~~p~~~~~l~~L~~L~L~~n~l~~  160 (562)
T 3a79_B          133 FDVLPVCKEFGNLTKLTFLGLSAAKFRQ  160 (562)
T ss_dssp             CSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred             ccccCchHhhcccCcccEEecCCCcccc
Confidence            997 567999999999999999999876

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.27  E-value=9.8e-12  Score=119.18  Aligned_cols=103  Identities=25%  Similarity=0.232  Sum_probs=84.5

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccc-cCCCCCCEEeCcCCcCC-------CCCCcEEEccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKLD-------VASLEILNLSN   72 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~-~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~   72 (453)
                      +|+.|++++|++++..|..++++++|+.|+|++|.+++..|..+ .++++|+.|++++|.++       +++|+.|++++
T Consensus       121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~  200 (317)
T 3o53_A          121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSS  200 (317)
T ss_dssp             SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCS
T ss_pred             CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCC
Confidence            36788888888888777788888899999999999988777776 47888999999999884       67889999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |.+++. |..+..+++|+.|++++|.+.+ +|.
T Consensus       201 N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-l~~  231 (317)
T 3o53_A          201 NKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEK  231 (317)
T ss_dssp             SCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECT
T ss_pred             CcCCcc-hhhhcccCcccEEECcCCcccc-hhh
Confidence            999864 5558888999999999998874 444

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.27  E-value=1.4e-11  Score=115.50  Aligned_cols=104  Identities=24%  Similarity=0.286  Sum_probs=94.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..+..+.++++|+.|+|++|.+++..|..+.++++|+.|++++|.+.         +++|+.|+++
T Consensus        53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  132 (276)
T 2z62_A           53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA  132 (276)
T ss_dssp             TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred             CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECc
Confidence            4889999999999877778999999999999999999988888999999999999999874         6789999999


Q ss_pred             cccccc-cCchhhhcCCCCCEEECccCccccccc
Q 036792           72 NNEIYG-LIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        72 ~n~~~g-~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +|.+++ .+|..+..+++|+.|++++|.+++-.+
T Consensus       133 ~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A          133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             CCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            999987 479999999999999999999987543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.27  E-value=1.2e-11  Score=129.20  Aligned_cols=102  Identities=19%  Similarity=0.230  Sum_probs=92.5

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|.+++..|..|+++++|+.|+|++|.+++..|..|+++++|+.|+|++|.+.         +++|+.|+|+
T Consensus        76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls  155 (597)
T 3oja_B           76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS  155 (597)
T ss_dssp             CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEee
Confidence            4789999999999888889999999999999999999977778899999999999999874         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +|.+++..|..+..+++|+.|++++|.+++.
T Consensus       156 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          156 NNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             CCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence            9999999888999999999999999998764

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.26  E-value=1.1e-11  Score=125.79  Aligned_cols=105  Identities=26%  Similarity=0.338  Sum_probs=93.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..|..|.++++|+.|+|++|.+++..|..|+++++|+.|+|++|.+.         +++|+.|+|+
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  112 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS  112 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence            4788999999999888889999999999999999999988889999999999999999873         5789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++..|..+..+++|+.|++++|.+.+..+.
T Consensus       113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  146 (477)
T 2id5_A          113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR  146 (477)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred             CCccccCChhHccccccCCEEECCCCccceeChh
Confidence            9999988888999999999999999988775543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.25  E-value=1.3e-11  Score=127.35  Aligned_cols=105  Identities=23%  Similarity=0.196  Sum_probs=93.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|+.|++++|.+.         +++|+.|+++
T Consensus        27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  106 (549)
T 2z81_A           27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM  106 (549)
T ss_dssp             TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred             CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence            4789999999999888889999999999999999999988888999999999999999884         6789999999


Q ss_pred             cccccc-cCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYG-LIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g-~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++ .+|..+..+++|+.|++++|.+.+.+|.
T Consensus       107 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~  141 (549)
T 2z81_A          107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR  141 (549)
T ss_dssp             TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred             CCcccccchhhhhhccCCccEEECCCCccccccCH
Confidence            999987 4678889999999999999987777764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.25  E-value=2.4e-11  Score=124.57  Aligned_cols=102  Identities=28%  Similarity=0.361  Sum_probs=85.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccc--cCcccccCCCCCCEEeCcCCcCC----------CCCCcEE
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS--DMPATIGGLISLKTLSLAYNKLD----------VASLEIL   68 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g--~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l   68 (453)
                      +|+.|++++|.+++.+|..++++++|+.|+|++|++++  .+|..++++++|+.|++++|.+.          +++|+.|
T Consensus       325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L  404 (520)
T 2z7x_B          325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL  404 (520)
T ss_dssp             CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred             cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence            47889999999999899999999999999999999997  67788899999999999999874          3678888


Q ss_pred             EcccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           69 NLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        69 ~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      ++++|++++.+|..+.  ++|+.|++++|.++ .+|.
T Consensus       405 ~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~  438 (520)
T 2z7x_B          405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPK  438 (520)
T ss_dssp             ECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCG
T ss_pred             ECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccch
Confidence            8888888887777654  67888888888887 5554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.24  E-value=3.7e-11  Score=115.89  Aligned_cols=101  Identities=22%  Similarity=0.229  Sum_probs=92.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~   74 (453)
                      +|+.|+|++|.+.+..|..|.++++|+.|+|++|.+++..|..++++++|+.|++++|.+.      .++|+.|++++|.
T Consensus        55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~L~~L~l~~n~  134 (332)
T 2ft3_A           55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNR  134 (332)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCCTTCCEEECCSSC
T ss_pred             CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCccccccCCEEECCCCc
Confidence            4789999999999877889999999999999999999988999999999999999999985      4689999999999


Q ss_pred             ccccCchhhhcCCCCCEEECccCcccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +++..+..+..+++|+.|++++|.+..
T Consensus       135 i~~~~~~~~~~l~~L~~L~l~~n~l~~  161 (332)
T 2ft3_A          135 IRKVPKGVFSGLRNMNCIEMGGNPLEN  161 (332)
T ss_dssp             CCCCCSGGGSSCSSCCEEECCSCCCBG
T ss_pred             cCccCHhHhCCCccCCEEECCCCcccc
Confidence            998777789999999999999999864

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.24  E-value=2.3e-11  Score=126.91  Aligned_cols=102  Identities=26%  Similarity=0.302  Sum_probs=58.3

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CC------------
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VA------------   63 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~------------   63 (453)
                      |+.|+|++|.+++..+..|+++++|+.|+|++|.+++..|..|+++++|+.|++++|.+.      ++            
T Consensus       125 L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l  204 (597)
T 3oja_B          125 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL  204 (597)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred             CCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcc
Confidence            455555555555333333455555666666666665555555555666666666555542      11            


Q ss_pred             ----------------------------CCcEEEcccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           64 ----------------------------SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        64 ----------------------------~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                                                  +|+.|+|++|.+++  |.++..+++|+.|++++|.+.+.+|.
T Consensus       205 ~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~  272 (597)
T 3oja_B          205 STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH  272 (597)
T ss_dssp             SEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESG
T ss_pred             ccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHH
Confidence                                        23444444444443  35567778888888888888776654

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.24  E-value=4.1e-11  Score=115.37  Aligned_cols=101  Identities=26%  Similarity=0.313  Sum_probs=93.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~   74 (453)
                      +|+.|+|++|++++..+..|+++++|+.|+|++|.+++..|..++++++|+.|++++|.+.      .++|+.|++++|.
T Consensus        53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~~L~~L~l~~n~  132 (330)
T 1xku_A           53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE  132 (330)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSC
T ss_pred             CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhcccccEEECCCCc
Confidence            4789999999999877778999999999999999999988999999999999999999985      4689999999999


Q ss_pred             ccccCchhhhcCCCCCEEECccCcccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +++..|..+..+++|+.|++++|.+..
T Consensus       133 l~~~~~~~~~~l~~L~~L~l~~n~l~~  159 (330)
T 1xku_A          133 ITKVRKSVFNGLNQMIVVELGTNPLKS  159 (330)
T ss_dssp             CCBBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred             ccccCHhHhcCCccccEEECCCCcCCc
Confidence            999888899999999999999999864

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.24  E-value=2.1e-11  Score=122.80  Aligned_cols=105  Identities=24%  Similarity=0.221  Sum_probs=93.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|.++         +++|+.|+|+
T Consensus        76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  155 (452)
T 3zyi_A           76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR  155 (452)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred             CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence            4789999999999988999999999999999999999988889999999999999999884         6789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++..+..+..+++|+.|++++|+..+.++.
T Consensus       156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~  189 (452)
T 3zyi_A          156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE  189 (452)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred             CCCcceeCHhHHhcCCcccEEeCCCCCCccccCh
Confidence            9999977777888999999999998766666654

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.24  E-value=8.5e-12  Score=119.34  Aligned_cols=100  Identities=22%  Similarity=0.240  Sum_probs=85.7

Q ss_pred             CccEEEcCCCcCcCCCCcCC--CCCcCCCEEECcCCcccccCcccccCC-----CCCCEEeCcCCcCC---------CCC
Q 036792            1 DILNFDFSSNSLEGPLSLDI--GNLKAVVEINLSRNNLSSDMPATIGGL-----ISLKTLSLAYNKLD---------VAS   64 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~--~~l~~l~~l~ls~N~l~g~~p~~~~~l-----~~l~~l~l~~n~~~---------~~~   64 (453)
                      +|+.|+|++|+++|.+|..+  +++++|++|+|++|.+++. |..++++     ++|+.|++++|.+.         +++
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            47889999999999999887  8999999999999999986 8888877     89999999999874         678


Q ss_pred             CcEEEccccccccc--Cchhh--hcCCCCCEEECccCcccc
Q 036792           65 LEILNLSNNEIYGL--IPTSL--EKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        65 l~~l~l~~n~~~g~--~P~~~--~~~~~l~~l~ls~n~l~g  101 (453)
                      |+.|++++|+++|.  +|..+  ..+++|+.|++++|.+++
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  215 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET  215 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCC
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcc
Confidence            99999999998876  34455  788999999999999873

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.24  E-value=1.7e-11  Score=126.98  Aligned_cols=121  Identities=21%  Similarity=0.299  Sum_probs=93.9

Q ss_pred             CccEEEcCCCcCcCCCC-cCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEE
Q 036792            1 DILNFDFSSNSLEGPLS-LDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILN   69 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p-~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~   69 (453)
                      +|+.|++++|.+.+..| ..+.++++|+.|+|++|.+++.+|..++++++|+.|++++|.+.          +++|+.|+
T Consensus       397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~  476 (570)
T 2z63_A          397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD  476 (570)
T ss_dssp             TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred             CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence            47788889988888766 45788888888999888888888888888888888888888763          57888888


Q ss_pred             cccccccccCchhhhcCCCCCEEECccCcccccccCC-CcceeeccccccCCC
Q 036792           70 LSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFKGNE  121 (453)
Q Consensus        70 l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~gn~  121 (453)
                      +++|++++..|.++..+++|+.|++++|.+++..|.. ..+.++....+.+|+
T Consensus       477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~  529 (570)
T 2z63_A          477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP  529 (570)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCc
Confidence            8888888888888888888888888888888765432 123333334445554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.24  E-value=3e-11  Score=105.40  Aligned_cols=96  Identities=22%  Similarity=0.233  Sum_probs=83.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCc-CCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLK-AVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~-~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|++++|++.. +| .+..+. +|+.|+|++|.+++.  +.++++++|+.|++++|.++         +++|+.|++
T Consensus        20 ~L~~L~l~~n~l~~-i~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   95 (176)
T 1a9n_A           20 RDRELDLRGYKIPV-IE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   95 (176)
T ss_dssp             SCEEEECTTSCCCS-CC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             CceEEEeeCCCCch-hH-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence            47899999999995 54 466666 999999999999984  67999999999999999985         689999999


Q ss_pred             ccccccccCch--hhhcCCCCCEEECccCcccc
Q 036792           71 SNNEIYGLIPT--SLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        71 ~~n~~~g~~P~--~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ++|.++ .+|.  .+..+++|+.|++++|.+..
T Consensus        96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~  127 (176)
T 1a9n_A           96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN  127 (176)
T ss_dssp             CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             CCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC
Confidence            999996 5676  88899999999999999863

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.24  E-value=1.8e-11  Score=127.85  Aligned_cols=105  Identities=24%  Similarity=0.299  Sum_probs=92.4

Q ss_pred             CccEEEcCCCcCcCCCCcC-CCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------------CCCCcE
Q 036792            1 DILNFDFSSNSLEGPLSLD-IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------------VASLEI   67 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~-~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------------~~~l~~   67 (453)
                      +|+.|++++|.+.+..|+. +.++++|+.|+|++|.+++..|..++++++|+.|++++|.+.            +++|+.
T Consensus       401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~  480 (606)
T 3t6q_A          401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI  480 (606)
T ss_dssp             TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCE
T ss_pred             cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccE
Confidence            4788999999999887765 889999999999999999988888999999999999999873            578999


Q ss_pred             EEcccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           68 LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        68 l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |++++|.+++..|..+..+++|+.|++++|.+++.+|.
T Consensus       481 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  518 (606)
T 3t6q_A          481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE  518 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGG
T ss_pred             EECCCCccCccChhhhccccCCCEEECCCCccCcCChh
Confidence            99999999988889999999999999999999887664

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.24  E-value=3e-11  Score=125.14  Aligned_cols=102  Identities=26%  Similarity=0.364  Sum_probs=83.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccc--cCcccccCCCCCCEEeCcCCcCC----------CCCCcEE
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS--DMPATIGGLISLKTLSLAYNKLD----------VASLEIL   68 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g--~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l   68 (453)
                      +|+.|++++|++++.+|..++++++|+.|+|++|++++  .+|..++++++|+.|++++|.+.          +++|+.|
T Consensus       354 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L  433 (562)
T 3a79_B          354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL  433 (562)
T ss_dssp             CCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEE
T ss_pred             CceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEE
Confidence            47889999999999899999999999999999999997  45567889999999999999874          3678888


Q ss_pred             EcccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           69 NLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        69 ~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      ++++|.+++.+|..+.  ++|+.|++++|.++ .+|.
T Consensus       434 ~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~  467 (562)
T 3a79_B          434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPK  467 (562)
T ss_dssp             ECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCT
T ss_pred             ECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccCh
Confidence            8888888877776554  67888888888876 4554

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.22  E-value=3.1e-11  Score=119.07  Aligned_cols=102  Identities=19%  Similarity=0.230  Sum_probs=84.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|.+.+..+..+.++++|+.|+|++|.+++..|..++++++|+.|++++|.+.         +++|+.|+++
T Consensus        70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~  149 (390)
T 3o6n_A           70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS  149 (390)
T ss_dssp             CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECC
Confidence            4778888888888766778888888888888888888876777888888888888888873         5678888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +|.+++..|..+..+++|+.|++++|.+.+.
T Consensus       150 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  180 (390)
T 3o6n_A          150 NNNLERIEDDTFQATTSLQNLQLSSNRLTHV  180 (390)
T ss_dssp             SSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred             CCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence            8888887777888888888888888888653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.22  E-value=1.4e-11  Score=107.56  Aligned_cols=97  Identities=21%  Similarity=0.194  Sum_probs=86.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCccc-ccCCCCCCEEeCcCCcCC----------CCCCcEEE
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPAT-IGGLISLKTLSLAYNKLD----------VASLEILN   69 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~-~~~l~~l~~l~l~~n~~~----------~~~l~~l~   69 (453)
                      +|+.|+|++|.+++.  +.++++++|+.|+|++|.+++ +|+. ++++++|+.|++++|.+.          +++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEE
Confidence            488999999999975  789999999999999999997 5554 599999999999999984          57899999


Q ss_pred             cccccccccCchh----hhcCCCCCEEECccCcccc
Q 036792           70 LSNNEIYGLIPTS----LEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        70 l~~n~~~g~~P~~----~~~~~~l~~l~ls~n~l~g  101 (453)
                      +++|.++ .+|..    +..+++|+.||++.|....
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            9999998 56764    8999999999999998754

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.22  E-value=2.3e-11  Score=128.91  Aligned_cols=105  Identities=25%  Similarity=0.277  Sum_probs=90.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..+..|+++++|+.|+|++|.+++..|..++++++|+.|+|++|.++         +++|+.|+++
T Consensus        26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~  105 (680)
T 1ziw_A           26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM  105 (680)
T ss_dssp             TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred             CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence            4788999999999877777999999999999999999888888899999999999999873         5788999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++..|..+..+++|++|++++|.+++..|.
T Consensus       106 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  139 (680)
T 1ziw_A          106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG  139 (680)
T ss_dssp             SSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCC
T ss_pred             CCccCccChhHccccCCCCEEECCCCcccccCch
Confidence            9998877778888888999999999988876554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.22  E-value=3e-11  Score=125.05  Aligned_cols=105  Identities=22%  Similarity=0.259  Sum_probs=86.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCc-ccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMP-ATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p-~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +|+.|++++|.+.+. |+.+.++++|+.|+|++|.+++..| ..+.++++|+.|++++|.+.         +++|+.|++
T Consensus       374 ~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  452 (570)
T 2z63_A          374 SLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM  452 (570)
T ss_dssp             CCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred             ccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEEC
Confidence            478889999988864 4448888899999999999888766 46788899999999988763         678899999


Q ss_pred             cccccc-ccCchhhhcCCCCCEEECccCcccccccCC
Q 036792           71 SNNEIY-GLIPTSLEKLLYLKELSLSFNKLEGEILRG  106 (453)
Q Consensus        71 ~~n~~~-g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~  106 (453)
                      ++|.++ +.+|..+..+++|+.|++++|.+++..|..
T Consensus       453 ~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  489 (570)
T 2z63_A          453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA  489 (570)
T ss_dssp             TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred             cCCcCccccchhhhhcccCCCEEECCCCccccCChhh
Confidence            999887 678888888889999999999888776643

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.21  E-value=8.5e-12  Score=119.64  Aligned_cols=100  Identities=27%  Similarity=0.328  Sum_probs=73.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----CCCCcEEE-------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----VASLEILN-------   69 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----~~~l~~l~-------   69 (453)
                      +|+.|+|++|.+.+..|..|.++++|+.|+|++|.+++..|  ++++++|+.|++++|.++    .++|+.|+       
T Consensus        35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~  112 (317)
T 3o53_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS  112 (317)
T ss_dssp             GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCS
T ss_pred             CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccC
Confidence            47899999999999888889999999999999999998554  999999999999999874    34444554       


Q ss_pred             --------------cccccccccCchhhhcCCCCCEEECccCccccc
Q 036792           70 --------------LSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        70 --------------l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                                    +++|.+++..|..+..+++|+.|++++|.+.+.
T Consensus       113 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  159 (317)
T 3o53_A          113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV  159 (317)
T ss_dssp             EEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred             CcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence                          445555544444555555555555555555443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.21  E-value=4.7e-11  Score=119.82  Aligned_cols=105  Identities=24%  Similarity=0.261  Sum_probs=92.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++.+..+..|.++++|+.|+|++|.+++..|..|.++++|+.|+|++|.++         +++|+.|+|+
T Consensus        65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  144 (440)
T 3zyj_A           65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR  144 (440)
T ss_dssp             TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred             CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence            4788999999999988899999999999999999999977788999999999999999884         5789999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|.+++..+..+..+++|+.|++++|+..+.++.
T Consensus       145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~  178 (440)
T 3zyj_A          145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE  178 (440)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT
T ss_pred             CCcccccCHHHhhhCcccCEeCCCCCCCcceeCc
Confidence            9999987777888999999999998766666654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.20  E-value=1.8e-11  Score=132.90  Aligned_cols=100  Identities=18%  Similarity=0.150  Sum_probs=51.2

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccC-cccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDM-PATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~-p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      |+.||||+|.+++..|..|.++++|+.|+|++|++.+.+ |..|+++++|+.|+|++|.+.         +++|+.|+|+
T Consensus        26 l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  105 (844)
T 3j0a_A           26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY  105 (844)
T ss_dssp             CCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECT
T ss_pred             cCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCc
Confidence            455666666665555555555555555555555444444 334555555555555555542         3444555555


Q ss_pred             cccccccCchh--hhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTS--LEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~--~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|.+++.+|..  +..+++|+.|++++|.+.+
T Consensus       106 ~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~  137 (844)
T 3j0a_A          106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS  137 (844)
T ss_dssp             TCCCSSCCSTTCCCSSCSSCCEEEEESCCCCC
T ss_pred             CCCCCcccccCccccccCCCCEEECCCCcccc
Confidence            55555444433  4444455555555554443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.20  E-value=6.7e-11  Score=111.92  Aligned_cols=93  Identities=27%  Similarity=0.324  Sum_probs=42.7

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEccccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNNE   74 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n~   74 (453)
                      |+.|++++|.+.+. | .+..+++|+.|+|++|.+++ +|+ +.++++|+.|++++|.+.       +++|+.|++++|+
T Consensus        48 L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n~  123 (291)
T 1h6t_A           48 IDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG  123 (291)
T ss_dssp             CCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTSC
T ss_pred             ccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCCc
Confidence            44455555554432 2 24445555555555555544 222 444555555555555442       3444444444444


Q ss_pred             ccccCchhhhcCCCCCEEECccCccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      +++.  ..+..+++|+.|++++|.++
T Consensus       124 i~~~--~~l~~l~~L~~L~l~~n~l~  147 (291)
T 1h6t_A          124 ISDI--NGLVHLPQLESLYLGNNKIT  147 (291)
T ss_dssp             CCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred             CCCC--hhhcCCCCCCEEEccCCcCC
Confidence            4431  23444444444444444443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.20  E-value=6.9e-11  Score=109.93  Aligned_cols=152  Identities=11%  Similarity=0.045  Sum_probs=110.5

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      ...++.|+.+.||+.... +..+++|............+.+|+++++.+. |..+.++++++...+..++||||++|.+|
T Consensus        19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   97 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence            455777888999999854 6899999987532222346888999998885 67788899999888899999999999998


Q ss_pred             hHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 036792          280 ENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG-----------------------------------------------  312 (453)
Q Consensus       280 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~-----------------------------------------------  312 (453)
                      .+.+...      .....++.++++++..||..                                               
T Consensus        98 ~~~~~~~------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  171 (263)
T 3tm0_A           98 SEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY  171 (263)
T ss_dssp             HHHCCTT------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred             hhccCCc------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence            7653211      12235677888888889751                                               


Q ss_pred             ---------CCCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHH
Q 036792          313 ---------HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMET  364 (453)
Q Consensus       313 ---------h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el  364 (453)
                               ....++|+|+++.||+++++..+.|.|||.+..+  ..   .|-++.+++.+
T Consensus       172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g--d~---~~Dla~~~~~~  227 (263)
T 3tm0_A          172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA--DK---WYDIAFCVRSI  227 (263)
T ss_dssp             HHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE--EH---HHHHHHHHHHH
T ss_pred             HHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC--CH---HHHHHHHHHHh
Confidence                     1144899999999999987666679999875332  11   34555555443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.19  E-value=1.4e-11  Score=124.91  Aligned_cols=102  Identities=19%  Similarity=0.247  Sum_probs=77.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|.+.+.+|+.+....+|+.|+|++|++++..+..++++++|+.|+|++|.+.         +++|+.|+|+
T Consensus       201 ~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  280 (477)
T 2id5_A          201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV  280 (477)
T ss_dssp             TCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECC
T ss_pred             ccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECC
Confidence            3677888888877778877777777888888888887533346777888888888888763         5677888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +|++++..|..+..+++|+.|++++|.+++-
T Consensus       281 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  311 (477)
T 2id5_A          281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL  311 (477)
T ss_dssp             SSCCSEECTTTBTTCTTCCEEECCSSCCSCC
T ss_pred             CCccceECHHHhcCcccCCEEECCCCcCcee
Confidence            8888877777777788888888888877653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.19  E-value=5.5e-11  Score=115.36  Aligned_cols=95  Identities=25%  Similarity=0.308  Sum_probs=83.1

Q ss_pred             EEEcCCC-cCcCCCCcCCCCCcCCCEEECcC-CcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            4 NFDFSSN-SLEGPLSLDIGNLKAVVEINLSR-NNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         4 ~l~ls~n-~l~g~~p~~~~~l~~l~~l~ls~-N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      .+++++| +|.+ +|. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+         +++|+.|||++
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            5788998 8985 888 99999999999996 9999977788999999999999999984         78999999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCcccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      |+|++..|..+..++ |+.|++++|.|..
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            999976555555554 9999999999864

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.18  E-value=2.7e-12  Score=136.69  Aligned_cols=104  Identities=23%  Similarity=0.263  Sum_probs=93.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLSN   72 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~~   72 (453)
                      +|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|.|.        +++|+.|+|++
T Consensus       248 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~  325 (727)
T 4b8c_D          248 FLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEG  325 (727)
T ss_dssp             SCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTT
T ss_pred             CCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCC
Confidence            4789999999999 89999999999999999999999 79999999999999999999984        67999999999


Q ss_pred             ccccccCchhhhcCCC-CCEEECccCcccccccCC
Q 036792           73 NEIYGLIPTSLEKLLY-LKELSLSFNKLEGEILRG  106 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~-l~~l~ls~n~l~g~~p~~  106 (453)
                      |.++|.+|..+..+.. +..+++++|.++|.+|..
T Consensus       326 N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~  360 (727)
T 4b8c_D          326 NPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE  360 (727)
T ss_dssp             SCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred             CccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence            9999999998876542 234789999999998875

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.18  E-value=5e-11  Score=126.30  Aligned_cols=99  Identities=25%  Similarity=0.353  Sum_probs=54.4

Q ss_pred             ccEEEcCCCcCc--CCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----------------C
Q 036792            2 ILNFDFSSNSLE--GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----------------V   62 (453)
Q Consensus         2 l~~l~ls~n~l~--g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----------------~   62 (453)
                      |+.|++++|.+.  |.+|..++++++|+.|+|++|++++..|..++++++|+.|++++|.++                 +
T Consensus       456 L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l  535 (680)
T 1ziw_A          456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL  535 (680)
T ss_dssp             CCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTC
T ss_pred             cccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCC
Confidence            555666666555  445555666666666666666666544444555666666666665542                 2


Q ss_pred             CCCcEEEcccccccccCchhhhcCCCCCEEECccCccc
Q 036792           63 ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        63 ~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      ++|+.|+|++|+++...+..+..+++|+.|++++|.++
T Consensus       536 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~  573 (680)
T 1ziw_A          536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN  573 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCC
Confidence            45555555555555222234555555555555555554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.18  E-value=3.4e-11  Score=117.12  Aligned_cols=103  Identities=23%  Similarity=0.257  Sum_probs=90.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|++++..+..+.++++|+.|+|++|.+++..|..++++++|+.|++++|.++         +++|+.|+++
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  132 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL  132 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence            4789999999999866668999999999999999999988888999999999999999984         6899999999


Q ss_pred             cccccccCch--hhhcCCCCCEEECccCccccccc
Q 036792           72 NNEIYGLIPT--SLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        72 ~n~~~g~~P~--~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +|++++ +|.  .+..+++|+.|++++|...+.++
T Consensus       133 ~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~  166 (353)
T 2z80_A          133 GNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQ  166 (353)
T ss_dssp             TCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             CCCCcc-cCchhhhccCCCCcEEECCCCccccccC
Confidence            999995 554  78899999999999996444443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.18  E-value=5.8e-11  Score=115.50  Aligned_cols=98  Identities=27%  Similarity=0.270  Sum_probs=82.5

Q ss_pred             EEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccccc
Q 036792            4 NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNNE   74 (453)
Q Consensus         4 ~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n~   74 (453)
                      ..++++|+++ .+|..+.  ++|+.|+|++|++++..+..++++++|+.|++++|.+.         +++|+.|++++|.
T Consensus        35 ~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  111 (353)
T 2z80_A           35 ICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY  111 (353)
T ss_dssp             EEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc
Confidence            4688899998 5887766  48999999999999855558999999999999999884         5789999999999


Q ss_pred             ccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +++..+..+..+++|+.|++++|.+.+ +|.
T Consensus       112 l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~  141 (353)
T 2z80_A          112 LSNLSSSWFKPLSSLTFLNLLGNPYKT-LGE  141 (353)
T ss_dssp             CSSCCHHHHTTCTTCSEEECTTCCCSS-SCS
T ss_pred             CCcCCHhHhCCCccCCEEECCCCCCcc-cCc
Confidence            997656668899999999999999874 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.18  E-value=2.3e-11  Score=125.46  Aligned_cols=106  Identities=25%  Similarity=0.250  Sum_probs=95.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      +|+.|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|+.|++++|.+.          +++|+.|++
T Consensus        51 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  130 (549)
T 2z81_A           51 NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI  130 (549)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEE
T ss_pred             cccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEEC
Confidence            4889999999999988889999999999999999999977777999999999999999874          568999999


Q ss_pred             ccccccccCc-hhhhcCCCCCEEECccCcccccccCC
Q 036792           71 SNNEIYGLIP-TSLEKLLYLKELSLSFNKLEGEILRG  106 (453)
Q Consensus        71 ~~n~~~g~~P-~~~~~~~~l~~l~ls~n~l~g~~p~~  106 (453)
                      ++|.+.+.+| ..+..+++|+.|++++|.+.+.+|..
T Consensus       131 ~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  167 (549)
T 2z81_A          131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS  167 (549)
T ss_dssp             EESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred             CCCccccccCHhhhhcccccCeeeccCCcccccChhh
Confidence            9999666666 68999999999999999999877654

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.17  E-value=4.5e-11  Score=109.61  Aligned_cols=100  Identities=17%  Similarity=0.184  Sum_probs=84.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCc-ccccCcccccCCCCCCEEeCcC-CcCC---------CCCCcEEE
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNN-LSSDMPATIGGLISLKTLSLAY-NKLD---------VASLEILN   69 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~-l~g~~p~~~~~l~~l~~l~l~~-n~~~---------~~~l~~l~   69 (453)
                      +|+.|++++|++++..+..+.++++|+.|+|++|. +++..+..|+++++|+.|++++ |.+.         +++|+.|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            47899999999998767789999999999999997 8775555889999999999998 8874         67899999


Q ss_pred             cccccccccCchhhhcCCCCC---EEECccC-ccccc
Q 036792           70 LSNNEIYGLIPTSLEKLLYLK---ELSLSFN-KLEGE  102 (453)
Q Consensus        70 l~~n~~~g~~P~~~~~~~~l~---~l~ls~n-~l~g~  102 (453)
                      +++|.+++ +|. +..+++|+   .|++++| .+.+-
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i  146 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSI  146 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEE
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhc
Confidence            99999987 676 77888887   9999998 77653

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.17  E-value=2.1e-11  Score=116.44  Aligned_cols=75  Identities=17%  Similarity=0.123  Sum_probs=41.1

Q ss_pred             ccEEEcCCCcCcCCCCcCC--CCCcCCCEEECcCCcccccCc----ccccCCCCCCEEeCcCCcCC---------CCCCc
Q 036792            2 ILNFDFSSNSLEGPLSLDI--GNLKAVVEINLSRNNLSSDMP----ATIGGLISLKTLSLAYNKLD---------VASLE   66 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~--~~l~~l~~l~ls~N~l~g~~p----~~~~~l~~l~~l~l~~n~~~---------~~~l~   66 (453)
                      |+.|++++|.+.|.+|..+  .++++|+.|+|++|.+++.+|    ..+..+++|+.|++++|.+.         +++|+
T Consensus        93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  172 (310)
T 4glp_A           93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT  172 (310)
T ss_dssp             CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred             eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence            5667777777777666665  556666666666666555433    22234555555555555442         34445


Q ss_pred             EEEccccccc
Q 036792           67 ILNLSNNEIY   76 (453)
Q Consensus        67 ~l~l~~n~~~   76 (453)
                      .|||++|++.
T Consensus       173 ~L~Ls~N~l~  182 (310)
T 4glp_A          173 SLDLSDNPGL  182 (310)
T ss_dssp             EEECCSCTTC
T ss_pred             EEECCCCCCc
Confidence            5555555443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.17  E-value=1.1e-10  Score=115.03  Aligned_cols=39  Identities=33%  Similarity=0.402  Sum_probs=25.4

Q ss_pred             CcEEEcccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           65 LEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        65 l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |+.|++++|.+++.  .++..+++|+.|++++|.+.+..|.
T Consensus       228 L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~  266 (390)
T 3o6n_A          228 LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH  266 (390)
T ss_dssp             CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred             ccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence            34444444444432  4567788889999999988876554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.17  E-value=9.1e-11  Score=113.68  Aligned_cols=99  Identities=21%  Similarity=0.283  Sum_probs=58.9

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEccccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNNE   74 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n~   74 (453)
                      |+.|++++|.+++..+  +.++++|+.|+|++|.+++ + +.+..+++|+.|++++|.+.       +++|+.|++++|.
T Consensus       223 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~  298 (347)
T 4fmz_A          223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQ  298 (347)
T ss_dssp             CCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSC
T ss_pred             CCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCc
Confidence            4556666666654322  5566666666666666655 2 34556666666666666553       4566666666666


Q ss_pred             ccccCchhhhcCCCCCEEECccCccccccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +++..|..+..+++|+.|++++|.+++..|
T Consensus       299 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  328 (347)
T 4fmz_A          299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP  328 (347)
T ss_dssp             CCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred             CCCcChhHhhccccCCEEEccCCccccccC
Confidence            666666666666666666666666655444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.16  E-value=1.1e-10  Score=108.85  Aligned_cols=96  Identities=31%  Similarity=0.420  Sum_probs=77.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~   74 (453)
                      +|+.|++++|.++. +| .+..+++|+.|+|++|++++ +|+ ++++++|+.|++++|++.      .++|+.|++++|+
T Consensus        42 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~~~~~~~L~~L~L~~N~  117 (263)
T 1xeu_A           42 GVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNE  117 (263)
T ss_dssp             TCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCTTCCCSSCCEEECCSSC
T ss_pred             cCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcCccccCcccEEEccCCc
Confidence            47788999998884 55 78888999999999999987 555 888999999999999874      2578888888888


Q ss_pred             ccccCchhhhcCCCCCEEECccCccccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +++ +| .+..+++|+.|++++|.+++-
T Consensus       118 l~~-~~-~l~~l~~L~~L~Ls~N~i~~~  143 (263)
T 1xeu_A          118 LRD-TD-SLIHLKNLEILSIRNNKLKSI  143 (263)
T ss_dssp             CSB-SG-GGTTCTTCCEEECTTSCCCBC
T ss_pred             cCC-Ch-hhcCcccccEEECCCCcCCCC
Confidence            886 34 577888888888888888763

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.16  E-value=6.3e-11  Score=128.69  Aligned_cols=104  Identities=24%  Similarity=0.255  Sum_probs=82.8

Q ss_pred             CccEEEcCCCcCcCCC-CcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----------CCCCcEE
Q 036792            1 DILNFDFSSNSLEGPL-SLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----------VASLEIL   68 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~-p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----------~~~l~~l   68 (453)
                      +|+.|+|++|.+.+.+ |..|++|++|+.|+|++|++++..|..|+++++|+.|+|++|.+.           +++|+.|
T Consensus        49 ~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L  128 (844)
T 3j0a_A           49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL  128 (844)
T ss_dssp             SCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEE
T ss_pred             cCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEE
Confidence            4778888888777777 566888888888888888888877888888888888888888773           4678888


Q ss_pred             EcccccccccCc-hhhhcCCCCCEEECccCccccccc
Q 036792           69 NLSNNEIYGLIP-TSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        69 ~l~~n~~~g~~P-~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      +|++|.+++..| ..++++++|+.|++++|.+.+..+
T Consensus       129 ~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~  165 (844)
T 3j0a_A          129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE  165 (844)
T ss_dssp             EEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCS
T ss_pred             ECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCH
Confidence            888888887655 577888888888888888776544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.16  E-value=7.8e-11  Score=111.49  Aligned_cols=98  Identities=30%  Similarity=0.392  Sum_probs=83.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|++++..|  +.++++|+.|+|++|.+++ +| .++++++|+.|++++|.+.       +++|+.|++++|
T Consensus        69 ~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~~~l~~l~~L~~L~l~~n  144 (291)
T 1h6t_A           69 NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN  144 (291)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSS
T ss_pred             CCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCChhhcCCCCCCEEEccCC
Confidence            47899999999997544  8999999999999999987 44 4899999999999999884       678999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      .+++.  ..+..+++|+.|++++|.+++..+
T Consensus       145 ~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~  173 (291)
T 1h6t_A          145 KITDI--TVLSRLTKLDTLSLEDNQISDIVP  173 (291)
T ss_dssp             CCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred             cCCcc--hhhccCCCCCEEEccCCccccchh
Confidence            99874  578889999999999998877554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.15  E-value=1.2e-10  Score=117.30  Aligned_cols=101  Identities=23%  Similarity=0.239  Sum_probs=83.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..++++++|+.|+|++|.+.         +++|+.|+++
T Consensus       100 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  179 (452)
T 3zyi_A          100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG  179 (452)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCC
Confidence            4789999999999888888999999999999999999866666899999999999999884         6788888888


Q ss_pred             cccccccCc-hhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIP-TSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P-~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|+..+.+| ..+..+++|+.|++++|.+++
T Consensus       180 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             CCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred             CCCCccccChhhccCCCCCCEEECCCCcccc
Confidence            855444555 467778888888888888865

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.15  E-value=1e-10  Score=101.42  Aligned_cols=80  Identities=21%  Similarity=0.166  Sum_probs=72.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..|+++++|+.|+|++|+++         +++|+.|+|+
T Consensus        31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  110 (170)
T 3g39_A           31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL  110 (170)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeC
Confidence            4789999999999988999999999999999999999865556799999999999999984         6789999999


Q ss_pred             cccccccCc
Q 036792           72 NNEIYGLIP   80 (453)
Q Consensus        72 ~n~~~g~~P   80 (453)
                      +|.++...+
T Consensus       111 ~N~~~c~c~  119 (170)
T 3g39_A          111 NNPWDCACS  119 (170)
T ss_dssp             SSCBCTTBG
T ss_pred             CCCCCCCch
Confidence            999997755

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.15  E-value=1e-10  Score=121.73  Aligned_cols=98  Identities=30%  Similarity=0.390  Sum_probs=63.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|++++..|  +.+|++|+.|+|++|.|++ +| .+++|++|+.|+|++|.+.       +++|+.|+|++|
T Consensus        66 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N  141 (605)
T 1m9s_A           66 NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN  141 (605)
T ss_dssp             TCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCCGGGGGCTTCSEEECCSS
T ss_pred             CCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCCccccCCCccCEEECCCC
Confidence            36677777777776443  6677777777777777765 33 5666777777777777663       456666666666


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      .+++.  ..+..+++|+.|+|++|.+++..|
T Consensus       142 ~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A          142 KITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             CCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             ccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            66653  455666666666666666665444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.15  E-value=1.1e-10  Score=121.33  Aligned_cols=95  Identities=27%  Similarity=0.432  Sum_probs=64.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|.|.+ + +.+++|++|+.|+|++|.|++ + +.+.+|++|+.|+|++|.++       +++|+.|+|++|
T Consensus        88 ~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N  163 (605)
T 1m9s_A           88 NLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDN  163 (605)
T ss_dssp             TCCEEECCSSCCCC-C-TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGGSCTTCSEEECCSS
T ss_pred             CCCEEECcCCCCCC-C-hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCchhhcccCCCCEEECcCC
Confidence            36667777777765 2 356777777777777777775 3 34667777777777777663       566777777777


Q ss_pred             cccccCchhhhcCCCCCEEECccCcccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ++++..|  +..+++|+.|+|++|.+++
T Consensus       164 ~l~~~~~--l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          164 QISDIVP--LAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             cCCCchh--hccCCCCCEEECcCCCCCC
Confidence            7776555  6667777777777777665

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.14  E-value=1.2e-10  Score=116.82  Aligned_cols=104  Identities=24%  Similarity=0.247  Sum_probs=79.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|.+.+..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+.         +++|+.|+++
T Consensus        89 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~  168 (440)
T 3zyj_A           89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG  168 (440)
T ss_dssp             SCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCC
Confidence            4788899999888777778888888999999999888755557888888888888888873         5778888888


Q ss_pred             cccccccCc-hhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIP-TSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P-~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|+..+.+| ..+..+++|+.|++++|.++ .+|.
T Consensus       169 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~  202 (440)
T 3zyj_A          169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN  202 (440)
T ss_dssp             CCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC
T ss_pred             CCCCcceeCcchhhcccccCeecCCCCcCc-cccc
Confidence            755444444 46777788888888888776 3443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.14  E-value=1.1e-10  Score=112.50  Aligned_cols=103  Identities=22%  Similarity=0.268  Sum_probs=77.8

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCccc--ccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLS--SDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~--g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n   73 (453)
                      |+.|++++|.+.+..+..+.++++|+.|+|++|.++  |..|..++++++|+.|++++|.+.      .++|+.|++++|
T Consensus       123 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n  202 (330)
T 1xku_A          123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGN  202 (330)
T ss_dssp             CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTS
T ss_pred             ccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCC
Confidence            566666666666655555777777777777777775  356667777888888888887774      367888888888


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      .+++..|..+..+++|+.|++++|.+.+..+
T Consensus       203 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  233 (330)
T 1xku_A          203 KITKVDAASLKGLNNLAKLGLSFNSISAVDN  233 (330)
T ss_dssp             CCCEECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCceeCh
Confidence            8888878888888888888888888877544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.11  E-value=2.7e-10  Score=108.62  Aligned_cols=95  Identities=20%  Similarity=0.371  Sum_probs=60.9

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEccccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNNE   74 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n~   74 (453)
                      |+.|++++|.+.. +| .+..+++|+.|+|++|.+++ +|+ ++++++|+.|++++|.+.       +++|+.|++++|.
T Consensus        43 L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~  118 (308)
T 1h6u_A           43 ITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ  118 (308)
T ss_dssp             CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCCGGGTTCTTCCEEECTTSC
T ss_pred             cCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCchhhcCCCCCCEEECCCCC
Confidence            5667777776664 44 46666777777777777665 444 666777777777777663       4566667777666


Q ss_pred             ccccCchhhhcCCCCCEEECccCccccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +++ +|. +..+++|+.|++++|.+++-
T Consensus       119 l~~-~~~-l~~l~~L~~L~l~~n~l~~~  144 (308)
T 1h6u_A          119 ITD-VTP-LAGLSNLQVLYLDLNQITNI  144 (308)
T ss_dssp             CCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred             CCC-chh-hcCCCCCCEEECCCCccCcC
Confidence            665 332 66666666666666666543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.11  E-value=2.3e-12  Score=114.73  Aligned_cols=96  Identities=30%  Similarity=0.457  Sum_probs=66.4

Q ss_pred             ccEEEcCCCcCcCCCCc------CCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcE
Q 036792            2 ILNFDFSSNSLEGPLSL------DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEI   67 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~------~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~   67 (453)
                      ++.++++.|.++|.+|+      .++++++|+.|+|++|.+++ +| .++++++|+.|++++|.+.        +++|+.
T Consensus        20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~   97 (198)
T 1ds9_A           20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEE   97 (198)
T ss_dssp             CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSE
T ss_pred             ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCE
Confidence            45566777777777666      67777777777777777776 66 6777777777777777764        356777


Q ss_pred             EEcccccccccCchhhhcCCCCCEEECccCcccc
Q 036792           68 LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        68 l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      |++++|++++ +| .+..+++|+.|++++|.+++
T Consensus        98 L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~  129 (198)
T 1ds9_A           98 LWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN  129 (198)
T ss_dssp             EEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred             EECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence            7777777765 44 56666677777777776654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.11  E-value=3.3e-10  Score=105.53  Aligned_cols=95  Identities=25%  Similarity=0.368  Sum_probs=83.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|++++..|  +.++++|+.|+|++|++++ +|....  ++|+.|++++|.++       +++|+.|++++|
T Consensus        64 ~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~~~l~~l~~L~~L~Ls~N  138 (263)
T 1xeu_A           64 NLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRDTDSLIHLKNLEILSIRNN  138 (263)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSBSGGGTTCTTCCEEECTTS
T ss_pred             CCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCCChhhcCcccccEEECCCC
Confidence            48899999999997544  9999999999999999998 665333  99999999999984       789999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      ++++. | .+..+++|+.|++++|.+++.
T Consensus       139 ~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A          139 KLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             CCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             cCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            99974 5 788999999999999999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.10  E-value=1.4e-10  Score=107.30  Aligned_cols=128  Identities=13%  Similarity=0.045  Sum_probs=93.4

Q ss_pred             CCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--ceeEEeEEecCCeeEEEEeccCCCCchHH
Q 036792          205 GMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN--LVKVISSCSNDDFKALVLEYMPKGSLENC  282 (453)
Q Consensus       205 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~E~~~~g~L~~~  282 (453)
                      +.|..+.||+....+|..+++|.....   ....+.+|+++++.+++.+  +.+++++...++..++||||++|.++.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456669999998777888999997654   2245778899888886544  456888888878889999999998884  


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------------
Q 036792          283 LYSSTCMLDIFQRLNIMIDATSTLEYLYFGH-------------------------------------------------  313 (453)
Q Consensus       283 l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h-------------------------------------------------  313 (453)
                      ...    .+   ...++.++++.+..||...                                                 
T Consensus       104 ~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  176 (264)
T 1nd4_A          104 SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  176 (264)
T ss_dssp             TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence            111    11   1245566667777774321                                                 


Q ss_pred             ------CCCceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          314 ------TTPIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       314 ------~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                            ...++|+|++|.||+++++..+.|.|||.+.
T Consensus       177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                  1228999999999999877667799999853

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.10  E-value=1e-10  Score=107.26  Aligned_cols=105  Identities=24%  Similarity=0.223  Sum_probs=90.3

Q ss_pred             CccEEEcCCCc-CcCCCCcCCCCCcCCCEEECcC-CcccccCcccccCCCCCCEEeCcCCcCC-------CCCCc---EE
Q 036792            1 DILNFDFSSNS-LEGPLSLDIGNLKAVVEINLSR-NNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLE---IL   68 (453)
Q Consensus         1 ~l~~l~ls~n~-l~g~~p~~~~~l~~l~~l~ls~-N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~---~l   68 (453)
                      +|+.|++++|. +.+..+..|.++++|+.|+|++ |.+++..|..|+++++|+.|++++|.+.       +++|+   .|
T Consensus        56 ~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp~~~~l~~L~~L~~L  135 (239)
T 2xwt_C           56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFIL  135 (239)
T ss_dssp             TCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSCCCCTTCCBCCSEEEE
T ss_pred             CCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCccccccccccccccccEE
Confidence            48899999997 7765556789999999999998 9999866678999999999999999874       45666   99


Q ss_pred             Ecccc-cccccCchhhhcCCCCC-EEECccCcccccccCC
Q 036792           69 NLSNN-EIYGLIPTSLEKLLYLK-ELSLSFNKLEGEILRG  106 (453)
Q Consensus        69 ~l~~n-~~~g~~P~~~~~~~~l~-~l~ls~n~l~g~~p~~  106 (453)
                      ++++| .+++..|..+..+++|+ .+++++|.+. .+|..
T Consensus       136 ~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~  174 (239)
T 2xwt_C          136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY  174 (239)
T ss_dssp             EEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred             ECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence            99999 99987777899999999 9999999997 66653

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.10  E-value=2.2e-10  Score=99.64  Aligned_cols=79  Identities=20%  Similarity=0.166  Sum_probs=71.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|+|++|+|.+..|..|+++++|+.|+|++|+|++..+..|+++++|+.|+|++|++.         +++|+.|+|+
T Consensus        34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~  113 (174)
T 2r9u_A           34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY  113 (174)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred             CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence            4789999999999988999999999999999999999844445799999999999999984         6799999999


Q ss_pred             cccccccC
Q 036792           72 NNEIYGLI   79 (453)
Q Consensus        72 ~n~~~g~~   79 (453)
                      +|.+....
T Consensus       114 ~N~~~c~~  121 (174)
T 2r9u_A          114 NNPWDCEC  121 (174)
T ss_dssp             SSCBCTTB
T ss_pred             CCCccccc
Confidence            99998653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.09  E-value=1.7e-10  Score=118.93  Aligned_cols=95  Identities=21%  Similarity=0.225  Sum_probs=69.7

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-C----CCC-------cEEE
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-V----ASL-------EILN   69 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-~----~~l-------~~l~   69 (453)
                      |+.|+|++|+|++ +|.   .+++|+.|+|++|.|++ +|. |.  ++|+.|+|++|.++ +    .+|       +.|+
T Consensus       142 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~~~~~L~~~~~~L~~L~  213 (571)
T 3cvr_A          142 LEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPAVPVRNHHSEETEIFFR  213 (571)
T ss_dssp             CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCCCC--------CCEEEE
T ss_pred             ccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhhHHHhhhcccccceEEe
Confidence            5566666666665 554   45667777777777776 666 55  77788888888775 1    156       8889


Q ss_pred             cccccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           70 LSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        70 l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      |++|+++ .+|.++..+++|+.|++++|.+++.+|.
T Consensus       214 Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             CCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             cCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            9999988 5888888899999999999999988775

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.09  E-value=2.1e-10  Score=109.48  Aligned_cols=97  Identities=24%  Similarity=0.423  Sum_probs=77.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|.+.+.  +.+.++++|+.|+|++|.+++ +|+ ++++++|+.|++++|.++       +++|+.|++++|
T Consensus        86 ~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n  161 (308)
T 1h6u_A           86 KITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA  161 (308)
T ss_dssp             SCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSS
T ss_pred             CCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCccccCCCCccEEEccCC
Confidence            478889999988863  368888889999999998887 554 888888888888888874       578888888888


Q ss_pred             cccccCchhhhcCCCCCEEECccCcccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      .+++. |. +..+++|+.|++++|.+++-.
T Consensus       162 ~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~  189 (308)
T 1h6u_A          162 QVSDL-TP-LANLSKLTTLKADDNKISDIS  189 (308)
T ss_dssp             CCCCC-GG-GTTCTTCCEEECCSSCCCCCG
T ss_pred             cCCCC-hh-hcCCCCCCEEECCCCccCcCh
Confidence            88864 43 778888888888888887643

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.09  E-value=2.9e-10  Score=117.17  Aligned_cols=87  Identities=28%  Similarity=0.376  Sum_probs=47.3

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----CCCCcEEEccccccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----VASLEILNLSNNEIY   76 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----~~~l~~l~l~~n~~~   76 (453)
                      |+.|+|++|+|++ +|. +.+  +|+.|+|++|+|++ +|.   .+++|+.|++++|.++     +++|+.|+|++|.++
T Consensus       102 L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          102 LEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             CCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS
T ss_pred             CCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCCcCCCcCEEECCCCCCC
Confidence            4455555555554 444 443  55555555555555 444   4555555555555553     345566666666665


Q ss_pred             ccCchhhhcCCCCCEEECccCccc
Q 036792           77 GLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        77 g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      + +|. +.  ++|+.|++++|.|+
T Consensus       174 ~-lp~-l~--~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          174 F-LPE-LP--ESLEALDVSTNLLE  193 (571)
T ss_dssp             C-CCC-CC--TTCCEEECCSSCCS
T ss_pred             C-cch-hh--CCCCEEECcCCCCC
Confidence            5 454 33  55666666666655

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.08  E-value=2.5e-10  Score=109.98  Aligned_cols=99  Identities=22%  Similarity=0.314  Sum_probs=89.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|++++ +|..+.  ++|+.|+|++|.+++..|..+.++++|+.|++++|.+.         +++|+.|+++
T Consensus       173 ~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  249 (332)
T 2ft3_A          173 KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLD  249 (332)
T ss_dssp             CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECC
T ss_pred             ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECC
Confidence            47889999999996 777665  78999999999999988889999999999999999984         6799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      +|.++ .+|.++..+++|+.|++++|.+++-.
T Consensus       250 ~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~  280 (332)
T 2ft3_A          250 NNKLS-RVPAGLPDLKLLQVVYLHTNNITKVG  280 (332)
T ss_dssp             SSCCC-BCCTTGGGCTTCCEEECCSSCCCBCC
T ss_pred             CCcCe-ecChhhhcCccCCEEECCCCCCCccC
Confidence            99999 78999999999999999999997643

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.07  E-value=2.7e-10  Score=117.73  Aligned_cols=91  Identities=24%  Similarity=0.305  Sum_probs=81.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      +|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .+++|++|+.|+|++|.++          +++|+.|+|
T Consensus       464 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L  540 (567)
T 1dce_A          464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL  540 (567)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEEC
T ss_pred             cCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEe
Confidence            5889999999999 899999999999999999999998 88 8999999999999999984          578999999


Q ss_pred             ccccccccCch---hhhcCCCCCEEEC
Q 036792           71 SNNEIYGLIPT---SLEKLLYLKELSL   94 (453)
Q Consensus        71 ~~n~~~g~~P~---~~~~~~~l~~l~l   94 (453)
                      ++|.+++.+|.   -+..+++|+.||+
T Consensus       541 ~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          541 QGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             TTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             cCCcCCCCccHHHHHHHHCcccCccCC
Confidence            99999987663   2344889998874

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.05  E-value=3.8e-12  Score=113.39  Aligned_cols=102  Identities=24%  Similarity=0.320  Sum_probs=91.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|.+++ +| .+.++++|+.|+|++|.++ .+|..+..+++|+.|++++|.++       +++|+.|++++|
T Consensus        49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l~~~~~l~~L~~L~l~~N  125 (198)
T 1ds9_A           49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNN  125 (198)
T ss_dssp             TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCHHHHHHHHHSSEEEESEE
T ss_pred             CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcCCccccCCCCCEEECCCC
Confidence            47899999999998 77 8999999999999999999 58998888999999999999985       678999999999


Q ss_pred             cccccCc-hhhhcCCCCCEEECccCcccccccC
Q 036792           74 EIYGLIP-TSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        74 ~~~g~~P-~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      ++++..+ ..+..+++|+.|++++|.+.+.+|.
T Consensus       126 ~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A          126 KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             ECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             cCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            9996433 5788999999999999999888765

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.03  E-value=6.9e-10  Score=111.84  Aligned_cols=93  Identities=20%  Similarity=0.299  Sum_probs=78.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~   74 (453)
                      +|+.|++++|.++|. | .++++++|+.|+|++|++++ +|  ++++++|+.|++++|.+.      +++|+.|++++|.
T Consensus        43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~~~~l~~L~~L~L~~N~  117 (457)
T 3bz5_A           43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNK  117 (457)
T ss_dssp             TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECCSSC
T ss_pred             CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCceeecCCCCcCCEEECCCCc
Confidence            478899999999974 5 78899999999999999998 55  888999999999999884      6788899999998


Q ss_pred             ccccCchhhhcCCCCCEEECccCcccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +++ +|  ++.+++|+.|++++|.+++
T Consensus       118 l~~-l~--~~~l~~L~~L~l~~N~l~~  141 (457)
T 3bz5_A          118 LTK-LD--VSQNPLLTYLNCARNTLTE  141 (457)
T ss_dssp             CSC-CC--CTTCTTCCEEECTTSCCSC
T ss_pred             CCe-ec--CCCCCcCCEEECCCCccce
Confidence            887 45  7888888888998888877

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.02  E-value=6.6e-10  Score=115.85  Aligned_cols=77  Identities=29%  Similarity=0.307  Sum_probs=63.2

Q ss_pred             cCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----CCCCcEEEcccccccccCchhhhcCCCCCEEECccCc
Q 036792           24 KAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        24 ~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~   98 (453)
                      ++|+.|+|++|+|++ +|   ..+++|+.|++++|.++     +++|+.|+|++|+++ .+|..+..+++|+.|++++|.
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~  295 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP  295 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCcccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCC
Confidence            567777777777776 66   45677888888888875     567899999999998 789889999999999999999


Q ss_pred             ccccccC
Q 036792           99 LEGEILR  105 (453)
Q Consensus        99 l~g~~p~  105 (453)
                      +++.+|.
T Consensus       296 l~~~~~~  302 (622)
T 3g06_A          296 LSERTLQ  302 (622)
T ss_dssp             CCHHHHH
T ss_pred             CCCcCHH
Confidence            9887765

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.01  E-value=1.6e-10  Score=113.77  Aligned_cols=101  Identities=19%  Similarity=0.254  Sum_probs=86.3

Q ss_pred             CccEEEcCCCcCc-CCCC---cCCCCCcCCCEEECcCCccc--c---cCcccccCCCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSNSLE-GPLS---LDIGNLKAVVEINLSRNNLS--S---DMPATIGGLISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~-g~~p---~~~~~l~~l~~l~ls~N~l~--g---~~p~~~~~l~~l~~l~l~~n~~~----------   61 (453)
                      +|+.|+|++|+++ +.+|   ..+.++++|+.|+|++|.++  |   .+|..+.++++|+.|+|++|.++          
T Consensus       160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~  239 (386)
T 2ca6_A          160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA  239 (386)
T ss_dssp             CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred             CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence            4789999999998 5566   56778899999999999998  4   45558899999999999999983          


Q ss_pred             ---CCCCcEEEccccccccc----Cchhhhc--CCCCCEEECccCcccc
Q 036792           62 ---VASLEILNLSNNEIYGL----IPTSLEK--LLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ---~~~l~~l~l~~n~~~g~----~P~~~~~--~~~l~~l~ls~n~l~g  101 (453)
                         +++|+.|+|++|.+++.    +|..+..  +++|+.|++++|.+++
T Consensus       240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~  288 (386)
T 2ca6_A          240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  288 (386)
T ss_dssp             GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence               57999999999999876    6777744  8999999999999988

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.01  E-value=9.5e-10  Score=111.12  Aligned_cols=96  Identities=26%  Similarity=0.450  Sum_probs=71.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|++++|.+.+..|  +.++++|+.|+|++|.+++ +|+ +..+++|+.|++++|.+.       +++|+.|++++|
T Consensus       244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n  319 (466)
T 1o6v_A          244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN  319 (466)
T ss_dssp             TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSS
T ss_pred             CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCC
Confidence            46788888888887554  7778888888888888887 443 777888888888888774       567777777777


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      ++++..|  +..+++|+.|++++|.+++.
T Consensus       320 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          320 NISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             CCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             cCCCchh--hccCccCCEeECCCCccCCc
Confidence            7777655  56777777777777777653

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.00  E-value=1.2e-09  Score=110.24  Aligned_cols=98  Identities=24%  Similarity=0.441  Sum_probs=84.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|++++|++.+.  +.+.++++|+.|+|++|.+++..|  ++++++|+.|++++|.+.       +++|+.|++++|
T Consensus       222 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n  297 (466)
T 1o6v_A          222 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN  297 (466)
T ss_dssp             TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred             CCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcCCC
Confidence            478999999999863  468899999999999999998544  889999999999999884       678999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      ++++..|  +..+++|+.|++++|.+++..|
T Consensus       298 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  326 (466)
T 1o6v_A          298 QLEDISP--ISNLKNLTYLTLYFNNISDISP  326 (466)
T ss_dssp             CCSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred             cccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence            9997554  7889999999999999988765

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.99  E-value=5.2e-10  Score=112.62  Aligned_cols=98  Identities=27%  Similarity=0.329  Sum_probs=65.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccc--cCccccc-------------CC-CCCCEEeCcCCcCC---
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSS--DMPATIG-------------GL-ISLKTLSLAYNKLD---   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g--~~p~~~~-------------~l-~~l~~l~l~~n~~~---   61 (453)
                      +|+.|++++|++.+ +|..   +++|+.|+|++|.+++  .+|+.+.             .+ ++|+.|++++|+++   
T Consensus       258 ~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~lp  333 (454)
T 1jl5_A          258 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELP  333 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCC
T ss_pred             ccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccccc
Confidence            35667777777765 5543   3566666666666666  3333221             22 46777777777774   


Q ss_pred             --CCCCcEEEcccccccccCchhhhcCCCCCEEECccCcccc--cccCC
Q 036792           62 --VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG--EILRG  106 (453)
Q Consensus        62 --~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g--~~p~~  106 (453)
                        +++|+.|++++|.++ .+|.   .+++|++|++++|.+++  .+|..
T Consensus       334 ~~~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~  378 (454)
T 1jl5_A          334 ALPPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPES  378 (454)
T ss_dssp             CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTT
T ss_pred             ccCCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHH
Confidence              467888888888887 4666   46788888888888888  66653

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.98  E-value=1.3e-09  Score=105.57  Aligned_cols=94  Identities=21%  Similarity=0.354  Sum_probs=83.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|.+++.  +.+..+++|+.|+|++|.+++ + +.+..+++|+.|++++|.+.         +++|+.|+++
T Consensus       244 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~  319 (347)
T 4fmz_A          244 QLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS  319 (347)
T ss_dssp             TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECC
T ss_pred             CCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEcc
Confidence            488999999999974  578999999999999999998 4 45899999999999999984         7899999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      +|.+++..|  +..+++|+.+++++|.++
T Consensus       320 ~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          320 QNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             SSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCccccccC--hhhhhccceeehhhhccc
Confidence            999998766  889999999999999875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.97  E-value=1.6e-09  Score=109.19  Aligned_cols=95  Identities=20%  Similarity=0.216  Sum_probs=84.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC------CCCCcEEEccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD------VASLEILNLSNNE   74 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~------~~~l~~l~l~~n~   74 (453)
                      +|+.|++++|+..|.+  .++.+++|+.|+|++|++++ +|  ++++++|+.|++++|.++      +++|+.|++++|+
T Consensus       149 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~  223 (457)
T 3bz5_A          149 QLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNK  223 (457)
T ss_dssp             TCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSC
T ss_pred             cCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCc
Confidence            4789999999888887  48899999999999999998 66  889999999999999984      6789999999999


Q ss_pred             ccccCchhhhcCCCCCEEECccCcccccc
Q 036792           75 IYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        75 ~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      +++ +|  +..+++|+.|++++|.+++..
T Consensus       224 l~~-ip--~~~l~~L~~L~l~~N~l~~~~  249 (457)
T 3bz5_A          224 LTE-ID--VTPLTQLTYFDCSVNPLTELD  249 (457)
T ss_dssp             CSC-CC--CTTCTTCSEEECCSSCCSCCC
T ss_pred             ccc-cC--ccccCCCCEEEeeCCcCCCcC
Confidence            998 67  788999999999999998853

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.97  E-value=2e-10  Score=110.69  Aligned_cols=100  Identities=23%  Similarity=0.270  Sum_probs=76.1

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCccccc-CcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSD-MPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~-~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      |+.|++++|.+.+.++. +.++++|+.|+|++|.+++. +|..+.++++|+.|++++|.++         +++|+.|+++
T Consensus        72 l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~  150 (336)
T 2ast_B           72 VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS  150 (336)
T ss_dssp             CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred             ceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC
Confidence            66788888888876554 56788888888888888766 7777888888888888888774         6778888888


Q ss_pred             cc-ccccc-CchhhhcCCCCCEEECccC-ccccc
Q 036792           72 NN-EIYGL-IPTSLEKLLYLKELSLSFN-KLEGE  102 (453)
Q Consensus        72 ~n-~~~g~-~P~~~~~~~~l~~l~ls~n-~l~g~  102 (453)
                      +| .+++. +|..+..+++|+.|++++| .+++.
T Consensus       151 ~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~  184 (336)
T 2ast_B          151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK  184 (336)
T ss_dssp             TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred             CCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH
Confidence            88 56653 6777777888888888888 77653

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.96  E-value=2.2e-09  Score=107.98  Aligned_cols=74  Identities=26%  Similarity=0.400  Sum_probs=61.0

Q ss_pred             cCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----CCCCcEEEcccccccccCchhhhcCCCCCEEECccCc
Q 036792           24 KAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        24 ~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~   98 (453)
                      ++|+.|+|++|++++ +| +++++++|+.|++++|++.     ..+|+.|++++|.+++ +| ++..+++|+.|++++|.
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~  206 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNS  206 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCc
Confidence            477888888888887 77 5888888888888888875     4578888888888887 67 58888888888888888


Q ss_pred             ccc
Q 036792           99 LEG  101 (453)
Q Consensus        99 l~g  101 (453)
                      +.+
T Consensus       207 l~~  209 (454)
T 1jl5_A          207 LKK  209 (454)
T ss_dssp             CSS
T ss_pred             CCc
Confidence            876

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.95  E-value=3.1e-10  Score=109.32  Aligned_cols=97  Identities=20%  Similarity=0.211  Sum_probs=76.5

Q ss_pred             CccEEEcCCCcCcCC-CCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCC-cCC----------CCCCcEE
Q 036792            1 DILNFDFSSNSLEGP-LSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYN-KLD----------VASLEIL   68 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~-~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n-~~~----------~~~l~~l   68 (453)
                      +|+.|+|++|.+++. +|..+.++++|+.|+|++|.+++.+|..++++++|+.|++++| .++          +++|+.|
T Consensus        94 ~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L  173 (336)
T 2ast_B           94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  173 (336)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEE
Confidence            467888888888766 7777888888888888888888878888888888888888888 453          6778888


Q ss_pred             Ecccc-ccccc-CchhhhcCC-CCCEEECccC
Q 036792           69 NLSNN-EIYGL-IPTSLEKLL-YLKELSLSFN   97 (453)
Q Consensus        69 ~l~~n-~~~g~-~P~~~~~~~-~l~~l~ls~n   97 (453)
                      ++++| .+++. +|..+..++ +|+.|++++|
T Consensus       174 ~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          174 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             cCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            88888 77764 577777777 8888888877

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.93  E-value=4.8e-09  Score=102.15  Aligned_cols=139  Identities=12%  Similarity=0.147  Sum_probs=101.7

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEee--ccc-hhhHHHHHHHHHHHHcCC--CCCceeEEeEEecC---CeeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFH--QEC-ARALKSFEAQCEVMKSIR--HPNLVKVISSCSND---DFKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~E~  273 (453)
                      +.++.|.++.||+....+ ..+++|+..  ... ......+.+|+++++.++  +..+.++++++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            568899999999988754 678888776  332 122356788999999887  45678889888776   457899999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH----------------------------------------  313 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h----------------------------------------  313 (453)
                      ++|..+.+..   ...++...+..++.++++.|..||...                                        
T Consensus       123 v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          123 VSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             CCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             cCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            9998774311   123566777888899999999998521                                        


Q ss_pred             ---------------CCCceecCCCCCceeeCCCCc--EEEeccccCC
Q 036792          314 ---------------TTPIIHCDLKPISVLLDEDMV--AHLSDFEYGM  344 (453)
Q Consensus       314 ---------------~~~i~Hrdlk~~NiLl~~~~~--~kl~df~~~~  344 (453)
                                     ...++|+|+++.||+++.++.  +.|.|||.+.
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                           246899999999999997653  6899999764

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.89  E-value=2.3e-09  Score=103.86  Aligned_cols=80  Identities=20%  Similarity=0.226  Sum_probs=71.9

Q ss_pred             CccEEEcCC-CcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------CCCCcEEEcc
Q 036792            1 DILNFDFSS-NSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~-n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------~~~l~~l~l~   71 (453)
                      +|+.|+|++ |+|.+..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|+|++|+|+        ...|+.|+|+
T Consensus        32 ~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~  111 (347)
T 2ifg_A           32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLS  111 (347)
T ss_dssp             CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECC
T ss_pred             CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEee
Confidence            489999996 9999877788999999999999999999988889999999999999999985        2249999999


Q ss_pred             cccccccCc
Q 036792           72 NNEIYGLIP   80 (453)
Q Consensus        72 ~n~~~g~~P   80 (453)
                      +|.+.....
T Consensus       112 ~N~~~c~c~  120 (347)
T 2ifg_A          112 GNPLHCSCA  120 (347)
T ss_dssp             SSCCCCCGG
T ss_pred             CCCccCCCc
Confidence            999986544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.89  E-value=6.9e-10  Score=109.25  Aligned_cols=100  Identities=23%  Similarity=0.280  Sum_probs=74.8

Q ss_pred             CccEEEcCCCcCcCC----CCcCCCCCcCCCEEECcC---CcccccCcccc-------cCCCCCCEEeCcCCcCC-----
Q 036792            1 DILNFDFSSNSLEGP----LSLDIGNLKAVVEINLSR---NNLSSDMPATI-------GGLISLKTLSLAYNKLD-----   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~----~p~~~~~l~~l~~l~ls~---N~l~g~~p~~~-------~~l~~l~~l~l~~n~~~-----   61 (453)
                      +|+.|+|++|++++.    ++..+.++++|+.|+|++   |+++|.+|..+       .++++|+.|+|++|.+.     
T Consensus        33 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~  112 (386)
T 2ca6_A           33 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE  112 (386)
T ss_dssp             CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred             CccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHH
Confidence            477888888888876    444577888888888888   46667777765       67888888888888874     


Q ss_pred             --------CCCCcEEEcccccccccCchhhhc----C---------CCCCEEECccCccc
Q 036792           62 --------VASLEILNLSNNEIYGLIPTSLEK----L---------LYLKELSLSFNKLE  100 (453)
Q Consensus        62 --------~~~l~~l~l~~n~~~g~~P~~~~~----~---------~~l~~l~ls~n~l~  100 (453)
                              +++|+.|+|++|.+++..+..+..    +         ++|+.|++++|.++
T Consensus       113 ~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~  172 (386)
T 2ca6_A          113 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  172 (386)
T ss_dssp             HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence                    478888888888887554444443    3         78888888888876

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.88  E-value=1.3e-09  Score=106.32  Aligned_cols=100  Identities=25%  Similarity=0.259  Sum_probs=70.9

Q ss_pred             EEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCc----ccccCCC-CCCEEeCcCCcCC--------------CCC
Q 036792            4 NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMP----ATIGGLI-SLKTLSLAYNKLD--------------VAS   64 (453)
Q Consensus         4 ~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p----~~~~~l~-~l~~l~l~~n~~~--------------~~~   64 (453)
                      .++++.|+++|.+|..+....+|++|+|++|.+++..+    ..+.+++ +|+.|+|++|.++              .++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            45677777777777766666667777777777777555    5666777 7777777777774              167


Q ss_pred             CcEEEcccccccccCchhhhcC-----CCCCEEECccCcccccc
Q 036792           65 LEILNLSNNEIYGLIPTSLEKL-----LYLKELSLSFNKLEGEI  103 (453)
Q Consensus        65 l~~l~l~~n~~~g~~P~~~~~~-----~~l~~l~ls~n~l~g~~  103 (453)
                      |+.|+|++|.+++..+..+...     ++|+.|++++|.+++..
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  125 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS  125 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence            7777777777777766655543     67777777777775543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.84  E-value=2e-09  Score=104.94  Aligned_cols=102  Identities=22%  Similarity=0.272  Sum_probs=89.2

Q ss_pred             CccEEEcCCCcCcCCCC----cCCCCCc-CCCEEECcCCcccccCcccccCC-----CCCCEEeCcCCcCC---------
Q 036792            1 DILNFDFSSNSLEGPLS----LDIGNLK-AVVEINLSRNNLSSDMPATIGGL-----ISLKTLSLAYNKLD---------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p----~~~~~l~-~l~~l~ls~N~l~g~~p~~~~~l-----~~l~~l~l~~n~~~---------   61 (453)
                      +|+.|||++|.+++..+    ..+.+++ +|+.|+|++|.+++..+..+..+     ++|+.|+|++|.++         
T Consensus        23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~  102 (362)
T 3goz_A           23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK  102 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence            48999999999998776    7788888 89999999999999888888775     99999999999984         


Q ss_pred             ----C-CCCcEEEcccccccccCchhhhc-----CCCCCEEECccCccccc
Q 036792           62 ----V-ASLEILNLSNNEIYGLIPTSLEK-----LLYLKELSLSFNKLEGE  102 (453)
Q Consensus        62 ----~-~~l~~l~l~~n~~~g~~P~~~~~-----~~~l~~l~ls~n~l~g~  102 (453)
                          . ++|+.|+|++|.+++..+..+..     .++|+.|++++|.+.+.
T Consensus       103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~  153 (362)
T 3goz_A          103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK  153 (362)
T ss_dssp             HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred             HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence                2 79999999999999887776654     36999999999999753

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.83  E-value=1e-08  Score=106.91  Aligned_cols=69  Identities=32%  Similarity=0.354  Sum_probs=35.2

Q ss_pred             cCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----CCCCcEEEcccccccccCchhhhcCCCCCEEECccCc
Q 036792           24 KAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        24 ~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~   98 (453)
                      ++|+.|+|++|.+++ +|..   +++|+.|++++|.++     +++|+.|++++|.+++ +|   ..+++|+.|++++|.
T Consensus       181 ~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~  252 (622)
T 3g06_A          181 SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNR  252 (622)
T ss_dssp             TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSC
T ss_pred             CCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCC
Confidence            444455555555544 3332   233334444444332     2456666666666664 45   344566666666666


Q ss_pred             cc
Q 036792           99 LE  100 (453)
Q Consensus        99 l~  100 (453)
                      ++
T Consensus       253 L~  254 (622)
T 3g06_A          253 LT  254 (622)
T ss_dssp             CS
T ss_pred             CC
Confidence            65

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.72  E-value=2.6e-09  Score=107.49  Aligned_cols=101  Identities=16%  Similarity=0.078  Sum_probs=59.9

Q ss_pred             CccEEEcCCCcCcCC----CCcCCCCCcCCCEEECcCCcccccCcccccC-----CCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSNSLEGP----LSLDIGNLKAVVEINLSRNNLSSDMPATIGG-----LISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~----~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~-----l~~l~~l~l~~n~~~----------   61 (453)
                      +|+.|++++|++++.    ++..+.++++|+.|+|++|.+++..+..+..     .++|+.|++++|.++          
T Consensus       257 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~  336 (461)
T 1z7x_W          257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV  336 (461)
T ss_dssp             CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             CceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHH
Confidence            366777777777754    5666666777777777777766543333322     246666666666653          


Q ss_pred             ---CCCCcEEEcccccccccCchhhhc-----CCCCCEEECccCcccc
Q 036792           62 ---VASLEILNLSNNEIYGLIPTSLEK-----LLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ---~~~l~~l~l~~n~~~g~~P~~~~~-----~~~l~~l~ls~n~l~g  101 (453)
                         +++|+.|++++|.+++..+..+..     .++|+.|++++|.+++
T Consensus       337 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~  384 (461)
T 1z7x_W          337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  384 (461)
T ss_dssp             HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             HhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence               256666666666665544444432     4466666666666654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.71  E-value=1.8e-08  Score=97.77  Aligned_cols=96  Identities=16%  Similarity=0.241  Sum_probs=71.1

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcc-cccCCCCCCEEeCcCCcCC----------CCCCc-EEEc
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLSLAYNKLD----------VASLE-ILNL   70 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~l~~l~l~~n~~~----------~~~l~-~l~l   70 (453)
                      +.++-++|+|+ .+|..+.  ++++.|+|++|+|+. ||+ .|+++++|+.|+|++|.+.          ++++. .+++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSE-ECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCC-cCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            35677778887 6777663  568888888888886 554 5788888888888888762          34444 4666


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCccccc
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      ++|++++..|..+..+++|+.|++++|.+.+.
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~  119 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHL  119 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSC
T ss_pred             cCCcccccCchhhhhccccccccccccccccC
Confidence            77888877778888888888888888887654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.69  E-value=3.7e-08  Score=93.52  Aligned_cols=161  Identities=13%  Similarity=0.126  Sum_probs=106.8

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCC--ceeEEeEEecCC---eeEEEEeccC
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPN--LVKVISSCSNDD---FKALVLEYMP  275 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~E~~~  275 (453)
                      +.++.|....||+..    ..+++|+....  .....+.+|.++|+.+. +..  +.++++.....+   ..|+||||++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            357899999998764    56888886533  33467889999998874 332  345555443333   3578999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF--------------------------------------------  311 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~--------------------------------------------  311 (453)
                      |.++......   .++..++..++.++++.+..||.                                            
T Consensus       100 G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A          100 GVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9888653221   23445555666666666666653                                            


Q ss_pred             -----------cCCCCceecCCCCCceeeCC--CCcEEEeccccCCCC-----------C---cC------------c--
Q 036792          312 -----------GHTTPIIHCDLKPISVLLDE--DMVAHLSDFEYGMEG-----------Q---VS------------T--  350 (453)
Q Consensus       312 -----------~h~~~i~Hrdlk~~NiLl~~--~~~~kl~df~~~~~~-----------~---~~------------~--  350 (453)
                                 .....++|+|+++.||++++  +..+.+.|||.+..+           .   ++            .  
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                       11235799999999999998  456789999754210           0   11            1  


Q ss_pred             ----------ccchHHHHHHHHHHHhCCCCC
Q 036792          351 ----------RSDIYGYGIVLMETFTRKKPT  371 (453)
Q Consensus       351 ----------~~Dv~S~Gvvl~el~tg~~p~  371 (453)
                                ..+.|+++.++|++.+|..++
T Consensus       257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                      147788899999988887764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.64  E-value=2.8e-08  Score=96.36  Aligned_cols=78  Identities=21%  Similarity=0.219  Sum_probs=54.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcc-cccCCCCCCE-EeCcCCcCC---------CCCCcEEE
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKT-LSLAYNKLD---------VASLEILN   69 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~l~~-l~l~~n~~~---------~~~l~~l~   69 (453)
                      +|+.|+|++|+|+...+..|.+|++|+.|+|++|.+.+.+|. .|.+++++.. +.+.+|++.         +++|+.|+
T Consensus        31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~  110 (350)
T 4ay9_X           31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  110 (350)
T ss_dssp             TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred             CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence            477888888888853334588888888888888888777765 4566766664 445556652         45666666


Q ss_pred             ccccccccc
Q 036792           70 LSNNEIYGL   78 (453)
Q Consensus        70 l~~n~~~g~   78 (453)
                      +++|.+++.
T Consensus       111 l~~n~l~~~  119 (350)
T 4ay9_X          111 ISNTGIKHL  119 (350)
T ss_dssp             EEEECCSSC
T ss_pred             ccccccccC
Confidence            666666543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.63  E-value=1e-08  Score=100.33  Aligned_cols=101  Identities=18%  Similarity=0.207  Sum_probs=63.5

Q ss_pred             CccEEEcCCCcCcCCCCcCCC-CCcCCCEEECcCCcccccCcccc-----cCCCCCCEEeCcCCcCC-------------
Q 036792            1 DILNFDFSSNSLEGPLSLDIG-NLKAVVEINLSRNNLSSDMPATI-----GGLISLKTLSLAYNKLD-------------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~-----~~l~~l~~l~l~~n~~~-------------   61 (453)
                      +|+.|+|++|.++..-...+. .+.+|+.|+|++|+|+..-...+     .+.++|+.|+|++|.++             
T Consensus       102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~  181 (372)
T 3un9_A          102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG  181 (372)
T ss_dssp             CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred             CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence            366777777777654333333 45667777777777765433333     24566777777777762             


Q ss_pred             CCCCcEEEccccccccc----CchhhhcCCCCCEEECccCcccc
Q 036792           62 VASLEILNLSNNEIYGL----IPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ~~~l~~l~l~~n~~~g~----~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      .++|+.|||++|.++..    ++..+...++|+.|++++|.++.
T Consensus       182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred             CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence            45677777777777532    34455566677777777777654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.58  E-value=1.9e-08  Score=101.07  Aligned_cols=101  Identities=19%  Similarity=0.142  Sum_probs=57.2

Q ss_pred             CccEEEcCCCcCcCC----CCcCCCCCcCCCEEECcCCcccccC-----cccccCCCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSNSLEGP----LSLDIGNLKAVVEINLSRNNLSSDM-----PATIGGLISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~----~p~~~~~l~~l~~l~ls~N~l~g~~-----p~~~~~l~~l~~l~l~~n~~~----------   61 (453)
                      +|+.|+|++|.+++.    ++..+.++++|++|+|++|.+++.-     +..+.++++|+.|++++|.++          
T Consensus       200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  279 (461)
T 1z7x_W          200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV  279 (461)
T ss_dssp             CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence            366777777777663    4555666666777777777665532     112234566666666666653          


Q ss_pred             ---CCCCcEEEcccccccccCchhhhcC-----CCCCEEECccCcccc
Q 036792           62 ---VASLEILNLSNNEIYGLIPTSLEKL-----LYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ---~~~l~~l~l~~n~~~g~~P~~~~~~-----~~l~~l~ls~n~l~g  101 (453)
                         +++|+.|++++|.+++..+..+...     ++|+.|++++|.+++
T Consensus       280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~  327 (461)
T 1z7x_W          280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA  327 (461)
T ss_dssp             HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred             HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCch
Confidence               3556666666666554433333332     455566666555544

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.54  E-value=1.5e-08  Score=93.79  Aligned_cols=60  Identities=32%  Similarity=0.426  Sum_probs=35.4

Q ss_pred             CCCcCCCEEECcCCcccc--cCcccccCCCCCCEEeCcCCcCC-------CC--CCcEEEcccccccccCc
Q 036792           21 GNLKAVVEINLSRNNLSS--DMPATIGGLISLKTLSLAYNKLD-------VA--SLEILNLSNNEIYGLIP   80 (453)
Q Consensus        21 ~~l~~l~~l~ls~N~l~g--~~p~~~~~l~~l~~l~l~~n~~~-------~~--~l~~l~l~~n~~~g~~P   80 (453)
                      .++++|+.|+||+|+|++  .+|..++.+++|+.|+|++|.+.       +.  +|+.|+|++|.+++.+|
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccC
Confidence            456777777777777777  45566666766666666555553       11  44444444444444443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.47  E-value=3.3e-08  Score=96.62  Aligned_cols=101  Identities=20%  Similarity=0.249  Sum_probs=67.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCC-----cCCCEEECcCCcccccCcccc-cCCCCCCEEeCcCCcCC-------------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNL-----KAVVEINLSRNNLSSDMPATI-GGLISLKTLSLAYNKLD-------------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l-----~~l~~l~ls~N~l~g~~p~~~-~~l~~l~~l~l~~n~~~-------------   61 (453)
                      .|+.|+|++|.+++.-...+..+     .+|+.|+|++|.++..-...+ ..+++|+.|+|++|.++             
T Consensus        73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~  152 (372)
T 3un9_A           73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH  152 (372)
T ss_dssp             TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred             hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence            36778888888776533333322     578888888888765433333 34567788888888873             


Q ss_pred             -CCCCcEEEcccccccc----cCchhhhcCCCCCEEECccCcccc
Q 036792           62 -VASLEILNLSNNEIYG----LIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 -~~~l~~l~l~~n~~~g----~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                       .++|+.|+|++|.++.    .++..+..+++|++|++++|.+..
T Consensus       153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~  197 (372)
T 3un9_A          153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD  197 (372)
T ss_dssp             TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred             cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence             3568888888888764    244555667788888888887754

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.37  E-value=1.6e-07  Score=82.31  Aligned_cols=100  Identities=16%  Similarity=0.177  Sum_probs=59.6

Q ss_pred             CccEEEcCCC-cCcCC----CCcCCCCCcCCCEEECcCCccccc----CcccccCCCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSN-SLEGP----LSLDIGNLKAVVEINLSRNNLSSD----MPATIGGLISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n-~l~g~----~p~~~~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~l~~l~l~~n~~~----------   61 (453)
                      +|+.|+|++| .+...    +...+...++|+.|+|++|.+...    +...+...++|+.|+|++|.+.          
T Consensus        37 ~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~  116 (185)
T 1io0_A           37 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEA  116 (185)
T ss_dssp             TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHG
T ss_pred             CCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHH
Confidence            3566777776 66543    344455556677777777776542    3334445566777777777763          


Q ss_pred             ---CCCCcEEEc--cccccccc----CchhhhcCCCCCEEECccCccc
Q 036792           62 ---VASLEILNL--SNNEIYGL----IPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        62 ---~~~l~~l~l--~~n~~~g~----~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                         .+.|+.|+|  ++|.++..    +...+...++|+.|++++|.+.
T Consensus       117 L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          117 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence               346777777  66666543    2334444566777777776653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.31  E-value=6.5e-06  Score=78.00  Aligned_cols=74  Identities=7%  Similarity=0.019  Sum_probs=54.0

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCC---CceeEEeEEe-cCCeeEEEEeccCCC
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP---NLVKVISSCS-NDDFKALVLEYMPKG  277 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~E~~~~g  277 (453)
                      +.++.|....||+.    |..+++|+...  ......+.+|.++|+.+.+.   .+.+.+.++. ..+..++||||++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            34778888899987    56788888532  23446788999999998753   3556666664 455678999999998


Q ss_pred             CchH
Q 036792          278 SLEN  281 (453)
Q Consensus       278 ~L~~  281 (453)
                      ++.+
T Consensus        99 ~l~~  102 (306)
T 3tdw_A           99 ILGE  102 (306)
T ss_dssp             ECHH
T ss_pred             ECch
Confidence            8765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.23  E-value=1e-05  Score=75.02  Aligned_cols=133  Identities=15%  Similarity=0.059  Sum_probs=87.8

Q ss_pred             cCCCCcc-EEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccCCCCch
Q 036792          204 IGMGSFG-SVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMPKGSLE  280 (453)
Q Consensus       204 lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~~g~L~  280 (453)
                      +..|..| .||+.... ++..+.+|+-...   ....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445555 68987765 4678899986543   3356788999888774 323667888998999999999999998776


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 036792          281 NCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG------------------------------------------------  312 (453)
Q Consensus       281 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~------------------------------------------------  312 (453)
                      +......     .....+..++++.+..||..                                                
T Consensus       109 ~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  183 (272)
T 4gkh_A          109 QVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM  183 (272)
T ss_dssp             HHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred             ccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence            5432210     11112223333333333310                                                


Q ss_pred             -------CCCCceecCCCCCceeeCCCCcEEEeccccCC
Q 036792          313 -------HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM  344 (453)
Q Consensus       313 -------h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~  344 (453)
                             +...++|+|+.+.||+++.++.+-|.|||.+.
T Consensus       184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                   11237899999999999987777799998763

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.22  E-value=3.2e-07  Score=95.20  Aligned_cols=101  Identities=11%  Similarity=0.100  Sum_probs=58.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCC-CcCCCEEECc----CCccccc-----CcccccCCCCCCEEeCcCCc--CC-------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGN-LKAVVEINLS----RNNLSSD-----MPATIGGLISLKTLSLAYNK--LD-------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~-l~~l~~l~ls----~N~l~g~-----~p~~~~~l~~l~~l~l~~n~--~~-------   61 (453)
                      +|+.|+++.|++++..+..++. +++|+.|+|+    .|++++.     ++..+.++++|+.|+++++.  ++       
T Consensus       379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~  458 (592)
T 3ogk_B          379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI  458 (592)
T ss_dssp             TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred             cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence            3566777667776666666554 6667777664    5666652     44445556666666665322  31       


Q ss_pred             ---CCCCcEEEcccccccc-cCchhhhcCCCCCEEECccCcccc
Q 036792           62 ---VASLEILNLSNNEIYG-LIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ---~~~l~~l~l~~n~~~g-~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                         +++|+.|++++|.+++ .+|..+..+++|+.|++++|.+++
T Consensus       459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~  502 (592)
T 3ogk_B          459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE  502 (592)
T ss_dssp             HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred             HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence               4556666666666654 334444556666666666666544

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.12  E-value=1.7e-06  Score=79.94  Aligned_cols=59  Identities=27%  Similarity=0.328  Sum_probs=50.8

Q ss_pred             CccEEEcCCCcCcC--CCCcCCCCCcCCCEEECcCCcccccCcccccCCC--CCCEEeCcCCcCC
Q 036792            1 DILNFDFSSNSLEG--PLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLI--SLKTLSLAYNKLD   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g--~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~--~l~~l~l~~n~~~   61 (453)
                      +|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++.  .++..+.  +|+.|+|++|.+.
T Consensus       171 ~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~  233 (267)
T 3rw6_A          171 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC  233 (267)
T ss_dssp             TCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred             CCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence            48899999999999  6777788999999999999999985  3455555  8999999999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.08  E-value=3.7e-06  Score=81.39  Aligned_cols=79  Identities=10%  Similarity=0.042  Sum_probs=54.0

Q ss_pred             ccc-CCCCccEEEEEEEC-------CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCC---CCceeEEeEEecC---
Q 036792          202 NLI-GMGSFGSVYRARLR-------DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRH---PNLVKVISSCSND---  264 (453)
Q Consensus       202 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---  264 (453)
                      +.| +.|....+|+....       ++..+++|......   ......+.+|+.+|+.+..   -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78889999988754       26678888865432   1012456778888877742   3466788877654   


Q ss_pred             CeeEEEEeccCCCCch
Q 036792          265 DFKALVLEYMPKGSLE  280 (453)
Q Consensus       265 ~~~~lv~E~~~~g~L~  280 (453)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.06  E-value=1.6e-06  Score=89.86  Aligned_cols=94  Identities=13%  Similarity=0.137  Sum_probs=61.6

Q ss_pred             ccEEEcCCCc-CcC-CCCcCCCCCcCCCEEECcCCccccc----CcccccCCCCCCEEeCcCCcCC-------------C
Q 036792            2 ILNFDFSSNS-LEG-PLSLDIGNLKAVVEINLSRNNLSSD----MPATIGGLISLKTLSLAYNKLD-------------V   62 (453)
Q Consensus         2 l~~l~ls~n~-l~g-~~p~~~~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~l~~l~l~~n~~~-------------~   62 (453)
                      |+.|+|++|. ++. .++.-+.++++|+.|+|++|.+++.    ++..+.++++|+.|++++|.++             +
T Consensus       140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~  219 (592)
T 3ogk_B          140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC  219 (592)
T ss_dssp             CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred             CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence            6777777765 211 1222234667777777777777665    4445566777777777777763             5


Q ss_pred             CCCcEEEcccccccccCchhhhcCCCCCEEECcc
Q 036792           63 ASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSF   96 (453)
Q Consensus        63 ~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~   96 (453)
                      ++|+.|++++|.+.+ +|..+..+++|+.|+++.
T Consensus       220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            677777777777775 566777777777777764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.99  E-value=3.3e-05  Score=75.92  Aligned_cols=74  Identities=14%  Similarity=0.185  Sum_probs=48.2

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccch-------hhHHHHHHHHHHHHcCCC--CC-ceeEEeEEecCCeeEEE
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-------RALKSFEAQCEVMKSIRH--PN-LVKVISSCSNDDFKALV  270 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~lv  270 (453)
                      +.+|.|.++.||++... +++.++||.......       ....++..|.++++.+..  +. +.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            56899999999999754 468899998653211       122456778888877632  33 3455544  34456899


Q ss_pred             EeccCCC
Q 036792          271 LEYMPKG  277 (453)
Q Consensus       271 ~E~~~~g  277 (453)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.83  E-value=1.5e-05  Score=76.29  Aligned_cols=59  Identities=17%  Similarity=0.220  Sum_probs=43.4

Q ss_pred             CccEEEcCCCcCc------C-------------CCCc-CCCC--------CcCCCEEECcCCcccccCcccccCCCCCCE
Q 036792            1 DILNFDFSSNSLE------G-------------PLSL-DIGN--------LKAVVEINLSRNNLSSDMPATIGGLISLKT   52 (453)
Q Consensus         1 ~l~~l~ls~n~l~------g-------------~~p~-~~~~--------l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~   52 (453)
                      +|+.||||+|++.      |             .+|+ .|.+        +++|+.|+|+. +++..-+..|.+|++|+.
T Consensus        50 ~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~  128 (329)
T 3sb4_A           50 SLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKI  128 (329)
T ss_dssp             TCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCE
T ss_pred             cCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccce
Confidence            4788999999888      1             1232 3556        88999999988 777644456889999999


Q ss_pred             EeCcCCcC
Q 036792           53 LSLAYNKL   60 (453)
Q Consensus        53 l~l~~n~~   60 (453)
                      +++++|.+
T Consensus       129 l~l~~n~i  136 (329)
T 3sb4_A          129 CQIRKKTA  136 (329)
T ss_dssp             EEBCCSSC
T ss_pred             EEcCCCCc
Confidence            99988864

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.81  E-value=3.7e-05  Score=73.51  Aligned_cols=75  Identities=17%  Similarity=0.175  Sum_probs=37.3

Q ss_pred             CcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCc-EEEcccccccccCchhhhcCCCCCEE
Q 036792           23 LKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLE-ILNLSNNEIYGLIPTSLEKLLYLKEL   92 (453)
Q Consensus        23 l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~-~l~l~~n~~~g~~P~~~~~~~~l~~l   92 (453)
                      +++|+.|+|++|+++..-+..|.+|++|+.++|++| +.         +.+|+ .+++++ +++..-+..|..+++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            445555555555555322223455555555555554 21         34455 555555 4443334555556666666


Q ss_pred             ECccCcc
Q 036792           93 SLSFNKL   99 (453)
Q Consensus        93 ~ls~n~l   99 (453)
                      +++.|.+
T Consensus       303 ~l~~n~i  309 (329)
T 3sb4_A          303 LATGDKI  309 (329)
T ss_dssp             EECSSCC
T ss_pred             EeCCCcc
Confidence            6655554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.79  E-value=7.6e-06  Score=84.71  Aligned_cols=101  Identities=15%  Similarity=0.144  Sum_probs=69.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCC-CCcCCCEEECc--C----Ccccc-----cCcccccCCCCCCEEeCcCCcCC-------
Q 036792            1 DILNFDFSSNSLEGPLSLDIG-NLKAVVEINLS--R----NNLSS-----DMPATIGGLISLKTLSLAYNKLD-------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~-~l~~l~~l~ls--~----N~l~g-----~~p~~~~~l~~l~~l~l~~n~~~-------   61 (453)
                      +|+.|+++.|++++..+..+. ++++|+.|+|+  +    |++++     .++.-+.++++|+.|++++ .++       
T Consensus       373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l  451 (594)
T 2p1m_B          373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI  451 (594)
T ss_dssp             TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred             hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence            467778888888776666665 57788888887  3    55552     2333366778888888866 442       


Q ss_pred             ---CCCCcEEEcccccccccCchhh-hcCCCCCEEECccCccccc
Q 036792           62 ---VASLEILNLSNNEIYGLIPTSL-EKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        62 ---~~~l~~l~l~~n~~~g~~P~~~-~~~~~l~~l~ls~n~l~g~  102 (453)
                         +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++.
T Consensus       452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~  496 (594)
T 2p1m_B          452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK  496 (594)
T ss_dssp             HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred             HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence               5678888888888776555555 5677888888888877543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.79  E-value=2.4e-05  Score=68.23  Aligned_cols=84  Identities=21%  Similarity=0.214  Sum_probs=69.1

Q ss_pred             CCCCCcCCCEEECcCC-ccccc----CcccccCCCCCCEEeCcCCcCC-------------CCCCcEEEccccccccc--
Q 036792           19 DIGNLKAVVEINLSRN-NLSSD----MPATIGGLISLKTLSLAYNKLD-------------VASLEILNLSNNEIYGL--   78 (453)
Q Consensus        19 ~~~~l~~l~~l~ls~N-~l~g~----~p~~~~~l~~l~~l~l~~n~~~-------------~~~l~~l~l~~n~~~g~--   78 (453)
                      .+.+.++|++|+|++| .+...    +...+...++|+.|+|++|.+.             .+.|+.|+|++|.++..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4566788999999999 88753    4556778899999999999995             47899999999999854  


Q ss_pred             --CchhhhcCCCCCEEEC--ccCccccc
Q 036792           79 --IPTSLEKLLYLKELSL--SFNKLEGE  102 (453)
Q Consensus        79 --~P~~~~~~~~l~~l~l--s~n~l~g~  102 (453)
                        +...+...++|+.|++  ++|.+...
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~  138 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNN  138 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence              4567777889999999  88988643

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.74  E-value=1e-05  Score=78.41  Aligned_cols=99  Identities=15%  Similarity=0.164  Sum_probs=66.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCccccc--CCCCCCEEeCcC--Cc------C----------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIG--GLISLKTLSLAY--NK------L----------   60 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~--~l~~l~~l~l~~--n~------~----------   60 (453)
                      +|+.|+|++|.-. .+++ +. +++|+.|+|..+.++...-..+.  .+|+|+.|+|+.  |.      +          
T Consensus       173 ~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~  249 (362)
T 2ra8_A          173 LLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD  249 (362)
T ss_dssp             TCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTT
T ss_pred             CCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcC
Confidence            4788888887311 2443 43 77888888888877654444443  688888888742  21      1          


Q ss_pred             CCCCCcEEEcccccccccCchhhh---cCCCCCEEECccCccccc
Q 036792           61 DVASLEILNLSNNEIYGLIPTSLE---KLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        61 ~~~~l~~l~l~~n~~~g~~P~~~~---~~~~l~~l~ls~n~l~g~  102 (453)
                      .+++|+.|+|++|.++...+..+.   .+++|+.|+++.|.+.+.
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~  294 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE  294 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence            157888888888888765554444   366888888888887663

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.74  E-value=0.00019  Score=68.53  Aligned_cols=47  Identities=15%  Similarity=0.126  Sum_probs=35.1

Q ss_pred             CCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHHH
Q 036792          314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETF  365 (453)
Q Consensus       314 ~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~  365 (453)
                      ...++|+|+.+.||+++.++.+.+.||+.+..+  .   -.|-++.++...+
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g--~---~~~Dla~~l~~~~  267 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD--L---PIRDLRKMIIPLL  267 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEEC--C---THHHHHHHHHHHT
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcccC--C---hHHHHHHHHHHHH
Confidence            567999999999999987788999999976332  1   2455555566554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.67  E-value=7.3e-06  Score=84.82  Aligned_cols=102  Identities=13%  Similarity=0.097  Sum_probs=73.5

Q ss_pred             CccEEEc---------CCCcCcCCCCcCCC-CCcCCCEEECcCCcccccCccccc-CCCCCCEEeCc--C----CcCC--
Q 036792            1 DILNFDF---------SSNSLEGPLSLDIG-NLKAVVEINLSRNNLSSDMPATIG-GLISLKTLSLA--Y----NKLD--   61 (453)
Q Consensus         1 ~l~~l~l---------s~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~-~l~~l~~l~l~--~----n~~~--   61 (453)
                      +|+.|++         +.|.+++.....+. ++++|+.|.++.|++++..+..+. ++++|+.|+++  +    |.++  
T Consensus       339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~  418 (594)
T 2p1m_B          339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLE  418 (594)
T ss_dssp             TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCC
T ss_pred             CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCC
Confidence            4777877         33555554333333 478888888888998887776665 58889999988  3    3443  


Q ss_pred             ------------CCCCcEEEcccccccccCchhhhc-CCCCCEEECccCcccccc
Q 036792           62 ------------VASLEILNLSNNEIYGLIPTSLEK-LLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        62 ------------~~~l~~l~l~~n~~~g~~P~~~~~-~~~l~~l~ls~n~l~g~~  103 (453)
                                  +++|+.|++++ .+++..+..+.. +++|+.|++++|.+++..
T Consensus       419 ~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~  472 (594)
T 2p1m_B          419 PLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG  472 (594)
T ss_dssp             CTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred             chhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence                        46889999977 677666666666 888999999999886543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.00018  Score=67.24  Aligned_cols=74  Identities=18%  Similarity=0.191  Sum_probs=53.7

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCC---CceeEEeEEecCCeeEEEEeccCCCC
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP---NLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      +.+|.|..+.||+.+..+|+.|.+|+-..........|..|++.|+.+.-.   -+.+++++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            458999999999999999999999987654433334678899988877421   234455432    2378999998765


Q ss_pred             c
Q 036792          279 L  279 (453)
Q Consensus       279 L  279 (453)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.43  E-value=0.0018  Score=61.10  Aligned_cols=74  Identities=16%  Similarity=0.162  Sum_probs=58.7

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR---HPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      +.++.|....+|+... ++..+++|+....   ....+..|.+.|+.+.   ...+.++++++...+..++||||+++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            4588999999999885 4678889987643   2466888988888774   3567888888888888999999999876


Q ss_pred             c
Q 036792          279 L  279 (453)
Q Consensus       279 L  279 (453)
                      +
T Consensus       118 ~  118 (312)
T 3jr1_A          118 N  118 (312)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.39  E-value=0.00013  Score=70.73  Aligned_cols=99  Identities=15%  Similarity=0.070  Sum_probs=68.1

Q ss_pred             CccEEEcCCCcCc---------CCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSNSLE---------GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~---------g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------   61 (453)
                      +|+.|.+..+.+.         +.+.+-+..+++|+.|+|++|.-. .+|+ +. +++|+.|+|..|.+.          
T Consensus       140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~  216 (362)
T 2ra8_A          140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGS  216 (362)
T ss_dssp             TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred             hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHc
Confidence            4778888766431         234455667899999999988422 2444 43 889999999999873          


Q ss_pred             -CCCCcEEEccc--ccccccC-----chhh--hcCCCCCEEECccCccccc
Q 036792           62 -VASLEILNLSN--NEIYGLI-----PTSL--EKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        62 -~~~l~~l~l~~--n~~~g~~-----P~~~--~~~~~l~~l~ls~n~l~g~  102 (453)
                       +++|+.|+|+.  |...|..     -..+  ..+++|+.|++++|.+...
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~  267 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV  267 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchH
Confidence             78999999863  3322221     1112  2478999999999988653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.30  E-value=0.0011  Score=65.50  Aligned_cols=72  Identities=14%  Similarity=0.159  Sum_probs=43.9

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeecc------c-h--hhHHHHHHHHHHHH-cCCCCCceeEEeEEecCCeeEEEE
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQE------C-A--RALKSFEAQCEVMK-SIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      +.+|.|..+.||+... ++..++||.....      . .  .....+..|+..+. ...+..+.+++.+.  ++..++||
T Consensus        40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~  116 (420)
T 2pyw_A           40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM  116 (420)
T ss_dssp             EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred             EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence            4688999999999964 4678999943211      0 0  12233444443322 22234566666655  46678999


Q ss_pred             ecc-CC
Q 036792          272 EYM-PK  276 (453)
Q Consensus       272 E~~-~~  276 (453)
                      ||+ ++
T Consensus       117 e~l~~g  122 (420)
T 2pyw_A          117 RYLEPP  122 (420)
T ss_dssp             CCCCTT
T ss_pred             eecCCc
Confidence            999 76

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.13  E-value=0.00077  Score=66.81  Aligned_cols=72  Identities=19%  Similarity=0.281  Sum_probs=48.1

Q ss_pred             cccCCCCccEEEEEEECC--------CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-eeEEeEEecCCeeEEEEe
Q 036792          202 NLIGMGSFGSVYRARLRD--------GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL-VKVISSCSNDDFKALVLE  272 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~E  272 (453)
                      +.|+.|....+|+....+        +..+.+|+......  ...+.+|..+++.+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            457888889999998753        47889998743211  1345578888877753333 566766532    38999


Q ss_pred             ccCCCCc
Q 036792          273 YMPKGSL  279 (453)
Q Consensus       273 ~~~~g~L  279 (453)
                      |++|.++
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.02  E-value=0.0017  Score=63.17  Aligned_cols=155  Identities=14%  Similarity=0.133  Sum_probs=86.8

Q ss_pred             cccCCCCccEEEEEEEC--------CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCC-ceeEEeEEecCCeeEEEEe
Q 036792          202 NLIGMGSFGSVYRARLR--------DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN-LVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~E  272 (453)
                      +.+..|-...+|+....        ++..+.+|+.... ........+|.++++.+.-.+ ..++++.+.+    .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            35667888889998864        2478889886332 223455668888887774222 3566666543    39999


Q ss_pred             ccCCCCchHH-----------------hhcCC----CCCC--HHHHHHHHHHH-------------------HHHHHHH-
Q 036792          273 YMPKGSLENC-----------------LYSST----CMLD--IFQRLNIMIDA-------------------TSTLEYL-  309 (453)
Q Consensus       273 ~~~~g~L~~~-----------------l~~~~----~~l~--~~~~~~i~~~i-------------------~~~l~~L-  309 (453)
                      |++|.+|..-                 |+...    ....  +.+......++                   .+.+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655310                 11111    1112  11111111111                   1112222 


Q ss_pred             ---Hh-cCCCCceecCCCCCceeeCCC----CcEEEeccccCCCCCcCcccchHHHHHHHHHHHh
Q 036792          310 ---YF-GHTTPIIHCDLKPISVLLDED----MVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFT  366 (453)
Q Consensus       310 ---~~-~h~~~i~Hrdlk~~NiLl~~~----~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~t  366 (453)
                         .. .....++|+|+.+.||+++.+    +.+.+.|||++..+     --.|-+|..+.|...
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~-----~~~~Dla~~~~~~~~  270 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN-----YRGFDIGNHFCEWVY  270 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE-----EHHHHHHHHHHHTTE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC-----ChHHHHHHHHHHHHh
Confidence               11 223457899999999999876    68999999987332     235677888888763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.97  E-value=0.0021  Score=64.17  Aligned_cols=73  Identities=11%  Similarity=0.153  Sum_probs=46.5

Q ss_pred             cccCCCCccEEEEEEECC-CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-eeEEeEEecCCeeEEEEeccCCCCc
Q 036792          202 NLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL-VKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      +.|+.|-...+|+....+ +..+++|+........ -...+|..++..+...++ .++++.+.  +  .+|+||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            457888889999998765 4778888764332111 112578888888765445 46777663  2  359999987544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.92  E-value=0.0016  Score=52.93  Aligned_cols=55  Identities=25%  Similarity=0.297  Sum_probs=26.7

Q ss_pred             EEEcCCCcCc-CCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC
Q 036792            4 NFDFSSNSLE-GPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL   60 (453)
Q Consensus         4 ~l~ls~n~l~-g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~   60 (453)
                      .++-++++|+ ..+|..|.  .+|+.|+|++|+|+..-+..|.++++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            3455555554 33443322  2355556666665543233345555555555555544

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.91  E-value=0.00047  Score=59.05  Aligned_cols=83  Identities=16%  Similarity=0.071  Sum_probs=62.3

Q ss_pred             CCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCc-CC---------C----CCCcEEEccccc-ccccCc
Q 036792           16 LSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK-LD---------V----ASLEILNLSNNE-IYGLIP   80 (453)
Q Consensus        16 ~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~-~~---------~----~~l~~l~l~~n~-~~g~~P   80 (453)
                      +|.....-.+|+.||||++.++..=-..+.+|++|+.|+|+++. ++         +    ++|+.|+|+++. +|-.==
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            45433233469999999999876544567899999999999996 53         2    369999999975 663322


Q ss_pred             hhhhcCCCCCEEECccCc
Q 036792           81 TSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        81 ~~~~~~~~l~~l~ls~n~   98 (453)
                      ..+..+++|+.|++++..
T Consensus       133 ~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HHGGGCTTCCEEEEESCT
T ss_pred             HHHhcCCCCCEEECCCCC
Confidence            456789999999999874

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.89  E-value=0.0057  Score=58.14  Aligned_cols=34  Identities=18%  Similarity=0.232  Sum_probs=27.6

Q ss_pred             CCCCceecCCCCCceeeCCC----CcEEEeccccCCCC
Q 036792          313 HTTPIIHCDLKPISVLLDED----MVAHLSDFEYGMEG  346 (453)
Q Consensus       313 h~~~i~Hrdlk~~NiLl~~~----~~~kl~df~~~~~~  346 (453)
                      +...++|+|+.+.||+++.+    ..+.+.||+.+..+
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            34568999999999999874    67899999876443

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.84  E-value=0.0012  Score=56.57  Aligned_cols=73  Identities=16%  Similarity=0.160  Sum_probs=53.0

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCc-ccccCcccccCC----CCCCEEeCcCCc-CC---------CCCCc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNN-LSSDMPATIGGL----ISLKTLSLAYNK-LD---------VASLE   66 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~-l~g~~p~~~~~l----~~l~~l~l~~n~-~~---------~~~l~   66 (453)
                      |+.||||++.++..--..+.++++|+.|+|+++. ++..-=..++.+    ++|+.|+|+++. ++         +++|+
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~  142 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK  142 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence            6788888888776655667788888888888874 665433345554    468888888875 53         77888


Q ss_pred             EEEccccc
Q 036792           67 ILNLSNNE   74 (453)
Q Consensus        67 ~l~l~~n~   74 (453)
                      .|+|+++.
T Consensus       143 ~L~L~~c~  150 (176)
T 3e4g_A          143 YLFLSDLP  150 (176)
T ss_dssp             EEEEESCT
T ss_pred             EEECCCCC
Confidence            88888765

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.80  E-value=0.00075  Score=58.93  Aligned_cols=75  Identities=17%  Similarity=0.170  Sum_probs=41.3

Q ss_pred             CcCCCEEECcCC-ccccc----CcccccCCCCCCEEeCcCCcCC-------------CCCCcEEEccccccccc----Cc
Q 036792           23 LKAVVEINLSRN-NLSSD----MPATIGGLISLKTLSLAYNKLD-------------VASLEILNLSNNEIYGL----IP   80 (453)
Q Consensus        23 l~~l~~l~ls~N-~l~g~----~p~~~~~l~~l~~l~l~~n~~~-------------~~~l~~l~l~~n~~~g~----~P   80 (453)
                      -+.|++|+|++| .+...    +-..+..-+.|+.|+|++|.+.             =+.|+.|+|++|.++..    +-
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala  119 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL  119 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence            345666777664 54321    2223445566677777777663             24667777777776532    11


Q ss_pred             hhhhcCCCCCEEECccC
Q 036792           81 TSLEKLLYLKELSLSFN   97 (453)
Q Consensus        81 ~~~~~~~~l~~l~ls~n   97 (453)
                      ..+..-++|+.|++++|
T Consensus       120 ~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          120 RSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHTTTTCCCSEEECCCC
T ss_pred             HHHhhCCceeEEECCCC
Confidence            22333445777777654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.74  E-value=0.0025  Score=59.77  Aligned_cols=71  Identities=10%  Similarity=0.074  Sum_probs=42.1

Q ss_pred             hcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-eeEEeEEecCCeeEEEEecc-CCCC
Q 036792          201 SNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL-VKVISSCSNDDFKALVLEYM-PKGS  278 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~E~~-~~g~  278 (453)
                      .+.++.|....+|+.     ..+++|+........ ....+|..+++.+...++ .++++++  ++.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            356888999999998     568888776432111 122457766666542222 3555543  33347899999 6544


Q ss_pred             c
Q 036792          279 L  279 (453)
Q Consensus       279 L  279 (453)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.68  E-value=0.0019  Score=61.04  Aligned_cols=156  Identities=13%  Similarity=0.129  Sum_probs=82.6

Q ss_pred             cccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--ceeEEeE------EecCCeeEEEEec
Q 036792          202 NLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN--LVKVISS------CSNDDFKALVLEY  273 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~E~  273 (453)
                      +.++.|....+|+....+| .+++|......  ..+.+..|..++..+...+  +.+++..      ....+..++++||
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            3467788889999987655 68889886521  1123455666666553212  2223211      1123567899999


Q ss_pred             cCCCCchH-----------H---hhc---C-CC----CC---CHHHHHH------------HHHHHHHHHHHHHhc----
Q 036792          274 MPKGSLEN-----------C---LYS---S-TC----ML---DIFQRLN------------IMIDATSTLEYLYFG----  312 (453)
Q Consensus       274 ~~~g~L~~-----------~---l~~---~-~~----~l---~~~~~~~------------i~~~i~~~l~~L~~~----  312 (453)
                      ++|..+..           .   ++.   . ..    ..   .|.....            +...+.+.+..+...    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            98865421           0   111   0 00    01   1221110            001123344444321    


Q ss_pred             CCCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHHH
Q 036792          313 HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETF  365 (453)
Q Consensus       313 h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~  365 (453)
                      ....++|+|+.+.||+++++..+.+.||+.+..+     .-+|-++.++..+.
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g-----~~~~Dla~~l~~~~  232 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACND-----LLAYDVSICLNAWC  232 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE-----EHHHHHHHHHHHHS
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccCc-----hhHHHHHHHHHHHH
Confidence            2346899999999999998766689999876332     12456666665543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.60  E-value=0.0024  Score=61.83  Aligned_cols=153  Identities=16%  Similarity=0.245  Sum_probs=81.2

Q ss_pred             cccCCCCccEEEEEEECC---------CCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCC-ceeEEeEEecCCeeEEEE
Q 036792          202 NLIGMGSFGSVYRARLRD---------GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPN-LVKVISSCSNDDFKALVL  271 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~  271 (453)
                      ..++.|....+|+....+         +..+++|+....... ......|.++++.+...+ ..++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457788888999998654         268888887543221 112356777777664333 34566544  2  26899


Q ss_pred             eccCCCCchH--------------Hh---hc----C--CCCCC----HHHHHH-H--------------------HHHHH
Q 036792          272 EYMPKGSLEN--------------CL---YS----S--TCMLD----IFQRLN-I--------------------MIDAT  303 (453)
Q Consensus       272 E~~~~g~L~~--------------~l---~~----~--~~~l~----~~~~~~-i--------------------~~~i~  303 (453)
                      ||++|.++..              .|   +.    .  ...++    ...++. .                    ...+.
T Consensus       114 e~i~G~~l~~~~~~~~~~~~~~a~~La~lH~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (369)
T 3c5i_A          114 EWLYGDPLRIDDLKNPTILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLFKYKNIEKYNCDIHKYIKESD  193 (369)
T ss_dssp             ECCCSEECCGGGGGCHHHHHHHHHHHHHHHTHHHHSCCCTTSCCSCHHHHHHHHHHHHHTTCSSGGGC-CCHHHHHHHHH
T ss_pred             EEecCCcCChhhcCChHHHHHHHHHHHHHHcCcccccCcccCCCCCcHHHHHHHHHHHHhhhhhHHHHHhhHHHHHHHHH
Confidence            9998754411              00   11    0  00111    111110 0                    00111


Q ss_pred             HHHHHHHh-------cCCCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHHH
Q 036792          304 STLEYLYF-------GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETF  365 (453)
Q Consensus       304 ~~l~~L~~-------~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~  365 (453)
                      ....++..       .....++|+|+.+.|||++++. +.+.|||++..+     -=.|-+|..+.+..
T Consensus       194 ~l~~~l~~~~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g-----~~~~Dla~~~~~~~  256 (369)
T 3c5i_A          194 KFIKFMKVYSKSDNLANTIVFCHNDLQENNIINTNKC-LRLIDFEYSGFN-----FLATDIANFFIETS  256 (369)
T ss_dssp             HHHHHHHHHTTSSCGGGCEEEECSCCCGGGEEECC-C-EEECCCTTCEEE-----EHHHHHHHHHHGGG
T ss_pred             HHHHHHHHhhhhcccCCCeEEEeCCCCcccEEecCCc-EEEEEecCCCCC-----chHHHHHHHHHHHh
Confidence            12223321       1224579999999999998654 899999986432     12456777777764

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.47  E-value=0.0057  Score=59.94  Aligned_cols=92  Identities=11%  Similarity=0.131  Sum_probs=58.7

Q ss_pred             CccEEEcCCCcCcCCCCc-CCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC--------------CCCC
Q 036792            1 DILNFDFSSNSLEGPLSL-DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD--------------VASL   65 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~-~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~--------------~~~l   65 (453)
                      +|+.++++.| +. .++. .|.+ ++|+.+.| .|+++..-+..|.+|++|+.+++.+|.+.              +++|
T Consensus       227 ~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L  302 (401)
T 4fdw_A          227 QLKTIEIPEN-VS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL  302 (401)
T ss_dssp             TCCCEECCTT-CC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred             CCCEEecCCC-cc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence            3667777764 44 2333 3445 67788777 55566533556778888888887766542              5677


Q ss_pred             cEEEcccccccccCchhhhcCCCCCEEECccC
Q 036792           66 EILNLSNNEIYGLIPTSLEKLLYLKELSLSFN   97 (453)
Q Consensus        66 ~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n   97 (453)
                      +.++|.+ .++-.-...|..+.+|+.+++..|
T Consensus       303 ~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~  333 (401)
T 4fdw_A          303 ARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN  333 (401)
T ss_dssp             CEECCCT-TCCEECTTTTTTCCSCCEEEECTT
T ss_pred             CeEEeCC-ceEEEhhhhhcCCCCccEEEECcc
Confidence            8887773 455333456667778888877554

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.45  E-value=0.0057  Score=49.62  Aligned_cols=57  Identities=23%  Similarity=0.329  Sum_probs=45.0

Q ss_pred             CEEECcCCccc-ccCcccccCCCCCCEEeCcCCcCCCCCCcEEEcccccccccCchhhhcCCCCCEEECccCccc
Q 036792           27 VEINLSRNNLS-SDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        27 ~~l~ls~N~l~-g~~p~~~~~l~~l~~l~l~~n~~~~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      ..++.+++.|+ ..+|..+   +              ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~l---p--------------~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAF---P--------------VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCC---C--------------TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCC---C--------------cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            47888888887 3477533   2              46789999999999766677888999999999999874

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.41  E-value=0.01  Score=56.14  Aligned_cols=75  Identities=11%  Similarity=0.097  Sum_probs=46.9

Q ss_pred             ccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCC--CceeEEeE-----EecCCeeEEEEeccC
Q 036792          203 LIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHP--NLVKVISS-----CSNDDFKALVLEYMP  275 (453)
Q Consensus       203 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~E~~~  275 (453)
                      .++ |....||+....+|+.+++|....... ....+..|..++..+...  .+++++..     ...++..++++||++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            355 777899988777777899999863311 234556677777666421  23334332     122456688999998


Q ss_pred             CCCc
Q 036792          276 KGSL  279 (453)
Q Consensus       276 ~g~L  279 (453)
                      |..+
T Consensus       111 G~~~  114 (328)
T 1zyl_A          111 GRQF  114 (328)
T ss_dssp             CEEC
T ss_pred             CCCC
Confidence            7543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=95.84  E-value=0.027  Score=55.09  Aligned_cols=70  Identities=16%  Similarity=0.198  Sum_probs=39.1

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC--------CCCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--------DVASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~--------~~~~l~~l~l~~n   73 (453)
                      |+.+.++. ++...-+..|.++.+|+.++|+.|+++. ||...-.+.+|+.+.|..|--        .+++|+.+++..|
T Consensus       159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~-I~~~aF~~~~L~~l~lp~~l~~I~~~aF~~~~~L~~l~l~~~  236 (401)
T 4fdw_A          159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK-LPASTFVYAGIEEVLLPVTLKEIGSQAFLKTSQLKTIEIPEN  236 (401)
T ss_dssp             CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE-ECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCCEECCTT
T ss_pred             ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE-echhhEeecccCEEEeCCchheehhhHhhCCCCCCEEecCCC
Confidence            56666664 5553334556777777777777777664 444332355666666654311        1445555555543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.36  E-value=0.07  Score=50.75  Aligned_cols=68  Identities=12%  Similarity=0.149  Sum_probs=42.3

Q ss_pred             CCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCceeEEeE------EecCCeeEEEEeccC
Q 036792          205 GMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR---HPNLVKVISS------CSNDDFKALVLEYMP  275 (453)
Q Consensus       205 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~------~~~~~~~~lv~E~~~  275 (453)
                      |.|....||+....+| .+++|+......      ..|..+++.+.   -|.+++.+..      ....+..+++|||++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            4444689999987767 899998765432      23444444442   1224444432      233567789999999


Q ss_pred             CCCc
Q 036792          276 KGSL  279 (453)
Q Consensus       276 ~g~L  279 (453)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8755

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=95.32  E-value=0.021  Score=49.68  Aligned_cols=97  Identities=18%  Similarity=0.190  Sum_probs=47.9

Q ss_pred             ccEEEcCCC-cCcCC----CCcCCCCCcCCCEEECcCCccccc----CcccccCCCCCCEEeCcCCcCC-----------
Q 036792            2 ILNFDFSSN-SLEGP----LSLDIGNLKAVVEINLSRNNLSSD----MPATIGGLISLKTLSLAYNKLD-----------   61 (453)
Q Consensus         2 l~~l~ls~n-~l~g~----~p~~~~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~l~~l~l~~n~~~-----------   61 (453)
                      |+.|+|++| ++...    +-..+..=+.|+.|+|++|.+...    |-..+..-+.|+.|+|++|.+.           
T Consensus        43 L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL  122 (197)
T 1pgv_A           43 LKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRST  122 (197)
T ss_dssp             CCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHT
T ss_pred             ccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHH
Confidence            556666664 44322    223333345566666666666532    2222334455666666666663           


Q ss_pred             --CCCCcEEEccccc---ccc----cCchhhhcCCCCCEEECccCc
Q 036792           62 --VASLEILNLSNNE---IYG----LIPTSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        62 --~~~l~~l~l~~n~---~~g----~~P~~~~~~~~l~~l~ls~n~   98 (453)
                        -+.|+.|+|++|.   +..    .+-..+..-++|+.|+++.|.
T Consensus       123 ~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          123 LVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             TTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             hhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence              2346666666432   221    122233334455555555443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.99  E-value=0.024  Score=55.79  Aligned_cols=45  Identities=18%  Similarity=0.162  Sum_probs=35.4

Q ss_pred             CCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHHH
Q 036792          315 TPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETF  365 (453)
Q Consensus       315 ~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~  365 (453)
                      ..++|+|+.+.||+ +.++.+.+.|||++..+     -=.|-+|..+.|..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~-----~~~~Dla~~~~~~~  306 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN-----FAGADIANYFCEYI  306 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEEE-----EHHHHHHHHHHTTT
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCcC-----ChHHHHHHHHHHHH
Confidence            34789999999999 77888999999987332     23577888888876

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.43  E-value=0.12  Score=45.42  Aligned_cols=94  Identities=15%  Similarity=0.078  Sum_probs=64.9

Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEecccc------CCCCC---
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEY------GMEGQ---  347 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~------~~~~~---  347 (453)
                      -+|.+.|.....+++..+...++.|.+..|.-.-.. ..+ ..+=.-|..|++..+|.+...+-.-      .....   
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~~~s~~~~~~~~~pe~~~  110 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAPAADDAGEPPPVAGKLGY  110 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECCC------------CCSS
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceecccccccccccCCCChhhcc
Confidence            378899988888999999999999999988766221 111 1233446889999999887764221      01111   


Q ss_pred             --cCcccchHHHHHHHHHHHhCCCCCC
Q 036792          348 --VSTRSDIYGYGIVLMETFTRKKPTD  372 (453)
Q Consensus       348 --~~~~~Dv~S~Gvvl~el~tg~~p~~  372 (453)
                        .+.+.-|||+|+++|.-+--..|-+
T Consensus       111 ~~~te~~~IysLG~tLY~ALDygL~e~  137 (229)
T 2yle_A          111 SQCMETEVIESLGIIIYKALDYGLKEN  137 (229)
T ss_dssp             SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence              2466789999999999888766643

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.29  E-value=0.41  Score=46.54  Aligned_cols=44  Identities=27%  Similarity=0.303  Sum_probs=34.1

Q ss_pred             ceecCCCCCceee------CCCCcEEEeccccCCCCCcCcccchHHHHHHHHHHH
Q 036792          317 IIHCDLKPISVLL------DEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETF  365 (453)
Q Consensus       317 i~Hrdlk~~NiLl------~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~  365 (453)
                      ++|+|+.+.|||+      +++..+.+.|||++..+.     =.|-+|-.+.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~-----~~fDlan~f~ew~  295 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY-----RGFDIGNHFCEWM  295 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE-----HHHHHHHHHHHTT
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC-----chHhHHHHHHHHh
Confidence            5799999999999      456779999999874432     2566888888865

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=91.29  E-value=0.96  Score=43.61  Aligned_cols=76  Identities=20%  Similarity=0.320  Sum_probs=41.6

Q ss_pred             CCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCc-------C-CCCCCcEEEcccccccccCc-hhhhcCCCCC
Q 036792           20 IGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK-------L-DVASLEILNLSNNEIYGLIP-TSLEKLLYLK   90 (453)
Q Consensus        20 ~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~-------~-~~~~l~~l~l~~n~~~g~~P-~~~~~~~~l~   90 (453)
                      +.++..|+.+.+. +.++..-...|.+|.+|+.+.+..|-       | .+.+|+.+.+..+ ++ .|+ ..|..+.+|+
T Consensus       284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~  360 (394)
T 4gt6_A          284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEGITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALN  360 (394)
T ss_dssp             TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCC
T ss_pred             cccccccccccCC-CcccccCceeecCCCCcCEEEeCCcccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCC
Confidence            4555666666663 34443222346666677766665441       1 2566677666543 43 233 4556666777


Q ss_pred             EEECccCc
Q 036792           91 ELSLSFNK   98 (453)
Q Consensus        91 ~l~ls~n~   98 (453)
                      .+++.+|.
T Consensus       361 ~i~~~~~~  368 (394)
T 4gt6_A          361 NIEYSGSR  368 (394)
T ss_dssp             EEEESSCH
T ss_pred             EEEECCce
Confidence            77666554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=90.53  E-value=0.44  Score=46.02  Aligned_cols=93  Identities=10%  Similarity=0.190  Sum_probs=58.3

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCc--C------CCCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK--L------DVASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~--~------~~~~l~~l~l~~n   73 (453)
                      |+.+.++ +.+...-...|.++.+|+.+.|..| ++-.-...|.+|.+|+.+.+..+-  +      .+++|+.+++.+|
T Consensus       290 L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~sv~~I~~~aF~~C~~L~~i~~~~~  367 (394)
T 4gt6_A          290 LQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSSVTKIPESAFSNCTALNNIEYSGS  367 (394)
T ss_dssp             CCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTTCCBCCGGGGTTCTTCCEEEESSC
T ss_pred             cccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcccCEEhHhHhhCCCCCCEEEECCc
Confidence            4555554 3444222345788999999999654 654334578999999999997652  1      3789999999988


Q ss_pred             cccccCchhhhcCCCCCEEECccCcc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKL   99 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l   99 (453)
                      ....   ..+....+|+.+.+..|.+
T Consensus       368 ~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          368 RSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             HHHH---HTCBCCCCC----------
T ss_pred             eeeh---hhhhccCCCCEEEeCCCCE
Confidence            7542   4566778888888776654

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=90.11  E-value=0.66  Score=44.40  Aligned_cols=80  Identities=21%  Similarity=0.212  Sum_probs=55.5

Q ss_pred             CcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC--------CCCCCcEEEcccccccccCchhhhcCCC
Q 036792           17 SLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--------DVASLEILNLSNNEIYGLIPTSLEKLLY   88 (453)
Q Consensus        17 p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~--------~~~~l~~l~l~~n~~~g~~P~~~~~~~~   88 (453)
                      ...+.++..|+.+.+..+ ++..-...+.++.+|+.+.+..+--        .+++|+.+++.+|.++---...|..+.+
T Consensus       233 ~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~  311 (379)
T 4h09_A          233 DGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAKVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK  311 (379)
T ss_dssp             TTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCCCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred             cccccCCccceEEEcCCC-ccEeCccccceeehhccccccccceeccccccccccccccccccccccceehhhhhcCCCC
Confidence            344667888888888554 5543344677888888888765421        2678888888888777433467778888


Q ss_pred             CCEEECccC
Q 036792           89 LKELSLSFN   97 (453)
Q Consensus        89 l~~l~ls~n   97 (453)
                      |+.+++..+
T Consensus       312 L~~i~lp~~  320 (379)
T 4h09_A          312 LSSVTLPTA  320 (379)
T ss_dssp             CCEEECCTT
T ss_pred             CCEEEcCcc
Confidence            888888644

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.73  E-value=0.03  Score=55.88  Aligned_cols=59  Identities=14%  Similarity=0.161  Sum_probs=16.9

Q ss_pred             hcccCCCCccEEEEEEECC-CCEEEE------EEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEe
Q 036792          201 SNLIGMGSFGSVYRARLRD-GIEVAV------KVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCS  262 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  262 (453)
                      .+.+|   ||.||+|.+.. ..+|||      |..+...  .+....|.+|..++...+|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            45566   99999999864 468999      7766432  233457889999999999999999887654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=88.44  E-value=0.73  Score=44.45  Aligned_cols=77  Identities=16%  Similarity=0.170  Sum_probs=56.1

Q ss_pred             CCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC--------CCCCCcEEEcccccccccCchhhhcCCCCC
Q 036792           19 DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--------DVASLEILNLSNNEIYGLIPTSLEKLLYLK   90 (453)
Q Consensus        19 ~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~--------~~~~l~~l~l~~n~~~g~~P~~~~~~~~l~   90 (453)
                      .+.++.+|+.+.+..+ +.-.-...|.+|++|+.+++..+--        .+.+|+.+++..| ++---...|..+.+|+
T Consensus       292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~  369 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYLVEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLK  369 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCC
T ss_pred             cccccccccccccccc-cceechhhhcCCCCCCEEEeCCcccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCC
Confidence            4678888999988544 5543344688999999999875521        2788999999876 5533346788899999


Q ss_pred             EEECccC
Q 036792           91 ELSLSFN   97 (453)
Q Consensus        91 ~l~ls~n   97 (453)
                      .+++..|
T Consensus       370 ~i~lp~~  376 (394)
T 4fs7_A          370 KVELPKR  376 (394)
T ss_dssp             EEEEEGG
T ss_pred             EEEECCC
Confidence            9998755

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=84.81  E-value=2.1  Score=41.08  Aligned_cols=91  Identities=14%  Similarity=0.107  Sum_probs=64.5

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCc-------C-CCCCCcEEEcccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK-------L-DVASLEILNLSNN   73 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~-------~-~~~~l~~l~l~~n   73 (453)
                      |+.+.++.|... .-...+.++..++.+.+..+.+.   ...+.++.+|..+.+..+-       | .+.+|+.+++.++
T Consensus       255 l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~i~~I~~~aF~~c~~L~~i~lp~~  330 (394)
T 4fs7_A          255 LESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDSVKFIGEEAFESCTSLVSIDLPYL  330 (394)
T ss_dssp             CCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTTCCEECTTTTTTCTTCCEECCCTT
T ss_pred             ceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccccceechhhhcCCCCCCEEEeCCc
Confidence            556677666443 34455778888998888766532   2357889999999987652       1 3789999999755


Q ss_pred             cccccCchhhhcCCCCCEEECccC
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFN   97 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n   97 (453)
                       ++---...|..+.+|+.+++..|
T Consensus       331 -v~~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          331 -VEEIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             -CCEECTTTTTTCTTCCEECCCTT
T ss_pred             -ccEEhHHhccCCCCCCEEEECcc
Confidence             55322467888999999998766

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=84.31  E-value=3.2  Score=39.44  Aligned_cols=80  Identities=11%  Similarity=0.143  Sum_probs=45.8

Q ss_pred             cCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC--------CCCCCcEEEcccccccccCchhhhcCCCC
Q 036792           18 LDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--------DVASLEILNLSNNEIYGLIPTSLEKLLYL   89 (453)
Q Consensus        18 ~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~--------~~~~l~~l~l~~n~~~g~~P~~~~~~~~l   89 (453)
                      ..+.....|+.+.+..+ +...-...+.++..|+.+.+..+--        .+.+|+.+.+..+ ++-.-...+..+.+|
T Consensus       211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L  288 (379)
T 4h09_A          211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKNVTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL  288 (379)
T ss_dssp             TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTTCCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred             cccccccccceeeeccc-eeEEccccccCCccceEEEcCCCccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence            34455666777766433 3332334566777777777765421        2556777776544 332223456667777


Q ss_pred             CEEECccCcc
Q 036792           90 KELSLSFNKL   99 (453)
Q Consensus        90 ~~l~ls~n~l   99 (453)
                      +.+.+.+|.+
T Consensus       289 ~~i~l~~~~i  298 (379)
T 4h09_A          289 TKVVMDNSAI  298 (379)
T ss_dssp             CEEEECCTTC
T ss_pred             cccccccccc
Confidence            7777766554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	453
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-42
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-37
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-36
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-34
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-33
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-33
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-32
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-32
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-28
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-24
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-24
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-23
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-23
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-22
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-22
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-22
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-20
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-18
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-47
 Identities = 60/287 (20%), Positives = 113/287 (39%), Gaps = 53/287 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVK 256
            +   IG GSFG+VY+ +     +VAVK+ +      + L++F+ +  V++  RH N++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
            +   +     A+V ++    SL + L+      ++ + ++I       ++YL   H   
Sbjct: 69  FMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKS 124

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF------------------------------EYGMEG 346
           IIH DLK  ++ L ED+   + DF                                  + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 347 QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK 406
             S +SD+Y +GIVL E  T + P   +   +  +       L   L +V          
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV---------- 234

Query: 407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK 453
                +  C  ++  L  EC  +  ++R     I+  +  +  +L K
Sbjct: 235 -----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 4e-42
 Identities = 55/278 (19%), Positives = 102/278 (36%), Gaps = 49/278 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
                IG G FG V+     +  +VA+K   +  A + + F  + EVM  + HP LV++ 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
             C       LV E+M  G L + L +   +      L + +D    + YL       +I
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 123

Query: 319 HCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTRS 352
           H DL   + L+ E+ V  +SDF                          E     + S++S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 353 DIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK 412
           D++ +G+++ E F+  K           + + ++    +    +    +           
Sbjct: 184 DVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDISTGFRLYKPRLASTHVYQ--------- 233

Query: 413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT 450
                    +   C  E PE R     ++ +L +I ++
Sbjct: 234 ---------IMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-41
 Identities = 53/273 (19%), Positives = 103/273 (37%), Gaps = 51/273 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   +G G FG V+        +VAVK   Q  + +  +F A+  +MK ++H  LV++ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +  + +    ++ EYM  GSL + L + + + L I + L++       + ++        
Sbjct: 75  AVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNY 130

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           IH DL+  ++L+ + +   ++DF                          E    G  + +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA 411
           SD++ +GI+L E  T  +           +++                          V 
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------------VR 231

Query: 412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
            + C   +  L   C  E PE R     + + L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 5e-41
 Identities = 53/275 (19%), Positives = 100/275 (36%), Gaps = 49/275 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
                +G G FG V   + R   +VA+K+  +  + +   F  + +VM ++ H  LV++ 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPII 318
             C+      ++ EYM  G L N L          Q L +  D    +EYL    +   +
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 122

Query: 319 HCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTRS 352
           H DL   + L+++  V  +SDF                          E  M  + S++S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 353 DIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK 412
           DI+ +G+++ E ++  K     F    + +     L                        
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------------------YRP 223

Query: 413 EQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
                 +  +   C  E  ++R   K +++ +L +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 7e-41
 Identities = 71/274 (25%), Positives = 110/274 (40%), Gaps = 49/274 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           +L   IG G FG V     R G +VAVK    +     ++F A+  VM  +RH NLV+++
Sbjct: 10  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 66

Query: 259 SSCSNDDFK-ALVLEYMPKGSLENCLYSSTC-MLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                +     +V EYM KGSL + L S    +L     L   +D    +EYL       
Sbjct: 67  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNN 123

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRSDI 354
            +H DL   +VL+ ED VA +SDF                      E   E + ST+SD+
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183

Query: 355 YGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQ 414
           + +GI+L E ++  +         + LKD V  +     M+  D                
Sbjct: 184 WSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDAPDG--------------- 224

Query: 415 CVLSILGLAMECAMELPEKRINAKDIVTRLLKIR 448
           C  ++  +   C       R +   +  +L  I+
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-39
 Identities = 63/295 (21%), Positives = 106/295 (35%), Gaps = 49/295 (16%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVIS 259
           L   IG G FG V+R + R G EVAVK+F     R+    EA+      +RH N++  I+
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIA 64

Query: 260 SCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY----- 310
           + + D+       LV +Y   GSL + L   T  + +   + + +   S L +L+     
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------------ 340
                 I H DLK  ++L+ ++    ++D                               
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 341 -----EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM- 394
                      +   R+DIY  G+V  E   R          +L   D V +   +  M 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
           +VV +  L           + +  +  +  EC       R+ A  I   L ++  
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 63/305 (20%), Positives = 114/305 (37%), Gaps = 58/305 (19%)

Query: 184 DVSNDGILPSQATLRRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKS 238
            V +  I PS   +   + +IG G FG VY   L D     I  AVK  ++      +  
Sbjct: 16  AVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74

Query: 239 FEAQCEVMKSIRHPNLVKVISSCSNDDFKA-LVLEYMPKGSLENCLYSSTCMLDIFQRLN 297
           F  +  +MK   HPN++ ++  C   +    +VL YM  G L N + + T    +   + 
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134

Query: 298 IMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------- 340
             +      + + F  +   +H DL   + +LDE     ++DF                 
Sbjct: 135 FGLQ---VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 341 ------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL 388
                       E     + +T+SD++ +G++L E  TR  P       +++  D    L
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYL 247

Query: 389 LPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR 448
           L               + +  +  E C   +  + ++C     E R +  ++V+R+  I 
Sbjct: 248 L---------------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

Query: 449 DTLSK 453
            T   
Sbjct: 293 STFIG 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 5e-39
 Identities = 51/284 (17%), Positives = 107/284 (37%), Gaps = 57/284 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPN 253
           ++  +IG G FG V    L+      I VA+K        +  + F ++  +M    HPN
Sbjct: 29  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 88

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           ++ +    +      ++ E+M  GSL++ L  +     + Q + ++    + ++YL    
Sbjct: 89  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---A 145

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF------------------------------EYG 343
               +H DL   ++L++ ++V  +SDF                              E  
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205

Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
              + ++ SD++ YGIV+ E  +  +        +++ +D +N +     +         
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGER----PYWDMTNQDVINAIEQDYRLP-------- 253

Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
                      C  ++  L ++C  +    R     IV  L K+
Sbjct: 254 -------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 7e-39
 Identities = 58/273 (21%), Positives = 111/273 (40%), Gaps = 51/273 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVI 258
           RL   +G G FG V+         VA+K        + ++F  + +VMK +RH  LV++ 
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLY 78

Query: 259 SSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIF-QRLNIMIDATSTLEYLYFGHTTPI 317
           +  S +    +V EYM KGSL + L   T       Q +++     S + Y+        
Sbjct: 79  AVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNY 134

Query: 318 IHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVSTR 351
           +H DL+  ++L+ E++V  ++DF                          E  + G+ + +
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA 411
           SD++ +GI+L E  T+ +                  ++   +++ V++            
Sbjct: 195 SDVWSFGILLTELTTKGRV-------------PYPGMVNREVLDQVERGY------RMPC 235

Query: 412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
             +C  S+  L  +C  + PE+R   + +   L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-38
 Identities = 56/283 (19%), Positives = 103/283 (36%), Gaps = 57/283 (20%)

Query: 204 IGMGSFGSVYRARLR---DGIEVAVKVFHQECARA-LKSFEAQCEVMKSIRHPNLVKVIS 259
           +G G+FGSV +   R     I+VA+KV  Q   +A  +    + ++M  + +P +V++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 260 SCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIH 319
            C  +    LV+E    G L   L      + +     ++   +  ++YL        +H
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 132

Query: 320 CDLKPISVLLDEDMVAHLSDF----------------------------EYGMEGQVSTR 351
            DL   +VLL     A +SDF                            E     + S+R
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

Query: 352 SDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV 410
           SD++ YG+ + E  +  +KP  +M   E+         +                     
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP------------------ 234

Query: 411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK 453
              +C   +  L  +C +   E R +   +  R+     +L+ 
Sbjct: 235 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-37
 Identities = 48/273 (17%), Positives = 97/273 (35%), Gaps = 52/273 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            +   +G G+FG VY+A+ ++  +  A KV   +    L+ +  + +++ S  HPN+VK+
Sbjct: 15  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           + +   ++   +++E+   G+++  +      L   Q   +       L YL   H   I
Sbjct: 75  LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKI 131

Query: 318 IHCDLKPISVLLDEDMVAHLSDF------------------------------EYGMEGQ 347
           IH DLK  ++L   D    L+DF                              E   +  
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191

Query: 348 VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
              ++D++  GI L+E    + P   +    + LK                  +   E  
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK------------------IAKSEPP 233

Query: 408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
                 +   +      +C  +  + R     +
Sbjct: 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-37
 Identities = 54/280 (19%), Positives = 102/280 (36%), Gaps = 35/280 (12%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPNLVK 256
              + +G G+ G V++   +  G+ +A K+ H E   A+++    + +V+     P +V 
Sbjct: 9   EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
              +  +D   ++ +E+M  GSL+  L  +   +       + I     L YL   H   
Sbjct: 69  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH--K 125

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF-----------------------EYGMEGQVSTRSD 353
           I+H D+KP ++L++      L DF                       E       S +SD
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185

Query: 354 IYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE 413
           I+  G+ L+E    + P      +EL L  +   +   +                +    
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELM-FGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 414 QCVLSILGLAMECAMELPEKRIN------AKDIVTRLLKI 447
           +  ++I  L      E P K  +       +D V + L  
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 57/292 (19%), Positives = 107/292 (36%), Gaps = 59/292 (20%)

Query: 190 ILPSQATLRRLSNLIGMGSFGSVYRARLRDG-----IEVAVKVFHQECA-RALKSFEAQC 243
           I PS  T      +IG G FG VY+  L+       + VA+K        +    F  + 
Sbjct: 4   IHPSCVTR---QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 244 EVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDAT 303
            +M    H N++++    S      ++ EYM  G+L+  L        + Q + ++    
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 304 STLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------- 340
           + ++Y         +H DL   ++L++ ++V  +SDF                       
Sbjct: 121 AGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 341 -----EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME 395
                E     + ++ SD++ +GIV+ E  T  +                  L    +M+
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMK 224

Query: 396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
            ++      +         C  +I  L M+C  +   +R    DIV+ L K+
Sbjct: 225 AIN------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (334), Expect = 4e-36
 Identities = 55/277 (19%), Positives = 103/277 (37%), Gaps = 51/277 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            + + +G G +G VY    +   + VAVK   ++    ++ F  +  VMK I+HPNLV++
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +  C+ +    ++ E+M  G+L + L       +     L +    +S +EYL       
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKN 135

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVST 350
            IH DL   + L+ E+ +  ++DF                          E     + S 
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195

Query: 351 RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV 410
           +SD++ +G++L E  T                     +    + E+++K           
Sbjct: 196 KSDVWAFGVLLWEIATYGMS-------------PYPGIDLSQVYELLEK------DYRME 236

Query: 411 AKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
             E C   +  L   C    P  R +  +I      +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 6e-36
 Identities = 52/274 (18%), Positives = 96/274 (35%), Gaps = 52/274 (18%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLV 255
           +    IG GSF +VY+    +  +EVA              + F+ + E++K ++HPN+V
Sbjct: 12  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71

Query: 256 KVISSC----SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           +   S            LV E M  G+L+  L      + I    +        L++L+ 
Sbjct: 72  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT 130

Query: 312 GHTTPIIHCDLKPISVLL-DEDMVAHLSDF-----------------------EYGMEGQ 347
             T PIIH DLK  ++ +        + D                        E   E +
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM-YEEK 188

Query: 348 VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
                D+Y +G+ ++E  T + P           +   + + P S  +V    +      
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE---- 244

Query: 408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIV 441
                         +   C  +  ++R + KD++
Sbjct: 245 --------------IIEGCIRQNKDERYSIKDLL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 9e-36
 Identities = 52/277 (18%), Positives = 96/277 (34%), Gaps = 59/277 (21%)

Query: 202 NLIGMGSFGSVYRARLRD---GIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVK 256
             +G G+FG+V +   +       VAVK+   E           A+  VM+ + +P +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +I  C  + +  LV+E    G L   L  +   +     + ++   +  ++YL     + 
Sbjct: 73  MIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL---EESN 127

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF----------------------------EYGMEGQV 348
            +H DL   +VLL     A +SDF                            E     + 
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 349 STRSDIYGYGIVLMETFTRKK-PTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
           S++SD++ +G+++ E F+  + P   M   E++        +                  
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP--------------- 232

Query: 408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRL 444
                  C   +  L   C     E R     +  RL
Sbjct: 233 -----AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-35
 Identities = 59/295 (20%), Positives = 114/295 (38%), Gaps = 66/295 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLRDG---IEVAVKVFHQECAR-ALKSFEAQCEVMKSI-RHPN 253
           +  ++IG G+FG V +AR++     ++ A+K   +  ++   + F  + EV+  +  HPN
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM---------------LDIFQRLNI 298
           ++ ++ +C +  +  L +EY P G+L + L  S  +               L   Q L+ 
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 299 MIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------ 340
             D    ++YL        IH DL   ++L+ E+ VA ++DF                  
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 189

Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLM 394
                 E       +T SD++ YG++L E  +            ++  +    L     +
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYEKLPQGYRL 245

Query: 395 EVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
           E                   C   +  L  +C  E P +R +   I+  L ++ +
Sbjct: 246 EK---------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  130 bits (329), Expect = 3e-35
 Identities = 55/271 (20%), Positives = 91/271 (33%), Gaps = 51/271 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNL 254
                IG GSFG+VY AR +R+   VA+K             +    +   ++ +RHPN 
Sbjct: 18  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           ++       +    LV+EY    + +         L   +   +   A   L YL   H+
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYL---HS 133

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF------------------------EYGMEGQVST 350
             +IH D+K  ++LL E  +  L DF                            EGQ   
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 351 RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV 410
           + D++  GI  +E   RK P   M      L     N  P        +   +       
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFRN------- 245

Query: 411 AKEQCVLSILGLAMECAMELPEKRINAKDIV 441
                          C  ++P+ R  ++ ++
Sbjct: 246 -----------FVDSCLQKIPQDRPTSEVLL 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-34
 Identities = 59/285 (20%), Positives = 95/285 (33%), Gaps = 57/285 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRH 251
           RL   +G GSFG V R          + VAVK    +      A+  F  +   M S+ H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
            NL+++         K +V E  P GSL + L        +       +     + YL  
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL-- 127

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EYG 343
             +   IH DL   ++LL    +  + DF                            E  
Sbjct: 128 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
                S  SD + +G+ L E FT  +     ++               +  +++ K    
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGL-------------NGSQILHKIDKE 230

Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR 448
           GE+      E C   I  + ++C    PE R     +   LL+ +
Sbjct: 231 GER--LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 44/269 (16%), Positives = 86/269 (31%), Gaps = 47/269 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            +   +G G+FG V+R      G   A K          ++   + + M  +RHP LV +
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +  +D+   ++ E+M  G L   +      +   + +  M      L ++   H    
Sbjct: 89  HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNY 145

Query: 318 IHCDLKPISVLL--DEDMVAHLSDF------------------------EYGMEGQVSTR 351
           +H DLKP +++          L DF                        E      V   
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA 411
           +D++  G++     +   P      +E  L++  +    +          +S + K F+ 
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNMDDSAFSG---ISEDGKDFIR 261

Query: 412 KEQCVLSILGLAMECAMELPEKRINAKDI 440
           K               +  P  R+     
Sbjct: 262 K-------------LLLADPNTRMTIHQA 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (319), Expect = 4e-34
 Identities = 62/306 (20%), Positives = 108/306 (35%), Gaps = 79/306 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRH 251
                IG G+FG V++AR            VAVK+  +E  A     F+ +  +M    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM---------------------- 289
           PN+VK++  C+      L+ EYM  G L   L S +                        
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 290 -LDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------- 340
            L   ++L I     + + YL        +H DL   + L+ E+MV  ++DF        
Sbjct: 136 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 341 -------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL 381
                              E     + +T SD++ YG+VL E F+            ++ 
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ----PYYGMAH 248

Query: 382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV 441
           ++ +  +   +++   +                C L +  L   C  +LP  R +   I 
Sbjct: 249 EEVIYYVRDGNILACPEN---------------CPLELYNLMRLCWSKLPADRPSFCSIH 293

Query: 442 TRLLKI 447
             L ++
Sbjct: 294 RILQRM 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 6e-34
 Identities = 55/268 (20%), Positives = 94/268 (35%), Gaps = 49/268 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
                IG G+ G+VY A  +  G EVA++  + +     +    +  VM+  ++PN+V  
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           + S    D   +V+EY+  GSL + +  +    D  Q   +  +    LE+L   H+  +
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFL---HSNQV 137

Query: 318 IHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQVSTRS 352
           IH D+K  ++LL  D    L+DF                         E         + 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 353 DIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK 412
           DI+  GI+ +E    + P               N    +   E +               
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD--------- 248

Query: 413 EQCVLSILGLAMECAMELPEKRINAKDI 440
                        C     EKR +AK++
Sbjct: 249 ---------FLNRCLDMDVEKRGSAKEL 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-33
 Identities = 50/270 (18%), Positives = 100/270 (37%), Gaps = 52/270 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQ---ECARALKSFEAQCEVMKSIRHPNL 254
            +   +G G FG+VY AR +     +A+KV  +   E A        + E+   +RHPN+
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +++     +     L+LEY P G++   L   +   D  +    + +  + L Y    H+
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC---HS 124

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF-----------------------EYGMEGQVSTR 351
             +IH D+KP ++LL       ++DF                       E         +
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA 411
            D++  G++  E    K P +    +E   +        IS +E      ++   +  ++
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKR--------ISRVEFTFPDFVTEGARDLIS 236

Query: 412 KEQCVLSILGLAMECAMELPEKRINAKDIV 441
           +                  P +R   ++++
Sbjct: 237 R-------------LLKHNPSQRPMLREVL 253

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-33
 Identities = 52/303 (17%), Positives = 97/303 (32%), Gaps = 78/303 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLRD------GIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-R 250
               ++G G+FG V  A           I+VAVK+  ++  +   ++  ++ ++M  +  
Sbjct: 40  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 99

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYS----------------------STC 288
           H N+V ++ +C+      L+ EY   G L N L S                         
Sbjct: 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159

Query: 289 MLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------- 340
           +L     L         +E+L        +H DL   +VL+    V  + DF        
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216

Query: 341 -------------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSL 381
                              E   EG  + +SD++ YGI+L E F+           + + 
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276

Query: 382 KDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV 441
              + N   +       + +                    +   C      KR +  ++ 
Sbjct: 277 YKLIQNGFKMDQPFYATEEIYI------------------IMQSCWAFDSRKRPSFPNLT 318

Query: 442 TRL 444
           + L
Sbjct: 319 SFL 321

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-33
 Identities = 49/282 (17%), Positives = 98/282 (34%), Gaps = 54/282 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQECARALKS-FEAQCEVMKSIRHPN 253
            L   IG G FG V++          + VA+K      + +++  F  +   M+   HP+
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           +VK+I   + ++   +++E    G L + L      LD+   +      ++ L YL    
Sbjct: 70  IVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---E 125

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQ 347
           +   +H D+   +VL+  +    L DF                          E     +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 348 VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
            ++ SD++ +G+ + E            V+   +   + N   + +      TL S    
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLPMPPNCPPTLYS---- 240

Query: 408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
                         L  +C    P +R    ++  +L  I +
Sbjct: 241 --------------LMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-33
 Identities = 50/278 (17%), Positives = 89/278 (32%), Gaps = 55/278 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLV 255
            +   IG GS+G   + R + DG  +  K            +   ++  +++ ++HPN+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 256 KVISSC--SNDDFKALVLEYMPKGSLENCLYSST---CMLDIFQRLNIMIDATSTLEYLY 310
           +         +    +V+EY   G L + +   T     LD    L +M   T  L+  +
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 311 FGHTT--PIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYG 343
                   ++H DLKP +V LD      L DF                         E  
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186

Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
                + +SDI+  G +L E      P      +EL+ K        I            
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP----------- 235

Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIV 441
                     +    +  +           R + ++I+
Sbjct: 236 ---------YRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 1e-32
 Identities = 56/272 (20%), Positives = 91/272 (33%), Gaps = 52/272 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVK 256
            L   +G G++G V  A  R     VAVK+   +      ++ + +  + K + H N+VK
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
                   + + L LEY   G L + +      +             + + YL   H   
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYL---HGIG 123

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF---------------------------EYGMEGQVS 349
           I H D+KP ++LLDE     +SDF                           E     +  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 350 TR-SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG 408
               D++  GIVL      + P D+         DW      ++  + +D   L+     
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA----- 238

Query: 409 FVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
                        L  +  +E P  RI   DI
Sbjct: 239 -------------LLHKILVENPSARITIPDI 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-32
 Identities = 51/301 (16%), Positives = 88/301 (29%), Gaps = 73/301 (24%)

Query: 199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQE-CARALKSFEAQCEVMKSI-R 250
                +G G+FG V  A           + VAVK+          ++  ++ +V+  +  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 251 HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSS-----------------TCMLDIF 293
           H N+V ++ +C+      ++ EY   G L N L                       LD+ 
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------- 340
             L+        + +L    +   IH DL   ++LL    +  + DF             
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 341 --------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN 386
                         E       +  SD++ YGI L E F+           +      + 
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

Query: 387 NLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK 446
               +   E     +                    +   C    P KR   K IV  + K
Sbjct: 263 EGFRMLSPEHAPAEMYD------------------IMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 447 I 447
            
Sbjct: 305 Q 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 5e-32
 Identities = 46/288 (15%), Positives = 104/288 (36%), Gaps = 56/288 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-----GIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHP 252
           +   ++G G+FG+VY+           I VA+K   +    +A K    +  VM S+ +P
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 253 NLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFG 312
           ++ +++  C     + L+ + MP G L + +      +     LN  +     + YL   
Sbjct: 72  HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 313 HTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------------EYGME 345
               ++H DL   +VL+       ++DF                           E  + 
Sbjct: 131 R---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 346 GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE 405
              + +SD++ YG+ + E  T          + +   +         +  +++K      
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASE---------ISSILEK------ 228

Query: 406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLSK 453
            +       C + +  + ++C M   + R   ++++    K+     +
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 4e-31
 Identities = 45/203 (22%), Positives = 74/203 (36%), Gaps = 35/203 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNL 254
           +   ++G GSF +V  AR L    E A+K+  +        +     + +VM  + HP  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  +  +D+     L Y   G L   +       D         +    +  L + H 
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEI---VSALEYLHG 126

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF---------------------------EYGMEGQ 347
             IIH DLKP ++LL+EDM   ++DF                           E   E  
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 348 VSTRSDIYGYGIVLMETFTRKKP 370
               SD++  G ++ +      P
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  120 bits (301), Expect = 5e-31
 Identities = 44/269 (16%), Positives = 90/269 (33%), Gaps = 47/269 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            +   +G G+FG V+R      G     K  +        + + +  +M  + HP L+ +
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             +  +     L+LE++  G L + + +    +   + +N M  A   L+++   H   I
Sbjct: 92  HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSI 148

Query: 318 IHCDLKPISVLLD--EDMVAHLSDF------------------------EYGMEGQVSTR 351
           +H D+KP +++ +  +     + DF                        E      V   
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA 411
           +D++  G++     +   P       E  L++                  +S E K F+ 
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWEFDEDAFSS---VSPEAKDFIK 264

Query: 412 KEQCVLSILGLAMECAMELPEKRINAKDI 440
                            + P KR+   D 
Sbjct: 265 N-------------LLQKEPRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-30
 Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 65/294 (22%)

Query: 199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRH 251
            +S  +G GSFG VY    +          VA+K  ++  + R    F  +  VMK    
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLY---------SSTCMLDIFQRLNIMIDA 302
            ++V+++   S      +++E M +G L++ L                 + + + +  + 
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF---------------------- 340
              + YL   +    +H DL   + ++ ED    + DF                      
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 341 -----EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME 395
                E   +G  +T SD++ +G+VL E  T  +       + LS +  +  ++   L++
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLRFVMEGGLLD 255

Query: 396 VVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD 449
             D                C   +  L   C    P+ R +  +I++ + +  +
Sbjct: 256 KPDN---------------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (293), Expect = 1e-30
 Identities = 59/288 (20%), Positives = 106/288 (36%), Gaps = 58/288 (20%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR---ALKSFEAQCEVMKSIRHPNL 254
            L  ++G G    V+ AR LR   +VAVKV   + AR       F  + +   ++ HP +
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 255 VKVISSCSNDDFKA----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLY 310
           V V  +   +        +V+EY+   +L + +++    +   + + ++ DA   L +  
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFS- 127

Query: 311 FGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EY 342
             H   IIH D+KP ++++       + DF                            E 
Sbjct: 128 --HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 343 GMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL 402
                V  RSD+Y  G VL E  T + P        ++ +    + +P S         L
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----RHEGL 241

Query: 403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRI-NAKDIVTRLLKIRD 449
           S +    V K                + PE R   A ++   L+++ +
Sbjct: 242 SADLDAVVLK-------------ALAKNPENRYQTAAEMRADLVRVHN 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (295), Expect = 2e-30
 Identities = 40/198 (20%), Positives = 80/198 (40%), Gaps = 30/198 (15%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNL 254
           ++   +G GSFG V+  R R +G   A+KV  +E     + ++    +  ++  + HP +
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +++  +  +     ++++Y+  G     L   +             +    LEYL   H+
Sbjct: 67  IRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL---HS 122

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRS 352
             II+ DLKP ++LLD++    ++DF                      E       +   
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 353 DIYGYGIVLMETFTRKKP 370
           D + +GI++ E      P
Sbjct: 183 DWWSFGILIYEMLAGYTP 200

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-29
 Identities = 62/302 (20%), Positives = 109/302 (36%), Gaps = 76/302 (25%)

Query: 199 RLSNLIGMGSFGSVYRARLR--------DGIEVAVKVFHQECA-RALKSFEAQCEVMKSI 249
            L   +G G+FG V  A              +VAVK+   +   + L    ++ E+MK I
Sbjct: 16  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75

Query: 250 -RHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCM---------------LDIF 293
            +H N++ ++ +C+ D    +++EY  KG+L   L +                   L   
Sbjct: 76  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 294 QRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------- 340
             ++        +EYL    +   IH DL   +VL+ ED V  ++DF             
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 341 --------------EYGMEGQVSTRSDIYGYGIVLMETFTRKK-PTDRMFVEELSLKDWV 385
                         E   +   + +SD++ +G++L E FT    P   + VEEL      
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

Query: 386 NNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL 445
            + +                         C   +  +  +C   +P +R   K +V  L 
Sbjct: 253 GHRMDKP--------------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 446 KI 447
           +I
Sbjct: 293 RI 294

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  114 bits (286), Expect = 6e-29
 Identities = 42/234 (17%), Positives = 80/234 (34%), Gaps = 35/234 (14%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFH------QECARALKSFEAQCEVMKSIRH 251
            +  +IG G FG VY  R  D G   A+K         ++      +      ++ +   
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           P +V +  +    D  + +L+ M  G L   L       +         +    LE++  
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHM-- 123

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------EYGMEGQ- 347
            H   +++ DLKP ++LLDE     +SD                        E   +G  
Sbjct: 124 -HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVA 182

Query: 348 VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL 401
             + +D +  G +L +      P  +   ++    D +   + + L +     L
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 9e-29
 Identities = 36/269 (13%), Positives = 94/269 (34%), Gaps = 48/269 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            ++  +G G FG V+R            K    +        + +  ++   RH N++ +
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHL 66

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
             S  + +   ++ E++    +   + +S   L+  + ++ +      L++L   H+  I
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNI 123

Query: 318 IHCDLKPISVLLDEDMVAH--LSDF------------------------EYGMEGQVSTR 351
            H D++P +++      +   + +F                        E      VST 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 352 SDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA 411
           +D++  G ++    +   P      +++ +++ +N           +   +S E   FV 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEYTFDEEAFKE---ISIEAMDFVD 239

Query: 412 KEQCVLSILGLAMECAMELPEKRINAKDI 440
           +               ++  + R+ A + 
Sbjct: 240 R-------------LLVKERKSRMTASEA 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  112 bits (280), Expect = 1e-28
 Identities = 51/278 (18%), Positives = 95/278 (34%), Gaps = 40/278 (14%)

Query: 199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVK 256
                IG G++G VY+A+   G   A+K    E        +   +  ++K ++H N+VK
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +           LV E++    L+  L      L+     + ++     L  + + H   
Sbjct: 65  LYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQL---LNGIAYCHDRR 120

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVST 350
           ++H DLKP ++L++ +    ++DF                                + ST
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 351 RSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV 410
             DI+  G +  E          +   +  ++ +     P S        L   +    V
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 411 AKEQCVLSILGLAMECAMEL--------PEKRINAKDI 440
            +     S L    E  ++L        P +RI AK  
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (269), Expect = 6e-27
 Identities = 43/268 (16%), Positives = 80/268 (29%), Gaps = 44/268 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECAR-ALKSFEAQCEVMKSIRHPNLVK 256
              +++G G+F  V  A   R    VA+K   ++       S E +  V+  I+HPN+V 
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP 316
           +     +     L+++ +  G L + +              ++      ++YL+      
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 317 IIHCDLKPISVLLDEDMVAHLSDF------------------------EYGMEGQVSTRS 352
                   +   LDED    +SDF                        E   +   S   
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190

Query: 353 DIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAK 412
           D +  G++         P       +L  +  +            D   +S   K F+  
Sbjct: 191 DCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKAEYEFDSPYWDD---ISDSAKDFIRH 246

Query: 413 EQCVLSILGLAMECAMELPEKRINAKDI 440
                           + PEKR   +  
Sbjct: 247 -------------LMEKDPEKRFTCEQA 261

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-26
 Identities = 51/279 (18%), Positives = 101/279 (36%), Gaps = 40/279 (14%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLV 255
           +    IG G++G VY+AR +  G  VA+K    +        +   +  ++K + HPN+V
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           K++     ++   LV E++ +   +    S+   + +    + +      L +    H+ 
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSH 121

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
            ++H DLKP ++L++ +    L+DF                                  S
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 350 TRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF 409
           T  DI+  G +  E  TR+         +   + +     P  ++     ++   +    
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 410 VAKEQCVLSILGLAMECAMEL--------PEKRINAKDI 440
               Q    ++    E    L        P KRI+AK  
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 2e-26
 Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 45/279 (16%)

Query: 202 NLIGMGSFGSVYRARLR-DGIEVAVKVFH-----QECARALKSFEAQCEVMKSIRHPNLV 255
           + +G G F +VY+AR +     VA+K        +      ++   + ++++ + HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
            ++ +  +    +LV ++M    LE  +  ++ +L        M+     LEYL   H  
Sbjct: 64  GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQH 119

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
            I+H DLKP ++LLDE+ V  L+DF                                   
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 350 TRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF 409
              D++  G +L E   R          +  L      L   +  +  D   L       
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 410 VAKEQCVLSILGLAMECAMEL--------PEKRINAKDI 440
                 +  I   A +  ++L        P  RI A   
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  103 bits (259), Expect = 7e-26
 Identities = 52/283 (18%), Positives = 94/283 (33%), Gaps = 62/283 (21%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH---------QECARALKSFEAQCEVMKS 248
               ++G G    V R        E AVK+           +E     ++   + ++++ 
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 249 IR-HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
           +  HPN++++  +   + F  LV + M KG L + L      L   +   IM      + 
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVIC 124

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------- 340
            L   H   I+H DLKP ++LLD+DM   L+DF                           
Sbjct: 125 AL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVV 397
                          D++  G+++        P        + L+  ++        E  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNYQFGSPEWD 240

Query: 398 DKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
           D    S   K  V++               +  P+KR  A++ 
Sbjct: 241 D---YSDTVKDLVSR-------------FLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 51/273 (18%), Positives = 96/273 (35%), Gaps = 55/273 (20%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFEAQCEVM-KSIRHPN 253
            L  ++G GSFG V+ A  +      A+K   ++       ++    +  V+  +  HP 
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 254 LVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGH 313
           L  +  +    +    V+EY+  G L   + S     D+ +      +    L++L+   
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKG 123

Query: 314 TTPIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQV 348
              I++ DLK  ++LLD+D    ++DF                         E  +  + 
Sbjct: 124 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 349 STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG 408
           +   D + +G++L E    + P      EEL           I +        L  E K 
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--------FHSIRMDNPFYPRWLEKEAKD 232

Query: 409 FVAKEQCVLSILGLAMECAMELPEKRINAKDIV 441
            + K               +  PEKR+  +  +
Sbjct: 233 LLVK-------------LFVREPEKRLGVRGDI 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 4e-25
 Identities = 55/285 (19%), Positives = 97/285 (34%), Gaps = 50/285 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLRD-GIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
             + +IG GSFG VY+A+L D G  VA+K   Q+     +    + ++M+ + H N+V++
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL 78

Query: 258 ISSC------SNDDFKALVLEYMPKGSLENCLYSSTCM--LDIFQRLNIMIDATSTLEYL 309
                      ++ +  LVL+Y+P+       + S     L +      M     +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 310 YFGHTTPIIHCDLKPISVLLDED-MVAHLSDF-------------------------EYG 343
              H+  I H D+KP ++LLD D  V  L DF                            
Sbjct: 139 ---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
                ++  D++  G VL E    +         +  ++       P            +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 404 GEKKGFVAKEQCVLSILGLAMECAMEL--------PEKRINAKDI 440
             K   +                A+ L        P  R+   + 
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 1e-24
 Identities = 50/280 (17%), Positives = 100/280 (35%), Gaps = 42/280 (15%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLV 255
                IG G++G+V++A+ R     VA+K    +        S   +  ++K ++H N+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 256 KVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTT 315
           ++     +D    LV E+  +   +     +  + D     + +      L+ L F H+ 
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQL---LKGLGFCHSR 120

Query: 316 PIIHCDLKPISVLLDEDMVAHLSDF--------------------------EYGMEGQVS 349
            ++H DLKP ++L++ +    L++F                                  S
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 350 TRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF 409
           T  D++  G +  E     +P       +  LK     L   +  +    T L   K   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 410 VAKEQCVLSILGLAM-ECAMEL--------PEKRINAKDI 440
           +      L  +   +     +L        P +RI+A++ 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 48/277 (17%), Positives = 92/277 (33%), Gaps = 56/277 (20%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFH------QECARALKSFEAQCEVMKSIRH 251
                +G G F  V + R    G++ A K              + +  E +  ++K I+H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 252 PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
           PN++ +     N     L+LE +  G L + L     + +      +       L  +Y+
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----ILNGVYY 128

Query: 312 GHTTPIIHCDLKPISVLLDEDMVA----HLSDF------------------------EYG 343
            H+  I H DLKP +++L +  V      + DF                        E  
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188

Query: 344 MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS 403
               +   +D++  G++     +   P      +E      V+ +      E       S
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN--VSAVNYEFEDEYFSN--TS 244

Query: 404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
              K F+ +               ++ P+KR+  +D 
Sbjct: 245 ALAKDFIRR-------------LLVKDPKKRMTIQDS 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 3e-24
 Identities = 52/286 (18%), Positives = 99/286 (34%), Gaps = 49/286 (17%)

Query: 199 RLSNLIGMGSFGSVYRARLR--DGIEVAVKVFHQECARALKSFEAQCEV-----MKSIRH 251
                IG G++G V++AR     G  VA+K    +            EV     +++  H
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 252 PNLVKVISSCSNDDFKA-----LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTL 306
           PN+V++   C+           LV E++ +             +      ++M      L
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 307 EYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------EY 342
           ++L   H+  ++H DLKP ++L+       L+DF                        E 
Sbjct: 130 DFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 343 GMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL 402
            ++   +T  D++  G +  E F RK         +   K  + +++ +   E   + + 
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK--ILDVIGLPGEEDWPRDVA 244

Query: 403 SGEKKGFVAKEQCVLSILGLAMECAMEL--------PEKRINAKDI 440
              +       Q +   +    E   +L        P KRI+A   
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 8e-24
 Identities = 50/285 (17%), Positives = 94/285 (32%), Gaps = 46/285 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQ-ECARALKSFEAQCEVMKSIRHPNLVK 256
              + IG G++G V  A    + + VA+K     E     +    + +++   RH N++ 
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70

Query: 257 VISSCSNDDFKALVLEYMPKGSLENCLYS--STCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +         + +   Y+    +   LY    T  L        +      L+Y+   H+
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI---HS 127

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF----------------------------EYGMEG 346
             ++H DLKP ++LL+      + DF                            E  +  
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 347 QVSTRS-DIYGYGIVLMETFTRKKPTDRMFVEEL------SLKDWVNNLLPISLMEVVDK 399
           +  T+S DI+  G +L E  + +         +        L       L   +      
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247

Query: 400 TLLSGEKKGFVAKEQCVLSILGLAMECAMEL----PEKRINAKDI 440
            LLS   K  V   +   +    A++   ++    P KRI  +  
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 1e-23
 Identities = 44/300 (14%), Positives = 92/300 (30%), Gaps = 72/300 (24%)

Query: 199 RLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQECARA-LKSFEAQCEVMKSIRH 251
           +L   +G G+FG V  A             VAVK+  +    +  ++  ++ +++  I H
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 252 PNLVKVI--SSCSNDDFKALVLEYMPKGSLENCLYSSTCM---------------LDIFQ 294
              V  +  +         +++E+   G+L   L S                   L +  
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 295 RLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-------------- 340
            +         +E+L    +   IH DL   ++LL E  V  + DF              
Sbjct: 136 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 341 -------------EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNN 387
                        E   +   + +SD++ +G++L E F+           +      +  
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252

Query: 388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
              +   +     +                      ++C    P +R    ++V  L  +
Sbjct: 253 GTRMRAPDYTTPEMYQ------------------TMLDCWHGEPSQRPTFSELVEHLGNL 294

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 41/276 (14%), Positives = 91/276 (32%), Gaps = 53/276 (19%)

Query: 198 RRLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK 256
           +  S ++G+G  G V +    R   + A+K+   +C +A +  E      ++ + P++V+
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELH---WRASQCPHIVR 69

Query: 257 VISSC----SNDDFKALVLEYMPKGSLENCLYSSTCM-LDIFQRLNIMIDATSTLEYLYF 311
           ++       +      +V+E +  G L + +           +   IM      ++YL  
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL-- 127

Query: 312 GHTTPIIHCDLKPISVLLD---EDMVAHLSDF------------------------EYGM 344
            H+  I H D+KP ++L      + +  L+DF                        E   
Sbjct: 128 -HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 345 EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG 404
             +     D++  G+++        P        +S        +        + + +S 
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDI 440
           E K  +                    P +R+   + 
Sbjct: 247 EVKMLIRN-------------LLKTEPTQRMTITEF 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 98.7 bits (245), Expect = 2e-23
 Identities = 38/198 (19%), Positives = 76/198 (38%), Gaps = 30/198 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA---RALKSFEAQCEVMKSIRHPNL 254
                +G GSFG V   +    G   A+K+  ++     + ++    +  +++++  P L
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           VK+  S  ++    +V+EY+  G + + L                     T EYL   H+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYL---HS 159

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF----------------------EYGMEGQVSTRS 352
             +I+ DLKP ++L+D+     ++DF                      E  +    +   
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 353 DIYGYGIVLMETFTRKKP 370
           D +  G+++ E      P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 2e-23
 Identities = 43/210 (20%), Positives = 77/210 (36%), Gaps = 33/210 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARA---LKSFEAQCEVMKSIRHPNL 254
               L+G G+FG V   R    G   A+K+  +E   A   +     +  V+++ RHP L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 255 VKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
             +  +    D    V+EY   G L   L S   +    +      +    +  L + H+
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEI---VSALEYLHS 123

Query: 315 TPIIHCDLKPISVLLDEDMVAHLSDF-------------------------EYGMEGQVS 349
             +++ D+K  +++LD+D    ++DF                         E   +    
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 350 TRSDIYGYGIVLMETFTRKKPTDRMFVEEL 379
              D +G G+V+ E    + P      E L
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 96.4 bits (239), Expect = 6e-23
 Identities = 46/285 (16%), Positives = 88/285 (30%), Gaps = 54/285 (18%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           RL   IG GSFG +Y    +  G EVA+K+   +          + ++ K ++    +  
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPT 67

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           I  C  +    +++  +   SLE+     +    +   L +     S +EY+   H+   
Sbjct: 68  IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNF 124

Query: 318 IHCDLKPISVL---LDEDMVAHLSDF--------------------------------EY 342
           IH D+KP + L     +  + ++ DF                                  
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 343 GMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL 402
            +  + S R D+   G VLM       P   +       K    +   +S    V     
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

Query: 403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI 447
             E   ++               C     + + +   +      +
Sbjct: 245 PSEFATYLNF-------------CRSLRFDDKPDYSYLRQLFRNL 276

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 1e-22
 Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 41/209 (19%)

Query: 199 RLSNLIGMGSFGSVYRARL----RDGIEVAVKVFHQEC----ARALKSFEAQCEVMKSIR 250
            L  ++G G++G V+  R       G   A+KV  +      A+  +    + +V++ IR
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 251 H-PNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
             P LV +  +   +    L+L+Y+  G L   L       +      + I     +  L
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIVLAL 142

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF----------------------------E 341
              H   II+ D+K  ++LLD +    L+DF                             
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 342 YGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
            G +       D +  G+++ E  T   P
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 2e-22
 Identities = 59/294 (20%), Positives = 104/294 (35%), Gaps = 56/294 (19%)

Query: 199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEV--MKSIRHPNLV 255
                IG G+FG V++AR R  G +VA+K    E  +      A  E+  ++ ++H N+V
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 256 KVISSCSNDDFKA--------LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLE 307
            +I  C               LV ++                  + +   +M      L 
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML---LN 128

Query: 308 YLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF--------------------------- 340
            LY+ H   I+H D+K  +VL+  D V  L+DF                           
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 341 ---EYGMEGQVSTRSDIYGYGIVLMETFTRKKP-TDRMFVEELSLKDWVNNLLPISLMEV 396
                  E       D++G G ++ E +TR           +L+L   +   +   +   
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 397 VDKTLLSGEKKGFVAKEQCVLSILGLAM--ECAMEL--------PEKRINAKDI 440
           VD   L  + +    +++ V   L   +    A++L        P +RI++ D 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.4 bits (234), Expect = 2e-22
 Identities = 34/206 (16%), Positives = 69/206 (33%), Gaps = 37/206 (17%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARA------LKSFEAQCEVMKSIR- 250
           ++  L+G G FGSVY    + D + VA+K   ++                +  ++K +  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 251 -HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
               +++++      D   L+LE            +    L      +        + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 310 YFGHTTPIIHCDLKPISVLLDED-MVAHLSDF-----------------------EYGME 345
              H   ++H D+K  ++L+D +     L DF                       E+   
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183

Query: 346 GQVSTRS-DIYGYGIVLMETFTRKKP 370
            +   RS  ++  GI+L +      P
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 7e-22
 Identities = 55/284 (19%), Positives = 101/284 (35%), Gaps = 48/284 (16%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLV 255
           R    +G G++G+V  A   R G +VA+K  ++        K    +  ++K +RH N++
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80

Query: 256 KVISSCSNDDFKA------LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            ++   + D+         LV+ +M     +   +     L   +   ++      L Y+
Sbjct: 81  GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYI 137

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------EYGMEG 346
              H   IIH DLKP ++ ++ED    + DF                             
Sbjct: 138 ---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWM 194

Query: 347 QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDW-VNNLLPISLMEVVDKTLLSGE 405
           + +   DI+  G ++ E  T K         +   +   V    P   ++ +        
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254

Query: 406 KKGFVAKEQCVL-SILGLAMECAMEL--------PEKRINAKDI 440
            KG    E+    SIL  A   A+ L         E+R+ A + 
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 89.1 bits (220), Expect = 2e-20
 Identities = 34/293 (11%), Positives = 75/293 (25%), Gaps = 60/293 (20%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
           ++   IG GSFG ++    L +  +VA+K   +           +    K +     +  
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPN 65

Query: 258 ISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPI 317
           +     +    +++  +   SLE+ L        +           + ++ +   H   +
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSL 122

Query: 318 IHCDLKPISVLLDEDMVAH-----LSDF-------------------------------- 340
           ++ D+KP + L+      +     + DF                                
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 341 EYGMEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDW--VNNLLPISLMEVVD 398
              +  + S R D+   G V M       P   +       K            L E+  
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL 451
                                            +   +   +     K+ + L
Sbjct: 243 G---------------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 89.9 bits (222), Expect = 2e-20
 Identities = 44/289 (15%), Positives = 97/289 (33%), Gaps = 57/289 (19%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVK 256
           +L   +G G +  V+ A  + +  +V VK+         K  + + ++++++R  PN++ 
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIIT 94

Query: 257 VISSCSNDDFK--ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHT 314
           +     +   +  ALV E++     +    +    L  +     M +    L+Y    H+
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC---HS 147

Query: 315 TPIIHCDLKPISVLLD-EDMVAHLSDF-------------------------EYGMEGQV 348
             I+H D+KP +V++D E     L D+                                 
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 349 STRSDIYGYGIVLMETFTRKKP---------TDRMFVEELSLKDWVNNLLPISLMEVVDK 399
               D++  G +L     RK+P               + L  +D  + +   ++      
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 400 TLLSGEKKGFVAKEQCVLSILGLAMECAMEL--------PEKRINAKDI 440
             + G       +         L    A++          + R+ A++ 
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 1e-18
 Identities = 49/282 (17%), Positives = 101/282 (35%), Gaps = 44/282 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLV 255
           +  + +G G++GSV  A   + G+ VAVK   +        K    +  ++K ++H N++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80

Query: 256 KVISSCSND----DFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF 311
            ++   +      +F  + L     G+  N +     + D      ++      L+Y+  
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-DHVQFLIYQILRGLKYI-- 137

Query: 312 GHTTPIIHCDLKPISVLLDEDMVAHLSDF-----------------------EYGMEGQV 348
            H+  IIH DLKP ++ ++ED    + DF                               
Sbjct: 138 -HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 196

Query: 349 STRSDIYGYGIVLMETFTRKKP-TDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK 407
           +   DI+  G ++ E  T +        +++L L   +       L++ +         +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 408 GFVAKEQCVLS-ILGLAMECAMEL--------PEKRINAKDI 440
                 +   + +   A   A++L         +KRI A   
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.5 bits (200), Expect = 1e-17
 Identities = 47/285 (16%), Positives = 97/285 (34%), Gaps = 43/285 (15%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLV 255
           +    IG G+ G V  A        VA+K   +        K    +  +MK + H N++
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 256 KVISSCSNDDFK------ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYL 309
            +++  +            LV+E M     +         LD  +   ++      +++L
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHL 135

Query: 310 YFGHTTPIIHCDLKPISVLLDEDMVAHLSDF------------------------EYGME 345
              H+  IIH DLKP ++++  D    + DF                        E  + 
Sbjct: 136 ---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 346 GQVSTRSDIYGYGIVLMETFTRKKP-TDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG 404
                  DI+  G ++ E    K     R ++++ +             M+ +  T+ + 
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 405 EKKGFVAKEQCVLSILGLAMECAMELPEKRI--NAKDIVTRLLKI 447
            +            +   ++  A     K     A+D+++++L I
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.0 bits (181), Expect = 5e-16
 Identities = 23/159 (14%), Positives = 52/159 (32%), Gaps = 34/159 (21%)

Query: 200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA------------------RALKSFEA 241
           +  L+G G   +V+        E  VK                          A++S   
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 242 QCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMID 301
           +   ++ ++   + KV +   N    A+++E +               + +     ++  
Sbjct: 64  EFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK--------ELYRVRVENPDEVLDM 111

Query: 302 ATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDF 340
               +      +   I+H DL   +VL+ E+ +  + DF
Sbjct: 112 ILEEVAKF---YHRGIVHGDLSQYNVLVSEEGI-WIIDF 146

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 77.0 bits (188), Expect = 5e-16
 Identities = 35/216 (16%), Positives = 72/216 (33%), Gaps = 47/216 (21%)

Query: 199 RLSNLIGMGSFGSVYRAR-LRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKV 257
            L   +G G F +V+ A+ + +   VA+K+   +     ++ E + ++++ +   +  K 
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKE 74

Query: 258 ISSCSNDDFK---------------ALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDA 302
            S  +N   K                +V E + +  L          + +     I    
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 303 TSTLEYLYFGHTTPIIHCDLKPISVLLD-EDMVAHLSDF--------------------- 340
              L+Y++      IIH D+KP +VL++  D   +L                        
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 341 ------EYGMEGQVSTRSDIYGYGIVLMETFTRKKP 370
                 E  +       +DI+    ++ E  T    
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 71.3 bits (173), Expect = 2e-14
 Identities = 29/66 (43%), Positives = 40/66 (60%), Gaps = 3/66 (4%)

Query: 69  NLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPN 128
           +L NN IYG +P  L +L +L  L++SFN L GEI +GG    F   ++  N+ LCGSP 
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP- 308

Query: 129 LQVPPC 134
             +P C
Sbjct: 309 --LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 49.4 bits (116), Expect = 4e-07
 Identities = 17/57 (29%), Positives = 26/57 (45%), Gaps = 1/57 (1%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
             D  +N + G L   +  LK +  +N+S NNL  ++P   G L      + A NK 
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 2e-08
 Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 11/83 (13%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL-------DVASLEILNLSNNE 74
           NLK +  + L  NN+S   P  +  L  L+ L  A NK+       ++ ++  L+  +N+
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQ 362

Query: 75  IYGLIPTSLEKLLYLKELSLSFN 97
           I  L P  L  L  + +L L+  
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 9e-06
 Identities = 28/137 (20%), Positives = 50/137 (36%), Gaps = 35/137 (25%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMP--------------------AT 43
           + D ++N +     L    L  + E+ L  N +S+  P                    + 
Sbjct: 245 DLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302

Query: 44  IGGLISLKTLSLAYNKL-------DVASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSF 96
           I  L +L  L+L +N +        +  L+ L  +NN++     +SL  L  +  LS   
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 97  NKLEGEILRGGPFVNFT 113
           N++        P  N T
Sbjct: 361 NQISDLT----PLANLT 373

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 23/94 (24%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPT 81
            L   ++  L + N++          +S   L           +  L      I  +   
Sbjct: 20  ALAEKMKTVLGKTNVT--------DTVSQTDLD---------QVTTLQADRLGIKSI--D 60

Query: 82  SLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAM 115
            +E L  L +++ S N+L        P  N T +
Sbjct: 61  GVEYLNNLTQINFSNNQLTDIT----PLKNLTKL 90

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 21/92 (22%)

Query: 6  DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASL 65
               ++   +S    +L  V  +   R  + S     I G+  L             +L
Sbjct: 28 VLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-----IDGVEYLN------------NL 68

Query: 66 EILNLSNNEIYGLIPTSLEKLLYLKELSLSFN 97
            +N SNN++  + P  L+ L  L ++ ++ N
Sbjct: 69 TQINFSNNQLTDITP--LKNLTKLVDILMNNN 98

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 6e-07
 Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 11/90 (12%)

Query: 4   NFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL--- 60
              +  N+    +        ++ E+N+S N L   +PA       L+ L  ++N L   
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAEV 319

Query: 61  --DVASLEILNLSNNEIYGL--IPTSLEKL 86
                +L+ L++  N +     IP S+E L
Sbjct: 320 PELPQNLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 1e-05
 Identities = 19/78 (24%), Positives = 33/78 (42%), Gaps = 11/78 (14%)

Query: 30  NLSRNNLSSDMPATIGGLISLKTLSLAYNKL-----DVASLEILNLSNNEIYGLIPTSLE 84
               N  S+++ +      SL+ L+++ NKL         LE L  S N +       + 
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHL-----AEVP 320

Query: 85  KLLY-LKELSLSFNKLEG 101
           +L   LK+L + +N L  
Sbjct: 321 ELPQNLKQLHVEYNPLRE 338

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.6 bits (102), Expect = 4e-06
 Identities = 27/105 (25%), Positives = 38/105 (36%), Gaps = 11/105 (10%)

Query: 6   DFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVAS- 64
             +   L     L    L  V  ++LS N L +  PA +  L  L+ L  + N L+    
Sbjct: 4   HLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60

Query: 65  ------LEILNLSNNEIYGL-IPTSLEKLLYLKELSLSFNKLEGE 102
                 L+ L L NN +        L     L  L+L  N L  E
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.4 bits (106), Expect = 6e-06
 Identities = 28/123 (22%), Positives = 48/123 (39%), Gaps = 6/123 (4%)

Query: 1   DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL 60
           D    D  +N +      D  NLK +  + L  N +S   P     L+ L+ L L+ N+L
Sbjct: 32  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 61  DVASLEI------LNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTA 114
                ++      L +  NEI  +  +    L  +  + L  N L+   +  G F     
Sbjct: 92  KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151

Query: 115 MSF 117
           +S+
Sbjct: 152 LSY 154

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 26/126 (20%), Positives = 40/126 (31%), Gaps = 6/126 (4%)

Query: 17  SLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDV------ASLEILNL 70
             +  N   VVE+  +    S        G+  L  + +A   +         SL  L+L
Sbjct: 119 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHL 178

Query: 71  SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQ 130
             N+I  +   SL+ L  L +L LSFN +                    N  L   P   
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238

Query: 131 VPPCKL 136
                +
Sbjct: 239 ADHKYI 244

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 8e-06
 Identities = 13/85 (15%), Positives = 30/85 (35%), Gaps = 15/85 (17%)

Query: 22  NLKAVVEINLSRNNLS-SDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIP 80
           +++    +++    LS +     +  L   + + L    L  A  + +            
Sbjct: 3   DIQ---SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI-----------S 48

Query: 81  TSLEKLLYLKELSLSFNKLEGEILR 105
           ++L     L EL+L  N+L    + 
Sbjct: 49  SALRVNPALAELNLRSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 4e-05
 Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 17/101 (16%)

Query: 1  DILNFDFSSNSL-EGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK 59
          DI + D     L +   +  +  L+    + L    L+      I   + +         
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP------- 55

Query: 60 LDVASLEILNLSNNEIYGLIPTSLEKLL-----YLKELSLS 95
              +L  LNL +NE+  +    + + L      +++LSL 
Sbjct: 56 ----ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 6e-05
 Identities = 20/88 (22%), Positives = 33/88 (37%), Gaps = 22/88 (25%)

Query: 28  EINLSRNNLS----SDMPATIGGLISLKTLSLAYNKLDVA--------------SLEILN 69
            + L+  ++S    S + AT+    SL+ L L+ N L  A               LE L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 70  LSNNEIYGLIPTSLEKLL----YLKELS 93
           L +      +   L+ L      L+ +S
Sbjct: 433 LYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 16/86 (18%), Positives = 26/86 (30%), Gaps = 18/86 (20%)

Query: 38  SDMPATIGGLISLKTLSLAYNKLDVA-------------SLEILNLSNNEIYGLIPTSLE 84
                       L+ L LA   +  +             SL  L+LSNN +       L 
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 85  KLL-----YLKELSLSFNKLEGEILR 105
           + +      L++L L       E+  
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMED 444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 9e-06
 Identities = 15/77 (19%), Positives = 31/77 (40%), Gaps = 18/77 (23%)

Query: 19 DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGL 78
          ++  + + +E+N  + NL++ +P  +                      IL+LS N +Y  
Sbjct: 5  EVSKVASHLEVNCDKRNLTA-LPPDLP-----------------KDTTILHLSENLLYTF 46

Query: 79 IPTSLEKLLYLKELSLS 95
             +L     L +L+L 
Sbjct: 47 SLATLMPYTRLTQLNLD 63

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 12/80 (15%), Positives = 33/80 (41%), Gaps = 19/80 (23%)

Query: 22  NLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPT 81
                ++ NL + +++          ++   L+         S++ +  +N++I  +   
Sbjct: 22  AFAETIKDNLKKKSVT--------DAVTQNELN---------SIDQIIANNSDIKSVQG- 63

Query: 82  SLEKLLYLKELSLSFNKLEG 101
            ++ L  + +L L+ NKL  
Sbjct: 64  -IQYLPNVTKLFLNGNKLTD 82

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.001
 Identities = 11/35 (31%), Positives = 15/35 (42%)

Query: 64  SLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNK 98
              IL++S   I+ L    LE L  L+  S    K
Sbjct: 202 GPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.2 bits (84), Expect = 0.003
 Identities = 19/79 (24%), Positives = 28/79 (35%), Gaps = 14/79 (17%)

Query: 29  INLSRNNLSSDMPATIGGLISLKTLSLAYNKLDVASLEILNLSNNEIYGLIPTSL----- 83
           + L+   LS+   A +    S               L+ L L  NEI      +L     
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENI---------GLQTLRLQYNEIELDAVRTLKTVID 298

Query: 84  EKLLYLKELSLSFNKLEGE 102
           EK+  L  L L+ N+   E
Sbjct: 299 EKMPDLLFLELNGNRFSEE 317

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	453
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.49
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.45
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.35
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.3
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.23
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.2
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.19
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.17
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.16
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.09
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.08
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.01
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.98
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.96
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.95
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.91
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.86
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.81
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.8
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.74
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.72
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.7
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.65
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.61
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.55
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.51
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.5
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.34
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.23
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.16
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.1
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.07
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.91
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.82
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.73
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.67
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.64
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.57
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.44
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.05
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.82
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.8
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.76
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	94.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.21

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=370.96  Aligned_cols=228  Identities=24%  Similarity=0.406  Sum_probs=188.8

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      ++.+.||+|+||.||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|..++..++||||+++|+
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence            45678999999999999999889999999976433 34789999999999999999999999999999999999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------------  344 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------------  344 (453)
                      |.+++......+++..+..++.|+++||.||   |+++|+||||||+|||+++++.+||+|||++.              
T Consensus        87 L~~~l~~~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  163 (263)
T d1sm2a_          87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  163 (263)
T ss_dssp             HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred             HHHHhhccccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence            9999988777889999999999999999999   78899999999999999999999999998642              


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhC-CCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTR-KKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                  ...++.++|||||||++|||+|+ .+|+......  .+...+..                +  .+...
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~----------------~--~~~~~  223 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIST----------------G--FRLYK  223 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHHH----------------T--CCCCC
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHHHh----------------c--CCCCC
Confidence                        23567889999999999999995 5554432111  11111111                0  01122


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      +..+++++.+|+.+||+.||++||||+||++.|++|.+.
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            345677899999999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=372.06  Aligned_cols=233  Identities=24%  Similarity=0.401  Sum_probs=190.0

Q ss_pred             HHHhcccCCCCccEEEEEEECCCCEEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQE--CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      +++.+.||+|+||.||+|+++  ..||||+++..  .....+.|.+|+++|++++|||||+++|++.+ +..++|||||+
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            356788999999999999865  36999999754  34556789999999999999999999998765 56799999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++......+++..++.++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.           
T Consensus        87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~  163 (276)
T d1uwha_          87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF  163 (276)
T ss_dssp             EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence            9999999987767799999999999999999999   78899999999999999999999999998652           


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         ...++.++|||||||++|||+||+.||.+................+.              
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--------------  229 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--------------  229 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC--------------
T ss_pred             cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--------------
Confidence                               12367789999999999999999999975432211111111110000              


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                       .....+..+++++.+|+.+||+.||++||||+|+++.|+.+++.+
T Consensus       230 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         230 -DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             -CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence             011233467788999999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-48  Score=371.70  Aligned_cols=229  Identities=22%  Similarity=0.429  Sum_probs=187.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CC---CEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DG---IEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||+||+|+++ ++   ..||||.+... .....++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus        28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E  107 (299)
T d1jpaa_          28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE  107 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            345688999999999999976 33   36899998755 34456789999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      ||++|+|.+++......+++..+..++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.        
T Consensus       108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence            9999999999888777799999999999999999999   78899999999999999999999999998652        


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            ...++.++|||||||++|||+| |++||.+....+  +...+.               
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i~---------------  247 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAIE---------------  247 (299)
T ss_dssp             -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---------------
T ss_pred             ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHHH---------------
Confidence                                  1346778999999999999998 899987542211  111111               


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                       .+  .+.+.+..++.++.+|+.+||+.||++||||+||++.|+++..
T Consensus       248 -~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         248 -QD--YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -TT--CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -cC--CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence             11  1122345677889999999999999999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=364.59  Aligned_cols=228  Identities=25%  Similarity=0.426  Sum_probs=188.5

Q ss_pred             hc-ccCCCCccEEEEEEEC---CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          201 SN-LIGMGSFGSVYRARLR---DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       201 ~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .+ .||+|+||.||+|.++   ++..||||+++... ....++|.+|+++|++++|||||+++|+|.++ ..++|||||+
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~   91 (285)
T d1u59a_          13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAG   91 (285)
T ss_dssp             EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCC
Confidence            45 4999999999999865   35689999997653 34567899999999999999999999999754 5789999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++......+++..+..++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.           
T Consensus        92 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (285)
T d1u59a_          92 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  168 (285)
T ss_dssp             TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence            9999999877767799999999999999999999   78899999999999999999999999998652           


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                       ...++.++|||||||++|||+| |+.||......+  +...+.                .+  
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~----------------~~--  228 (285)
T d1u59a_         169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE----------------QG--  228 (285)
T ss_dssp             CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH----------------TT--
T ss_pred             ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH----------------cC--
Confidence                             1235678999999999999998 899997543211  111111                11  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      .+.+.+..+++++.+|+.+||+.+|++||||.+|++.|+.+...+.
T Consensus       229 ~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            1223345678899999999999999999999999999998876543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=358.67  Aligned_cols=224  Identities=24%  Similarity=0.423  Sum_probs=189.4

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~g~  278 (453)
                      ++.+.||+|+||.||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+++..++||||+++|+
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence            45678999999999999999899999999986543 34689999999999999999999999999999999999999999


Q ss_pred             chHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-------------
Q 036792          279 LENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-------------  345 (453)
Q Consensus       279 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-------------  345 (453)
                      |.+++......+++..+..++.|+++||.||   |+++|+||||||+||+++.++.+||+|||++..             
T Consensus        86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  162 (258)
T d1k2pa_          86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  162 (258)
T ss_dssp             HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred             HHHhhhccccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence            9999877766788999999999999999999   778999999999999999999999999987521             


Q ss_pred             -------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          346 -------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       346 -------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ..++.++|||||||++|||+| |+.||......+.  ...+.                .+.  +...
T Consensus       163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~~i~----------------~~~--~~~~  222 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIA----------------QGL--RLYR  222 (258)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HHHHH----------------TTC--CCCC
T ss_pred             CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HHHHH----------------hCC--CCCC
Confidence                         245778999999999999998 7999976533221  11111                111  1223


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVTRLLK  446 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~  446 (453)
                      +..+++++.+|+.+||+.||++||||+|+++.|.+
T Consensus       223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            34567789999999999999999999999998864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-48  Score=365.52  Aligned_cols=228  Identities=24%  Similarity=0.404  Sum_probs=188.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +++.+.||+|+||+||+|.++ +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+++..++|||||++
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   97 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   97 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence            456788999999999999986 589999999976543 357899999999999999999999999999999999999999


Q ss_pred             CCchHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          277 GSLENCLYS-STCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       277 g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      |+|.+++.. ....+++..+..++.|+++||.||   |+++|+||||||+|||+++++.+||+|||++..          
T Consensus        98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred             cchHHHhhhccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence            999999865 345789999999999999999999   778999999999999999999999999987631          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                      ..++.++|||||||++|||++|..|+.....    ...         +.+.+...      .+.
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~---------~~~~i~~~------~~~  235 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQ---------VYELLEKD------YRM  235 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHH---------HHHHHHTT------CCC
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHH---------HHHHHhcC------CCC
Confidence                            3567899999999999999997776532211    111         11111111      112


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                      +.+..+++++.+|+.+||+.||++||||+|+++.|+.+.
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            234467788999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=364.73  Aligned_cols=226  Identities=20%  Similarity=0.347  Sum_probs=189.9

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      ..|++.+.||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            34677889999999999999976 68999999998776666678999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++......+++.....++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.          
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999998876555789999999999999999999   78899999999999999999999999998641          


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ...++.++|||||||++|||+||+.||.+....+. +...                .. .
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i----------------~~-~  230 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKI----------------AK-S  230 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHH----------------HH-S
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHH----------------Hc-C
Confidence                                12367889999999999999999999975432211 1111                11 1


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+....+..+++++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11122234566788999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=362.17  Aligned_cols=229  Identities=23%  Similarity=0.395  Sum_probs=184.9

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      .+++.+.||+|+||.||+|++++++.||||+++.... ..+.|.+|+++|++++|||||+++|++.+ +..++||||+++
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence            4567788999999999999999889999999976543 34679999999999999999999998865 567899999999


Q ss_pred             CCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      |+|.+++.... ..+++..++.++.|+++||.||   |+++|+||||||+|||+++++.+||+|||++.           
T Consensus        92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence            99998775432 3588999999999999999999   77899999999999999999999999998752           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++|||||||++|||+||..|+....... .....+.                .+  .+.
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i~----------------~~--~~~  229 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLE----------------RG--YRM  229 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHH----------------TT--CCC
T ss_pred             ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHHH----------------hc--CCC
Confidence                           1245778999999999999999765543221111 1111111                11  112


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ..+..+++++.+|+.+||+.||++||||+||++.|+++-.
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            2334577789999999999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=357.44  Aligned_cols=223  Identities=24%  Similarity=0.372  Sum_probs=181.7

Q ss_pred             cccCCCCccEEEEEEECC---CCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          202 NLIGMGSFGSVYRARLRD---GIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      +.||+|+||.||+|.+++   ++.||||+++...  ....++|.+|+++|++++|||||+++|+|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            369999999999998653   4689999997543  33457899999999999999999999999654 56899999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++.... .+++..++.++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.            
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999987654 589999999999999999999   78899999999999999999999999998752            


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                      ...++.++|||||||++|||+| |+.||.+....+  +...            +.    .+  .
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~------------i~----~~--~  227 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAM------------LE----KG--E  227 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH------------HH----TT--C
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHH------------HH----cC--C
Confidence                            1235678999999999999998 899997542211  1111            11    11  1


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +.+.+..+++++.+|+.+||+.||++||||++|.+.|+....
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            223345678899999999999999999999999999987643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-47  Score=356.24  Aligned_cols=229  Identities=23%  Similarity=0.412  Sum_probs=187.1

Q ss_pred             HHhcccCCCCccEEEEEEECCC-----CEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          199 RLSNLIGMGSFGSVYRARLRDG-----IEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      ++.++||+|+||.||+|.+++.     ..||||+++... .....+|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence            4567899999999999987632     479999997653 3445679999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+.+|++.+.+......+++..+..++.|++.|+.||   |+++|+||||||+|||++.++.+||+|||++.        
T Consensus        90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            9999999998887777899999999999999999999   78899999999999999999999999998752        


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                          ...++.++|||||||++|||+|+..|+......    .+.         .+.+...    
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~---------~~~i~~~----  229 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEV---------MKAINDG----  229 (283)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH---------HHHHHTT----
T ss_pred             ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHH---------HHHHhcc----
Confidence                                134677899999999999999976664322111    111         1111111    


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                        .+.+.+..++.++.+|+.+||+.||++||||+||++.|+++.+
T Consensus       230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence              1223345677889999999999999999999999999998864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=355.60  Aligned_cols=222  Identities=24%  Similarity=0.302  Sum_probs=185.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            566788999999999999975 7999999999876555567899999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      |+|.+++...  .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.            
T Consensus       102 g~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         102 GSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             CBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             CcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            9999987654  488899999999999999999   78899999999999999999999999998652            


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++||||+||++|||+||+.||.+....+. +.....                 ........
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~-----------------~~~~~~~~  238 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT-----------------NGTPELQN  238 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH-----------------HCSCCCSS
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHh-----------------CCCCCCCC
Confidence                         23467899999999999999999999965422111 000110                 00111223


Q ss_pred             hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +..+++++.+|+.+||+.||++|||++|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4456778999999999999999999999874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=351.07  Aligned_cols=220  Identities=22%  Similarity=0.358  Sum_probs=183.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            456789999999999999986 68999999997543   23456789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.         
T Consensus        88 ~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  163 (263)
T d2j4za1          88 APLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT  163 (263)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEE
T ss_pred             cCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccc
Confidence            99999999987643 588999999999999999999   78899999999999999999999999998752         


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||+||+.||......+     ...            .... ..   ..
T Consensus       164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~------------~i~~-~~---~~  222 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYK------------RISR-VE---FT  222 (263)
T ss_dssp             TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHH------------HHHT-TC---CC
T ss_pred             cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-----HHH------------HHHc-CC---CC
Confidence                          2357889999999999999999999997542211     111            1000 10   11


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      .+..+++++.+|+.+||+.||++|||++|+++
T Consensus       223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            22345678999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-47  Score=353.51  Aligned_cols=223  Identities=24%  Similarity=0.307  Sum_probs=179.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            456789999999999999986 69999999997653 2344678999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      +|+|.+++.... .+++.....++.|+++||.||   |+++|+||||||+|||+++++.+||+|||++..          
T Consensus        87 gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          87 GGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             TEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            999999987543 688999999999999999999   788999999999999999999999999987521          


Q ss_pred             -----------------CCc-CcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          346 -----------------GQV-STRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       346 -----------------~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ..+ +.++||||+||++|||+||++||............+....                  .
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~------------------~  224 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------------------T  224 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC------------------T
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------C
Confidence                             122 4578999999999999999999975432222211111100                  0


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ........++++.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122345667889999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=349.84  Aligned_cols=230  Identities=21%  Similarity=0.358  Sum_probs=186.8

Q ss_pred             HHHHhcccCCCCccEEEEEEECC----CCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRD----GIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      .+++.+.||+|+||.||+|++..    +..||||.++... ....+.|.+|+++|++++|||||+++|++. ++..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence            35677899999999999998752    3578999987543 344578999999999999999999999996 46789999


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+++|+|.+++......+++.....++.|+++||.||   |+++|+||||||+||+++.++.+||+|||++.       
T Consensus        87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            99999999998887777899999999999999999999   88999999999999999999999999998652       


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcC
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSG  404 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  404 (453)
                                         ...++.++|||||||++|||+| |.+||......+  +...+.                .+
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~----------------~~  225 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE----------------NG  225 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHH----------------TT
T ss_pred             eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHH----------------cC
Confidence                               1346778999999999999998 899987543221  111111                11


Q ss_pred             ccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          405 EKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       405 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .  +.+.+..+++++.+|+.+||+.||++||||+||++.|+++.++
T Consensus       226 ~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         226 E--RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            1  1223456778899999999999999999999999999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=347.58  Aligned_cols=223  Identities=23%  Similarity=0.345  Sum_probs=178.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec----CCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN----DDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv  270 (453)
                      +++.+.||+|+||+||+|+++ +++.||+|.+....  ....+.|.+|+++|++++|||||++++++.+    +...++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            355678999999999999976 68999999997653  3445789999999999999999999999865    4568999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCceeeC-CCCcEEEeccccCC---
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTP--IIHCDLKPISVLLD-EDMVAHLSDFEYGM---  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~--i~Hrdlk~~NiLl~-~~~~~kl~df~~~~---  344 (453)
                      |||+++|+|.+++.... .+++.....++.|+++||.||   |+++  |+||||||+|||++ +++.+||+|||++.   
T Consensus        91 mE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999987643 588888999999999999999   6665  99999999999996 47899999998652   


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         .+.++.++|||||||++|||++|+.||.............                 ..+ 
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i-----------------~~~-  228 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-----------------TSG-  228 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-----------------TTT-
T ss_pred             CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH-----------------HcC-
Confidence                               1357889999999999999999999996432211111110                 001 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...+..+++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0111223345667899999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.5e-46  Score=359.35  Aligned_cols=226  Identities=17%  Similarity=0.252  Sum_probs=188.3

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      .|++.+.||+|+||.||+|+.+ +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            4678899999999999999975 799999999987665566788999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC--CCCcEEEeccccCC---------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD--EDMVAHLSDFEYGM---------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~--~~~~~kl~df~~~~---------  344 (453)
                      +|+|.+.+......++......++.|++.||.||   |+++|+||||||+|||++  .++.+||+|||++.         
T Consensus       110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            9999998877666789999999999999999999   789999999999999998  57899999998752         


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     ...++.++||||+||++|||+||+.||.+....+                 .+............
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----------------~~~~i~~~~~~~~~  249 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----------------TLQNVKRCDWEFDE  249 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----------------HHHHHHHCCCCCCS
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhCCCCCCc
Confidence                           2357889999999999999999999997542211                 11111111111111


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ......++++.+|+.+||+.||++|||++|+++
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            223356678899999999999999999999975

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=352.66  Aligned_cols=229  Identities=24%  Similarity=0.448  Sum_probs=186.8

Q ss_pred             hcccCCCCccEEEEEEECC----CCEEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEEEecc
Q 036792          201 SNLIGMGSFGSVYRARLRD----GIEVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALVLEYM  274 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~E~~  274 (453)
                      .++||+|+||+||+|++.+    ...||||+++.. .....++|.+|+++|++++|||||+++|+|.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5689999999999999753    236899999754 44556889999999999999999999999875 56889999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      ++|+|.+++.......++..++.++.|+++||.|+   |+++|+||||||+|||+++++.+||+|||++.          
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999988777788899999999999999999   78899999999999999999999999998652          


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE  405 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  405 (453)
                                         .+.++.++||||||+++|||+||..||....... .+..++.                .+ 
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~----------------~g-  250 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL----------------QG-  250 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH----------------TT-
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHH----------------cC-
Confidence                               1345778999999999999999888875432111 1111111                11 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                       .+...+..+++++.+|+.+||+.||++||||+||++.|+++....
T Consensus       251 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence             112233456778999999999999999999999999999997653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=358.02  Aligned_cols=226  Identities=24%  Similarity=0.377  Sum_probs=182.5

Q ss_pred             HHHhcccCCCCccEEEEEEECC-C-----CEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLRD-G-----IEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  269 (453)
                      +++.+.||+|+||+||+|+++. +     ..||||.+.... ......+.+|+.+|.++ +|||||+++|+|.+.+..++
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  118 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence            4567899999999999998652 2     369999986543 33446789999999998 89999999999999999999


Q ss_pred             EEeccCCCCchHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 036792          270 VLEYMPKGSLENCLYSST----------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISV  327 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~Ni  327 (453)
                      |||||++|+|.+++....                      ..+++..++.++.|+++||.||   |+++|+||||||+||
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL---H~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNV  195 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCSGGGE
T ss_pred             EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCchhcc
Confidence            999999999999997643                      2478889999999999999999   788999999999999


Q ss_pred             eeCCCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccc
Q 036792          328 LLDEDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEEL  379 (453)
Q Consensus       328 Ll~~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~  379 (453)
                      |++.++.+||+|||++.                           ...++.++|||||||++|||+| |++||.+..... 
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-  274 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-  274 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence            99999999999998752                           1346778999999999999998 899997543221 


Q ss_pred             cHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHH
Q 036792          380 SLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLL  445 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~  445 (453)
                      .+.+.+.                .+  .+.+.+..+++++.+|+.+||+.||++||||+||++.|.
T Consensus       275 ~~~~~~~----------------~~--~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 NFYKLIQ----------------NG--FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHHHH----------------TT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHh----------------cC--CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1111111                11  112234567788999999999999999999999999884

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-46  Score=355.37  Aligned_cols=228  Identities=30%  Similarity=0.463  Sum_probs=187.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|+++      +++.||||+++... ....++|.+|+++|++++||||++++++|...+..+++
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            456788999999999999864      35789999997654 34457899999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCce
Q 036792          271 LEYMPKGSLENCLYSST-----------------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISV  327 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~Ni  327 (453)
                      |||+++|+|.+++....                       ..+++..++.++.|++.||+||   |+++|+||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl---H~~~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc---ccCCeEeeEEcccce
Confidence            99999999999986421                       2478889999999999999999   789999999999999


Q ss_pred             eeCCCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHhCC-CCCCccccccc
Q 036792          328 LLDEDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFTRK-KPTDRMFVEEL  379 (453)
Q Consensus       328 Ll~~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~  379 (453)
                      |++.++.+||+|||++.                           ...++.++|||||||++|||++|. +||......+ 
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e-  250 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-  250 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH-
Confidence            99999999999998641                           124678999999999999999996 5665442221 


Q ss_pred             cHHhHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHH
Q 036792          380 SLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIR  448 (453)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~  448 (453)
                       ....+                ..+.  ..+.+..+++++.+|+.+||+.+|++||||.||++.|++|.
T Consensus       251 -~~~~v----------------~~~~--~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         251 -VIYYV----------------RDGN--ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             -HHHHH----------------HTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -HHHHH----------------HcCC--CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             11111                1111  12234567788999999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-45  Score=357.32  Aligned_cols=225  Identities=18%  Similarity=0.237  Sum_probs=187.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      |++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  107 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            567889999999999999976 6999999999877666667899999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC--CCcEEEeccccCC----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE--DMVAHLSDFEYGM----------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~--~~~~kl~df~~~~----------  344 (453)
                      |+|.+++......+++.....++.|++.||.||   |+++|+||||||+|||++.  ++.+||+|||++.          
T Consensus       108 g~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            999999977666799999999999999999999   7899999999999999964  6789999998752          


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++||||+||++|||+||+.||.+....+                 .+.............
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----------------~~~~i~~~~~~~~~~  247 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----------------TLRNVKSCDWNMDDS  247 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHTCCCSCCG
T ss_pred             ecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhCCCCCCcc
Confidence                          2346778999999999999999999997542211                 111111111111122


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+++++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            23456678999999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=352.31  Aligned_cols=227  Identities=26%  Similarity=0.418  Sum_probs=184.8

Q ss_pred             HHHHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      -+++.+.||+|+||.||+|++++++.||||+++.... ..+.|.+|+.+|++++|||||+++|+|.+ +..++||||+++
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence            3567889999999999999999888999999975543 34789999999999999999999999855 567899999999


Q ss_pred             CCchHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          277 GSLENCLYSS-TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       277 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      |+|..++... ...+++..++.++.++++||.||   |+++|+||||||+|||++.++.+||+|||++.           
T Consensus        96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CchhhhhhhcccccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence            9999887653 34589999999999999999999   78899999999999999999999999998752           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGF  409 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  409 (453)
                                     .+.++.++|||||||++|||+||..|+....... .....+            .   . +  .+.
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i------------~---~-~--~~~  233 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV------------E---R-G--YRM  233 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH------------H---T-T--CCC
T ss_pred             cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHH------------H---h-c--CCC
Confidence                           1346778999999999999999766654321111 111111            1   0 1  112


Q ss_pred             hhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          410 VAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       410 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      +.+..+++++.+++.+||+.||++||||++|++.|++.
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            23456778899999999999999999999999888764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-45  Score=351.40  Aligned_cols=225  Identities=20%  Similarity=0.267  Sum_probs=178.1

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA-RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      .|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~   89 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV   89 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            3667889999999999999976 689999999976543 33456889999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC---CCCcEEEeccccCC-------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD---EDMVAHLSDFEYGM-------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~---~~~~~kl~df~~~~-------  344 (453)
                      ++|+|.+++.... .+++.....++.|++.||.||   |+++|+||||||+|||+.   +++.+||+|||++.       
T Consensus        90 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          90 SGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             CCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            9999999997643 688999999999999999999   788999999999999995   57899999998652       


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++||||+||++|||++|+.||.+....+  .               ...........
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~---------------~~~i~~~~~~~  228 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--L---------------FEQILKAEYEF  228 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H---------------HHHHHTTCCCC
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--H---------------HHHHhccCCCC
Confidence                             2357889999999999999999999997542211  1               11111111111


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+.....++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            12233456778999999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=349.51  Aligned_cols=245  Identities=24%  Similarity=0.282  Sum_probs=182.3

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----eeEEEEeccC
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----FKALVLEYMP  275 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~E~~~  275 (453)
                      +.+.||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+++    ..++|||||+
T Consensus         7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~   84 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence            457899999999999997 5889999999754321 122334555556789999999999998754    5789999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYF-----GHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~-----~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      +|+|.++++..  .++|..++.++.+++.||.|+|.     .|+++|+||||||+|||++.++.+||+|||++..     
T Consensus        85 ~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~  162 (303)
T d1vjya_          85 HGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT  162 (303)
T ss_dssp             TCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence            99999999865  48899999999999999999984     3578999999999999999999999999985410     


Q ss_pred             -----------------------C-------CcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhh
Q 036792          346 -----------------------G-------QVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLME  395 (453)
Q Consensus       346 -----------------------~-------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  395 (453)
                                             .       .++.++|||||||++|||+||..|+...............  ......+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~--~~~~~~~  240 (303)
T d1vjya_         163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP--SDPSVEE  240 (303)
T ss_dssp             TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC--SSCCHHH
T ss_pred             cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc--ccchHHH
Confidence                                   0       1455799999999999999999887543222211111000  0111111


Q ss_pred             hhhhhhhcCcc---CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          396 VVDKTLLSGEK---KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       396 ~~d~~~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      +.+........   +.......++..+.+|+.+||+.||++||||.||++.|+++.++
T Consensus       241 ~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            11111111111   11222345777899999999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-45  Score=352.34  Aligned_cols=225  Identities=23%  Similarity=0.294  Sum_probs=183.3

Q ss_pred             HHHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          195 ATLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       195 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      ...|+..+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|+++|++++|||||++++++.+++..++|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            344666788999999999999975 68999999997553   23456799999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      ||||++|+|..++... ..+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.      
T Consensus        94 ~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (309)
T ss_dssp             EECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred             EEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence            9999999987665544 3689999999999999999999   78899999999999999999999999998652      


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...++.++|||||||++|||++|..||.+....+.                 +........ 
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----------------~~~i~~~~~-  231 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------------LYHIAQNES-  231 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------------HHHHHHSCC-
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----------------HHHHHhCCC-
Confidence                              13478899999999999999999999865322110                 000111000 


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ....+..+++++.+|+.+||+.||++|||++|+++
T Consensus       232 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 -PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence             11112345678999999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=347.41  Aligned_cols=226  Identities=19%  Similarity=0.258  Sum_probs=185.2

Q ss_pred             HHHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeE
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA------RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  268 (453)
                      ..|++.+.||+|+||+||+|+++ +|+.||||+++....      ...+.+.+|+++|++++|||||++++++.+++..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34677899999999999999986 799999999975422      23578999999999999999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC----cEEEeccccCC
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM----VAHLSDFEYGM  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~----~~kl~df~~~~  344 (453)
                      +|||||++|+|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++    .+|++|||++.
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            9999999999999987654 688999999999999999999   788999999999999998776    49999998652


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ...++.++|||||||++|||+||+.||.+....+.                 +...
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----------------~~~i  228 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----------------LANV  228 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHH
T ss_pred             hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-----------------HHHH
Confidence                                    23578899999999999999999999975422111                 1111


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..............++.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         229 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111112233456778999999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=350.26  Aligned_cols=227  Identities=26%  Similarity=0.371  Sum_probs=177.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC--CC--CEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR--DG--IEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|++.  ++  ..||||+++...   ....++|.+|+++|++++|||||+++|+|.++ ..++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence            456778999999999999864  23  479999987542   34457899999999999999999999999764 67899


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC-----
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME-----  345 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~-----  345 (453)
                      |||+++|++.+.+......+++..++.++.|+++||.||   |+++|+||||||+||+++.++.+||+|||++..     
T Consensus        89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            999999999998877666799999999999999999999   778999999999999999999999999986531     


Q ss_pred             -----------------------CCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          346 -----------------------GQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       346 -----------------------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                             ..++.++|||||||++|||+| |+.||.+....+                 ++....
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----------------~~~~i~  228 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----------------ILHKID  228 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----------------HHHHHH
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----------------HHHHHH
Confidence                                   234668999999999999998 899997542221                 111111


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                      ..+  .+.+.+..++.++.+|+.+||+.||++||||.||.+.|++.
T Consensus       229 ~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 KEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TSC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hCC--CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111  12223456677899999999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=347.65  Aligned_cols=225  Identities=30%  Similarity=0.451  Sum_probs=183.7

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEec-CCeeEEEEeccCCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSN-DDFKALVLEYMPKG  277 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~E~~~~g  277 (453)
                      ++.+.||+|+||.||+|+++ |..||||+++.+.  ..++|.+|++++++++|||||+++|+|.+ .+..++||||+++|
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g   86 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   86 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence            45688999999999999985 7889999997543  34779999999999999999999999865 45689999999999


Q ss_pred             CchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          278 SLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       278 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      +|.+++.... ..+++..++.++.|++.||.||   |+++|+||||||+|||++.++.+|++|||++.            
T Consensus        87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~  163 (262)
T d1byga_          87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  163 (262)
T ss_dssp             EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecCCCCEeecccccceecCCCCcccccc
Confidence            9999986532 3578999999999999999999   78899999999999999999999999997652            


Q ss_pred             ----------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchhhH
Q 036792          345 ----------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVAKE  413 (453)
Q Consensus       345 ----------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  413 (453)
                                ...++.++|||||||++|||+| |++||......+  +..++.                .  +.+.+.+.
T Consensus       164 ~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~----------------~--~~~~~~~~  223 (262)
T d1byga_         164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE----------------K--GYKMDAPD  223 (262)
T ss_dssp             TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHT----------------T--TCCCCCCT
T ss_pred             ccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHH----------------c--CCCCCCCc
Confidence                      2457889999999999999998 688876542221  111111                0  11223445


Q ss_pred             HHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          414 QCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       414 ~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      .+++++.+|+.+||+.||++||||.|+++.|++++.
T Consensus       224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            667889999999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=345.85  Aligned_cols=225  Identities=21%  Similarity=0.264  Sum_probs=173.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec--CCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN--DDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~E  272 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||.++...  ....+.+.+|+++|++++|||||++++++.+  ++..++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            566789999999999999976 68999999997653  3345678999999999999999999999865  456899999


Q ss_pred             ccCCCCchHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCceeeCCCCcEEEeccccC----
Q 036792          273 YMPKGSLENCLYS---STCMLDIFQRLNIMIDATSTLEYLYFGH--TTPIIHCDLKPISVLLDEDMVAHLSDFEYG----  343 (453)
Q Consensus       273 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~L~~~h--~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~----  343 (453)
                      ||++|+|.+++..   ....+++.....++.|++.||.|||...  ..+|+||||||+|||++.++.+||+|||++    
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence            9999999998854   2346899999999999999999996432  245999999999999999999999999653    


Q ss_pred             ---------------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          344 ---------------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       344 ---------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                           ....++.++|||||||++|||+||+.||......+  +...+               ..
T Consensus       166 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i---------------~~  228 (269)
T d2java1         166 HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKI---------------RE  228 (269)
T ss_dssp             ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH---------------HH
T ss_pred             cCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHH---------------Hc
Confidence                                 12457889999999999999999999997542221  11111               00


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ..  ....+..+++++.+|+.+||+.||++|||++|+++
T Consensus       229 -~~--~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         229 -GK--FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -TC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             10  11123456678999999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=353.50  Aligned_cols=245  Identities=21%  Similarity=0.287  Sum_probs=186.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|++++|||||+++++|.+++..++|||||+
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~   87 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   87 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            455688999999999999976 68999999997653 3445788999999999999999999999999999999999999


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      +|+|.+++.... .+++.....++.|++.||.|||.  ..+|+||||||+|||++.++.+||+|||++.           
T Consensus        88 gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  164 (322)
T d1s9ja_          88 GGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  164 (322)
T ss_dssp             TEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---C
T ss_pred             CCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccccc
Confidence            999999987643 58889999999999999999942  3489999999999999999999999998652           


Q ss_pred             ------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh--h-----------------------
Q 036792          345 ------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN--N-----------------------  387 (453)
Q Consensus       345 ------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~--~-----------------------  387 (453)
                                  ...++.++||||+||++|||++|+.||......+........  .                       
T Consensus       165 GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T d1s9ja_         165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS  244 (322)
T ss_dssp             CSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------------
T ss_pred             CCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccccc
Confidence                        246889999999999999999999999754322111100000  0                       


Q ss_pred             hcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH--HHHHH
Q 036792          388 LLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT--RLLKI  447 (453)
Q Consensus       388 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~--~L~~i  447 (453)
                      ..+....+..+..... .. +.......+.++.+|+.+||+.||++|||++|+++  .+++.
T Consensus       245 ~~~~~~~~~~~~~~~~-~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         245 RPPMAIFELLDYIVNE-PP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             -CCCCHHHHHHHHHTS-CC-CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccchhHHHHHhhhhcc-CC-ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence            0000111111111110 00 00011124567899999999999999999999986  35443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=350.69  Aligned_cols=230  Identities=27%  Similarity=0.501  Sum_probs=185.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCC--EEEEEEeecc-chhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGI--EVAVKVFHQE-CARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      +++.+.||+|+||.||+|.++ +|.  .||||+++.. .....++|.+|+++|.++ +|||||+++|+|.+++..++|||
T Consensus        12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e   91 (309)
T d1fvra_          12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   91 (309)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence            355788999999999999976 444  5788888644 334556899999999998 79999999999999999999999


Q ss_pred             ccCCCCchHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEE
Q 036792          273 YMPKGSLENCLYSS---------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHL  337 (453)
Q Consensus       273 ~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl  337 (453)
                      |+++|+|.++++..               ...+++..+..++.|+++|+.|+   |+++|+||||||+|||++.++.+||
T Consensus        92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEE
T ss_pred             ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCccccccccceEEEcCCCceEE
Confidence            99999999998643               35689999999999999999999   7889999999999999999999999


Q ss_pred             eccccCC------------------------CCCcCcccchHHHHHHHHHHHhCCC-CCCccccccccHHhHHhhhcCCc
Q 036792          338 SDFEYGM------------------------EGQVSTRSDIYGYGIVLMETFTRKK-PTDRMFVEELSLKDWVNNLLPIS  392 (453)
Q Consensus       338 ~df~~~~------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~  392 (453)
                      +|||++.                        ...++.++|||||||++|||++|.. ||......+              
T Consensus       169 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------------  234 (309)
T d1fvra_         169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------------  234 (309)
T ss_dssp             CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------------
T ss_pred             ccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------------
Confidence            9998752                        1346778999999999999999764 665432111              


Q ss_pred             hhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          393 LMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       393 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                         +.+... .+  .+.+.+..+++++.+|+.+||+.||++||||+||++.|+++.++
T Consensus       235 ---~~~~i~-~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         235 ---LYEKLP-QG--YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             ---HHHHGG-GT--CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---HHHHHH-hc--CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence               111111 11  11223445778899999999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=346.42  Aligned_cols=220  Identities=24%  Similarity=0.323  Sum_probs=182.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||+++...   ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            577899999999999999976 68999999997543   23457799999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      +++|+|.+++.... .+++.....++.|++.||.||   |+++|+||||||+|||+++++.+||+|||++.         
T Consensus        90 ~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          90 AKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            99999999887644 688899999999999999999   88999999999999999999999999998652         


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...++.++||||+||++|||+||+.||......+                 +...... .. 
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----------------~~~~i~~-~~-  226 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----------------IFQKIIK-LE-  226 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHT-TC-
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-----------------HHHHHHc-CC-
Confidence                              1346778999999999999999999997542111                 1111111 10 


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ...+...++++.+|+.+||+.||++|||++|+++
T Consensus       227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence              1122345677899999999999999999998754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.9e-45  Score=340.55  Aligned_cols=224  Identities=21%  Similarity=0.316  Sum_probs=183.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---------hhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---------RALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDF  266 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  266 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||+++....         ...+.+.+|+.+|++++ |||||++++++.+++.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            356788999999999999975 789999999975421         22356889999999997 9999999999999999


Q ss_pred             eEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--
Q 036792          267 KALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--  344 (453)
Q Consensus       267 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--  344 (453)
                      .++|||||++|+|.+++.... .+++.....++.|+++||.||   |+++|+||||||+|||++.++.+||+|||.+.  
T Consensus        85 ~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            999999999999999997644 689999999999999999999   78899999999999999999999999998652  


Q ss_pred             ----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhh
Q 036792          345 ----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEV  396 (453)
Q Consensus       345 ----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (453)
                                                  ...++.++||||+||++|||+||+.||......+. ....            
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~~~i------------  227 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMI------------  227 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH------------
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-HHHH------------
Confidence                                        12346789999999999999999999975432111 1111            


Q ss_pred             hhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                          .........+....+++++.+|+.+||+.||++|||++|+++
T Consensus       228 ----~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 ----MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                111111112233457788999999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=347.09  Aligned_cols=224  Identities=14%  Similarity=0.222  Sum_probs=183.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      |++.+.||+|+||+||+|.++ +|+.||||.++..... ...+.+|+++|+.++|||||++++++.+++..|+|||||++
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            456789999999999999976 6899999999865433 35688999999999999999999999999999999999999


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC--CCcEEEeccccCC----------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE--DMVAHLSDFEYGM----------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~--~~~~kl~df~~~~----------  344 (453)
                      |+|.+.+......++......++.|+++||.||   |+.+|+||||||+|||++.  ...+||+|||.+.          
T Consensus        86 g~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~  162 (321)
T d1tkia_          86 LDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence            999999987666789999999999999999999   7889999999999999985  4589999998652          


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++||||+||++|||++|+.||......+                 ++.............
T Consensus       163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----------------~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----------------IIENIMNAEYTFDEE  225 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HHHHHHHTCCCCCHH
T ss_pred             cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhCCCCCChh
Confidence                          2346778999999999999999999997542211                 111111111111112


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+++++.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22345678899999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-45  Score=348.48  Aligned_cols=228  Identities=22%  Similarity=0.419  Sum_probs=185.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCC----EEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGI----EVAVKVFHQE-CARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~  271 (453)
                      |++.+.||+|+||+||+|.+. +|+    .||||.++.. .....++|.+|+++|++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            466789999999999999875 443    6899988654 334567899999999999999999999999875 467889


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+.+|+|.+.+......+++..++.++.|+++||.||   |+++|+||||||+|||++.++.+||+|||++.       
T Consensus        90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            99999999999888777899999999999999999999   77899999999999999999999999997541       


Q ss_pred             --------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhc
Q 036792          345 --------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLS  403 (453)
Q Consensus       345 --------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  403 (453)
                                          .+.++.++|||||||++|||+| |.+||+.....+  +...            +..    
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~------------i~~----  228 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI------------LEK----  228 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHH------------HHH----
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHH------------HHc----
Confidence                                1346789999999999999999 788887543222  1111            111    


Q ss_pred             CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          404 GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      +.  +.+.+..+++++.+|+.+||+.||++||||+|+++.|.++..
T Consensus       229 ~~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         229 GE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             TC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC--CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            11  122345677889999999999999999999999999988854

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=343.18  Aligned_cols=233  Identities=27%  Similarity=0.436  Sum_probs=185.0

Q ss_pred             HHHHHhcccCCCCccEEEEEEECC--------CCEEEEEEeeccch-hhHHHHHHHHHHHHcC-CCCCceeEEeEEecCC
Q 036792          196 TLRRLSNLIGMGSFGSVYRARLRD--------GIEVAVKVFHQECA-RALKSFEAQCEVMKSI-RHPNLVKVISSCSNDD  265 (453)
Q Consensus       196 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  265 (453)
                      ..+++.+.||+|+||.||+|+..+        +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            345667899999999999998532        24799999976643 4457889999998888 8999999999999999


Q ss_pred             eeEEEEeccCCCCchHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeC
Q 036792          266 FKALVLEYMPKGSLENCLYSST---------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLD  330 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~  330 (453)
                      ..++||||+++|+|.+++....               ..+++..++.++.|+++||.||   |+.+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh---hhCCEEeeeecccceeec
Confidence            9999999999999999996543               3578999999999999999999   889999999999999999


Q ss_pred             CCCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHH
Q 036792          331 EDMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLK  382 (453)
Q Consensus       331 ~~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~  382 (453)
                      .++.+||+|||.+.                           .+.++.++|||||||++|||++ |.+||......+  +.
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~~  247 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LF  247 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--HH
Confidence            99999999997642                           1357789999999999999998 688876543221  11


Q ss_pred             hHHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          383 DWVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       383 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      ..+.                .+  .+.+.+..+++++.+|+.+||+.||++||||.||++.|++|..-.
T Consensus       248 ~~i~----------------~~--~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~  298 (299)
T d1fgka_         248 KLLK----------------EG--HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  298 (299)
T ss_dssp             HHHH----------------TT--CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHH----------------cC--CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence            1111                11  112233456778999999999999999999999999999986643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.7e-45  Score=341.55  Aligned_cols=231  Identities=21%  Similarity=0.347  Sum_probs=188.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----eeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----FKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l  269 (453)
                      |++.+.||+|+||.||+|+.. +|+.||||+++...   ....+.|.+|+++|+.++|||||++++++...+    ..|+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            567789999999999999975 79999999997553   234567999999999999999999999987644    4789


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC------
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG------  343 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~------  343 (453)
                      ||||+++|+|.+.+.... .+++.....++.|+++||.||   |+++|+||||||+|||++.++..+++||+..      
T Consensus        89 vmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            999999999998886644 588999999999999999999   7889999999999999999999999999643      


Q ss_pred             ----------------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh
Q 036792          344 ----------------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL  401 (453)
Q Consensus       344 ----------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  401 (453)
                                            ....++.++||||+||++|||+||++||......+.                 ....+
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----------------~~~~~  227 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----------------AYQHV  227 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------------HHHHH
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----------------HHHHH
Confidence                                  123578899999999999999999999975422211                 11111


Q ss_pred             hcCccCCchhhHHHHHHHHHHhhhccccCcccCC-ChHHHHHHHHHHHH
Q 036792          402 LSGEKKGFVAKEQCVLSILGLAMECAMELPEKRI-NAKDIVTRLLKIRD  449 (453)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~  449 (453)
                      .............+++++.+++.+||+.||++|| |++++...|.+++.
T Consensus       228 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             hcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1111111122235667899999999999999999 89999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=343.20  Aligned_cols=234  Identities=23%  Similarity=0.350  Sum_probs=188.4

Q ss_pred             HHHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecCCeeE
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  268 (453)
                      .+++.+.||+|+||.||+|+++      +++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+++..+
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~  103 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence            4456789999999999999852      45789999997654 34556899999999998 6999999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC
Q 036792          269 LVLEYMPKGSLENCLYSST-----------------CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE  331 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~  331 (453)
                      +|||||++|+|.++++...                 ..+++..+..++.|+++|+.||   |+++++||||||+||+++.
T Consensus       104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEET
T ss_pred             EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccccccccccc
Confidence            9999999999999986532                 2578889999999999999999   7889999999999999999


Q ss_pred             CCcEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHh-CCCCCCccccccccHHh
Q 036792          332 DMVAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFT-RKKPTDRMFVEELSLKD  383 (453)
Q Consensus       332 ~~~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~  383 (453)
                      ++.+|++|||.+.                           ...++.++|||||||++|||+| |.+|+..... ...+.+
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-~~~~~~  259 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSKFYK  259 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SHHHHH
T ss_pred             cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-HHHHHH
Confidence            9999999997652                           1346778999999999999999 4555543321 111222


Q ss_pred             HHhhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHhc
Q 036792          384 WVNNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTLS  452 (453)
Q Consensus       384 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~  452 (453)
                      .+...            .      +...+..++.++.+|+.+||+.||++||||+||++.|+++-.+.+
T Consensus       260 ~i~~~------------~------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         260 MIKEG------------F------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             HHHHT------------C------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHhcC------------C------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence            22111            1      112234566789999999999999999999999999998766643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=342.81  Aligned_cols=227  Identities=22%  Similarity=0.375  Sum_probs=185.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      +++.+.||+|+||.||+|.++      +++.||||+++... ......|.+|++++++++|||||+++|+|..++..++|
T Consensus        22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv  101 (308)
T d1p4oa_          22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  101 (308)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence            356788999999999999864      35789999997543 34456799999999999999999999999999999999


Q ss_pred             EeccCCCCchHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          271 LEYMPKGSLENCLYSS---------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      |||+++|+|.+++...         ...+++..+..++.++++||.||   |+++|+||||||+|||+++++++||+|||
T Consensus       102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~~NiLld~~~~~Kl~DFG  178 (308)
T d1p4oa_         102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFG  178 (308)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeeceEcCCceeecCCceEEEeecc
Confidence            9999999999987532         23568889999999999999999   77899999999999999999999999998


Q ss_pred             cCC---------------------------CCCcCcccchHHHHHHHHHHHhCC-CCCCccccccccHHhHHhhhcCCch
Q 036792          342 YGM---------------------------EGQVSTRSDIYGYGIVLMETFTRK-KPTDRMFVEELSLKDWVNNLLPISL  393 (453)
Q Consensus       342 ~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~  393 (453)
                      ++.                           ...++.++|||||||++|||+||. +||......     +...       
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-----~~~~-------  246 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLR-------  246 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----HHHH-------
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-----HHHH-------
Confidence            763                           134677899999999999999985 666543221     1111       


Q ss_pred             hhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHH
Q 036792          394 MEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKI  447 (453)
Q Consensus       394 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i  447 (453)
                           ... .+  ...+.+..+++++.+++.+||+.+|++||||+||++.|++.
T Consensus       247 -----~i~-~~--~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         247 -----FVM-EG--GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             -----HHH-TT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -----HHH-hC--CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                 111 11  11223456778899999999999999999999999998765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-44  Score=339.82  Aligned_cols=232  Identities=21%  Similarity=0.370  Sum_probs=177.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC------CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCceeEEeEEecC-CeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR------DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSI-RHPNLVKVISSCSND-DFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~  268 (453)
                      +++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|...+.++ +|+|||.+++++..+ +..+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            566789999999999999864      24689999997553 34456788888888776 689999999998764 4689


Q ss_pred             EEEeccCCCCchHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC
Q 036792          269 LVLEYMPKGSLENCLYSS---------------TCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM  333 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~  333 (453)
                      +|||||++|+|.+++...               ...+++..+..++.|+++||.||   |+++|+||||||+|||+++++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---HhCCCcCCcCCccceeECCCC
Confidence            999999999999998643               23478889999999999999999   788999999999999999999


Q ss_pred             cEEEeccccCC---------------------------CCCcCcccchHHHHHHHHHHHhCC-CCCCccccccccHHhHH
Q 036792          334 VAHLSDFEYGM---------------------------EGQVSTRSDIYGYGIVLMETFTRK-KPTDRMFVEELSLKDWV  385 (453)
Q Consensus       334 ~~kl~df~~~~---------------------------~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~  385 (453)
                      .+||+|||++.                           ...++.++|||||||++|||+||. +||......+. +...+
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~~~~~  250 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRL  250 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHHHH
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-HHHHH
Confidence            99999998752                           124577899999999999999975 56754322111 11111


Q ss_pred             hhhcCCchhhhhhhhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHHh
Q 036792          386 NNLLPISLMEVVDKTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDTL  451 (453)
Q Consensus       386 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~  451 (453)
                      .                .+.  +...+..+++++.+++.+||+.||++||||+|+++.|+++.+.-
T Consensus       251 ~----------------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         251 K----------------EGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             H----------------HTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             h----------------cCC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            1                111  12233456778999999999999999999999999999986653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-43  Score=336.65  Aligned_cols=220  Identities=21%  Similarity=0.306  Sum_probs=181.7

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||+++...   ....+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            456788999999999999976 69999999997543   23457899999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      |++|+|...+.... .++......++.|++.|+.||   |+++|+||||||+|||++.++.+||+|||++.         
T Consensus        86 ~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~  161 (316)
T d1fota_          86 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  161 (316)
T ss_dssp             CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             cCCccccccccccc-cccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEEEecCccceEeccccccc
Confidence            99999998887654 567778888999999999999   89999999999999999999999999998652         


Q ss_pred             -------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCchh
Q 036792          345 -------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFVA  411 (453)
Q Consensus       345 -------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  411 (453)
                                   ...++.++||||+||++|||+||+.||......+                 .........    ...
T Consensus       162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----------------~~~~i~~~~----~~~  220 (316)
T d1fota_         162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----------------TYEKILNAE----LRF  220 (316)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HHHHHHHCC----CCC
T ss_pred             cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-----------------HHHHHHcCC----CCC
Confidence                         2457889999999999999999999997542211                 111111111    112


Q ss_pred             hHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          412 KEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       412 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      +...++++.+++.+||+.||++||     |++|+++
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            234566789999999999999996     8888864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-43  Score=336.28  Aligned_cols=220  Identities=23%  Similarity=0.320  Sum_probs=181.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~  273 (453)
                      |++.+.||+|+||.||+|+.+ +|+.||||++++..   ....+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            355688999999999999975 79999999998653   23457789999999999999999999999999999999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC---------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM---------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~---------  344 (453)
                      |++|+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.         
T Consensus        87 ~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          87 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             cCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            99999999887654 577888888999999999999   88999999999999999999999999998652         


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCC
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKG  408 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  408 (453)
                                      ...++.++||||+||++|||++|++||......+.                 ........    
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----------------~~~i~~~~----  221 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----------------FELILMEE----  221 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHCC----
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-----------------HHHHhcCC----
Confidence                            23578899999999999999999999975432211                 11111110    


Q ss_pred             chhhHHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          409 FVAKEQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       409 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      ...+..+++++.+|+.+||+.||++||+     ++|+++
T Consensus       222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1123346678899999999999999995     777764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-43  Score=333.17  Aligned_cols=241  Identities=22%  Similarity=0.231  Sum_probs=177.0

Q ss_pred             HHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          199 RLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++.+.||+|+||+||+|++. +|+.||||+++....  ...+.+.+|+++|++++|||||++++++.+++..++||||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence            45678999999999999975 799999999975432  234688999999999999999999999999999999999997


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----------  344 (453)
                      ++.+..........+++.....++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.           
T Consensus        85 ~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~  161 (298)
T d1gz8a_          85 QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  161 (298)
T ss_dssp             EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred             CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence            6544433344455689999999999999999999   78999999999999999999999999997541           


Q ss_pred             ---------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC-chhhhhhh---hhhcCc
Q 036792          345 ---------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI-SLMEVVDK---TLLSGE  405 (453)
Q Consensus       345 ---------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~---~~~~~~  405 (453)
                                     ...++.++||||+||++|||++|+.||......+.....+.....+. .....+..   ......
T Consensus       162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP  241 (298)
T ss_dssp             CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred             ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence                           12346789999999999999999999975432221111111111111 00000000   000000


Q ss_pred             c-CC---chhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 K-KG---FVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~-~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      . ..   .......++++.+|+.+||..||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0 00   0111234567899999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6e-43  Score=330.89  Aligned_cols=239  Identities=20%  Similarity=0.209  Sum_probs=182.0

Q ss_pred             HHhcccCCCCccEEEEEEECCCCEEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccCC
Q 036792          199 RLSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA--RALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMPK  276 (453)
Q Consensus       199 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~~  276 (453)
                      ++.+.||+|+||+||+|++++|+.||||+++....  ...+.+.+|+.+|++++|||||++++++.+++..++++||+.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence            45678999999999999999999999999976532  2357899999999999999999999999999999999999987


Q ss_pred             CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------------
Q 036792          277 GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------------  344 (453)
Q Consensus       277 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------------  344 (453)
                      +.+..+. .....++......++.|+++||+||   |+.+|+||||||+|||++.++.+|++|||.+.            
T Consensus        85 ~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          85 DLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             EHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             hhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            6665544 4445789999999999999999999   78899999999999999999999999997531            


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---chhhhh-----hhhhh
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SLMEVV-----DKTLL  402 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----d~~~~  402 (453)
                                    ...++.++||||+||++|||++|+.||.+....+. +.+........   .+.+..     +....
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcccccc
Confidence                          13457899999999999999999999976533222 11111111110   011100     00000


Q ss_pred             c-CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 S-GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      . ............++++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 000111222345678899999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-43  Score=335.33  Aligned_cols=219  Identities=22%  Similarity=0.330  Sum_probs=178.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHH-cCCCCCceeEEeEEecCCeeEEEEe
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMK-SIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      |++.+.||+|+||+||+|+++ +|+.||||++++..   ....+.+..|..++. .++|||||++++++.+++..|+|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            345788999999999999976 68999999997643   234466777777765 6899999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      ||++|+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||+++++.+||+|||.+.        
T Consensus        84 y~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          84 YLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             ecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            999999999987644 578888999999999999999   78899999999999999999999999997652        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccC
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKK  407 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  407 (453)
                                       ...++.++||||+||++|||+||+.||.+....+.                 ...... .   
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----------------~~~i~~-~---  218 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----------------FHSIRM-D---  218 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHH-C---
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHc-C---
Confidence                             23578899999999999999999999975432211                 111111 1   


Q ss_pred             CchhhHHHHHHHHHHhhhccccCcccCCChH-HHH
Q 036792          408 GFVAKEQCVLSILGLAMECAMELPEKRINAK-DIV  441 (453)
Q Consensus       408 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-~v~  441 (453)
                      ....+..+++++.+|+.+||+.||++|||+. |++
T Consensus       219 ~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            0112334567899999999999999999995 664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-43  Score=331.99  Aligned_cols=236  Identities=22%  Similarity=0.257  Sum_probs=173.4

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeeccchh-----hHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEeccC
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQECAR-----ALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      ++||+|+||+||+|+.+ +|+.||||+++.....     ..+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            67999999999999975 6999999999754321     12468899999999999999999999999999999999998


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCCC----------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGME----------  345 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~----------  345 (453)
                      ++++.... .....++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||.+..          
T Consensus        84 ~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          84 TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             EEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred             chHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence            87666544 3344677788889999999999999   789999999999999999999999999986521          


Q ss_pred             ----------------CCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---chhhhhhhhh--hcC
Q 036792          346 ----------------GQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SLMEVVDKTL--LSG  404 (453)
Q Consensus       346 ----------------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~~--~~~  404 (453)
                                      ..++.++|||||||++|||+||.+||......+. +....+.....   .+.+......  ...
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccchhhhhc
Confidence                            2357789999999999999999999975432221 11111111000   0000000000  000


Q ss_pred             ccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          405 EKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       405 ~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+..   ......++++.+|+.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000   011234567999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-42  Score=338.50  Aligned_cols=223  Identities=18%  Similarity=0.222  Sum_probs=176.9

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch---hhHHHHH---HHHHHHHcCCCCCceeEEeEEecCCeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA---RALKSFE---AQCEVMKSIRHPNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~lv  270 (453)
                      |++.+.||+|+||.||+|+.+ +|+.||||++.....   .....+.   +|+++++.++|||||++++++.+++..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            456788999999999999976 699999999975432   1122333   456778888999999999999999999999


Q ss_pred             EeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC------
Q 036792          271 LEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM------  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~------  344 (453)
                      |||+++|+|.+++.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.      
T Consensus        86 mE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  161 (364)
T ss_dssp             ECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred             EEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence            99999999999987643 577888899999999999999   88999999999999999999999999998652      


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCcc
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEK  406 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  406 (453)
                                        ...++.++|||||||++|||+||+.||......+.  .......            . ..  
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~------------~-~~--  224 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMT------------L-TM--  224 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHS------------S-SC--
T ss_pred             ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhc------------c-cC--
Confidence                              12468899999999999999999999975432211  1111100            0 00  


Q ss_pred             CCchhhHHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          407 KGFVAKEQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       407 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                       ....+..+++++.+|+.+||+.||++|||     ++|+++
T Consensus       225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             11123345678999999999999999999     577763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-42  Score=335.19  Aligned_cols=221  Identities=19%  Similarity=0.252  Sum_probs=182.9

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEe
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC---ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLE  272 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E  272 (453)
                      .|++.+.||+|+||.||+|+++ +|+.||||+++...   ....+.+.+|+++|+.++|||||++++++.+....++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            3567789999999999999986 79999999997543   2345778999999999999999999999999999999999


Q ss_pred             ccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC--------
Q 036792          273 YMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM--------  344 (453)
Q Consensus       273 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~--------  344 (453)
                      |+.+|+|.+.+.... .++......++.|++.||.||   |+++|+||||||+|||++.++.+||+|||++.        
T Consensus       122 ~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~  197 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT  197 (350)
T ss_dssp             CCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred             cccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence            999999999887644 588899999999999999999   78899999999999999999999999998652        


Q ss_pred             --------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCccCCch
Q 036792          345 --------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGEKKGFV  410 (453)
Q Consensus       345 --------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  410 (453)
                                    ...++.++|||||||++|||+||+.||.......                 .........    ..
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----------------~~~~i~~~~----~~  256 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----------------IYEKIVSGK----VR  256 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHCC----CC
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-----------------HHHHHhcCC----CC
Confidence                          2457889999999999999999999997542111                 111111110    11


Q ss_pred             hhHHHHHHHHHHhhhccccCcccCC-----ChHHHHH
Q 036792          411 AKEQCVLSILGLAMECAMELPEKRI-----NAKDIVT  442 (453)
Q Consensus       411 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~~v~~  442 (453)
                      .+..+++++.+++.+||+.||++|+     |++|+++
T Consensus       257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            2234567889999999999999994     8998874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-42  Score=329.28  Aligned_cols=220  Identities=16%  Similarity=0.259  Sum_probs=173.1

Q ss_pred             hcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHc-CCCCCceeEEeEEec----CCeeEEEEecc
Q 036792          201 SNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKS-IRHPNLVKVISSCSN----DDFKALVLEYM  274 (453)
Q Consensus       201 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~lv~E~~  274 (453)
                      .+.||+|+||.||+|+.. +++.||||+++..     +.+.+|++++.+ .+|||||++++++.+    ....|+|||||
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence            356999999999999975 7899999999643     456789988655 589999999999865    46689999999


Q ss_pred             CCCCchHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC------
Q 036792          275 PKGSLENCLYSST-CMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~------  344 (453)
                      ++|+|.+++.... ..+++.....++.|++.||.||   |+.+|+||||||+|||++.   ++.+||+|||++.      
T Consensus        92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCccccccccccccccccccccccccccceeeeccCCC
Confidence            9999999997653 4688999999999999999999   7899999999999999985   5679999998652      


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhhcCc-
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLLSGE-  405 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-  405 (453)
                                        ...++.++||||+||++|||+||++||.+......  ...            +...+.... 
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~------------~~~~i~~~~~  234 (335)
T d2ozaa1         169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPG------------MKTRIRMGQY  234 (335)
T ss_dssp             CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------------CCCSCSS
T ss_pred             ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHH------------HHHHHhcCCC
Confidence                              12467889999999999999999999965422111  000            000011111 


Q ss_pred             cCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          406 KKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       406 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+.+....+++++.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1112233467788999999999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=316.28  Aligned_cols=241  Identities=19%  Similarity=0.196  Sum_probs=182.0

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCCeeEEEEecc
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDDFKALVLEYM  274 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~E~~  274 (453)
                      |++.+.||+|+||+||+|++. +++.||||+++...  ....+++.+|+.+|+.++|||||++++++.+.+..++|+|++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~   83 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence            345678999999999999975 78999999997543  344678999999999999999999999999999999999999


Q ss_pred             CCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----------
Q 036792          275 PKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----------  344 (453)
Q Consensus       275 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----------  344 (453)
                      .++++..++... ..++......++.|++.||+||   |+++|+||||||+|||++.++.+|++|||.+.          
T Consensus        84 ~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          84 DQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             SEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             cccccccccccc-cccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            998888776654 4678888899999999999999   78899999999999999999999999997652          


Q ss_pred             ----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC---ch---hhhhhhh--
Q 036792          345 ----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI---SL---MEVVDKT--  400 (453)
Q Consensus       345 ----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~d~~--  400 (453)
                                      ...++.++||||+||++|||++|+.||.........+........+.   ..   ....+..  
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence                            12357889999999999999999999643222111111111111110   00   0000000  


Q ss_pred             -hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          401 -LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       401 -~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ...............++++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000001111222345667899999999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-42  Score=321.81  Aligned_cols=214  Identities=18%  Similarity=0.250  Sum_probs=172.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccch------hhHHHHHHHHHHHHcCC--CCCceeEEeEEecCCeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECA------RALKSFEAQCEVMKSIR--HPNLVKVISSCSNDDFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~  268 (453)
                      |++.+.||+|+||.||+|+.. +|+.||||+++....      ....++.+|+.+|++++  |||||++++++.+++..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            567789999999999999975 799999999975421      12234678999999986  899999999999999999


Q ss_pred             EEEeccCC-CCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-CCcEEEeccccCCC-
Q 036792          269 LVLEYMPK-GSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-DMVAHLSDFEYGME-  345 (453)
Q Consensus       269 lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-~~~~kl~df~~~~~-  345 (453)
                      +||||+.+ +++.+++... ..+++.....++.|+++||.||   |+++|+||||||+|||++. ++.+||+|||.+.. 
T Consensus        86 lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            99999976 5677766553 3688899999999999999999   7899999999999999985 47999999987521 


Q ss_pred             ----------------------CC-cCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhhh
Q 036792          346 ----------------------GQ-VSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTLL  402 (453)
Q Consensus       346 ----------------------~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  402 (453)
                                            .. ++.++||||+||++|||+||+.||....       ....            ... 
T Consensus       162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~------------~~~-  221 (273)
T d1xwsa_         162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR------------GQV-  221 (273)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH------------CCC-
T ss_pred             ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhh------------ccc-
Confidence                                  12 2456899999999999999999996421       0000            000 


Q ss_pred             cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          403 SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                             ..+...++++.+|+.+||+.||++|||++|+++
T Consensus       222 -------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 -------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   011234567899999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=321.17  Aligned_cols=240  Identities=17%  Similarity=0.165  Sum_probs=174.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC----eeEEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC-ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD----FKALVL  271 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~  271 (453)
                      |++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+++|++++|||||++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            566789999999999999865 79999999997543 345678999999999999999999999987643    234555


Q ss_pred             eccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-------
Q 036792          272 EYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-------  344 (453)
Q Consensus       272 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-------  344 (453)
                      ||+.+|+|.+++...  .+++.....++.|+++||+||   |+++|+||||||+|||++.++.+||+|||++.       
T Consensus        90 ~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          90 THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            667799999999764  488999999999999999999   78899999999999999999999999997641       


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCch-------hh
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISL-------ME  395 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~  395 (453)
                                            ...++.++||||+||++|||++|+.||......+...........+...       ..
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence                                  1234678999999999999999999997543222111110000011000       00


Q ss_pred             hhhhhhhcCccCCc---hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTLLSGEKKGF---VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+...........   ......+.++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000000001   111233467899999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-41  Score=319.04  Aligned_cols=241  Identities=21%  Similarity=0.258  Sum_probs=175.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-C-CCEEEEEEeeccch--hhHHHHHHHHHHHHcC---CCCCceeEEeEEec-----CC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-D-GIEVAVKVFHQECA--RALKSFEAQCEVMKSI---RHPNLVKVISSCSN-----DD  265 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~  265 (453)
                      |++.+.||+|+||+||+|++. + ++.||||+++....  .....+.+|+.+|+.+   +|||||+++++|..     ..
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            566788999999999999974 4 67799999975432  2223456777776655   89999999999853     34


Q ss_pred             eeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-
Q 036792          266 FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-  344 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-  344 (453)
                      ..+++|||+.+|++..........+++.....++.|++.||+||   |+++|+||||||+|||++.++.+||+|||.+. 
T Consensus        89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            68999999998877665555566788888899999999999999   78899999999999999999999999997642 


Q ss_pred             -----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC--chhhh--
Q 036792          345 -----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI--SLMEV--  396 (453)
Q Consensus       345 -----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~--  396 (453)
                                             ...++.++||||+||++|||+||++||......+ .+........ +.  .+...  
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGSCTTCS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchhccccccc
Confidence                                   2457889999999999999999999997653222 1111111111 00  00000  


Q ss_pred             -hhhhhhc-CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 -VDKTLLS-GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 -~d~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                       ....... ............++++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             0000000 000111122345667899999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=321.02  Aligned_cols=236  Identities=23%  Similarity=0.274  Sum_probs=171.8

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCceeEEeEEecC------CeeEEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVKVISSCSND------DFKALV  270 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~lv  270 (453)
                      |+..++||+|+||+||+|++. +|+.||||+++....    .+.+|+++|++++|||||+++++|...      .+.++|
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            445678999999999999976 699999999976532    234799999999999999999998542      357899


Q ss_pred             EeccCCCCchHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC---
Q 036792          271 LEYMPKGSLENCLY--SSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM---  344 (453)
Q Consensus       271 ~E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~---  344 (453)
                      ||||++|.+.....  .....+++.....++.|+++||+||   |+++|+||||||+|||++.++ .+||+|||++.   
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            99998764333322  2345689999999999999999999   789999999999999999765 89999998642   


Q ss_pred             ----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhhh-
Q 036792          345 ----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKTL-  401 (453)
Q Consensus       345 ----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-  401 (453)
                                            ...++.++||||+||++|||++|++||......+. +....+.... ...+.+.... 
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~-~~~~~~~~~~~  252 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGT-PTREQIREMNP  252 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCC-CCHHHHHHHCC
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCC-ChHHhhhhhcc
Confidence                                  13467899999999999999999999975432211 1111111110 0001110000 


Q ss_pred             --hcC-----ccC--CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          402 --LSG-----EKK--GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       402 --~~~-----~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        ...     ...  ........++++.+|+.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000     000  00112235667899999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-40  Score=319.70  Aligned_cols=238  Identities=22%  Similarity=0.241  Sum_probs=173.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecCC------eeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSNDD------FKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~  268 (453)
                      |++.+.||+|+||+||+|..+ +|+.||||+++...  ....+.+.+|+++|++++|||||+++++|...+      ..+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            566788999999999999975 69999999997542  344578899999999999999999999997654      569


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      +||||+ +++|.......  .++......++.|++.||.||   |+++|+||||||+|||++.++.+|++|||.+.    
T Consensus       100 lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             EEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhhcccccccccccccceeccCC
Confidence            999999 56777766543  588999999999999999999   78999999999999999999999999997652    


Q ss_pred             -------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhh--cCCchhh--------
Q 036792          345 -------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNL--LPISLME--------  395 (453)
Q Consensus       345 -------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~--------  395 (453)
                                         ...++.++||||+||++|||++|++||......+. +.......  .+....+        
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  252 (346)
T d1cm8a_         174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQRLQSDEAK  252 (346)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred             ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhhhcchhhh
Confidence                               12357899999999999999999999976432211 11111111  1110000        


Q ss_pred             hhhhhhhcCccC-CchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          396 VVDKTLLSGEKK-GFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       396 ~~d~~~~~~~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ............ ........++++.+|+.+||..||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000001000000 11122344567899999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=320.04  Aligned_cols=224  Identities=23%  Similarity=0.281  Sum_probs=178.2

Q ss_pred             HHHhcccCCCCccEEEEEEEC----CCCEEEEEEeeccc----hhhHHHHHHHHHHHHcCCC-CCceeEEeEEecCCeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR----DGIEVAVKVFHQEC----ARALKSFEAQCEVMKSIRH-PNLVKVISSCSNDDFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~  268 (453)
                      |++.+.||+|+||+||+|+..    +|+.||||.++...    ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            567889999999999999852    47899999986542    2334678899999999976 89999999999999999


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM----  344 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~----  344 (453)
                      ++|||+.+|+|.+.+.... .+.......++.|++.|+.|+   |+++|+||||||+|||++.++.+||+|||++.    
T Consensus       106 ~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             eeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999999887654 456677888899999999999   78899999999999999999999999997641    


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ...++.++||||+||++|||+||+.||......+.... ..            ...
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~------------~~~  248 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-IS------------RRI  248 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HH------------HHH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH------------Hhc
Confidence                                    12356789999999999999999999976533322111 11            111


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCC-----hHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRIN-----AKDIVT  442 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~~v~~  442 (453)
                      ...    ..+.+..+++++.+|+.+||++||++|||     ++|+++
T Consensus       249 ~~~----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 LKS----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ccC----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            110    11223456788999999999999999994     788764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-39  Score=309.71  Aligned_cols=241  Identities=22%  Similarity=0.272  Sum_probs=173.8

Q ss_pred             HHHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec--------CC
Q 036792          197 LRRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN--------DD  265 (453)
Q Consensus       197 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~  265 (453)
                      -|++.+.||+|+||+||+|++. +|+.||||++....  ....+++.+|+++|++++||||+++++++..        ++
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            3567789999999999999975 79999999986542  2344678999999999999999999998865        34


Q ss_pred             eeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-
Q 036792          266 FKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-  344 (453)
Q Consensus       266 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-  344 (453)
                      ..++||||++++.+.. .......++......++.|++.||.||   |+++|+||||||+|||++.++.+|++|||++. 
T Consensus        91 ~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          91 SIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence            5799999998766554 344444677888889999999999999   78999999999999999999999999998651 


Q ss_pred             -----------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh--hhcCCch
Q 036792          345 -----------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN--NLLPISL  393 (453)
Q Consensus       345 -----------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~  393 (453)
                                                   ...++.++||||+||++|||++|+.||+.....+. .....+  ...+...
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTT
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCCChhh
Confidence                                         12467899999999999999999999975432211 111111  1111111


Q ss_pred             hhhhh-----hhhhcCccCCchh-----hHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          394 MEVVD-----KTLLSGEKKGFVA-----KEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       394 ~~~~d-----~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ....+     .............     .....+++.+|+.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00000     0000000111111     1123457789999999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-39  Score=309.22  Aligned_cols=233  Identities=20%  Similarity=0.211  Sum_probs=177.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcee-EEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNLVK-VISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||.||+|++. +|+.||||++.....  .+++.+|+++++.++|+|+|. +.++..+++..++||||+ 
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            567789999999999999975 689999999876532  245788999999998776555 455567788899999999 


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC---CCcEEEeccccCC--------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE---DMVAHLSDFEYGM--------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~---~~~~kl~df~~~~--------  344 (453)
                      +|++.+.+......+++.....++.|++.||+||   |+++|+||||||+|||++.   +..+|++|||++.        
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            5677777766666789999999999999999999   7899999999999999753   5679999998652        


Q ss_pred             ------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhhhh
Q 036792          345 ------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVDKT  400 (453)
Q Consensus       345 ------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  400 (453)
                                              ...++.++|||||||++|||+||+.||............ .         ......
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-~---------~~~~~~  232 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-E---------RISEKK  232 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H-H---------HHHHHH
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH-H---------Hhhccc
Confidence                                    123577899999999999999999999764332211110 0         000000


Q ss_pred             hhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHH
Q 036792          401 LLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRD  449 (453)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~  449 (453)
                      ...   +.......+++++.+++..||+.+|++||+++++.+.|+++..
T Consensus       233 ~~~---~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         233 MST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHS---CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCC---ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            000   0011223567889999999999999999999999999988744

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-39  Score=314.97  Aligned_cols=239  Identities=21%  Similarity=0.216  Sum_probs=176.6

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEecC-----CeeEE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSND-----DFKAL  269 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l  269 (453)
                      |++.+.||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|+++|++++|||+|++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            567789999999999999975 79999999997553  33456789999999999999999999998643     34467


Q ss_pred             EEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccCC-----
Q 036792          270 VLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYGM-----  344 (453)
Q Consensus       270 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~-----  344 (453)
                      ++||+.+|+|.+++...  .++......++.|++.||.||   |+++|+||||||+|||++.++.+|++|||.+.     
T Consensus       100 i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             EEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             EEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCccccccccccccccccchhcccCcc
Confidence            77888899999988654  588999999999999999999   78899999999999999999999999997642     


Q ss_pred             ------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhc-CC-chh--------hh
Q 036792          345 ------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLL-PI-SLM--------EV  396 (453)
Q Consensus       345 ------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~--------~~  396 (453)
                                        ...++.++||||+||++|||++|++||.+...... ......... +. ...        ..
T Consensus       175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKISSESARN  253 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred             cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhccchhhhh
Confidence                              12357899999999999999999999975422211 111111110 00 000        00


Q ss_pred             hhhhhhcCccCCc-hhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          397 VDKTLLSGEKKGF-VAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       397 ~d~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ............. ......++++.+|+.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0000000000000 111234667899999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5e-39  Score=309.78  Aligned_cols=235  Identities=17%  Similarity=0.225  Sum_probs=174.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEec--CCeeEEEEec
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSN--DDFKALVLEY  273 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~E~  273 (453)
                      |++.+.||+|+||+||+|+.. +|+.||||+++...   .+++.+|+++|++++ ||||+++++++..  ....++||||
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            567889999999999999975 78999999997543   467889999999995 9999999999875  4568999999


Q ss_pred             cCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC-cEEEeccccCC--------
Q 036792          274 MPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM-VAHLSDFEYGM--------  344 (453)
Q Consensus       274 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~-~~kl~df~~~~--------  344 (453)
                      +++|+|.+...    .++......++.|++.||.||   |+++|+||||||+|||++.++ .+||+|||.+.        
T Consensus       114 ~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         114 VNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             CCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             cCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence            99999976542    578888999999999999999   789999999999999998654 68999998652        


Q ss_pred             -----------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHh------------hhcCC---c
Q 036792          345 -----------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVN------------NLLPI---S  392 (453)
Q Consensus       345 -----------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~------------~~~~~---~  392 (453)
                                       ...++.++||||+||++|||++|+.||...............            .....   .
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence                             123578899999999999999999998643221111111000            00000   0


Q ss_pred             hhhhhhhhhhc--CccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          393 LMEVVDKTLLS--GEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       393 ~~~~~d~~~~~--~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      ..+........  ............++++.+|+.+||..||++|||++|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000000  000111122345678999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=309.74  Aligned_cols=237  Identities=20%  Similarity=0.182  Sum_probs=175.4

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCceeEEeEEec------CCeeE
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQEC--ARALKSFEAQCEVMKSIRHPNLVKVISSCSN------DDFKA  268 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~  268 (453)
                      |++.++||+|+||+||+|++. +|+.||||+++...  ....+++.+|+.+|++++|||||++++++..      ....|
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            566789999999999999976 69999999998653  3445678999999999999999999999864      36789


Q ss_pred             EEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccccC-----
Q 036792          269 LVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFEYG-----  343 (453)
Q Consensus       269 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~-----  343 (453)
                      +||||+.++ +.+.+..   .++......++.|++.||.||   |+++|+||||||+|||++.++.+|++||+..     
T Consensus        99 iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          99 LVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHh---hhcccccccCCccccccccccceeeechhhhhcccc
Confidence            999999765 4444432   478888999999999999999   7889999999999999999999999999653     


Q ss_pred             -------------------CCCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCC----------chh
Q 036792          344 -------------------MEGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPI----------SLM  394 (453)
Q Consensus       344 -------------------~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~  394 (453)
                                         ....++.++||||+||++|||++|++||....... ............          ...
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHHhhhhHH
Confidence                               23457889999999999999999999997542211 111111111000          000


Q ss_pred             hhhhhhhh------------cCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          395 EVVDKTLL------------SGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       395 ~~~d~~~~------------~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                      +..+....            .............++++.+|+.+|+..||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            01110000            0000111233456788999999999999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-38  Score=301.27  Aligned_cols=234  Identities=14%  Similarity=0.116  Sum_probs=184.3

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC-CCceeEEeEEecCCeeEEEEeccC
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIRH-PNLVKVISSCSNDDFKALVLEYMP  275 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~E~~~  275 (453)
                      |++.+.||+|+||+||+|++. +|+.||||+++....  .+.+.+|++.++.++| +|++.+++++..+...++||||+ 
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            456788999999999999976 689999999865432  2356788889999876 89999999999999999999999 


Q ss_pred             CCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCC-----CCcEEEeccccCC------
Q 036792          276 KGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDE-----DMVAHLSDFEYGM------  344 (453)
Q Consensus       276 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~-----~~~~kl~df~~~~------  344 (453)
                      +|+|.+++......++......++.+++.||.||   |+++|+||||||+|||++.     ++.+||+|||++.      
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            6899999887777789999999999999999999   8999999999999999974     5689999998652      


Q ss_pred             --------------------------CCCcCcccchHHHHHHHHHHHhCCCCCCccccccccHHhHHhhhcCCchhhhhh
Q 036792          345 --------------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEELSLKDWVNNLLPISLMEVVD  398 (453)
Q Consensus       345 --------------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  398 (453)
                                                ...++.++|||||||++|||+||+.||..........  ...        .+.+
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~--------~i~~  230 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYE--------RIGE  230 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHH--------HHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHH--------HHHh
Confidence                                      1235678999999999999999999997543221110  000        0000


Q ss_pred             hhhhcCccCCchhhHHHHHHHHHHhhhccccCcccCCChHHHHHHHHHHHHH
Q 036792          399 KTLLSGEKKGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVTRLLKIRDT  450 (453)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~  450 (453)
                      .....   ........+|+++.+++..||+.+|++||+++.+.+.|+++.++
T Consensus       231 ~~~~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         231 KKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCCC---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            00000   00112234677899999999999999999999999999887654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=2.1e-33  Score=273.93  Aligned_cols=242  Identities=17%  Similarity=0.195  Sum_probs=167.5

Q ss_pred             HHHhcccCCCCccEEEEEEEC-CCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-----------CCCceeEEeEEec--
Q 036792          198 RRLSNLIGMGSFGSVYRARLR-DGIEVAVKVFHQECARALKSFEAQCEVMKSIR-----------HPNLVKVISSCSN--  263 (453)
Q Consensus       198 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~--  263 (453)
                      |++.+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.++           |+|||++++++..  
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            677899999999999999975 799999999986533 3467788998888775           5789999988765  


Q ss_pred             CCeeEEEEeccCCCCchHHh--hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCC------cE
Q 036792          264 DDFKALVLEYMPKGSLENCL--YSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDM------VA  335 (453)
Q Consensus       264 ~~~~~lv~E~~~~g~L~~~l--~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~------~~  335 (453)
                      ....+++++++..+......  ......++......++.+++.|+.|||  +..+|+||||||+|||++.++      .+
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCChhHeeeeccCccccccee
Confidence            45667777777665443322  233456778888899999999999995  357899999999999998654      38


Q ss_pred             EEeccccCC----------------------CCCcCcccchHHHHHHHHHHHhCCCCCCcccccc-----ccHHhHHhhh
Q 036792          336 HLSDFEYGM----------------------EGQVSTRSDIYGYGIVLMETFTRKKPTDRMFVEE-----LSLKDWVNNL  388 (453)
Q Consensus       336 kl~df~~~~----------------------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-----~~~~~~~~~~  388 (453)
                      +++|||.+.                      ...++.++||||+||+++||++|+.||.......     ..+...+...
T Consensus       172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~l  251 (362)
T d1q8ya_         172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL  251 (362)
T ss_dssp             EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred             eEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHh
Confidence            999997642                      2346789999999999999999999986432110     0111111110


Q ss_pred             --cCCchh-------hhhhhh-----hhcCcc--------CCchhhHHHHHHHHHHhhhccccCcccCCChHHHHH
Q 036792          389 --LPISLM-------EVVDKT-----LLSGEK--------KGFVAKEQCVLSILGLAMECAMELPEKRINAKDIVT  442 (453)
Q Consensus       389 --~~~~~~-------~~~d~~-----~~~~~~--------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~~v~~  442 (453)
                        .+....       ...+..     +.....        .........++++.+|+.+|++.||++|||++|+++
T Consensus       252 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              010000       000000     000000        001123456788999999999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=9.7e-23  Score=179.46  Aligned_cols=128  Identities=18%  Similarity=0.225  Sum_probs=100.6

Q ss_pred             HhcccCCCCccEEEEEEECCCCEEEEEEeeccch------------------hhHHHHHHHHHHHHcCCCCCceeEEeEE
Q 036792          200 LSNLIGMGSFGSVYRARLRDGIEVAVKVFHQECA------------------RALKSFEAQCEVMKSIRHPNLVKVISSC  261 (453)
Q Consensus       200 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~  261 (453)
                      +++.||+|+||.||+|...+|+.||||+++....                  .......+|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4678999999999999988999999998753210                  1123456788899999999999887653


Q ss_pred             ecCCeeEEEEeccCCCCchHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCceeeCCCCcEEEeccc
Q 036792          262 SNDDFKALVLEYMPKGSLENCLYSSTCMLDIFQRLNIMIDATSTLEYLYFGHTTPIIHCDLKPISVLLDEDMVAHLSDFE  341 (453)
Q Consensus       262 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L~~~h~~~i~Hrdlk~~NiLl~~~~~~kl~df~  341 (453)
                      .    .+++|||++++.+.+        ++......++.++++++.||   |+.+|+||||||+|||++++ .++++|||
T Consensus        84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             C----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCC-CEEEEECC
Confidence            2    379999998866543        22233456889999999999   78899999999999999965 58999999


Q ss_pred             cC
Q 036792          342 YG  343 (453)
Q Consensus       342 ~~  343 (453)
                      .+
T Consensus       148 ~a  149 (191)
T d1zara2         148 QS  149 (191)
T ss_dssp             TC
T ss_pred             Cc
Confidence            76

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.74  E-value=1.3e-18  Score=164.77  Aligned_cols=70  Identities=44%  Similarity=0.847  Sum_probs=61.8

Q ss_pred             CCCCcEEEcccccccccCchhhhcCCCCCEEECccCcccccccCCCcceeeccccccCCCCCCCCCCCCCCCC
Q 036792           62 VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGGPFVNFTAMSFKGNEPLCGSPNLQVPPC  134 (453)
Q Consensus        62 ~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~~~~~~~~~~~~gn~~l~~~~~~~~~~c  134 (453)
                      +++|+.|+|++|+++|.+|.+++++++|++|++++|+|+|.+|..+.+.++....+.+|..+||.|   .|+|
T Consensus       243 ~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---lp~c  312 (313)
T d1ogqa_         243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC  312 (313)
T ss_dssp             CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred             ccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC---CCCC
Confidence            357899999999999999999999999999999999999999987777888888889998888865   3555

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.49  E-value=2.4e-14  Score=125.04  Aligned_cols=102  Identities=29%  Similarity=0.395  Sum_probs=75.0

Q ss_pred             CccEEEcCCCcCcCCCC-cCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLS-LDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p-~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l   70 (453)
                      +++.|+|++|+|++.++ ..|.++++|+.|+|++|++++..+..+.++++|+.|+|++|++.         +++|+.|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            36677777777776553 44577777777777777777777777777777777777777763         567777777


Q ss_pred             ccccccccCchhhhcCCCCCEEECccCccccc
Q 036792           71 SNNEIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        71 ~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      ++|++++..|.+|..+++|+++++++|.+...
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CCccccccCHHHhcCCcccccccccccccccc
Confidence            77777776677777777777777777777543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.45  E-value=2.1e-13  Score=109.84  Aligned_cols=96  Identities=26%  Similarity=0.304  Sum_probs=85.6

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccccc
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNNEI   75 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n~~   75 (453)
                      +.|||++|+++ .++ .+.++++|++|+|++|.|+. +|+.++.+++|+.|++++|.++       +++|+.+++++|++
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l~~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCCGGGTTCSSCCEEECCSSCC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccccCccccccccCeEECCCCcc
Confidence            46999999999 455 59999999999999999985 8999999999999999999985       78999999999999


Q ss_pred             cccC-chhhhcCCCCCEEECccCcccc
Q 036792           76 YGLI-PTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        76 ~g~~-P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +... +..+..+++|+.+++++|+++.
T Consensus        78 ~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          78 QQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             CCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            8543 2578899999999999999865

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.35  E-value=1.7e-12  Score=113.04  Aligned_cols=101  Identities=25%  Similarity=0.257  Sum_probs=89.0

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCc-ccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMP-ATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p-~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      .+.++.++|+|+ .+|..+.  +++++|+|++|+|++.++ ..|+++++|+.|+|++|.+.         +++|+.|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            357899999999 7998775  689999999999998664 46799999999999999984         6799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILR  105 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~  105 (453)
                      +|++++..|..|..+++|+.|++++|.|++-.+.
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~  120 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG  120 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTT
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHH
Confidence            9999988888999999999999999999875443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=9e-12  Score=114.11  Aligned_cols=118  Identities=28%  Similarity=0.311  Sum_probs=74.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------------------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------------------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------------------   61 (453)
                      +|+.|+|++|+|+. +| .++.+++|+.|+|++|++++ +|..+.++++|+.|++++|.+.                   
T Consensus        56 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~  132 (266)
T d1p9ag_          56 RLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK  132 (266)
T ss_dssp             TCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred             cccccccccccccc-cc-cccccccccccccccccccc-cccccccccccccccccccccceeecccccccccccccccc
Confidence            36677777777763 43 34667777777777777765 4556666777777776666542                   


Q ss_pred             --------------CCCCcEEEcccccccccCchhhhcCCCCCEEECccCcccccccCCC-cceeeccccccCCCC
Q 036792           62 --------------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRGG-PFVNFTAMSFKGNEP  122 (453)
Q Consensus        62 --------------~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~~-~~~~~~~~~~~gn~~  122 (453)
                                    ++.|+.+++++|++++..|..+..+++|+.|++++|.|+ .+|.+. ....+....+.||+.
T Consensus       133 ~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence                          356777777777777666666777777777777777776 565431 122333344455543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=1.9e-11  Score=103.05  Aligned_cols=96  Identities=22%  Similarity=0.215  Sum_probs=81.7

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      |+.|||++|+++. +|.-+.++++|+.|+||+|.++. ++ .+..+++|+.|++++|.+.         +++|+.|++++
T Consensus        20 lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~   96 (162)
T d1a9na_          20 DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN   96 (162)
T ss_dssp             CEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred             CcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence            6789999999985 67666789999999999999995 54 5889999999999999984         67999999999


Q ss_pred             ccccccCc--hhhhcCCCCCEEECccCcccc
Q 036792           73 NEIYGLIP--TSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        73 n~~~g~~P--~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      |+++. ++  ..+..+++|+.+++++|.++.
T Consensus        97 N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          97 NSLVE-LGDLDPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             CCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             ccccc-cccccccccccccchhhcCCCcccc
Confidence            99984 34  467888999999999998754

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=2.7e-11  Score=111.92  Aligned_cols=121  Identities=21%  Similarity=0.198  Sum_probs=92.1

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.|++++|.+.+..+..+..+.+|+.+++++|+|++..+..|..+++|+.|++++|++.         +++|+.++++
T Consensus       106 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~  185 (284)
T d1ozna_         106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (284)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence            4778888888888777777888888888888888888755567788888888888888874         6788888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccccCC-CcceeeccccccCCC
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEILRG-GPFVNFTAMSFKGNE  121 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p~~-~~~~~~~~~~~~gn~  121 (453)
                      +|++++..|.+|..+++|+.|++++|.+.+..+.. +...++....+.+|+
T Consensus       186 ~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~  236 (284)
T d1ozna_         186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP  236 (284)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSC
T ss_pred             hccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCC
Confidence            88888888888888888888888888887755432 122233334445554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=2.9e-11  Score=111.66  Aligned_cols=96  Identities=24%  Similarity=0.240  Sum_probs=53.3

Q ss_pred             CCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcccccccccC
Q 036792            9 SNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNNEIYGLI   79 (453)
Q Consensus         9 ~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n~~~g~~   79 (453)
                      .|.+....|..+.++++|+.|+|++|.+.+..+..++.+++|+.+++++|.++         ++.|+.|++++|++++..
T Consensus        90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~  169 (284)
T d1ozna_          90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (284)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence            34444444445555666666666666655544445555555666666666552         345556666666665555


Q ss_pred             chhhhcCCCCCEEECccCccccccc
Q 036792           80 PTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        80 P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      |..+..+++|+.+++++|.+.+-.|
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~  194 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHP  194 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             hhhhccccccchhhhhhccccccCh
Confidence            5555555666666666665555433

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.17  E-value=8.9e-12  Score=116.88  Aligned_cols=99  Identities=32%  Similarity=0.387  Sum_probs=88.2

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSN   72 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~   72 (453)
                      +..++++.|.+.|.+|..++.+++++.+++++|+++|.+| .++.+++|+.|+|++|+++         +++|+.|||++
T Consensus       199 ~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~  277 (313)
T d1ogqa_         199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF  277 (313)
T ss_dssp             CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence            3568888999999999999999999999999999999655 6999999999999999984         68899999999


Q ss_pred             ccccccCchhhhcCCCCCEEECccCc-cccc
Q 036792           73 NEIYGLIPTSLEKLLYLKELSLSFNK-LEGE  102 (453)
Q Consensus        73 n~~~g~~P~~~~~~~~l~~l~ls~n~-l~g~  102 (453)
                      |+++|.+|. ++++++|+.+++++|+ +.|.
T Consensus       278 N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             SEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred             CcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence            999999994 6889999999999997 5654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.16  E-value=6.3e-11  Score=95.00  Aligned_cols=89  Identities=25%  Similarity=0.333  Sum_probs=75.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      .|+.|++++|.++ .+|+.++.+++|+.|++++|.+++ +| .++++++|+.+++++|++.          +++|+.+++
T Consensus        21 ~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l   97 (124)
T d1dcea3          21 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL   97 (124)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEEC
T ss_pred             CCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEEC
Confidence            4789999999998 588899999999999999999997 66 5999999999999999984          578999999


Q ss_pred             cccccccc---CchhhhcCCCCCEE
Q 036792           71 SNNEIYGL---IPTSLEKLLYLKEL   92 (453)
Q Consensus        71 ~~n~~~g~---~P~~~~~~~~l~~l   92 (453)
                      ++|+++..   ...-+..+++|+.+
T Consensus        98 ~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          98 QGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             TTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCcCCcCccHHHHHHHHCcCcceE
Confidence            99999743   22333446777654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=2e-10  Score=104.95  Aligned_cols=97  Identities=28%  Similarity=0.249  Sum_probs=70.8

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcccc
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLSNN   73 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~~n   73 (453)
                      +.|++++|.+.+..+..+..+.+++.|++++|.+++..|..+..++.|+.+++++|+++         +++|+.|||++|
T Consensus       103 ~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N  182 (266)
T d1p9ag_         103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN  182 (266)
T ss_dssp             CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             ccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccC
Confidence            33344444443333333444455555555555555544445677899999999999984         678999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      +++ .+|.++..+++|+.|++++|++.
T Consensus       183 ~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         183 SLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            999 89999999999999999999875

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.08  E-value=2.8e-10  Score=95.05  Aligned_cols=97  Identities=22%  Similarity=0.191  Sum_probs=82.4

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCc-ccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNN-LSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~-l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      .+.++.+++++. .+|..+..+++|++|+|++|+ ++..-+..|.++++|+.|++++|+++         +++|+.|+|+
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            356888998888 578889999999999998775 88755567999999999999999984         7799999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      +|+++ .+|..+....+|+.|++++|++.
T Consensus        89 ~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          89 FNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             SSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             CCCCc-ccChhhhccccccccccCCCccc
Confidence            99999 56666666668999999999884

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.01  E-value=5.8e-10  Score=97.97  Aligned_cols=95  Identities=31%  Similarity=0.415  Sum_probs=64.6

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|.+++ ++ .+++|++|+.|++++|++++ +| .+.++++|+.|++++|.+.       ++.++.++++.|
T Consensus        69 ~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~n  144 (210)
T d1h6ta2          69 NVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN  144 (210)
T ss_dssp             TCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCSS
T ss_pred             CCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccccccccccccccccccccccccccc
Confidence            36677777777765 33 25667777777777777765 44 4666777777777777653       456677777777


Q ss_pred             cccccCchhhhcCCCCCEEECccCcccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      .+++  +..+..+++|+.+++++|.+++
T Consensus       145 ~l~~--~~~~~~l~~L~~l~l~~n~l~~  170 (210)
T d1h6ta2         145 KITD--ITVLSRLTKLDTLSLEDNQISD  170 (210)
T ss_dssp             CCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred             cccc--cccccccccccccccccccccc
Confidence            7664  3356677888888888888875

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.98  E-value=4.1e-10  Score=94.63  Aligned_cols=92  Identities=21%  Similarity=0.199  Sum_probs=77.7

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      .|+.||||+|+++. + +.+.++++|+.|+|++|.++...+..+.++++|+.|++++|++.          +++|+.+++
T Consensus        42 ~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l  119 (162)
T d1a9na_          42 QFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI  119 (162)
T ss_dssp             CCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEEC
T ss_pred             cCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhc
Confidence            47899999999994 5 45899999999999999999844445678999999999999984          689999999


Q ss_pred             ccccccccCc----hhhhcCCCCCEEECc
Q 036792           71 SNNEIYGLIP----TSLEKLLYLKELSLS   95 (453)
Q Consensus        71 ~~n~~~g~~P----~~~~~~~~l~~l~ls   95 (453)
                      ++|.++.. |    ..+..+++|+.||-+
T Consensus       120 ~~N~i~~~-~~~r~~~i~~lp~L~~LD~~  147 (162)
T d1a9na_         120 LRNPVTNK-KHYRLYVIYKVPQVRVLDFQ  147 (162)
T ss_dssp             CSSGGGGS-TTHHHHHHHHCTTCSEETTE
T ss_pred             CCCccccc-cchHHHHHHHCCCcCeeCCC
Confidence            99999853 4    357889999988743

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.96  E-value=1.9e-09  Score=100.09  Aligned_cols=104  Identities=31%  Similarity=0.349  Sum_probs=86.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------------------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------------------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------------------   61 (453)
                      +|+.|+|++|+++...+..|.++++|+.|++++|.++...|..|.+++.|+.|++++|++.                   
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~  111 (305)
T d1xkua_          32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENE  111 (305)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSC
T ss_pred             CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccc
Confidence            4789999999999655557999999999999999999877888999999999999999761                   


Q ss_pred             ----------------------------------------------------------CCCCcEEEcccccccccCchhh
Q 036792           62 ----------------------------------------------------------VASLEILNLSNNEIYGLIPTSL   83 (453)
Q Consensus        62 ----------------------------------------------------------~~~l~~l~l~~n~~~g~~P~~~   83 (453)
                                                                                +++|+.|++++|..++..|..+
T Consensus       112 l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~  191 (305)
T d1xkua_         112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASL  191 (305)
T ss_dssp             CCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGG
T ss_pred             hhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHh
Confidence                                                                      3467777777777777777788


Q ss_pred             hcCCCCCEEECccCccccccc
Q 036792           84 EKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        84 ~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      ..++.++.|++++|.+.+-.+
T Consensus       192 ~~~~~l~~L~~s~n~l~~~~~  212 (305)
T d1xkua_         192 KGLNNLAKLGLSFNSISAVDN  212 (305)
T ss_dssp             TTCTTCCEEECCSSCCCEECT
T ss_pred             hcccccccccccccccccccc
Confidence            888888888888888766444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.95  E-value=1.9e-09  Score=93.71  Aligned_cols=94  Identities=23%  Similarity=0.381  Sum_probs=65.9

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|++++|.+.. + +.+..+++|+.|+|++|++++ +++ ++++++|+.|+++.|.+.       ++.|+.|++++|
T Consensus        41 ~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~~  116 (199)
T d2omxa2          41 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN  116 (199)
T ss_dssp             TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred             CCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-ccc-ccCCccccccccccccccccccccccccccccccccc
Confidence            36678888887774 3 346777888888888888876 443 778888888888887763       566777777777


Q ss_pred             cccccCchhhhcCCCCCEEECccCccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLE  100 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~  100 (453)
                      .....  ..+..+++|+.+++++|.+.
T Consensus       117 ~~~~~--~~~~~l~~L~~L~l~~n~l~  141 (199)
T d2omxa2         117 QITDI--DPLKNLTNLNRLELSSNTIS  141 (199)
T ss_dssp             CCCCC--GGGTTCTTCSEEECCSSCCC
T ss_pred             ccccc--cccchhhhhHHhhhhhhhhc
Confidence            76642  23566777777777777664

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.91  E-value=3.4e-11  Score=105.03  Aligned_cols=97  Identities=25%  Similarity=0.337  Sum_probs=51.5

Q ss_pred             ccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEccccc
Q 036792            2 ILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNNE   74 (453)
Q Consensus         2 l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n~   74 (453)
                      |+.|+|++|+++ .++ .+.+|++|+.|+|++|.++. +|.....+++|+.|++++|.++       +++|+.|++++|+
T Consensus        50 L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l~~~~~l~~L~~L~L~~N~  126 (198)
T d1m9la_          50 CKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNK  126 (198)
T ss_dssp             CCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCHHHHHHHHHSSEEEESEEE
T ss_pred             cceeECcccCCC-Ccc-cccCCccccChhhccccccc-ccccccccccccccccccccccccccccccccccccccccch
Confidence            455555555555 233 35555555666665555553 4544444455555555555553       3455666666665


Q ss_pred             ccccCc-hhhhcCCCCCEEECccCcccc
Q 036792           75 IYGLIP-TSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        75 ~~g~~P-~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ++.... ..+..+++|+.|++++|++..
T Consensus       127 i~~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         127 ITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             CCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             hccccccccccCCCccceeecCCCcccc
Confidence            553211 345555566666666665544

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.86  E-value=3.3e-09  Score=98.44  Aligned_cols=97  Identities=21%  Similarity=0.399  Sum_probs=87.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC---------CCCCcEEEcc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD---------VASLEILNLS   71 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~---------~~~l~~l~l~   71 (453)
                      +|+.+++++|.+. .+|..+  +++|+.|++++|..++..|..+.+++.++.|++++|.+.         +++|+.|+|+
T Consensus       151 ~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~  227 (305)
T d1xkua_         151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN  227 (305)
T ss_dssp             TCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred             ccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence            4778999999998 466554  588999999999999999999999999999999999984         6899999999


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      +|.++ .+|.++..+++|+.|++++|+++.
T Consensus       228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         228 NNKLV-KVPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             SSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             ccccc-ccccccccccCCCEEECCCCccCc
Confidence            99998 679999999999999999999874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.81  E-value=1e-08  Score=88.95  Aligned_cols=96  Identities=28%  Similarity=0.458  Sum_probs=82.5

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|++++|++++..|  ++++++|+.|++++|.+.. +| .+++++.|+.+++++|.+.       +++|+.|++++|
T Consensus        63 nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n  138 (199)
T d2omxa2          63 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN  138 (199)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred             CcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccccccchhhhhHHhhhhhh
Confidence            58899999999997543  8999999999999999885 55 4899999999999999874       789999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      +++. +| .+..+++|+.+++++|.+++-
T Consensus       139 ~l~~-~~-~l~~~~~L~~L~l~~n~l~~l  165 (199)
T d2omxa2         139 TISD-IS-ALSGLTSLQQLNFSSNQVTDL  165 (199)
T ss_dssp             CCCC-CG-GGTTCTTCSEEECCSSCCCCC
T ss_pred             hhcc-cc-cccccccccccccccccccCC
Confidence            9984 44 588899999999999998763

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.80  E-value=6e-09  Score=99.54  Aligned_cols=98  Identities=22%  Similarity=0.392  Sum_probs=82.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|++++|.+++..  .+.++..++.+.++.|.+++ + ..+..+++++.|++++|+++       +++|+.|++++|
T Consensus       264 ~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n  339 (384)
T d2omza2         264 KLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANN  339 (384)
T ss_dssp             TCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSS
T ss_pred             cCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCC
Confidence            4788999999998743  37788889999999999987 3 35788999999999999884       678999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      ++++ +| ++..+++|+.|++++|++++-.|
T Consensus       340 ~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         340 KVSD-VS-SLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             CCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred             CCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence            9985 55 68889999999999999987554

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.74  E-value=2e-08  Score=95.79  Aligned_cols=95  Identities=23%  Similarity=0.408  Sum_probs=71.3

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------------------
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------------------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------------------   61 (453)
                      +|+.|++++|++.. + +.+.++++|+.|++++|.+++. ++ ++.+++|+.+++++|.+.                   
T Consensus       220 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~-~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n  295 (384)
T d2omza2         220 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNL-AP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN  295 (384)
T ss_dssp             TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred             CCCEEECCCCCCCC-c-chhhcccccchhccccCccCCC-Cc-ccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence            36677777777775 2 3566777777777777777763 32 666777777777776652                   


Q ss_pred             ----------CCCCcEEEcccccccccCchhhhcCCCCCEEECccCcccc
Q 036792           62 ----------VASLEILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ----------~~~l~~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                                +++++.|++++|++++. + .+..+++|+.|++++|.+++
T Consensus       296 ~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~  343 (384)
T d2omza2         296 QLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD  343 (384)
T ss_dssp             CCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC
T ss_pred             ccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC
Confidence                      56899999999999975 3 38889999999999999875

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.72  E-value=3.3e-08  Score=86.38  Aligned_cols=96  Identities=27%  Similarity=0.305  Sum_probs=82.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|++++|.+.+..  .+..+++|+.|+|++|.+++ +|+ +++|++|+.|++++|+++       +++|+.|++++|
T Consensus        47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~~l~~l~~l~~L~~L~l~~~  122 (210)
T d1h6ta2          47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN  122 (210)
T ss_dssp             TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTS
T ss_pred             CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-ccc-cccCccccccccccccccccccccccccccccccccc
Confidence            4788999999998643  48899999999999999998 553 789999999999999984       689999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCccccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                      .+.. + ..+..+++++.++++.|.+++.
T Consensus       123 ~~~~-~-~~l~~l~~l~~l~~~~n~l~~~  149 (210)
T d1h6ta2         123 GISD-I-NGLVHLPQLESLYLGNNKITDI  149 (210)
T ss_dssp             CCCC-C-GGGGGCTTCCEEECCSSCCCCC
T ss_pred             cccc-c-cccccccccccccccccccccc
Confidence            9873 3 4688899999999999998764

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.70  E-value=3.4e-08  Score=87.38  Aligned_cols=56  Identities=18%  Similarity=0.315  Sum_probs=34.8

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcC
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKL   60 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~   60 (453)
                      +|+.|++++|+++. + +.+..|++|+.|+|++|++++..|  +..++.|+.+++++|.+
T Consensus        42 ~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~   97 (227)
T d1h6ua2          42 GITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL   97 (227)
T ss_dssp             TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred             CcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence            35667777777663 4 346677777777777777765322  56666666666665554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=7.3e-08  Score=79.89  Aligned_cols=100  Identities=19%  Similarity=0.251  Sum_probs=79.1

Q ss_pred             CCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCc-CC---------CCCCcEEEcccccccccCchhhhcCCC
Q 036792           19 DIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNK-LD---------VASLEILNLSNNEIYGLIPTSLEKLLY   88 (453)
Q Consensus        19 ~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~-~~---------~~~l~~l~l~~n~~~g~~P~~~~~~~~   88 (453)
                      +...+...+.++.+++++.. +|..+.++++|+.|++++|+ ++         +++|+.|++++|++++..|..|..+++
T Consensus         3 ~~C~c~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~   81 (156)
T d2ifga3           3 DACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR   81 (156)
T ss_dssp             SSSCCSSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC
T ss_pred             CCCCcCCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccc
Confidence            34566677889999999985 88889999999999998775 63         789999999999999888899999999


Q ss_pred             CCEEECccCcccccccCCCcce--eeccccccCCC
Q 036792           89 LKELSLSFNKLEGEILRGGPFV--NFTAMSFKGNE  121 (453)
Q Consensus        89 l~~l~ls~n~l~g~~p~~~~~~--~~~~~~~~gn~  121 (453)
                      |++|++++|.+. .+|.+. +.  .+....+.+|+
T Consensus        82 L~~L~Ls~N~l~-~l~~~~-~~~~~l~~L~L~~Np  114 (156)
T d2ifga3          82 LSRLNLSFNALE-SLSWKT-VQGLSLQELVLSGNP  114 (156)
T ss_dssp             CCEEECCSSCCS-CCCSTT-TCSCCCCEEECCSSC
T ss_pred             ccceeccCCCCc-ccChhh-hccccccccccCCCc
Confidence            999999999997 455432 22  23334445554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.61  E-value=1.3e-07  Score=88.68  Aligned_cols=94  Identities=26%  Similarity=0.302  Sum_probs=78.5

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----CCCCcEEEcccccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----VASLEILNLSNNEI   75 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----~~~l~~l~l~~n~~   75 (453)
                      +|+.|||++|+++ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|.++     .+.|+.|++++|.+
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~~lp~~L~~L~L~~n~l  110 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQL  110 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCCSCCTTCCEEECCSSCC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchhhhhcccccccccccccc
Confidence            4789999999998 58853   578999999999999 688764   57888999999885     35799999999999


Q ss_pred             cccCchhhhcCCCCCEEECccCccccccc
Q 036792           76 YGLIPTSLEKLLYLKELSLSFNKLEGEIL  104 (453)
Q Consensus        76 ~g~~P~~~~~~~~l~~l~ls~n~l~g~~p  104 (453)
                      + .+|. ++.+++|+.+++++|.+.+...
T Consensus       111 ~-~lp~-~~~l~~L~~L~l~~~~~~~~~~  137 (353)
T d1jl5a_         111 E-KLPE-LQNSSFLKIIDVDNNSLKKLPD  137 (353)
T ss_dssp             S-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred             c-cccc-hhhhccceeecccccccccccc
Confidence            8 5674 5789999999999998876443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.55  E-value=8.7e-08  Score=84.62  Aligned_cols=95  Identities=23%  Similarity=0.366  Sum_probs=76.0

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.++++++...+..  .+.....+..+.++++.+....  .+.++++|+.|+++.|.+.       +++|+.|+|++|
T Consensus       108 ~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n  183 (227)
T d1h6ua2         108 SIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN  183 (227)
T ss_dssp             TCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             cccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccchhhcccccceecccCCC
Confidence            4778899998887643  3567788888999888887643  3678888999999998873       688899999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCcccc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ++++ +|. +..+++|+.|++++|++++
T Consensus       184 ~l~~-l~~-l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         184 KISD-ISP-LASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             CCCC-CGG-GGGCTTCCEEECTTSCCCB
T ss_pred             ccCC-Chh-hcCCCCCCEEECcCCcCCC
Confidence            9885 443 7888999999999998875

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.51  E-value=1.1e-07  Score=84.65  Aligned_cols=54  Identities=15%  Similarity=0.226  Sum_probs=36.4

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcc-cccCCCCCCEEe
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPA-TIGGLISLKTLS   54 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~l~~l~   54 (453)
                      +++.|||++|.+....+..|.++++|++|+|++|.+...+|+ .|.+++.++.+.
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~   84 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   84 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence            477888888888854444578888888888888887765543 234444444433

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.50  E-value=2.9e-09  Score=92.45  Aligned_cols=90  Identities=23%  Similarity=0.337  Sum_probs=75.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNL   70 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l   70 (453)
                      +|+.|+|++|+++ .+|..+..+++|+.|++++|.++. ++ .+.++++|+.|++++|+++          +++|+.|++
T Consensus        71 ~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L  147 (198)
T d1m9la_          71 NLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLL  147 (198)
T ss_dssp             TCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEE
T ss_pred             cccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhccccccccccCCCccceeec
Confidence            5899999999998 577666667789999999999996 54 4889999999999999984          789999999


Q ss_pred             ccccccccCchh----------hhcCCCCCEEE
Q 036792           71 SNNEIYGLIPTS----------LEKLLYLKELS   93 (453)
Q Consensus        71 ~~n~~~g~~P~~----------~~~~~~l~~l~   93 (453)
                      ++|.++...+..          +..+++|+.||
T Consensus       148 ~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             CSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             CCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            999987654432          56688888876

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.34  E-value=4.3e-08  Score=95.36  Aligned_cols=101  Identities=26%  Similarity=0.314  Sum_probs=84.3

Q ss_pred             CccEEEcCCCcCcCCC-CcCCCCCcCCCEEECcCCcccc----cCcccccCCCCCCEEeCcCCcCC--------------
Q 036792            1 DILNFDFSSNSLEGPL-SLDIGNLKAVVEINLSRNNLSS----DMPATIGGLISLKTLSLAYNKLD--------------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~-p~~~~~l~~l~~l~ls~N~l~g----~~p~~~~~l~~l~~l~l~~n~~~--------------   61 (453)
                      +|+.||++.|++++.- ..-+..+++++.|+|++|.++-    .|+..+..+++|+.|+|++|.++              
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5899999999999853 3335678899999999999883    45667889999999999999983              


Q ss_pred             CCCCcEEEccccccccc----CchhhhcCCCCCEEECccCcccc
Q 036792           62 VASLEILNLSNNEIYGL----IPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ~~~l~~l~l~~n~~~g~----~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ..+|+.|+|++|+++..    ++..+..+++|+.|++++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            24799999999999754    56677889999999999999864

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.23  E-value=1.5e-06  Score=77.02  Aligned_cols=96  Identities=15%  Similarity=0.252  Sum_probs=80.5

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC----------CCCCcEEEcc-
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD----------VASLEILNLS-   71 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~----------~~~l~~l~l~-   71 (453)
                      ..++.+++.++ .+|+++.  ++++.|+|++|+++..-+..|.++++|+.|++++|.+.          ++.++.+++. 
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            46788888888 7887764  57999999999999744446899999999999999863          5778888875 


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      .|++....|..+..+++|+.+++++|.+..
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~  117 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKH  117 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred             cccccccccccccccccccccccchhhhcc
Confidence            578888888889999999999999999864

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.16  E-value=9.5e-07  Score=80.62  Aligned_cols=56  Identities=18%  Similarity=0.184  Sum_probs=32.2

Q ss_pred             ccEEEcCCCcCcCCC-CcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcC
Q 036792            2 ILNFDFSSNSLEGPL-SLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAY   57 (453)
Q Consensus         2 l~~l~ls~n~l~g~~-p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~   57 (453)
                      |+.|||+++.+.+.. +.-+.++++|++|+|+++.+++..+..++.+++|+.|++++
T Consensus        48 L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          48 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             CCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             CCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            556666666555432 23345556666666666666655555566666666666655

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.10  E-value=9.6e-07  Score=82.84  Aligned_cols=99  Identities=18%  Similarity=0.246  Sum_probs=45.9

Q ss_pred             ccEEEcCCCcCcCC----CCcCCCCCcCCCEEECcCCccccc-----CcccccCCCCCCEEeCcCCcCC-----------
Q 036792            2 ILNFDFSSNSLEGP----LSLDIGNLKAVVEINLSRNNLSSD-----MPATIGGLISLKTLSLAYNKLD-----------   61 (453)
Q Consensus         2 l~~l~ls~n~l~g~----~p~~~~~l~~l~~l~ls~N~l~g~-----~p~~~~~l~~l~~l~l~~n~~~-----------   61 (453)
                      |+.|++++|.+...    +...+.....|+.|+|++|.++..     +...+..++.|+.|+|+.|.+.           
T Consensus       160 L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l  239 (344)
T d2ca6a1         160 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL  239 (344)
T ss_dssp             CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred             cceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc
Confidence            44555555554422    222233444555555555555421     2223444555555555555542           


Q ss_pred             --CCCCcEEEcccccccccCchhh----hc--CCCCCEEECccCccc
Q 036792           62 --VASLEILNLSNNEIYGLIPTSL----EK--LLYLKELSLSFNKLE  100 (453)
Q Consensus        62 --~~~l~~l~l~~n~~~g~~P~~~----~~--~~~l~~l~ls~n~l~  100 (453)
                        .+.|+.|+|++|.+++.-...+    ..  ..+|+.|++++|.+.
T Consensus       240 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~  286 (344)
T d2ca6a1         240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE  286 (344)
T ss_dssp             GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred             cccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence              3455555555555543311222    11  234555555555543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.07  E-value=1.3e-05  Score=71.70  Aligned_cols=146  Identities=12%  Similarity=0.078  Sum_probs=90.7

Q ss_pred             CCccEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCceeEEeEEecCCeeEEEEeccCCCCchHHhhc
Q 036792          207 GSFGSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIR-HPNLVKVISSCSNDDFKALVLEYMPKGSLENCLYS  285 (453)
Q Consensus       207 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~E~~~~g~L~~~l~~  285 (453)
                      ++.+.||+... ++..+.+|+...........+.+|...+..+. +--+.+++.+...++..++|||+++|.++.+....
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            34468998764 46677888876554433445677888877664 33356778888888899999999998777543321


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------------
Q 036792          286 STCMLDIFQRLNIMIDATSTLEYLYFG-----------------------------------------------------  312 (453)
Q Consensus       286 ~~~~l~~~~~~~i~~~i~~~l~~L~~~-----------------------------------------------------  312 (453)
                      ..   ..   ..++.++++.+..||..                                                     
T Consensus       104 ~~---~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (263)
T d1j7la_         104 EQ---SP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             CS---CH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred             cc---cH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence            11   11   11222233333333210                                                     


Q ss_pred             ---CCCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHH
Q 036792          313 ---HTTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMET  364 (453)
Q Consensus       313 ---h~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el  364 (453)
                         ....++|+|+.|.||+++++..+-|.||+.+..+.     -.|-++.+++.+
T Consensus       178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~-----~~~Dla~~~~~~  227 (263)
T d1j7la_         178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD-----KWYDIAFCVRSI  227 (263)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE-----HHHHHHHHHHHH
T ss_pred             CCcCCcEEEEeeccCcceeecCCceEEEeechhcccCC-----HHHHHHHHHHHh
Confidence               11237899999999999987667799998764321     134455555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.91  E-value=1.7e-06  Score=71.84  Aligned_cols=96  Identities=26%  Similarity=0.224  Sum_probs=61.7

Q ss_pred             cEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-----------CCCCcEEEcc
Q 036792            3 LNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-----------VASLEILNLS   71 (453)
Q Consensus         3 ~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-----------~~~l~~l~l~   71 (453)
                      ..||++++...    +.+..+..+..+++++|.. ..++.....++.|+.|+|++|+++           +++|+.|||+
T Consensus        25 ~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls   99 (162)
T d1koha1          25 QALDLKGLRSD----PDLVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS   99 (162)
T ss_dssp             CCBCCCCCSSC----TTTTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCT
T ss_pred             CeeecccCCCC----chhhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccc
Confidence            34666655432    2344555555555554443 335555567888888888888874           5678888888


Q ss_pred             cccccccCchhhhcCCCCCEEECccCcccccc
Q 036792           72 NNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        72 ~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      +|.++..-+.......+|+.+++++|++....
T Consensus       100 ~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~  131 (162)
T d1koha1         100 GNELKSERELDKIKGLKLEELWLDGNSLSDTF  131 (162)
T ss_dssp             TSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred             cCccccchhhhhhhccccceeecCCCCcCcCc
Confidence            88888543334445557888888888887644

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.86  E-value=9.6e-07  Score=73.39  Aligned_cols=40  Identities=43%  Similarity=0.534  Sum_probs=25.0

Q ss_pred             CCCCcEEEccccccccc--CchhhhcCCCCCEEECccCcccc
Q 036792           62 VASLEILNLSNNEIYGL--IPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ~~~l~~l~l~~n~~~g~--~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                      ++.|+.|+|++|+++..  ++..+..+++|+.|++++|.++.
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~  105 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS  105 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc
Confidence            56677777777776642  23445566677777777776643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.82  E-value=4.9e-05  Score=67.32  Aligned_cols=73  Identities=14%  Similarity=0.144  Sum_probs=51.7

Q ss_pred             cCCCCc-cEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCC--CCceeEEeEEecCCeeEEEEeccCCCCc
Q 036792          204 IGMGSF-GSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRH--PNLVKVISSCSNDDFKALVLEYMPKGSL  279 (453)
Q Consensus       204 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~E~~~~g~L  279 (453)
                      +..|.. +.||+....++..+.+|.-.....   ..+..|+..++.+..  -.+.+++++..+++..++||||++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444443 678999887788889998664432   235667777665533  3356778888888889999999987655

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.73  E-value=7.1e-05  Score=69.18  Aligned_cols=86  Identities=23%  Similarity=0.287  Sum_probs=62.2

Q ss_pred             CccEEEcCCCcCcCCCCcCCCCCcCCCEEECcCCcccccCcccccCCCCCCEEeCcCCcCC-------CCCCcEEEcccc
Q 036792            1 DILNFDFSSNSLEGPLSLDIGNLKAVVEINLSRNNLSSDMPATIGGLISLKTLSLAYNKLD-------VASLEILNLSNN   73 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~l~~l~l~~n~~~-------~~~l~~l~l~~n   73 (453)
                      +|+.|+|++|+|+ .+|..+   .+|+.|++++|+++. ++. +  .+.|+.|++++|.+.       ++.|+.|++++|
T Consensus        59 ~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~n~l~~lp~~~~l~~L~~L~l~~~  130 (353)
T d1jl5a_          59 HLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNN  130 (353)
T ss_dssp             TCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS-C--CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSS
T ss_pred             CCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhh-h--ccccccccccccccccccchhhhccceeeccccc
Confidence            4789999999999 788654   568888999999884 543 1  236899999999984       678999999999


Q ss_pred             cccccCchhhhcCCCCCEEECccCc
Q 036792           74 EIYGLIPTSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        74 ~~~g~~P~~~~~~~~l~~l~ls~n~   98 (453)
                      .+++. |..   ...+..+++..+.
T Consensus       131 ~~~~~-~~~---~~~l~~l~~~~~~  151 (353)
T d1jl5a_         131 SLKKL-PDL---PPSLEFIAAGNNQ  151 (353)
T ss_dssp             CCSCC-CCC---CTTCCEEECCSSC
T ss_pred             ccccc-ccc---cccccchhhcccc
Confidence            88754 322   2344445554443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.67  E-value=9.5e-06  Score=78.15  Aligned_cols=102  Identities=17%  Similarity=0.164  Sum_probs=74.3

Q ss_pred             CccEEEcCCCcCcCCCCcCC-----CCCcCCCEEECcCCcccccCccc----ccCCCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSNSLEGPLSLDI-----GNLKAVVEINLSRNNLSSDMPAT----IGGLISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~~p~~~-----~~l~~l~~l~ls~N~l~g~~p~~----~~~l~~l~~l~l~~n~~~----------   61 (453)
                      ++..+++++|.+++.-...+     .....|+.+++++|.++..-...    +..+++|+.|+|++|.++          
T Consensus       284 ~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~  363 (460)
T d1z7xw1         284 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG  363 (460)
T ss_dssp             TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhh
Confidence            36788999998875322221     23457899999999988653333    345678999999999873          


Q ss_pred             ----CCCCcEEEcccccccc----cCchhhhcCCCCCEEECccCccccc
Q 036792           62 ----VASLEILNLSNNEIYG----LIPTSLEKLLYLKELSLSFNKLEGE  102 (453)
Q Consensus        62 ----~~~l~~l~l~~n~~~g----~~P~~~~~~~~l~~l~ls~n~l~g~  102 (453)
                          .+.|+.|+|++|.++.    .++..+..+++|+.|++++|+++..
T Consensus       364 l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~  412 (460)
T d1z7xw1         364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  412 (460)
T ss_dssp             HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             hhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence                3468999999999874    3556677788999999999998653

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.64  E-value=1.4e-05  Score=74.65  Aligned_cols=101  Identities=22%  Similarity=0.273  Sum_probs=60.3

Q ss_pred             CccEEEcCCCcCcCC----C---------CcCCCCCcCCCEEECcCCccccc----CcccccCCCCCCEEeCcCCcCC--
Q 036792            1 DILNFDFSSNSLEGP----L---------SLDIGNLKAVVEINLSRNNLSSD----MPATIGGLISLKTLSLAYNKLD--   61 (453)
Q Consensus         1 ~l~~l~ls~n~l~g~----~---------p~~~~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~l~~l~l~~n~~~--   61 (453)
                      +|+.|++++|.+...    +         .........|+.|.+++|+++..    +...+..++.|+.++|+.|.++  
T Consensus       122 ~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~  201 (344)
T d2ca6a1         122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE  201 (344)
T ss_dssp             TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred             cchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccccc
Confidence            366777777765321    1         11113445677777777776532    3334455667777777777763  


Q ss_pred             ------------CCCCcEEEccccccccc----CchhhhcCCCCCEEECccCcccc
Q 036792           62 ------------VASLEILNLSNNEIYGL----IPTSLEKLLYLKELSLSFNKLEG  101 (453)
Q Consensus        62 ------------~~~l~~l~l~~n~~~g~----~P~~~~~~~~l~~l~ls~n~l~g  101 (453)
                                  .+.|+.|+|++|.++..    +...+..+++|+.|++++|.+++
T Consensus       202 g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             ccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence                        45677777777776532    33445566677777777777654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.57  E-value=0.00015  Score=68.74  Aligned_cols=76  Identities=13%  Similarity=0.158  Sum_probs=47.6

Q ss_pred             cccCCCCccEEEEEEEC-CCCEEEEEEeecc-------chhhHHHHHHHHHHHHcCC-C--CCceeEEeEEecCCeeEEE
Q 036792          202 NLIGMGSFGSVYRARLR-DGIEVAVKVFHQE-------CARALKSFEAQCEVMKSIR-H--PNLVKVISSCSNDDFKALV  270 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lv  270 (453)
                      +.||.|....||+.... +++.|+||.-...       ......+...|.+.|+.+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            45899999999999865 4678999975421       1112234456777776552 2  345556554  34456799


Q ss_pred             EeccCCCCc
Q 036792          271 LEYMPKGSL  279 (453)
Q Consensus       271 ~E~~~~g~L  279 (453)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999976543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.44  E-value=6.7e-05  Score=62.13  Aligned_cols=76  Identities=17%  Similarity=0.179  Sum_probs=36.7

Q ss_pred             CcCCCEEECcCC-ccccc----CcccccCCCCCCEEeCcCCcCC-------------CCCCcEEEcccccccccC----c
Q 036792           23 LKAVVEINLSRN-NLSSD----MPATIGGLISLKTLSLAYNKLD-------------VASLEILNLSNNEIYGLI----P   80 (453)
Q Consensus        23 l~~l~~l~ls~N-~l~g~----~p~~~~~l~~l~~l~l~~n~~~-------------~~~l~~l~l~~n~~~g~~----P   80 (453)
                      .++|++|+|+++ .++..    +-..+...+.|+.|+|++|.+.             .+.|+.|+|++|.++..-    -
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            345555555542 33321    1123444555555666555553             345666666666655321    1


Q ss_pred             hhhhcCCCCCEEECccCc
Q 036792           81 TSLEKLLYLKELSLSFNK   98 (453)
Q Consensus        81 ~~~~~~~~l~~l~ls~n~   98 (453)
                      ..+...++|+.|++++|.
T Consensus        94 ~aL~~n~sL~~L~l~~n~  111 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQR  111 (167)
T ss_dssp             HHTTTTCCCSEEECCCCS
T ss_pred             HHHHhCCcCCEEECCCCc
Confidence            123334456666666554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.05  E-value=0.00019  Score=64.84  Aligned_cols=100  Identities=21%  Similarity=0.201  Sum_probs=70.4

Q ss_pred             CccEEEcCCC--cCcCC-CCcCCCCCcCCCEEECcCC-cccccCcccccCCCCCCEEeCcCC-cCC---------CCCCc
Q 036792            1 DILNFDFSSN--SLEGP-LSLDIGNLKAVVEINLSRN-NLSSDMPATIGGLISLKTLSLAYN-KLD---------VASLE   66 (453)
Q Consensus         1 ~l~~l~ls~n--~l~g~-~p~~~~~l~~l~~l~ls~N-~l~g~~p~~~~~l~~l~~l~l~~n-~~~---------~~~l~   66 (453)
                      +|+.|++++.  .++.. +..-+.++++|++|+|++| .+++..+..++++++|+.|+++++ .++         +++|+
T Consensus       149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~  228 (284)
T d2astb2         149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK  228 (284)
T ss_dssp             TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCC
Confidence            4788888864  34432 3333457889999999885 588888888999999999999985 453         68899


Q ss_pred             EEEcccccccccCchhhhcCCCCCEEECccCcccccc
Q 036792           67 ILNLSNNEIYGLIPTSLEKLLYLKELSLSFNKLEGEI  103 (453)
Q Consensus        67 ~l~l~~n~~~g~~P~~~~~~~~l~~l~ls~n~l~g~~  103 (453)
                      .|+++++--.+.++.-...+++|+   +..++++...
T Consensus       229 ~L~l~~~~~d~~l~~l~~~lp~L~---i~~~~ls~~~  262 (284)
T d2astb2         229 TLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIA  262 (284)
T ss_dssp             EEECTTSSCTTCHHHHHHHSTTSE---ESCCCSCCTT
T ss_pred             EEeeeCCCCHHHHHHHHHhCcccc---ccCccCCCCC
Confidence            999988743344444444566654   5667776543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.82  E-value=0.00081  Score=55.25  Aligned_cols=99  Identities=19%  Similarity=0.217  Sum_probs=71.8

Q ss_pred             CccEEEcCCC-cCcCC----CCcCCCCCcCCCEEECcCCccccc----CcccccCCCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSSN-SLEGP----LSLDIGNLKAVVEINLSRNNLSSD----MPATIGGLISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~n-~l~g~----~p~~~~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~l~~l~l~~n~~~----------   61 (453)
                      +|+.|+|+++ .++..    +-..+...+.|+.|+|++|.+...    +-..+...+.|+.|+|++|.++          
T Consensus        16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~a   95 (167)
T d1pgva_          16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS   95 (167)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred             CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHH
Confidence            4889999974 45543    444566778899999999998743    2234556789999999999985          


Q ss_pred             ---CCCCcEEEccccccccc-------CchhhhcCCCCCEEECccCcc
Q 036792           62 ---VASLEILNLSNNEIYGL-------IPTSLEKLLYLKELSLSFNKL   99 (453)
Q Consensus        62 ---~~~l~~l~l~~n~~~g~-------~P~~~~~~~~l~~l~ls~n~l   99 (453)
                         -++|+.|++++|.....       +...+...++|+.|+++++..
T Consensus        96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence               46799999998875421       344555577888888876653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.80  E-value=0.0017  Score=61.24  Aligned_cols=72  Identities=19%  Similarity=0.272  Sum_probs=46.4

Q ss_pred             cccCCCCccEEEEEEECCC--------CEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-eeEEeEEecCCeeEEEEe
Q 036792          202 NLIGMGSFGSVYRARLRDG--------IEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL-VKVISSCSNDDFKALVLE  272 (453)
Q Consensus       202 ~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~E  272 (453)
                      +.|+.|-.-.+|+....++        ..|.+++.. .... .....+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4578888889999986532        456666654 2222 2344578888877743344 467777643    58999


Q ss_pred             ccCCCCc
Q 036792          273 YMPKGSL  279 (453)
Q Consensus       273 ~~~~g~L  279 (453)
                      |++|..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.56  E-value=0.00046  Score=56.69  Aligned_cols=32  Identities=22%  Similarity=0.199  Sum_probs=16.5

Q ss_pred             cCCCCCCEEeCcCCcCC-------------CCCCcEEEccccccc
Q 036792           45 GGLISLKTLSLAYNKLD-------------VASLEILNLSNNEIY   76 (453)
Q Consensus        45 ~~l~~l~~l~l~~n~~~-------------~~~l~~l~l~~n~~~   76 (453)
                      ...+.|+.|++++|.++             .+.++.+++++|.++
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            34555555555555552             345555555555543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.76  E-value=0.013  Score=53.20  Aligned_cols=68  Identities=12%  Similarity=0.133  Sum_probs=44.6

Q ss_pred             cEEEEEEECCCCEEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc--eeEE-----eEEecCCeeEEEEeccCCCC
Q 036792          210 GSVYRARLRDGIEVAVKVFHQECARALKSFEAQCEVMKSIRHPNL--VKVI-----SSCSNDDFKALVLEYMPKGS  278 (453)
Q Consensus       210 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lv~E~~~~g~  278 (453)
                      -.||+...++|..|++|+.+.... ..+++..|...|..+....+  +..+     ..+..++..+.+++|++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            579999999999999999765422 33567778887776642222  1111     12234667788999997643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=94.38  E-value=0.031  Score=45.08  Aligned_cols=99  Identities=16%  Similarity=0.184  Sum_probs=59.0

Q ss_pred             CccEEEcCC-CcCcCC----CCcCCCCCcCCCEEECcCCccccc----CcccccCCCCCCEEeCcCCcCC----------
Q 036792            1 DILNFDFSS-NSLEGP----LSLDIGNLKAVVEINLSRNNLSSD----MPATIGGLISLKTLSLAYNKLD----------   61 (453)
Q Consensus         1 ~l~~l~ls~-n~l~g~----~p~~~~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~l~~l~l~~n~~~----------   61 (453)
                      +|+.|+|++ |.++..    +-..+...++|+.|+|++|.++..    +-..+...++++.++++.|.+.          
T Consensus        18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~   97 (166)
T d1io0a_          18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEA   97 (166)
T ss_dssp             TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHG
T ss_pred             CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHH
Confidence            366777776 445433    334445667777788887777643    2223455677777888777763          


Q ss_pred             ---CCCCcEEEc--ccccccc----cCchhhhcCCCCCEEECccCcc
Q 036792           62 ---VASLEILNL--SNNEIYG----LIPTSLEKLLYLKELSLSFNKL   99 (453)
Q Consensus        62 ---~~~l~~l~l--~~n~~~g----~~P~~~~~~~~l~~l~ls~n~l   99 (453)
                         .++|+.++|  ++|.+.-    .+-..+...++|+.|+++.|..
T Consensus        98 l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          98 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence               356665444  4555532    2344555666777777766543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.21  E-value=0.26  Score=43.67  Aligned_cols=48  Identities=25%  Similarity=0.268  Sum_probs=36.9

Q ss_pred             CCCceecCCCCCceeeCCCCcEEEeccccCCCCCcCcccchHHHHHHHHHHHh
Q 036792          314 TTPIIHCDLKPISVLLDEDMVAHLSDFEYGMEGQVSTRSDIYGYGIVLMETFT  366 (453)
Q Consensus       314 ~~~i~Hrdlk~~NiLl~~~~~~kl~df~~~~~~~~~~~~Dv~S~Gvvl~el~t  366 (453)
                      ..+++|+|+.+.||+++.+...-+.||+.+..+     .=+|=+++.+..++.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~-----~~~~DLAi~~~~~~~  229 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACND-----LLAYDVSICLNAWCF  229 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEEE-----EHHHHHHHHHHHHSB
T ss_pred             ccccccCCcchhhhhcccccceeEecccccccc-----hhhhhHHHHHHHHhh
Confidence            457899999999999999877789999876322     235667887777654